data_1uvg_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1uvg _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 63.4 mmm . . . . . 0 N--CA 1.489 1.48 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 5.6 m -81.61 -13.92 57.38 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.328 -0.858 . . . . 0.0 109.251 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 40.5 mttm -54.78 -30.37 56.68 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.294 -0.879 . . . . 0.0 109.84 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -150.56 63.69 0.94 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.169 -0.957 . . . . 0.0 109.839 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.406 ' CE2' ' CE2' ' A' ' 16' ' ' TYR . 9.0 p90 -116.04 175.47 5.53 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.158 -0.963 . . . . 0.0 109.332 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 70.9 mtt180 -148.68 140.07 23.37 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.214 -0.929 . . . . 0.0 109.53 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.493 HG22 ' CD2' ' A' ' 44' ' ' LEU . 92.3 t -133.01 139.8 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.365 -0.834 . . . . 0.0 109.349 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.464 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.4 OUTLIER -128.13 172.0 7.59 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.26 -0.9 . . . . 0.0 109.262 179.991 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.464 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 45.1 Cg_endo -67.32 -24.78 43.07 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 122.549 2.166 . . . . 0.0 111.439 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 55.6 mtt180 -106.89 -27.69 10.55 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.359 -0.838 . . . . 0.0 109.123 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.421 ' HB ' ' HB2' ' A' ' 11' ' ' LEU . 98.1 mt -85.66 -41.92 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.357 -0.839 . . . . 0.0 109.349 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 71.49 -140.35 30.5 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.455 ' OH ' ' SG ' ' A' ' 40' ' ' CYS . 3.1 t80 -110.52 151.34 27.69 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.125 -1.221 . . . . 0.0 109.486 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.443 ' O ' ' SG ' ' A' ' 37' ' ' CYS . 52.2 mt -111.21 131.24 55.27 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.291 -0.881 . . . . 0.0 109.349 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.408 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 84.6 m -139.64 156.95 70.97 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.207 -0.933 . . . . 0.0 109.596 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.469 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 47.9 Cg_endo -69.81 166.38 27.86 Favored 'Trans proline' 0 C--O 1.215 -0.634 0 C-N-CA 122.666 2.244 . . . . 0.0 111.661 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 52.7 tttp -87.17 -17.62 32.27 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.307 -0.87 . . . . 0.0 109.359 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -66.98 121.73 16.18 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.254 -0.904 . . . . 0.0 109.379 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.479 ' CD1' ' C ' ' A' ' 22' ' ' LEU . 3.5 tm? -85.66 125.29 33.05 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.266 -0.896 . . . . 0.0 109.465 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.46 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 8.8 mtpt -147.49 113.03 4.04 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.254 -0.904 . . . . 0.0 109.739 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.542 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 43.5 Cg_endo -66.14 123.5 11.32 Favored 'Trans proline' 0 C--O 1.214 -0.711 0 C-N-CA 122.973 2.448 . . . . 0.0 111.74 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 29.8 m -118.54 154.13 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.246 -0.909 . . . . 0.0 109.86 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 45.5 t -97.09 142.16 29.36 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 178.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -99.5 139.28 14.35 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 -179.287 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.479 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 54.9 p30 -64.58 -10.85 29.1 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.357 -1.084 . . . . 0.0 109.52 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.461 ' OD2' ' OG1' ' A' ' 50' ' ' THR . 70.5 m-20 -91.09 12.65 19.23 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.272 -0.893 . . . . 0.0 109.501 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 81.59 15.4 76.0 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.526 ' O ' ' N ' ' A' ' 27' ' ' GLY . 55.6 mt-30 -117.75 155.51 29.87 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.207 -1.173 . . . . 0.0 109.4 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.44 HG22 ' HA ' ' A' ' 57' ' ' LYS . 23.6 m -118.0 146.74 43.81 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.148 -0.97 . . . . 0.0 109.427 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.58 ' CD2' ' CD1' ' A' ' 39' ' ' LEU . 78.5 m-85 -124.01 128.01 48.74 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.253 -0.904 . . . . 0.0 109.478 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.499 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 56.7 t-20 -47.84 -79.95 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.277 -0.89 . . . . 0.0 109.604 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.517 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 3.9 t-20 -81.09 148.63 64.5 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 120.977 -1.077 . . . . 0.0 109.104 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.465 ' HD2' ' CG ' ' A' ' 35' ' ' ASN . 39.3 Cg_endo -62.09 -52.66 2.58 Favored 'Trans proline' 0 C--O 1.215 -0.644 0 C-N-CA 122.62 2.213 . . . . 0.0 111.958 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.517 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 4.8 t -60.34 -30.48 69.56 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 120.977 -1.077 . . . . 0.0 108.256 179.005 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.461 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 24.1 mtp -61.64 -18.29 58.86 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.492 -0.755 . . . . 0.0 109.175 179.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.58 ' CD1' ' CD2' ' A' ' 33' ' ' TYR . 6.7 tt -69.21 -52.74 24.75 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.245 -0.909 . . . . 0.0 108.919 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.502 ' O ' ' HB2' ' A' ' 43' ' ' ASN . 4.9 t -49.48 -32.78 12.79 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 179.053 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.466 ' O ' HG12 ' A' ' 45' ' ' ILE . 27.6 t60 -53.96 -48.08 70.66 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 179.122 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.575 ' HB2' ' CE1' ' A' ' 33' ' ' TYR . 24.5 tp10 -61.28 -16.84 49.76 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.265 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.519 ' OD1' ' N ' ' A' ' 50' ' ' THR . 2.8 m-80 -80.33 -32.8 37.84 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.379 -0.825 . . . . 0.0 109.271 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.504 ' N ' HD13 ' A' ' 44' ' ' LEU . 7.9 mp -75.69 -31.68 59.81 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.33 -0.856 . . . . 0.0 109.596 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.466 HG12 ' O ' ' A' ' 41' ' ' HIS . 8.9 mm -78.77 -51.32 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.229 -0.919 . . . . 0.0 109.531 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.454 ' HG2' ' NH1' ' A' ' 46' ' ' ARG . 15.2 mtt-85 -81.77 -30.78 32.19 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.301 -0.874 . . . . 0.0 109.729 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.438 ' HA ' ' O ' ' A' ' 43' ' ' ASN . 14.6 mt-30 61.62 34.67 17.56 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.265 -0.897 . . . . 0.0 109.474 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.465 ' O ' ' HB2' ' A' ' 49' ' ' ASN . 52.7 p -106.03 2.86 27.65 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.207 -0.933 . . . . 0.0 109.667 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.465 ' HB2' ' O ' ' A' ' 48' ' ' THR . 22.3 m120 64.88 49.82 2.08 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.196 -0.94 . . . . 0.0 109.572 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.519 ' N ' ' OD1' ' A' ' 43' ' ' ASN . 88.4 m -77.77 128.77 34.55 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.264 -0.897 . . . . 0.0 109.465 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 7.3 m-70 -110.72 -173.35 2.22 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.28 -0.888 . . . . 0.0 109.257 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.437 HG22 HD12 ' A' ' 52' ' ' ILE . 22.1 mt -88.31 126.53 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.296 -0.877 . . . . 0.0 109.446 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.479 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 31.6 ttt180 -80.42 -40.93 25.45 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.363 -0.836 . . . . 0.0 109.274 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -160.53 151.71 19.12 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.497 -0.752 . . . . 0.0 109.09 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.2 p -67.46 148.42 51.57 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.121 -0.987 . . . . 0.0 109.422 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.542 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 84.6 165.7 40.06 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.457 ' HG2' ' N ' ' A' ' 58' ' ' CYS . 23.2 tttp -57.03 151.54 14.84 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.333 -1.098 . . . . 0.0 109.253 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.457 ' N ' ' HG2' ' A' ' 57' ' ' LYS . 96.6 m . . . . . 0 N--CA 1.489 1.52 0 O-C-N 121.202 -0.936 . . . . 0.0 109.33 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 74.8 mtm . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.582 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 3.9 m -92.91 -8.27 43.75 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.237 -0.914 . . . . 0.0 109.629 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.4 mttt -60.64 -24.65 65.7 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.281 -0.887 . . . . 0.0 109.745 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 59.5 t0 -153.56 63.06 0.74 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.135 -0.978 . . . . 0.0 109.912 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.582 ' CD1' ' HA ' ' A' ' 5' ' ' CYS . 9.2 p90 -122.0 178.59 4.83 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.082 -1.011 . . . . 0.0 109.501 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 37.5 mtm180 -150.1 144.42 25.72 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.276 -0.89 . . . . 0.0 109.295 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.508 ' CG1' ' O ' ' A' ' 15' ' ' GLY . 84.1 t -138.94 132.02 38.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.144 -0.972 . . . . 0.0 109.765 -179.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.534 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 2.3 mp -123.39 176.35 2.23 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.402 -0.811 . . . . 0.0 109.11 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.534 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 43.4 Cg_endo -65.57 -24.44 55.94 Favored 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 122.533 2.155 . . . . 0.0 111.733 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 10.5 mtm180 -108.26 -35.3 6.58 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.258 -0.901 . . . . 0.0 109.032 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.474 HD11 HG22 ' A' ' 14' ' ' ILE . 86.8 mt -76.55 -35.56 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.372 -0.83 . . . . 0.0 109.194 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.508 ' O ' ' CG1' ' A' ' 10' ' ' VAL . . . 61.38 -134.56 48.05 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.154 -1.578 . . . . 0.0 109.154 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.495 ' CE2' ' CE2' ' A' ' 8' ' ' TYR . 3.4 t80 -113.65 155.6 25.21 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.149 -1.207 . . . . 0.0 109.547 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.417 ' N ' ' CD1' ' A' ' 16' ' ' TYR . 18.3 tp -112.95 123.29 49.98 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.345 -0.847 . . . . 0.0 109.726 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.417 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 67.0 m -138.33 156.64 73.48 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.354 -0.842 . . . . 0.0 109.011 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.405 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 48.7 Cg_endo -70.89 165.95 30.59 Favored 'Trans proline' 0 C--O 1.214 -0.687 0 C-N-CA 122.491 2.127 . . . . 0.0 111.573 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 40.1 mttp -85.51 -17.83 35.26 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.232 -0.918 . . . . 0.0 109.41 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 -71.2 130.86 42.53 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.33 -0.856 . . . . 0.0 109.23 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.459 ' CD1' ' C ' ' A' ' 22' ' ' LEU . 3.4 tm? -95.05 112.65 24.33 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.147 -0.97 . . . . 0.0 109.588 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.492 ' O ' ' O ' ' A' ' 34' ' ' ASN . 0.2 OUTLIER -121.72 104.92 38.81 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.322 -0.861 . . . . 0.0 109.202 179.75 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.534 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 41.1 Cg_endo -63.43 117.74 4.68 Favored 'Trans proline' 0 C--O 1.213 -0.752 0 C-N-CA 123.039 2.493 . . . . 0.0 112.03 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 17.8 m -118.44 156.28 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.4 -0.813 . . . . 0.0 109.805 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.509 ' O ' ' N ' ' A' ' 53' ' ' ARG . 27.4 t -99.06 111.99 24.24 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.307 -0.87 . . . . 0.0 109.299 179.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.497 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -66.21 138.62 36.86 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.504 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 50.8 p30 -69.83 -10.03 56.92 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.303 -1.116 . . . . 0.0 109.539 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.413 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 91.0 m-20 -83.56 5.25 24.83 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.243 -0.911 . . . . 0.0 109.336 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.43 13.12 58.9 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.497 ' O ' ' N ' ' A' ' 27' ' ' GLY . 85.5 mt-30 -122.76 147.79 46.1 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.446 -1.032 . . . . 0.0 109.464 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.517 ' CG2' ' HA ' ' A' ' 57' ' ' LYS . 28.9 m -108.82 141.89 40.2 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.211 -0.93 . . . . 0.0 109.357 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.584 ' CD1' ' CD1' ' A' ' 39' ' ' LEU . 10.8 m-85 -121.21 131.11 54.04 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.368 -0.833 . . . . 0.0 109.172 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.492 ' O ' ' O ' ' A' ' 23' ' ' LYS . 1.6 m-20 -53.95 -76.73 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.187 -0.946 . . . . 0.0 109.365 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.538 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 8.0 t-20 -82.17 146.74 55.57 Favored Pre-proline 0 C--N 1.3 -1.572 0 O-C-N 121.06 -1.025 . . . . 0.0 109.554 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.479 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 41.3 Cg_endo -63.46 -52.14 2.13 Favored 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 122.695 2.263 . . . . 0.0 111.858 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.538 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 11.4 t -64.27 -27.46 69.06 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.964 -1.085 . . . . 0.0 108.319 179.104 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.506 ' CG ' ' HB3' ' A' ' 35' ' ' ASN . 31.5 mmm -60.05 -20.66 59.14 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.578 -0.701 . . . . 0.0 109.165 179.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.584 ' CD1' ' CD1' ' A' ' 33' ' ' TYR . 6.3 tp -67.05 -51.81 50.05 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.307 -0.871 . . . . 0.0 108.883 179.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.478 ' HA ' ' HB2' ' A' ' 43' ' ' ASN . 2.0 t -54.59 -23.05 15.21 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.174 -0.954 . . . . 0.0 108.534 179.194 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 27.5 t60 -60.05 -59.3 5.64 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.473 ' OE1' ' CE2' ' A' ' 33' ' ' TYR . 53.2 tt0 -65.12 -21.31 66.78 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.371 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.519 ' O ' ' N ' ' A' ' 47' ' ' GLN . 87.7 m-20 -77.41 -26.8 52.03 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 28.6 tp -69.83 -33.98 73.03 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.373 -0.829 . . . . 0.0 109.219 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 10.7 mm -80.12 -51.41 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.31 -0.869 . . . . 0.0 109.536 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.472 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 94.3 mtt-85 -80.18 -33.55 38.23 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.288 -0.882 . . . . 0.0 109.729 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.519 ' N ' ' O ' ' A' ' 43' ' ' ASN . 89.8 mt-30 63.96 39.89 7.7 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.308 -0.87 . . . . 0.0 109.434 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.47 ' O ' ' HB2' ' A' ' 49' ' ' ASN . 44.2 p -94.52 -6.75 43.04 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.239 -0.913 . . . . 0.0 109.456 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.47 ' HB2' ' O ' ' A' ' 48' ' ' THR . 74.6 m-20 63.03 55.31 1.98 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.289 -0.882 . . . . 0.0 109.476 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.474 HG23 HD12 ' A' ' 39' ' ' LEU . 53.7 m -72.11 138.27 47.62 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.186 -0.946 . . . . 0.0 109.51 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 25.4 m-70 -109.62 177.59 4.69 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.325 -0.86 . . . . 0.0 109.204 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.437 HD12 HG22 ' A' ' 52' ' ' ILE . 17.7 mt -89.67 124.65 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.224 -0.923 . . . . 0.0 109.777 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.509 ' N ' ' O ' ' A' ' 26' ' ' CYS . 41.9 ttt180 -80.54 -56.34 4.24 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 121.722 0.772 . . . . 0.0 109.334 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 60.4 p -149.43 147.49 28.32 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 16.0 p -64.27 148.43 50.21 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.221 -0.925 . . . . 0.0 109.381 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.534 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 82.12 163.55 32.6 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.517 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 34.9 mttt -70.47 129.53 39.48 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.439 -1.036 . . . . 0.0 109.457 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 O-C-N 121.174 -0.954 . . . . 0.0 109.281 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 55.0 mmm . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.568 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 4.3 m -83.24 -0.92 51.68 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.464 -0.772 . . . . 0.0 109.4 179.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.9 mttm -68.53 -21.24 64.58 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.24 -0.913 . . . . 0.0 109.605 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -150.42 59.63 0.95 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.327 -0.858 . . . . 0.0 109.681 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.568 ' CD1' ' HA ' ' A' ' 5' ' ' CYS . 6.4 p90 -124.78 173.29 8.68 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.166 -0.959 . . . . 0.0 109.324 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 20.9 ptt-85 -156.0 143.77 19.58 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.259 -0.901 . . . . 0.0 109.383 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.522 HG23 ' CD2' ' A' ' 16' ' ' TYR . 58.7 t -130.28 137.76 55.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.327 -0.858 . . . . 0.0 109.38 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.52 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 1.4 mp -119.26 174.4 2.81 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.22 -0.925 . . . . 0.0 109.514 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.52 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 46.3 Cg_endo -68.38 -25.02 36.33 Favored 'Trans proline' 0 C--O 1.215 -0.641 0 C-N-CA 122.602 2.201 . . . . 0.0 111.723 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 52.6 mtt180 -108.37 -25.29 11.07 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.332 -0.855 . . . . 0.0 109.318 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 29.3 mm -85.59 -44.5 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.238 -0.914 . . . . 0.0 109.503 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.412 ' C ' HG12 ' A' ' 10' ' ' VAL . . . 69.33 -144.95 41.77 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.522 ' CD2' HG23 ' A' ' 10' ' ' VAL . 1.2 t80 -104.4 155.96 18.33 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.172 -1.193 . . . . 0.0 109.427 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.456 ' CD1' ' C ' ' A' ' 17' ' ' LEU . 1.8 tm? -119.12 113.01 20.26 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.262 -0.899 . . . . 0.0 109.622 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.442 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 61.3 m -127.03 155.84 75.24 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.347 -0.846 . . . . 0.0 109.305 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -70.53 167.67 24.77 Favored 'Trans proline' 0 C--O 1.214 -0.683 0 C-N-CA 122.654 2.236 . . . . 0.0 111.787 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -87.7 -14.56 39.52 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.352 -0.843 . . . . 0.0 109.45 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -72.68 112.88 9.13 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.121 -0.987 . . . . 0.0 109.414 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 56.6 tp -74.53 121.49 21.62 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.11 -0.994 . . . . 0.0 109.449 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.499 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -132.17 100.64 15.42 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.217 -0.927 . . . . 0.0 109.185 179.88 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.532 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 42.6 Cg_endo -64.8 118.74 5.69 Favored 'Trans proline' 0 C--O 1.213 -0.758 0 C-N-CA 122.962 2.441 . . . . 0.0 112.27 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.462 ' O ' HG21 ' A' ' 32' ' ' THR . 5.4 m -117.91 156.39 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.284 -0.885 . . . . 0.0 109.784 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.495 ' O ' ' N ' ' A' ' 53' ' ' ARG . 33.8 t -100.41 108.19 20.13 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.33 -0.856 . . . . 0.0 109.287 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -61.77 139.91 46.89 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 -179.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.487 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 54.9 p30 -70.04 -9.01 53.91 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.347 -1.09 . . . . 0.0 109.613 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.423 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 55.0 p30 -83.2 1.54 40.15 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.24 -0.913 . . . . 0.0 109.463 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.33 18.34 36.51 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.131 -1.588 . . . . 0.0 109.131 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.472 ' O ' ' N ' ' A' ' 27' ' ' GLY . 91.1 mt-30 -124.72 165.53 17.79 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.29 -1.124 . . . . 0.0 109.37 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.491 HG22 ' HA ' ' A' ' 57' ' ' LYS . 93.7 m -120.88 133.84 55.3 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.3 -0.875 . . . . 0.0 109.277 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.565 ' CE2' ' OE1' ' A' ' 42' ' ' GLU . 7.8 m-85 -115.02 118.29 33.01 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.243 -0.911 . . . . 0.0 109.162 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.488 ' O ' ' O ' ' A' ' 23' ' ' LYS . 5.4 m-20 -43.88 -80.84 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.287 -0.883 . . . . 0.0 109.746 -179.35 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.487 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 13.6 t-20 -81.72 145.61 54.63 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 120.957 -1.089 . . . . 0.0 109.621 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.499 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.3 Cg_endo -63.27 -50.44 3.61 Favored 'Trans proline' 0 C--O 1.215 -0.667 0 C-N-CA 122.66 2.24 . . . . 0.0 111.351 179.444 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.487 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 5.3 t -61.62 -27.61 68.78 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 178.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.468 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 17.7 mtp -66.12 -18.68 65.5 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.409 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.553 HD13 ' CE2' ' A' ' 33' ' ' TYR . 30.0 tp -63.86 -52.82 58.28 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.48 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 4.3 t -59.27 -29.51 67.63 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.433 ' CE1' ' HB2' ' A' ' 16' ' ' TYR . 23.2 t60 -64.49 -59.23 4.57 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.565 ' OE1' ' CE2' ' A' ' 33' ' ' TYR . 79.6 mt-10 -58.34 -22.77 54.59 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 179.122 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.492 ' O ' ' N ' ' A' ' 47' ' ' GLN . 94.7 m-20 -73.31 -32.03 64.37 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.503 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.488 ' CD2' ' OH ' ' A' ' 8' ' ' TYR . 55.3 mt -61.38 -31.34 71.24 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 179.197 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.521 HD12 HG22 ' A' ' 45' ' ' ILE . 1.3 mt -80.37 -39.91 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.441 -0.787 . . . . 0.0 109.043 179.438 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.459 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 62.1 mtt85 -79.51 -24.04 42.53 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.36 -0.837 . . . . 0.0 109.112 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.492 ' N ' ' O ' ' A' ' 43' ' ' ASN . 90.3 mt-30 62.59 42.22 8.73 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.362 -0.836 . . . . 0.0 109.484 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 13.6 t -132.83 164.42 26.89 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.243 -0.911 . . . . 0.0 109.335 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.567 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 84.0 m-20 -94.86 61.21 2.53 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.247 -0.908 . . . . 0.0 109.435 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.46 HG23 HD12 ' A' ' 39' ' ' LEU . 86.4 m -66.23 135.63 54.74 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.229 -0.919 . . . . 0.0 109.542 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . 0.567 ' CE1' ' O ' ' A' ' 49' ' ' ASN . 57.5 m80 -110.82 -178.84 3.58 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.286 -0.884 . . . . 0.0 109.249 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.48 HG23 HD11 ' A' ' 52' ' ' ILE . 12.7 mt -89.6 127.13 42.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.1 -1.0 . . . . 0.0 109.742 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.495 ' N ' ' O ' ' A' ' 26' ' ' CYS . 20.2 ttt180 -80.1 -57.04 3.82 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.439 -0.788 . . . . 0.0 109.258 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 30.9 m -152.4 142.92 22.71 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 26.0 p -59.62 146.6 40.39 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.123 -0.986 . . . . 0.0 109.689 -179.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.532 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 86.15 162.21 36.42 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.491 ' HA ' HG22 ' A' ' 32' ' ' THR . 67.6 mttt -71.07 124.77 25.16 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.483 -1.01 . . . . 0.0 109.401 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.526 0 O-C-N 121.227 -0.92 . . . . 0.0 109.626 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 73.8 mtp . . . . . 0 N--CA 1.489 1.493 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.58 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 3.7 m -87.43 -8.39 56.56 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.37 -0.831 . . . . 0.0 109.417 179.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 40.9 mttt -63.47 -20.09 65.29 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.167 -0.958 . . . . 0.0 109.592 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 -149.73 60.65 1.0 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.26 -0.9 . . . . 0.0 109.673 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.618 ' CE2' ' CE2' ' A' ' 16' ' ' TYR . 1.7 p90 -133.07 163.29 29.57 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.201 -0.937 . . . . 0.0 109.48 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 92.3 mtt180 -136.18 144.6 45.06 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.223 -0.923 . . . . 0.0 109.508 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.407 HG22 ' CD2' ' A' ' 16' ' ' TYR . 53.4 t -141.13 136.24 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.244 -0.91 . . . . 0.0 109.473 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.542 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.2 OUTLIER -125.94 175.32 3.25 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.309 -0.869 . . . . 0.0 109.478 -179.936 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.542 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 45.1 Cg_endo -67.29 -25.9 42.17 Favored 'Trans proline' 0 C--O 1.214 -0.714 0 C-N-CA 122.655 2.237 . . . . 0.0 111.913 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 84.3 mtt-85 -104.86 -26.76 12.09 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.339 -0.85 . . . . 0.0 109.279 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 25.5 mm -82.37 -44.69 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.276 -0.89 . . . . 0.0 109.536 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 75.17 -156.43 48.82 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.618 ' CE2' ' CE2' ' A' ' 8' ' ' TYR . 2.8 t80 -101.92 154.62 18.78 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.238 -1.154 . . . . 0.0 109.429 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.409 ' N ' ' CD1' ' A' ' 16' ' ' TYR . 20.7 tp -107.43 104.82 14.48 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.238 -0.914 . . . . 0.0 109.847 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.448 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 58.9 m -125.39 154.88 72.33 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.275 -0.891 . . . . 0.0 109.159 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -71.21 166.96 27.58 Favored 'Trans proline' 0 C--O 1.216 -0.611 0 C-N-CA 122.7 2.266 . . . . 0.0 111.759 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -82.79 -31.87 28.02 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.317 -0.864 . . . . 0.0 109.416 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -56.88 127.29 31.04 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.214 -0.929 . . . . 0.0 109.47 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 60.6 tp -87.74 117.65 26.72 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.217 -0.927 . . . . 0.0 109.281 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.512 ' CB ' ' HD3' ' A' ' 36' ' ' PRO . 19.2 mttt -123.78 99.99 37.96 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.26 -0.9 . . . . 0.0 109.463 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.533 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 42.9 Cg_endo -65.17 116.75 4.03 Favored 'Trans proline' 0 C--O 1.214 -0.712 0 C-N-CA 122.933 2.422 . . . . 0.0 111.901 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.453 ' O ' HG22 ' A' ' 32' ' ' THR . 11.4 m -119.84 156.35 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.254 -0.903 . . . . 0.0 109.976 -179.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.512 ' O ' ' N ' ' A' ' 53' ' ' ARG . 14.2 t -99.94 110.75 23.08 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.341 -0.849 . . . . 0.0 109.203 179.53 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -65.27 139.26 39.7 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.5 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 51.1 p30 -69.01 -10.61 58.42 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.294 -1.121 . . . . 0.0 109.638 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.441 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 89.6 m-20 -81.28 3.75 22.91 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.19 -0.944 . . . . 0.0 109.3 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.65 16.15 52.92 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.201 -1.56 . . . . 0.0 109.201 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.508 ' O ' ' N ' ' A' ' 27' ' ' GLY . 84.8 mt-30 -125.86 153.45 44.13 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.392 -1.064 . . . . 0.0 109.425 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.508 ' CG2' ' HA ' ' A' ' 57' ' ' LYS . 56.6 m -110.06 142.43 41.52 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.29 -0.881 . . . . 0.0 109.32 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.63 ' CD1' ' CD1' ' A' ' 39' ' ' LEU . 28.9 m-85 -121.24 119.23 31.67 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.364 -0.835 . . . . 0.0 109.212 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.495 ' O ' ' O ' ' A' ' 23' ' ' LYS . 8.7 m-20 -43.5 -78.82 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.268 -0.895 . . . . 0.0 109.255 -179.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.473 ' O ' ' HB2' ' A' ' 38' ' ' MET . 15.3 t-20 -82.63 145.88 51.9 Favored Pre-proline 0 C--N 1.301 -1.53 0 O-C-N 120.988 -1.07 . . . . 0.0 109.231 179.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.512 ' HD3' ' CB ' ' A' ' 23' ' ' LYS . 41.2 Cg_endo -63.66 -49.39 4.32 Favored 'Trans proline' 0 C--O 1.215 -0.67 0 C-N-CA 122.425 2.083 . . . . 0.0 111.493 179.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.484 ' SG ' ' CE1' ' A' ' 16' ' ' TYR . 7.6 t -63.02 -27.64 69.55 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.473 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 29.1 mmm -63.56 -14.66 53.54 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.478 -0.764 . . . . 0.0 109.123 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.63 ' CD1' ' CD1' ' A' ' 33' ' ' TYR . 9.3 tp -69.43 -53.32 19.87 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.242 -0.911 . . . . 0.0 108.881 179.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.494 ' HB3' ' CZ ' ' A' ' 16' ' ' TYR . 8.3 t -52.26 -22.18 4.19 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.187 -0.946 . . . . 0.0 108.451 179.242 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 53.0 t60 -59.44 -61.41 2.64 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.576 -0.702 . . . . 0.0 109.258 179.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -67.37 -15.43 63.68 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.19 -0.944 . . . . 0.0 108.895 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.522 ' O ' ' N ' ' A' ' 47' ' ' GLN . 98.1 m-20 -78.27 -24.03 47.0 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.379 -0.826 . . . . 0.0 109.012 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.483 ' CD1' ' C ' ' A' ' 44' ' ' LEU . 3.1 tm? -72.27 -34.67 68.39 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.249 -0.907 . . . . 0.0 108.825 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.452 HD12 HD11 ' A' ' 44' ' ' LEU . 8.4 mm -77.57 -49.86 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.372 -0.83 . . . . 0.0 109.132 179.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.466 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 53.0 mtt-85 -80.0 -37.26 34.59 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.34 -0.85 . . . . 0.0 109.3 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.522 ' N ' ' O ' ' A' ' 43' ' ' ASN . 92.8 mt-30 63.21 37.01 11.53 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.381 -0.824 . . . . 0.0 109.65 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.414 HG21 ' HB3' ' A' ' 46' ' ' ARG . 43.5 p -100.34 8.85 43.41 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.31 -0.869 . . . . 0.0 109.428 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 66.5 m-20 52.77 56.96 6.88 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.26 -0.9 . . . . 0.0 109.52 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.467 HG23 HD12 ' A' ' 39' ' ' LEU . 36.7 m -68.02 135.9 53.01 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.254 -0.904 . . . . 0.0 109.39 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 80.2 m-70 -108.77 178.59 4.43 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.325 -0.859 . . . . 0.0 109.354 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.448 HG22 HD12 ' A' ' 52' ' ' ILE . 21.0 mt -88.78 125.75 41.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.134 -0.979 . . . . 0.0 109.655 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.512 ' N ' ' O ' ' A' ' 26' ' ' CYS . 74.4 ttt-85 -81.69 -57.11 3.59 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.433 -0.792 . . . . 0.0 109.576 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 95.8 p -150.18 139.36 21.21 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -179.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.4 p -55.72 148.88 15.41 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.178 -0.951 . . . . 0.0 109.425 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.533 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 83.61 165.85 39.1 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.508 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 66.2 mttt -74.63 130.97 40.51 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.438 -1.036 . . . . 0.0 109.362 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.514 0 O-C-N 121.088 -1.007 . . . . 0.0 109.361 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 84.5 mtp . . . . . 0 N--CA 1.489 1.491 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.475 ' O ' ' N ' ' A' ' 8' ' ' TYR . 57.8 m -80.05 -14.09 58.8 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.476 -0.765 . . . . 0.0 109.053 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.9 mttm -45.8 -28.2 1.01 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.288 -0.882 . . . . 0.0 109.307 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -109.98 29.87 7.23 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.316 -0.865 . . . . 0.0 108.947 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.675 ' CZ ' ' CE1' ' A' ' 16' ' ' TYR . 2.2 t80 -79.97 159.13 26.39 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.557 -0.714 . . . . 0.0 109.93 -179.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.3 mtt-85 -149.77 113.82 5.13 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.418 -0.801 . . . . 0.0 108.994 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.558 ' CG2' ' CD2' ' A' ' 16' ' ' TYR . 77.9 t -118.6 151.93 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.281 -0.887 . . . . 0.0 109.619 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.535 ' CD2' ' HD2' ' A' ' 12' ' ' PRO . 0.2 OUTLIER -130.03 171.87 8.19 Favored Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 121.303 -0.873 . . . . 0.0 108.991 179.842 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.535 ' HD2' ' CD2' ' A' ' 11' ' ' LEU . 43.5 Cg_endo -66.25 -22.63 53.18 Favored 'Trans proline' 0 C--O 1.214 -0.692 0 C-N-CA 122.541 2.161 . . . . 0.0 111.729 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -108.55 -26.37 10.45 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.248 -0.908 . . . . 0.0 109.58 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 24.0 mm -80.33 -51.49 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.193 -0.942 . . . . 0.0 109.655 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.4 ' C ' HG12 ' A' ' 10' ' ' VAL . . . 84.12 -166.7 42.74 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.675 ' CE1' ' CZ ' ' A' ' 8' ' ' TYR . 1.8 t80 -99.48 148.68 24.0 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.217 -1.166 . . . . 0.0 109.432 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.493 ' CD1' ' C ' ' A' ' 17' ' ' LEU . 2.0 tm? -111.94 120.83 43.25 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.258 -0.902 . . . . 0.0 109.564 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.442 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 82.1 m -134.21 156.72 78.8 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.347 -0.846 . . . . 0.0 109.365 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.49 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 49.5 Cg_endo -70.19 167.07 26.05 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 122.726 2.284 . . . . 0.0 111.738 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 64.3 mttm -92.84 -5.77 50.26 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.252 -0.905 . . . . 0.0 109.482 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -75.98 110.34 10.36 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.145 -0.972 . . . . 0.0 109.324 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.491 ' CD1' ' C ' ' A' ' 22' ' ' LEU . 3.5 tm? -74.21 121.37 21.13 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.348 -0.845 . . . . 0.0 109.466 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.467 ' O ' ' O ' ' A' ' 34' ' ' ASN . 1.7 mtpm? -145.88 111.49 4.48 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.248 -0.908 . . . . 0.0 109.528 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.545 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 44.3 Cg_endo -65.71 124.48 12.83 Favored 'Trans proline' 0 C--O 1.213 -0.756 0 C-N-CA 123.049 2.499 . . . . 0.0 112.295 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.461 ' O ' HG22 ' A' ' 32' ' ' THR . 31.7 m -116.44 153.62 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.249 -0.907 . . . . 0.0 109.489 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.462 ' O ' ' N ' ' A' ' 53' ' ' ARG . 45.2 t -99.59 119.49 38.15 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.307 -0.87 . . . . 0.0 109.068 179.484 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -76.68 139.87 24.31 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.487 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 51.0 p30 -69.8 -11.61 60.99 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.32 -1.106 . . . . 0.0 109.409 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.467 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 70.5 m-20 -82.38 7.83 13.04 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.376 -0.828 . . . . 0.0 109.467 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 88.37 12.62 64.84 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.47 ' O ' ' N ' ' A' ' 27' ' ' GLY . 92.7 mt-30 -118.22 170.54 8.79 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.337 -1.096 . . . . 0.0 109.533 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.473 ' CG2' ' HA ' ' A' ' 57' ' ' LYS . 95.1 m -130.22 134.68 47.44 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.337 -0.852 . . . . 0.0 109.258 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.64 ' CE1' ' CD1' ' A' ' 39' ' ' LEU . 48.3 m-85 -112.68 126.79 55.77 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.168 -0.958 . . . . 0.0 109.346 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.494 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 60.1 t-20 -48.76 -80.23 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.356 -0.84 . . . . 0.0 110.023 -179.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.519 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 2.0 t-20 -80.71 149.59 67.97 Favored Pre-proline 0 C--N 1.301 -1.518 0 O-C-N 120.864 -1.148 . . . . 0.0 109.357 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.451 ' HD2' ' CG ' ' A' ' 35' ' ' ASN . 40.1 Cg_endo -62.86 -54.42 1.19 Allowed 'Trans proline' 0 C--O 1.216 -0.614 0 C-N-CA 122.723 2.282 . . . . 0.0 111.876 -179.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.519 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 8.1 t -62.9 -28.52 70.11 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.062 -1.024 . . . . 0.0 108.475 179.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.515 ' CG ' ' HB3' ' A' ' 35' ' ' ASN . 59.2 mmm -62.31 -14.29 37.65 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.64 ' CD1' ' CE1' ' A' ' 33' ' ' TYR . 25.6 tp -68.49 -51.69 40.51 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.421 -0.799 . . . . 0.0 109.468 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.468 ' HB2' ' OH ' ' A' ' 16' ' ' TYR . 3.1 m -67.97 -17.86 64.56 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 179.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.498 ' CE1' ' HB2' ' A' ' 16' ' ' TYR . 46.7 t60 -73.28 -55.74 6.01 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.1 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.559 ' OE1' ' CE2' ' A' ' 33' ' ' TYR . 87.1 tt0 -63.75 -18.89 64.51 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.247 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.495 ' O ' ' N ' ' A' ' 47' ' ' GLN . 93.4 m-20 -74.77 -36.12 62.56 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.552 HD13 ' CD2' ' A' ' 16' ' ' TYR . 19.3 mt -61.25 -32.44 72.25 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.372 -0.83 . . . . 0.0 108.821 179.199 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.509 HD12 ' N ' ' A' ' 45' ' ' ILE . 3.6 mm -75.58 -42.75 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.41 -0.806 . . . . 0.0 108.913 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.473 ' HG2' ' NH1' ' A' ' 46' ' ' ARG . 29.0 mtp85 -80.05 -17.67 52.12 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.379 -0.826 . . . . 0.0 109.038 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.495 ' N ' ' O ' ' A' ' 43' ' ' ASN . 87.8 mt-30 62.21 42.92 9.0 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.278 -0.889 . . . . 0.0 109.409 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 15.4 p -127.66 164.96 20.91 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.292 -0.88 . . . . 0.0 109.353 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -102.3 63.6 0.89 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.181 -0.949 . . . . 0.0 109.433 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.422 ' OG1' ' OD2' ' A' ' 29' ' ' ASP . 49.8 m -75.03 141.83 43.85 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.302 -0.874 . . . . 0.0 109.567 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -117.87 170.0 9.17 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.311 -0.868 . . . . 0.0 109.049 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.468 HD11 HG22 ' A' ' 52' ' ' ILE . 21.1 mt -79.95 123.37 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.198 -0.939 . . . . 0.0 109.222 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.487 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 49.7 tpt85 -79.62 -49.03 12.76 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.356 -0.84 . . . . 0.0 109.327 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.3 t -156.03 151.73 27.22 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.466 -0.771 . . . . 0.0 109.21 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 38.8 p -65.24 147.7 52.98 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.172 -0.955 . . . . 0.0 109.218 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.545 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 88.82 165.93 41.73 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 108.986 -1.646 . . . . 0.0 108.986 -179.459 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.492 ' CG ' ' HB2' ' A' ' 24' ' ' PRO . 89.7 mttt -64.28 161.26 17.01 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.43 -1.041 . . . . 0.0 109.579 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 86.5 m . . . . . 0 N--CA 1.491 1.624 0 O-C-N 121.229 -0.92 . . . . 0.0 109.366 179.922 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 90.4 mtp . . . . . 0 N--CA 1.489 1.498 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.454 ' O ' ' HB2' ' A' ' 8' ' ' TYR . 4.2 m -79.93 -23.46 41.73 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.357 -0.84 . . . . 0.0 109.136 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 73.0 mttt -48.45 -24.69 1.35 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.251 -0.906 . . . . 0.0 108.873 179.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -110.14 29.76 7.36 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.454 ' HB2' ' O ' ' A' ' 5' ' ' CYS . 1.6 t80 -85.94 153.79 21.94 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.55 -0.719 . . . . 0.0 109.932 -179.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 8.9 mtm180 -147.02 113.82 6.08 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.424 -0.797 . . . . 0.0 109.293 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.436 HG22 ' HA ' ' A' ' 16' ' ' TYR . 4.6 p -130.64 152.26 37.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.328 -0.857 . . . . 0.0 109.12 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.524 ' CG ' ' HD2' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -109.32 171.64 4.28 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.152 -0.968 . . . . 0.0 109.711 -179.676 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.524 ' HD2' ' CG ' ' A' ' 11' ' ' LEU . 47.7 Cg_endo -69.51 -23.32 32.06 Favored 'Trans proline' 0 C--O 1.214 -0.687 0 C-N-CA 122.699 2.266 . . . . 0.0 111.497 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.465 ' O ' ' HG2' ' A' ' 13' ' ' ARG . 23.1 ttt180 -91.82 -16.23 27.08 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.351 -0.843 . . . . 0.0 109.147 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.429 HG22 HD11 ' A' ' 14' ' ' ILE . 26.3 mm -99.8 -41.86 9.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.237 -0.915 . . . . 0.0 109.391 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.403 ' O ' ' C ' ' A' ' 16' ' ' TYR . . . 69.22 139.69 0.1 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.455 ' HB2' ' CE1' ' A' ' 41' ' ' HIS . 0.9 OUTLIER -44.88 154.8 0.12 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.261 -1.141 . . . . 0.0 109.401 179.984 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.559 ' N ' ' CD1' ' A' ' 17' ' ' LEU . 0.3 OUTLIER -118.62 128.07 54.19 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.196 -0.94 . . . . 0.0 109.5 179.957 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.414 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 62.8 m -140.02 156.61 70.33 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.374 -0.828 . . . . 0.0 109.065 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -71.38 167.18 27.02 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.548 2.165 . . . . 0.0 111.492 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 33.3 mttp -86.9 -23.5 25.18 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.182 -0.949 . . . . 0.0 109.586 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -62.14 128.63 37.05 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.119 -0.988 . . . . 0.0 109.257 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 27.8 tp -87.49 117.52 26.34 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.158 -0.963 . . . . 0.0 109.619 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.511 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 0.2 OUTLIER -126.94 100.85 26.95 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.383 -0.823 . . . . 0.0 109.063 179.87 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.529 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 43.4 Cg_endo -65.46 117.93 5.02 Favored 'Trans proline' 0 C--O 1.214 -0.714 0 C-N-CA 123.102 2.535 . . . . 0.0 112.246 -179.363 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.5 m -116.31 154.75 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.359 -0.838 . . . . 0.0 109.568 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 40.3 t -95.97 131.83 41.93 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.368 -0.832 . . . . 0.0 108.803 179.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.477 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -90.49 134.63 12.44 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -179.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.485 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 1.5 m-20 -66.1 -9.02 27.23 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.3 -1.118 . . . . 0.0 109.606 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.424 ' CG ' HG22 ' A' ' 50' ' ' THR . 50.1 p-10 -85.2 13.85 5.87 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.167 -0.958 . . . . 0.0 109.507 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 81.35 22.65 60.16 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.477 ' O ' ' N ' ' A' ' 27' ' ' GLY . 66.7 mt-30 -131.86 174.1 10.5 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.292 -1.122 . . . . 0.0 109.524 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.525 ' CG2' ' HA ' ' A' ' 57' ' ' LYS . 49.5 m -134.52 137.92 44.25 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.348 -0.845 . . . . 0.0 109.192 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.635 ' CE1' ' CD1' ' A' ' 39' ' ' LEU . 55.1 m-85 -112.08 122.5 47.92 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.237 -0.914 . . . . 0.0 109.452 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.494 ' O ' ' O ' ' A' ' 23' ' ' LYS . 7.0 m-20 -46.32 -79.55 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.345 -0.847 . . . . 0.0 109.616 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.539 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 7.6 t-20 -81.94 146.73 56.34 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.034 -1.041 . . . . 0.0 109.358 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.511 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.1 Cg_endo -63.03 -52.96 1.78 Allowed 'Trans proline' 0 C--O 1.216 -0.623 0 C-N-CA 122.824 2.349 . . . . 0.0 111.793 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.539 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 7.8 t -60.67 -26.48 67.12 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 178.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.456 ' HB2' ' HB3' ' A' ' 35' ' ' ASN . 33.6 mmm -70.72 -8.37 51.64 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.175 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.635 ' CD1' ' CE1' ' A' ' 33' ' ' TYR . 21.8 tp -72.89 -56.02 5.78 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.332 -0.855 . . . . 0.0 109.233 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 3.6 m -63.15 -23.25 67.35 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 119.204 -0.998 . . . . 0.0 108.339 179.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.455 ' CE1' ' HB2' ' A' ' 16' ' ' TYR . 49.6 t60 -65.11 -54.66 26.53 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 178.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.415 ' HB2' ' CE2' ' A' ' 33' ' ' TYR . 75.6 mt-10 -66.73 -16.75 64.46 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.111 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.518 ' O ' ' N ' ' A' ' 47' ' ' GLN . 94.3 m-20 -79.16 -26.53 42.73 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.407 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.478 ' CD1' ' C ' ' A' ' 44' ' ' LEU . 2.5 tm? -69.72 -35.07 74.72 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.247 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.479 HD11 HG22 ' A' ' 45' ' ' ILE . 1.8 mt -76.18 -43.48 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.471 -0.768 . . . . 0.0 109.071 179.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.439 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 68.5 mtt85 -79.8 -36.1 37.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.343 -0.848 . . . . 0.0 109.385 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.518 ' N ' ' O ' ' A' ' 43' ' ' ASN . 91.0 mt-30 62.07 40.2 12.28 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.386 -0.821 . . . . 0.0 109.451 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 37.4 p -111.17 15.16 21.68 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.34 -0.85 . . . . 0.0 109.241 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.419 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 70.0 m-20 45.31 58.22 4.3 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.305 -0.872 . . . . 0.0 109.329 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.448 HG21 ' N ' ' A' ' 51' ' ' HIS . 69.9 m -78.15 147.74 34.43 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.269 -0.894 . . . . 0.0 109.557 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . 0.448 ' N ' HG21 ' A' ' 50' ' ' THR . 62.2 m80 -124.63 169.91 11.47 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.258 -0.901 . . . . 0.0 109.209 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.432 HD11 HG22 ' A' ' 52' ' ' ILE . 18.9 mt -79.45 122.31 34.41 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 121.099 -1.001 . . . . 0.0 109.307 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.485 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 59.7 ttt-85 -83.11 -38.62 22.19 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.351 -0.843 . . . . 0.0 109.463 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.4 t -158.37 155.08 28.05 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.373 -0.83 . . . . 0.0 109.2 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.2 p -75.33 132.74 41.18 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.187 -0.945 . . . . 0.0 109.49 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.529 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 98.4 165.15 30.86 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.525 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 13.2 tttp -50.16 150.39 2.44 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.352 -1.087 . . . . 0.0 109.327 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.433 ' SG ' ' O ' ' A' ' 31' ' ' GLN . 43.2 m . . . . . 0 N--CA 1.49 1.542 0 O-C-N 121.279 -0.888 . . . . 0.0 109.396 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' MET . . . . . 0.443 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 74.5 mtp . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.473 ' O ' ' HB2' ' A' ' 8' ' ' TYR . 11.5 m -85.65 -17.85 34.92 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.288 -0.883 . . . . 0.0 109.278 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 27.2 mttt -50.47 -24.34 3.06 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.218 -0.926 . . . . 0.0 108.941 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.443 ' OD1' ' O ' ' A' ' 4' ' ' MET . 55.9 p30 -112.97 32.65 5.55 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 179.227 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.473 ' HB2' ' O ' ' A' ' 5' ' ' CYS . 5.4 t80 -80.13 162.14 24.91 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 121.535 0.683 . . . . 0.0 110.225 -179.228 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 10.9 mtm180 -144.16 116.5 8.52 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.487 ' CG1' ' HA3' ' A' ' 15' ' ' GLY . 53.3 t -112.17 139.11 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.143 -0.973 . . . . 0.0 109.684 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.475 ' HB3' ' HD2' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -119.92 172.7 4.27 Favored Pre-proline 0 N--CA 1.488 1.466 0 O-C-N 121.481 -0.762 . . . . 0.0 109.091 179.866 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.475 ' HD2' ' HB3' ' A' ' 11' ' ' LEU . 44.3 Cg_endo -66.85 -23.05 48.24 Favored 'Trans proline' 0 C--O 1.214 -0.678 0 C-N-CA 122.579 2.186 . . . . 0.0 111.729 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.415 ' O ' ' HG2' ' A' ' 13' ' ' ARG . 61.1 ttt-85 -110.5 -22.98 11.39 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.309 -0.869 . . . . 0.0 109.292 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 82.9 mt -89.43 -41.67 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.381 -0.825 . . . . 0.0 109.474 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.487 ' HA3' ' CG1' ' A' ' 10' ' ' VAL . . . 62.04 -146.67 49.1 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.486 ' OH ' ' CB ' ' A' ' 40' ' ' CYS . 1.4 t80 -100.6 148.46 24.81 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.316 -1.108 . . . . 0.0 109.566 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.462 ' HB2' ' OH ' ' A' ' 8' ' ' TYR . 53.8 mt -118.43 128.88 55.03 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.376 -0.827 . . . . 0.0 109.557 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.448 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 79.1 m -139.0 157.2 71.87 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.312 -0.868 . . . . 0.0 109.254 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.446 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 47.4 Cg_endo -69.49 166.69 26.41 Favored 'Trans proline' 0 C--O 1.214 -0.695 0 C-N-CA 122.592 2.195 . . . . 0.0 111.455 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -87.76 -16.02 35.35 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.207 -0.933 . . . . 0.0 109.502 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -69.91 118.01 12.21 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.199 -0.938 . . . . 0.0 109.074 179.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 60.3 tp -84.51 122.39 28.94 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.174 -0.954 . . . . 0.0 109.82 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.488 ' O ' ' O ' ' A' ' 34' ' ' ASN . 0.3 OUTLIER -139.91 110.81 7.29 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.276 -0.89 . . . . 0.0 109.039 179.649 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.528 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 42.2 Cg_endo -64.82 122.98 10.98 Favored 'Trans proline' 0 C--O 1.213 -0.747 0 C-N-CA 122.996 2.464 . . . . 0.0 112.496 -179.23 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.464 HG22 HD11 ' A' ' 39' ' ' LEU . 32.9 m -118.56 155.16 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.45 -0.781 . . . . 0.0 109.681 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.416 ' O ' ' N ' ' A' ' 53' ' ' ARG . 42.5 t -100.54 117.7 35.21 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.327 -0.858 . . . . 0.0 108.991 179.219 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -73.63 138.28 24.71 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 -179.612 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.478 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 53.1 p30 -67.74 -11.1 57.67 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.249 -1.148 . . . . 0.0 109.473 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.461 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 58.5 p30 -82.94 8.68 11.93 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.292 -0.88 . . . . 0.0 109.402 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.09 13.94 65.34 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.515 ' O ' ' N ' ' A' ' 27' ' ' GLY . 92.1 mt-30 -119.56 167.04 12.38 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.27 -1.135 . . . . 0.0 109.461 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.526 ' CG2' ' HA ' ' A' ' 57' ' ' LYS . 90.6 m -126.11 140.47 52.55 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.272 -0.893 . . . . 0.0 109.265 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.586 ' CE1' ' HB2' ' A' ' 42' ' ' GLU . 59.5 m-85 -118.85 126.24 51.36 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.228 -0.92 . . . . 0.0 109.327 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.497 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 5.9 m-20 -49.77 -75.94 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.21 -0.931 . . . . 0.0 109.397 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.531 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 4.6 t-20 -82.04 148.57 60.75 Favored Pre-proline 0 C--N 1.299 -1.6 0 O-C-N 121.105 -0.997 . . . . 0.0 109.527 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.486 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.0 Cg_endo -62.99 -53.35 1.62 Allowed 'Trans proline' 0 C--O 1.216 -0.619 0 C-N-CA 122.603 2.202 . . . . 0.0 111.728 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.531 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 4.5 t -60.64 -27.63 67.94 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 120.961 -1.087 . . . . 0.0 108.156 179.025 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.467 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 52.6 mmm -65.28 -20.08 66.25 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.549 HD13 ' CE2' ' A' ' 33' ' ' TYR . 6.6 tt -68.42 -51.84 39.44 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.287 -0.883 . . . . 0.0 108.788 179.43 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.519 ' HA ' ' ND2' ' A' ' 43' ' ' ASN . 64.0 m -51.22 -27.99 10.35 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.142 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.402 ' O ' HG13 ' A' ' 45' ' ' ILE . 28.2 t60 -58.63 -47.5 84.18 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.586 ' HB2' ' CE1' ' A' ' 33' ' ' TYR . 26.9 tp10 -60.36 -17.17 41.56 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 179.116 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.527 ' OD1' ' N ' ' A' ' 50' ' ' THR . 3.5 m-80 -80.07 -34.91 37.75 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.405 -0.81 . . . . 0.0 108.927 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.488 ' CD1' ' C ' ' A' ' 44' ' ' LEU . 2.6 tm? -70.27 -35.79 74.0 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.349 -0.844 . . . . 0.0 109.34 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.402 HG13 ' O ' ' A' ' 41' ' ' HIS . 2.8 mt -76.11 -53.22 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.302 -0.874 . . . . 0.0 109.678 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.46 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 49.8 mtp180 -80.37 -34.51 36.41 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.224 -0.923 . . . . 0.0 109.89 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.498 ' N ' ' O ' ' A' ' 43' ' ' ASN . 90.4 mt-30 62.32 35.17 15.31 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.215 -0.928 . . . . 0.0 109.547 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.443 ' O ' ' HB2' ' A' ' 49' ' ' ASN . 72.3 p -105.64 7.78 32.84 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.195 -0.941 . . . . 0.0 109.623 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.443 ' HB2' ' O ' ' A' ' 48' ' ' THR . 20.5 m120 64.23 49.82 2.52 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.254 -0.904 . . . . 0.0 109.391 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.527 ' N ' ' OD1' ' A' ' 43' ' ' ASN . 63.6 m -76.76 132.53 39.32 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.251 -0.906 . . . . 0.0 109.378 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 15.2 m-70 -115.21 -174.83 2.57 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.282 -0.886 . . . . 0.0 109.521 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 16.4 mt -86.68 124.77 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.324 -0.86 . . . . 0.0 109.678 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.478 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 75.8 ttt-85 -80.08 -54.73 5.5 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.525 -0.735 . . . . 0.0 109.503 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 77.7 p -151.87 138.95 19.15 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.716 -0.615 . . . . 0.0 109.357 -179.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 8.0 p -54.35 148.93 10.82 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.189 -0.944 . . . . 0.0 109.412 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.528 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 88.51 166.66 42.5 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.274 -1.53 . . . . 0.0 109.274 -179.665 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.526 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 27.1 mttt -66.32 143.37 57.22 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.376 -1.073 . . . . 0.0 109.562 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.413 ' C ' ' O ' ' A' ' 57' ' ' LYS . 66.9 m . . . . . 0 N--CA 1.491 1.595 0 O-C-N 121.278 -0.889 . . . . 0.0 109.47 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 56.5 mmm . . . . . 0 N--CA 1.488 1.449 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.59 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 59.2 m -80.12 -21.3 43.36 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.422 -0.799 . . . . 0.0 109.284 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 42.1 mttp -80.69 11.74 3.62 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.331 -0.856 . . . . 0.0 109.786 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -132.75 -1.82 3.37 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.023 -1.048 . . . . 0.0 110.181 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.59 ' CD1' ' HA ' ' A' ' 5' ' ' CYS . 1.6 p90 -114.24 156.56 24.09 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.868 -1.145 . . . . 0.0 109.98 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 31.8 mtm105 -137.16 133.86 35.71 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.351 -0.843 . . . . 0.0 109.202 179.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.533 HG22 ' CD1' ' A' ' 16' ' ' TYR . 75.7 t -117.65 142.61 31.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.189 -0.944 . . . . 0.0 109.8 -179.601 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.541 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.4 OUTLIER -126.02 175.45 3.17 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.366 -0.834 . . . . 0.0 109.159 179.946 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.541 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 43.9 Cg_endo -67.22 -22.24 46.96 Favored 'Trans proline' 0 C--O 1.214 -0.679 0 C-N-CA 122.557 2.171 . . . . 0.0 111.672 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 89.7 mtt180 -103.69 -29.28 11.17 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.298 -0.876 . . . . 0.0 109.56 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 89.2 mt -80.04 -49.64 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.244 -0.91 . . . . 0.0 109.497 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.4 ' C ' HG12 ' A' ' 10' ' ' VAL . . . 82.15 -163.63 43.45 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.533 ' CD1' HG22 ' A' ' 10' ' ' VAL . 0.9 OUTLIER -92.86 151.84 19.75 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.285 -1.126 . . . . 0.0 109.444 -179.973 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 26.0 tp -127.67 116.08 19.73 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.198 -0.939 . . . . 0.0 109.816 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.431 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 77.4 m -129.86 157.36 77.03 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.281 -0.887 . . . . 0.0 109.035 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.489 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 49.4 Cg_endo -70.94 167.96 24.47 Favored 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 122.558 2.172 . . . . 0.0 111.44 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 24.5 mttp -94.8 -6.13 43.62 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.191 -0.943 . . . . 0.0 109.585 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.44 ' OD2' ' HE2' ' A' ' 23' ' ' LYS . 58.6 t0 -76.09 117.4 17.76 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.198 -0.939 . . . . 0.0 109.253 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.49 ' CD1' ' C ' ' A' ' 22' ' ' LEU . 3.2 tm? -78.4 122.5 25.88 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.234 -0.916 . . . . 0.0 109.706 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.489 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 5.2 mttt -142.2 104.01 5.61 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.404 -0.81 . . . . 0.0 109.22 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.542 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 42.6 Cg_endo -65.09 120.86 8.17 Favored 'Trans proline' 0 C--O 1.213 -0.756 0 C-N-CA 123.056 2.504 . . . . 0.0 112.036 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.467 ' O ' HG21 ' A' ' 32' ' ' THR . 24.5 m -116.65 155.0 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.321 -0.862 . . . . 0.0 110.005 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.489 ' O ' ' N ' ' A' ' 53' ' ' ARG . 28.0 t -99.67 108.64 21.05 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.475 -0.766 . . . . 0.0 109.319 179.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -62.61 138.79 44.99 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.501 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 57.1 p30 -68.86 -10.31 56.25 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.258 -1.143 . . . . 0.0 109.482 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.452 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 90.0 m-20 -84.0 4.93 27.67 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.18 -0.95 . . . . 0.0 109.409 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.51 13.45 58.35 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.223 -1.551 . . . . 0.0 109.223 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.508 ' O ' ' N ' ' A' ' 27' ' ' GLY . 93.5 mt-30 -117.95 160.53 21.29 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.321 -1.106 . . . . 0.0 109.497 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.467 HG21 ' O ' ' A' ' 25' ' ' VAL . 57.4 m -116.99 130.23 56.55 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.244 -0.91 . . . . 0.0 109.24 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.602 ' CD1' ' CD1' ' A' ' 39' ' ' LEU . 65.8 m-85 -111.25 119.36 38.65 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.273 -0.892 . . . . 0.0 109.157 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.487 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 51.2 t-20 -46.31 -80.44 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.399 -0.813 . . . . 0.0 110.092 -179.363 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.528 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 1.9 t-20 -81.03 150.0 67.72 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.003 -1.061 . . . . 0.0 109.722 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.489 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.9 Cg_endo -63.97 -55.23 0.68 Allowed 'Trans proline' 0 C--O 1.216 -0.612 0 C-N-CA 122.756 2.304 . . . . 0.0 111.818 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.528 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 10.8 t -60.92 -30.45 70.21 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 120.91 -1.119 . . . . 0.0 108.17 178.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.48 ' CG ' ' HB3' ' A' ' 35' ' ' ASN . 52.5 mmm -60.11 -17.73 42.19 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.263 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.602 ' CD1' ' CD1' ' A' ' 33' ' ' TYR . 33.5 tp -68.5 -58.27 4.57 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 179.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.464 ' HB3' ' OH ' ' A' ' 16' ' ' TYR . 8.1 t -56.38 -24.08 42.1 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 178.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 30.0 t60 -70.63 -62.81 1.25 Allowed 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 179.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.482 ' OE1' ' CE2' ' A' ' 33' ' ' TYR . 78.6 mt-10 -55.47 -21.87 18.25 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.176 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.511 ' O ' ' N ' ' A' ' 47' ' ' GLN . 98.7 m-20 -73.65 -35.88 65.32 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 179.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.476 ' CD1' ' C ' ' A' ' 44' ' ' LEU . 2.0 tm? -62.61 -37.33 85.86 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.399 -0.813 . . . . 0.0 109.005 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.9 mt -71.82 -42.13 69.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.386 -0.821 . . . . 0.0 109.113 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.458 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 12.8 mtt-85 -79.84 -22.3 43.14 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.36 -0.838 . . . . 0.0 109.174 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.511 ' N ' ' O ' ' A' ' 43' ' ' ASN . 92.5 mt-30 63.3 44.68 5.41 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.316 -0.865 . . . . 0.0 109.475 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 21.9 p -128.02 169.88 13.53 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.373 -0.83 . . . . 0.0 109.413 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.571 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 43.9 t30 -102.7 64.84 0.89 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.233 -0.917 . . . . 0.0 109.304 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.443 HG21 ' N ' ' A' ' 51' ' ' HIS . 33.9 m -74.83 147.32 41.26 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.338 -0.851 . . . . 0.0 109.613 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . 0.571 ' CE1' ' O ' ' A' ' 49' ' ' ASN . 51.4 m80 -122.77 -173.65 2.75 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.383 -0.823 . . . . 0.0 109.263 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 11.3 mt -95.82 124.07 48.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.137 -0.977 . . . . 0.0 109.531 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.501 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 72.3 ttt-85 -80.04 -56.0 4.55 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 121.622 0.725 . . . . 0.0 109.558 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 88.7 p -153.95 139.22 17.53 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 6.5 p -56.56 148.49 19.51 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.116 -0.99 . . . . 0.0 109.349 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.542 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 82.66 161.39 29.93 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.484 ' CG ' ' HB2' ' A' ' 24' ' ' PRO . 26.1 mttp -68.36 131.75 45.86 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.558 -0.966 . . . . 0.0 109.535 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.504 0 O-C-N 121.198 -0.939 . . . . 0.0 109.475 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 75.6 mtp . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.578 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 3.4 m -91.95 -12.45 33.37 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.364 -0.835 . . . . 0.0 109.632 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.4 mttm -57.37 -25.07 58.9 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.276 -0.89 . . . . 0.0 109.721 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 61.5 t0 -152.69 64.45 0.8 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.108 -0.995 . . . . 0.0 109.776 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.578 ' CD1' ' HA ' ' A' ' 5' ' ' CYS . 4.5 p90 -126.42 169.01 13.42 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.169 -0.957 . . . . 0.0 109.324 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 79.9 mtt180 -142.56 145.98 34.16 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.202 -0.936 . . . . 0.0 109.496 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.495 HG23 ' CD2' ' A' ' 16' ' ' TYR . 90.8 t -140.32 134.53 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.266 -0.896 . . . . 0.0 109.471 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.535 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 1.1 mp -123.34 176.08 2.38 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.289 -0.882 . . . . 0.0 109.251 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.535 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 45.4 Cg_endo -67.51 -27.24 39.59 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 122.547 2.165 . . . . 0.0 111.514 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 71.3 mtt-85 -104.06 -29.77 10.68 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.292 -0.88 . . . . 0.0 109.005 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 26.7 mm -81.79 -41.26 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.429 -0.794 . . . . 0.0 109.519 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 64.78 -147.06 50.82 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.495 ' CD2' HG23 ' A' ' 10' ' ' VAL . 1.5 t80 -104.98 151.75 23.55 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.244 -1.151 . . . . 0.0 109.538 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 24.3 tp -104.9 109.41 21.37 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.245 -0.909 . . . . 0.0 109.476 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 63.6 m -129.24 156.43 78.36 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.325 -0.859 . . . . 0.0 109.371 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -72.04 172.6 14.37 Favored 'Trans proline' 0 C--O 1.215 -0.673 0 C-N-CA 122.663 2.242 . . . . 0.0 111.567 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 20.4 tttm -89.51 -15.58 32.67 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.18 -0.95 . . . . 0.0 109.393 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -73.4 108.9 6.53 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.305 -0.872 . . . . 0.0 109.496 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.476 HD21 ' HB2' ' A' ' 35' ' ' ASN . 3.5 tm? -77.79 109.72 12.04 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.221 -0.924 . . . . 0.0 109.258 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.494 ' O ' ' O ' ' A' ' 34' ' ' ASN . 7.1 mtmt -120.49 106.84 39.58 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.313 -0.867 . . . . 0.0 109.308 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.547 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 41.4 Cg_endo -63.44 120.54 8.0 Favored 'Trans proline' 0 C--O 1.213 -0.743 0 C-N-CA 123.151 2.567 . . . . 0.0 112.376 -179.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 18.3 m -115.58 155.52 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.228 -0.92 . . . . 0.0 109.744 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.464 ' O ' ' N ' ' A' ' 53' ' ' ARG . 39.9 t -98.04 115.54 28.43 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.335 -0.853 . . . . 0.0 109.319 179.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -70.83 138.84 29.0 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.505 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 53.2 t0 -70.92 -9.44 57.8 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.281 -1.129 . . . . 0.0 109.654 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.4 ' OD1' ' HB2' ' A' ' 31' ' ' GLN . 58.5 p30 -85.72 8.58 19.24 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.11 -0.994 . . . . 0.0 109.253 179.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.31 9.63 66.9 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.511 ' O ' ' N ' ' A' ' 27' ' ' GLY . 69.6 mt-30 -118.14 156.64 28.35 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.329 -1.101 . . . . 0.0 109.317 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.529 ' CG2' ' HA ' ' A' ' 57' ' ' LYS . 33.5 m -116.9 151.88 35.68 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.212 -0.93 . . . . 0.0 109.293 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.601 ' CD1' ' CD1' ' A' ' 39' ' ' LEU . 73.7 m-85 -129.77 131.06 46.12 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.197 -0.939 . . . . 0.0 109.239 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.498 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 2.7 m-20 -53.21 -79.38 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.288 -0.882 . . . . 0.0 109.636 -179.531 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.521 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 13.2 t-20 -82.64 145.69 51.45 Favored Pre-proline 0 C--N 1.3 -1.555 0 O-C-N 120.893 -1.13 . . . . 0.0 109.826 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.484 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.3 Cg_endo -63.63 -51.13 2.66 Favored 'Trans proline' 0 C--O 1.214 -0.689 0 C-N-CA 122.67 2.247 . . . . 0.0 111.278 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.521 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 5.6 t -60.44 -29.78 69.23 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 178.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.452 ' HB2' ' HB3' ' A' ' 35' ' ' ASN . 35.9 mmm -66.29 -10.87 46.77 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 179.234 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.601 ' CD1' ' CD1' ' A' ' 33' ' ' TYR . 52.0 tp -69.24 -55.28 11.03 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.286 -0.884 . . . . 0.0 108.822 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.455 ' SG ' ' OH ' ' A' ' 16' ' ' TYR . 11.5 t -54.85 -29.6 55.58 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 179.085 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 32.5 t60 -60.15 -60.92 3.05 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.44 ' HA ' ' OE1' ' A' ' 42' ' ' GLU . 68.8 mm-40 -58.86 -22.61 59.49 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 179.057 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.508 ' O ' ' N ' ' A' ' 47' ' ' GLN . 98.5 m-20 -75.97 -23.2 55.32 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.368 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.497 ' CD2' ' OH ' ' A' ' 8' ' ' TYR . 2.0 tm? -72.4 -36.63 68.69 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.32 -0.862 . . . . 0.0 108.797 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.524 HD12 ' N ' ' A' ' 45' ' ' ILE . 3.8 mm -76.31 -41.96 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.428 -0.795 . . . . 0.0 109.154 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.472 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 21.1 mtt-85 -83.07 -40.2 20.18 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.41 -0.807 . . . . 0.0 109.482 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.508 ' N ' ' O ' ' A' ' 43' ' ' ASN . 89.8 mt-30 63.54 43.44 5.85 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.48 -0.763 . . . . 0.0 109.482 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 72.2 p -113.01 18.75 17.83 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.248 -0.908 . . . . 0.0 109.334 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 54.7 m-20 44.76 58.71 3.77 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.274 -0.891 . . . . 0.0 109.465 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.467 ' HB ' ' OD1' ' A' ' 43' ' ' ASN . 21.1 m -75.22 145.28 42.13 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.15 -0.969 . . . . 0.0 109.744 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 29.4 m-70 -118.69 171.77 7.97 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.302 -0.874 . . . . 0.0 108.981 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.476 HD11 HG22 ' A' ' 52' ' ' ILE . 20.2 mt -84.15 124.49 39.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.105 -0.997 . . . . 0.0 109.574 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.505 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 37.1 ttt180 -79.85 -52.41 7.93 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-O 121.701 0.762 . . . . 0.0 109.245 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 24.7 p -151.78 153.91 35.22 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 20.9 p -71.8 136.6 47.13 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.185 -0.947 . . . . 0.0 109.438 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.547 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 95.87 163.32 33.75 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.529 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 73.6 tttt -49.64 152.62 1.38 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.46 -1.023 . . . . 0.0 109.373 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.413 ' N ' ' HG2' ' A' ' 57' ' ' LYS . 24.5 m . . . . . 0 N--CA 1.49 1.55 0 O-C-N 121.174 -0.954 . . . . 0.0 109.491 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 79.4 mmm . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.591 ' HB3' ' CE1' ' A' ' 8' ' ' TYR . 2.7 m -85.06 5.48 29.36 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.461 -0.775 . . . . 0.0 109.039 179.386 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.446 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 11.5 mttm -66.23 -28.35 68.67 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.18 -0.95 . . . . 0.0 109.554 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.446 ' OD1' ' O ' ' A' ' 6' ' ' LYS . 80.3 m-20 -146.2 65.76 1.2 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.269 -0.894 . . . . 0.0 110.153 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.591 ' CE1' ' HB3' ' A' ' 5' ' ' CYS . 12.6 p90 -125.8 -177.7 4.02 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.146 -0.971 . . . . 0.0 109.234 179.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 66.4 mtm180 -150.39 143.48 24.85 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.171 -0.955 . . . . 0.0 109.634 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.42 HG12 ' C ' ' A' ' 15' ' ' GLY . 69.1 t -128.4 130.97 69.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.241 -0.912 . . . . 0.0 109.442 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.529 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.2 OUTLIER -111.41 175.0 2.05 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.291 -0.881 . . . . 0.0 109.415 -179.867 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.529 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 46.1 Cg_endo -67.6 -24.17 42.05 Favored 'Trans proline' 0 C--O 1.216 -0.611 0 C-N-CA 122.665 2.243 . . . . 0.0 111.565 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 82.3 mtp180 -94.36 -31.7 13.91 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.342 -0.849 . . . . 0.0 109.104 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 80.5 mt -85.38 -46.99 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.415 -0.803 . . . . 0.0 109.357 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.42 ' C ' HG12 ' A' ' 10' ' ' VAL . . . 70.59 -165.06 52.56 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.527 ' OH ' ' CB ' ' A' ' 40' ' ' CYS . 0.8 OUTLIER -104.41 146.62 28.59 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.235 -1.156 . . . . 0.0 109.377 179.928 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.554 ' N ' ' CD1' ' A' ' 17' ' ' LEU . 0.6 OUTLIER -112.59 124.87 53.51 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.248 -0.907 . . . . 0.0 109.452 179.86 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.437 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 59.6 m -142.16 155.84 64.9 Favored Pre-proline 0 C--N 1.3 -1.585 0 O-C-N 121.373 -0.829 . . . . 0.0 108.81 179.443 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -70.88 164.45 35.61 Favored 'Trans proline' 0 C--O 1.214 -0.695 0 C-N-CA 122.236 1.957 . . . . 0.0 111.344 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.2 mtpm? -82.54 -26.43 32.46 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.311 -0.868 . . . . 0.0 109.415 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -63.29 124.83 22.23 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.311 -0.868 . . . . 0.0 109.446 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.532 HD22 ' CB ' ' A' ' 34' ' ' ASN . 3.4 tm? -86.53 106.96 17.89 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.137 -0.977 . . . . 0.0 109.305 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.493 ' O ' ' O ' ' A' ' 34' ' ' ASN . 9.5 mttt -115.22 106.79 50.62 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.222 -0.924 . . . . 0.0 109.47 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.537 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 41.7 Cg_endo -63.21 116.94 3.91 Favored 'Trans proline' 0 C--O 1.214 -0.698 0 C-N-CA 123.032 2.488 . . . . 0.0 112.176 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.45 ' O ' HG21 ' A' ' 32' ' ' THR . 16.4 m -115.09 154.86 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.285 -0.885 . . . . 0.0 109.266 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 45.1 t -95.08 143.81 26.23 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 178.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -97.06 141.49 15.65 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 -178.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.479 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 54.6 p30 -67.42 -8.63 34.63 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.313 -1.11 . . . . 0.0 109.431 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -95.88 10.84 35.84 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.317 -0.864 . . . . 0.0 109.49 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.45 12.31 73.08 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.538 ' O ' ' N ' ' A' ' 27' ' ' GLY . 53.4 mt-30 -115.84 148.26 40.13 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.298 -1.119 . . . . 0.0 109.504 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.542 ' CG2' ' HA ' ' A' ' 57' ' ' LYS . 8.4 m -112.32 152.23 28.79 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.146 -0.971 . . . . 0.0 109.731 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.57 ' CE1' ' HB2' ' A' ' 42' ' ' GLU . 94.6 m-85 -129.34 133.4 47.4 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.303 -0.873 . . . . 0.0 109.187 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.532 ' CB ' HD22 ' A' ' 22' ' ' LEU . 1.5 m-20 -53.57 -75.37 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.111 -0.993 . . . . 0.0 109.194 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.526 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 8.4 t-20 -82.38 146.56 54.39 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.155 -0.966 . . . . 0.0 109.188 179.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.492 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 42.0 Cg_endo -64.69 -51.38 1.84 Allowed 'Trans proline' 0 C--O 1.216 -0.608 0 C-N-CA 122.649 2.233 . . . . 0.0 111.486 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.526 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 9.5 t -62.38 -27.24 68.94 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 178.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.491 ' CG ' ' HB3' ' A' ' 35' ' ' ASN . 44.9 mmm -66.44 -21.83 66.21 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.686 -0.634 . . . . 0.0 109.29 179.308 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.552 ' CD1' ' CD2' ' A' ' 33' ' ' TYR . 6.4 tt -64.83 -51.48 61.86 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.247 -0.908 . . . . 0.0 108.841 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.527 ' CB ' ' OH ' ' A' ' 16' ' ' TYR . 33.8 m -51.41 -33.64 31.26 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.06 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 19.1 t60 -53.3 -46.31 69.33 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.237 -0.915 . . . . 0.0 108.552 179.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.57 ' HB2' ' CE1' ' A' ' 33' ' ' TYR . 21.4 tp10 -62.03 -17.46 57.38 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.198 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.519 ' HB2' ' O ' ' A' ' 40' ' ' CYS . 2.7 m-80 -79.13 -33.93 43.77 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 119.492 -0.883 . . . . 0.0 109.247 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.52 ' CD2' ' OH ' ' A' ' 8' ' ' TYR . 46.6 mt -70.5 -32.93 70.62 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.256 -0.903 . . . . 0.0 109.8 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.7 mm -79.39 -51.6 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.255 -0.903 . . . . 0.0 109.654 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.462 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 18.5 mtt-85 -82.51 -33.98 28.1 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.21 -0.931 . . . . 0.0 109.833 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.486 ' N ' ' O ' ' A' ' 43' ' ' ASN . 89.6 mt-30 62.52 36.7 13.79 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.247 -0.908 . . . . 0.0 109.422 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.461 ' O ' ' HB2' ' A' ' 49' ' ' ASN . 39.0 p -102.87 3.28 36.41 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.226 -0.921 . . . . 0.0 109.631 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.461 ' HB2' ' O ' ' A' ' 48' ' ' THR . 18.6 m120 65.07 48.31 2.29 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.317 -0.864 . . . . 0.0 109.512 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.518 ' N ' ' OD1' ' A' ' 43' ' ' ASN . 48.4 m -80.19 131.39 35.7 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.206 -0.933 . . . . 0.0 109.607 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 11.1 m-70 -114.25 -171.45 1.92 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.272 -0.893 . . . . 0.0 109.38 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.501 HG22 HD12 ' A' ' 52' ' ' ILE . 42.9 mt -89.03 127.05 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.311 -0.868 . . . . 0.0 109.574 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.479 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 39.3 ttt85 -81.37 -43.44 19.02 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.424 -0.798 . . . . 0.0 109.255 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.6 m -160.44 146.4 15.18 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.569 -0.707 . . . . 0.0 109.319 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.7 p -61.68 143.5 56.04 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.2 -0.937 . . . . 0.0 109.488 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.537 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 87.58 162.04 37.4 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.542 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 62.0 tttt -52.91 152.46 3.94 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.667 -0.902 . . . . 0.0 109.603 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 85.3 m . . . . . 0 N--CA 1.492 1.63 0 O-C-N 121.302 -0.874 . . . . 0.0 109.552 179.963 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' MET . . . . . 0.428 ' HE1' ' HB3' ' A' ' 4' ' ' MET . 92.2 mtp . . . . . 0 N--CA 1.488 1.469 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.588 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 26.2 m -81.42 -14.42 57.14 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.458 -0.776 . . . . 0.0 109.39 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.462 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 22.6 mttm -80.59 5.23 16.04 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.201 -0.937 . . . . 0.0 109.509 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.462 ' OD1' ' O ' ' A' ' 6' ' ' LYS . 93.2 m-20 -135.76 12.82 3.42 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.061 -1.024 . . . . 0.0 110.405 -179.405 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.613 ' CE2' ' CE2' ' A' ' 16' ' ' TYR . 0.6 OUTLIER -123.54 150.72 43.66 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.873 -1.142 . . . . 0.0 109.682 179.815 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 46.1 mtt85 -130.5 132.73 45.78 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.246 -0.908 . . . . 0.0 109.393 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.568 HG22 ' CE2' ' A' ' 8' ' ' TYR . 54.2 t -123.39 147.08 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.187 -0.945 . . . . 0.0 109.716 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.543 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -128.97 176.26 2.93 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.423 -0.798 . . . . 0.0 109.17 -179.999 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.543 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 44.0 Cg_endo -66.64 -22.1 51.15 Favored 'Trans proline' 0 C--O 1.214 -0.681 0 C-N-CA 122.477 2.118 . . . . 0.0 111.782 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 60.5 mtt180 -101.55 -30.02 11.63 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.24 -0.913 . . . . 0.0 109.498 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 95.4 mt -81.47 -47.66 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.279 -0.888 . . . . 0.0 109.739 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.434 ' C ' HG12 ' A' ' 10' ' ' VAL . . . 77.14 -167.78 54.41 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.613 ' CE2' ' CE2' ' A' ' 8' ' ' TYR . 1.5 t80 -95.75 150.77 20.03 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.177 -1.19 . . . . 0.0 109.662 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 25.7 tp -117.51 105.81 12.49 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.322 -0.861 . . . . 0.0 109.465 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.416 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 76.2 m -117.77 157.3 48.43 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.239 -0.913 . . . . 0.0 109.183 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.436 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 49.5 Cg_endo -72.17 166.01 30.94 Favored 'Trans proline' 0 C--O 1.216 -0.622 0 C-N-CA 122.63 2.22 . . . . 0.0 111.545 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 60.1 mttt -89.38 -13.2 38.31 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.184 -0.948 . . . . 0.0 109.475 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -73.53 113.72 10.96 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.231 -0.918 . . . . 0.0 109.248 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.423 HD12 ' HB3' ' A' ' 34' ' ' ASN . 49.4 tp -76.54 112.54 13.18 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.174 -0.954 . . . . 0.0 109.628 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.489 ' O ' ' O ' ' A' ' 34' ' ' ASN . 14.2 mttt -126.22 110.14 24.0 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.295 -0.878 . . . . 0.0 108.941 179.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.542 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 43.5 Cg_endo -64.93 123.98 12.42 Favored 'Trans proline' 0 C--O 1.213 -0.744 0 C-N-CA 123.025 2.483 . . . . 0.0 112.487 -179.187 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.456 ' O ' HG21 ' A' ' 32' ' ' THR . 27.2 m -118.77 153.38 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.434 -0.791 . . . . 0.0 109.452 179.674 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 41.9 t -99.45 139.65 34.8 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 178.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -93.91 144.44 17.11 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 -178.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.491 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 49.3 p30 -68.87 -15.0 63.38 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.365 -1.079 . . . . 0.0 109.432 179.626 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.457 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 88.1 m-20 -84.46 5.73 26.26 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.232 -0.917 . . . . 0.0 109.542 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.04 17.17 56.65 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.444 ' O ' ' SG ' ' A' ' 58' ' ' CYS . 90.8 mt-30 -115.82 171.13 7.96 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.307 -1.113 . . . . 0.0 109.485 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.527 HG22 ' CB ' ' A' ' 57' ' ' LYS . 64.0 m -133.03 136.0 45.73 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.232 -0.918 . . . . 0.0 109.522 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.639 ' CE1' ' CD1' ' A' ' 39' ' ' LEU . 44.4 m-85 -116.14 133.17 56.32 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.292 -0.88 . . . . 0.0 109.247 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.491 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 7.7 m-20 -55.3 -77.57 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.262 -0.899 . . . . 0.0 110.031 -179.423 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.524 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 5.4 t-20 -81.63 147.66 59.84 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 120.91 -1.119 . . . . 0.0 109.728 -179.626 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.472 ' HD3' ' O ' ' A' ' 23' ' ' LYS . 41.3 Cg_endo -64.18 -53.09 1.27 Allowed 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 122.771 2.314 . . . . 0.0 111.552 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.524 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 10.1 t -62.34 -29.0 70.14 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 178.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.508 ' CG ' ' HB3' ' A' ' 35' ' ' ASN . 44.6 mmm -62.76 -14.09 40.63 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.241 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.639 ' CD1' ' CE1' ' A' ' 33' ' ' TYR . 39.8 tp -73.23 -60.17 2.37 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.407 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.458 ' HB3' ' OH ' ' A' ' 16' ' ' TYR . 17.8 t -54.54 -23.56 17.11 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 54.3 t60 -69.46 -62.25 1.46 Allowed 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 -58.09 -19.1 29.5 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.513 ' O ' ' N ' ' A' ' 47' ' ' GLN . 99.6 m-20 -76.36 -29.66 57.28 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.482 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.47 ' CD1' ' C ' ' A' ' 44' ' ' LEU . 1.8 tm? -69.81 -38.79 76.73 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.416 -0.803 . . . . 0.0 109.014 179.543 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.522 HD12 ' N ' ' A' ' 45' ' ' ILE . 3.7 mm -71.54 -46.42 63.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.301 -0.875 . . . . 0.0 109.385 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.445 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 13.4 mtt-85 -79.59 -33.23 41.82 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.286 -0.884 . . . . 0.0 109.354 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.513 ' N ' ' O ' ' A' ' 43' ' ' ASN . 92.3 mt-30 61.24 39.43 15.7 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.368 -0.832 . . . . 0.0 109.52 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 52.2 p -104.28 8.21 35.99 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.261 -0.9 . . . . 0.0 109.481 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.58 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 35.5 t-20 50.78 57.69 6.36 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.296 -0.878 . . . . 0.0 109.505 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.448 ' HB ' ' OD1' ' A' ' 43' ' ' ASN . 26.6 m -80.32 148.54 30.64 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.182 -0.949 . . . . 0.0 109.785 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . 0.58 ' CE1' ' O ' ' A' ' 49' ' ' ASN . 13.7 m80 -122.0 171.34 9.02 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.396 -0.815 . . . . 0.0 108.851 179.472 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.465 HG12 HD21 ' A' ' 39' ' ' LEU . 11.7 mt -83.29 126.48 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.156 -0.965 . . . . 0.0 109.701 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.491 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 55.8 ttt180 -80.04 -46.45 16.55 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.452 -0.78 . . . . 0.0 109.409 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -160.54 142.92 12.89 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.8 p -54.71 148.4 12.84 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.192 -0.942 . . . . 0.0 109.112 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.542 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 84.42 168.2 43.83 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.068 -1.613 . . . . 0.0 109.068 -179.513 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.527 ' CB ' HG22 ' A' ' 32' ' ' THR . 81.7 mttt -63.93 167.14 6.52 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.257 -1.143 . . . . 0.0 109.238 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.459 ' SG ' ' OG1' ' A' ' 32' ' ' THR . 84.0 m . . . . . 0 N--CA 1.488 1.453 0 O-C-N 121.219 -0.926 . . . . 0.0 109.098 179.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 84.5 mmm . . . . . 0 N--CA 1.489 1.477 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.42 ' O ' ' N ' ' A' ' 8' ' ' TYR . 16.8 p -79.76 -7.76 58.84 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.14 -0.975 . . . . 0.0 109.286 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 24.7 mttm -49.05 -24.92 1.75 Allowed 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.079 -1.013 . . . . 0.0 108.391 179.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.401 ' OD1' ' C ' ' A' ' 7' ' ' ASP . 58.8 p30 -112.98 25.57 11.28 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.319 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.577 ' CZ ' ' CE1' ' A' ' 16' ' ' TYR . 3.7 t80 -79.19 162.82 25.49 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.544 -0.723 . . . . 0.0 109.99 -179.394 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 12.7 mtm180 -148.92 115.36 5.87 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.368 -0.832 . . . . 0.0 108.977 179.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.454 ' CG1' ' C ' ' A' ' 15' ' ' GLY . 99.8 t -111.32 148.99 14.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.229 -0.919 . . . . 0.0 109.468 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.544 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.5 OUTLIER -129.58 175.82 3.3 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.251 -0.905 . . . . 0.0 109.453 -179.674 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.544 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 43.7 Cg_endo -66.77 -22.26 49.93 Favored 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 122.644 2.229 . . . . 0.0 111.584 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.43 ' NH1' ' HB3' ' A' ' 13' ' ' ARG . 19.5 mtp-105 -114.29 -29.49 6.91 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.375 -0.828 . . . . 0.0 109.215 179.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 97.1 mt -78.92 -42.02 24.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.338 -0.851 . . . . 0.0 109.383 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.454 ' C ' ' CG1' ' A' ' 10' ' ' VAL . . . 64.12 -150.89 50.25 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.577 ' CE1' ' CZ ' ' A' ' 8' ' ' TYR . 1.0 OUTLIER -102.68 147.6 26.62 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.266 -1.138 . . . . 0.0 109.352 179.858 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.472 ' N ' ' OH ' ' A' ' 8' ' ' TYR . 37.5 mt -113.86 124.14 51.49 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.118 -0.989 . . . . 0.0 109.919 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.432 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 61.4 m -138.97 156.32 72.57 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.433 -0.792 . . . . 0.0 109.026 179.724 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -70.74 167.05 26.84 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.573 2.182 . . . . 0.0 111.671 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -88.2 -13.7 40.44 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.208 -0.933 . . . . 0.0 109.698 -179.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -74.19 123.48 24.57 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.133 -0.98 . . . . 0.0 109.391 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 39.7 tp -80.61 118.55 22.29 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.275 -0.89 . . . . 0.0 109.515 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.521 ' CB ' ' HD3' ' A' ' 36' ' ' PRO . 10.8 mttp -127.65 100.09 25.69 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.347 -0.846 . . . . 0.0 109.17 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.541 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 42.2 Cg_endo -64.41 118.22 5.2 Favored 'Trans proline' 0 C--O 1.214 -0.713 0 C-N-CA 122.874 2.383 . . . . 0.0 112.133 -179.449 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.445 ' O ' HG21 ' A' ' 32' ' ' THR . 12.2 m -114.65 155.74 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.309 -0.87 . . . . 0.0 109.557 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.417 ' SG ' ' NE ' ' A' ' 53' ' ' ARG . 42.4 t -95.62 138.96 32.55 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.237 -0.914 . . . . 0.0 108.661 179.051 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -92.11 136.16 13.1 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.483 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 53.8 t0 -68.96 -7.15 32.51 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.196 -1.179 . . . . 0.0 109.426 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.413 ' OD1' ' C ' ' A' ' 29' ' ' ASP . 59.2 p30 -89.72 2.95 54.19 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.265 -0.897 . . . . 0.0 109.413 179.672 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.64 16.57 39.02 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.463 ' O ' ' SG ' ' A' ' 58' ' ' CYS . 66.2 mt-30 -121.78 -178.37 3.81 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.301 -1.117 . . . . 0.0 109.592 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.534 ' CG2' ' HA ' ' A' ' 57' ' ' LYS . 11.1 m -143.3 138.85 29.83 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.287 -0.883 . . . . 0.0 109.319 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.594 ' CG ' HD11 ' A' ' 39' ' ' LEU . 40.2 m-85 -116.13 134.09 55.31 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.217 -0.927 . . . . 0.0 109.366 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.487 ' O ' ' O ' ' A' ' 23' ' ' LYS . 13.1 m-20 -55.07 -78.94 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.255 -0.903 . . . . 0.0 109.666 -179.611 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.505 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 10.9 t-20 -82.33 146.14 53.61 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.08 -1.013 . . . . 0.0 109.525 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.521 ' HD3' ' CB ' ' A' ' 23' ' ' LYS . 41.4 Cg_endo -63.94 -51.64 2.16 Favored 'Trans proline' 0 C--O 1.215 -0.651 0 C-N-CA 122.753 2.302 . . . . 0.0 111.621 179.438 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.505 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 8.0 t -62.06 -25.62 67.79 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 178.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.499 ' CG ' ' HB3' ' A' ' 35' ' ' ASN . 65.2 mmm -72.35 -3.02 21.47 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 179.191 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.594 HD11 ' CG ' ' A' ' 33' ' ' TYR . 21.2 tp -74.37 -60.03 2.46 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.287 -0.883 . . . . 0.0 109.175 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.474 ' HB3' ' OH ' ' A' ' 16' ' ' TYR . 2.2 t -56.44 -25.73 51.43 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.122 -0.986 . . . . 0.0 108.468 179.51 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 27.4 t60 -61.9 -56.91 14.42 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.468 ' OE1' ' CD2' ' A' ' 33' ' ' TYR . 65.1 tt0 -64.2 -20.57 66.11 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.145 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.501 ' O ' ' N ' ' A' ' 47' ' ' GLN . 88.6 m-20 -79.19 -29.88 43.12 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.61 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.481 ' CD1' ' C ' ' A' ' 44' ' ' LEU . 1.7 tm? -65.41 -36.9 85.35 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.284 -0.885 . . . . 0.0 109.165 179.629 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.2 mt -79.4 -38.88 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.372 -0.83 . . . . 0.0 109.317 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.464 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 17.0 mtt-85 -80.11 -32.79 39.08 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.174 -0.954 . . . . 0.0 109.417 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.501 ' N ' ' O ' ' A' ' 43' ' ' ASN . 73.8 mm-40 61.84 40.93 12.2 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.254 -0.904 . . . . 0.0 109.578 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 25.4 p -113.73 9.84 17.79 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.187 -0.946 . . . . 0.0 109.625 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 49.6 m-20 45.35 58.81 3.91 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.201 -0.937 . . . . 0.0 109.529 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.423 ' HB ' ' OD1' ' A' ' 43' ' ' ASN . 66.0 m -80.33 137.55 36.59 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.158 -0.964 . . . . 0.0 109.779 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 72.2 m80 -110.77 172.02 7.12 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.255 -0.903 . . . . 0.0 108.967 179.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.445 HG12 HD21 ' A' ' 39' ' ' LEU . 34.7 mt -82.12 126.03 39.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.131 -0.981 . . . . 0.0 109.435 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.483 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 46.6 ttp180 -79.99 -44.56 19.99 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 121.642 0.734 . . . . 0.0 109.309 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 17.1 p -158.49 156.1 29.67 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -179.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 36.5 p -71.68 140.32 49.58 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.119 -0.988 . . . . 0.0 109.407 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.541 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 89.5 162.25 38.24 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.551 -1.419 . . . . 0.0 109.551 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.534 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 46.2 tttp -50.63 148.54 3.83 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.537 -0.978 . . . . 0.0 109.49 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.463 ' SG ' ' O ' ' A' ' 31' ' ' GLN . 92.5 m . . . . . 0 N--CA 1.489 1.523 0 O-C-N 121.318 -0.864 . . . . 0.0 109.331 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 77.4 mtm . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.585 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 48.7 m -80.09 -19.13 48.16 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.396 -0.815 . . . . 0.0 109.351 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.442 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 25.3 mttt -81.04 11.65 3.93 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.362 -0.836 . . . . 0.0 109.985 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' A' ' 6' ' ' LYS . 94.4 m-20 -136.23 4.05 2.91 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.026 -1.046 . . . . 0.0 109.972 -179.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.585 ' CD1' ' HA ' ' A' ' 5' ' ' CYS . 0.7 OUTLIER -121.12 147.98 44.81 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.946 -1.096 . . . . 0.0 109.675 -179.951 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 29.2 mtt180 -132.44 124.64 29.01 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.333 -0.854 . . . . 0.0 108.957 179.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.527 HG23 ' CD1' ' A' ' 16' ' ' TYR . 75.8 t -108.95 141.44 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.333 -0.854 . . . . 0.0 110.183 -179.229 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.533 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 2.0 mp -130.71 176.18 3.08 Favored Pre-proline 0 N--CA 1.489 1.503 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.533 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 44.2 Cg_endo -66.55 -23.05 50.39 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 122.593 2.196 . . . . 0.0 111.801 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 31.6 ttp180 -97.78 -35.06 10.65 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.332 -0.855 . . . . 0.0 109.404 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 87.3 mt -80.34 -50.75 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.324 -0.86 . . . . 0.0 109.398 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 82.51 -171.67 51.6 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.527 ' CD1' HG23 ' A' ' 10' ' ' VAL . 0.9 OUTLIER -86.73 152.92 22.12 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.235 -1.156 . . . . 0.0 109.548 179.984 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 19.1 tp -129.45 117.1 19.98 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.235 -0.915 . . . . 0.0 109.915 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.455 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 75.8 m -133.82 156.72 79.12 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.401 -0.812 . . . . 0.0 108.928 179.515 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.502 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 49.6 Cg_endo -70.62 167.37 25.75 Favored 'Trans proline' 0 C--O 1.216 -0.623 0 C-N-CA 122.689 2.259 . . . . 0.0 111.679 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -93.91 -6.77 44.84 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.302 -0.873 . . . . 0.0 109.573 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.523 ' CB ' ' HE2' ' A' ' 23' ' ' LYS . 77.5 m-20 -74.46 137.01 42.29 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.228 -0.92 . . . . 0.0 109.115 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.488 ' CD1' ' C ' ' A' ' 22' ' ' LEU . 3.3 tm? -92.66 119.6 32.23 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.201 -0.937 . . . . 0.0 109.599 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.523 ' HE2' ' CB ' ' A' ' 21' ' ' ASP . 11.5 mttt -139.22 104.26 7.24 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.176 -0.952 . . . . 0.0 109.403 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.543 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 44.2 Cg_endo -67.25 118.47 5.6 Favored 'Trans proline' 0 C--O 1.214 -0.691 0 C-N-CA 122.921 2.414 . . . . 0.0 111.857 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.47 ' O ' HG21 ' A' ' 32' ' ' THR . 23.2 m -112.89 155.57 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.247 -0.908 . . . . 0.0 109.927 -179.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.498 ' O ' ' N ' ' A' ' 53' ' ' ARG . 39.3 t -101.49 109.57 21.41 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.315 -0.866 . . . . 0.0 109.338 179.63 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.485 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -62.5 142.17 47.64 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 -179.56 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.503 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 58.4 p30 -70.62 -10.37 59.18 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.326 -1.102 . . . . 0.0 109.378 179.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.438 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 55.1 p30 -85.33 6.58 25.74 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.224 -0.923 . . . . 0.0 109.312 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.65 9.47 64.45 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.191 -1.564 . . . . 0.0 109.191 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.485 ' O ' ' N ' ' A' ' 27' ' ' GLY . 88.0 mt-30 -111.18 168.28 9.63 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.381 -1.07 . . . . 0.0 109.517 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.489 ' CG2' ' HA ' ' A' ' 57' ' ' LYS . 30.3 m -127.68 130.79 49.5 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.243 -0.91 . . . . 0.0 109.402 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.578 ' CD1' ' CD1' ' A' ' 39' ' ' LEU . 47.1 m-85 -109.44 123.73 49.85 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.208 -0.932 . . . . 0.0 109.188 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.482 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 52.5 t-20 -48.3 -78.86 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.252 -0.905 . . . . 0.0 110.057 -179.387 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.535 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 1.4 t-20 -81.2 150.36 67.85 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.002 -1.061 . . . . 0.0 109.617 -179.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.468 ' HD2' ' CG ' ' A' ' 35' ' ' ASN . 40.7 Cg_endo -63.52 -55.5 0.7 Allowed 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 122.874 2.383 . . . . 0.0 112.037 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.535 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 13.6 t -63.31 -28.65 70.16 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.995 -1.066 . . . . 0.0 108.539 179.23 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.467 ' CG ' ' HB3' ' A' ' 35' ' ' ASN . 51.5 mmm -61.16 -17.66 54.06 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.345 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.578 ' CD1' ' CD1' ' A' ' 33' ' ' TYR . 30.7 tp -67.11 -59.0 3.83 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.269 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.469 ' HB3' ' OH ' ' A' ' 16' ' ' TYR . 8.2 t -55.8 -27.47 51.3 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.734 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 49.1 t60 -63.5 -61.09 2.56 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 63.1 mt-10 -57.47 -20.88 33.7 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 178.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.529 ' O ' ' N ' ' A' ' 47' ' ' GLN . 95.9 m-20 -80.27 -26.68 38.83 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.564 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.407 ' HA ' HD11 ' A' ' 44' ' ' LEU . 35.8 tp -71.3 -32.26 68.42 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.275 -0.891 . . . . 0.0 108.722 179.589 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 6.6 mm -80.57 -46.5 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.415 -0.803 . . . . 0.0 109.181 179.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.469 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 58.0 mtt-85 -80.12 -36.69 34.96 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.253 -0.905 . . . . 0.0 109.285 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.529 ' N ' ' O ' ' A' ' 43' ' ' ASN . 91.7 mt-30 63.89 39.8 7.92 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.535 -0.728 . . . . 0.0 109.518 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 39.6 p -101.77 6.02 41.51 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.293 -0.879 . . . . 0.0 109.415 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.462 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 49.6 t30 52.78 57.24 6.58 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.301 -0.874 . . . . 0.0 109.687 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 58.4 m -80.12 141.34 35.85 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.185 -0.947 . . . . 0.0 109.633 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . 0.462 ' CE1' ' O ' ' A' ' 49' ' ' ASN . 13.9 m80 -111.13 178.83 4.22 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.331 -0.855 . . . . 0.0 109.192 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.442 HG22 HD11 ' A' ' 52' ' ' ILE . 10.9 mt -90.25 127.22 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.123 -0.985 . . . . 0.0 109.799 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.503 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 28.4 ttt180 -80.18 -59.83 2.56 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.494 -0.754 . . . . 0.0 109.287 179.694 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 21.1 m -154.04 142.25 20.45 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.3 p -53.3 143.41 18.71 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.157 -0.965 . . . . 0.0 109.542 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.543 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 95.26 162.95 34.46 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.489 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 18.0 mttp -64.26 149.68 47.53 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.465 -1.02 . . . . 0.0 109.341 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.457 ' SG ' ' O ' ' A' ' 31' ' ' GLN . 70.2 m . . . . . 0 N--CA 1.489 1.524 0 O-C-N 121.223 -0.923 . . . . 0.0 109.41 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' MET . . . . . 0.452 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 86.4 mtp . . . . . 0 N--CA 1.488 1.466 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.575 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 27.1 m -87.15 -16.64 34.83 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.479 -0.763 . . . . 0.0 109.123 179.579 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.7 mttp -81.15 14.25 2.43 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.303 -0.873 . . . . 0.0 109.943 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.452 ' OD1' ' O ' ' A' ' 4' ' ' MET . 51.7 p30 -145.79 10.5 1.21 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.918 -1.114 . . . . 0.0 110.098 -179.698 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.645 ' CE2' ' CE2' ' A' ' 16' ' ' TYR . 1.1 p90 -119.0 150.48 39.88 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.933 -1.104 . . . . 0.0 109.546 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 57.8 mtm180 -130.01 133.82 47.0 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.237 -0.914 . . . . 0.0 109.289 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.526 HG21 ' CE2' ' A' ' 8' ' ' TYR . 54.1 t -122.92 149.98 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.202 -0.936 . . . . 0.0 109.711 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.536 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.2 OUTLIER -131.39 175.91 3.31 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.322 -0.861 . . . . 0.0 109.261 -179.971 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.536 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 43.7 Cg_endo -66.07 -22.97 54.04 Favored 'Trans proline' 0 C--O 1.214 -0.684 0 C-N-CA 122.65 2.233 . . . . 0.0 111.929 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 3.5 mtm180 -106.29 -31.77 8.47 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.301 -0.874 . . . . 0.0 109.357 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 92.9 mt -77.17 -39.33 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.374 -0.829 . . . . 0.0 109.347 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.448 ' O ' ' CG1' ' A' ' 10' ' ' VAL . . . 70.73 -162.81 53.71 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.645 ' CE2' ' CE2' ' A' ' 8' ' ' TYR . 2.0 t80 -95.01 150.55 20.04 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.211 -1.17 . . . . 0.0 109.632 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 23.0 tp -113.13 111.33 21.92 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.412 -0.805 . . . . 0.0 109.593 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.459 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 84.6 m -128.68 156.63 77.17 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.147 -0.971 . . . . 0.0 109.317 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.477 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 48.9 Cg_endo -70.82 167.53 25.57 Favored 'Trans proline' 0 C--O 1.216 -0.611 0 C-N-CA 122.717 2.278 . . . . 0.0 111.577 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 62.6 mttm -94.94 -4.56 46.54 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.255 -0.903 . . . . 0.0 109.631 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -76.69 123.98 26.97 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.206 -0.934 . . . . 0.0 109.348 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.496 HD22 ' ND2' ' A' ' 34' ' ' ASN . 3.3 tm? -82.73 119.02 23.8 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.208 -0.933 . . . . 0.0 109.498 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.474 ' O ' ' O ' ' A' ' 34' ' ' ASN . 15.5 mttp -141.88 107.51 5.87 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.302 -0.874 . . . . 0.0 109.476 179.744 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.546 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 43.3 Cg_endo -65.9 123.66 11.61 Favored 'Trans proline' 0 C--O 1.213 -0.728 0 C-N-CA 123.017 2.478 . . . . 0.0 112.14 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 29.7 m -116.32 155.02 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.265 -0.897 . . . . 0.0 109.71 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.455 ' O ' ' N ' ' A' ' 53' ' ' ARG . 43.5 t -99.27 122.94 43.12 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.428 -0.795 . . . . 0.0 108.914 179.418 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -81.45 137.99 18.36 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.49 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 47.0 p30 -68.54 -8.33 40.46 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.248 -1.148 . . . . 0.0 109.575 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.405 ' OD2' ' OG1' ' A' ' 50' ' ' THR . 75.8 m-20 -84.14 10.04 11.19 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.194 -0.941 . . . . 0.0 109.189 179.556 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.32 15.66 66.1 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.167 -1.573 . . . . 0.0 109.167 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.505 ' O ' ' N ' ' A' ' 27' ' ' GLY . 86.6 mt-30 -124.27 167.85 13.76 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.344 -1.092 . . . . 0.0 109.535 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.53 ' CG2' ' HA ' ' A' ' 57' ' ' LYS . 42.1 m -127.96 137.91 52.43 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.251 -0.906 . . . . 0.0 109.526 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.622 ' CD1' ' CD1' ' A' ' 39' ' ' LEU . 71.4 m-85 -113.79 129.26 56.6 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.288 -0.882 . . . . 0.0 109.28 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.496 ' ND2' HD22 ' A' ' 22' ' ' LEU . 45.4 t-20 -51.09 -78.95 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.363 -0.836 . . . . 0.0 110.255 -179.197 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.53 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 1.7 t-20 -81.6 149.91 65.46 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 120.964 -1.085 . . . . 0.0 109.762 -179.492 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.458 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.9 Cg_endo -63.88 -55.53 0.64 Allowed 'Trans proline' 0 C--O 1.215 -0.674 0 C-N-CA 122.765 2.31 . . . . 0.0 111.864 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.53 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 12.9 t -61.41 -30.58 70.65 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.022 -1.049 . . . . 0.0 108.175 179.097 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.515 ' CG ' ' HB3' ' A' ' 35' ' ' ASN . 65.0 mmm -61.41 -15.15 34.05 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.016 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.622 ' CD1' ' CD1' ' A' ' 33' ' ' TYR . 37.8 tp -68.94 -58.55 3.97 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.434 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.452 ' HB3' ' OH ' ' A' ' 16' ' ' TYR . 19.5 t -53.28 -29.34 32.72 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 179.001 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 48.1 t60 -64.19 -61.57 2.17 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.426 ' HA ' ' OE1' ' A' ' 42' ' ' GLU . 71.2 mm-40 -56.06 -20.3 16.44 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.412 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.517 ' O ' ' N ' ' A' ' 47' ' ' GLN . 97.3 m-20 -79.44 -24.75 42.23 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.752 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.485 ' CD1' ' C ' ' A' ' 44' ' ' LEU . 1.7 tm? -71.86 -37.34 70.25 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.333 -0.855 . . . . 0.0 108.766 179.35 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.8 mm -75.92 -44.68 38.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.404 -0.81 . . . . 0.0 109.232 179.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.459 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 14.7 mtt-85 -79.61 -37.72 35.53 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.359 -0.838 . . . . 0.0 109.19 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.517 ' N ' ' O ' ' A' ' 43' ' ' ASN . 91.6 mt-30 62.06 40.46 12.05 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.334 -0.854 . . . . 0.0 109.469 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.414 ' O ' ' C ' ' A' ' 49' ' ' ASN . 62.4 p -107.53 17.22 22.96 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.239 -0.913 . . . . 0.0 109.45 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.567 ' OD1' ' CE1' ' A' ' 51' ' ' HIS . 13.4 t-20 44.82 58.61 3.86 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.294 -0.879 . . . . 0.0 109.511 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.453 ' HB ' ' OD1' ' A' ' 43' ' ' ASN . 50.1 m -80.32 147.28 31.19 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.212 -0.93 . . . . 0.0 109.715 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . 0.567 ' CE1' ' OD1' ' A' ' 49' ' ' ASN . 30.6 m-70 -122.16 169.78 10.53 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.345 -0.847 . . . . 0.0 108.988 179.497 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.441 HD11 HG22 ' A' ' 52' ' ' ILE . 10.7 mt -81.2 122.29 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.15 -0.969 . . . . 0.0 109.611 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.49 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 56.5 ttt180 -79.9 -44.84 19.68 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.436 -0.79 . . . . 0.0 109.301 179.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.4 t -157.95 154.4 27.73 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.43 -0.794 . . . . 0.0 109.195 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.6 p -73.31 132.46 43.12 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.22 -0.925 . . . . 0.0 109.568 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.546 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 100.16 164.2 28.7 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.53 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 39.7 tttt -50.2 150.31 2.51 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.443 -1.033 . . . . 0.0 109.263 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 36.2 m . . . . . 0 N--CA 1.49 1.541 0 O-C-N 121.179 -0.951 . . . . 0.0 109.42 -179.875 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' MET . . . . . 0.428 ' O ' ' CG ' ' A' ' 7' ' ' ASP . 67.8 mmm . . . . . 0 N--CA 1.489 1.482 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 35.1 m -80.91 -17.17 51.47 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.376 -0.827 . . . . 0.0 109.198 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 34.3 mttp -80.28 8.18 7.97 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.313 -0.867 . . . . 0.0 109.665 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.428 ' CG ' ' O ' ' A' ' 4' ' ' MET . 17.4 p30 -117.45 -10.93 10.59 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.182 -0.948 . . . . 0.0 109.638 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.58 ' OH ' ' CZ ' ' A' ' 16' ' ' TYR . 1.5 p90 -104.3 171.28 7.42 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.159 -0.963 . . . . 0.0 109.546 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 85.9 mtt180 -131.42 157.06 44.46 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.294 -0.879 . . . . 0.0 109.215 179.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.456 HG22 ' HA ' ' A' ' 16' ' ' TYR . 14.5 p -136.97 158.35 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.166 -0.959 . . . . 0.0 109.816 -179.562 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.53 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 1.6 mp -108.2 175.36 2.02 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.265 -0.897 . . . . 0.0 109.354 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.53 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 45.7 Cg_endo -67.56 -27.71 38.81 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 122.589 2.193 . . . . 0.0 111.682 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 37.6 mtm180 -84.15 -38.75 20.28 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.381 -0.824 . . . . 0.0 109.055 179.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.483 ' CG2' ' HG ' ' A' ' 17' ' ' LEU . 98.7 mt -77.12 -34.79 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.381 -0.824 . . . . 0.0 109.024 179.62 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.447 ' C ' ' CG2' ' A' ' 10' ' ' VAL . . . 68.2 -65.45 0.37 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 179.733 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.58 ' CZ ' ' OH ' ' A' ' 8' ' ' TYR . 1.2 t80 -160.59 150.82 18.0 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.31 -1.112 . . . . 0.0 109.328 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.578 ' N ' ' CD1' ' A' ' 17' ' ' LEU . 0.4 OUTLIER -123.07 141.61 51.78 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.25 -0.906 . . . . 0.0 109.472 179.976 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.45 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 75.0 m -146.26 158.01 48.39 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.308 -0.87 . . . . 0.0 109.15 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.488 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 46.6 Cg_endo -69.93 165.3 31.63 Favored 'Trans proline' 0 C--O 1.214 -0.695 0 C-N-CA 122.494 2.129 . . . . 0.0 111.308 179.739 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -91.81 -8.52 46.42 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.204 -0.935 . . . . 0.0 109.508 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 -74.54 129.48 37.82 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.274 -0.891 . . . . 0.0 109.218 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.496 ' CD1' ' C ' ' A' ' 22' ' ' LEU . 3.4 tm? -87.92 121.24 30.09 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.207 -0.933 . . . . 0.0 109.37 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.47 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 14.0 mttt -144.3 109.39 4.95 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.091 -1.006 . . . . 0.0 109.717 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.533 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 44.1 Cg_endo -66.58 122.84 10.33 Favored 'Trans proline' 0 C--O 1.214 -0.706 0 C-N-CA 122.947 2.431 . . . . 0.0 111.899 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 8.7 m -117.46 156.9 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.22 -0.925 . . . . 0.0 109.858 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 45.5 t -97.54 136.62 37.69 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 178.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -94.04 135.19 12.4 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 -179.482 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.475 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 49.0 p30 -64.26 -11.31 30.27 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.303 -1.116 . . . . 0.0 109.349 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.463 ' OD1' ' HB2' ' A' ' 31' ' ' GLN . 58.0 p30 -84.24 9.49 12.79 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.323 -0.861 . . . . 0.0 109.488 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 83.87 23.51 52.43 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.463 ' HB2' ' OD1' ' A' ' 29' ' ' ASP . 67.8 mt-30 -129.17 171.71 12.16 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.312 -1.11 . . . . 0.0 109.409 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.532 ' CG2' ' HA ' ' A' ' 57' ' ' LYS . 24.0 m -131.12 139.42 49.82 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.284 -0.885 . . . . 0.0 109.26 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.581 ' CD1' HD11 ' A' ' 39' ' ' LEU . 70.9 m-85 -118.68 131.62 56.16 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.277 -0.889 . . . . 0.0 109.416 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.496 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 53.5 t-20 -51.65 -79.09 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.374 -0.829 . . . . 0.0 110.174 -179.381 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.527 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 1.9 t-20 -81.39 149.41 65.21 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 120.932 -1.105 . . . . 0.0 109.597 -179.553 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.47 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.4 Cg_endo -63.28 -55.1 0.81 Allowed 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 122.685 2.257 . . . . 0.0 111.884 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.527 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 10.6 t -60.06 -33.22 71.76 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 120.996 -1.065 . . . . 0.0 108.128 178.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.463 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 39.7 mmm -55.63 -20.21 13.08 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.086 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.581 HD11 ' CD1' ' A' ' 33' ' ' TYR . 51.5 tp -68.48 -46.59 69.28 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.563 -0.711 . . . . 0.0 109.098 179.612 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.466 ' HB2' ' OH ' ' A' ' 16' ' ' TYR . 3.2 m -69.04 -21.25 64.12 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 179.15 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 41.0 t60 -67.21 -54.83 17.46 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 178.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.416 ' HA ' ' OE1' ' A' ' 42' ' ' GLU . 68.6 mm-40 -62.51 -19.99 64.16 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 178.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.527 ' O ' ' N ' ' A' ' 47' ' ' GLN . 83.1 m-20 -80.27 -24.27 40.2 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 23.3 tp -73.24 -31.82 64.35 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.1 mm -80.11 -48.2 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.381 -0.824 . . . . 0.0 108.937 179.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.467 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 63.7 mtt-85 -80.66 -33.79 35.31 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.267 -0.896 . . . . 0.0 109.353 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.527 ' N ' ' O ' ' A' ' 43' ' ' ASN . 91.7 mt-30 63.31 38.54 10.2 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.386 -0.822 . . . . 0.0 109.659 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 55.1 p -101.68 3.84 40.13 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.21 -0.931 . . . . 0.0 109.452 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 63.9 m-20 54.64 58.08 5.18 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.227 -0.921 . . . . 0.0 109.427 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 31.6 m -78.46 139.22 38.72 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.239 -0.913 . . . . 0.0 109.589 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 49.3 m-70 -113.63 167.38 10.66 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.303 -0.873 . . . . 0.0 108.893 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.491 HD11 HG22 ' A' ' 52' ' ' ILE . 36.9 mt -79.63 125.59 38.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.169 -0.957 . . . . 0.0 109.256 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.475 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 69.9 ttt-85 -81.3 -38.61 26.5 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.415 -0.803 . . . . 0.0 109.346 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -160.45 151.16 18.59 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.47 -0.769 . . . . 0.0 109.084 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.3 p -70.46 143.59 51.71 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.168 -0.958 . . . . 0.0 109.467 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.533 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 88.87 164.37 40.28 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.532 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 33.8 ttpt -54.53 151.08 8.31 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.474 -1.016 . . . . 0.0 109.442 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.454 ' SG ' ' OG1' ' A' ' 32' ' ' THR . 88.8 m . . . . . 0 N--CA 1.489 1.481 0 O-C-N 121.247 -0.908 . . . . 0.0 109.446 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 84.3 mtp . . . . . 0 N--CA 1.489 1.497 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.571 ' SG ' ' CE1' ' A' ' 8' ' ' TYR . 10.6 t -84.19 -8.23 59.12 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.464 -0.772 . . . . 0.0 109.069 179.518 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.7 pttp -57.46 -15.7 7.6 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.32 -0.863 . . . . 0.0 109.733 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 51.0 p-10 -159.03 32.66 0.21 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.043 -1.035 . . . . 0.0 109.811 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.571 ' CE1' ' SG ' ' A' ' 5' ' ' CYS . 5.1 p90 -79.71 175.61 10.47 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.119 -0.988 . . . . 0.0 109.194 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 53.7 mtm180 -143.98 136.43 26.85 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.145 -0.972 . . . . 0.0 109.911 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.418 HG12 ' C ' ' A' ' 15' ' ' GLY . 23.4 t -137.41 135.61 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.371 -0.83 . . . . 0.0 109.097 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.486 ' HB3' ' HD2' ' A' ' 12' ' ' PRO . 1.6 mp -102.83 172.4 4.33 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.231 -0.918 . . . . 0.0 109.701 -179.532 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.486 ' HD2' ' HB3' ' A' ' 11' ' ' LEU . 45.7 Cg_endo -67.68 -22.78 43.31 Favored 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 122.637 2.225 . . . . 0.0 111.563 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 82.1 mtt180 -99.8 -24.96 14.53 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.341 -0.849 . . . . 0.0 109.16 179.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 79.2 mt -85.34 -47.3 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.312 -0.867 . . . . 0.0 109.428 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.418 ' C ' HG12 ' A' ' 10' ' ' VAL . . . 71.58 -169.54 49.91 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.581 ' CB ' ' NE2' ' A' ' 41' ' ' HIS . 0.8 OUTLIER -92.36 150.2 20.97 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.259 -1.142 . . . . 0.0 109.591 -179.94 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.488 ' CD1' ' C ' ' A' ' 17' ' ' LEU . 2.3 tm? -119.66 105.35 11.1 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.254 -0.904 . . . . 0.0 109.309 179.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.424 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 58.5 m -118.75 155.64 52.39 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.305 -0.872 . . . . 0.0 109.305 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -72.42 171.73 16.43 Favored 'Trans proline' 0 C--O 1.215 -0.667 0 C-N-CA 122.618 2.212 . . . . 0.0 111.324 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 45.0 mttp -91.45 -23.32 20.04 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.213 -0.93 . . . . 0.0 109.355 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -62.34 130.49 45.52 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.339 -0.85 . . . . 0.0 109.179 179.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 24.0 tp -90.72 111.83 23.35 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.211 -0.931 . . . . 0.0 109.805 -179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.479 ' O ' ' O ' ' A' ' 34' ' ' ASN . 0.0 OUTLIER -123.28 108.64 31.71 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.324 -0.86 . . . . 0.0 108.87 179.637 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.526 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 43.6 Cg_endo -66.16 119.58 6.62 Favored 'Trans proline' 0 C--O 1.214 -0.713 0 C-N-CA 122.865 2.377 . . . . 0.0 112.052 -179.417 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.46 ' HB ' HG22 ' A' ' 52' ' ' ILE . 11.2 m -112.57 155.31 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.418 -0.801 . . . . 0.0 109.512 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.408 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 43.4 t -97.07 141.4 30.27 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -98.47 133.85 11.48 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 -179.365 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.487 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 37.5 p30 -61.83 -12.49 17.67 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.315 -1.109 . . . . 0.0 109.586 179.754 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.42 ' CG ' HG22 ' A' ' 50' ' ' THR . 73.3 m-20 -87.01 15.46 5.98 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.21 -0.931 . . . . 0.0 109.414 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 79.37 19.41 71.72 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.471 ' O ' ' SG ' ' A' ' 58' ' ' CYS . 44.5 mt-30 -120.95 179.33 4.4 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.152 -1.205 . . . . 0.0 109.496 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.496 ' CG2' ' HA ' ' A' ' 57' ' ' LYS . 14.5 m -143.36 137.2 28.57 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.264 -0.897 . . . . 0.0 109.557 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.569 ' CD1' HD13 ' A' ' 39' ' ' LEU . 41.2 m-85 -113.03 134.8 54.35 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.364 -0.835 . . . . 0.0 109.46 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.48 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 9.9 m-20 -54.16 -78.06 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.322 -0.861 . . . . 0.0 109.785 -179.652 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.53 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 4.1 t-20 -81.88 147.72 59.1 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.018 -1.051 . . . . 0.0 109.022 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.46 ' HD3' ' O ' ' A' ' 23' ' ' LYS . 41.7 Cg_endo -63.97 -52.55 1.63 Allowed 'Trans proline' 0 C--O 1.215 -0.629 0 C-N-CA 122.522 2.148 . . . . 0.0 111.758 -179.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.53 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 11.3 t -62.09 -29.03 70.03 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.078 -1.014 . . . . 0.0 108.324 179.021 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.48 ' HB2' ' HB3' ' A' ' 35' ' ' ASN . 35.3 mmm -69.04 -12.82 62.03 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.566 -0.709 . . . . 0.0 109.278 179.52 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.569 HD13 ' CD1' ' A' ' 33' ' ' TYR . 9.6 tt -67.97 -52.55 34.62 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.189 -0.945 . . . . 0.0 108.955 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.483 ' SG ' ' CE1' ' A' ' 8' ' ' TYR . 9.3 t -61.46 -34.17 74.99 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 179.19 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.581 ' NE2' ' CB ' ' A' ' 16' ' ' TYR . 0.2 OUTLIER -50.94 -46.69 61.03 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 178.51 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -66.11 -32.08 73.32 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.08 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.52 ' ND2' ' O ' ' A' ' 50' ' ' THR . 34.0 m-20 -68.74 -23.47 64.34 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.51 -0.744 . . . . 0.0 109.396 179.683 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.466 ' CD1' ' C ' ' A' ' 44' ' ' LEU . 2.4 tm? -72.2 -36.4 69.19 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.285 -0.884 . . . . 0.0 109.66 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.436 HD12 HD11 ' A' ' 44' ' ' LEU . 4.8 mm -78.04 -46.04 26.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.242 -0.911 . . . . 0.0 109.381 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.46 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 14.4 mtt-85 -81.73 -33.19 31.19 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.289 -0.882 . . . . 0.0 109.611 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.474 ' N ' ' O ' ' A' ' 43' ' ' ASN . 92.0 mt-30 62.49 33.76 15.83 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.272 -0.892 . . . . 0.0 109.63 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 58.9 p -95.65 7.43 46.31 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.224 -0.922 . . . . 0.0 109.415 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.577 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 57.8 t30 52.63 49.0 21.32 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.276 -0.89 . . . . 0.0 109.649 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.52 ' O ' ' ND2' ' A' ' 43' ' ' ASN . 39.4 m -80.78 149.05 29.78 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.37 -0.831 . . . . 0.0 109.359 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . 0.577 ' CE1' ' O ' ' A' ' 49' ' ' ASN . 13.6 m80 -127.21 -176.76 3.82 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.189 -0.945 . . . . 0.0 109.348 179.688 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.499 HD11 HG22 ' A' ' 52' ' ' ILE . 29.4 mt -84.89 128.13 39.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 O-C-N 121.39 -0.819 . . . . 0.0 109.46 179.709 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.487 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 42.3 ttt85 -83.83 -38.55 21.08 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.321 -0.862 . . . . 0.0 109.059 179.765 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -160.75 148.83 16.08 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 27.0 p -67.17 135.97 54.33 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.123 -0.986 . . . . 0.0 109.462 -179.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.526 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 95.2 161.87 34.16 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.496 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 47.5 tttp -50.03 148.23 3.46 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.402 -1.058 . . . . 0.0 109.287 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.471 ' SG ' ' O ' ' A' ' 31' ' ' GLN . 95.6 m . . . . . 0 N--CA 1.491 1.575 0 O-C-N 121.309 -0.869 . . . . 0.0 109.568 -179.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 82.8 mtp . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.534 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 70.2 m -79.92 -20.77 44.93 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.324 -0.86 . . . . 0.0 109.217 179.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 33.4 mttt -80.63 7.46 10.06 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.194 -0.941 . . . . 0.0 109.391 179.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -123.18 -3.63 8.49 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.199 -0.938 . . . . 0.0 110.217 -179.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.687 ' CE2' ' CZ ' ' A' ' 16' ' ' TYR . 2.1 p90 -114.57 173.0 6.68 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.959 -1.088 . . . . 0.0 109.848 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 39.5 ptt180 -157.34 134.47 10.3 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.474 HG23 ' HA ' ' A' ' 16' ' ' TYR . 79.9 t -116.79 145.41 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.226 -0.921 . . . . 0.0 110.215 -179.071 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.536 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 2.1 mp -117.67 175.81 1.87 Allowed Pre-proline 0 N--CA 1.49 1.527 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.536 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 44.7 Cg_endo -67.56 -22.52 44.39 Favored 'Trans proline' 0 C--O 1.216 -0.621 0 C-N-CA 122.451 2.101 . . . . 0.0 111.81 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 63.1 mtt180 -113.63 -22.44 10.27 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.294 -0.879 . . . . 0.0 109.64 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.451 ' CD1' ' HB2' ' A' ' 11' ' ' LEU . 92.4 mt -78.23 -44.35 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.216 -0.927 . . . . 0.0 109.504 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.421 ' C ' HG12 ' A' ' 10' ' ' VAL . . . 74.94 -165.33 54.74 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.687 ' CZ ' ' CE2' ' A' ' 8' ' ' TYR . 0.9 OUTLIER -93.76 149.55 21.14 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.16 -1.2 . . . . 0.0 109.557 179.999 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 16.8 tp -119.61 115.54 24.18 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.288 -0.883 . . . . 0.0 109.688 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.4 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 75.6 m -126.07 156.8 71.38 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.292 -0.88 . . . . 0.0 109.177 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.436 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 50.5 Cg_endo -71.35 167.33 26.6 Favored 'Trans proline' 0 C--O 1.216 -0.59 0 C-N-CA 122.64 2.227 . . . . 0.0 111.685 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.4 mttt -86.59 -23.43 25.77 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.271 -0.893 . . . . 0.0 109.328 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -63.21 130.48 44.74 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.29 -0.881 . . . . 0.0 109.241 179.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 48.7 tp -93.83 117.47 30.14 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.184 -0.947 . . . . 0.0 109.541 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.487 ' O ' ' O ' ' A' ' 34' ' ' ASN . 0.1 OUTLIER -129.1 106.52 17.93 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.324 -0.86 . . . . 0.0 108.941 179.719 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.538 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 43.2 Cg_endo -65.1 119.91 7.04 Favored 'Trans proline' 0 C--O 1.213 -0.765 0 C-N-CA 122.93 2.42 . . . . 0.0 112.086 -179.564 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.455 ' HB ' HG22 ' A' ' 52' ' ' ILE . 35.6 m -116.5 153.74 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.336 -0.852 . . . . 0.0 109.688 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 43.0 t -96.05 135.52 37.72 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.354 -0.841 . . . . 0.0 108.787 179.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -92.44 139.12 14.51 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -179.585 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.492 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 50.9 p30 -68.5 -7.86 36.01 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.366 -1.079 . . . . 0.0 109.579 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.437 ' OD1' ' HB2' ' A' ' 31' ' ' GLN . 56.6 p30 -88.52 9.21 24.62 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.163 -0.961 . . . . 0.0 109.35 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.23 13.99 64.97 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.464 ' O ' ' N ' ' A' ' 27' ' ' GLY . 83.2 mt-30 -120.26 171.97 8.12 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.278 -1.131 . . . . 0.0 109.447 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.531 ' CG2' ' HA ' ' A' ' 57' ' ' LYS . 25.9 m -133.95 138.31 45.39 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.248 -0.908 . . . . 0.0 109.353 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.635 ' CE1' ' CD1' ' A' ' 39' ' ' LEU . 28.7 m-85 -113.0 128.5 56.52 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.28 -0.888 . . . . 0.0 109.205 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.487 ' O ' ' O ' ' A' ' 23' ' ' LYS . 13.1 m-20 -51.66 -78.17 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.239 -0.913 . . . . 0.0 109.692 -179.543 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.533 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 5.1 t-20 -81.85 147.9 59.69 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.171 -0.956 . . . . 0.0 109.688 -179.692 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.466 ' HD2' ' CG ' ' A' ' 35' ' ' ASN . 40.5 Cg_endo -63.22 -52.98 1.7 Allowed 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.766 2.311 . . . . 0.0 111.909 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.533 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 9.2 t -62.54 -28.36 69.8 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 120.97 -1.081 . . . . 0.0 108.11 178.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.457 ' CG ' ' HB3' ' A' ' 35' ' ' ASN . 49.7 mmm -64.75 -14.2 57.92 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.377 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.635 ' CD1' ' CE1' ' A' ' 33' ' ' TYR . 23.7 tp -71.68 -65.33 0.77 Allowed 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 179.284 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.456 ' HB3' ' OH ' ' A' ' 16' ' ' TYR . 8.5 t -49.25 -28.33 4.56 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 66.5 t60 -63.02 -62.54 1.64 Allowed 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 77.2 tt0 -59.13 -19.08 41.58 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.511 ' O ' ' N ' ' A' ' 47' ' ' GLN . 98.1 m-20 -78.16 -29.65 48.74 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.391 -0.818 . . . . 0.0 108.815 179.425 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 17.6 tp -72.37 -27.75 62.58 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.313 -0.867 . . . . 0.0 108.847 179.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.3 mt -79.87 -49.64 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.321 -0.862 . . . . 0.0 108.9 179.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.468 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 52.8 mtt180 -80.73 -32.82 35.58 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.338 -0.851 . . . . 0.0 109.307 179.749 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.511 ' N ' ' O ' ' A' ' 43' ' ' ASN . 92.1 mt-30 62.62 36.68 13.49 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.373 -0.829 . . . . 0.0 109.627 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 59.5 p -96.21 2.45 53.02 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.217 -0.927 . . . . 0.0 109.585 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.4 m120 58.0 54.76 5.75 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.251 -0.905 . . . . 0.0 109.449 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.411 HG21 ' N ' ' A' ' 51' ' ' HIS . 43.3 m -79.94 144.06 33.66 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.292 -0.88 . . . . 0.0 109.68 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . 0.411 ' N ' HG21 ' A' ' 50' ' ' THR . 30.5 m-70 -118.62 173.5 6.81 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.329 -0.857 . . . . 0.0 109.023 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.51 HD11 HG22 ' A' ' 52' ' ' ILE . 12.0 mt -84.38 123.99 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.16 -0.962 . . . . 0.0 109.472 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.492 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 45.2 ttt85 -79.75 -43.0 23.39 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.297 -0.877 . . . . 0.0 109.248 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.8 t -160.02 155.09 24.77 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.9 p -72.56 132.83 44.31 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.198 -0.939 . . . . 0.0 109.483 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.538 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 99.07 164.49 29.93 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -179.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.531 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 71.1 tttt -53.13 148.4 8.27 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.429 -1.042 . . . . 0.0 109.397 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.419 ' SG ' ' OG1' ' A' ' 32' ' ' THR . 91.2 m . . . . . 0 N--CA 1.491 1.61 0 O-C-N 121.263 -0.898 . . . . 0.0 109.376 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' MET . . . . . 0.402 ' HE1' ' HB2' ' A' ' 4' ' ' MET . 44.4 ttm . . . . . 0 N--CA 1.488 1.465 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.584 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 15.6 m -79.56 -12.7 59.84 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.498 -0.751 . . . . 0.0 108.974 179.523 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.1 mtmp? -56.58 -24.54 48.1 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.255 -0.903 . . . . 0.0 109.714 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 64.8 m-20 -149.71 64.49 0.99 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.136 -0.978 . . . . 0.0 110.334 -179.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.597 ' CE2' ' CE2' ' A' ' 16' ' ' TYR . 5.0 p90 -131.44 170.25 14.94 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.045 -1.034 . . . . 0.0 109.359 179.259 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.406 ' HG3' ' N ' ' A' ' 10' ' ' VAL . 12.5 tpt180 -145.32 150.13 36.06 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.21 -0.932 . . . . 0.0 109.593 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.443 HG22 ' CD2' ' A' ' 16' ' ' TYR . 71.0 t -141.63 130.98 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.239 -0.913 . . . . 0.0 109.315 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.473 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 2.5 mp -118.56 172.86 3.8 Favored Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 121.321 -0.862 . . . . 0.0 109.317 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.473 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 46.5 Cg_endo -68.38 -24.96 36.34 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 122.575 2.184 . . . . 0.0 111.614 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 54.5 mtt180 -104.68 -26.04 12.46 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.262 -0.899 . . . . 0.0 109.254 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 87.9 mt -84.54 -46.88 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.267 -0.896 . . . . 0.0 109.41 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 77.73 -155.51 43.14 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.597 ' CE2' ' CE2' ' A' ' 8' ' ' TYR . 2.5 t80 -105.4 152.56 22.82 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.307 -1.114 . . . . 0.0 109.503 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 34.6 tp -113.74 119.21 36.6 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.231 -0.918 . . . . 0.0 109.725 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 75.9 m -130.15 157.22 77.76 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.316 -0.865 . . . . 0.0 109.603 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.474 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 52.5 Cg_endo -72.55 168.93 23.06 Favored 'Trans proline' 0 C--O 1.215 -0.629 0 C-N-CA 122.762 2.308 . . . . 0.0 111.591 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 41.3 mmtt -89.61 -13.09 37.9 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.203 -0.936 . . . . 0.0 109.334 179.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -67.98 131.8 46.14 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.296 -0.878 . . . . 0.0 109.38 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.494 ' CD1' ' C ' ' A' ' 22' ' ' LEU . 3.3 tm? -90.63 123.65 34.42 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.263 -0.898 . . . . 0.0 109.332 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.496 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 15.4 mttp -145.6 105.8 4.31 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.156 -0.965 . . . . 0.0 109.657 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.537 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 44.1 Cg_endo -65.85 120.84 8.08 Favored 'Trans proline' 0 C--O 1.214 -0.705 0 C-N-CA 123.116 2.544 . . . . 0.0 112.324 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.433 ' HB ' HG22 ' A' ' 52' ' ' ILE . 19.7 m -116.18 154.57 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.382 -0.824 . . . . 0.0 109.35 179.562 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.418 ' O ' ' N ' ' A' ' 53' ' ' ARG . 41.6 t -96.07 138.26 33.95 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 178.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -95.6 139.21 14.37 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.726 -1.349 . . . . 0.0 109.726 -179.285 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.472 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 48.5 p30 -65.38 -11.15 39.52 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.38 -1.07 . . . . 0.0 109.454 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.453 ' OD1' ' HB2' ' A' ' 31' ' ' GLN . 59.0 p30 -83.09 7.33 16.19 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.226 -0.921 . . . . 0.0 109.398 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.22 22.59 51.41 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.456 ' O ' ' SG ' ' A' ' 58' ' ' CYS . 75.5 mt-30 -129.3 175.37 8.79 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.291 -1.123 . . . . 0.0 109.375 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.543 ' CG2' ' HA ' ' A' ' 57' ' ' LYS . 13.0 m -131.83 140.21 49.07 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.258 -0.901 . . . . 0.0 109.816 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.63 ' CD2' ' CD1' ' A' ' 39' ' ' LEU . 44.7 m-85 -115.86 127.15 54.81 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.431 -0.793 . . . . 0.0 109.139 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.5 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 41.1 t-20 -49.01 -78.98 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.299 -0.876 . . . . 0.0 110.032 -179.425 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.542 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 4.6 t-20 -81.14 147.28 60.62 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 120.863 -1.148 . . . . 0.0 109.263 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.496 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.8 Cg_endo -63.44 -52.89 1.66 Allowed 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 122.701 2.267 . . . . 0.0 111.849 -179.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.542 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 5.8 t -61.78 -28.23 69.31 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 178.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.418 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 35.7 mmm -65.51 -12.45 52.88 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.292 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.63 ' CD1' ' CD2' ' A' ' 33' ' ' TYR . 8.4 tt -72.99 -57.63 3.9 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.284 -0.885 . . . . 0.0 108.849 179.602 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.519 ' O ' ' HB2' ' A' ' 43' ' ' ASN . 2.2 t -46.59 -45.18 18.74 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 179.064 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.474 ' ND1' ' HB2' ' A' ' 16' ' ' TYR . 13.9 t60 -48.46 -50.37 31.66 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.062 -1.024 . . . . 0.0 108.309 178.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.578 ' HG3' ' CE1' ' A' ' 33' ' ' TYR . 34.2 mm-40 -56.41 -19.21 13.87 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.567 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.519 ' HB2' ' O ' ' A' ' 40' ' ' CYS . 2.3 m-80 -78.59 -35.33 45.9 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 119.471 -0.892 . . . . 0.0 108.617 179.209 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.516 ' CD2' ' OH ' ' A' ' 8' ' ' TYR . 40.3 mt -72.07 -30.79 65.48 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.332 -0.855 . . . . 0.0 109.302 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.469 HG13 ' O ' ' A' ' 41' ' ' HIS . 2.5 mt -79.74 -51.12 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.279 -0.888 . . . . 0.0 109.378 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.457 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 93.3 mtt-85 -80.3 -32.92 38.0 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.337 -0.852 . . . . 0.0 109.267 179.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.49 ' N ' ' O ' ' A' ' 43' ' ' ASN . 91.9 mt-30 62.19 40.22 11.91 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.403 -0.811 . . . . 0.0 109.537 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 35.6 p -113.63 5.62 16.59 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.32 -0.863 . . . . 0.0 109.541 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.566 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 11.8 t-20 62.39 50.91 3.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.236 -0.915 . . . . 0.0 109.45 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.519 ' N ' ' OD1' ' A' ' 43' ' ' ASN . 99.6 m -78.87 134.7 36.91 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.298 -0.876 . . . . 0.0 109.729 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . 0.566 ' CE1' ' O ' ' A' ' 49' ' ' ASN . 8.0 m80 -115.98 -170.13 1.73 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.218 -0.926 . . . . 0.0 109.167 179.558 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.483 HD11 HG22 ' A' ' 52' ' ' ILE . 20.4 mt -92.91 122.97 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.306 -0.872 . . . . 0.0 109.445 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.472 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 46.9 ttt-85 -81.1 -41.62 22.23 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.304 -0.872 . . . . 0.0 109.542 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.0 p -160.45 145.01 14.33 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.543 -0.723 . . . . 0.0 109.505 -179.434 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 20.2 p -63.62 139.51 58.78 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.244 -0.91 . . . . 0.0 109.401 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.537 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 90.76 163.13 38.74 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.543 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 48.1 tttp -49.46 148.65 2.64 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.498 -1.001 . . . . 0.0 109.48 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.456 ' SG ' ' O ' ' A' ' 31' ' ' GLN . 57.8 m . . . . . 0 N--CA 1.491 1.588 0 O-C-N 121.257 -0.902 . . . . 0.0 109.426 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 92.8 mmm . . . . . 0 N--CA 1.488 1.438 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 3.8 m -80.03 4.58 16.61 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.457 -0.777 . . . . 0.0 109.109 179.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.2 mttm -57.65 -30.13 65.15 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.082 -1.011 . . . . 0.0 109.514 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -143.29 69.94 1.31 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.281 -0.887 . . . . 0.0 109.938 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.552 ' CD1' ' N ' ' A' ' 9' ' ' ARG . 18.4 p90 -115.04 -172.88 2.21 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.125 -0.985 . . . . 0.0 109.311 179.605 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.552 ' N ' ' CD1' ' A' ' 8' ' ' TYR . 86.0 mtt180 -149.64 145.57 26.82 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.189 -0.944 . . . . 0.0 109.466 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.457 HG21 ' O ' ' A' ' 9' ' ' ARG . 34.0 t -148.11 142.66 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.284 -0.885 . . . . 0.0 109.17 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.485 ' HB3' ' HD2' ' A' ' 12' ' ' PRO . 1.4 mp -116.13 171.93 4.24 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.204 -0.935 . . . . 0.0 109.844 -179.536 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.485 ' HD2' ' HB3' ' A' ' 11' ' ' LEU . 48.2 Cg_endo -68.45 -23.77 37.27 Favored 'Trans proline' 0 C--O 1.215 -0.659 0 C-N-CA 122.628 2.219 . . . . 0.0 111.73 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 53.0 mtt180 -100.27 -23.86 14.69 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.288 -0.882 . . . . 0.0 109.17 179.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 97.6 mt -88.84 -40.91 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.306 -0.871 . . . . 0.0 109.774 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 70.53 -174.92 37.95 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.49 ' HB2' ' CE1' ' A' ' 41' ' ' HIS . 1.3 t80 -81.61 154.78 25.98 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.17 -1.194 . . . . 0.0 109.417 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 34.0 tp -112.65 117.92 33.62 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.215 -0.928 . . . . 0.0 109.749 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 76.9 m -134.86 156.54 78.42 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.267 -0.896 . . . . 0.0 109.423 179.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.453 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 51.5 Cg_endo -71.4 168.79 22.5 Favored 'Trans proline' 0 C--O 1.215 -0.674 0 C-N-CA 122.692 2.261 . . . . 0.0 111.83 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -93.11 -3.89 53.29 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.263 -0.898 . . . . 0.0 109.52 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -79.08 130.16 35.22 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.212 -0.93 . . . . 0.0 109.307 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.487 ' CD1' ' C ' ' A' ' 22' ' ' LEU . 3.1 tm? -85.77 124.12 31.91 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.246 -0.909 . . . . 0.0 109.447 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.511 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 29.4 mttp -144.05 103.1 4.8 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.194 -0.941 . . . . 0.0 109.468 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.536 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 44.0 Cg_endo -65.35 121.92 9.48 Favored 'Trans proline' 0 C--O 1.214 -0.719 0 C-N-CA 123.133 2.555 . . . . 0.0 112.064 -179.689 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.462 ' HB ' HG22 ' A' ' 52' ' ' ILE . 13.9 m -120.26 154.86 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.272 -0.892 . . . . 0.0 110.05 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.423 ' O ' ' N ' ' A' ' 53' ' ' ARG . 13.3 t -99.95 131.52 45.87 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.034 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -89.23 138.83 14.9 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 -179.688 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.478 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 38.1 p30 -65.86 -10.05 34.63 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.357 -1.084 . . . . 0.0 109.66 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.4 ' OD2' ' OG1' ' A' ' 50' ' ' THR . 59.1 m-20 -85.64 10.55 13.02 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.241 -0.912 . . . . 0.0 109.44 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 81.9 27.65 45.06 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.442 ' O ' ' N ' ' A' ' 27' ' ' GLY . 94.1 mt-30 -131.04 161.31 32.29 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.289 -1.124 . . . . 0.0 109.384 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.509 HG22 ' CB ' ' A' ' 57' ' ' LYS . 98.8 m -122.35 135.04 54.64 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.134 -0.979 . . . . 0.0 109.36 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.562 ' CG ' HD11 ' A' ' 39' ' ' LEU . 47.8 m-85 -116.45 125.2 51.65 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.312 -0.867 . . . . 0.0 109.293 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.5 ' O ' ' O ' ' A' ' 23' ' ' LYS . 40.2 t-20 -48.56 -79.76 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.393 -0.817 . . . . 0.0 109.97 -179.386 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.533 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 5.4 t-20 -80.9 146.96 60.7 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 120.851 -1.156 . . . . 0.0 109.415 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.511 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.1 Cg_endo -62.7 -53.13 1.87 Allowed 'Trans proline' 0 C--O 1.216 -0.594 0 C-N-CA 122.902 2.401 . . . . 0.0 111.875 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.533 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 8.9 t -62.75 -27.9 69.6 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.005 -1.059 . . . . 0.0 108.212 178.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.46 ' HB2' ' HB3' ' A' ' 35' ' ' ASN . 28.1 mmm -64.54 -11.86 38.7 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.124 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.562 HD11 ' CG ' ' A' ' 33' ' ' TYR . 20.4 tp -69.88 -54.07 15.15 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.324 -0.86 . . . . 0.0 109.079 179.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.454 ' HA ' ' HB2' ' A' ' 43' ' ' ASN . 3.5 m -63.28 -14.26 47.53 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 119.021 -1.072 . . . . 0.0 108.253 179.087 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.49 ' CE1' ' HB2' ' A' ' 16' ' ' TYR . 19.5 t60 -67.26 -55.15 15.16 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 178.711 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 49.8 tt0 -67.19 -20.37 65.7 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.017 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.477 ' O ' ' N ' ' A' ' 47' ' ' GLN . 91.7 m-20 -76.26 -31.5 58.33 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.524 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.418 HD11 ' OH ' ' A' ' 8' ' ' TYR . 22.3 tp -67.48 -30.56 70.29 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.287 -0.883 . . . . 0.0 108.653 179.363 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -77.73 -44.74 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.451 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.461 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 60.0 mtt-85 -80.21 -19.33 47.26 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.393 -0.817 . . . . 0.0 109.175 179.669 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.477 ' N ' ' O ' ' A' ' 43' ' ' ASN . 91.1 mt-30 63.51 37.9 10.18 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.466 -0.771 . . . . 0.0 109.653 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 13.0 p -116.07 173.05 6.78 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.268 -0.895 . . . . 0.0 109.322 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -107.99 60.89 0.61 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.211 -0.931 . . . . 0.0 109.475 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.4 ' OG1' ' OD2' ' A' ' 29' ' ' ASP . 44.9 m -74.81 136.12 41.63 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.269 -0.895 . . . . 0.0 109.546 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 61.3 m-70 -115.01 173.27 6.57 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.247 -0.908 . . . . 0.0 109.229 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.462 HG22 ' HB ' ' A' ' 25' ' ' VAL . 20.0 mt -79.63 124.24 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.211 -0.93 . . . . 0.0 109.28 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.478 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 44.1 ttt180 -80.52 -47.48 14.19 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.352 -0.842 . . . . 0.0 109.367 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -154.07 149.22 26.92 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.488 -0.757 . . . . 0.0 109.115 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 27.5 p -66.45 143.48 57.08 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.209 -0.932 . . . . 0.0 109.567 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.536 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 90.44 167.35 41.76 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -179.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.509 ' CB ' HG22 ' A' ' 32' ' ' THR . 43.4 mttt -76.19 120.98 22.21 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.303 -1.116 . . . . 0.0 109.477 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.408 ' C ' ' O ' ' A' ' 57' ' ' LYS . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.522 0 O-C-N 121.266 -0.896 . . . . 0.0 109.621 179.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 82.6 mmm . . . . . 0 N--CA 1.489 1.484 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.495 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 3.9 m -79.88 -7.97 59.03 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.38 -0.825 . . . . 0.0 109.321 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 26.3 mttm -58.79 -23.21 59.91 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.213 -0.929 . . . . 0.0 110.039 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 61.9 t0 -150.1 64.46 0.97 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.079 -1.013 . . . . 0.0 110.37 -179.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.495 ' CD1' ' HA ' ' A' ' 5' ' ' CYS . 4.7 p90 -131.65 168.07 18.36 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.11 -0.994 . . . . 0.0 109.123 179.11 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 48.2 mtt180 -144.8 140.87 28.74 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.182 -0.949 . . . . 0.0 109.719 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.526 HG22 ' CD2' ' A' ' 16' ' ' TYR . 55.0 t -135.31 127.9 47.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.264 -0.898 . . . . 0.0 109.471 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.483 ' HB3' ' HD2' ' A' ' 12' ' ' PRO . 7.2 mp -114.81 168.17 8.53 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.275 -0.89 . . . . 0.0 109.312 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.483 ' HD2' ' HB3' ' A' ' 11' ' ' LEU . 43.0 Cg_endo -66.43 -24.63 49.36 Favored 'Trans proline' 0 C--O 1.216 -0.609 0 C-N-CA 122.479 2.119 . . . . 0.0 111.409 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 79.2 mtt-85 -98.71 -27.55 13.92 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.344 -0.848 . . . . 0.0 108.857 179.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 25.4 mm -87.67 -44.68 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.416 -0.803 . . . . 0.0 109.337 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.0 -165.43 54.82 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.526 ' CD2' HG22 ' A' ' 10' ' ' VAL . 1.9 t80 -100.03 149.76 23.15 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.238 -1.154 . . . . 0.0 109.44 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.471 ' O ' ' SG ' ' A' ' 37' ' ' CYS . 3.0 mm? -111.01 135.51 51.4 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.288 -0.883 . . . . 0.0 109.453 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.449 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 85.6 m -147.12 157.71 45.72 Favored Pre-proline 0 N--CA 1.492 1.662 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.401 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 47.4 Cg_endo -70.82 165.59 31.69 Favored 'Trans proline' 0 C--O 1.215 -0.653 0 C-N-CA 122.448 2.099 . . . . 0.0 111.596 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.3 tptp -84.58 -29.45 25.81 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.3 -0.875 . . . . 0.0 109.539 -179.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -58.49 126.11 26.18 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.28 -0.888 . . . . 0.0 109.381 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 60.4 tp -90.0 116.99 28.46 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.2 -0.937 . . . . 0.0 109.494 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.502 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 3.5 mttp -128.36 106.45 19.4 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.153 -0.967 . . . . 0.0 109.203 179.754 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.532 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 42.6 Cg_endo -64.79 122.62 10.51 Favored 'Trans proline' 0 C--O 1.214 -0.692 0 C-N-CA 123.036 2.49 . . . . 0.0 112.166 -179.404 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.468 ' O ' HG21 ' A' ' 32' ' ' THR . 17.3 m -118.19 154.26 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.318 -0.864 . . . . 0.0 109.934 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.426 ' SG ' ' HB3' ' A' ' 53' ' ' ARG . 41.4 t -97.78 138.06 35.71 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -92.35 140.37 15.1 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.911 -1.276 . . . . 0.0 109.911 -179.28 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.489 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 53.6 p30 -69.48 -11.37 60.77 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.305 -1.114 . . . . 0.0 109.436 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.451 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 57.0 p30 -89.57 10.43 23.01 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.303 -0.873 . . . . 0.0 109.593 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.59 18.95 57.7 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.47 ' O ' ' N ' ' A' ' 27' ' ' GLY . 90.0 mt-30 -119.32 170.17 9.34 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.329 -1.1 . . . . 0.0 109.385 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.518 HG22 ' CB ' ' A' ' 57' ' ' LYS . 54.7 m -134.04 134.25 42.16 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.199 -0.938 . . . . 0.0 109.3 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.587 ' CG ' HD11 ' A' ' 39' ' ' LEU . 38.4 m-85 -114.57 131.04 56.81 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.262 -0.899 . . . . 0.0 109.221 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.5 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 10.1 m-20 -55.7 -78.4 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.287 -0.883 . . . . 0.0 109.676 -179.661 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.519 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 7.1 t-20 -81.96 147.1 57.18 Favored Pre-proline 0 C--N 1.301 -1.527 0 O-C-N 120.927 -1.108 . . . . 0.0 109.645 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.502 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.2 Cg_endo -62.7 -52.07 2.64 Favored 'Trans proline' 0 C--O 1.216 -0.617 0 C-N-CA 122.753 2.302 . . . . 0.0 111.811 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.519 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 8.6 t -61.38 -29.99 70.26 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 120.882 -1.136 . . . . 0.0 108.046 178.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 13.0 mtt -63.87 -12.91 40.61 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.587 HD11 ' CG ' ' A' ' 33' ' ' TYR . 29.3 tp -68.04 -54.33 19.11 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 10.9 t -62.12 -22.43 65.81 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.414 ' CE1' ' HB2' ' A' ' 16' ' ' TYR . 37.4 t60 -69.7 -57.33 5.27 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.315 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.46 ' OE1' ' CD2' ' A' ' 33' ' ' TYR . 82.1 tt0 -63.61 -20.27 65.53 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 179.267 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.507 ' O ' ' N ' ' A' ' 47' ' ' GLN . 96.5 m-20 -75.42 -32.21 60.63 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.514 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.482 ' CD1' ' C ' ' A' ' 44' ' ' LEU . 2.8 tm? -65.82 -38.16 88.17 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.32 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.473 HD12 ' N ' ' A' ' 45' ' ' ILE . 4.6 mm -69.76 -43.16 80.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.392 -0.818 . . . . 0.0 108.953 179.481 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.463 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 73.2 mtt-85 -79.73 -23.37 42.36 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.415 -0.803 . . . . 0.0 109.098 179.692 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.507 ' N ' ' O ' ' A' ' 43' ' ' ASN . 92.6 mt-30 63.0 45.33 5.37 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.374 -0.829 . . . . 0.0 109.353 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.1 p -128.53 159.17 36.31 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.302 -0.874 . . . . 0.0 109.374 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.418 ' O ' ' CG ' ' A' ' 49' ' ' ASN . 47.6 p-10 -91.49 59.49 3.84 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.169 -0.957 . . . . 0.0 109.301 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 81.6 m -72.36 141.95 48.77 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.352 -0.843 . . . . 0.0 109.843 -179.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 62.6 m-70 -122.44 171.62 8.95 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.471 HD11 HG22 ' A' ' 52' ' ' ILE . 29.2 mt -79.72 126.85 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.075 -1.016 . . . . 0.0 109.581 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.489 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 67.2 ttt-85 -80.07 -44.63 19.72 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.447 -0.783 . . . . 0.0 109.035 179.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.4 t -160.23 155.59 25.14 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.706 -0.849 . . . . 0.0 108.706 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 26.1 p -67.5 140.22 57.03 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.091 -1.005 . . . . 0.0 109.314 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.532 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 94.89 169.04 36.59 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.167 -1.573 . . . . 0.0 109.167 -179.748 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.518 ' CB ' HG22 ' A' ' 32' ' ' THR . 44.8 mttp -68.1 144.62 54.97 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.304 -1.116 . . . . 0.0 109.446 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.461 ' SG ' ' O ' ' A' ' 31' ' ' GLN . 73.9 m . . . . . 0 N--CA 1.491 1.595 0 O-C-N 121.254 -0.904 . . . . 0.0 109.289 179.911 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 66.0 mtt . . . . . 0 N--CA 1.488 1.447 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.421 ' HB3' ' HB3' ' A' ' 40' ' ' CYS . 3.7 m -83.19 1.63 39.69 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.341 -0.849 . . . . 0.0 109.114 179.388 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.2 mttm -61.89 -31.74 72.05 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.138 -0.976 . . . . 0.0 109.416 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -145.21 68.54 1.23 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.212 -0.93 . . . . 0.0 109.952 -179.893 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.463 ' CE2' ' CE2' ' A' ' 16' ' ' TYR . 13.9 p90 -119.03 -171.23 2.06 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.175 -0.953 . . . . 0.0 109.19 179.524 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 21.4 ttt180 -150.83 152.32 33.58 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.232 -0.918 . . . . 0.0 109.747 -179.999 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 45.4 t -148.63 131.46 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.293 -0.88 . . . . 0.0 109.46 179.839 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.521 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -104.26 174.86 2.47 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.253 -0.905 . . . . 0.0 109.249 179.81 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.521 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 45.8 Cg_endo -67.48 -24.62 42.26 Favored 'Trans proline' 0 C--O 1.215 -0.667 0 C-N-CA 122.706 2.271 . . . . 0.0 112.056 -179.995 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -96.62 -28.23 14.44 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.29 -0.881 . . . . 0.0 109.41 179.966 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 89.9 mt -83.05 -45.77 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.302 -0.874 . . . . 0.0 109.598 -179.916 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 68.66 -168.74 42.74 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 179.997 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.463 ' CE2' ' CE2' ' A' ' 8' ' ' TYR . 1.4 t80 -95.33 149.25 21.56 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.212 -1.169 . . . . 0.0 109.645 -179.907 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.492 ' CD1' ' C ' ' A' ' 17' ' ' LEU . 2.3 tm? -111.24 112.21 23.82 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.287 -0.883 . . . . 0.0 109.163 179.873 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.427 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 62.0 m -128.63 155.77 78.47 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.26 -0.9 . . . . 0.0 109.608 -179.896 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -71.28 168.52 23.17 Favored 'Trans proline' 0 C--O 1.215 -0.675 0 C-N-CA 122.694 2.263 . . . . 0.0 111.526 179.781 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 25.4 mttm -91.09 -14.92 30.34 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.219 -0.926 . . . . 0.0 109.639 -179.828 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 51.3 t0 -72.3 119.48 16.56 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.246 -0.908 . . . . 0.0 109.349 179.866 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.436 HD12 ' HB3' ' A' ' 34' ' ' ASN . 52.4 tp -79.59 113.64 17.9 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.199 -0.938 . . . . 0.0 109.646 -179.944 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.481 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -127.5 110.12 20.96 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.211 -0.931 . . . . 0.0 109.079 179.738 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.553 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 42.6 Cg_endo -64.66 122.48 10.36 Favored 'Trans proline' 0 C--O 1.213 -0.774 0 C-N-CA 122.943 2.428 . . . . 0.0 112.203 -179.715 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.456 ' O ' HG21 ' A' ' 32' ' ' THR . 18.8 m -119.31 154.71 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.283 -0.886 . . . . 0.0 109.4 179.785 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.436 ' SG ' ' HB3' ' A' ' 53' ' ' ARG . 39.7 t -96.56 142.71 28.3 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 178.598 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -95.69 139.43 14.49 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 -179.859 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.462 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 55.0 t0 -69.29 -6.18 27.84 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.234 -1.157 . . . . 0.0 109.592 -179.781 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.434 ' OD2' ' OG1' ' A' ' 50' ' ' THR . 41.7 m-20 -90.87 0.87 57.37 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.149 -0.969 . . . . 0.0 109.548 179.913 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.43 24.61 15.74 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.634 -1.387 . . . . 0.0 109.634 179.935 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.519 ' O ' ' N ' ' A' ' 27' ' ' GLY . 81.5 mt-30 -131.84 164.17 26.65 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.292 -1.122 . . . . 0.0 109.279 -179.982 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.511 ' CG2' ' HG3' ' A' ' 57' ' ' LYS . 12.0 m -121.03 150.32 41.34 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.123 -0.985 . . . . 0.0 109.384 179.797 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.588 ' CE1' ' HG3' ' A' ' 42' ' ' GLU . 36.7 m-85 -128.74 131.75 47.89 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.341 -0.849 . . . . 0.0 109.253 -179.909 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.469 ' O ' ' O ' ' A' ' 23' ' ' LYS . 11.8 m-20 -51.75 -78.77 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.358 -0.839 . . . . 0.0 109.889 -179.429 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.534 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 5.8 t-20 -82.01 147.7 58.55 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.104 -0.997 . . . . 0.0 109.827 -179.789 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.481 ' HD3' ' O ' ' A' ' 23' ' ' LYS . 41.7 Cg_endo -64.04 -52.76 1.49 Allowed 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 122.777 2.318 . . . . 0.0 111.606 179.826 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.534 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 11.6 t -62.2 -30.01 70.78 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.969 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.483 ' CG ' ' HB3' ' A' ' 35' ' ' ASN . 29.3 mtt -65.3 -16.12 63.24 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.435 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.584 ' CD1' ' CD2' ' A' ' 33' ' ' TYR . 8.0 tt -69.07 -52.87 24.02 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.34 -0.85 . . . . 0.0 108.899 179.71 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.513 ' O ' ' HB2' ' A' ' 43' ' ' ASN . 14.4 m -51.0 -39.66 56.3 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.424 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 13.3 t60 -49.2 -45.12 43.82 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.851 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.588 ' HG3' ' CE1' ' A' ' 33' ' ' TYR . 45.4 mm-40 -61.73 -20.99 64.12 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.263 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.524 ' O ' ' N ' ' A' ' 47' ' ' GLN . 2.5 m-80 -76.69 -31.33 57.17 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 119.694 -0.803 . . . . 0.0 109.034 179.508 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.486 ' CD1' ' C ' ' A' ' 44' ' ' LEU . 1.7 tm? -70.22 -36.46 74.55 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.265 -0.897 . . . . 0.0 109.396 179.932 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 6.4 mt -74.87 -51.46 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.258 -0.901 . . . . 0.0 109.554 -179.896 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.488 ' NH2' ' OE1' ' A' ' 42' ' ' GLU . 40.8 mtt85 -81.12 -36.74 29.92 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.299 -0.875 . . . . 0.0 109.842 -179.653 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.524 ' N ' ' O ' ' A' ' 43' ' ' ASN . 92.6 mt-30 63.07 34.05 14.13 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.309 -0.869 . . . . 0.0 109.554 -179.809 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.469 ' O ' ' HB2' ' A' ' 49' ' ' ASN . 38.9 p -103.74 7.51 37.24 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.276 -0.89 . . . . 0.0 109.486 179.956 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.536 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 65.6 m-20 63.59 47.98 3.56 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.192 -0.942 . . . . 0.0 109.469 -179.895 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.524 ' N ' ' OD1' ' A' ' 43' ' ' ASN . 71.1 m -80.3 125.75 30.28 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.395 -0.815 . . . . 0.0 109.366 179.752 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . 0.536 ' CE1' ' O ' ' A' ' 49' ' ' ASN . 7.2 m80 -109.71 -171.09 1.77 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.124 -0.985 . . . . 0.0 109.459 179.822 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.522 HD11 HG22 ' A' ' 52' ' ' ILE . 43.6 mt -87.04 126.56 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.408 -0.808 . . . . 0.0 109.557 179.934 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.462 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 21.7 ttt85 -79.63 -46.4 17.27 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.446 -0.784 . . . . 0.0 109.275 179.841 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 95.3 p -158.31 138.84 12.71 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -179.72 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 20.8 p -56.02 151.33 12.13 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.134 -0.979 . . . . 0.0 109.49 -179.839 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.553 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 74.73 161.91 8.87 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 -179.595 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.511 ' HG3' ' CG2' ' A' ' 32' ' ' THR . 25.8 tttp -59.6 145.02 46.0 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.424 -1.045 . . . . 0.0 109.144 179.96 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.6 0 O-C-N 121.257 -0.902 . . . . 0.0 109.526 -179.846 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 90.7 mtp . . . . . 0 N--CA 1.488 1.429 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.592 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 19.9 m -80.32 -12.64 59.58 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.477 -0.765 . . . . 0.0 109.251 179.892 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.459 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 26.3 mttt -80.96 6.41 13.45 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.148 -0.97 . . . . 0.0 109.816 179.831 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.459 ' OD1' ' O ' ' A' ' 6' ' ' LYS . 96.3 m-20 -139.13 15.22 2.63 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.005 -1.06 . . . . 0.0 110.416 -179.387 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.686 ' CE2' ' CE2' ' A' ' 16' ' ' TYR . 1.0 OUTLIER -122.69 151.38 41.59 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.913 -1.117 . . . . 0.0 109.533 179.846 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 91.3 mtt180 -129.06 136.05 49.73 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.402 -0.811 . . . . 0.0 109.119 179.693 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.532 HG22 ' CE2' ' A' ' 8' ' ' TYR . 49.7 t -127.16 148.43 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.246 -0.909 . . . . 0.0 109.499 -179.628 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.53 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.2 OUTLIER -123.65 175.12 2.99 Favored Pre-proline 0 N--CA 1.488 1.458 0 O-C-N 121.233 -0.917 . . . . 0.0 109.621 -179.689 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.53 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 45.1 Cg_endo -67.76 -22.27 43.55 Favored 'Trans proline' 0 C--O 1.215 -0.675 0 C-N-CA 122.691 2.261 . . . . 0.0 111.713 -179.987 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 69.9 mtt85 -105.7 -24.31 12.55 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.341 -0.85 . . . . 0.0 109.526 179.948 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 24.4 mm -81.9 -48.17 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.246 -0.909 . . . . 0.0 109.54 -179.893 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.502 ' O ' ' CG1' ' A' ' 10' ' ' VAL . . . 82.17 -163.83 43.57 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.344 -1.503 . . . . 0.0 109.344 -179.923 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.686 ' CE2' ' CE2' ' A' ' 8' ' ' TYR . 2.1 t80 -97.57 150.6 20.94 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.125 -1.221 . . . . 0.0 109.621 179.983 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.482 ' CD1' ' C ' ' A' ' 17' ' ' LEU . 2.2 tm? -111.86 109.65 19.57 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.333 -0.854 . . . . 0.0 109.749 -179.779 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.427 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 63.6 m -125.86 156.12 71.87 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.284 -0.885 . . . . 0.0 108.985 179.649 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -71.02 165.48 32.24 Favored 'Trans proline' 0 C--O 1.214 -0.686 0 C-N-CA 122.453 2.102 . . . . 0.0 111.701 -179.98 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 24.3 mttt -83.76 -22.93 31.75 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.261 -0.9 . . . . 0.0 109.521 -179.805 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 -63.62 125.41 24.19 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.226 -0.921 . . . . 0.0 109.401 179.781 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 41.2 tp -85.69 122.92 30.47 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.211 -0.931 . . . . 0.0 109.507 179.94 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.521 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 1.3 mmmt -135.21 103.28 10.59 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.305 -0.872 . . . . 0.0 109.284 179.987 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.528 ' O ' ' N ' ' A' ' 56' ' ' GLY . 43.3 Cg_endo -65.02 120.02 7.16 Favored 'Trans proline' 0 C--O 1.213 -0.744 0 C-N-CA 123.18 2.587 . . . . 0.0 112.529 -179.125 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.469 HG22 HD11 ' A' ' 39' ' ' LEU . 7.8 m -116.98 155.94 18.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.399 -0.813 . . . . 0.0 109.754 179.683 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.481 ' O ' ' N ' ' A' ' 53' ' ' ARG . 14.8 t -102.67 109.9 21.66 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.389 -0.82 . . . . 0.0 108.97 179.369 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -66.03 137.7 36.3 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 -179.652 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.506 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 55.1 p30 -68.65 -10.14 54.31 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.316 -1.108 . . . . 0.0 109.57 179.858 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.443 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 38.9 m-20 -82.62 4.47 24.63 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.246 -0.909 . . . . 0.0 109.378 179.757 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.73 14.68 56.33 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.137 -1.585 . . . . 0.0 109.137 -179.809 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.501 ' O ' ' N ' ' A' ' 27' ' ' GLY . 88.9 mt-30 -121.36 157.54 30.22 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.382 -1.07 . . . . 0.0 109.373 -179.969 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.509 ' CG2' ' HA ' ' A' ' 57' ' ' LYS . 25.6 m -119.19 134.97 54.91 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.257 -0.902 . . . . 0.0 109.356 179.916 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.585 ' CE1' ' HB2' ' A' ' 42' ' ' GLU . 54.2 m-85 -113.13 129.67 56.43 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.289 -0.882 . . . . 0.0 109.288 179.986 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.503 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 6.6 m-20 -52.47 -76.29 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.216 -0.928 . . . . 0.0 109.441 -179.812 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.514 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 10.2 t-20 -81.99 147.35 57.72 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.039 -1.038 . . . . 0.0 109.495 179.797 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.521 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 39.9 Cg_endo -63.12 -51.68 2.63 Favored 'Trans proline' 0 C--O 1.214 -0.693 0 C-N-CA 122.673 2.248 . . . . 0.0 111.451 179.555 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.514 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 5.7 t -60.25 -28.36 67.98 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 178.81 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.471 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 34.7 mmm -66.02 -18.94 65.67 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.384 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.548 HD13 ' CD2' ' A' ' 33' ' ' TYR . 8.1 tt -66.84 -52.74 40.09 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.179 -0.951 . . . . 0.0 108.577 179.382 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.487 ' O ' ' HB2' ' A' ' 43' ' ' ASN . 38.0 t -50.81 -25.97 5.12 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 178.983 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.445 ' O ' HG12 ' A' ' 45' ' ' ILE . 28.1 t60 -60.09 -50.05 75.25 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.162 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.585 ' HB2' ' CE1' ' A' ' 33' ' ' TYR . 23.9 tp10 -58.66 -19.42 39.2 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.201 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.52 ' O ' ' N ' ' A' ' 47' ' ' GLN . 4.0 m-80 -78.26 -35.81 47.64 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.29 -0.881 . . . . 0.0 108.913 179.589 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.497 ' O ' ' CD1' ' A' ' 44' ' ' LEU . 2.1 tm? -69.34 -34.3 74.41 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.286 -0.884 . . . . 0.0 109.327 179.717 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.445 HG12 ' O ' ' A' ' 41' ' ' HIS . 6.1 mm -74.67 -53.84 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.382 -0.824 . . . . 0.0 110.118 -179.633 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.464 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 10.5 mtt-85 -88.38 -30.3 19.62 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.145 -0.972 . . . . 0.0 110.36 -179.159 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.52 ' N ' ' O ' ' A' ' 43' ' ' ASN . 87.2 mt-30 62.33 37.07 14.13 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.128 -0.983 . . . . 0.0 109.277 -179.706 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.462 ' O ' ' HB2' ' A' ' 49' ' ' ASN . 72.7 p -101.25 6.68 43.02 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.295 -0.878 . . . . 0.0 109.715 -179.84 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.462 ' HB2' ' O ' ' A' ' 48' ' ' THR . 73.0 m-20 61.65 51.77 3.85 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.165 -0.959 . . . . 0.0 109.556 179.894 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.506 ' N ' ' OD1' ' A' ' 43' ' ' ASN . 47.9 m -76.53 140.63 41.22 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.24 -0.913 . . . . 0.0 109.262 179.755 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 12.0 m-70 -119.53 -176.47 3.16 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.219 -0.926 . . . . 0.0 109.63 -179.879 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.498 HD11 HG22 ' A' ' 52' ' ' ILE . 15.9 mt -87.47 124.07 40.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 O-C-N 121.383 -0.823 . . . . 0.0 109.575 179.883 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.506 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 16.7 tpt180 -81.07 -56.38 4.14 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.476 -0.765 . . . . 0.0 109.477 179.904 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 72.8 m -148.9 141.17 24.07 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -179.832 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 12.2 p -58.34 144.51 41.25 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.197 -0.939 . . . . 0.0 109.522 -179.67 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 24' ' ' PRO . . . 86.32 162.61 37.13 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.79 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.509 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 21.7 mttp -70.65 133.09 46.36 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.559 -0.965 . . . . 0.0 109.386 179.895 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.495 0 O-C-N 121.219 -0.926 . . . . 0.0 109.406 -179.995 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 70.7 mtm . . . . . 0 N--CA 1.487 1.415 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 3.4 m -82.93 7.56 15.09 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 179.41 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.6 mttm -61.11 -35.69 77.69 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.997 -1.064 . . . . 0.0 109.305 179.724 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -140.65 70.8 1.36 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.321 -0.862 . . . . 0.0 109.915 -179.793 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.437 ' CD2' ' N ' ' A' ' 9' ' ' ARG . 26.9 p90 -115.07 -169.75 1.62 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.208 -0.933 . . . . 0.0 109.3 179.633 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.437 ' N ' ' CD2' ' A' ' 8' ' ' TYR . 71.9 mtt-85 -152.41 142.37 22.15 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.256 -0.903 . . . . 0.0 109.569 179.905 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 39.9 t -143.06 138.7 27.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.264 -0.897 . . . . 0.0 109.2 179.98 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.531 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.7 OUTLIER -119.55 174.72 2.62 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.221 -0.924 . . . . 0.0 109.449 -179.788 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.531 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 46.6 Cg_endo -68.36 -24.31 37.24 Favored 'Trans proline' 0 C--O 1.214 -0.678 0 C-N-CA 122.748 2.299 . . . . 0.0 111.881 179.965 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.474 ' O ' ' HG2' ' A' ' 13' ' ' ARG . 23.4 ttm180 -101.18 -16.69 16.93 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.322 -0.861 . . . . 0.0 109.282 179.897 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 85.2 mt -96.99 -42.19 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.244 -0.91 . . . . 0.0 109.654 -179.754 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 71.55 179.38 31.3 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 -179.812 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.468 ' OH ' ' HB2' ' A' ' 40' ' ' CYS . 1.8 t80 -77.61 153.92 32.76 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.153 -1.204 . . . . 0.0 109.546 -179.989 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.449 ' O ' ' SG ' ' A' ' 37' ' ' CYS . 48.1 mt -110.42 123.58 50.15 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.216 -0.927 . . . . 0.0 109.594 179.999 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.474 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 82.4 m -146.98 156.72 47.27 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.453 -0.779 . . . . 0.0 109.032 179.895 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.473 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 48.9 Cg_endo -70.86 168.29 23.42 Favored 'Trans proline' 0 C--O 1.216 -0.608 0 C-N-CA 122.583 2.188 . . . . 0.0 111.515 179.889 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -94.26 -8.73 38.27 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.124 -0.985 . . . . 0.0 109.628 -179.796 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -76.62 118.53 19.36 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.169 -0.957 . . . . 0.0 109.414 179.957 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 44.3 tp -76.09 116.92 17.26 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.201 -0.937 . . . . 0.0 109.739 -179.973 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.515 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 2.2 mtpt -132.1 106.76 13.66 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.306 -0.871 . . . . 0.0 108.996 179.767 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.527 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 43.2 Cg_endo -64.58 120.24 7.48 Favored 'Trans proline' 0 C--O 1.214 -0.711 0 C-N-CA 122.912 2.408 . . . . 0.0 112.1 -179.448 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.448 ' O ' HG21 ' A' ' 32' ' ' THR . 11.4 m -120.26 155.2 23.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.445 -0.784 . . . . 0.0 110.047 -179.768 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.409 ' SG ' ' HB3' ' A' ' 53' ' ' ARG . 41.4 t -96.88 148.18 23.2 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 178.713 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -100.04 139.66 14.54 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.545 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.465 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 53.4 t0 -64.82 -10.7 30.08 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.279 -1.13 . . . . 0.0 109.409 179.834 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 59.9 p30 -90.39 1.6 56.43 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.24 -0.913 . . . . 0.0 109.667 -179.932 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.64 19.45 34.75 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.994 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.473 ' O ' ' N ' ' A' ' 27' ' ' GLY . 87.0 mt-30 -119.23 167.88 11.43 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.209 -1.171 . . . . 0.0 109.429 -179.946 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.485 HG22 ' CB ' ' A' ' 57' ' ' LYS . 94.3 m -127.73 146.91 50.42 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.118 -0.989 . . . . 0.0 109.445 179.792 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.62 ' N ' ' CD1' ' A' ' 33' ' ' TYR . 5.0 m-85 -128.8 128.64 44.34 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.23 -0.918 . . . . 0.0 109.463 -179.835 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.477 ' O ' ' O ' ' A' ' 23' ' ' LYS . 7.5 m-20 -49.79 -77.22 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.282 -0.886 . . . . 0.0 109.663 -179.551 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.543 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 2.0 t-20 -81.91 149.23 62.85 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.161 -0.962 . . . . 0.0 109.443 179.995 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.515 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 41.2 Cg_endo -64.62 -54.71 0.68 Allowed 'Trans proline' 0 C--O 1.216 -0.622 0 C-N-CA 122.842 2.361 . . . . 0.0 111.955 179.873 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.543 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 15.7 t -62.09 -28.6 69.73 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 120.974 -1.079 . . . . 0.0 108.417 179.049 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.437 ' CG ' ' HB3' ' A' ' 35' ' ' ASN . 37.0 mmm -61.45 -15.56 38.47 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 179.363 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.583 HD12 ' CD1' ' A' ' 33' ' ' TYR . 50.8 tp -63.47 -46.01 88.15 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.346 -0.846 . . . . 0.0 108.982 179.61 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.468 ' HB2' ' OH ' ' A' ' 16' ' ' TYR . 2.8 m -71.8 -19.98 61.92 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 178.764 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 28.4 t60 -66.89 -52.76 39.48 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.017 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.474 ' OE1' ' CE2' ' A' ' 33' ' ' TYR . 85.5 tt0 -66.91 -19.86 65.8 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 178.983 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.502 ' O ' ' N ' ' A' ' 47' ' ' GLN . 87.9 m-20 -77.46 -32.75 54.65 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.327 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 23.9 tp -64.28 -31.36 72.54 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.259 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.448 HG22 HD11 ' A' ' 45' ' ' ILE . 7.3 mm -77.63 -44.7 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.442 -0.787 . . . . 0.0 108.972 179.376 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.46 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 63.2 mtt-85 -79.89 -15.36 57.49 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.353 -0.842 . . . . 0.0 109.123 179.629 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.502 ' N ' ' O ' ' A' ' 43' ' ' ASN . 89.0 mt-30 63.09 44.32 5.91 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.421 -0.799 . . . . 0.0 109.486 179.995 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.401 ' O ' ' HB3' ' A' ' 43' ' ' ASN . 7.3 p -128.54 164.52 22.64 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.211 -0.93 . . . . 0.0 109.294 179.829 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 47.5 p-10 -104.58 58.62 0.7 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.123 -0.986 . . . . 0.0 109.573 -179.935 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 86.5 m -71.91 137.77 47.65 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.255 -0.903 . . . . 0.0 109.541 179.9 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 71.4 m80 -112.55 176.54 4.98 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.229 -0.92 . . . . 0.0 109.091 179.723 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.46 HD11 HG22 ' A' ' 52' ' ' ILE . 39.2 mt -80.28 126.66 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.231 -0.918 . . . . 0.0 109.509 179.999 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.465 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 67.6 ttt180 -79.88 -46.39 16.91 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.443 -0.786 . . . . 0.0 109.448 -179.922 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 54.4 p -160.44 138.88 10.14 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -179.331 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 10.6 p -51.29 147.4 5.75 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.163 -0.961 . . . . 0.0 109.485 179.978 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.527 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 85.14 165.95 41.03 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.484 -1.447 . . . . 0.0 109.484 179.923 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.485 ' CB ' HG22 ' A' ' 32' ' ' THR . 33.7 mttm -65.33 146.24 55.16 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.49 -1.006 . . . . 0.0 109.406 179.981 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.45 ' SG ' ' O ' ' A' ' 31' ' ' GLN . 79.2 m . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.279 -0.888 . . . . 0.0 109.48 179.945 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 62.1 mmm . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.534 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 3.3 m -82.32 -14.92 54.57 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.313 -0.867 . . . . 0.0 109.143 179.862 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -56.2 -25.09 45.81 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.205 -0.934 . . . . 0.0 109.585 -179.994 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -154.27 63.04 0.69 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.179 -0.951 . . . . 0.0 109.841 -179.833 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.54 ' CE2' ' CE2' ' A' ' 16' ' ' TYR . 7.9 p90 -119.84 174.15 6.61 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.172 -0.955 . . . . 0.0 109.308 179.591 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 66.9 mtt-85 -145.26 137.34 25.69 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.19 -0.944 . . . . 0.0 109.514 -179.969 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.46 HG22 ' CD2' ' A' ' 16' ' ' TYR . 98.7 t -134.21 139.82 47.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.243 -0.911 . . . . 0.0 109.48 -179.981 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.533 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.2 OUTLIER -131.28 175.57 3.58 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.345 -0.847 . . . . 0.0 109.389 -179.924 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.533 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 46.0 Cg_endo -67.76 -24.95 40.18 Favored 'Trans proline' 0 C--O 1.214 -0.69 0 C-N-CA 122.673 2.249 . . . . 0.0 111.729 179.884 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.469 ' O ' ' HG2' ' A' ' 13' ' ' ARG . 54.6 ttt180 -110.97 -20.54 12.39 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.328 -0.857 . . . . 0.0 109.204 179.778 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 80.6 mt -90.98 -38.53 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.344 -0.848 . . . . 0.0 109.406 179.978 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 67.97 -142.22 39.38 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.948 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.54 ' CE2' ' CE2' ' A' ' 8' ' ' TYR . 2.9 t80 -108.23 153.97 22.44 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.172 -1.193 . . . . 0.0 109.57 -179.898 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 29.4 tp -112.33 119.46 38.36 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.398 -0.814 . . . . 0.0 109.581 179.911 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.413 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 58.5 m -131.55 155.92 80.81 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.279 -0.888 . . . . 0.0 109.269 179.903 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -71.11 166.4 29.31 Favored 'Trans proline' 0 C--O 1.216 -0.62 0 C-N-CA 122.523 2.149 . . . . 0.0 111.661 -179.994 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -88.42 -7.13 57.12 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.274 -0.891 . . . . 0.0 109.541 -179.934 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -74.39 128.42 35.49 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.231 -0.918 . . . . 0.0 109.4 179.846 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.482 ' CD1' ' C ' ' A' ' 22' ' ' LEU . 3.2 tm? -85.5 113.81 22.05 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.212 -0.93 . . . . 0.0 109.666 -179.831 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.501 ' O ' ' O ' ' A' ' 34' ' ' ASN . 5.5 mmtt -132.75 102.84 13.46 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.271 -0.893 . . . . 0.0 108.818 179.606 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.529 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 41.4 Cg_endo -63.43 124.18 13.35 Favored 'Trans proline' 0 C--O 1.213 -0.734 0 C-N-CA 122.963 2.442 . . . . 0.0 112.417 -179.067 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.465 ' O ' HG21 ' A' ' 32' ' ' THR . 35.0 m -123.06 154.08 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.47 -0.769 . . . . 0.0 109.921 -179.93 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.441 ' SG ' ' HB3' ' A' ' 53' ' ' ARG . 43.8 t -100.67 136.47 40.49 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.611 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -93.8 139.07 14.38 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 110.109 -1.196 . . . . 0.0 110.109 -179.099 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.492 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 48.9 p30 -64.14 -13.33 47.34 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.327 -1.102 . . . . 0.0 109.348 179.67 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.441 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 31.6 m-20 -85.61 11.31 11.03 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.236 -0.915 . . . . 0.0 109.237 179.844 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.5 20.32 66.71 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.886 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.523 ' O ' ' N ' ' A' ' 27' ' ' GLY . 83.0 mt-30 -121.98 145.93 47.65 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.304 -1.115 . . . . 0.0 109.503 -179.955 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.507 ' CG2' ' HA ' ' A' ' 57' ' ' LYS . 85.5 m -111.43 153.25 26.38 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.245 -0.909 . . . . 0.0 109.494 179.975 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.53 ' OH ' ' CG ' ' A' ' 42' ' ' GLU . 62.9 m-85 -135.69 145.67 46.96 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.246 -0.909 . . . . 0.0 109.196 179.648 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.528 ' N ' ' ND2' ' A' ' 34' ' ' ASN . 0.2 OUTLIER -63.92 -72.44 0.14 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.144 -0.972 . . . . 0.0 108.574 179.9 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.544 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 9.3 t-20 -83.09 146.9 52.66 Favored Pre-proline 0 C--N 1.299 -1.63 0 O-C-N 121.446 -0.784 . . . . 0.0 109.461 179.709 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.477 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 41.7 Cg_endo -64.15 -51.75 1.98 Allowed 'Trans proline' 0 C--O 1.215 -0.629 0 C-N-CA 122.512 2.141 . . . . 0.0 111.414 179.678 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.544 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 6.6 t -59.34 -25.85 64.54 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 178.8 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.473 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 10.2 mmm -65.6 -19.21 65.82 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.232 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.525 ' CD1' ' CD1' ' A' ' 52' ' ' ILE . 5.7 tt -73.97 -52.19 13.6 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.126 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.513 ' O ' ' HB2' ' A' ' 43' ' ' ASN . 7.3 t -47.92 -33.36 7.52 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 178.685 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 58.1 t60 -49.95 -56.0 12.32 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 178.934 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.53 ' CG ' ' OH ' ' A' ' 33' ' ' TYR . 16.8 tt0 -50.67 -23.13 2.42 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.072 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.513 ' HB2' ' O ' ' A' ' 40' ' ' CYS . 5.4 m-80 -80.92 -29.67 35.48 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 119.545 -0.862 . . . . 0.0 109.095 179.828 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.452 HD23 ' CG1' ' A' ' 10' ' ' VAL . 27.7 tp -77.39 -35.87 53.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.293 -0.879 . . . . 0.0 109.369 179.942 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 8.0 mm -77.25 -52.77 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.174 -0.954 . . . . 0.0 109.296 179.816 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.44 ' HB3' HG22 ' A' ' 48' ' ' THR . 17.5 mtt-85 -79.84 -15.31 57.65 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.311 -0.868 . . . . 0.0 109.49 179.86 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.45 ' HA ' ' O ' ' A' ' 43' ' ' ASN . 92.8 mt-30 60.9 33.4 19.9 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.242 -0.911 . . . . 0.0 109.542 -179.978 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.44 HG22 ' HB3' ' A' ' 46' ' ' ARG . 18.4 p -108.96 176.28 5.16 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.318 -0.864 . . . . 0.0 109.451 179.978 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.488 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 88.8 m-20 -102.91 54.03 0.77 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.285 -0.884 . . . . 0.0 109.423 179.95 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.497 ' N ' ' OD1' ' A' ' 43' ' ' ASN . 60.7 m -73.53 124.24 25.49 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.282 -0.886 . . . . 0.0 109.467 -179.971 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . 0.488 ' CE1' ' O ' ' A' ' 49' ' ' ASN . 11.9 m-70 -111.89 -171.19 1.8 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.201 -0.937 . . . . 0.0 109.379 179.908 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.525 ' CD1' ' CD1' ' A' ' 39' ' ' LEU . 21.4 mm -86.45 125.05 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.276 -0.89 . . . . 0.0 109.702 -179.992 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.492 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 59.8 ttt180 -80.73 -42.82 21.24 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.415 -0.803 . . . . 0.0 109.38 179.6 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 7.6 p -160.87 131.67 5.37 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.6 -0.687 . . . . 0.0 109.305 -179.188 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 8.0 p -49.13 147.38 2.98 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.214 -0.929 . . . . 0.0 109.089 179.803 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.529 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 85.46 172.45 48.98 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.239 -1.544 . . . . 0.0 109.239 -179.713 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.507 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 55.9 mttm -66.27 149.4 50.41 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.279 -1.13 . . . . 0.0 109.676 -179.77 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.453 ' SG ' ' OG1' ' A' ' 32' ' ' THR . 93.4 m . . . . . 0 N--CA 1.489 1.513 0 O-C-N 121.297 -0.877 . . . . 0.0 109.23 179.878 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 72.8 mmm . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.593 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 44.5 m -80.26 -19.26 47.19 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.48 -0.762 . . . . 0.0 109.392 179.936 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 20.8 mttt -80.08 4.82 15.98 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.24 -0.913 . . . . 0.0 109.652 -179.911 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -128.84 4.75 5.43 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.03 -1.044 . . . . 0.0 110.415 -179.409 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.689 ' CE2' ' CZ ' ' A' ' 16' ' ' TYR . 0.9 OUTLIER -120.43 150.21 41.14 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.912 -1.117 . . . . 0.0 109.554 179.78 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 81.2 mtt180 -131.87 130.69 41.98 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.26 -0.9 . . . . 0.0 109.167 179.76 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.508 HG21 ' CE2' ' A' ' 8' ' ' TYR . 58.5 t -118.1 149.3 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.303 -0.873 . . . . 0.0 110.099 -179.484 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.537 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.7 OUTLIER -127.55 175.42 3.4 Favored Pre-proline 0 N--CA 1.488 1.459 0 O-C-N 121.375 -0.828 . . . . 0.0 108.905 179.484 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.537 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 43.6 Cg_endo -67.22 -22.37 46.78 Favored 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 122.465 2.11 . . . . 0.0 111.746 179.908 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 15.5 mtt-85 -102.04 -28.99 12.03 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.214 -0.929 . . . . 0.0 109.635 -179.999 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . 0.422 HD11 ' HB2' ' A' ' 11' ' ' LEU . 84.9 mt -79.54 -48.7 20.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.229 -0.919 . . . . 0.0 109.582 -179.685 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.403 ' C ' HG12 ' A' ' 10' ' ' VAL . . . 81.9 -167.97 48.59 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 -179.93 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.689 ' CZ ' ' CE2' ' A' ' 8' ' ' TYR . 1.0 OUTLIER -97.69 146.87 24.91 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.131 -1.217 . . . . 0.0 109.618 179.985 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 24.9 tp -118.24 120.63 38.26 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.355 -0.841 . . . . 0.0 109.527 179.969 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.428 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 80.1 m -129.22 156.15 78.78 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.325 -0.859 . . . . 0.0 109.128 179.67 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.481 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 46.2 Cg_endo -69.72 163.95 36.33 Favored 'Trans proline' 0 C--O 1.216 -0.613 0 C-N-CA 122.655 2.236 . . . . 0.0 111.729 -179.987 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -89.78 -7.83 53.52 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.278 -0.889 . . . . 0.0 109.412 -179.987 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 -73.62 120.82 19.74 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.297 -0.877 . . . . 0.0 109.375 179.903 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.523 ' CD2' ' OD1' ' A' ' 34' ' ' ASN . 3.1 tm? -81.41 124.0 29.05 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.283 -0.886 . . . . 0.0 109.417 -179.923 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.488 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 11.9 mttt -146.31 104.74 4.06 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.308 -0.87 . . . . 0.0 109.371 179.769 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.546 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 42.6 Cg_endo -65.23 123.61 11.77 Favored 'Trans proline' 0 C--O 1.213 -0.752 0 C-N-CA 122.954 2.436 . . . . 0.0 111.95 -179.92 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.449 ' O ' HG21 ' A' ' 32' ' ' THR . 27.2 m -118.69 154.51 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.191 -0.943 . . . . 0.0 109.637 179.978 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.428 ' SG ' ' HB3' ' A' ' 53' ' ' ARG . 41.5 t -96.59 138.4 34.22 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.273 -0.892 . . . . 0.0 108.83 179.327 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -91.99 139.46 14.71 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 179.995 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.502 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 55.5 t0 -71.03 -7.17 44.51 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.265 -1.138 . . . . 0.0 109.511 -179.925 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.415 ' OD1' ' C ' ' A' ' 29' ' ' ASP . 59.1 p30 -89.6 3.62 52.0 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.187 -0.946 . . . . 0.0 109.462 179.732 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.21 13.39 52.41 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 -179.891 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.467 ' O ' ' N ' ' A' ' 27' ' ' GLY . 76.9 mt-30 -118.72 174.04 6.51 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.256 -1.144 . . . . 0.0 109.402 -179.964 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.499 ' CG2' ' HA ' ' A' ' 57' ' ' LYS . 23.2 m -135.93 137.23 41.14 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.308 -0.87 . . . . 0.0 109.341 179.839 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.631 ' CE1' ' CD1' ' A' ' 39' ' ' LEU . 29.3 m-85 -114.2 129.12 56.63 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.299 -0.876 . . . . 0.0 109.348 -179.915 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.523 ' OD1' ' CD2' ' A' ' 22' ' ' LEU . 63.6 t-20 -52.55 -79.78 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.297 -0.877 . . . . 0.0 109.742 -179.583 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.532 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 2.0 t-20 -81.17 149.66 66.53 Favored Pre-proline 0 C--N 1.3 -1.57 0 O-C-N 120.927 -1.108 . . . . 0.0 109.567 -179.813 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.488 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 39.9 Cg_endo -63.07 -54.53 1.08 Allowed 'Trans proline' 0 C--O 1.214 -0.68 0 C-N-CA 122.729 2.286 . . . . 0.0 111.925 -179.765 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.532 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 9.1 t -61.15 -29.15 69.61 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.997 -1.064 . . . . 0.0 108.224 179.116 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.53 ' CG ' ' HB3' ' A' ' 35' ' ' ASN . 69.6 mmm -62.56 -16.42 56.05 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 179.321 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.631 ' CD1' ' CE1' ' A' ' 33' ' ' TYR . 24.5 tp -69.08 -58.14 4.48 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.382 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.482 ' HB3' ' OH ' ' A' ' 16' ' ' TYR . 8.8 t -56.95 -29.82 63.49 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 178.685 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 54.9 t60 -64.1 -60.45 3.21 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.189 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.567 ' OE1' ' CE2' ' A' ' 33' ' ' TYR . 83.9 tt0 -57.79 -22.33 46.62 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.328 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.505 ' O ' ' N ' ' A' ' 47' ' ' GLN . 97.3 m-20 -76.4 -31.97 58.27 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.41 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 15.9 tp -66.49 -31.82 72.8 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.267 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.487 HD11 HG22 ' A' ' 45' ' ' ILE . 5.4 mt -75.81 -44.7 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 179.41 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.469 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 73.4 mtt-85 -80.61 -20.48 43.14 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.493 -0.754 . . . . 0.0 109.378 179.786 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.505 ' N ' ' O ' ' A' ' 43' ' ' ASN . 89.2 mt-30 63.3 43.49 6.15 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.313 -0.867 . . . . 0.0 109.43 -179.927 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.428 HG22 ' HB3' ' A' ' 46' ' ' ARG . 10.3 p -123.75 161.82 24.41 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.343 -0.848 . . . . 0.0 109.298 179.868 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.425 ' O ' ' CG ' ' A' ' 49' ' ' ASN . 44.8 p-10 -96.51 59.71 1.83 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.185 -0.947 . . . . 0.0 109.448 179.957 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 34.7 m -72.81 140.45 47.66 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.199 -0.938 . . . . 0.0 109.82 -179.872 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 49.3 m-70 -118.49 172.03 7.75 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.39 -0.819 . . . . 0.0 108.918 179.578 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.487 HD11 HG22 ' A' ' 52' ' ' ILE . 35.9 mt -81.54 126.28 39.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.141 -0.974 . . . . 0.0 109.291 179.772 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.502 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 39.8 ttt180 -79.73 -44.17 21.25 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.458 -0.776 . . . . 0.0 109.202 179.978 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.3 t -160.0 157.99 29.79 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.909 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 29.9 p -72.38 144.95 48.03 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.159 -0.963 . . . . 0.0 109.444 -179.907 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.546 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 84.83 165.92 40.71 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.865 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.499 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 41.5 tttt -53.1 150.23 6.01 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.43 -1.041 . . . . 0.0 109.438 -179.98 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 98.8 m . . . . . 0 N--CA 1.49 1.551 0 O-C-N 121.248 -0.907 . . . . 0.0 109.317 179.887 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 74.6 mtm . . . . . 0 N--CA 1.488 1.453 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.574 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 24.5 m -80.48 -14.27 58.41 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.506 -0.746 . . . . 0.0 109.21 179.659 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.459 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 46.0 mttm -80.94 6.89 11.98 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.27 -0.894 . . . . 0.0 109.649 -179.954 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.459 ' OD1' ' O ' ' A' ' 6' ' ' LYS . 99.3 m-20 -139.12 14.94 2.63 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.108 -0.995 . . . . 0.0 110.309 -179.415 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.629 ' CE2' ' CE2' ' A' ' 16' ' ' TYR . 0.7 OUTLIER -123.93 152.38 42.51 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.889 -1.132 . . . . 0.0 109.561 179.876 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 16.8 mtm-85 -130.29 132.81 46.07 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.327 -0.858 . . . . 0.0 109.3 179.859 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.574 HG22 ' CE2' ' A' ' 8' ' ' TYR . 53.2 t -123.85 145.98 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.144 -0.972 . . . . 0.0 109.462 -179.93 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.546 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.2 OUTLIER -125.12 175.92 2.74 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.241 -0.912 . . . . 0.0 109.339 -179.791 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.546 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 46.4 Cg_endo -67.65 -22.81 43.4 Favored 'Trans proline' 0 C--O 1.214 -0.681 0 C-N-CA 122.6 2.2 . . . . 0.0 111.664 179.971 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 62.6 ttt-85 -103.27 -22.87 13.65 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.323 -0.86 . . . . 0.0 109.493 179.927 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 36.3 mm -86.1 -51.33 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.223 -0.923 . . . . 0.0 109.425 -179.963 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.444 ' O ' ' CG1' ' A' ' 10' ' ' VAL . . . 81.42 -163.23 44.47 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -179.917 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.629 ' CE2' ' CE2' ' A' ' 8' ' ' TYR . 1.4 t80 -99.29 150.48 22.06 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.172 -1.193 . . . . 0.0 109.514 179.957 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 18.1 tp -117.85 108.02 14.83 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.22 -0.925 . . . . 0.0 109.693 -179.841 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 61.3 m -118.13 155.74 51.14 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.258 -0.901 . . . . 0.0 109.269 179.792 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -72.3 167.28 27.34 Favored 'Trans proline' 0 C--O 1.216 -0.624 0 C-N-CA 122.671 2.248 . . . . 0.0 111.675 -179.929 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 61.3 tttm -83.08 -31.01 27.54 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.24 -0.913 . . . . 0.0 109.373 -179.932 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -57.73 126.97 29.73 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.257 -0.902 . . . . 0.0 109.541 179.941 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 66.3 tp -87.93 117.86 27.08 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.315 -0.866 . . . . 0.0 109.393 179.829 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.524 ' CB ' ' HD3' ' A' ' 36' ' ' PRO . 2.8 mttm -125.57 101.8 30.11 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.229 -0.919 . . . . 0.0 109.466 -179.795 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.546 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 42.5 Cg_endo -64.83 118.96 5.89 Favored 'Trans proline' 0 C--O 1.212 -0.809 0 C-N-CA 122.96 2.44 . . . . 0.0 112.28 -179.599 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.457 ' O ' HG21 ' A' ' 32' ' ' THR . 15.8 m -119.41 154.59 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.221 -0.925 . . . . 0.0 109.589 179.709 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.454 ' SG ' ' HB3' ' A' ' 53' ' ' ARG . 31.7 t -95.63 141.02 29.63 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.213 -0.93 . . . . 0.0 108.797 178.995 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -95.61 137.35 13.36 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 179.997 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.487 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 54.3 t0 -69.69 -5.41 24.8 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.236 -1.156 . . . . 0.0 109.579 -179.936 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -89.96 1.24 56.5 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.221 -0.924 . . . . 0.0 109.483 179.646 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.47 27.21 12.04 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.861 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.536 ' O ' ' N ' ' A' ' 27' ' ' GLY . 79.2 mt-30 -136.68 153.7 50.82 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.235 -1.156 . . . . 0.0 109.51 -179.968 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.467 HG23 ' HG3' ' A' ' 57' ' ' LYS . 3.5 m -114.96 139.59 49.7 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.294 -0.879 . . . . 0.0 109.31 179.854 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.586 ' CD1' ' CD1' ' A' ' 39' ' ' LEU . 86.0 m-85 -116.54 132.21 56.74 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.291 -0.881 . . . . 0.0 109.381 -179.904 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.486 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 9.8 m-20 -54.8 -78.93 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.352 -0.842 . . . . 0.0 109.728 -179.546 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.494 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 14.3 t-20 -82.35 146.5 54.38 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 120.999 -1.063 . . . . 0.0 109.664 -179.976 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.524 ' HD3' ' CB ' ' A' ' 23' ' ' LYS . 41.3 Cg_endo -63.81 -50.86 2.75 Favored 'Trans proline' 0 C--O 1.214 -0.715 0 C-N-CA 122.63 2.22 . . . . 0.0 111.282 179.367 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.528 ' SG ' ' CE1' ' A' ' 16' ' ' TYR . 7.8 t -60.9 -29.68 69.73 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 178.767 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.461 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 37.8 mmm -64.36 -15.88 61.23 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.103 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.586 ' CD1' ' CD1' ' A' ' 33' ' ' TYR . 54.5 tp -71.49 -58.84 3.14 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.346 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.446 ' HB3' ' OH ' ' A' ' 16' ' ' TYR . 13.6 t -53.51 -25.8 18.14 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 178.832 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 48.5 t60 -70.94 -63.32 1.12 Allowed 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.353 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -52.72 -21.73 4.4 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 179.237 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.464 ' OD1' ' HB ' ' A' ' 50' ' ' THR . 98.3 m-20 -75.21 -34.56 61.51 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.506 -0.746 . . . . 0.0 109.21 179.652 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.43 ' HG ' ' O ' ' A' ' 40' ' ' CYS . 17.6 mt -64.16 -29.34 70.46 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.183 -0.948 . . . . 0.0 109.047 179.58 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.4 mt -80.42 -44.22 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.385 -0.822 . . . . 0.0 109.433 179.69 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.456 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 93.1 mtt-85 -79.97 -34.64 38.5 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.29 -0.881 . . . . 0.0 109.572 179.938 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.456 ' HB2' ' O ' ' A' ' 46' ' ' ARG . 92.1 mt-30 63.01 43.74 6.4 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.334 -0.854 . . . . 0.0 109.561 179.979 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 68.4 p -117.31 16.56 14.8 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.329 -0.857 . . . . 0.0 109.295 179.77 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 47.9 t30 43.8 60.91 2.49 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.288 -0.882 . . . . 0.0 109.568 -179.902 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.464 ' HB ' ' OD1' ' A' ' 43' ' ' ASN . 25.7 m -77.96 147.34 34.98 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.26 -0.9 . . . . 0.0 109.626 179.869 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . 0.416 ' N ' HG21 ' A' ' 50' ' ' THR . 56.8 m-70 -121.63 168.16 12.09 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.362 -0.836 . . . . 0.0 108.788 179.481 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.473 HG22 HD12 ' A' ' 52' ' ' ILE . 26.2 mt -79.79 123.71 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.076 -1.015 . . . . 0.0 109.279 179.977 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.487 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 75.2 ttt-85 -80.21 -42.83 22.56 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.474 -0.766 . . . . 0.0 109.363 -179.94 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -158.45 147.3 18.93 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.444 -0.785 . . . . 0.0 109.279 179.998 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.9 p -66.51 149.74 49.99 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.207 -0.933 . . . . 0.0 109.42 -179.86 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.546 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 73.44 162.3 7.39 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 108.961 -1.656 . . . . 0.0 108.961 -179.594 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.467 ' HG3' HG23 ' A' ' 32' ' ' THR . 22.4 tttp -51.57 146.25 7.81 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.314 -1.109 . . . . 0.0 108.755 179.883 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.438 ' O ' ' O ' ' A' ' 57' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.519 0 O-C-N 121.171 -0.956 . . . . 0.0 109.543 -179.612 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 56.4 mtt . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.437 ' O ' ' N ' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -89.8 -13.43 36.63 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.338 -0.851 . . . . 0.0 108.743 179.663 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.423 ' C ' ' O ' ' A' ' 5' ' ' CYS . 34.5 mttm -46.58 -27.46 1.14 Allowed 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 179.327 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.4 ' N ' ' C ' ' A' ' 5' ' ' CYS . 45.4 p-10 -119.15 39.26 3.6 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 178.752 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.573 ' CE2' ' OH ' ' A' ' 16' ' ' TYR . 1.6 t80 -79.48 157.43 27.48 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.62 -0.675 . . . . 0.0 109.839 -179.258 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 15.1 mtt180 -150.17 115.25 5.37 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.398 -0.814 . . . . 0.0 109.055 179.542 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 54.4 t -123.22 146.88 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.342 -0.848 . . . . 0.0 109.521 -179.625 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.503 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.2 OUTLIER -121.2 172.91 4.35 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.384 -0.823 . . . . 0.0 109.347 -179.881 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.503 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 44.2 Cg_endo -66.29 -22.81 52.66 Favored 'Trans proline' 0 C--O 1.216 -0.592 0 C-N-CA 122.669 2.246 . . . . 0.0 111.594 179.802 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 86.6 mtt-85 -101.51 -25.86 13.76 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.365 -0.835 . . . . 0.0 109.328 179.824 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 85.7 mt -87.52 -47.41 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.281 -0.887 . . . . 0.0 109.415 179.966 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 69.46 -172.35 38.79 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.894 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.573 ' OH ' ' CE2' ' A' ' 8' ' ' TYR . 1.5 t80 -95.0 150.86 19.7 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.203 -1.175 . . . . 0.0 109.494 179.927 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 21.8 tp -113.38 106.04 14.11 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.255 -0.903 . . . . 0.0 109.633 -179.83 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.427 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 56.0 m -124.54 154.89 69.8 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.304 -0.873 . . . . 0.0 109.389 179.774 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -72.5 170.77 18.55 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 C-N-CA 122.639 2.226 . . . . 0.0 111.491 179.823 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 41.3 tttp -86.77 -33.9 19.77 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.301 -0.875 . . . . 0.0 109.51 -179.926 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -54.14 133.16 44.12 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.318 -0.864 . . . . 0.0 109.383 179.97 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.434 HD12 ' HB3' ' A' ' 34' ' ' ASN . 54.7 tp -92.4 113.14 25.33 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.164 -0.96 . . . . 0.0 109.417 -179.974 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.508 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 5.3 mmtt -118.94 101.68 49.93 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.301 -0.874 . . . . 0.0 109.172 179.981 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.548 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 43.0 Cg_endo -65.35 118.15 5.2 Favored 'Trans proline' 0 C--O 1.213 -0.76 0 C-N-CA 122.848 2.365 . . . . 0.0 112.034 -179.491 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.401 ' HB ' HG22 ' A' ' 52' ' ' ILE . 11.1 m -114.26 155.99 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.224 -0.923 . . . . 0.0 109.583 179.842 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 46.1 t -96.32 133.77 40.29 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.124 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -91.12 137.01 13.64 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.555 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.464 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 49.9 p30 -66.19 -9.12 28.82 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.341 -1.094 . . . . 0.0 109.502 179.855 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.405 ' OD1' ' HB2' ' A' ' 31' ' ' GLN . 56.0 p30 -86.09 8.81 19.32 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.18 -0.95 . . . . 0.0 109.397 179.894 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.23 18.78 58.53 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 -179.921 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.47 ' O ' ' N ' ' A' ' 27' ' ' GLY . 64.4 mt-30 -125.97 176.09 7.24 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.205 -1.174 . . . . 0.0 109.39 -179.942 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.528 ' CG2' ' HA ' ' A' ' 57' ' ' LYS . 25.1 m -135.44 139.3 44.01 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.258 -0.901 . . . . 0.0 109.442 -179.981 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.631 ' CE1' ' CD1' ' A' ' 39' ' ' LEU . 58.1 m-85 -113.38 130.57 56.26 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.36 -0.838 . . . . 0.0 109.293 179.855 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.486 ' O ' ' O ' ' A' ' 23' ' ' LYS . 13.9 m-20 -51.83 -80.47 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.317 -0.864 . . . . 0.0 109.693 -179.542 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.509 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 12.0 t-20 -82.39 146.04 53.16 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.005 -1.059 . . . . 0.0 109.482 179.945 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.508 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.9 Cg_endo -63.68 -50.86 2.84 Favored 'Trans proline' 0 C--O 1.216 -0.612 0 C-N-CA 122.653 2.235 . . . . 0.0 111.563 179.723 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.556 ' SG ' ' CE1' ' A' ' 16' ' ' TYR . 11.0 t -61.99 -28.21 69.41 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 178.931 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.467 ' HB2' ' HB3' ' A' ' 35' ' ' ASN . 43.0 mmm -68.92 -7.81 38.43 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 179.24 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.631 ' CD1' ' CE1' ' A' ' 33' ' ' TYR . 25.5 tp -73.72 -60.09 2.41 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.29 -0.881 . . . . 0.0 108.902 179.802 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.462 ' SG ' ' OH ' ' A' ' 16' ' ' TYR . 12.0 t -52.91 -24.84 10.08 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.382 -0.969 . . . . 0.0 108.382 179.273 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 33.8 t60 -65.09 -60.7 2.74 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.193 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 66.0 mt-10 -60.22 -21.57 61.95 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 179.063 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.523 ' O ' ' N ' ' A' ' 47' ' ' GLN . 97.2 m-20 -78.22 -27.01 47.64 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.512 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.488 ' O ' ' CD1' ' A' ' 44' ' ' LEU . 1.4 tm? -68.54 -36.34 78.68 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.269 -0.894 . . . . 0.0 108.732 179.422 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.405 HG22 HD11 ' A' ' 45' ' ' ILE . 0.8 OUTLIER -77.24 -41.66 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.46 -0.775 . . . . 0.0 109.165 179.719 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 93.2 mtt-85 -80.11 -36.23 35.67 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.329 -0.857 . . . . 0.0 109.307 179.898 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.523 ' N ' ' O ' ' A' ' 43' ' ' ASN . 53.1 mt-30 60.05 35.4 21.38 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.368 -0.832 . . . . 0.0 109.678 179.834 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 34.6 p -103.13 11.21 37.35 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.171 -0.956 . . . . 0.0 109.413 179.785 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 65.1 m-20 52.51 54.4 10.7 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.232 -0.918 . . . . 0.0 109.478 179.976 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.47 ' HB ' ' OD1' ' A' ' 43' ' ' ASN . 42.9 m -79.77 137.24 36.95 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.198 -0.938 . . . . 0.0 109.527 179.984 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 41.1 m80 -115.53 170.53 8.35 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.363 -0.836 . . . . 0.0 108.947 179.505 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.469 HD11 HG22 ' A' ' 52' ' ' ILE . 29.3 mt -79.62 125.79 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.183 -0.948 . . . . 0.0 109.312 179.884 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.464 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 47.8 ttt180 -81.74 -40.86 22.06 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.501 -0.75 . . . . 0.0 109.496 -179.887 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -158.91 150.59 20.77 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.398 -0.814 . . . . 0.0 109.237 -179.999 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 31.0 p -69.81 139.11 53.14 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.234 -0.917 . . . . 0.0 109.516 -179.873 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.548 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 92.44 162.92 37.44 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.85 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.528 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 39.5 tttp -50.62 148.55 3.82 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.434 -1.039 . . . . 0.0 109.272 179.887 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.405 ' SG ' ' O ' ' A' ' 31' ' ' GLN . 57.8 m . . . . . 0 N--CA 1.49 1.539 0 O-C-N 121.191 -0.943 . . . . 0.0 109.501 -179.975 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 76.8 mtm . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.5 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 12.9 m -79.81 -14.0 59.01 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.289 -0.882 . . . . 0.0 109.0 179.696 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 47.2 mttm -56.6 -28.2 59.83 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.336 -0.853 . . . . 0.0 109.724 -179.792 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -149.21 61.89 1.04 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.196 -0.94 . . . . 0.0 110.044 -179.779 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.5 ' CD1' ' HA ' ' A' ' 5' ' ' CYS . 4.7 p90 -121.91 168.2 12.16 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.093 -1.005 . . . . 0.0 109.348 179.534 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.434 ' O ' HG21 ' A' ' 10' ' ' VAL . 34.2 ttt85 -147.99 149.02 31.39 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.148 -0.97 . . . . 0.0 109.605 179.922 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.434 HG21 ' O ' ' A' ' 9' ' ' ARG . 87.2 t -140.94 134.96 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.302 -0.874 . . . . 0.0 109.369 179.888 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.506 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -120.59 173.71 3.55 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.15 -0.969 . . . . 0.0 109.391 179.961 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.506 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 47.3 Cg_endo -67.9 -23.94 40.51 Favored 'Trans proline' 0 C--O 1.215 -0.644 0 C-N-CA 122.604 2.203 . . . . 0.0 111.737 179.944 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -104.62 -26.87 12.16 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.283 -0.886 . . . . 0.0 109.453 179.992 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 95.2 mt -86.2 -44.43 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.241 -0.912 . . . . 0.0 109.512 -179.94 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.92 -158.73 52.38 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -179.957 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.476 ' HB2' ' CE1' ' A' ' 41' ' ' HIS . 1.9 t80 -99.64 155.29 17.68 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.285 -1.126 . . . . 0.0 109.345 179.803 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.442 ' O ' ' SG ' ' A' ' 37' ' ' CYS . 30.5 tp -114.16 120.1 39.36 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.229 -0.919 . . . . 0.0 109.883 -179.63 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.409 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 69.4 m -138.65 156.22 73.15 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.279 -0.888 . . . . 0.0 109.366 179.894 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.448 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 52.0 Cg_endo -71.65 168.76 22.78 Favored 'Trans proline' 0 C--O 1.215 -0.635 0 C-N-CA 122.681 2.254 . . . . 0.0 111.638 -179.989 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 29.0 mttt -89.9 -12.72 38.09 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.156 -0.965 . . . . 0.0 109.366 179.961 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -72.2 132.06 43.59 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.285 -0.885 . . . . 0.0 109.202 179.698 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 28.7 tp -91.85 114.19 26.66 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.216 -0.927 . . . . 0.0 109.807 -179.679 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.517 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -126.96 106.78 22.21 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.344 -0.848 . . . . 0.0 108.897 179.604 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.546 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 44.0 Cg_endo -65.88 119.93 7.02 Favored 'Trans proline' 0 C--O 1.214 -0.722 0 C-N-CA 122.825 2.35 . . . . 0.0 112.144 -179.315 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.4 m -116.96 153.22 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.232 -0.917 . . . . 0.0 109.518 179.75 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.434 ' SG ' ' HB3' ' A' ' 53' ' ' ARG . 48.6 t -97.04 142.28 29.17 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 178.989 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -93.88 140.52 15.09 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 -178.999 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.464 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 52.4 p30 -67.41 -10.51 51.94 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.31 -1.112 . . . . 0.0 109.264 179.627 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.437 ' OD1' ' HB2' ' A' ' 31' ' ' GLN . 57.0 p30 -90.07 5.91 44.68 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.226 -0.922 . . . . 0.0 109.474 179.891 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.32 15.36 57.37 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 -179.925 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.458 ' O ' ' SG ' ' A' ' 58' ' ' CYS . 84.3 mt-30 -114.87 178.88 4.12 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.374 -1.074 . . . . 0.0 109.387 179.981 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.511 ' CG2' ' HA ' ' A' ' 57' ' ' LYS . 30.7 m -141.21 144.82 34.97 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.193 -0.942 . . . . 0.0 109.335 179.866 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.644 ' CE1' ' CD1' ' A' ' 39' ' ' LEU . 23.9 m-85 -124.59 126.7 46.22 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.269 -0.895 . . . . 0.0 109.278 -179.965 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.485 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 9.8 m-20 -48.38 -78.57 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.301 -0.874 . . . . 0.0 109.736 -179.467 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.542 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 4.5 t-20 -81.49 147.67 60.4 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 120.941 -1.1 . . . . 0.0 109.393 179.983 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.517 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 41.0 Cg_endo -63.66 -53.77 1.22 Allowed 'Trans proline' 0 C--O 1.215 -0.644 0 C-N-CA 122.872 2.381 . . . . 0.0 111.926 -179.963 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.542 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 11.3 t -62.98 -25.68 68.48 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 120.942 -1.099 . . . . 0.0 108.141 179.051 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.44 ' HB2' ' HB3' ' A' ' 35' ' ' ASN . 42.1 mmm -67.35 -13.08 61.67 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.21 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.644 ' CD1' ' CE1' ' A' ' 33' ' ' TYR . 19.1 tp -70.3 -57.55 4.74 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.427 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.471 ' HB3' ' OH ' ' A' ' 16' ' ' TYR . 3.3 t -56.05 -26.77 50.6 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.026 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.476 ' CE1' ' HB2' ' A' ' 16' ' ' TYR . 31.2 t60 -62.43 -59.55 4.82 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.963 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -58.33 -22.89 54.94 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 178.915 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.503 ' O ' ' N ' ' A' ' 47' ' ' GLN . 91.3 m-20 -79.19 -27.75 42.6 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.584 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.461 ' CD1' ' OH ' ' A' ' 8' ' ' TYR . 32.6 tp -70.22 -30.86 68.05 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.498 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 6.5 mm -80.31 -46.29 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.475 -0.766 . . . . 0.0 109.113 179.467 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.47 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 85.3 mtt180 -79.88 -36.56 36.42 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.309 -0.87 . . . . 0.0 109.394 179.712 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.503 ' N ' ' O ' ' A' ' 43' ' ' ASN . 92.4 mt-30 63.75 42.34 6.29 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.497 -0.752 . . . . 0.0 109.616 -179.862 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 49.4 p -106.8 10.16 30.82 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.195 -0.94 . . . . 0.0 109.417 179.737 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 51.51 54.68 10.62 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.273 -0.892 . . . . 0.0 109.71 179.874 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.451 ' HB ' ' OD1' ' A' ' 43' ' ' ASN . 51.5 m -79.88 139.93 36.94 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.215 -0.928 . . . . 0.0 109.528 179.985 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . 0.449 ' CD2' ' OD2' ' A' ' 28' ' ' ASP . 8.4 m-70 -112.47 -173.42 2.24 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.239 -0.913 . . . . 0.0 109.397 179.722 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.474 HD11 HG22 ' A' ' 52' ' ' ILE . 39.8 mt -93.87 126.46 46.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.378 -0.826 . . . . 0.0 109.594 -179.933 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.464 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 68.1 ttt-85 -80.02 -45.77 17.78 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.43 -0.794 . . . . 0.0 109.3 179.787 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 49.4 p -160.88 147.59 15.17 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 -179.445 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.3 p -61.23 144.14 54.32 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.137 -0.977 . . . . 0.0 109.411 179.929 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.546 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 87.51 164.01 39.66 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 -179.775 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.511 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 53.1 mttt -60.44 148.81 36.17 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.414 -1.051 . . . . 0.0 109.293 179.913 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.458 ' SG ' ' O ' ' A' ' 31' ' ' GLN . 61.8 m . . . . . 0 N--CA 1.489 1.484 0 O-C-N 121.189 -0.944 . . . . 0.0 108.999 179.532 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 64.1 mmm . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.567 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 29.3 m -81.82 -15.34 54.44 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.483 -0.761 . . . . 0.0 109.112 179.709 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.452 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 45.4 mttm -80.72 5.56 15.4 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.195 -0.94 . . . . 0.0 109.789 -179.954 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.452 ' OD1' ' O ' ' A' ' 6' ' ' LYS . 95.4 m-20 -135.97 12.05 3.36 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.025 -1.047 . . . . 0.0 110.333 -179.367 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.635 ' CE2' ' CE2' ' A' ' 16' ' ' TYR . 0.6 OUTLIER -123.11 155.94 35.98 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.866 -1.146 . . . . 0.0 109.576 179.822 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 47.0 mtt85 -134.19 132.81 40.21 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.372 -0.83 . . . . 0.0 109.149 179.804 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.56 HG22 ' CE2' ' A' ' 8' ' ' TYR . 55.6 t -125.45 147.56 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.195 -0.941 . . . . 0.0 109.872 -179.535 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.523 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 1.3 mp -123.28 174.96 3.04 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.288 -0.883 . . . . 0.0 109.202 179.797 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.523 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 44.8 Cg_endo -67.2 -21.72 47.88 Favored 'Trans proline' 0 C--O 1.215 -0.647 0 C-N-CA 122.561 2.174 . . . . 0.0 111.732 179.923 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 95.0 mtt-85 -104.61 -25.73 12.62 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.369 -0.832 . . . . 0.0 109.684 -179.953 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 24.4 mm -80.95 -47.23 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.232 -0.917 . . . . 0.0 109.532 -179.703 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.531 ' O ' ' CG1' ' A' ' 10' ' ' VAL . . . 82.38 -163.17 42.58 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.935 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.635 ' CE2' ' CE2' ' A' ' 8' ' ' TYR . 1.6 t80 -102.51 148.9 24.96 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.205 -1.174 . . . . 0.0 109.466 179.925 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 27.1 tp -115.63 111.86 21.26 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.31 -0.869 . . . . 0.0 109.532 179.885 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 80.7 m -120.23 157.54 53.07 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.197 -0.939 . . . . 0.0 109.353 -179.977 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.475 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 50.6 Cg_endo -71.57 166.48 29.26 Favored 'Trans proline' 0 C--O 1.215 -0.642 0 C-N-CA 122.713 2.275 . . . . 0.0 111.884 -179.774 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -87.3 -9.74 54.15 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.307 -0.87 . . . . 0.0 109.449 179.902 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -76.31 110.94 11.24 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.183 -0.948 . . . . 0.0 109.106 179.736 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 42.7 tp -79.66 123.62 27.81 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.216 -0.927 . . . . 0.0 109.708 -179.76 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.481 ' O ' ' O ' ' A' ' 34' ' ' ASN . 5.2 mtpt -139.66 107.98 7.12 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.308 -0.87 . . . . 0.0 109.052 179.661 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.556 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 41.5 Cg_endo -64.28 120.23 7.49 Favored 'Trans proline' 0 C--O 1.212 -0.779 0 C-N-CA 122.937 2.424 . . . . 0.0 112.082 -179.558 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.47 ' O ' HG21 ' A' ' 32' ' ' THR . 16.6 m -115.71 154.63 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.282 -0.886 . . . . 0.0 109.835 -179.937 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 43.9 t -97.21 126.28 42.29 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.456 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -78.57 137.66 19.9 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 -179.994 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.485 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 52.9 t0 -70.82 -10.33 59.32 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.174 -1.192 . . . . 0.0 109.566 -179.944 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.427 ' OD1' ' HB2' ' A' ' 31' ' ' GLN . 56.5 p30 -87.96 10.38 19.09 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.257 -0.902 . . . . 0.0 109.24 179.586 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.45 21.39 48.4 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.08 -1.608 . . . . 0.0 109.08 -179.722 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.456 ' O ' ' SG ' ' A' ' 58' ' ' CYS . 87.5 mt-30 -121.0 177.21 5.2 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.277 -1.131 . . . . 0.0 109.542 179.98 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.518 ' CG2' ' HG3' ' A' ' 57' ' ' LYS . 56.7 m -140.37 134.75 31.33 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.314 -0.866 . . . . 0.0 109.304 179.96 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.631 ' CE1' ' CD1' ' A' ' 39' ' ' LEU . 39.0 m-85 -117.36 130.09 56.28 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.309 -0.869 . . . . 0.0 109.295 179.994 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.489 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 7.1 m-20 -54.54 -77.83 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.221 -0.924 . . . . 0.0 109.73 -179.628 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.527 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 5.1 t-20 -81.68 148.69 62.43 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.094 -1.004 . . . . 0.0 109.641 -179.906 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.472 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.6 Cg_endo -63.1 -52.62 1.99 Allowed 'Trans proline' 0 C--O 1.215 -0.631 0 C-N-CA 122.568 2.179 . . . . 0.0 111.807 179.829 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.527 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 5.4 t -61.98 -28.18 69.38 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 178.982 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.486 ' CG ' ' HB3' ' A' ' 35' ' ' ASN . 52.6 mmm -63.32 -16.57 60.76 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.444 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.631 ' CD1' ' CE1' ' A' ' 33' ' ' TYR . 39.0 tp -68.71 -56.87 6.7 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 179.327 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.47 ' HB3' ' OH ' ' A' ' 16' ' ' TYR . 10.9 t -55.78 -23.14 28.13 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 178.864 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 47.1 t60 -71.69 -63.46 1.12 Allowed 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 179.393 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.416 ' HB2' ' CE2' ' A' ' 33' ' ' TYR . 62.2 mt-10 -54.35 -21.77 10.38 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.342 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.495 ' O ' ' N ' ' A' ' 47' ' ' GLN . 99.4 m-20 -73.29 -37.22 66.3 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.424 -0.797 . . . . 0.0 109.116 179.686 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.46 ' HG ' ' O ' ' A' ' 40' ' ' CYS . 24.0 mt -61.41 -32.59 72.53 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.139 -0.975 . . . . 0.0 108.912 179.627 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.8 mt -74.4 -42.58 49.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.377 -0.827 . . . . 0.0 108.832 179.296 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.456 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 69.1 mtt-85 -79.85 -22.57 42.78 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.428 -0.795 . . . . 0.0 109.391 179.744 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.495 ' N ' ' O ' ' A' ' 43' ' ' ASN . 89.5 mt-30 63.21 41.69 7.73 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.395 -0.816 . . . . 0.0 109.427 -179.838 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.409 HG22 ' HB3' ' A' ' 46' ' ' ARG . 16.0 p -128.35 163.5 24.7 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.344 -0.847 . . . . 0.0 109.371 179.87 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 50.9 p-10 -94.3 61.48 2.83 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.175 -0.953 . . . . 0.0 109.428 -179.958 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 31.7 m -69.75 139.0 53.26 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.402 -0.811 . . . . 0.0 109.742 -179.937 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 62.1 m-70 -119.8 169.36 10.2 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.307 -0.871 . . . . 0.0 109.032 179.538 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.463 HD11 HG22 ' A' ' 52' ' ' ILE . 41.1 mt -79.43 126.42 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.182 -0.949 . . . . 0.0 109.387 179.983 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.485 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 68.8 ttt180 -79.92 -47.98 14.17 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-O 121.638 0.732 . . . . 0.0 109.449 179.988 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 65.2 p -159.71 135.55 8.6 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -179.483 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.5 p -50.88 147.97 4.54 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.245 -0.91 . . . . 0.0 109.525 -179.834 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.556 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 85.94 164.22 38.97 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.326 -1.509 . . . . 0.0 109.326 -179.764 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.521 ' HG2' ' N ' ' A' ' 58' ' ' CYS . 26.0 tttt -59.32 153.72 18.2 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.374 -1.074 . . . . 0.0 109.387 -179.924 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.521 ' N ' ' HG2' ' A' ' 57' ' ' LYS . 98.2 m . . . . . 0 N--CA 1.492 1.633 0 O-C-N 121.267 -0.896 . . . . 0.0 109.704 -179.772 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 4' ' ' MET . . . . . 0.442 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 57.2 mmm . . . . . 0 N--CA 1.488 1.444 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 . . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.401 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 17.2 m -81.97 -18.21 44.24 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.483 -0.761 . . . . 0.0 109.155 179.586 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 49.6 mttt -80.2 -3.78 50.41 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.32 -0.862 . . . . 0.0 109.745 -179.886 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' A' ' 4' ' ' MET . 19.3 p30 -118.56 -0.82 11.29 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.08 -1.013 . . . . 0.0 109.714 -179.835 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.573 ' OH ' ' CE2' ' A' ' 16' ' ' TYR . 0.1 OUTLIER -118.51 168.9 10.24 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.053 -1.029 . . . . 0.0 109.284 179.979 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 41.9 mtm-85 -149.63 128.14 12.29 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.243 -0.911 . . . . 0.0 109.254 179.817 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.503 HG22 ' HA ' ' A' ' 16' ' ' TYR . 6.4 p -124.99 145.48 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.218 -0.926 . . . . 0.0 109.847 -179.77 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.464 ' HB3' ' HD2' ' A' ' 12' ' ' PRO . 0.2 OUTLIER -108.37 170.37 5.57 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.359 -0.838 . . . . 0.0 109.229 179.921 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.464 ' HD2' ' HB3' ' A' ' 11' ' ' LEU . 45.7 Cg_endo -67.54 -23.86 42.79 Favored 'Trans proline' 0 C--O 1.215 -0.659 0 C-N-CA 122.622 2.215 . . . . 0.0 111.787 179.951 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 73.2 mtt85 -87.7 -26.28 23.05 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.289 -0.882 . . . . 0.0 109.131 179.734 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 97.7 mt -90.26 -44.49 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.277 -0.889 . . . . 0.0 109.327 179.883 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.432 ' C ' HG22 ' A' ' 10' ' ' VAL . . . 72.97 148.9 1.0 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.991 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.573 ' CE2' ' OH ' ' A' ' 8' ' ' TYR . 0.9 OUTLIER -47.48 148.91 1.24 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.327 -1.102 . . . . 0.0 109.788 -179.874 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 25.9 tp -115.82 110.29 18.84 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.373 -0.829 . . . . 0.0 109.521 -179.992 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 56.1 m -120.74 154.96 57.54 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.272 -0.892 . . . . 0.0 109.445 179.966 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -72.47 169.7 21.12 Favored 'Trans proline' 0 C--O 1.215 -0.669 0 C-N-CA 122.591 2.194 . . . . 0.0 111.475 179.978 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 47.6 mttm -88.7 -17.89 29.02 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.185 -0.947 . . . . 0.0 109.471 -179.911 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -66.94 130.34 42.83 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.262 -0.899 . . . . 0.0 109.296 179.721 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.457 HD12 ' HB3' ' A' ' 34' ' ' ASN . 43.3 tp -87.46 121.88 30.47 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.177 -0.952 . . . . 0.0 109.558 -179.894 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.53 ' CB ' ' HD3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -132.77 99.72 15.18 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.234 -0.916 . . . . 0.0 109.044 179.768 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.544 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 41.9 Cg_endo -63.88 119.77 6.93 Favored 'Trans proline' 0 C--O 1.214 -0.702 0 C-N-CA 122.899 2.399 . . . . 0.0 112.492 -179.248 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.457 ' O ' HG21 ' A' ' 32' ' ' THR . 32.9 m -115.71 154.37 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.345 -0.847 . . . . 0.0 109.473 179.689 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.497 ' O ' ' N ' ' A' ' 53' ' ' ARG . 41.6 t -100.65 121.32 41.43 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.323 -0.86 . . . . 0.0 108.819 179.372 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -74.83 141.62 28.6 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.804 -1.319 . . . . 0.0 109.804 -179.701 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.504 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 55.1 t0 -71.28 -9.69 58.53 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.156 -1.202 . . . . 0.0 109.598 179.969 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -86.81 6.62 30.74 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.234 -0.916 . . . . 0.0 109.198 179.64 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.79 16.6 54.36 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 -179.836 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.516 ' O ' ' N ' ' A' ' 27' ' ' GLY . 87.5 mt-30 -118.19 169.58 9.58 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.194 -1.18 . . . . 0.0 109.532 179.992 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.459 HG22 ' HA ' ' A' ' 57' ' ' LYS . 27.8 m -132.39 134.47 45.19 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.224 -0.922 . . . . 0.0 109.367 179.874 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.578 ' CE1' ' CD1' ' A' ' 39' ' ' LEU . 47.6 m-85 -114.43 130.28 56.7 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.185 -0.947 . . . . 0.0 109.195 179.835 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.506 ' O ' ' O ' ' A' ' 23' ' ' LYS . 5.1 m-20 -52.49 -77.88 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.19 -0.944 . . . . 0.0 109.73 -179.516 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.517 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 13.7 t-20 -81.91 146.5 55.94 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 120.975 -1.078 . . . . 0.0 109.646 -179.895 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.53 ' HD3' ' CB ' ' A' ' 23' ' ' LYS . 40.1 Cg_endo -63.43 -51.29 2.69 Favored 'Trans proline' 0 C--O 1.214 -0.709 0 C-N-CA 122.592 2.195 . . . . 0.0 111.304 179.474 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.517 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 8.8 t -60.62 -28.79 68.8 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 178.835 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.464 ' HB2' ' HB3' ' A' ' 35' ' ' ASN . 12.3 mtt -65.25 -12.7 54.18 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.202 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.578 ' CD1' ' CE1' ' A' ' 33' ' ' TYR . 51.0 tp -71.47 -58.07 3.85 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.294 -0.879 . . . . 0.0 108.726 179.569 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.465 ' SG ' ' OH ' ' A' ' 16' ' ' TYR . 36.0 t -54.61 -24.75 22.67 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 179.048 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 35.1 t60 -68.52 -61.38 1.85 Allowed 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.293 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.419 ' HB2' ' CE2' ' A' ' 33' ' ' TYR . 72.3 mm-40 -56.08 -20.0 15.37 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.259 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.523 ' O ' ' N ' ' A' ' 47' ' ' GLN . 98.0 m-20 -78.61 -29.72 46.17 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.718 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.454 ' HG ' ' O ' ' A' ' 40' ' ' CYS . 16.8 mt -68.95 -30.44 68.89 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.25 -0.906 . . . . 0.0 108.795 179.401 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -80.43 -47.33 21.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.346 -0.846 . . . . 0.0 109.355 179.715 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.452 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 94.9 mtt-85 -79.73 -34.47 39.97 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.285 -0.885 . . . . 0.0 109.321 179.875 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.523 ' N ' ' O ' ' A' ' 43' ' ' ASN . 92.1 mt-30 62.15 39.65 12.63 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.362 -0.836 . . . . 0.0 109.518 -179.939 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.408 ' O ' ' C ' ' A' ' 49' ' ' ASN . 68.1 p -107.63 17.08 23.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.302 -0.874 . . . . 0.0 109.468 179.986 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.408 ' C ' ' O ' ' A' ' 48' ' ' THR . 57.4 m-20 44.15 60.0 2.96 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.174 -0.954 . . . . 0.0 109.285 -179.936 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.473 ' HB ' ' OD1' ' A' ' 43' ' ' ASN . 22.1 m -77.12 145.77 37.59 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.213 -0.929 . . . . 0.0 109.669 -179.742 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 28.6 m-70 -118.49 173.8 6.62 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.281 -0.887 . . . . 0.0 109.137 179.565 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 9.4 mt -86.32 124.66 40.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.224 -0.922 . . . . 0.0 109.713 -179.966 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.504 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 21.0 ttt180 -79.51 -51.82 8.82 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-O 121.631 0.729 . . . . 0.0 109.389 179.959 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 57.8 m -159.76 140.15 11.97 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.507 -0.746 . . . . 0.0 109.122 -179.738 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.8 p -52.85 148.06 8.13 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.151 -0.968 . . . . 0.0 109.518 -179.861 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.544 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 88.64 164.95 40.8 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 -179.883 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.468 ' HG3' ' HB2' ' A' ' 24' ' ' PRO . 24.3 mttt -64.32 150.73 45.56 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.493 -1.004 . . . . 0.0 109.224 179.871 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.458 ' SG ' ' OG1' ' A' ' 32' ' ' THR . 86.5 m . . . . . 0 N--CA 1.492 1.639 0 O-C-N 121.23 -0.919 . . . . 0.0 109.429 179.964 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 66.4 mmm . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 . . . . . . . . . 0 0 . 1 . 031 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.574 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 39.1 m -80.71 -16.12 54.74 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.539 -0.726 . . . . 0.0 109.367 179.744 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.429 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 60.5 mttt -80.8 9.14 6.73 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.262 -0.899 . . . . 0.0 109.861 179.95 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.429 ' OD1' ' O ' ' A' ' 6' ' ' LYS . 90.6 m-20 -135.35 3.99 3.13 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.874 -1.141 . . . . 0.0 110.551 -179.526 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . 0.664 ' CE2' ' CE2' ' A' ' 16' ' ' TYR . 1.5 p90 -114.76 156.87 24.06 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.805 -1.184 . . . . 0.0 109.803 -179.996 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 62.7 mtm180 -137.15 133.01 34.78 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.331 -0.855 . . . . 0.0 109.462 179.82 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.543 HG22 ' CE2' ' A' ' 8' ' ' TYR . 79.3 t -121.55 143.29 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.351 -0.843 . . . . 0.0 109.687 -179.78 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.542 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 1.8 mp -123.99 176.09 2.47 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.329 -0.857 . . . . 0.0 109.103 179.877 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.542 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 44.3 Cg_endo -67.19 -22.68 46.46 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 122.561 2.174 . . . . 0.0 111.759 179.873 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 71.5 mtt85 -102.94 -28.45 12.02 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.277 -0.889 . . . . 0.0 109.506 179.907 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 94.8 mt -82.79 -46.43 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.358 -0.839 . . . . 0.0 109.766 -179.731 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.428 ' C ' HG12 ' A' ' 10' ' ' VAL . . . 75.81 -169.99 54.7 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.391 -1.483 . . . . 0.0 109.391 -179.87 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.664 ' CE2' ' CE2' ' A' ' 8' ' ' TYR . 1.5 t80 -90.81 151.02 21.34 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.163 -1.198 . . . . 0.0 109.436 179.914 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.409 ' O ' ' SG ' ' A' ' 37' ' ' CYS . 43.1 mt -120.26 126.16 49.91 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.269 -0.894 . . . . 0.0 109.721 -179.839 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.411 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 63.3 m -138.16 155.42 74.29 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.319 -0.863 . . . . 0.0 109.057 179.818 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -70.02 165.06 32.54 Favored 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 122.583 2.189 . . . . 0.0 111.659 179.951 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 77.8 mttt -83.7 -21.71 32.27 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.338 -0.851 . . . . 0.0 109.433 -179.801 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -65.7 122.9 18.34 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.263 -0.898 . . . . 0.0 109.202 179.751 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.426 ' C ' HD12 ' A' ' 22' ' ' LEU . 3.5 tm? -89.68 108.33 19.61 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.18 -0.95 . . . . 0.0 109.338 -179.771 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.505 ' O ' ' O ' ' A' ' 34' ' ' ASN . 4.2 mtpm? -117.42 104.68 49.59 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.389 -0.819 . . . . 0.0 109.132 179.933 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.547 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 42.3 Cg_endo -63.95 119.93 7.14 Favored 'Trans proline' 0 C--O 1.213 -0.739 0 C-N-CA 123.067 2.511 . . . . 0.0 112.502 -179.353 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.473 ' O ' HG21 ' A' ' 32' ' ' THR . 30.1 m -117.35 154.32 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.342 -0.849 . . . . 0.0 109.424 179.703 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 26' ' ' CYS . . . . . 0.503 ' O ' ' N ' ' A' ' 53' ' ' ARG . 43.3 t -98.82 118.21 35.05 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.328 -0.857 . . . . 0.0 109.077 179.622 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -72.57 141.6 31.1 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 110.179 -1.169 . . . . 0.0 110.179 -179.405 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.508 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 54.5 p30 -69.98 -11.26 60.75 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.324 -1.103 . . . . 0.0 109.434 179.748 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.428 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 91.5 m-20 -83.52 9.24 11.79 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.21 -0.931 . . . . 0.0 109.291 179.778 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.52 13.71 67.2 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 -179.908 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.493 ' O ' ' N ' ' A' ' 27' ' ' GLY . 91.8 mt-30 -118.35 170.78 8.62 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.302 -1.116 . . . . 0.0 109.481 179.98 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.513 ' CG2' ' HA ' ' A' ' 57' ' ' LYS . 56.7 m -129.4 138.94 51.77 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.353 -0.842 . . . . 0.0 109.333 -179.95 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.627 ' CD1' ' CD1' ' A' ' 39' ' ' LEU . 23.2 m-85 -118.38 121.88 41.45 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.304 -0.872 . . . . 0.0 108.93 179.643 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.505 ' O ' ' O ' ' A' ' 23' ' ' LYS . 1.6 m-20 -47.8 -78.47 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.355 -0.841 . . . . 0.0 109.557 -179.361 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . 0.531 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 9.6 t-20 -82.36 146.32 53.9 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.019 -1.05 . . . . 0.0 109.788 -179.706 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.483 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.9 Cg_endo -63.67 -51.63 2.33 Favored 'Trans proline' 0 C--O 1.215 -0.667 0 C-N-CA 122.706 2.271 . . . . 0.0 111.627 179.789 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.531 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 9.2 t -62.51 -26.09 68.37 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 178.842 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 38' ' ' MET . . . . . 0.451 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 41.6 mmm -67.37 -17.37 64.71 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.31 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.627 ' CD1' ' CD1' ' A' ' 33' ' ' TYR . 10.6 tp -70.18 -59.95 2.58 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.305 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.473 ' HB3' ' OH ' ' A' ' 16' ' ' TYR . 16.6 t -54.02 -25.62 22.15 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 178.803 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 72.9 t60 -65.19 -62.12 1.73 Allowed 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.096 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.405 ' OE1' ' CE2' ' A' ' 33' ' ' TYR . 82.3 mt-10 -57.46 -19.34 23.53 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 179.002 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.523 ' O ' ' N ' ' A' ' 47' ' ' GLN . 98.9 m-20 -79.72 -26.55 40.8 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.395 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 40.4 tp -72.98 -31.8 64.77 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.412 -0.805 . . . . 0.0 108.912 179.577 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 8.7 mm -80.04 -49.57 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.347 -0.846 . . . . 0.0 109.097 179.629 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.467 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 53.3 mtt-85 -80.9 -34.27 33.62 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.294 -0.879 . . . . 0.0 109.246 179.832 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.523 ' N ' ' O ' ' A' ' 43' ' ' ASN . 92.9 mt-30 63.12 39.95 9.46 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.529 -0.732 . . . . 0.0 109.489 -179.887 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 41.7 p -97.26 2.15 50.49 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.243 -0.91 . . . . 0.0 109.534 179.826 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.456 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 70.4 m-20 55.5 56.23 6.49 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.175 -0.953 . . . . 0.0 109.623 179.989 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.42 HG21 ' N ' ' A' ' 51' ' ' HIS . 55.7 m -79.72 143.06 34.89 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.174 -0.954 . . . . 0.0 109.674 -179.929 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 51' ' ' HIS . . . . . 0.456 ' CE1' ' O ' ' A' ' 49' ' ' ASN . 26.2 m80 -114.25 172.53 6.95 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.269 -0.894 . . . . 0.0 109.054 179.668 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.463 HD11 HG22 ' A' ' 52' ' ' ILE . 19.6 mt -85.74 124.38 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.131 -0.981 . . . . 0.0 109.706 -179.919 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.508 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 31.5 ttt-85 -79.77 -56.68 4.1 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.546 -0.721 . . . . 0.0 109.272 179.81 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -152.34 148.8 27.93 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.545 -0.722 . . . . 0.0 109.162 179.91 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 33.6 p -59.02 151.88 21.13 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.164 -0.96 . . . . 0.0 109.302 -179.963 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.547 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 85.5 166.51 42.06 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 108.955 -1.658 . . . . 0.0 108.955 -179.577 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.513 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 88.6 mttt -66.35 166.67 11.81 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.296 -1.12 . . . . 0.0 109.443 -179.98 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.457 ' SG ' ' OG1' ' A' ' 32' ' ' THR . 85.9 m . . . . . 0 N--CA 1.49 1.549 0 O-C-N 121.294 -0.879 . . . . 0.0 108.955 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.445 ' OD1' HD11 ' A' ' 52' ' ' ILE . 70.3 m-20 . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.5 m -51.27 -30.79 18.97 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.257 -0.902 . . . . 0.0 109.595 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.445 ' HA ' ' HG3' ' A' ' 6' ' ' LYS . 8.3 mt-10 -53.49 -25.55 17.0 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.278 -0.889 . . . . 0.0 109.011 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 63.4 mmm -74.79 -26.38 59.7 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.462 -0.774 . . . . 0.0 109.022 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 5.6 m -81.61 -13.92 57.38 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.328 -0.858 . . . . 0.0 109.251 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.445 ' HG3' ' HA ' ' A' ' 3' ' ' GLU . 40.5 mttm -54.78 -30.37 56.68 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.294 -0.879 . . . . 0.0 109.84 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -150.56 63.69 0.94 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.169 -0.957 . . . . 0.0 109.839 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.406 ' CE2' ' CE2' ' A' ' 16' ' ' TYR . 9.0 p90 -116.04 175.47 5.53 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.158 -0.963 . . . . 0.0 109.332 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 70.9 mtt180 -148.68 140.07 23.37 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.214 -0.929 . . . . 0.0 109.53 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.493 HG22 ' CD2' ' A' ' 44' ' ' LEU . 92.3 t -133.01 139.8 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.365 -0.834 . . . . 0.0 109.349 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.464 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.4 OUTLIER -128.13 172.0 7.59 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.26 -0.9 . . . . 0.0 109.262 179.991 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.464 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 45.1 Cg_endo -67.32 -24.78 43.07 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 122.549 2.166 . . . . 0.0 111.439 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 55.6 mtt180 -106.89 -27.69 10.55 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.359 -0.838 . . . . 0.0 109.123 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.421 ' HB ' ' HB2' ' A' ' 11' ' ' LEU . 98.1 mt -85.66 -41.92 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.357 -0.839 . . . . 0.0 109.349 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 71.49 -140.35 30.5 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.455 ' OH ' ' SG ' ' A' ' 40' ' ' CYS . 3.1 t80 -110.52 151.34 27.69 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.125 -1.221 . . . . 0.0 109.486 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.443 ' O ' ' SG ' ' A' ' 37' ' ' CYS . 52.2 mt -111.21 131.24 55.27 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.291 -0.881 . . . . 0.0 109.349 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.408 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 84.6 m -139.64 156.95 70.97 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.207 -0.933 . . . . 0.0 109.596 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.469 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 47.9 Cg_endo -69.81 166.38 27.86 Favored 'Trans proline' 0 C--O 1.215 -0.634 0 C-N-CA 122.666 2.244 . . . . 0.0 111.661 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 52.7 tttp -87.17 -17.62 32.27 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.307 -0.87 . . . . 0.0 109.359 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -66.98 121.73 16.18 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.254 -0.904 . . . . 0.0 109.379 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.479 ' CD1' ' C ' ' A' ' 22' ' ' LEU . 3.5 tm? -85.66 125.29 33.05 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.266 -0.896 . . . . 0.0 109.465 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.46 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 8.8 mtpt -147.49 113.03 4.04 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.254 -0.904 . . . . 0.0 109.739 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.542 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 43.5 Cg_endo -66.14 123.5 11.32 Favored 'Trans proline' 0 C--O 1.214 -0.711 0 C-N-CA 122.973 2.448 . . . . 0.0 111.74 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 29.8 m -118.54 154.13 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.246 -0.909 . . . . 0.0 109.86 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 45.5 t -97.09 142.16 29.36 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 178.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -99.5 139.28 14.35 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 -179.287 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.479 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 54.9 p30 -64.58 -10.85 29.1 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.357 -1.084 . . . . 0.0 109.52 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.461 ' OD2' ' OG1' ' A' ' 50' ' ' THR . 70.5 m-20 -91.09 12.65 19.23 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.272 -0.893 . . . . 0.0 109.501 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 81.59 15.4 76.0 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.526 ' O ' ' N ' ' A' ' 27' ' ' GLY . 55.6 mt-30 -117.75 155.51 29.87 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.207 -1.173 . . . . 0.0 109.4 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.44 HG22 ' HA ' ' A' ' 57' ' ' LYS . 23.6 m -118.0 146.74 43.81 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.148 -0.97 . . . . 0.0 109.427 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.58 ' CD2' ' CD1' ' A' ' 39' ' ' LEU . 78.5 m-85 -124.01 128.01 48.74 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.253 -0.904 . . . . 0.0 109.478 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.499 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 56.7 t-20 -47.84 -79.95 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.277 -0.89 . . . . 0.0 109.604 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.517 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 3.9 t-20 -81.09 148.63 64.5 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 120.977 -1.077 . . . . 0.0 109.104 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.465 ' HD2' ' CG ' ' A' ' 35' ' ' ASN . 39.3 Cg_endo -62.09 -52.66 2.58 Favored 'Trans proline' 0 C--O 1.215 -0.644 0 C-N-CA 122.62 2.213 . . . . 0.0 111.958 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.517 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 4.8 t -60.34 -30.48 69.56 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 120.977 -1.077 . . . . 0.0 108.256 179.005 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.461 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 24.1 mtp -61.64 -18.29 58.86 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.492 -0.755 . . . . 0.0 109.175 179.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.58 ' CD1' ' CD2' ' A' ' 33' ' ' TYR . 6.7 tt -69.21 -52.74 24.75 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.245 -0.909 . . . . 0.0 108.919 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.502 ' O ' ' HB2' ' A' ' 43' ' ' ASN . 4.9 t -49.48 -32.78 12.79 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 179.053 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.466 ' O ' HG12 ' A' ' 45' ' ' ILE . 27.6 t60 -53.96 -48.08 70.66 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 179.122 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.575 ' HB2' ' CE1' ' A' ' 33' ' ' TYR . 24.5 tp10 -61.28 -16.84 49.76 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.265 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.519 ' OD1' ' N ' ' A' ' 50' ' ' THR . 2.8 m-80 -80.33 -32.8 37.84 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.379 -0.825 . . . . 0.0 109.271 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.504 ' N ' HD13 ' A' ' 44' ' ' LEU . 7.9 mp -75.69 -31.68 59.81 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.33 -0.856 . . . . 0.0 109.596 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.466 HG12 ' O ' ' A' ' 41' ' ' HIS . 8.9 mm -78.77 -51.32 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.229 -0.919 . . . . 0.0 109.531 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.454 ' HG2' ' NH1' ' A' ' 46' ' ' ARG . 15.2 mtt-85 -81.77 -30.78 32.19 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.301 -0.874 . . . . 0.0 109.729 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.438 ' HA ' ' O ' ' A' ' 43' ' ' ASN . 14.6 mt-30 61.62 34.67 17.56 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.265 -0.897 . . . . 0.0 109.474 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.465 ' O ' ' HB2' ' A' ' 49' ' ' ASN . 52.7 p -106.03 2.86 27.65 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.207 -0.933 . . . . 0.0 109.667 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.465 ' HB2' ' O ' ' A' ' 48' ' ' THR . 22.3 m120 64.88 49.82 2.08 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.196 -0.94 . . . . 0.0 109.572 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.519 ' N ' ' OD1' ' A' ' 43' ' ' ASN . 88.4 m -77.77 128.77 34.55 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.264 -0.897 . . . . 0.0 109.465 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 7.3 m-70 -110.72 -173.35 2.22 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.28 -0.888 . . . . 0.0 109.257 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.445 HD11 ' OD1' ' A' ' 1' ' ' ASP . 22.1 mt -88.31 126.53 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.296 -0.877 . . . . 0.0 109.446 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.479 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 31.6 ttt180 -80.42 -40.93 25.45 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.363 -0.836 . . . . 0.0 109.274 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -160.53 151.71 19.12 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.497 -0.752 . . . . 0.0 109.09 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.2 p -67.46 148.42 51.57 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.121 -0.987 . . . . 0.0 109.422 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.542 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 84.6 165.7 40.06 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.457 ' HG2' ' N ' ' A' ' 58' ' ' CYS . 23.2 tttp -57.03 151.54 14.84 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.333 -1.098 . . . . 0.0 109.253 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.457 ' N ' ' HG2' ' A' ' 57' ' ' LYS . 96.6 m -53.51 172.62 0.06 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.202 -0.936 . . . . 0.0 109.33 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.4 ' HG2' ' OG ' ' A' ' 62' ' ' SER . 59.4 tt0 -82.56 9.29 9.66 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.225 -0.922 . . . . 0.0 109.679 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -58.73 -39.54 81.18 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.207 -0.933 . . . . 0.0 109.39 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 82.5 p -55.05 -33.38 62.64 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.279 -0.888 . . . . 0.0 109.505 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.4 ' OG ' ' HG2' ' A' ' 59' ' ' GLU . 22.5 p -62.31 159.36 15.3 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.209 -0.932 . . . . 0.0 109.469 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -61.47 148.19 86.53 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.207 -0.933 . . . . 0.0 109.506 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -70.42 -17.22 34.72 Favored 'Trans proline' 0 C--O 1.216 -0.621 0 C-N-CA 122.693 2.262 . . . . 0.0 111.82 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -85.95 -173.28 49.3 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 41.3 m -117.21 140.57 49.37 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.27 -1.135 . . . . 0.0 109.478 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.452 ' O ' ' OG ' ' A' ' 70' ' ' SER . 57.6 p -66.02 -23.8 66.63 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.296 -0.877 . . . . 0.0 109.497 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.447 ' O ' ' HB2' ' A' ' 71' ' ' MET . . . -61.68 -33.02 73.26 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.226 -0.921 . . . . 0.0 109.51 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.419 ' C ' ' HD2' ' A' ' 72' ' ' PRO . . . -64.6 -26.92 68.61 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.222 -0.924 . . . . 0.0 109.426 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.452 ' OG ' ' O ' ' A' ' 67' ' ' THR . 86.2 p -69.69 -28.46 65.86 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.189 -0.945 . . . . 0.0 109.46 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.482 ' N ' ' HD2' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -49.2 -59.3 6.72 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.228 -0.92 . . . . 0.0 109.495 -179.968 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.482 ' HD2' ' N ' ' A' ' 71' ' ' MET . 50.2 Cg_endo -70.38 146.64 56.94 Favored 'Trans proline' 0 C--O 1.215 -0.653 0 C-N-CA 122.684 2.256 . . . . 0.0 111.827 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -70.4 164.65 34.43 Favored 'Trans proline' 0 C--O 1.215 -0.642 0 C-N-CA 122.637 2.224 . . . . 0.0 111.721 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 50.9 m -136.6 141.9 43.29 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.244 -0.91 . . . . 0.0 109.484 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 49.7 t0 -55.51 -34.11 64.35 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.223 -0.923 . . . . 0.0 109.509 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 118.037 -0.983 . . . . 0.0 109.465 179.966 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.459 ' N ' ' OD1' ' A' ' 1' ' ' ASP . 14.5 p30 . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 121.274 0.559 . . . . 0.0 109.607 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.443 ' O ' ' N ' ' A' ' 5' ' ' CYS . 3.6 m -45.39 -26.86 0.6 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.36 -0.837 . . . . 0.0 109.562 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.462 ' HA ' ' HG3' ' A' ' 6' ' ' LYS . 2.9 tt0 -50.62 -25.14 3.85 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.158 -0.964 . . . . 0.0 108.924 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.442 ' HE1' ' N ' ' A' ' 1' ' ' ASP . 74.8 mtm -80.45 -22.91 40.64 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.447 -0.783 . . . . 0.0 109.382 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.582 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 3.9 m -92.91 -8.27 43.75 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.237 -0.914 . . . . 0.0 109.629 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.462 ' HG3' ' HA ' ' A' ' 3' ' ' GLU . 56.4 mttt -60.64 -24.65 65.7 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.281 -0.887 . . . . 0.0 109.745 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 59.5 t0 -153.56 63.06 0.74 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.135 -0.978 . . . . 0.0 109.912 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.582 ' CD1' ' HA ' ' A' ' 5' ' ' CYS . 9.2 p90 -122.0 178.59 4.83 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.082 -1.011 . . . . 0.0 109.501 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 37.5 mtm180 -150.1 144.42 25.72 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.276 -0.89 . . . . 0.0 109.295 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.508 ' CG1' ' O ' ' A' ' 15' ' ' GLY . 84.1 t -138.94 132.02 38.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.144 -0.972 . . . . 0.0 109.765 -179.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.534 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 2.3 mp -123.39 176.35 2.23 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.402 -0.811 . . . . 0.0 109.11 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.534 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 43.4 Cg_endo -65.57 -24.44 55.94 Favored 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 122.533 2.155 . . . . 0.0 111.733 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 10.5 mtm180 -108.26 -35.3 6.58 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.258 -0.901 . . . . 0.0 109.032 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.474 HD11 HG22 ' A' ' 14' ' ' ILE . 86.8 mt -76.55 -35.56 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.372 -0.83 . . . . 0.0 109.194 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.508 ' O ' ' CG1' ' A' ' 10' ' ' VAL . . . 61.38 -134.56 48.05 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.154 -1.578 . . . . 0.0 109.154 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.495 ' CE2' ' CE2' ' A' ' 8' ' ' TYR . 3.4 t80 -113.65 155.6 25.21 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.149 -1.207 . . . . 0.0 109.547 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.417 ' N ' ' CD1' ' A' ' 16' ' ' TYR . 18.3 tp -112.95 123.29 49.98 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.345 -0.847 . . . . 0.0 109.726 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.417 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 67.0 m -138.33 156.64 73.48 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.354 -0.842 . . . . 0.0 109.011 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.405 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 48.7 Cg_endo -70.89 165.95 30.59 Favored 'Trans proline' 0 C--O 1.214 -0.687 0 C-N-CA 122.491 2.127 . . . . 0.0 111.573 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 40.1 mttp -85.51 -17.83 35.26 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.232 -0.918 . . . . 0.0 109.41 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 -71.2 130.86 42.53 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.33 -0.856 . . . . 0.0 109.23 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.459 ' CD1' ' C ' ' A' ' 22' ' ' LEU . 3.4 tm? -95.05 112.65 24.33 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.147 -0.97 . . . . 0.0 109.588 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.492 ' O ' ' O ' ' A' ' 34' ' ' ASN . 0.2 OUTLIER -121.72 104.92 38.81 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.322 -0.861 . . . . 0.0 109.202 179.75 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.534 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 41.1 Cg_endo -63.43 117.74 4.68 Favored 'Trans proline' 0 C--O 1.213 -0.752 0 C-N-CA 123.039 2.493 . . . . 0.0 112.03 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 17.8 m -118.44 156.28 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.4 -0.813 . . . . 0.0 109.805 -179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.509 ' O ' ' N ' ' A' ' 53' ' ' ARG . 27.4 t -99.06 111.99 24.24 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.307 -0.87 . . . . 0.0 109.299 179.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.497 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -66.21 138.62 36.86 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.504 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 50.8 p30 -69.83 -10.03 56.92 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.303 -1.116 . . . . 0.0 109.539 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.413 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 91.0 m-20 -83.56 5.25 24.83 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.243 -0.911 . . . . 0.0 109.336 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.43 13.12 58.9 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.497 ' O ' ' N ' ' A' ' 27' ' ' GLY . 85.5 mt-30 -122.76 147.79 46.1 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.446 -1.032 . . . . 0.0 109.464 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.517 ' CG2' ' HA ' ' A' ' 57' ' ' LYS . 28.9 m -108.82 141.89 40.2 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.211 -0.93 . . . . 0.0 109.357 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.584 ' CD1' ' CD1' ' A' ' 39' ' ' LEU . 10.8 m-85 -121.21 131.11 54.04 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.368 -0.833 . . . . 0.0 109.172 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.492 ' O ' ' O ' ' A' ' 23' ' ' LYS . 1.6 m-20 -53.95 -76.73 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.187 -0.946 . . . . 0.0 109.365 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.538 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 8.0 t-20 -82.17 146.74 55.57 Favored Pre-proline 0 C--N 1.3 -1.572 0 O-C-N 121.06 -1.025 . . . . 0.0 109.554 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.479 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 41.3 Cg_endo -63.46 -52.14 2.13 Favored 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 122.695 2.263 . . . . 0.0 111.858 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.538 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 11.4 t -64.27 -27.46 69.06 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.964 -1.085 . . . . 0.0 108.319 179.104 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.506 ' CG ' ' HB3' ' A' ' 35' ' ' ASN . 31.5 mmm -60.05 -20.66 59.14 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.578 -0.701 . . . . 0.0 109.165 179.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.584 ' CD1' ' CD1' ' A' ' 33' ' ' TYR . 6.3 tp -67.05 -51.81 50.05 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.307 -0.871 . . . . 0.0 108.883 179.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.478 ' HA ' ' HB2' ' A' ' 43' ' ' ASN . 2.0 t -54.59 -23.05 15.21 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.174 -0.954 . . . . 0.0 108.534 179.194 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 27.5 t60 -60.05 -59.3 5.64 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.473 ' OE1' ' CE2' ' A' ' 33' ' ' TYR . 53.2 tt0 -65.12 -21.31 66.78 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.371 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.519 ' O ' ' N ' ' A' ' 47' ' ' GLN . 87.7 m-20 -77.41 -26.8 52.03 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 28.6 tp -69.83 -33.98 73.03 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.373 -0.829 . . . . 0.0 109.219 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 10.7 mm -80.12 -51.41 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.31 -0.869 . . . . 0.0 109.536 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.472 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 94.3 mtt-85 -80.18 -33.55 38.23 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.288 -0.882 . . . . 0.0 109.729 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.519 ' N ' ' O ' ' A' ' 43' ' ' ASN . 89.8 mt-30 63.96 39.89 7.7 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.308 -0.87 . . . . 0.0 109.434 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.47 ' O ' ' HB2' ' A' ' 49' ' ' ASN . 44.2 p -94.52 -6.75 43.04 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.239 -0.913 . . . . 0.0 109.456 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.47 ' HB2' ' O ' ' A' ' 48' ' ' THR . 74.6 m-20 63.03 55.31 1.98 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.289 -0.882 . . . . 0.0 109.476 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.474 HG23 HD12 ' A' ' 39' ' ' LEU . 53.7 m -72.11 138.27 47.62 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.186 -0.946 . . . . 0.0 109.51 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 25.4 m-70 -109.62 177.59 4.69 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.325 -0.86 . . . . 0.0 109.204 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.437 HD12 HG22 ' A' ' 52' ' ' ILE . 17.7 mt -89.67 124.65 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.224 -0.923 . . . . 0.0 109.777 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.509 ' N ' ' O ' ' A' ' 26' ' ' CYS . 41.9 ttt180 -80.54 -56.34 4.24 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 121.722 0.772 . . . . 0.0 109.334 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 60.4 p -149.43 147.49 28.32 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 16.0 p -64.27 148.43 50.21 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.221 -0.925 . . . . 0.0 109.381 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.534 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 82.12 163.55 32.6 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.517 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 34.9 mttt -70.47 129.53 39.48 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.439 -1.036 . . . . 0.0 109.457 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -52.15 -32.35 35.42 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.174 -0.954 . . . . 0.0 109.281 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.448 ' O ' ' HG2' ' A' ' 59' ' ' GLU . 83.1 tt0 -81.04 -12.68 59.29 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.366 -0.834 . . . . 0.0 109.36 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.428 ' HB3' ' O ' ' A' ' 57' ' ' LYS . 61.2 tt0 -70.02 -31.49 69.17 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.271 -0.893 . . . . 0.0 109.39 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 32.7 t -83.08 127.82 33.93 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.27 -0.894 . . . . 0.0 109.593 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 98.5 p -111.64 152.63 27.44 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.245 -0.909 . . . . 0.0 109.395 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 45.9 p -65.62 152.27 93.0 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.199 -0.938 . . . . 0.0 109.439 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -69.6 -18.37 37.8 Favored 'Trans proline' 0 C--O 1.215 -0.642 0 C-N-CA 122.716 2.277 . . . . 0.0 111.82 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 91.35 5.79 66.98 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 19.2 p -125.43 161.95 25.93 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.15 -1.206 . . . . 0.0 109.422 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 17.8 p -121.33 163.06 19.23 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.237 -0.914 . . . . 0.0 109.452 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -60.92 -34.36 74.57 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.336 -0.853 . . . . 0.0 109.379 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.1 139.45 56.19 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.298 -0.876 . . . . 0.0 109.376 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 83.8 p -62.1 -27.53 68.99 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.256 -0.902 . . . . 0.0 109.516 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.47 137.82 94.78 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.258 -0.901 . . . . 0.0 109.46 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -70.52 161.16 47.02 Favored 'Trans proline' 0 C--O 1.214 -0.688 0 C-N-CA 122.701 2.267 . . . . 0.0 111.764 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -69.85 158.45 56.81 Favored 'Trans proline' 0 C--O 1.215 -0.642 0 C-N-CA 122.648 2.232 . . . . 0.0 111.748 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 48.9 m -135.94 146.06 46.89 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.223 -0.923 . . . . 0.0 109.459 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -58.31 -33.97 70.06 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.218 -0.926 . . . . 0.0 109.485 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 118.053 -0.975 . . . . 0.0 109.422 179.923 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.423 ' OD1' HG13 ' A' ' 52' ' ' ILE . 37.0 m-20 . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.1 m -61.32 -24.31 66.34 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.245 -0.909 . . . . 0.0 109.641 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.455 ' HA ' ' HG3' ' A' ' 6' ' ' LYS . 1.5 mt-10 -52.99 -22.89 6.24 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.208 -0.932 . . . . 0.0 108.865 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 55.0 mmm -80.29 -34.65 36.73 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.387 -0.82 . . . . 0.0 108.84 179.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.568 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 4.3 m -83.24 -0.92 51.68 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.464 -0.772 . . . . 0.0 109.4 179.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.455 ' HG3' ' HA ' ' A' ' 3' ' ' GLU . 19.9 mttm -68.53 -21.24 64.58 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.24 -0.913 . . . . 0.0 109.605 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -150.42 59.63 0.95 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.327 -0.858 . . . . 0.0 109.681 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.568 ' CD1' ' HA ' ' A' ' 5' ' ' CYS . 6.4 p90 -124.78 173.29 8.68 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.166 -0.959 . . . . 0.0 109.324 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 20.9 ptt-85 -156.0 143.77 19.58 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.259 -0.901 . . . . 0.0 109.383 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.522 HG23 ' CD2' ' A' ' 16' ' ' TYR . 58.7 t -130.28 137.76 55.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.327 -0.858 . . . . 0.0 109.38 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.52 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 1.4 mp -119.26 174.4 2.81 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.22 -0.925 . . . . 0.0 109.514 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.52 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 46.3 Cg_endo -68.38 -25.02 36.33 Favored 'Trans proline' 0 C--O 1.215 -0.641 0 C-N-CA 122.602 2.201 . . . . 0.0 111.723 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 52.6 mtt180 -108.37 -25.29 11.07 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.332 -0.855 . . . . 0.0 109.318 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 29.3 mm -85.59 -44.5 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.238 -0.914 . . . . 0.0 109.503 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.412 ' C ' HG12 ' A' ' 10' ' ' VAL . . . 69.33 -144.95 41.77 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.522 ' CD2' HG23 ' A' ' 10' ' ' VAL . 1.2 t80 -104.4 155.96 18.33 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.172 -1.193 . . . . 0.0 109.427 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.456 ' CD1' ' C ' ' A' ' 17' ' ' LEU . 1.8 tm? -119.12 113.01 20.26 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.262 -0.899 . . . . 0.0 109.622 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.442 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 61.3 m -127.03 155.84 75.24 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.347 -0.846 . . . . 0.0 109.305 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -70.53 167.67 24.77 Favored 'Trans proline' 0 C--O 1.214 -0.683 0 C-N-CA 122.654 2.236 . . . . 0.0 111.787 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -87.7 -14.56 39.52 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.352 -0.843 . . . . 0.0 109.45 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -72.68 112.88 9.13 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.121 -0.987 . . . . 0.0 109.414 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 56.6 tp -74.53 121.49 21.62 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.11 -0.994 . . . . 0.0 109.449 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.499 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -132.17 100.64 15.42 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.217 -0.927 . . . . 0.0 109.185 179.88 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.532 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 42.6 Cg_endo -64.8 118.74 5.69 Favored 'Trans proline' 0 C--O 1.213 -0.758 0 C-N-CA 122.962 2.441 . . . . 0.0 112.27 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.462 ' O ' HG21 ' A' ' 32' ' ' THR . 5.4 m -117.91 156.39 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.284 -0.885 . . . . 0.0 109.784 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.495 ' O ' ' N ' ' A' ' 53' ' ' ARG . 33.8 t -100.41 108.19 20.13 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.33 -0.856 . . . . 0.0 109.287 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -61.77 139.91 46.89 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 -179.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.487 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 54.9 p30 -70.04 -9.01 53.91 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.347 -1.09 . . . . 0.0 109.613 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.423 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 55.0 p30 -83.2 1.54 40.15 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.24 -0.913 . . . . 0.0 109.463 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.33 18.34 36.51 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.131 -1.588 . . . . 0.0 109.131 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.472 ' O ' ' N ' ' A' ' 27' ' ' GLY . 91.1 mt-30 -124.72 165.53 17.79 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.29 -1.124 . . . . 0.0 109.37 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.491 HG22 ' HA ' ' A' ' 57' ' ' LYS . 93.7 m -120.88 133.84 55.3 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.3 -0.875 . . . . 0.0 109.277 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.565 ' CE2' ' OE1' ' A' ' 42' ' ' GLU . 7.8 m-85 -115.02 118.29 33.01 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.243 -0.911 . . . . 0.0 109.162 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.488 ' O ' ' O ' ' A' ' 23' ' ' LYS . 5.4 m-20 -43.88 -80.84 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.287 -0.883 . . . . 0.0 109.746 -179.35 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.487 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 13.6 t-20 -81.72 145.61 54.63 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 120.957 -1.089 . . . . 0.0 109.621 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.499 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.3 Cg_endo -63.27 -50.44 3.61 Favored 'Trans proline' 0 C--O 1.215 -0.667 0 C-N-CA 122.66 2.24 . . . . 0.0 111.351 179.444 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.487 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 5.3 t -61.62 -27.61 68.78 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 178.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.468 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 17.7 mtp -66.12 -18.68 65.5 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.409 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.553 HD13 ' CE2' ' A' ' 33' ' ' TYR . 30.0 tp -63.86 -52.82 58.28 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.48 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 4.3 t -59.27 -29.51 67.63 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.433 ' CE1' ' HB2' ' A' ' 16' ' ' TYR . 23.2 t60 -64.49 -59.23 4.57 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.565 ' OE1' ' CE2' ' A' ' 33' ' ' TYR . 79.6 mt-10 -58.34 -22.77 54.59 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 179.122 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.492 ' O ' ' N ' ' A' ' 47' ' ' GLN . 94.7 m-20 -73.31 -32.03 64.37 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.503 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.488 ' CD2' ' OH ' ' A' ' 8' ' ' TYR . 55.3 mt -61.38 -31.34 71.24 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 179.197 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.521 HD12 HG22 ' A' ' 45' ' ' ILE . 1.3 mt -80.37 -39.91 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.441 -0.787 . . . . 0.0 109.043 179.438 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.459 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 62.1 mtt85 -79.51 -24.04 42.53 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.36 -0.837 . . . . 0.0 109.112 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.492 ' N ' ' O ' ' A' ' 43' ' ' ASN . 90.3 mt-30 62.59 42.22 8.73 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.362 -0.836 . . . . 0.0 109.484 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 13.6 t -132.83 164.42 26.89 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.243 -0.911 . . . . 0.0 109.335 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.567 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 84.0 m-20 -94.86 61.21 2.53 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.247 -0.908 . . . . 0.0 109.435 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.46 HG23 HD12 ' A' ' 39' ' ' LEU . 86.4 m -66.23 135.63 54.74 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.229 -0.919 . . . . 0.0 109.542 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.567 ' CE1' ' O ' ' A' ' 49' ' ' ASN . 57.5 m80 -110.82 -178.84 3.58 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.286 -0.884 . . . . 0.0 109.249 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.48 HG23 HD11 ' A' ' 52' ' ' ILE . 12.7 mt -89.6 127.13 42.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.1 -1.0 . . . . 0.0 109.742 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.495 ' N ' ' O ' ' A' ' 26' ' ' CYS . 20.2 ttt180 -80.1 -57.04 3.82 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.439 -0.788 . . . . 0.0 109.258 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 30.9 m -152.4 142.92 22.71 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 26.0 p -59.62 146.6 40.39 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.123 -0.986 . . . . 0.0 109.689 -179.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.532 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 86.15 162.21 36.42 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.53 ' HB2' ' CB ' ' A' ' 60' ' ' GLU . 67.6 mttt -71.07 124.77 25.16 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.483 -1.01 . . . . 0.0 109.401 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -47.02 -35.81 7.16 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.227 -0.92 . . . . 0.0 109.626 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.465 ' O ' ' HG2' ' A' ' 59' ' ' GLU . 74.4 tt0 -81.18 -15.78 54.76 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.342 -0.849 . . . . 0.0 109.412 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.53 ' CB ' ' HB2' ' A' ' 57' ' ' LYS . 86.2 tt0 -95.74 120.6 36.29 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.305 -0.872 . . . . 0.0 109.571 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 71.4 p -140.28 150.84 44.55 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.316 -0.865 . . . . 0.0 109.313 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 49.1 m -111.87 146.49 37.63 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.222 -0.924 . . . . 0.0 109.518 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.498 ' O ' ' CB ' ' A' ' 69' ' ' ALA . 5.1 p -135.01 162.82 55.42 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.322 -0.861 . . . . 0.0 109.434 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.445 ' HD2' ' HB ' ' A' ' 63' ' ' THR . 50.7 Cg_endo -70.68 -17.69 33.24 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 122.717 2.278 . . . . 0.0 111.864 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -59.26 -31.49 69.72 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 50.5 m -78.91 136.39 37.26 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.232 -1.158 . . . . 0.0 109.521 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 54.4 m -62.87 -28.85 70.31 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.246 -0.909 . . . . 0.0 109.528 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -69.45 -30.77 68.75 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.304 -0.872 . . . . 0.0 109.478 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.498 ' CB ' ' O ' ' A' ' 63' ' ' THR . . . -62.83 -34.54 77.53 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.341 -0.849 . . . . 0.0 109.43 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 85.4 p -60.46 -27.9 67.9 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.216 -0.927 . . . . 0.0 109.469 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 3.2 mtt -124.33 83.67 56.85 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.259 -0.9 . . . . 0.0 109.456 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -70.81 146.75 54.52 Favored 'Trans proline' 0 C--O 1.216 -0.621 0 C-N-CA 122.654 2.236 . . . . 0.0 111.856 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -71.09 145.14 48.79 Favored 'Trans proline' 0 C--O 1.215 -0.634 0 C-N-CA 122.688 2.259 . . . . 0.0 111.729 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 99.2 p -120.49 154.84 34.71 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.162 -0.961 . . . . 0.0 109.576 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 60.6 t0 -85.66 118.81 25.39 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.221 -0.925 . . . . 0.0 109.448 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 117.984 -1.008 . . . . 0.0 109.492 -179.998 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.452 ' OD1' HG13 ' A' ' 52' ' ' ILE . 83.5 m-20 . . . . . 0 N--CA 1.492 1.64 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.42 ' HB2' ' CE1' ' A' ' 51' ' ' HIS . 2.8 m -59.69 -26.44 65.59 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.295 -0.878 . . . . 0.0 109.426 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.466 ' HA ' ' HG3' ' A' ' 6' ' ' LYS . 1.2 mt-10 -54.35 -21.47 9.58 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.182 -0.948 . . . . 0.0 108.986 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 73.8 mtp -77.9 -28.27 49.76 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.363 -0.836 . . . . 0.0 108.964 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.58 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 3.7 m -87.43 -8.39 56.56 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.37 -0.831 . . . . 0.0 109.417 179.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.466 ' HG3' ' HA ' ' A' ' 3' ' ' GLU . 40.9 mttt -63.47 -20.09 65.29 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.167 -0.958 . . . . 0.0 109.592 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 -149.73 60.65 1.0 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.26 -0.9 . . . . 0.0 109.673 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.618 ' CE2' ' CE2' ' A' ' 16' ' ' TYR . 1.7 p90 -133.07 163.29 29.57 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.201 -0.937 . . . . 0.0 109.48 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 92.3 mtt180 -136.18 144.6 45.06 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.223 -0.923 . . . . 0.0 109.508 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.407 HG22 ' CD2' ' A' ' 16' ' ' TYR . 53.4 t -141.13 136.24 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.244 -0.91 . . . . 0.0 109.473 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.542 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.2 OUTLIER -125.94 175.32 3.25 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.309 -0.869 . . . . 0.0 109.478 -179.936 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.542 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 45.1 Cg_endo -67.29 -25.9 42.17 Favored 'Trans proline' 0 C--O 1.214 -0.714 0 C-N-CA 122.655 2.237 . . . . 0.0 111.913 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 84.3 mtt-85 -104.86 -26.76 12.09 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.339 -0.85 . . . . 0.0 109.279 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 25.5 mm -82.37 -44.69 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.276 -0.89 . . . . 0.0 109.536 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 75.17 -156.43 48.82 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.618 ' CE2' ' CE2' ' A' ' 8' ' ' TYR . 2.8 t80 -101.92 154.62 18.78 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.238 -1.154 . . . . 0.0 109.429 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.409 ' N ' ' CD1' ' A' ' 16' ' ' TYR . 20.7 tp -107.43 104.82 14.48 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.238 -0.914 . . . . 0.0 109.847 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.448 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 58.9 m -125.39 154.88 72.33 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.275 -0.891 . . . . 0.0 109.159 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -71.21 166.96 27.58 Favored 'Trans proline' 0 C--O 1.216 -0.611 0 C-N-CA 122.7 2.266 . . . . 0.0 111.759 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -82.79 -31.87 28.02 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.317 -0.864 . . . . 0.0 109.416 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -56.88 127.29 31.04 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.214 -0.929 . . . . 0.0 109.47 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 60.6 tp -87.74 117.65 26.72 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.217 -0.927 . . . . 0.0 109.281 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.512 ' CB ' ' HD3' ' A' ' 36' ' ' PRO . 19.2 mttt -123.78 99.99 37.96 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.26 -0.9 . . . . 0.0 109.463 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.533 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 42.9 Cg_endo -65.17 116.75 4.03 Favored 'Trans proline' 0 C--O 1.214 -0.712 0 C-N-CA 122.933 2.422 . . . . 0.0 111.901 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.453 ' O ' HG22 ' A' ' 32' ' ' THR . 11.4 m -119.84 156.35 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.254 -0.903 . . . . 0.0 109.976 -179.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.512 ' O ' ' N ' ' A' ' 53' ' ' ARG . 14.2 t -99.94 110.75 23.08 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.341 -0.849 . . . . 0.0 109.203 179.53 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -65.27 139.26 39.7 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.5 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 51.1 p30 -69.01 -10.61 58.42 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.294 -1.121 . . . . 0.0 109.638 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.441 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 89.6 m-20 -81.28 3.75 22.91 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.19 -0.944 . . . . 0.0 109.3 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.65 16.15 52.92 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.201 -1.56 . . . . 0.0 109.201 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.508 ' O ' ' N ' ' A' ' 27' ' ' GLY . 84.8 mt-30 -125.86 153.45 44.13 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.392 -1.064 . . . . 0.0 109.425 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.508 ' CG2' ' HA ' ' A' ' 57' ' ' LYS . 56.6 m -110.06 142.43 41.52 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.29 -0.881 . . . . 0.0 109.32 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.63 ' CD1' ' CD1' ' A' ' 39' ' ' LEU . 28.9 m-85 -121.24 119.23 31.67 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.364 -0.835 . . . . 0.0 109.212 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.495 ' O ' ' O ' ' A' ' 23' ' ' LYS . 8.7 m-20 -43.5 -78.82 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.268 -0.895 . . . . 0.0 109.255 -179.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.473 ' O ' ' HB2' ' A' ' 38' ' ' MET . 15.3 t-20 -82.63 145.88 51.9 Favored Pre-proline 0 C--N 1.301 -1.53 0 O-C-N 120.988 -1.07 . . . . 0.0 109.231 179.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.512 ' HD3' ' CB ' ' A' ' 23' ' ' LYS . 41.2 Cg_endo -63.66 -49.39 4.32 Favored 'Trans proline' 0 C--O 1.215 -0.67 0 C-N-CA 122.425 2.083 . . . . 0.0 111.493 179.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.484 ' SG ' ' CE1' ' A' ' 16' ' ' TYR . 7.6 t -63.02 -27.64 69.55 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.473 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 29.1 mmm -63.56 -14.66 53.54 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.478 -0.764 . . . . 0.0 109.123 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.63 ' CD1' ' CD1' ' A' ' 33' ' ' TYR . 9.3 tp -69.43 -53.32 19.87 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.242 -0.911 . . . . 0.0 108.881 179.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.494 ' HB3' ' CZ ' ' A' ' 16' ' ' TYR . 8.3 t -52.26 -22.18 4.19 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.187 -0.946 . . . . 0.0 108.451 179.242 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 53.0 t60 -59.44 -61.41 2.64 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.576 -0.702 . . . . 0.0 109.258 179.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -67.37 -15.43 63.68 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.19 -0.944 . . . . 0.0 108.895 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.522 ' O ' ' N ' ' A' ' 47' ' ' GLN . 98.1 m-20 -78.27 -24.03 47.0 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.379 -0.826 . . . . 0.0 109.012 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.483 ' CD1' ' C ' ' A' ' 44' ' ' LEU . 3.1 tm? -72.27 -34.67 68.39 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.249 -0.907 . . . . 0.0 108.825 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.452 HD12 HD11 ' A' ' 44' ' ' LEU . 8.4 mm -77.57 -49.86 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.372 -0.83 . . . . 0.0 109.132 179.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.466 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 53.0 mtt-85 -80.0 -37.26 34.59 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.34 -0.85 . . . . 0.0 109.3 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.522 ' N ' ' O ' ' A' ' 43' ' ' ASN . 92.8 mt-30 63.21 37.01 11.53 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.381 -0.824 . . . . 0.0 109.65 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.414 HG21 ' HB3' ' A' ' 46' ' ' ARG . 43.5 p -100.34 8.85 43.41 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.31 -0.869 . . . . 0.0 109.428 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 66.5 m-20 52.77 56.96 6.88 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.26 -0.9 . . . . 0.0 109.52 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.467 HG23 HD12 ' A' ' 39' ' ' LEU . 36.7 m -68.02 135.9 53.01 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.254 -0.904 . . . . 0.0 109.39 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.42 ' CE1' ' HB2' ' A' ' 2' ' ' SER . 80.2 m-70 -108.77 178.59 4.43 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.325 -0.859 . . . . 0.0 109.354 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.452 HG13 ' OD1' ' A' ' 1' ' ' ASP . 21.0 mt -88.78 125.75 41.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.134 -0.979 . . . . 0.0 109.655 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.512 ' N ' ' O ' ' A' ' 26' ' ' CYS . 74.4 ttt-85 -81.69 -57.11 3.59 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.433 -0.792 . . . . 0.0 109.576 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 95.8 p -150.18 139.36 21.21 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -179.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.4 p -55.72 148.88 15.41 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.178 -0.951 . . . . 0.0 109.425 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.533 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 83.61 165.85 39.1 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.508 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 66.2 mttt -74.63 130.97 40.51 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.438 -1.036 . . . . 0.0 109.362 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -55.68 -31.92 62.82 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.088 -1.007 . . . . 0.0 109.361 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -82.41 -19.9 38.14 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.359 -0.838 . . . . 0.0 108.775 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.472 ' HB3' ' O ' ' A' ' 57' ' ' LYS . 24.3 tt0 -63.79 -16.25 60.74 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 19.1 m -78.32 -31.53 48.83 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.41 -0.806 . . . . 0.0 109.528 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 87.6 p -114.31 149.23 36.32 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.277 -0.889 . . . . 0.0 109.414 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.9 p -115.11 80.69 7.25 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.175 -0.953 . . . . 0.0 109.66 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -71.18 141.93 40.65 Favored 'Trans proline' 0 C--O 1.216 -0.601 0 C-N-CA 122.631 2.221 . . . . 0.0 111.679 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -166.5 -170.94 32.04 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 17.9 p -123.44 163.6 20.54 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.301 -1.117 . . . . 0.0 109.43 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 37.1 m -115.34 140.64 48.94 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.241 -0.912 . . . . 0.0 109.524 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.56 -34.11 72.28 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.246 -0.909 . . . . 0.0 109.444 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -63.34 136.6 57.76 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.261 -0.9 . . . . 0.0 109.518 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 87.4 p -64.52 -27.67 69.12 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.301 -0.874 . . . . 0.0 109.501 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 3.2 mtt -129.04 82.64 68.23 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.198 -0.939 . . . . 0.0 109.395 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -70.81 154.4 63.6 Favored 'Trans proline' 0 C--O 1.214 -0.687 0 C-N-CA 122.75 2.3 . . . . 0.0 111.902 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -71.36 151.75 60.2 Favored 'Trans proline' 0 C--O 1.214 -0.713 0 C-N-CA 122.712 2.275 . . . . 0.0 111.675 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 31.6 t -136.27 141.74 43.9 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.245 -0.91 . . . . 0.0 109.494 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 50.2 t0 -54.85 -34.76 63.27 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.243 -0.911 . . . . 0.0 109.438 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 118.035 -0.983 . . . . 0.0 109.5 179.97 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 121.273 0.558 . . . . 0.0 109.499 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.46 ' HB2' ' HA ' ' A' ' 51' ' ' HIS . 3.1 m -45.95 -30.81 1.91 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.238 -0.914 . . . . 0.0 109.431 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.449 ' HA ' ' HG3' ' A' ' 6' ' ' LYS . 11.1 mt-10 -51.74 -27.87 13.37 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 84.5 mtp -76.83 -24.72 52.73 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 179.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.475 ' O ' ' N ' ' A' ' 8' ' ' TYR . 57.8 m -80.05 -14.09 58.8 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.476 -0.765 . . . . 0.0 109.053 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.449 ' HG3' ' HA ' ' A' ' 3' ' ' GLU . 16.9 mttm -45.8 -28.2 1.01 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.288 -0.882 . . . . 0.0 109.307 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -109.98 29.87 7.23 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.316 -0.865 . . . . 0.0 108.947 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.675 ' CZ ' ' CE1' ' A' ' 16' ' ' TYR . 2.2 t80 -79.97 159.13 26.39 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.557 -0.714 . . . . 0.0 109.93 -179.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.3 mtt-85 -149.77 113.82 5.13 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.418 -0.801 . . . . 0.0 108.994 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.558 ' CG2' ' CD2' ' A' ' 16' ' ' TYR . 77.9 t -118.6 151.93 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.281 -0.887 . . . . 0.0 109.619 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.535 ' CD2' ' HD2' ' A' ' 12' ' ' PRO . 0.2 OUTLIER -130.03 171.87 8.19 Favored Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 121.303 -0.873 . . . . 0.0 108.991 179.842 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.535 ' HD2' ' CD2' ' A' ' 11' ' ' LEU . 43.5 Cg_endo -66.25 -22.63 53.18 Favored 'Trans proline' 0 C--O 1.214 -0.692 0 C-N-CA 122.541 2.161 . . . . 0.0 111.729 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -108.55 -26.37 10.45 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.248 -0.908 . . . . 0.0 109.58 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 24.0 mm -80.33 -51.49 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.193 -0.942 . . . . 0.0 109.655 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.4 ' C ' HG12 ' A' ' 10' ' ' VAL . . . 84.12 -166.7 42.74 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.675 ' CE1' ' CZ ' ' A' ' 8' ' ' TYR . 1.8 t80 -99.48 148.68 24.0 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.217 -1.166 . . . . 0.0 109.432 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.493 ' CD1' ' C ' ' A' ' 17' ' ' LEU . 2.0 tm? -111.94 120.83 43.25 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.258 -0.902 . . . . 0.0 109.564 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.442 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 82.1 m -134.21 156.72 78.8 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.347 -0.846 . . . . 0.0 109.365 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.49 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 49.5 Cg_endo -70.19 167.07 26.05 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 122.726 2.284 . . . . 0.0 111.738 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 64.3 mttm -92.84 -5.77 50.26 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.252 -0.905 . . . . 0.0 109.482 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -75.98 110.34 10.36 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.145 -0.972 . . . . 0.0 109.324 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.491 ' CD1' ' C ' ' A' ' 22' ' ' LEU . 3.5 tm? -74.21 121.37 21.13 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.348 -0.845 . . . . 0.0 109.466 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.467 ' O ' ' O ' ' A' ' 34' ' ' ASN . 1.7 mtpm? -145.88 111.49 4.48 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.248 -0.908 . . . . 0.0 109.528 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.545 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 44.3 Cg_endo -65.71 124.48 12.83 Favored 'Trans proline' 0 C--O 1.213 -0.756 0 C-N-CA 123.049 2.499 . . . . 0.0 112.295 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.461 ' O ' HG22 ' A' ' 32' ' ' THR . 31.7 m -116.44 153.62 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.249 -0.907 . . . . 0.0 109.489 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.462 ' O ' ' N ' ' A' ' 53' ' ' ARG . 45.2 t -99.59 119.49 38.15 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.307 -0.87 . . . . 0.0 109.068 179.484 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -76.68 139.87 24.31 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 -179.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.487 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 51.0 p30 -69.8 -11.61 60.99 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.32 -1.106 . . . . 0.0 109.409 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.467 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 70.5 m-20 -82.38 7.83 13.04 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.376 -0.828 . . . . 0.0 109.467 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 88.37 12.62 64.84 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.47 ' O ' ' N ' ' A' ' 27' ' ' GLY . 92.7 mt-30 -118.22 170.54 8.79 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.337 -1.096 . . . . 0.0 109.533 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.473 ' CG2' ' HA ' ' A' ' 57' ' ' LYS . 95.1 m -130.22 134.68 47.44 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.337 -0.852 . . . . 0.0 109.258 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.64 ' CE1' ' CD1' ' A' ' 39' ' ' LEU . 48.3 m-85 -112.68 126.79 55.77 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.168 -0.958 . . . . 0.0 109.346 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.494 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 60.1 t-20 -48.76 -80.23 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.356 -0.84 . . . . 0.0 110.023 -179.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.519 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 2.0 t-20 -80.71 149.59 67.97 Favored Pre-proline 0 C--N 1.301 -1.518 0 O-C-N 120.864 -1.148 . . . . 0.0 109.357 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.451 ' HD2' ' CG ' ' A' ' 35' ' ' ASN . 40.1 Cg_endo -62.86 -54.42 1.19 Allowed 'Trans proline' 0 C--O 1.216 -0.614 0 C-N-CA 122.723 2.282 . . . . 0.0 111.876 -179.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.519 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 8.1 t -62.9 -28.52 70.11 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.062 -1.024 . . . . 0.0 108.475 179.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.515 ' CG ' ' HB3' ' A' ' 35' ' ' ASN . 59.2 mmm -62.31 -14.29 37.65 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.64 ' CD1' ' CE1' ' A' ' 33' ' ' TYR . 25.6 tp -68.49 -51.69 40.51 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.421 -0.799 . . . . 0.0 109.468 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.468 ' HB2' ' OH ' ' A' ' 16' ' ' TYR . 3.1 m -67.97 -17.86 64.56 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 179.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.498 ' CE1' ' HB2' ' A' ' 16' ' ' TYR . 46.7 t60 -73.28 -55.74 6.01 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.1 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.559 ' OE1' ' CE2' ' A' ' 33' ' ' TYR . 87.1 tt0 -63.75 -18.89 64.51 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.247 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.495 ' O ' ' N ' ' A' ' 47' ' ' GLN . 93.4 m-20 -74.77 -36.12 62.56 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.552 HD13 ' CD2' ' A' ' 16' ' ' TYR . 19.3 mt -61.25 -32.44 72.25 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.372 -0.83 . . . . 0.0 108.821 179.199 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.509 HD12 ' N ' ' A' ' 45' ' ' ILE . 3.6 mm -75.58 -42.75 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.41 -0.806 . . . . 0.0 108.913 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.473 ' HG2' ' NH1' ' A' ' 46' ' ' ARG . 29.0 mtp85 -80.05 -17.67 52.12 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.379 -0.826 . . . . 0.0 109.038 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.495 ' N ' ' O ' ' A' ' 43' ' ' ASN . 87.8 mt-30 62.21 42.92 9.0 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.278 -0.889 . . . . 0.0 109.409 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 15.4 p -127.66 164.96 20.91 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.292 -0.88 . . . . 0.0 109.353 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -102.3 63.6 0.89 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.181 -0.949 . . . . 0.0 109.433 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.422 ' OG1' ' OD2' ' A' ' 29' ' ' ASP . 49.8 m -75.03 141.83 43.85 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.302 -0.874 . . . . 0.0 109.567 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.46 ' HA ' ' HB2' ' A' ' 2' ' ' SER . 96.5 m-70 -117.87 170.0 9.17 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.311 -0.868 . . . . 0.0 109.049 179.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.468 HD11 HG22 ' A' ' 52' ' ' ILE . 21.1 mt -79.95 123.37 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.198 -0.939 . . . . 0.0 109.222 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.487 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 49.7 tpt85 -79.62 -49.03 12.76 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.356 -0.84 . . . . 0.0 109.327 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.3 t -156.03 151.73 27.22 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.466 -0.771 . . . . 0.0 109.21 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 38.8 p -65.24 147.7 52.98 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.172 -0.955 . . . . 0.0 109.218 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.545 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 88.82 165.93 41.73 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 108.986 -1.646 . . . . 0.0 108.986 -179.459 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.514 ' N ' ' HG3' ' A' ' 60' ' ' GLU . 89.7 mttt -64.28 161.26 17.01 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.43 -1.041 . . . . 0.0 109.579 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 86.5 m -67.98 -18.99 64.89 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.229 -0.92 . . . . 0.0 109.366 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -80.76 -21.52 40.98 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.389 -0.819 . . . . 0.0 109.211 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.514 ' HG3' ' N ' ' A' ' 57' ' ' LYS . 2.1 mt-10 -74.2 -21.05 59.98 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 93.4 p -76.72 -11.55 59.86 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.591 -0.693 . . . . 0.0 109.36 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 16.6 m -72.5 162.78 29.02 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.338 -0.851 . . . . 0.0 109.503 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 24.1 p -133.16 90.6 30.26 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.225 -0.922 . . . . 0.0 109.421 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -70.63 141.75 42.45 Favored 'Trans proline' 0 C--O 1.215 -0.647 0 C-N-CA 122.772 2.314 . . . . 0.0 111.732 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.86 -173.26 43.14 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 61.6 m -63.05 -27.42 69.39 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.31 -1.112 . . . . 0.0 109.444 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 13.2 t -141.94 158.95 43.17 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.256 -0.902 . . . . 0.0 109.449 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.76 -33.3 75.54 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.195 -0.94 . . . . 0.0 109.508 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.62 139.27 58.63 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.297 -0.877 . . . . 0.0 109.527 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 83.1 p -60.87 -31.68 71.14 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.202 -0.936 . . . . 0.0 109.464 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 18.8 mmt -66.86 148.61 98.78 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.249 -0.907 . . . . 0.0 109.448 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -70.37 159.77 51.81 Favored 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 122.706 2.271 . . . . 0.0 111.8 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -70.39 169.34 19.95 Favored 'Trans proline' 0 C--O 1.215 -0.636 0 C-N-CA 122.735 2.29 . . . . 0.0 111.697 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 20.1 m -89.46 -6.96 56.03 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.225 -0.922 . . . . 0.0 109.587 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -81.04 -21.97 39.69 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.146 -0.971 . . . . 0.0 109.393 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.454 ' HG2' ' OXT' ' A' ' 76' ' ' GLU . 85.2 tt0 . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 118.018 -0.991 . . . . 0.0 109.491 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.514 ' N ' ' OD1' ' A' ' 1' ' ' ASP . 21.8 p-10 . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.307 0.575 . . . . 0.0 109.716 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.465 ' HB2' ' HA ' ' A' ' 51' ' ' HIS . 1.5 m -52.02 -35.39 46.71 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.289 -0.882 . . . . 0.0 109.46 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.44 ' HA ' ' HG3' ' A' ' 6' ' ' LYS . 6.1 mt-10 -49.71 -23.76 1.94 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.281 -0.887 . . . . 0.0 108.779 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 90.4 mtp -75.41 -29.86 59.89 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.492 -0.755 . . . . 0.0 109.015 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.454 ' N ' ' O ' ' A' ' 2' ' ' SER . 4.2 m -79.93 -23.46 41.73 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.357 -0.84 . . . . 0.0 109.136 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.44 ' HG3' ' HA ' ' A' ' 3' ' ' GLU . 73.0 mttt -48.45 -24.69 1.35 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.251 -0.906 . . . . 0.0 108.873 179.499 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -110.14 29.76 7.36 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.454 ' HB2' ' O ' ' A' ' 5' ' ' CYS . 1.6 t80 -85.94 153.79 21.94 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.55 -0.719 . . . . 0.0 109.932 -179.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 8.9 mtm180 -147.02 113.82 6.08 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.424 -0.797 . . . . 0.0 109.293 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.436 HG22 ' HA ' ' A' ' 16' ' ' TYR . 4.6 p -130.64 152.26 37.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.328 -0.857 . . . . 0.0 109.12 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.524 ' CG ' ' HD2' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -109.32 171.64 4.28 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.152 -0.968 . . . . 0.0 109.711 -179.676 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.524 ' HD2' ' CG ' ' A' ' 11' ' ' LEU . 47.7 Cg_endo -69.51 -23.32 32.06 Favored 'Trans proline' 0 C--O 1.214 -0.687 0 C-N-CA 122.699 2.266 . . . . 0.0 111.497 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.465 ' O ' ' HG2' ' A' ' 13' ' ' ARG . 23.1 ttt180 -91.82 -16.23 27.08 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.351 -0.843 . . . . 0.0 109.147 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.429 HG22 HD11 ' A' ' 14' ' ' ILE . 26.3 mm -99.8 -41.86 9.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.237 -0.915 . . . . 0.0 109.391 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.403 ' O ' ' C ' ' A' ' 16' ' ' TYR . . . 69.22 139.69 0.1 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.455 ' HB2' ' CE1' ' A' ' 41' ' ' HIS . 0.9 OUTLIER -44.88 154.8 0.12 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.261 -1.141 . . . . 0.0 109.401 179.984 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.559 ' N ' ' CD1' ' A' ' 17' ' ' LEU . 0.3 OUTLIER -118.62 128.07 54.19 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.196 -0.94 . . . . 0.0 109.5 179.957 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.414 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 62.8 m -140.02 156.61 70.33 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.374 -0.828 . . . . 0.0 109.065 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -71.38 167.18 27.02 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.548 2.165 . . . . 0.0 111.492 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 33.3 mttp -86.9 -23.5 25.18 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.182 -0.949 . . . . 0.0 109.586 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -62.14 128.63 37.05 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.119 -0.988 . . . . 0.0 109.257 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 27.8 tp -87.49 117.52 26.34 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.158 -0.963 . . . . 0.0 109.619 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.511 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 0.2 OUTLIER -126.94 100.85 26.95 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.383 -0.823 . . . . 0.0 109.063 179.87 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.529 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 43.4 Cg_endo -65.46 117.93 5.02 Favored 'Trans proline' 0 C--O 1.214 -0.714 0 C-N-CA 123.102 2.535 . . . . 0.0 112.246 -179.363 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.5 m -116.31 154.75 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.359 -0.838 . . . . 0.0 109.568 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 40.3 t -95.97 131.83 41.93 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.368 -0.832 . . . . 0.0 108.803 179.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.477 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -90.49 134.63 12.44 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -179.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.485 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 1.5 m-20 -66.1 -9.02 27.23 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.3 -1.118 . . . . 0.0 109.606 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.424 ' CG ' HG22 ' A' ' 50' ' ' THR . 50.1 p-10 -85.2 13.85 5.87 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.167 -0.958 . . . . 0.0 109.507 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 81.35 22.65 60.16 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.477 ' O ' ' N ' ' A' ' 27' ' ' GLY . 66.7 mt-30 -131.86 174.1 10.5 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.292 -1.122 . . . . 0.0 109.524 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.525 ' CG2' ' HA ' ' A' ' 57' ' ' LYS . 49.5 m -134.52 137.92 44.25 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.348 -0.845 . . . . 0.0 109.192 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.635 ' CE1' ' CD1' ' A' ' 39' ' ' LEU . 55.1 m-85 -112.08 122.5 47.92 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.237 -0.914 . . . . 0.0 109.452 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.494 ' O ' ' O ' ' A' ' 23' ' ' LYS . 7.0 m-20 -46.32 -79.55 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.345 -0.847 . . . . 0.0 109.616 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.539 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 7.6 t-20 -81.94 146.73 56.34 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.034 -1.041 . . . . 0.0 109.358 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.511 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.1 Cg_endo -63.03 -52.96 1.78 Allowed 'Trans proline' 0 C--O 1.216 -0.623 0 C-N-CA 122.824 2.349 . . . . 0.0 111.793 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.539 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 7.8 t -60.67 -26.48 67.12 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 178.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.456 ' HB2' ' HB3' ' A' ' 35' ' ' ASN . 33.6 mmm -70.72 -8.37 51.64 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.175 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.635 ' CD1' ' CE1' ' A' ' 33' ' ' TYR . 21.8 tp -72.89 -56.02 5.78 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.332 -0.855 . . . . 0.0 109.233 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 3.6 m -63.15 -23.25 67.35 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 119.204 -0.998 . . . . 0.0 108.339 179.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.455 ' CE1' ' HB2' ' A' ' 16' ' ' TYR . 49.6 t60 -65.11 -54.66 26.53 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 178.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.415 ' HB2' ' CE2' ' A' ' 33' ' ' TYR . 75.6 mt-10 -66.73 -16.75 64.46 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.111 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.518 ' O ' ' N ' ' A' ' 47' ' ' GLN . 94.3 m-20 -79.16 -26.53 42.73 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.407 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.478 ' CD1' ' C ' ' A' ' 44' ' ' LEU . 2.5 tm? -69.72 -35.07 74.72 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.247 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.479 HD11 HG22 ' A' ' 45' ' ' ILE . 1.8 mt -76.18 -43.48 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.471 -0.768 . . . . 0.0 109.071 179.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.439 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 68.5 mtt85 -79.8 -36.1 37.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.343 -0.848 . . . . 0.0 109.385 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.518 ' N ' ' O ' ' A' ' 43' ' ' ASN . 91.0 mt-30 62.07 40.2 12.28 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.386 -0.821 . . . . 0.0 109.451 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 37.4 p -111.17 15.16 21.68 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.34 -0.85 . . . . 0.0 109.241 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.419 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 70.0 m-20 45.31 58.22 4.3 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.305 -0.872 . . . . 0.0 109.329 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.448 HG21 ' N ' ' A' ' 51' ' ' HIS . 69.9 m -78.15 147.74 34.43 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.269 -0.894 . . . . 0.0 109.557 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.465 ' HA ' ' HB2' ' A' ' 2' ' ' SER . 62.2 m80 -124.63 169.91 11.47 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.258 -0.901 . . . . 0.0 109.209 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.432 HD11 HG22 ' A' ' 52' ' ' ILE . 18.9 mt -79.45 122.31 34.41 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 121.099 -1.001 . . . . 0.0 109.307 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.485 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 59.7 ttt-85 -83.11 -38.62 22.19 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.351 -0.843 . . . . 0.0 109.463 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.4 t -158.37 155.08 28.05 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.373 -0.83 . . . . 0.0 109.2 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.2 p -75.33 132.74 41.18 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.187 -0.945 . . . . 0.0 109.49 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.529 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 98.4 165.15 30.86 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.525 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 13.2 tttp -50.16 150.39 2.44 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.352 -1.087 . . . . 0.0 109.327 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.433 ' SG ' ' O ' ' A' ' 31' ' ' GLN . 43.2 m -55.91 -27.26 51.33 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.279 -0.888 . . . . 0.0 109.396 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.41 ' O ' ' HG2' ' A' ' 59' ' ' GLU . 54.4 tt0 -88.35 -22.78 23.64 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.346 -0.846 . . . . 0.0 109.243 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 54.2 tt0 -62.76 -35.94 81.43 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.353 -0.842 . . . . 0.0 109.31 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.6 m -65.92 -33.36 75.65 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.272 -0.892 . . . . 0.0 109.509 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 50.3 m -62.53 153.01 33.13 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.264 -0.897 . . . . 0.0 109.467 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.6 t -121.5 84.24 41.88 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.273 -0.892 . . . . 0.0 109.465 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -72.09 137.72 29.52 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 122.647 2.231 . . . . 0.0 111.793 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 88.75 -164.47 32.82 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.499 -1.441 . . . . 0.0 109.499 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 18.1 p -128.6 156.83 42.75 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.257 -1.143 . . . . 0.0 109.431 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 51.8 p -62.26 -14.57 40.01 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.254 -0.904 . . . . 0.0 109.517 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -61.43 -27.62 68.68 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.223 -0.923 . . . . 0.0 109.389 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -52.16 145.61 10.33 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.294 -0.879 . . . . 0.0 109.563 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 34.8 m -67.77 -26.24 66.01 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.236 -0.915 . . . . 0.0 109.353 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.42 81.3 49.4 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.288 -0.883 . . . . 0.0 109.32 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -70.04 149.65 65.42 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 122.73 2.287 . . . . 0.0 111.919 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -71.47 -19.44 28.55 Favored 'Trans proline' 0 C--O 1.215 -0.669 0 C-N-CA 122.699 2.266 . . . . 0.0 111.684 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 25.9 t -132.12 137.33 47.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.279 -0.888 . . . . 0.0 109.485 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -55.31 -36.7 66.48 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.149 -0.97 . . . . 0.0 109.447 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 118.029 -0.986 . . . . 0.0 109.48 -179.899 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.444 ' OG ' ' HA ' ' A' ' 51' ' ' HIS . 4.6 m -52.08 -25.56 8.98 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.237 -0.915 . . . . 0.0 109.456 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.446 ' HA ' ' HG3' ' A' ' 6' ' ' LYS . 2.4 tt0 -52.35 -24.72 8.1 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.263 -0.898 . . . . 0.0 109.158 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.443 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 74.5 mtp -72.2 -29.25 63.8 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.436 -0.79 . . . . 0.0 109.391 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.473 ' O ' ' HB2' ' A' ' 8' ' ' TYR . 11.5 m -85.65 -17.85 34.92 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.288 -0.883 . . . . 0.0 109.278 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.446 ' HG3' ' HA ' ' A' ' 3' ' ' GLU . 27.2 mttt -50.47 -24.34 3.06 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.218 -0.926 . . . . 0.0 108.941 179.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.443 ' OD1' ' O ' ' A' ' 4' ' ' MET . 55.9 p30 -112.97 32.65 5.55 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 179.227 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.473 ' HB2' ' O ' ' A' ' 5' ' ' CYS . 5.4 t80 -80.13 162.14 24.91 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 121.535 0.683 . . . . 0.0 110.225 -179.228 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 10.9 mtm180 -144.16 116.5 8.52 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.487 ' CG1' ' HA3' ' A' ' 15' ' ' GLY . 53.3 t -112.17 139.11 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.143 -0.973 . . . . 0.0 109.684 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.475 ' HB3' ' HD2' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -119.92 172.7 4.27 Favored Pre-proline 0 N--CA 1.488 1.466 0 O-C-N 121.481 -0.762 . . . . 0.0 109.091 179.866 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.475 ' HD2' ' HB3' ' A' ' 11' ' ' LEU . 44.3 Cg_endo -66.85 -23.05 48.24 Favored 'Trans proline' 0 C--O 1.214 -0.678 0 C-N-CA 122.579 2.186 . . . . 0.0 111.729 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.415 ' O ' ' HG2' ' A' ' 13' ' ' ARG . 61.1 ttt-85 -110.5 -22.98 11.39 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.309 -0.869 . . . . 0.0 109.292 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 82.9 mt -89.43 -41.67 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.381 -0.825 . . . . 0.0 109.474 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.487 ' HA3' ' CG1' ' A' ' 10' ' ' VAL . . . 62.04 -146.67 49.1 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.486 ' OH ' ' CB ' ' A' ' 40' ' ' CYS . 1.4 t80 -100.6 148.46 24.81 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.316 -1.108 . . . . 0.0 109.566 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.462 ' HB2' ' OH ' ' A' ' 8' ' ' TYR . 53.8 mt -118.43 128.88 55.03 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.376 -0.827 . . . . 0.0 109.557 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.448 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 79.1 m -139.0 157.2 71.87 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.312 -0.868 . . . . 0.0 109.254 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.446 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 47.4 Cg_endo -69.49 166.69 26.41 Favored 'Trans proline' 0 C--O 1.214 -0.695 0 C-N-CA 122.592 2.195 . . . . 0.0 111.455 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -87.76 -16.02 35.35 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.207 -0.933 . . . . 0.0 109.502 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -69.91 118.01 12.21 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.199 -0.938 . . . . 0.0 109.074 179.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 60.3 tp -84.51 122.39 28.94 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.174 -0.954 . . . . 0.0 109.82 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.488 ' O ' ' O ' ' A' ' 34' ' ' ASN . 0.3 OUTLIER -139.91 110.81 7.29 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.276 -0.89 . . . . 0.0 109.039 179.649 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.528 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 42.2 Cg_endo -64.82 122.98 10.98 Favored 'Trans proline' 0 C--O 1.213 -0.747 0 C-N-CA 122.996 2.464 . . . . 0.0 112.496 -179.23 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.464 HG22 HD11 ' A' ' 39' ' ' LEU . 32.9 m -118.56 155.16 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.45 -0.781 . . . . 0.0 109.681 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.416 ' O ' ' N ' ' A' ' 53' ' ' ARG . 42.5 t -100.54 117.7 35.21 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.327 -0.858 . . . . 0.0 108.991 179.219 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -73.63 138.28 24.71 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 -179.612 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.478 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 53.1 p30 -67.74 -11.1 57.67 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.249 -1.148 . . . . 0.0 109.473 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.461 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 58.5 p30 -82.94 8.68 11.93 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.292 -0.88 . . . . 0.0 109.402 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.09 13.94 65.34 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.515 ' O ' ' N ' ' A' ' 27' ' ' GLY . 92.1 mt-30 -119.56 167.04 12.38 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.27 -1.135 . . . . 0.0 109.461 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.526 ' CG2' ' HA ' ' A' ' 57' ' ' LYS . 90.6 m -126.11 140.47 52.55 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.272 -0.893 . . . . 0.0 109.265 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.586 ' CE1' ' HB2' ' A' ' 42' ' ' GLU . 59.5 m-85 -118.85 126.24 51.36 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.228 -0.92 . . . . 0.0 109.327 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.497 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 5.9 m-20 -49.77 -75.94 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.21 -0.931 . . . . 0.0 109.397 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.531 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 4.6 t-20 -82.04 148.57 60.75 Favored Pre-proline 0 C--N 1.299 -1.6 0 O-C-N 121.105 -0.997 . . . . 0.0 109.527 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.486 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.0 Cg_endo -62.99 -53.35 1.62 Allowed 'Trans proline' 0 C--O 1.216 -0.619 0 C-N-CA 122.603 2.202 . . . . 0.0 111.728 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.531 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 4.5 t -60.64 -27.63 67.94 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 120.961 -1.087 . . . . 0.0 108.156 179.025 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.467 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 52.6 mmm -65.28 -20.08 66.25 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.549 HD13 ' CE2' ' A' ' 33' ' ' TYR . 6.6 tt -68.42 -51.84 39.44 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.287 -0.883 . . . . 0.0 108.788 179.43 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.519 ' HA ' ' ND2' ' A' ' 43' ' ' ASN . 64.0 m -51.22 -27.99 10.35 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.142 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.402 ' O ' HG13 ' A' ' 45' ' ' ILE . 28.2 t60 -58.63 -47.5 84.18 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.586 ' HB2' ' CE1' ' A' ' 33' ' ' TYR . 26.9 tp10 -60.36 -17.17 41.56 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 179.116 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.527 ' OD1' ' N ' ' A' ' 50' ' ' THR . 3.5 m-80 -80.07 -34.91 37.75 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.405 -0.81 . . . . 0.0 108.927 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.488 ' CD1' ' C ' ' A' ' 44' ' ' LEU . 2.6 tm? -70.27 -35.79 74.0 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.349 -0.844 . . . . 0.0 109.34 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.402 HG13 ' O ' ' A' ' 41' ' ' HIS . 2.8 mt -76.11 -53.22 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.302 -0.874 . . . . 0.0 109.678 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.46 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 49.8 mtp180 -80.37 -34.51 36.41 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.224 -0.923 . . . . 0.0 109.89 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.498 ' N ' ' O ' ' A' ' 43' ' ' ASN . 90.4 mt-30 62.32 35.17 15.31 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.215 -0.928 . . . . 0.0 109.547 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.443 ' O ' ' HB2' ' A' ' 49' ' ' ASN . 72.3 p -105.64 7.78 32.84 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.195 -0.941 . . . . 0.0 109.623 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.443 ' HB2' ' O ' ' A' ' 48' ' ' THR . 20.5 m120 64.23 49.82 2.52 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.254 -0.904 . . . . 0.0 109.391 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.527 ' N ' ' OD1' ' A' ' 43' ' ' ASN . 63.6 m -76.76 132.53 39.32 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.251 -0.906 . . . . 0.0 109.378 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.444 ' HA ' ' OG ' ' A' ' 2' ' ' SER . 15.2 m-70 -115.21 -174.83 2.57 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.282 -0.886 . . . . 0.0 109.521 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 16.4 mt -86.68 124.77 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.324 -0.86 . . . . 0.0 109.678 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.478 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 75.8 ttt-85 -80.08 -54.73 5.5 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.525 -0.735 . . . . 0.0 109.503 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 77.7 p -151.87 138.95 19.15 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.716 -0.615 . . . . 0.0 109.357 -179.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 8.0 p -54.35 148.93 10.82 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.189 -0.944 . . . . 0.0 109.412 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.528 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 88.51 166.66 42.5 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.274 -1.53 . . . . 0.0 109.274 -179.665 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.526 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 27.1 mttt -66.32 143.37 57.22 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.376 -1.073 . . . . 0.0 109.562 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.413 ' C ' ' O ' ' A' ' 57' ' ' LYS . 66.9 m -44.61 -34.47 2.18 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.278 -0.889 . . . . 0.0 109.47 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -81.2 -36.11 30.5 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.334 -0.854 . . . . 0.0 109.208 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.454 ' OE1' ' CA ' ' A' ' 56' ' ' GLY . 35.6 tt0 -56.84 -21.98 33.27 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.325 -0.859 . . . . 0.0 108.87 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 16.5 m -65.58 -34.31 77.94 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.434 -0.791 . . . . 0.0 109.539 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 91.0 p -119.34 155.95 30.95 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.12 -0.987 . . . . 0.0 109.501 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.1 m 62.16 70.65 0.8 Allowed Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.27 -0.894 . . . . 0.0 109.644 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -70.38 145.77 54.49 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 122.648 2.232 . . . . 0.0 111.767 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -82.48 179.32 53.17 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 50.0 m -122.43 142.48 50.5 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.245 -1.15 . . . . 0.0 109.465 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 60.4 p -70.08 -20.31 63.22 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.253 -0.905 . . . . 0.0 109.345 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.8 -32.03 73.4 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.261 -0.899 . . . . 0.0 109.379 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.22 144.78 55.07 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.235 -0.916 . . . . 0.0 109.437 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.2 t -51.96 -29.38 20.21 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.18 -0.95 . . . . 0.0 109.475 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 2.6 ttp 47.56 70.7 1.92 Allowed Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.208 -0.932 . . . . 0.0 109.498 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -70.21 153.01 67.24 Favored 'Trans proline' 0 C--O 1.215 -0.674 0 C-N-CA 122.76 2.306 . . . . 0.0 111.82 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -70.14 155.34 64.92 Favored 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 122.564 2.176 . . . . 0.0 111.666 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 83.1 p -81.23 -10.31 59.63 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.288 -0.883 . . . . 0.0 109.528 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.436 ' O ' ' O ' ' A' ' 76' ' ' GLU . 88.1 m-20 -68.13 -31.48 71.1 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.244 -0.91 . . . . 0.0 109.377 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.436 ' O ' ' O ' ' A' ' 75' ' ' ASP . 81.8 tt0 . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 118.054 -0.974 . . . . 0.0 109.41 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 . . . . . 0 N--CA 1.489 1.492 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.54 ' HB2' ' CD2' ' A' ' 51' ' ' HIS . 5.0 m -56.19 -34.35 66.16 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.304 -0.873 . . . . 0.0 109.537 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -54.75 -24.63 23.24 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.33 -0.856 . . . . 0.0 109.101 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 56.5 mmm -73.06 -24.33 60.67 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.343 -0.848 . . . . 0.0 108.909 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.59 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 59.2 m -80.12 -21.3 43.36 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.422 -0.799 . . . . 0.0 109.284 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 42.1 mttp -80.69 11.74 3.62 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.331 -0.856 . . . . 0.0 109.786 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -132.75 -1.82 3.37 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.023 -1.048 . . . . 0.0 110.181 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.59 ' CD1' ' HA ' ' A' ' 5' ' ' CYS . 1.6 p90 -114.24 156.56 24.09 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.868 -1.145 . . . . 0.0 109.98 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 31.8 mtm105 -137.16 133.86 35.71 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.351 -0.843 . . . . 0.0 109.202 179.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.533 HG22 ' CD1' ' A' ' 16' ' ' TYR . 75.7 t -117.65 142.61 31.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.189 -0.944 . . . . 0.0 109.8 -179.601 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.541 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.4 OUTLIER -126.02 175.45 3.17 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.366 -0.834 . . . . 0.0 109.159 179.946 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.541 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 43.9 Cg_endo -67.22 -22.24 46.96 Favored 'Trans proline' 0 C--O 1.214 -0.679 0 C-N-CA 122.557 2.171 . . . . 0.0 111.672 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 89.7 mtt180 -103.69 -29.28 11.17 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.298 -0.876 . . . . 0.0 109.56 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 89.2 mt -80.04 -49.64 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.244 -0.91 . . . . 0.0 109.497 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.4 ' C ' HG12 ' A' ' 10' ' ' VAL . . . 82.15 -163.63 43.45 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.533 ' CD1' HG22 ' A' ' 10' ' ' VAL . 0.9 OUTLIER -92.86 151.84 19.75 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.285 -1.126 . . . . 0.0 109.444 -179.973 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 26.0 tp -127.67 116.08 19.73 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.198 -0.939 . . . . 0.0 109.816 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.431 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 77.4 m -129.86 157.36 77.03 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.281 -0.887 . . . . 0.0 109.035 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.489 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 49.4 Cg_endo -70.94 167.96 24.47 Favored 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 122.558 2.172 . . . . 0.0 111.44 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 24.5 mttp -94.8 -6.13 43.62 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.191 -0.943 . . . . 0.0 109.585 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.44 ' OD2' ' HE2' ' A' ' 23' ' ' LYS . 58.6 t0 -76.09 117.4 17.76 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.198 -0.939 . . . . 0.0 109.253 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.49 ' CD1' ' C ' ' A' ' 22' ' ' LEU . 3.2 tm? -78.4 122.5 25.88 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.234 -0.916 . . . . 0.0 109.706 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.489 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 5.2 mttt -142.2 104.01 5.61 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.404 -0.81 . . . . 0.0 109.22 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.542 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 42.6 Cg_endo -65.09 120.86 8.17 Favored 'Trans proline' 0 C--O 1.213 -0.756 0 C-N-CA 123.056 2.504 . . . . 0.0 112.036 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.467 ' O ' HG21 ' A' ' 32' ' ' THR . 24.5 m -116.65 155.0 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.321 -0.862 . . . . 0.0 110.005 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.489 ' O ' ' N ' ' A' ' 53' ' ' ARG . 28.0 t -99.67 108.64 21.05 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.475 -0.766 . . . . 0.0 109.319 179.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -62.61 138.79 44.99 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.501 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 57.1 p30 -68.86 -10.31 56.25 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.258 -1.143 . . . . 0.0 109.482 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.452 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 90.0 m-20 -84.0 4.93 27.67 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.18 -0.95 . . . . 0.0 109.409 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.51 13.45 58.35 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.223 -1.551 . . . . 0.0 109.223 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.508 ' O ' ' N ' ' A' ' 27' ' ' GLY . 93.5 mt-30 -117.95 160.53 21.29 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.321 -1.106 . . . . 0.0 109.497 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.467 HG21 ' O ' ' A' ' 25' ' ' VAL . 57.4 m -116.99 130.23 56.55 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.244 -0.91 . . . . 0.0 109.24 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.602 ' CD1' ' CD1' ' A' ' 39' ' ' LEU . 65.8 m-85 -111.25 119.36 38.65 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.273 -0.892 . . . . 0.0 109.157 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.487 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 51.2 t-20 -46.31 -80.44 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.399 -0.813 . . . . 0.0 110.092 -179.363 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.528 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 1.9 t-20 -81.03 150.0 67.72 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.003 -1.061 . . . . 0.0 109.722 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.489 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.9 Cg_endo -63.97 -55.23 0.68 Allowed 'Trans proline' 0 C--O 1.216 -0.612 0 C-N-CA 122.756 2.304 . . . . 0.0 111.818 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.528 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 10.8 t -60.92 -30.45 70.21 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 120.91 -1.119 . . . . 0.0 108.17 178.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.48 ' CG ' ' HB3' ' A' ' 35' ' ' ASN . 52.5 mmm -60.11 -17.73 42.19 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.263 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.602 ' CD1' ' CD1' ' A' ' 33' ' ' TYR . 33.5 tp -68.5 -58.27 4.57 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 179.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.464 ' HB3' ' OH ' ' A' ' 16' ' ' TYR . 8.1 t -56.38 -24.08 42.1 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 178.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 30.0 t60 -70.63 -62.81 1.25 Allowed 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 179.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.482 ' OE1' ' CE2' ' A' ' 33' ' ' TYR . 78.6 mt-10 -55.47 -21.87 18.25 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.176 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.511 ' O ' ' N ' ' A' ' 47' ' ' GLN . 98.7 m-20 -73.65 -35.88 65.32 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 179.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.476 ' CD1' ' C ' ' A' ' 44' ' ' LEU . 2.0 tm? -62.61 -37.33 85.86 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.399 -0.813 . . . . 0.0 109.005 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.9 mt -71.82 -42.13 69.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.386 -0.821 . . . . 0.0 109.113 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.458 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 12.8 mtt-85 -79.84 -22.3 43.14 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.36 -0.838 . . . . 0.0 109.174 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.511 ' N ' ' O ' ' A' ' 43' ' ' ASN . 92.5 mt-30 63.3 44.68 5.41 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.316 -0.865 . . . . 0.0 109.475 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 21.9 p -128.02 169.88 13.53 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.373 -0.83 . . . . 0.0 109.413 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.571 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 43.9 t30 -102.7 64.84 0.89 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.233 -0.917 . . . . 0.0 109.304 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.443 HG21 ' N ' ' A' ' 51' ' ' HIS . 33.9 m -74.83 147.32 41.26 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.338 -0.851 . . . . 0.0 109.613 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.571 ' CE1' ' O ' ' A' ' 49' ' ' ASN . 51.4 m80 -122.77 -173.65 2.75 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.383 -0.823 . . . . 0.0 109.263 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 11.3 mt -95.82 124.07 48.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.137 -0.977 . . . . 0.0 109.531 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.501 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 72.3 ttt-85 -80.04 -56.0 4.55 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 121.622 0.725 . . . . 0.0 109.558 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 88.7 p -153.95 139.22 17.53 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 6.5 p -56.56 148.49 19.51 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.116 -0.99 . . . . 0.0 109.349 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.542 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 82.66 161.39 29.93 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.484 ' CG ' ' HB2' ' A' ' 24' ' ' PRO . 26.1 mttp -68.36 131.75 45.86 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.558 -0.966 . . . . 0.0 109.535 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -55.01 -34.32 63.37 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.198 -0.939 . . . . 0.0 109.475 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.461 ' O ' ' HG2' ' A' ' 59' ' ' GLU . 78.9 tt0 -81.67 -15.74 53.57 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.312 -0.868 . . . . 0.0 109.462 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.451 ' HB2' ' HB2' ' A' ' 57' ' ' LYS . 51.9 tt0 -73.43 -30.16 63.04 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.219 -0.925 . . . . 0.0 109.29 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.9 m -63.11 -31.15 72.23 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.317 -0.864 . . . . 0.0 109.434 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 49.9 m -115.28 146.72 41.22 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.271 -0.893 . . . . 0.0 109.577 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 20.3 p -70.05 159.68 83.41 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.311 -0.868 . . . . 0.0 109.287 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -69.92 -17.38 36.88 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 122.704 2.269 . . . . 0.0 111.721 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -147.34 171.69 27.92 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 19.2 p -121.82 157.45 31.06 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.251 -1.146 . . . . 0.0 109.388 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 59.9 m -65.7 -28.26 68.94 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.293 -0.879 . . . . 0.0 109.536 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.45 ' O ' ' HB3' ' A' ' 71' ' ' MET . . . -65.31 -36.97 85.7 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.228 -0.92 . . . . 0.0 109.463 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.409 ' C ' ' O ' ' A' ' 68' ' ' ALA . . . 44.17 -151.37 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.267 -0.896 . . . . 0.0 109.475 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 83.8 p -54.88 -31.31 59.72 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.209 -0.932 . . . . 0.0 109.557 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.516 ' CG ' ' HD2' ' A' ' 72' ' ' PRO . 6.3 ttm -57.68 143.12 76.67 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.302 -0.874 . . . . 0.0 109.457 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.516 ' HD2' ' CG ' ' A' ' 71' ' ' MET . 49.3 Cg_endo -69.75 153.48 68.94 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 122.691 2.261 . . . . 0.0 111.806 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -70.65 158.01 57.02 Favored 'Trans proline' 0 C--O 1.214 -0.691 0 C-N-CA 122.63 2.22 . . . . 0.0 111.754 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 86.2 p -82.72 -9.18 59.47 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.3 -0.875 . . . . 0.0 109.593 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.484 ' OD1' ' N ' ' A' ' 76' ' ' GLU . 39.7 p30 -73.6 -15.75 61.26 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.178 -0.951 . . . . 0.0 109.416 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.484 ' N ' ' OD1' ' A' ' 75' ' ' ASP . 83.3 tt0 . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 118.048 -0.977 . . . . 0.0 109.414 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.425 ' OD1' ' HB2' ' A' ' 3' ' ' GLU . 7.0 p30 . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.311 0.577 . . . . 0.0 109.496 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.6 m -46.48 -28.71 1.47 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.273 -0.892 . . . . 0.0 109.479 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.449 ' HA ' ' HG3' ' A' ' 6' ' ' LYS . 1.5 tt0 -51.87 -25.86 8.84 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.198 -0.939 . . . . 0.0 108.946 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 75.6 mtp -80.04 -21.06 43.92 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.486 -0.759 . . . . 0.0 109.115 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.578 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 3.4 m -91.95 -12.45 33.37 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.364 -0.835 . . . . 0.0 109.632 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.449 ' HG3' ' HA ' ' A' ' 3' ' ' GLU . 23.4 mttm -57.37 -25.07 58.9 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.276 -0.89 . . . . 0.0 109.721 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 61.5 t0 -152.69 64.45 0.8 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.108 -0.995 . . . . 0.0 109.776 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.578 ' CD1' ' HA ' ' A' ' 5' ' ' CYS . 4.5 p90 -126.42 169.01 13.42 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.169 -0.957 . . . . 0.0 109.324 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 79.9 mtt180 -142.56 145.98 34.16 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.202 -0.936 . . . . 0.0 109.496 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.495 HG23 ' CD2' ' A' ' 16' ' ' TYR . 90.8 t -140.32 134.53 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.266 -0.896 . . . . 0.0 109.471 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.535 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 1.1 mp -123.34 176.08 2.38 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.289 -0.882 . . . . 0.0 109.251 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.535 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 45.4 Cg_endo -67.51 -27.24 39.59 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 122.547 2.165 . . . . 0.0 111.514 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 71.3 mtt-85 -104.06 -29.77 10.68 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.292 -0.88 . . . . 0.0 109.005 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 26.7 mm -81.79 -41.26 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.429 -0.794 . . . . 0.0 109.519 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 64.78 -147.06 50.82 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.495 ' CD2' HG23 ' A' ' 10' ' ' VAL . 1.5 t80 -104.98 151.75 23.55 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.244 -1.151 . . . . 0.0 109.538 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 24.3 tp -104.9 109.41 21.37 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.245 -0.909 . . . . 0.0 109.476 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 63.6 m -129.24 156.43 78.36 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.325 -0.859 . . . . 0.0 109.371 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -72.04 172.6 14.37 Favored 'Trans proline' 0 C--O 1.215 -0.673 0 C-N-CA 122.663 2.242 . . . . 0.0 111.567 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 20.4 tttm -89.51 -15.58 32.67 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.18 -0.95 . . . . 0.0 109.393 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -73.4 108.9 6.53 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.305 -0.872 . . . . 0.0 109.496 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.476 HD21 ' HB2' ' A' ' 35' ' ' ASN . 3.5 tm? -77.79 109.72 12.04 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.221 -0.924 . . . . 0.0 109.258 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.494 ' O ' ' O ' ' A' ' 34' ' ' ASN . 7.1 mtmt -120.49 106.84 39.58 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.313 -0.867 . . . . 0.0 109.308 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.547 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 41.4 Cg_endo -63.44 120.54 8.0 Favored 'Trans proline' 0 C--O 1.213 -0.743 0 C-N-CA 123.151 2.567 . . . . 0.0 112.376 -179.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 18.3 m -115.58 155.52 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.228 -0.92 . . . . 0.0 109.744 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.464 ' O ' ' N ' ' A' ' 53' ' ' ARG . 39.9 t -98.04 115.54 28.43 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.335 -0.853 . . . . 0.0 109.319 179.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -70.83 138.84 29.0 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.505 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 53.2 t0 -70.92 -9.44 57.8 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.281 -1.129 . . . . 0.0 109.654 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.4 ' OD1' ' HB2' ' A' ' 31' ' ' GLN . 58.5 p30 -85.72 8.58 19.24 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.11 -0.994 . . . . 0.0 109.253 179.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.31 9.63 66.9 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.511 ' O ' ' N ' ' A' ' 27' ' ' GLY . 69.6 mt-30 -118.14 156.64 28.35 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.329 -1.101 . . . . 0.0 109.317 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.529 ' CG2' ' HA ' ' A' ' 57' ' ' LYS . 33.5 m -116.9 151.88 35.68 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.212 -0.93 . . . . 0.0 109.293 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.601 ' CD1' ' CD1' ' A' ' 39' ' ' LEU . 73.7 m-85 -129.77 131.06 46.12 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.197 -0.939 . . . . 0.0 109.239 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.498 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 2.7 m-20 -53.21 -79.38 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.288 -0.882 . . . . 0.0 109.636 -179.531 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.521 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 13.2 t-20 -82.64 145.69 51.45 Favored Pre-proline 0 C--N 1.3 -1.555 0 O-C-N 120.893 -1.13 . . . . 0.0 109.826 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.484 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.3 Cg_endo -63.63 -51.13 2.66 Favored 'Trans proline' 0 C--O 1.214 -0.689 0 C-N-CA 122.67 2.247 . . . . 0.0 111.278 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.521 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 5.6 t -60.44 -29.78 69.23 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 178.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.452 ' HB2' ' HB3' ' A' ' 35' ' ' ASN . 35.9 mmm -66.29 -10.87 46.77 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 179.234 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.601 ' CD1' ' CD1' ' A' ' 33' ' ' TYR . 52.0 tp -69.24 -55.28 11.03 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.286 -0.884 . . . . 0.0 108.822 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.455 ' SG ' ' OH ' ' A' ' 16' ' ' TYR . 11.5 t -54.85 -29.6 55.58 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 179.085 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 32.5 t60 -60.15 -60.92 3.05 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.44 ' HA ' ' OE1' ' A' ' 42' ' ' GLU . 68.8 mm-40 -58.86 -22.61 59.49 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 179.057 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.508 ' O ' ' N ' ' A' ' 47' ' ' GLN . 98.5 m-20 -75.97 -23.2 55.32 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.368 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.497 ' CD2' ' OH ' ' A' ' 8' ' ' TYR . 2.0 tm? -72.4 -36.63 68.69 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.32 -0.862 . . . . 0.0 108.797 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.524 HD12 ' N ' ' A' ' 45' ' ' ILE . 3.8 mm -76.31 -41.96 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.428 -0.795 . . . . 0.0 109.154 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.472 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 21.1 mtt-85 -83.07 -40.2 20.18 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.41 -0.807 . . . . 0.0 109.482 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.508 ' N ' ' O ' ' A' ' 43' ' ' ASN . 89.8 mt-30 63.54 43.44 5.85 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.48 -0.763 . . . . 0.0 109.482 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 72.2 p -113.01 18.75 17.83 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.248 -0.908 . . . . 0.0 109.334 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 54.7 m-20 44.76 58.71 3.77 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.274 -0.891 . . . . 0.0 109.465 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.467 ' HB ' ' OD1' ' A' ' 43' ' ' ASN . 21.1 m -75.22 145.28 42.13 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.15 -0.969 . . . . 0.0 109.744 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 29.4 m-70 -118.69 171.77 7.97 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.302 -0.874 . . . . 0.0 108.981 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.476 HD11 HG22 ' A' ' 52' ' ' ILE . 20.2 mt -84.15 124.49 39.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.105 -0.997 . . . . 0.0 109.574 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.505 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 37.1 ttt180 -79.85 -52.41 7.93 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-O 121.701 0.762 . . . . 0.0 109.245 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 24.7 p -151.78 153.91 35.22 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 20.9 p -71.8 136.6 47.13 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.185 -0.947 . . . . 0.0 109.438 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.547 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 95.87 163.32 33.75 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.529 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 73.6 tttt -49.64 152.62 1.38 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.46 -1.023 . . . . 0.0 109.373 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.413 ' N ' ' HG2' ' A' ' 57' ' ' LYS . 24.5 m -57.87 -28.75 64.45 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.174 -0.954 . . . . 0.0 109.491 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.448 ' O ' ' O ' ' A' ' 62' ' ' SER . 61.7 tt0 -89.3 -25.02 21.88 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.224 -0.922 . . . . 0.0 109.178 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 64.1 tt0 -61.35 -29.62 70.01 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.325 -0.86 . . . . 0.0 109.407 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 86.6 p -67.2 -22.81 65.7 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.36 -0.838 . . . . 0.0 109.56 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.448 ' O ' ' O ' ' A' ' 59' ' ' GLU . 60.7 m -125.57 139.6 53.45 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.246 -0.908 . . . . 0.0 109.443 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.466 ' OG1' ' CB ' ' A' ' 69' ' ' ALA . 20.0 p -117.18 93.02 41.4 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.331 -0.855 . . . . 0.0 109.575 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -70.91 -18.19 31.79 Favored 'Trans proline' 0 C--O 1.214 -0.691 0 C-N-CA 122.738 2.292 . . . . 0.0 111.783 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -53.32 -28.47 35.32 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 45.3 m -126.92 138.09 53.24 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.12 -1.224 . . . . 0.0 109.549 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 61.3 p -70.88 -22.17 62.32 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.267 -0.896 . . . . 0.0 109.421 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -62.19 -28.63 69.81 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.22 -0.925 . . . . 0.0 109.49 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.466 ' CB ' ' OG1' ' A' ' 63' ' ' THR . . . -67.96 -26.79 66.11 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.201 -0.937 . . . . 0.0 109.395 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 30.6 m -59.58 -28.73 67.41 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.305 -0.872 . . . . 0.0 109.45 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 4.9 tpt -130.55 78.57 73.82 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.301 -0.874 . . . . 0.0 109.39 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.436 ' HD3' ' O ' ' A' ' 69' ' ' ALA . 50.2 Cg_endo -70.28 163.43 38.71 Favored 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 122.754 2.303 . . . . 0.0 111.838 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -70.88 164.48 35.49 Favored 'Trans proline' 0 C--O 1.215 -0.658 0 C-N-CA 122.706 2.27 . . . . 0.0 111.669 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 87.0 p -86.18 -5.56 59.17 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.265 -0.897 . . . . 0.0 109.562 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.483 ' O ' ' CG ' ' A' ' 76' ' ' GLU . 85.4 m-20 -74.31 -27.12 60.56 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.24 -0.912 . . . . 0.0 109.526 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.483 ' CG ' ' O ' ' A' ' 75' ' ' ASP . 93.7 mt-10 . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 118.051 -0.976 . . . . 0.0 109.477 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.415 ' O ' ' C ' ' A' ' 2' ' ' SER . 79.5 m-20 . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.415 ' C ' ' O ' ' A' ' 1' ' ' ASP . 4.0 m -43.93 -29.43 0.57 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.335 -0.853 . . . . 0.0 109.409 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.431 ' HA ' ' HG3' ' A' ' 6' ' ' LYS . 15.3 mt-10 -50.15 -28.27 7.12 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 79.4 mmm -77.4 -33.2 55.11 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.591 ' HB3' ' CE1' ' A' ' 8' ' ' TYR . 2.7 m -85.06 5.48 29.36 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.461 -0.775 . . . . 0.0 109.039 179.386 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.446 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 11.5 mttm -66.23 -28.35 68.67 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.18 -0.95 . . . . 0.0 109.554 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.446 ' OD1' ' O ' ' A' ' 6' ' ' LYS . 80.3 m-20 -146.2 65.76 1.2 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.269 -0.894 . . . . 0.0 110.153 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.591 ' CE1' ' HB3' ' A' ' 5' ' ' CYS . 12.6 p90 -125.8 -177.7 4.02 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.146 -0.971 . . . . 0.0 109.234 179.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 66.4 mtm180 -150.39 143.48 24.85 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.171 -0.955 . . . . 0.0 109.634 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.42 HG12 ' C ' ' A' ' 15' ' ' GLY . 69.1 t -128.4 130.97 69.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.241 -0.912 . . . . 0.0 109.442 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.529 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.2 OUTLIER -111.41 175.0 2.05 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.291 -0.881 . . . . 0.0 109.415 -179.867 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.529 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 46.1 Cg_endo -67.6 -24.17 42.05 Favored 'Trans proline' 0 C--O 1.216 -0.611 0 C-N-CA 122.665 2.243 . . . . 0.0 111.565 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 82.3 mtp180 -94.36 -31.7 13.91 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.342 -0.849 . . . . 0.0 109.104 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 80.5 mt -85.38 -46.99 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.415 -0.803 . . . . 0.0 109.357 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.42 ' C ' HG12 ' A' ' 10' ' ' VAL . . . 70.59 -165.06 52.56 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.527 ' OH ' ' CB ' ' A' ' 40' ' ' CYS . 0.8 OUTLIER -104.41 146.62 28.59 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.235 -1.156 . . . . 0.0 109.377 179.928 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.554 ' N ' ' CD1' ' A' ' 17' ' ' LEU . 0.6 OUTLIER -112.59 124.87 53.51 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.248 -0.907 . . . . 0.0 109.452 179.86 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.437 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 59.6 m -142.16 155.84 64.9 Favored Pre-proline 0 C--N 1.3 -1.585 0 O-C-N 121.373 -0.829 . . . . 0.0 108.81 179.443 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -70.88 164.45 35.61 Favored 'Trans proline' 0 C--O 1.214 -0.695 0 C-N-CA 122.236 1.957 . . . . 0.0 111.344 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.2 mtpm? -82.54 -26.43 32.46 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.311 -0.868 . . . . 0.0 109.415 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -63.29 124.83 22.23 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.311 -0.868 . . . . 0.0 109.446 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.532 HD22 ' CB ' ' A' ' 34' ' ' ASN . 3.4 tm? -86.53 106.96 17.89 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.137 -0.977 . . . . 0.0 109.305 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.493 ' O ' ' O ' ' A' ' 34' ' ' ASN . 9.5 mttt -115.22 106.79 50.62 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.222 -0.924 . . . . 0.0 109.47 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.537 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 41.7 Cg_endo -63.21 116.94 3.91 Favored 'Trans proline' 0 C--O 1.214 -0.698 0 C-N-CA 123.032 2.488 . . . . 0.0 112.176 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.45 ' O ' HG21 ' A' ' 32' ' ' THR . 16.4 m -115.09 154.86 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.285 -0.885 . . . . 0.0 109.266 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 45.1 t -95.08 143.81 26.23 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 178.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.538 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -97.06 141.49 15.65 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 -178.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.479 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 54.6 p30 -67.42 -8.63 34.63 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.313 -1.11 . . . . 0.0 109.431 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -95.88 10.84 35.84 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.317 -0.864 . . . . 0.0 109.49 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.45 12.31 73.08 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.538 ' O ' ' N ' ' A' ' 27' ' ' GLY . 53.4 mt-30 -115.84 148.26 40.13 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.298 -1.119 . . . . 0.0 109.504 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.542 ' CG2' ' HA ' ' A' ' 57' ' ' LYS . 8.4 m -112.32 152.23 28.79 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.146 -0.971 . . . . 0.0 109.731 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.57 ' CE1' ' HB2' ' A' ' 42' ' ' GLU . 94.6 m-85 -129.34 133.4 47.4 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.303 -0.873 . . . . 0.0 109.187 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.532 ' CB ' HD22 ' A' ' 22' ' ' LEU . 1.5 m-20 -53.57 -75.37 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.111 -0.993 . . . . 0.0 109.194 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.526 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 8.4 t-20 -82.38 146.56 54.39 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.155 -0.966 . . . . 0.0 109.188 179.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.492 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 42.0 Cg_endo -64.69 -51.38 1.84 Allowed 'Trans proline' 0 C--O 1.216 -0.608 0 C-N-CA 122.649 2.233 . . . . 0.0 111.486 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.526 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 9.5 t -62.38 -27.24 68.94 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 178.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.491 ' CG ' ' HB3' ' A' ' 35' ' ' ASN . 44.9 mmm -66.44 -21.83 66.21 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.686 -0.634 . . . . 0.0 109.29 179.308 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.552 ' CD1' ' CD2' ' A' ' 33' ' ' TYR . 6.4 tt -64.83 -51.48 61.86 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.247 -0.908 . . . . 0.0 108.841 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.527 ' CB ' ' OH ' ' A' ' 16' ' ' TYR . 33.8 m -51.41 -33.64 31.26 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.06 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 19.1 t60 -53.3 -46.31 69.33 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.237 -0.915 . . . . 0.0 108.552 179.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.57 ' HB2' ' CE1' ' A' ' 33' ' ' TYR . 21.4 tp10 -62.03 -17.46 57.38 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.198 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.519 ' HB2' ' O ' ' A' ' 40' ' ' CYS . 2.7 m-80 -79.13 -33.93 43.77 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 119.492 -0.883 . . . . 0.0 109.247 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.52 ' CD2' ' OH ' ' A' ' 8' ' ' TYR . 46.6 mt -70.5 -32.93 70.62 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.256 -0.903 . . . . 0.0 109.8 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.7 mm -79.39 -51.6 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.255 -0.903 . . . . 0.0 109.654 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.462 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 18.5 mtt-85 -82.51 -33.98 28.1 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.21 -0.931 . . . . 0.0 109.833 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.486 ' N ' ' O ' ' A' ' 43' ' ' ASN . 89.6 mt-30 62.52 36.7 13.79 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.247 -0.908 . . . . 0.0 109.422 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.461 ' O ' ' HB2' ' A' ' 49' ' ' ASN . 39.0 p -102.87 3.28 36.41 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.226 -0.921 . . . . 0.0 109.631 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.461 ' HB2' ' O ' ' A' ' 48' ' ' THR . 18.6 m120 65.07 48.31 2.29 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.317 -0.864 . . . . 0.0 109.512 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.518 ' N ' ' OD1' ' A' ' 43' ' ' ASN . 48.4 m -80.19 131.39 35.7 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.206 -0.933 . . . . 0.0 109.607 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 11.1 m-70 -114.25 -171.45 1.92 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.272 -0.893 . . . . 0.0 109.38 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.501 HG22 HD12 ' A' ' 52' ' ' ILE . 42.9 mt -89.03 127.05 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.311 -0.868 . . . . 0.0 109.574 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.479 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 39.3 ttt85 -81.37 -43.44 19.02 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.424 -0.798 . . . . 0.0 109.255 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.6 m -160.44 146.4 15.18 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.569 -0.707 . . . . 0.0 109.319 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.7 p -61.68 143.5 56.04 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.2 -0.937 . . . . 0.0 109.488 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.537 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 87.58 162.04 37.4 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.542 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 62.0 tttt -52.91 152.46 3.94 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.667 -0.902 . . . . 0.0 109.603 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 85.3 m -58.74 -23.46 59.88 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.302 -0.874 . . . . 0.0 109.552 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.461 ' HB3' ' HD3' ' A' ' 57' ' ' LYS . 62.0 tt0 -79.66 -21.13 45.16 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.378 -0.827 . . . . 0.0 109.543 -179.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.464 ' HG3' ' HB3' ' A' ' 57' ' ' LYS . 5.4 mt-10 -74.2 -33.28 63.36 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.306 -0.871 . . . . 0.0 109.254 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 95.1 p -70.91 -7.58 46.78 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.402 -0.811 . . . . 0.0 109.573 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 42.0 p -84.3 173.81 10.66 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.147 -0.971 . . . . 0.0 109.563 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.454 ' HB ' ' HD2' ' A' ' 64' ' ' PRO . 43.0 p -123.09 160.34 50.16 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.318 -0.863 . . . . 0.0 109.333 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.454 ' HD2' ' HB ' ' A' ' 63' ' ' THR . 48.0 Cg_endo -69.16 130.34 19.9 Favored 'Trans proline' 0 C--O 1.214 -0.721 0 C-N-CA 122.589 2.193 . . . . 0.0 111.765 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -74.79 -166.54 17.02 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 50.3 m -70.31 -31.51 68.86 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.29 -1.123 . . . . 0.0 109.349 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 64.3 m -65.09 -30.27 71.2 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.287 -0.883 . . . . 0.0 109.381 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.451 ' HB1' ' HB2' ' A' ' 64' ' ' PRO . . . -76.71 -29.36 56.21 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.24 -0.913 . . . . 0.0 109.336 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.62 143.42 54.83 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.265 -0.897 . . . . 0.0 109.317 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 83.7 p -57.29 -28.61 63.17 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.151 -0.968 . . . . 0.0 109.549 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 9.6 mtt -60.59 147.74 82.86 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.287 -0.883 . . . . 0.0 109.52 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -70.3 166.79 27.12 Favored 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 122.684 2.256 . . . . 0.0 111.846 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -69.9 158.49 56.61 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 122.668 2.245 . . . . 0.0 111.778 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 46.8 m -135.3 144.85 46.99 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.277 -0.89 . . . . 0.0 109.521 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.437 ' O ' ' HB2' ' A' ' 76' ' ' GLU . 76.1 m-20 -57.89 -35.44 71.02 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.174 -0.953 . . . . 0.0 109.436 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.437 ' HB2' ' O ' ' A' ' 75' ' ' ASP . 83.4 tt0 . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.453 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.559 ' HB2' ' CD2' ' A' ' 51' ' ' HIS . 3.8 m -61.78 -31.35 71.55 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.215 -0.928 . . . . 0.0 109.322 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -53.51 -26.52 21.15 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.286 -0.883 . . . . 0.0 108.905 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.428 ' HE1' ' HB3' ' A' ' 4' ' ' MET . 92.2 mtp -75.51 -26.08 57.8 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.353 -0.842 . . . . 0.0 108.833 179.408 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.588 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 26.2 m -81.42 -14.42 57.14 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.458 -0.776 . . . . 0.0 109.39 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.462 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 22.6 mttm -80.59 5.23 16.04 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.201 -0.937 . . . . 0.0 109.509 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.462 ' OD1' ' O ' ' A' ' 6' ' ' LYS . 93.2 m-20 -135.76 12.82 3.42 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.061 -1.024 . . . . 0.0 110.405 -179.405 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.613 ' CE2' ' CE2' ' A' ' 16' ' ' TYR . 0.6 OUTLIER -123.54 150.72 43.66 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.873 -1.142 . . . . 0.0 109.682 179.815 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 46.1 mtt85 -130.5 132.73 45.78 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.246 -0.908 . . . . 0.0 109.393 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.568 HG22 ' CE2' ' A' ' 8' ' ' TYR . 54.2 t -123.39 147.08 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.187 -0.945 . . . . 0.0 109.716 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.543 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -128.97 176.26 2.93 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.423 -0.798 . . . . 0.0 109.17 -179.999 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.543 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 44.0 Cg_endo -66.64 -22.1 51.15 Favored 'Trans proline' 0 C--O 1.214 -0.681 0 C-N-CA 122.477 2.118 . . . . 0.0 111.782 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 60.5 mtt180 -101.55 -30.02 11.63 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.24 -0.913 . . . . 0.0 109.498 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 95.4 mt -81.47 -47.66 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.279 -0.888 . . . . 0.0 109.739 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.434 ' C ' HG12 ' A' ' 10' ' ' VAL . . . 77.14 -167.78 54.41 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.613 ' CE2' ' CE2' ' A' ' 8' ' ' TYR . 1.5 t80 -95.75 150.77 20.03 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.177 -1.19 . . . . 0.0 109.662 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 25.7 tp -117.51 105.81 12.49 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.322 -0.861 . . . . 0.0 109.465 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.416 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 76.2 m -117.77 157.3 48.43 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.239 -0.913 . . . . 0.0 109.183 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.436 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 49.5 Cg_endo -72.17 166.01 30.94 Favored 'Trans proline' 0 C--O 1.216 -0.622 0 C-N-CA 122.63 2.22 . . . . 0.0 111.545 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 60.1 mttt -89.38 -13.2 38.31 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.184 -0.948 . . . . 0.0 109.475 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -73.53 113.72 10.96 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.231 -0.918 . . . . 0.0 109.248 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.423 HD12 ' HB3' ' A' ' 34' ' ' ASN . 49.4 tp -76.54 112.54 13.18 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.174 -0.954 . . . . 0.0 109.628 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.489 ' O ' ' O ' ' A' ' 34' ' ' ASN . 14.2 mttt -126.22 110.14 24.0 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.295 -0.878 . . . . 0.0 108.941 179.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.542 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 43.5 Cg_endo -64.93 123.98 12.42 Favored 'Trans proline' 0 C--O 1.213 -0.744 0 C-N-CA 123.025 2.483 . . . . 0.0 112.487 -179.187 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.456 ' O ' HG21 ' A' ' 32' ' ' THR . 27.2 m -118.77 153.38 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.434 -0.791 . . . . 0.0 109.452 179.674 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 41.9 t -99.45 139.65 34.8 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 178.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -93.91 144.44 17.11 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 -178.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.491 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 49.3 p30 -68.87 -15.0 63.38 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.365 -1.079 . . . . 0.0 109.432 179.626 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.457 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 88.1 m-20 -84.46 5.73 26.26 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.232 -0.917 . . . . 0.0 109.542 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.04 17.17 56.65 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.444 ' O ' ' SG ' ' A' ' 58' ' ' CYS . 90.8 mt-30 -115.82 171.13 7.96 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.307 -1.113 . . . . 0.0 109.485 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.527 HG22 ' CB ' ' A' ' 57' ' ' LYS . 64.0 m -133.03 136.0 45.73 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.232 -0.918 . . . . 0.0 109.522 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.639 ' CE1' ' CD1' ' A' ' 39' ' ' LEU . 44.4 m-85 -116.14 133.17 56.32 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.292 -0.88 . . . . 0.0 109.247 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.491 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 7.7 m-20 -55.3 -77.57 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.262 -0.899 . . . . 0.0 110.031 -179.423 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.524 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 5.4 t-20 -81.63 147.66 59.84 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 120.91 -1.119 . . . . 0.0 109.728 -179.626 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.472 ' HD3' ' O ' ' A' ' 23' ' ' LYS . 41.3 Cg_endo -64.18 -53.09 1.27 Allowed 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 122.771 2.314 . . . . 0.0 111.552 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.524 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 10.1 t -62.34 -29.0 70.14 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 178.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.508 ' CG ' ' HB3' ' A' ' 35' ' ' ASN . 44.6 mmm -62.76 -14.09 40.63 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.241 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.639 ' CD1' ' CE1' ' A' ' 33' ' ' TYR . 39.8 tp -73.23 -60.17 2.37 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.407 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.458 ' HB3' ' OH ' ' A' ' 16' ' ' TYR . 17.8 t -54.54 -23.56 17.11 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 54.3 t60 -69.46 -62.25 1.46 Allowed 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 -58.09 -19.1 29.5 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.513 ' O ' ' N ' ' A' ' 47' ' ' GLN . 99.6 m-20 -76.36 -29.66 57.28 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.482 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.47 ' CD1' ' C ' ' A' ' 44' ' ' LEU . 1.8 tm? -69.81 -38.79 76.73 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.416 -0.803 . . . . 0.0 109.014 179.543 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.522 HD12 ' N ' ' A' ' 45' ' ' ILE . 3.7 mm -71.54 -46.42 63.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.301 -0.875 . . . . 0.0 109.385 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.445 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 13.4 mtt-85 -79.59 -33.23 41.82 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.286 -0.884 . . . . 0.0 109.354 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.513 ' N ' ' O ' ' A' ' 43' ' ' ASN . 92.3 mt-30 61.24 39.43 15.7 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.368 -0.832 . . . . 0.0 109.52 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 52.2 p -104.28 8.21 35.99 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.261 -0.9 . . . . 0.0 109.481 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.58 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 35.5 t-20 50.78 57.69 6.36 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.296 -0.878 . . . . 0.0 109.505 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.448 ' HB ' ' OD1' ' A' ' 43' ' ' ASN . 26.6 m -80.32 148.54 30.64 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.182 -0.949 . . . . 0.0 109.785 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.58 ' CE1' ' O ' ' A' ' 49' ' ' ASN . 13.7 m80 -122.0 171.34 9.02 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.396 -0.815 . . . . 0.0 108.851 179.472 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.465 HG12 HD21 ' A' ' 39' ' ' LEU . 11.7 mt -83.29 126.48 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.156 -0.965 . . . . 0.0 109.701 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.491 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 55.8 ttt180 -80.04 -46.45 16.55 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.452 -0.78 . . . . 0.0 109.409 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -160.54 142.92 12.89 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.8 p -54.71 148.4 12.84 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.192 -0.942 . . . . 0.0 109.112 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.542 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 84.42 168.2 43.83 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.068 -1.613 . . . . 0.0 109.068 -179.513 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.527 ' CB ' HG22 ' A' ' 32' ' ' THR . 81.7 mttt -63.93 167.14 6.52 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.257 -1.143 . . . . 0.0 109.238 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.459 ' SG ' ' OG1' ' A' ' 32' ' ' THR . 84.0 m -74.38 -15.52 60.93 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.219 -0.926 . . . . 0.0 109.098 179.689 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.447 ' O ' ' HG2' ' A' ' 59' ' ' GLU . 65.3 tt0 -79.71 -16.56 55.45 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.48 -0.763 . . . . 0.0 109.368 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.462 ' HG3' ' O ' ' A' ' 57' ' ' LYS . 9.1 mt-10 -73.7 -33.8 64.56 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.278 -0.889 . . . . 0.0 108.96 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 93.1 p -60.11 -18.22 45.7 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.433 -0.792 . . . . 0.0 109.108 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 42.5 m -119.4 152.29 37.07 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.29 -0.881 . . . . 0.0 109.412 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 17.1 m -123.47 79.52 54.3 Favored Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.215 -0.928 . . . . 0.0 109.502 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -70.38 147.07 58.08 Favored 'Trans proline' 0 C--O 1.216 -0.61 0 C-N-CA 122.709 2.273 . . . . 0.0 111.771 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.24 172.9 55.25 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.559 -1.417 . . . . 0.0 109.559 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 16.9 p -123.74 163.53 20.96 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.287 -1.125 . . . . 0.0 109.437 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 17.4 p -123.32 160.82 25.9 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.255 -0.903 . . . . 0.0 109.503 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.417 ' O ' ' O ' ' A' ' 71' ' ' MET . . . -60.67 -33.6 73.08 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.205 -0.934 . . . . 0.0 109.46 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.04 -25.7 65.5 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.316 -0.865 . . . . 0.0 109.547 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 27.8 m -61.65 -27.77 68.91 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.185 -0.947 . . . . 0.0 109.51 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.417 ' O ' ' O ' ' A' ' 68' ' ' ALA . 22.5 mtt -133.03 158.64 75.31 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.252 -0.905 . . . . 0.0 109.579 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -70.48 148.95 61.51 Favored 'Trans proline' 0 C--O 1.214 -0.695 0 C-N-CA 122.708 2.272 . . . . 0.0 111.723 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -69.8 -5.46 16.29 Favored 'Trans proline' 0 C--O 1.214 -0.712 0 C-N-CA 122.668 2.245 . . . . 0.0 111.833 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 83.7 p -84.62 -11.45 55.95 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.173 -0.954 . . . . 0.0 109.37 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -67.1 -29.65 69.46 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.229 -0.919 . . . . 0.0 109.399 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 . . . . . 0 N--CA 1.489 1.506 0 CA-C-O 118.024 -0.989 . . . . 0.0 109.504 179.931 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.475 ' HA ' HD13 ' A' ' 52' ' ' ILE . 58.9 m-20 . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.453 ' O ' ' SG ' ' A' ' 5' ' ' CYS . 1.3 m -47.13 -34.95 6.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.179 -0.95 . . . . 0.0 109.231 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.465 ' HA ' ' HG3' ' A' ' 6' ' ' LYS . 9.2 mt-10 -50.72 -25.53 4.46 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.261 -0.9 . . . . 0.0 108.758 179.591 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 84.5 mmm -75.63 -32.5 60.27 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.46 -0.775 . . . . 0.0 109.389 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.453 ' SG ' ' O ' ' A' ' 2' ' ' SER . 16.8 p -79.76 -7.76 58.84 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.14 -0.975 . . . . 0.0 109.286 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.465 ' HG3' ' HA ' ' A' ' 3' ' ' GLU . 24.7 mttm -49.05 -24.92 1.75 Allowed 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.079 -1.013 . . . . 0.0 108.391 179.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.401 ' OD1' ' C ' ' A' ' 7' ' ' ASP . 58.8 p30 -112.98 25.57 11.28 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.319 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.577 ' CZ ' ' CE1' ' A' ' 16' ' ' TYR . 3.7 t80 -79.19 162.82 25.49 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.544 -0.723 . . . . 0.0 109.99 -179.394 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 12.7 mtm180 -148.92 115.36 5.87 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.368 -0.832 . . . . 0.0 108.977 179.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.454 ' CG1' ' C ' ' A' ' 15' ' ' GLY . 99.8 t -111.32 148.99 14.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.229 -0.919 . . . . 0.0 109.468 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.544 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.5 OUTLIER -129.58 175.82 3.3 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.251 -0.905 . . . . 0.0 109.453 -179.674 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.544 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 43.7 Cg_endo -66.77 -22.26 49.93 Favored 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 122.644 2.229 . . . . 0.0 111.584 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.43 ' NH1' ' HB3' ' A' ' 13' ' ' ARG . 19.5 mtp-105 -114.29 -29.49 6.91 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.375 -0.828 . . . . 0.0 109.215 179.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 97.1 mt -78.92 -42.02 24.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.338 -0.851 . . . . 0.0 109.383 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.454 ' C ' ' CG1' ' A' ' 10' ' ' VAL . . . 64.12 -150.89 50.25 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.577 ' CE1' ' CZ ' ' A' ' 8' ' ' TYR . 1.0 OUTLIER -102.68 147.6 26.62 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.266 -1.138 . . . . 0.0 109.352 179.858 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.472 ' N ' ' OH ' ' A' ' 8' ' ' TYR . 37.5 mt -113.86 124.14 51.49 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.118 -0.989 . . . . 0.0 109.919 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.432 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 61.4 m -138.97 156.32 72.57 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.433 -0.792 . . . . 0.0 109.026 179.724 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -70.74 167.05 26.84 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.573 2.182 . . . . 0.0 111.671 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -88.2 -13.7 40.44 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.208 -0.933 . . . . 0.0 109.698 -179.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -74.19 123.48 24.57 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.133 -0.98 . . . . 0.0 109.391 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 39.7 tp -80.61 118.55 22.29 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.275 -0.89 . . . . 0.0 109.515 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.521 ' CB ' ' HD3' ' A' ' 36' ' ' PRO . 10.8 mttp -127.65 100.09 25.69 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.347 -0.846 . . . . 0.0 109.17 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.541 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 42.2 Cg_endo -64.41 118.22 5.2 Favored 'Trans proline' 0 C--O 1.214 -0.713 0 C-N-CA 122.874 2.383 . . . . 0.0 112.133 -179.449 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.445 ' O ' HG21 ' A' ' 32' ' ' THR . 12.2 m -114.65 155.74 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.309 -0.87 . . . . 0.0 109.557 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.417 ' SG ' ' NE ' ' A' ' 53' ' ' ARG . 42.4 t -95.62 138.96 32.55 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.237 -0.914 . . . . 0.0 108.661 179.051 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -92.11 136.16 13.1 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.483 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 53.8 t0 -68.96 -7.15 32.51 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.196 -1.179 . . . . 0.0 109.426 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.413 ' OD1' ' C ' ' A' ' 29' ' ' ASP . 59.2 p30 -89.72 2.95 54.19 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.265 -0.897 . . . . 0.0 109.413 179.672 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.64 16.57 39.02 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.463 ' O ' ' SG ' ' A' ' 58' ' ' CYS . 66.2 mt-30 -121.78 -178.37 3.81 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.301 -1.117 . . . . 0.0 109.592 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.534 ' CG2' ' HA ' ' A' ' 57' ' ' LYS . 11.1 m -143.3 138.85 29.83 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.287 -0.883 . . . . 0.0 109.319 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.594 ' CG ' HD11 ' A' ' 39' ' ' LEU . 40.2 m-85 -116.13 134.09 55.31 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.217 -0.927 . . . . 0.0 109.366 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.487 ' O ' ' O ' ' A' ' 23' ' ' LYS . 13.1 m-20 -55.07 -78.94 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.255 -0.903 . . . . 0.0 109.666 -179.611 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.505 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 10.9 t-20 -82.33 146.14 53.61 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.08 -1.013 . . . . 0.0 109.525 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.521 ' HD3' ' CB ' ' A' ' 23' ' ' LYS . 41.4 Cg_endo -63.94 -51.64 2.16 Favored 'Trans proline' 0 C--O 1.215 -0.651 0 C-N-CA 122.753 2.302 . . . . 0.0 111.621 179.438 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.505 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 8.0 t -62.06 -25.62 67.79 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 178.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.499 ' CG ' ' HB3' ' A' ' 35' ' ' ASN . 65.2 mmm -72.35 -3.02 21.47 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 179.191 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.594 HD11 ' CG ' ' A' ' 33' ' ' TYR . 21.2 tp -74.37 -60.03 2.46 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.287 -0.883 . . . . 0.0 109.175 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.474 ' HB3' ' OH ' ' A' ' 16' ' ' TYR . 2.2 t -56.44 -25.73 51.43 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.122 -0.986 . . . . 0.0 108.468 179.51 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 27.4 t60 -61.9 -56.91 14.42 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.468 ' OE1' ' CD2' ' A' ' 33' ' ' TYR . 65.1 tt0 -64.2 -20.57 66.11 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.145 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.501 ' O ' ' N ' ' A' ' 47' ' ' GLN . 88.6 m-20 -79.19 -29.88 43.12 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.61 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.481 ' CD1' ' C ' ' A' ' 44' ' ' LEU . 1.7 tm? -65.41 -36.9 85.35 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.284 -0.885 . . . . 0.0 109.165 179.629 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.2 mt -79.4 -38.88 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.372 -0.83 . . . . 0.0 109.317 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.464 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 17.0 mtt-85 -80.11 -32.79 39.08 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.174 -0.954 . . . . 0.0 109.417 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.501 ' N ' ' O ' ' A' ' 43' ' ' ASN . 73.8 mm-40 61.84 40.93 12.2 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.254 -0.904 . . . . 0.0 109.578 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 25.4 p -113.73 9.84 17.79 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.187 -0.946 . . . . 0.0 109.625 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 49.6 m-20 45.35 58.81 3.91 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.201 -0.937 . . . . 0.0 109.529 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.423 ' HB ' ' OD1' ' A' ' 43' ' ' ASN . 66.0 m -80.33 137.55 36.59 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.158 -0.964 . . . . 0.0 109.779 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 72.2 m80 -110.77 172.02 7.12 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.255 -0.903 . . . . 0.0 108.967 179.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.475 HD13 ' HA ' ' A' ' 1' ' ' ASP . 34.7 mt -82.12 126.03 39.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.131 -0.981 . . . . 0.0 109.435 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.483 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 46.6 ttp180 -79.99 -44.56 19.99 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 121.642 0.734 . . . . 0.0 109.309 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 17.1 p -158.49 156.1 29.67 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -179.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 36.5 p -71.68 140.32 49.58 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.119 -0.988 . . . . 0.0 109.407 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.541 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 89.5 162.25 38.24 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.551 -1.419 . . . . 0.0 109.551 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.534 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 46.2 tttp -50.63 148.54 3.83 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.537 -0.978 . . . . 0.0 109.49 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.463 ' SG ' ' O ' ' A' ' 31' ' ' GLN . 92.5 m -52.53 -25.48 10.5 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.318 -0.864 . . . . 0.0 109.331 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -85.3 -20.87 29.35 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.367 -0.833 . . . . 0.0 109.29 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -91.68 116.57 28.99 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.317 -0.865 . . . . 0.0 109.328 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 25.3 t -129.21 140.64 51.41 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.199 -0.938 . . . . 0.0 109.579 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 97.3 p -120.08 155.28 33.3 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.2 -0.938 . . . . 0.0 109.415 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.31 77.42 61.29 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.249 -0.907 . . . . 0.0 109.482 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -69.95 149.16 65.28 Favored 'Trans proline' 0 C--O 1.214 -0.682 0 C-N-CA 122.723 2.282 . . . . 0.0 111.814 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.422 ' HA2' ' CB ' ' A' ' 70' ' ' SER . . . -78.87 -176.73 48.49 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 63.7 m -64.29 -29.27 70.36 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.278 -1.13 . . . . 0.0 109.428 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 17.7 p -133.28 158.76 42.11 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.366 -0.834 . . . . 0.0 109.465 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -57.86 -30.31 65.71 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.228 -0.92 . . . . 0.0 109.461 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.72 -35.28 79.23 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.287 -0.883 . . . . 0.0 109.53 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.422 ' CB ' ' HA2' ' A' ' 65' ' ' GLY . 32.0 m -53.46 -34.35 57.59 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.238 -0.914 . . . . 0.0 109.513 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -63.43 154.56 78.63 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.266 -0.896 . . . . 0.0 109.473 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -69.96 142.46 47.1 Favored 'Trans proline' 0 C--O 1.214 -0.692 0 C-N-CA 122.736 2.291 . . . . 0.0 111.844 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -70.26 166.82 26.95 Favored 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 122.727 2.285 . . . . 0.0 111.815 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 20.2 m -90.74 -8.03 50.89 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.263 -0.898 . . . . 0.0 109.626 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 54.7 t0 -104.48 109.71 21.69 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.14 -0.975 . . . . 0.0 109.498 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 118.027 -0.987 . . . . 0.0 109.451 179.957 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.344 0.593 . . . . 0.0 109.556 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.51 ' HB2' ' CD2' ' A' ' 51' ' ' HIS . 4.6 m -61.75 -24.91 67.12 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.266 -0.896 . . . . 0.0 109.571 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -54.95 -22.03 13.71 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.167 -0.958 . . . . 0.0 109.041 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 77.4 mtm -73.8 -30.02 62.49 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.239 -0.913 . . . . 0.0 109.061 179.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.585 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 48.7 m -80.09 -19.13 48.16 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.396 -0.815 . . . . 0.0 109.351 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.442 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 25.3 mttt -81.04 11.65 3.93 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.362 -0.836 . . . . 0.0 109.985 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' A' ' 6' ' ' LYS . 94.4 m-20 -136.23 4.05 2.91 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.026 -1.046 . . . . 0.0 109.972 -179.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.585 ' CD1' ' HA ' ' A' ' 5' ' ' CYS . 0.7 OUTLIER -121.12 147.98 44.81 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.946 -1.096 . . . . 0.0 109.675 -179.951 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 29.2 mtt180 -132.44 124.64 29.01 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.333 -0.854 . . . . 0.0 108.957 179.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.527 HG23 ' CD1' ' A' ' 16' ' ' TYR . 75.8 t -108.95 141.44 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.333 -0.854 . . . . 0.0 110.183 -179.229 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.533 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 2.0 mp -130.71 176.18 3.08 Favored Pre-proline 0 N--CA 1.489 1.503 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.533 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 44.2 Cg_endo -66.55 -23.05 50.39 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 122.593 2.196 . . . . 0.0 111.801 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 31.6 ttp180 -97.78 -35.06 10.65 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.332 -0.855 . . . . 0.0 109.404 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 87.3 mt -80.34 -50.75 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.324 -0.86 . . . . 0.0 109.398 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 82.51 -171.67 51.6 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.527 ' CD1' HG23 ' A' ' 10' ' ' VAL . 0.9 OUTLIER -86.73 152.92 22.12 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.235 -1.156 . . . . 0.0 109.548 179.984 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 19.1 tp -129.45 117.1 19.98 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.235 -0.915 . . . . 0.0 109.915 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.455 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 75.8 m -133.82 156.72 79.12 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.401 -0.812 . . . . 0.0 108.928 179.515 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.502 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 49.6 Cg_endo -70.62 167.37 25.75 Favored 'Trans proline' 0 C--O 1.216 -0.623 0 C-N-CA 122.689 2.259 . . . . 0.0 111.679 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -93.91 -6.77 44.84 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.302 -0.873 . . . . 0.0 109.573 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.523 ' CB ' ' HE2' ' A' ' 23' ' ' LYS . 77.5 m-20 -74.46 137.01 42.29 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.228 -0.92 . . . . 0.0 109.115 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.488 ' CD1' ' C ' ' A' ' 22' ' ' LEU . 3.3 tm? -92.66 119.6 32.23 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.201 -0.937 . . . . 0.0 109.599 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.523 ' HE2' ' CB ' ' A' ' 21' ' ' ASP . 11.5 mttt -139.22 104.26 7.24 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.176 -0.952 . . . . 0.0 109.403 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.543 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 44.2 Cg_endo -67.25 118.47 5.6 Favored 'Trans proline' 0 C--O 1.214 -0.691 0 C-N-CA 122.921 2.414 . . . . 0.0 111.857 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.47 ' O ' HG21 ' A' ' 32' ' ' THR . 23.2 m -112.89 155.57 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.247 -0.908 . . . . 0.0 109.927 -179.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.498 ' O ' ' N ' ' A' ' 53' ' ' ARG . 39.3 t -101.49 109.57 21.41 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.315 -0.866 . . . . 0.0 109.338 179.63 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.485 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -62.5 142.17 47.64 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 -179.56 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.503 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 58.4 p30 -70.62 -10.37 59.18 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.326 -1.102 . . . . 0.0 109.378 179.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.438 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 55.1 p30 -85.33 6.58 25.74 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.224 -0.923 . . . . 0.0 109.312 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.65 9.47 64.45 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.191 -1.564 . . . . 0.0 109.191 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.485 ' O ' ' N ' ' A' ' 27' ' ' GLY . 88.0 mt-30 -111.18 168.28 9.63 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.381 -1.07 . . . . 0.0 109.517 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.489 ' CG2' ' HA ' ' A' ' 57' ' ' LYS . 30.3 m -127.68 130.79 49.5 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.243 -0.91 . . . . 0.0 109.402 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.578 ' CD1' ' CD1' ' A' ' 39' ' ' LEU . 47.1 m-85 -109.44 123.73 49.85 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.208 -0.932 . . . . 0.0 109.188 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.482 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 52.5 t-20 -48.3 -78.86 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.252 -0.905 . . . . 0.0 110.057 -179.387 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.535 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 1.4 t-20 -81.2 150.36 67.85 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.002 -1.061 . . . . 0.0 109.617 -179.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.468 ' HD2' ' CG ' ' A' ' 35' ' ' ASN . 40.7 Cg_endo -63.52 -55.5 0.7 Allowed 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 122.874 2.383 . . . . 0.0 112.037 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.535 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 13.6 t -63.31 -28.65 70.16 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.995 -1.066 . . . . 0.0 108.539 179.23 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.467 ' CG ' ' HB3' ' A' ' 35' ' ' ASN . 51.5 mmm -61.16 -17.66 54.06 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.345 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.578 ' CD1' ' CD1' ' A' ' 33' ' ' TYR . 30.7 tp -67.11 -59.0 3.83 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.269 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.469 ' HB3' ' OH ' ' A' ' 16' ' ' TYR . 8.2 t -55.8 -27.47 51.3 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.734 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 49.1 t60 -63.5 -61.09 2.56 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 63.1 mt-10 -57.47 -20.88 33.7 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 178.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.529 ' O ' ' N ' ' A' ' 47' ' ' GLN . 95.9 m-20 -80.27 -26.68 38.83 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.564 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.407 ' HA ' HD11 ' A' ' 44' ' ' LEU . 35.8 tp -71.3 -32.26 68.42 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.275 -0.891 . . . . 0.0 108.722 179.589 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 6.6 mm -80.57 -46.5 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.415 -0.803 . . . . 0.0 109.181 179.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.469 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 58.0 mtt-85 -80.12 -36.69 34.96 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.253 -0.905 . . . . 0.0 109.285 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.529 ' N ' ' O ' ' A' ' 43' ' ' ASN . 91.7 mt-30 63.89 39.8 7.92 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.535 -0.728 . . . . 0.0 109.518 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 39.6 p -101.77 6.02 41.51 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.293 -0.879 . . . . 0.0 109.415 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.462 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 49.6 t30 52.78 57.24 6.58 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.301 -0.874 . . . . 0.0 109.687 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 58.4 m -80.12 141.34 35.85 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.185 -0.947 . . . . 0.0 109.633 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.51 ' CD2' ' HB2' ' A' ' 2' ' ' SER . 13.9 m80 -111.13 178.83 4.22 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.331 -0.855 . . . . 0.0 109.192 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.442 HG22 HD11 ' A' ' 52' ' ' ILE . 10.9 mt -90.25 127.22 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.123 -0.985 . . . . 0.0 109.799 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.503 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 28.4 ttt180 -80.18 -59.83 2.56 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.494 -0.754 . . . . 0.0 109.287 179.694 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 21.1 m -154.04 142.25 20.45 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.3 p -53.3 143.41 18.71 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.157 -0.965 . . . . 0.0 109.542 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.543 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 95.26 162.95 34.46 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.489 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 18.0 mttp -64.26 149.68 47.53 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.465 -1.02 . . . . 0.0 109.341 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.457 ' SG ' ' O ' ' A' ' 31' ' ' GLN . 70.2 m -56.16 -25.76 47.8 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.223 -0.923 . . . . 0.0 109.41 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.453 ' O ' ' HG2' ' A' ' 59' ' ' GLU . 66.0 tt0 -86.08 -19.06 30.8 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.323 -0.86 . . . . 0.0 109.375 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 53.9 tt0 -76.87 -27.84 55.18 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.296 -0.877 . . . . 0.0 109.478 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 17.3 m -71.73 -26.71 62.59 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.279 -0.888 . . . . 0.0 109.683 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 97.3 p -120.34 152.82 37.32 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.173 -0.954 . . . . 0.0 109.663 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.464 ' OG1' ' HD2' ' A' ' 64' ' ' PRO . 0.1 OUTLIER -68.57 153.8 95.31 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.323 -0.861 . . . . 0.0 109.504 179.976 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.506 ' HB2' ' CB ' ' A' ' 68' ' ' ALA . 49.2 Cg_endo -69.26 141.25 46.73 Favored 'Trans proline' 0 C--O 1.215 -0.647 0 C-N-CA 122.71 2.273 . . . . 0.0 111.752 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -76.54 -171.53 33.54 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 56.1 m -68.12 -29.96 68.99 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.27 -1.135 . . . . 0.0 109.355 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 57.9 m -65.66 -29.11 69.63 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.291 -0.881 . . . . 0.0 109.406 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.506 ' CB ' ' HB2' ' A' ' 64' ' ' PRO . . . -72.78 -29.4 63.27 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.212 -0.93 . . . . 0.0 109.374 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.459 ' O ' ' HD3' ' A' ' 72' ' ' PRO . . . -70.57 -19.78 62.84 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.242 -0.911 . . . . 0.0 109.27 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 19.7 m -69.44 -27.0 64.87 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.271 -0.893 . . . . 0.0 109.199 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 6.8 mtp -128.63 71.41 80.76 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.33 -0.857 . . . . 0.0 109.276 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.459 ' HD3' ' O ' ' A' ' 69' ' ' ALA . 48.4 Cg_endo -69.54 169.41 18.69 Favored 'Trans proline' 0 C--O 1.215 -0.631 0 C-N-CA 122.739 2.293 . . . . 0.0 111.938 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -70.39 -14.69 34.34 Favored 'Trans proline' 0 C--O 1.216 -0.61 0 C-N-CA 122.833 2.355 . . . . 0.0 111.96 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 97.0 p -142.25 152.7 43.3 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.147 -0.97 . . . . 0.0 109.62 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -60.04 134.99 57.57 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.24 -0.912 . . . . 0.0 109.451 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 118.022 -0.989 . . . . 0.0 109.442 -179.939 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.454 ' HB2' ' CE1' ' A' ' 51' ' ' HIS . 2.1 m -57.52 -34.85 69.54 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.234 -0.916 . . . . 0.0 109.408 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -55.12 -27.03 42.22 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.331 -0.855 . . . . 0.0 109.054 179.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.452 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 86.4 mtp -72.3 -21.56 61.32 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.576 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.575 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 27.1 m -87.15 -16.64 34.83 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.479 -0.763 . . . . 0.0 109.123 179.579 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.7 mttp -81.15 14.25 2.43 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.303 -0.873 . . . . 0.0 109.943 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.452 ' OD1' ' O ' ' A' ' 4' ' ' MET . 51.7 p30 -145.79 10.5 1.21 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.918 -1.114 . . . . 0.0 110.098 -179.698 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.645 ' CE2' ' CE2' ' A' ' 16' ' ' TYR . 1.1 p90 -119.0 150.48 39.88 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.933 -1.104 . . . . 0.0 109.546 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 57.8 mtm180 -130.01 133.82 47.0 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.237 -0.914 . . . . 0.0 109.289 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.526 HG21 ' CE2' ' A' ' 8' ' ' TYR . 54.1 t -122.92 149.98 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.202 -0.936 . . . . 0.0 109.711 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.536 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.2 OUTLIER -131.39 175.91 3.31 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.322 -0.861 . . . . 0.0 109.261 -179.971 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.536 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 43.7 Cg_endo -66.07 -22.97 54.04 Favored 'Trans proline' 0 C--O 1.214 -0.684 0 C-N-CA 122.65 2.233 . . . . 0.0 111.929 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 3.5 mtm180 -106.29 -31.77 8.47 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.301 -0.874 . . . . 0.0 109.357 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 92.9 mt -77.17 -39.33 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.374 -0.829 . . . . 0.0 109.347 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.448 ' O ' ' CG1' ' A' ' 10' ' ' VAL . . . 70.73 -162.81 53.71 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.645 ' CE2' ' CE2' ' A' ' 8' ' ' TYR . 2.0 t80 -95.01 150.55 20.04 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.211 -1.17 . . . . 0.0 109.632 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 23.0 tp -113.13 111.33 21.92 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.412 -0.805 . . . . 0.0 109.593 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.459 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 84.6 m -128.68 156.63 77.17 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.147 -0.971 . . . . 0.0 109.317 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.477 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 48.9 Cg_endo -70.82 167.53 25.57 Favored 'Trans proline' 0 C--O 1.216 -0.611 0 C-N-CA 122.717 2.278 . . . . 0.0 111.577 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 62.6 mttm -94.94 -4.56 46.54 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.255 -0.903 . . . . 0.0 109.631 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -76.69 123.98 26.97 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.206 -0.934 . . . . 0.0 109.348 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.496 HD22 ' ND2' ' A' ' 34' ' ' ASN . 3.3 tm? -82.73 119.02 23.8 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.208 -0.933 . . . . 0.0 109.498 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.474 ' O ' ' O ' ' A' ' 34' ' ' ASN . 15.5 mttp -141.88 107.51 5.87 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.302 -0.874 . . . . 0.0 109.476 179.744 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.546 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 43.3 Cg_endo -65.9 123.66 11.61 Favored 'Trans proline' 0 C--O 1.213 -0.728 0 C-N-CA 123.017 2.478 . . . . 0.0 112.14 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 29.7 m -116.32 155.02 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.265 -0.897 . . . . 0.0 109.71 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.455 ' O ' ' N ' ' A' ' 53' ' ' ARG . 43.5 t -99.27 122.94 43.12 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.428 -0.795 . . . . 0.0 108.914 179.418 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.505 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -81.45 137.99 18.36 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.49 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 47.0 p30 -68.54 -8.33 40.46 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.248 -1.148 . . . . 0.0 109.575 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.405 ' OD2' ' OG1' ' A' ' 50' ' ' THR . 75.8 m-20 -84.14 10.04 11.19 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.194 -0.941 . . . . 0.0 109.189 179.556 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.32 15.66 66.1 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.167 -1.573 . . . . 0.0 109.167 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.505 ' O ' ' N ' ' A' ' 27' ' ' GLY . 86.6 mt-30 -124.27 167.85 13.76 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.344 -1.092 . . . . 0.0 109.535 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.53 ' CG2' ' HA ' ' A' ' 57' ' ' LYS . 42.1 m -127.96 137.91 52.43 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.251 -0.906 . . . . 0.0 109.526 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.622 ' CD1' ' CD1' ' A' ' 39' ' ' LEU . 71.4 m-85 -113.79 129.26 56.6 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.288 -0.882 . . . . 0.0 109.28 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.496 ' ND2' HD22 ' A' ' 22' ' ' LEU . 45.4 t-20 -51.09 -78.95 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.363 -0.836 . . . . 0.0 110.255 -179.197 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.53 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 1.7 t-20 -81.6 149.91 65.46 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 120.964 -1.085 . . . . 0.0 109.762 -179.492 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.458 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.9 Cg_endo -63.88 -55.53 0.64 Allowed 'Trans proline' 0 C--O 1.215 -0.674 0 C-N-CA 122.765 2.31 . . . . 0.0 111.864 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.53 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 12.9 t -61.41 -30.58 70.65 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.022 -1.049 . . . . 0.0 108.175 179.097 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.515 ' CG ' ' HB3' ' A' ' 35' ' ' ASN . 65.0 mmm -61.41 -15.15 34.05 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.016 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.622 ' CD1' ' CD1' ' A' ' 33' ' ' TYR . 37.8 tp -68.94 -58.55 3.97 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.434 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.452 ' HB3' ' OH ' ' A' ' 16' ' ' TYR . 19.5 t -53.28 -29.34 32.72 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 179.001 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 48.1 t60 -64.19 -61.57 2.17 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.426 ' HA ' ' OE1' ' A' ' 42' ' ' GLU . 71.2 mm-40 -56.06 -20.3 16.44 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.412 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.517 ' O ' ' N ' ' A' ' 47' ' ' GLN . 97.3 m-20 -79.44 -24.75 42.23 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.752 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.485 ' CD1' ' C ' ' A' ' 44' ' ' LEU . 1.7 tm? -71.86 -37.34 70.25 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.333 -0.855 . . . . 0.0 108.766 179.35 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.8 mm -75.92 -44.68 38.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.404 -0.81 . . . . 0.0 109.232 179.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.459 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 14.7 mtt-85 -79.61 -37.72 35.53 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.359 -0.838 . . . . 0.0 109.19 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.517 ' N ' ' O ' ' A' ' 43' ' ' ASN . 91.6 mt-30 62.06 40.46 12.05 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.334 -0.854 . . . . 0.0 109.469 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.414 ' O ' ' C ' ' A' ' 49' ' ' ASN . 62.4 p -107.53 17.22 22.96 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.239 -0.913 . . . . 0.0 109.45 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.567 ' OD1' ' CE1' ' A' ' 51' ' ' HIS . 13.4 t-20 44.82 58.61 3.86 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.294 -0.879 . . . . 0.0 109.511 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.453 ' HB ' ' OD1' ' A' ' 43' ' ' ASN . 50.1 m -80.32 147.28 31.19 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.212 -0.93 . . . . 0.0 109.715 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.567 ' CE1' ' OD1' ' A' ' 49' ' ' ASN . 30.6 m-70 -122.16 169.78 10.53 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.345 -0.847 . . . . 0.0 108.988 179.497 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.441 HD11 HG22 ' A' ' 52' ' ' ILE . 10.7 mt -81.2 122.29 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.15 -0.969 . . . . 0.0 109.611 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.49 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 56.5 ttt180 -79.9 -44.84 19.68 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.436 -0.79 . . . . 0.0 109.301 179.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.4 t -157.95 154.4 27.73 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.43 -0.794 . . . . 0.0 109.195 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.6 p -73.31 132.46 43.12 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.22 -0.925 . . . . 0.0 109.568 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.546 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 100.16 164.2 28.7 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.53 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 39.7 tttt -50.2 150.31 2.51 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.443 -1.033 . . . . 0.0 109.263 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 36.2 m -56.25 -31.7 63.82 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.179 -0.951 . . . . 0.0 109.42 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.424 ' CD ' ' HE2' ' A' ' 57' ' ' LYS . 19.0 mt-10 -82.12 -31.34 30.69 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.308 -0.87 . . . . 0.0 108.892 179.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.453 ' OE1' ' HA2' ' A' ' 56' ' ' GLY . 37.9 tt0 -53.52 -21.98 7.37 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.466 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 13.5 m -68.76 -35.94 77.71 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.433 -0.792 . . . . 0.0 109.547 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 43.7 m -113.04 143.17 44.78 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.256 -0.902 . . . . 0.0 109.558 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.05 77.32 41.43 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.322 -0.861 . . . . 0.0 109.278 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -69.39 -20.12 36.99 Favored 'Trans proline' 0 C--O 1.215 -0.664 0 C-N-CA 122.735 2.29 . . . . 0.0 111.762 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 171.05 -179.03 43.15 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 21.0 p -122.12 159.94 26.12 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.201 -1.176 . . . . 0.0 109.487 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 63.2 p -68.07 -26.93 66.09 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.231 -0.918 . . . . 0.0 109.42 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -62.72 -33.31 74.84 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.274 -0.891 . . . . 0.0 109.506 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.42 ' O ' ' HD3' ' A' ' 72' ' ' PRO . . . -66.49 -31.69 72.57 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.221 -0.924 . . . . 0.0 109.409 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 32.9 t -60.92 -28.53 69.0 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.218 -0.926 . . . . 0.0 109.495 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.87 77.72 76.28 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.278 -0.889 . . . . 0.0 109.404 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.42 ' HD3' ' O ' ' A' ' 69' ' ' ALA . 49.9 Cg_endo -70.07 151.03 67.11 Favored 'Trans proline' 0 C--O 1.215 -0.635 0 C-N-CA 122.69 2.26 . . . . 0.0 111.894 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -70.45 156.72 60.93 Favored 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 122.689 2.259 . . . . 0.0 111.788 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 81.4 p -82.71 -8.21 59.6 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.275 -0.891 . . . . 0.0 109.61 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 -69.69 -28.86 66.2 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.189 -0.945 . . . . 0.0 109.472 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 118.038 -0.982 . . . . 0.0 109.438 -179.999 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -54.12 -32.28 54.65 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.214 -0.929 . . . . 0.0 109.346 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.454 ' HA ' ' HG3' ' A' ' 6' ' ' LYS . 5.0 mt-10 -53.93 -23.13 11.84 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.2 -0.937 . . . . 0.0 108.92 179.74 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.428 ' O ' ' CG ' ' A' ' 7' ' ' ASP . 67.8 mmm -71.15 -27.98 63.94 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.277 -0.889 . . . . 0.0 108.98 179.554 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 35.1 m -80.91 -17.17 51.47 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.376 -0.827 . . . . 0.0 109.198 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.454 ' HG3' ' HA ' ' A' ' 3' ' ' GLU . 34.3 mttp -80.28 8.18 7.97 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.313 -0.867 . . . . 0.0 109.665 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.428 ' CG ' ' O ' ' A' ' 4' ' ' MET . 17.4 p30 -117.45 -10.93 10.59 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.182 -0.948 . . . . 0.0 109.638 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.58 ' OH ' ' CZ ' ' A' ' 16' ' ' TYR . 1.5 p90 -104.3 171.28 7.42 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.159 -0.963 . . . . 0.0 109.546 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 85.9 mtt180 -131.42 157.06 44.46 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.294 -0.879 . . . . 0.0 109.215 179.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.456 HG22 ' HA ' ' A' ' 16' ' ' TYR . 14.5 p -136.97 158.35 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.166 -0.959 . . . . 0.0 109.816 -179.562 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.53 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 1.6 mp -108.2 175.36 2.02 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.265 -0.897 . . . . 0.0 109.354 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.53 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 45.7 Cg_endo -67.56 -27.71 38.81 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 122.589 2.193 . . . . 0.0 111.682 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 37.6 mtm180 -84.15 -38.75 20.28 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.381 -0.824 . . . . 0.0 109.055 179.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.483 ' CG2' ' HG ' ' A' ' 17' ' ' LEU . 98.7 mt -77.12 -34.79 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.381 -0.824 . . . . 0.0 109.024 179.62 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.447 ' C ' ' CG2' ' A' ' 10' ' ' VAL . . . 68.2 -65.45 0.37 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 179.733 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.58 ' CZ ' ' OH ' ' A' ' 8' ' ' TYR . 1.2 t80 -160.59 150.82 18.0 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.31 -1.112 . . . . 0.0 109.328 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.578 ' N ' ' CD1' ' A' ' 17' ' ' LEU . 0.4 OUTLIER -123.07 141.61 51.78 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.25 -0.906 . . . . 0.0 109.472 179.976 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.45 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 75.0 m -146.26 158.01 48.39 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.308 -0.87 . . . . 0.0 109.15 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.488 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 46.6 Cg_endo -69.93 165.3 31.63 Favored 'Trans proline' 0 C--O 1.214 -0.695 0 C-N-CA 122.494 2.129 . . . . 0.0 111.308 179.739 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -91.81 -8.52 46.42 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.204 -0.935 . . . . 0.0 109.508 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 -74.54 129.48 37.82 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.274 -0.891 . . . . 0.0 109.218 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.496 ' CD1' ' C ' ' A' ' 22' ' ' LEU . 3.4 tm? -87.92 121.24 30.09 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.207 -0.933 . . . . 0.0 109.37 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.47 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 14.0 mttt -144.3 109.39 4.95 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.091 -1.006 . . . . 0.0 109.717 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.533 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 44.1 Cg_endo -66.58 122.84 10.33 Favored 'Trans proline' 0 C--O 1.214 -0.706 0 C-N-CA 122.947 2.431 . . . . 0.0 111.899 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 8.7 m -117.46 156.9 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.22 -0.925 . . . . 0.0 109.858 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 45.5 t -97.54 136.62 37.69 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 178.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -94.04 135.19 12.4 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 -179.482 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.475 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 49.0 p30 -64.26 -11.31 30.27 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.303 -1.116 . . . . 0.0 109.349 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.463 ' OD1' ' HB2' ' A' ' 31' ' ' GLN . 58.0 p30 -84.24 9.49 12.79 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.323 -0.861 . . . . 0.0 109.488 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 83.87 23.51 52.43 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.463 ' HB2' ' OD1' ' A' ' 29' ' ' ASP . 67.8 mt-30 -129.17 171.71 12.16 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.312 -1.11 . . . . 0.0 109.409 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.532 ' CG2' ' HA ' ' A' ' 57' ' ' LYS . 24.0 m -131.12 139.42 49.82 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.284 -0.885 . . . . 0.0 109.26 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.581 ' CD1' HD11 ' A' ' 39' ' ' LEU . 70.9 m-85 -118.68 131.62 56.16 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.277 -0.889 . . . . 0.0 109.416 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.496 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 53.5 t-20 -51.65 -79.09 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.374 -0.829 . . . . 0.0 110.174 -179.381 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.527 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 1.9 t-20 -81.39 149.41 65.21 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 120.932 -1.105 . . . . 0.0 109.597 -179.553 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.47 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.4 Cg_endo -63.28 -55.1 0.81 Allowed 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 122.685 2.257 . . . . 0.0 111.884 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.527 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 10.6 t -60.06 -33.22 71.76 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 120.996 -1.065 . . . . 0.0 108.128 178.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.463 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 39.7 mmm -55.63 -20.21 13.08 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.086 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.581 HD11 ' CD1' ' A' ' 33' ' ' TYR . 51.5 tp -68.48 -46.59 69.28 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.563 -0.711 . . . . 0.0 109.098 179.612 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.466 ' HB2' ' OH ' ' A' ' 16' ' ' TYR . 3.2 m -69.04 -21.25 64.12 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 179.15 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 41.0 t60 -67.21 -54.83 17.46 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 178.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.416 ' HA ' ' OE1' ' A' ' 42' ' ' GLU . 68.6 mm-40 -62.51 -19.99 64.16 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 178.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.527 ' O ' ' N ' ' A' ' 47' ' ' GLN . 83.1 m-20 -80.27 -24.27 40.2 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 23.3 tp -73.24 -31.82 64.35 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.1 mm -80.11 -48.2 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.381 -0.824 . . . . 0.0 108.937 179.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.467 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 63.7 mtt-85 -80.66 -33.79 35.31 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.267 -0.896 . . . . 0.0 109.353 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.527 ' N ' ' O ' ' A' ' 43' ' ' ASN . 91.7 mt-30 63.31 38.54 10.2 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.386 -0.822 . . . . 0.0 109.659 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 55.1 p -101.68 3.84 40.13 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.21 -0.931 . . . . 0.0 109.452 179.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 63.9 m-20 54.64 58.08 5.18 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.227 -0.921 . . . . 0.0 109.427 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 31.6 m -78.46 139.22 38.72 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.239 -0.913 . . . . 0.0 109.589 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 49.3 m-70 -113.63 167.38 10.66 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.303 -0.873 . . . . 0.0 108.893 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.491 HD11 HG22 ' A' ' 52' ' ' ILE . 36.9 mt -79.63 125.59 38.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.169 -0.957 . . . . 0.0 109.256 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.475 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 69.9 ttt-85 -81.3 -38.61 26.5 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.415 -0.803 . . . . 0.0 109.346 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -160.45 151.16 18.59 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.47 -0.769 . . . . 0.0 109.084 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.3 p -70.46 143.59 51.71 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.168 -0.958 . . . . 0.0 109.467 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.533 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 88.87 164.37 40.28 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.532 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 33.8 ttpt -54.53 151.08 8.31 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.474 -1.016 . . . . 0.0 109.442 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.454 ' SG ' ' OG1' ' A' ' 32' ' ' THR . 88.8 m -57.07 -179.71 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.247 -0.908 . . . . 0.0 109.446 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -93.73 19.84 8.27 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.179 -0.951 . . . . 0.0 109.711 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 66.9 tt0 -60.86 -35.85 77.64 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.253 -0.904 . . . . 0.0 109.356 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 24.7 p -58.96 144.99 43.24 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.346 -0.846 . . . . 0.0 109.502 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 40.8 m -115.81 153.45 31.44 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.252 -0.905 . . . . 0.0 109.447 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 62.6 p -86.66 130.73 47.85 Favored Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.298 -0.877 . . . . 0.0 109.514 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -70.69 -17.01 33.65 Favored 'Trans proline' 0 C--O 1.214 -0.679 0 C-N-CA 122.755 2.303 . . . . 0.0 111.83 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -55.07 -30.57 54.69 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 24.0 p -120.13 163.65 17.39 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.259 -1.142 . . . . 0.0 109.486 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 39.1 m -116.87 139.08 51.04 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.139 -0.976 . . . . 0.0 109.465 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.437 ' O ' ' HB2' ' A' ' 71' ' ' MET . . . -65.0 -28.13 69.3 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.248 -0.907 . . . . 0.0 109.473 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.414 ' O ' ' HD2' ' A' ' 72' ' ' PRO . . . -65.63 -31.84 73.09 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.228 -0.92 . . . . 0.0 109.459 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 87.2 p -65.56 -27.4 68.41 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.311 -0.868 . . . . 0.0 109.452 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.502 ' CB ' ' CD ' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -53.79 -61.41 5.26 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.314 -0.866 . . . . 0.0 109.495 -179.981 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.502 ' CD ' ' CB ' ' A' ' 71' ' ' MET . 50.1 Cg_endo -70.62 151.28 64.08 Favored 'Trans proline' 0 C--O 1.214 -0.71 0 C-N-CA 122.599 2.199 . . . . 0.0 111.75 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -70.74 143.73 46.93 Favored 'Trans proline' 0 C--O 1.215 -0.626 0 C-N-CA 122.668 2.245 . . . . 0.0 111.815 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 32.1 t -115.52 142.33 46.86 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.282 -0.886 . . . . 0.0 109.456 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 54.8 p30 -91.71 10.04 29.99 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.233 -0.917 . . . . 0.0 109.478 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.474 -179.971 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.395 0.617 . . . . 0.0 109.532 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.45 ' O ' ' N ' ' A' ' 5' ' ' CYS . 37.5 m -74.31 -0.67 17.81 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.47 -0.769 . . . . 0.0 109.632 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.459 ' O ' ' HG2' ' A' ' 6' ' ' LYS . 3.4 mt-10 -48.27 -23.81 1.0 Allowed 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.122 -0.987 . . . . 0.0 108.741 179.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 84.3 mtp -66.95 -29.14 68.91 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.377 -0.827 . . . . 0.0 108.797 179.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.571 ' SG ' ' CE1' ' A' ' 8' ' ' TYR . 10.6 t -84.19 -8.23 59.12 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.464 -0.772 . . . . 0.0 109.069 179.518 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.459 ' HG2' ' O ' ' A' ' 3' ' ' GLU . 3.7 pttp -57.46 -15.7 7.6 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.32 -0.863 . . . . 0.0 109.733 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 51.0 p-10 -159.03 32.66 0.21 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.043 -1.035 . . . . 0.0 109.811 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.571 ' CE1' ' SG ' ' A' ' 5' ' ' CYS . 5.1 p90 -79.71 175.61 10.47 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.119 -0.988 . . . . 0.0 109.194 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 53.7 mtm180 -143.98 136.43 26.85 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.145 -0.972 . . . . 0.0 109.911 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.418 HG12 ' C ' ' A' ' 15' ' ' GLY . 23.4 t -137.41 135.61 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.371 -0.83 . . . . 0.0 109.097 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.486 ' HB3' ' HD2' ' A' ' 12' ' ' PRO . 1.6 mp -102.83 172.4 4.33 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.231 -0.918 . . . . 0.0 109.701 -179.532 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.486 ' HD2' ' HB3' ' A' ' 11' ' ' LEU . 45.7 Cg_endo -67.68 -22.78 43.31 Favored 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 122.637 2.225 . . . . 0.0 111.563 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 82.1 mtt180 -99.8 -24.96 14.53 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.341 -0.849 . . . . 0.0 109.16 179.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 79.2 mt -85.34 -47.3 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.312 -0.867 . . . . 0.0 109.428 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.418 ' C ' HG12 ' A' ' 10' ' ' VAL . . . 71.58 -169.54 49.91 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.581 ' CB ' ' NE2' ' A' ' 41' ' ' HIS . 0.8 OUTLIER -92.36 150.2 20.97 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.259 -1.142 . . . . 0.0 109.591 -179.94 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.488 ' CD1' ' C ' ' A' ' 17' ' ' LEU . 2.3 tm? -119.66 105.35 11.1 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.254 -0.904 . . . . 0.0 109.309 179.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.424 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 58.5 m -118.75 155.64 52.39 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.305 -0.872 . . . . 0.0 109.305 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -72.42 171.73 16.43 Favored 'Trans proline' 0 C--O 1.215 -0.667 0 C-N-CA 122.618 2.212 . . . . 0.0 111.324 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 45.0 mttp -91.45 -23.32 20.04 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.213 -0.93 . . . . 0.0 109.355 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -62.34 130.49 45.52 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.339 -0.85 . . . . 0.0 109.179 179.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 24.0 tp -90.72 111.83 23.35 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.211 -0.931 . . . . 0.0 109.805 -179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.479 ' O ' ' O ' ' A' ' 34' ' ' ASN . 0.0 OUTLIER -123.28 108.64 31.71 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.324 -0.86 . . . . 0.0 108.87 179.637 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.526 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 43.6 Cg_endo -66.16 119.58 6.62 Favored 'Trans proline' 0 C--O 1.214 -0.713 0 C-N-CA 122.865 2.377 . . . . 0.0 112.052 -179.417 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.46 ' HB ' HG22 ' A' ' 52' ' ' ILE . 11.2 m -112.57 155.31 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.418 -0.801 . . . . 0.0 109.512 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.408 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 43.4 t -97.07 141.4 30.27 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -98.47 133.85 11.48 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 -179.365 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.487 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 37.5 p30 -61.83 -12.49 17.67 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.315 -1.109 . . . . 0.0 109.586 179.754 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.42 ' CG ' HG22 ' A' ' 50' ' ' THR . 73.3 m-20 -87.01 15.46 5.98 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.21 -0.931 . . . . 0.0 109.414 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 79.37 19.41 71.72 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.471 ' O ' ' SG ' ' A' ' 58' ' ' CYS . 44.5 mt-30 -120.95 179.33 4.4 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.152 -1.205 . . . . 0.0 109.496 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.496 ' CG2' ' HA ' ' A' ' 57' ' ' LYS . 14.5 m -143.36 137.2 28.57 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.264 -0.897 . . . . 0.0 109.557 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.569 ' CD1' HD13 ' A' ' 39' ' ' LEU . 41.2 m-85 -113.03 134.8 54.35 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.364 -0.835 . . . . 0.0 109.46 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.48 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 9.9 m-20 -54.16 -78.06 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.322 -0.861 . . . . 0.0 109.785 -179.652 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.53 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 4.1 t-20 -81.88 147.72 59.1 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.018 -1.051 . . . . 0.0 109.022 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.46 ' HD3' ' O ' ' A' ' 23' ' ' LYS . 41.7 Cg_endo -63.97 -52.55 1.63 Allowed 'Trans proline' 0 C--O 1.215 -0.629 0 C-N-CA 122.522 2.148 . . . . 0.0 111.758 -179.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.53 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 11.3 t -62.09 -29.03 70.03 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.078 -1.014 . . . . 0.0 108.324 179.021 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.48 ' HB2' ' HB3' ' A' ' 35' ' ' ASN . 35.3 mmm -69.04 -12.82 62.03 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.566 -0.709 . . . . 0.0 109.278 179.52 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.569 HD13 ' CD1' ' A' ' 33' ' ' TYR . 9.6 tt -67.97 -52.55 34.62 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.189 -0.945 . . . . 0.0 108.955 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.483 ' SG ' ' CE1' ' A' ' 8' ' ' TYR . 9.3 t -61.46 -34.17 74.99 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 179.19 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.581 ' NE2' ' CB ' ' A' ' 16' ' ' TYR . 0.2 OUTLIER -50.94 -46.69 61.03 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 178.51 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -66.11 -32.08 73.32 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.08 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.52 ' ND2' ' O ' ' A' ' 50' ' ' THR . 34.0 m-20 -68.74 -23.47 64.34 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.51 -0.744 . . . . 0.0 109.396 179.683 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.466 ' CD1' ' C ' ' A' ' 44' ' ' LEU . 2.4 tm? -72.2 -36.4 69.19 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.285 -0.884 . . . . 0.0 109.66 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.436 HD12 HD11 ' A' ' 44' ' ' LEU . 4.8 mm -78.04 -46.04 26.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.242 -0.911 . . . . 0.0 109.381 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.46 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 14.4 mtt-85 -81.73 -33.19 31.19 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.289 -0.882 . . . . 0.0 109.611 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.474 ' N ' ' O ' ' A' ' 43' ' ' ASN . 92.0 mt-30 62.49 33.76 15.83 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.272 -0.892 . . . . 0.0 109.63 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 58.9 p -95.65 7.43 46.31 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.224 -0.922 . . . . 0.0 109.415 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.577 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 57.8 t30 52.63 49.0 21.32 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.276 -0.89 . . . . 0.0 109.649 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.52 ' O ' ' ND2' ' A' ' 43' ' ' ASN . 39.4 m -80.78 149.05 29.78 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.37 -0.831 . . . . 0.0 109.359 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.577 ' CE1' ' O ' ' A' ' 49' ' ' ASN . 13.6 m80 -127.21 -176.76 3.82 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.189 -0.945 . . . . 0.0 109.348 179.688 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.499 HD11 HG22 ' A' ' 52' ' ' ILE . 29.4 mt -84.89 128.13 39.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 O-C-N 121.39 -0.819 . . . . 0.0 109.46 179.709 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.487 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 42.3 ttt85 -83.83 -38.55 21.08 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.321 -0.862 . . . . 0.0 109.059 179.765 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -160.75 148.83 16.08 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 27.0 p -67.17 135.97 54.33 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.123 -0.986 . . . . 0.0 109.462 -179.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.526 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 95.2 161.87 34.16 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.496 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 47.5 tttp -50.03 148.23 3.46 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.402 -1.058 . . . . 0.0 109.287 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.471 ' SG ' ' O ' ' A' ' 31' ' ' GLN . 95.6 m -51.43 -30.19 18.54 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.309 -0.869 . . . . 0.0 109.568 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -84.6 -30.4 25.02 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.304 -0.873 . . . . 0.0 109.13 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -60.39 -16.9 39.96 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.286 -0.884 . . . . 0.0 108.801 179.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 30.1 m -71.34 142.82 50.4 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.386 -0.822 . . . . 0.0 109.515 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 87.7 p -115.71 153.13 31.92 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.181 -0.949 . . . . 0.0 109.433 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.417 ' HB ' ' HD2' ' A' ' 64' ' ' PRO . 1.6 p -62.16 163.68 13.12 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.246 -0.908 . . . . 0.0 109.458 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.417 ' HD2' ' HB ' ' A' ' 63' ' ' THR . 52.5 Cg_endo -72.28 -20.81 24.05 Favored 'Trans proline' 0 C--O 1.215 -0.664 0 C-N-CA 122.598 2.198 . . . . 0.0 111.659 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.72 19.76 62.96 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 41.6 m -121.25 136.11 55.02 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.339 -1.095 . . . . 0.0 109.416 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 18.9 p -123.17 164.94 17.73 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.312 -0.867 . . . . 0.0 109.559 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -62.96 -33.53 75.57 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.327 -0.858 . . . . 0.0 109.522 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -144.48 155.11 43.56 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.339 -0.85 . . . . 0.0 109.44 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 25.1 m -60.08 -29.56 68.66 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.225 -0.922 . . . . 0.0 109.387 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 23.4 mtt -74.86 145.4 81.32 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.276 -0.89 . . . . 0.0 109.46 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -70.46 148.06 59.74 Favored 'Trans proline' 0 C--O 1.215 -0.644 0 C-N-CA 122.664 2.243 . . . . 0.0 111.834 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -71.94 -15.96 29.31 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 122.677 2.251 . . . . 0.0 111.742 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.447 ' O ' ' HG3' ' A' ' 76' ' ' GLU . 86.1 p -145.83 154.16 41.69 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.221 -0.924 . . . . 0.0 109.551 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -55.23 -36.29 65.86 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.215 -0.928 . . . . 0.0 109.471 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.447 ' HG3' ' O ' ' A' ' 74' ' ' SER . 96.7 mt-10 . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.509 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.568 ' OG ' ' CE1' ' A' ' 51' ' ' HIS . 2.1 m -55.46 -31.68 62.15 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.306 -0.871 . . . . 0.0 109.515 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -53.29 -25.61 15.38 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.327 -0.858 . . . . 0.0 109.023 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 82.8 mtp -73.84 -26.78 60.76 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.385 -0.822 . . . . 0.0 109.245 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.534 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 70.2 m -79.92 -20.77 44.93 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.324 -0.86 . . . . 0.0 109.217 179.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 33.4 mttt -80.63 7.46 10.06 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.194 -0.941 . . . . 0.0 109.391 179.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -123.18 -3.63 8.49 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.199 -0.938 . . . . 0.0 110.217 -179.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.687 ' CE2' ' CZ ' ' A' ' 16' ' ' TYR . 2.1 p90 -114.57 173.0 6.68 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.959 -1.088 . . . . 0.0 109.848 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 39.5 ptt180 -157.34 134.47 10.3 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.474 HG23 ' HA ' ' A' ' 16' ' ' TYR . 79.9 t -116.79 145.41 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.226 -0.921 . . . . 0.0 110.215 -179.071 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.536 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 2.1 mp -117.67 175.81 1.87 Allowed Pre-proline 0 N--CA 1.49 1.527 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.536 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 44.7 Cg_endo -67.56 -22.52 44.39 Favored 'Trans proline' 0 C--O 1.216 -0.621 0 C-N-CA 122.451 2.101 . . . . 0.0 111.81 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 63.1 mtt180 -113.63 -22.44 10.27 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.294 -0.879 . . . . 0.0 109.64 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.451 ' CD1' ' HB2' ' A' ' 11' ' ' LEU . 92.4 mt -78.23 -44.35 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.216 -0.927 . . . . 0.0 109.504 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.421 ' C ' HG12 ' A' ' 10' ' ' VAL . . . 74.94 -165.33 54.74 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.687 ' CZ ' ' CE2' ' A' ' 8' ' ' TYR . 0.9 OUTLIER -93.76 149.55 21.14 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.16 -1.2 . . . . 0.0 109.557 179.999 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 16.8 tp -119.61 115.54 24.18 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.288 -0.883 . . . . 0.0 109.688 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.4 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 75.6 m -126.07 156.8 71.38 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.292 -0.88 . . . . 0.0 109.177 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.436 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 50.5 Cg_endo -71.35 167.33 26.6 Favored 'Trans proline' 0 C--O 1.216 -0.59 0 C-N-CA 122.64 2.227 . . . . 0.0 111.685 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.4 mttt -86.59 -23.43 25.77 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.271 -0.893 . . . . 0.0 109.328 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -63.21 130.48 44.74 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.29 -0.881 . . . . 0.0 109.241 179.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 48.7 tp -93.83 117.47 30.14 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.184 -0.947 . . . . 0.0 109.541 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.487 ' O ' ' O ' ' A' ' 34' ' ' ASN . 0.1 OUTLIER -129.1 106.52 17.93 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.324 -0.86 . . . . 0.0 108.941 179.719 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.538 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 43.2 Cg_endo -65.1 119.91 7.04 Favored 'Trans proline' 0 C--O 1.213 -0.765 0 C-N-CA 122.93 2.42 . . . . 0.0 112.086 -179.564 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.455 ' HB ' HG22 ' A' ' 52' ' ' ILE . 35.6 m -116.5 153.74 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.336 -0.852 . . . . 0.0 109.688 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 43.0 t -96.05 135.52 37.72 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.354 -0.841 . . . . 0.0 108.787 179.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -92.44 139.12 14.51 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -179.585 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.492 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 50.9 p30 -68.5 -7.86 36.01 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.366 -1.079 . . . . 0.0 109.579 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.437 ' OD1' ' HB2' ' A' ' 31' ' ' GLN . 56.6 p30 -88.52 9.21 24.62 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.163 -0.961 . . . . 0.0 109.35 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.23 13.99 64.97 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.464 ' O ' ' N ' ' A' ' 27' ' ' GLY . 83.2 mt-30 -120.26 171.97 8.12 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.278 -1.131 . . . . 0.0 109.447 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.531 ' CG2' ' HA ' ' A' ' 57' ' ' LYS . 25.9 m -133.95 138.31 45.39 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.248 -0.908 . . . . 0.0 109.353 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.635 ' CE1' ' CD1' ' A' ' 39' ' ' LEU . 28.7 m-85 -113.0 128.5 56.52 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.28 -0.888 . . . . 0.0 109.205 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.487 ' O ' ' O ' ' A' ' 23' ' ' LYS . 13.1 m-20 -51.66 -78.17 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.239 -0.913 . . . . 0.0 109.692 -179.543 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.533 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 5.1 t-20 -81.85 147.9 59.69 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.171 -0.956 . . . . 0.0 109.688 -179.692 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.466 ' HD2' ' CG ' ' A' ' 35' ' ' ASN . 40.5 Cg_endo -63.22 -52.98 1.7 Allowed 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.766 2.311 . . . . 0.0 111.909 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.533 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 9.2 t -62.54 -28.36 69.8 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 120.97 -1.081 . . . . 0.0 108.11 178.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.457 ' CG ' ' HB3' ' A' ' 35' ' ' ASN . 49.7 mmm -64.75 -14.2 57.92 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.377 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.635 ' CD1' ' CE1' ' A' ' 33' ' ' TYR . 23.7 tp -71.68 -65.33 0.77 Allowed 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 179.284 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.456 ' HB3' ' OH ' ' A' ' 16' ' ' TYR . 8.5 t -49.25 -28.33 4.56 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 66.5 t60 -63.02 -62.54 1.64 Allowed 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 77.2 tt0 -59.13 -19.08 41.58 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.511 ' O ' ' N ' ' A' ' 47' ' ' GLN . 98.1 m-20 -78.16 -29.65 48.74 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.391 -0.818 . . . . 0.0 108.815 179.425 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 17.6 tp -72.37 -27.75 62.58 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.313 -0.867 . . . . 0.0 108.847 179.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.3 mt -79.87 -49.64 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.321 -0.862 . . . . 0.0 108.9 179.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.468 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 52.8 mtt180 -80.73 -32.82 35.58 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.338 -0.851 . . . . 0.0 109.307 179.749 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.511 ' N ' ' O ' ' A' ' 43' ' ' ASN . 92.1 mt-30 62.62 36.68 13.49 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.373 -0.829 . . . . 0.0 109.627 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 59.5 p -96.21 2.45 53.02 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.217 -0.927 . . . . 0.0 109.585 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.4 m120 58.0 54.76 5.75 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.251 -0.905 . . . . 0.0 109.449 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.411 HG21 ' N ' ' A' ' 51' ' ' HIS . 43.3 m -79.94 144.06 33.66 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.292 -0.88 . . . . 0.0 109.68 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.568 ' CE1' ' OG ' ' A' ' 2' ' ' SER . 30.5 m-70 -118.62 173.5 6.81 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.329 -0.857 . . . . 0.0 109.023 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.51 HD11 HG22 ' A' ' 52' ' ' ILE . 12.0 mt -84.38 123.99 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.16 -0.962 . . . . 0.0 109.472 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.492 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 45.2 ttt85 -79.75 -43.0 23.39 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.297 -0.877 . . . . 0.0 109.248 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.8 t -160.02 155.09 24.77 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.9 p -72.56 132.83 44.31 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.198 -0.939 . . . . 0.0 109.483 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.538 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 99.07 164.49 29.93 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -179.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.531 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 71.1 tttt -53.13 148.4 8.27 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.429 -1.042 . . . . 0.0 109.397 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.419 ' SG ' ' OG1' ' A' ' 32' ' ' THR . 91.2 m -54.81 -25.93 31.6 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.263 -0.898 . . . . 0.0 109.376 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 76.6 tt0 -86.06 -21.55 27.65 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.36 -0.838 . . . . 0.0 109.346 -179.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.425 ' OE1' ' HA2' ' A' ' 56' ' ' GLY . 71.7 tt0 -63.53 -34.35 77.59 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.299 -0.876 . . . . 0.0 109.372 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 32.6 t -71.34 135.96 47.59 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.382 -0.823 . . . . 0.0 109.449 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 23.3 t -117.67 153.18 33.76 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.194 -0.942 . . . . 0.0 109.559 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 37.4 m -134.55 78.71 55.71 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.322 -0.861 . . . . 0.0 109.457 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -69.59 -23.01 32.04 Favored 'Trans proline' 0 C--O 1.216 -0.617 0 C-N-CA 122.74 2.293 . . . . 0.0 111.714 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 59.31 -131.28 51.43 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 12.3 t -136.32 161.4 35.89 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.224 -1.162 . . . . 0.0 109.482 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.516 ' O ' ' CB ' ' A' ' 68' ' ' ALA . 53.0 m -59.45 -40.38 86.66 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.27 -0.894 . . . . 0.0 109.46 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.516 ' CB ' ' O ' ' A' ' 67' ' ' THR . . . 163.3 53.88 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.389 -0.819 . . . . 0.0 109.478 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.4 ' O ' ' HD3' ' A' ' 72' ' ' PRO . . . -62.54 -35.59 79.94 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.268 -0.895 . . . . 0.0 109.525 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.8 m -60.31 -31.07 69.92 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.182 -0.949 . . . . 0.0 109.475 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -128.3 78.9 74.93 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.281 -0.887 . . . . 0.0 109.43 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.4 ' HD3' ' O ' ' A' ' 69' ' ' ALA . 50.6 Cg_endo -70.32 152.96 66.72 Favored 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 122.697 2.264 . . . . 0.0 111.765 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -69.93 157.42 60.13 Favored 'Trans proline' 0 C--O 1.214 -0.69 0 C-N-CA 122.71 2.273 . . . . 0.0 111.66 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 87.5 p -82.83 -9.64 59.23 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.303 -0.873 . . . . 0.0 109.55 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 84.4 m-20 -73.3 -26.93 61.27 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.191 -0.943 . . . . 0.0 109.536 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 118.002 -0.999 . . . . 0.0 109.437 -179.997 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.2 m -46.47 -32.36 3.27 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.332 -0.855 . . . . 0.0 109.333 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.454 ' HA ' ' HG3' ' A' ' 6' ' ' LYS . 18.6 mt-10 -52.45 -28.59 20.72 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.742 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.402 ' HE1' ' HB2' ' A' ' 4' ' ' MET . 44.4 ttm -71.74 -26.21 62.37 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.441 -0.787 . . . . 0.0 108.951 179.53 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.584 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 15.6 m -79.56 -12.7 59.84 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.498 -0.751 . . . . 0.0 108.974 179.523 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.454 ' HG3' ' HA ' ' A' ' 3' ' ' GLU . 4.1 mtmp? -56.58 -24.54 48.1 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.255 -0.903 . . . . 0.0 109.714 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 64.8 m-20 -149.71 64.49 0.99 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.136 -0.978 . . . . 0.0 110.334 -179.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.597 ' CE2' ' CE2' ' A' ' 16' ' ' TYR . 5.0 p90 -131.44 170.25 14.94 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.045 -1.034 . . . . 0.0 109.359 179.259 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.406 ' HG3' ' N ' ' A' ' 10' ' ' VAL . 12.5 tpt180 -145.32 150.13 36.06 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.21 -0.932 . . . . 0.0 109.593 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.443 HG22 ' CD2' ' A' ' 16' ' ' TYR . 71.0 t -141.63 130.98 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.239 -0.913 . . . . 0.0 109.315 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.473 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 2.5 mp -118.56 172.86 3.8 Favored Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 121.321 -0.862 . . . . 0.0 109.317 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.473 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 46.5 Cg_endo -68.38 -24.96 36.34 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 122.575 2.184 . . . . 0.0 111.614 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 54.5 mtt180 -104.68 -26.04 12.46 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.262 -0.899 . . . . 0.0 109.254 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 87.9 mt -84.54 -46.88 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.267 -0.896 . . . . 0.0 109.41 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 77.73 -155.51 43.14 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.597 ' CE2' ' CE2' ' A' ' 8' ' ' TYR . 2.5 t80 -105.4 152.56 22.82 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.307 -1.114 . . . . 0.0 109.503 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 34.6 tp -113.74 119.21 36.6 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.231 -0.918 . . . . 0.0 109.725 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 75.9 m -130.15 157.22 77.76 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.316 -0.865 . . . . 0.0 109.603 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.474 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 52.5 Cg_endo -72.55 168.93 23.06 Favored 'Trans proline' 0 C--O 1.215 -0.629 0 C-N-CA 122.762 2.308 . . . . 0.0 111.591 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 41.3 mmtt -89.61 -13.09 37.9 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.203 -0.936 . . . . 0.0 109.334 179.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -67.98 131.8 46.14 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.296 -0.878 . . . . 0.0 109.38 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.494 ' CD1' ' C ' ' A' ' 22' ' ' LEU . 3.3 tm? -90.63 123.65 34.42 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.263 -0.898 . . . . 0.0 109.332 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.496 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 15.4 mttp -145.6 105.8 4.31 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.156 -0.965 . . . . 0.0 109.657 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.537 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 44.1 Cg_endo -65.85 120.84 8.08 Favored 'Trans proline' 0 C--O 1.214 -0.705 0 C-N-CA 123.116 2.544 . . . . 0.0 112.324 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.433 ' HB ' HG22 ' A' ' 52' ' ' ILE . 19.7 m -116.18 154.57 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.382 -0.824 . . . . 0.0 109.35 179.562 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.418 ' O ' ' N ' ' A' ' 53' ' ' ARG . 41.6 t -96.07 138.26 33.95 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 178.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -95.6 139.21 14.37 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.726 -1.349 . . . . 0.0 109.726 -179.285 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.472 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 48.5 p30 -65.38 -11.15 39.52 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.38 -1.07 . . . . 0.0 109.454 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.453 ' OD1' ' HB2' ' A' ' 31' ' ' GLN . 59.0 p30 -83.09 7.33 16.19 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.226 -0.921 . . . . 0.0 109.398 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.22 22.59 51.41 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.456 ' O ' ' SG ' ' A' ' 58' ' ' CYS . 75.5 mt-30 -129.3 175.37 8.79 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.291 -1.123 . . . . 0.0 109.375 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.543 ' CG2' ' HA ' ' A' ' 57' ' ' LYS . 13.0 m -131.83 140.21 49.07 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.258 -0.901 . . . . 0.0 109.816 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.63 ' CD2' ' CD1' ' A' ' 39' ' ' LEU . 44.7 m-85 -115.86 127.15 54.81 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.431 -0.793 . . . . 0.0 109.139 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.5 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 41.1 t-20 -49.01 -78.98 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.299 -0.876 . . . . 0.0 110.032 -179.425 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.542 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 4.6 t-20 -81.14 147.28 60.62 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 120.863 -1.148 . . . . 0.0 109.263 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.496 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.8 Cg_endo -63.44 -52.89 1.66 Allowed 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 122.701 2.267 . . . . 0.0 111.849 -179.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.542 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 5.8 t -61.78 -28.23 69.31 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 178.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.418 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 35.7 mmm -65.51 -12.45 52.88 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.292 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.63 ' CD1' ' CD2' ' A' ' 33' ' ' TYR . 8.4 tt -72.99 -57.63 3.9 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.284 -0.885 . . . . 0.0 108.849 179.602 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.519 ' O ' ' HB2' ' A' ' 43' ' ' ASN . 2.2 t -46.59 -45.18 18.74 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 179.064 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.474 ' ND1' ' HB2' ' A' ' 16' ' ' TYR . 13.9 t60 -48.46 -50.37 31.66 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.062 -1.024 . . . . 0.0 108.309 178.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.578 ' HG3' ' CE1' ' A' ' 33' ' ' TYR . 34.2 mm-40 -56.41 -19.21 13.87 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.567 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.519 ' HB2' ' O ' ' A' ' 40' ' ' CYS . 2.3 m-80 -78.59 -35.33 45.9 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 119.471 -0.892 . . . . 0.0 108.617 179.209 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.516 ' CD2' ' OH ' ' A' ' 8' ' ' TYR . 40.3 mt -72.07 -30.79 65.48 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.332 -0.855 . . . . 0.0 109.302 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.469 HG13 ' O ' ' A' ' 41' ' ' HIS . 2.5 mt -79.74 -51.12 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.279 -0.888 . . . . 0.0 109.378 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.457 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 93.3 mtt-85 -80.3 -32.92 38.0 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.337 -0.852 . . . . 0.0 109.267 179.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.49 ' N ' ' O ' ' A' ' 43' ' ' ASN . 91.9 mt-30 62.19 40.22 11.91 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.403 -0.811 . . . . 0.0 109.537 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 35.6 p -113.63 5.62 16.59 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.32 -0.863 . . . . 0.0 109.541 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.566 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 11.8 t-20 62.39 50.91 3.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.236 -0.915 . . . . 0.0 109.45 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.519 ' N ' ' OD1' ' A' ' 43' ' ' ASN . 99.6 m -78.87 134.7 36.91 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.298 -0.876 . . . . 0.0 109.729 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.566 ' CE1' ' O ' ' A' ' 49' ' ' ASN . 8.0 m80 -115.98 -170.13 1.73 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.218 -0.926 . . . . 0.0 109.167 179.558 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.483 HD11 HG22 ' A' ' 52' ' ' ILE . 20.4 mt -92.91 122.97 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.306 -0.872 . . . . 0.0 109.445 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.472 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 46.9 ttt-85 -81.1 -41.62 22.23 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.304 -0.872 . . . . 0.0 109.542 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.4 ' OG ' ' HB3' ' A' ' 61' ' ' SER . 2.0 p -160.45 145.01 14.33 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.543 -0.723 . . . . 0.0 109.505 -179.434 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 20.2 p -63.62 139.51 58.78 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.244 -0.91 . . . . 0.0 109.401 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.537 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 90.76 163.13 38.74 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.543 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 48.1 tttp -49.46 148.65 2.64 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.498 -1.001 . . . . 0.0 109.48 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.456 ' SG ' ' O ' ' A' ' 31' ' ' GLN . 57.8 m -51.51 -32.68 28.54 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.257 -0.902 . . . . 0.0 109.426 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -83.09 -34.37 26.17 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.348 -0.845 . . . . 0.0 108.782 179.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -58.72 -23.69 60.16 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.4 ' HB3' ' OG ' ' A' ' 54' ' ' SER . 60.0 p -72.08 142.54 49.21 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.304 -0.872 . . . . 0.0 109.567 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 43.8 m -112.95 144.14 43.04 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.258 -0.901 . . . . 0.0 109.38 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.26 74.2 21.69 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.218 -0.926 . . . . 0.0 109.573 -179.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -70.98 -20.02 29.58 Favored 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 122.665 2.243 . . . . 0.0 111.74 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.14 -166.96 41.05 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 58.9 p -73.13 -27.3 61.6 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.14 -1.212 . . . . 0.0 109.437 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.437 HG23 ' HB2' ' A' ' 69' ' ' ALA . 55.0 m -126.71 137.64 53.28 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.263 -0.898 . . . . 0.0 109.481 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -62.48 -30.81 71.53 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.323 -0.861 . . . . 0.0 109.532 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.437 ' HB2' HG23 ' A' ' 67' ' ' THR . . . -64.1 -28.67 69.93 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.226 -0.921 . . . . 0.0 109.454 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 28.9 m -57.73 -27.85 63.35 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.261 -0.899 . . . . 0.0 109.407 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.54 134.4 76.15 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.239 -0.913 . . . . 0.0 109.524 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -70.31 143.4 48.08 Favored 'Trans proline' 0 C--O 1.216 -0.602 0 C-N-CA 122.707 2.271 . . . . 0.0 111.822 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -70.27 143.11 47.41 Favored 'Trans proline' 0 C--O 1.215 -0.629 0 C-N-CA 122.768 2.312 . . . . 0.0 111.838 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 24.0 t -114.51 142.33 46.54 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.331 -0.855 . . . . 0.0 109.397 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 53.2 p30 -90.38 11.0 22.84 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.237 -0.914 . . . . 0.0 109.518 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.432 ' HG2' ' OXT' ' A' ' 76' ' ' GLU . 84.5 tt0 . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 118.065 -0.969 . . . . 0.0 109.449 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.498 ' N ' ' OD1' ' A' ' 1' ' ' ASP . 14.2 p-10 . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.489 ' O ' ' N ' ' A' ' 5' ' ' CYS . 1.7 m -43.18 -29.22 0.36 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.373 -0.829 . . . . 0.0 109.283 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.469 ' HA ' ' HG3' ' A' ' 6' ' ' LYS . 19.4 mt-10 -46.96 -29.85 2.26 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.434 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 92.8 mmm -80.47 -34.47 35.88 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.489 ' N ' ' O ' ' A' ' 2' ' ' SER . 3.8 m -80.03 4.58 16.61 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.457 -0.777 . . . . 0.0 109.109 179.258 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.469 ' HG3' ' HA ' ' A' ' 3' ' ' GLU . 14.2 mttm -57.65 -30.13 65.15 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.082 -1.011 . . . . 0.0 109.514 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -143.29 69.94 1.31 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.281 -0.887 . . . . 0.0 109.938 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.552 ' CD1' ' N ' ' A' ' 9' ' ' ARG . 18.4 p90 -115.04 -172.88 2.21 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.125 -0.985 . . . . 0.0 109.311 179.605 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.552 ' N ' ' CD1' ' A' ' 8' ' ' TYR . 86.0 mtt180 -149.64 145.57 26.82 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.189 -0.944 . . . . 0.0 109.466 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.457 HG21 ' O ' ' A' ' 9' ' ' ARG . 34.0 t -148.11 142.66 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.284 -0.885 . . . . 0.0 109.17 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.485 ' HB3' ' HD2' ' A' ' 12' ' ' PRO . 1.4 mp -116.13 171.93 4.24 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.204 -0.935 . . . . 0.0 109.844 -179.536 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.485 ' HD2' ' HB3' ' A' ' 11' ' ' LEU . 48.2 Cg_endo -68.45 -23.77 37.27 Favored 'Trans proline' 0 C--O 1.215 -0.659 0 C-N-CA 122.628 2.219 . . . . 0.0 111.73 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 53.0 mtt180 -100.27 -23.86 14.69 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.288 -0.882 . . . . 0.0 109.17 179.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 97.6 mt -88.84 -40.91 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.306 -0.871 . . . . 0.0 109.774 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 70.53 -174.92 37.95 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.49 ' HB2' ' CE1' ' A' ' 41' ' ' HIS . 1.3 t80 -81.61 154.78 25.98 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.17 -1.194 . . . . 0.0 109.417 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 34.0 tp -112.65 117.92 33.62 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.215 -0.928 . . . . 0.0 109.749 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 76.9 m -134.86 156.54 78.42 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.267 -0.896 . . . . 0.0 109.423 179.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.453 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 51.5 Cg_endo -71.4 168.79 22.5 Favored 'Trans proline' 0 C--O 1.215 -0.674 0 C-N-CA 122.692 2.261 . . . . 0.0 111.83 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -93.11 -3.89 53.29 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.263 -0.898 . . . . 0.0 109.52 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -79.08 130.16 35.22 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.212 -0.93 . . . . 0.0 109.307 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.487 ' CD1' ' C ' ' A' ' 22' ' ' LEU . 3.1 tm? -85.77 124.12 31.91 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.246 -0.909 . . . . 0.0 109.447 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.511 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 29.4 mttp -144.05 103.1 4.8 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.194 -0.941 . . . . 0.0 109.468 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.536 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 44.0 Cg_endo -65.35 121.92 9.48 Favored 'Trans proline' 0 C--O 1.214 -0.719 0 C-N-CA 123.133 2.555 . . . . 0.0 112.064 -179.689 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.462 ' HB ' HG22 ' A' ' 52' ' ' ILE . 13.9 m -120.26 154.86 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.272 -0.892 . . . . 0.0 110.05 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.423 ' O ' ' N ' ' A' ' 53' ' ' ARG . 13.3 t -99.95 131.52 45.87 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.034 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -89.23 138.83 14.9 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 -179.688 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.478 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 38.1 p30 -65.86 -10.05 34.63 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.357 -1.084 . . . . 0.0 109.66 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.4 ' OD2' ' OG1' ' A' ' 50' ' ' THR . 59.1 m-20 -85.64 10.55 13.02 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.241 -0.912 . . . . 0.0 109.44 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 81.9 27.65 45.06 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.442 ' O ' ' N ' ' A' ' 27' ' ' GLY . 94.1 mt-30 -131.04 161.31 32.29 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.289 -1.124 . . . . 0.0 109.384 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.509 HG22 ' CB ' ' A' ' 57' ' ' LYS . 98.8 m -122.35 135.04 54.64 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.134 -0.979 . . . . 0.0 109.36 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.562 ' CG ' HD11 ' A' ' 39' ' ' LEU . 47.8 m-85 -116.45 125.2 51.65 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.312 -0.867 . . . . 0.0 109.293 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.5 ' O ' ' O ' ' A' ' 23' ' ' LYS . 40.2 t-20 -48.56 -79.76 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.393 -0.817 . . . . 0.0 109.97 -179.386 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.533 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 5.4 t-20 -80.9 146.96 60.7 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 120.851 -1.156 . . . . 0.0 109.415 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.511 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.1 Cg_endo -62.7 -53.13 1.87 Allowed 'Trans proline' 0 C--O 1.216 -0.594 0 C-N-CA 122.902 2.401 . . . . 0.0 111.875 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.533 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 8.9 t -62.75 -27.9 69.6 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.005 -1.059 . . . . 0.0 108.212 178.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.46 ' HB2' ' HB3' ' A' ' 35' ' ' ASN . 28.1 mmm -64.54 -11.86 38.7 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.124 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.562 HD11 ' CG ' ' A' ' 33' ' ' TYR . 20.4 tp -69.88 -54.07 15.15 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.324 -0.86 . . . . 0.0 109.079 179.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.454 ' HA ' ' HB2' ' A' ' 43' ' ' ASN . 3.5 m -63.28 -14.26 47.53 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 119.021 -1.072 . . . . 0.0 108.253 179.087 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.49 ' CE1' ' HB2' ' A' ' 16' ' ' TYR . 19.5 t60 -67.26 -55.15 15.16 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 178.711 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 49.8 tt0 -67.19 -20.37 65.7 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.017 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.477 ' O ' ' N ' ' A' ' 47' ' ' GLN . 91.7 m-20 -76.26 -31.5 58.33 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.524 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.418 HD11 ' OH ' ' A' ' 8' ' ' TYR . 22.3 tp -67.48 -30.56 70.29 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.287 -0.883 . . . . 0.0 108.653 179.363 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -77.73 -44.74 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.451 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.461 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 60.0 mtt-85 -80.21 -19.33 47.26 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.393 -0.817 . . . . 0.0 109.175 179.669 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.477 ' N ' ' O ' ' A' ' 43' ' ' ASN . 91.1 mt-30 63.51 37.9 10.18 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.466 -0.771 . . . . 0.0 109.653 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 13.0 p -116.07 173.05 6.78 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.268 -0.895 . . . . 0.0 109.322 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -107.99 60.89 0.61 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.211 -0.931 . . . . 0.0 109.475 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.4 ' OG1' ' OD2' ' A' ' 29' ' ' ASP . 44.9 m -74.81 136.12 41.63 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.269 -0.895 . . . . 0.0 109.546 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 61.3 m-70 -115.01 173.27 6.57 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.247 -0.908 . . . . 0.0 109.229 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.462 HG22 ' HB ' ' A' ' 25' ' ' VAL . 20.0 mt -79.63 124.24 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.211 -0.93 . . . . 0.0 109.28 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.478 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 44.1 ttt180 -80.52 -47.48 14.19 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.352 -0.842 . . . . 0.0 109.367 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -154.07 149.22 26.92 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.488 -0.757 . . . . 0.0 109.115 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 27.5 p -66.45 143.48 57.08 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.209 -0.932 . . . . 0.0 109.567 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.536 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 90.44 167.35 41.76 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -179.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.509 ' CB ' HG22 ' A' ' 32' ' ' THR . 43.4 mttt -76.19 120.98 22.21 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.303 -1.116 . . . . 0.0 109.477 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.408 ' C ' ' O ' ' A' ' 57' ' ' LYS . 0.5 OUTLIER -45.02 -35.26 2.85 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.266 -0.896 . . . . 0.0 109.621 179.736 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -82.23 -21.36 36.39 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.331 -0.856 . . . . 0.0 109.465 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.494 ' N ' ' O ' ' A' ' 57' ' ' LYS . 28.6 tt0 -55.54 -19.37 9.72 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.509 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 93.9 p -68.61 -33.22 73.67 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.286 -0.884 . . . . 0.0 109.735 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 7.5 t -108.49 149.41 28.85 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.281 -0.887 . . . . 0.0 109.627 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.519 ' CG2' ' HA ' ' A' ' 68' ' ' ALA . 69.4 p -65.85 147.6 98.68 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.213 -0.929 . . . . 0.0 109.404 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -71.16 -14.85 31.92 Favored 'Trans proline' 0 C--O 1.215 -0.636 0 C-N-CA 122.702 2.268 . . . . 0.0 111.827 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.489 ' HA2' ' CB ' ' A' ' 70' ' ' SER . . . -88.5 -176.6 47.16 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 69.1 p -74.6 -25.13 59.05 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.245 -1.15 . . . . 0.0 109.425 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 13.6 p -128.17 164.93 21.44 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.222 -0.924 . . . . 0.0 109.425 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.519 ' HA ' ' CG2' ' A' ' 63' ' ' THR . . . -67.56 -26.97 66.56 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.188 -0.945 . . . . 0.0 109.499 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.25 -24.18 67.57 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.201 -0.937 . . . . 0.0 109.479 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.489 ' CB ' ' HA2' ' A' ' 65' ' ' GLY . 36.7 m -58.0 -28.39 64.37 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.223 -0.923 . . . . 0.0 109.525 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.421 ' HB2' HG23 ' A' ' 63' ' ' THR . 0.0 OUTLIER -69.22 146.48 96.85 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.326 -0.859 . . . . 0.0 109.55 -179.955 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -70.47 144.55 50.55 Favored 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 122.66 2.24 . . . . 0.0 111.724 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -70.62 0.32 6.47 Favored 'Trans proline' 0 C--O 1.214 -0.68 0 C-N-CA 122.748 2.299 . . . . 0.0 111.866 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 41.8 m -140.54 138.7 34.72 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.219 -0.926 . . . . 0.0 109.558 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -51.72 -35.43 43.06 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.326 -0.859 . . . . 0.0 109.52 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 117.972 -1.013 . . . . 0.0 109.568 -179.991 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.578 ' HB2' ' CE1' ' A' ' 51' ' ' HIS . 3.6 m -48.36 -28.8 3.41 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.174 -0.953 . . . . 0.0 109.48 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.473 ' HA ' ' HG3' ' A' ' 6' ' ' LYS . 16.5 mt-10 -48.97 -27.41 3.13 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.714 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 82.6 mmm -76.48 -29.96 57.07 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.495 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 3.9 m -79.88 -7.97 59.03 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.38 -0.825 . . . . 0.0 109.321 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.473 ' HG3' ' HA ' ' A' ' 3' ' ' GLU . 26.3 mttm -58.79 -23.21 59.91 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.213 -0.929 . . . . 0.0 110.039 -179.767 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 61.9 t0 -150.1 64.46 0.97 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.079 -1.013 . . . . 0.0 110.37 -179.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.495 ' CD1' ' HA ' ' A' ' 5' ' ' CYS . 4.7 p90 -131.65 168.07 18.36 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.11 -0.994 . . . . 0.0 109.123 179.11 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 48.2 mtt180 -144.8 140.87 28.74 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.182 -0.949 . . . . 0.0 109.719 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.526 HG22 ' CD2' ' A' ' 16' ' ' TYR . 55.0 t -135.31 127.9 47.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.264 -0.898 . . . . 0.0 109.471 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.483 ' HB3' ' HD2' ' A' ' 12' ' ' PRO . 7.2 mp -114.81 168.17 8.53 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.275 -0.89 . . . . 0.0 109.312 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.483 ' HD2' ' HB3' ' A' ' 11' ' ' LEU . 43.0 Cg_endo -66.43 -24.63 49.36 Favored 'Trans proline' 0 C--O 1.216 -0.609 0 C-N-CA 122.479 2.119 . . . . 0.0 111.409 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 79.2 mtt-85 -98.71 -27.55 13.92 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.344 -0.848 . . . . 0.0 108.857 179.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 25.4 mm -87.67 -44.68 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.416 -0.803 . . . . 0.0 109.337 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.0 -165.43 54.82 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.526 ' CD2' HG22 ' A' ' 10' ' ' VAL . 1.9 t80 -100.03 149.76 23.15 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.238 -1.154 . . . . 0.0 109.44 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.471 ' O ' ' SG ' ' A' ' 37' ' ' CYS . 3.0 mm? -111.01 135.51 51.4 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.288 -0.883 . . . . 0.0 109.453 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.449 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 85.6 m -147.12 157.71 45.72 Favored Pre-proline 0 N--CA 1.492 1.662 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.401 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 47.4 Cg_endo -70.82 165.59 31.69 Favored 'Trans proline' 0 C--O 1.215 -0.653 0 C-N-CA 122.448 2.099 . . . . 0.0 111.596 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.3 tptp -84.58 -29.45 25.81 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.3 -0.875 . . . . 0.0 109.539 -179.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -58.49 126.11 26.18 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.28 -0.888 . . . . 0.0 109.381 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 60.4 tp -90.0 116.99 28.46 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.2 -0.937 . . . . 0.0 109.494 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.502 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 3.5 mttp -128.36 106.45 19.4 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.153 -0.967 . . . . 0.0 109.203 179.754 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.532 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 42.6 Cg_endo -64.79 122.62 10.51 Favored 'Trans proline' 0 C--O 1.214 -0.692 0 C-N-CA 123.036 2.49 . . . . 0.0 112.166 -179.404 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.468 ' O ' HG21 ' A' ' 32' ' ' THR . 17.3 m -118.19 154.26 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.318 -0.864 . . . . 0.0 109.934 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.426 ' SG ' ' HB3' ' A' ' 53' ' ' ARG . 41.4 t -97.78 138.06 35.71 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -92.35 140.37 15.1 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.911 -1.276 . . . . 0.0 109.911 -179.28 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.489 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 53.6 p30 -69.48 -11.37 60.77 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.305 -1.114 . . . . 0.0 109.436 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.451 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 57.0 p30 -89.57 10.43 23.01 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.303 -0.873 . . . . 0.0 109.593 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.59 18.95 57.7 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.47 ' O ' ' N ' ' A' ' 27' ' ' GLY . 90.0 mt-30 -119.32 170.17 9.34 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.329 -1.1 . . . . 0.0 109.385 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.518 HG22 ' CB ' ' A' ' 57' ' ' LYS . 54.7 m -134.04 134.25 42.16 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.199 -0.938 . . . . 0.0 109.3 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.587 ' CG ' HD11 ' A' ' 39' ' ' LEU . 38.4 m-85 -114.57 131.04 56.81 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.262 -0.899 . . . . 0.0 109.221 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.5 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 10.1 m-20 -55.7 -78.4 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.287 -0.883 . . . . 0.0 109.676 -179.661 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.519 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 7.1 t-20 -81.96 147.1 57.18 Favored Pre-proline 0 C--N 1.301 -1.527 0 O-C-N 120.927 -1.108 . . . . 0.0 109.645 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.502 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.2 Cg_endo -62.7 -52.07 2.64 Favored 'Trans proline' 0 C--O 1.216 -0.617 0 C-N-CA 122.753 2.302 . . . . 0.0 111.811 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.519 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 8.6 t -61.38 -29.99 70.26 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 120.882 -1.136 . . . . 0.0 108.046 178.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 13.0 mtt -63.87 -12.91 40.61 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.587 HD11 ' CG ' ' A' ' 33' ' ' TYR . 29.3 tp -68.04 -54.33 19.11 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 10.9 t -62.12 -22.43 65.81 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.414 ' CE1' ' HB2' ' A' ' 16' ' ' TYR . 37.4 t60 -69.7 -57.33 5.27 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.315 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.46 ' OE1' ' CD2' ' A' ' 33' ' ' TYR . 82.1 tt0 -63.61 -20.27 65.53 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 179.267 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.507 ' O ' ' N ' ' A' ' 47' ' ' GLN . 96.5 m-20 -75.42 -32.21 60.63 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.514 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.482 ' CD1' ' C ' ' A' ' 44' ' ' LEU . 2.8 tm? -65.82 -38.16 88.17 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.32 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.473 HD12 ' N ' ' A' ' 45' ' ' ILE . 4.6 mm -69.76 -43.16 80.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.392 -0.818 . . . . 0.0 108.953 179.481 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.463 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 73.2 mtt-85 -79.73 -23.37 42.36 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.415 -0.803 . . . . 0.0 109.098 179.692 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.507 ' N ' ' O ' ' A' ' 43' ' ' ASN . 92.6 mt-30 63.0 45.33 5.37 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.374 -0.829 . . . . 0.0 109.353 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.1 p -128.53 159.17 36.31 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.302 -0.874 . . . . 0.0 109.374 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.418 ' O ' ' CG ' ' A' ' 49' ' ' ASN . 47.6 p-10 -91.49 59.49 3.84 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.169 -0.957 . . . . 0.0 109.301 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 81.6 m -72.36 141.95 48.77 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.352 -0.843 . . . . 0.0 109.843 -179.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.578 ' CE1' ' HB2' ' A' ' 2' ' ' SER . 62.6 m-70 -122.44 171.62 8.95 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.275 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.471 HD11 HG22 ' A' ' 52' ' ' ILE . 29.2 mt -79.72 126.85 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.075 -1.016 . . . . 0.0 109.581 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.489 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 67.2 ttt-85 -80.07 -44.63 19.72 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.447 -0.783 . . . . 0.0 109.035 179.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.4 t -160.23 155.59 25.14 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.706 -0.849 . . . . 0.0 108.706 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 26.1 p -67.5 140.22 57.03 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.091 -1.005 . . . . 0.0 109.314 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.532 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 94.89 169.04 36.59 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.167 -1.573 . . . . 0.0 109.167 -179.748 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.518 ' CB ' HG22 ' A' ' 32' ' ' THR . 44.8 mttp -68.1 144.62 54.97 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.304 -1.116 . . . . 0.0 109.446 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.461 ' SG ' ' O ' ' A' ' 31' ' ' GLN . 73.9 m -49.54 -27.46 4.43 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.254 -0.904 . . . . 0.0 109.289 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.46 ' O ' ' O ' ' A' ' 62' ' ' SER . 82.5 tt0 -84.21 -25.42 29.51 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.301 -0.874 . . . . 0.0 109.485 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.404 ' OE1' ' HA2' ' A' ' 56' ' ' GLY . 63.2 tt0 -66.37 -30.37 70.74 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.226 -0.921 . . . . 0.0 109.429 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 21.1 m -63.43 -37.75 88.51 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.247 -0.908 . . . . 0.0 109.754 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.46 ' O ' ' O ' ' A' ' 59' ' ' GLU . 46.4 m -115.88 148.07 40.39 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.168 -0.958 . . . . 0.0 109.688 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -65.26 158.52 71.9 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.214 -0.929 . . . . 0.0 109.394 179.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.424 ' HB2' HG22 ' A' ' 66' ' ' THR . 48.6 Cg_endo -69.63 -20.61 35.21 Favored 'Trans proline' 0 C--O 1.215 -0.673 0 C-N-CA 122.618 2.212 . . . . 0.0 111.77 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 91.01 7.75 65.59 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.424 HG22 ' HB2' ' A' ' 64' ' ' PRO . 71.9 p -68.5 -22.69 64.53 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.291 -1.123 . . . . 0.0 109.509 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.438 ' O ' ' OG ' ' A' ' 70' ' ' SER . 59.6 p -69.71 -22.89 63.36 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.198 -0.939 . . . . 0.0 109.533 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -62.11 -32.77 73.38 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.257 -0.902 . . . . 0.0 109.466 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.411 ' C ' ' HD2' ' A' ' 72' ' ' PRO . . . -65.85 -27.04 67.94 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.26 -0.9 . . . . 0.0 109.463 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.438 ' OG ' ' O ' ' A' ' 67' ' ' THR . 85.3 p -68.41 -27.64 66.38 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.331 -0.856 . . . . 0.0 109.542 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.483 ' N ' ' HD2' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -53.61 -59.52 9.33 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.244 -0.91 . . . . 0.0 109.491 179.995 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.483 ' HD2' ' N ' ' A' ' 71' ' ' MET . 49.9 Cg_endo -70.1 150.84 66.73 Favored 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 122.651 2.234 . . . . 0.0 111.8 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -69.36 -23.16 32.92 Favored 'Trans proline' 0 C--O 1.215 -0.625 0 C-N-CA 122.706 2.271 . . . . 0.0 111.78 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 49.1 m -129.01 142.33 50.95 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.264 -0.897 . . . . 0.0 109.447 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -58.62 -36.59 74.3 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.306 -0.871 . . . . 0.0 109.538 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 118.004 -0.998 . . . . 0.0 109.519 179.998 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.41 ' O ' ' C ' ' A' ' 2' ' ' SER . 72.5 m-20 . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 . . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.449 ' OG ' ' HA ' ' A' ' 51' ' ' HIS . 3.5 m -44.71 -33.42 1.85 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.291 -0.881 . . . . 0.0 109.475 179.932 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.433 ' HA ' ' HG3' ' A' ' 6' ' ' LYS . 21.1 mt-10 -51.31 -28.98 13.55 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.311 -0.868 . . . . 0.0 108.711 179.728 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 66.0 mtt -78.33 -32.13 49.03 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 179.389 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.421 ' HB3' ' HB3' ' A' ' 40' ' ' CYS . 3.7 m -83.19 1.63 39.69 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.341 -0.849 . . . . 0.0 109.114 179.388 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.433 ' HG3' ' HA ' ' A' ' 3' ' ' GLU . 14.2 mttm -61.89 -31.74 72.05 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.138 -0.976 . . . . 0.0 109.416 179.994 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -145.21 68.54 1.23 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.212 -0.93 . . . . 0.0 109.952 -179.893 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.463 ' CE2' ' CE2' ' A' ' 16' ' ' TYR . 13.9 p90 -119.03 -171.23 2.06 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.175 -0.953 . . . . 0.0 109.19 179.524 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 21.4 ttt180 -150.83 152.32 33.58 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.232 -0.918 . . . . 0.0 109.747 -179.999 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 45.4 t -148.63 131.46 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.293 -0.88 . . . . 0.0 109.46 179.839 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.521 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -104.26 174.86 2.47 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.253 -0.905 . . . . 0.0 109.249 179.81 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.521 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 45.8 Cg_endo -67.48 -24.62 42.26 Favored 'Trans proline' 0 C--O 1.215 -0.667 0 C-N-CA 122.706 2.271 . . . . 0.0 112.056 -179.995 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -96.62 -28.23 14.44 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.29 -0.881 . . . . 0.0 109.41 179.966 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 89.9 mt -83.05 -45.77 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.302 -0.874 . . . . 0.0 109.598 -179.916 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 68.66 -168.74 42.74 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 179.997 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.463 ' CE2' ' CE2' ' A' ' 8' ' ' TYR . 1.4 t80 -95.33 149.25 21.56 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.212 -1.169 . . . . 0.0 109.645 -179.907 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.492 ' CD1' ' C ' ' A' ' 17' ' ' LEU . 2.3 tm? -111.24 112.21 23.82 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.287 -0.883 . . . . 0.0 109.163 179.873 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.427 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 62.0 m -128.63 155.77 78.47 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.26 -0.9 . . . . 0.0 109.608 -179.896 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -71.28 168.52 23.17 Favored 'Trans proline' 0 C--O 1.215 -0.675 0 C-N-CA 122.694 2.263 . . . . 0.0 111.526 179.781 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 25.4 mttm -91.09 -14.92 30.34 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.219 -0.926 . . . . 0.0 109.639 -179.828 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 51.3 t0 -72.3 119.48 16.56 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.246 -0.908 . . . . 0.0 109.349 179.866 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.436 HD12 ' HB3' ' A' ' 34' ' ' ASN . 52.4 tp -79.59 113.64 17.9 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.199 -0.938 . . . . 0.0 109.646 -179.944 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.481 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -127.5 110.12 20.96 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.211 -0.931 . . . . 0.0 109.079 179.738 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.553 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 42.6 Cg_endo -64.66 122.48 10.36 Favored 'Trans proline' 0 C--O 1.213 -0.774 0 C-N-CA 122.943 2.428 . . . . 0.0 112.203 -179.715 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.456 ' O ' HG21 ' A' ' 32' ' ' THR . 18.8 m -119.31 154.71 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.283 -0.886 . . . . 0.0 109.4 179.785 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.436 ' SG ' ' HB3' ' A' ' 53' ' ' ARG . 39.7 t -96.56 142.71 28.3 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 178.598 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -95.69 139.43 14.49 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 -179.859 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.462 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 55.0 t0 -69.29 -6.18 27.84 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.234 -1.157 . . . . 0.0 109.592 -179.781 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.434 ' OD2' ' OG1' ' A' ' 50' ' ' THR . 41.7 m-20 -90.87 0.87 57.37 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.149 -0.969 . . . . 0.0 109.548 179.913 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.43 24.61 15.74 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.634 -1.387 . . . . 0.0 109.634 179.935 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.519 ' O ' ' N ' ' A' ' 27' ' ' GLY . 81.5 mt-30 -131.84 164.17 26.65 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.292 -1.122 . . . . 0.0 109.279 -179.982 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.511 ' CG2' ' HG3' ' A' ' 57' ' ' LYS . 12.0 m -121.03 150.32 41.34 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.123 -0.985 . . . . 0.0 109.384 179.797 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.588 ' CE1' ' HG3' ' A' ' 42' ' ' GLU . 36.7 m-85 -128.74 131.75 47.89 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.341 -0.849 . . . . 0.0 109.253 -179.909 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.469 ' O ' ' O ' ' A' ' 23' ' ' LYS . 11.8 m-20 -51.75 -78.77 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.358 -0.839 . . . . 0.0 109.889 -179.429 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.534 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 5.8 t-20 -82.01 147.7 58.55 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.104 -0.997 . . . . 0.0 109.827 -179.789 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.481 ' HD3' ' O ' ' A' ' 23' ' ' LYS . 41.7 Cg_endo -64.04 -52.76 1.49 Allowed 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 122.777 2.318 . . . . 0.0 111.606 179.826 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.534 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 11.6 t -62.2 -30.01 70.78 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.969 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.483 ' CG ' ' HB3' ' A' ' 35' ' ' ASN . 29.3 mtt -65.3 -16.12 63.24 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.435 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.584 ' CD1' ' CD2' ' A' ' 33' ' ' TYR . 8.0 tt -69.07 -52.87 24.02 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.34 -0.85 . . . . 0.0 108.899 179.71 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.513 ' O ' ' HB2' ' A' ' 43' ' ' ASN . 14.4 m -51.0 -39.66 56.3 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.424 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 13.3 t60 -49.2 -45.12 43.82 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.851 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.588 ' HG3' ' CE1' ' A' ' 33' ' ' TYR . 45.4 mm-40 -61.73 -20.99 64.12 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.263 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.524 ' O ' ' N ' ' A' ' 47' ' ' GLN . 2.5 m-80 -76.69 -31.33 57.17 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 119.694 -0.803 . . . . 0.0 109.034 179.508 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.486 ' CD1' ' C ' ' A' ' 44' ' ' LEU . 1.7 tm? -70.22 -36.46 74.55 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.265 -0.897 . . . . 0.0 109.396 179.932 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 6.4 mt -74.87 -51.46 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.258 -0.901 . . . . 0.0 109.554 -179.896 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.488 ' NH2' ' OE1' ' A' ' 42' ' ' GLU . 40.8 mtt85 -81.12 -36.74 29.92 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.299 -0.875 . . . . 0.0 109.842 -179.653 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.524 ' N ' ' O ' ' A' ' 43' ' ' ASN . 92.6 mt-30 63.07 34.05 14.13 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.309 -0.869 . . . . 0.0 109.554 -179.809 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.469 ' O ' ' HB2' ' A' ' 49' ' ' ASN . 38.9 p -103.74 7.51 37.24 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.276 -0.89 . . . . 0.0 109.486 179.956 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.536 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 65.6 m-20 63.59 47.98 3.56 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.192 -0.942 . . . . 0.0 109.469 -179.895 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.524 ' N ' ' OD1' ' A' ' 43' ' ' ASN . 71.1 m -80.3 125.75 30.28 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.395 -0.815 . . . . 0.0 109.366 179.752 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.536 ' CE1' ' O ' ' A' ' 49' ' ' ASN . 7.2 m80 -109.71 -171.09 1.77 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.124 -0.985 . . . . 0.0 109.459 179.822 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.522 HD11 HG22 ' A' ' 52' ' ' ILE . 43.6 mt -87.04 126.56 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.408 -0.808 . . . . 0.0 109.557 179.934 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.462 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 21.7 ttt85 -79.63 -46.4 17.27 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.446 -0.784 . . . . 0.0 109.275 179.841 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 95.3 p -158.31 138.84 12.71 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -179.72 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 20.8 p -56.02 151.33 12.13 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.134 -0.979 . . . . 0.0 109.49 -179.839 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.553 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 74.73 161.91 8.87 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 -179.595 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.511 ' HG3' ' CG2' ' A' ' 32' ' ' THR . 25.8 tttp -59.6 145.02 46.0 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.424 -1.045 . . . . 0.0 109.144 179.96 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -61.72 -35.37 77.88 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.257 -0.902 . . . . 0.0 109.526 -179.846 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -81.27 -22.79 38.41 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.503 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.463 ' CB ' ' HB3' ' A' ' 57' ' ' LYS . 32.7 tt0 -66.9 -19.05 65.66 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.838 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 94.6 p -79.03 -25.51 43.23 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.409 -0.807 . . . . 0.0 109.728 -179.846 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 60.0 p -69.36 158.65 34.67 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.197 -0.94 . . . . 0.0 109.57 -179.85 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.434 HG23 ' HB3' ' A' ' 71' ' ' MET . 15.9 p -57.81 154.55 26.61 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.239 -0.913 . . . . 0.0 109.532 179.99 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.484 ' CD ' ' HB1' ' A' ' 69' ' ' ALA . 49.3 Cg_endo -69.6 -14.14 36.13 Favored 'Trans proline' 0 C--O 1.215 -0.666 0 C-N-CA 122.721 2.28 . . . . 0.0 111.768 179.957 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 91.43 10.05 62.48 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.947 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 18.8 p -122.38 159.51 27.35 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.266 -1.138 . . . . 0.0 109.449 179.966 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 41.8 p -73.44 -15.04 61.35 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.299 -0.875 . . . . 0.0 109.416 -179.966 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -66.2 -29.99 70.37 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.319 -0.863 . . . . 0.0 109.41 -179.984 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.484 ' HB1' ' CD ' ' A' ' 64' ' ' PRO . . . -60.66 142.99 55.07 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.221 -0.925 . . . . 0.0 109.498 179.959 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 33.0 t -59.48 -33.23 71.06 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.359 -0.838 . . . . 0.0 109.508 -179.928 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.434 ' HB3' HG23 ' A' ' 63' ' ' THR . 0.0 OUTLIER -64.27 153.0 87.16 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.262 -0.899 . . . . 0.0 109.531 -179.945 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -69.99 149.63 65.68 Favored 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 122.824 2.349 . . . . 0.0 111.873 -179.923 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -69.75 165.56 30.53 Favored 'Trans proline' 0 C--O 1.214 -0.681 0 C-N-CA 122.706 2.271 . . . . 0.0 111.797 179.928 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 91.2 p -86.56 -11.67 50.9 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.25 -0.907 . . . . 0.0 109.497 -179.907 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.46 ' O ' ' HB2' ' A' ' 76' ' ' GLU . 22.6 t70 -89.73 117.98 28.99 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.201 -0.937 . . . . 0.0 109.497 179.987 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.46 ' HB2' ' O ' ' A' ' 75' ' ' ASP . 73.3 mm-40 . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 118.021 -0.99 . . . . 0.0 109.481 179.967 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 . . . . . 0 N--CA 1.489 1.507 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.408 ' O ' ' N ' ' A' ' 5' ' ' CYS . 5.7 m -56.85 -34.95 68.31 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.256 -0.902 . . . . 0.0 109.514 179.931 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -52.28 -26.61 12.4 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.265 -0.897 . . . . 0.0 108.779 179.819 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 90.7 mtp -75.1 -27.42 59.86 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.325 -0.86 . . . . 0.0 108.856 179.316 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.592 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 19.9 m -80.32 -12.64 59.58 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.477 -0.765 . . . . 0.0 109.251 179.892 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.459 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 26.3 mttt -80.96 6.41 13.45 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.148 -0.97 . . . . 0.0 109.816 179.831 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.459 ' OD1' ' O ' ' A' ' 6' ' ' LYS . 96.3 m-20 -139.13 15.22 2.63 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.005 -1.06 . . . . 0.0 110.416 -179.387 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.686 ' CE2' ' CE2' ' A' ' 16' ' ' TYR . 1.0 OUTLIER -122.69 151.38 41.59 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.913 -1.117 . . . . 0.0 109.533 179.846 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 91.3 mtt180 -129.06 136.05 49.73 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.402 -0.811 . . . . 0.0 109.119 179.693 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.532 HG22 ' CE2' ' A' ' 8' ' ' TYR . 49.7 t -127.16 148.43 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.246 -0.909 . . . . 0.0 109.499 -179.628 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.53 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.2 OUTLIER -123.65 175.12 2.99 Favored Pre-proline 0 N--CA 1.488 1.458 0 O-C-N 121.233 -0.917 . . . . 0.0 109.621 -179.689 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.53 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 45.1 Cg_endo -67.76 -22.27 43.55 Favored 'Trans proline' 0 C--O 1.215 -0.675 0 C-N-CA 122.691 2.261 . . . . 0.0 111.713 -179.987 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 69.9 mtt85 -105.7 -24.31 12.55 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.341 -0.85 . . . . 0.0 109.526 179.948 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 24.4 mm -81.9 -48.17 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.246 -0.909 . . . . 0.0 109.54 -179.893 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.502 ' O ' ' CG1' ' A' ' 10' ' ' VAL . . . 82.17 -163.83 43.57 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.344 -1.503 . . . . 0.0 109.344 -179.923 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.686 ' CE2' ' CE2' ' A' ' 8' ' ' TYR . 2.1 t80 -97.57 150.6 20.94 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.125 -1.221 . . . . 0.0 109.621 179.983 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.482 ' CD1' ' C ' ' A' ' 17' ' ' LEU . 2.2 tm? -111.86 109.65 19.57 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.333 -0.854 . . . . 0.0 109.749 -179.779 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.427 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 63.6 m -125.86 156.12 71.87 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.284 -0.885 . . . . 0.0 108.985 179.649 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -71.02 165.48 32.24 Favored 'Trans proline' 0 C--O 1.214 -0.686 0 C-N-CA 122.453 2.102 . . . . 0.0 111.701 -179.98 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 24.3 mttt -83.76 -22.93 31.75 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.261 -0.9 . . . . 0.0 109.521 -179.805 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 -63.62 125.41 24.19 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.226 -0.921 . . . . 0.0 109.401 179.781 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 41.2 tp -85.69 122.92 30.47 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.211 -0.931 . . . . 0.0 109.507 179.94 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.521 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 1.3 mmmt -135.21 103.28 10.59 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.305 -0.872 . . . . 0.0 109.284 179.987 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.528 ' O ' ' N ' ' A' ' 56' ' ' GLY . 43.3 Cg_endo -65.02 120.02 7.16 Favored 'Trans proline' 0 C--O 1.213 -0.744 0 C-N-CA 123.18 2.587 . . . . 0.0 112.529 -179.125 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.469 HG22 HD11 ' A' ' 39' ' ' LEU . 7.8 m -116.98 155.94 18.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.399 -0.813 . . . . 0.0 109.754 179.683 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.481 ' O ' ' N ' ' A' ' 53' ' ' ARG . 14.8 t -102.67 109.9 21.66 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.389 -0.82 . . . . 0.0 108.97 179.369 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -66.03 137.7 36.3 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 -179.652 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.506 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 55.1 p30 -68.65 -10.14 54.31 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.316 -1.108 . . . . 0.0 109.57 179.858 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.443 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 38.9 m-20 -82.62 4.47 24.63 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.246 -0.909 . . . . 0.0 109.378 179.757 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.73 14.68 56.33 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.137 -1.585 . . . . 0.0 109.137 -179.809 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.501 ' O ' ' N ' ' A' ' 27' ' ' GLY . 88.9 mt-30 -121.36 157.54 30.22 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.382 -1.07 . . . . 0.0 109.373 -179.969 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.509 ' CG2' ' HA ' ' A' ' 57' ' ' LYS . 25.6 m -119.19 134.97 54.91 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.257 -0.902 . . . . 0.0 109.356 179.916 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.585 ' CE1' ' HB2' ' A' ' 42' ' ' GLU . 54.2 m-85 -113.13 129.67 56.43 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.289 -0.882 . . . . 0.0 109.288 179.986 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.503 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 6.6 m-20 -52.47 -76.29 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.216 -0.928 . . . . 0.0 109.441 -179.812 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.514 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 10.2 t-20 -81.99 147.35 57.72 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.039 -1.038 . . . . 0.0 109.495 179.797 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.521 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 39.9 Cg_endo -63.12 -51.68 2.63 Favored 'Trans proline' 0 C--O 1.214 -0.693 0 C-N-CA 122.673 2.248 . . . . 0.0 111.451 179.555 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.514 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 5.7 t -60.25 -28.36 67.98 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 178.81 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.471 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 34.7 mmm -66.02 -18.94 65.67 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.384 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.548 HD13 ' CD2' ' A' ' 33' ' ' TYR . 8.1 tt -66.84 -52.74 40.09 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.179 -0.951 . . . . 0.0 108.577 179.382 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.487 ' O ' ' HB2' ' A' ' 43' ' ' ASN . 38.0 t -50.81 -25.97 5.12 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 178.983 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.445 ' O ' HG12 ' A' ' 45' ' ' ILE . 28.1 t60 -60.09 -50.05 75.25 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.162 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.585 ' HB2' ' CE1' ' A' ' 33' ' ' TYR . 23.9 tp10 -58.66 -19.42 39.2 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.201 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.52 ' O ' ' N ' ' A' ' 47' ' ' GLN . 4.0 m-80 -78.26 -35.81 47.64 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.29 -0.881 . . . . 0.0 108.913 179.589 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.497 ' O ' ' CD1' ' A' ' 44' ' ' LEU . 2.1 tm? -69.34 -34.3 74.41 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.286 -0.884 . . . . 0.0 109.327 179.717 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.445 HG12 ' O ' ' A' ' 41' ' ' HIS . 6.1 mm -74.67 -53.84 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.382 -0.824 . . . . 0.0 110.118 -179.633 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.464 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 10.5 mtt-85 -88.38 -30.3 19.62 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.145 -0.972 . . . . 0.0 110.36 -179.159 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.52 ' N ' ' O ' ' A' ' 43' ' ' ASN . 87.2 mt-30 62.33 37.07 14.13 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.128 -0.983 . . . . 0.0 109.277 -179.706 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.462 ' O ' ' HB2' ' A' ' 49' ' ' ASN . 72.7 p -101.25 6.68 43.02 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.295 -0.878 . . . . 0.0 109.715 -179.84 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.462 ' HB2' ' O ' ' A' ' 48' ' ' THR . 73.0 m-20 61.65 51.77 3.85 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.165 -0.959 . . . . 0.0 109.556 179.894 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.506 ' N ' ' OD1' ' A' ' 43' ' ' ASN . 47.9 m -76.53 140.63 41.22 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.24 -0.913 . . . . 0.0 109.262 179.755 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 12.0 m-70 -119.53 -176.47 3.16 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.219 -0.926 . . . . 0.0 109.63 -179.879 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.498 HD11 HG22 ' A' ' 52' ' ' ILE . 15.9 mt -87.47 124.07 40.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 O-C-N 121.383 -0.823 . . . . 0.0 109.575 179.883 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.506 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 16.7 tpt180 -81.07 -56.38 4.14 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.476 -0.765 . . . . 0.0 109.477 179.904 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 72.8 m -148.9 141.17 24.07 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -179.832 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 12.2 p -58.34 144.51 41.25 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.197 -0.939 . . . . 0.0 109.522 -179.67 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' 24' ' ' PRO . . . 86.32 162.61 37.13 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.79 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.509 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 21.7 mttp -70.65 133.09 46.36 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.559 -0.965 . . . . 0.0 109.386 179.895 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -60.21 -30.95 69.71 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.219 -0.926 . . . . 0.0 109.406 -179.995 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.456 ' O ' ' HG2' ' A' ' 59' ' ' GLU . 83.2 tt0 -83.78 -13.18 54.49 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.265 -0.897 . . . . 0.0 109.412 179.838 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.465 ' HB2' ' HB2' ' A' ' 57' ' ' LYS . 51.6 tt0 -71.8 -29.46 64.48 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.324 -0.86 . . . . 0.0 109.16 179.904 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 34.6 m -63.26 -35.28 79.83 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.307 -0.871 . . . . 0.0 109.415 179.866 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.452 ' O ' ' O ' ' A' ' 59' ' ' GLU . 43.2 m -118.48 149.16 41.75 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.223 -0.923 . . . . 0.0 109.644 -179.946 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -117.85 164.88 17.77 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.282 -0.886 . . . . 0.0 109.335 179.905 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -70.47 -20.72 31.12 Favored 'Trans proline' 0 C--O 1.215 -0.641 0 C-N-CA 122.649 2.232 . . . . 0.0 111.831 -179.842 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -87.05 -175.47 49.15 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.943 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 17.3 p -123.99 161.8 24.72 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.307 -1.114 . . . . 0.0 109.435 179.972 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.429 ' OG1' ' O ' ' A' ' 69' ' ' ALA . 25.3 p -116.25 165.32 13.31 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.218 -0.926 . . . . 0.0 109.535 -179.953 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.76 -29.66 70.2 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.215 -0.928 . . . . 0.0 109.446 -179.958 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.429 ' O ' ' OG1' ' A' ' 67' ' ' THR . . . -106.25 137.81 43.54 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.209 -0.932 . . . . 0.0 109.495 179.948 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 18.5 m -55.74 -33.09 63.96 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.196 -0.94 . . . . 0.0 109.479 179.99 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 9.6 mmt -124.37 88.12 53.38 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.362 -0.836 . . . . 0.0 109.456 179.933 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -70.07 154.54 66.4 Favored 'Trans proline' 0 C--O 1.216 -0.624 0 C-N-CA 122.674 2.249 . . . . 0.0 111.773 179.947 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -70.59 0.35 6.39 Favored 'Trans proline' 0 C--O 1.216 -0.612 0 C-N-CA 122.682 2.255 . . . . 0.0 111.933 -179.875 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 85.7 p -92.33 -13.31 30.43 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.163 -0.961 . . . . 0.0 109.451 -179.968 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -94.97 106.13 18.09 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.305 -0.872 . . . . 0.0 109.274 179.947 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 118.001 -1.0 . . . . 0.0 109.531 -179.829 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.414 ' OD1' HD13 ' A' ' 52' ' ' ILE . 51.5 m-20 . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 . . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.518 ' O ' ' N ' ' A' ' 5' ' ' CYS . 5.8 m -43.76 -26.8 0.27 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.268 -0.895 . . . . 0.0 109.484 179.945 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.451 ' HA ' ' HG3' ' A' ' 6' ' ' LYS . 39.6 mt-10 -47.04 -31.58 3.4 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 179.704 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 70.7 mtm -77.18 -33.6 56.42 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.056 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.518 ' N ' ' O ' ' A' ' 2' ' ' SER . 3.4 m -82.93 7.56 15.09 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 179.41 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.451 ' HG3' ' HA ' ' A' ' 3' ' ' GLU . 12.6 mttm -61.11 -35.69 77.69 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.997 -1.064 . . . . 0.0 109.305 179.724 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -140.65 70.8 1.36 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.321 -0.862 . . . . 0.0 109.915 -179.793 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.437 ' CD2' ' N ' ' A' ' 9' ' ' ARG . 26.9 p90 -115.07 -169.75 1.62 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.208 -0.933 . . . . 0.0 109.3 179.633 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.437 ' N ' ' CD2' ' A' ' 8' ' ' TYR . 71.9 mtt-85 -152.41 142.37 22.15 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.256 -0.903 . . . . 0.0 109.569 179.905 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 39.9 t -143.06 138.7 27.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.264 -0.897 . . . . 0.0 109.2 179.98 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.531 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.7 OUTLIER -119.55 174.72 2.62 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.221 -0.924 . . . . 0.0 109.449 -179.788 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.531 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 46.6 Cg_endo -68.36 -24.31 37.24 Favored 'Trans proline' 0 C--O 1.214 -0.678 0 C-N-CA 122.748 2.299 . . . . 0.0 111.881 179.965 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.474 ' O ' ' HG2' ' A' ' 13' ' ' ARG . 23.4 ttm180 -101.18 -16.69 16.93 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.322 -0.861 . . . . 0.0 109.282 179.897 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 85.2 mt -96.99 -42.19 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.244 -0.91 . . . . 0.0 109.654 -179.754 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 71.55 179.38 31.3 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 -179.812 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.468 ' OH ' ' HB2' ' A' ' 40' ' ' CYS . 1.8 t80 -77.61 153.92 32.76 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.153 -1.204 . . . . 0.0 109.546 -179.989 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.449 ' O ' ' SG ' ' A' ' 37' ' ' CYS . 48.1 mt -110.42 123.58 50.15 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.216 -0.927 . . . . 0.0 109.594 179.999 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.474 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 82.4 m -146.98 156.72 47.27 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.453 -0.779 . . . . 0.0 109.032 179.895 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.473 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 48.9 Cg_endo -70.86 168.29 23.42 Favored 'Trans proline' 0 C--O 1.216 -0.608 0 C-N-CA 122.583 2.188 . . . . 0.0 111.515 179.889 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -94.26 -8.73 38.27 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.124 -0.985 . . . . 0.0 109.628 -179.796 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -76.62 118.53 19.36 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.169 -0.957 . . . . 0.0 109.414 179.957 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 44.3 tp -76.09 116.92 17.26 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.201 -0.937 . . . . 0.0 109.739 -179.973 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.515 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 2.2 mtpt -132.1 106.76 13.66 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.306 -0.871 . . . . 0.0 108.996 179.767 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.527 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 43.2 Cg_endo -64.58 120.24 7.48 Favored 'Trans proline' 0 C--O 1.214 -0.711 0 C-N-CA 122.912 2.408 . . . . 0.0 112.1 -179.448 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.448 ' O ' HG21 ' A' ' 32' ' ' THR . 11.4 m -120.26 155.2 23.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.445 -0.784 . . . . 0.0 110.047 -179.768 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.409 ' SG ' ' HB3' ' A' ' 53' ' ' ARG . 41.4 t -96.88 148.18 23.2 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 178.713 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -100.04 139.66 14.54 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.545 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.465 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 53.4 t0 -64.82 -10.7 30.08 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.279 -1.13 . . . . 0.0 109.409 179.834 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 59.9 p30 -90.39 1.6 56.43 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.24 -0.913 . . . . 0.0 109.667 -179.932 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.64 19.45 34.75 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.994 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.473 ' O ' ' N ' ' A' ' 27' ' ' GLY . 87.0 mt-30 -119.23 167.88 11.43 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.209 -1.171 . . . . 0.0 109.429 -179.946 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.485 HG22 ' CB ' ' A' ' 57' ' ' LYS . 94.3 m -127.73 146.91 50.42 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.118 -0.989 . . . . 0.0 109.445 179.792 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.62 ' N ' ' CD1' ' A' ' 33' ' ' TYR . 5.0 m-85 -128.8 128.64 44.34 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.23 -0.918 . . . . 0.0 109.463 -179.835 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.477 ' O ' ' O ' ' A' ' 23' ' ' LYS . 7.5 m-20 -49.79 -77.22 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.282 -0.886 . . . . 0.0 109.663 -179.551 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.543 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 2.0 t-20 -81.91 149.23 62.85 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.161 -0.962 . . . . 0.0 109.443 179.995 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.515 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 41.2 Cg_endo -64.62 -54.71 0.68 Allowed 'Trans proline' 0 C--O 1.216 -0.622 0 C-N-CA 122.842 2.361 . . . . 0.0 111.955 179.873 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.543 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 15.7 t -62.09 -28.6 69.73 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 120.974 -1.079 . . . . 0.0 108.417 179.049 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.437 ' CG ' ' HB3' ' A' ' 35' ' ' ASN . 37.0 mmm -61.45 -15.56 38.47 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 179.363 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.583 HD12 ' CD1' ' A' ' 33' ' ' TYR . 50.8 tp -63.47 -46.01 88.15 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.346 -0.846 . . . . 0.0 108.982 179.61 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.468 ' HB2' ' OH ' ' A' ' 16' ' ' TYR . 2.8 m -71.8 -19.98 61.92 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 178.764 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 28.4 t60 -66.89 -52.76 39.48 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.017 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.474 ' OE1' ' CE2' ' A' ' 33' ' ' TYR . 85.5 tt0 -66.91 -19.86 65.8 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 178.983 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.502 ' O ' ' N ' ' A' ' 47' ' ' GLN . 87.9 m-20 -77.46 -32.75 54.65 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.327 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 23.9 tp -64.28 -31.36 72.54 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.259 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.448 HG22 HD11 ' A' ' 45' ' ' ILE . 7.3 mm -77.63 -44.7 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.442 -0.787 . . . . 0.0 108.972 179.376 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.46 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 63.2 mtt-85 -79.89 -15.36 57.49 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.353 -0.842 . . . . 0.0 109.123 179.629 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.502 ' N ' ' O ' ' A' ' 43' ' ' ASN . 89.0 mt-30 63.09 44.32 5.91 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.421 -0.799 . . . . 0.0 109.486 179.995 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.401 ' O ' ' HB3' ' A' ' 43' ' ' ASN . 7.3 p -128.54 164.52 22.64 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.211 -0.93 . . . . 0.0 109.294 179.829 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 47.5 p-10 -104.58 58.62 0.7 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.123 -0.986 . . . . 0.0 109.573 -179.935 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.45 ' O ' ' OG ' ' A' ' 2' ' ' SER . 86.5 m -71.91 137.77 47.65 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.255 -0.903 . . . . 0.0 109.541 179.9 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.433 ' CD2' ' HB2' ' A' ' 2' ' ' SER . 71.4 m80 -112.55 176.54 4.98 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.229 -0.92 . . . . 0.0 109.091 179.723 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.46 HD11 HG22 ' A' ' 52' ' ' ILE . 39.2 mt -80.28 126.66 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.231 -0.918 . . . . 0.0 109.509 179.999 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.465 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 67.6 ttt180 -79.88 -46.39 16.91 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.443 -0.786 . . . . 0.0 109.448 -179.922 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 54.4 p -160.44 138.88 10.14 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -179.331 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 10.6 p -51.29 147.4 5.75 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.163 -0.961 . . . . 0.0 109.485 179.978 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.527 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 85.14 165.95 41.03 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.484 -1.447 . . . . 0.0 109.484 179.923 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.485 ' CB ' HG22 ' A' ' 32' ' ' THR . 33.7 mttm -65.33 146.24 55.16 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.49 -1.006 . . . . 0.0 109.406 179.981 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.45 ' SG ' ' O ' ' A' ' 31' ' ' GLN . 79.2 m -49.37 -30.21 7.4 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.279 -0.888 . . . . 0.0 109.48 179.945 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -80.22 -32.31 38.5 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.335 -0.853 . . . . 0.0 109.314 -179.83 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -58.01 -20.3 37.63 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.287 -0.883 . . . . 0.0 108.948 179.718 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 20.4 m -72.93 -32.42 65.27 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.376 -0.827 . . . . 0.0 109.848 -179.749 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 83.7 p -123.8 156.42 36.15 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.083 -1.011 . . . . 0.0 109.802 -179.692 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.456 ' HB ' ' HD2' ' A' ' 64' ' ' PRO . 5.8 p -118.18 161.51 34.52 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.374 -0.829 . . . . 0.0 109.192 179.824 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.456 ' HD2' ' HB ' ' A' ' 63' ' ' THR . 50.4 Cg_endo -70.62 -17.62 33.52 Favored 'Trans proline' 0 C--O 1.214 -0.697 0 C-N-CA 122.626 2.217 . . . . 0.0 111.838 -179.897 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -172.69 173.41 45.46 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.96 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 40.6 m -114.92 138.59 50.64 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.294 -1.121 . . . . 0.0 109.534 -180.0 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 17.0 p -120.95 159.36 25.74 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.293 -0.879 . . . . 0.0 109.459 179.872 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.9 -30.48 69.05 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.277 -0.889 . . . . 0.0 109.591 -179.889 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.7 -37.26 85.81 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.277 -0.889 . . . . 0.0 109.509 -179.97 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 43.4 m -56.47 -33.01 65.52 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.203 -0.935 . . . . 0.0 109.609 -179.944 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.92 151.71 76.55 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.243 -0.911 . . . . 0.0 109.479 -179.997 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -70.16 146.8 58.78 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 122.691 2.261 . . . . 0.0 111.889 179.999 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -70.1 163.56 38.1 Favored 'Trans proline' 0 C--O 1.215 -0.632 0 C-N-CA 122.641 2.227 . . . . 0.0 111.753 179.987 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 19.5 m -86.47 -7.87 58.06 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.26 -0.9 . . . . 0.0 109.679 -179.895 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.481 ' O ' ' CG ' ' A' ' 76' ' ' GLU . 85.1 m-20 -83.13 -25.12 32.23 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.214 -0.929 . . . . 0.0 109.537 -179.896 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.481 ' CG ' ' O ' ' A' ' 75' ' ' ASP . 90.7 mt-10 . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.501 179.988 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.7 m -55.54 -30.22 60.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.302 -0.874 . . . . 0.0 109.424 -179.978 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.455 ' HA ' ' HG3' ' A' ' 6' ' ' LYS . 5.6 mt-10 -57.82 -22.51 47.99 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.327 -0.858 . . . . 0.0 109.309 179.906 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 62.1 mmm -77.51 -26.58 51.3 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.313 -0.867 . . . . 0.0 109.141 179.755 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.534 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 3.3 m -82.32 -14.92 54.57 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.313 -0.867 . . . . 0.0 109.143 179.862 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.455 ' HG3' ' HA ' ' A' ' 3' ' ' GLU . 85.0 mttt -56.2 -25.09 45.81 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.205 -0.934 . . . . 0.0 109.585 -179.994 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -154.27 63.04 0.69 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.179 -0.951 . . . . 0.0 109.841 -179.833 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.54 ' CE2' ' CE2' ' A' ' 16' ' ' TYR . 7.9 p90 -119.84 174.15 6.61 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.172 -0.955 . . . . 0.0 109.308 179.591 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 66.9 mtt-85 -145.26 137.34 25.69 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.19 -0.944 . . . . 0.0 109.514 -179.969 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.46 HG22 ' CD2' ' A' ' 16' ' ' TYR . 98.7 t -134.21 139.82 47.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.243 -0.911 . . . . 0.0 109.48 -179.981 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.533 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.2 OUTLIER -131.28 175.57 3.58 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.345 -0.847 . . . . 0.0 109.389 -179.924 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.533 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 46.0 Cg_endo -67.76 -24.95 40.18 Favored 'Trans proline' 0 C--O 1.214 -0.69 0 C-N-CA 122.673 2.249 . . . . 0.0 111.729 179.884 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.469 ' O ' ' HG2' ' A' ' 13' ' ' ARG . 54.6 ttt180 -110.97 -20.54 12.39 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.328 -0.857 . . . . 0.0 109.204 179.778 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 80.6 mt -90.98 -38.53 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.344 -0.848 . . . . 0.0 109.406 179.978 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 67.97 -142.22 39.38 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.948 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.54 ' CE2' ' CE2' ' A' ' 8' ' ' TYR . 2.9 t80 -108.23 153.97 22.44 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.172 -1.193 . . . . 0.0 109.57 -179.898 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 29.4 tp -112.33 119.46 38.36 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.398 -0.814 . . . . 0.0 109.581 179.911 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.413 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 58.5 m -131.55 155.92 80.81 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.279 -0.888 . . . . 0.0 109.269 179.903 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -71.11 166.4 29.31 Favored 'Trans proline' 0 C--O 1.216 -0.62 0 C-N-CA 122.523 2.149 . . . . 0.0 111.661 -179.994 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -88.42 -7.13 57.12 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.274 -0.891 . . . . 0.0 109.541 -179.934 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -74.39 128.42 35.49 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.231 -0.918 . . . . 0.0 109.4 179.846 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.482 ' CD1' ' C ' ' A' ' 22' ' ' LEU . 3.2 tm? -85.5 113.81 22.05 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.212 -0.93 . . . . 0.0 109.666 -179.831 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.501 ' O ' ' O ' ' A' ' 34' ' ' ASN . 5.5 mmtt -132.75 102.84 13.46 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.271 -0.893 . . . . 0.0 108.818 179.606 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.529 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 41.4 Cg_endo -63.43 124.18 13.35 Favored 'Trans proline' 0 C--O 1.213 -0.734 0 C-N-CA 122.963 2.442 . . . . 0.0 112.417 -179.067 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.465 ' O ' HG21 ' A' ' 32' ' ' THR . 35.0 m -123.06 154.08 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.47 -0.769 . . . . 0.0 109.921 -179.93 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.441 ' SG ' ' HB3' ' A' ' 53' ' ' ARG . 43.8 t -100.67 136.47 40.49 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.611 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -93.8 139.07 14.38 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 110.109 -1.196 . . . . 0.0 110.109 -179.099 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.492 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 48.9 p30 -64.14 -13.33 47.34 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.327 -1.102 . . . . 0.0 109.348 179.67 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.441 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 31.6 m-20 -85.61 11.31 11.03 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.236 -0.915 . . . . 0.0 109.237 179.844 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.5 20.32 66.71 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.886 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.523 ' O ' ' N ' ' A' ' 27' ' ' GLY . 83.0 mt-30 -121.98 145.93 47.65 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.304 -1.115 . . . . 0.0 109.503 -179.955 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.507 ' CG2' ' HA ' ' A' ' 57' ' ' LYS . 85.5 m -111.43 153.25 26.38 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.245 -0.909 . . . . 0.0 109.494 179.975 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.53 ' OH ' ' CG ' ' A' ' 42' ' ' GLU . 62.9 m-85 -135.69 145.67 46.96 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.246 -0.909 . . . . 0.0 109.196 179.648 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.528 ' N ' ' ND2' ' A' ' 34' ' ' ASN . 0.2 OUTLIER -63.92 -72.44 0.14 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.144 -0.972 . . . . 0.0 108.574 179.9 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.544 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 9.3 t-20 -83.09 146.9 52.66 Favored Pre-proline 0 C--N 1.299 -1.63 0 O-C-N 121.446 -0.784 . . . . 0.0 109.461 179.709 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.477 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 41.7 Cg_endo -64.15 -51.75 1.98 Allowed 'Trans proline' 0 C--O 1.215 -0.629 0 C-N-CA 122.512 2.141 . . . . 0.0 111.414 179.678 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.544 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 6.6 t -59.34 -25.85 64.54 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 178.8 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.473 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 10.2 mmm -65.6 -19.21 65.82 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.232 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.525 ' CD1' ' CD1' ' A' ' 52' ' ' ILE . 5.7 tt -73.97 -52.19 13.6 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.126 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.513 ' O ' ' HB2' ' A' ' 43' ' ' ASN . 7.3 t -47.92 -33.36 7.52 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 178.685 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 58.1 t60 -49.95 -56.0 12.32 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 178.934 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.53 ' CG ' ' OH ' ' A' ' 33' ' ' TYR . 16.8 tt0 -50.67 -23.13 2.42 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.072 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.513 ' HB2' ' O ' ' A' ' 40' ' ' CYS . 5.4 m-80 -80.92 -29.67 35.48 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 119.545 -0.862 . . . . 0.0 109.095 179.828 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.452 HD23 ' CG1' ' A' ' 10' ' ' VAL . 27.7 tp -77.39 -35.87 53.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.293 -0.879 . . . . 0.0 109.369 179.942 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 8.0 mm -77.25 -52.77 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.174 -0.954 . . . . 0.0 109.296 179.816 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.44 ' HB3' HG22 ' A' ' 48' ' ' THR . 17.5 mtt-85 -79.84 -15.31 57.65 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.311 -0.868 . . . . 0.0 109.49 179.86 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.45 ' HA ' ' O ' ' A' ' 43' ' ' ASN . 92.8 mt-30 60.9 33.4 19.9 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.242 -0.911 . . . . 0.0 109.542 -179.978 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.44 HG22 ' HB3' ' A' ' 46' ' ' ARG . 18.4 p -108.96 176.28 5.16 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.318 -0.864 . . . . 0.0 109.451 179.978 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.488 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 88.8 m-20 -102.91 54.03 0.77 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.285 -0.884 . . . . 0.0 109.423 179.95 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.497 ' N ' ' OD1' ' A' ' 43' ' ' ASN . 60.7 m -73.53 124.24 25.49 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.282 -0.886 . . . . 0.0 109.467 -179.971 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.488 ' CE1' ' O ' ' A' ' 49' ' ' ASN . 11.9 m-70 -111.89 -171.19 1.8 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.201 -0.937 . . . . 0.0 109.379 179.908 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.525 ' CD1' ' CD1' ' A' ' 39' ' ' LEU . 21.4 mm -86.45 125.05 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.276 -0.89 . . . . 0.0 109.702 -179.992 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.492 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 59.8 ttt180 -80.73 -42.82 21.24 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.415 -0.803 . . . . 0.0 109.38 179.6 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 7.6 p -160.87 131.67 5.37 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.6 -0.687 . . . . 0.0 109.305 -179.188 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 8.0 p -49.13 147.38 2.98 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.214 -0.929 . . . . 0.0 109.089 179.803 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.529 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 85.46 172.45 48.98 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.239 -1.544 . . . . 0.0 109.239 -179.713 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.507 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 55.9 mttm -66.27 149.4 50.41 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.279 -1.13 . . . . 0.0 109.676 -179.77 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.453 ' SG ' ' OG1' ' A' ' 32' ' ' THR . 93.4 m -51.5 -31.18 22.85 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.297 -0.877 . . . . 0.0 109.23 179.878 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 69.6 tt0 -82.87 -25.95 32.05 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.26 -0.9 . . . . 0.0 109.355 -179.967 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.5 tp10 -92.66 116.13 28.73 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.167 -0.958 . . . . 0.0 109.361 179.923 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 9.9 p -127.54 149.95 49.91 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.29 -0.881 . . . . 0.0 109.33 179.96 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 22.8 t -114.24 156.12 24.89 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.278 -0.889 . . . . 0.0 109.537 179.973 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 72.1 p -71.06 156.9 91.37 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.217 -0.927 . . . . 0.0 109.412 179.967 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -70.03 142.64 47.26 Favored 'Trans proline' 0 C--O 1.214 -0.686 0 C-N-CA 122.691 2.261 . . . . 0.0 111.77 179.998 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -81.07 -174.66 49.15 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.998 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 49.2 p -66.3 -26.08 67.15 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.305 -1.115 . . . . 0.0 109.464 -179.998 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.444 ' OG1' ' O ' ' A' ' 69' ' ' ALA . 22.7 p -120.53 164.07 17.01 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.309 -0.87 . . . . 0.0 109.458 179.944 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.69 -35.04 79.63 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.187 -0.945 . . . . 0.0 109.483 179.944 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.444 ' O ' ' OG1' ' A' ' 67' ' ' THR . . . -104.31 138.06 41.3 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.2 -0.937 . . . . 0.0 109.427 -179.962 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 87.3 p -63.0 -27.38 69.38 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.187 -0.946 . . . . 0.0 109.475 179.935 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.61 149.79 77.38 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.3 -0.875 . . . . 0.0 109.478 -179.977 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -70.71 149.41 60.81 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 122.717 2.278 . . . . 0.0 111.84 179.98 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -70.61 -2.99 11.67 Favored 'Trans proline' 0 C--O 1.215 -0.632 0 C-N-CA 122.733 2.289 . . . . 0.0 111.927 -179.945 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 82.9 p -85.83 -10.66 55.06 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.128 -0.983 . . . . 0.0 109.43 -179.883 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 31.9 p-10 -72.42 -26.43 61.85 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.202 -0.936 . . . . 0.0 109.511 -179.973 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 117.97 -1.014 . . . . 0.0 109.501 179.997 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.519 ' HB2' ' CE1' ' A' ' 51' ' ' HIS . 13.0 m -58.09 -36.81 73.4 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.278 -0.889 . . . . 0.0 109.264 179.814 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -54.29 -26.12 27.52 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.376 -0.827 . . . . 0.0 108.941 179.766 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 72.8 mmm -74.91 -25.35 58.86 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.522 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.593 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 44.5 m -80.26 -19.26 47.19 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.48 -0.762 . . . . 0.0 109.392 179.936 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 20.8 mttt -80.08 4.82 15.98 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.24 -0.913 . . . . 0.0 109.652 -179.911 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -128.84 4.75 5.43 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.03 -1.044 . . . . 0.0 110.415 -179.409 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.689 ' CE2' ' CZ ' ' A' ' 16' ' ' TYR . 0.9 OUTLIER -120.43 150.21 41.14 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.912 -1.117 . . . . 0.0 109.554 179.78 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 81.2 mtt180 -131.87 130.69 41.98 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.26 -0.9 . . . . 0.0 109.167 179.76 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.508 HG21 ' CE2' ' A' ' 8' ' ' TYR . 58.5 t -118.1 149.3 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.303 -0.873 . . . . 0.0 110.099 -179.484 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.537 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.7 OUTLIER -127.55 175.42 3.4 Favored Pre-proline 0 N--CA 1.488 1.459 0 O-C-N 121.375 -0.828 . . . . 0.0 108.905 179.484 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.537 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 43.6 Cg_endo -67.22 -22.37 46.78 Favored 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 122.465 2.11 . . . . 0.0 111.746 179.908 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 15.5 mtt-85 -102.04 -28.99 12.03 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.214 -0.929 . . . . 0.0 109.635 -179.999 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.422 HD11 ' HB2' ' A' ' 11' ' ' LEU . 84.9 mt -79.54 -48.7 20.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.229 -0.919 . . . . 0.0 109.582 -179.685 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.403 ' C ' HG12 ' A' ' 10' ' ' VAL . . . 81.9 -167.97 48.59 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 -179.93 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.689 ' CZ ' ' CE2' ' A' ' 8' ' ' TYR . 1.0 OUTLIER -97.69 146.87 24.91 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.131 -1.217 . . . . 0.0 109.618 179.985 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 24.9 tp -118.24 120.63 38.26 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.355 -0.841 . . . . 0.0 109.527 179.969 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.428 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 80.1 m -129.22 156.15 78.78 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.325 -0.859 . . . . 0.0 109.128 179.67 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.481 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 46.2 Cg_endo -69.72 163.95 36.33 Favored 'Trans proline' 0 C--O 1.216 -0.613 0 C-N-CA 122.655 2.236 . . . . 0.0 111.729 -179.987 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -89.78 -7.83 53.52 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.278 -0.889 . . . . 0.0 109.412 -179.987 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 -73.62 120.82 19.74 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.297 -0.877 . . . . 0.0 109.375 179.903 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.523 ' CD2' ' OD1' ' A' ' 34' ' ' ASN . 3.1 tm? -81.41 124.0 29.05 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.283 -0.886 . . . . 0.0 109.417 -179.923 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.488 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 11.9 mttt -146.31 104.74 4.06 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.308 -0.87 . . . . 0.0 109.371 179.769 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.546 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 42.6 Cg_endo -65.23 123.61 11.77 Favored 'Trans proline' 0 C--O 1.213 -0.752 0 C-N-CA 122.954 2.436 . . . . 0.0 111.95 -179.92 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.449 ' O ' HG21 ' A' ' 32' ' ' THR . 27.2 m -118.69 154.51 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.191 -0.943 . . . . 0.0 109.637 179.978 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.428 ' SG ' ' HB3' ' A' ' 53' ' ' ARG . 41.5 t -96.59 138.4 34.22 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.273 -0.892 . . . . 0.0 108.83 179.327 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -91.99 139.46 14.71 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 179.995 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.502 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 55.5 t0 -71.03 -7.17 44.51 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.265 -1.138 . . . . 0.0 109.511 -179.925 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.415 ' OD1' ' C ' ' A' ' 29' ' ' ASP . 59.1 p30 -89.6 3.62 52.0 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.187 -0.946 . . . . 0.0 109.462 179.732 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.21 13.39 52.41 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 -179.891 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.467 ' O ' ' N ' ' A' ' 27' ' ' GLY . 76.9 mt-30 -118.72 174.04 6.51 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.256 -1.144 . . . . 0.0 109.402 -179.964 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.499 ' CG2' ' HA ' ' A' ' 57' ' ' LYS . 23.2 m -135.93 137.23 41.14 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.308 -0.87 . . . . 0.0 109.341 179.839 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.631 ' CE1' ' CD1' ' A' ' 39' ' ' LEU . 29.3 m-85 -114.2 129.12 56.63 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.299 -0.876 . . . . 0.0 109.348 -179.915 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.523 ' OD1' ' CD2' ' A' ' 22' ' ' LEU . 63.6 t-20 -52.55 -79.78 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.297 -0.877 . . . . 0.0 109.742 -179.583 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.532 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 2.0 t-20 -81.17 149.66 66.53 Favored Pre-proline 0 C--N 1.3 -1.57 0 O-C-N 120.927 -1.108 . . . . 0.0 109.567 -179.813 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.488 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 39.9 Cg_endo -63.07 -54.53 1.08 Allowed 'Trans proline' 0 C--O 1.214 -0.68 0 C-N-CA 122.729 2.286 . . . . 0.0 111.925 -179.765 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.532 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 9.1 t -61.15 -29.15 69.61 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.997 -1.064 . . . . 0.0 108.224 179.116 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.53 ' CG ' ' HB3' ' A' ' 35' ' ' ASN . 69.6 mmm -62.56 -16.42 56.05 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 179.321 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.631 ' CD1' ' CE1' ' A' ' 33' ' ' TYR . 24.5 tp -69.08 -58.14 4.48 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.382 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.482 ' HB3' ' OH ' ' A' ' 16' ' ' TYR . 8.8 t -56.95 -29.82 63.49 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 178.685 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 54.9 t60 -64.1 -60.45 3.21 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.189 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.567 ' OE1' ' CE2' ' A' ' 33' ' ' TYR . 83.9 tt0 -57.79 -22.33 46.62 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.328 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.505 ' O ' ' N ' ' A' ' 47' ' ' GLN . 97.3 m-20 -76.4 -31.97 58.27 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.41 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 15.9 tp -66.49 -31.82 72.8 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.267 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.487 HD11 HG22 ' A' ' 45' ' ' ILE . 5.4 mt -75.81 -44.7 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 179.41 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.469 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 73.4 mtt-85 -80.61 -20.48 43.14 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.493 -0.754 . . . . 0.0 109.378 179.786 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.505 ' N ' ' O ' ' A' ' 43' ' ' ASN . 89.2 mt-30 63.3 43.49 6.15 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.313 -0.867 . . . . 0.0 109.43 -179.927 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.428 HG22 ' HB3' ' A' ' 46' ' ' ARG . 10.3 p -123.75 161.82 24.41 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.343 -0.848 . . . . 0.0 109.298 179.868 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.425 ' O ' ' CG ' ' A' ' 49' ' ' ASN . 44.8 p-10 -96.51 59.71 1.83 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.185 -0.947 . . . . 0.0 109.448 179.957 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 34.7 m -72.81 140.45 47.66 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.199 -0.938 . . . . 0.0 109.82 -179.872 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.519 ' CE1' ' HB2' ' A' ' 2' ' ' SER . 49.3 m-70 -118.49 172.03 7.75 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.39 -0.819 . . . . 0.0 108.918 179.578 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.487 HD11 HG22 ' A' ' 52' ' ' ILE . 35.9 mt -81.54 126.28 39.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.141 -0.974 . . . . 0.0 109.291 179.772 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.502 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 39.8 ttt180 -79.73 -44.17 21.25 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.458 -0.776 . . . . 0.0 109.202 179.978 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.3 t -160.0 157.99 29.79 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.909 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 29.9 p -72.38 144.95 48.03 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.159 -0.963 . . . . 0.0 109.444 -179.907 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.546 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 84.83 165.92 40.71 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.865 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.499 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 41.5 tttt -53.1 150.23 6.01 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.43 -1.041 . . . . 0.0 109.438 -179.98 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 98.8 m -52.95 -25.97 13.64 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.248 -0.907 . . . . 0.0 109.317 179.887 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 78.1 tt0 -82.31 -20.52 37.24 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.346 -0.846 . . . . 0.0 109.339 179.935 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -89.61 123.16 33.43 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.252 -0.905 . . . . 0.0 109.365 179.914 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 41.6 p -135.75 155.18 50.77 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.202 -0.936 . . . . 0.0 109.536 179.966 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 95.5 p -117.74 157.23 26.9 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.277 -0.89 . . . . 0.0 109.543 -179.987 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -125.84 85.05 59.85 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.301 -0.874 . . . . 0.0 109.356 179.902 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -68.25 -22.11 40.75 Favored 'Trans proline' 0 C--O 1.214 -0.715 0 C-N-CA 122.757 2.305 . . . . 0.0 111.94 -179.948 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.86 12.39 68.75 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.837 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 48.2 m -121.47 136.67 54.93 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.216 -1.167 . . . . 0.0 109.511 179.965 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 51.5 p -74.06 -13.51 60.85 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.282 -0.886 . . . . 0.0 109.445 -179.97 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -60.62 -32.36 71.51 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.244 -0.91 . . . . 0.0 109.489 -179.946 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.407 ' C ' ' HD2' ' A' ' 72' ' ' PRO . . . -57.5 147.22 27.27 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.159 -0.963 . . . . 0.0 109.487 179.971 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 85.3 p -67.81 -28.37 67.52 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.261 -0.9 . . . . 0.0 109.548 -179.983 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.469 ' N ' ' HD2' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -51.07 -60.15 6.19 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.278 -0.889 . . . . 0.0 109.439 -179.912 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.469 ' HD2' ' N ' ' A' ' 71' ' ' MET . 49.0 Cg_endo -70.16 151.97 67.04 Favored 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 122.651 2.234 . . . . 0.0 111.757 -179.973 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -68.78 149.3 72.82 Favored 'Trans proline' 0 C--O 1.216 -0.623 0 C-N-CA 122.683 2.255 . . . . 0.0 111.819 179.966 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 25.2 t -122.49 141.03 52.08 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.187 -0.946 . . . . 0.0 109.522 -179.918 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -68.34 142.03 55.61 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.254 -0.904 . . . . 0.0 109.475 179.883 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.435 -179.985 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.555 ' HB2' ' CE1' ' A' ' 51' ' ' HIS . 5.1 m -56.4 -26.7 54.11 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.342 -0.849 . . . . 0.0 109.454 -179.997 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -52.33 -25.42 9.61 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.182 -0.949 . . . . 0.0 108.736 179.8 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 74.6 mtm -72.45 -26.73 61.94 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.171 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.574 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 24.5 m -80.48 -14.27 58.41 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.506 -0.746 . . . . 0.0 109.21 179.659 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.459 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 46.0 mttm -80.94 6.89 11.98 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.27 -0.894 . . . . 0.0 109.649 -179.954 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.459 ' OD1' ' O ' ' A' ' 6' ' ' LYS . 99.3 m-20 -139.12 14.94 2.63 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.108 -0.995 . . . . 0.0 110.309 -179.415 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.629 ' CE2' ' CE2' ' A' ' 16' ' ' TYR . 0.7 OUTLIER -123.93 152.38 42.51 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.889 -1.132 . . . . 0.0 109.561 179.876 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 16.8 mtm-85 -130.29 132.81 46.07 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.327 -0.858 . . . . 0.0 109.3 179.859 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.574 HG22 ' CE2' ' A' ' 8' ' ' TYR . 53.2 t -123.85 145.98 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.144 -0.972 . . . . 0.0 109.462 -179.93 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.546 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.2 OUTLIER -125.12 175.92 2.74 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.241 -0.912 . . . . 0.0 109.339 -179.791 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.546 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 46.4 Cg_endo -67.65 -22.81 43.4 Favored 'Trans proline' 0 C--O 1.214 -0.681 0 C-N-CA 122.6 2.2 . . . . 0.0 111.664 179.971 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 62.6 ttt-85 -103.27 -22.87 13.65 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.323 -0.86 . . . . 0.0 109.493 179.927 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 36.3 mm -86.1 -51.33 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.223 -0.923 . . . . 0.0 109.425 -179.963 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.444 ' O ' ' CG1' ' A' ' 10' ' ' VAL . . . 81.42 -163.23 44.47 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -179.917 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.629 ' CE2' ' CE2' ' A' ' 8' ' ' TYR . 1.4 t80 -99.29 150.48 22.06 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.172 -1.193 . . . . 0.0 109.514 179.957 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 18.1 tp -117.85 108.02 14.83 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.22 -0.925 . . . . 0.0 109.693 -179.841 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 61.3 m -118.13 155.74 51.14 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.258 -0.901 . . . . 0.0 109.269 179.792 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -72.3 167.28 27.34 Favored 'Trans proline' 0 C--O 1.216 -0.624 0 C-N-CA 122.671 2.248 . . . . 0.0 111.675 -179.929 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 61.3 tttm -83.08 -31.01 27.54 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.24 -0.913 . . . . 0.0 109.373 -179.932 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -57.73 126.97 29.73 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.257 -0.902 . . . . 0.0 109.541 179.941 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 66.3 tp -87.93 117.86 27.08 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.315 -0.866 . . . . 0.0 109.393 179.829 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.524 ' CB ' ' HD3' ' A' ' 36' ' ' PRO . 2.8 mttm -125.57 101.8 30.11 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.229 -0.919 . . . . 0.0 109.466 -179.795 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.546 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 42.5 Cg_endo -64.83 118.96 5.89 Favored 'Trans proline' 0 C--O 1.212 -0.809 0 C-N-CA 122.96 2.44 . . . . 0.0 112.28 -179.599 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.457 ' O ' HG21 ' A' ' 32' ' ' THR . 15.8 m -119.41 154.59 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.221 -0.925 . . . . 0.0 109.589 179.709 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.454 ' SG ' ' HB3' ' A' ' 53' ' ' ARG . 31.7 t -95.63 141.02 29.63 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.213 -0.93 . . . . 0.0 108.797 178.995 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -95.61 137.35 13.36 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 179.997 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.487 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 54.3 t0 -69.69 -5.41 24.8 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.236 -1.156 . . . . 0.0 109.579 -179.936 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -89.96 1.24 56.5 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.221 -0.924 . . . . 0.0 109.483 179.646 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.47 27.21 12.04 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.861 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.536 ' O ' ' N ' ' A' ' 27' ' ' GLY . 79.2 mt-30 -136.68 153.7 50.82 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.235 -1.156 . . . . 0.0 109.51 -179.968 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.467 HG23 ' HG3' ' A' ' 57' ' ' LYS . 3.5 m -114.96 139.59 49.7 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.294 -0.879 . . . . 0.0 109.31 179.854 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.586 ' CD1' ' CD1' ' A' ' 39' ' ' LEU . 86.0 m-85 -116.54 132.21 56.74 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.291 -0.881 . . . . 0.0 109.381 -179.904 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.486 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 9.8 m-20 -54.8 -78.93 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.352 -0.842 . . . . 0.0 109.728 -179.546 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.494 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 14.3 t-20 -82.35 146.5 54.38 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 120.999 -1.063 . . . . 0.0 109.664 -179.976 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.524 ' HD3' ' CB ' ' A' ' 23' ' ' LYS . 41.3 Cg_endo -63.81 -50.86 2.75 Favored 'Trans proline' 0 C--O 1.214 -0.715 0 C-N-CA 122.63 2.22 . . . . 0.0 111.282 179.367 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.528 ' SG ' ' CE1' ' A' ' 16' ' ' TYR . 7.8 t -60.9 -29.68 69.73 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 178.767 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.461 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 37.8 mmm -64.36 -15.88 61.23 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.103 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.586 ' CD1' ' CD1' ' A' ' 33' ' ' TYR . 54.5 tp -71.49 -58.84 3.14 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.346 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.446 ' HB3' ' OH ' ' A' ' 16' ' ' TYR . 13.6 t -53.51 -25.8 18.14 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 178.832 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 48.5 t60 -70.94 -63.32 1.12 Allowed 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.353 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -52.72 -21.73 4.4 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 179.237 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.464 ' OD1' ' HB ' ' A' ' 50' ' ' THR . 98.3 m-20 -75.21 -34.56 61.51 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.506 -0.746 . . . . 0.0 109.21 179.652 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.43 ' HG ' ' O ' ' A' ' 40' ' ' CYS . 17.6 mt -64.16 -29.34 70.46 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.183 -0.948 . . . . 0.0 109.047 179.58 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.4 mt -80.42 -44.22 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.385 -0.822 . . . . 0.0 109.433 179.69 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.456 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 93.1 mtt-85 -79.97 -34.64 38.5 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.29 -0.881 . . . . 0.0 109.572 179.938 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.456 ' HB2' ' O ' ' A' ' 46' ' ' ARG . 92.1 mt-30 63.01 43.74 6.4 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.334 -0.854 . . . . 0.0 109.561 179.979 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 68.4 p -117.31 16.56 14.8 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.329 -0.857 . . . . 0.0 109.295 179.77 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 47.9 t30 43.8 60.91 2.49 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.288 -0.882 . . . . 0.0 109.568 -179.902 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.464 ' HB ' ' OD1' ' A' ' 43' ' ' ASN . 25.7 m -77.96 147.34 34.98 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.26 -0.9 . . . . 0.0 109.626 179.869 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.555 ' CE1' ' HB2' ' A' ' 2' ' ' SER . 56.8 m-70 -121.63 168.16 12.09 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.362 -0.836 . . . . 0.0 108.788 179.481 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.473 HG22 HD12 ' A' ' 52' ' ' ILE . 26.2 mt -79.79 123.71 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.076 -1.015 . . . . 0.0 109.279 179.977 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.487 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 75.2 ttt-85 -80.21 -42.83 22.56 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.474 -0.766 . . . . 0.0 109.363 -179.94 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -158.45 147.3 18.93 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.444 -0.785 . . . . 0.0 109.279 179.998 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.9 p -66.51 149.74 49.99 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.207 -0.933 . . . . 0.0 109.42 -179.86 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.546 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 73.44 162.3 7.39 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 108.961 -1.656 . . . . 0.0 108.961 -179.594 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.467 ' HG3' HG23 ' A' ' 32' ' ' THR . 22.4 tttp -51.57 146.25 7.81 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.314 -1.109 . . . . 0.0 108.755 179.883 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.438 ' O ' ' O ' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -59.75 -155.34 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.171 -0.956 . . . . 0.0 109.543 -179.612 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.468 ' O ' ' HG2' ' A' ' 59' ' ' GLU . 86.4 tt0 -79.39 1.52 25.01 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.18 -0.95 . . . . 0.0 109.742 -179.552 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.401 ' HB2' ' HE3' ' A' ' 57' ' ' LYS . 6.0 mt-10 -59.99 -43.79 94.94 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.108 -0.995 . . . . 0.0 109.281 179.766 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.437 ' HB3' ' HD3' ' A' ' 57' ' ' LYS . 21.7 p -58.23 -21.92 49.99 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.276 -0.89 . . . . 0.0 109.482 -179.984 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 25.6 m -64.95 151.27 46.23 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.267 -0.896 . . . . 0.0 109.512 -179.94 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.21 156.63 48.93 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.308 -0.87 . . . . 0.0 109.495 -179.989 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -70.42 138.65 36.18 Favored 'Trans proline' 0 C--O 1.216 -0.614 0 C-N-CA 122.674 2.25 . . . . 0.0 111.775 -179.929 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -83.42 178.99 52.65 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.968 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 17.6 p -122.72 164.79 17.64 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.232 -1.158 . . . . 0.0 109.488 -179.917 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 16.0 p -123.03 159.3 28.7 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.269 -0.894 . . . . 0.0 109.473 179.983 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -60.03 -30.9 69.48 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.23 -0.918 . . . . 0.0 109.577 -179.973 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.48 -35.14 78.39 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.192 -0.943 . . . . 0.0 109.458 -179.95 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.3 m -55.43 -30.24 60.11 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.291 -0.881 . . . . 0.0 109.542 -179.984 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.22 81.0 71.36 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.331 -0.855 . . . . 0.0 109.515 179.921 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -70.5 156.74 60.78 Favored 'Trans proline' 0 C--O 1.214 -0.701 0 C-N-CA 122.688 2.259 . . . . 0.0 111.806 -179.838 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -70.57 163.91 37.22 Favored 'Trans proline' 0 C--O 1.214 -0.69 0 C-N-CA 122.69 2.26 . . . . 0.0 111.764 179.991 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 89.6 p -82.4 -7.68 59.63 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.265 -0.897 . . . . 0.0 109.636 -179.957 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -66.44 -30.26 70.57 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.178 -0.951 . . . . 0.0 109.574 -179.978 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 117.931 -1.033 . . . . 0.0 109.569 179.939 . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 . . . . . 0 N--CA 1.491 1.621 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.408 ' O ' ' N ' ' A' ' 5' ' ' CYS . 4.3 m -52.36 -22.35 4.51 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.258 -0.901 . . . . 0.0 109.315 179.97 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.46 ' HA ' ' HG3' ' A' ' 6' ' ' LYS . 1.4 tt0 -50.94 -23.26 2.74 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.222 -0.924 . . . . 0.0 108.865 179.77 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 56.4 mtt -77.79 -28.78 50.53 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 179.598 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.437 ' O ' ' N ' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -89.8 -13.43 36.63 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.338 -0.851 . . . . 0.0 108.743 179.663 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.46 ' HG3' ' HA ' ' A' ' 3' ' ' GLU . 34.5 mttm -46.58 -27.46 1.14 Allowed 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 179.327 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.4 ' N ' ' C ' ' A' ' 5' ' ' CYS . 45.4 p-10 -119.15 39.26 3.6 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 178.752 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.573 ' CE2' ' OH ' ' A' ' 16' ' ' TYR . 1.6 t80 -79.48 157.43 27.48 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.62 -0.675 . . . . 0.0 109.839 -179.258 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 15.1 mtt180 -150.17 115.25 5.37 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.398 -0.814 . . . . 0.0 109.055 179.542 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 54.4 t -123.22 146.88 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.342 -0.848 . . . . 0.0 109.521 -179.625 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.503 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.2 OUTLIER -121.2 172.91 4.35 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.384 -0.823 . . . . 0.0 109.347 -179.881 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.503 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 44.2 Cg_endo -66.29 -22.81 52.66 Favored 'Trans proline' 0 C--O 1.216 -0.592 0 C-N-CA 122.669 2.246 . . . . 0.0 111.594 179.802 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 86.6 mtt-85 -101.51 -25.86 13.76 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.365 -0.835 . . . . 0.0 109.328 179.824 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 85.7 mt -87.52 -47.41 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.281 -0.887 . . . . 0.0 109.415 179.966 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 69.46 -172.35 38.79 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.894 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.573 ' OH ' ' CE2' ' A' ' 8' ' ' TYR . 1.5 t80 -95.0 150.86 19.7 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.203 -1.175 . . . . 0.0 109.494 179.927 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 21.8 tp -113.38 106.04 14.11 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.255 -0.903 . . . . 0.0 109.633 -179.83 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.427 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 56.0 m -124.54 154.89 69.8 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.304 -0.873 . . . . 0.0 109.389 179.774 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -72.5 170.77 18.55 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 C-N-CA 122.639 2.226 . . . . 0.0 111.491 179.823 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 41.3 tttp -86.77 -33.9 19.77 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.301 -0.875 . . . . 0.0 109.51 -179.926 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -54.14 133.16 44.12 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.318 -0.864 . . . . 0.0 109.383 179.97 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.434 HD12 ' HB3' ' A' ' 34' ' ' ASN . 54.7 tp -92.4 113.14 25.33 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.164 -0.96 . . . . 0.0 109.417 -179.974 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.508 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 5.3 mmtt -118.94 101.68 49.93 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.301 -0.874 . . . . 0.0 109.172 179.981 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.548 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 43.0 Cg_endo -65.35 118.15 5.2 Favored 'Trans proline' 0 C--O 1.213 -0.76 0 C-N-CA 122.848 2.365 . . . . 0.0 112.034 -179.491 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.401 ' HB ' HG22 ' A' ' 52' ' ' ILE . 11.1 m -114.26 155.99 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.224 -0.923 . . . . 0.0 109.583 179.842 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 46.1 t -96.32 133.77 40.29 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.124 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -91.12 137.01 13.64 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.555 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.464 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 49.9 p30 -66.19 -9.12 28.82 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.341 -1.094 . . . . 0.0 109.502 179.855 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.405 ' OD1' ' HB2' ' A' ' 31' ' ' GLN . 56.0 p30 -86.09 8.81 19.32 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.18 -0.95 . . . . 0.0 109.397 179.894 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.23 18.78 58.53 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 -179.921 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.47 ' O ' ' N ' ' A' ' 27' ' ' GLY . 64.4 mt-30 -125.97 176.09 7.24 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.205 -1.174 . . . . 0.0 109.39 -179.942 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.528 ' CG2' ' HA ' ' A' ' 57' ' ' LYS . 25.1 m -135.44 139.3 44.01 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.258 -0.901 . . . . 0.0 109.442 -179.981 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.631 ' CE1' ' CD1' ' A' ' 39' ' ' LEU . 58.1 m-85 -113.38 130.57 56.26 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.36 -0.838 . . . . 0.0 109.293 179.855 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.486 ' O ' ' O ' ' A' ' 23' ' ' LYS . 13.9 m-20 -51.83 -80.47 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.317 -0.864 . . . . 0.0 109.693 -179.542 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.509 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 12.0 t-20 -82.39 146.04 53.16 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.005 -1.059 . . . . 0.0 109.482 179.945 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.508 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.9 Cg_endo -63.68 -50.86 2.84 Favored 'Trans proline' 0 C--O 1.216 -0.612 0 C-N-CA 122.653 2.235 . . . . 0.0 111.563 179.723 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.556 ' SG ' ' CE1' ' A' ' 16' ' ' TYR . 11.0 t -61.99 -28.21 69.41 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 178.931 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.467 ' HB2' ' HB3' ' A' ' 35' ' ' ASN . 43.0 mmm -68.92 -7.81 38.43 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 179.24 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.631 ' CD1' ' CE1' ' A' ' 33' ' ' TYR . 25.5 tp -73.72 -60.09 2.41 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.29 -0.881 . . . . 0.0 108.902 179.802 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.462 ' SG ' ' OH ' ' A' ' 16' ' ' TYR . 12.0 t -52.91 -24.84 10.08 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.382 -0.969 . . . . 0.0 108.382 179.273 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 33.8 t60 -65.09 -60.7 2.74 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.193 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 66.0 mt-10 -60.22 -21.57 61.95 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 179.063 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.523 ' O ' ' N ' ' A' ' 47' ' ' GLN . 97.2 m-20 -78.22 -27.01 47.64 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.512 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.488 ' O ' ' CD1' ' A' ' 44' ' ' LEU . 1.4 tm? -68.54 -36.34 78.68 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.269 -0.894 . . . . 0.0 108.732 179.422 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.405 HG22 HD11 ' A' ' 45' ' ' ILE . 0.8 OUTLIER -77.24 -41.66 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.46 -0.775 . . . . 0.0 109.165 179.719 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 93.2 mtt-85 -80.11 -36.23 35.67 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.329 -0.857 . . . . 0.0 109.307 179.898 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.523 ' N ' ' O ' ' A' ' 43' ' ' ASN . 53.1 mt-30 60.05 35.4 21.38 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.368 -0.832 . . . . 0.0 109.678 179.834 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 34.6 p -103.13 11.21 37.35 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.171 -0.956 . . . . 0.0 109.413 179.785 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 65.1 m-20 52.51 54.4 10.7 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.232 -0.918 . . . . 0.0 109.478 179.976 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.47 ' HB ' ' OD1' ' A' ' 43' ' ' ASN . 42.9 m -79.77 137.24 36.95 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.198 -0.938 . . . . 0.0 109.527 179.984 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 41.1 m80 -115.53 170.53 8.35 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.363 -0.836 . . . . 0.0 108.947 179.505 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.469 HD11 HG22 ' A' ' 52' ' ' ILE . 29.3 mt -79.62 125.79 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.183 -0.948 . . . . 0.0 109.312 179.884 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.464 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 47.8 ttt180 -81.74 -40.86 22.06 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.501 -0.75 . . . . 0.0 109.496 -179.887 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -158.91 150.59 20.77 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.398 -0.814 . . . . 0.0 109.237 -179.999 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 31.0 p -69.81 139.11 53.14 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.234 -0.917 . . . . 0.0 109.516 -179.873 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.548 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 92.44 162.92 37.44 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.85 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.528 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 39.5 tttp -50.62 148.55 3.82 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.434 -1.039 . . . . 0.0 109.272 179.887 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.405 ' SG ' ' O ' ' A' ' 31' ' ' GLN . 57.8 m -52.07 -26.75 11.76 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.191 -0.943 . . . . 0.0 109.501 -179.975 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.426 ' O ' ' HG2' ' A' ' 59' ' ' GLU . 54.7 tt0 -87.48 -22.17 25.07 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.26 -0.9 . . . . 0.0 109.229 179.864 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 60.4 tt0 -68.45 -33.24 73.84 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.397 -0.814 . . . . 0.0 109.304 179.869 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 16.2 m -61.49 -32.75 72.78 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.213 -0.929 . . . . 0.0 109.438 179.97 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 23.0 t -106.4 153.77 21.77 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.316 -0.865 . . . . 0.0 109.48 179.992 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.49 82.85 66.64 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.228 -0.92 . . . . 0.0 109.437 -179.924 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -71.49 -14.82 30.88 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 122.741 2.294 . . . . 0.0 111.777 -179.967 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 83.04 -162.9 41.1 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.979 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 38.0 m -119.62 142.24 48.59 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.232 -1.157 . . . . 0.0 109.498 -179.981 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 40.2 m -56.02 -31.96 63.58 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.293 -0.879 . . . . 0.0 109.527 -179.999 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -67.78 -30.56 70.04 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.313 -0.867 . . . . 0.0 109.369 -179.965 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.441 ' O ' ' HD3' ' A' ' 72' ' ' PRO . . . -62.85 -31.98 73.11 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.204 -0.935 . . . . 0.0 109.412 179.999 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 86.3 p -58.55 -28.28 65.36 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.193 -0.942 . . . . 0.0 109.47 -179.988 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 65.5 mtp -123.78 76.92 56.98 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.315 -0.866 . . . . 0.0 109.436 179.947 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.441 ' HD3' ' O ' ' A' ' 69' ' ' ALA . 50.4 Cg_endo -70.4 145.56 53.78 Favored 'Trans proline' 0 C--O 1.214 -0.7 0 C-N-CA 122.747 2.298 . . . . 0.0 111.832 179.992 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -71.21 144.0 45.39 Favored 'Trans proline' 0 C--O 1.215 -0.629 0 C-N-CA 122.641 2.227 . . . . 0.0 111.748 179.942 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 29.9 t -128.92 141.11 51.38 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.22 -0.925 . . . . 0.0 109.53 179.987 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -58.59 -36.0 73.31 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.215 -0.928 . . . . 0.0 109.426 -179.963 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 117.946 -1.026 . . . . 0.0 109.43 179.973 . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.429 ' N ' ' HE1' ' A' ' 4' ' ' MET . 87.8 m-20 . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 . . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.1 m -52.79 -24.39 8.79 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.247 -0.908 . . . . 0.0 109.326 179.905 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.45 ' HA ' ' HG3' ' A' ' 6' ' ' LYS . 3.9 mt-10 -54.92 -21.73 12.57 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.326 -0.859 . . . . 0.0 109.133 179.933 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.429 ' HE1' ' N ' ' A' ' 1' ' ' ASP . 76.8 mtm -76.11 -29.46 57.89 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.261 -0.9 . . . . 0.0 108.957 179.525 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.5 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 12.9 m -79.81 -14.0 59.01 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.289 -0.882 . . . . 0.0 109.0 179.696 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.45 ' HG3' ' HA ' ' A' ' 3' ' ' GLU . 47.2 mttm -56.6 -28.2 59.83 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.336 -0.853 . . . . 0.0 109.724 -179.792 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -149.21 61.89 1.04 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.196 -0.94 . . . . 0.0 110.044 -179.779 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.5 ' CD1' ' HA ' ' A' ' 5' ' ' CYS . 4.7 p90 -121.91 168.2 12.16 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.093 -1.005 . . . . 0.0 109.348 179.534 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.434 ' O ' HG21 ' A' ' 10' ' ' VAL . 34.2 ttt85 -147.99 149.02 31.39 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.148 -0.97 . . . . 0.0 109.605 179.922 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.434 HG21 ' O ' ' A' ' 9' ' ' ARG . 87.2 t -140.94 134.96 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.302 -0.874 . . . . 0.0 109.369 179.888 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.506 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -120.59 173.71 3.55 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.15 -0.969 . . . . 0.0 109.391 179.961 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.506 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 47.3 Cg_endo -67.9 -23.94 40.51 Favored 'Trans proline' 0 C--O 1.215 -0.644 0 C-N-CA 122.604 2.203 . . . . 0.0 111.737 179.944 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -104.62 -26.87 12.16 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.283 -0.886 . . . . 0.0 109.453 179.992 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 95.2 mt -86.2 -44.43 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.241 -0.912 . . . . 0.0 109.512 -179.94 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 73.92 -158.73 52.38 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -179.957 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.476 ' HB2' ' CE1' ' A' ' 41' ' ' HIS . 1.9 t80 -99.64 155.29 17.68 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.285 -1.126 . . . . 0.0 109.345 179.803 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.442 ' O ' ' SG ' ' A' ' 37' ' ' CYS . 30.5 tp -114.16 120.1 39.36 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.229 -0.919 . . . . 0.0 109.883 -179.63 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.409 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 69.4 m -138.65 156.22 73.15 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.279 -0.888 . . . . 0.0 109.366 179.894 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.448 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 52.0 Cg_endo -71.65 168.76 22.78 Favored 'Trans proline' 0 C--O 1.215 -0.635 0 C-N-CA 122.681 2.254 . . . . 0.0 111.638 -179.989 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 29.0 mttt -89.9 -12.72 38.09 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.156 -0.965 . . . . 0.0 109.366 179.961 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -72.2 132.06 43.59 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.285 -0.885 . . . . 0.0 109.202 179.698 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 28.7 tp -91.85 114.19 26.66 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.216 -0.927 . . . . 0.0 109.807 -179.679 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.517 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -126.96 106.78 22.21 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.344 -0.848 . . . . 0.0 108.897 179.604 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.546 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 44.0 Cg_endo -65.88 119.93 7.02 Favored 'Trans proline' 0 C--O 1.214 -0.722 0 C-N-CA 122.825 2.35 . . . . 0.0 112.144 -179.315 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.4 m -116.96 153.22 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.232 -0.917 . . . . 0.0 109.518 179.75 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.434 ' SG ' ' HB3' ' A' ' 53' ' ' ARG . 48.6 t -97.04 142.28 29.17 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 178.989 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -93.88 140.52 15.09 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 -178.999 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.464 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 52.4 p30 -67.41 -10.51 51.94 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.31 -1.112 . . . . 0.0 109.264 179.627 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.437 ' OD1' ' HB2' ' A' ' 31' ' ' GLN . 57.0 p30 -90.07 5.91 44.68 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.226 -0.922 . . . . 0.0 109.474 179.891 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.32 15.36 57.37 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 -179.925 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.458 ' O ' ' SG ' ' A' ' 58' ' ' CYS . 84.3 mt-30 -114.87 178.88 4.12 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.374 -1.074 . . . . 0.0 109.387 179.981 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.511 ' CG2' ' HA ' ' A' ' 57' ' ' LYS . 30.7 m -141.21 144.82 34.97 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.193 -0.942 . . . . 0.0 109.335 179.866 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.644 ' CE1' ' CD1' ' A' ' 39' ' ' LEU . 23.9 m-85 -124.59 126.7 46.22 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.269 -0.895 . . . . 0.0 109.278 -179.965 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.485 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 9.8 m-20 -48.38 -78.57 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.301 -0.874 . . . . 0.0 109.736 -179.467 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.542 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 4.5 t-20 -81.49 147.67 60.4 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 120.941 -1.1 . . . . 0.0 109.393 179.983 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.517 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 41.0 Cg_endo -63.66 -53.77 1.22 Allowed 'Trans proline' 0 C--O 1.215 -0.644 0 C-N-CA 122.872 2.381 . . . . 0.0 111.926 -179.963 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.542 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 11.3 t -62.98 -25.68 68.48 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 120.942 -1.099 . . . . 0.0 108.141 179.051 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.44 ' HB2' ' HB3' ' A' ' 35' ' ' ASN . 42.1 mmm -67.35 -13.08 61.67 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.21 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.644 ' CD1' ' CE1' ' A' ' 33' ' ' TYR . 19.1 tp -70.3 -57.55 4.74 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.427 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.471 ' HB3' ' OH ' ' A' ' 16' ' ' TYR . 3.3 t -56.05 -26.77 50.6 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.026 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.476 ' CE1' ' HB2' ' A' ' 16' ' ' TYR . 31.2 t60 -62.43 -59.55 4.82 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.963 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -58.33 -22.89 54.94 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 178.915 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.503 ' O ' ' N ' ' A' ' 47' ' ' GLN . 91.3 m-20 -79.19 -27.75 42.6 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.584 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.461 ' CD1' ' OH ' ' A' ' 8' ' ' TYR . 32.6 tp -70.22 -30.86 68.05 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.498 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 6.5 mm -80.31 -46.29 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.475 -0.766 . . . . 0.0 109.113 179.467 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.47 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 85.3 mtt180 -79.88 -36.56 36.42 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.309 -0.87 . . . . 0.0 109.394 179.712 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.503 ' N ' ' O ' ' A' ' 43' ' ' ASN . 92.4 mt-30 63.75 42.34 6.29 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.497 -0.752 . . . . 0.0 109.616 -179.862 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 49.4 p -106.8 10.16 30.82 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.195 -0.94 . . . . 0.0 109.417 179.737 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 51.51 54.68 10.62 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.273 -0.892 . . . . 0.0 109.71 179.874 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.451 ' HB ' ' OD1' ' A' ' 43' ' ' ASN . 51.5 m -79.88 139.93 36.94 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.215 -0.928 . . . . 0.0 109.528 179.985 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.449 ' CD2' ' OD2' ' A' ' 28' ' ' ASP . 8.4 m-70 -112.47 -173.42 2.24 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.239 -0.913 . . . . 0.0 109.397 179.722 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.474 HD11 HG22 ' A' ' 52' ' ' ILE . 39.8 mt -93.87 126.46 46.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.378 -0.826 . . . . 0.0 109.594 -179.933 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.464 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 68.1 ttt-85 -80.02 -45.77 17.78 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.43 -0.794 . . . . 0.0 109.3 179.787 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 49.4 p -160.88 147.59 15.17 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 -179.445 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.3 p -61.23 144.14 54.32 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.137 -0.977 . . . . 0.0 109.411 179.929 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.546 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 87.51 164.01 39.66 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 -179.775 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.511 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 53.1 mttt -60.44 148.81 36.17 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.414 -1.051 . . . . 0.0 109.293 179.913 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.458 ' SG ' ' O ' ' A' ' 31' ' ' GLN . 61.8 m -54.7 -19.33 5.98 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.189 -0.944 . . . . 0.0 108.999 179.532 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -79.69 -13.12 59.7 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.448 -0.783 . . . . 0.0 109.236 179.873 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.419 ' HG2' ' HB2' ' A' ' 57' ' ' LYS . 13.8 mm-40 -87.37 -24.54 24.21 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 179.263 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 84.0 p -62.95 -13.39 34.15 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.39 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 9.0 t -127.92 155.0 44.89 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.42 -0.8 . . . . 0.0 109.326 179.996 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.99 83.03 64.87 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.14 -0.975 . . . . 0.0 109.737 -179.783 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -72.19 141.68 36.41 Favored 'Trans proline' 0 C--O 1.217 -0.567 0 C-N-CA 122.545 2.163 . . . . 0.0 111.682 179.815 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 89.85 14.93 58.74 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.802 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 58.3 m -112.61 139.4 48.24 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.195 -1.18 . . . . 0.0 109.486 179.877 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 34.1 m -122.19 143.67 49.42 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.288 -0.883 . . . . 0.0 109.438 -179.985 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.0 -29.42 70.81 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.261 -0.9 . . . . 0.0 109.403 179.988 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -101.61 142.58 32.76 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.208 -0.933 . . . . 0.0 109.414 179.995 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 17.0 m -57.99 -28.77 64.71 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.237 -0.914 . . . . 0.0 109.414 -179.947 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.466 ' HB2' ' HD2' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -130.72 159.64 70.15 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.279 -0.888 . . . . 0.0 109.583 179.964 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.466 ' HD2' ' HB2' ' A' ' 71' ' ' MET . 49.4 Cg_endo -69.75 158.78 55.8 Favored 'Trans proline' 0 C--O 1.214 -0.69 0 C-N-CA 122.757 2.304 . . . . 0.0 111.747 -179.964 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -70.42 157.77 58.11 Favored 'Trans proline' 0 C--O 1.216 -0.62 0 C-N-CA 122.729 2.286 . . . . 0.0 111.811 -179.969 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 92.6 p -132.67 154.11 50.44 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.206 -0.934 . . . . 0.0 109.384 -179.983 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -70.07 139.04 52.53 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.218 -0.926 . . . . 0.0 109.471 179.997 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 . . . . . 0 N--CA 1.488 1.461 0 CA-C-O 117.945 -1.026 . . . . 0.0 109.532 179.998 . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.575 ' HB2' ' CE1' ' A' ' 51' ' ' HIS . 4.3 m -55.55 -34.48 64.78 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.295 -0.878 . . . . 0.0 109.345 179.952 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -53.75 -26.01 21.49 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.33 -0.856 . . . . 0.0 109.138 179.908 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 64.1 mmm -73.56 -24.73 60.14 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.297 -0.877 . . . . 0.0 108.821 179.434 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.567 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 29.3 m -81.82 -15.34 54.44 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.483 -0.761 . . . . 0.0 109.112 179.709 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.452 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 45.4 mttm -80.72 5.56 15.4 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.195 -0.94 . . . . 0.0 109.789 -179.954 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.452 ' OD1' ' O ' ' A' ' 6' ' ' LYS . 95.4 m-20 -135.97 12.05 3.36 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.025 -1.047 . . . . 0.0 110.333 -179.367 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.635 ' CE2' ' CE2' ' A' ' 16' ' ' TYR . 0.6 OUTLIER -123.11 155.94 35.98 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.866 -1.146 . . . . 0.0 109.576 179.822 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 47.0 mtt85 -134.19 132.81 40.21 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.372 -0.83 . . . . 0.0 109.149 179.804 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.56 HG22 ' CE2' ' A' ' 8' ' ' TYR . 55.6 t -125.45 147.56 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.195 -0.941 . . . . 0.0 109.872 -179.535 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.523 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 1.3 mp -123.28 174.96 3.04 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.288 -0.883 . . . . 0.0 109.202 179.797 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.523 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 44.8 Cg_endo -67.2 -21.72 47.88 Favored 'Trans proline' 0 C--O 1.215 -0.647 0 C-N-CA 122.561 2.174 . . . . 0.0 111.732 179.923 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 95.0 mtt-85 -104.61 -25.73 12.62 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.369 -0.832 . . . . 0.0 109.684 -179.953 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 24.4 mm -80.95 -47.23 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.232 -0.917 . . . . 0.0 109.532 -179.703 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.531 ' O ' ' CG1' ' A' ' 10' ' ' VAL . . . 82.38 -163.17 42.58 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.935 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.635 ' CE2' ' CE2' ' A' ' 8' ' ' TYR . 1.6 t80 -102.51 148.9 24.96 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.205 -1.174 . . . . 0.0 109.466 179.925 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 27.1 tp -115.63 111.86 21.26 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.31 -0.869 . . . . 0.0 109.532 179.885 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 80.7 m -120.23 157.54 53.07 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.197 -0.939 . . . . 0.0 109.353 -179.977 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.475 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 50.6 Cg_endo -71.57 166.48 29.26 Favored 'Trans proline' 0 C--O 1.215 -0.642 0 C-N-CA 122.713 2.275 . . . . 0.0 111.884 -179.774 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -87.3 -9.74 54.15 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.307 -0.87 . . . . 0.0 109.449 179.902 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -76.31 110.94 11.24 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.183 -0.948 . . . . 0.0 109.106 179.736 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 42.7 tp -79.66 123.62 27.81 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.216 -0.927 . . . . 0.0 109.708 -179.76 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.481 ' O ' ' O ' ' A' ' 34' ' ' ASN . 5.2 mtpt -139.66 107.98 7.12 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.308 -0.87 . . . . 0.0 109.052 179.661 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.556 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 41.5 Cg_endo -64.28 120.23 7.49 Favored 'Trans proline' 0 C--O 1.212 -0.779 0 C-N-CA 122.937 2.424 . . . . 0.0 112.082 -179.558 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.47 ' O ' HG21 ' A' ' 32' ' ' THR . 16.6 m -115.71 154.63 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.282 -0.886 . . . . 0.0 109.835 -179.937 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 43.9 t -97.21 126.28 42.29 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.456 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -78.57 137.66 19.9 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 -179.994 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.485 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 52.9 t0 -70.82 -10.33 59.32 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.174 -1.192 . . . . 0.0 109.566 -179.944 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.427 ' OD1' ' HB2' ' A' ' 31' ' ' GLN . 56.5 p30 -87.96 10.38 19.09 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.257 -0.902 . . . . 0.0 109.24 179.586 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.45 21.39 48.4 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.08 -1.608 . . . . 0.0 109.08 -179.722 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.456 ' O ' ' SG ' ' A' ' 58' ' ' CYS . 87.5 mt-30 -121.0 177.21 5.2 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.277 -1.131 . . . . 0.0 109.542 179.98 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.518 ' CG2' ' HG3' ' A' ' 57' ' ' LYS . 56.7 m -140.37 134.75 31.33 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.314 -0.866 . . . . 0.0 109.304 179.96 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.631 ' CE1' ' CD1' ' A' ' 39' ' ' LEU . 39.0 m-85 -117.36 130.09 56.28 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.309 -0.869 . . . . 0.0 109.295 179.994 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.489 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 7.1 m-20 -54.54 -77.83 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.221 -0.924 . . . . 0.0 109.73 -179.628 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.527 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 5.1 t-20 -81.68 148.69 62.43 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.094 -1.004 . . . . 0.0 109.641 -179.906 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.472 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.6 Cg_endo -63.1 -52.62 1.99 Allowed 'Trans proline' 0 C--O 1.215 -0.631 0 C-N-CA 122.568 2.179 . . . . 0.0 111.807 179.829 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.527 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 5.4 t -61.98 -28.18 69.38 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 178.982 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.486 ' CG ' ' HB3' ' A' ' 35' ' ' ASN . 52.6 mmm -63.32 -16.57 60.76 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.444 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.631 ' CD1' ' CE1' ' A' ' 33' ' ' TYR . 39.0 tp -68.71 -56.87 6.7 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 179.327 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.47 ' HB3' ' OH ' ' A' ' 16' ' ' TYR . 10.9 t -55.78 -23.14 28.13 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 178.864 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 47.1 t60 -71.69 -63.46 1.12 Allowed 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 179.393 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.416 ' HB2' ' CE2' ' A' ' 33' ' ' TYR . 62.2 mt-10 -54.35 -21.77 10.38 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.342 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.495 ' O ' ' N ' ' A' ' 47' ' ' GLN . 99.4 m-20 -73.29 -37.22 66.3 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.424 -0.797 . . . . 0.0 109.116 179.686 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.46 ' HG ' ' O ' ' A' ' 40' ' ' CYS . 24.0 mt -61.41 -32.59 72.53 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.139 -0.975 . . . . 0.0 108.912 179.627 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.8 mt -74.4 -42.58 49.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.377 -0.827 . . . . 0.0 108.832 179.296 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.456 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 69.1 mtt-85 -79.85 -22.57 42.78 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.428 -0.795 . . . . 0.0 109.391 179.744 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.495 ' N ' ' O ' ' A' ' 43' ' ' ASN . 89.5 mt-30 63.21 41.69 7.73 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.395 -0.816 . . . . 0.0 109.427 -179.838 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.409 HG22 ' HB3' ' A' ' 46' ' ' ARG . 16.0 p -128.35 163.5 24.7 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.344 -0.847 . . . . 0.0 109.371 179.87 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 50.9 p-10 -94.3 61.48 2.83 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.175 -0.953 . . . . 0.0 109.428 -179.958 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 31.7 m -69.75 139.0 53.26 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.402 -0.811 . . . . 0.0 109.742 -179.937 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.575 ' CE1' ' HB2' ' A' ' 2' ' ' SER . 62.1 m-70 -119.8 169.36 10.2 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.307 -0.871 . . . . 0.0 109.032 179.538 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.463 HD11 HG22 ' A' ' 52' ' ' ILE . 41.1 mt -79.43 126.42 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.182 -0.949 . . . . 0.0 109.387 179.983 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.485 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 68.8 ttt180 -79.92 -47.98 14.17 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-O 121.638 0.732 . . . . 0.0 109.449 179.988 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 65.2 p -159.71 135.55 8.6 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -179.483 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.5 p -50.88 147.97 4.54 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.245 -0.91 . . . . 0.0 109.525 -179.834 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.556 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 85.94 164.22 38.97 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.326 -1.509 . . . . 0.0 109.326 -179.764 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.521 ' HG2' ' N ' ' A' ' 58' ' ' CYS . 26.0 tttt -59.32 153.72 18.2 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.374 -1.074 . . . . 0.0 109.387 -179.924 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.521 ' N ' ' HG2' ' A' ' 57' ' ' LYS . 98.2 m -55.96 -28.21 55.99 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.267 -0.896 . . . . 0.0 109.704 -179.772 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.453 ' HB3' ' HD3' ' A' ' 57' ' ' LYS . 78.6 tt0 -82.91 -22.57 33.87 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.241 -0.912 . . . . 0.0 109.552 -179.831 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 62.1 tt0 -68.82 -29.63 68.01 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.286 -0.884 . . . . 0.0 109.344 179.96 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 82.6 p -72.67 -19.9 61.34 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.334 -0.853 . . . . 0.0 109.64 -179.87 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 87.6 p -109.09 152.75 24.64 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.169 -0.957 . . . . 0.0 109.597 -179.856 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 11.3 p -126.72 85.6 60.32 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.34 -0.85 . . . . 0.0 109.326 179.888 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -69.62 -18.11 37.86 Favored 'Trans proline' 0 C--O 1.214 -0.684 0 C-N-CA 122.778 2.319 . . . . 0.0 111.886 -179.943 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.27 17.14 65.26 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 179.905 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 14.1 t -131.28 158.27 41.08 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.207 -1.172 . . . . 0.0 109.518 179.939 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 14.8 p -122.77 160.51 25.82 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.31 -0.869 . . . . 0.0 109.377 179.93 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.03 -30.91 66.51 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.219 -0.926 . . . . 0.0 109.52 -179.952 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.31 -34.26 76.26 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.309 -0.869 . . . . 0.0 109.486 -179.893 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 33.9 m -54.5 -33.34 59.66 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.23 -0.919 . . . . 0.0 109.563 179.987 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 7.9 mtp -72.76 151.83 91.19 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.36 -0.838 . . . . 0.0 109.47 -179.973 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -69.92 146.58 59.63 Favored 'Trans proline' 0 C--O 1.215 -0.646 0 C-N-CA 122.742 2.295 . . . . 0.0 111.839 179.997 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -69.79 157.98 58.48 Favored 'Trans proline' 0 C--O 1.215 -0.638 0 C-N-CA 122.765 2.31 . . . . 0.0 111.876 179.983 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 83.8 p -79.73 -10.07 59.74 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.208 -0.933 . . . . 0.0 109.572 -179.984 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.417 ' O ' ' HB2' ' A' ' 76' ' ' GLU . 87.3 m-20 -67.97 -34.61 76.89 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.189 -0.944 . . . . 0.0 109.435 -179.968 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.417 ' HB2' ' O ' ' A' ' 75' ' ' ASP . 75.0 mm-40 . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.498 179.993 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.46 ' OD1' HG13 ' A' ' 52' ' ' ILE . 92.0 m-20 . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 121.288 0.566 . . . . 0.0 109.486 . . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -56.06 -34.83 66.3 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.303 -0.873 . . . . 0.0 109.367 179.888 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -56.56 -24.93 50.41 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.36 -0.837 . . . . 0.0 109.146 179.947 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.442 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 57.2 mmm -74.3 -23.11 59.03 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.316 -0.865 . . . . 0.0 108.722 179.401 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.401 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 17.2 m -81.97 -18.21 44.24 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.483 -0.761 . . . . 0.0 109.155 179.586 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 49.6 mttt -80.2 -3.78 50.41 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.32 -0.862 . . . . 0.0 109.745 -179.886 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' A' ' 4' ' ' MET . 19.3 p30 -118.56 -0.82 11.29 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.08 -1.013 . . . . 0.0 109.714 -179.835 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.573 ' OH ' ' CE2' ' A' ' 16' ' ' TYR . 0.1 OUTLIER -118.51 168.9 10.24 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.053 -1.029 . . . . 0.0 109.284 179.979 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 41.9 mtm-85 -149.63 128.14 12.29 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.243 -0.911 . . . . 0.0 109.254 179.817 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.503 HG22 ' HA ' ' A' ' 16' ' ' TYR . 6.4 p -124.99 145.48 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.218 -0.926 . . . . 0.0 109.847 -179.77 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.464 ' HB3' ' HD2' ' A' ' 12' ' ' PRO . 0.2 OUTLIER -108.37 170.37 5.57 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.359 -0.838 . . . . 0.0 109.229 179.921 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.464 ' HD2' ' HB3' ' A' ' 11' ' ' LEU . 45.7 Cg_endo -67.54 -23.86 42.79 Favored 'Trans proline' 0 C--O 1.215 -0.659 0 C-N-CA 122.622 2.215 . . . . 0.0 111.787 179.951 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 73.2 mtt85 -87.7 -26.28 23.05 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.289 -0.882 . . . . 0.0 109.131 179.734 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 97.7 mt -90.26 -44.49 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.277 -0.889 . . . . 0.0 109.327 179.883 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.432 ' C ' HG22 ' A' ' 10' ' ' VAL . . . 72.97 148.9 1.0 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.991 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.573 ' CE2' ' OH ' ' A' ' 8' ' ' TYR . 0.9 OUTLIER -47.48 148.91 1.24 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.327 -1.102 . . . . 0.0 109.788 -179.874 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 25.9 tp -115.82 110.29 18.84 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.373 -0.829 . . . . 0.0 109.521 -179.992 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 56.1 m -120.74 154.96 57.54 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.272 -0.892 . . . . 0.0 109.445 179.966 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -72.47 169.7 21.12 Favored 'Trans proline' 0 C--O 1.215 -0.669 0 C-N-CA 122.591 2.194 . . . . 0.0 111.475 179.978 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 47.6 mttm -88.7 -17.89 29.02 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.185 -0.947 . . . . 0.0 109.471 -179.911 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -66.94 130.34 42.83 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.262 -0.899 . . . . 0.0 109.296 179.721 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.457 HD12 ' HB3' ' A' ' 34' ' ' ASN . 43.3 tp -87.46 121.88 30.47 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.177 -0.952 . . . . 0.0 109.558 -179.894 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.53 ' CB ' ' HD3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -132.77 99.72 15.18 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.234 -0.916 . . . . 0.0 109.044 179.768 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.544 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 41.9 Cg_endo -63.88 119.77 6.93 Favored 'Trans proline' 0 C--O 1.214 -0.702 0 C-N-CA 122.899 2.399 . . . . 0.0 112.492 -179.248 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.457 ' O ' HG21 ' A' ' 32' ' ' THR . 32.9 m -115.71 154.37 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.345 -0.847 . . . . 0.0 109.473 179.689 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.497 ' O ' ' N ' ' A' ' 53' ' ' ARG . 41.6 t -100.65 121.32 41.43 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.323 -0.86 . . . . 0.0 108.819 179.372 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -74.83 141.62 28.6 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.804 -1.319 . . . . 0.0 109.804 -179.701 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.504 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 55.1 t0 -71.28 -9.69 58.53 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.156 -1.202 . . . . 0.0 109.598 179.969 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -86.81 6.62 30.74 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.234 -0.916 . . . . 0.0 109.198 179.64 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.79 16.6 54.36 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 -179.836 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.516 ' O ' ' N ' ' A' ' 27' ' ' GLY . 87.5 mt-30 -118.19 169.58 9.58 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.194 -1.18 . . . . 0.0 109.532 179.992 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.459 HG22 ' HA ' ' A' ' 57' ' ' LYS . 27.8 m -132.39 134.47 45.19 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.224 -0.922 . . . . 0.0 109.367 179.874 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.578 ' CE1' ' CD1' ' A' ' 39' ' ' LEU . 47.6 m-85 -114.43 130.28 56.7 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.185 -0.947 . . . . 0.0 109.195 179.835 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.506 ' O ' ' O ' ' A' ' 23' ' ' LYS . 5.1 m-20 -52.49 -77.88 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.19 -0.944 . . . . 0.0 109.73 -179.516 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.517 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 13.7 t-20 -81.91 146.5 55.94 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 120.975 -1.078 . . . . 0.0 109.646 -179.895 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.53 ' HD3' ' CB ' ' A' ' 23' ' ' LYS . 40.1 Cg_endo -63.43 -51.29 2.69 Favored 'Trans proline' 0 C--O 1.214 -0.709 0 C-N-CA 122.592 2.195 . . . . 0.0 111.304 179.474 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.517 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 8.8 t -60.62 -28.79 68.8 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 178.835 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.464 ' HB2' ' HB3' ' A' ' 35' ' ' ASN . 12.3 mtt -65.25 -12.7 54.18 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.202 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.578 ' CD1' ' CE1' ' A' ' 33' ' ' TYR . 51.0 tp -71.47 -58.07 3.85 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.294 -0.879 . . . . 0.0 108.726 179.569 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.465 ' SG ' ' OH ' ' A' ' 16' ' ' TYR . 36.0 t -54.61 -24.75 22.67 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 179.048 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 35.1 t60 -68.52 -61.38 1.85 Allowed 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.293 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.419 ' HB2' ' CE2' ' A' ' 33' ' ' TYR . 72.3 mm-40 -56.08 -20.0 15.37 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.259 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.523 ' O ' ' N ' ' A' ' 47' ' ' GLN . 98.0 m-20 -78.61 -29.72 46.17 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.718 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.454 ' HG ' ' O ' ' A' ' 40' ' ' CYS . 16.8 mt -68.95 -30.44 68.89 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.25 -0.906 . . . . 0.0 108.795 179.401 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -80.43 -47.33 21.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.346 -0.846 . . . . 0.0 109.355 179.715 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.452 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 94.9 mtt-85 -79.73 -34.47 39.97 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.285 -0.885 . . . . 0.0 109.321 179.875 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.523 ' N ' ' O ' ' A' ' 43' ' ' ASN . 92.1 mt-30 62.15 39.65 12.63 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.362 -0.836 . . . . 0.0 109.518 -179.939 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.408 ' O ' ' C ' ' A' ' 49' ' ' ASN . 68.1 p -107.63 17.08 23.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.302 -0.874 . . . . 0.0 109.468 179.986 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.408 ' C ' ' O ' ' A' ' 48' ' ' THR . 57.4 m-20 44.15 60.0 2.96 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.174 -0.954 . . . . 0.0 109.285 -179.936 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.473 ' HB ' ' OD1' ' A' ' 43' ' ' ASN . 22.1 m -77.12 145.77 37.59 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.213 -0.929 . . . . 0.0 109.669 -179.742 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 28.6 m-70 -118.49 173.8 6.62 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.281 -0.887 . . . . 0.0 109.137 179.565 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.46 HG13 ' OD1' ' A' ' 1' ' ' ASP . 9.4 mt -86.32 124.66 40.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.224 -0.922 . . . . 0.0 109.713 -179.966 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.504 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 21.0 ttt180 -79.51 -51.82 8.82 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-O 121.631 0.729 . . . . 0.0 109.389 179.959 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 57.8 m -159.76 140.15 11.97 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.507 -0.746 . . . . 0.0 109.122 -179.738 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.8 p -52.85 148.06 8.13 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.151 -0.968 . . . . 0.0 109.518 -179.861 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.544 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 88.64 164.95 40.8 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 -179.883 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.508 ' N ' ' HG3' ' A' ' 60' ' ' GLU . 24.3 mttt -64.32 150.73 45.56 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.493 -1.004 . . . . 0.0 109.224 179.871 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.458 ' SG ' ' OG1' ' A' ' 32' ' ' THR . 86.5 m -55.98 -22.02 24.31 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.23 -0.919 . . . . 0.0 109.429 179.964 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.443 ' O ' ' HG2' ' A' ' 59' ' ' GLU . 48.2 tt0 -80.19 -14.68 58.26 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.267 -0.896 . . . . 0.0 109.617 -179.871 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.508 ' HG3' ' N ' ' A' ' 57' ' ' LYS . 3.5 mt-10 -87.12 -27.88 22.83 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.117 -0.989 . . . . 0.0 109.355 -179.982 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.3 m -64.65 -10.45 26.86 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.249 -0.907 . . . . 0.0 109.544 -179.87 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 24.7 m -133.79 131.56 39.45 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.269 -0.894 . . . . 0.0 109.405 179.952 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.427 ' OG1' ' HD2' ' A' ' 64' ' ' PRO . 1.1 t -54.98 151.33 16.37 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.192 -0.942 . . . . 0.0 109.511 179.969 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.427 ' HD2' ' OG1' ' A' ' 63' ' ' THR . 51.0 Cg_endo -71.07 143.53 44.8 Favored 'Trans proline' 0 C--O 1.215 -0.636 0 C-N-CA 122.735 2.29 . . . . 0.0 111.799 -179.983 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 88.04 -154.53 25.59 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.867 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 19.4 p -127.43 153.8 45.83 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.348 -1.09 . . . . 0.0 109.417 179.994 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 65.6 p -60.98 -26.28 67.45 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.296 -0.878 . . . . 0.0 109.574 -179.983 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.72 -32.09 68.88 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.27 -0.894 . . . . 0.0 109.465 179.936 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -61.85 -37.63 85.24 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.279 -0.888 . . . . 0.0 109.487 179.973 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 21.3 m -53.24 -35.42 59.95 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.221 -0.924 . . . . 0.0 109.519 179.998 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.512 ' CG ' ' HD2' ' A' ' 72' ' ' PRO . 4.8 ttt -65.14 141.3 98.23 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.295 -0.878 . . . . 0.0 109.461 179.893 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.512 ' HD2' ' CG ' ' A' ' 71' ' ' MET . 47.7 Cg_endo -68.75 139.99 45.42 Favored 'Trans proline' 0 C--O 1.215 -0.658 0 C-N-CA 122.641 2.228 . . . . 0.0 111.908 -179.95 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -70.37 172.82 12.5 Favored 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 122.767 2.312 . . . . 0.0 111.784 -179.876 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 23.5 m -89.29 -5.94 57.15 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.311 -0.868 . . . . 0.0 109.633 -179.921 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.437 ' O ' ' HB2' ' A' ' 76' ' ' GLU . 84.0 m-20 -82.18 -23.07 35.7 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.198 -0.939 . . . . 0.0 109.411 179.96 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.437 ' HB2' ' O ' ' A' ' 75' ' ' ASP . 87.5 tt0 . . . . . 0 N--CA 1.489 1.492 0 CA-C-O 117.949 -1.024 . . . . 0.0 109.437 -179.982 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.415 ' OD1' ' HG2' ' A' ' 4' ' ' MET . 51.1 p30 . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 121.264 0.554 . . . . 0.0 109.595 . . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.577 ' HB2' ' CD2' ' A' ' 51' ' ' HIS . 1.2 m -52.71 -35.56 55.89 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.272 -0.893 . . . . 0.0 109.088 179.68 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -55.72 -26.76 46.95 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.485 -0.759 . . . . 0.0 109.177 179.871 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.415 ' HG2' ' OD1' ' A' ' 1' ' ' ASP . 66.4 mmm -70.75 -27.16 63.74 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.32 -0.863 . . . . 0.0 108.917 179.545 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.574 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 39.1 m -80.71 -16.12 54.74 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.539 -0.726 . . . . 0.0 109.367 179.744 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.429 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 60.5 mttt -80.8 9.14 6.73 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.262 -0.899 . . . . 0.0 109.861 179.95 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.429 ' OD1' ' O ' ' A' ' 6' ' ' LYS . 90.6 m-20 -135.35 3.99 3.13 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.874 -1.141 . . . . 0.0 110.551 -179.526 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . 0.664 ' CE2' ' CE2' ' A' ' 16' ' ' TYR . 1.5 p90 -114.76 156.87 24.06 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.805 -1.184 . . . . 0.0 109.803 -179.996 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 62.7 mtm180 -137.15 133.01 34.78 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.331 -0.855 . . . . 0.0 109.462 179.82 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.543 HG22 ' CE2' ' A' ' 8' ' ' TYR . 79.3 t -121.55 143.29 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.351 -0.843 . . . . 0.0 109.687 -179.78 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.542 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 1.8 mp -123.99 176.09 2.47 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.329 -0.857 . . . . 0.0 109.103 179.877 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.542 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 44.3 Cg_endo -67.19 -22.68 46.46 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 122.561 2.174 . . . . 0.0 111.759 179.873 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 71.5 mtt85 -102.94 -28.45 12.02 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.277 -0.889 . . . . 0.0 109.506 179.907 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 94.8 mt -82.79 -46.43 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.358 -0.839 . . . . 0.0 109.766 -179.731 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.428 ' C ' HG12 ' A' ' 10' ' ' VAL . . . 75.81 -169.99 54.7 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.391 -1.483 . . . . 0.0 109.391 -179.87 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.664 ' CE2' ' CE2' ' A' ' 8' ' ' TYR . 1.5 t80 -90.81 151.02 21.34 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.163 -1.198 . . . . 0.0 109.436 179.914 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.409 ' O ' ' SG ' ' A' ' 37' ' ' CYS . 43.1 mt -120.26 126.16 49.91 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.269 -0.894 . . . . 0.0 109.721 -179.839 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.411 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 63.3 m -138.16 155.42 74.29 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.319 -0.863 . . . . 0.0 109.057 179.818 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -70.02 165.06 32.54 Favored 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 122.583 2.189 . . . . 0.0 111.659 179.951 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 77.8 mttt -83.7 -21.71 32.27 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.338 -0.851 . . . . 0.0 109.433 -179.801 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -65.7 122.9 18.34 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.263 -0.898 . . . . 0.0 109.202 179.751 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.426 ' C ' HD12 ' A' ' 22' ' ' LEU . 3.5 tm? -89.68 108.33 19.61 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.18 -0.95 . . . . 0.0 109.338 -179.771 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.505 ' O ' ' O ' ' A' ' 34' ' ' ASN . 4.2 mtpm? -117.42 104.68 49.59 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.389 -0.819 . . . . 0.0 109.132 179.933 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.547 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 42.3 Cg_endo -63.95 119.93 7.14 Favored 'Trans proline' 0 C--O 1.213 -0.739 0 C-N-CA 123.067 2.511 . . . . 0.0 112.502 -179.353 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.473 ' O ' HG21 ' A' ' 32' ' ' THR . 30.1 m -117.35 154.32 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.342 -0.849 . . . . 0.0 109.424 179.703 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 26' ' ' CYS . . . . . 0.503 ' O ' ' N ' ' A' ' 53' ' ' ARG . 43.3 t -98.82 118.21 35.05 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.328 -0.857 . . . . 0.0 109.077 179.622 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -72.57 141.6 31.1 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 110.179 -1.169 . . . . 0.0 110.179 -179.405 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.508 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 54.5 p30 -69.98 -11.26 60.75 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.324 -1.103 . . . . 0.0 109.434 179.748 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.428 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 91.5 m-20 -83.52 9.24 11.79 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.21 -0.931 . . . . 0.0 109.291 179.778 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.52 13.71 67.2 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 -179.908 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.493 ' O ' ' N ' ' A' ' 27' ' ' GLY . 91.8 mt-30 -118.35 170.78 8.62 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.302 -1.116 . . . . 0.0 109.481 179.98 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.513 ' CG2' ' HA ' ' A' ' 57' ' ' LYS . 56.7 m -129.4 138.94 51.77 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.353 -0.842 . . . . 0.0 109.333 -179.95 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.627 ' CD1' ' CD1' ' A' ' 39' ' ' LEU . 23.2 m-85 -118.38 121.88 41.45 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.304 -0.872 . . . . 0.0 108.93 179.643 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.505 ' O ' ' O ' ' A' ' 23' ' ' LYS . 1.6 m-20 -47.8 -78.47 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.355 -0.841 . . . . 0.0 109.557 -179.361 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.531 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 9.6 t-20 -82.36 146.32 53.9 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.019 -1.05 . . . . 0.0 109.788 -179.706 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.483 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.9 Cg_endo -63.67 -51.63 2.33 Favored 'Trans proline' 0 C--O 1.215 -0.667 0 C-N-CA 122.706 2.271 . . . . 0.0 111.627 179.789 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.531 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 9.2 t -62.51 -26.09 68.37 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 178.842 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 38' ' ' MET . . . . . 0.451 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 41.6 mmm -67.37 -17.37 64.71 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.31 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.627 ' CD1' ' CD1' ' A' ' 33' ' ' TYR . 10.6 tp -70.18 -59.95 2.58 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.305 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.473 ' HB3' ' OH ' ' A' ' 16' ' ' TYR . 16.6 t -54.02 -25.62 22.15 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 178.803 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 72.9 t60 -65.19 -62.12 1.73 Allowed 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.096 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.405 ' OE1' ' CE2' ' A' ' 33' ' ' TYR . 82.3 mt-10 -57.46 -19.34 23.53 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 179.002 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.523 ' O ' ' N ' ' A' ' 47' ' ' GLN . 98.9 m-20 -79.72 -26.55 40.8 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.395 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 40.4 tp -72.98 -31.8 64.77 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.412 -0.805 . . . . 0.0 108.912 179.577 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 8.7 mm -80.04 -49.57 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.347 -0.846 . . . . 0.0 109.097 179.629 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.467 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 53.3 mtt-85 -80.9 -34.27 33.62 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.294 -0.879 . . . . 0.0 109.246 179.832 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.523 ' N ' ' O ' ' A' ' 43' ' ' ASN . 92.9 mt-30 63.12 39.95 9.46 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.529 -0.732 . . . . 0.0 109.489 -179.887 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 41.7 p -97.26 2.15 50.49 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.243 -0.91 . . . . 0.0 109.534 179.826 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.456 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 70.4 m-20 55.5 56.23 6.49 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.175 -0.953 . . . . 0.0 109.623 179.989 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.42 HG21 ' N ' ' A' ' 51' ' ' HIS . 55.7 m -79.72 143.06 34.89 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.174 -0.954 . . . . 0.0 109.674 -179.929 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 51' ' ' HIS . . . . . 0.577 ' CD2' ' HB2' ' A' ' 2' ' ' SER . 26.2 m80 -114.25 172.53 6.95 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.269 -0.894 . . . . 0.0 109.054 179.668 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.463 HD11 HG22 ' A' ' 52' ' ' ILE . 19.6 mt -85.74 124.38 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.131 -0.981 . . . . 0.0 109.706 -179.919 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.508 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 31.5 ttt-85 -79.77 -56.68 4.1 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.546 -0.721 . . . . 0.0 109.272 179.81 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -152.34 148.8 27.93 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.545 -0.722 . . . . 0.0 109.162 179.91 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 33.6 p -59.02 151.88 21.13 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.164 -0.96 . . . . 0.0 109.302 -179.963 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.547 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 85.5 166.51 42.06 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 108.955 -1.658 . . . . 0.0 108.955 -179.577 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.513 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 88.6 mttt -66.35 166.67 11.81 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.296 -1.12 . . . . 0.0 109.443 -179.98 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.457 ' SG ' ' OG1' ' A' ' 32' ' ' THR . 85.9 m -72.92 -17.58 61.49 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.294 -0.879 . . . . 0.0 108.955 179.789 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.416 ' O ' ' HG2' ' A' ' 59' ' ' GLU . 56.3 tt0 -79.83 -18.31 51.15 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.482 -0.761 . . . . 0.0 109.43 -179.826 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.472 ' HG3' ' O ' ' A' ' 57' ' ' LYS . 6.7 mt-10 -70.34 -36.61 74.34 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.27 -0.894 . . . . 0.0 109.002 179.731 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 96.8 p -62.64 -15.2 50.83 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.388 -0.82 . . . . 0.0 109.289 179.778 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 23.1 t -121.53 156.31 33.11 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.263 -0.898 . . . . 0.0 109.434 -179.916 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.419 ' O ' HG21 ' A' ' 63' ' ' THR . 2.7 t -132.78 84.74 49.03 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.225 -0.922 . . . . 0.0 109.468 -179.977 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.49 ' HB2' ' CB ' ' A' ' 68' ' ' ALA . 50.3 Cg_endo -71.17 145.48 49.21 Favored 'Trans proline' 0 C--O 1.215 -0.635 0 C-N-CA 122.671 2.247 . . . . 0.0 111.727 179.877 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.77 -179.67 51.71 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.9 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 70.9 m -64.39 -29.47 70.53 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.241 -1.152 . . . . 0.0 109.55 -179.972 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 72.9 p -67.48 -27.81 67.33 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.197 -0.94 . . . . 0.0 109.392 179.941 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.49 ' CB ' ' HB2' ' A' ' 64' ' ' PRO . . . -62.38 -31.5 72.18 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.201 -0.937 . . . . 0.0 109.454 179.95 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.34 -32.21 73.0 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.176 -0.952 . . . . 0.0 109.475 179.923 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 25.3 m -54.41 -30.62 52.86 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.316 -0.865 . . . . 0.0 109.42 -179.931 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.448 ' HB3' ' HD2' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -116.28 166.66 12.01 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.335 -0.853 . . . . 0.0 109.443 179.947 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.448 ' HD2' ' HB3' ' A' ' 71' ' ' MET . 48.8 Cg_endo -70.2 150.7 65.95 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 122.687 2.258 . . . . 0.0 111.733 -179.965 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -70.2 158.51 56.16 Favored 'Trans proline' 0 C--O 1.215 -0.651 0 C-N-CA 122.661 2.24 . . . . 0.0 111.695 179.954 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 29.6 m -134.92 143.8 47.13 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.213 -0.929 . . . . 0.0 109.474 -179.983 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -57.51 -32.89 67.47 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.314 -0.866 . . . . 0.0 109.494 179.974 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.47 179.968 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 63.4 mmm . . . . . 0 N--CA 1.489 1.48 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 5.6 m -81.61 -13.92 57.38 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.328 -0.858 . . . . 0.0 109.251 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 40.5 mttm -54.78 -30.37 56.68 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.294 -0.879 . . . . 0.0 109.84 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -150.56 63.69 0.94 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.169 -0.957 . . . . 0.0 109.839 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.786 ' HE2' HD21 ' A' ' 44' ' ' LEU . 9.0 p90 -116.04 175.47 5.53 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.158 -0.963 . . . . 0.0 109.332 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 70.9 mtt180 -148.68 140.07 23.37 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.214 -0.929 . . . . 0.0 109.53 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.85 HG13 ' O ' ' A' ' 15' ' ' GLY . 92.3 t -133.01 139.8 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.365 -0.834 . . . . 0.0 109.349 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.575 HD13 HD12 ' A' ' 14' ' ' ILE . 0.4 OUTLIER -128.13 172.0 7.59 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.26 -0.9 . . . . 0.0 109.262 179.991 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.478 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 45.1 Cg_endo -67.32 -24.78 43.07 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 122.549 2.166 . . . . 0.0 111.439 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 55.6 mtt180 -106.89 -27.69 10.55 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.359 -0.838 . . . . 0.0 109.123 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.575 HD12 HD13 ' A' ' 11' ' ' LEU . 98.1 mt -85.66 -41.92 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.357 -0.839 . . . . 0.0 109.349 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.85 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 71.49 -140.35 30.5 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.464 ' CD2' HG21 ' A' ' 10' ' ' VAL . 3.1 t80 -110.52 151.34 27.69 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.125 -1.221 . . . . 0.0 109.486 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.458 ' HA ' HD23 ' A' ' 17' ' ' LEU . 52.2 mt -111.21 131.24 55.27 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.291 -0.881 . . . . 0.0 109.349 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.46 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 84.6 m -139.64 156.95 70.97 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.207 -0.933 . . . . 0.0 109.596 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.515 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 47.9 Cg_endo -69.81 166.38 27.86 Favored 'Trans proline' 0 C--O 1.215 -0.634 0 C-N-CA 122.666 2.244 . . . . 0.0 111.661 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 52.7 tttp -87.17 -17.62 32.27 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.307 -0.87 . . . . 0.0 109.359 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -66.98 121.73 16.18 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.254 -0.904 . . . . 0.0 109.379 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.755 HD21 ' OD1' ' A' ' 34' ' ' ASN . 3.5 tm? -85.66 125.29 33.05 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.266 -0.896 . . . . 0.0 109.465 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.672 ' N ' HD13 ' A' ' 22' ' ' LEU . 8.8 mtpt -147.49 113.03 4.04 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.254 -0.904 . . . . 0.0 109.739 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.542 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 43.5 Cg_endo -66.14 123.5 11.32 Favored 'Trans proline' 0 C--O 1.214 -0.711 0 C-N-CA 122.973 2.448 . . . . 0.0 111.74 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.49 ' O ' HG23 ' A' ' 32' ' ' THR . 29.8 m -118.54 154.13 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.246 -0.909 . . . . 0.0 109.86 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.408 ' O ' ' N ' ' A' ' 53' ' ' ARG . 45.5 t -97.09 142.16 29.36 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 178.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -99.5 139.28 14.35 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 -179.287 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.496 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 54.9 p30 -64.58 -10.85 29.1 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.357 -1.084 . . . . 0.0 109.52 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.457 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 70.5 m-20 -91.09 12.65 19.23 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.272 -0.893 . . . . 0.0 109.501 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 81.59 15.4 76.0 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.526 ' O ' ' N ' ' A' ' 27' ' ' GLY . 55.6 mt-30 -117.75 155.51 29.87 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.207 -1.173 . . . . 0.0 109.4 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.636 HG21 ' HG3' ' A' ' 57' ' ' LYS . 23.6 m -118.0 146.74 43.81 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.148 -0.97 . . . . 0.0 109.427 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.892 ' CD2' HD12 ' A' ' 39' ' ' LEU . 78.5 m-85 -124.01 128.01 48.74 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.253 -0.904 . . . . 0.0 109.478 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.755 ' OD1' HD21 ' A' ' 22' ' ' LEU . 56.7 t-20 -47.84 -79.95 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.277 -0.89 . . . . 0.0 109.604 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.517 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 3.9 t-20 -81.09 148.63 64.5 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 120.977 -1.077 . . . . 0.0 109.104 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.48 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 39.3 Cg_endo -62.09 -52.66 2.58 Favored 'Trans proline' 0 C--O 1.215 -0.644 0 C-N-CA 122.62 2.213 . . . . 0.0 111.958 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.517 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 4.8 t -60.34 -30.48 69.56 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 120.977 -1.077 . . . . 0.0 108.256 179.005 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.472 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 24.1 mtp -61.64 -18.29 58.86 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.492 -0.755 . . . . 0.0 109.175 179.566 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.892 HD12 ' CD2' ' A' ' 33' ' ' TYR . 6.7 tt -69.21 -52.74 24.75 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.245 -0.909 . . . . 0.0 108.919 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.499 ' O ' ' HB2' ' A' ' 43' ' ' ASN . 4.9 t -49.48 -32.78 12.79 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 179.053 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.476 ' O ' HG12 ' A' ' 45' ' ' ILE . 27.6 t60 -53.96 -48.08 70.66 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 179.122 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.587 ' HB2' ' CE1' ' A' ' 33' ' ' TYR . 24.5 tp10 -61.28 -16.84 49.76 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.265 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.519 ' OD1' ' N ' ' A' ' 50' ' ' THR . 2.8 m-80 -80.33 -32.8 37.84 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.379 -0.825 . . . . 0.0 109.271 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.786 HD21 ' HE2' ' A' ' 8' ' ' TYR . 7.9 mp -75.69 -31.68 59.81 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.33 -0.856 . . . . 0.0 109.596 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.476 HG12 ' O ' ' A' ' 41' ' ' HIS . 8.9 mm -78.77 -51.32 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.229 -0.919 . . . . 0.0 109.531 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.459 ' NH1' ' HG2' ' A' ' 46' ' ' ARG . 15.2 mtt-85 -81.77 -30.78 32.19 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.301 -0.874 . . . . 0.0 109.729 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.443 ' HA ' ' O ' ' A' ' 43' ' ' ASN . 14.6 mt-30 61.62 34.67 17.56 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.265 -0.897 . . . . 0.0 109.474 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.45 ' O ' ' HB2' ' A' ' 49' ' ' ASN . 52.7 p -106.03 2.86 27.65 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.207 -0.933 . . . . 0.0 109.667 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.45 ' HB2' ' O ' ' A' ' 48' ' ' THR . 22.3 m120 64.88 49.82 2.08 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.196 -0.94 . . . . 0.0 109.572 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.519 ' N ' ' OD1' ' A' ' 43' ' ' ASN . 88.4 m -77.77 128.77 34.55 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.264 -0.897 . . . . 0.0 109.465 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 7.3 m-70 -110.72 -173.35 2.22 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.28 -0.888 . . . . 0.0 109.257 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.768 HG12 HD13 ' A' ' 39' ' ' LEU . 22.1 mt -88.31 126.53 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.296 -0.877 . . . . 0.0 109.446 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.496 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 31.6 ttt180 -80.42 -40.93 25.45 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.363 -0.836 . . . . 0.0 109.274 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -160.53 151.71 19.12 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.497 -0.752 . . . . 0.0 109.09 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.2 p -67.46 148.42 51.57 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.121 -0.987 . . . . 0.0 109.422 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.542 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 84.6 165.7 40.06 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.636 ' HG3' HG21 ' A' ' 32' ' ' THR . 23.2 tttp -57.03 151.54 14.84 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.333 -1.098 . . . . 0.0 109.253 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.469 ' N ' ' HG2' ' A' ' 57' ' ' LYS . 96.6 m . . . . . 0 N--CA 1.489 1.52 0 O-C-N 121.202 -0.936 . . . . 0.0 109.33 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 74.8 mtm . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.588 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 3.9 m -92.91 -8.27 43.75 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.237 -0.914 . . . . 0.0 109.629 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.4 mttt -60.64 -24.65 65.7 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.281 -0.887 . . . . 0.0 109.745 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 59.5 t0 -153.56 63.06 0.74 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.135 -0.978 . . . . 0.0 109.912 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.588 ' CD1' ' HA ' ' A' ' 5' ' ' CYS . 9.2 p90 -122.0 178.59 4.83 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.082 -1.011 . . . . 0.0 109.501 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 37.5 mtm180 -150.1 144.42 25.72 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.276 -0.89 . . . . 0.0 109.295 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.944 HG13 ' O ' ' A' ' 15' ' ' GLY . 84.1 t -138.94 132.02 38.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.144 -0.972 . . . . 0.0 109.765 -179.782 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.553 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 2.3 mp -123.39 176.35 2.23 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.402 -0.811 . . . . 0.0 109.11 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.553 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 43.4 Cg_endo -65.57 -24.44 55.94 Favored 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 122.533 2.155 . . . . 0.0 111.733 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 10.5 mtm180 -108.26 -35.3 6.58 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.258 -0.901 . . . . 0.0 109.032 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 86.8 mt -76.55 -35.56 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.372 -0.83 . . . . 0.0 109.194 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.944 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 61.38 -134.56 48.05 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.154 -1.578 . . . . 0.0 109.154 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.528 ' CD2' HG21 ' A' ' 10' ' ' VAL . 3.4 t80 -113.65 155.6 25.21 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.149 -1.207 . . . . 0.0 109.547 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.445 ' HA ' HD12 ' A' ' 17' ' ' LEU . 18.3 tp -112.95 123.29 49.98 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.345 -0.847 . . . . 0.0 109.726 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.447 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 67.0 m -138.33 156.64 73.48 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.354 -0.842 . . . . 0.0 109.011 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.449 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 48.7 Cg_endo -70.89 165.95 30.59 Favored 'Trans proline' 0 C--O 1.214 -0.687 0 C-N-CA 122.491 2.127 . . . . 0.0 111.573 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 40.1 mttp -85.51 -17.83 35.26 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.232 -0.918 . . . . 0.0 109.41 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 -71.2 130.86 42.53 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.33 -0.856 . . . . 0.0 109.23 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.719 ' C ' HD13 ' A' ' 22' ' ' LEU . 3.4 tm? -95.05 112.65 24.33 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.147 -0.97 . . . . 0.0 109.588 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.505 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 0.2 OUTLIER -121.72 104.92 38.81 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.322 -0.861 . . . . 0.0 109.202 179.75 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.534 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 41.1 Cg_endo -63.43 117.74 4.68 Favored 'Trans proline' 0 C--O 1.213 -0.752 0 C-N-CA 123.039 2.493 . . . . 0.0 112.03 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.527 ' O ' HG23 ' A' ' 32' ' ' THR . 17.8 m -118.44 156.28 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.4 -0.813 . . . . 0.0 109.805 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.421 ' O ' ' N ' ' A' ' 53' ' ' ARG . 27.4 t -99.06 111.99 24.24 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.307 -0.87 . . . . 0.0 109.299 179.675 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.497 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -66.21 138.62 36.86 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.521 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 50.8 p30 -69.83 -10.03 56.92 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.303 -1.116 . . . . 0.0 109.539 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.413 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 91.0 m-20 -83.56 5.25 24.83 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.243 -0.911 . . . . 0.0 109.336 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.43 13.12 58.9 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.497 ' O ' ' N ' ' A' ' 27' ' ' GLY . 85.5 mt-30 -122.76 147.79 46.1 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.446 -1.032 . . . . 0.0 109.464 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.527 HG23 ' O ' ' A' ' 25' ' ' VAL . 28.9 m -108.82 141.89 40.2 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.211 -0.93 . . . . 0.0 109.357 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.693 ' CG ' HD12 ' A' ' 39' ' ' LEU . 10.8 m-85 -121.21 131.11 54.04 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.368 -0.833 . . . . 0.0 109.172 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.522 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 1.6 m-20 -53.95 -76.73 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.187 -0.946 . . . . 0.0 109.365 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.538 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 8.0 t-20 -82.17 146.74 55.57 Favored Pre-proline 0 C--N 1.3 -1.572 0 O-C-N 121.06 -1.025 . . . . 0.0 109.554 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.505 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 41.3 Cg_endo -63.46 -52.14 2.13 Favored 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 122.695 2.263 . . . . 0.0 111.858 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.538 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 11.4 t -64.27 -27.46 69.06 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.964 -1.085 . . . . 0.0 108.319 179.104 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.515 ' CG ' ' HB3' ' A' ' 35' ' ' ASN . 31.5 mmm -60.05 -20.66 59.14 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.578 -0.701 . . . . 0.0 109.165 179.486 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.693 HD12 ' CG ' ' A' ' 33' ' ' TYR . 6.3 tp -67.05 -51.81 50.05 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.307 -0.871 . . . . 0.0 108.883 179.657 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.486 ' HA ' ' HB2' ' A' ' 43' ' ' ASN . 2.0 t -54.59 -23.05 15.21 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.174 -0.954 . . . . 0.0 108.534 179.194 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 27.5 t60 -60.05 -59.3 5.64 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.33 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.473 ' OE1' ' CE2' ' A' ' 33' ' ' TYR . 53.2 tt0 -65.12 -21.31 66.78 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.371 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.519 ' O ' ' N ' ' A' ' 47' ' ' GLN . 87.7 m-20 -77.41 -26.8 52.03 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 28.6 tp -69.83 -33.98 73.03 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.373 -0.829 . . . . 0.0 109.219 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 10.7 mm -80.12 -51.41 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.31 -0.869 . . . . 0.0 109.536 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.543 ' HB3' HG23 ' A' ' 48' ' ' THR . 94.3 mtt-85 -80.18 -33.55 38.23 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.288 -0.882 . . . . 0.0 109.729 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.519 ' N ' ' O ' ' A' ' 43' ' ' ASN . 89.8 mt-30 63.96 39.89 7.7 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.308 -0.87 . . . . 0.0 109.434 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.543 HG23 ' HB3' ' A' ' 46' ' ' ARG . 44.2 p -94.52 -6.75 43.04 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.239 -0.913 . . . . 0.0 109.456 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.46 ' HB2' ' O ' ' A' ' 48' ' ' THR . 74.6 m-20 63.03 55.31 1.98 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.289 -0.882 . . . . 0.0 109.476 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 53.7 m -72.11 138.27 47.62 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.186 -0.946 . . . . 0.0 109.51 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 9.5 m80 -109.62 177.59 4.69 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.325 -0.86 . . . . 0.0 109.204 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.431 HG23 ' HB ' ' A' ' 25' ' ' VAL . 17.7 mt -89.67 124.65 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.224 -0.923 . . . . 0.0 109.777 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.521 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 41.9 ttt180 -80.54 -56.34 4.24 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 121.722 0.772 . . . . 0.0 109.334 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 60.4 p -149.43 147.49 28.32 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 16.0 p -64.27 148.43 50.21 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.221 -0.925 . . . . 0.0 109.381 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.534 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 82.12 163.55 32.6 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.525 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 34.9 mttt -70.47 129.53 39.48 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.439 -1.036 . . . . 0.0 109.457 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 O-C-N 121.174 -0.954 . . . . 0.0 109.281 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 55.0 mmm . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.574 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 4.3 m -83.24 -0.92 51.68 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.464 -0.772 . . . . 0.0 109.4 179.646 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.9 mttm -68.53 -21.24 64.58 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.24 -0.913 . . . . 0.0 109.605 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -150.42 59.63 0.95 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.327 -0.858 . . . . 0.0 109.681 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.703 ' OH ' HD21 ' A' ' 44' ' ' LEU . 6.4 p90 -124.78 173.29 8.68 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.166 -0.959 . . . . 0.0 109.324 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 20.9 ptt-85 -156.0 143.77 19.58 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.259 -0.901 . . . . 0.0 109.383 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.882 HG13 ' O ' ' A' ' 15' ' ' GLY . 58.7 t -130.28 137.76 55.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.327 -0.858 . . . . 0.0 109.38 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.538 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 1.4 mp -119.26 174.4 2.81 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.22 -0.925 . . . . 0.0 109.514 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.538 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 46.3 Cg_endo -68.38 -25.02 36.33 Favored 'Trans proline' 0 C--O 1.215 -0.641 0 C-N-CA 122.602 2.201 . . . . 0.0 111.723 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 52.6 mtt180 -108.37 -25.29 11.07 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.332 -0.855 . . . . 0.0 109.318 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 29.3 mm -85.59 -44.5 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.238 -0.914 . . . . 0.0 109.503 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.882 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 69.33 -144.95 41.77 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.516 ' CE2' HD11 ' A' ' 44' ' ' LEU . 1.2 t80 -104.4 155.96 18.33 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.172 -1.193 . . . . 0.0 109.427 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.651 ' C ' HD13 ' A' ' 17' ' ' LEU . 1.8 tm? -119.12 113.01 20.26 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.262 -0.899 . . . . 0.0 109.622 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.568 ' N ' HD13 ' A' ' 17' ' ' LEU . 61.3 m -127.03 155.84 75.24 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.347 -0.846 . . . . 0.0 109.305 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -70.53 167.67 24.77 Favored 'Trans proline' 0 C--O 1.214 -0.683 0 C-N-CA 122.654 2.236 . . . . 0.0 111.787 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -87.7 -14.56 39.52 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.352 -0.843 . . . . 0.0 109.45 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -72.68 112.88 9.13 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.121 -0.987 . . . . 0.0 109.414 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.417 HD11 ' HB3' ' A' ' 34' ' ' ASN . 56.6 tp -74.53 121.49 21.62 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.11 -0.994 . . . . 0.0 109.449 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.529 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -132.17 100.64 15.42 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.217 -0.927 . . . . 0.0 109.185 179.88 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.532 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 42.6 Cg_endo -64.8 118.74 5.69 Favored 'Trans proline' 0 C--O 1.213 -0.758 0 C-N-CA 122.962 2.441 . . . . 0.0 112.27 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 5.4 m -117.91 156.39 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.284 -0.885 . . . . 0.0 109.784 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.453 ' O ' ' N ' ' A' ' 53' ' ' ARG . 33.8 t -100.41 108.19 20.13 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.33 -0.856 . . . . 0.0 109.287 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -61.77 139.91 46.89 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 -179.723 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.499 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 54.9 p30 -70.04 -9.01 53.91 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.347 -1.09 . . . . 0.0 109.613 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.423 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 55.0 p30 -83.2 1.54 40.15 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.24 -0.913 . . . . 0.0 109.463 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.33 18.34 36.51 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.131 -1.588 . . . . 0.0 109.131 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.472 ' O ' ' N ' ' A' ' 27' ' ' GLY . 91.1 mt-30 -124.72 165.53 17.79 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.29 -1.124 . . . . 0.0 109.37 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 93.7 m -120.88 133.84 55.3 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.3 -0.875 . . . . 0.0 109.277 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.642 ' CD2' HD12 ' A' ' 39' ' ' LEU . 7.8 m-85 -115.02 118.29 33.01 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.243 -0.911 . . . . 0.0 109.162 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.529 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 5.4 m-20 -43.88 -80.84 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.287 -0.883 . . . . 0.0 109.746 -179.35 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.487 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 13.6 t-20 -81.72 145.61 54.63 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 120.957 -1.089 . . . . 0.0 109.621 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.529 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.3 Cg_endo -63.27 -50.44 3.61 Favored 'Trans proline' 0 C--O 1.215 -0.667 0 C-N-CA 122.66 2.24 . . . . 0.0 111.351 179.444 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.487 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 5.3 t -61.62 -27.61 68.78 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 178.7 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.48 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 17.7 mtp -66.12 -18.68 65.5 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.409 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.642 HD12 ' CD2' ' A' ' 33' ' ' TYR . 30.0 tp -63.86 -52.82 58.28 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.551 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.492 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 4.3 t -59.27 -29.51 67.63 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.454 ' CE1' ' HB2' ' A' ' 16' ' ' TYR . 23.2 t60 -64.49 -59.23 4.57 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.565 ' OE1' ' CE2' ' A' ' 33' ' ' TYR . 79.6 mt-10 -58.34 -22.77 54.59 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 179.122 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.492 ' O ' ' N ' ' A' ' 47' ' ' GLN . 94.7 m-20 -73.31 -32.03 64.37 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.503 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.703 HD21 ' OH ' ' A' ' 8' ' ' TYR . 55.3 mt -61.38 -31.34 71.24 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 179.197 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.3 mt -80.37 -39.91 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.441 -0.787 . . . . 0.0 109.043 179.438 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.45 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 62.1 mtt85 -79.51 -24.04 42.53 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.36 -0.837 . . . . 0.0 109.112 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.492 ' N ' ' O ' ' A' ' 43' ' ' ASN . 90.3 mt-30 62.59 42.22 8.73 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.362 -0.836 . . . . 0.0 109.484 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 13.6 t -132.83 164.42 26.89 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.243 -0.911 . . . . 0.0 109.335 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.567 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 84.0 m-20 -94.86 61.21 2.53 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.247 -0.908 . . . . 0.0 109.435 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 86.4 m -66.23 135.63 54.74 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.229 -0.919 . . . . 0.0 109.542 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' HIS . . . . . 0.567 ' CE1' ' O ' ' A' ' 49' ' ' ASN . 57.5 m80 -110.82 -178.84 3.58 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.286 -0.884 . . . . 0.0 109.249 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 12.7 mt -89.6 127.13 42.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.1 -1.0 . . . . 0.0 109.742 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.499 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 20.2 ttt180 -80.1 -57.04 3.82 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.439 -0.788 . . . . 0.0 109.258 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 30.9 m -152.4 142.92 22.71 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.407 ' H ' HG23 ' A' ' 55' ' ' THR . 26.0 p -59.62 146.6 40.39 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.123 -0.986 . . . . 0.0 109.689 -179.618 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.532 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 86.15 162.21 36.42 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.518 ' HG3' ' HB2' ' A' ' 24' ' ' PRO . 67.6 mttt -71.07 124.77 25.16 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.483 -1.01 . . . . 0.0 109.401 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.526 0 O-C-N 121.227 -0.92 . . . . 0.0 109.626 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 73.8 mtp . . . . . 0 N--CA 1.489 1.493 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.587 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 3.7 m -87.43 -8.39 56.56 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.37 -0.831 . . . . 0.0 109.417 179.682 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 40.9 mttt -63.47 -20.09 65.29 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.167 -0.958 . . . . 0.0 109.592 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 -149.73 60.65 1.0 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.26 -0.9 . . . . 0.0 109.673 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.806 ' OH ' HD23 ' A' ' 44' ' ' LEU . 1.7 p90 -133.07 163.29 29.57 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.201 -0.937 . . . . 0.0 109.48 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 92.3 mtt180 -136.18 144.6 45.06 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.223 -0.923 . . . . 0.0 109.508 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.573 HG13 ' O ' ' A' ' 15' ' ' GLY . 53.4 t -141.13 136.24 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.244 -0.91 . . . . 0.0 109.473 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.559 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.2 OUTLIER -125.94 175.32 3.25 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.309 -0.869 . . . . 0.0 109.478 -179.936 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.559 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 45.1 Cg_endo -67.29 -25.9 42.17 Favored 'Trans proline' 0 C--O 1.214 -0.714 0 C-N-CA 122.655 2.237 . . . . 0.0 111.913 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 84.3 mtt-85 -104.86 -26.76 12.09 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.339 -0.85 . . . . 0.0 109.279 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 25.5 mm -82.37 -44.69 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.276 -0.89 . . . . 0.0 109.536 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.573 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 75.17 -156.43 48.82 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.618 ' CE2' ' CE2' ' A' ' 8' ' ' TYR . 2.8 t80 -101.92 154.62 18.78 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.238 -1.154 . . . . 0.0 109.429 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.412 ' HA ' HD12 ' A' ' 17' ' ' LEU . 20.7 tp -107.43 104.82 14.48 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.238 -0.914 . . . . 0.0 109.847 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.43 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 58.9 m -125.39 154.88 72.33 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.275 -0.891 . . . . 0.0 109.159 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -71.21 166.96 27.58 Favored 'Trans proline' 0 C--O 1.216 -0.611 0 C-N-CA 122.7 2.266 . . . . 0.0 111.759 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -82.79 -31.87 28.02 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.317 -0.864 . . . . 0.0 109.416 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -56.88 127.29 31.04 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.214 -0.929 . . . . 0.0 109.47 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.531 HD11 ' HB3' ' A' ' 34' ' ' ASN . 60.6 tp -87.74 117.65 26.72 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.217 -0.927 . . . . 0.0 109.281 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.531 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 19.2 mttt -123.78 99.99 37.96 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.26 -0.9 . . . . 0.0 109.463 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.533 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 42.9 Cg_endo -65.17 116.75 4.03 Favored 'Trans proline' 0 C--O 1.214 -0.712 0 C-N-CA 122.933 2.422 . . . . 0.0 111.901 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.508 ' O ' HG23 ' A' ' 32' ' ' THR . 11.4 m -119.84 156.35 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.254 -0.903 . . . . 0.0 109.976 -179.779 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.45 ' O ' ' N ' ' A' ' 53' ' ' ARG . 14.2 t -99.94 110.75 23.08 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.341 -0.849 . . . . 0.0 109.203 179.53 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -65.27 139.26 39.7 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.517 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 51.1 p30 -69.01 -10.61 58.42 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.294 -1.121 . . . . 0.0 109.638 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.441 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 89.6 m-20 -81.28 3.75 22.91 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.19 -0.944 . . . . 0.0 109.3 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.65 16.15 52.92 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.201 -1.56 . . . . 0.0 109.201 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.508 ' O ' ' N ' ' A' ' 27' ' ' GLY . 84.8 mt-30 -125.86 153.45 44.13 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.392 -1.064 . . . . 0.0 109.425 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.516 ' CG2' ' HA ' ' A' ' 57' ' ' LYS . 56.6 m -110.06 142.43 41.52 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.29 -0.881 . . . . 0.0 109.32 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.663 ' CG ' HD12 ' A' ' 39' ' ' LEU . 28.9 m-85 -121.24 119.23 31.67 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.364 -0.835 . . . . 0.0 109.212 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.531 ' HB3' HD11 ' A' ' 22' ' ' LEU . 8.7 m-20 -43.5 -78.82 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.268 -0.895 . . . . 0.0 109.255 -179.671 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.486 ' O ' ' HB2' ' A' ' 38' ' ' MET . 15.3 t-20 -82.63 145.88 51.9 Favored Pre-proline 0 C--N 1.301 -1.53 0 O-C-N 120.988 -1.07 . . . . 0.0 109.231 179.404 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.531 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 41.2 Cg_endo -63.66 -49.39 4.32 Favored 'Trans proline' 0 C--O 1.215 -0.67 0 C-N-CA 122.425 2.083 . . . . 0.0 111.493 179.472 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.484 ' SG ' ' CE1' ' A' ' 16' ' ' TYR . 7.6 t -63.02 -27.64 69.55 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.486 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 29.1 mmm -63.56 -14.66 53.54 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.478 -0.764 . . . . 0.0 109.123 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.663 HD12 ' CG ' ' A' ' 33' ' ' TYR . 9.3 tp -69.43 -53.32 19.87 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.242 -0.911 . . . . 0.0 108.881 179.496 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.499 ' HB3' ' CZ ' ' A' ' 16' ' ' TYR . 8.3 t -52.26 -22.18 4.19 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.187 -0.946 . . . . 0.0 108.451 179.242 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 53.0 t60 -59.44 -61.41 2.64 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.576 -0.702 . . . . 0.0 109.258 179.44 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -67.37 -15.43 63.68 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.19 -0.944 . . . . 0.0 108.895 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.522 ' O ' ' N ' ' A' ' 47' ' ' GLN . 98.1 m-20 -78.27 -24.03 47.0 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.379 -0.826 . . . . 0.0 109.012 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.96 HD13 ' O ' ' A' ' 44' ' ' LEU . 3.1 tm? -72.27 -34.67 68.39 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.249 -0.907 . . . . 0.0 108.825 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 8.4 mm -77.57 -49.86 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.372 -0.83 . . . . 0.0 109.132 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.554 ' HB3' HG23 ' A' ' 48' ' ' THR . 53.0 mtt-85 -80.0 -37.26 34.59 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.34 -0.85 . . . . 0.0 109.3 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.522 ' N ' ' O ' ' A' ' 43' ' ' ASN . 92.8 mt-30 63.21 37.01 11.53 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.381 -0.824 . . . . 0.0 109.65 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.554 HG23 ' HB3' ' A' ' 46' ' ' ARG . 43.5 p -100.34 8.85 43.41 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.31 -0.869 . . . . 0.0 109.428 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 66.5 m-20 52.77 56.96 6.88 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.26 -0.9 . . . . 0.0 109.52 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 36.7 m -68.02 135.9 53.01 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.254 -0.904 . . . . 0.0 109.39 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 80.2 m-70 -108.77 178.59 4.43 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.325 -0.859 . . . . 0.0 109.354 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 21.0 mt -88.78 125.75 41.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.134 -0.979 . . . . 0.0 109.655 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.517 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 74.4 ttt-85 -81.69 -57.11 3.59 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.433 -0.792 . . . . 0.0 109.576 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 95.8 p -150.18 139.36 21.21 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -179.382 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.4 p -55.72 148.88 15.41 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.178 -0.951 . . . . 0.0 109.425 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.533 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 83.61 165.85 39.1 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.516 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 66.2 mttt -74.63 130.97 40.51 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.438 -1.036 . . . . 0.0 109.362 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.514 0 O-C-N 121.088 -1.007 . . . . 0.0 109.361 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 84.5 mtp . . . . . 0 N--CA 1.489 1.491 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.471 ' O ' ' HB2' ' A' ' 8' ' ' TYR . 57.8 m -80.05 -14.09 58.8 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.476 -0.765 . . . . 0.0 109.053 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.9 mttm -45.8 -28.2 1.01 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.288 -0.882 . . . . 0.0 109.307 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -109.98 29.87 7.23 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.316 -0.865 . . . . 0.0 108.947 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.675 ' CZ ' ' CE1' ' A' ' 16' ' ' TYR . 2.2 t80 -79.97 159.13 26.39 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.557 -0.714 . . . . 0.0 109.93 -179.685 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.3 mtt-85 -149.77 113.82 5.13 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.418 -0.801 . . . . 0.0 108.994 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.939 HG21 ' CD2' ' A' ' 16' ' ' TYR . 77.9 t -118.6 151.93 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.281 -0.887 . . . . 0.0 109.619 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.832 HD23 ' HD2' ' A' ' 12' ' ' PRO . 0.2 OUTLIER -130.03 171.87 8.19 Favored Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 121.303 -0.873 . . . . 0.0 108.991 179.842 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.832 ' HD2' HD23 ' A' ' 11' ' ' LEU . 43.5 Cg_endo -66.25 -22.63 53.18 Favored 'Trans proline' 0 C--O 1.214 -0.692 0 C-N-CA 122.541 2.161 . . . . 0.0 111.729 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -108.55 -26.37 10.45 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.248 -0.908 . . . . 0.0 109.58 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 24.0 mm -80.33 -51.49 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.193 -0.942 . . . . 0.0 109.655 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.89 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 84.12 -166.7 42.74 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.939 ' CD2' HG21 ' A' ' 10' ' ' VAL . 1.8 t80 -99.48 148.68 24.0 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.217 -1.166 . . . . 0.0 109.432 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.746 HD13 ' N ' ' A' ' 18' ' ' CYS . 2.0 tm? -111.94 120.83 43.25 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.258 -0.902 . . . . 0.0 109.564 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.746 ' N ' HD13 ' A' ' 17' ' ' LEU . 82.1 m -134.21 156.72 78.8 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.347 -0.846 . . . . 0.0 109.365 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.535 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 49.5 Cg_endo -70.19 167.07 26.05 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 122.726 2.284 . . . . 0.0 111.738 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 64.3 mttm -92.84 -5.77 50.26 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.252 -0.905 . . . . 0.0 109.482 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -75.98 110.34 10.36 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.145 -0.972 . . . . 0.0 109.324 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.823 HD21 ' OD1' ' A' ' 34' ' ' ASN . 3.5 tm? -74.21 121.37 21.13 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.348 -0.845 . . . . 0.0 109.466 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.609 ' N ' HD13 ' A' ' 22' ' ' LEU . 1.7 mtpm? -145.88 111.49 4.48 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.248 -0.908 . . . . 0.0 109.528 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.545 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 44.3 Cg_endo -65.71 124.48 12.83 Favored 'Trans proline' 0 C--O 1.213 -0.756 0 C-N-CA 123.049 2.499 . . . . 0.0 112.295 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.5 ' O ' HG23 ' A' ' 32' ' ' THR . 31.7 m -116.44 153.62 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.249 -0.907 . . . . 0.0 109.489 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.411 ' O ' ' N ' ' A' ' 53' ' ' ARG . 45.2 t -99.59 119.49 38.15 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.307 -0.87 . . . . 0.0 109.068 179.484 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -76.68 139.87 24.31 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.503 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 51.0 p30 -69.8 -11.61 60.99 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.32 -1.106 . . . . 0.0 109.409 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.467 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 70.5 m-20 -82.38 7.83 13.04 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.376 -0.828 . . . . 0.0 109.467 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 88.37 12.62 64.84 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 -118.22 170.54 8.79 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.337 -1.096 . . . . 0.0 109.533 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.5 HG23 ' O ' ' A' ' 25' ' ' VAL . 95.1 m -130.22 134.68 47.44 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.337 -0.852 . . . . 0.0 109.258 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.83 ' CD1' HD13 ' A' ' 39' ' ' LEU . 48.3 m-85 -112.68 126.79 55.77 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.168 -0.958 . . . . 0.0 109.346 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.823 ' OD1' HD21 ' A' ' 22' ' ' LEU . 60.1 t-20 -48.76 -80.23 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.356 -0.84 . . . . 0.0 110.023 -179.491 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.523 ' HB3' ' CG ' ' A' ' 38' ' ' MET . 2.0 t-20 -80.71 149.59 67.97 Favored Pre-proline 0 C--N 1.301 -1.518 0 O-C-N 120.864 -1.148 . . . . 0.0 109.357 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.456 ' HD2' ' CG ' ' A' ' 35' ' ' ASN . 40.1 Cg_endo -62.86 -54.42 1.19 Allowed 'Trans proline' 0 C--O 1.216 -0.614 0 C-N-CA 122.723 2.282 . . . . 0.0 111.876 -179.715 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.535 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 8.1 t -62.9 -28.52 70.11 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.062 -1.024 . . . . 0.0 108.475 179.258 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.523 ' CG ' ' HB3' ' A' ' 35' ' ' ASN . 59.2 mmm -62.31 -14.29 37.65 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.417 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.83 HD13 ' CD1' ' A' ' 33' ' ' TYR . 25.6 tp -68.49 -51.69 40.51 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.421 -0.799 . . . . 0.0 109.468 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.487 ' HB2' ' OH ' ' A' ' 16' ' ' TYR . 3.1 m -67.97 -17.86 64.56 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 179.207 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.52 ' CE1' ' HB2' ' A' ' 16' ' ' TYR . 46.7 t60 -73.28 -55.74 6.01 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.1 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.559 ' OE1' ' CE2' ' A' ' 33' ' ' TYR . 87.1 tt0 -63.75 -18.89 64.51 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.247 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.495 ' O ' ' N ' ' A' ' 47' ' ' GLN . 93.4 m-20 -74.77 -36.12 62.56 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.643 HD11 ' HE2' ' A' ' 16' ' ' TYR . 19.3 mt -61.25 -32.44 72.25 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.372 -0.83 . . . . 0.0 108.821 179.199 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.521 ' N ' HD13 ' A' ' 45' ' ' ILE . 3.6 mm -75.58 -42.75 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.41 -0.806 . . . . 0.0 108.913 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.464 ' NH1' ' HG2' ' A' ' 46' ' ' ARG . 29.0 mtp85 -80.05 -17.67 52.12 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.379 -0.826 . . . . 0.0 109.038 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.495 ' N ' ' O ' ' A' ' 43' ' ' ASN . 87.8 mt-30 62.21 42.92 9.0 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.278 -0.889 . . . . 0.0 109.409 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 15.4 p -127.66 164.96 20.91 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.292 -0.88 . . . . 0.0 109.353 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -102.3 63.6 0.89 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.181 -0.949 . . . . 0.0 109.433 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 49.8 m -75.03 141.83 43.85 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.302 -0.874 . . . . 0.0 109.567 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -117.87 170.0 9.17 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.311 -0.868 . . . . 0.0 109.049 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.455 HG12 HD22 ' A' ' 39' ' ' LEU . 21.1 mt -79.95 123.37 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.198 -0.939 . . . . 0.0 109.222 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.503 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 49.7 tpt85 -79.62 -49.03 12.76 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.356 -0.84 . . . . 0.0 109.327 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.3 t -156.03 151.73 27.22 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.466 -0.771 . . . . 0.0 109.21 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 38.8 p -65.24 147.7 52.98 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.172 -0.955 . . . . 0.0 109.218 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.545 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 88.82 165.93 41.73 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 108.986 -1.646 . . . . 0.0 108.986 -179.459 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.525 ' CG ' ' HB2' ' A' ' 24' ' ' PRO . 89.7 mttt -64.28 161.26 17.01 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.43 -1.041 . . . . 0.0 109.579 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 86.5 m . . . . . 0 N--CA 1.491 1.624 0 O-C-N 121.229 -0.92 . . . . 0.0 109.366 179.922 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 90.4 mtp . . . . . 0 N--CA 1.489 1.498 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.465 ' O ' ' HB2' ' A' ' 8' ' ' TYR . 4.2 m -79.93 -23.46 41.73 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.357 -0.84 . . . . 0.0 109.136 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 73.0 mttt -48.45 -24.69 1.35 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.251 -0.906 . . . . 0.0 108.873 179.499 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -110.14 29.76 7.36 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.363 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.465 ' HB2' ' O ' ' A' ' 5' ' ' CYS . 1.6 t80 -85.94 153.79 21.94 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.55 -0.719 . . . . 0.0 109.932 -179.417 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 8.9 mtm180 -147.02 113.82 6.08 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.424 -0.797 . . . . 0.0 109.293 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.606 HG21 ' N ' ' A' ' 16' ' ' TYR . 4.6 p -130.64 152.26 37.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.328 -0.857 . . . . 0.0 109.12 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.548 ' CG ' ' HD2' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -109.32 171.64 4.28 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.152 -0.968 . . . . 0.0 109.711 -179.676 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.548 ' HD2' ' CG ' ' A' ' 11' ' ' LEU . 47.7 Cg_endo -69.51 -23.32 32.06 Favored 'Trans proline' 0 C--O 1.214 -0.687 0 C-N-CA 122.699 2.266 . . . . 0.0 111.497 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.472 ' HG2' ' O ' ' A' ' 13' ' ' ARG . 23.1 ttt180 -91.82 -16.23 27.08 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.351 -0.843 . . . . 0.0 109.147 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.422 HD13 ' HA ' ' A' ' 14' ' ' ILE . 26.3 mm -99.8 -41.86 9.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.237 -0.915 . . . . 0.0 109.391 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.564 ' C ' HG21 ' A' ' 10' ' ' VAL . . . 69.22 139.69 0.1 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.606 ' N ' HG21 ' A' ' 10' ' ' VAL . 0.9 OUTLIER -44.88 154.8 0.12 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.261 -1.141 . . . . 0.0 109.401 179.984 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.803 ' N ' HD12 ' A' ' 17' ' ' LEU . 0.3 OUTLIER -118.62 128.07 54.19 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.196 -0.94 . . . . 0.0 109.5 179.957 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.419 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 62.8 m -140.02 156.61 70.33 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.374 -0.828 . . . . 0.0 109.065 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -71.38 167.18 27.02 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.548 2.165 . . . . 0.0 111.492 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 33.3 mttp -86.9 -23.5 25.18 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.182 -0.949 . . . . 0.0 109.586 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -62.14 128.63 37.05 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.119 -0.988 . . . . 0.0 109.257 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.437 HD11 ' HB3' ' A' ' 34' ' ' ASN . 27.8 tp -87.49 117.52 26.34 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.158 -0.963 . . . . 0.0 109.619 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.55 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 0.2 OUTLIER -126.94 100.85 26.95 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.383 -0.823 . . . . 0.0 109.063 179.87 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.529 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 43.4 Cg_endo -65.46 117.93 5.02 Favored 'Trans proline' 0 C--O 1.214 -0.714 0 C-N-CA 123.102 2.535 . . . . 0.0 112.246 -179.363 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.67 ' O ' HG23 ' A' ' 32' ' ' THR . 15.5 m -116.31 154.75 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.359 -0.838 . . . . 0.0 109.568 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 40.3 t -95.97 131.83 41.93 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.368 -0.832 . . . . 0.0 108.803 179.215 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -90.49 134.63 12.44 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -179.672 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.506 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 1.5 m-20 -66.1 -9.02 27.23 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.3 -1.118 . . . . 0.0 109.606 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 50.1 p-10 -85.2 13.85 5.87 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.167 -0.958 . . . . 0.0 109.507 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 81.35 22.65 60.16 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.436 ' O ' ' N ' ' A' ' 27' ' ' GLY . 66.7 mt-30 -131.86 174.1 10.5 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.292 -1.122 . . . . 0.0 109.524 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.67 HG23 ' O ' ' A' ' 25' ' ' VAL . 49.5 m -134.52 137.92 44.25 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.348 -0.845 . . . . 0.0 109.192 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.923 ' CD1' HD13 ' A' ' 39' ' ' LEU . 55.1 m-85 -112.08 122.5 47.92 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.237 -0.914 . . . . 0.0 109.452 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.522 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 7.0 m-20 -46.32 -79.55 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.345 -0.847 . . . . 0.0 109.616 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.539 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 7.6 t-20 -81.94 146.73 56.34 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.034 -1.041 . . . . 0.0 109.358 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.55 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.1 Cg_endo -63.03 -52.96 1.78 Allowed 'Trans proline' 0 C--O 1.216 -0.623 0 C-N-CA 122.824 2.349 . . . . 0.0 111.793 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.539 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 7.8 t -60.67 -26.48 67.12 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 178.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.45 ' HB2' ' HB3' ' A' ' 35' ' ' ASN . 33.6 mmm -70.72 -8.37 51.64 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.175 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.923 HD13 ' CD1' ' A' ' 33' ' ' TYR . 21.8 tp -72.89 -56.02 5.78 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.332 -0.855 . . . . 0.0 109.233 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 3.6 m -63.15 -23.25 67.35 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 119.204 -0.998 . . . . 0.0 108.339 179.323 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.477 ' CE1' ' HB2' ' A' ' 16' ' ' TYR . 49.6 t60 -65.11 -54.66 26.53 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 178.805 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.438 ' HB2' ' CE2' ' A' ' 33' ' ' TYR . 75.6 mt-10 -66.73 -16.75 64.46 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.111 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.45 ' OD1' ' HB ' ' A' ' 50' ' ' THR . 94.3 m-20 -79.16 -26.53 42.73 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.407 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.974 HD13 ' O ' ' A' ' 44' ' ' LEU . 2.5 tm? -69.72 -35.07 74.72 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.247 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.8 mt -76.18 -43.48 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.471 -0.768 . . . . 0.0 109.071 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.443 ' HB3' HG23 ' A' ' 48' ' ' THR . 68.5 mtt85 -79.8 -36.1 37.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.343 -0.848 . . . . 0.0 109.385 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.429 ' N ' ' O ' ' A' ' 43' ' ' ASN . 91.0 mt-30 62.07 40.2 12.28 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.386 -0.821 . . . . 0.0 109.451 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.443 HG23 ' HB3' ' A' ' 46' ' ' ARG . 37.4 p -111.17 15.16 21.68 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.34 -0.85 . . . . 0.0 109.241 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.419 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 70.0 m-20 45.31 58.22 4.3 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.305 -0.872 . . . . 0.0 109.329 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.45 ' HB ' ' OD1' ' A' ' 43' ' ' ASN . 69.9 m -78.15 147.74 34.43 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.269 -0.894 . . . . 0.0 109.557 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' HIS . . . . . 0.419 ' CE1' ' O ' ' A' ' 49' ' ' ASN . 62.2 m80 -124.63 169.91 11.47 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.258 -0.901 . . . . 0.0 109.209 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.421 HG12 HD22 ' A' ' 39' ' ' LEU . 18.9 mt -79.45 122.31 34.41 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 121.099 -1.001 . . . . 0.0 109.307 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.506 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 59.7 ttt-85 -83.11 -38.62 22.19 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.351 -0.843 . . . . 0.0 109.463 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.4 t -158.37 155.08 28.05 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.373 -0.83 . . . . 0.0 109.2 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.2 p -75.33 132.74 41.18 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.187 -0.945 . . . . 0.0 109.49 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.529 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 98.4 165.15 30.86 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.658 ' HA ' HG21 ' A' ' 32' ' ' THR . 13.2 tttp -50.16 150.39 2.44 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.352 -1.087 . . . . 0.0 109.327 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.433 ' SG ' ' O ' ' A' ' 31' ' ' GLN . 43.2 m . . . . . 0 N--CA 1.49 1.542 0 O-C-N 121.279 -0.888 . . . . 0.0 109.396 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' MET . . . . . 0.443 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 74.5 mtp . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.49 ' O ' ' HB2' ' A' ' 8' ' ' TYR . 11.5 m -85.65 -17.85 34.92 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.288 -0.883 . . . . 0.0 109.278 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 27.2 mttt -50.47 -24.34 3.06 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.218 -0.926 . . . . 0.0 108.941 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.443 ' OD1' ' O ' ' A' ' 4' ' ' MET . 55.9 p30 -112.97 32.65 5.55 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 179.227 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.49 ' HB2' ' O ' ' A' ' 5' ' ' CYS . 5.4 t80 -80.13 162.14 24.91 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 121.535 0.683 . . . . 0.0 110.225 -179.228 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 10.9 mtm180 -144.16 116.5 8.52 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.941 HG13 ' C ' ' A' ' 15' ' ' GLY . 53.3 t -112.17 139.11 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.143 -0.973 . . . . 0.0 109.684 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.691 HD23 ' HD2' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -119.92 172.7 4.27 Favored Pre-proline 0 N--CA 1.488 1.466 0 O-C-N 121.481 -0.762 . . . . 0.0 109.091 179.866 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.691 ' HD2' HD23 ' A' ' 11' ' ' LEU . 44.3 Cg_endo -66.85 -23.05 48.24 Favored 'Trans proline' 0 C--O 1.214 -0.678 0 C-N-CA 122.579 2.186 . . . . 0.0 111.729 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.425 ' HG2' ' O ' ' A' ' 13' ' ' ARG . 61.1 ttt-85 -110.5 -22.98 11.39 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.309 -0.869 . . . . 0.0 109.292 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.553 HD12 HD13 ' A' ' 11' ' ' LEU . 82.9 mt -89.43 -41.67 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.381 -0.825 . . . . 0.0 109.474 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.941 ' C ' HG13 ' A' ' 10' ' ' VAL . . . 62.04 -146.67 49.1 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.521 ' HD1' HG21 ' A' ' 10' ' ' VAL . 1.4 t80 -100.6 148.46 24.81 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.316 -1.108 . . . . 0.0 109.566 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.477 HD23 ' HA ' ' A' ' 17' ' ' LEU . 53.8 mt -118.43 128.88 55.03 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.376 -0.827 . . . . 0.0 109.557 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.45 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 79.1 m -139.0 157.2 71.87 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.312 -0.868 . . . . 0.0 109.254 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.486 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 47.4 Cg_endo -69.49 166.69 26.41 Favored 'Trans proline' 0 C--O 1.214 -0.695 0 C-N-CA 122.592 2.195 . . . . 0.0 111.455 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -87.76 -16.02 35.35 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.207 -0.933 . . . . 0.0 109.502 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -69.91 118.01 12.21 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.199 -0.938 . . . . 0.0 109.074 179.584 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 60.3 tp -84.51 122.39 28.94 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.174 -0.954 . . . . 0.0 109.82 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.49 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 0.3 OUTLIER -139.91 110.81 7.29 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.276 -0.89 . . . . 0.0 109.039 179.649 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.535 ' HA ' ' O ' ' A' ' 34' ' ' ASN . 42.2 Cg_endo -64.82 122.98 10.98 Favored 'Trans proline' 0 C--O 1.213 -0.747 0 C-N-CA 122.996 2.464 . . . . 0.0 112.496 -179.23 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.512 ' O ' HG23 ' A' ' 32' ' ' THR . 32.9 m -118.56 155.16 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.45 -0.781 . . . . 0.0 109.681 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.416 ' O ' ' N ' ' A' ' 53' ' ' ARG . 42.5 t -100.54 117.7 35.21 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.327 -0.858 . . . . 0.0 108.991 179.219 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -73.63 138.28 24.71 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 -179.612 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.497 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 53.1 p30 -67.74 -11.1 57.67 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.249 -1.148 . . . . 0.0 109.473 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.461 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 58.5 p30 -82.94 8.68 11.93 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.292 -0.88 . . . . 0.0 109.402 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.09 13.94 65.34 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.473 ' O ' ' N ' ' A' ' 27' ' ' GLY . 92.1 mt-30 -119.56 167.04 12.38 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.27 -1.135 . . . . 0.0 109.461 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.533 ' CG2' ' HA ' ' A' ' 57' ' ' LYS . 90.6 m -126.11 140.47 52.55 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.272 -0.893 . . . . 0.0 109.265 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.845 ' HD2' HD12 ' A' ' 39' ' ' LEU . 59.5 m-85 -118.85 126.24 51.36 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.228 -0.92 . . . . 0.0 109.327 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.535 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 5.9 m-20 -49.77 -75.94 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.21 -0.931 . . . . 0.0 109.397 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.531 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 4.6 t-20 -82.04 148.57 60.75 Favored Pre-proline 0 C--N 1.299 -1.6 0 O-C-N 121.105 -0.997 . . . . 0.0 109.527 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.49 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.0 Cg_endo -62.99 -53.35 1.62 Allowed 'Trans proline' 0 C--O 1.216 -0.619 0 C-N-CA 122.603 2.202 . . . . 0.0 111.728 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.531 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 4.5 t -60.64 -27.63 67.94 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 120.961 -1.087 . . . . 0.0 108.156 179.025 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.475 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 52.6 mmm -65.28 -20.08 66.25 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.845 HD12 ' HD2' ' A' ' 33' ' ' TYR . 6.6 tt -68.42 -51.84 39.44 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.287 -0.883 . . . . 0.0 108.788 179.43 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.51 ' HA ' ' ND2' ' A' ' 43' ' ' ASN . 64.0 m -51.22 -27.99 10.35 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.142 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.419 ' O ' HG13 ' A' ' 45' ' ' ILE . 28.2 t60 -58.63 -47.5 84.18 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.6 ' HB2' ' CE1' ' A' ' 33' ' ' TYR . 26.9 tp10 -60.36 -17.17 41.56 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 179.116 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.527 ' OD1' ' N ' ' A' ' 50' ' ' THR . 3.5 m-80 -80.07 -34.91 37.75 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.405 -0.81 . . . . 0.0 108.927 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.966 HD13 ' O ' ' A' ' 44' ' ' LEU . 2.6 tm? -70.27 -35.79 74.0 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.349 -0.844 . . . . 0.0 109.34 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.419 HG13 ' O ' ' A' ' 41' ' ' HIS . 2.8 mt -76.11 -53.22 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.302 -0.874 . . . . 0.0 109.678 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.449 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 49.8 mtp180 -80.37 -34.51 36.41 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.224 -0.923 . . . . 0.0 109.89 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.498 ' N ' ' O ' ' A' ' 43' ' ' ASN . 90.4 mt-30 62.32 35.17 15.31 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.215 -0.928 . . . . 0.0 109.547 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.427 ' O ' ' HB2' ' A' ' 49' ' ' ASN . 72.3 p -105.64 7.78 32.84 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.195 -0.941 . . . . 0.0 109.623 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.427 ' HB2' ' O ' ' A' ' 48' ' ' THR . 20.5 m120 64.23 49.82 2.52 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.254 -0.904 . . . . 0.0 109.391 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.527 ' N ' ' OD1' ' A' ' 43' ' ' ASN . 63.6 m -76.76 132.53 39.32 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.251 -0.906 . . . . 0.0 109.378 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 15.2 m-70 -115.21 -174.83 2.57 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.282 -0.886 . . . . 0.0 109.521 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.693 HG12 HD13 ' A' ' 39' ' ' LEU . 16.4 mt -86.68 124.77 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.324 -0.86 . . . . 0.0 109.678 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.497 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 75.8 ttt-85 -80.08 -54.73 5.5 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.525 -0.735 . . . . 0.0 109.503 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 77.7 p -151.87 138.95 19.15 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.716 -0.615 . . . . 0.0 109.357 -179.313 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 8.0 p -54.35 148.93 10.82 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.189 -0.944 . . . . 0.0 109.412 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.528 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 88.51 166.66 42.5 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.274 -1.53 . . . . 0.0 109.274 -179.665 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.533 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 27.1 mttt -66.32 143.37 57.22 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.376 -1.073 . . . . 0.0 109.562 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.413 ' C ' ' O ' ' A' ' 57' ' ' LYS . 66.9 m . . . . . 0 N--CA 1.491 1.595 0 O-C-N 121.278 -0.889 . . . . 0.0 109.47 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 56.5 mmm . . . . . 0 N--CA 1.488 1.449 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.598 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 59.2 m -80.12 -21.3 43.36 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.422 -0.799 . . . . 0.0 109.284 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 42.1 mttp -80.69 11.74 3.62 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.331 -0.856 . . . . 0.0 109.786 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -132.75 -1.82 3.37 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.023 -1.048 . . . . 0.0 110.181 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.598 ' CD1' ' HA ' ' A' ' 5' ' ' CYS . 1.6 p90 -114.24 156.56 24.09 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.868 -1.145 . . . . 0.0 109.98 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 31.8 mtm105 -137.16 133.86 35.71 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.351 -0.843 . . . . 0.0 109.202 179.597 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.848 HG13 ' O ' ' A' ' 15' ' ' GLY . 75.7 t -117.65 142.61 31.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.189 -0.944 . . . . 0.0 109.8 -179.601 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.596 ' HB2' HD12 ' A' ' 14' ' ' ILE . 0.4 OUTLIER -126.02 175.45 3.17 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.366 -0.834 . . . . 0.0 109.159 179.946 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.558 ' HD2' ' CG ' ' A' ' 11' ' ' LEU . 43.9 Cg_endo -67.22 -22.24 46.96 Favored 'Trans proline' 0 C--O 1.214 -0.679 0 C-N-CA 122.557 2.171 . . . . 0.0 111.672 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 89.7 mtt180 -103.69 -29.28 11.17 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.298 -0.876 . . . . 0.0 109.56 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.596 HD12 ' HB2' ' A' ' 11' ' ' LEU . 89.2 mt -80.04 -49.64 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.244 -0.91 . . . . 0.0 109.497 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.848 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 82.15 -163.63 43.45 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.558 ' CD1' HG21 ' A' ' 10' ' ' VAL . 0.9 OUTLIER -92.86 151.84 19.75 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.285 -1.126 . . . . 0.0 109.444 -179.973 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 26.0 tp -127.67 116.08 19.73 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.198 -0.939 . . . . 0.0 109.816 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.444 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 77.4 m -129.86 157.36 77.03 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.281 -0.887 . . . . 0.0 109.035 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.537 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 49.4 Cg_endo -70.94 167.96 24.47 Favored 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 122.558 2.172 . . . . 0.0 111.44 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 24.5 mttp -94.8 -6.13 43.62 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.191 -0.943 . . . . 0.0 109.585 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.46 ' OD2' ' HE2' ' A' ' 23' ' ' LYS . 58.6 t0 -76.09 117.4 17.76 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.198 -0.939 . . . . 0.0 109.253 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.754 HD21 ' OD1' ' A' ' 34' ' ' ASN . 3.2 tm? -78.4 122.5 25.88 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.234 -0.916 . . . . 0.0 109.706 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.686 ' N ' HD13 ' A' ' 22' ' ' LEU . 5.2 mttt -142.2 104.01 5.61 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.404 -0.81 . . . . 0.0 109.22 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.542 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 42.6 Cg_endo -65.09 120.86 8.17 Favored 'Trans proline' 0 C--O 1.213 -0.756 0 C-N-CA 123.056 2.504 . . . . 0.0 112.036 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 24.5 m -116.65 155.0 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.321 -0.862 . . . . 0.0 110.005 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.461 ' O ' ' N ' ' A' ' 53' ' ' ARG . 28.0 t -99.67 108.64 21.05 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.475 -0.766 . . . . 0.0 109.319 179.586 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -62.61 138.79 44.99 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.51 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 57.1 p30 -68.86 -10.31 56.25 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.258 -1.143 . . . . 0.0 109.482 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.452 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 90.0 m-20 -84.0 4.93 27.67 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.18 -0.95 . . . . 0.0 109.409 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.51 13.45 58.35 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.223 -1.551 . . . . 0.0 109.223 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.508 ' O ' ' N ' ' A' ' 27' ' ' GLY . 93.5 mt-30 -117.95 160.53 21.29 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.321 -1.106 . . . . 0.0 109.497 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 57.4 m -116.99 130.23 56.55 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.244 -0.91 . . . . 0.0 109.24 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.701 ' CD1' HD13 ' A' ' 39' ' ' LEU . 65.8 m-85 -111.25 119.36 38.65 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.273 -0.892 . . . . 0.0 109.157 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.754 ' OD1' HD21 ' A' ' 22' ' ' LEU . 51.2 t-20 -46.31 -80.44 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.399 -0.813 . . . . 0.0 110.092 -179.363 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.528 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 1.9 t-20 -81.03 150.0 67.72 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.003 -1.061 . . . . 0.0 109.722 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.506 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.9 Cg_endo -63.97 -55.23 0.68 Allowed 'Trans proline' 0 C--O 1.216 -0.612 0 C-N-CA 122.756 2.304 . . . . 0.0 111.818 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.537 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 10.8 t -60.92 -30.45 70.21 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 120.91 -1.119 . . . . 0.0 108.17 178.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.487 ' CG ' ' HB3' ' A' ' 35' ' ' ASN . 52.5 mmm -60.11 -17.73 42.19 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.263 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.701 HD13 ' CD1' ' A' ' 33' ' ' TYR . 33.5 tp -68.5 -58.27 4.57 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 179.455 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.456 ' SG ' ' OH ' ' A' ' 16' ' ' TYR . 8.1 t -56.38 -24.08 42.1 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 178.837 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 30.0 t60 -70.63 -62.81 1.25 Allowed 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 179.148 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.482 ' OE1' ' CE2' ' A' ' 33' ' ' TYR . 78.6 mt-10 -55.47 -21.87 18.25 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.176 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.511 ' O ' ' N ' ' A' ' 47' ' ' GLN . 98.7 m-20 -73.65 -35.88 65.32 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 179.497 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.931 HD13 ' O ' ' A' ' 44' ' ' LEU . 2.0 tm? -62.61 -37.33 85.86 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.399 -0.813 . . . . 0.0 109.005 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.9 mt -71.82 -42.13 69.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.386 -0.821 . . . . 0.0 109.113 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.451 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 12.8 mtt-85 -79.84 -22.3 43.14 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.36 -0.838 . . . . 0.0 109.174 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.511 ' N ' ' O ' ' A' ' 43' ' ' ASN . 92.5 mt-30 63.3 44.68 5.41 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.316 -0.865 . . . . 0.0 109.475 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 21.9 p -128.02 169.88 13.53 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.373 -0.83 . . . . 0.0 109.413 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.571 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 43.9 t30 -102.7 64.84 0.89 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.233 -0.917 . . . . 0.0 109.304 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 33.9 m -74.83 147.32 41.26 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.338 -0.851 . . . . 0.0 109.613 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' HIS . . . . . 0.571 ' CE1' ' O ' ' A' ' 49' ' ' ASN . 51.4 m80 -122.77 -173.65 2.75 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.383 -0.823 . . . . 0.0 109.263 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 11.3 mt -95.82 124.07 48.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.137 -0.977 . . . . 0.0 109.531 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.51 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 72.3 ttt-85 -80.04 -56.0 4.55 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 121.622 0.725 . . . . 0.0 109.558 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 88.7 p -153.95 139.22 17.53 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.45 ' H ' HG23 ' A' ' 55' ' ' THR . 6.5 p -56.56 148.49 19.51 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.116 -0.99 . . . . 0.0 109.349 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.542 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 82.66 161.39 29.93 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.526 ' HG3' ' HB2' ' A' ' 24' ' ' PRO . 26.1 mttp -68.36 131.75 45.86 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.558 -0.966 . . . . 0.0 109.535 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.504 0 O-C-N 121.198 -0.939 . . . . 0.0 109.475 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 75.6 mtp . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.584 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 3.4 m -91.95 -12.45 33.37 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.364 -0.835 . . . . 0.0 109.632 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.4 mttm -57.37 -25.07 58.9 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.276 -0.89 . . . . 0.0 109.721 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 61.5 t0 -152.69 64.45 0.8 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.108 -0.995 . . . . 0.0 109.776 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.997 ' OH ' HD23 ' A' ' 44' ' ' LEU . 4.5 p90 -126.42 169.01 13.42 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.169 -0.957 . . . . 0.0 109.324 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 79.9 mtt180 -142.56 145.98 34.16 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.202 -0.936 . . . . 0.0 109.496 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.732 HG13 ' C ' ' A' ' 15' ' ' GLY . 90.8 t -140.32 134.53 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.266 -0.896 . . . . 0.0 109.471 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.551 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 1.1 mp -123.34 176.08 2.38 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.289 -0.882 . . . . 0.0 109.251 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.551 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 45.4 Cg_endo -67.51 -27.24 39.59 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 122.547 2.165 . . . . 0.0 111.514 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 71.3 mtt-85 -104.06 -29.77 10.68 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.292 -0.88 . . . . 0.0 109.005 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.43 ' HA ' HD13 ' A' ' 14' ' ' ILE . 26.7 mm -81.79 -41.26 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.429 -0.794 . . . . 0.0 109.519 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.732 ' C ' HG13 ' A' ' 10' ' ' VAL . . . 64.78 -147.06 50.82 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.474 ' CE2' ' CE2' ' A' ' 8' ' ' TYR . 1.5 t80 -104.98 151.75 23.55 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.244 -1.151 . . . . 0.0 109.538 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.425 ' HA ' HD12 ' A' ' 17' ' ' LEU . 24.3 tp -104.9 109.41 21.37 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.245 -0.909 . . . . 0.0 109.476 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 63.6 m -129.24 156.43 78.36 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.325 -0.859 . . . . 0.0 109.371 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -72.04 172.6 14.37 Favored 'Trans proline' 0 C--O 1.215 -0.673 0 C-N-CA 122.663 2.242 . . . . 0.0 111.567 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 20.4 tttm -89.51 -15.58 32.67 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.18 -0.95 . . . . 0.0 109.393 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -73.4 108.9 6.53 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.305 -0.872 . . . . 0.0 109.496 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.674 ' C ' HD13 ' A' ' 22' ' ' LEU . 3.5 tm? -77.79 109.72 12.04 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.221 -0.924 . . . . 0.0 109.258 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.502 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 7.1 mtmt -120.49 106.84 39.58 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.313 -0.867 . . . . 0.0 109.308 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.547 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 41.4 Cg_endo -63.44 120.54 8.0 Favored 'Trans proline' 0 C--O 1.213 -0.743 0 C-N-CA 123.151 2.567 . . . . 0.0 112.376 -179.498 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.615 ' O ' HG23 ' A' ' 32' ' ' THR . 18.3 m -115.58 155.52 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.228 -0.92 . . . . 0.0 109.744 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 39.9 t -98.04 115.54 28.43 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.335 -0.853 . . . . 0.0 109.319 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -70.83 138.84 29.0 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.52 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 53.2 t0 -70.92 -9.44 57.8 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.281 -1.129 . . . . 0.0 109.654 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 58.5 p30 -85.72 8.58 19.24 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.11 -0.994 . . . . 0.0 109.253 179.637 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.31 9.63 66.9 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.511 ' O ' ' N ' ' A' ' 27' ' ' GLY . 69.6 mt-30 -118.14 156.64 28.35 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.329 -1.101 . . . . 0.0 109.317 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.623 HG21 ' HA ' ' A' ' 57' ' ' LYS . 33.5 m -116.9 151.88 35.68 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.212 -0.93 . . . . 0.0 109.293 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.841 ' CD1' HD13 ' A' ' 39' ' ' LEU . 73.7 m-85 -129.77 131.06 46.12 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.197 -0.939 . . . . 0.0 109.239 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.539 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 2.7 m-20 -53.21 -79.38 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.288 -0.882 . . . . 0.0 109.636 -179.531 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.521 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 13.2 t-20 -82.64 145.69 51.45 Favored Pre-proline 0 C--N 1.3 -1.555 0 O-C-N 120.893 -1.13 . . . . 0.0 109.826 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.502 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.3 Cg_endo -63.63 -51.13 2.66 Favored 'Trans proline' 0 C--O 1.214 -0.689 0 C-N-CA 122.67 2.247 . . . . 0.0 111.278 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.521 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 5.6 t -60.44 -29.78 69.23 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 178.607 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.447 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 35.9 mmm -66.29 -10.87 46.77 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 179.234 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.841 HD13 ' CD1' ' A' ' 33' ' ' TYR . 52.0 tp -69.24 -55.28 11.03 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.286 -0.884 . . . . 0.0 108.822 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.442 ' HA ' ' HB2' ' A' ' 43' ' ' ASN . 11.5 t -54.85 -29.6 55.58 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 179.085 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 32.5 t60 -60.15 -60.92 3.05 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.149 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.452 ' HA ' ' OE1' ' A' ' 42' ' ' GLU . 68.8 mm-40 -58.86 -22.61 59.49 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 179.057 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.508 ' O ' ' N ' ' A' ' 47' ' ' GLN . 98.5 m-20 -75.97 -23.2 55.32 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.368 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.997 HD23 ' OH ' ' A' ' 8' ' ' TYR . 2.0 tm? -72.4 -36.63 68.69 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.32 -0.862 . . . . 0.0 108.797 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.528 ' N ' HD13 ' A' ' 45' ' ' ILE . 3.8 mm -76.31 -41.96 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.428 -0.795 . . . . 0.0 109.154 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.462 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 21.1 mtt-85 -83.07 -40.2 20.18 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.41 -0.807 . . . . 0.0 109.482 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.508 ' N ' ' O ' ' A' ' 43' ' ' ASN . 89.8 mt-30 63.54 43.44 5.85 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.48 -0.763 . . . . 0.0 109.482 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 72.2 p -113.01 18.75 17.83 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.248 -0.908 . . . . 0.0 109.334 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 54.7 m-20 44.76 58.71 3.77 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.274 -0.891 . . . . 0.0 109.465 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.475 ' HB ' ' OD1' ' A' ' 43' ' ' ASN . 21.1 m -75.22 145.28 42.13 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.15 -0.969 . . . . 0.0 109.744 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 29.4 m-70 -118.69 171.77 7.97 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.302 -0.874 . . . . 0.0 108.981 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.481 HG23 ' HB ' ' A' ' 25' ' ' VAL . 20.2 mt -84.15 124.49 39.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.105 -0.997 . . . . 0.0 109.574 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.52 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 37.1 ttt180 -79.85 -52.41 7.93 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-O 121.701 0.762 . . . . 0.0 109.245 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 24.7 p -151.78 153.91 35.22 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 20.9 p -71.8 136.6 47.13 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.185 -0.947 . . . . 0.0 109.438 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.547 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 95.87 163.32 33.75 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.623 ' HA ' HG21 ' A' ' 32' ' ' THR . 73.6 tttt -49.64 152.62 1.38 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.46 -1.023 . . . . 0.0 109.373 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.42 ' N ' ' HG2' ' A' ' 57' ' ' LYS . 24.5 m . . . . . 0 N--CA 1.49 1.55 0 O-C-N 121.174 -0.954 . . . . 0.0 109.491 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 79.4 mmm . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.598 ' HB3' ' CE1' ' A' ' 8' ' ' TYR . 2.7 m -85.06 5.48 29.36 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.461 -0.775 . . . . 0.0 109.039 179.386 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.446 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 11.5 mttm -66.23 -28.35 68.67 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.18 -0.95 . . . . 0.0 109.554 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.446 ' OD1' ' O ' ' A' ' 6' ' ' LYS . 80.3 m-20 -146.2 65.76 1.2 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.269 -0.894 . . . . 0.0 110.153 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.718 ' CZ ' HD21 ' A' ' 44' ' ' LEU . 12.6 p90 -125.8 -177.7 4.02 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.146 -0.971 . . . . 0.0 109.234 179.348 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 66.4 mtm180 -150.39 143.48 24.85 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.171 -0.955 . . . . 0.0 109.634 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.797 HG13 ' O ' ' A' ' 15' ' ' GLY . 69.1 t -128.4 130.97 69.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.241 -0.912 . . . . 0.0 109.442 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.545 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.2 OUTLIER -111.41 175.0 2.05 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.291 -0.881 . . . . 0.0 109.415 -179.867 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.545 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 46.1 Cg_endo -67.6 -24.17 42.05 Favored 'Trans proline' 0 C--O 1.216 -0.611 0 C-N-CA 122.665 2.243 . . . . 0.0 111.565 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 82.3 mtp180 -94.36 -31.7 13.91 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.342 -0.849 . . . . 0.0 109.104 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 80.5 mt -85.38 -46.99 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.415 -0.803 . . . . 0.0 109.357 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.797 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 70.59 -165.06 52.56 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.527 ' OH ' ' CB ' ' A' ' 40' ' ' CYS . 0.8 OUTLIER -104.41 146.62 28.59 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.235 -1.156 . . . . 0.0 109.377 179.928 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.829 ' N ' HD12 ' A' ' 17' ' ' LEU . 0.6 OUTLIER -112.59 124.87 53.51 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.248 -0.907 . . . . 0.0 109.452 179.86 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.434 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 59.6 m -142.16 155.84 64.9 Favored Pre-proline 0 C--N 1.3 -1.585 0 O-C-N 121.373 -0.829 . . . . 0.0 108.81 179.443 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -70.88 164.45 35.61 Favored 'Trans proline' 0 C--O 1.214 -0.695 0 C-N-CA 122.236 1.957 . . . . 0.0 111.344 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.2 mtpm? -82.54 -26.43 32.46 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.311 -0.868 . . . . 0.0 109.415 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -63.29 124.83 22.23 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.311 -0.868 . . . . 0.0 109.446 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.753 ' C ' HD13 ' A' ' 22' ' ' LEU . 3.4 tm? -86.53 106.96 17.89 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.137 -0.977 . . . . 0.0 109.305 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.516 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 9.5 mttt -115.22 106.79 50.62 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.222 -0.924 . . . . 0.0 109.47 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.537 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 41.7 Cg_endo -63.21 116.94 3.91 Favored 'Trans proline' 0 C--O 1.214 -0.698 0 C-N-CA 123.032 2.488 . . . . 0.0 112.176 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.564 ' HB ' HG23 ' A' ' 52' ' ' ILE . 16.4 m -115.09 154.86 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.285 -0.885 . . . . 0.0 109.266 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.431 ' O ' ' N ' ' A' ' 53' ' ' ARG . 45.1 t -95.08 143.81 26.23 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 178.788 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -97.06 141.49 15.65 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 -178.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.489 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 54.6 p30 -67.42 -8.63 34.63 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.313 -1.11 . . . . 0.0 109.431 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -95.88 10.84 35.84 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.317 -0.864 . . . . 0.0 109.49 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.45 12.31 73.08 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.534 ' O ' ' N ' ' A' ' 27' ' ' GLY . 53.4 mt-30 -115.84 148.26 40.13 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.298 -1.119 . . . . 0.0 109.504 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.641 HG21 ' HA ' ' A' ' 57' ' ' LYS . 8.4 m -112.32 152.23 28.79 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.146 -0.971 . . . . 0.0 109.731 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.852 ' CD2' HD12 ' A' ' 39' ' ' LEU . 94.6 m-85 -129.34 133.4 47.4 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.303 -0.873 . . . . 0.0 109.187 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.693 ' CB ' HD21 ' A' ' 22' ' ' LEU . 1.5 m-20 -53.57 -75.37 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.111 -0.993 . . . . 0.0 109.194 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.526 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 8.4 t-20 -82.38 146.56 54.39 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.155 -0.966 . . . . 0.0 109.188 179.56 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.516 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 42.0 Cg_endo -64.69 -51.38 1.84 Allowed 'Trans proline' 0 C--O 1.216 -0.608 0 C-N-CA 122.649 2.233 . . . . 0.0 111.486 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.526 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 9.5 t -62.38 -27.24 68.94 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 178.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.499 ' CG ' ' HB3' ' A' ' 35' ' ' ASN . 44.9 mmm -66.44 -21.83 66.21 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.686 -0.634 . . . . 0.0 109.29 179.308 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.852 HD12 ' CD2' ' A' ' 33' ' ' TYR . 6.4 tt -64.83 -51.48 61.86 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.247 -0.908 . . . . 0.0 108.841 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.527 ' CB ' ' OH ' ' A' ' 16' ' ' TYR . 33.8 m -51.41 -33.64 31.26 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.06 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 19.1 t60 -53.3 -46.31 69.33 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.237 -0.915 . . . . 0.0 108.552 179.115 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.581 ' HB2' ' CE1' ' A' ' 33' ' ' TYR . 21.4 tp10 -62.03 -17.46 57.38 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.198 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.52 ' HB2' ' O ' ' A' ' 40' ' ' CYS . 2.7 m-80 -79.13 -33.93 43.77 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 119.492 -0.883 . . . . 0.0 109.247 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.718 HD21 ' CZ ' ' A' ' 8' ' ' TYR . 46.6 mt -70.5 -32.93 70.62 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.256 -0.903 . . . . 0.0 109.8 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.7 mm -79.39 -51.6 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.255 -0.903 . . . . 0.0 109.654 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.538 ' HB3' HG23 ' A' ' 48' ' ' THR . 18.5 mtt-85 -82.51 -33.98 28.1 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.21 -0.931 . . . . 0.0 109.833 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.486 ' N ' ' O ' ' A' ' 43' ' ' ASN . 89.6 mt-30 62.52 36.7 13.79 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.247 -0.908 . . . . 0.0 109.422 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.538 HG23 ' HB3' ' A' ' 46' ' ' ARG . 39.0 p -102.87 3.28 36.41 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.226 -0.921 . . . . 0.0 109.631 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.445 ' HB2' ' O ' ' A' ' 48' ' ' THR . 18.6 m120 65.07 48.31 2.29 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.317 -0.864 . . . . 0.0 109.512 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.518 ' N ' ' OD1' ' A' ' 43' ' ' ASN . 48.4 m -80.19 131.39 35.7 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.206 -0.933 . . . . 0.0 109.607 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 11.1 m-70 -114.25 -171.45 1.92 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.272 -0.893 . . . . 0.0 109.38 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.564 HG23 ' HB ' ' A' ' 25' ' ' VAL . 42.9 mt -89.03 127.05 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.311 -0.868 . . . . 0.0 109.574 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.489 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 39.3 ttt85 -81.37 -43.44 19.02 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.424 -0.798 . . . . 0.0 109.255 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.6 m -160.44 146.4 15.18 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.569 -0.707 . . . . 0.0 109.319 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.7 p -61.68 143.5 56.04 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.2 -0.937 . . . . 0.0 109.488 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.537 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 87.58 162.04 37.4 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.641 ' HA ' HG21 ' A' ' 32' ' ' THR . 62.0 tttt -52.91 152.46 3.94 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.667 -0.902 . . . . 0.0 109.603 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 85.3 m . . . . . 0 N--CA 1.492 1.63 0 O-C-N 121.302 -0.874 . . . . 0.0 109.552 179.963 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 92.2 mtp . . . . . 0 N--CA 1.488 1.469 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.6 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 26.2 m -81.42 -14.42 57.14 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.458 -0.776 . . . . 0.0 109.39 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.462 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 22.6 mttm -80.59 5.23 16.04 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.201 -0.937 . . . . 0.0 109.509 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.462 ' OD1' ' O ' ' A' ' 6' ' ' LYS . 93.2 m-20 -135.76 12.82 3.42 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.061 -1.024 . . . . 0.0 110.405 -179.405 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.613 ' CE2' ' CE2' ' A' ' 16' ' ' TYR . 0.6 OUTLIER -123.54 150.72 43.66 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.873 -1.142 . . . . 0.0 109.682 179.815 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 46.1 mtt85 -130.5 132.73 45.78 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.246 -0.908 . . . . 0.0 109.393 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.761 HG13 ' O ' ' A' ' 15' ' ' GLY . 54.2 t -123.39 147.08 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.187 -0.945 . . . . 0.0 109.716 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.709 HD23 ' HD2' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -128.97 176.26 2.93 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.423 -0.798 . . . . 0.0 109.17 -179.999 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.709 ' HD2' HD23 ' A' ' 11' ' ' LEU . 44.0 Cg_endo -66.64 -22.1 51.15 Favored 'Trans proline' 0 C--O 1.214 -0.681 0 C-N-CA 122.477 2.118 . . . . 0.0 111.782 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 60.5 mtt180 -101.55 -30.02 11.63 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.24 -0.913 . . . . 0.0 109.498 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.44 HD12 ' HB2' ' A' ' 11' ' ' LEU . 95.4 mt -81.47 -47.66 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.279 -0.888 . . . . 0.0 109.739 -179.684 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.761 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 77.14 -167.78 54.41 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.613 ' CE2' ' CE2' ' A' ' 8' ' ' TYR . 1.5 t80 -95.75 150.77 20.03 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.177 -1.19 . . . . 0.0 109.662 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 25.7 tp -117.51 105.81 12.49 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.322 -0.861 . . . . 0.0 109.465 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.402 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 76.2 m -117.77 157.3 48.43 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.239 -0.913 . . . . 0.0 109.183 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.485 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 49.5 Cg_endo -72.17 166.01 30.94 Favored 'Trans proline' 0 C--O 1.216 -0.622 0 C-N-CA 122.63 2.22 . . . . 0.0 111.545 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 60.1 mttt -89.38 -13.2 38.31 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.184 -0.948 . . . . 0.0 109.475 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -73.53 113.72 10.96 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.231 -0.918 . . . . 0.0 109.248 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.491 HD11 ' HB3' ' A' ' 34' ' ' ASN . 49.4 tp -76.54 112.54 13.18 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.174 -0.954 . . . . 0.0 109.628 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.489 ' O ' ' O ' ' A' ' 34' ' ' ASN . 14.2 mttt -126.22 110.14 24.0 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.295 -0.878 . . . . 0.0 108.941 179.66 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.542 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 43.5 Cg_endo -64.93 123.98 12.42 Favored 'Trans proline' 0 C--O 1.213 -0.744 0 C-N-CA 123.025 2.483 . . . . 0.0 112.487 -179.187 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.445 ' HB ' HG23 ' A' ' 52' ' ' ILE . 27.2 m -118.77 153.38 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.434 -0.791 . . . . 0.0 109.452 179.674 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 41.9 t -99.45 139.65 34.8 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 178.839 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -93.91 144.44 17.11 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 -178.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.497 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 49.3 p30 -68.87 -15.0 63.38 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.365 -1.079 . . . . 0.0 109.432 179.626 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.457 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 88.1 m-20 -84.46 5.73 26.26 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.232 -0.917 . . . . 0.0 109.542 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.04 17.17 56.65 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.444 ' O ' ' SG ' ' A' ' 58' ' ' CYS . 90.8 mt-30 -115.82 171.13 7.96 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.307 -1.113 . . . . 0.0 109.485 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.554 HG23 ' HA ' ' A' ' 57' ' ' LYS . 64.0 m -133.03 136.0 45.73 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.232 -0.918 . . . . 0.0 109.522 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.927 ' CD1' HD13 ' A' ' 39' ' ' LEU . 44.4 m-85 -116.14 133.17 56.32 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.292 -0.88 . . . . 0.0 109.247 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.54 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 7.7 m-20 -55.3 -77.57 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.262 -0.899 . . . . 0.0 110.031 -179.423 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.524 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 5.4 t-20 -81.63 147.66 59.84 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 120.91 -1.119 . . . . 0.0 109.728 -179.626 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.479 ' HD3' ' O ' ' A' ' 23' ' ' LYS . 41.3 Cg_endo -64.18 -53.09 1.27 Allowed 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 122.771 2.314 . . . . 0.0 111.552 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.524 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 10.1 t -62.34 -29.0 70.14 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 178.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.515 ' CG ' ' HB3' ' A' ' 35' ' ' ASN . 44.6 mmm -62.76 -14.09 40.63 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.241 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.927 HD13 ' CD1' ' A' ' 33' ' ' TYR . 39.8 tp -73.23 -60.17 2.37 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.407 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.455 ' HB3' ' OH ' ' A' ' 16' ' ' TYR . 17.8 t -54.54 -23.56 17.11 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 54.3 t60 -69.46 -62.25 1.46 Allowed 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.283 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 -58.09 -19.1 29.5 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.229 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.494 ' O ' ' N ' ' A' ' 47' ' ' GLN . 99.6 m-20 -76.36 -29.66 57.28 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.482 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.937 HD13 ' O ' ' A' ' 44' ' ' LEU . 1.8 tm? -69.81 -38.79 76.73 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.416 -0.803 . . . . 0.0 109.014 179.543 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.555 ' N ' HD13 ' A' ' 45' ' ' ILE . 3.7 mm -71.54 -46.42 63.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.301 -0.875 . . . . 0.0 109.385 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.447 ' HB3' HG23 ' A' ' 48' ' ' THR . 13.4 mtt-85 -79.59 -33.23 41.82 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.286 -0.884 . . . . 0.0 109.354 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.494 ' N ' ' O ' ' A' ' 43' ' ' ASN . 92.3 mt-30 61.24 39.43 15.7 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.368 -0.832 . . . . 0.0 109.52 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.447 HG23 ' HB3' ' A' ' 46' ' ' ARG . 52.2 p -104.28 8.21 35.99 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.261 -0.9 . . . . 0.0 109.481 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.58 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 35.5 t-20 50.78 57.69 6.36 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.296 -0.878 . . . . 0.0 109.505 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.457 ' HB ' ' OD1' ' A' ' 43' ' ' ASN . 26.6 m -80.32 148.54 30.64 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.182 -0.949 . . . . 0.0 109.785 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' HIS . . . . . 0.58 ' CE1' ' O ' ' A' ' 49' ' ' ASN . 13.7 m80 -122.0 171.34 9.02 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.396 -0.815 . . . . 0.0 108.851 179.472 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.453 HG12 HD22 ' A' ' 39' ' ' LEU . 11.7 mt -83.29 126.48 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.156 -0.965 . . . . 0.0 109.701 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.497 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 55.8 ttt180 -80.04 -46.45 16.55 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.452 -0.78 . . . . 0.0 109.409 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -160.54 142.92 12.89 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.418 ' H ' HG23 ' A' ' 55' ' ' THR . 25.8 p -54.71 148.4 12.84 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.192 -0.942 . . . . 0.0 109.112 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.542 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 84.42 168.2 43.83 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.068 -1.613 . . . . 0.0 109.068 -179.513 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.554 ' HA ' HG23 ' A' ' 32' ' ' THR . 81.7 mttt -63.93 167.14 6.52 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.257 -1.143 . . . . 0.0 109.238 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.444 ' SG ' ' O ' ' A' ' 31' ' ' GLN . 84.0 m . . . . . 0 N--CA 1.488 1.453 0 O-C-N 121.219 -0.926 . . . . 0.0 109.098 179.689 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 84.5 mmm . . . . . 0 N--CA 1.489 1.477 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 16.8 p -79.76 -7.76 58.84 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.14 -0.975 . . . . 0.0 109.286 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 24.7 mttm -49.05 -24.92 1.75 Allowed 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.079 -1.013 . . . . 0.0 108.391 179.486 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.401 ' OD1' ' C ' ' A' ' 7' ' ' ASP . 58.8 p30 -112.98 25.57 11.28 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.319 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.577 ' CZ ' ' CE1' ' A' ' 16' ' ' TYR . 3.7 t80 -79.19 162.82 25.49 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.544 -0.723 . . . . 0.0 109.99 -179.394 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 12.7 mtm180 -148.92 115.36 5.87 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.368 -0.832 . . . . 0.0 108.977 179.651 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.95 HG13 ' C ' ' A' ' 15' ' ' GLY . 99.8 t -111.32 148.99 14.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.229 -0.919 . . . . 0.0 109.468 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.562 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.5 OUTLIER -129.58 175.82 3.3 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.251 -0.905 . . . . 0.0 109.453 -179.674 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.562 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 43.7 Cg_endo -66.77 -22.26 49.93 Favored 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 122.644 2.229 . . . . 0.0 111.584 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.44 ' HB3' ' NH1' ' A' ' 13' ' ' ARG . 19.5 mtp-105 -114.29 -29.49 6.91 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.375 -0.828 . . . . 0.0 109.215 179.683 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.487 HD12 ' HB2' ' A' ' 11' ' ' LEU . 97.1 mt -78.92 -42.02 24.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.338 -0.851 . . . . 0.0 109.383 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.95 ' C ' HG13 ' A' ' 10' ' ' VAL . . . 64.12 -150.89 50.25 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.577 ' CE1' ' CZ ' ' A' ' 8' ' ' TYR . 1.0 OUTLIER -102.68 147.6 26.62 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.266 -1.138 . . . . 0.0 109.352 179.858 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.465 ' HB2' ' OH ' ' A' ' 8' ' ' TYR . 37.5 mt -113.86 124.14 51.49 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.118 -0.989 . . . . 0.0 109.919 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.413 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 61.4 m -138.97 156.32 72.57 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.433 -0.792 . . . . 0.0 109.026 179.724 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -70.74 167.05 26.84 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.573 2.182 . . . . 0.0 111.671 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -88.2 -13.7 40.44 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.208 -0.933 . . . . 0.0 109.698 -179.681 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -74.19 123.48 24.57 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.133 -0.98 . . . . 0.0 109.391 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.542 HD11 ' HB3' ' A' ' 34' ' ' ASN . 39.7 tp -80.61 118.55 22.29 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.275 -0.89 . . . . 0.0 109.515 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.532 ' CB ' ' HD3' ' A' ' 36' ' ' PRO . 10.8 mttp -127.65 100.09 25.69 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.347 -0.846 . . . . 0.0 109.17 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.541 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 42.2 Cg_endo -64.41 118.22 5.2 Favored 'Trans proline' 0 C--O 1.214 -0.713 0 C-N-CA 122.874 2.383 . . . . 0.0 112.133 -179.449 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.526 ' HB ' HG23 ' A' ' 52' ' ' ILE . 12.2 m -114.65 155.74 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.309 -0.87 . . . . 0.0 109.557 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.417 ' SG ' ' NE ' ' A' ' 53' ' ' ARG . 42.4 t -95.62 138.96 32.55 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.237 -0.914 . . . . 0.0 108.661 179.051 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -92.11 136.16 13.1 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.487 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 53.8 t0 -68.96 -7.15 32.51 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.196 -1.179 . . . . 0.0 109.426 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.413 ' OD1' ' C ' ' A' ' 29' ' ' ASP . 59.2 p30 -89.72 2.95 54.19 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.265 -0.897 . . . . 0.0 109.413 179.672 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.64 16.57 39.02 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.463 ' O ' ' SG ' ' A' ' 58' ' ' CYS . 66.2 mt-30 -121.78 -178.37 3.81 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.301 -1.117 . . . . 0.0 109.592 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.615 HG21 ' HA ' ' A' ' 57' ' ' LYS . 11.1 m -143.3 138.85 29.83 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.287 -0.883 . . . . 0.0 109.319 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.871 ' CD1' HD13 ' A' ' 39' ' ' LEU . 40.2 m-85 -116.13 134.09 55.31 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.217 -0.927 . . . . 0.0 109.366 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.542 ' HB3' HD11 ' A' ' 22' ' ' LEU . 13.1 m-20 -55.07 -78.94 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.255 -0.903 . . . . 0.0 109.666 -179.611 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.51 ' HB3' ' CG ' ' A' ' 38' ' ' MET . 10.9 t-20 -82.33 146.14 53.61 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.08 -1.013 . . . . 0.0 109.525 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.532 ' HD3' ' CB ' ' A' ' 23' ' ' LYS . 41.4 Cg_endo -63.94 -51.64 2.16 Favored 'Trans proline' 0 C--O 1.215 -0.651 0 C-N-CA 122.753 2.302 . . . . 0.0 111.621 179.438 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.505 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 8.0 t -62.06 -25.62 67.79 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 178.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.51 ' CG ' ' HB3' ' A' ' 35' ' ' ASN . 65.2 mmm -72.35 -3.02 21.47 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 179.191 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.871 HD13 ' CD1' ' A' ' 33' ' ' TYR . 21.2 tp -74.37 -60.03 2.46 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.287 -0.883 . . . . 0.0 109.175 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.488 ' HB3' ' OH ' ' A' ' 16' ' ' TYR . 2.2 t -56.44 -25.73 51.43 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.122 -0.986 . . . . 0.0 108.468 179.51 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 27.4 t60 -61.9 -56.91 14.42 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.223 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.468 ' OE1' ' CD2' ' A' ' 33' ' ' TYR . 65.1 tt0 -64.2 -20.57 66.11 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.145 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.501 ' O ' ' N ' ' A' ' 47' ' ' GLN . 88.6 m-20 -79.19 -29.88 43.12 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.61 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.977 HD13 ' O ' ' A' ' 44' ' ' LEU . 1.7 tm? -65.41 -36.9 85.35 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.284 -0.885 . . . . 0.0 109.165 179.629 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.2 mt -79.4 -38.88 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.372 -0.83 . . . . 0.0 109.317 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.456 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 17.0 mtt-85 -80.11 -32.79 39.08 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.174 -0.954 . . . . 0.0 109.417 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.501 ' N ' ' O ' ' A' ' 43' ' ' ASN . 73.8 mm-40 61.84 40.93 12.2 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.254 -0.904 . . . . 0.0 109.578 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 25.4 p -113.73 9.84 17.79 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.187 -0.946 . . . . 0.0 109.625 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 49.6 m-20 45.35 58.81 3.91 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.201 -0.937 . . . . 0.0 109.529 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.432 ' HB ' ' OD1' ' A' ' 43' ' ' ASN . 66.0 m -80.33 137.55 36.59 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.158 -0.964 . . . . 0.0 109.779 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 72.2 m80 -110.77 172.02 7.12 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.255 -0.903 . . . . 0.0 108.967 179.451 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.526 HG23 ' HB ' ' A' ' 25' ' ' VAL . 34.7 mt -82.12 126.03 39.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.131 -0.981 . . . . 0.0 109.435 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.487 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 46.6 ttp180 -79.99 -44.56 19.99 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 121.642 0.734 . . . . 0.0 109.309 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 17.1 p -158.49 156.1 29.67 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -179.503 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 36.5 p -71.68 140.32 49.58 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.119 -0.988 . . . . 0.0 109.407 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.541 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 89.5 162.25 38.24 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.551 -1.419 . . . . 0.0 109.551 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.615 ' HA ' HG21 ' A' ' 32' ' ' THR . 46.2 tttp -50.63 148.54 3.83 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.537 -0.978 . . . . 0.0 109.49 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.463 ' SG ' ' O ' ' A' ' 31' ' ' GLN . 92.5 m . . . . . 0 N--CA 1.489 1.523 0 O-C-N 121.318 -0.864 . . . . 0.0 109.331 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 77.4 mtm . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.592 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 48.7 m -80.09 -19.13 48.16 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.396 -0.815 . . . . 0.0 109.351 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.442 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 25.3 mttt -81.04 11.65 3.93 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.362 -0.836 . . . . 0.0 109.985 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' A' ' 6' ' ' LYS . 94.4 m-20 -136.23 4.05 2.91 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.026 -1.046 . . . . 0.0 109.972 -179.759 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.592 ' CD1' ' HA ' ' A' ' 5' ' ' CYS . 0.7 OUTLIER -121.12 147.98 44.81 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.946 -1.096 . . . . 0.0 109.675 -179.951 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 29.2 mtt180 -132.44 124.64 29.01 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.333 -0.854 . . . . 0.0 108.957 179.609 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.74 HG13 ' O ' ' A' ' 15' ' ' GLY . 75.8 t -108.95 141.44 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.333 -0.854 . . . . 0.0 110.183 -179.229 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.687 HD12 ' O ' ' A' ' 10' ' ' VAL . 2.0 mp -130.71 176.18 3.08 Favored Pre-proline 0 N--CA 1.489 1.503 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.723 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.546 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 44.2 Cg_endo -66.55 -23.05 50.39 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 122.593 2.196 . . . . 0.0 111.801 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 31.6 ttp180 -97.78 -35.06 10.65 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.332 -0.855 . . . . 0.0 109.404 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 87.3 mt -80.34 -50.75 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.324 -0.86 . . . . 0.0 109.398 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.74 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 82.51 -171.67 51.6 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.536 ' CD1' HG21 ' A' ' 10' ' ' VAL . 0.9 OUTLIER -86.73 152.92 22.12 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.235 -1.156 . . . . 0.0 109.548 179.984 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 19.1 tp -129.45 117.1 19.98 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.235 -0.915 . . . . 0.0 109.915 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.444 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 75.8 m -133.82 156.72 79.12 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.401 -0.812 . . . . 0.0 108.928 179.515 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.549 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 49.6 Cg_endo -70.62 167.37 25.75 Favored 'Trans proline' 0 C--O 1.216 -0.623 0 C-N-CA 122.689 2.259 . . . . 0.0 111.679 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -93.91 -6.77 44.84 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.302 -0.873 . . . . 0.0 109.573 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.541 ' CB ' ' HE2' ' A' ' 23' ' ' LYS . 77.5 m-20 -74.46 137.01 42.29 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.228 -0.92 . . . . 0.0 109.115 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.839 HD21 ' OD1' ' A' ' 34' ' ' ASN . 3.3 tm? -92.66 119.6 32.23 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.201 -0.937 . . . . 0.0 109.599 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.609 ' N ' HD13 ' A' ' 22' ' ' LEU . 11.5 mttt -139.22 104.26 7.24 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.176 -0.952 . . . . 0.0 109.403 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.543 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 44.2 Cg_endo -67.25 118.47 5.6 Favored 'Trans proline' 0 C--O 1.214 -0.691 0 C-N-CA 122.921 2.414 . . . . 0.0 111.857 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 23.2 m -112.89 155.57 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.247 -0.908 . . . . 0.0 109.927 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.461 ' O ' ' N ' ' A' ' 53' ' ' ARG . 39.3 t -101.49 109.57 21.41 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.315 -0.866 . . . . 0.0 109.338 179.63 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.485 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -62.5 142.17 47.64 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 -179.56 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.51 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 58.4 p30 -70.62 -10.37 59.18 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.326 -1.102 . . . . 0.0 109.378 179.654 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.438 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 55.1 p30 -85.33 6.58 25.74 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.224 -0.923 . . . . 0.0 109.312 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.65 9.47 64.45 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.191 -1.564 . . . . 0.0 109.191 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.485 ' O ' ' N ' ' A' ' 27' ' ' GLY . 88.0 mt-30 -111.18 168.28 9.63 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.381 -1.07 . . . . 0.0 109.517 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.566 HG23 ' HA ' ' A' ' 57' ' ' LYS . 30.3 m -127.68 130.79 49.5 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.243 -0.91 . . . . 0.0 109.402 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.805 ' CD1' HD13 ' A' ' 39' ' ' LEU . 47.1 m-85 -109.44 123.73 49.85 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.208 -0.932 . . . . 0.0 109.188 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.839 ' OD1' HD21 ' A' ' 22' ' ' LEU . 52.5 t-20 -48.3 -78.86 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.252 -0.905 . . . . 0.0 110.057 -179.387 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.535 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 1.4 t-20 -81.2 150.36 67.85 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.002 -1.061 . . . . 0.0 109.617 -179.75 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.469 ' HD2' ' CG ' ' A' ' 35' ' ' ASN . 40.7 Cg_endo -63.52 -55.5 0.7 Allowed 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 122.874 2.383 . . . . 0.0 112.037 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.549 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 13.6 t -63.31 -28.65 70.16 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.995 -1.066 . . . . 0.0 108.539 179.23 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.475 ' CG ' ' HB3' ' A' ' 35' ' ' ASN . 51.5 mmm -61.16 -17.66 54.06 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.345 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.805 HD13 ' CD1' ' A' ' 33' ' ' TYR . 30.7 tp -67.11 -59.0 3.83 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.269 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.458 ' HB3' ' OH ' ' A' ' 16' ' ' TYR . 8.2 t -55.8 -27.47 51.3 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.734 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.407 ' HB3' ' O ' ' A' ' 38' ' ' MET . 49.1 t60 -63.5 -61.09 2.56 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.0 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 63.1 mt-10 -57.47 -20.88 33.7 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 178.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.5 ' O ' ' N ' ' A' ' 47' ' ' GLN . 95.9 m-20 -80.27 -26.68 38.83 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.564 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 35.8 tp -71.3 -32.26 68.42 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.275 -0.891 . . . . 0.0 108.722 179.589 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 6.6 mm -80.57 -46.5 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.415 -0.803 . . . . 0.0 109.181 179.525 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.521 ' HB3' HG23 ' A' ' 48' ' ' THR . 58.0 mtt-85 -80.12 -36.69 34.96 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.253 -0.905 . . . . 0.0 109.285 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.5 ' N ' ' O ' ' A' ' 43' ' ' ASN . 91.7 mt-30 63.89 39.8 7.92 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.535 -0.728 . . . . 0.0 109.518 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.521 HG23 ' HB3' ' A' ' 46' ' ' ARG . 39.6 p -101.77 6.02 41.51 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.293 -0.879 . . . . 0.0 109.415 179.691 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.462 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 49.6 t30 52.78 57.24 6.58 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.301 -0.874 . . . . 0.0 109.687 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 58.4 m -80.12 141.34 35.85 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.185 -0.947 . . . . 0.0 109.633 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' HIS . . . . . 0.462 ' CE1' ' O ' ' A' ' 49' ' ' ASN . 13.9 m80 -111.13 178.83 4.22 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.331 -0.855 . . . . 0.0 109.192 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.9 mt -90.25 127.22 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.123 -0.985 . . . . 0.0 109.799 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.51 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 28.4 ttt180 -80.18 -59.83 2.56 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.494 -0.754 . . . . 0.0 109.287 179.694 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 21.1 m -154.04 142.25 20.45 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.3 p -53.3 143.41 18.71 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.157 -0.965 . . . . 0.0 109.542 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.543 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 95.26 162.95 34.46 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.566 ' HA ' HG23 ' A' ' 32' ' ' THR . 18.0 mttp -64.26 149.68 47.53 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.465 -1.02 . . . . 0.0 109.341 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.457 ' SG ' ' O ' ' A' ' 31' ' ' GLN . 70.2 m . . . . . 0 N--CA 1.489 1.524 0 O-C-N 121.223 -0.923 . . . . 0.0 109.41 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' MET . . . . . 0.452 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 86.4 mtp . . . . . 0 N--CA 1.488 1.466 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.581 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 27.1 m -87.15 -16.64 34.83 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.479 -0.763 . . . . 0.0 109.123 179.579 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.7 mttp -81.15 14.25 2.43 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.303 -0.873 . . . . 0.0 109.943 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.452 ' OD1' ' O ' ' A' ' 4' ' ' MET . 51.7 p30 -145.79 10.5 1.21 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.918 -1.114 . . . . 0.0 110.098 -179.698 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.645 ' CE2' ' CE2' ' A' ' 16' ' ' TYR . 1.1 p90 -119.0 150.48 39.88 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.933 -1.104 . . . . 0.0 109.546 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 57.8 mtm180 -130.01 133.82 47.0 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.237 -0.914 . . . . 0.0 109.289 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.929 HG13 ' O ' ' A' ' 15' ' ' GLY . 54.1 t -122.92 149.98 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.202 -0.936 . . . . 0.0 109.711 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.553 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.2 OUTLIER -131.39 175.91 3.31 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.322 -0.861 . . . . 0.0 109.261 -179.971 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.553 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 43.7 Cg_endo -66.07 -22.97 54.04 Favored 'Trans proline' 0 C--O 1.214 -0.684 0 C-N-CA 122.65 2.233 . . . . 0.0 111.929 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 3.5 mtm180 -106.29 -31.77 8.47 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.301 -0.874 . . . . 0.0 109.357 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.488 HD12 ' HB2' ' A' ' 11' ' ' LEU . 92.9 mt -77.17 -39.33 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.374 -0.829 . . . . 0.0 109.347 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.929 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 70.73 -162.81 53.71 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.645 ' CE2' ' CE2' ' A' ' 8' ' ' TYR . 2.0 t80 -95.01 150.55 20.04 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.211 -1.17 . . . . 0.0 109.632 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 23.0 tp -113.13 111.33 21.92 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.412 -0.805 . . . . 0.0 109.593 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.452 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 84.6 m -128.68 156.63 77.17 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.147 -0.971 . . . . 0.0 109.317 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.525 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 48.9 Cg_endo -70.82 167.53 25.57 Favored 'Trans proline' 0 C--O 1.216 -0.611 0 C-N-CA 122.717 2.278 . . . . 0.0 111.577 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 62.6 mttm -94.94 -4.56 46.54 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.255 -0.903 . . . . 0.0 109.631 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -76.69 123.98 26.97 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.206 -0.934 . . . . 0.0 109.348 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.751 HD21 ' OD1' ' A' ' 34' ' ' ASN . 3.3 tm? -82.73 119.02 23.8 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.208 -0.933 . . . . 0.0 109.498 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.595 ' N ' HD13 ' A' ' 22' ' ' LEU . 15.5 mttp -141.88 107.51 5.87 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.302 -0.874 . . . . 0.0 109.476 179.744 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.546 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 43.3 Cg_endo -65.9 123.66 11.61 Favored 'Trans proline' 0 C--O 1.213 -0.728 0 C-N-CA 123.017 2.478 . . . . 0.0 112.14 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.663 ' O ' HG23 ' A' ' 32' ' ' THR . 29.7 m -116.32 155.02 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.265 -0.897 . . . . 0.0 109.71 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.455 ' O ' ' N ' ' A' ' 53' ' ' ARG . 43.5 t -99.27 122.94 43.12 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.428 -0.795 . . . . 0.0 108.914 179.418 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -81.45 137.99 18.36 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.514 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 47.0 p30 -68.54 -8.33 40.46 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.248 -1.148 . . . . 0.0 109.575 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -84.14 10.04 11.19 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.194 -0.941 . . . . 0.0 109.189 179.556 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.32 15.66 66.1 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.167 -1.573 . . . . 0.0 109.167 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.446 ' O ' ' N ' ' A' ' 27' ' ' GLY . 86.6 mt-30 -124.27 167.85 13.76 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.344 -1.092 . . . . 0.0 109.535 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.663 HG23 ' O ' ' A' ' 25' ' ' VAL . 42.1 m -127.96 137.91 52.43 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.251 -0.906 . . . . 0.0 109.526 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.879 ' CD1' HD13 ' A' ' 39' ' ' LEU . 71.4 m-85 -113.79 129.26 56.6 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.288 -0.882 . . . . 0.0 109.28 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.751 ' OD1' HD21 ' A' ' 22' ' ' LEU . 45.4 t-20 -51.09 -78.95 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.363 -0.836 . . . . 0.0 110.255 -179.197 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.53 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 1.7 t-20 -81.6 149.91 65.46 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 120.964 -1.085 . . . . 0.0 109.762 -179.492 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.469 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.9 Cg_endo -63.88 -55.53 0.64 Allowed 'Trans proline' 0 C--O 1.215 -0.674 0 C-N-CA 122.765 2.31 . . . . 0.0 111.864 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.53 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 12.9 t -61.41 -30.58 70.65 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.022 -1.049 . . . . 0.0 108.175 179.097 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.521 ' CG ' ' HB3' ' A' ' 35' ' ' ASN . 65.0 mmm -61.41 -15.15 34.05 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.016 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.879 HD13 ' CD1' ' A' ' 33' ' ' TYR . 37.8 tp -68.94 -58.55 3.97 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.434 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.453 ' HB3' ' OH ' ' A' ' 16' ' ' TYR . 19.5 t -53.28 -29.34 32.72 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 179.001 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 48.1 t60 -64.19 -61.57 2.17 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.13 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.444 ' HA ' ' OE1' ' A' ' 42' ' ' GLU . 71.2 mm-40 -56.06 -20.3 16.44 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.412 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.479 ' O ' ' N ' ' A' ' 47' ' ' GLN . 97.3 m-20 -79.44 -24.75 42.23 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.752 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.96 HD13 ' O ' ' A' ' 44' ' ' LEU . 1.7 tm? -71.86 -37.34 70.25 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.333 -0.855 . . . . 0.0 108.766 179.35 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.542 ' N ' HD13 ' A' ' 45' ' ' ILE . 3.8 mm -75.92 -44.68 38.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.404 -0.81 . . . . 0.0 109.232 179.609 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.447 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 14.7 mtt-85 -79.61 -37.72 35.53 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.359 -0.838 . . . . 0.0 109.19 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.479 ' N ' ' O ' ' A' ' 43' ' ' ASN . 91.6 mt-30 62.06 40.46 12.05 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.334 -0.854 . . . . 0.0 109.469 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.42 HG23 ' HB3' ' A' ' 46' ' ' ARG . 62.4 p -107.53 17.22 22.96 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.239 -0.913 . . . . 0.0 109.45 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.567 ' OD1' ' CE1' ' A' ' 51' ' ' HIS . 13.4 t-20 44.82 58.61 3.86 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.294 -0.879 . . . . 0.0 109.511 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.461 ' HB ' ' OD1' ' A' ' 43' ' ' ASN . 50.1 m -80.32 147.28 31.19 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.212 -0.93 . . . . 0.0 109.715 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' HIS . . . . . 0.567 ' CE1' ' OD1' ' A' ' 49' ' ' ASN . 30.6 m-70 -122.16 169.78 10.53 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.345 -0.847 . . . . 0.0 108.988 179.497 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.454 HG12 HD22 ' A' ' 39' ' ' LEU . 10.7 mt -81.2 122.29 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.15 -0.969 . . . . 0.0 109.611 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.514 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 56.5 ttt180 -79.9 -44.84 19.68 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.436 -0.79 . . . . 0.0 109.301 179.743 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.4 t -157.95 154.4 27.73 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.43 -0.794 . . . . 0.0 109.195 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.6 p -73.31 132.46 43.12 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.22 -0.925 . . . . 0.0 109.568 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.546 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 100.16 164.2 28.7 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.654 ' HA ' HG21 ' A' ' 32' ' ' THR . 39.7 tttt -50.2 150.31 2.51 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.443 -1.033 . . . . 0.0 109.263 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 36.2 m . . . . . 0 N--CA 1.49 1.541 0 O-C-N 121.179 -0.951 . . . . 0.0 109.42 -179.875 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' MET . . . . . 0.428 ' O ' ' CG ' ' A' ' 7' ' ' ASP . 67.8 mmm . . . . . 0 N--CA 1.489 1.482 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 35.1 m -80.91 -17.17 51.47 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.376 -0.827 . . . . 0.0 109.198 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 34.3 mttp -80.28 8.18 7.97 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.313 -0.867 . . . . 0.0 109.665 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.428 ' CG ' ' O ' ' A' ' 4' ' ' MET . 17.4 p30 -117.45 -10.93 10.59 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.182 -0.948 . . . . 0.0 109.638 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.58 ' OH ' ' CZ ' ' A' ' 16' ' ' TYR . 1.5 p90 -104.3 171.28 7.42 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.159 -0.963 . . . . 0.0 109.546 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 85.9 mtt180 -131.42 157.06 44.46 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.294 -0.879 . . . . 0.0 109.215 179.661 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.849 HG21 ' C ' ' A' ' 15' ' ' GLY . 14.5 p -136.97 158.35 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.166 -0.959 . . . . 0.0 109.816 -179.562 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.543 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 1.6 mp -108.2 175.36 2.02 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.265 -0.897 . . . . 0.0 109.354 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.543 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 45.7 Cg_endo -67.56 -27.71 38.81 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 122.589 2.193 . . . . 0.0 111.682 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 37.6 mtm180 -84.15 -38.75 20.28 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.381 -0.824 . . . . 0.0 109.055 179.577 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.488 ' CG2' ' HG ' ' A' ' 17' ' ' LEU . 98.7 mt -77.12 -34.79 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.381 -0.824 . . . . 0.0 109.024 179.62 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.849 ' C ' HG21 ' A' ' 10' ' ' VAL . . . 68.2 -65.45 0.37 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 179.733 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.58 ' CZ ' ' OH ' ' A' ' 8' ' ' TYR . 1.2 t80 -160.59 150.82 18.0 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.31 -1.112 . . . . 0.0 109.328 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.827 ' N ' HD12 ' A' ' 17' ' ' LEU . 0.4 OUTLIER -123.07 141.61 51.78 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.25 -0.906 . . . . 0.0 109.472 179.976 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.451 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 75.0 m -146.26 158.01 48.39 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.308 -0.87 . . . . 0.0 109.15 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.538 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 46.6 Cg_endo -69.93 165.3 31.63 Favored 'Trans proline' 0 C--O 1.214 -0.695 0 C-N-CA 122.494 2.129 . . . . 0.0 111.308 179.739 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -91.81 -8.52 46.42 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.204 -0.935 . . . . 0.0 109.508 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 -74.54 129.48 37.82 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.274 -0.891 . . . . 0.0 109.218 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.809 HD21 ' OD1' ' A' ' 34' ' ' ASN . 3.4 tm? -87.92 121.24 30.09 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.207 -0.933 . . . . 0.0 109.37 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.615 ' N ' HD13 ' A' ' 22' ' ' LEU . 14.0 mttt -144.3 109.39 4.95 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.091 -1.006 . . . . 0.0 109.717 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.536 ' HA ' ' O ' ' A' ' 34' ' ' ASN . 44.1 Cg_endo -66.58 122.84 10.33 Favored 'Trans proline' 0 C--O 1.214 -0.706 0 C-N-CA 122.947 2.431 . . . . 0.0 111.899 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.507 ' HB ' HG23 ' A' ' 52' ' ' ILE . 8.7 m -117.46 156.9 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.22 -0.925 . . . . 0.0 109.858 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 45.5 t -97.54 136.62 37.69 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 178.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -94.04 135.19 12.4 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 -179.482 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.489 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 49.0 p30 -64.26 -11.31 30.27 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.303 -1.116 . . . . 0.0 109.349 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.458 ' OD1' ' HB2' ' A' ' 31' ' ' GLN . 58.0 p30 -84.24 9.49 12.79 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.323 -0.861 . . . . 0.0 109.488 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 83.87 23.51 52.43 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.458 ' HB2' ' OD1' ' A' ' 29' ' ' ASP . 67.8 mt-30 -129.17 171.71 12.16 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.312 -1.11 . . . . 0.0 109.409 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.576 HG21 ' HG3' ' A' ' 57' ' ' LYS . 24.0 m -131.12 139.42 49.82 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.284 -0.885 . . . . 0.0 109.26 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.821 ' CD1' HD13 ' A' ' 39' ' ' LEU . 70.9 m-85 -118.68 131.62 56.16 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.277 -0.889 . . . . 0.0 109.416 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.809 ' OD1' HD21 ' A' ' 22' ' ' LEU . 53.5 t-20 -51.65 -79.09 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.374 -0.829 . . . . 0.0 110.174 -179.381 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.527 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 1.9 t-20 -81.39 149.41 65.21 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 120.932 -1.105 . . . . 0.0 109.597 -179.553 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.486 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.4 Cg_endo -63.28 -55.1 0.81 Allowed 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 122.685 2.257 . . . . 0.0 111.884 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.538 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 10.6 t -60.06 -33.22 71.76 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 120.996 -1.065 . . . . 0.0 108.128 178.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.473 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 39.7 mmm -55.63 -20.21 13.08 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.086 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.821 HD13 ' CD1' ' A' ' 33' ' ' TYR . 51.5 tp -68.48 -46.59 69.28 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.563 -0.711 . . . . 0.0 109.098 179.612 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.484 ' HB2' ' OH ' ' A' ' 16' ' ' TYR . 3.2 m -69.04 -21.25 64.12 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 179.15 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 41.0 t60 -67.21 -54.83 17.46 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 178.728 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.436 ' HA ' ' OE1' ' A' ' 42' ' ' GLU . 68.6 mm-40 -62.51 -19.99 64.16 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 178.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.527 ' O ' ' N ' ' A' ' 47' ' ' GLN . 83.1 m-20 -80.27 -24.27 40.2 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.557 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 23.3 tp -73.24 -31.82 64.35 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.43 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.1 mm -80.11 -48.2 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.381 -0.824 . . . . 0.0 108.937 179.421 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.456 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 63.7 mtt-85 -80.66 -33.79 35.31 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.267 -0.896 . . . . 0.0 109.353 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.527 ' N ' ' O ' ' A' ' 43' ' ' ASN . 91.7 mt-30 63.31 38.54 10.2 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.386 -0.822 . . . . 0.0 109.659 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.435 HG23 ' HB3' ' A' ' 46' ' ' ARG . 55.1 p -101.68 3.84 40.13 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.21 -0.931 . . . . 0.0 109.452 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 63.9 m-20 54.64 58.08 5.18 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.227 -0.921 . . . . 0.0 109.427 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 31.6 m -78.46 139.22 38.72 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.239 -0.913 . . . . 0.0 109.589 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 49.3 m-70 -113.63 167.38 10.66 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.303 -0.873 . . . . 0.0 108.893 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.507 HG23 ' HB ' ' A' ' 25' ' ' VAL . 36.9 mt -79.63 125.59 38.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.169 -0.957 . . . . 0.0 109.256 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.489 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 69.9 ttt-85 -81.3 -38.61 26.5 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.415 -0.803 . . . . 0.0 109.346 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -160.45 151.16 18.59 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.47 -0.769 . . . . 0.0 109.084 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.3 p -70.46 143.59 51.71 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.168 -0.958 . . . . 0.0 109.467 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.533 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 88.87 164.37 40.28 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.576 ' HG3' HG21 ' A' ' 32' ' ' THR . 33.8 ttpt -54.53 151.08 8.31 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.474 -1.016 . . . . 0.0 109.442 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 88.8 m . . . . . 0 N--CA 1.489 1.481 0 O-C-N 121.247 -0.908 . . . . 0.0 109.446 179.948 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 84.3 mtp . . . . . 0 N--CA 1.489 1.497 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.571 ' SG ' ' CE1' ' A' ' 8' ' ' TYR . 10.6 t -84.19 -8.23 59.12 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.464 -0.772 . . . . 0.0 109.069 179.518 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.7 pttp -57.46 -15.7 7.6 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.32 -0.863 . . . . 0.0 109.733 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 51.0 p-10 -159.03 32.66 0.21 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.043 -1.035 . . . . 0.0 109.811 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.571 ' CE1' ' SG ' ' A' ' 5' ' ' CYS . 5.1 p90 -79.71 175.61 10.47 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.119 -0.988 . . . . 0.0 109.194 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 53.7 mtm180 -143.98 136.43 26.85 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.145 -0.972 . . . . 0.0 109.911 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.58 HG13 ' O ' ' A' ' 15' ' ' GLY . 23.4 t -137.41 135.61 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.371 -0.83 . . . . 0.0 109.097 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.662 ' HB2' HD12 ' A' ' 14' ' ' ILE . 1.6 mp -102.83 172.4 4.33 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.231 -0.918 . . . . 0.0 109.701 -179.532 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.487 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 45.7 Cg_endo -67.68 -22.78 43.31 Favored 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 122.637 2.225 . . . . 0.0 111.563 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 82.1 mtt180 -99.8 -24.96 14.53 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.341 -0.849 . . . . 0.0 109.16 179.735 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.662 HD12 ' HB2' ' A' ' 11' ' ' LEU . 79.2 mt -85.34 -47.3 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.312 -0.867 . . . . 0.0 109.428 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.58 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 71.58 -169.54 49.91 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.581 ' CB ' ' NE2' ' A' ' 41' ' ' HIS . 0.8 OUTLIER -92.36 150.2 20.97 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.259 -1.142 . . . . 0.0 109.591 -179.94 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.698 ' C ' HD13 ' A' ' 17' ' ' LEU . 2.3 tm? -119.66 105.35 11.1 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.254 -0.904 . . . . 0.0 109.309 179.781 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.445 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 58.5 m -118.75 155.64 52.39 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.305 -0.872 . . . . 0.0 109.305 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -72.42 171.73 16.43 Favored 'Trans proline' 0 C--O 1.215 -0.667 0 C-N-CA 122.618 2.212 . . . . 0.0 111.324 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 45.0 mttp -91.45 -23.32 20.04 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.213 -0.93 . . . . 0.0 109.355 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -62.34 130.49 45.52 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.339 -0.85 . . . . 0.0 109.179 179.68 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 24.0 tp -90.72 111.83 23.35 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.211 -0.931 . . . . 0.0 109.805 -179.825 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.479 ' O ' ' O ' ' A' ' 34' ' ' ASN . 0.0 OUTLIER -123.28 108.64 31.71 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.324 -0.86 . . . . 0.0 108.87 179.637 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.526 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 43.6 Cg_endo -66.16 119.58 6.62 Favored 'Trans proline' 0 C--O 1.214 -0.713 0 C-N-CA 122.865 2.377 . . . . 0.0 112.052 -179.417 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.591 ' O ' HG23 ' A' ' 32' ' ' THR . 11.2 m -112.57 155.31 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.418 -0.801 . . . . 0.0 109.512 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.411 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 43.4 t -97.07 141.4 30.27 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.81 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -98.47 133.85 11.48 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 -179.365 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.65 ' OD1' HG23 ' A' ' 50' ' ' THR . 37.5 p30 -61.83 -12.49 17.67 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.315 -1.109 . . . . 0.0 109.586 179.754 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -87.01 15.46 5.98 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.21 -0.931 . . . . 0.0 109.414 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 79.37 19.41 71.72 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.471 ' O ' ' SG ' ' A' ' 58' ' ' CYS . 44.5 mt-30 -120.95 179.33 4.4 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.152 -1.205 . . . . 0.0 109.496 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.605 HG21 ' HG3' ' A' ' 57' ' ' LYS . 14.5 m -143.36 137.2 28.57 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.264 -0.897 . . . . 0.0 109.557 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.572 ' CD1' ' HG ' ' A' ' 39' ' ' LEU . 41.2 m-85 -113.03 134.8 54.35 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.364 -0.835 . . . . 0.0 109.46 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.518 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 9.9 m-20 -54.16 -78.06 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.322 -0.861 . . . . 0.0 109.785 -179.652 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.53 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 4.1 t-20 -81.88 147.72 59.1 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.018 -1.051 . . . . 0.0 109.022 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.469 ' HD3' ' O ' ' A' ' 23' ' ' LYS . 41.7 Cg_endo -63.97 -52.55 1.63 Allowed 'Trans proline' 0 C--O 1.215 -0.629 0 C-N-CA 122.522 2.148 . . . . 0.0 111.758 -179.706 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.53 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 11.3 t -62.09 -29.03 70.03 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.078 -1.014 . . . . 0.0 108.324 179.021 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.473 ' HB2' ' HB3' ' A' ' 35' ' ' ASN . 35.3 mmm -69.04 -12.82 62.03 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.566 -0.709 . . . . 0.0 109.278 179.52 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.777 HD13 HG12 ' A' ' 52' ' ' ILE . 9.6 tt -67.97 -52.55 34.62 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.189 -0.945 . . . . 0.0 108.955 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.483 ' SG ' ' CE1' ' A' ' 8' ' ' TYR . 9.3 t -61.46 -34.17 74.99 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 179.19 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.581 ' NE2' ' CB ' ' A' ' 16' ' ' TYR . 0.2 OUTLIER -50.94 -46.69 61.03 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 178.51 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -66.11 -32.08 73.32 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.08 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.52 ' ND2' ' O ' ' A' ' 50' ' ' THR . 34.0 m-20 -68.74 -23.47 64.34 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.51 -0.744 . . . . 0.0 109.396 179.683 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.954 HD13 ' O ' ' A' ' 44' ' ' LEU . 2.4 tm? -72.2 -36.4 69.19 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.285 -0.884 . . . . 0.0 109.66 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.411 ' N ' HD13 ' A' ' 45' ' ' ILE . 4.8 mm -78.04 -46.04 26.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.242 -0.911 . . . . 0.0 109.381 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.491 ' HB3' HG23 ' A' ' 48' ' ' THR . 14.4 mtt-85 -81.73 -33.19 31.19 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.289 -0.882 . . . . 0.0 109.611 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.474 ' N ' ' O ' ' A' ' 43' ' ' ASN . 92.0 mt-30 62.49 33.76 15.83 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.272 -0.892 . . . . 0.0 109.63 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.491 HG23 ' HB3' ' A' ' 46' ' ' ARG . 58.9 p -95.65 7.43 46.31 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.224 -0.922 . . . . 0.0 109.415 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.577 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 57.8 t30 52.63 49.0 21.32 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.276 -0.89 . . . . 0.0 109.649 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.65 HG23 ' OD1' ' A' ' 28' ' ' ASP . 39.4 m -80.78 149.05 29.78 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.37 -0.831 . . . . 0.0 109.359 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' HIS . . . . . 0.577 ' CE1' ' O ' ' A' ' 49' ' ' ASN . 13.6 m80 -127.21 -176.76 3.82 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.189 -0.945 . . . . 0.0 109.348 179.688 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.777 HG12 HD13 ' A' ' 39' ' ' LEU . 29.4 mt -84.89 128.13 39.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 O-C-N 121.39 -0.819 . . . . 0.0 109.46 179.709 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.505 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 42.3 ttt85 -83.83 -38.55 21.08 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.321 -0.862 . . . . 0.0 109.059 179.765 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -160.75 148.83 16.08 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 27.0 p -67.17 135.97 54.33 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.123 -0.986 . . . . 0.0 109.462 -179.809 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.526 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 95.2 161.87 34.16 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.605 ' HG3' HG21 ' A' ' 32' ' ' THR . 47.5 tttp -50.03 148.23 3.46 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.402 -1.058 . . . . 0.0 109.287 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.471 ' SG ' ' O ' ' A' ' 31' ' ' GLN . 95.6 m . . . . . 0 N--CA 1.491 1.575 0 O-C-N 121.309 -0.869 . . . . 0.0 109.568 -179.776 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 82.8 mtp . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.539 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 70.2 m -79.92 -20.77 44.93 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.324 -0.86 . . . . 0.0 109.217 179.753 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 33.4 mttt -80.63 7.46 10.06 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.194 -0.941 . . . . 0.0 109.391 179.577 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -123.18 -3.63 8.49 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.199 -0.938 . . . . 0.0 110.217 -179.417 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.687 ' CE2' ' CZ ' ' A' ' 16' ' ' TYR . 2.1 p90 -114.57 173.0 6.68 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.959 -1.088 . . . . 0.0 109.848 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 39.5 ptt180 -157.34 134.47 10.3 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.519 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.8 HG13 ' O ' ' A' ' 15' ' ' GLY . 79.9 t -116.79 145.41 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.226 -0.921 . . . . 0.0 110.215 -179.071 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.756 ' HB2' HD12 ' A' ' 14' ' ' ILE . 2.1 mp -117.67 175.81 1.87 Allowed Pre-proline 0 N--CA 1.49 1.527 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.549 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 44.7 Cg_endo -67.56 -22.52 44.39 Favored 'Trans proline' 0 C--O 1.216 -0.621 0 C-N-CA 122.451 2.101 . . . . 0.0 111.81 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 63.1 mtt180 -113.63 -22.44 10.27 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.294 -0.879 . . . . 0.0 109.64 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.756 HD12 ' HB2' ' A' ' 11' ' ' LEU . 92.4 mt -78.23 -44.35 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.216 -0.927 . . . . 0.0 109.504 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.8 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 74.94 -165.33 54.74 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.687 ' CZ ' ' CE2' ' A' ' 8' ' ' TYR . 0.9 OUTLIER -93.76 149.55 21.14 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.16 -1.2 . . . . 0.0 109.557 179.999 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 16.8 tp -119.61 115.54 24.18 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.288 -0.883 . . . . 0.0 109.688 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 75.6 m -126.07 156.8 71.38 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.292 -0.88 . . . . 0.0 109.177 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.48 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 50.5 Cg_endo -71.35 167.33 26.6 Favored 'Trans proline' 0 C--O 1.216 -0.59 0 C-N-CA 122.64 2.227 . . . . 0.0 111.685 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.4 mttt -86.59 -23.43 25.77 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.271 -0.893 . . . . 0.0 109.328 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -63.21 130.48 44.74 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.29 -0.881 . . . . 0.0 109.241 179.731 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 48.7 tp -93.83 117.47 30.14 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.184 -0.947 . . . . 0.0 109.541 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.487 ' O ' ' O ' ' A' ' 34' ' ' ASN . 0.1 OUTLIER -129.1 106.52 17.93 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.324 -0.86 . . . . 0.0 108.941 179.719 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.538 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 43.2 Cg_endo -65.1 119.91 7.04 Favored 'Trans proline' 0 C--O 1.213 -0.765 0 C-N-CA 122.93 2.42 . . . . 0.0 112.086 -179.564 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.609 ' O ' HG23 ' A' ' 32' ' ' THR . 35.6 m -116.5 153.74 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.336 -0.852 . . . . 0.0 109.688 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 43.0 t -96.05 135.52 37.72 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.354 -0.841 . . . . 0.0 108.787 179.214 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -92.44 139.12 14.51 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -179.585 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.504 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 50.9 p30 -68.5 -7.86 36.01 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.366 -1.079 . . . . 0.0 109.579 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.427 ' OD1' ' HB2' ' A' ' 31' ' ' GLN . 56.6 p30 -88.52 9.21 24.62 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.163 -0.961 . . . . 0.0 109.35 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.23 13.99 64.97 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.464 ' O ' ' N ' ' A' ' 27' ' ' GLY . 83.2 mt-30 -120.26 171.97 8.12 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.278 -1.131 . . . . 0.0 109.447 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.661 HG21 ' HA ' ' A' ' 57' ' ' LYS . 25.9 m -133.95 138.31 45.39 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.248 -0.908 . . . . 0.0 109.353 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.811 ' CD1' HD13 ' A' ' 39' ' ' LEU . 28.7 m-85 -113.0 128.5 56.52 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.28 -0.888 . . . . 0.0 109.205 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.519 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 13.1 m-20 -51.66 -78.17 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.239 -0.913 . . . . 0.0 109.692 -179.543 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.533 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 5.1 t-20 -81.85 147.9 59.69 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.171 -0.956 . . . . 0.0 109.688 -179.692 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.469 ' HD2' ' CG ' ' A' ' 35' ' ' ASN . 40.5 Cg_endo -63.22 -52.98 1.7 Allowed 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.766 2.311 . . . . 0.0 111.909 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.533 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 9.2 t -62.54 -28.36 69.8 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 120.97 -1.081 . . . . 0.0 108.11 178.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.465 ' CG ' ' HB3' ' A' ' 35' ' ' ASN . 49.7 mmm -64.75 -14.2 57.92 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.377 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.811 HD13 ' CD1' ' A' ' 33' ' ' TYR . 23.7 tp -71.68 -65.33 0.77 Allowed 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 179.284 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.452 ' HB3' ' OH ' ' A' ' 16' ' ' TYR . 8.5 t -49.25 -28.33 4.56 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.805 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 66.5 t60 -63.02 -62.54 1.64 Allowed 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.309 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 77.2 tt0 -59.13 -19.08 41.58 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.477 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.471 ' O ' ' N ' ' A' ' 47' ' ' GLN . 98.1 m-20 -78.16 -29.65 48.74 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.391 -0.818 . . . . 0.0 108.815 179.425 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 17.6 tp -72.37 -27.75 62.58 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.313 -0.867 . . . . 0.0 108.847 179.447 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.3 mt -79.87 -49.64 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.321 -0.862 . . . . 0.0 108.9 179.455 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.549 ' HB3' HG23 ' A' ' 48' ' ' THR . 52.8 mtt180 -80.73 -32.82 35.58 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.338 -0.851 . . . . 0.0 109.307 179.749 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.471 ' N ' ' O ' ' A' ' 43' ' ' ASN . 92.1 mt-30 62.62 36.68 13.49 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.373 -0.829 . . . . 0.0 109.627 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.549 HG23 ' HB3' ' A' ' 46' ' ' ARG . 59.5 p -96.21 2.45 53.02 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.217 -0.927 . . . . 0.0 109.585 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.4 m120 58.0 54.76 5.75 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.251 -0.905 . . . . 0.0 109.449 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.404 ' HB ' ' OD1' ' A' ' 43' ' ' ASN . 43.3 m -79.94 144.06 33.66 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.292 -0.88 . . . . 0.0 109.68 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 13.4 m80 -118.62 173.5 6.81 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.329 -0.857 . . . . 0.0 109.023 179.654 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.462 HG12 HD22 ' A' ' 39' ' ' LEU . 12.0 mt -84.38 123.99 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.16 -0.962 . . . . 0.0 109.472 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.504 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 45.2 ttt85 -79.75 -43.0 23.39 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.297 -0.877 . . . . 0.0 109.248 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.8 t -160.02 155.09 24.77 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.9 p -72.56 132.83 44.31 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.198 -0.939 . . . . 0.0 109.483 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.538 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 99.07 164.49 29.93 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -179.779 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.661 ' HA ' HG21 ' A' ' 32' ' ' THR . 71.1 tttt -53.13 148.4 8.27 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.429 -1.042 . . . . 0.0 109.397 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 91.2 m . . . . . 0 N--CA 1.491 1.61 0 O-C-N 121.263 -0.898 . . . . 0.0 109.376 179.963 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 44.4 ttm . . . . . 0 N--CA 1.488 1.465 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.593 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 15.6 m -79.56 -12.7 59.84 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.498 -0.751 . . . . 0.0 108.974 179.523 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.1 mtmp? -56.58 -24.54 48.1 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.255 -0.903 . . . . 0.0 109.714 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 64.8 m-20 -149.71 64.49 0.99 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.136 -0.978 . . . . 0.0 110.334 -179.613 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.983 ' OH ' HD21 ' A' ' 44' ' ' LEU . 5.0 p90 -131.44 170.25 14.94 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.045 -1.034 . . . . 0.0 109.359 179.259 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 12.5 tpt180 -145.32 150.13 36.06 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.21 -0.932 . . . . 0.0 109.593 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.554 HG13 ' C ' ' A' ' 15' ' ' GLY . 71.0 t -141.63 130.98 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.239 -0.913 . . . . 0.0 109.315 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.66 ' HB2' HD12 ' A' ' 14' ' ' ILE . 2.5 mp -118.56 172.86 3.8 Favored Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 121.321 -0.862 . . . . 0.0 109.317 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.491 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 46.5 Cg_endo -68.38 -24.96 36.34 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 122.575 2.184 . . . . 0.0 111.614 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 54.5 mtt180 -104.68 -26.04 12.46 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.262 -0.899 . . . . 0.0 109.254 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.66 HD12 ' HB2' ' A' ' 11' ' ' LEU . 87.9 mt -84.54 -46.88 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.267 -0.896 . . . . 0.0 109.41 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.554 ' C ' HG13 ' A' ' 10' ' ' VAL . . . 77.73 -155.51 43.14 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.597 ' CE2' ' CE2' ' A' ' 8' ' ' TYR . 2.5 t80 -105.4 152.56 22.82 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.307 -1.114 . . . . 0.0 109.503 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 34.6 tp -113.74 119.21 36.6 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.231 -0.918 . . . . 0.0 109.725 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 75.9 m -130.15 157.22 77.76 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.316 -0.865 . . . . 0.0 109.603 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.519 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 52.5 Cg_endo -72.55 168.93 23.06 Favored 'Trans proline' 0 C--O 1.215 -0.629 0 C-N-CA 122.762 2.308 . . . . 0.0 111.591 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 41.3 mmtt -89.61 -13.09 37.9 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.203 -0.936 . . . . 0.0 109.334 179.817 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -67.98 131.8 46.14 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.296 -0.878 . . . . 0.0 109.38 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.745 ' C ' HD13 ' A' ' 22' ' ' LEU . 3.3 tm? -90.63 123.65 34.42 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.263 -0.898 . . . . 0.0 109.332 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.691 ' N ' HD13 ' A' ' 22' ' ' LEU . 15.4 mttp -145.6 105.8 4.31 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.156 -0.965 . . . . 0.0 109.657 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.539 ' HA ' ' O ' ' A' ' 34' ' ' ASN . 44.1 Cg_endo -65.85 120.84 8.08 Favored 'Trans proline' 0 C--O 1.214 -0.705 0 C-N-CA 123.116 2.544 . . . . 0.0 112.324 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.463 ' O ' HG23 ' A' ' 32' ' ' THR . 19.7 m -116.18 154.57 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.382 -0.824 . . . . 0.0 109.35 179.562 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.418 ' O ' ' N ' ' A' ' 53' ' ' ARG . 41.6 t -96.07 138.26 33.95 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 178.673 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -95.6 139.21 14.37 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.726 -1.349 . . . . 0.0 109.726 -179.285 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.483 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 48.5 p30 -65.38 -11.15 39.52 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.38 -1.07 . . . . 0.0 109.454 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.447 ' OD1' ' HB2' ' A' ' 31' ' ' GLN . 59.0 p30 -83.09 7.33 16.19 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.226 -0.921 . . . . 0.0 109.398 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.22 22.59 51.41 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.456 ' O ' ' SG ' ' A' ' 58' ' ' CYS . 75.5 mt-30 -129.3 175.37 8.79 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.291 -1.123 . . . . 0.0 109.375 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.647 HG21 ' HA ' ' A' ' 57' ' ' LYS . 13.0 m -131.83 140.21 49.07 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.258 -0.901 . . . . 0.0 109.816 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.869 ' CD2' HD12 ' A' ' 39' ' ' LEU . 44.7 m-85 -115.86 127.15 54.81 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.431 -0.793 . . . . 0.0 109.139 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.745 ' OD1' HD21 ' A' ' 22' ' ' LEU . 41.1 t-20 -49.01 -78.98 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.299 -0.876 . . . . 0.0 110.032 -179.425 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.542 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 4.6 t-20 -81.14 147.28 60.62 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 120.863 -1.148 . . . . 0.0 109.263 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.514 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.8 Cg_endo -63.44 -52.89 1.66 Allowed 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 122.701 2.267 . . . . 0.0 111.849 -179.712 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.542 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 5.8 t -61.78 -28.23 69.31 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 178.809 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.429 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 35.7 mmm -65.51 -12.45 52.88 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.292 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.869 HD12 ' CD2' ' A' ' 33' ' ' TYR . 8.4 tt -72.99 -57.63 3.9 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.284 -0.885 . . . . 0.0 108.849 179.602 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.519 ' O ' ' HB2' ' A' ' 43' ' ' ASN . 2.2 t -46.59 -45.18 18.74 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 179.064 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.491 ' ND1' ' HB2' ' A' ' 16' ' ' TYR . 13.9 t60 -48.46 -50.37 31.66 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.062 -1.024 . . . . 0.0 108.309 178.812 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.578 ' HG3' ' CE1' ' A' ' 33' ' ' TYR . 34.2 mm-40 -56.41 -19.21 13.87 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.567 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.519 ' HB2' ' O ' ' A' ' 40' ' ' CYS . 2.3 m-80 -78.59 -35.33 45.9 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 119.471 -0.892 . . . . 0.0 108.617 179.209 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.983 HD21 ' OH ' ' A' ' 8' ' ' TYR . 40.3 mt -72.07 -30.79 65.48 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.332 -0.855 . . . . 0.0 109.302 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.485 HG13 ' O ' ' A' ' 41' ' ' HIS . 2.5 mt -79.74 -51.12 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.279 -0.888 . . . . 0.0 109.378 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.447 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 93.3 mtt-85 -80.3 -32.92 38.0 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.337 -0.852 . . . . 0.0 109.267 179.739 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.49 ' N ' ' O ' ' A' ' 43' ' ' ASN . 91.9 mt-30 62.19 40.22 11.91 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.403 -0.811 . . . . 0.0 109.537 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 35.6 p -113.63 5.62 16.59 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.32 -0.863 . . . . 0.0 109.541 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.566 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 11.8 t-20 62.39 50.91 3.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.236 -0.915 . . . . 0.0 109.45 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.789 HG21 ' OH ' ' A' ' 33' ' ' TYR . 99.6 m -78.87 134.7 36.91 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.298 -0.876 . . . . 0.0 109.729 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' HIS . . . . . 0.566 ' CE1' ' O ' ' A' ' 49' ' ' ASN . 8.0 m80 -115.98 -170.13 1.73 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.218 -0.926 . . . . 0.0 109.167 179.558 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.749 HG12 HD13 ' A' ' 39' ' ' LEU . 20.4 mt -92.91 122.97 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.306 -0.872 . . . . 0.0 109.445 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.483 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 46.9 ttt-85 -81.1 -41.62 22.23 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.304 -0.872 . . . . 0.0 109.542 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.0 p -160.45 145.01 14.33 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.543 -0.723 . . . . 0.0 109.505 -179.434 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 20.2 p -63.62 139.51 58.78 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.244 -0.91 . . . . 0.0 109.401 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.537 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 90.76 163.13 38.74 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.647 ' HA ' HG21 ' A' ' 32' ' ' THR . 48.1 tttp -49.46 148.65 2.64 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.498 -1.001 . . . . 0.0 109.48 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.456 ' SG ' ' O ' ' A' ' 31' ' ' GLN . 57.8 m . . . . . 0 N--CA 1.491 1.588 0 O-C-N 121.257 -0.902 . . . . 0.0 109.426 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 92.8 mmm . . . . . 0 N--CA 1.488 1.438 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 3.8 m -80.03 4.58 16.61 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.457 -0.777 . . . . 0.0 109.109 179.258 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.2 mttm -57.65 -30.13 65.15 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.082 -1.011 . . . . 0.0 109.514 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -143.29 69.94 1.31 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.281 -0.887 . . . . 0.0 109.938 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.552 ' CD1' ' N ' ' A' ' 9' ' ' ARG . 18.4 p90 -115.04 -172.88 2.21 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.125 -0.985 . . . . 0.0 109.311 179.605 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.552 ' N ' ' CD1' ' A' ' 8' ' ' TYR . 86.0 mtt180 -149.64 145.57 26.82 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.189 -0.944 . . . . 0.0 109.466 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.581 HG13 ' O ' ' A' ' 15' ' ' GLY . 34.0 t -148.11 142.66 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.284 -0.885 . . . . 0.0 109.17 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.472 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 1.4 mp -116.13 171.93 4.24 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.204 -0.935 . . . . 0.0 109.844 -179.536 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.472 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 48.2 Cg_endo -68.45 -23.77 37.27 Favored 'Trans proline' 0 C--O 1.215 -0.659 0 C-N-CA 122.628 2.219 . . . . 0.0 111.73 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 53.0 mtt180 -100.27 -23.86 14.69 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.288 -0.882 . . . . 0.0 109.17 179.729 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.426 HD12 ' HB2' ' A' ' 11' ' ' LEU . 97.6 mt -88.84 -40.91 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.306 -0.871 . . . . 0.0 109.774 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.581 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 70.53 -174.92 37.95 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.512 ' HB2' ' CE1' ' A' ' 41' ' ' HIS . 1.3 t80 -81.61 154.78 25.98 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.17 -1.194 . . . . 0.0 109.417 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 34.0 tp -112.65 117.92 33.62 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.215 -0.928 . . . . 0.0 109.749 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.419 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 76.9 m -134.86 156.54 78.42 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.267 -0.896 . . . . 0.0 109.423 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.497 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 51.5 Cg_endo -71.4 168.79 22.5 Favored 'Trans proline' 0 C--O 1.215 -0.674 0 C-N-CA 122.692 2.261 . . . . 0.0 111.83 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -93.11 -3.89 53.29 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.263 -0.898 . . . . 0.0 109.52 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -79.08 130.16 35.22 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.212 -0.93 . . . . 0.0 109.307 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.739 ' C ' HD13 ' A' ' 22' ' ' LEU . 3.1 tm? -85.77 124.12 31.91 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.246 -0.909 . . . . 0.0 109.447 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.733 ' N ' HD13 ' A' ' 22' ' ' LEU . 29.4 mttp -144.05 103.1 4.8 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.194 -0.941 . . . . 0.0 109.468 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.537 ' HA ' ' O ' ' A' ' 34' ' ' ASN . 44.0 Cg_endo -65.35 121.92 9.48 Favored 'Trans proline' 0 C--O 1.214 -0.719 0 C-N-CA 123.133 2.555 . . . . 0.0 112.064 -179.689 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.476 ' HB ' HG23 ' A' ' 52' ' ' ILE . 13.9 m -120.26 154.86 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.272 -0.892 . . . . 0.0 110.05 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.423 ' O ' ' N ' ' A' ' 53' ' ' ARG . 13.3 t -99.95 131.52 45.87 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.034 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -89.23 138.83 14.9 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 -179.688 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.494 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 38.1 p30 -65.86 -10.05 34.63 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.357 -1.084 . . . . 0.0 109.66 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 -85.64 10.55 13.02 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.241 -0.912 . . . . 0.0 109.44 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 81.9 27.65 45.06 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -131.04 161.31 32.29 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.289 -1.124 . . . . 0.0 109.384 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.451 HG21 ' CB ' ' A' ' 57' ' ' LYS . 98.8 m -122.35 135.04 54.64 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.134 -0.979 . . . . 0.0 109.36 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.65 ' CD1' HD13 ' A' ' 39' ' ' LEU . 47.8 m-85 -116.45 125.2 51.65 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.312 -0.867 . . . . 0.0 109.293 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.739 ' CG ' HD21 ' A' ' 22' ' ' LEU . 40.2 t-20 -48.56 -79.76 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.393 -0.817 . . . . 0.0 109.97 -179.386 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.533 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 5.4 t-20 -80.9 146.96 60.7 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 120.851 -1.156 . . . . 0.0 109.415 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.539 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.1 Cg_endo -62.7 -53.13 1.87 Allowed 'Trans proline' 0 C--O 1.216 -0.594 0 C-N-CA 122.902 2.401 . . . . 0.0 111.875 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.533 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 8.9 t -62.75 -27.9 69.6 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.005 -1.059 . . . . 0.0 108.212 178.956 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.451 ' HB2' ' HB3' ' A' ' 35' ' ' ASN . 28.1 mmm -64.54 -11.86 38.7 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.124 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.65 HD13 ' CD1' ' A' ' 33' ' ' TYR . 20.4 tp -69.88 -54.07 15.15 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.324 -0.86 . . . . 0.0 109.079 179.656 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.46 ' HB2' ' OH ' ' A' ' 16' ' ' TYR . 3.5 m -63.28 -14.26 47.53 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 119.021 -1.072 . . . . 0.0 108.253 179.087 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.512 ' CE1' ' HB2' ' A' ' 16' ' ' TYR . 19.5 t60 -67.26 -55.15 15.16 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 178.711 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 49.8 tt0 -67.19 -20.37 65.7 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.017 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.477 ' O ' ' N ' ' A' ' 47' ' ' GLN . 91.7 m-20 -76.26 -31.5 58.33 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.524 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.55 HD13 ' OH ' ' A' ' 8' ' ' TYR . 22.3 tp -67.48 -30.56 70.29 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.287 -0.883 . . . . 0.0 108.653 179.363 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -77.73 -44.74 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.451 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.452 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 60.0 mtt-85 -80.21 -19.33 47.26 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.393 -0.817 . . . . 0.0 109.175 179.669 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.477 ' N ' ' O ' ' A' ' 43' ' ' ASN . 91.1 mt-30 63.51 37.9 10.18 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.466 -0.771 . . . . 0.0 109.653 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 13.0 p -116.07 173.05 6.78 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.268 -0.895 . . . . 0.0 109.322 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -107.99 60.89 0.61 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.211 -0.931 . . . . 0.0 109.475 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.421 HG23 ' OD1' ' A' ' 28' ' ' ASP . 44.9 m -74.81 136.12 41.63 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.269 -0.895 . . . . 0.0 109.546 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 61.3 m-70 -115.01 173.27 6.57 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.247 -0.908 . . . . 0.0 109.229 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.476 HG23 ' HB ' ' A' ' 25' ' ' VAL . 20.0 mt -79.63 124.24 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.211 -0.93 . . . . 0.0 109.28 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.494 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 44.1 ttt180 -80.52 -47.48 14.19 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.352 -0.842 . . . . 0.0 109.367 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -154.07 149.22 26.92 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.488 -0.757 . . . . 0.0 109.115 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 27.5 p -66.45 143.48 57.08 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.209 -0.932 . . . . 0.0 109.567 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.536 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 90.44 167.35 41.76 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -179.825 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.496 ' HG3' ' HB2' ' A' ' 24' ' ' PRO . 43.4 mttt -76.19 120.98 22.21 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.303 -1.116 . . . . 0.0 109.477 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.408 ' C ' ' O ' ' A' ' 57' ' ' LYS . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.522 0 O-C-N 121.266 -0.896 . . . . 0.0 109.621 179.736 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 82.6 mmm . . . . . 0 N--CA 1.489 1.484 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.498 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 3.9 m -79.88 -7.97 59.03 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.38 -0.825 . . . . 0.0 109.321 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 26.3 mttm -58.79 -23.21 59.91 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.213 -0.929 . . . . 0.0 110.039 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 61.9 t0 -150.1 64.46 0.97 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.079 -1.013 . . . . 0.0 110.37 -179.525 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.638 ' OH ' HD23 ' A' ' 44' ' ' LEU . 4.7 p90 -131.65 168.07 18.36 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.11 -0.994 . . . . 0.0 109.123 179.11 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 48.2 mtt180 -144.8 140.87 28.74 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.182 -0.949 . . . . 0.0 109.719 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.712 HG21 ' CD2' ' A' ' 16' ' ' TYR . 55.0 t -135.31 127.9 47.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.264 -0.898 . . . . 0.0 109.471 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.478 ' HB3' ' HD2' ' A' ' 12' ' ' PRO . 7.2 mp -114.81 168.17 8.53 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.275 -0.89 . . . . 0.0 109.312 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.478 ' HD2' ' HB3' ' A' ' 11' ' ' LEU . 43.0 Cg_endo -66.43 -24.63 49.36 Favored 'Trans proline' 0 C--O 1.216 -0.609 0 C-N-CA 122.479 2.119 . . . . 0.0 111.409 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 79.2 mtt-85 -98.71 -27.55 13.92 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.344 -0.848 . . . . 0.0 108.857 179.363 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 25.4 mm -87.67 -44.68 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.416 -0.803 . . . . 0.0 109.337 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.572 ' C ' HG13 ' A' ' 10' ' ' VAL . . . 73.0 -165.43 54.82 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.712 ' CD2' HG21 ' A' ' 10' ' ' VAL . 1.9 t80 -100.03 149.76 23.15 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.238 -1.154 . . . . 0.0 109.44 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.612 ' N ' HD22 ' A' ' 17' ' ' LEU . 3.0 mm? -111.01 135.51 51.4 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.288 -0.883 . . . . 0.0 109.453 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.437 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 85.6 m -147.12 157.71 45.72 Favored Pre-proline 0 N--CA 1.492 1.662 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.444 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 47.4 Cg_endo -70.82 165.59 31.69 Favored 'Trans proline' 0 C--O 1.215 -0.653 0 C-N-CA 122.448 2.099 . . . . 0.0 111.596 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.3 tptp -84.58 -29.45 25.81 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.3 -0.875 . . . . 0.0 109.539 -179.783 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -58.49 126.11 26.18 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.28 -0.888 . . . . 0.0 109.381 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 60.4 tp -90.0 116.99 28.46 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.2 -0.937 . . . . 0.0 109.494 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.529 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 3.5 mttp -128.36 106.45 19.4 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.153 -0.967 . . . . 0.0 109.203 179.754 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.544 ' HA ' ' O ' ' A' ' 34' ' ' ASN . 42.6 Cg_endo -64.79 122.62 10.51 Favored 'Trans proline' 0 C--O 1.214 -0.692 0 C-N-CA 123.036 2.49 . . . . 0.0 112.166 -179.404 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.53 ' HB ' HG23 ' A' ' 52' ' ' ILE . 17.3 m -118.19 154.26 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.318 -0.864 . . . . 0.0 109.934 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.442 ' SG ' ' HB3' ' A' ' 53' ' ' ARG . 41.4 t -97.78 138.06 35.71 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.71 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -92.35 140.37 15.1 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.911 -1.276 . . . . 0.0 109.911 -179.28 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.503 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 53.6 p30 -69.48 -11.37 60.77 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.305 -1.114 . . . . 0.0 109.436 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.451 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 57.0 p30 -89.57 10.43 23.01 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.303 -0.873 . . . . 0.0 109.593 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.59 18.95 57.7 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.47 ' O ' ' N ' ' A' ' 27' ' ' GLY . 90.0 mt-30 -119.32 170.17 9.34 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.329 -1.1 . . . . 0.0 109.385 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.581 HG23 ' HA ' ' A' ' 57' ' ' LYS . 54.7 m -134.04 134.25 42.16 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.199 -0.938 . . . . 0.0 109.3 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.898 ' CD1' HD13 ' A' ' 39' ' ' LEU . 38.4 m-85 -114.57 131.04 56.81 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.262 -0.899 . . . . 0.0 109.221 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.544 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 10.1 m-20 -55.7 -78.4 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.287 -0.883 . . . . 0.0 109.676 -179.661 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.519 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 7.1 t-20 -81.96 147.1 57.18 Favored Pre-proline 0 C--N 1.301 -1.527 0 O-C-N 120.927 -1.108 . . . . 0.0 109.645 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.529 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.2 Cg_endo -62.7 -52.07 2.64 Favored 'Trans proline' 0 C--O 1.216 -0.617 0 C-N-CA 122.753 2.302 . . . . 0.0 111.811 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.519 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 8.6 t -61.38 -29.99 70.26 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 120.882 -1.136 . . . . 0.0 108.046 178.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.402 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 13.0 mtt -63.87 -12.91 40.61 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.312 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.898 HD13 ' CD1' ' A' ' 33' ' ' TYR . 29.3 tp -68.04 -54.33 19.11 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.622 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 10.9 t -62.12 -22.43 65.81 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.118 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.437 ' CE1' ' HB2' ' A' ' 16' ' ' TYR . 37.4 t60 -69.7 -57.33 5.27 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.315 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.46 ' OE1' ' CD2' ' A' ' 33' ' ' TYR . 82.1 tt0 -63.61 -20.27 65.53 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 179.267 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.507 ' O ' ' N ' ' A' ' 47' ' ' GLN . 96.5 m-20 -75.42 -32.21 60.63 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.514 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.924 HD13 ' O ' ' A' ' 44' ' ' LEU . 2.8 tm? -65.82 -38.16 88.17 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.32 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.511 ' N ' HD13 ' A' ' 45' ' ' ILE . 4.6 mm -69.76 -43.16 80.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.392 -0.818 . . . . 0.0 108.953 179.481 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.453 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 73.2 mtt-85 -79.73 -23.37 42.36 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.415 -0.803 . . . . 0.0 109.098 179.692 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.507 ' N ' ' O ' ' A' ' 43' ' ' ASN . 92.6 mt-30 63.0 45.33 5.37 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.374 -0.829 . . . . 0.0 109.353 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.1 p -128.53 159.17 36.31 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.302 -0.874 . . . . 0.0 109.374 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.418 ' O ' ' CG ' ' A' ' 49' ' ' ASN . 47.6 p-10 -91.49 59.49 3.84 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.169 -0.957 . . . . 0.0 109.301 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 81.6 m -72.36 141.95 48.77 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.352 -0.843 . . . . 0.0 109.843 -179.795 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 62.6 m-70 -122.44 171.62 8.95 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.275 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.53 HG23 ' HB ' ' A' ' 25' ' ' VAL . 29.2 mt -79.72 126.85 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.075 -1.016 . . . . 0.0 109.581 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.503 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 67.2 ttt-85 -80.07 -44.63 19.72 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.447 -0.783 . . . . 0.0 109.035 179.783 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.4 t -160.23 155.59 25.14 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.706 -0.849 . . . . 0.0 108.706 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 26.1 p -67.5 140.22 57.03 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.091 -1.005 . . . . 0.0 109.314 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.532 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 94.89 169.04 36.59 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.167 -1.573 . . . . 0.0 109.167 -179.748 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.581 ' HA ' HG23 ' A' ' 32' ' ' THR . 44.8 mttp -68.1 144.62 54.97 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.304 -1.116 . . . . 0.0 109.446 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.461 ' SG ' ' O ' ' A' ' 31' ' ' GLN . 73.9 m . . . . . 0 N--CA 1.491 1.595 0 O-C-N 121.254 -0.904 . . . . 0.0 109.289 179.911 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 66.0 mtt . . . . . 0 N--CA 1.488 1.447 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.44 ' HB3' ' HB3' ' A' ' 40' ' ' CYS . 3.7 m -83.19 1.63 39.69 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.341 -0.849 . . . . 0.0 109.114 179.388 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.2 mttm -61.89 -31.74 72.05 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.138 -0.976 . . . . 0.0 109.416 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -145.21 68.54 1.23 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.212 -0.93 . . . . 0.0 109.952 -179.893 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.463 ' CE2' ' CE2' ' A' ' 16' ' ' TYR . 13.9 p90 -119.03 -171.23 2.06 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.175 -0.953 . . . . 0.0 109.19 179.524 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 21.4 ttt180 -150.83 152.32 33.58 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.232 -0.918 . . . . 0.0 109.747 -179.999 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.557 HG13 ' O ' ' A' ' 15' ' ' GLY . 45.4 t -148.63 131.46 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.293 -0.88 . . . . 0.0 109.46 179.839 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.682 HD23 ' HD2' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -104.26 174.86 2.47 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.253 -0.905 . . . . 0.0 109.249 179.81 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.682 ' HD2' HD23 ' A' ' 11' ' ' LEU . 45.8 Cg_endo -67.48 -24.62 42.26 Favored 'Trans proline' 0 C--O 1.215 -0.667 0 C-N-CA 122.706 2.271 . . . . 0.0 112.056 -179.995 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -96.62 -28.23 14.44 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.29 -0.881 . . . . 0.0 109.41 179.966 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.444 HD12 ' HB2' ' A' ' 11' ' ' LEU . 89.9 mt -83.05 -45.77 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.302 -0.874 . . . . 0.0 109.598 -179.916 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.557 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 68.66 -168.74 42.74 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 179.997 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.463 ' CE2' ' CE2' ' A' ' 8' ' ' TYR . 1.4 t80 -95.33 149.25 21.56 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.212 -1.169 . . . . 0.0 109.645 -179.907 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.687 ' C ' HD13 ' A' ' 17' ' ' LEU . 2.3 tm? -111.24 112.21 23.82 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.287 -0.883 . . . . 0.0 109.163 179.873 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.578 ' N ' HD13 ' A' ' 17' ' ' LEU . 62.0 m -128.63 155.77 78.47 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.26 -0.9 . . . . 0.0 109.608 -179.896 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.406 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 49.6 Cg_endo -71.28 168.52 23.17 Favored 'Trans proline' 0 C--O 1.215 -0.675 0 C-N-CA 122.694 2.263 . . . . 0.0 111.526 179.781 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 25.4 mttm -91.09 -14.92 30.34 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.219 -0.926 . . . . 0.0 109.639 -179.828 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 51.3 t0 -72.3 119.48 16.56 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.246 -0.908 . . . . 0.0 109.349 179.866 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.557 HD11 ' HB3' ' A' ' 34' ' ' ASN . 52.4 tp -79.59 113.64 17.9 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.199 -0.938 . . . . 0.0 109.646 -179.944 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.492 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -127.5 110.12 20.96 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.211 -0.931 . . . . 0.0 109.079 179.738 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.553 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 42.6 Cg_endo -64.66 122.48 10.36 Favored 'Trans proline' 0 C--O 1.213 -0.774 0 C-N-CA 122.943 2.428 . . . . 0.0 112.203 -179.715 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.487 ' HB ' HG23 ' A' ' 52' ' ' ILE . 18.8 m -119.31 154.71 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.283 -0.886 . . . . 0.0 109.4 179.785 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.456 ' SG ' ' HB3' ' A' ' 53' ' ' ARG . 39.7 t -96.56 142.71 28.3 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 178.598 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.481 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -95.69 139.43 14.49 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 -179.859 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.466 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 55.0 t0 -69.29 -6.18 27.84 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.234 -1.157 . . . . 0.0 109.592 -179.781 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.434 ' OD2' ' OG1' ' A' ' 50' ' ' THR . 41.7 m-20 -90.87 0.87 57.37 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.149 -0.969 . . . . 0.0 109.548 179.913 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.43 24.61 15.74 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.634 -1.387 . . . . 0.0 109.634 179.935 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.481 ' O ' ' N ' ' A' ' 27' ' ' GLY . 81.5 mt-30 -131.84 164.17 26.65 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.292 -1.122 . . . . 0.0 109.279 -179.982 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.978 HG21 ' HG3' ' A' ' 57' ' ' LYS . 12.0 m -121.03 150.32 41.34 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.123 -0.985 . . . . 0.0 109.384 179.797 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.844 ' CD2' HD12 ' A' ' 39' ' ' LEU . 36.7 m-85 -128.74 131.75 47.89 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.341 -0.849 . . . . 0.0 109.253 -179.909 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.557 ' HB3' HD11 ' A' ' 22' ' ' LEU . 11.8 m-20 -51.75 -78.77 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.358 -0.839 . . . . 0.0 109.889 -179.429 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.534 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 5.8 t-20 -82.01 147.7 58.55 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.104 -0.997 . . . . 0.0 109.827 -179.789 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.492 ' HD3' ' O ' ' A' ' 23' ' ' LYS . 41.7 Cg_endo -64.04 -52.76 1.49 Allowed 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 122.777 2.318 . . . . 0.0 111.606 179.826 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.534 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 11.6 t -62.2 -30.01 70.78 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.969 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.494 ' CG ' ' HB3' ' A' ' 35' ' ' ASN . 29.3 mtt -65.3 -16.12 63.24 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.435 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.844 HD12 ' CD2' ' A' ' 33' ' ' TYR . 8.0 tt -69.07 -52.87 24.02 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.34 -0.85 . . . . 0.0 108.899 179.71 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.513 ' O ' ' HB2' ' A' ' 43' ' ' ASN . 14.4 m -51.0 -39.66 56.3 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.424 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 13.3 t60 -49.2 -45.12 43.82 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.851 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.595 ' HG3' ' CE1' ' A' ' 33' ' ' TYR . 45.4 mm-40 -61.73 -20.99 64.12 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.263 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.524 ' O ' ' N ' ' A' ' 47' ' ' GLN . 2.5 m-80 -76.69 -31.33 57.17 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 119.694 -0.803 . . . . 0.0 109.034 179.508 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.975 HD13 ' O ' ' A' ' 44' ' ' LEU . 1.7 tm? -70.22 -36.46 74.55 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.265 -0.897 . . . . 0.0 109.396 179.932 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 6.4 mt -74.87 -51.46 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.258 -0.901 . . . . 0.0 109.554 -179.896 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.488 ' NH2' ' OE1' ' A' ' 42' ' ' GLU . 40.8 mtt85 -81.12 -36.74 29.92 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.299 -0.875 . . . . 0.0 109.842 -179.653 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.524 ' N ' ' O ' ' A' ' 43' ' ' ASN . 92.6 mt-30 63.07 34.05 14.13 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.309 -0.869 . . . . 0.0 109.554 -179.809 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.466 HG23 ' HB3' ' A' ' 46' ' ' ARG . 38.9 p -103.74 7.51 37.24 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.276 -0.89 . . . . 0.0 109.486 179.956 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.536 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 65.6 m-20 63.59 47.98 3.56 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.192 -0.942 . . . . 0.0 109.469 -179.895 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.524 ' N ' ' OD1' ' A' ' 43' ' ' ASN . 71.1 m -80.3 125.75 30.28 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.395 -0.815 . . . . 0.0 109.366 179.752 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 51' ' ' HIS . . . . . 0.536 ' CE1' ' O ' ' A' ' 49' ' ' ASN . 7.2 m80 -109.71 -171.09 1.77 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.124 -0.985 . . . . 0.0 109.459 179.822 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.822 HG12 HD13 ' A' ' 39' ' ' LEU . 43.6 mt -87.04 126.56 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.408 -0.808 . . . . 0.0 109.557 179.934 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.466 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 21.7 ttt85 -79.63 -46.4 17.27 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.446 -0.784 . . . . 0.0 109.275 179.841 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 95.3 p -158.31 138.84 12.71 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -179.72 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 20.8 p -56.02 151.33 12.13 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.134 -0.979 . . . . 0.0 109.49 -179.839 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.553 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 74.73 161.91 8.87 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 -179.595 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.978 ' HG3' HG21 ' A' ' 32' ' ' THR . 25.8 tttp -59.6 145.02 46.0 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.424 -1.045 . . . . 0.0 109.144 179.96 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.6 0 O-C-N 121.257 -0.902 . . . . 0.0 109.526 -179.846 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 90.7 mtp . . . . . 0 N--CA 1.488 1.429 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.605 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 19.9 m -80.32 -12.64 59.58 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.477 -0.765 . . . . 0.0 109.251 179.892 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.459 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 26.3 mttt -80.96 6.41 13.45 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.148 -0.97 . . . . 0.0 109.816 179.831 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.459 ' OD1' ' O ' ' A' ' 6' ' ' LYS . 96.3 m-20 -139.13 15.22 2.63 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.005 -1.06 . . . . 0.0 110.416 -179.387 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.686 ' CE2' ' CE2' ' A' ' 16' ' ' TYR . 1.0 OUTLIER -122.69 151.38 41.59 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.913 -1.117 . . . . 0.0 109.533 179.846 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 91.3 mtt180 -129.06 136.05 49.73 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.402 -0.811 . . . . 0.0 109.119 179.693 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.873 HG13 ' O ' ' A' ' 15' ' ' GLY . 49.7 t -127.16 148.43 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.246 -0.909 . . . . 0.0 109.499 -179.628 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.548 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.2 OUTLIER -123.65 175.12 2.99 Favored Pre-proline 0 N--CA 1.488 1.458 0 O-C-N 121.233 -0.917 . . . . 0.0 109.621 -179.689 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.548 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 45.1 Cg_endo -67.76 -22.27 43.55 Favored 'Trans proline' 0 C--O 1.215 -0.675 0 C-N-CA 122.691 2.261 . . . . 0.0 111.713 -179.987 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 69.9 mtt85 -105.7 -24.31 12.55 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.341 -0.85 . . . . 0.0 109.526 179.948 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 24.4 mm -81.9 -48.17 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.246 -0.909 . . . . 0.0 109.54 -179.893 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.873 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 82.17 -163.83 43.57 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.344 -1.503 . . . . 0.0 109.344 -179.923 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.686 ' CE2' ' CE2' ' A' ' 8' ' ' TYR . 2.1 t80 -97.57 150.6 20.94 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.125 -1.221 . . . . 0.0 109.621 179.983 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.696 ' C ' HD13 ' A' ' 17' ' ' LEU . 2.2 tm? -111.86 109.65 19.57 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.333 -0.854 . . . . 0.0 109.749 -179.779 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.519 ' N ' HD13 ' A' ' 17' ' ' LEU . 63.6 m -125.86 156.12 71.87 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.284 -0.885 . . . . 0.0 108.985 179.649 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -71.02 165.48 32.24 Favored 'Trans proline' 0 C--O 1.214 -0.686 0 C-N-CA 122.453 2.102 . . . . 0.0 111.701 -179.98 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 24.3 mttt -83.76 -22.93 31.75 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.261 -0.9 . . . . 0.0 109.521 -179.805 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 -63.62 125.41 24.19 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.226 -0.921 . . . . 0.0 109.401 179.781 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 41.2 tp -85.69 122.92 30.47 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.211 -0.931 . . . . 0.0 109.507 179.94 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.555 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 1.3 mmmt -135.21 103.28 10.59 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.305 -0.872 . . . . 0.0 109.284 179.987 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.536 ' HA ' ' O ' ' A' ' 34' ' ' ASN . 43.3 Cg_endo -65.02 120.02 7.16 Favored 'Trans proline' 0 C--O 1.213 -0.744 0 C-N-CA 123.18 2.587 . . . . 0.0 112.529 -179.125 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.475 ' O ' HG23 ' A' ' 32' ' ' THR . 7.8 m -116.98 155.94 18.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.399 -0.813 . . . . 0.0 109.754 179.683 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.428 ' O ' ' N ' ' A' ' 53' ' ' ARG . 14.8 t -102.67 109.9 21.66 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.389 -0.82 . . . . 0.0 108.97 179.369 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -66.03 137.7 36.3 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 -179.652 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.521 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 55.1 p30 -68.65 -10.14 54.31 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.316 -1.108 . . . . 0.0 109.57 179.858 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.443 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 38.9 m-20 -82.62 4.47 24.63 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.246 -0.909 . . . . 0.0 109.378 179.757 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.73 14.68 56.33 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.137 -1.585 . . . . 0.0 109.137 -179.809 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.501 ' O ' ' N ' ' A' ' 27' ' ' GLY . 88.9 mt-30 -121.36 157.54 30.22 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.382 -1.07 . . . . 0.0 109.373 -179.969 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.517 ' CG2' ' HA ' ' A' ' 57' ' ' LYS . 25.6 m -119.19 134.97 54.91 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.257 -0.902 . . . . 0.0 109.356 179.916 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.632 ' HD2' HD12 ' A' ' 39' ' ' LEU . 54.2 m-85 -113.13 129.67 56.43 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.289 -0.882 . . . . 0.0 109.288 179.986 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.536 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 6.6 m-20 -52.47 -76.29 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.216 -0.928 . . . . 0.0 109.441 -179.812 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.514 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 10.2 t-20 -81.99 147.35 57.72 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.039 -1.038 . . . . 0.0 109.495 179.797 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.555 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 39.9 Cg_endo -63.12 -51.68 2.63 Favored 'Trans proline' 0 C--O 1.214 -0.693 0 C-N-CA 122.673 2.248 . . . . 0.0 111.451 179.555 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.514 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 5.7 t -60.25 -28.36 67.98 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 178.81 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.482 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 34.7 mmm -66.02 -18.94 65.67 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.384 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.632 HD12 ' HD2' ' A' ' 33' ' ' TYR . 8.1 tt -66.84 -52.74 40.09 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.179 -0.951 . . . . 0.0 108.577 179.382 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.483 ' O ' ' HB2' ' A' ' 43' ' ' ASN . 38.0 t -50.81 -25.97 5.12 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 178.983 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.456 ' O ' HG12 ' A' ' 45' ' ' ILE . 28.1 t60 -60.09 -50.05 75.25 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.162 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.602 ' HB2' ' CE1' ' A' ' 33' ' ' TYR . 23.9 tp10 -58.66 -19.42 39.2 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.201 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.518 ' O ' ' N ' ' A' ' 47' ' ' GLN . 4.0 m-80 -78.26 -35.81 47.64 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.29 -0.881 . . . . 0.0 108.913 179.589 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 1.005 HD13 ' O ' ' A' ' 44' ' ' LEU . 2.1 tm? -69.34 -34.3 74.41 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.286 -0.884 . . . . 0.0 109.327 179.717 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.456 HG12 ' O ' ' A' ' 41' ' ' HIS . 6.1 mm -74.67 -53.84 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.382 -0.824 . . . . 0.0 110.118 -179.633 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.564 ' HB3' HG23 ' A' ' 48' ' ' THR . 10.5 mtt-85 -88.38 -30.3 19.62 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.145 -0.972 . . . . 0.0 110.36 -179.159 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.518 ' N ' ' O ' ' A' ' 43' ' ' ASN . 87.2 mt-30 62.33 37.07 14.13 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.128 -0.983 . . . . 0.0 109.277 -179.706 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.564 HG23 ' HB3' ' A' ' 46' ' ' ARG . 72.7 p -101.25 6.68 43.02 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.295 -0.878 . . . . 0.0 109.715 -179.84 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.452 ' HB2' ' O ' ' A' ' 48' ' ' THR . 73.0 m-20 61.65 51.77 3.85 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.165 -0.959 . . . . 0.0 109.556 179.894 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.506 ' N ' ' OD1' ' A' ' 43' ' ' ASN . 47.9 m -76.53 140.63 41.22 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.24 -0.913 . . . . 0.0 109.262 179.755 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 12.0 m-70 -119.53 -176.47 3.16 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.219 -0.926 . . . . 0.0 109.63 -179.879 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.595 HG12 HD13 ' A' ' 39' ' ' LEU . 15.9 mt -87.47 124.07 40.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 O-C-N 121.383 -0.823 . . . . 0.0 109.575 179.883 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.521 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 16.7 tpt180 -81.07 -56.38 4.14 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.476 -0.765 . . . . 0.0 109.477 179.904 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 72.8 m -148.9 141.17 24.07 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -179.832 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.428 ' H ' HG23 ' A' ' 55' ' ' THR . 12.2 p -58.34 144.51 41.25 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.197 -0.939 . . . . 0.0 109.522 -179.67 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.526 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 86.32 162.61 37.13 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.79 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.517 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 21.7 mttp -70.65 133.09 46.36 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.559 -0.965 . . . . 0.0 109.386 179.895 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.495 0 O-C-N 121.219 -0.926 . . . . 0.0 109.406 -179.995 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 70.7 mtm . . . . . 0 N--CA 1.487 1.415 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 3.4 m -82.93 7.56 15.09 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 179.41 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.6 mttm -61.11 -35.69 77.69 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.997 -1.064 . . . . 0.0 109.305 179.724 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -140.65 70.8 1.36 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.321 -0.862 . . . . 0.0 109.915 -179.793 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.457 ' CE2' HG23 ' A' ' 10' ' ' VAL . 26.9 p90 -115.07 -169.75 1.62 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.208 -0.933 . . . . 0.0 109.3 179.633 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.437 ' N ' ' CD2' ' A' ' 8' ' ' TYR . 71.9 mtt-85 -152.41 142.37 22.15 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.256 -0.903 . . . . 0.0 109.569 179.905 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.559 HG13 ' C ' ' A' ' 15' ' ' GLY . 39.9 t -143.06 138.7 27.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.264 -0.897 . . . . 0.0 109.2 179.98 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.549 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.7 OUTLIER -119.55 174.72 2.62 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.221 -0.924 . . . . 0.0 109.449 -179.788 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.549 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 46.6 Cg_endo -68.36 -24.31 37.24 Favored 'Trans proline' 0 C--O 1.214 -0.678 0 C-N-CA 122.748 2.299 . . . . 0.0 111.881 179.965 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.486 ' HG2' ' O ' ' A' ' 13' ' ' ARG . 23.4 ttm180 -101.18 -16.69 16.93 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.322 -0.861 . . . . 0.0 109.282 179.897 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 85.2 mt -96.99 -42.19 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.244 -0.91 . . . . 0.0 109.654 -179.754 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.559 ' C ' HG13 ' A' ' 10' ' ' VAL . . . 71.55 179.38 31.3 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 -179.812 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.487 ' OH ' ' HB2' ' A' ' 40' ' ' CYS . 1.8 t80 -77.61 153.92 32.76 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.153 -1.204 . . . . 0.0 109.546 -179.989 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.462 HD23 ' HA ' ' A' ' 17' ' ' LEU . 48.1 mt -110.42 123.58 50.15 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.216 -0.927 . . . . 0.0 109.594 179.999 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.466 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 82.4 m -146.98 156.72 47.27 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.453 -0.779 . . . . 0.0 109.032 179.895 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.518 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 48.9 Cg_endo -70.86 168.29 23.42 Favored 'Trans proline' 0 C--O 1.216 -0.608 0 C-N-CA 122.583 2.188 . . . . 0.0 111.515 179.889 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -94.26 -8.73 38.27 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.124 -0.985 . . . . 0.0 109.628 -179.796 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -76.62 118.53 19.36 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.169 -0.957 . . . . 0.0 109.414 179.957 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.501 HD11 ' HB3' ' A' ' 34' ' ' ASN . 44.3 tp -76.09 116.92 17.26 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.201 -0.937 . . . . 0.0 109.739 -179.973 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.539 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 2.2 mtpt -132.1 106.76 13.66 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.306 -0.871 . . . . 0.0 108.996 179.767 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.527 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 43.2 Cg_endo -64.58 120.24 7.48 Favored 'Trans proline' 0 C--O 1.214 -0.711 0 C-N-CA 122.912 2.408 . . . . 0.0 112.1 -179.448 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.492 ' HB ' HG23 ' A' ' 52' ' ' ILE . 11.4 m -120.26 155.2 23.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.445 -0.784 . . . . 0.0 110.047 -179.768 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.429 ' SG ' ' HB3' ' A' ' 53' ' ' ARG . 41.4 t -96.88 148.18 23.2 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 178.713 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -100.04 139.66 14.54 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.545 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.477 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 53.4 t0 -64.82 -10.7 30.08 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.279 -1.13 . . . . 0.0 109.409 179.834 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 59.9 p30 -90.39 1.6 56.43 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.24 -0.913 . . . . 0.0 109.667 -179.932 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.64 19.45 34.75 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.994 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.473 ' O ' ' N ' ' A' ' 27' ' ' GLY . 87.0 mt-30 -119.23 167.88 11.43 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.209 -1.171 . . . . 0.0 109.429 -179.946 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.549 HG23 ' HA ' ' A' ' 57' ' ' LYS . 94.3 m -127.73 146.91 50.42 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.118 -0.989 . . . . 0.0 109.445 179.792 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.62 ' CD1' ' N ' ' A' ' 33' ' ' TYR . 5.0 m-85 -128.8 128.64 44.34 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.23 -0.918 . . . . 0.0 109.463 -179.835 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.501 ' HB3' HD11 ' A' ' 22' ' ' LEU . 7.5 m-20 -49.79 -77.22 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.282 -0.886 . . . . 0.0 109.663 -179.551 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.543 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 2.0 t-20 -81.91 149.23 62.85 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.161 -0.962 . . . . 0.0 109.443 179.995 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.539 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 41.2 Cg_endo -64.62 -54.71 0.68 Allowed 'Trans proline' 0 C--O 1.216 -0.622 0 C-N-CA 122.842 2.361 . . . . 0.0 111.955 179.873 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.543 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 15.7 t -62.09 -28.6 69.73 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 120.974 -1.079 . . . . 0.0 108.417 179.049 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.444 ' CG ' ' HB3' ' A' ' 35' ' ' ASN . 37.0 mmm -61.45 -15.56 38.47 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 179.363 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.609 HD13 ' CD1' ' A' ' 33' ' ' TYR . 50.8 tp -63.47 -46.01 88.15 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.346 -0.846 . . . . 0.0 108.982 179.61 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.487 ' HB2' ' OH ' ' A' ' 16' ' ' TYR . 2.8 m -71.8 -19.98 61.92 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 178.764 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 28.4 t60 -66.89 -52.76 39.48 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.017 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.474 ' OE1' ' CE2' ' A' ' 33' ' ' TYR . 85.5 tt0 -66.91 -19.86 65.8 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 178.983 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.502 ' O ' ' N ' ' A' ' 47' ' ' GLN . 87.9 m-20 -77.46 -32.75 54.65 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.327 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.409 HD12 ' HA ' ' A' ' 44' ' ' LEU . 23.9 tp -64.28 -31.36 72.54 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.259 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.3 mm -77.63 -44.7 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.442 -0.787 . . . . 0.0 108.972 179.376 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.453 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 63.2 mtt-85 -79.89 -15.36 57.49 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.353 -0.842 . . . . 0.0 109.123 179.629 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.502 ' N ' ' O ' ' A' ' 43' ' ' ASN . 89.0 mt-30 63.09 44.32 5.91 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.421 -0.799 . . . . 0.0 109.486 179.995 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.408 ' O ' ' HB3' ' A' ' 43' ' ' ASN . 7.3 p -128.54 164.52 22.64 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.211 -0.93 . . . . 0.0 109.294 179.829 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 47.5 p-10 -104.58 58.62 0.7 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.123 -0.986 . . . . 0.0 109.573 -179.935 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 86.5 m -71.91 137.77 47.65 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.255 -0.903 . . . . 0.0 109.541 179.9 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 71.4 m80 -112.55 176.54 4.98 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.229 -0.92 . . . . 0.0 109.091 179.723 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.492 HG23 ' HB ' ' A' ' 25' ' ' VAL . 39.2 mt -80.28 126.66 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.231 -0.918 . . . . 0.0 109.509 179.999 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.477 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 67.6 ttt180 -79.88 -46.39 16.91 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.443 -0.786 . . . . 0.0 109.448 -179.922 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.405 ' H ' ' HB3' ' A' ' 26' ' ' CYS . 54.4 p -160.44 138.88 10.14 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -179.331 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.446 ' H ' HG23 ' A' ' 55' ' ' THR . 10.6 p -51.29 147.4 5.75 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.163 -0.961 . . . . 0.0 109.485 179.978 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.527 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 85.14 165.95 41.03 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.484 -1.447 . . . . 0.0 109.484 179.923 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.549 ' HA ' HG23 ' A' ' 32' ' ' THR . 33.7 mttm -65.33 146.24 55.16 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.49 -1.006 . . . . 0.0 109.406 179.981 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.45 ' SG ' ' O ' ' A' ' 31' ' ' GLN . 79.2 m . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.279 -0.888 . . . . 0.0 109.48 179.945 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 62.1 mmm . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.544 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 3.3 m -82.32 -14.92 54.57 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.313 -0.867 . . . . 0.0 109.143 179.862 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -56.2 -25.09 45.81 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.205 -0.934 . . . . 0.0 109.585 -179.994 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -154.27 63.04 0.69 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.179 -0.951 . . . . 0.0 109.841 -179.833 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.544 ' CD1' ' HA ' ' A' ' 5' ' ' CYS . 7.9 p90 -119.84 174.15 6.61 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.172 -0.955 . . . . 0.0 109.308 179.591 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 66.9 mtt-85 -145.26 137.34 25.69 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.19 -0.944 . . . . 0.0 109.514 -179.969 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.86 HG11 ' CD2' ' A' ' 44' ' ' LEU . 98.7 t -134.21 139.82 47.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.243 -0.911 . . . . 0.0 109.48 -179.981 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.548 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.2 OUTLIER -131.28 175.57 3.58 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.345 -0.847 . . . . 0.0 109.389 -179.924 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.548 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 46.0 Cg_endo -67.76 -24.95 40.18 Favored 'Trans proline' 0 C--O 1.214 -0.69 0 C-N-CA 122.673 2.249 . . . . 0.0 111.729 179.884 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.48 ' HG2' ' O ' ' A' ' 13' ' ' ARG . 54.6 ttt180 -110.97 -20.54 12.39 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.328 -0.857 . . . . 0.0 109.204 179.778 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 80.6 mt -90.98 -38.53 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.344 -0.848 . . . . 0.0 109.406 179.978 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.843 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 67.97 -142.22 39.38 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.948 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.54 ' CE2' ' CE2' ' A' ' 8' ' ' TYR . 2.9 t80 -108.23 153.97 22.44 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.172 -1.193 . . . . 0.0 109.57 -179.898 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 29.4 tp -112.33 119.46 38.36 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.398 -0.814 . . . . 0.0 109.581 179.911 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.459 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 58.5 m -131.55 155.92 80.81 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.279 -0.888 . . . . 0.0 109.269 179.903 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -71.11 166.4 29.31 Favored 'Trans proline' 0 C--O 1.216 -0.62 0 C-N-CA 122.523 2.149 . . . . 0.0 111.661 -179.994 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -88.42 -7.13 57.12 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.274 -0.891 . . . . 0.0 109.541 -179.934 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -74.39 128.42 35.49 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.231 -0.918 . . . . 0.0 109.4 179.846 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.731 ' C ' HD13 ' A' ' 22' ' ' LEU . 3.2 tm? -85.5 113.81 22.05 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.212 -0.93 . . . . 0.0 109.666 -179.831 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.519 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 5.5 mmtt -132.75 102.84 13.46 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.271 -0.893 . . . . 0.0 108.818 179.606 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.529 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 41.4 Cg_endo -63.43 124.18 13.35 Favored 'Trans proline' 0 C--O 1.213 -0.734 0 C-N-CA 122.963 2.442 . . . . 0.0 112.417 -179.067 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.46 ' HB ' HG23 ' A' ' 52' ' ' ILE . 35.0 m -123.06 154.08 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.47 -0.769 . . . . 0.0 109.921 -179.93 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.457 ' SG ' ' HB3' ' A' ' 53' ' ' ARG . 43.8 t -100.67 136.47 40.49 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.611 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -93.8 139.07 14.38 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 110.109 -1.196 . . . . 0.0 110.109 -179.099 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.504 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 48.9 p30 -64.14 -13.33 47.34 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.327 -1.102 . . . . 0.0 109.348 179.67 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.441 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 31.6 m-20 -85.61 11.31 11.03 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.236 -0.915 . . . . 0.0 109.237 179.844 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.5 20.32 66.71 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.886 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.523 ' O ' ' N ' ' A' ' 27' ' ' GLY . 83.0 mt-30 -121.98 145.93 47.65 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.304 -1.115 . . . . 0.0 109.503 -179.955 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.512 ' CG2' ' HA ' ' A' ' 57' ' ' LYS . 85.5 m -111.43 153.25 26.38 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.245 -0.909 . . . . 0.0 109.494 179.975 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.53 ' OH ' ' CG ' ' A' ' 42' ' ' GLU . 62.9 m-85 -135.69 145.67 46.96 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.246 -0.909 . . . . 0.0 109.196 179.648 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.514 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 0.1 OUTLIER -63.92 -72.44 0.14 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.144 -0.972 . . . . 0.0 108.574 179.9 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.544 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 9.3 t-20 -83.09 146.9 52.66 Favored Pre-proline 0 C--N 1.299 -1.63 0 O-C-N 121.446 -0.784 . . . . 0.0 109.461 179.709 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.519 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 41.7 Cg_endo -64.15 -51.75 1.98 Allowed 'Trans proline' 0 C--O 1.215 -0.629 0 C-N-CA 122.512 2.141 . . . . 0.0 111.414 179.678 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.544 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 6.6 t -59.34 -25.85 64.54 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 178.8 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.489 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 10.2 mmm -65.6 -19.21 65.82 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.232 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 1.077 HD13 ' CD1' ' A' ' 52' ' ' ILE . 5.7 tt -73.97 -52.19 13.6 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.126 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.576 ' N ' HD23 ' A' ' 39' ' ' LEU . 7.3 t -47.92 -33.36 7.52 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 178.685 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 58.1 t60 -49.95 -56.0 12.32 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 178.934 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.53 ' CG ' ' OH ' ' A' ' 33' ' ' TYR . 16.8 tt0 -50.67 -23.13 2.42 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.072 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.511 ' HB2' ' O ' ' A' ' 40' ' ' CYS . 5.4 m-80 -80.92 -29.67 35.48 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 119.545 -0.862 . . . . 0.0 109.095 179.828 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.86 ' CD2' HG11 ' A' ' 10' ' ' VAL . 27.7 tp -77.39 -35.87 53.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.293 -0.879 . . . . 0.0 109.369 179.942 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 8.0 mm -77.25 -52.77 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.174 -0.954 . . . . 0.0 109.296 179.816 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.416 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 17.5 mtt-85 -79.84 -15.31 57.65 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.311 -0.868 . . . . 0.0 109.49 179.86 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.454 ' HA ' ' O ' ' A' ' 43' ' ' ASN . 92.8 mt-30 60.9 33.4 19.9 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.242 -0.911 . . . . 0.0 109.542 -179.978 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 18.4 p -108.96 176.28 5.16 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.318 -0.864 . . . . 0.0 109.451 179.978 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.488 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 88.8 m-20 -102.91 54.03 0.77 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.285 -0.884 . . . . 0.0 109.423 179.95 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.497 ' N ' ' OD1' ' A' ' 43' ' ' ASN . 60.7 m -73.53 124.24 25.49 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.282 -0.886 . . . . 0.0 109.467 -179.971 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 51' ' ' HIS . . . . . 0.488 ' CE1' ' O ' ' A' ' 49' ' ' ASN . 11.9 m-70 -111.89 -171.19 1.8 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.201 -0.937 . . . . 0.0 109.379 179.908 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 1.077 ' CD1' HD13 ' A' ' 39' ' ' LEU . 21.4 mm -86.45 125.05 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.276 -0.89 . . . . 0.0 109.702 -179.992 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.504 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 59.8 ttt180 -80.73 -42.82 21.24 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.415 -0.803 . . . . 0.0 109.38 179.6 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.403 ' H ' ' HB3' ' A' ' 26' ' ' CYS . 7.6 p -160.87 131.67 5.37 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.6 -0.687 . . . . 0.0 109.305 -179.188 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.425 ' H ' HG23 ' A' ' 55' ' ' THR . 8.0 p -49.13 147.38 2.98 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.214 -0.929 . . . . 0.0 109.089 179.803 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.529 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 85.46 172.45 48.98 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.239 -1.544 . . . . 0.0 109.239 -179.713 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.512 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 55.9 mttm -66.27 149.4 50.41 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.279 -1.13 . . . . 0.0 109.676 -179.77 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.408 ' SG ' ' OG1' ' A' ' 32' ' ' THR . 93.4 m . . . . . 0 N--CA 1.489 1.513 0 O-C-N 121.297 -0.877 . . . . 0.0 109.23 179.878 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 72.8 mmm . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.601 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 44.5 m -80.26 -19.26 47.19 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.48 -0.762 . . . . 0.0 109.392 179.936 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 20.8 mttt -80.08 4.82 15.98 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.24 -0.913 . . . . 0.0 109.652 -179.911 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -128.84 4.75 5.43 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.03 -1.044 . . . . 0.0 110.415 -179.409 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.689 ' CE2' ' CZ ' ' A' ' 16' ' ' TYR . 0.9 OUTLIER -120.43 150.21 41.14 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.912 -1.117 . . . . 0.0 109.554 179.78 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 81.2 mtt180 -131.87 130.69 41.98 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.26 -0.9 . . . . 0.0 109.167 179.76 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.777 HG13 ' O ' ' A' ' 15' ' ' GLY . 58.5 t -118.1 149.3 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.303 -0.873 . . . . 0.0 110.099 -179.484 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.551 ' HB2' HD12 ' A' ' 14' ' ' ILE . 0.7 OUTLIER -127.55 175.42 3.4 Favored Pre-proline 0 N--CA 1.488 1.459 0 O-C-N 121.375 -0.828 . . . . 0.0 108.905 179.484 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.55 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 43.6 Cg_endo -67.22 -22.37 46.78 Favored 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 122.465 2.11 . . . . 0.0 111.746 179.908 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 15.5 mtt-85 -102.04 -28.99 12.03 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.214 -0.929 . . . . 0.0 109.635 -179.999 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.551 HD12 ' HB2' ' A' ' 11' ' ' LEU . 84.9 mt -79.54 -48.7 20.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.229 -0.919 . . . . 0.0 109.582 -179.685 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.777 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 81.9 -167.97 48.59 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 -179.93 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.689 ' CZ ' ' CE2' ' A' ' 8' ' ' TYR . 1.0 OUTLIER -97.69 146.87 24.91 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.131 -1.217 . . . . 0.0 109.618 179.985 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 24.9 tp -118.24 120.63 38.26 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.355 -0.841 . . . . 0.0 109.527 179.969 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.435 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 80.1 m -129.22 156.15 78.78 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.325 -0.859 . . . . 0.0 109.128 179.67 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.525 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 46.2 Cg_endo -69.72 163.95 36.33 Favored 'Trans proline' 0 C--O 1.216 -0.613 0 C-N-CA 122.655 2.236 . . . . 0.0 111.729 -179.987 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -89.78 -7.83 53.52 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.278 -0.889 . . . . 0.0 109.412 -179.987 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 -73.62 120.82 19.74 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.297 -0.877 . . . . 0.0 109.375 179.903 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.921 HD21 ' OD1' ' A' ' 34' ' ' ASN . 3.1 tm? -81.41 124.0 29.05 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.283 -0.886 . . . . 0.0 109.417 -179.923 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.723 ' N ' HD13 ' A' ' 22' ' ' LEU . 11.9 mttt -146.31 104.74 4.06 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.308 -0.87 . . . . 0.0 109.371 179.769 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.549 ' HA ' ' O ' ' A' ' 34' ' ' ASN . 42.6 Cg_endo -65.23 123.61 11.77 Favored 'Trans proline' 0 C--O 1.213 -0.752 0 C-N-CA 122.954 2.436 . . . . 0.0 111.95 -179.92 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.529 ' O ' HG23 ' A' ' 32' ' ' THR . 27.2 m -118.69 154.51 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.191 -0.943 . . . . 0.0 109.637 179.978 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.445 ' SG ' ' HB3' ' A' ' 53' ' ' ARG . 41.5 t -96.59 138.4 34.22 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.273 -0.892 . . . . 0.0 108.83 179.327 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -91.99 139.46 14.71 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 179.995 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.51 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 55.5 t0 -71.03 -7.17 44.51 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.265 -1.138 . . . . 0.0 109.511 -179.925 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.415 ' OD1' ' C ' ' A' ' 29' ' ' ASP . 59.1 p30 -89.6 3.62 52.0 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.187 -0.946 . . . . 0.0 109.462 179.732 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.21 13.39 52.41 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 -179.891 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.451 ' O ' ' N ' ' A' ' 27' ' ' GLY . 76.9 mt-30 -118.72 174.04 6.51 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.256 -1.144 . . . . 0.0 109.402 -179.964 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.612 HG21 ' HG3' ' A' ' 57' ' ' LYS . 23.2 m -135.93 137.23 41.14 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.308 -0.87 . . . . 0.0 109.341 179.839 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.788 ' CD1' HD13 ' A' ' 39' ' ' LEU . 29.3 m-85 -114.2 129.12 56.63 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.299 -0.876 . . . . 0.0 109.348 -179.915 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.921 ' OD1' HD21 ' A' ' 22' ' ' LEU . 63.6 t-20 -52.55 -79.78 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.297 -0.877 . . . . 0.0 109.742 -179.583 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.537 ' HB3' ' CG ' ' A' ' 38' ' ' MET . 2.0 t-20 -81.17 149.66 66.53 Favored Pre-proline 0 C--N 1.3 -1.57 0 O-C-N 120.927 -1.108 . . . . 0.0 109.567 -179.813 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.508 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 39.9 Cg_endo -63.07 -54.53 1.08 Allowed 'Trans proline' 0 C--O 1.214 -0.68 0 C-N-CA 122.729 2.286 . . . . 0.0 111.925 -179.765 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.532 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 9.1 t -61.15 -29.15 69.61 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.997 -1.064 . . . . 0.0 108.224 179.116 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.537 ' CG ' ' HB3' ' A' ' 35' ' ' ASN . 69.6 mmm -62.56 -16.42 56.05 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 179.321 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.788 HD13 ' CD1' ' A' ' 33' ' ' TYR . 24.5 tp -69.08 -58.14 4.48 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.382 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.481 ' HB3' ' OH ' ' A' ' 16' ' ' TYR . 8.8 t -56.95 -29.82 63.49 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 178.685 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 54.9 t60 -64.1 -60.45 3.21 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.189 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.567 ' OE1' ' CE2' ' A' ' 33' ' ' TYR . 83.9 tt0 -57.79 -22.33 46.62 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.328 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.505 ' O ' ' N ' ' A' ' 47' ' ' GLN . 97.3 m-20 -76.4 -31.97 58.27 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.41 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 15.9 tp -66.49 -31.82 72.8 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.267 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 5.4 mt -75.81 -44.7 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 179.41 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.461 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 73.4 mtt-85 -80.61 -20.48 43.14 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.493 -0.754 . . . . 0.0 109.378 179.786 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.505 ' N ' ' O ' ' A' ' 43' ' ' ASN . 89.2 mt-30 63.3 43.49 6.15 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.313 -0.867 . . . . 0.0 109.43 -179.927 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.3 p -123.75 161.82 24.41 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.343 -0.848 . . . . 0.0 109.298 179.868 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.425 ' O ' ' CG ' ' A' ' 49' ' ' ASN . 44.8 p-10 -96.51 59.71 1.83 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.185 -0.947 . . . . 0.0 109.448 179.957 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 34.7 m -72.81 140.45 47.66 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.199 -0.938 . . . . 0.0 109.82 -179.872 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 49.3 m-70 -118.49 172.03 7.75 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.39 -0.819 . . . . 0.0 108.918 179.578 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.478 HG23 ' HB ' ' A' ' 25' ' ' VAL . 35.9 mt -81.54 126.28 39.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.141 -0.974 . . . . 0.0 109.291 179.772 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.51 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 39.8 ttt180 -79.73 -44.17 21.25 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.458 -0.776 . . . . 0.0 109.202 179.978 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.3 t -160.0 157.99 29.79 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.909 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 29.9 p -72.38 144.95 48.03 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.159 -0.963 . . . . 0.0 109.444 -179.907 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.546 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 84.83 165.92 40.71 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.865 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.612 ' HG3' HG21 ' A' ' 32' ' ' THR . 41.5 tttt -53.1 150.23 6.01 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.43 -1.041 . . . . 0.0 109.438 -179.98 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 98.8 m . . . . . 0 N--CA 1.49 1.551 0 O-C-N 121.248 -0.907 . . . . 0.0 109.317 179.887 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 74.6 mtm . . . . . 0 N--CA 1.488 1.453 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.582 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 24.5 m -80.48 -14.27 58.41 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.506 -0.746 . . . . 0.0 109.21 179.659 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.459 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 46.0 mttm -80.94 6.89 11.98 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.27 -0.894 . . . . 0.0 109.649 -179.954 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.459 ' OD1' ' O ' ' A' ' 6' ' ' LYS . 99.3 m-20 -139.12 14.94 2.63 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.108 -0.995 . . . . 0.0 110.309 -179.415 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.844 ' OH ' HD11 ' A' ' 44' ' ' LEU . 0.7 OUTLIER -123.93 152.38 42.51 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.889 -1.132 . . . . 0.0 109.561 179.876 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 16.8 mtm-85 -130.29 132.81 46.07 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.327 -0.858 . . . . 0.0 109.3 179.859 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.844 HG13 ' O ' ' A' ' 15' ' ' GLY . 53.2 t -123.85 145.98 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.144 -0.972 . . . . 0.0 109.462 -179.93 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.567 ' CG ' ' HD2' ' A' ' 12' ' ' PRO . 0.2 OUTLIER -125.12 175.92 2.74 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.241 -0.912 . . . . 0.0 109.339 -179.791 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.567 ' HD2' ' CG ' ' A' ' 11' ' ' LEU . 46.4 Cg_endo -67.65 -22.81 43.4 Favored 'Trans proline' 0 C--O 1.214 -0.681 0 C-N-CA 122.6 2.2 . . . . 0.0 111.664 179.971 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 62.6 ttt-85 -103.27 -22.87 13.65 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.323 -0.86 . . . . 0.0 109.493 179.927 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 36.3 mm -86.1 -51.33 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.223 -0.923 . . . . 0.0 109.425 -179.963 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.844 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 81.42 -163.23 44.47 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -179.917 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.629 ' CE2' ' CE2' ' A' ' 8' ' ' TYR . 1.4 t80 -99.29 150.48 22.06 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.172 -1.193 . . . . 0.0 109.514 179.957 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 18.1 tp -117.85 108.02 14.83 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.22 -0.925 . . . . 0.0 109.693 -179.841 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.442 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 61.3 m -118.13 155.74 51.14 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.258 -0.901 . . . . 0.0 109.269 179.792 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -72.3 167.28 27.34 Favored 'Trans proline' 0 C--O 1.216 -0.624 0 C-N-CA 122.671 2.248 . . . . 0.0 111.675 -179.929 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 61.3 tttm -83.08 -31.01 27.54 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.24 -0.913 . . . . 0.0 109.373 -179.932 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -57.73 126.97 29.73 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.257 -0.902 . . . . 0.0 109.541 179.941 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.575 HD11 ' HB3' ' A' ' 34' ' ' ASN . 66.3 tp -87.93 117.86 27.08 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.315 -0.866 . . . . 0.0 109.393 179.829 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.535 ' CB ' ' HD3' ' A' ' 36' ' ' PRO . 2.8 mttm -125.57 101.8 30.11 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.229 -0.919 . . . . 0.0 109.466 -179.795 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.546 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 42.5 Cg_endo -64.83 118.96 5.89 Favored 'Trans proline' 0 C--O 1.212 -0.809 0 C-N-CA 122.96 2.44 . . . . 0.0 112.28 -179.599 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.485 ' HB ' HG23 ' A' ' 52' ' ' ILE . 15.8 m -119.41 154.59 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.221 -0.925 . . . . 0.0 109.589 179.709 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.47 ' SG ' ' HB3' ' A' ' 53' ' ' ARG . 31.7 t -95.63 141.02 29.63 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.213 -0.93 . . . . 0.0 108.797 178.995 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -95.61 137.35 13.36 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 179.997 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.5 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 54.3 t0 -69.69 -5.41 24.8 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.236 -1.156 . . . . 0.0 109.579 -179.936 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -89.96 1.24 56.5 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.221 -0.924 . . . . 0.0 109.483 179.646 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.47 27.21 12.04 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.861 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.536 ' O ' ' N ' ' A' ' 27' ' ' GLY . 79.2 mt-30 -136.68 153.7 50.82 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.235 -1.156 . . . . 0.0 109.51 -179.968 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.818 HG21 ' HG3' ' A' ' 57' ' ' LYS . 3.5 m -114.96 139.59 49.7 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.294 -0.879 . . . . 0.0 109.31 179.854 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.83 ' CD1' HD13 ' A' ' 39' ' ' LEU . 86.0 m-85 -116.54 132.21 56.74 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.291 -0.881 . . . . 0.0 109.381 -179.904 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.575 ' HB3' HD11 ' A' ' 22' ' ' LEU . 9.8 m-20 -54.8 -78.93 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.352 -0.842 . . . . 0.0 109.728 -179.546 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.494 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 14.3 t-20 -82.35 146.5 54.38 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 120.999 -1.063 . . . . 0.0 109.664 -179.976 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.535 ' HD3' ' CB ' ' A' ' 23' ' ' LYS . 41.3 Cg_endo -63.81 -50.86 2.75 Favored 'Trans proline' 0 C--O 1.214 -0.715 0 C-N-CA 122.63 2.22 . . . . 0.0 111.282 179.367 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.528 ' SG ' ' CE1' ' A' ' 16' ' ' TYR . 7.8 t -60.9 -29.68 69.73 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 178.767 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.47 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 37.8 mmm -64.36 -15.88 61.23 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.103 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.83 HD13 ' CD1' ' A' ' 33' ' ' TYR . 54.5 tp -71.49 -58.84 3.14 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.346 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.447 ' HB3' ' OH ' ' A' ' 16' ' ' TYR . 13.6 t -53.51 -25.8 18.14 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 178.832 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 48.5 t60 -70.94 -63.32 1.12 Allowed 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.353 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.404 ' HA ' ' OE1' ' A' ' 42' ' ' GLU . 74.2 mm-40 -52.72 -21.73 4.4 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 179.237 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.474 ' OD1' ' HB ' ' A' ' 50' ' ' THR . 98.3 m-20 -75.21 -34.56 61.51 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.506 -0.746 . . . . 0.0 109.21 179.652 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.844 HD11 ' OH ' ' A' ' 8' ' ' TYR . 17.6 mt -64.16 -29.34 70.46 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.183 -0.948 . . . . 0.0 109.047 179.58 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.4 mt -80.42 -44.22 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.385 -0.822 . . . . 0.0 109.433 179.69 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.445 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 93.1 mtt-85 -79.97 -34.64 38.5 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.29 -0.881 . . . . 0.0 109.572 179.938 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.446 ' N ' ' O ' ' A' ' 43' ' ' ASN . 92.1 mt-30 63.01 43.74 6.4 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.334 -0.854 . . . . 0.0 109.561 179.979 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 68.4 p -117.31 16.56 14.8 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.329 -0.857 . . . . 0.0 109.295 179.77 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 47.9 t30 43.8 60.91 2.49 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.288 -0.882 . . . . 0.0 109.568 -179.902 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.474 ' HB ' ' OD1' ' A' ' 43' ' ' ASN . 25.7 m -77.96 147.34 34.98 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.26 -0.9 . . . . 0.0 109.626 179.869 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 56.8 m-70 -121.63 168.16 12.09 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.362 -0.836 . . . . 0.0 108.788 179.481 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.485 HG23 ' HB ' ' A' ' 25' ' ' VAL . 26.2 mt -79.79 123.71 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.076 -1.015 . . . . 0.0 109.279 179.977 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.5 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 75.2 ttt-85 -80.21 -42.83 22.56 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.474 -0.766 . . . . 0.0 109.363 -179.94 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -158.45 147.3 18.93 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.444 -0.785 . . . . 0.0 109.279 179.998 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.9 p -66.51 149.74 49.99 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.207 -0.933 . . . . 0.0 109.42 -179.86 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.546 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 73.44 162.3 7.39 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 108.961 -1.656 . . . . 0.0 108.961 -179.594 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.818 ' HG3' HG21 ' A' ' 32' ' ' THR . 22.4 tttp -51.57 146.25 7.81 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.314 -1.109 . . . . 0.0 108.755 179.883 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.438 ' O ' ' O ' ' A' ' 57' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.519 0 O-C-N 121.171 -0.956 . . . . 0.0 109.543 -179.612 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 56.4 mtt . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.437 ' O ' ' N ' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -89.8 -13.43 36.63 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.338 -0.851 . . . . 0.0 108.743 179.663 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.423 ' C ' ' O ' ' A' ' 5' ' ' CYS . 34.5 mttm -46.58 -27.46 1.14 Allowed 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 179.327 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.4 ' N ' ' C ' ' A' ' 5' ' ' CYS . 45.4 p-10 -119.15 39.26 3.6 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 178.752 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.573 ' CE2' ' OH ' ' A' ' 16' ' ' TYR . 1.6 t80 -79.48 157.43 27.48 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.62 -0.675 . . . . 0.0 109.839 -179.258 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 15.1 mtt180 -150.17 115.25 5.37 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.398 -0.814 . . . . 0.0 109.055 179.542 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.581 HG13 ' C ' ' A' ' 15' ' ' GLY . 54.4 t -123.22 146.88 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.342 -0.848 . . . . 0.0 109.521 -179.625 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.534 ' HB2' HD12 ' A' ' 14' ' ' ILE . 0.2 OUTLIER -121.2 172.91 4.35 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.384 -0.823 . . . . 0.0 109.347 -179.881 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.518 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 44.2 Cg_endo -66.29 -22.81 52.66 Favored 'Trans proline' 0 C--O 1.216 -0.592 0 C-N-CA 122.669 2.246 . . . . 0.0 111.594 179.802 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 86.6 mtt-85 -101.51 -25.86 13.76 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.365 -0.835 . . . . 0.0 109.328 179.824 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.534 HD12 ' HB2' ' A' ' 11' ' ' LEU . 85.7 mt -87.52 -47.41 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.281 -0.887 . . . . 0.0 109.415 179.966 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.581 ' C ' HG13 ' A' ' 10' ' ' VAL . . . 69.46 -172.35 38.79 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.894 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.573 ' OH ' ' CE2' ' A' ' 8' ' ' TYR . 1.5 t80 -95.0 150.86 19.7 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.203 -1.175 . . . . 0.0 109.494 179.927 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 21.8 tp -113.38 106.04 14.11 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.255 -0.903 . . . . 0.0 109.633 -179.83 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.418 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 56.0 m -124.54 154.89 69.8 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.304 -0.873 . . . . 0.0 109.389 179.774 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -72.5 170.77 18.55 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 C-N-CA 122.639 2.226 . . . . 0.0 111.491 179.823 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 41.3 tttp -86.77 -33.9 19.77 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.301 -0.875 . . . . 0.0 109.51 -179.926 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -54.14 133.16 44.12 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.318 -0.864 . . . . 0.0 109.383 179.97 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.628 HD11 ' HB3' ' A' ' 34' ' ' ASN . 54.7 tp -92.4 113.14 25.33 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.164 -0.96 . . . . 0.0 109.417 -179.974 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.545 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 5.3 mmtt -118.94 101.68 49.93 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.301 -0.874 . . . . 0.0 109.172 179.981 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.548 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 43.0 Cg_endo -65.35 118.15 5.2 Favored 'Trans proline' 0 C--O 1.213 -0.76 0 C-N-CA 122.848 2.365 . . . . 0.0 112.034 -179.491 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.636 ' O ' HG23 ' A' ' 32' ' ' THR . 11.1 m -114.26 155.99 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.224 -0.923 . . . . 0.0 109.583 179.842 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 46.1 t -96.32 133.77 40.29 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.124 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -91.12 137.01 13.64 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.555 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.48 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 49.9 p30 -66.19 -9.12 28.82 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.341 -1.094 . . . . 0.0 109.502 179.855 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 56.0 p30 -86.09 8.81 19.32 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.18 -0.95 . . . . 0.0 109.397 179.894 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.23 18.78 58.53 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 -179.921 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.405 ' O ' ' SG ' ' A' ' 58' ' ' CYS . 64.4 mt-30 -125.97 176.09 7.24 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.205 -1.174 . . . . 0.0 109.39 -179.942 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.662 HG21 ' HA ' ' A' ' 57' ' ' LYS . 25.1 m -135.44 139.3 44.01 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.258 -0.901 . . . . 0.0 109.442 -179.981 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.971 ' CD1' HD13 ' A' ' 39' ' ' LEU . 58.1 m-85 -113.38 130.57 56.26 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.36 -0.838 . . . . 0.0 109.293 179.855 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.628 ' HB3' HD11 ' A' ' 22' ' ' LEU . 13.9 m-20 -51.83 -80.47 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.317 -0.864 . . . . 0.0 109.693 -179.542 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.509 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 12.0 t-20 -82.39 146.04 53.16 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.005 -1.059 . . . . 0.0 109.482 179.945 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.545 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.9 Cg_endo -63.68 -50.86 2.84 Favored 'Trans proline' 0 C--O 1.216 -0.612 0 C-N-CA 122.653 2.235 . . . . 0.0 111.563 179.723 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.556 ' SG ' ' CE1' ' A' ' 16' ' ' TYR . 11.0 t -61.99 -28.21 69.41 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 178.931 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.461 ' HB2' ' HB3' ' A' ' 35' ' ' ASN . 43.0 mmm -68.92 -7.81 38.43 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 179.24 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.971 HD13 ' CD1' ' A' ' 33' ' ' TYR . 25.5 tp -73.72 -60.09 2.41 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.29 -0.881 . . . . 0.0 108.902 179.802 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.462 ' SG ' ' OH ' ' A' ' 16' ' ' TYR . 12.0 t -52.91 -24.84 10.08 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.382 -0.969 . . . . 0.0 108.382 179.273 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 33.8 t60 -65.09 -60.7 2.74 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.193 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 66.0 mt-10 -60.22 -21.57 61.95 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 179.063 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.501 ' ND2' ' HG ' ' A' ' 39' ' ' LEU . 97.2 m-20 -78.22 -27.01 47.64 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.512 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.97 HD13 ' O ' ' A' ' 44' ' ' LEU . 1.4 tm? -68.54 -36.34 78.68 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.269 -0.894 . . . . 0.0 108.732 179.422 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -77.24 -41.66 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.46 -0.775 . . . . 0.0 109.165 179.719 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.506 ' HB3' HG23 ' A' ' 48' ' ' THR . 93.2 mtt-85 -80.11 -36.23 35.67 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.329 -0.857 . . . . 0.0 109.307 179.898 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.445 ' N ' ' O ' ' A' ' 43' ' ' ASN . 53.1 mt-30 60.05 35.4 21.38 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.368 -0.832 . . . . 0.0 109.678 179.834 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.506 HG23 ' HB3' ' A' ' 46' ' ' ARG . 34.6 p -103.13 11.21 37.35 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.171 -0.956 . . . . 0.0 109.413 179.785 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 65.1 m-20 52.51 54.4 10.7 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.232 -0.918 . . . . 0.0 109.478 179.976 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.477 ' HB ' ' OD1' ' A' ' 43' ' ' ASN . 42.9 m -79.77 137.24 36.95 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.198 -0.938 . . . . 0.0 109.527 179.984 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 41.1 m80 -115.53 170.53 8.35 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.363 -0.836 . . . . 0.0 108.947 179.505 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.573 HG23 ' HB ' ' A' ' 25' ' ' VAL . 29.3 mt -79.62 125.79 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.183 -0.948 . . . . 0.0 109.312 179.884 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.48 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 47.8 ttt180 -81.74 -40.86 22.06 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.501 -0.75 . . . . 0.0 109.496 -179.887 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -158.91 150.59 20.77 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.398 -0.814 . . . . 0.0 109.237 -179.999 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 31.0 p -69.81 139.11 53.14 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.234 -0.917 . . . . 0.0 109.516 -179.873 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.548 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 92.44 162.92 37.44 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.85 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.662 ' HA ' HG21 ' A' ' 32' ' ' THR . 39.5 tttp -50.62 148.55 3.82 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.434 -1.039 . . . . 0.0 109.272 179.887 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.405 ' SG ' ' O ' ' A' ' 31' ' ' GLN . 57.8 m . . . . . 0 N--CA 1.49 1.539 0 O-C-N 121.191 -0.943 . . . . 0.0 109.501 -179.975 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 76.8 mtm . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.507 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 12.9 m -79.81 -14.0 59.01 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.289 -0.882 . . . . 0.0 109.0 179.696 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 47.2 mttm -56.6 -28.2 59.83 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.336 -0.853 . . . . 0.0 109.724 -179.792 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -149.21 61.89 1.04 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.196 -0.94 . . . . 0.0 110.044 -179.779 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.664 ' OH ' HD13 ' A' ' 44' ' ' LEU . 4.7 p90 -121.91 168.2 12.16 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.093 -1.005 . . . . 0.0 109.348 179.534 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 34.2 ttt85 -147.99 149.02 31.39 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.148 -0.97 . . . . 0.0 109.605 179.922 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.757 HG13 ' C ' ' A' ' 15' ' ' GLY . 87.2 t -140.94 134.96 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.302 -0.874 . . . . 0.0 109.369 179.888 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.551 HD23 ' HD2' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -120.59 173.71 3.55 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.15 -0.969 . . . . 0.0 109.391 179.961 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.551 ' HD2' HD23 ' A' ' 11' ' ' LEU . 47.3 Cg_endo -67.9 -23.94 40.51 Favored 'Trans proline' 0 C--O 1.215 -0.644 0 C-N-CA 122.604 2.203 . . . . 0.0 111.737 179.944 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -104.62 -26.87 12.16 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.283 -0.886 . . . . 0.0 109.453 179.992 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.437 HD12 ' HB2' ' A' ' 11' ' ' LEU . 95.2 mt -86.2 -44.43 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.241 -0.912 . . . . 0.0 109.512 -179.94 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.757 ' C ' HG13 ' A' ' 10' ' ' VAL . . . 73.92 -158.73 52.38 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -179.957 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.525 ' CD2' HG21 ' A' ' 10' ' ' VAL . 1.9 t80 -99.64 155.29 17.68 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.285 -1.126 . . . . 0.0 109.345 179.803 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.442 ' O ' ' SG ' ' A' ' 37' ' ' CYS . 30.5 tp -114.16 120.1 39.36 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.229 -0.919 . . . . 0.0 109.883 -179.63 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.401 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 69.4 m -138.65 156.22 73.15 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.279 -0.888 . . . . 0.0 109.366 179.894 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.489 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 52.0 Cg_endo -71.65 168.76 22.78 Favored 'Trans proline' 0 C--O 1.215 -0.635 0 C-N-CA 122.681 2.254 . . . . 0.0 111.638 -179.989 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 29.0 mttt -89.9 -12.72 38.09 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.156 -0.965 . . . . 0.0 109.366 179.961 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -72.2 132.06 43.59 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.285 -0.885 . . . . 0.0 109.202 179.698 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.425 HD11 ' HB3' ' A' ' 34' ' ' ASN . 28.7 tp -91.85 114.19 26.66 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.216 -0.927 . . . . 0.0 109.807 -179.679 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.554 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -126.96 106.78 22.21 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.344 -0.848 . . . . 0.0 108.897 179.604 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.546 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 44.0 Cg_endo -65.88 119.93 7.02 Favored 'Trans proline' 0 C--O 1.214 -0.722 0 C-N-CA 122.825 2.35 . . . . 0.0 112.144 -179.315 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.472 ' O ' HG23 ' A' ' 32' ' ' THR . 21.4 m -116.96 153.22 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.232 -0.917 . . . . 0.0 109.518 179.75 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.454 ' SG ' ' HB3' ' A' ' 53' ' ' ARG . 48.6 t -97.04 142.28 29.17 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 178.989 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -93.88 140.52 15.09 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 -178.999 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.473 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 52.4 p30 -67.41 -10.51 51.94 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.31 -1.112 . . . . 0.0 109.264 179.627 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.426 ' OD1' ' HB2' ' A' ' 31' ' ' GLN . 57.0 p30 -90.07 5.91 44.68 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.226 -0.922 . . . . 0.0 109.474 179.891 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.32 15.36 57.37 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 -179.925 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.458 ' O ' ' SG ' ' A' ' 58' ' ' CYS . 84.3 mt-30 -114.87 178.88 4.12 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.374 -1.074 . . . . 0.0 109.387 179.981 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.519 ' CG2' ' HA ' ' A' ' 57' ' ' LYS . 30.7 m -141.21 144.82 34.97 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.193 -0.942 . . . . 0.0 109.335 179.866 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.813 ' CD1' HD13 ' A' ' 39' ' ' LEU . 23.9 m-85 -124.59 126.7 46.22 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.269 -0.895 . . . . 0.0 109.278 -179.965 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.527 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 9.8 m-20 -48.38 -78.57 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.301 -0.874 . . . . 0.0 109.736 -179.467 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.542 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 4.5 t-20 -81.49 147.67 60.4 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 120.941 -1.1 . . . . 0.0 109.393 179.983 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.554 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 41.0 Cg_endo -63.66 -53.77 1.22 Allowed 'Trans proline' 0 C--O 1.215 -0.644 0 C-N-CA 122.872 2.381 . . . . 0.0 111.926 -179.963 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.542 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 11.3 t -62.98 -25.68 68.48 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 120.942 -1.099 . . . . 0.0 108.141 179.051 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.435 ' CG ' ' HB3' ' A' ' 35' ' ' ASN . 42.1 mmm -67.35 -13.08 61.67 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.21 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.813 HD13 ' CD1' ' A' ' 33' ' ' TYR . 19.1 tp -70.3 -57.55 4.74 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.427 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.473 ' HB3' ' OH ' ' A' ' 16' ' ' TYR . 3.3 t -56.05 -26.77 50.6 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.026 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.499 ' CE1' ' HB2' ' A' ' 16' ' ' TYR . 31.2 t60 -62.43 -59.55 4.82 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.963 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -58.33 -22.89 54.94 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 178.915 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.503 ' O ' ' N ' ' A' ' 47' ' ' GLN . 91.3 m-20 -79.19 -27.75 42.6 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.584 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.664 HD13 ' OH ' ' A' ' 8' ' ' TYR . 32.6 tp -70.22 -30.86 68.05 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.498 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 6.5 mm -80.31 -46.29 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.475 -0.766 . . . . 0.0 109.113 179.467 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.461 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 85.3 mtt180 -79.88 -36.56 36.42 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.309 -0.87 . . . . 0.0 109.394 179.712 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.503 ' N ' ' O ' ' A' ' 43' ' ' ASN . 92.4 mt-30 63.75 42.34 6.29 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.497 -0.752 . . . . 0.0 109.616 -179.862 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.404 HG23 ' HB3' ' A' ' 46' ' ' ARG . 49.4 p -106.8 10.16 30.82 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.195 -0.94 . . . . 0.0 109.417 179.737 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 51.51 54.68 10.62 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.273 -0.892 . . . . 0.0 109.71 179.874 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.46 ' HB ' ' OD1' ' A' ' 43' ' ' ASN . 51.5 m -79.88 139.93 36.94 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.215 -0.928 . . . . 0.0 109.528 179.985 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 3.5 m80 -112.47 -173.42 2.24 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.239 -0.913 . . . . 0.0 109.397 179.722 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 39.8 mt -93.87 126.46 46.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.378 -0.826 . . . . 0.0 109.594 -179.933 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.473 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 68.1 ttt-85 -80.02 -45.77 17.78 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.43 -0.794 . . . . 0.0 109.3 179.787 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.41 ' H ' ' HB3' ' A' ' 26' ' ' CYS . 49.4 p -160.88 147.59 15.17 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 -179.445 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.3 p -61.23 144.14 54.32 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.137 -0.977 . . . . 0.0 109.411 179.929 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.546 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 87.51 164.01 39.66 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 -179.775 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.519 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 53.1 mttt -60.44 148.81 36.17 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.414 -1.051 . . . . 0.0 109.293 179.913 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.458 ' SG ' ' O ' ' A' ' 31' ' ' GLN . 61.8 m . . . . . 0 N--CA 1.489 1.484 0 O-C-N 121.189 -0.944 . . . . 0.0 108.999 179.532 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 64.1 mmm . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.576 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 29.3 m -81.82 -15.34 54.44 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.483 -0.761 . . . . 0.0 109.112 179.709 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.452 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 45.4 mttm -80.72 5.56 15.4 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.195 -0.94 . . . . 0.0 109.789 -179.954 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.452 ' OD1' ' O ' ' A' ' 6' ' ' LYS . 95.4 m-20 -135.97 12.05 3.36 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.025 -1.047 . . . . 0.0 110.333 -179.367 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.772 ' OH ' HD11 ' A' ' 44' ' ' LEU . 0.6 OUTLIER -123.11 155.94 35.98 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.866 -1.146 . . . . 0.0 109.576 179.822 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 47.0 mtt85 -134.19 132.81 40.21 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.372 -0.83 . . . . 0.0 109.149 179.804 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.902 HG13 ' O ' ' A' ' 15' ' ' GLY . 55.6 t -125.45 147.56 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.195 -0.941 . . . . 0.0 109.872 -179.535 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.541 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 1.3 mp -123.28 174.96 3.04 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.288 -0.883 . . . . 0.0 109.202 179.797 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.541 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 44.8 Cg_endo -67.2 -21.72 47.88 Favored 'Trans proline' 0 C--O 1.215 -0.647 0 C-N-CA 122.561 2.174 . . . . 0.0 111.732 179.923 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 95.0 mtt-85 -104.61 -25.73 12.62 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.369 -0.832 . . . . 0.0 109.684 -179.953 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 24.4 mm -80.95 -47.23 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.232 -0.917 . . . . 0.0 109.532 -179.703 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.902 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 82.38 -163.17 42.58 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.935 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.635 ' CE2' ' CE2' ' A' ' 8' ' ' TYR . 1.6 t80 -102.51 148.9 24.96 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.205 -1.174 . . . . 0.0 109.466 179.925 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 27.1 tp -115.63 111.86 21.26 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.31 -0.869 . . . . 0.0 109.532 179.885 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.431 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 80.7 m -120.23 157.54 53.07 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.197 -0.939 . . . . 0.0 109.353 -179.977 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.52 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 50.6 Cg_endo -71.57 166.48 29.26 Favored 'Trans proline' 0 C--O 1.215 -0.642 0 C-N-CA 122.713 2.275 . . . . 0.0 111.884 -179.774 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -87.3 -9.74 54.15 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.307 -0.87 . . . . 0.0 109.449 179.902 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -76.31 110.94 11.24 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.183 -0.948 . . . . 0.0 109.106 179.736 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 42.7 tp -79.66 123.62 27.81 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.216 -0.927 . . . . 0.0 109.708 -179.76 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.481 ' HD3' ' HG3' ' A' ' 36' ' ' PRO . 5.2 mtpt -139.66 107.98 7.12 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.308 -0.87 . . . . 0.0 109.052 179.661 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.556 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 41.5 Cg_endo -64.28 120.23 7.49 Favored 'Trans proline' 0 C--O 1.212 -0.779 0 C-N-CA 122.937 2.424 . . . . 0.0 112.082 -179.558 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.525 ' HB ' HG23 ' A' ' 52' ' ' ILE . 16.6 m -115.71 154.63 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.282 -0.886 . . . . 0.0 109.835 -179.937 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 43.9 t -97.21 126.28 42.29 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.456 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -78.57 137.66 19.9 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 -179.994 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.495 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 52.9 t0 -70.82 -10.33 59.32 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.174 -1.192 . . . . 0.0 109.566 -179.944 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.416 ' OD1' ' HB2' ' A' ' 31' ' ' GLN . 56.5 p30 -87.96 10.38 19.09 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.257 -0.902 . . . . 0.0 109.24 179.586 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.45 21.39 48.4 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.08 -1.608 . . . . 0.0 109.08 -179.722 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.456 ' O ' ' SG ' ' A' ' 58' ' ' CYS . 87.5 mt-30 -121.0 177.21 5.2 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.277 -1.131 . . . . 0.0 109.542 179.98 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 32' ' ' THR . . . . . 1.001 HG21 ' HG3' ' A' ' 57' ' ' LYS . 56.7 m -140.37 134.75 31.33 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.314 -0.866 . . . . 0.0 109.304 179.96 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.835 ' CD1' HD13 ' A' ' 39' ' ' LEU . 39.0 m-85 -117.36 130.09 56.28 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.309 -0.869 . . . . 0.0 109.295 179.994 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.53 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 7.1 m-20 -54.54 -77.83 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.221 -0.924 . . . . 0.0 109.73 -179.628 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.527 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 5.1 t-20 -81.68 148.69 62.43 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.094 -1.004 . . . . 0.0 109.641 -179.906 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.481 ' HG3' ' HD3' ' A' ' 23' ' ' LYS . 40.6 Cg_endo -63.1 -52.62 1.99 Allowed 'Trans proline' 0 C--O 1.215 -0.631 0 C-N-CA 122.568 2.179 . . . . 0.0 111.807 179.829 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.527 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 5.4 t -61.98 -28.18 69.38 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 178.982 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.494 ' CG ' ' HB3' ' A' ' 35' ' ' ASN . 52.6 mmm -63.32 -16.57 60.76 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.444 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.835 HD13 ' CD1' ' A' ' 33' ' ' TYR . 39.0 tp -68.71 -56.87 6.7 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 179.327 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.471 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 10.9 t -55.78 -23.14 28.13 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 178.864 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 47.1 t60 -71.69 -63.46 1.12 Allowed 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 179.393 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.439 ' HB2' ' CE2' ' A' ' 33' ' ' TYR . 62.2 mt-10 -54.35 -21.77 10.38 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.342 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.495 ' O ' ' N ' ' A' ' 47' ' ' GLN . 99.4 m-20 -73.29 -37.22 66.3 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.424 -0.797 . . . . 0.0 109.116 179.686 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.772 HD11 ' OH ' ' A' ' 8' ' ' TYR . 24.0 mt -61.41 -32.59 72.53 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.139 -0.975 . . . . 0.0 108.912 179.627 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.8 mt -74.4 -42.58 49.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.377 -0.827 . . . . 0.0 108.832 179.296 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.448 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 69.1 mtt-85 -79.85 -22.57 42.78 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.428 -0.795 . . . . 0.0 109.391 179.744 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.495 ' N ' ' O ' ' A' ' 43' ' ' ASN . 89.5 mt-30 63.21 41.69 7.73 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.395 -0.816 . . . . 0.0 109.427 -179.838 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 16.0 p -128.35 163.5 24.7 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.344 -0.847 . . . . 0.0 109.371 179.87 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 50.9 p-10 -94.3 61.48 2.83 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.175 -0.953 . . . . 0.0 109.428 -179.958 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 31.7 m -69.75 139.0 53.26 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.402 -0.811 . . . . 0.0 109.742 -179.937 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 62.1 m-70 -119.8 169.36 10.2 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.307 -0.871 . . . . 0.0 109.032 179.538 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.525 HG23 ' HB ' ' A' ' 25' ' ' VAL . 41.1 mt -79.43 126.42 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.182 -0.949 . . . . 0.0 109.387 179.983 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.495 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 68.8 ttt180 -79.92 -47.98 14.17 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-O 121.638 0.732 . . . . 0.0 109.449 179.988 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 65.2 p -159.71 135.55 8.6 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -179.483 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.441 ' H ' HG23 ' A' ' 55' ' ' THR . 11.5 p -50.88 147.97 4.54 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.245 -0.91 . . . . 0.0 109.525 -179.834 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.556 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 85.94 164.22 38.97 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.326 -1.509 . . . . 0.0 109.326 -179.764 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 1.001 ' HG3' HG21 ' A' ' 32' ' ' THR . 26.0 tttt -59.32 153.72 18.2 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.374 -1.074 . . . . 0.0 109.387 -179.924 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.528 ' N ' ' HG2' ' A' ' 57' ' ' LYS . 98.2 m . . . . . 0 N--CA 1.492 1.633 0 O-C-N 121.267 -0.896 . . . . 0.0 109.704 -179.772 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 4' ' ' MET . . . . . 0.442 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 57.2 mmm . . . . . 0 N--CA 1.488 1.444 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 . . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.411 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 17.2 m -81.97 -18.21 44.24 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.483 -0.761 . . . . 0.0 109.155 179.586 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 49.6 mttt -80.2 -3.78 50.41 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.32 -0.862 . . . . 0.0 109.745 -179.886 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' A' ' 4' ' ' MET . 19.3 p30 -118.56 -0.82 11.29 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.08 -1.013 . . . . 0.0 109.714 -179.835 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.484 ' OH ' ' CE2' ' A' ' 16' ' ' TYR . 0.1 OUTLIER -118.51 168.9 10.24 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.053 -1.029 . . . . 0.0 109.284 179.979 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 41.9 mtm-85 -149.63 128.14 12.29 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.243 -0.911 . . . . 0.0 109.254 179.817 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.542 HG21 ' C ' ' A' ' 15' ' ' GLY . 6.4 p -124.99 145.48 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.218 -0.926 . . . . 0.0 109.847 -179.77 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.66 HD23 ' HD2' ' A' ' 12' ' ' PRO . 0.2 OUTLIER -108.37 170.37 5.57 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.359 -0.838 . . . . 0.0 109.229 179.921 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.66 ' HD2' HD23 ' A' ' 11' ' ' LEU . 45.7 Cg_endo -67.54 -23.86 42.79 Favored 'Trans proline' 0 C--O 1.215 -0.659 0 C-N-CA 122.622 2.215 . . . . 0.0 111.787 179.951 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 73.2 mtt85 -87.7 -26.28 23.05 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.289 -0.882 . . . . 0.0 109.131 179.734 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 97.7 mt -90.26 -44.49 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.277 -0.889 . . . . 0.0 109.327 179.883 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.542 ' C ' HG21 ' A' ' 10' ' ' VAL . . . 72.97 148.9 1.0 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.991 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.542 ' N ' HG21 ' A' ' 10' ' ' VAL . 0.9 OUTLIER -47.48 148.91 1.24 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.327 -1.102 . . . . 0.0 109.788 -179.874 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 25.9 tp -115.82 110.29 18.84 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.373 -0.829 . . . . 0.0 109.521 -179.992 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 56.1 m -120.74 154.96 57.54 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.272 -0.892 . . . . 0.0 109.445 179.966 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -72.47 169.7 21.12 Favored 'Trans proline' 0 C--O 1.215 -0.669 0 C-N-CA 122.591 2.194 . . . . 0.0 111.475 179.978 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 47.6 mttm -88.7 -17.89 29.02 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.185 -0.947 . . . . 0.0 109.471 -179.911 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -66.94 130.34 42.83 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.262 -0.899 . . . . 0.0 109.296 179.721 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.498 HD11 ' HB3' ' A' ' 34' ' ' ASN . 43.3 tp -87.46 121.88 30.47 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.177 -0.952 . . . . 0.0 109.558 -179.894 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.541 ' CB ' ' HD3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -132.77 99.72 15.18 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.234 -0.916 . . . . 0.0 109.044 179.768 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.544 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 41.9 Cg_endo -63.88 119.77 6.93 Favored 'Trans proline' 0 C--O 1.214 -0.702 0 C-N-CA 122.899 2.399 . . . . 0.0 112.492 -179.248 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 32.9 m -115.71 154.37 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.345 -0.847 . . . . 0.0 109.473 179.689 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.404 ' O ' ' N ' ' A' ' 53' ' ' ARG . 41.6 t -100.65 121.32 41.43 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.323 -0.86 . . . . 0.0 108.819 179.372 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -74.83 141.62 28.6 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.804 -1.319 . . . . 0.0 109.804 -179.701 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.508 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 55.1 t0 -71.28 -9.69 58.53 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.156 -1.202 . . . . 0.0 109.598 179.969 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -86.81 6.62 30.74 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.234 -0.916 . . . . 0.0 109.198 179.64 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.79 16.6 54.36 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 -179.836 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.454 ' O ' ' SG ' ' A' ' 58' ' ' CYS . 87.5 mt-30 -118.19 169.58 9.58 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.194 -1.18 . . . . 0.0 109.532 179.992 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.481 HG23 ' HA ' ' A' ' 57' ' ' LYS . 27.8 m -132.39 134.47 45.19 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.224 -0.922 . . . . 0.0 109.367 179.874 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.812 ' CD1' HD13 ' A' ' 39' ' ' LEU . 47.6 m-85 -114.43 130.28 56.7 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.185 -0.947 . . . . 0.0 109.195 179.835 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.526 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 5.1 m-20 -52.49 -77.88 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.19 -0.944 . . . . 0.0 109.73 -179.516 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.517 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 13.7 t-20 -81.91 146.5 55.94 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 120.975 -1.078 . . . . 0.0 109.646 -179.895 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.541 ' HD3' ' CB ' ' A' ' 23' ' ' LYS . 40.1 Cg_endo -63.43 -51.29 2.69 Favored 'Trans proline' 0 C--O 1.214 -0.709 0 C-N-CA 122.592 2.195 . . . . 0.0 111.304 179.474 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.517 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 8.8 t -60.62 -28.79 68.8 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 178.835 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.45 ' HB2' ' HB3' ' A' ' 35' ' ' ASN . 12.3 mtt -65.25 -12.7 54.18 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.202 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.812 HD13 ' CD1' ' A' ' 33' ' ' TYR . 51.0 tp -71.47 -58.07 3.85 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.294 -0.879 . . . . 0.0 108.726 179.569 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.465 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 36.0 t -54.61 -24.75 22.67 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 179.048 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 35.1 t60 -68.52 -61.38 1.85 Allowed 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.293 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.438 ' HB2' ' CE2' ' A' ' 33' ' ' TYR . 72.3 mm-40 -56.08 -20.0 15.37 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.259 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.523 ' O ' ' N ' ' A' ' 47' ' ' GLN . 98.0 m-20 -78.61 -29.72 46.17 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.718 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.473 HD23 ' HA ' ' A' ' 44' ' ' LEU . 16.8 mt -68.95 -30.44 68.89 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.25 -0.906 . . . . 0.0 108.795 179.401 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -80.43 -47.33 21.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.346 -0.846 . . . . 0.0 109.355 179.715 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.445 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 94.9 mtt-85 -79.73 -34.47 39.97 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.285 -0.885 . . . . 0.0 109.321 179.875 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.523 ' N ' ' O ' ' A' ' 43' ' ' ASN . 92.1 mt-30 62.15 39.65 12.63 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.362 -0.836 . . . . 0.0 109.518 -179.939 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.408 ' O ' ' C ' ' A' ' 49' ' ' ASN . 68.1 p -107.63 17.08 23.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.302 -0.874 . . . . 0.0 109.468 179.986 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.408 ' C ' ' O ' ' A' ' 48' ' ' THR . 57.4 m-20 44.15 60.0 2.96 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.174 -0.954 . . . . 0.0 109.285 -179.936 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.48 ' HB ' ' OD1' ' A' ' 43' ' ' ASN . 22.1 m -77.12 145.77 37.59 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.213 -0.929 . . . . 0.0 109.669 -179.742 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 28.6 m-70 -118.49 173.8 6.62 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.281 -0.887 . . . . 0.0 109.137 179.565 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 9.4 mt -86.32 124.66 40.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.224 -0.922 . . . . 0.0 109.713 -179.966 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.508 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 21.0 ttt180 -79.51 -51.82 8.82 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-O 121.631 0.729 . . . . 0.0 109.389 179.959 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 57.8 m -159.76 140.15 11.97 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.507 -0.746 . . . . 0.0 109.122 -179.738 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.408 ' H ' HG23 ' A' ' 55' ' ' THR . 21.8 p -52.85 148.06 8.13 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.151 -0.968 . . . . 0.0 109.518 -179.861 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.544 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 88.64 164.95 40.8 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 -179.883 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.527 ' HG3' ' HB2' ' A' ' 24' ' ' PRO . 24.3 mttt -64.32 150.73 45.56 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.493 -1.004 . . . . 0.0 109.224 179.871 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.454 ' SG ' ' O ' ' A' ' 31' ' ' GLN . 86.5 m . . . . . 0 N--CA 1.492 1.639 0 O-C-N 121.23 -0.919 . . . . 0.0 109.429 179.964 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 66.4 mmm . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 . . . . . . . . . 0 0 . 1 . 031 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.584 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 39.1 m -80.71 -16.12 54.74 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.539 -0.726 . . . . 0.0 109.367 179.744 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.429 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 60.5 mttt -80.8 9.14 6.73 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.262 -0.899 . . . . 0.0 109.861 179.95 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.429 ' OD1' ' O ' ' A' ' 6' ' ' LYS . 90.6 m-20 -135.35 3.99 3.13 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.874 -1.141 . . . . 0.0 110.551 -179.526 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.664 ' CE2' ' CE2' ' A' ' 16' ' ' TYR . 1.5 p90 -114.76 156.87 24.06 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.805 -1.184 . . . . 0.0 109.803 -179.996 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 62.7 mtm180 -137.15 133.01 34.78 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.331 -0.855 . . . . 0.0 109.462 179.82 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.78 HG13 ' O ' ' A' ' 15' ' ' GLY . 79.3 t -121.55 143.29 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.351 -0.843 . . . . 0.0 109.687 -179.78 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.558 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 1.8 mp -123.99 176.09 2.47 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.329 -0.857 . . . . 0.0 109.103 179.877 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.558 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 44.3 Cg_endo -67.19 -22.68 46.46 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 122.561 2.174 . . . . 0.0 111.759 179.873 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 71.5 mtt85 -102.94 -28.45 12.02 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.277 -0.889 . . . . 0.0 109.506 179.907 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 14' ' ' ILE . . . . . 0.508 HD12 ' HB2' ' A' ' 11' ' ' LEU . 94.8 mt -82.79 -46.43 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.358 -0.839 . . . . 0.0 109.766 -179.731 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.78 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 75.81 -169.99 54.7 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.391 -1.483 . . . . 0.0 109.391 -179.87 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.664 ' CE2' ' CE2' ' A' ' 8' ' ' TYR . 1.5 t80 -90.81 151.02 21.34 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.163 -1.198 . . . . 0.0 109.436 179.914 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.463 HD23 ' HA ' ' A' ' 17' ' ' LEU . 43.1 mt -120.26 126.16 49.91 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.269 -0.894 . . . . 0.0 109.721 -179.839 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.402 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 63.3 m -138.16 155.42 74.29 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.319 -0.863 . . . . 0.0 109.057 179.818 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.408 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 47.3 Cg_endo -70.02 165.06 32.54 Favored 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 122.583 2.189 . . . . 0.0 111.659 179.951 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 77.8 mttt -83.7 -21.71 32.27 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.338 -0.851 . . . . 0.0 109.433 -179.801 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -65.7 122.9 18.34 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.263 -0.898 . . . . 0.0 109.202 179.751 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.686 ' C ' HD13 ' A' ' 22' ' ' LEU . 3.5 tm? -89.68 108.33 19.61 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.18 -0.95 . . . . 0.0 109.338 -179.771 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.509 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 4.2 mtpm? -117.42 104.68 49.59 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.389 -0.819 . . . . 0.0 109.132 179.933 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.547 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 42.3 Cg_endo -63.95 119.93 7.14 Favored 'Trans proline' 0 C--O 1.213 -0.739 0 C-N-CA 123.067 2.511 . . . . 0.0 112.502 -179.353 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.442 ' O ' HG23 ' A' ' 32' ' ' THR . 30.1 m -117.35 154.32 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.342 -0.849 . . . . 0.0 109.424 179.703 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 26' ' ' CYS . . . . . 0.425 ' O ' ' N ' ' A' ' 53' ' ' ARG . 43.3 t -98.82 118.21 35.05 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.328 -0.857 . . . . 0.0 109.077 179.622 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -72.57 141.6 31.1 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 110.179 -1.169 . . . . 0.0 110.179 -179.405 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.522 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 54.5 p30 -69.98 -11.26 60.75 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.324 -1.103 . . . . 0.0 109.434 179.748 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.428 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 91.5 m-20 -83.52 9.24 11.79 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.21 -0.931 . . . . 0.0 109.291 179.778 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.52 13.71 67.2 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 -179.908 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.493 ' O ' ' N ' ' A' ' 27' ' ' GLY . 91.8 mt-30 -118.35 170.78 8.62 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.302 -1.116 . . . . 0.0 109.481 179.98 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.553 HG23 ' HA ' ' A' ' 57' ' ' LYS . 56.7 m -129.4 138.94 51.77 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.353 -0.842 . . . . 0.0 109.333 -179.95 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.627 ' CD1' ' CD1' ' A' ' 39' ' ' LEU . 23.2 m-85 -118.38 121.88 41.45 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.304 -0.872 . . . . 0.0 108.93 179.643 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.545 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 1.6 m-20 -47.8 -78.47 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.355 -0.841 . . . . 0.0 109.557 -179.361 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 35' ' ' ASN . . . . . 0.531 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 9.6 t-20 -82.36 146.32 53.9 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.019 -1.05 . . . . 0.0 109.788 -179.706 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.509 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.9 Cg_endo -63.67 -51.63 2.33 Favored 'Trans proline' 0 C--O 1.215 -0.667 0 C-N-CA 122.706 2.271 . . . . 0.0 111.627 179.789 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.531 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 9.2 t -62.51 -26.09 68.37 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 178.842 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 38' ' ' MET . . . . . 0.46 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 41.6 mmm -67.37 -17.37 64.71 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.31 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.627 ' CD1' ' CD1' ' A' ' 33' ' ' TYR . 10.6 tp -70.18 -59.95 2.58 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.305 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.471 ' HB3' ' OH ' ' A' ' 16' ' ' TYR . 16.6 t -54.02 -25.62 22.15 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 178.803 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 72.9 t60 -65.19 -62.12 1.73 Allowed 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.096 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.405 ' OE1' ' CE2' ' A' ' 33' ' ' TYR . 82.3 mt-10 -57.46 -19.34 23.53 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 179.002 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.523 ' O ' ' N ' ' A' ' 47' ' ' GLN . 98.9 m-20 -79.72 -26.55 40.8 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.395 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 40.4 tp -72.98 -31.8 64.77 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.412 -0.805 . . . . 0.0 108.912 179.577 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 8.7 mm -80.04 -49.57 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.347 -0.846 . . . . 0.0 109.097 179.629 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.564 ' HB3' HG23 ' A' ' 48' ' ' THR . 53.3 mtt-85 -80.9 -34.27 33.62 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.294 -0.879 . . . . 0.0 109.246 179.832 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.523 ' N ' ' O ' ' A' ' 43' ' ' ASN . 92.9 mt-30 63.12 39.95 9.46 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.529 -0.732 . . . . 0.0 109.489 -179.887 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.564 HG23 ' HB3' ' A' ' 46' ' ' ARG . 41.7 p -97.26 2.15 50.49 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.243 -0.91 . . . . 0.0 109.534 179.826 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.456 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 70.4 m-20 55.5 56.23 6.49 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.175 -0.953 . . . . 0.0 109.623 179.989 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 55.7 m -79.72 143.06 34.89 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.174 -0.954 . . . . 0.0 109.674 -179.929 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 51' ' ' HIS . . . . . 0.456 ' CE1' ' O ' ' A' ' 49' ' ' ASN . 26.2 m80 -114.25 172.53 6.95 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.269 -0.894 . . . . 0.0 109.054 179.668 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 19.6 mt -85.74 124.38 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.131 -0.981 . . . . 0.0 109.706 -179.919 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.522 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 31.5 ttt-85 -79.77 -56.68 4.1 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.546 -0.721 . . . . 0.0 109.272 179.81 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -152.34 148.8 27.93 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.545 -0.722 . . . . 0.0 109.162 179.91 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 33.6 p -59.02 151.88 21.13 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.164 -0.96 . . . . 0.0 109.302 -179.963 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.547 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 85.5 166.51 42.06 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 108.955 -1.658 . . . . 0.0 108.955 -179.577 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.553 ' HA ' HG23 ' A' ' 32' ' ' THR . 88.6 mttt -66.35 166.67 11.81 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.296 -1.12 . . . . 0.0 109.443 -179.98 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.454 ' SG ' ' O ' ' A' ' 31' ' ' GLN . 85.9 m . . . . . 0 N--CA 1.49 1.549 0 O-C-N 121.294 -0.879 . . . . 0.0 108.955 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.485 ' OD1' HD12 ' A' ' 52' ' ' ILE . 70.3 m-20 . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.5 m -51.27 -30.79 18.97 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.257 -0.902 . . . . 0.0 109.595 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.447 ' HA ' ' HG3' ' A' ' 6' ' ' LYS . 8.3 mt-10 -53.49 -25.55 17.0 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.278 -0.889 . . . . 0.0 109.011 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 63.4 mmm -74.79 -26.38 59.7 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.462 -0.774 . . . . 0.0 109.022 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 5.6 m -81.61 -13.92 57.38 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.328 -0.858 . . . . 0.0 109.251 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.447 ' HG3' ' HA ' ' A' ' 3' ' ' GLU . 40.5 mttm -54.78 -30.37 56.68 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.294 -0.879 . . . . 0.0 109.84 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -150.56 63.69 0.94 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.169 -0.957 . . . . 0.0 109.839 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.786 ' HE2' HD21 ' A' ' 44' ' ' LEU . 9.0 p90 -116.04 175.47 5.53 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.158 -0.963 . . . . 0.0 109.332 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 70.9 mtt180 -148.68 140.07 23.37 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.214 -0.929 . . . . 0.0 109.53 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.85 HG13 ' O ' ' A' ' 15' ' ' GLY . 92.3 t -133.01 139.8 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.365 -0.834 . . . . 0.0 109.349 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.575 HD13 HD12 ' A' ' 14' ' ' ILE . 0.4 OUTLIER -128.13 172.0 7.59 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.26 -0.9 . . . . 0.0 109.262 179.991 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.478 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 45.1 Cg_endo -67.32 -24.78 43.07 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 122.549 2.166 . . . . 0.0 111.439 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 55.6 mtt180 -106.89 -27.69 10.55 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.359 -0.838 . . . . 0.0 109.123 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.575 HD12 HD13 ' A' ' 11' ' ' LEU . 98.1 mt -85.66 -41.92 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.357 -0.839 . . . . 0.0 109.349 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.85 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 71.49 -140.35 30.5 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.464 ' CD2' HG21 ' A' ' 10' ' ' VAL . 3.1 t80 -110.52 151.34 27.69 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.125 -1.221 . . . . 0.0 109.486 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.458 ' HA ' HD23 ' A' ' 17' ' ' LEU . 52.2 mt -111.21 131.24 55.27 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.291 -0.881 . . . . 0.0 109.349 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.46 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 84.6 m -139.64 156.95 70.97 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.207 -0.933 . . . . 0.0 109.596 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.515 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 47.9 Cg_endo -69.81 166.38 27.86 Favored 'Trans proline' 0 C--O 1.215 -0.634 0 C-N-CA 122.666 2.244 . . . . 0.0 111.661 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 52.7 tttp -87.17 -17.62 32.27 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.307 -0.87 . . . . 0.0 109.359 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -66.98 121.73 16.18 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.254 -0.904 . . . . 0.0 109.379 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.755 HD21 ' OD1' ' A' ' 34' ' ' ASN . 3.5 tm? -85.66 125.29 33.05 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.266 -0.896 . . . . 0.0 109.465 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.672 ' N ' HD13 ' A' ' 22' ' ' LEU . 8.8 mtpt -147.49 113.03 4.04 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.254 -0.904 . . . . 0.0 109.739 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.542 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 43.5 Cg_endo -66.14 123.5 11.32 Favored 'Trans proline' 0 C--O 1.214 -0.711 0 C-N-CA 122.973 2.448 . . . . 0.0 111.74 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.49 ' O ' HG23 ' A' ' 32' ' ' THR . 29.8 m -118.54 154.13 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.246 -0.909 . . . . 0.0 109.86 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.408 ' O ' ' N ' ' A' ' 53' ' ' ARG . 45.5 t -97.09 142.16 29.36 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 178.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -99.5 139.28 14.35 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 -179.287 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.496 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 54.9 p30 -64.58 -10.85 29.1 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.357 -1.084 . . . . 0.0 109.52 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.457 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 70.5 m-20 -91.09 12.65 19.23 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.272 -0.893 . . . . 0.0 109.501 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 81.59 15.4 76.0 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.526 ' O ' ' N ' ' A' ' 27' ' ' GLY . 55.6 mt-30 -117.75 155.51 29.87 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.207 -1.173 . . . . 0.0 109.4 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.636 HG21 ' HG3' ' A' ' 57' ' ' LYS . 23.6 m -118.0 146.74 43.81 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.148 -0.97 . . . . 0.0 109.427 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.892 ' CD2' HD12 ' A' ' 39' ' ' LEU . 78.5 m-85 -124.01 128.01 48.74 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.253 -0.904 . . . . 0.0 109.478 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.755 ' OD1' HD21 ' A' ' 22' ' ' LEU . 56.7 t-20 -47.84 -79.95 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.277 -0.89 . . . . 0.0 109.604 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.517 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 3.9 t-20 -81.09 148.63 64.5 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 120.977 -1.077 . . . . 0.0 109.104 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.48 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 39.3 Cg_endo -62.09 -52.66 2.58 Favored 'Trans proline' 0 C--O 1.215 -0.644 0 C-N-CA 122.62 2.213 . . . . 0.0 111.958 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.517 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 4.8 t -60.34 -30.48 69.56 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 120.977 -1.077 . . . . 0.0 108.256 179.005 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.472 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 24.1 mtp -61.64 -18.29 58.86 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.492 -0.755 . . . . 0.0 109.175 179.566 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.892 HD12 ' CD2' ' A' ' 33' ' ' TYR . 6.7 tt -69.21 -52.74 24.75 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.245 -0.909 . . . . 0.0 108.919 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.499 ' O ' ' HB2' ' A' ' 43' ' ' ASN . 4.9 t -49.48 -32.78 12.79 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 179.053 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.476 ' O ' HG12 ' A' ' 45' ' ' ILE . 27.6 t60 -53.96 -48.08 70.66 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 179.122 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.587 ' HB2' ' CE1' ' A' ' 33' ' ' TYR . 24.5 tp10 -61.28 -16.84 49.76 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.265 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.519 ' OD1' ' N ' ' A' ' 50' ' ' THR . 2.8 m-80 -80.33 -32.8 37.84 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.379 -0.825 . . . . 0.0 109.271 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.786 HD21 ' HE2' ' A' ' 8' ' ' TYR . 7.9 mp -75.69 -31.68 59.81 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.33 -0.856 . . . . 0.0 109.596 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.476 HG12 ' O ' ' A' ' 41' ' ' HIS . 8.9 mm -78.77 -51.32 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.229 -0.919 . . . . 0.0 109.531 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.459 ' NH1' ' HG2' ' A' ' 46' ' ' ARG . 15.2 mtt-85 -81.77 -30.78 32.19 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.301 -0.874 . . . . 0.0 109.729 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.443 ' HA ' ' O ' ' A' ' 43' ' ' ASN . 14.6 mt-30 61.62 34.67 17.56 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.265 -0.897 . . . . 0.0 109.474 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.45 ' O ' ' HB2' ' A' ' 49' ' ' ASN . 52.7 p -106.03 2.86 27.65 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.207 -0.933 . . . . 0.0 109.667 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.45 ' HB2' ' O ' ' A' ' 48' ' ' THR . 22.3 m120 64.88 49.82 2.08 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.196 -0.94 . . . . 0.0 109.572 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.519 ' N ' ' OD1' ' A' ' 43' ' ' ASN . 88.4 m -77.77 128.77 34.55 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.264 -0.897 . . . . 0.0 109.465 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 7.3 m-70 -110.72 -173.35 2.22 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.28 -0.888 . . . . 0.0 109.257 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.768 HG12 HD13 ' A' ' 39' ' ' LEU . 22.1 mt -88.31 126.53 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.296 -0.877 . . . . 0.0 109.446 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.496 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 31.6 ttt180 -80.42 -40.93 25.45 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.363 -0.836 . . . . 0.0 109.274 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -160.53 151.71 19.12 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.497 -0.752 . . . . 0.0 109.09 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.2 p -67.46 148.42 51.57 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.121 -0.987 . . . . 0.0 109.422 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.542 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 84.6 165.7 40.06 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.636 ' HG3' HG21 ' A' ' 32' ' ' THR . 23.2 tttp -57.03 151.54 14.84 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.333 -1.098 . . . . 0.0 109.253 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.469 ' N ' ' HG2' ' A' ' 57' ' ' LYS . 96.6 m -53.51 172.62 0.06 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.202 -0.936 . . . . 0.0 109.33 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.412 ' HG2' ' OG ' ' A' ' 62' ' ' SER . 59.4 tt0 -82.56 9.29 9.66 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.225 -0.922 . . . . 0.0 109.679 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -58.73 -39.54 81.18 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.207 -0.933 . . . . 0.0 109.39 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 82.5 p -55.05 -33.38 62.64 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.279 -0.888 . . . . 0.0 109.505 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.412 ' OG ' ' HG2' ' A' ' 59' ' ' GLU . 22.5 p -62.31 159.36 15.3 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.209 -0.932 . . . . 0.0 109.469 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -61.47 148.19 86.53 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.207 -0.933 . . . . 0.0 109.506 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -70.42 -17.22 34.72 Favored 'Trans proline' 0 C--O 1.216 -0.621 0 C-N-CA 122.693 2.262 . . . . 0.0 111.82 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -85.95 -173.28 49.3 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.712 HG22 ' H ' ' A' ' 68' ' ' ALA . 41.3 m -117.21 140.57 49.37 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.27 -1.135 . . . . 0.0 109.478 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 57.6 p -66.02 -23.8 66.63 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.296 -0.877 . . . . 0.0 109.497 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.712 ' H ' HG22 ' A' ' 66' ' ' THR . . . -61.68 -33.02 73.26 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.226 -0.921 . . . . 0.0 109.51 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.413 ' C ' ' HD2' ' A' ' 72' ' ' PRO . . . -64.6 -26.92 68.61 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.222 -0.924 . . . . 0.0 109.426 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 86.2 p -69.69 -28.46 65.86 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.189 -0.945 . . . . 0.0 109.46 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.497 ' N ' ' HD2' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -49.2 -59.3 6.72 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.228 -0.92 . . . . 0.0 109.495 -179.968 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.497 ' HD2' ' N ' ' A' ' 71' ' ' MET . 50.2 Cg_endo -70.38 146.64 56.94 Favored 'Trans proline' 0 C--O 1.215 -0.653 0 C-N-CA 122.684 2.256 . . . . 0.0 111.827 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -70.4 164.65 34.43 Favored 'Trans proline' 0 C--O 1.215 -0.642 0 C-N-CA 122.637 2.224 . . . . 0.0 111.721 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 50.9 m -136.6 141.9 43.29 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.244 -0.91 . . . . 0.0 109.484 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 49.7 t0 -55.51 -34.11 64.35 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.223 -0.923 . . . . 0.0 109.509 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 118.037 -0.983 . . . . 0.0 109.465 179.966 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.459 ' OD1' ' N ' ' A' ' 1' ' ' ASP . 14.5 p30 . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 121.274 0.559 . . . . 0.0 109.607 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.405 ' O ' ' N ' ' A' ' 5' ' ' CYS . 3.6 m -45.39 -26.86 0.6 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.36 -0.837 . . . . 0.0 109.562 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.452 ' HA ' ' HG3' ' A' ' 6' ' ' LYS . 2.9 tt0 -50.62 -25.14 3.85 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.158 -0.964 . . . . 0.0 108.924 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.726 ' HE3' ' HA ' ' A' ' 37' ' ' CYS . 74.8 mtm -80.45 -22.91 40.64 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.447 -0.783 . . . . 0.0 109.382 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.588 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 3.9 m -92.91 -8.27 43.75 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.237 -0.914 . . . . 0.0 109.629 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.452 ' HG3' ' HA ' ' A' ' 3' ' ' GLU . 56.4 mttt -60.64 -24.65 65.7 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.281 -0.887 . . . . 0.0 109.745 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 59.5 t0 -153.56 63.06 0.74 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.135 -0.978 . . . . 0.0 109.912 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.588 ' CD1' ' HA ' ' A' ' 5' ' ' CYS . 9.2 p90 -122.0 178.59 4.83 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.082 -1.011 . . . . 0.0 109.501 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 37.5 mtm180 -150.1 144.42 25.72 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.276 -0.89 . . . . 0.0 109.295 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.944 HG13 ' O ' ' A' ' 15' ' ' GLY . 84.1 t -138.94 132.02 38.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.144 -0.972 . . . . 0.0 109.765 -179.782 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.553 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 2.3 mp -123.39 176.35 2.23 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.402 -0.811 . . . . 0.0 109.11 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.553 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 43.4 Cg_endo -65.57 -24.44 55.94 Favored 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 122.533 2.155 . . . . 0.0 111.733 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 10.5 mtm180 -108.26 -35.3 6.58 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.258 -0.901 . . . . 0.0 109.032 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 86.8 mt -76.55 -35.56 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.372 -0.83 . . . . 0.0 109.194 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.944 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 61.38 -134.56 48.05 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.154 -1.578 . . . . 0.0 109.154 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.528 ' CD2' HG21 ' A' ' 10' ' ' VAL . 3.4 t80 -113.65 155.6 25.21 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.149 -1.207 . . . . 0.0 109.547 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.445 ' HA ' HD12 ' A' ' 17' ' ' LEU . 18.3 tp -112.95 123.29 49.98 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.345 -0.847 . . . . 0.0 109.726 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.447 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 67.0 m -138.33 156.64 73.48 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.354 -0.842 . . . . 0.0 109.011 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.449 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 48.7 Cg_endo -70.89 165.95 30.59 Favored 'Trans proline' 0 C--O 1.214 -0.687 0 C-N-CA 122.491 2.127 . . . . 0.0 111.573 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 40.1 mttp -85.51 -17.83 35.26 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.232 -0.918 . . . . 0.0 109.41 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 -71.2 130.86 42.53 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.33 -0.856 . . . . 0.0 109.23 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.719 ' C ' HD13 ' A' ' 22' ' ' LEU . 3.4 tm? -95.05 112.65 24.33 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.147 -0.97 . . . . 0.0 109.588 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.505 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 0.2 OUTLIER -121.72 104.92 38.81 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.322 -0.861 . . . . 0.0 109.202 179.75 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.534 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 41.1 Cg_endo -63.43 117.74 4.68 Favored 'Trans proline' 0 C--O 1.213 -0.752 0 C-N-CA 123.039 2.493 . . . . 0.0 112.03 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.527 ' O ' HG23 ' A' ' 32' ' ' THR . 17.8 m -118.44 156.28 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.4 -0.813 . . . . 0.0 109.805 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.421 ' O ' ' N ' ' A' ' 53' ' ' ARG . 27.4 t -99.06 111.99 24.24 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.307 -0.87 . . . . 0.0 109.299 179.675 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.497 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -66.21 138.62 36.86 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.521 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 50.8 p30 -69.83 -10.03 56.92 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.303 -1.116 . . . . 0.0 109.539 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.413 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 91.0 m-20 -83.56 5.25 24.83 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.243 -0.911 . . . . 0.0 109.336 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.43 13.12 58.9 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.497 ' O ' ' N ' ' A' ' 27' ' ' GLY . 85.5 mt-30 -122.76 147.79 46.1 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.446 -1.032 . . . . 0.0 109.464 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.527 HG23 ' O ' ' A' ' 25' ' ' VAL . 28.9 m -108.82 141.89 40.2 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.211 -0.93 . . . . 0.0 109.357 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.693 ' CG ' HD12 ' A' ' 39' ' ' LEU . 10.8 m-85 -121.21 131.11 54.04 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.368 -0.833 . . . . 0.0 109.172 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.522 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 1.6 m-20 -53.95 -76.73 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.187 -0.946 . . . . 0.0 109.365 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.538 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 8.0 t-20 -82.17 146.74 55.57 Favored Pre-proline 0 C--N 1.3 -1.572 0 O-C-N 121.06 -1.025 . . . . 0.0 109.554 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.505 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 41.3 Cg_endo -63.46 -52.14 2.13 Favored 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 122.695 2.263 . . . . 0.0 111.858 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.726 ' HA ' ' HE3' ' A' ' 4' ' ' MET . 11.4 t -64.27 -27.46 69.06 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.964 -1.085 . . . . 0.0 108.319 179.104 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.515 ' CG ' ' HB3' ' A' ' 35' ' ' ASN . 31.5 mmm -60.05 -20.66 59.14 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.578 -0.701 . . . . 0.0 109.165 179.486 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.693 HD12 ' CG ' ' A' ' 33' ' ' TYR . 6.3 tp -67.05 -51.81 50.05 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.307 -0.871 . . . . 0.0 108.883 179.657 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.486 ' HA ' ' HB2' ' A' ' 43' ' ' ASN . 2.0 t -54.59 -23.05 15.21 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.174 -0.954 . . . . 0.0 108.534 179.194 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 27.5 t60 -60.05 -59.3 5.64 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.33 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.473 ' OE1' ' CE2' ' A' ' 33' ' ' TYR . 53.2 tt0 -65.12 -21.31 66.78 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.371 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.519 ' O ' ' N ' ' A' ' 47' ' ' GLN . 87.7 m-20 -77.41 -26.8 52.03 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 28.6 tp -69.83 -33.98 73.03 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.373 -0.829 . . . . 0.0 109.219 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 10.7 mm -80.12 -51.41 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.31 -0.869 . . . . 0.0 109.536 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.543 ' HB3' HG23 ' A' ' 48' ' ' THR . 94.3 mtt-85 -80.18 -33.55 38.23 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.288 -0.882 . . . . 0.0 109.729 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.519 ' N ' ' O ' ' A' ' 43' ' ' ASN . 89.8 mt-30 63.96 39.89 7.7 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.308 -0.87 . . . . 0.0 109.434 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.543 HG23 ' HB3' ' A' ' 46' ' ' ARG . 44.2 p -94.52 -6.75 43.04 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.239 -0.913 . . . . 0.0 109.456 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.46 ' HB2' ' O ' ' A' ' 48' ' ' THR . 74.6 m-20 63.03 55.31 1.98 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.289 -0.882 . . . . 0.0 109.476 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 53.7 m -72.11 138.27 47.62 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.186 -0.946 . . . . 0.0 109.51 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 25.4 m-70 -109.62 177.59 4.69 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.325 -0.86 . . . . 0.0 109.204 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.431 HG23 ' HB ' ' A' ' 25' ' ' VAL . 17.7 mt -89.67 124.65 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.224 -0.923 . . . . 0.0 109.777 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.521 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 41.9 ttt180 -80.54 -56.34 4.24 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 121.722 0.772 . . . . 0.0 109.334 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 60.4 p -149.43 147.49 28.32 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 16.0 p -64.27 148.43 50.21 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.221 -0.925 . . . . 0.0 109.381 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.534 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 82.12 163.55 32.6 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.525 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 34.9 mttt -70.47 129.53 39.48 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.439 -1.036 . . . . 0.0 109.457 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -52.15 -32.35 35.42 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.174 -0.954 . . . . 0.0 109.281 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.456 ' HG2' ' O ' ' A' ' 59' ' ' GLU . 83.1 tt0 -81.04 -12.68 59.29 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.366 -0.834 . . . . 0.0 109.36 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.438 ' HB3' ' O ' ' A' ' 57' ' ' LYS . 61.2 tt0 -70.02 -31.49 69.17 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.271 -0.893 . . . . 0.0 109.39 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 32.7 t -83.08 127.82 33.93 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.27 -0.894 . . . . 0.0 109.593 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 98.5 p -111.64 152.63 27.44 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.245 -0.909 . . . . 0.0 109.395 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 45.9 p -65.62 152.27 93.0 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.199 -0.938 . . . . 0.0 109.439 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -69.6 -18.37 37.8 Favored 'Trans proline' 0 C--O 1.215 -0.642 0 C-N-CA 122.716 2.277 . . . . 0.0 111.82 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 91.35 5.79 66.98 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 19.2 p -125.43 161.95 25.93 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.15 -1.206 . . . . 0.0 109.422 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 17.8 p -121.33 163.06 19.23 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.237 -0.914 . . . . 0.0 109.452 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -60.92 -34.36 74.57 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.336 -0.853 . . . . 0.0 109.379 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.1 139.45 56.19 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.298 -0.876 . . . . 0.0 109.376 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 83.8 p -62.1 -27.53 68.99 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.256 -0.902 . . . . 0.0 109.516 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.47 137.82 94.78 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.258 -0.901 . . . . 0.0 109.46 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -70.52 161.16 47.02 Favored 'Trans proline' 0 C--O 1.214 -0.688 0 C-N-CA 122.701 2.267 . . . . 0.0 111.764 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -69.85 158.45 56.81 Favored 'Trans proline' 0 C--O 1.215 -0.642 0 C-N-CA 122.648 2.232 . . . . 0.0 111.748 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 48.9 m -135.94 146.06 46.89 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.223 -0.923 . . . . 0.0 109.459 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -58.31 -33.97 70.06 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.218 -0.926 . . . . 0.0 109.485 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 118.053 -0.975 . . . . 0.0 109.422 179.923 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.403 ' OD1' HG13 ' A' ' 52' ' ' ILE . 37.0 m-20 . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.1 m -61.32 -24.31 66.34 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.245 -0.909 . . . . 0.0 109.641 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.443 ' HA ' ' HG3' ' A' ' 6' ' ' LYS . 1.5 mt-10 -52.99 -22.89 6.24 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.208 -0.932 . . . . 0.0 108.865 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 55.0 mmm -80.29 -34.65 36.73 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.387 -0.82 . . . . 0.0 108.84 179.322 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.574 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 4.3 m -83.24 -0.92 51.68 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.464 -0.772 . . . . 0.0 109.4 179.646 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.443 ' HG3' ' HA ' ' A' ' 3' ' ' GLU . 19.9 mttm -68.53 -21.24 64.58 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.24 -0.913 . . . . 0.0 109.605 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -150.42 59.63 0.95 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.327 -0.858 . . . . 0.0 109.681 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.703 ' OH ' HD21 ' A' ' 44' ' ' LEU . 6.4 p90 -124.78 173.29 8.68 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.166 -0.959 . . . . 0.0 109.324 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 20.9 ptt-85 -156.0 143.77 19.58 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.259 -0.901 . . . . 0.0 109.383 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.882 HG13 ' O ' ' A' ' 15' ' ' GLY . 58.7 t -130.28 137.76 55.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.327 -0.858 . . . . 0.0 109.38 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.538 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 1.4 mp -119.26 174.4 2.81 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.22 -0.925 . . . . 0.0 109.514 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.538 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 46.3 Cg_endo -68.38 -25.02 36.33 Favored 'Trans proline' 0 C--O 1.215 -0.641 0 C-N-CA 122.602 2.201 . . . . 0.0 111.723 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 52.6 mtt180 -108.37 -25.29 11.07 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.332 -0.855 . . . . 0.0 109.318 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 29.3 mm -85.59 -44.5 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.238 -0.914 . . . . 0.0 109.503 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.882 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 69.33 -144.95 41.77 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.516 ' CE2' HD11 ' A' ' 44' ' ' LEU . 1.2 t80 -104.4 155.96 18.33 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.172 -1.193 . . . . 0.0 109.427 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.651 ' C ' HD13 ' A' ' 17' ' ' LEU . 1.8 tm? -119.12 113.01 20.26 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.262 -0.899 . . . . 0.0 109.622 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.568 ' N ' HD13 ' A' ' 17' ' ' LEU . 61.3 m -127.03 155.84 75.24 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.347 -0.846 . . . . 0.0 109.305 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -70.53 167.67 24.77 Favored 'Trans proline' 0 C--O 1.214 -0.683 0 C-N-CA 122.654 2.236 . . . . 0.0 111.787 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -87.7 -14.56 39.52 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.352 -0.843 . . . . 0.0 109.45 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -72.68 112.88 9.13 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.121 -0.987 . . . . 0.0 109.414 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.417 HD11 ' HB3' ' A' ' 34' ' ' ASN . 56.6 tp -74.53 121.49 21.62 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.11 -0.994 . . . . 0.0 109.449 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.529 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -132.17 100.64 15.42 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.217 -0.927 . . . . 0.0 109.185 179.88 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.532 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 42.6 Cg_endo -64.8 118.74 5.69 Favored 'Trans proline' 0 C--O 1.213 -0.758 0 C-N-CA 122.962 2.441 . . . . 0.0 112.27 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 5.4 m -117.91 156.39 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.284 -0.885 . . . . 0.0 109.784 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.453 ' O ' ' N ' ' A' ' 53' ' ' ARG . 33.8 t -100.41 108.19 20.13 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.33 -0.856 . . . . 0.0 109.287 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -61.77 139.91 46.89 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 -179.723 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.499 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 54.9 p30 -70.04 -9.01 53.91 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.347 -1.09 . . . . 0.0 109.613 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.423 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 55.0 p30 -83.2 1.54 40.15 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.24 -0.913 . . . . 0.0 109.463 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.33 18.34 36.51 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.131 -1.588 . . . . 0.0 109.131 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.472 ' O ' ' N ' ' A' ' 27' ' ' GLY . 91.1 mt-30 -124.72 165.53 17.79 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.29 -1.124 . . . . 0.0 109.37 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 93.7 m -120.88 133.84 55.3 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.3 -0.875 . . . . 0.0 109.277 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.642 ' CD2' HD12 ' A' ' 39' ' ' LEU . 7.8 m-85 -115.02 118.29 33.01 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.243 -0.911 . . . . 0.0 109.162 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.529 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 5.4 m-20 -43.88 -80.84 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.287 -0.883 . . . . 0.0 109.746 -179.35 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.487 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 13.6 t-20 -81.72 145.61 54.63 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 120.957 -1.089 . . . . 0.0 109.621 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.529 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.3 Cg_endo -63.27 -50.44 3.61 Favored 'Trans proline' 0 C--O 1.215 -0.667 0 C-N-CA 122.66 2.24 . . . . 0.0 111.351 179.444 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.487 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 5.3 t -61.62 -27.61 68.78 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 178.7 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.48 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 17.7 mtp -66.12 -18.68 65.5 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.409 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.642 HD12 ' CD2' ' A' ' 33' ' ' TYR . 30.0 tp -63.86 -52.82 58.28 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.551 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.492 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 4.3 t -59.27 -29.51 67.63 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.454 ' CE1' ' HB2' ' A' ' 16' ' ' TYR . 23.2 t60 -64.49 -59.23 4.57 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.565 ' OE1' ' CE2' ' A' ' 33' ' ' TYR . 79.6 mt-10 -58.34 -22.77 54.59 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 179.122 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.492 ' O ' ' N ' ' A' ' 47' ' ' GLN . 94.7 m-20 -73.31 -32.03 64.37 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.503 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.703 HD21 ' OH ' ' A' ' 8' ' ' TYR . 55.3 mt -61.38 -31.34 71.24 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 179.197 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.3 mt -80.37 -39.91 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.441 -0.787 . . . . 0.0 109.043 179.438 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.45 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 62.1 mtt85 -79.51 -24.04 42.53 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.36 -0.837 . . . . 0.0 109.112 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.492 ' N ' ' O ' ' A' ' 43' ' ' ASN . 90.3 mt-30 62.59 42.22 8.73 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.362 -0.836 . . . . 0.0 109.484 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 13.6 t -132.83 164.42 26.89 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.243 -0.911 . . . . 0.0 109.335 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.567 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 84.0 m-20 -94.86 61.21 2.53 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.247 -0.908 . . . . 0.0 109.435 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 86.4 m -66.23 135.63 54.74 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.229 -0.919 . . . . 0.0 109.542 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.567 ' CE1' ' O ' ' A' ' 49' ' ' ASN . 57.5 m80 -110.82 -178.84 3.58 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.286 -0.884 . . . . 0.0 109.249 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.403 HG13 ' OD1' ' A' ' 1' ' ' ASP . 12.7 mt -89.6 127.13 42.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.1 -1.0 . . . . 0.0 109.742 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.499 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 20.2 ttt180 -80.1 -57.04 3.82 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.439 -0.788 . . . . 0.0 109.258 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 30.9 m -152.4 142.92 22.71 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.407 ' H ' HG23 ' A' ' 55' ' ' THR . 26.0 p -59.62 146.6 40.39 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.123 -0.986 . . . . 0.0 109.689 -179.618 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.532 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 86.15 162.21 36.42 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.542 ' HB2' ' CB ' ' A' ' 60' ' ' GLU . 67.6 mttt -71.07 124.77 25.16 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.483 -1.01 . . . . 0.0 109.401 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -47.02 -35.81 7.16 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.227 -0.92 . . . . 0.0 109.626 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.478 ' HG2' ' O ' ' A' ' 59' ' ' GLU . 74.4 tt0 -81.18 -15.78 54.76 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.342 -0.849 . . . . 0.0 109.412 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.542 ' CB ' ' HB2' ' A' ' 57' ' ' LYS . 86.2 tt0 -95.74 120.6 36.29 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.305 -0.872 . . . . 0.0 109.571 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 71.4 p -140.28 150.84 44.55 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.316 -0.865 . . . . 0.0 109.313 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 49.1 m -111.87 146.49 37.63 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.222 -0.924 . . . . 0.0 109.518 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.498 ' O ' ' CB ' ' A' ' 69' ' ' ALA . 5.1 p -135.01 162.82 55.42 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.322 -0.861 . . . . 0.0 109.434 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.456 ' HD2' ' HB ' ' A' ' 63' ' ' THR . 50.7 Cg_endo -70.68 -17.69 33.24 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 122.717 2.278 . . . . 0.0 111.864 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -59.26 -31.49 69.72 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.652 HG22 ' H ' ' A' ' 68' ' ' ALA . 50.5 m -78.91 136.39 37.26 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.232 -1.158 . . . . 0.0 109.521 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 54.4 m -62.87 -28.85 70.31 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.246 -0.909 . . . . 0.0 109.528 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.652 ' H ' HG22 ' A' ' 66' ' ' THR . . . -69.45 -30.77 68.75 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.304 -0.872 . . . . 0.0 109.478 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.498 ' CB ' ' O ' ' A' ' 63' ' ' THR . . . -62.83 -34.54 77.53 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.341 -0.849 . . . . 0.0 109.43 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 85.4 p -60.46 -27.9 67.9 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.216 -0.927 . . . . 0.0 109.469 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 3.2 mtt -124.33 83.67 56.85 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.259 -0.9 . . . . 0.0 109.456 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -70.81 146.75 54.52 Favored 'Trans proline' 0 C--O 1.216 -0.621 0 C-N-CA 122.654 2.236 . . . . 0.0 111.856 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -71.09 145.14 48.79 Favored 'Trans proline' 0 C--O 1.215 -0.634 0 C-N-CA 122.688 2.259 . . . . 0.0 111.729 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 99.2 p -120.49 154.84 34.71 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.162 -0.961 . . . . 0.0 109.576 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 60.6 t0 -85.66 118.81 25.39 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.221 -0.925 . . . . 0.0 109.448 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 117.984 -1.008 . . . . 0.0 109.492 -179.998 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.441 ' OD1' HG13 ' A' ' 52' ' ' ILE . 83.5 m-20 . . . . . 0 N--CA 1.492 1.64 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.429 ' HB2' ' CE1' ' A' ' 51' ' ' HIS . 2.8 m -59.69 -26.44 65.59 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.295 -0.878 . . . . 0.0 109.426 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.455 ' HA ' ' HG3' ' A' ' 6' ' ' LYS . 1.2 mt-10 -54.35 -21.47 9.58 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.182 -0.948 . . . . 0.0 108.986 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 73.8 mtp -77.9 -28.27 49.76 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.363 -0.836 . . . . 0.0 108.964 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.587 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 3.7 m -87.43 -8.39 56.56 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.37 -0.831 . . . . 0.0 109.417 179.682 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.455 ' HG3' ' HA ' ' A' ' 3' ' ' GLU . 40.9 mttt -63.47 -20.09 65.29 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.167 -0.958 . . . . 0.0 109.592 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 -149.73 60.65 1.0 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.26 -0.9 . . . . 0.0 109.673 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.806 ' OH ' HD23 ' A' ' 44' ' ' LEU . 1.7 p90 -133.07 163.29 29.57 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.201 -0.937 . . . . 0.0 109.48 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 92.3 mtt180 -136.18 144.6 45.06 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.223 -0.923 . . . . 0.0 109.508 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.573 HG13 ' O ' ' A' ' 15' ' ' GLY . 53.4 t -141.13 136.24 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.244 -0.91 . . . . 0.0 109.473 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.559 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.2 OUTLIER -125.94 175.32 3.25 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.309 -0.869 . . . . 0.0 109.478 -179.936 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.559 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 45.1 Cg_endo -67.29 -25.9 42.17 Favored 'Trans proline' 0 C--O 1.214 -0.714 0 C-N-CA 122.655 2.237 . . . . 0.0 111.913 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 84.3 mtt-85 -104.86 -26.76 12.09 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.339 -0.85 . . . . 0.0 109.279 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 25.5 mm -82.37 -44.69 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.276 -0.89 . . . . 0.0 109.536 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.573 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 75.17 -156.43 48.82 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.618 ' CE2' ' CE2' ' A' ' 8' ' ' TYR . 2.8 t80 -101.92 154.62 18.78 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.238 -1.154 . . . . 0.0 109.429 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.412 ' HA ' HD12 ' A' ' 17' ' ' LEU . 20.7 tp -107.43 104.82 14.48 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.238 -0.914 . . . . 0.0 109.847 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.43 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 58.9 m -125.39 154.88 72.33 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.275 -0.891 . . . . 0.0 109.159 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -71.21 166.96 27.58 Favored 'Trans proline' 0 C--O 1.216 -0.611 0 C-N-CA 122.7 2.266 . . . . 0.0 111.759 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -82.79 -31.87 28.02 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.317 -0.864 . . . . 0.0 109.416 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -56.88 127.29 31.04 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.214 -0.929 . . . . 0.0 109.47 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.531 HD11 ' HB3' ' A' ' 34' ' ' ASN . 60.6 tp -87.74 117.65 26.72 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.217 -0.927 . . . . 0.0 109.281 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.531 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 19.2 mttt -123.78 99.99 37.96 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.26 -0.9 . . . . 0.0 109.463 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.533 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 42.9 Cg_endo -65.17 116.75 4.03 Favored 'Trans proline' 0 C--O 1.214 -0.712 0 C-N-CA 122.933 2.422 . . . . 0.0 111.901 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.508 ' O ' HG23 ' A' ' 32' ' ' THR . 11.4 m -119.84 156.35 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.254 -0.903 . . . . 0.0 109.976 -179.779 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.45 ' O ' ' N ' ' A' ' 53' ' ' ARG . 14.2 t -99.94 110.75 23.08 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.341 -0.849 . . . . 0.0 109.203 179.53 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -65.27 139.26 39.7 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.517 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 51.1 p30 -69.01 -10.61 58.42 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.294 -1.121 . . . . 0.0 109.638 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.441 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 89.6 m-20 -81.28 3.75 22.91 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.19 -0.944 . . . . 0.0 109.3 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.65 16.15 52.92 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.201 -1.56 . . . . 0.0 109.201 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.508 ' O ' ' N ' ' A' ' 27' ' ' GLY . 84.8 mt-30 -125.86 153.45 44.13 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.392 -1.064 . . . . 0.0 109.425 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.516 ' CG2' ' HA ' ' A' ' 57' ' ' LYS . 56.6 m -110.06 142.43 41.52 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.29 -0.881 . . . . 0.0 109.32 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.663 ' CG ' HD12 ' A' ' 39' ' ' LEU . 28.9 m-85 -121.24 119.23 31.67 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.364 -0.835 . . . . 0.0 109.212 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.531 ' HB3' HD11 ' A' ' 22' ' ' LEU . 8.7 m-20 -43.5 -78.82 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.268 -0.895 . . . . 0.0 109.255 -179.671 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.486 ' O ' ' HB2' ' A' ' 38' ' ' MET . 15.3 t-20 -82.63 145.88 51.9 Favored Pre-proline 0 C--N 1.301 -1.53 0 O-C-N 120.988 -1.07 . . . . 0.0 109.231 179.404 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.531 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 41.2 Cg_endo -63.66 -49.39 4.32 Favored 'Trans proline' 0 C--O 1.215 -0.67 0 C-N-CA 122.425 2.083 . . . . 0.0 111.493 179.472 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.484 ' SG ' ' CE1' ' A' ' 16' ' ' TYR . 7.6 t -63.02 -27.64 69.55 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.486 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 29.1 mmm -63.56 -14.66 53.54 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.478 -0.764 . . . . 0.0 109.123 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.663 HD12 ' CG ' ' A' ' 33' ' ' TYR . 9.3 tp -69.43 -53.32 19.87 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.242 -0.911 . . . . 0.0 108.881 179.496 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.499 ' HB3' ' CZ ' ' A' ' 16' ' ' TYR . 8.3 t -52.26 -22.18 4.19 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.187 -0.946 . . . . 0.0 108.451 179.242 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 53.0 t60 -59.44 -61.41 2.64 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.576 -0.702 . . . . 0.0 109.258 179.44 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -67.37 -15.43 63.68 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.19 -0.944 . . . . 0.0 108.895 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.522 ' O ' ' N ' ' A' ' 47' ' ' GLN . 98.1 m-20 -78.27 -24.03 47.0 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.379 -0.826 . . . . 0.0 109.012 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.96 HD13 ' O ' ' A' ' 44' ' ' LEU . 3.1 tm? -72.27 -34.67 68.39 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.249 -0.907 . . . . 0.0 108.825 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 8.4 mm -77.57 -49.86 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.372 -0.83 . . . . 0.0 109.132 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.554 ' HB3' HG23 ' A' ' 48' ' ' THR . 53.0 mtt-85 -80.0 -37.26 34.59 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.34 -0.85 . . . . 0.0 109.3 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.522 ' N ' ' O ' ' A' ' 43' ' ' ASN . 92.8 mt-30 63.21 37.01 11.53 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.381 -0.824 . . . . 0.0 109.65 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.554 HG23 ' HB3' ' A' ' 46' ' ' ARG . 43.5 p -100.34 8.85 43.41 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.31 -0.869 . . . . 0.0 109.428 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 66.5 m-20 52.77 56.96 6.88 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.26 -0.9 . . . . 0.0 109.52 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 36.7 m -68.02 135.9 53.01 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.254 -0.904 . . . . 0.0 109.39 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.429 ' CE1' ' HB2' ' A' ' 2' ' ' SER . 80.2 m-70 -108.77 178.59 4.43 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.325 -0.859 . . . . 0.0 109.354 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.441 HG13 ' OD1' ' A' ' 1' ' ' ASP . 21.0 mt -88.78 125.75 41.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.134 -0.979 . . . . 0.0 109.655 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.517 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 74.4 ttt-85 -81.69 -57.11 3.59 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.433 -0.792 . . . . 0.0 109.576 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 95.8 p -150.18 139.36 21.21 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -179.382 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.4 p -55.72 148.88 15.41 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.178 -0.951 . . . . 0.0 109.425 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.533 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 83.61 165.85 39.1 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.516 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 66.2 mttt -74.63 130.97 40.51 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.438 -1.036 . . . . 0.0 109.362 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -55.68 -31.92 62.82 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.088 -1.007 . . . . 0.0 109.361 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -82.41 -19.9 38.14 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.359 -0.838 . . . . 0.0 108.775 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.482 ' HB3' ' O ' ' A' ' 57' ' ' LYS . 24.3 tt0 -63.79 -16.25 60.74 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 19.1 m -78.32 -31.53 48.83 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.41 -0.806 . . . . 0.0 109.528 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 87.6 p -114.31 149.23 36.32 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.277 -0.889 . . . . 0.0 109.414 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.9 p -115.11 80.69 7.25 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.175 -0.953 . . . . 0.0 109.66 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -71.18 141.93 40.65 Favored 'Trans proline' 0 C--O 1.216 -0.601 0 C-N-CA 122.631 2.221 . . . . 0.0 111.679 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -166.5 -170.94 32.04 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 17.9 p -123.44 163.6 20.54 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.301 -1.117 . . . . 0.0 109.43 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.533 HG22 ' H ' ' A' ' 69' ' ' ALA . 37.1 m -115.34 140.64 48.94 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.241 -0.912 . . . . 0.0 109.524 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.56 -34.11 72.28 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.246 -0.909 . . . . 0.0 109.444 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.533 ' H ' HG22 ' A' ' 67' ' ' THR . . . -63.34 136.6 57.76 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.261 -0.9 . . . . 0.0 109.518 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 87.4 p -64.52 -27.67 69.12 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.301 -0.874 . . . . 0.0 109.501 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 3.2 mtt -129.04 82.64 68.23 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.198 -0.939 . . . . 0.0 109.395 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.407 ' HB3' ' HB ' ' A' ' 67' ' ' THR . 51.6 Cg_endo -70.81 154.4 63.6 Favored 'Trans proline' 0 C--O 1.214 -0.687 0 C-N-CA 122.75 2.3 . . . . 0.0 111.902 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -71.36 151.75 60.2 Favored 'Trans proline' 0 C--O 1.214 -0.713 0 C-N-CA 122.712 2.275 . . . . 0.0 111.675 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 31.6 t -136.27 141.74 43.9 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.245 -0.91 . . . . 0.0 109.494 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 50.2 t0 -54.85 -34.76 63.27 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.243 -0.911 . . . . 0.0 109.438 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 118.035 -0.983 . . . . 0.0 109.5 179.97 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 121.273 0.558 . . . . 0.0 109.499 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.482 ' HB2' ' HA ' ' A' ' 51' ' ' HIS . 3.1 m -45.95 -30.81 1.91 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.238 -0.914 . . . . 0.0 109.431 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.452 ' HA ' ' HG3' ' A' ' 6' ' ' LYS . 11.1 mt-10 -51.74 -27.87 13.37 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 84.5 mtp -76.83 -24.72 52.73 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 179.332 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.471 ' O ' ' HB2' ' A' ' 8' ' ' TYR . 57.8 m -80.05 -14.09 58.8 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.476 -0.765 . . . . 0.0 109.053 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.452 ' HG3' ' HA ' ' A' ' 3' ' ' GLU . 16.9 mttm -45.8 -28.2 1.01 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.288 -0.882 . . . . 0.0 109.307 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -109.98 29.87 7.23 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.316 -0.865 . . . . 0.0 108.947 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.675 ' CZ ' ' CE1' ' A' ' 16' ' ' TYR . 2.2 t80 -79.97 159.13 26.39 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.557 -0.714 . . . . 0.0 109.93 -179.685 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.3 mtt-85 -149.77 113.82 5.13 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.418 -0.801 . . . . 0.0 108.994 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.939 HG21 ' CD2' ' A' ' 16' ' ' TYR . 77.9 t -118.6 151.93 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.281 -0.887 . . . . 0.0 109.619 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.832 HD23 ' HD2' ' A' ' 12' ' ' PRO . 0.2 OUTLIER -130.03 171.87 8.19 Favored Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 121.303 -0.873 . . . . 0.0 108.991 179.842 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.832 ' HD2' HD23 ' A' ' 11' ' ' LEU . 43.5 Cg_endo -66.25 -22.63 53.18 Favored 'Trans proline' 0 C--O 1.214 -0.692 0 C-N-CA 122.541 2.161 . . . . 0.0 111.729 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -108.55 -26.37 10.45 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.248 -0.908 . . . . 0.0 109.58 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 24.0 mm -80.33 -51.49 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.193 -0.942 . . . . 0.0 109.655 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.89 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 84.12 -166.7 42.74 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.939 ' CD2' HG21 ' A' ' 10' ' ' VAL . 1.8 t80 -99.48 148.68 24.0 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.217 -1.166 . . . . 0.0 109.432 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.746 HD13 ' N ' ' A' ' 18' ' ' CYS . 2.0 tm? -111.94 120.83 43.25 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.258 -0.902 . . . . 0.0 109.564 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.746 ' N ' HD13 ' A' ' 17' ' ' LEU . 82.1 m -134.21 156.72 78.8 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.347 -0.846 . . . . 0.0 109.365 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.535 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 49.5 Cg_endo -70.19 167.07 26.05 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 122.726 2.284 . . . . 0.0 111.738 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 64.3 mttm -92.84 -5.77 50.26 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.252 -0.905 . . . . 0.0 109.482 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -75.98 110.34 10.36 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.145 -0.972 . . . . 0.0 109.324 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.823 HD21 ' OD1' ' A' ' 34' ' ' ASN . 3.5 tm? -74.21 121.37 21.13 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.348 -0.845 . . . . 0.0 109.466 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.609 ' N ' HD13 ' A' ' 22' ' ' LEU . 1.7 mtpm? -145.88 111.49 4.48 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.248 -0.908 . . . . 0.0 109.528 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.545 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 44.3 Cg_endo -65.71 124.48 12.83 Favored 'Trans proline' 0 C--O 1.213 -0.756 0 C-N-CA 123.049 2.499 . . . . 0.0 112.295 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.5 ' O ' HG23 ' A' ' 32' ' ' THR . 31.7 m -116.44 153.62 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.249 -0.907 . . . . 0.0 109.489 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.411 ' O ' ' N ' ' A' ' 53' ' ' ARG . 45.2 t -99.59 119.49 38.15 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.307 -0.87 . . . . 0.0 109.068 179.484 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -76.68 139.87 24.31 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.503 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 51.0 p30 -69.8 -11.61 60.99 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.32 -1.106 . . . . 0.0 109.409 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.467 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 70.5 m-20 -82.38 7.83 13.04 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.376 -0.828 . . . . 0.0 109.467 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 88.37 12.62 64.84 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 -118.22 170.54 8.79 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.337 -1.096 . . . . 0.0 109.533 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.5 HG23 ' O ' ' A' ' 25' ' ' VAL . 95.1 m -130.22 134.68 47.44 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.337 -0.852 . . . . 0.0 109.258 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.83 ' CD1' HD13 ' A' ' 39' ' ' LEU . 48.3 m-85 -112.68 126.79 55.77 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.168 -0.958 . . . . 0.0 109.346 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.823 ' OD1' HD21 ' A' ' 22' ' ' LEU . 60.1 t-20 -48.76 -80.23 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.356 -0.84 . . . . 0.0 110.023 -179.491 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.523 ' HB3' ' CG ' ' A' ' 38' ' ' MET . 2.0 t-20 -80.71 149.59 67.97 Favored Pre-proline 0 C--N 1.301 -1.518 0 O-C-N 120.864 -1.148 . . . . 0.0 109.357 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.456 ' HD2' ' CG ' ' A' ' 35' ' ' ASN . 40.1 Cg_endo -62.86 -54.42 1.19 Allowed 'Trans proline' 0 C--O 1.216 -0.614 0 C-N-CA 122.723 2.282 . . . . 0.0 111.876 -179.715 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.535 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 8.1 t -62.9 -28.52 70.11 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.062 -1.024 . . . . 0.0 108.475 179.258 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.523 ' CG ' ' HB3' ' A' ' 35' ' ' ASN . 59.2 mmm -62.31 -14.29 37.65 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.417 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.83 HD13 ' CD1' ' A' ' 33' ' ' TYR . 25.6 tp -68.49 -51.69 40.51 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.421 -0.799 . . . . 0.0 109.468 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.487 ' HB2' ' OH ' ' A' ' 16' ' ' TYR . 3.1 m -67.97 -17.86 64.56 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 179.207 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.52 ' CE1' ' HB2' ' A' ' 16' ' ' TYR . 46.7 t60 -73.28 -55.74 6.01 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.1 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.559 ' OE1' ' CE2' ' A' ' 33' ' ' TYR . 87.1 tt0 -63.75 -18.89 64.51 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.247 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.495 ' O ' ' N ' ' A' ' 47' ' ' GLN . 93.4 m-20 -74.77 -36.12 62.56 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.643 HD11 ' HE2' ' A' ' 16' ' ' TYR . 19.3 mt -61.25 -32.44 72.25 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.372 -0.83 . . . . 0.0 108.821 179.199 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.521 ' N ' HD13 ' A' ' 45' ' ' ILE . 3.6 mm -75.58 -42.75 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.41 -0.806 . . . . 0.0 108.913 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.464 ' NH1' ' HG2' ' A' ' 46' ' ' ARG . 29.0 mtp85 -80.05 -17.67 52.12 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.379 -0.826 . . . . 0.0 109.038 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.495 ' N ' ' O ' ' A' ' 43' ' ' ASN . 87.8 mt-30 62.21 42.92 9.0 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.278 -0.889 . . . . 0.0 109.409 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 15.4 p -127.66 164.96 20.91 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.292 -0.88 . . . . 0.0 109.353 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -102.3 63.6 0.89 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.181 -0.949 . . . . 0.0 109.433 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 49.8 m -75.03 141.83 43.85 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.302 -0.874 . . . . 0.0 109.567 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.482 ' HA ' ' HB2' ' A' ' 2' ' ' SER . 96.5 m-70 -117.87 170.0 9.17 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.311 -0.868 . . . . 0.0 109.049 179.61 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.455 HG12 HD22 ' A' ' 39' ' ' LEU . 21.1 mt -79.95 123.37 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.198 -0.939 . . . . 0.0 109.222 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.503 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 49.7 tpt85 -79.62 -49.03 12.76 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.356 -0.84 . . . . 0.0 109.327 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.3 t -156.03 151.73 27.22 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.466 -0.771 . . . . 0.0 109.21 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 38.8 p -65.24 147.7 52.98 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.172 -0.955 . . . . 0.0 109.218 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.545 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 88.82 165.93 41.73 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 108.986 -1.646 . . . . 0.0 108.986 -179.459 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.525 ' CG ' ' HB2' ' A' ' 24' ' ' PRO . 89.7 mttt -64.28 161.26 17.01 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.43 -1.041 . . . . 0.0 109.579 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 86.5 m -67.98 -18.99 64.89 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.229 -0.92 . . . . 0.0 109.366 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -80.76 -21.52 40.98 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.389 -0.819 . . . . 0.0 109.211 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.513 ' HG3' ' N ' ' A' ' 57' ' ' LYS . 2.1 mt-10 -74.2 -21.05 59.98 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 93.4 p -76.72 -11.55 59.86 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.591 -0.693 . . . . 0.0 109.36 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 16.6 m -72.5 162.78 29.02 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.338 -0.851 . . . . 0.0 109.503 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 24.1 p -133.16 90.6 30.26 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.225 -0.922 . . . . 0.0 109.421 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -70.63 141.75 42.45 Favored 'Trans proline' 0 C--O 1.215 -0.647 0 C-N-CA 122.772 2.314 . . . . 0.0 111.732 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.86 -173.26 43.14 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 61.6 m -63.05 -27.42 69.39 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.31 -1.112 . . . . 0.0 109.444 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 13.2 t -141.94 158.95 43.17 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.256 -0.902 . . . . 0.0 109.449 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.76 -33.3 75.54 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.195 -0.94 . . . . 0.0 109.508 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.62 139.27 58.63 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.297 -0.877 . . . . 0.0 109.527 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 83.1 p -60.87 -31.68 71.14 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.202 -0.936 . . . . 0.0 109.464 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 18.8 mmt -66.86 148.61 98.78 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.249 -0.907 . . . . 0.0 109.448 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -70.37 159.77 51.81 Favored 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 122.706 2.271 . . . . 0.0 111.8 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -70.39 169.34 19.95 Favored 'Trans proline' 0 C--O 1.215 -0.636 0 C-N-CA 122.735 2.29 . . . . 0.0 111.697 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 20.1 m -89.46 -6.96 56.03 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.225 -0.922 . . . . 0.0 109.587 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -81.04 -21.97 39.69 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.146 -0.971 . . . . 0.0 109.393 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.451 ' OXT' ' HG2' ' A' ' 76' ' ' GLU . 85.2 tt0 . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 118.018 -0.991 . . . . 0.0 109.491 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.457 ' OD1' ' N ' ' A' ' 1' ' ' ASP . 21.8 p-10 . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.307 0.575 . . . . 0.0 109.716 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.484 ' HB2' ' HA ' ' A' ' 51' ' ' HIS . 1.5 m -52.02 -35.39 46.71 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.289 -0.882 . . . . 0.0 109.46 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.422 ' HA ' ' HG3' ' A' ' 6' ' ' LYS . 6.1 mt-10 -49.71 -23.76 1.94 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.281 -0.887 . . . . 0.0 108.779 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 90.4 mtp -75.41 -29.86 59.89 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.492 -0.755 . . . . 0.0 109.015 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.465 ' O ' ' HB2' ' A' ' 8' ' ' TYR . 4.2 m -79.93 -23.46 41.73 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.357 -0.84 . . . . 0.0 109.136 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.422 ' HG3' ' HA ' ' A' ' 3' ' ' GLU . 73.0 mttt -48.45 -24.69 1.35 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.251 -0.906 . . . . 0.0 108.873 179.499 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -110.14 29.76 7.36 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.363 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.465 ' HB2' ' O ' ' A' ' 5' ' ' CYS . 1.6 t80 -85.94 153.79 21.94 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.55 -0.719 . . . . 0.0 109.932 -179.417 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 8.9 mtm180 -147.02 113.82 6.08 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.424 -0.797 . . . . 0.0 109.293 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.606 HG21 ' N ' ' A' ' 16' ' ' TYR . 4.6 p -130.64 152.26 37.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.328 -0.857 . . . . 0.0 109.12 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.548 ' CG ' ' HD2' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -109.32 171.64 4.28 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.152 -0.968 . . . . 0.0 109.711 -179.676 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.548 ' HD2' ' CG ' ' A' ' 11' ' ' LEU . 47.7 Cg_endo -69.51 -23.32 32.06 Favored 'Trans proline' 0 C--O 1.214 -0.687 0 C-N-CA 122.699 2.266 . . . . 0.0 111.497 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.472 ' HG2' ' O ' ' A' ' 13' ' ' ARG . 23.1 ttt180 -91.82 -16.23 27.08 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.351 -0.843 . . . . 0.0 109.147 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.422 HD13 ' HA ' ' A' ' 14' ' ' ILE . 26.3 mm -99.8 -41.86 9.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.237 -0.915 . . . . 0.0 109.391 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.564 ' C ' HG21 ' A' ' 10' ' ' VAL . . . 69.22 139.69 0.1 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.606 ' N ' HG21 ' A' ' 10' ' ' VAL . 0.9 OUTLIER -44.88 154.8 0.12 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.261 -1.141 . . . . 0.0 109.401 179.984 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.803 ' N ' HD12 ' A' ' 17' ' ' LEU . 0.3 OUTLIER -118.62 128.07 54.19 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.196 -0.94 . . . . 0.0 109.5 179.957 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.419 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 62.8 m -140.02 156.61 70.33 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.374 -0.828 . . . . 0.0 109.065 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -71.38 167.18 27.02 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.548 2.165 . . . . 0.0 111.492 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 33.3 mttp -86.9 -23.5 25.18 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.182 -0.949 . . . . 0.0 109.586 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -62.14 128.63 37.05 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.119 -0.988 . . . . 0.0 109.257 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.437 HD11 ' HB3' ' A' ' 34' ' ' ASN . 27.8 tp -87.49 117.52 26.34 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.158 -0.963 . . . . 0.0 109.619 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.55 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 0.2 OUTLIER -126.94 100.85 26.95 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.383 -0.823 . . . . 0.0 109.063 179.87 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.529 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 43.4 Cg_endo -65.46 117.93 5.02 Favored 'Trans proline' 0 C--O 1.214 -0.714 0 C-N-CA 123.102 2.535 . . . . 0.0 112.246 -179.363 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.67 ' O ' HG23 ' A' ' 32' ' ' THR . 15.5 m -116.31 154.75 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.359 -0.838 . . . . 0.0 109.568 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 40.3 t -95.97 131.83 41.93 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.368 -0.832 . . . . 0.0 108.803 179.215 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -90.49 134.63 12.44 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -179.672 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.506 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 1.5 m-20 -66.1 -9.02 27.23 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.3 -1.118 . . . . 0.0 109.606 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 50.1 p-10 -85.2 13.85 5.87 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.167 -0.958 . . . . 0.0 109.507 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 81.35 22.65 60.16 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.436 ' O ' ' N ' ' A' ' 27' ' ' GLY . 66.7 mt-30 -131.86 174.1 10.5 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.292 -1.122 . . . . 0.0 109.524 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.67 HG23 ' O ' ' A' ' 25' ' ' VAL . 49.5 m -134.52 137.92 44.25 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.348 -0.845 . . . . 0.0 109.192 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.923 ' CD1' HD13 ' A' ' 39' ' ' LEU . 55.1 m-85 -112.08 122.5 47.92 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.237 -0.914 . . . . 0.0 109.452 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.522 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 7.0 m-20 -46.32 -79.55 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.345 -0.847 . . . . 0.0 109.616 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.539 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 7.6 t-20 -81.94 146.73 56.34 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.034 -1.041 . . . . 0.0 109.358 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.55 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.1 Cg_endo -63.03 -52.96 1.78 Allowed 'Trans proline' 0 C--O 1.216 -0.623 0 C-N-CA 122.824 2.349 . . . . 0.0 111.793 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.539 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 7.8 t -60.67 -26.48 67.12 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 178.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.45 ' HB2' ' HB3' ' A' ' 35' ' ' ASN . 33.6 mmm -70.72 -8.37 51.64 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.175 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.923 HD13 ' CD1' ' A' ' 33' ' ' TYR . 21.8 tp -72.89 -56.02 5.78 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.332 -0.855 . . . . 0.0 109.233 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 3.6 m -63.15 -23.25 67.35 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 119.204 -0.998 . . . . 0.0 108.339 179.323 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.477 ' CE1' ' HB2' ' A' ' 16' ' ' TYR . 49.6 t60 -65.11 -54.66 26.53 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 178.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.438 ' HB2' ' CE2' ' A' ' 33' ' ' TYR . 75.6 mt-10 -66.73 -16.75 64.46 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.111 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.45 ' OD1' ' HB ' ' A' ' 50' ' ' THR . 94.3 m-20 -79.16 -26.53 42.73 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.407 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.974 HD13 ' O ' ' A' ' 44' ' ' LEU . 2.5 tm? -69.72 -35.07 74.72 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.247 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.8 mt -76.18 -43.48 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.471 -0.768 . . . . 0.0 109.071 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.443 ' HB3' HG23 ' A' ' 48' ' ' THR . 68.5 mtt85 -79.8 -36.1 37.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.343 -0.848 . . . . 0.0 109.385 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.429 ' N ' ' O ' ' A' ' 43' ' ' ASN . 91.0 mt-30 62.07 40.2 12.28 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.386 -0.821 . . . . 0.0 109.451 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.443 HG23 ' HB3' ' A' ' 46' ' ' ARG . 37.4 p -111.17 15.16 21.68 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.34 -0.85 . . . . 0.0 109.241 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.419 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 70.0 m-20 45.31 58.22 4.3 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.305 -0.872 . . . . 0.0 109.329 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.45 ' HB ' ' OD1' ' A' ' 43' ' ' ASN . 69.9 m -78.15 147.74 34.43 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.269 -0.894 . . . . 0.0 109.557 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.484 ' HA ' ' HB2' ' A' ' 2' ' ' SER . 62.2 m80 -124.63 169.91 11.47 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.258 -0.901 . . . . 0.0 109.209 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.421 HG12 HD22 ' A' ' 39' ' ' LEU . 18.9 mt -79.45 122.31 34.41 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 121.099 -1.001 . . . . 0.0 109.307 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.506 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 59.7 ttt-85 -83.11 -38.62 22.19 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.351 -0.843 . . . . 0.0 109.463 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.4 t -158.37 155.08 28.05 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.373 -0.83 . . . . 0.0 109.2 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.2 p -75.33 132.74 41.18 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.187 -0.945 . . . . 0.0 109.49 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.529 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 98.4 165.15 30.86 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.658 ' HA ' HG21 ' A' ' 32' ' ' THR . 13.2 tttp -50.16 150.39 2.44 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.352 -1.087 . . . . 0.0 109.327 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.433 ' SG ' ' O ' ' A' ' 31' ' ' GLN . 43.2 m -55.91 -27.26 51.33 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.279 -0.888 . . . . 0.0 109.396 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.421 ' O ' ' HG2' ' A' ' 59' ' ' GLU . 54.4 tt0 -88.35 -22.78 23.64 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.346 -0.846 . . . . 0.0 109.243 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 54.2 tt0 -62.76 -35.94 81.43 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.353 -0.842 . . . . 0.0 109.31 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.6 m -65.92 -33.36 75.65 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.272 -0.892 . . . . 0.0 109.509 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 50.3 m -62.53 153.01 33.13 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.264 -0.897 . . . . 0.0 109.467 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.628 HG23 ' O ' ' A' ' 63' ' ' THR . 4.6 t -121.5 84.24 41.88 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.273 -0.892 . . . . 0.0 109.465 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -72.09 137.72 29.52 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 122.647 2.231 . . . . 0.0 111.793 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 88.75 -164.47 32.82 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.499 -1.441 . . . . 0.0 109.499 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 18.1 p -128.6 156.83 42.75 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.257 -1.143 . . . . 0.0 109.431 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 51.8 p -62.26 -14.57 40.01 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.254 -0.904 . . . . 0.0 109.517 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -61.43 -27.62 68.68 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.223 -0.923 . . . . 0.0 109.389 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -52.16 145.61 10.33 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.294 -0.879 . . . . 0.0 109.563 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 34.8 m -67.77 -26.24 66.01 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.236 -0.915 . . . . 0.0 109.353 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.42 81.3 49.4 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.288 -0.883 . . . . 0.0 109.32 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -70.04 149.65 65.42 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 122.73 2.287 . . . . 0.0 111.919 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -71.47 -19.44 28.55 Favored 'Trans proline' 0 C--O 1.215 -0.669 0 C-N-CA 122.699 2.266 . . . . 0.0 111.684 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 25.9 t -132.12 137.33 47.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.279 -0.888 . . . . 0.0 109.485 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -55.31 -36.7 66.48 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.149 -0.97 . . . . 0.0 109.447 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 118.029 -0.986 . . . . 0.0 109.48 -179.899 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.454 ' OG ' ' HA ' ' A' ' 51' ' ' HIS . 4.6 m -52.08 -25.56 8.98 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.237 -0.915 . . . . 0.0 109.456 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.446 ' HA ' ' HG3' ' A' ' 6' ' ' LYS . 2.4 tt0 -52.35 -24.72 8.1 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.263 -0.898 . . . . 0.0 109.158 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.443 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 74.5 mtp -72.2 -29.25 63.8 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.436 -0.79 . . . . 0.0 109.391 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.49 ' O ' ' HB2' ' A' ' 8' ' ' TYR . 11.5 m -85.65 -17.85 34.92 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.288 -0.883 . . . . 0.0 109.278 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.446 ' HG3' ' HA ' ' A' ' 3' ' ' GLU . 27.2 mttt -50.47 -24.34 3.06 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.218 -0.926 . . . . 0.0 108.941 179.65 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.443 ' OD1' ' O ' ' A' ' 4' ' ' MET . 55.9 p30 -112.97 32.65 5.55 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 179.227 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.49 ' HB2' ' O ' ' A' ' 5' ' ' CYS . 5.4 t80 -80.13 162.14 24.91 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 121.535 0.683 . . . . 0.0 110.225 -179.228 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 10.9 mtm180 -144.16 116.5 8.52 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.941 HG13 ' C ' ' A' ' 15' ' ' GLY . 53.3 t -112.17 139.11 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.143 -0.973 . . . . 0.0 109.684 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.691 HD23 ' HD2' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -119.92 172.7 4.27 Favored Pre-proline 0 N--CA 1.488 1.466 0 O-C-N 121.481 -0.762 . . . . 0.0 109.091 179.866 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.691 ' HD2' HD23 ' A' ' 11' ' ' LEU . 44.3 Cg_endo -66.85 -23.05 48.24 Favored 'Trans proline' 0 C--O 1.214 -0.678 0 C-N-CA 122.579 2.186 . . . . 0.0 111.729 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.425 ' HG2' ' O ' ' A' ' 13' ' ' ARG . 61.1 ttt-85 -110.5 -22.98 11.39 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.309 -0.869 . . . . 0.0 109.292 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.553 HD12 HD13 ' A' ' 11' ' ' LEU . 82.9 mt -89.43 -41.67 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.381 -0.825 . . . . 0.0 109.474 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.941 ' C ' HG13 ' A' ' 10' ' ' VAL . . . 62.04 -146.67 49.1 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.521 ' HD1' HG21 ' A' ' 10' ' ' VAL . 1.4 t80 -100.6 148.46 24.81 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.316 -1.108 . . . . 0.0 109.566 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.477 HD23 ' HA ' ' A' ' 17' ' ' LEU . 53.8 mt -118.43 128.88 55.03 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.376 -0.827 . . . . 0.0 109.557 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.45 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 79.1 m -139.0 157.2 71.87 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.312 -0.868 . . . . 0.0 109.254 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.486 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 47.4 Cg_endo -69.49 166.69 26.41 Favored 'Trans proline' 0 C--O 1.214 -0.695 0 C-N-CA 122.592 2.195 . . . . 0.0 111.455 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -87.76 -16.02 35.35 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.207 -0.933 . . . . 0.0 109.502 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -69.91 118.01 12.21 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.199 -0.938 . . . . 0.0 109.074 179.584 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 60.3 tp -84.51 122.39 28.94 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.174 -0.954 . . . . 0.0 109.82 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.49 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 0.3 OUTLIER -139.91 110.81 7.29 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.276 -0.89 . . . . 0.0 109.039 179.649 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.535 ' HA ' ' O ' ' A' ' 34' ' ' ASN . 42.2 Cg_endo -64.82 122.98 10.98 Favored 'Trans proline' 0 C--O 1.213 -0.747 0 C-N-CA 122.996 2.464 . . . . 0.0 112.496 -179.23 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.512 ' O ' HG23 ' A' ' 32' ' ' THR . 32.9 m -118.56 155.16 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.45 -0.781 . . . . 0.0 109.681 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.416 ' O ' ' N ' ' A' ' 53' ' ' ARG . 42.5 t -100.54 117.7 35.21 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.327 -0.858 . . . . 0.0 108.991 179.219 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -73.63 138.28 24.71 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 -179.612 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.497 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 53.1 p30 -67.74 -11.1 57.67 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.249 -1.148 . . . . 0.0 109.473 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.461 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 58.5 p30 -82.94 8.68 11.93 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.292 -0.88 . . . . 0.0 109.402 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.09 13.94 65.34 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.473 ' O ' ' N ' ' A' ' 27' ' ' GLY . 92.1 mt-30 -119.56 167.04 12.38 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.27 -1.135 . . . . 0.0 109.461 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.533 ' CG2' ' HA ' ' A' ' 57' ' ' LYS . 90.6 m -126.11 140.47 52.55 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.272 -0.893 . . . . 0.0 109.265 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.845 ' HD2' HD12 ' A' ' 39' ' ' LEU . 59.5 m-85 -118.85 126.24 51.36 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.228 -0.92 . . . . 0.0 109.327 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.535 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 5.9 m-20 -49.77 -75.94 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.21 -0.931 . . . . 0.0 109.397 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.531 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 4.6 t-20 -82.04 148.57 60.75 Favored Pre-proline 0 C--N 1.299 -1.6 0 O-C-N 121.105 -0.997 . . . . 0.0 109.527 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.49 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.0 Cg_endo -62.99 -53.35 1.62 Allowed 'Trans proline' 0 C--O 1.216 -0.619 0 C-N-CA 122.603 2.202 . . . . 0.0 111.728 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.531 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 4.5 t -60.64 -27.63 67.94 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 120.961 -1.087 . . . . 0.0 108.156 179.025 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.475 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 52.6 mmm -65.28 -20.08 66.25 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.845 HD12 ' HD2' ' A' ' 33' ' ' TYR . 6.6 tt -68.42 -51.84 39.44 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.287 -0.883 . . . . 0.0 108.788 179.43 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.51 ' HA ' ' ND2' ' A' ' 43' ' ' ASN . 64.0 m -51.22 -27.99 10.35 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.142 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.419 ' O ' HG13 ' A' ' 45' ' ' ILE . 28.2 t60 -58.63 -47.5 84.18 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.6 ' HB2' ' CE1' ' A' ' 33' ' ' TYR . 26.9 tp10 -60.36 -17.17 41.56 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 179.116 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.527 ' OD1' ' N ' ' A' ' 50' ' ' THR . 3.5 m-80 -80.07 -34.91 37.75 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.405 -0.81 . . . . 0.0 108.927 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.966 HD13 ' O ' ' A' ' 44' ' ' LEU . 2.6 tm? -70.27 -35.79 74.0 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.349 -0.844 . . . . 0.0 109.34 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.419 HG13 ' O ' ' A' ' 41' ' ' HIS . 2.8 mt -76.11 -53.22 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.302 -0.874 . . . . 0.0 109.678 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.449 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 49.8 mtp180 -80.37 -34.51 36.41 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.224 -0.923 . . . . 0.0 109.89 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.498 ' N ' ' O ' ' A' ' 43' ' ' ASN . 90.4 mt-30 62.32 35.17 15.31 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.215 -0.928 . . . . 0.0 109.547 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.427 ' O ' ' HB2' ' A' ' 49' ' ' ASN . 72.3 p -105.64 7.78 32.84 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.195 -0.941 . . . . 0.0 109.623 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.427 ' HB2' ' O ' ' A' ' 48' ' ' THR . 20.5 m120 64.23 49.82 2.52 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.254 -0.904 . . . . 0.0 109.391 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.527 ' N ' ' OD1' ' A' ' 43' ' ' ASN . 63.6 m -76.76 132.53 39.32 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.251 -0.906 . . . . 0.0 109.378 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.454 ' HA ' ' OG ' ' A' ' 2' ' ' SER . 15.2 m-70 -115.21 -174.83 2.57 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.282 -0.886 . . . . 0.0 109.521 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.693 HG12 HD13 ' A' ' 39' ' ' LEU . 16.4 mt -86.68 124.77 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.324 -0.86 . . . . 0.0 109.678 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.497 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 75.8 ttt-85 -80.08 -54.73 5.5 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.525 -0.735 . . . . 0.0 109.503 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 77.7 p -151.87 138.95 19.15 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.716 -0.615 . . . . 0.0 109.357 -179.313 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 8.0 p -54.35 148.93 10.82 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.189 -0.944 . . . . 0.0 109.412 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.528 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 88.51 166.66 42.5 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.274 -1.53 . . . . 0.0 109.274 -179.665 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.533 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 27.1 mttt -66.32 143.37 57.22 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.376 -1.073 . . . . 0.0 109.562 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.413 ' C ' ' O ' ' A' ' 57' ' ' LYS . 66.9 m -44.61 -34.47 2.18 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.278 -0.889 . . . . 0.0 109.47 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -81.2 -36.11 30.5 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.334 -0.854 . . . . 0.0 109.208 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.454 ' OE1' ' CA ' ' A' ' 56' ' ' GLY . 35.6 tt0 -56.84 -21.98 33.27 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.325 -0.859 . . . . 0.0 108.87 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 16.5 m -65.58 -34.31 77.94 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.434 -0.791 . . . . 0.0 109.539 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 91.0 p -119.34 155.95 30.95 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.12 -0.987 . . . . 0.0 109.501 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.1 m 62.16 70.65 0.8 Allowed Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.27 -0.894 . . . . 0.0 109.644 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -70.38 145.77 54.49 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 122.648 2.232 . . . . 0.0 111.767 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -82.48 179.32 53.17 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.79 HG22 ' H ' ' A' ' 68' ' ' ALA . 50.0 m -122.43 142.48 50.5 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.245 -1.15 . . . . 0.0 109.465 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 60.4 p -70.08 -20.31 63.22 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.253 -0.905 . . . . 0.0 109.345 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.79 ' H ' HG22 ' A' ' 66' ' ' THR . . . -63.8 -32.03 73.4 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.261 -0.899 . . . . 0.0 109.379 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.22 144.78 55.07 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.235 -0.916 . . . . 0.0 109.437 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.2 t -51.96 -29.38 20.21 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.18 -0.95 . . . . 0.0 109.475 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 2.6 ttp 47.56 70.7 1.92 Allowed Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.208 -0.932 . . . . 0.0 109.498 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -70.21 153.01 67.24 Favored 'Trans proline' 0 C--O 1.215 -0.674 0 C-N-CA 122.76 2.306 . . . . 0.0 111.82 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -70.14 155.34 64.92 Favored 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 122.564 2.176 . . . . 0.0 111.666 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 83.1 p -81.23 -10.31 59.63 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.288 -0.883 . . . . 0.0 109.528 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.436 ' O ' ' O ' ' A' ' 76' ' ' GLU . 88.1 m-20 -68.13 -31.48 71.1 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.244 -0.91 . . . . 0.0 109.377 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.436 ' O ' ' O ' ' A' ' 75' ' ' ASP . 81.8 tt0 . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 118.054 -0.974 . . . . 0.0 109.41 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 . . . . . 0 N--CA 1.489 1.492 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.537 ' HB2' ' CD2' ' A' ' 51' ' ' HIS . 5.0 m -56.19 -34.35 66.16 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.304 -0.873 . . . . 0.0 109.537 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -54.75 -24.63 23.24 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.33 -0.856 . . . . 0.0 109.101 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 56.5 mmm -73.06 -24.33 60.67 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.343 -0.848 . . . . 0.0 108.909 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.598 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 59.2 m -80.12 -21.3 43.36 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.422 -0.799 . . . . 0.0 109.284 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 42.1 mttp -80.69 11.74 3.62 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.331 -0.856 . . . . 0.0 109.786 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -132.75 -1.82 3.37 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.023 -1.048 . . . . 0.0 110.181 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.598 ' CD1' ' HA ' ' A' ' 5' ' ' CYS . 1.6 p90 -114.24 156.56 24.09 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.868 -1.145 . . . . 0.0 109.98 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 31.8 mtm105 -137.16 133.86 35.71 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.351 -0.843 . . . . 0.0 109.202 179.597 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.848 HG13 ' O ' ' A' ' 15' ' ' GLY . 75.7 t -117.65 142.61 31.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.189 -0.944 . . . . 0.0 109.8 -179.601 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.596 ' HB2' HD12 ' A' ' 14' ' ' ILE . 0.4 OUTLIER -126.02 175.45 3.17 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.366 -0.834 . . . . 0.0 109.159 179.946 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.558 ' HD2' ' CG ' ' A' ' 11' ' ' LEU . 43.9 Cg_endo -67.22 -22.24 46.96 Favored 'Trans proline' 0 C--O 1.214 -0.679 0 C-N-CA 122.557 2.171 . . . . 0.0 111.672 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 89.7 mtt180 -103.69 -29.28 11.17 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.298 -0.876 . . . . 0.0 109.56 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.596 HD12 ' HB2' ' A' ' 11' ' ' LEU . 89.2 mt -80.04 -49.64 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.244 -0.91 . . . . 0.0 109.497 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.848 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 82.15 -163.63 43.45 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.558 ' CD1' HG21 ' A' ' 10' ' ' VAL . 0.9 OUTLIER -92.86 151.84 19.75 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.285 -1.126 . . . . 0.0 109.444 -179.973 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 26.0 tp -127.67 116.08 19.73 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.198 -0.939 . . . . 0.0 109.816 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.444 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 77.4 m -129.86 157.36 77.03 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.281 -0.887 . . . . 0.0 109.035 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.537 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 49.4 Cg_endo -70.94 167.96 24.47 Favored 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 122.558 2.172 . . . . 0.0 111.44 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 24.5 mttp -94.8 -6.13 43.62 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.191 -0.943 . . . . 0.0 109.585 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.46 ' OD2' ' HE2' ' A' ' 23' ' ' LYS . 58.6 t0 -76.09 117.4 17.76 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.198 -0.939 . . . . 0.0 109.253 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.754 HD21 ' OD1' ' A' ' 34' ' ' ASN . 3.2 tm? -78.4 122.5 25.88 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.234 -0.916 . . . . 0.0 109.706 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.686 ' N ' HD13 ' A' ' 22' ' ' LEU . 5.2 mttt -142.2 104.01 5.61 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.404 -0.81 . . . . 0.0 109.22 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.542 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 42.6 Cg_endo -65.09 120.86 8.17 Favored 'Trans proline' 0 C--O 1.213 -0.756 0 C-N-CA 123.056 2.504 . . . . 0.0 112.036 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 24.5 m -116.65 155.0 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.321 -0.862 . . . . 0.0 110.005 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.461 ' O ' ' N ' ' A' ' 53' ' ' ARG . 28.0 t -99.67 108.64 21.05 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.475 -0.766 . . . . 0.0 109.319 179.586 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -62.61 138.79 44.99 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.51 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 57.1 p30 -68.86 -10.31 56.25 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.258 -1.143 . . . . 0.0 109.482 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.452 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 90.0 m-20 -84.0 4.93 27.67 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.18 -0.95 . . . . 0.0 109.409 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.51 13.45 58.35 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.223 -1.551 . . . . 0.0 109.223 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.508 ' O ' ' N ' ' A' ' 27' ' ' GLY . 93.5 mt-30 -117.95 160.53 21.29 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.321 -1.106 . . . . 0.0 109.497 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 57.4 m -116.99 130.23 56.55 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.244 -0.91 . . . . 0.0 109.24 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.701 ' CD1' HD13 ' A' ' 39' ' ' LEU . 65.8 m-85 -111.25 119.36 38.65 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.273 -0.892 . . . . 0.0 109.157 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.754 ' OD1' HD21 ' A' ' 22' ' ' LEU . 51.2 t-20 -46.31 -80.44 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.399 -0.813 . . . . 0.0 110.092 -179.363 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.528 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 1.9 t-20 -81.03 150.0 67.72 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.003 -1.061 . . . . 0.0 109.722 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.506 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.9 Cg_endo -63.97 -55.23 0.68 Allowed 'Trans proline' 0 C--O 1.216 -0.612 0 C-N-CA 122.756 2.304 . . . . 0.0 111.818 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.537 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 10.8 t -60.92 -30.45 70.21 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 120.91 -1.119 . . . . 0.0 108.17 178.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.487 ' CG ' ' HB3' ' A' ' 35' ' ' ASN . 52.5 mmm -60.11 -17.73 42.19 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.263 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.701 HD13 ' CD1' ' A' ' 33' ' ' TYR . 33.5 tp -68.5 -58.27 4.57 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 179.455 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.456 ' SG ' ' OH ' ' A' ' 16' ' ' TYR . 8.1 t -56.38 -24.08 42.1 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 178.837 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 30.0 t60 -70.63 -62.81 1.25 Allowed 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 179.148 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.482 ' OE1' ' CE2' ' A' ' 33' ' ' TYR . 78.6 mt-10 -55.47 -21.87 18.25 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.176 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.511 ' O ' ' N ' ' A' ' 47' ' ' GLN . 98.7 m-20 -73.65 -35.88 65.32 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 179.497 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.931 HD13 ' O ' ' A' ' 44' ' ' LEU . 2.0 tm? -62.61 -37.33 85.86 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.399 -0.813 . . . . 0.0 109.005 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.9 mt -71.82 -42.13 69.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.386 -0.821 . . . . 0.0 109.113 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.451 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 12.8 mtt-85 -79.84 -22.3 43.14 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.36 -0.838 . . . . 0.0 109.174 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.511 ' N ' ' O ' ' A' ' 43' ' ' ASN . 92.5 mt-30 63.3 44.68 5.41 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.316 -0.865 . . . . 0.0 109.475 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 21.9 p -128.02 169.88 13.53 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.373 -0.83 . . . . 0.0 109.413 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.571 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 43.9 t30 -102.7 64.84 0.89 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.233 -0.917 . . . . 0.0 109.304 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 33.9 m -74.83 147.32 41.26 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.338 -0.851 . . . . 0.0 109.613 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.571 ' CE1' ' O ' ' A' ' 49' ' ' ASN . 51.4 m80 -122.77 -173.65 2.75 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.383 -0.823 . . . . 0.0 109.263 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 11.3 mt -95.82 124.07 48.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.137 -0.977 . . . . 0.0 109.531 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.51 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 72.3 ttt-85 -80.04 -56.0 4.55 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 121.622 0.725 . . . . 0.0 109.558 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 88.7 p -153.95 139.22 17.53 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.45 ' H ' HG23 ' A' ' 55' ' ' THR . 6.5 p -56.56 148.49 19.51 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.116 -0.99 . . . . 0.0 109.349 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.542 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 82.66 161.39 29.93 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.526 ' HG3' ' HB2' ' A' ' 24' ' ' PRO . 26.1 mttp -68.36 131.75 45.86 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.558 -0.966 . . . . 0.0 109.535 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -55.01 -34.32 63.37 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.198 -0.939 . . . . 0.0 109.475 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.472 ' HG2' ' O ' ' A' ' 59' ' ' GLU . 78.9 tt0 -81.67 -15.74 53.57 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.312 -0.868 . . . . 0.0 109.462 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.486 ' HB2' ' HB2' ' A' ' 57' ' ' LYS . 51.9 tt0 -73.43 -30.16 63.04 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.219 -0.925 . . . . 0.0 109.29 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.9 m -63.11 -31.15 72.23 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.317 -0.864 . . . . 0.0 109.434 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 49.9 m -115.28 146.72 41.22 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.271 -0.893 . . . . 0.0 109.577 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.402 ' HB ' ' HD2' ' A' ' 64' ' ' PRO . 20.3 p -70.05 159.68 83.41 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.311 -0.868 . . . . 0.0 109.287 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.402 ' HD2' ' HB ' ' A' ' 63' ' ' THR . 48.8 Cg_endo -69.92 -17.38 36.88 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 122.704 2.269 . . . . 0.0 111.721 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -147.34 171.69 27.92 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 19.2 p -121.82 157.45 31.06 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.251 -1.146 . . . . 0.0 109.388 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 59.9 m -65.7 -28.26 68.94 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.293 -0.879 . . . . 0.0 109.536 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.454 ' O ' ' HB3' ' A' ' 71' ' ' MET . . . -65.31 -36.97 85.7 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.228 -0.92 . . . . 0.0 109.463 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.409 ' C ' ' O ' ' A' ' 68' ' ' ALA . . . 44.17 -151.37 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.267 -0.896 . . . . 0.0 109.475 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 83.8 p -54.88 -31.31 59.72 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.209 -0.932 . . . . 0.0 109.557 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.517 ' CG ' ' HD2' ' A' ' 72' ' ' PRO . 6.3 ttm -57.68 143.12 76.67 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.302 -0.874 . . . . 0.0 109.457 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.517 ' HD2' ' CG ' ' A' ' 71' ' ' MET . 49.3 Cg_endo -69.75 153.48 68.94 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 122.691 2.261 . . . . 0.0 111.806 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -70.65 158.01 57.02 Favored 'Trans proline' 0 C--O 1.214 -0.691 0 C-N-CA 122.63 2.22 . . . . 0.0 111.754 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 86.2 p -82.72 -9.18 59.47 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.3 -0.875 . . . . 0.0 109.593 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.484 ' OD1' ' N ' ' A' ' 76' ' ' GLU . 39.7 p30 -73.6 -15.75 61.26 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.178 -0.951 . . . . 0.0 109.416 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.484 ' N ' ' OD1' ' A' ' 75' ' ' ASP . 83.3 tt0 . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 118.048 -0.977 . . . . 0.0 109.414 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.445 ' OD1' ' HB2' ' A' ' 3' ' ' GLU . 7.0 p30 . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.311 0.577 . . . . 0.0 109.496 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.6 m -46.48 -28.71 1.47 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.273 -0.892 . . . . 0.0 109.479 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.445 ' HB2' ' OD1' ' A' ' 1' ' ' ASP . 1.5 tt0 -51.87 -25.86 8.84 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.198 -0.939 . . . . 0.0 108.946 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 75.6 mtp -80.04 -21.06 43.92 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.486 -0.759 . . . . 0.0 109.115 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.584 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 3.4 m -91.95 -12.45 33.37 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.364 -0.835 . . . . 0.0 109.632 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.441 ' HG3' ' HA ' ' A' ' 3' ' ' GLU . 23.4 mttm -57.37 -25.07 58.9 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.276 -0.89 . . . . 0.0 109.721 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 61.5 t0 -152.69 64.45 0.8 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.108 -0.995 . . . . 0.0 109.776 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.997 ' OH ' HD23 ' A' ' 44' ' ' LEU . 4.5 p90 -126.42 169.01 13.42 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.169 -0.957 . . . . 0.0 109.324 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 79.9 mtt180 -142.56 145.98 34.16 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.202 -0.936 . . . . 0.0 109.496 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.732 HG13 ' C ' ' A' ' 15' ' ' GLY . 90.8 t -140.32 134.53 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.266 -0.896 . . . . 0.0 109.471 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.551 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 1.1 mp -123.34 176.08 2.38 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.289 -0.882 . . . . 0.0 109.251 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.551 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 45.4 Cg_endo -67.51 -27.24 39.59 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 122.547 2.165 . . . . 0.0 111.514 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 71.3 mtt-85 -104.06 -29.77 10.68 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.292 -0.88 . . . . 0.0 109.005 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.43 ' HA ' HD13 ' A' ' 14' ' ' ILE . 26.7 mm -81.79 -41.26 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.429 -0.794 . . . . 0.0 109.519 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.732 ' C ' HG13 ' A' ' 10' ' ' VAL . . . 64.78 -147.06 50.82 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.474 ' CE2' ' CE2' ' A' ' 8' ' ' TYR . 1.5 t80 -104.98 151.75 23.55 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.244 -1.151 . . . . 0.0 109.538 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.425 ' HA ' HD12 ' A' ' 17' ' ' LEU . 24.3 tp -104.9 109.41 21.37 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.245 -0.909 . . . . 0.0 109.476 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 63.6 m -129.24 156.43 78.36 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.325 -0.859 . . . . 0.0 109.371 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -72.04 172.6 14.37 Favored 'Trans proline' 0 C--O 1.215 -0.673 0 C-N-CA 122.663 2.242 . . . . 0.0 111.567 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 20.4 tttm -89.51 -15.58 32.67 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.18 -0.95 . . . . 0.0 109.393 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -73.4 108.9 6.53 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.305 -0.872 . . . . 0.0 109.496 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.674 ' C ' HD13 ' A' ' 22' ' ' LEU . 3.5 tm? -77.79 109.72 12.04 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.221 -0.924 . . . . 0.0 109.258 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.502 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 7.1 mtmt -120.49 106.84 39.58 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.313 -0.867 . . . . 0.0 109.308 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.547 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 41.4 Cg_endo -63.44 120.54 8.0 Favored 'Trans proline' 0 C--O 1.213 -0.743 0 C-N-CA 123.151 2.567 . . . . 0.0 112.376 -179.498 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.615 ' O ' HG23 ' A' ' 32' ' ' THR . 18.3 m -115.58 155.52 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.228 -0.92 . . . . 0.0 109.744 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 39.9 t -98.04 115.54 28.43 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.335 -0.853 . . . . 0.0 109.319 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -70.83 138.84 29.0 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.52 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 53.2 t0 -70.92 -9.44 57.8 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.281 -1.129 . . . . 0.0 109.654 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 58.5 p30 -85.72 8.58 19.24 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.11 -0.994 . . . . 0.0 109.253 179.637 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.31 9.63 66.9 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.511 ' O ' ' N ' ' A' ' 27' ' ' GLY . 69.6 mt-30 -118.14 156.64 28.35 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.329 -1.101 . . . . 0.0 109.317 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.623 HG21 ' HA ' ' A' ' 57' ' ' LYS . 33.5 m -116.9 151.88 35.68 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.212 -0.93 . . . . 0.0 109.293 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.841 ' CD1' HD13 ' A' ' 39' ' ' LEU . 73.7 m-85 -129.77 131.06 46.12 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.197 -0.939 . . . . 0.0 109.239 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.539 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 2.7 m-20 -53.21 -79.38 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.288 -0.882 . . . . 0.0 109.636 -179.531 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.521 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 13.2 t-20 -82.64 145.69 51.45 Favored Pre-proline 0 C--N 1.3 -1.555 0 O-C-N 120.893 -1.13 . . . . 0.0 109.826 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.502 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.3 Cg_endo -63.63 -51.13 2.66 Favored 'Trans proline' 0 C--O 1.214 -0.689 0 C-N-CA 122.67 2.247 . . . . 0.0 111.278 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.521 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 5.6 t -60.44 -29.78 69.23 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 178.607 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.447 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 35.9 mmm -66.29 -10.87 46.77 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 179.234 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.841 HD13 ' CD1' ' A' ' 33' ' ' TYR . 52.0 tp -69.24 -55.28 11.03 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.286 -0.884 . . . . 0.0 108.822 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.442 ' HA ' ' HB2' ' A' ' 43' ' ' ASN . 11.5 t -54.85 -29.6 55.58 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 179.085 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 32.5 t60 -60.15 -60.92 3.05 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.149 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.452 ' HA ' ' OE1' ' A' ' 42' ' ' GLU . 68.8 mm-40 -58.86 -22.61 59.49 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 179.057 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.508 ' O ' ' N ' ' A' ' 47' ' ' GLN . 98.5 m-20 -75.97 -23.2 55.32 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.368 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.997 HD23 ' OH ' ' A' ' 8' ' ' TYR . 2.0 tm? -72.4 -36.63 68.69 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.32 -0.862 . . . . 0.0 108.797 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.528 ' N ' HD13 ' A' ' 45' ' ' ILE . 3.8 mm -76.31 -41.96 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.428 -0.795 . . . . 0.0 109.154 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.462 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 21.1 mtt-85 -83.07 -40.2 20.18 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.41 -0.807 . . . . 0.0 109.482 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.508 ' N ' ' O ' ' A' ' 43' ' ' ASN . 89.8 mt-30 63.54 43.44 5.85 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.48 -0.763 . . . . 0.0 109.482 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 72.2 p -113.01 18.75 17.83 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.248 -0.908 . . . . 0.0 109.334 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 54.7 m-20 44.76 58.71 3.77 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.274 -0.891 . . . . 0.0 109.465 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.475 ' HB ' ' OD1' ' A' ' 43' ' ' ASN . 21.1 m -75.22 145.28 42.13 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.15 -0.969 . . . . 0.0 109.744 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 29.4 m-70 -118.69 171.77 7.97 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.302 -0.874 . . . . 0.0 108.981 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.481 HG23 ' HB ' ' A' ' 25' ' ' VAL . 20.2 mt -84.15 124.49 39.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.105 -0.997 . . . . 0.0 109.574 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.52 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 37.1 ttt180 -79.85 -52.41 7.93 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-O 121.701 0.762 . . . . 0.0 109.245 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 24.7 p -151.78 153.91 35.22 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 20.9 p -71.8 136.6 47.13 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.185 -0.947 . . . . 0.0 109.438 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.547 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 95.87 163.32 33.75 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.623 ' HA ' HG21 ' A' ' 32' ' ' THR . 73.6 tttt -49.64 152.62 1.38 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.46 -1.023 . . . . 0.0 109.373 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.42 ' N ' ' HG2' ' A' ' 57' ' ' LYS . 24.5 m -57.87 -28.75 64.45 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.174 -0.954 . . . . 0.0 109.491 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.448 ' O ' ' O ' ' A' ' 62' ' ' SER . 61.7 tt0 -89.3 -25.02 21.88 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.224 -0.922 . . . . 0.0 109.178 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 64.1 tt0 -61.35 -29.62 70.01 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.325 -0.86 . . . . 0.0 109.407 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 86.6 p -67.2 -22.81 65.7 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.36 -0.838 . . . . 0.0 109.56 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.448 ' O ' ' O ' ' A' ' 59' ' ' GLU . 60.7 m -125.57 139.6 53.45 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.246 -0.908 . . . . 0.0 109.443 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.533 ' OG1' ' HB2' ' A' ' 69' ' ' ALA . 20.0 p -117.18 93.02 41.4 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.331 -0.855 . . . . 0.0 109.575 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -70.91 -18.19 31.79 Favored 'Trans proline' 0 C--O 1.214 -0.691 0 C-N-CA 122.738 2.292 . . . . 0.0 111.783 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -53.32 -28.47 35.32 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.739 HG22 ' H ' ' A' ' 68' ' ' ALA . 45.3 m -126.92 138.09 53.24 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.12 -1.224 . . . . 0.0 109.549 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 61.3 p -70.88 -22.17 62.32 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.267 -0.896 . . . . 0.0 109.421 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.739 ' H ' HG22 ' A' ' 66' ' ' THR . . . -62.19 -28.63 69.81 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.22 -0.925 . . . . 0.0 109.49 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.533 ' HB2' ' OG1' ' A' ' 63' ' ' THR . . . -67.96 -26.79 66.11 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.201 -0.937 . . . . 0.0 109.395 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 30.6 m -59.58 -28.73 67.41 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.305 -0.872 . . . . 0.0 109.45 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 4.9 tpt -130.55 78.57 73.82 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.301 -0.874 . . . . 0.0 109.39 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.442 ' HD3' ' O ' ' A' ' 69' ' ' ALA . 50.2 Cg_endo -70.28 163.43 38.71 Favored 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 122.754 2.303 . . . . 0.0 111.838 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -70.88 164.48 35.49 Favored 'Trans proline' 0 C--O 1.215 -0.658 0 C-N-CA 122.706 2.27 . . . . 0.0 111.669 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 87.0 p -86.18 -5.56 59.17 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.265 -0.897 . . . . 0.0 109.562 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.483 ' O ' ' CG ' ' A' ' 76' ' ' GLU . 85.4 m-20 -74.31 -27.12 60.56 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.24 -0.912 . . . . 0.0 109.526 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.483 ' CG ' ' O ' ' A' ' 75' ' ' ASP . 93.7 mt-10 . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 118.051 -0.976 . . . . 0.0 109.477 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.415 ' O ' ' C ' ' A' ' 2' ' ' SER . 79.5 m-20 . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.415 ' C ' ' O ' ' A' ' 1' ' ' ASP . 4.0 m -43.93 -29.43 0.57 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.335 -0.853 . . . . 0.0 109.409 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.421 ' HA ' ' HG3' ' A' ' 6' ' ' LYS . 15.3 mt-10 -50.15 -28.27 7.12 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 79.4 mmm -77.4 -33.2 55.11 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.315 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.598 ' HB3' ' CE1' ' A' ' 8' ' ' TYR . 2.7 m -85.06 5.48 29.36 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.461 -0.775 . . . . 0.0 109.039 179.386 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.446 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 11.5 mttm -66.23 -28.35 68.67 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.18 -0.95 . . . . 0.0 109.554 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.446 ' OD1' ' O ' ' A' ' 6' ' ' LYS . 80.3 m-20 -146.2 65.76 1.2 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.269 -0.894 . . . . 0.0 110.153 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.718 ' CZ ' HD21 ' A' ' 44' ' ' LEU . 12.6 p90 -125.8 -177.7 4.02 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.146 -0.971 . . . . 0.0 109.234 179.348 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 66.4 mtm180 -150.39 143.48 24.85 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.171 -0.955 . . . . 0.0 109.634 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.797 HG13 ' O ' ' A' ' 15' ' ' GLY . 69.1 t -128.4 130.97 69.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.241 -0.912 . . . . 0.0 109.442 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.545 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.2 OUTLIER -111.41 175.0 2.05 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.291 -0.881 . . . . 0.0 109.415 -179.867 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.545 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 46.1 Cg_endo -67.6 -24.17 42.05 Favored 'Trans proline' 0 C--O 1.216 -0.611 0 C-N-CA 122.665 2.243 . . . . 0.0 111.565 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 82.3 mtp180 -94.36 -31.7 13.91 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.342 -0.849 . . . . 0.0 109.104 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 80.5 mt -85.38 -46.99 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.415 -0.803 . . . . 0.0 109.357 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.797 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 70.59 -165.06 52.56 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.527 ' OH ' ' CB ' ' A' ' 40' ' ' CYS . 0.8 OUTLIER -104.41 146.62 28.59 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.235 -1.156 . . . . 0.0 109.377 179.928 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.829 ' N ' HD12 ' A' ' 17' ' ' LEU . 0.6 OUTLIER -112.59 124.87 53.51 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.248 -0.907 . . . . 0.0 109.452 179.86 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.434 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 59.6 m -142.16 155.84 64.9 Favored Pre-proline 0 C--N 1.3 -1.585 0 O-C-N 121.373 -0.829 . . . . 0.0 108.81 179.443 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -70.88 164.45 35.61 Favored 'Trans proline' 0 C--O 1.214 -0.695 0 C-N-CA 122.236 1.957 . . . . 0.0 111.344 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.2 mtpm? -82.54 -26.43 32.46 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.311 -0.868 . . . . 0.0 109.415 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -63.29 124.83 22.23 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.311 -0.868 . . . . 0.0 109.446 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.753 ' C ' HD13 ' A' ' 22' ' ' LEU . 3.4 tm? -86.53 106.96 17.89 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.137 -0.977 . . . . 0.0 109.305 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.516 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 9.5 mttt -115.22 106.79 50.62 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.222 -0.924 . . . . 0.0 109.47 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.537 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 41.7 Cg_endo -63.21 116.94 3.91 Favored 'Trans proline' 0 C--O 1.214 -0.698 0 C-N-CA 123.032 2.488 . . . . 0.0 112.176 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.564 ' HB ' HG23 ' A' ' 52' ' ' ILE . 16.4 m -115.09 154.86 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.285 -0.885 . . . . 0.0 109.266 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.431 ' O ' ' N ' ' A' ' 53' ' ' ARG . 45.1 t -95.08 143.81 26.23 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 178.788 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -97.06 141.49 15.65 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 -178.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.489 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 54.6 p30 -67.42 -8.63 34.63 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.313 -1.11 . . . . 0.0 109.431 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -95.88 10.84 35.84 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.317 -0.864 . . . . 0.0 109.49 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.45 12.31 73.08 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.534 ' O ' ' N ' ' A' ' 27' ' ' GLY . 53.4 mt-30 -115.84 148.26 40.13 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.298 -1.119 . . . . 0.0 109.504 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.641 HG21 ' HA ' ' A' ' 57' ' ' LYS . 8.4 m -112.32 152.23 28.79 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.146 -0.971 . . . . 0.0 109.731 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.852 ' CD2' HD12 ' A' ' 39' ' ' LEU . 94.6 m-85 -129.34 133.4 47.4 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.303 -0.873 . . . . 0.0 109.187 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.693 ' CB ' HD21 ' A' ' 22' ' ' LEU . 1.5 m-20 -53.57 -75.37 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.111 -0.993 . . . . 0.0 109.194 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.526 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 8.4 t-20 -82.38 146.56 54.39 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.155 -0.966 . . . . 0.0 109.188 179.56 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.516 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 42.0 Cg_endo -64.69 -51.38 1.84 Allowed 'Trans proline' 0 C--O 1.216 -0.608 0 C-N-CA 122.649 2.233 . . . . 0.0 111.486 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.526 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 9.5 t -62.38 -27.24 68.94 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 178.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.499 ' CG ' ' HB3' ' A' ' 35' ' ' ASN . 44.9 mmm -66.44 -21.83 66.21 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.686 -0.634 . . . . 0.0 109.29 179.308 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.852 HD12 ' CD2' ' A' ' 33' ' ' TYR . 6.4 tt -64.83 -51.48 61.86 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.247 -0.908 . . . . 0.0 108.841 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.527 ' CB ' ' OH ' ' A' ' 16' ' ' TYR . 33.8 m -51.41 -33.64 31.26 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.06 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 19.1 t60 -53.3 -46.31 69.33 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.237 -0.915 . . . . 0.0 108.552 179.115 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.581 ' HB2' ' CE1' ' A' ' 33' ' ' TYR . 21.4 tp10 -62.03 -17.46 57.38 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.198 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.52 ' HB2' ' O ' ' A' ' 40' ' ' CYS . 2.7 m-80 -79.13 -33.93 43.77 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 119.492 -0.883 . . . . 0.0 109.247 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.718 HD21 ' CZ ' ' A' ' 8' ' ' TYR . 46.6 mt -70.5 -32.93 70.62 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.256 -0.903 . . . . 0.0 109.8 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.7 mm -79.39 -51.6 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.255 -0.903 . . . . 0.0 109.654 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.538 ' HB3' HG23 ' A' ' 48' ' ' THR . 18.5 mtt-85 -82.51 -33.98 28.1 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.21 -0.931 . . . . 0.0 109.833 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.486 ' N ' ' O ' ' A' ' 43' ' ' ASN . 89.6 mt-30 62.52 36.7 13.79 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.247 -0.908 . . . . 0.0 109.422 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.538 HG23 ' HB3' ' A' ' 46' ' ' ARG . 39.0 p -102.87 3.28 36.41 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.226 -0.921 . . . . 0.0 109.631 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.445 ' HB2' ' O ' ' A' ' 48' ' ' THR . 18.6 m120 65.07 48.31 2.29 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.317 -0.864 . . . . 0.0 109.512 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.518 ' N ' ' OD1' ' A' ' 43' ' ' ASN . 48.4 m -80.19 131.39 35.7 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.206 -0.933 . . . . 0.0 109.607 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 11.1 m-70 -114.25 -171.45 1.92 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.272 -0.893 . . . . 0.0 109.38 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.564 HG23 ' HB ' ' A' ' 25' ' ' VAL . 42.9 mt -89.03 127.05 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.311 -0.868 . . . . 0.0 109.574 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.489 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 39.3 ttt85 -81.37 -43.44 19.02 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.424 -0.798 . . . . 0.0 109.255 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.6 m -160.44 146.4 15.18 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.569 -0.707 . . . . 0.0 109.319 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.7 p -61.68 143.5 56.04 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.2 -0.937 . . . . 0.0 109.488 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.537 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 87.58 162.04 37.4 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.641 ' HA ' HG21 ' A' ' 32' ' ' THR . 62.0 tttt -52.91 152.46 3.94 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.667 -0.902 . . . . 0.0 109.603 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 85.3 m -58.74 -23.46 59.88 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.302 -0.874 . . . . 0.0 109.552 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.485 ' HB3' ' HD3' ' A' ' 57' ' ' LYS . 62.0 tt0 -79.66 -21.13 45.16 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.378 -0.827 . . . . 0.0 109.543 -179.533 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.491 ' HG3' ' HB3' ' A' ' 57' ' ' LYS . 5.4 mt-10 -74.2 -33.28 63.36 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.306 -0.871 . . . . 0.0 109.254 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 95.1 p -70.91 -7.58 46.78 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.402 -0.811 . . . . 0.0 109.573 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 42.0 p -84.3 173.81 10.66 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.147 -0.971 . . . . 0.0 109.563 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.47 ' HB ' ' HD2' ' A' ' 64' ' ' PRO . 43.0 p -123.09 160.34 50.16 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.318 -0.863 . . . . 0.0 109.333 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.524 ' HB2' ' HB3' ' A' ' 68' ' ' ALA . 48.0 Cg_endo -69.16 130.34 19.9 Favored 'Trans proline' 0 C--O 1.214 -0.721 0 C-N-CA 122.589 2.193 . . . . 0.0 111.765 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -74.79 -166.54 17.02 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 50.3 m -70.31 -31.51 68.86 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.29 -1.123 . . . . 0.0 109.349 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 64.3 m -65.09 -30.27 71.2 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.287 -0.883 . . . . 0.0 109.381 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.524 ' HB3' ' HB2' ' A' ' 64' ' ' PRO . . . -76.71 -29.36 56.21 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.24 -0.913 . . . . 0.0 109.336 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.62 143.42 54.83 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.265 -0.897 . . . . 0.0 109.317 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 83.7 p -57.29 -28.61 63.17 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.151 -0.968 . . . . 0.0 109.549 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 9.6 mtt -60.59 147.74 82.86 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.287 -0.883 . . . . 0.0 109.52 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -70.3 166.79 27.12 Favored 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 122.684 2.256 . . . . 0.0 111.846 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -69.9 158.49 56.61 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 122.668 2.245 . . . . 0.0 111.778 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 46.8 m -135.3 144.85 46.99 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.277 -0.89 . . . . 0.0 109.521 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.434 ' O ' ' HB2' ' A' ' 76' ' ' GLU . 76.1 m-20 -57.89 -35.44 71.02 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.174 -0.953 . . . . 0.0 109.436 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.434 ' HB2' ' O ' ' A' ' 75' ' ' ASP . 83.4 tt0 . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.453 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.556 ' HB2' ' CD2' ' A' ' 51' ' ' HIS . 3.8 m -61.78 -31.35 71.55 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.215 -0.928 . . . . 0.0 109.322 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -53.51 -26.52 21.15 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.286 -0.883 . . . . 0.0 108.905 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 92.2 mtp -75.51 -26.08 57.8 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.353 -0.842 . . . . 0.0 108.833 179.408 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.6 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 26.2 m -81.42 -14.42 57.14 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.458 -0.776 . . . . 0.0 109.39 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.462 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 22.6 mttm -80.59 5.23 16.04 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.201 -0.937 . . . . 0.0 109.509 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.462 ' OD1' ' O ' ' A' ' 6' ' ' LYS . 93.2 m-20 -135.76 12.82 3.42 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.061 -1.024 . . . . 0.0 110.405 -179.405 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.613 ' CE2' ' CE2' ' A' ' 16' ' ' TYR . 0.6 OUTLIER -123.54 150.72 43.66 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.873 -1.142 . . . . 0.0 109.682 179.815 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 46.1 mtt85 -130.5 132.73 45.78 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.246 -0.908 . . . . 0.0 109.393 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.761 HG13 ' O ' ' A' ' 15' ' ' GLY . 54.2 t -123.39 147.08 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.187 -0.945 . . . . 0.0 109.716 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.709 HD23 ' HD2' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -128.97 176.26 2.93 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.423 -0.798 . . . . 0.0 109.17 -179.999 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.709 ' HD2' HD23 ' A' ' 11' ' ' LEU . 44.0 Cg_endo -66.64 -22.1 51.15 Favored 'Trans proline' 0 C--O 1.214 -0.681 0 C-N-CA 122.477 2.118 . . . . 0.0 111.782 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 60.5 mtt180 -101.55 -30.02 11.63 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.24 -0.913 . . . . 0.0 109.498 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.44 HD12 ' HB2' ' A' ' 11' ' ' LEU . 95.4 mt -81.47 -47.66 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.279 -0.888 . . . . 0.0 109.739 -179.684 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.761 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 77.14 -167.78 54.41 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.613 ' CE2' ' CE2' ' A' ' 8' ' ' TYR . 1.5 t80 -95.75 150.77 20.03 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.177 -1.19 . . . . 0.0 109.662 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 25.7 tp -117.51 105.81 12.49 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.322 -0.861 . . . . 0.0 109.465 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.402 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 76.2 m -117.77 157.3 48.43 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.239 -0.913 . . . . 0.0 109.183 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.485 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 49.5 Cg_endo -72.17 166.01 30.94 Favored 'Trans proline' 0 C--O 1.216 -0.622 0 C-N-CA 122.63 2.22 . . . . 0.0 111.545 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 60.1 mttt -89.38 -13.2 38.31 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.184 -0.948 . . . . 0.0 109.475 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -73.53 113.72 10.96 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.231 -0.918 . . . . 0.0 109.248 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.491 HD11 ' HB3' ' A' ' 34' ' ' ASN . 49.4 tp -76.54 112.54 13.18 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.174 -0.954 . . . . 0.0 109.628 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.489 ' O ' ' O ' ' A' ' 34' ' ' ASN . 14.2 mttt -126.22 110.14 24.0 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.295 -0.878 . . . . 0.0 108.941 179.66 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.542 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 43.5 Cg_endo -64.93 123.98 12.42 Favored 'Trans proline' 0 C--O 1.213 -0.744 0 C-N-CA 123.025 2.483 . . . . 0.0 112.487 -179.187 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.445 ' HB ' HG23 ' A' ' 52' ' ' ILE . 27.2 m -118.77 153.38 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.434 -0.791 . . . . 0.0 109.452 179.674 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 41.9 t -99.45 139.65 34.8 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 178.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -93.91 144.44 17.11 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 -178.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.497 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 49.3 p30 -68.87 -15.0 63.38 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.365 -1.079 . . . . 0.0 109.432 179.626 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.457 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 88.1 m-20 -84.46 5.73 26.26 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.232 -0.917 . . . . 0.0 109.542 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.04 17.17 56.65 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.444 ' O ' ' SG ' ' A' ' 58' ' ' CYS . 90.8 mt-30 -115.82 171.13 7.96 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.307 -1.113 . . . . 0.0 109.485 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.554 HG23 ' HA ' ' A' ' 57' ' ' LYS . 64.0 m -133.03 136.0 45.73 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.232 -0.918 . . . . 0.0 109.522 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.927 ' CD1' HD13 ' A' ' 39' ' ' LEU . 44.4 m-85 -116.14 133.17 56.32 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.292 -0.88 . . . . 0.0 109.247 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.54 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 7.7 m-20 -55.3 -77.57 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.262 -0.899 . . . . 0.0 110.031 -179.423 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.524 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 5.4 t-20 -81.63 147.66 59.84 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 120.91 -1.119 . . . . 0.0 109.728 -179.626 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.479 ' HD3' ' O ' ' A' ' 23' ' ' LYS . 41.3 Cg_endo -64.18 -53.09 1.27 Allowed 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 122.771 2.314 . . . . 0.0 111.552 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.524 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 10.1 t -62.34 -29.0 70.14 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 178.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.515 ' CG ' ' HB3' ' A' ' 35' ' ' ASN . 44.6 mmm -62.76 -14.09 40.63 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.241 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.927 HD13 ' CD1' ' A' ' 33' ' ' TYR . 39.8 tp -73.23 -60.17 2.37 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.407 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.455 ' HB3' ' OH ' ' A' ' 16' ' ' TYR . 17.8 t -54.54 -23.56 17.11 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 54.3 t60 -69.46 -62.25 1.46 Allowed 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.283 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 -58.09 -19.1 29.5 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.229 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.494 ' O ' ' N ' ' A' ' 47' ' ' GLN . 99.6 m-20 -76.36 -29.66 57.28 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.482 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.937 HD13 ' O ' ' A' ' 44' ' ' LEU . 1.8 tm? -69.81 -38.79 76.73 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.416 -0.803 . . . . 0.0 109.014 179.543 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.555 ' N ' HD13 ' A' ' 45' ' ' ILE . 3.7 mm -71.54 -46.42 63.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.301 -0.875 . . . . 0.0 109.385 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.447 ' HB3' HG23 ' A' ' 48' ' ' THR . 13.4 mtt-85 -79.59 -33.23 41.82 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.286 -0.884 . . . . 0.0 109.354 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.494 ' N ' ' O ' ' A' ' 43' ' ' ASN . 92.3 mt-30 61.24 39.43 15.7 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.368 -0.832 . . . . 0.0 109.52 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.447 HG23 ' HB3' ' A' ' 46' ' ' ARG . 52.2 p -104.28 8.21 35.99 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.261 -0.9 . . . . 0.0 109.481 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.58 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 35.5 t-20 50.78 57.69 6.36 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.296 -0.878 . . . . 0.0 109.505 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.457 ' HB ' ' OD1' ' A' ' 43' ' ' ASN . 26.6 m -80.32 148.54 30.64 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.182 -0.949 . . . . 0.0 109.785 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.58 ' CE1' ' O ' ' A' ' 49' ' ' ASN . 13.7 m80 -122.0 171.34 9.02 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.396 -0.815 . . . . 0.0 108.851 179.472 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.453 HG12 HD22 ' A' ' 39' ' ' LEU . 11.7 mt -83.29 126.48 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.156 -0.965 . . . . 0.0 109.701 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.497 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 55.8 ttt180 -80.04 -46.45 16.55 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.452 -0.78 . . . . 0.0 109.409 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -160.54 142.92 12.89 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.418 ' H ' HG23 ' A' ' 55' ' ' THR . 25.8 p -54.71 148.4 12.84 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.192 -0.942 . . . . 0.0 109.112 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.542 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 84.42 168.2 43.83 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.068 -1.613 . . . . 0.0 109.068 -179.513 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.554 ' HA ' HG23 ' A' ' 32' ' ' THR . 81.7 mttt -63.93 167.14 6.52 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.257 -1.143 . . . . 0.0 109.238 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.444 ' SG ' ' O ' ' A' ' 31' ' ' GLN . 84.0 m -74.38 -15.52 60.93 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.219 -0.926 . . . . 0.0 109.098 179.689 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.459 ' HG2' ' O ' ' A' ' 59' ' ' GLU . 65.3 tt0 -79.71 -16.56 55.45 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.48 -0.763 . . . . 0.0 109.368 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.457 ' HG3' ' O ' ' A' ' 57' ' ' LYS . 9.1 mt-10 -73.7 -33.8 64.56 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.278 -0.889 . . . . 0.0 108.96 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 93.1 p -60.11 -18.22 45.7 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.433 -0.792 . . . . 0.0 109.108 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 42.5 m -119.4 152.29 37.07 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.29 -0.881 . . . . 0.0 109.412 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 17.1 m -123.47 79.52 54.3 Favored Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.215 -0.928 . . . . 0.0 109.502 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -70.38 147.07 58.08 Favored 'Trans proline' 0 C--O 1.216 -0.61 0 C-N-CA 122.709 2.273 . . . . 0.0 111.771 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.24 172.9 55.25 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.559 -1.417 . . . . 0.0 109.559 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 16.9 p -123.74 163.53 20.96 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.287 -1.125 . . . . 0.0 109.437 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 17.4 p -123.32 160.82 25.9 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.255 -0.903 . . . . 0.0 109.503 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.417 ' O ' ' O ' ' A' ' 71' ' ' MET . . . -60.67 -33.6 73.08 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.205 -0.934 . . . . 0.0 109.46 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.04 -25.7 65.5 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.316 -0.865 . . . . 0.0 109.547 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 27.8 m -61.65 -27.77 68.91 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.185 -0.947 . . . . 0.0 109.51 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.417 ' O ' ' O ' ' A' ' 68' ' ' ALA . 22.5 mtt -133.03 158.64 75.31 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.252 -0.905 . . . . 0.0 109.579 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -70.48 148.95 61.51 Favored 'Trans proline' 0 C--O 1.214 -0.695 0 C-N-CA 122.708 2.272 . . . . 0.0 111.723 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -69.8 -5.46 16.29 Favored 'Trans proline' 0 C--O 1.214 -0.712 0 C-N-CA 122.668 2.245 . . . . 0.0 111.833 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 83.7 p -84.62 -11.45 55.95 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.173 -0.954 . . . . 0.0 109.37 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -67.1 -29.65 69.46 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.229 -0.919 . . . . 0.0 109.399 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 . . . . . 0 N--CA 1.489 1.506 0 CA-C-O 118.024 -0.989 . . . . 0.0 109.504 179.931 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.624 ' OD1' HD12 ' A' ' 52' ' ' ILE . 58.9 m-20 . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.453 ' O ' ' SG ' ' A' ' 5' ' ' CYS . 1.3 m -47.13 -34.95 6.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.179 -0.95 . . . . 0.0 109.231 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.476 ' HA ' ' HG3' ' A' ' 6' ' ' LYS . 9.2 mt-10 -50.72 -25.53 4.46 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.261 -0.9 . . . . 0.0 108.758 179.591 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 84.5 mmm -75.63 -32.5 60.27 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.46 -0.775 . . . . 0.0 109.389 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.453 ' SG ' ' O ' ' A' ' 2' ' ' SER . 16.8 p -79.76 -7.76 58.84 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.14 -0.975 . . . . 0.0 109.286 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.476 ' HG3' ' HA ' ' A' ' 3' ' ' GLU . 24.7 mttm -49.05 -24.92 1.75 Allowed 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.079 -1.013 . . . . 0.0 108.391 179.486 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.401 ' OD1' ' C ' ' A' ' 7' ' ' ASP . 58.8 p30 -112.98 25.57 11.28 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.319 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.577 ' CZ ' ' CE1' ' A' ' 16' ' ' TYR . 3.7 t80 -79.19 162.82 25.49 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.544 -0.723 . . . . 0.0 109.99 -179.394 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 12.7 mtm180 -148.92 115.36 5.87 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.368 -0.832 . . . . 0.0 108.977 179.651 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.95 HG13 ' C ' ' A' ' 15' ' ' GLY . 99.8 t -111.32 148.99 14.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.229 -0.919 . . . . 0.0 109.468 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.562 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.5 OUTLIER -129.58 175.82 3.3 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.251 -0.905 . . . . 0.0 109.453 -179.674 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.562 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 43.7 Cg_endo -66.77 -22.26 49.93 Favored 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 122.644 2.229 . . . . 0.0 111.584 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.44 ' HB3' ' NH1' ' A' ' 13' ' ' ARG . 19.5 mtp-105 -114.29 -29.49 6.91 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.375 -0.828 . . . . 0.0 109.215 179.683 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.487 HD12 ' HB2' ' A' ' 11' ' ' LEU . 97.1 mt -78.92 -42.02 24.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.338 -0.851 . . . . 0.0 109.383 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.95 ' C ' HG13 ' A' ' 10' ' ' VAL . . . 64.12 -150.89 50.25 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.577 ' CE1' ' CZ ' ' A' ' 8' ' ' TYR . 1.0 OUTLIER -102.68 147.6 26.62 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.266 -1.138 . . . . 0.0 109.352 179.858 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.465 ' HB2' ' OH ' ' A' ' 8' ' ' TYR . 37.5 mt -113.86 124.14 51.49 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.118 -0.989 . . . . 0.0 109.919 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.413 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 61.4 m -138.97 156.32 72.57 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.433 -0.792 . . . . 0.0 109.026 179.724 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -70.74 167.05 26.84 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.573 2.182 . . . . 0.0 111.671 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -88.2 -13.7 40.44 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.208 -0.933 . . . . 0.0 109.698 -179.681 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -74.19 123.48 24.57 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.133 -0.98 . . . . 0.0 109.391 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.542 HD11 ' HB3' ' A' ' 34' ' ' ASN . 39.7 tp -80.61 118.55 22.29 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.275 -0.89 . . . . 0.0 109.515 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.532 ' CB ' ' HD3' ' A' ' 36' ' ' PRO . 10.8 mttp -127.65 100.09 25.69 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.347 -0.846 . . . . 0.0 109.17 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.541 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 42.2 Cg_endo -64.41 118.22 5.2 Favored 'Trans proline' 0 C--O 1.214 -0.713 0 C-N-CA 122.874 2.383 . . . . 0.0 112.133 -179.449 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.526 ' HB ' HG23 ' A' ' 52' ' ' ILE . 12.2 m -114.65 155.74 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.309 -0.87 . . . . 0.0 109.557 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.417 ' SG ' ' NE ' ' A' ' 53' ' ' ARG . 42.4 t -95.62 138.96 32.55 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.237 -0.914 . . . . 0.0 108.661 179.051 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -92.11 136.16 13.1 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.487 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 53.8 t0 -68.96 -7.15 32.51 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.196 -1.179 . . . . 0.0 109.426 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.413 ' OD1' ' C ' ' A' ' 29' ' ' ASP . 59.2 p30 -89.72 2.95 54.19 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.265 -0.897 . . . . 0.0 109.413 179.672 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.64 16.57 39.02 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.463 ' O ' ' SG ' ' A' ' 58' ' ' CYS . 66.2 mt-30 -121.78 -178.37 3.81 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.301 -1.117 . . . . 0.0 109.592 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.615 HG21 ' HA ' ' A' ' 57' ' ' LYS . 11.1 m -143.3 138.85 29.83 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.287 -0.883 . . . . 0.0 109.319 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.871 ' CD1' HD13 ' A' ' 39' ' ' LEU . 40.2 m-85 -116.13 134.09 55.31 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.217 -0.927 . . . . 0.0 109.366 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.542 ' HB3' HD11 ' A' ' 22' ' ' LEU . 13.1 m-20 -55.07 -78.94 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.255 -0.903 . . . . 0.0 109.666 -179.611 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.51 ' HB3' ' CG ' ' A' ' 38' ' ' MET . 10.9 t-20 -82.33 146.14 53.61 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.08 -1.013 . . . . 0.0 109.525 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.532 ' HD3' ' CB ' ' A' ' 23' ' ' LYS . 41.4 Cg_endo -63.94 -51.64 2.16 Favored 'Trans proline' 0 C--O 1.215 -0.651 0 C-N-CA 122.753 2.302 . . . . 0.0 111.621 179.438 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.505 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 8.0 t -62.06 -25.62 67.79 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 178.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.51 ' CG ' ' HB3' ' A' ' 35' ' ' ASN . 65.2 mmm -72.35 -3.02 21.47 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 179.191 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.871 HD13 ' CD1' ' A' ' 33' ' ' TYR . 21.2 tp -74.37 -60.03 2.46 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.287 -0.883 . . . . 0.0 109.175 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.488 ' HB3' ' OH ' ' A' ' 16' ' ' TYR . 2.2 t -56.44 -25.73 51.43 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.122 -0.986 . . . . 0.0 108.468 179.51 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 27.4 t60 -61.9 -56.91 14.42 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.223 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.468 ' OE1' ' CD2' ' A' ' 33' ' ' TYR . 65.1 tt0 -64.2 -20.57 66.11 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.145 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.606 HD22 ' HB ' ' A' ' 50' ' ' THR . 10.2 m120 -79.19 -29.88 43.12 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.61 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.977 HD13 ' O ' ' A' ' 44' ' ' LEU . 1.7 tm? -65.41 -36.9 85.35 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.284 -0.885 . . . . 0.0 109.165 179.629 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.2 mt -79.4 -38.88 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.372 -0.83 . . . . 0.0 109.317 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.456 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 17.0 mtt-85 -80.11 -32.79 39.08 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.174 -0.954 . . . . 0.0 109.417 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.501 ' N ' ' O ' ' A' ' 43' ' ' ASN . 73.8 mm-40 61.84 40.93 12.2 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.254 -0.904 . . . . 0.0 109.578 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 25.4 p -113.73 9.84 17.79 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.187 -0.946 . . . . 0.0 109.625 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 49.6 m-20 45.35 58.81 3.91 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.201 -0.937 . . . . 0.0 109.529 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.606 ' HB ' HD22 ' A' ' 43' ' ' ASN . 66.0 m -80.33 137.55 36.59 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.158 -0.964 . . . . 0.0 109.779 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 72.2 m80 -110.77 172.02 7.12 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.255 -0.903 . . . . 0.0 108.967 179.451 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.624 HD12 ' OD1' ' A' ' 1' ' ' ASP . 34.7 mt -82.12 126.03 39.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.131 -0.981 . . . . 0.0 109.435 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.487 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 46.6 ttp180 -79.99 -44.56 19.99 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 121.642 0.734 . . . . 0.0 109.309 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 17.1 p -158.49 156.1 29.67 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -179.503 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 36.5 p -71.68 140.32 49.58 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.119 -0.988 . . . . 0.0 109.407 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.541 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 89.5 162.25 38.24 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.551 -1.419 . . . . 0.0 109.551 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.615 ' HA ' HG21 ' A' ' 32' ' ' THR . 46.2 tttp -50.63 148.54 3.83 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.537 -0.978 . . . . 0.0 109.49 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.463 ' SG ' ' O ' ' A' ' 31' ' ' GLN . 92.5 m -52.53 -25.48 10.5 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.318 -0.864 . . . . 0.0 109.331 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -85.3 -20.87 29.35 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.367 -0.833 . . . . 0.0 109.29 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -91.68 116.57 28.99 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.317 -0.865 . . . . 0.0 109.328 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 25.3 t -129.21 140.64 51.41 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.199 -0.938 . . . . 0.0 109.579 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 97.3 p -120.08 155.28 33.3 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.2 -0.938 . . . . 0.0 109.415 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.31 77.42 61.29 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.249 -0.907 . . . . 0.0 109.482 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -69.95 149.16 65.28 Favored 'Trans proline' 0 C--O 1.214 -0.682 0 C-N-CA 122.723 2.282 . . . . 0.0 111.814 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.426 ' HA3' ' CB ' ' A' ' 70' ' ' SER . . . -78.87 -176.73 48.49 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 63.7 m -64.29 -29.27 70.36 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.278 -1.13 . . . . 0.0 109.428 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 17.7 p -133.28 158.76 42.11 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.366 -0.834 . . . . 0.0 109.465 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -57.86 -30.31 65.71 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.228 -0.92 . . . . 0.0 109.461 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.72 -35.28 79.23 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.287 -0.883 . . . . 0.0 109.53 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.426 ' CB ' ' HA3' ' A' ' 65' ' ' GLY . 32.0 m -53.46 -34.35 57.59 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.238 -0.914 . . . . 0.0 109.513 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -63.43 154.56 78.63 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.266 -0.896 . . . . 0.0 109.473 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -69.96 142.46 47.1 Favored 'Trans proline' 0 C--O 1.214 -0.692 0 C-N-CA 122.736 2.291 . . . . 0.0 111.844 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -70.26 166.82 26.95 Favored 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 122.727 2.285 . . . . 0.0 111.815 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 20.2 m -90.74 -8.03 50.89 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.263 -0.898 . . . . 0.0 109.626 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 54.7 t0 -104.48 109.71 21.69 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.14 -0.975 . . . . 0.0 109.498 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 118.027 -0.987 . . . . 0.0 109.451 179.957 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.344 0.593 . . . . 0.0 109.556 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.6 m -61.75 -24.91 67.12 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.266 -0.896 . . . . 0.0 109.571 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -54.95 -22.03 13.71 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.167 -0.958 . . . . 0.0 109.041 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 77.4 mtm -73.8 -30.02 62.49 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.239 -0.913 . . . . 0.0 109.061 179.656 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.592 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 48.7 m -80.09 -19.13 48.16 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.396 -0.815 . . . . 0.0 109.351 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.442 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 25.3 mttt -81.04 11.65 3.93 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.362 -0.836 . . . . 0.0 109.985 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' A' ' 6' ' ' LYS . 94.4 m-20 -136.23 4.05 2.91 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.026 -1.046 . . . . 0.0 109.972 -179.759 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.592 ' CD1' ' HA ' ' A' ' 5' ' ' CYS . 0.7 OUTLIER -121.12 147.98 44.81 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.946 -1.096 . . . . 0.0 109.675 -179.951 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 29.2 mtt180 -132.44 124.64 29.01 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.333 -0.854 . . . . 0.0 108.957 179.609 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.74 HG13 ' O ' ' A' ' 15' ' ' GLY . 75.8 t -108.95 141.44 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.333 -0.854 . . . . 0.0 110.183 -179.229 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.687 HD12 ' O ' ' A' ' 10' ' ' VAL . 2.0 mp -130.71 176.18 3.08 Favored Pre-proline 0 N--CA 1.489 1.503 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.723 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.546 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 44.2 Cg_endo -66.55 -23.05 50.39 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 122.593 2.196 . . . . 0.0 111.801 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 31.6 ttp180 -97.78 -35.06 10.65 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.332 -0.855 . . . . 0.0 109.404 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 87.3 mt -80.34 -50.75 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.324 -0.86 . . . . 0.0 109.398 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.74 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 82.51 -171.67 51.6 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.536 ' CD1' HG21 ' A' ' 10' ' ' VAL . 0.9 OUTLIER -86.73 152.92 22.12 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.235 -1.156 . . . . 0.0 109.548 179.984 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 19.1 tp -129.45 117.1 19.98 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.235 -0.915 . . . . 0.0 109.915 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.444 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 75.8 m -133.82 156.72 79.12 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.401 -0.812 . . . . 0.0 108.928 179.515 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.549 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 49.6 Cg_endo -70.62 167.37 25.75 Favored 'Trans proline' 0 C--O 1.216 -0.623 0 C-N-CA 122.689 2.259 . . . . 0.0 111.679 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -93.91 -6.77 44.84 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.302 -0.873 . . . . 0.0 109.573 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.541 ' CB ' ' HE2' ' A' ' 23' ' ' LYS . 77.5 m-20 -74.46 137.01 42.29 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.228 -0.92 . . . . 0.0 109.115 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.839 HD21 ' OD1' ' A' ' 34' ' ' ASN . 3.3 tm? -92.66 119.6 32.23 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.201 -0.937 . . . . 0.0 109.599 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.609 ' N ' HD13 ' A' ' 22' ' ' LEU . 11.5 mttt -139.22 104.26 7.24 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.176 -0.952 . . . . 0.0 109.403 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.543 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 44.2 Cg_endo -67.25 118.47 5.6 Favored 'Trans proline' 0 C--O 1.214 -0.691 0 C-N-CA 122.921 2.414 . . . . 0.0 111.857 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 23.2 m -112.89 155.57 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.247 -0.908 . . . . 0.0 109.927 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.461 ' O ' ' N ' ' A' ' 53' ' ' ARG . 39.3 t -101.49 109.57 21.41 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.315 -0.866 . . . . 0.0 109.338 179.63 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.485 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -62.5 142.17 47.64 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 -179.56 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.51 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 58.4 p30 -70.62 -10.37 59.18 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.326 -1.102 . . . . 0.0 109.378 179.654 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.438 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 55.1 p30 -85.33 6.58 25.74 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.224 -0.923 . . . . 0.0 109.312 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.65 9.47 64.45 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.191 -1.564 . . . . 0.0 109.191 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.485 ' O ' ' N ' ' A' ' 27' ' ' GLY . 88.0 mt-30 -111.18 168.28 9.63 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.381 -1.07 . . . . 0.0 109.517 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.566 HG23 ' HA ' ' A' ' 57' ' ' LYS . 30.3 m -127.68 130.79 49.5 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.243 -0.91 . . . . 0.0 109.402 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.805 ' CD1' HD13 ' A' ' 39' ' ' LEU . 47.1 m-85 -109.44 123.73 49.85 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.208 -0.932 . . . . 0.0 109.188 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.839 ' OD1' HD21 ' A' ' 22' ' ' LEU . 52.5 t-20 -48.3 -78.86 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.252 -0.905 . . . . 0.0 110.057 -179.387 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.535 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 1.4 t-20 -81.2 150.36 67.85 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.002 -1.061 . . . . 0.0 109.617 -179.75 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.469 ' HD2' ' CG ' ' A' ' 35' ' ' ASN . 40.7 Cg_endo -63.52 -55.5 0.7 Allowed 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 122.874 2.383 . . . . 0.0 112.037 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.549 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 13.6 t -63.31 -28.65 70.16 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.995 -1.066 . . . . 0.0 108.539 179.23 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.475 ' CG ' ' HB3' ' A' ' 35' ' ' ASN . 51.5 mmm -61.16 -17.66 54.06 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.345 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.805 HD13 ' CD1' ' A' ' 33' ' ' TYR . 30.7 tp -67.11 -59.0 3.83 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.269 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.458 ' HB3' ' OH ' ' A' ' 16' ' ' TYR . 8.2 t -55.8 -27.47 51.3 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.734 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.407 ' HB3' ' O ' ' A' ' 38' ' ' MET . 49.1 t60 -63.5 -61.09 2.56 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 63.1 mt-10 -57.47 -20.88 33.7 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 178.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.5 ' O ' ' N ' ' A' ' 47' ' ' GLN . 95.9 m-20 -80.27 -26.68 38.83 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.564 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 35.8 tp -71.3 -32.26 68.42 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.275 -0.891 . . . . 0.0 108.722 179.589 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 6.6 mm -80.57 -46.5 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.415 -0.803 . . . . 0.0 109.181 179.525 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.521 ' HB3' HG23 ' A' ' 48' ' ' THR . 58.0 mtt-85 -80.12 -36.69 34.96 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.253 -0.905 . . . . 0.0 109.285 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.5 ' N ' ' O ' ' A' ' 43' ' ' ASN . 91.7 mt-30 63.89 39.8 7.92 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.535 -0.728 . . . . 0.0 109.518 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.521 HG23 ' HB3' ' A' ' 46' ' ' ARG . 39.6 p -101.77 6.02 41.51 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.293 -0.879 . . . . 0.0 109.415 179.691 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 49.6 t30 52.78 57.24 6.58 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.301 -0.874 . . . . 0.0 109.687 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 58.4 m -80.12 141.34 35.85 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.185 -0.947 . . . . 0.0 109.633 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.545 ' CD2' ' N ' ' A' ' 51' ' ' HIS . 15.7 m-70 -111.13 178.83 4.22 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.331 -0.855 . . . . 0.0 109.192 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.9 mt -90.25 127.22 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.123 -0.985 . . . . 0.0 109.799 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.51 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 28.4 ttt180 -80.18 -59.83 2.56 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.494 -0.754 . . . . 0.0 109.287 179.694 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 21.1 m -154.04 142.25 20.45 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.3 p -53.3 143.41 18.71 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.157 -0.965 . . . . 0.0 109.542 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.543 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 95.26 162.95 34.46 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.566 ' HA ' HG23 ' A' ' 32' ' ' THR . 18.0 mttp -64.26 149.68 47.53 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.465 -1.02 . . . . 0.0 109.341 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.457 ' SG ' ' O ' ' A' ' 31' ' ' GLN . 70.2 m -56.16 -25.76 47.8 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.223 -0.923 . . . . 0.0 109.41 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.466 ' O ' ' HG2' ' A' ' 59' ' ' GLU . 66.0 tt0 -86.08 -19.06 30.8 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.323 -0.86 . . . . 0.0 109.375 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 53.9 tt0 -76.87 -27.84 55.18 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.296 -0.877 . . . . 0.0 109.478 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 17.3 m -71.73 -26.71 62.59 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.279 -0.888 . . . . 0.0 109.683 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 97.3 p -120.34 152.82 37.32 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.173 -0.954 . . . . 0.0 109.663 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.465 ' OG1' ' HD2' ' A' ' 64' ' ' PRO . 0.1 OUTLIER -68.57 153.8 95.31 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.323 -0.861 . . . . 0.0 109.504 179.976 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.726 ' HB2' ' HB3' ' A' ' 68' ' ' ALA . 49.2 Cg_endo -69.26 141.25 46.73 Favored 'Trans proline' 0 C--O 1.215 -0.647 0 C-N-CA 122.71 2.273 . . . . 0.0 111.752 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -76.54 -171.53 33.54 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 56.1 m -68.12 -29.96 68.99 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.27 -1.135 . . . . 0.0 109.355 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 57.9 m -65.66 -29.11 69.63 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.291 -0.881 . . . . 0.0 109.406 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.726 ' HB3' ' HB2' ' A' ' 64' ' ' PRO . . . -72.78 -29.4 63.27 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.212 -0.93 . . . . 0.0 109.374 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.465 ' O ' ' HD3' ' A' ' 72' ' ' PRO . . . -70.57 -19.78 62.84 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.242 -0.911 . . . . 0.0 109.27 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 19.7 m -69.44 -27.0 64.87 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.271 -0.893 . . . . 0.0 109.199 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 6.8 mtp -128.63 71.41 80.76 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.33 -0.857 . . . . 0.0 109.276 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.465 ' HD3' ' O ' ' A' ' 69' ' ' ALA . 48.4 Cg_endo -69.54 169.41 18.69 Favored 'Trans proline' 0 C--O 1.215 -0.631 0 C-N-CA 122.739 2.293 . . . . 0.0 111.938 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -70.39 -14.69 34.34 Favored 'Trans proline' 0 C--O 1.216 -0.61 0 C-N-CA 122.833 2.355 . . . . 0.0 111.96 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 97.0 p -142.25 152.7 43.3 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.147 -0.97 . . . . 0.0 109.62 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -60.04 134.99 57.57 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.24 -0.912 . . . . 0.0 109.451 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 118.022 -0.989 . . . . 0.0 109.442 -179.939 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.458 ' HB2' ' CE1' ' A' ' 51' ' ' HIS . 2.1 m -57.52 -34.85 69.54 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.234 -0.916 . . . . 0.0 109.408 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -55.12 -27.03 42.22 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.331 -0.855 . . . . 0.0 109.054 179.769 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.452 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 86.4 mtp -72.3 -21.56 61.32 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.576 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.581 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 27.1 m -87.15 -16.64 34.83 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.479 -0.763 . . . . 0.0 109.123 179.579 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.7 mttp -81.15 14.25 2.43 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.303 -0.873 . . . . 0.0 109.943 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.452 ' OD1' ' O ' ' A' ' 4' ' ' MET . 51.7 p30 -145.79 10.5 1.21 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.918 -1.114 . . . . 0.0 110.098 -179.698 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.645 ' CE2' ' CE2' ' A' ' 16' ' ' TYR . 1.1 p90 -119.0 150.48 39.88 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.933 -1.104 . . . . 0.0 109.546 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 57.8 mtm180 -130.01 133.82 47.0 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.237 -0.914 . . . . 0.0 109.289 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.929 HG13 ' O ' ' A' ' 15' ' ' GLY . 54.1 t -122.92 149.98 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.202 -0.936 . . . . 0.0 109.711 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.553 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.2 OUTLIER -131.39 175.91 3.31 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.322 -0.861 . . . . 0.0 109.261 -179.971 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.553 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 43.7 Cg_endo -66.07 -22.97 54.04 Favored 'Trans proline' 0 C--O 1.214 -0.684 0 C-N-CA 122.65 2.233 . . . . 0.0 111.929 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 3.5 mtm180 -106.29 -31.77 8.47 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.301 -0.874 . . . . 0.0 109.357 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.488 HD12 ' HB2' ' A' ' 11' ' ' LEU . 92.9 mt -77.17 -39.33 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.374 -0.829 . . . . 0.0 109.347 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.929 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 70.73 -162.81 53.71 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.645 ' CE2' ' CE2' ' A' ' 8' ' ' TYR . 2.0 t80 -95.01 150.55 20.04 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.211 -1.17 . . . . 0.0 109.632 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 23.0 tp -113.13 111.33 21.92 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.412 -0.805 . . . . 0.0 109.593 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.452 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 84.6 m -128.68 156.63 77.17 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.147 -0.971 . . . . 0.0 109.317 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.525 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 48.9 Cg_endo -70.82 167.53 25.57 Favored 'Trans proline' 0 C--O 1.216 -0.611 0 C-N-CA 122.717 2.278 . . . . 0.0 111.577 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 62.6 mttm -94.94 -4.56 46.54 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.255 -0.903 . . . . 0.0 109.631 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -76.69 123.98 26.97 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.206 -0.934 . . . . 0.0 109.348 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.751 HD21 ' OD1' ' A' ' 34' ' ' ASN . 3.3 tm? -82.73 119.02 23.8 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.208 -0.933 . . . . 0.0 109.498 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.595 ' N ' HD13 ' A' ' 22' ' ' LEU . 15.5 mttp -141.88 107.51 5.87 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.302 -0.874 . . . . 0.0 109.476 179.744 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.546 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 43.3 Cg_endo -65.9 123.66 11.61 Favored 'Trans proline' 0 C--O 1.213 -0.728 0 C-N-CA 123.017 2.478 . . . . 0.0 112.14 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.663 ' O ' HG23 ' A' ' 32' ' ' THR . 29.7 m -116.32 155.02 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.265 -0.897 . . . . 0.0 109.71 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.455 ' O ' ' N ' ' A' ' 53' ' ' ARG . 43.5 t -99.27 122.94 43.12 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.428 -0.795 . . . . 0.0 108.914 179.418 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -81.45 137.99 18.36 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.514 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 47.0 p30 -68.54 -8.33 40.46 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.248 -1.148 . . . . 0.0 109.575 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -84.14 10.04 11.19 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.194 -0.941 . . . . 0.0 109.189 179.556 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.32 15.66 66.1 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.167 -1.573 . . . . 0.0 109.167 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.446 ' O ' ' N ' ' A' ' 27' ' ' GLY . 86.6 mt-30 -124.27 167.85 13.76 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.344 -1.092 . . . . 0.0 109.535 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.663 HG23 ' O ' ' A' ' 25' ' ' VAL . 42.1 m -127.96 137.91 52.43 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.251 -0.906 . . . . 0.0 109.526 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.879 ' CD1' HD13 ' A' ' 39' ' ' LEU . 71.4 m-85 -113.79 129.26 56.6 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.288 -0.882 . . . . 0.0 109.28 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.751 ' OD1' HD21 ' A' ' 22' ' ' LEU . 45.4 t-20 -51.09 -78.95 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.363 -0.836 . . . . 0.0 110.255 -179.197 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.53 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 1.7 t-20 -81.6 149.91 65.46 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 120.964 -1.085 . . . . 0.0 109.762 -179.492 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.469 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.9 Cg_endo -63.88 -55.53 0.64 Allowed 'Trans proline' 0 C--O 1.215 -0.674 0 C-N-CA 122.765 2.31 . . . . 0.0 111.864 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.53 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 12.9 t -61.41 -30.58 70.65 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.022 -1.049 . . . . 0.0 108.175 179.097 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.521 ' CG ' ' HB3' ' A' ' 35' ' ' ASN . 65.0 mmm -61.41 -15.15 34.05 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.016 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.879 HD13 ' CD1' ' A' ' 33' ' ' TYR . 37.8 tp -68.94 -58.55 3.97 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.434 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.453 ' HB3' ' OH ' ' A' ' 16' ' ' TYR . 19.5 t -53.28 -29.34 32.72 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 179.001 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 48.1 t60 -64.19 -61.57 2.17 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.13 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.444 ' HA ' ' OE1' ' A' ' 42' ' ' GLU . 71.2 mm-40 -56.06 -20.3 16.44 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.412 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.479 ' O ' ' N ' ' A' ' 47' ' ' GLN . 97.3 m-20 -79.44 -24.75 42.23 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.752 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.96 HD13 ' O ' ' A' ' 44' ' ' LEU . 1.7 tm? -71.86 -37.34 70.25 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.333 -0.855 . . . . 0.0 108.766 179.35 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.542 ' N ' HD13 ' A' ' 45' ' ' ILE . 3.8 mm -75.92 -44.68 38.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.404 -0.81 . . . . 0.0 109.232 179.609 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.447 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 14.7 mtt-85 -79.61 -37.72 35.53 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.359 -0.838 . . . . 0.0 109.19 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.479 ' N ' ' O ' ' A' ' 43' ' ' ASN . 91.6 mt-30 62.06 40.46 12.05 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.334 -0.854 . . . . 0.0 109.469 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.42 HG23 ' HB3' ' A' ' 46' ' ' ARG . 62.4 p -107.53 17.22 22.96 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.239 -0.913 . . . . 0.0 109.45 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.567 ' OD1' ' CE1' ' A' ' 51' ' ' HIS . 13.4 t-20 44.82 58.61 3.86 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.294 -0.879 . . . . 0.0 109.511 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.461 ' HB ' ' OD1' ' A' ' 43' ' ' ASN . 50.1 m -80.32 147.28 31.19 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.212 -0.93 . . . . 0.0 109.715 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.567 ' CE1' ' OD1' ' A' ' 49' ' ' ASN . 30.6 m-70 -122.16 169.78 10.53 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.345 -0.847 . . . . 0.0 108.988 179.497 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.454 HG12 HD22 ' A' ' 39' ' ' LEU . 10.7 mt -81.2 122.29 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.15 -0.969 . . . . 0.0 109.611 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.514 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 56.5 ttt180 -79.9 -44.84 19.68 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.436 -0.79 . . . . 0.0 109.301 179.743 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.4 t -157.95 154.4 27.73 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.43 -0.794 . . . . 0.0 109.195 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.6 p -73.31 132.46 43.12 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.22 -0.925 . . . . 0.0 109.568 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.546 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 100.16 164.2 28.7 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.654 ' HA ' HG21 ' A' ' 32' ' ' THR . 39.7 tttt -50.2 150.31 2.51 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.443 -1.033 . . . . 0.0 109.263 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 36.2 m -56.25 -31.7 63.82 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.179 -0.951 . . . . 0.0 109.42 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.42 ' CD ' ' HE2' ' A' ' 57' ' ' LYS . 19.0 mt-10 -82.12 -31.34 30.69 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.308 -0.87 . . . . 0.0 108.892 179.706 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.467 ' OE1' ' HA3' ' A' ' 56' ' ' GLY . 37.9 tt0 -53.52 -21.98 7.37 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.466 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 13.5 m -68.76 -35.94 77.71 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.433 -0.792 . . . . 0.0 109.547 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 43.7 m -113.04 143.17 44.78 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.256 -0.902 . . . . 0.0 109.558 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.05 77.32 41.43 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.322 -0.861 . . . . 0.0 109.278 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -69.39 -20.12 36.99 Favored 'Trans proline' 0 C--O 1.215 -0.664 0 C-N-CA 122.735 2.29 . . . . 0.0 111.762 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 171.05 -179.03 43.15 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 21.0 p -122.12 159.94 26.12 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.201 -1.176 . . . . 0.0 109.487 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 63.2 p -68.07 -26.93 66.09 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.231 -0.918 . . . . 0.0 109.42 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -62.72 -33.31 74.84 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.274 -0.891 . . . . 0.0 109.506 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.427 ' O ' ' HD3' ' A' ' 72' ' ' PRO . . . -66.49 -31.69 72.57 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.221 -0.924 . . . . 0.0 109.409 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 32.9 t -60.92 -28.53 69.0 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.218 -0.926 . . . . 0.0 109.495 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.87 77.72 76.28 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.278 -0.889 . . . . 0.0 109.404 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.427 ' HD3' ' O ' ' A' ' 69' ' ' ALA . 49.9 Cg_endo -70.07 151.03 67.11 Favored 'Trans proline' 0 C--O 1.215 -0.635 0 C-N-CA 122.69 2.26 . . . . 0.0 111.894 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -70.45 156.72 60.93 Favored 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 122.689 2.259 . . . . 0.0 111.788 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 81.4 p -82.71 -8.21 59.6 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.275 -0.891 . . . . 0.0 109.61 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 -69.69 -28.86 66.2 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.189 -0.945 . . . . 0.0 109.472 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 118.038 -0.982 . . . . 0.0 109.438 -179.999 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.408 ' HA ' ' SG ' ' A' ' 40' ' ' CYS . 0.9 OUTLIER -54.12 -32.28 54.65 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.214 -0.929 . . . . 0.0 109.346 179.887 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.447 ' HA ' ' HG3' ' A' ' 6' ' ' LYS . 5.0 mt-10 -53.93 -23.13 11.84 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.2 -0.937 . . . . 0.0 108.92 179.74 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.428 ' O ' ' CG ' ' A' ' 7' ' ' ASP . 67.8 mmm -71.15 -27.98 63.94 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.277 -0.889 . . . . 0.0 108.98 179.554 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 35.1 m -80.91 -17.17 51.47 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.376 -0.827 . . . . 0.0 109.198 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.447 ' HG3' ' HA ' ' A' ' 3' ' ' GLU . 34.3 mttp -80.28 8.18 7.97 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.313 -0.867 . . . . 0.0 109.665 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.428 ' CG ' ' O ' ' A' ' 4' ' ' MET . 17.4 p30 -117.45 -10.93 10.59 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.182 -0.948 . . . . 0.0 109.638 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.58 ' OH ' ' CZ ' ' A' ' 16' ' ' TYR . 1.5 p90 -104.3 171.28 7.42 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.159 -0.963 . . . . 0.0 109.546 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 85.9 mtt180 -131.42 157.06 44.46 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.294 -0.879 . . . . 0.0 109.215 179.661 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.849 HG21 ' C ' ' A' ' 15' ' ' GLY . 14.5 p -136.97 158.35 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.166 -0.959 . . . . 0.0 109.816 -179.562 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.543 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 1.6 mp -108.2 175.36 2.02 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.265 -0.897 . . . . 0.0 109.354 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.543 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 45.7 Cg_endo -67.56 -27.71 38.81 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 122.589 2.193 . . . . 0.0 111.682 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 37.6 mtm180 -84.15 -38.75 20.28 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.381 -0.824 . . . . 0.0 109.055 179.577 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.488 ' CG2' ' HG ' ' A' ' 17' ' ' LEU . 98.7 mt -77.12 -34.79 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.381 -0.824 . . . . 0.0 109.024 179.62 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.849 ' C ' HG21 ' A' ' 10' ' ' VAL . . . 68.2 -65.45 0.37 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 179.733 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.58 ' CZ ' ' OH ' ' A' ' 8' ' ' TYR . 1.2 t80 -160.59 150.82 18.0 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.31 -1.112 . . . . 0.0 109.328 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.827 ' N ' HD12 ' A' ' 17' ' ' LEU . 0.4 OUTLIER -123.07 141.61 51.78 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.25 -0.906 . . . . 0.0 109.472 179.976 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.451 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 75.0 m -146.26 158.01 48.39 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.308 -0.87 . . . . 0.0 109.15 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.538 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 46.6 Cg_endo -69.93 165.3 31.63 Favored 'Trans proline' 0 C--O 1.214 -0.695 0 C-N-CA 122.494 2.129 . . . . 0.0 111.308 179.739 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -91.81 -8.52 46.42 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.204 -0.935 . . . . 0.0 109.508 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 -74.54 129.48 37.82 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.274 -0.891 . . . . 0.0 109.218 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.809 HD21 ' OD1' ' A' ' 34' ' ' ASN . 3.4 tm? -87.92 121.24 30.09 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.207 -0.933 . . . . 0.0 109.37 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.615 ' N ' HD13 ' A' ' 22' ' ' LEU . 14.0 mttt -144.3 109.39 4.95 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.091 -1.006 . . . . 0.0 109.717 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.536 ' HA ' ' O ' ' A' ' 34' ' ' ASN . 44.1 Cg_endo -66.58 122.84 10.33 Favored 'Trans proline' 0 C--O 1.214 -0.706 0 C-N-CA 122.947 2.431 . . . . 0.0 111.899 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.507 ' HB ' HG23 ' A' ' 52' ' ' ILE . 8.7 m -117.46 156.9 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.22 -0.925 . . . . 0.0 109.858 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 45.5 t -97.54 136.62 37.69 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 178.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -94.04 135.19 12.4 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 -179.482 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.489 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 49.0 p30 -64.26 -11.31 30.27 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.303 -1.116 . . . . 0.0 109.349 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.458 ' OD1' ' HB2' ' A' ' 31' ' ' GLN . 58.0 p30 -84.24 9.49 12.79 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.323 -0.861 . . . . 0.0 109.488 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 83.87 23.51 52.43 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.458 ' HB2' ' OD1' ' A' ' 29' ' ' ASP . 67.8 mt-30 -129.17 171.71 12.16 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.312 -1.11 . . . . 0.0 109.409 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.576 HG21 ' HG3' ' A' ' 57' ' ' LYS . 24.0 m -131.12 139.42 49.82 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.284 -0.885 . . . . 0.0 109.26 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.821 ' CD1' HD13 ' A' ' 39' ' ' LEU . 70.9 m-85 -118.68 131.62 56.16 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.277 -0.889 . . . . 0.0 109.416 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.809 ' OD1' HD21 ' A' ' 22' ' ' LEU . 53.5 t-20 -51.65 -79.09 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.374 -0.829 . . . . 0.0 110.174 -179.381 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.527 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 1.9 t-20 -81.39 149.41 65.21 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 120.932 -1.105 . . . . 0.0 109.597 -179.553 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.486 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.4 Cg_endo -63.28 -55.1 0.81 Allowed 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 122.685 2.257 . . . . 0.0 111.884 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.538 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 10.6 t -60.06 -33.22 71.76 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 120.996 -1.065 . . . . 0.0 108.128 178.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.473 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 39.7 mmm -55.63 -20.21 13.08 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.086 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.821 HD13 ' CD1' ' A' ' 33' ' ' TYR . 51.5 tp -68.48 -46.59 69.28 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.563 -0.711 . . . . 0.0 109.098 179.612 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.484 ' HB2' ' OH ' ' A' ' 16' ' ' TYR . 3.2 m -69.04 -21.25 64.12 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 179.15 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 41.0 t60 -67.21 -54.83 17.46 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 178.728 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.436 ' HA ' ' OE1' ' A' ' 42' ' ' GLU . 68.6 mm-40 -62.51 -19.99 64.16 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 178.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.527 ' O ' ' N ' ' A' ' 47' ' ' GLN . 83.1 m-20 -80.27 -24.27 40.2 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.557 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 23.3 tp -73.24 -31.82 64.35 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.43 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.1 mm -80.11 -48.2 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.381 -0.824 . . . . 0.0 108.937 179.421 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.456 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 63.7 mtt-85 -80.66 -33.79 35.31 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.267 -0.896 . . . . 0.0 109.353 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.527 ' N ' ' O ' ' A' ' 43' ' ' ASN . 91.7 mt-30 63.31 38.54 10.2 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.386 -0.822 . . . . 0.0 109.659 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.435 HG23 ' HB3' ' A' ' 46' ' ' ARG . 55.1 p -101.68 3.84 40.13 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.21 -0.931 . . . . 0.0 109.452 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 63.9 m-20 54.64 58.08 5.18 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.227 -0.921 . . . . 0.0 109.427 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 31.6 m -78.46 139.22 38.72 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.239 -0.913 . . . . 0.0 109.589 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 49.3 m-70 -113.63 167.38 10.66 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.303 -0.873 . . . . 0.0 108.893 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.507 HG23 ' HB ' ' A' ' 25' ' ' VAL . 36.9 mt -79.63 125.59 38.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.169 -0.957 . . . . 0.0 109.256 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.489 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 69.9 ttt-85 -81.3 -38.61 26.5 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.415 -0.803 . . . . 0.0 109.346 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -160.45 151.16 18.59 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.47 -0.769 . . . . 0.0 109.084 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.3 p -70.46 143.59 51.71 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.168 -0.958 . . . . 0.0 109.467 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.533 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 88.87 164.37 40.28 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.576 ' HG3' HG21 ' A' ' 32' ' ' THR . 33.8 ttpt -54.53 151.08 8.31 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.474 -1.016 . . . . 0.0 109.442 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 88.8 m -57.07 -179.71 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.247 -0.908 . . . . 0.0 109.446 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -93.73 19.84 8.27 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.179 -0.951 . . . . 0.0 109.711 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 66.9 tt0 -60.86 -35.85 77.64 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.253 -0.904 . . . . 0.0 109.356 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 24.7 p -58.96 144.99 43.24 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.346 -0.846 . . . . 0.0 109.502 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 40.8 m -115.81 153.45 31.44 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.252 -0.905 . . . . 0.0 109.447 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 62.6 p -86.66 130.73 47.85 Favored Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.298 -0.877 . . . . 0.0 109.514 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -70.69 -17.01 33.65 Favored 'Trans proline' 0 C--O 1.214 -0.679 0 C-N-CA 122.755 2.303 . . . . 0.0 111.83 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -55.07 -30.57 54.69 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 24.0 p -120.13 163.65 17.39 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.259 -1.142 . . . . 0.0 109.486 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.654 HG22 ' H ' ' A' ' 69' ' ' ALA . 39.1 m -116.87 139.08 51.04 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.139 -0.976 . . . . 0.0 109.465 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.45 ' O ' ' HB2' ' A' ' 71' ' ' MET . . . -65.0 -28.13 69.3 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.248 -0.907 . . . . 0.0 109.473 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.654 ' H ' HG22 ' A' ' 67' ' ' THR . . . -65.63 -31.84 73.09 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.228 -0.92 . . . . 0.0 109.459 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 87.2 p -65.56 -27.4 68.41 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.311 -0.868 . . . . 0.0 109.452 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.502 ' CB ' ' CD ' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -53.79 -61.41 5.26 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.314 -0.866 . . . . 0.0 109.495 -179.981 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.502 ' CD ' ' CB ' ' A' ' 71' ' ' MET . 50.1 Cg_endo -70.62 151.28 64.08 Favored 'Trans proline' 0 C--O 1.214 -0.71 0 C-N-CA 122.599 2.199 . . . . 0.0 111.75 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -70.74 143.73 46.93 Favored 'Trans proline' 0 C--O 1.215 -0.626 0 C-N-CA 122.668 2.245 . . . . 0.0 111.815 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 32.1 t -115.52 142.33 46.86 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.282 -0.886 . . . . 0.0 109.456 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 54.8 p30 -91.71 10.04 29.99 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.233 -0.917 . . . . 0.0 109.478 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.474 -179.971 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.395 0.617 . . . . 0.0 109.532 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.517 ' OG ' HD22 ' A' ' 39' ' ' LEU . 37.5 m -74.31 -0.67 17.81 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.47 -0.769 . . . . 0.0 109.632 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.44 ' O ' ' HG2' ' A' ' 6' ' ' LYS . 3.4 mt-10 -48.27 -23.81 1.0 Allowed 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.122 -0.987 . . . . 0.0 108.741 179.651 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 84.3 mtp -66.95 -29.14 68.91 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.377 -0.827 . . . . 0.0 108.797 179.507 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.571 ' SG ' ' CE1' ' A' ' 8' ' ' TYR . 10.6 t -84.19 -8.23 59.12 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.464 -0.772 . . . . 0.0 109.069 179.518 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.44 ' HG2' ' O ' ' A' ' 3' ' ' GLU . 3.7 pttp -57.46 -15.7 7.6 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.32 -0.863 . . . . 0.0 109.733 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 51.0 p-10 -159.03 32.66 0.21 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.043 -1.035 . . . . 0.0 109.811 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.571 ' CE1' ' SG ' ' A' ' 5' ' ' CYS . 5.1 p90 -79.71 175.61 10.47 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.119 -0.988 . . . . 0.0 109.194 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 53.7 mtm180 -143.98 136.43 26.85 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.145 -0.972 . . . . 0.0 109.911 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.58 HG13 ' O ' ' A' ' 15' ' ' GLY . 23.4 t -137.41 135.61 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.371 -0.83 . . . . 0.0 109.097 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.662 ' HB2' HD12 ' A' ' 14' ' ' ILE . 1.6 mp -102.83 172.4 4.33 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.231 -0.918 . . . . 0.0 109.701 -179.532 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.487 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 45.7 Cg_endo -67.68 -22.78 43.31 Favored 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 122.637 2.225 . . . . 0.0 111.563 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 82.1 mtt180 -99.8 -24.96 14.53 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.341 -0.849 . . . . 0.0 109.16 179.735 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.662 HD12 ' HB2' ' A' ' 11' ' ' LEU . 79.2 mt -85.34 -47.3 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.312 -0.867 . . . . 0.0 109.428 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.58 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 71.58 -169.54 49.91 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.581 ' CB ' ' NE2' ' A' ' 41' ' ' HIS . 0.8 OUTLIER -92.36 150.2 20.97 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.259 -1.142 . . . . 0.0 109.591 -179.94 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.698 ' C ' HD13 ' A' ' 17' ' ' LEU . 2.3 tm? -119.66 105.35 11.1 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.254 -0.904 . . . . 0.0 109.309 179.781 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.445 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 58.5 m -118.75 155.64 52.39 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.305 -0.872 . . . . 0.0 109.305 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -72.42 171.73 16.43 Favored 'Trans proline' 0 C--O 1.215 -0.667 0 C-N-CA 122.618 2.212 . . . . 0.0 111.324 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 45.0 mttp -91.45 -23.32 20.04 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.213 -0.93 . . . . 0.0 109.355 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -62.34 130.49 45.52 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.339 -0.85 . . . . 0.0 109.179 179.68 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 24.0 tp -90.72 111.83 23.35 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.211 -0.931 . . . . 0.0 109.805 -179.825 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.479 ' O ' ' O ' ' A' ' 34' ' ' ASN . 0.0 OUTLIER -123.28 108.64 31.71 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.324 -0.86 . . . . 0.0 108.87 179.637 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.526 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 43.6 Cg_endo -66.16 119.58 6.62 Favored 'Trans proline' 0 C--O 1.214 -0.713 0 C-N-CA 122.865 2.377 . . . . 0.0 112.052 -179.417 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.591 ' O ' HG23 ' A' ' 32' ' ' THR . 11.2 m -112.57 155.31 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.418 -0.801 . . . . 0.0 109.512 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.411 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 43.4 t -97.07 141.4 30.27 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.81 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -98.47 133.85 11.48 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 -179.365 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.65 ' OD1' HG23 ' A' ' 50' ' ' THR . 37.5 p30 -61.83 -12.49 17.67 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.315 -1.109 . . . . 0.0 109.586 179.754 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -87.01 15.46 5.98 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.21 -0.931 . . . . 0.0 109.414 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 79.37 19.41 71.72 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.471 ' O ' ' SG ' ' A' ' 58' ' ' CYS . 44.5 mt-30 -120.95 179.33 4.4 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.152 -1.205 . . . . 0.0 109.496 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.605 HG21 ' HG3' ' A' ' 57' ' ' LYS . 14.5 m -143.36 137.2 28.57 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.264 -0.897 . . . . 0.0 109.557 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.572 ' CD1' ' HG ' ' A' ' 39' ' ' LEU . 41.2 m-85 -113.03 134.8 54.35 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.364 -0.835 . . . . 0.0 109.46 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.518 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 9.9 m-20 -54.16 -78.06 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.322 -0.861 . . . . 0.0 109.785 -179.652 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.53 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 4.1 t-20 -81.88 147.72 59.1 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.018 -1.051 . . . . 0.0 109.022 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.469 ' HD3' ' O ' ' A' ' 23' ' ' LYS . 41.7 Cg_endo -63.97 -52.55 1.63 Allowed 'Trans proline' 0 C--O 1.215 -0.629 0 C-N-CA 122.522 2.148 . . . . 0.0 111.758 -179.706 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.53 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 11.3 t -62.09 -29.03 70.03 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.078 -1.014 . . . . 0.0 108.324 179.021 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.473 ' HB2' ' HB3' ' A' ' 35' ' ' ASN . 35.3 mmm -69.04 -12.82 62.03 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.566 -0.709 . . . . 0.0 109.278 179.52 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.777 HD13 HG12 ' A' ' 52' ' ' ILE . 9.6 tt -67.97 -52.55 34.62 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.189 -0.945 . . . . 0.0 108.955 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.483 ' SG ' ' CE1' ' A' ' 8' ' ' TYR . 9.3 t -61.46 -34.17 74.99 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 179.19 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.581 ' NE2' ' CB ' ' A' ' 16' ' ' TYR . 0.2 OUTLIER -50.94 -46.69 61.03 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 178.51 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -66.11 -32.08 73.32 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.08 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.52 ' ND2' ' O ' ' A' ' 50' ' ' THR . 34.0 m-20 -68.74 -23.47 64.34 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.51 -0.744 . . . . 0.0 109.396 179.683 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.954 HD13 ' O ' ' A' ' 44' ' ' LEU . 2.4 tm? -72.2 -36.4 69.19 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.285 -0.884 . . . . 0.0 109.66 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.411 ' N ' HD13 ' A' ' 45' ' ' ILE . 4.8 mm -78.04 -46.04 26.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.242 -0.911 . . . . 0.0 109.381 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.491 ' HB3' HG23 ' A' ' 48' ' ' THR . 14.4 mtt-85 -81.73 -33.19 31.19 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.289 -0.882 . . . . 0.0 109.611 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.474 ' N ' ' O ' ' A' ' 43' ' ' ASN . 92.0 mt-30 62.49 33.76 15.83 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.272 -0.892 . . . . 0.0 109.63 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.491 HG23 ' HB3' ' A' ' 46' ' ' ARG . 58.9 p -95.65 7.43 46.31 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.224 -0.922 . . . . 0.0 109.415 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.577 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 57.8 t30 52.63 49.0 21.32 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.276 -0.89 . . . . 0.0 109.649 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.65 HG23 ' OD1' ' A' ' 28' ' ' ASP . 39.4 m -80.78 149.05 29.78 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.37 -0.831 . . . . 0.0 109.359 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.577 ' CE1' ' O ' ' A' ' 49' ' ' ASN . 13.6 m80 -127.21 -176.76 3.82 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.189 -0.945 . . . . 0.0 109.348 179.688 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.777 HG12 HD13 ' A' ' 39' ' ' LEU . 29.4 mt -84.89 128.13 39.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 O-C-N 121.39 -0.819 . . . . 0.0 109.46 179.709 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.505 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 42.3 ttt85 -83.83 -38.55 21.08 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.321 -0.862 . . . . 0.0 109.059 179.765 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -160.75 148.83 16.08 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 27.0 p -67.17 135.97 54.33 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.123 -0.986 . . . . 0.0 109.462 -179.809 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.526 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 95.2 161.87 34.16 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.605 ' HG3' HG21 ' A' ' 32' ' ' THR . 47.5 tttp -50.03 148.23 3.46 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.402 -1.058 . . . . 0.0 109.287 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.471 ' SG ' ' O ' ' A' ' 31' ' ' GLN . 95.6 m -51.43 -30.19 18.54 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.309 -0.869 . . . . 0.0 109.568 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -84.6 -30.4 25.02 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.304 -0.873 . . . . 0.0 109.13 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -60.39 -16.9 39.96 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.286 -0.884 . . . . 0.0 108.801 179.578 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 30.1 m -71.34 142.82 50.4 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.386 -0.822 . . . . 0.0 109.515 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 87.7 p -115.71 153.13 31.92 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.181 -0.949 . . . . 0.0 109.433 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.432 ' HB ' ' HD2' ' A' ' 64' ' ' PRO . 1.6 p -62.16 163.68 13.12 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.246 -0.908 . . . . 0.0 109.458 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.432 ' HD2' ' HB ' ' A' ' 63' ' ' THR . 52.5 Cg_endo -72.28 -20.81 24.05 Favored 'Trans proline' 0 C--O 1.215 -0.664 0 C-N-CA 122.598 2.198 . . . . 0.0 111.659 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.72 19.76 62.96 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 41.6 m -121.25 136.11 55.02 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.339 -1.095 . . . . 0.0 109.416 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 18.9 p -123.17 164.94 17.73 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.312 -0.867 . . . . 0.0 109.559 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -62.96 -33.53 75.57 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.327 -0.858 . . . . 0.0 109.522 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -144.48 155.11 43.56 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.339 -0.85 . . . . 0.0 109.44 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 25.1 m -60.08 -29.56 68.66 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.225 -0.922 . . . . 0.0 109.387 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 23.4 mtt -74.86 145.4 81.32 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.276 -0.89 . . . . 0.0 109.46 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -70.46 148.06 59.74 Favored 'Trans proline' 0 C--O 1.215 -0.644 0 C-N-CA 122.664 2.243 . . . . 0.0 111.834 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -71.94 -15.96 29.31 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 122.677 2.251 . . . . 0.0 111.742 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.447 ' O ' ' HG3' ' A' ' 76' ' ' GLU . 86.1 p -145.83 154.16 41.69 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.221 -0.924 . . . . 0.0 109.551 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -55.23 -36.29 65.86 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.215 -0.928 . . . . 0.0 109.471 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.447 ' HG3' ' O ' ' A' ' 74' ' ' SER . 96.7 mt-10 . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.509 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.568 ' OG ' ' CE1' ' A' ' 51' ' ' HIS . 2.1 m -55.46 -31.68 62.15 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.306 -0.871 . . . . 0.0 109.515 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -53.29 -25.61 15.38 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.327 -0.858 . . . . 0.0 109.023 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 82.8 mtp -73.84 -26.78 60.76 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.385 -0.822 . . . . 0.0 109.245 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.539 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 70.2 m -79.92 -20.77 44.93 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.324 -0.86 . . . . 0.0 109.217 179.753 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 33.4 mttt -80.63 7.46 10.06 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.194 -0.941 . . . . 0.0 109.391 179.577 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -123.18 -3.63 8.49 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.199 -0.938 . . . . 0.0 110.217 -179.417 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.687 ' CE2' ' CZ ' ' A' ' 16' ' ' TYR . 2.1 p90 -114.57 173.0 6.68 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.959 -1.088 . . . . 0.0 109.848 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 39.5 ptt180 -157.34 134.47 10.3 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.519 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.8 HG13 ' O ' ' A' ' 15' ' ' GLY . 79.9 t -116.79 145.41 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.226 -0.921 . . . . 0.0 110.215 -179.071 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.756 ' HB2' HD12 ' A' ' 14' ' ' ILE . 2.1 mp -117.67 175.81 1.87 Allowed Pre-proline 0 N--CA 1.49 1.527 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.549 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 44.7 Cg_endo -67.56 -22.52 44.39 Favored 'Trans proline' 0 C--O 1.216 -0.621 0 C-N-CA 122.451 2.101 . . . . 0.0 111.81 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 63.1 mtt180 -113.63 -22.44 10.27 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.294 -0.879 . . . . 0.0 109.64 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.756 HD12 ' HB2' ' A' ' 11' ' ' LEU . 92.4 mt -78.23 -44.35 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.216 -0.927 . . . . 0.0 109.504 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.8 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 74.94 -165.33 54.74 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.687 ' CZ ' ' CE2' ' A' ' 8' ' ' TYR . 0.9 OUTLIER -93.76 149.55 21.14 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.16 -1.2 . . . . 0.0 109.557 179.999 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 16.8 tp -119.61 115.54 24.18 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.288 -0.883 . . . . 0.0 109.688 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 75.6 m -126.07 156.8 71.38 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.292 -0.88 . . . . 0.0 109.177 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.48 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 50.5 Cg_endo -71.35 167.33 26.6 Favored 'Trans proline' 0 C--O 1.216 -0.59 0 C-N-CA 122.64 2.227 . . . . 0.0 111.685 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.4 mttt -86.59 -23.43 25.77 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.271 -0.893 . . . . 0.0 109.328 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -63.21 130.48 44.74 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.29 -0.881 . . . . 0.0 109.241 179.731 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 48.7 tp -93.83 117.47 30.14 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.184 -0.947 . . . . 0.0 109.541 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.487 ' O ' ' O ' ' A' ' 34' ' ' ASN . 0.1 OUTLIER -129.1 106.52 17.93 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.324 -0.86 . . . . 0.0 108.941 179.719 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.538 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 43.2 Cg_endo -65.1 119.91 7.04 Favored 'Trans proline' 0 C--O 1.213 -0.765 0 C-N-CA 122.93 2.42 . . . . 0.0 112.086 -179.564 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.609 ' O ' HG23 ' A' ' 32' ' ' THR . 35.6 m -116.5 153.74 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.336 -0.852 . . . . 0.0 109.688 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 43.0 t -96.05 135.52 37.72 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.354 -0.841 . . . . 0.0 108.787 179.214 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -92.44 139.12 14.51 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -179.585 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.504 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 50.9 p30 -68.5 -7.86 36.01 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.366 -1.079 . . . . 0.0 109.579 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.427 ' OD1' ' HB2' ' A' ' 31' ' ' GLN . 56.6 p30 -88.52 9.21 24.62 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.163 -0.961 . . . . 0.0 109.35 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.23 13.99 64.97 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.464 ' O ' ' N ' ' A' ' 27' ' ' GLY . 83.2 mt-30 -120.26 171.97 8.12 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.278 -1.131 . . . . 0.0 109.447 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.661 HG21 ' HA ' ' A' ' 57' ' ' LYS . 25.9 m -133.95 138.31 45.39 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.248 -0.908 . . . . 0.0 109.353 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.811 ' CD1' HD13 ' A' ' 39' ' ' LEU . 28.7 m-85 -113.0 128.5 56.52 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.28 -0.888 . . . . 0.0 109.205 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.519 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 13.1 m-20 -51.66 -78.17 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.239 -0.913 . . . . 0.0 109.692 -179.543 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.533 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 5.1 t-20 -81.85 147.9 59.69 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.171 -0.956 . . . . 0.0 109.688 -179.692 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.469 ' HD2' ' CG ' ' A' ' 35' ' ' ASN . 40.5 Cg_endo -63.22 -52.98 1.7 Allowed 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.766 2.311 . . . . 0.0 111.909 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.533 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 9.2 t -62.54 -28.36 69.8 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 120.97 -1.081 . . . . 0.0 108.11 178.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.465 ' CG ' ' HB3' ' A' ' 35' ' ' ASN . 49.7 mmm -64.75 -14.2 57.92 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.377 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.811 HD13 ' CD1' ' A' ' 33' ' ' TYR . 23.7 tp -71.68 -65.33 0.77 Allowed 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 179.284 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.452 ' HB3' ' OH ' ' A' ' 16' ' ' TYR . 8.5 t -49.25 -28.33 4.56 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.805 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 66.5 t60 -63.02 -62.54 1.64 Allowed 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.309 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 77.2 tt0 -59.13 -19.08 41.58 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.477 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.471 ' O ' ' N ' ' A' ' 47' ' ' GLN . 98.1 m-20 -78.16 -29.65 48.74 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.391 -0.818 . . . . 0.0 108.815 179.425 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 17.6 tp -72.37 -27.75 62.58 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.313 -0.867 . . . . 0.0 108.847 179.447 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.3 mt -79.87 -49.64 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.321 -0.862 . . . . 0.0 108.9 179.455 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.549 ' HB3' HG23 ' A' ' 48' ' ' THR . 52.8 mtt180 -80.73 -32.82 35.58 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.338 -0.851 . . . . 0.0 109.307 179.749 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.471 ' N ' ' O ' ' A' ' 43' ' ' ASN . 92.1 mt-30 62.62 36.68 13.49 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.373 -0.829 . . . . 0.0 109.627 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.549 HG23 ' HB3' ' A' ' 46' ' ' ARG . 59.5 p -96.21 2.45 53.02 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.217 -0.927 . . . . 0.0 109.585 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.4 m120 58.0 54.76 5.75 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.251 -0.905 . . . . 0.0 109.449 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.404 ' HB ' ' OD1' ' A' ' 43' ' ' ASN . 43.3 m -79.94 144.06 33.66 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.292 -0.88 . . . . 0.0 109.68 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.568 ' CE1' ' OG ' ' A' ' 2' ' ' SER . 30.5 m-70 -118.62 173.5 6.81 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.329 -0.857 . . . . 0.0 109.023 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.462 HG12 HD22 ' A' ' 39' ' ' LEU . 12.0 mt -84.38 123.99 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.16 -0.962 . . . . 0.0 109.472 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.504 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 45.2 ttt85 -79.75 -43.0 23.39 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.297 -0.877 . . . . 0.0 109.248 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.8 t -160.02 155.09 24.77 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.9 p -72.56 132.83 44.31 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.198 -0.939 . . . . 0.0 109.483 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.538 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 99.07 164.49 29.93 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -179.779 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.661 ' HA ' HG21 ' A' ' 32' ' ' THR . 71.1 tttt -53.13 148.4 8.27 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.429 -1.042 . . . . 0.0 109.397 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 91.2 m -54.81 -25.93 31.6 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.263 -0.898 . . . . 0.0 109.376 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.403 ' HB3' ' HD3' ' A' ' 57' ' ' LYS . 76.6 tt0 -86.06 -21.55 27.65 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.36 -0.838 . . . . 0.0 109.346 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.443 ' OE1' ' HA3' ' A' ' 56' ' ' GLY . 71.7 tt0 -63.53 -34.35 77.59 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.299 -0.876 . . . . 0.0 109.372 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 32.6 t -71.34 135.96 47.59 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.382 -0.823 . . . . 0.0 109.449 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 23.3 t -117.67 153.18 33.76 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.194 -0.942 . . . . 0.0 109.559 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 37.4 m -134.55 78.71 55.71 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.322 -0.861 . . . . 0.0 109.457 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -69.59 -23.01 32.04 Favored 'Trans proline' 0 C--O 1.216 -0.617 0 C-N-CA 122.74 2.293 . . . . 0.0 111.714 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 59.31 -131.28 51.43 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 12.3 t -136.32 161.4 35.89 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.224 -1.162 . . . . 0.0 109.482 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.711 ' O ' ' HB2' ' A' ' 68' ' ' ALA . 53.0 m -59.45 -40.38 86.66 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.27 -0.894 . . . . 0.0 109.46 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.711 ' HB2' ' O ' ' A' ' 67' ' ' THR . . . 163.3 53.88 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.389 -0.819 . . . . 0.0 109.478 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.406 ' O ' ' HD3' ' A' ' 72' ' ' PRO . . . -62.54 -35.59 79.94 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.268 -0.895 . . . . 0.0 109.525 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.8 m -60.31 -31.07 69.92 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.182 -0.949 . . . . 0.0 109.475 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -128.3 78.9 74.93 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.281 -0.887 . . . . 0.0 109.43 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.406 ' HD3' ' O ' ' A' ' 69' ' ' ALA . 50.6 Cg_endo -70.32 152.96 66.72 Favored 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 122.697 2.264 . . . . 0.0 111.765 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -69.93 157.42 60.13 Favored 'Trans proline' 0 C--O 1.214 -0.69 0 C-N-CA 122.71 2.273 . . . . 0.0 111.66 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 87.5 p -82.83 -9.64 59.23 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.303 -0.873 . . . . 0.0 109.55 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 84.4 m-20 -73.3 -26.93 61.27 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.191 -0.943 . . . . 0.0 109.536 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 118.002 -0.999 . . . . 0.0 109.437 -179.997 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.2 m -46.47 -32.36 3.27 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.332 -0.855 . . . . 0.0 109.333 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.455 ' HA ' ' HG3' ' A' ' 6' ' ' LYS . 18.6 mt-10 -52.45 -28.59 20.72 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.742 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 44.4 ttm -71.74 -26.21 62.37 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.441 -0.787 . . . . 0.0 108.951 179.53 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.593 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 15.6 m -79.56 -12.7 59.84 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.498 -0.751 . . . . 0.0 108.974 179.523 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.455 ' HG3' ' HA ' ' A' ' 3' ' ' GLU . 4.1 mtmp? -56.58 -24.54 48.1 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.255 -0.903 . . . . 0.0 109.714 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 64.8 m-20 -149.71 64.49 0.99 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.136 -0.978 . . . . 0.0 110.334 -179.613 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.983 ' OH ' HD21 ' A' ' 44' ' ' LEU . 5.0 p90 -131.44 170.25 14.94 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.045 -1.034 . . . . 0.0 109.359 179.259 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 12.5 tpt180 -145.32 150.13 36.06 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.21 -0.932 . . . . 0.0 109.593 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.554 HG13 ' C ' ' A' ' 15' ' ' GLY . 71.0 t -141.63 130.98 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.239 -0.913 . . . . 0.0 109.315 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.66 ' HB2' HD12 ' A' ' 14' ' ' ILE . 2.5 mp -118.56 172.86 3.8 Favored Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 121.321 -0.862 . . . . 0.0 109.317 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.491 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 46.5 Cg_endo -68.38 -24.96 36.34 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 122.575 2.184 . . . . 0.0 111.614 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 54.5 mtt180 -104.68 -26.04 12.46 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.262 -0.899 . . . . 0.0 109.254 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.66 HD12 ' HB2' ' A' ' 11' ' ' LEU . 87.9 mt -84.54 -46.88 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.267 -0.896 . . . . 0.0 109.41 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.554 ' C ' HG13 ' A' ' 10' ' ' VAL . . . 77.73 -155.51 43.14 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.597 ' CE2' ' CE2' ' A' ' 8' ' ' TYR . 2.5 t80 -105.4 152.56 22.82 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.307 -1.114 . . . . 0.0 109.503 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 34.6 tp -113.74 119.21 36.6 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.231 -0.918 . . . . 0.0 109.725 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 75.9 m -130.15 157.22 77.76 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.316 -0.865 . . . . 0.0 109.603 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.519 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 52.5 Cg_endo -72.55 168.93 23.06 Favored 'Trans proline' 0 C--O 1.215 -0.629 0 C-N-CA 122.762 2.308 . . . . 0.0 111.591 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 41.3 mmtt -89.61 -13.09 37.9 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.203 -0.936 . . . . 0.0 109.334 179.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -67.98 131.8 46.14 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.296 -0.878 . . . . 0.0 109.38 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.745 ' C ' HD13 ' A' ' 22' ' ' LEU . 3.3 tm? -90.63 123.65 34.42 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.263 -0.898 . . . . 0.0 109.332 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.691 ' N ' HD13 ' A' ' 22' ' ' LEU . 15.4 mttp -145.6 105.8 4.31 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.156 -0.965 . . . . 0.0 109.657 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.539 ' HA ' ' O ' ' A' ' 34' ' ' ASN . 44.1 Cg_endo -65.85 120.84 8.08 Favored 'Trans proline' 0 C--O 1.214 -0.705 0 C-N-CA 123.116 2.544 . . . . 0.0 112.324 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.463 ' O ' HG23 ' A' ' 32' ' ' THR . 19.7 m -116.18 154.57 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.382 -0.824 . . . . 0.0 109.35 179.562 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.418 ' O ' ' N ' ' A' ' 53' ' ' ARG . 41.6 t -96.07 138.26 33.95 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 178.673 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -95.6 139.21 14.37 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.726 -1.349 . . . . 0.0 109.726 -179.285 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.483 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 48.5 p30 -65.38 -11.15 39.52 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.38 -1.07 . . . . 0.0 109.454 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.447 ' OD1' ' HB2' ' A' ' 31' ' ' GLN . 59.0 p30 -83.09 7.33 16.19 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.226 -0.921 . . . . 0.0 109.398 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.22 22.59 51.41 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.456 ' O ' ' SG ' ' A' ' 58' ' ' CYS . 75.5 mt-30 -129.3 175.37 8.79 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.291 -1.123 . . . . 0.0 109.375 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.647 HG21 ' HA ' ' A' ' 57' ' ' LYS . 13.0 m -131.83 140.21 49.07 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.258 -0.901 . . . . 0.0 109.816 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.869 ' CD2' HD12 ' A' ' 39' ' ' LEU . 44.7 m-85 -115.86 127.15 54.81 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.431 -0.793 . . . . 0.0 109.139 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.745 ' OD1' HD21 ' A' ' 22' ' ' LEU . 41.1 t-20 -49.01 -78.98 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.299 -0.876 . . . . 0.0 110.032 -179.425 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.542 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 4.6 t-20 -81.14 147.28 60.62 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 120.863 -1.148 . . . . 0.0 109.263 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.514 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.8 Cg_endo -63.44 -52.89 1.66 Allowed 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 122.701 2.267 . . . . 0.0 111.849 -179.712 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.542 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 5.8 t -61.78 -28.23 69.31 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 178.809 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.429 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 35.7 mmm -65.51 -12.45 52.88 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.292 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.869 HD12 ' CD2' ' A' ' 33' ' ' TYR . 8.4 tt -72.99 -57.63 3.9 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.284 -0.885 . . . . 0.0 108.849 179.602 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.519 ' O ' ' HB2' ' A' ' 43' ' ' ASN . 2.2 t -46.59 -45.18 18.74 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 179.064 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.491 ' ND1' ' HB2' ' A' ' 16' ' ' TYR . 13.9 t60 -48.46 -50.37 31.66 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.062 -1.024 . . . . 0.0 108.309 178.812 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.578 ' HG3' ' CE1' ' A' ' 33' ' ' TYR . 34.2 mm-40 -56.41 -19.21 13.87 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.567 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.519 ' HB2' ' O ' ' A' ' 40' ' ' CYS . 2.3 m-80 -78.59 -35.33 45.9 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 119.471 -0.892 . . . . 0.0 108.617 179.209 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.983 HD21 ' OH ' ' A' ' 8' ' ' TYR . 40.3 mt -72.07 -30.79 65.48 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.332 -0.855 . . . . 0.0 109.302 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.485 HG13 ' O ' ' A' ' 41' ' ' HIS . 2.5 mt -79.74 -51.12 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.279 -0.888 . . . . 0.0 109.378 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.447 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 93.3 mtt-85 -80.3 -32.92 38.0 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.337 -0.852 . . . . 0.0 109.267 179.739 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.49 ' N ' ' O ' ' A' ' 43' ' ' ASN . 91.9 mt-30 62.19 40.22 11.91 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.403 -0.811 . . . . 0.0 109.537 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 35.6 p -113.63 5.62 16.59 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.32 -0.863 . . . . 0.0 109.541 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.566 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 11.8 t-20 62.39 50.91 3.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.236 -0.915 . . . . 0.0 109.45 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.789 HG21 ' OH ' ' A' ' 33' ' ' TYR . 99.6 m -78.87 134.7 36.91 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.298 -0.876 . . . . 0.0 109.729 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.566 ' CE1' ' O ' ' A' ' 49' ' ' ASN . 8.0 m80 -115.98 -170.13 1.73 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.218 -0.926 . . . . 0.0 109.167 179.558 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.749 HG12 HD13 ' A' ' 39' ' ' LEU . 20.4 mt -92.91 122.97 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.306 -0.872 . . . . 0.0 109.445 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.483 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 46.9 ttt-85 -81.1 -41.62 22.23 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.304 -0.872 . . . . 0.0 109.542 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.424 ' OG ' ' HB3' ' A' ' 61' ' ' SER . 2.0 p -160.45 145.01 14.33 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.543 -0.723 . . . . 0.0 109.505 -179.434 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 20.2 p -63.62 139.51 58.78 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.244 -0.91 . . . . 0.0 109.401 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.537 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 90.76 163.13 38.74 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.647 ' HA ' HG21 ' A' ' 32' ' ' THR . 48.1 tttp -49.46 148.65 2.64 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.498 -1.001 . . . . 0.0 109.48 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.456 ' SG ' ' O ' ' A' ' 31' ' ' GLN . 57.8 m -51.51 -32.68 28.54 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.257 -0.902 . . . . 0.0 109.426 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -83.09 -34.37 26.17 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.348 -0.845 . . . . 0.0 108.782 179.625 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -58.72 -23.69 60.16 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.558 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.424 ' HB3' ' OG ' ' A' ' 54' ' ' SER . 60.0 p -72.08 142.54 49.21 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.304 -0.872 . . . . 0.0 109.567 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 43.8 m -112.95 144.14 43.04 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.258 -0.901 . . . . 0.0 109.38 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.26 74.2 21.69 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.218 -0.926 . . . . 0.0 109.573 -179.854 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.403 ' HA ' ' HG3' ' A' ' 71' ' ' MET . 50.6 Cg_endo -70.98 -20.02 29.58 Favored 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 122.665 2.243 . . . . 0.0 111.74 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.14 -166.96 41.05 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 58.9 p -73.13 -27.3 61.6 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.14 -1.212 . . . . 0.0 109.437 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.63 HG22 ' H ' ' A' ' 69' ' ' ALA . 55.0 m -126.71 137.64 53.28 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.263 -0.898 . . . . 0.0 109.481 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -62.48 -30.81 71.53 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.323 -0.861 . . . . 0.0 109.532 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.63 ' H ' HG22 ' A' ' 67' ' ' THR . . . -64.1 -28.67 69.93 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.226 -0.921 . . . . 0.0 109.454 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 28.9 m -57.73 -27.85 63.35 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.261 -0.899 . . . . 0.0 109.407 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.403 ' HG3' ' HA ' ' A' ' 64' ' ' PRO . 0.0 OUTLIER -74.54 134.4 76.15 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.239 -0.913 . . . . 0.0 109.524 -179.947 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -70.31 143.4 48.08 Favored 'Trans proline' 0 C--O 1.216 -0.602 0 C-N-CA 122.707 2.271 . . . . 0.0 111.822 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -70.27 143.11 47.41 Favored 'Trans proline' 0 C--O 1.215 -0.629 0 C-N-CA 122.768 2.312 . . . . 0.0 111.838 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 24.0 t -114.51 142.33 46.54 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.331 -0.855 . . . . 0.0 109.397 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 53.2 p30 -90.38 11.0 22.84 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.237 -0.914 . . . . 0.0 109.518 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.428 ' OXT' ' HG2' ' A' ' 76' ' ' GLU . 84.5 tt0 . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 118.065 -0.969 . . . . 0.0 109.449 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.43 ' O ' ' C ' ' A' ' 2' ' ' SER . 14.2 p-10 . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.489 ' O ' ' N ' ' A' ' 5' ' ' CYS . 1.7 m -43.18 -29.22 0.36 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.373 -0.829 . . . . 0.0 109.283 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.46 ' HA ' ' HG3' ' A' ' 6' ' ' LYS . 19.4 mt-10 -46.96 -29.85 2.26 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.434 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 92.8 mmm -80.47 -34.47 35.88 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.101 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.489 ' N ' ' O ' ' A' ' 2' ' ' SER . 3.8 m -80.03 4.58 16.61 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.457 -0.777 . . . . 0.0 109.109 179.258 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.46 ' HG3' ' HA ' ' A' ' 3' ' ' GLU . 14.2 mttm -57.65 -30.13 65.15 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.082 -1.011 . . . . 0.0 109.514 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -143.29 69.94 1.31 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.281 -0.887 . . . . 0.0 109.938 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.552 ' CD1' ' N ' ' A' ' 9' ' ' ARG . 18.4 p90 -115.04 -172.88 2.21 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.125 -0.985 . . . . 0.0 109.311 179.605 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.552 ' N ' ' CD1' ' A' ' 8' ' ' TYR . 86.0 mtt180 -149.64 145.57 26.82 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.189 -0.944 . . . . 0.0 109.466 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.581 HG13 ' O ' ' A' ' 15' ' ' GLY . 34.0 t -148.11 142.66 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.284 -0.885 . . . . 0.0 109.17 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.472 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 1.4 mp -116.13 171.93 4.24 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.204 -0.935 . . . . 0.0 109.844 -179.536 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.472 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 48.2 Cg_endo -68.45 -23.77 37.27 Favored 'Trans proline' 0 C--O 1.215 -0.659 0 C-N-CA 122.628 2.219 . . . . 0.0 111.73 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 53.0 mtt180 -100.27 -23.86 14.69 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.288 -0.882 . . . . 0.0 109.17 179.729 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.426 HD12 ' HB2' ' A' ' 11' ' ' LEU . 97.6 mt -88.84 -40.91 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.306 -0.871 . . . . 0.0 109.774 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.581 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 70.53 -174.92 37.95 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.512 ' HB2' ' CE1' ' A' ' 41' ' ' HIS . 1.3 t80 -81.61 154.78 25.98 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.17 -1.194 . . . . 0.0 109.417 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 34.0 tp -112.65 117.92 33.62 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.215 -0.928 . . . . 0.0 109.749 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.419 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 76.9 m -134.86 156.54 78.42 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.267 -0.896 . . . . 0.0 109.423 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.497 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 51.5 Cg_endo -71.4 168.79 22.5 Favored 'Trans proline' 0 C--O 1.215 -0.674 0 C-N-CA 122.692 2.261 . . . . 0.0 111.83 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -93.11 -3.89 53.29 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.263 -0.898 . . . . 0.0 109.52 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -79.08 130.16 35.22 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.212 -0.93 . . . . 0.0 109.307 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.739 ' C ' HD13 ' A' ' 22' ' ' LEU . 3.1 tm? -85.77 124.12 31.91 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.246 -0.909 . . . . 0.0 109.447 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.733 ' N ' HD13 ' A' ' 22' ' ' LEU . 29.4 mttp -144.05 103.1 4.8 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.194 -0.941 . . . . 0.0 109.468 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.537 ' HA ' ' O ' ' A' ' 34' ' ' ASN . 44.0 Cg_endo -65.35 121.92 9.48 Favored 'Trans proline' 0 C--O 1.214 -0.719 0 C-N-CA 123.133 2.555 . . . . 0.0 112.064 -179.689 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.476 ' HB ' HG23 ' A' ' 52' ' ' ILE . 13.9 m -120.26 154.86 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.272 -0.892 . . . . 0.0 110.05 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.423 ' O ' ' N ' ' A' ' 53' ' ' ARG . 13.3 t -99.95 131.52 45.87 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.034 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -89.23 138.83 14.9 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 -179.688 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.494 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 38.1 p30 -65.86 -10.05 34.63 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.357 -1.084 . . . . 0.0 109.66 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 -85.64 10.55 13.02 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.241 -0.912 . . . . 0.0 109.44 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 81.9 27.65 45.06 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -131.04 161.31 32.29 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.289 -1.124 . . . . 0.0 109.384 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.451 HG21 ' CB ' ' A' ' 57' ' ' LYS . 98.8 m -122.35 135.04 54.64 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.134 -0.979 . . . . 0.0 109.36 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.65 ' CD1' HD13 ' A' ' 39' ' ' LEU . 47.8 m-85 -116.45 125.2 51.65 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.312 -0.867 . . . . 0.0 109.293 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.739 ' CG ' HD21 ' A' ' 22' ' ' LEU . 40.2 t-20 -48.56 -79.76 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.393 -0.817 . . . . 0.0 109.97 -179.386 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.533 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 5.4 t-20 -80.9 146.96 60.7 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 120.851 -1.156 . . . . 0.0 109.415 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.539 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.1 Cg_endo -62.7 -53.13 1.87 Allowed 'Trans proline' 0 C--O 1.216 -0.594 0 C-N-CA 122.902 2.401 . . . . 0.0 111.875 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.533 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 8.9 t -62.75 -27.9 69.6 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.005 -1.059 . . . . 0.0 108.212 178.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.451 ' HB2' ' HB3' ' A' ' 35' ' ' ASN . 28.1 mmm -64.54 -11.86 38.7 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.124 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.65 HD13 ' CD1' ' A' ' 33' ' ' TYR . 20.4 tp -69.88 -54.07 15.15 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.324 -0.86 . . . . 0.0 109.079 179.656 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.46 ' HB2' ' OH ' ' A' ' 16' ' ' TYR . 3.5 m -63.28 -14.26 47.53 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 119.021 -1.072 . . . . 0.0 108.253 179.087 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.512 ' CE1' ' HB2' ' A' ' 16' ' ' TYR . 19.5 t60 -67.26 -55.15 15.16 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 178.711 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 49.8 tt0 -67.19 -20.37 65.7 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.017 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.477 ' O ' ' N ' ' A' ' 47' ' ' GLN . 91.7 m-20 -76.26 -31.5 58.33 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.524 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.55 HD13 ' OH ' ' A' ' 8' ' ' TYR . 22.3 tp -67.48 -30.56 70.29 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.287 -0.883 . . . . 0.0 108.653 179.363 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -77.73 -44.74 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.451 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.452 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 60.0 mtt-85 -80.21 -19.33 47.26 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.393 -0.817 . . . . 0.0 109.175 179.669 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.477 ' N ' ' O ' ' A' ' 43' ' ' ASN . 91.1 mt-30 63.51 37.9 10.18 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.466 -0.771 . . . . 0.0 109.653 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 13.0 p -116.07 173.05 6.78 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.268 -0.895 . . . . 0.0 109.322 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -107.99 60.89 0.61 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.211 -0.931 . . . . 0.0 109.475 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.421 HG23 ' OD1' ' A' ' 28' ' ' ASP . 44.9 m -74.81 136.12 41.63 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.269 -0.895 . . . . 0.0 109.546 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 61.3 m-70 -115.01 173.27 6.57 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.247 -0.908 . . . . 0.0 109.229 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.476 HG23 ' HB ' ' A' ' 25' ' ' VAL . 20.0 mt -79.63 124.24 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.211 -0.93 . . . . 0.0 109.28 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.494 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 44.1 ttt180 -80.52 -47.48 14.19 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.352 -0.842 . . . . 0.0 109.367 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -154.07 149.22 26.92 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.488 -0.757 . . . . 0.0 109.115 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 27.5 p -66.45 143.48 57.08 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.209 -0.932 . . . . 0.0 109.567 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.536 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 90.44 167.35 41.76 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -179.825 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.501 ' HB2' ' HB2' ' A' ' 60' ' ' GLU . 43.4 mttt -76.19 120.98 22.21 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.303 -1.116 . . . . 0.0 109.477 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.408 ' C ' ' O ' ' A' ' 57' ' ' LYS . 0.5 OUTLIER -45.02 -35.26 2.85 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.266 -0.896 . . . . 0.0 109.621 179.736 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -82.23 -21.36 36.39 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.331 -0.856 . . . . 0.0 109.465 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.501 ' HB2' ' HB2' ' A' ' 57' ' ' LYS . 28.6 tt0 -55.54 -19.37 9.72 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.509 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 93.9 p -68.61 -33.22 73.67 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.286 -0.884 . . . . 0.0 109.735 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 7.5 t -108.49 149.41 28.85 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.281 -0.887 . . . . 0.0 109.627 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.738 HG21 ' HA ' ' A' ' 68' ' ' ALA . 69.4 p -65.85 147.6 98.68 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.213 -0.929 . . . . 0.0 109.404 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -71.16 -14.85 31.92 Favored 'Trans proline' 0 C--O 1.215 -0.636 0 C-N-CA 122.702 2.268 . . . . 0.0 111.827 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.494 ' HA3' ' CB ' ' A' ' 70' ' ' SER . . . -88.5 -176.6 47.16 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 69.1 p -74.6 -25.13 59.05 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.245 -1.15 . . . . 0.0 109.425 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 13.6 p -128.17 164.93 21.44 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.222 -0.924 . . . . 0.0 109.425 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.738 ' HA ' HG21 ' A' ' 63' ' ' THR . . . -67.56 -26.97 66.56 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.188 -0.945 . . . . 0.0 109.499 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.25 -24.18 67.57 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.201 -0.937 . . . . 0.0 109.479 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.494 ' CB ' ' HA3' ' A' ' 65' ' ' GLY . 36.7 m -58.0 -28.39 64.37 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.223 -0.923 . . . . 0.0 109.525 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.22 146.48 96.85 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.326 -0.859 . . . . 0.0 109.55 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -70.47 144.55 50.55 Favored 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 122.66 2.24 . . . . 0.0 111.724 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -70.62 0.32 6.47 Favored 'Trans proline' 0 C--O 1.214 -0.68 0 C-N-CA 122.748 2.299 . . . . 0.0 111.866 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 41.8 m -140.54 138.7 34.72 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.219 -0.926 . . . . 0.0 109.558 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -51.72 -35.43 43.06 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.326 -0.859 . . . . 0.0 109.52 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 117.972 -1.013 . . . . 0.0 109.568 -179.991 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.591 ' HB2' ' CE1' ' A' ' 51' ' ' HIS . 3.6 m -48.36 -28.8 3.41 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.174 -0.953 . . . . 0.0 109.48 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.472 ' HA ' ' HG3' ' A' ' 6' ' ' LYS . 16.5 mt-10 -48.97 -27.41 3.13 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.714 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 82.6 mmm -76.48 -29.96 57.07 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.665 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.498 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 3.9 m -79.88 -7.97 59.03 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.38 -0.825 . . . . 0.0 109.321 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.472 ' HG3' ' HA ' ' A' ' 3' ' ' GLU . 26.3 mttm -58.79 -23.21 59.91 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.213 -0.929 . . . . 0.0 110.039 -179.767 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 61.9 t0 -150.1 64.46 0.97 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.079 -1.013 . . . . 0.0 110.37 -179.525 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.638 ' OH ' HD23 ' A' ' 44' ' ' LEU . 4.7 p90 -131.65 168.07 18.36 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.11 -0.994 . . . . 0.0 109.123 179.11 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 48.2 mtt180 -144.8 140.87 28.74 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.182 -0.949 . . . . 0.0 109.719 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.712 HG21 ' CD2' ' A' ' 16' ' ' TYR . 55.0 t -135.31 127.9 47.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.264 -0.898 . . . . 0.0 109.471 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.478 ' HB3' ' HD2' ' A' ' 12' ' ' PRO . 7.2 mp -114.81 168.17 8.53 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.275 -0.89 . . . . 0.0 109.312 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.478 ' HD2' ' HB3' ' A' ' 11' ' ' LEU . 43.0 Cg_endo -66.43 -24.63 49.36 Favored 'Trans proline' 0 C--O 1.216 -0.609 0 C-N-CA 122.479 2.119 . . . . 0.0 111.409 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 79.2 mtt-85 -98.71 -27.55 13.92 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.344 -0.848 . . . . 0.0 108.857 179.363 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 25.4 mm -87.67 -44.68 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.416 -0.803 . . . . 0.0 109.337 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.572 ' C ' HG13 ' A' ' 10' ' ' VAL . . . 73.0 -165.43 54.82 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.712 ' CD2' HG21 ' A' ' 10' ' ' VAL . 1.9 t80 -100.03 149.76 23.15 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.238 -1.154 . . . . 0.0 109.44 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.612 ' N ' HD22 ' A' ' 17' ' ' LEU . 3.0 mm? -111.01 135.51 51.4 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.288 -0.883 . . . . 0.0 109.453 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.437 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 85.6 m -147.12 157.71 45.72 Favored Pre-proline 0 N--CA 1.492 1.662 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.444 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 47.4 Cg_endo -70.82 165.59 31.69 Favored 'Trans proline' 0 C--O 1.215 -0.653 0 C-N-CA 122.448 2.099 . . . . 0.0 111.596 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.3 tptp -84.58 -29.45 25.81 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.3 -0.875 . . . . 0.0 109.539 -179.783 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -58.49 126.11 26.18 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.28 -0.888 . . . . 0.0 109.381 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 60.4 tp -90.0 116.99 28.46 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.2 -0.937 . . . . 0.0 109.494 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.529 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 3.5 mttp -128.36 106.45 19.4 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.153 -0.967 . . . . 0.0 109.203 179.754 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.544 ' HA ' ' O ' ' A' ' 34' ' ' ASN . 42.6 Cg_endo -64.79 122.62 10.51 Favored 'Trans proline' 0 C--O 1.214 -0.692 0 C-N-CA 123.036 2.49 . . . . 0.0 112.166 -179.404 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.53 ' HB ' HG23 ' A' ' 52' ' ' ILE . 17.3 m -118.19 154.26 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.318 -0.864 . . . . 0.0 109.934 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.442 ' SG ' ' HB3' ' A' ' 53' ' ' ARG . 41.4 t -97.78 138.06 35.71 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.71 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -92.35 140.37 15.1 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.911 -1.276 . . . . 0.0 109.911 -179.28 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.503 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 53.6 p30 -69.48 -11.37 60.77 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.305 -1.114 . . . . 0.0 109.436 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.451 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 57.0 p30 -89.57 10.43 23.01 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.303 -0.873 . . . . 0.0 109.593 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.59 18.95 57.7 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.47 ' O ' ' N ' ' A' ' 27' ' ' GLY . 90.0 mt-30 -119.32 170.17 9.34 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.329 -1.1 . . . . 0.0 109.385 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.581 HG23 ' HA ' ' A' ' 57' ' ' LYS . 54.7 m -134.04 134.25 42.16 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.199 -0.938 . . . . 0.0 109.3 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.898 ' CD1' HD13 ' A' ' 39' ' ' LEU . 38.4 m-85 -114.57 131.04 56.81 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.262 -0.899 . . . . 0.0 109.221 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.544 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 10.1 m-20 -55.7 -78.4 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.287 -0.883 . . . . 0.0 109.676 -179.661 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.519 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 7.1 t-20 -81.96 147.1 57.18 Favored Pre-proline 0 C--N 1.301 -1.527 0 O-C-N 120.927 -1.108 . . . . 0.0 109.645 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.529 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.2 Cg_endo -62.7 -52.07 2.64 Favored 'Trans proline' 0 C--O 1.216 -0.617 0 C-N-CA 122.753 2.302 . . . . 0.0 111.811 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.519 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 8.6 t -61.38 -29.99 70.26 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 120.882 -1.136 . . . . 0.0 108.046 178.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.402 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 13.0 mtt -63.87 -12.91 40.61 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.312 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.898 HD13 ' CD1' ' A' ' 33' ' ' TYR . 29.3 tp -68.04 -54.33 19.11 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.622 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 10.9 t -62.12 -22.43 65.81 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.118 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.437 ' CE1' ' HB2' ' A' ' 16' ' ' TYR . 37.4 t60 -69.7 -57.33 5.27 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.315 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.46 ' OE1' ' CD2' ' A' ' 33' ' ' TYR . 82.1 tt0 -63.61 -20.27 65.53 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 179.267 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.507 ' O ' ' N ' ' A' ' 47' ' ' GLN . 96.5 m-20 -75.42 -32.21 60.63 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.514 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.924 HD13 ' O ' ' A' ' 44' ' ' LEU . 2.8 tm? -65.82 -38.16 88.17 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.32 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.511 ' N ' HD13 ' A' ' 45' ' ' ILE . 4.6 mm -69.76 -43.16 80.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.392 -0.818 . . . . 0.0 108.953 179.481 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.453 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 73.2 mtt-85 -79.73 -23.37 42.36 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.415 -0.803 . . . . 0.0 109.098 179.692 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.507 ' N ' ' O ' ' A' ' 43' ' ' ASN . 92.6 mt-30 63.0 45.33 5.37 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.374 -0.829 . . . . 0.0 109.353 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.1 p -128.53 159.17 36.31 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.302 -0.874 . . . . 0.0 109.374 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.418 ' O ' ' CG ' ' A' ' 49' ' ' ASN . 47.6 p-10 -91.49 59.49 3.84 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.169 -0.957 . . . . 0.0 109.301 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 81.6 m -72.36 141.95 48.77 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.352 -0.843 . . . . 0.0 109.843 -179.795 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.591 ' CE1' ' HB2' ' A' ' 2' ' ' SER . 62.6 m-70 -122.44 171.62 8.95 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.275 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.53 HG23 ' HB ' ' A' ' 25' ' ' VAL . 29.2 mt -79.72 126.85 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.075 -1.016 . . . . 0.0 109.581 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.503 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 67.2 ttt-85 -80.07 -44.63 19.72 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.447 -0.783 . . . . 0.0 109.035 179.783 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.4 t -160.23 155.59 25.14 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.706 -0.849 . . . . 0.0 108.706 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 26.1 p -67.5 140.22 57.03 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.091 -1.005 . . . . 0.0 109.314 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.532 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 94.89 169.04 36.59 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.167 -1.573 . . . . 0.0 109.167 -179.748 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.581 ' HA ' HG23 ' A' ' 32' ' ' THR . 44.8 mttp -68.1 144.62 54.97 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.304 -1.116 . . . . 0.0 109.446 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.461 ' SG ' ' O ' ' A' ' 31' ' ' GLN . 73.9 m -49.54 -27.46 4.43 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.254 -0.904 . . . . 0.0 109.289 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.46 ' O ' ' O ' ' A' ' 62' ' ' SER . 82.5 tt0 -84.21 -25.42 29.51 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.301 -0.874 . . . . 0.0 109.485 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.425 ' OE1' ' HA3' ' A' ' 56' ' ' GLY . 63.2 tt0 -66.37 -30.37 70.74 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.226 -0.921 . . . . 0.0 109.429 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 21.1 m -63.43 -37.75 88.51 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.247 -0.908 . . . . 0.0 109.754 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.46 ' O ' ' O ' ' A' ' 59' ' ' GLU . 46.4 m -115.88 148.07 40.39 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.168 -0.958 . . . . 0.0 109.688 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -65.26 158.52 71.9 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.214 -0.929 . . . . 0.0 109.394 179.819 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.445 ' HB2' HG23 ' A' ' 66' ' ' THR . 48.6 Cg_endo -69.63 -20.61 35.21 Favored 'Trans proline' 0 C--O 1.215 -0.673 0 C-N-CA 122.618 2.212 . . . . 0.0 111.77 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 91.01 7.75 65.59 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.445 HG23 ' HB2' ' A' ' 64' ' ' PRO . 71.9 p -68.5 -22.69 64.53 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.291 -1.123 . . . . 0.0 109.509 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.423 ' O ' ' OG ' ' A' ' 70' ' ' SER . 59.6 p -69.71 -22.89 63.36 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.198 -0.939 . . . . 0.0 109.533 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -62.11 -32.77 73.38 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.257 -0.902 . . . . 0.0 109.466 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.405 ' C ' ' HD2' ' A' ' 72' ' ' PRO . . . -65.85 -27.04 67.94 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.26 -0.9 . . . . 0.0 109.463 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.423 ' OG ' ' O ' ' A' ' 67' ' ' THR . 85.3 p -68.41 -27.64 66.38 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.331 -0.856 . . . . 0.0 109.542 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.498 ' N ' ' HD2' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -53.61 -59.52 9.33 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.244 -0.91 . . . . 0.0 109.491 179.995 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.498 ' HD2' ' N ' ' A' ' 71' ' ' MET . 49.9 Cg_endo -70.1 150.84 66.73 Favored 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 122.651 2.234 . . . . 0.0 111.8 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -69.36 -23.16 32.92 Favored 'Trans proline' 0 C--O 1.215 -0.625 0 C-N-CA 122.706 2.271 . . . . 0.0 111.78 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 49.1 m -129.01 142.33 50.95 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.264 -0.897 . . . . 0.0 109.447 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -58.62 -36.59 74.3 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.306 -0.871 . . . . 0.0 109.538 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 118.004 -0.998 . . . . 0.0 109.519 179.998 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.41 ' O ' ' C ' ' A' ' 2' ' ' SER . 72.5 m-20 . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.556 ' OG ' HD22 ' A' ' 39' ' ' LEU . 3.5 m -44.71 -33.42 1.85 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.291 -0.881 . . . . 0.0 109.475 179.932 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.429 ' HA ' ' HG3' ' A' ' 6' ' ' LYS . 21.1 mt-10 -51.31 -28.98 13.55 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.311 -0.868 . . . . 0.0 108.711 179.728 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 66.0 mtt -78.33 -32.13 49.03 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 179.389 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.44 ' HB3' ' HB3' ' A' ' 40' ' ' CYS . 3.7 m -83.19 1.63 39.69 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.341 -0.849 . . . . 0.0 109.114 179.388 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.429 ' HG3' ' HA ' ' A' ' 3' ' ' GLU . 14.2 mttm -61.89 -31.74 72.05 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.138 -0.976 . . . . 0.0 109.416 179.994 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -145.21 68.54 1.23 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.212 -0.93 . . . . 0.0 109.952 -179.893 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.463 ' CE2' ' CE2' ' A' ' 16' ' ' TYR . 13.9 p90 -119.03 -171.23 2.06 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.175 -0.953 . . . . 0.0 109.19 179.524 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 21.4 ttt180 -150.83 152.32 33.58 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.232 -0.918 . . . . 0.0 109.747 -179.999 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.557 HG13 ' O ' ' A' ' 15' ' ' GLY . 45.4 t -148.63 131.46 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.293 -0.88 . . . . 0.0 109.46 179.839 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.682 HD23 ' HD2' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -104.26 174.86 2.47 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.253 -0.905 . . . . 0.0 109.249 179.81 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.682 ' HD2' HD23 ' A' ' 11' ' ' LEU . 45.8 Cg_endo -67.48 -24.62 42.26 Favored 'Trans proline' 0 C--O 1.215 -0.667 0 C-N-CA 122.706 2.271 . . . . 0.0 112.056 -179.995 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -96.62 -28.23 14.44 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.29 -0.881 . . . . 0.0 109.41 179.966 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.444 HD12 ' HB2' ' A' ' 11' ' ' LEU . 89.9 mt -83.05 -45.77 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.302 -0.874 . . . . 0.0 109.598 -179.916 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.557 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 68.66 -168.74 42.74 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 179.997 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.463 ' CE2' ' CE2' ' A' ' 8' ' ' TYR . 1.4 t80 -95.33 149.25 21.56 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.212 -1.169 . . . . 0.0 109.645 -179.907 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.687 ' C ' HD13 ' A' ' 17' ' ' LEU . 2.3 tm? -111.24 112.21 23.82 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.287 -0.883 . . . . 0.0 109.163 179.873 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.578 ' N ' HD13 ' A' ' 17' ' ' LEU . 62.0 m -128.63 155.77 78.47 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.26 -0.9 . . . . 0.0 109.608 -179.896 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.406 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 49.6 Cg_endo -71.28 168.52 23.17 Favored 'Trans proline' 0 C--O 1.215 -0.675 0 C-N-CA 122.694 2.263 . . . . 0.0 111.526 179.781 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 25.4 mttm -91.09 -14.92 30.34 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.219 -0.926 . . . . 0.0 109.639 -179.828 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 51.3 t0 -72.3 119.48 16.56 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.246 -0.908 . . . . 0.0 109.349 179.866 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.557 HD11 ' HB3' ' A' ' 34' ' ' ASN . 52.4 tp -79.59 113.64 17.9 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.199 -0.938 . . . . 0.0 109.646 -179.944 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.492 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -127.5 110.12 20.96 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.211 -0.931 . . . . 0.0 109.079 179.738 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.553 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 42.6 Cg_endo -64.66 122.48 10.36 Favored 'Trans proline' 0 C--O 1.213 -0.774 0 C-N-CA 122.943 2.428 . . . . 0.0 112.203 -179.715 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.487 ' HB ' HG23 ' A' ' 52' ' ' ILE . 18.8 m -119.31 154.71 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.283 -0.886 . . . . 0.0 109.4 179.785 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.456 ' SG ' ' HB3' ' A' ' 53' ' ' ARG . 39.7 t -96.56 142.71 28.3 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 178.598 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.481 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -95.69 139.43 14.49 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 -179.859 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.466 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 55.0 t0 -69.29 -6.18 27.84 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.234 -1.157 . . . . 0.0 109.592 -179.781 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.434 ' OD2' ' OG1' ' A' ' 50' ' ' THR . 41.7 m-20 -90.87 0.87 57.37 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.149 -0.969 . . . . 0.0 109.548 179.913 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.43 24.61 15.74 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.634 -1.387 . . . . 0.0 109.634 179.935 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.481 ' O ' ' N ' ' A' ' 27' ' ' GLY . 81.5 mt-30 -131.84 164.17 26.65 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.292 -1.122 . . . . 0.0 109.279 -179.982 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.978 HG21 ' HG3' ' A' ' 57' ' ' LYS . 12.0 m -121.03 150.32 41.34 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.123 -0.985 . . . . 0.0 109.384 179.797 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.844 ' CD2' HD12 ' A' ' 39' ' ' LEU . 36.7 m-85 -128.74 131.75 47.89 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.341 -0.849 . . . . 0.0 109.253 -179.909 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.557 ' HB3' HD11 ' A' ' 22' ' ' LEU . 11.8 m-20 -51.75 -78.77 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.358 -0.839 . . . . 0.0 109.889 -179.429 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.534 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 5.8 t-20 -82.01 147.7 58.55 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.104 -0.997 . . . . 0.0 109.827 -179.789 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.492 ' HD3' ' O ' ' A' ' 23' ' ' LYS . 41.7 Cg_endo -64.04 -52.76 1.49 Allowed 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 122.777 2.318 . . . . 0.0 111.606 179.826 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.534 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 11.6 t -62.2 -30.01 70.78 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.969 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.494 ' CG ' ' HB3' ' A' ' 35' ' ' ASN . 29.3 mtt -65.3 -16.12 63.24 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.435 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.844 HD12 ' CD2' ' A' ' 33' ' ' TYR . 8.0 tt -69.07 -52.87 24.02 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.34 -0.85 . . . . 0.0 108.899 179.71 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.513 ' O ' ' HB2' ' A' ' 43' ' ' ASN . 14.4 m -51.0 -39.66 56.3 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.424 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 13.3 t60 -49.2 -45.12 43.82 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.851 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.595 ' HG3' ' CE1' ' A' ' 33' ' ' TYR . 45.4 mm-40 -61.73 -20.99 64.12 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.263 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.524 ' O ' ' N ' ' A' ' 47' ' ' GLN . 2.5 m-80 -76.69 -31.33 57.17 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 119.694 -0.803 . . . . 0.0 109.034 179.508 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.975 HD13 ' O ' ' A' ' 44' ' ' LEU . 1.7 tm? -70.22 -36.46 74.55 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.265 -0.897 . . . . 0.0 109.396 179.932 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 6.4 mt -74.87 -51.46 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.258 -0.901 . . . . 0.0 109.554 -179.896 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.488 ' NH2' ' OE1' ' A' ' 42' ' ' GLU . 40.8 mtt85 -81.12 -36.74 29.92 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.299 -0.875 . . . . 0.0 109.842 -179.653 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.524 ' N ' ' O ' ' A' ' 43' ' ' ASN . 92.6 mt-30 63.07 34.05 14.13 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.309 -0.869 . . . . 0.0 109.554 -179.809 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.466 HG23 ' HB3' ' A' ' 46' ' ' ARG . 38.9 p -103.74 7.51 37.24 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.276 -0.89 . . . . 0.0 109.486 179.956 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.536 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 65.6 m-20 63.59 47.98 3.56 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.192 -0.942 . . . . 0.0 109.469 -179.895 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.524 ' N ' ' OD1' ' A' ' 43' ' ' ASN . 71.1 m -80.3 125.75 30.28 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.395 -0.815 . . . . 0.0 109.366 179.752 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.536 ' CE1' ' O ' ' A' ' 49' ' ' ASN . 7.2 m80 -109.71 -171.09 1.77 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.124 -0.985 . . . . 0.0 109.459 179.822 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.822 HG12 HD13 ' A' ' 39' ' ' LEU . 43.6 mt -87.04 126.56 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.408 -0.808 . . . . 0.0 109.557 179.934 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.466 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 21.7 ttt85 -79.63 -46.4 17.27 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.446 -0.784 . . . . 0.0 109.275 179.841 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 95.3 p -158.31 138.84 12.71 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -179.72 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 20.8 p -56.02 151.33 12.13 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.134 -0.979 . . . . 0.0 109.49 -179.839 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.553 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 74.73 161.91 8.87 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 -179.595 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.978 ' HG3' HG21 ' A' ' 32' ' ' THR . 25.8 tttp -59.6 145.02 46.0 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.424 -1.045 . . . . 0.0 109.144 179.96 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -61.72 -35.37 77.88 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.257 -0.902 . . . . 0.0 109.526 -179.846 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -81.27 -22.79 38.41 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.503 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.475 ' CB ' ' HB3' ' A' ' 57' ' ' LYS . 32.7 tt0 -66.9 -19.05 65.66 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.838 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 94.6 p -79.03 -25.51 43.23 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.409 -0.807 . . . . 0.0 109.728 -179.846 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 60.0 p -69.36 158.65 34.67 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.197 -0.94 . . . . 0.0 109.57 -179.85 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.43 HG23 ' H ' ' A' ' 63' ' ' THR . 15.9 p -57.81 154.55 26.61 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.239 -0.913 . . . . 0.0 109.532 179.99 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.927 ' CG ' ' HB2' ' A' ' 69' ' ' ALA . 49.3 Cg_endo -69.6 -14.14 36.13 Favored 'Trans proline' 0 C--O 1.215 -0.666 0 C-N-CA 122.721 2.28 . . . . 0.0 111.768 179.957 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 91.43 10.05 62.48 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.947 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 18.8 p -122.38 159.51 27.35 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.266 -1.138 . . . . 0.0 109.449 179.966 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 41.8 p -73.44 -15.04 61.35 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.299 -0.875 . . . . 0.0 109.416 -179.966 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -66.2 -29.99 70.37 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.319 -0.863 . . . . 0.0 109.41 -179.984 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.927 ' HB2' ' CG ' ' A' ' 64' ' ' PRO . . . -60.66 142.99 55.07 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.221 -0.925 . . . . 0.0 109.498 179.959 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 33.0 t -59.48 -33.23 71.06 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.359 -0.838 . . . . 0.0 109.508 -179.928 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.27 153.0 87.16 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.262 -0.899 . . . . 0.0 109.531 -179.945 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -69.99 149.63 65.68 Favored 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 122.824 2.349 . . . . 0.0 111.873 -179.923 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -69.75 165.56 30.53 Favored 'Trans proline' 0 C--O 1.214 -0.681 0 C-N-CA 122.706 2.271 . . . . 0.0 111.797 179.928 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 91.2 p -86.56 -11.67 50.9 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.25 -0.907 . . . . 0.0 109.497 -179.907 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.448 ' O ' ' HB2' ' A' ' 76' ' ' GLU . 22.6 t70 -89.73 117.98 28.99 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.201 -0.937 . . . . 0.0 109.497 179.987 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.448 ' HB2' ' O ' ' A' ' 75' ' ' ASP . 73.3 mm-40 . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 118.021 -0.99 . . . . 0.0 109.481 179.967 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 . . . . . 0 N--CA 1.489 1.507 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.7 m -56.85 -34.95 68.31 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.256 -0.902 . . . . 0.0 109.514 179.931 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -52.28 -26.61 12.4 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.265 -0.897 . . . . 0.0 108.779 179.819 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 90.7 mtp -75.1 -27.42 59.86 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.325 -0.86 . . . . 0.0 108.856 179.316 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.605 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 19.9 m -80.32 -12.64 59.58 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.477 -0.765 . . . . 0.0 109.251 179.892 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.459 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 26.3 mttt -80.96 6.41 13.45 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.148 -0.97 . . . . 0.0 109.816 179.831 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.459 ' OD1' ' O ' ' A' ' 6' ' ' LYS . 96.3 m-20 -139.13 15.22 2.63 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.005 -1.06 . . . . 0.0 110.416 -179.387 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.686 ' CE2' ' CE2' ' A' ' 16' ' ' TYR . 1.0 OUTLIER -122.69 151.38 41.59 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.913 -1.117 . . . . 0.0 109.533 179.846 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 91.3 mtt180 -129.06 136.05 49.73 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.402 -0.811 . . . . 0.0 109.119 179.693 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.873 HG13 ' O ' ' A' ' 15' ' ' GLY . 49.7 t -127.16 148.43 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.246 -0.909 . . . . 0.0 109.499 -179.628 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.548 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.2 OUTLIER -123.65 175.12 2.99 Favored Pre-proline 0 N--CA 1.488 1.458 0 O-C-N 121.233 -0.917 . . . . 0.0 109.621 -179.689 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.548 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 45.1 Cg_endo -67.76 -22.27 43.55 Favored 'Trans proline' 0 C--O 1.215 -0.675 0 C-N-CA 122.691 2.261 . . . . 0.0 111.713 -179.987 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 69.9 mtt85 -105.7 -24.31 12.55 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.341 -0.85 . . . . 0.0 109.526 179.948 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 24.4 mm -81.9 -48.17 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.246 -0.909 . . . . 0.0 109.54 -179.893 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.873 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 82.17 -163.83 43.57 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.344 -1.503 . . . . 0.0 109.344 -179.923 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.686 ' CE2' ' CE2' ' A' ' 8' ' ' TYR . 2.1 t80 -97.57 150.6 20.94 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.125 -1.221 . . . . 0.0 109.621 179.983 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.696 ' C ' HD13 ' A' ' 17' ' ' LEU . 2.2 tm? -111.86 109.65 19.57 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.333 -0.854 . . . . 0.0 109.749 -179.779 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.519 ' N ' HD13 ' A' ' 17' ' ' LEU . 63.6 m -125.86 156.12 71.87 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.284 -0.885 . . . . 0.0 108.985 179.649 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -71.02 165.48 32.24 Favored 'Trans proline' 0 C--O 1.214 -0.686 0 C-N-CA 122.453 2.102 . . . . 0.0 111.701 -179.98 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 24.3 mttt -83.76 -22.93 31.75 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.261 -0.9 . . . . 0.0 109.521 -179.805 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 -63.62 125.41 24.19 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.226 -0.921 . . . . 0.0 109.401 179.781 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 41.2 tp -85.69 122.92 30.47 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.211 -0.931 . . . . 0.0 109.507 179.94 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.555 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 1.3 mmmt -135.21 103.28 10.59 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.305 -0.872 . . . . 0.0 109.284 179.987 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.536 ' HA ' ' O ' ' A' ' 34' ' ' ASN . 43.3 Cg_endo -65.02 120.02 7.16 Favored 'Trans proline' 0 C--O 1.213 -0.744 0 C-N-CA 123.18 2.587 . . . . 0.0 112.529 -179.125 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.475 ' O ' HG23 ' A' ' 32' ' ' THR . 7.8 m -116.98 155.94 18.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.399 -0.813 . . . . 0.0 109.754 179.683 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.428 ' O ' ' N ' ' A' ' 53' ' ' ARG . 14.8 t -102.67 109.9 21.66 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.389 -0.82 . . . . 0.0 108.97 179.369 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -66.03 137.7 36.3 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 -179.652 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.521 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 55.1 p30 -68.65 -10.14 54.31 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.316 -1.108 . . . . 0.0 109.57 179.858 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.443 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 38.9 m-20 -82.62 4.47 24.63 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.246 -0.909 . . . . 0.0 109.378 179.757 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.73 14.68 56.33 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.137 -1.585 . . . . 0.0 109.137 -179.809 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.501 ' O ' ' N ' ' A' ' 27' ' ' GLY . 88.9 mt-30 -121.36 157.54 30.22 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.382 -1.07 . . . . 0.0 109.373 -179.969 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.517 ' CG2' ' HA ' ' A' ' 57' ' ' LYS . 25.6 m -119.19 134.97 54.91 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.257 -0.902 . . . . 0.0 109.356 179.916 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.632 ' HD2' HD12 ' A' ' 39' ' ' LEU . 54.2 m-85 -113.13 129.67 56.43 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.289 -0.882 . . . . 0.0 109.288 179.986 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.536 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 6.6 m-20 -52.47 -76.29 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.216 -0.928 . . . . 0.0 109.441 -179.812 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.514 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 10.2 t-20 -81.99 147.35 57.72 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.039 -1.038 . . . . 0.0 109.495 179.797 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.555 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 39.9 Cg_endo -63.12 -51.68 2.63 Favored 'Trans proline' 0 C--O 1.214 -0.693 0 C-N-CA 122.673 2.248 . . . . 0.0 111.451 179.555 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.514 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 5.7 t -60.25 -28.36 67.98 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 178.81 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.482 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 34.7 mmm -66.02 -18.94 65.67 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.384 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.632 HD12 ' HD2' ' A' ' 33' ' ' TYR . 8.1 tt -66.84 -52.74 40.09 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.179 -0.951 . . . . 0.0 108.577 179.382 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.483 ' O ' ' HB2' ' A' ' 43' ' ' ASN . 38.0 t -50.81 -25.97 5.12 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 178.983 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.456 ' O ' HG12 ' A' ' 45' ' ' ILE . 28.1 t60 -60.09 -50.05 75.25 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.162 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.602 ' HB2' ' CE1' ' A' ' 33' ' ' TYR . 23.9 tp10 -58.66 -19.42 39.2 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.201 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.518 ' O ' ' N ' ' A' ' 47' ' ' GLN . 4.0 m-80 -78.26 -35.81 47.64 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.29 -0.881 . . . . 0.0 108.913 179.589 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 1.005 HD13 ' O ' ' A' ' 44' ' ' LEU . 2.1 tm? -69.34 -34.3 74.41 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.286 -0.884 . . . . 0.0 109.327 179.717 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.456 HG12 ' O ' ' A' ' 41' ' ' HIS . 6.1 mm -74.67 -53.84 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.382 -0.824 . . . . 0.0 110.118 -179.633 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.564 ' HB3' HG23 ' A' ' 48' ' ' THR . 10.5 mtt-85 -88.38 -30.3 19.62 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.145 -0.972 . . . . 0.0 110.36 -179.159 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.518 ' N ' ' O ' ' A' ' 43' ' ' ASN . 87.2 mt-30 62.33 37.07 14.13 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.128 -0.983 . . . . 0.0 109.277 -179.706 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.564 HG23 ' HB3' ' A' ' 46' ' ' ARG . 72.7 p -101.25 6.68 43.02 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.295 -0.878 . . . . 0.0 109.715 -179.84 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.452 ' HB2' ' O ' ' A' ' 48' ' ' THR . 73.0 m-20 61.65 51.77 3.85 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.165 -0.959 . . . . 0.0 109.556 179.894 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.506 ' N ' ' OD1' ' A' ' 43' ' ' ASN . 47.9 m -76.53 140.63 41.22 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.24 -0.913 . . . . 0.0 109.262 179.755 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 12.0 m-70 -119.53 -176.47 3.16 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.219 -0.926 . . . . 0.0 109.63 -179.879 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.595 HG12 HD13 ' A' ' 39' ' ' LEU . 15.9 mt -87.47 124.07 40.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 O-C-N 121.383 -0.823 . . . . 0.0 109.575 179.883 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.521 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 16.7 tpt180 -81.07 -56.38 4.14 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.476 -0.765 . . . . 0.0 109.477 179.904 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 72.8 m -148.9 141.17 24.07 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -179.832 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.428 ' H ' HG23 ' A' ' 55' ' ' THR . 12.2 p -58.34 144.51 41.25 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.197 -0.939 . . . . 0.0 109.522 -179.67 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.526 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 86.32 162.61 37.13 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.79 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.517 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 21.7 mttp -70.65 133.09 46.36 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.559 -0.965 . . . . 0.0 109.386 179.895 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -60.21 -30.95 69.71 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.219 -0.926 . . . . 0.0 109.406 -179.995 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.468 ' HG2' ' O ' ' A' ' 59' ' ' GLU . 83.2 tt0 -83.78 -13.18 54.49 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.265 -0.897 . . . . 0.0 109.412 179.838 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.496 ' HB2' ' HB2' ' A' ' 57' ' ' LYS . 51.6 tt0 -71.8 -29.46 64.48 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.324 -0.86 . . . . 0.0 109.16 179.904 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 34.6 m -63.26 -35.28 79.83 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.307 -0.871 . . . . 0.0 109.415 179.866 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.452 ' O ' ' O ' ' A' ' 59' ' ' GLU . 43.2 m -118.48 149.16 41.75 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.223 -0.923 . . . . 0.0 109.644 -179.946 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.405 ' HB ' ' HD2' ' A' ' 64' ' ' PRO . 0.8 OUTLIER -117.85 164.88 17.77 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.282 -0.886 . . . . 0.0 109.335 179.905 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.405 ' HD2' ' HB ' ' A' ' 63' ' ' THR . 50.1 Cg_endo -70.47 -20.72 31.12 Favored 'Trans proline' 0 C--O 1.215 -0.641 0 C-N-CA 122.649 2.232 . . . . 0.0 111.831 -179.842 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -87.05 -175.47 49.15 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.943 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 17.3 p -123.99 161.8 24.72 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.307 -1.114 . . . . 0.0 109.435 179.972 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.452 HG21 ' HG3' ' A' ' 72' ' ' PRO . 25.3 p -116.25 165.32 13.31 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.218 -0.926 . . . . 0.0 109.535 -179.953 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.76 -29.66 70.2 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.215 -0.928 . . . . 0.0 109.446 -179.958 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.429 ' O ' ' OG1' ' A' ' 67' ' ' THR . . . -106.25 137.81 43.54 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.209 -0.932 . . . . 0.0 109.495 179.948 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 18.5 m -55.74 -33.09 63.96 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.196 -0.94 . . . . 0.0 109.479 179.99 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 9.6 mmt -124.37 88.12 53.38 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.362 -0.836 . . . . 0.0 109.456 179.933 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.452 ' HG3' HG21 ' A' ' 67' ' ' THR . 50.0 Cg_endo -70.07 154.54 66.4 Favored 'Trans proline' 0 C--O 1.216 -0.624 0 C-N-CA 122.674 2.249 . . . . 0.0 111.773 179.947 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -70.59 0.35 6.39 Favored 'Trans proline' 0 C--O 1.216 -0.612 0 C-N-CA 122.682 2.255 . . . . 0.0 111.933 -179.875 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 85.7 p -92.33 -13.31 30.43 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.163 -0.961 . . . . 0.0 109.451 -179.968 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -94.97 106.13 18.09 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.305 -0.872 . . . . 0.0 109.274 179.947 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 118.001 -1.0 . . . . 0.0 109.531 -179.829 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.601 ' OD1' HD12 ' A' ' 52' ' ' ILE . 51.5 m-20 . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 . . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.518 ' O ' ' N ' ' A' ' 5' ' ' CYS . 5.8 m -43.76 -26.8 0.27 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.268 -0.895 . . . . 0.0 109.484 179.945 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.478 ' HG2' ' HE3' ' A' ' 6' ' ' LYS . 39.6 mt-10 -47.04 -31.58 3.4 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 179.704 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 70.7 mtm -77.18 -33.6 56.42 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.056 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.518 ' N ' ' O ' ' A' ' 2' ' ' SER . 3.4 m -82.93 7.56 15.09 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 179.41 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.478 ' HE3' ' HG2' ' A' ' 3' ' ' GLU . 12.6 mttm -61.11 -35.69 77.69 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.997 -1.064 . . . . 0.0 109.305 179.724 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -140.65 70.8 1.36 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.321 -0.862 . . . . 0.0 109.915 -179.793 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.457 ' CE2' HG23 ' A' ' 10' ' ' VAL . 26.9 p90 -115.07 -169.75 1.62 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.208 -0.933 . . . . 0.0 109.3 179.633 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.437 ' N ' ' CD2' ' A' ' 8' ' ' TYR . 71.9 mtt-85 -152.41 142.37 22.15 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.256 -0.903 . . . . 0.0 109.569 179.905 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.559 HG13 ' C ' ' A' ' 15' ' ' GLY . 39.9 t -143.06 138.7 27.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.264 -0.897 . . . . 0.0 109.2 179.98 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.549 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.7 OUTLIER -119.55 174.72 2.62 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.221 -0.924 . . . . 0.0 109.449 -179.788 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.549 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 46.6 Cg_endo -68.36 -24.31 37.24 Favored 'Trans proline' 0 C--O 1.214 -0.678 0 C-N-CA 122.748 2.299 . . . . 0.0 111.881 179.965 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.486 ' HG2' ' O ' ' A' ' 13' ' ' ARG . 23.4 ttm180 -101.18 -16.69 16.93 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.322 -0.861 . . . . 0.0 109.282 179.897 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 85.2 mt -96.99 -42.19 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.244 -0.91 . . . . 0.0 109.654 -179.754 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.559 ' C ' HG13 ' A' ' 10' ' ' VAL . . . 71.55 179.38 31.3 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 -179.812 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.487 ' OH ' ' HB2' ' A' ' 40' ' ' CYS . 1.8 t80 -77.61 153.92 32.76 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.153 -1.204 . . . . 0.0 109.546 -179.989 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.462 HD23 ' HA ' ' A' ' 17' ' ' LEU . 48.1 mt -110.42 123.58 50.15 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.216 -0.927 . . . . 0.0 109.594 179.999 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.466 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 82.4 m -146.98 156.72 47.27 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.453 -0.779 . . . . 0.0 109.032 179.895 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.518 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 48.9 Cg_endo -70.86 168.29 23.42 Favored 'Trans proline' 0 C--O 1.216 -0.608 0 C-N-CA 122.583 2.188 . . . . 0.0 111.515 179.889 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -94.26 -8.73 38.27 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.124 -0.985 . . . . 0.0 109.628 -179.796 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -76.62 118.53 19.36 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.169 -0.957 . . . . 0.0 109.414 179.957 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.501 HD11 ' HB3' ' A' ' 34' ' ' ASN . 44.3 tp -76.09 116.92 17.26 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.201 -0.937 . . . . 0.0 109.739 -179.973 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.539 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 2.2 mtpt -132.1 106.76 13.66 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.306 -0.871 . . . . 0.0 108.996 179.767 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.527 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 43.2 Cg_endo -64.58 120.24 7.48 Favored 'Trans proline' 0 C--O 1.214 -0.711 0 C-N-CA 122.912 2.408 . . . . 0.0 112.1 -179.448 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.492 ' HB ' HG23 ' A' ' 52' ' ' ILE . 11.4 m -120.26 155.2 23.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.445 -0.784 . . . . 0.0 110.047 -179.768 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.429 ' SG ' ' HB3' ' A' ' 53' ' ' ARG . 41.4 t -96.88 148.18 23.2 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 178.713 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -100.04 139.66 14.54 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.545 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.477 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 53.4 t0 -64.82 -10.7 30.08 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.279 -1.13 . . . . 0.0 109.409 179.834 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 59.9 p30 -90.39 1.6 56.43 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.24 -0.913 . . . . 0.0 109.667 -179.932 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.64 19.45 34.75 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.994 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.473 ' O ' ' N ' ' A' ' 27' ' ' GLY . 87.0 mt-30 -119.23 167.88 11.43 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.209 -1.171 . . . . 0.0 109.429 -179.946 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.549 HG23 ' HA ' ' A' ' 57' ' ' LYS . 94.3 m -127.73 146.91 50.42 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.118 -0.989 . . . . 0.0 109.445 179.792 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.62 ' CD1' ' N ' ' A' ' 33' ' ' TYR . 5.0 m-85 -128.8 128.64 44.34 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.23 -0.918 . . . . 0.0 109.463 -179.835 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.501 ' HB3' HD11 ' A' ' 22' ' ' LEU . 7.5 m-20 -49.79 -77.22 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.282 -0.886 . . . . 0.0 109.663 -179.551 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.543 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 2.0 t-20 -81.91 149.23 62.85 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.161 -0.962 . . . . 0.0 109.443 179.995 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.539 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 41.2 Cg_endo -64.62 -54.71 0.68 Allowed 'Trans proline' 0 C--O 1.216 -0.622 0 C-N-CA 122.842 2.361 . . . . 0.0 111.955 179.873 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.543 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 15.7 t -62.09 -28.6 69.73 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 120.974 -1.079 . . . . 0.0 108.417 179.049 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.444 ' CG ' ' HB3' ' A' ' 35' ' ' ASN . 37.0 mmm -61.45 -15.56 38.47 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 179.363 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.609 HD13 ' CD1' ' A' ' 33' ' ' TYR . 50.8 tp -63.47 -46.01 88.15 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.346 -0.846 . . . . 0.0 108.982 179.61 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.487 ' HB2' ' OH ' ' A' ' 16' ' ' TYR . 2.8 m -71.8 -19.98 61.92 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 178.764 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 28.4 t60 -66.89 -52.76 39.48 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.017 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.474 ' OE1' ' CE2' ' A' ' 33' ' ' TYR . 85.5 tt0 -66.91 -19.86 65.8 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 178.983 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.502 ' O ' ' N ' ' A' ' 47' ' ' GLN . 87.9 m-20 -77.46 -32.75 54.65 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.327 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.409 HD12 ' HA ' ' A' ' 44' ' ' LEU . 23.9 tp -64.28 -31.36 72.54 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.259 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.3 mm -77.63 -44.7 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.442 -0.787 . . . . 0.0 108.972 179.376 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.453 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 63.2 mtt-85 -79.89 -15.36 57.49 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.353 -0.842 . . . . 0.0 109.123 179.629 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.502 ' N ' ' O ' ' A' ' 43' ' ' ASN . 89.0 mt-30 63.09 44.32 5.91 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.421 -0.799 . . . . 0.0 109.486 179.995 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.408 ' O ' ' HB3' ' A' ' 43' ' ' ASN . 7.3 p -128.54 164.52 22.64 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.211 -0.93 . . . . 0.0 109.294 179.829 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 47.5 p-10 -104.58 58.62 0.7 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.123 -0.986 . . . . 0.0 109.573 -179.935 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 86.5 m -71.91 137.77 47.65 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.255 -0.903 . . . . 0.0 109.541 179.9 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 88.3 m-70 -112.55 176.54 4.98 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.229 -0.92 . . . . 0.0 109.091 179.723 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.601 HD12 ' OD1' ' A' ' 1' ' ' ASP . 39.2 mt -80.28 126.66 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.231 -0.918 . . . . 0.0 109.509 179.999 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.477 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 67.6 ttt180 -79.88 -46.39 16.91 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.443 -0.786 . . . . 0.0 109.448 -179.922 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.405 ' H ' ' HB3' ' A' ' 26' ' ' CYS . 54.4 p -160.44 138.88 10.14 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -179.331 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.446 ' H ' HG23 ' A' ' 55' ' ' THR . 10.6 p -51.29 147.4 5.75 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.163 -0.961 . . . . 0.0 109.485 179.978 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.527 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 85.14 165.95 41.03 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.484 -1.447 . . . . 0.0 109.484 179.923 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.549 ' HA ' HG23 ' A' ' 32' ' ' THR . 33.7 mttm -65.33 146.24 55.16 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.49 -1.006 . . . . 0.0 109.406 179.981 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.45 ' SG ' ' O ' ' A' ' 31' ' ' GLN . 79.2 m -49.37 -30.21 7.4 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.279 -0.888 . . . . 0.0 109.48 179.945 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -80.22 -32.31 38.5 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.335 -0.853 . . . . 0.0 109.314 -179.83 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -58.01 -20.3 37.63 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.287 -0.883 . . . . 0.0 108.948 179.718 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 20.4 m -72.93 -32.42 65.27 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.376 -0.827 . . . . 0.0 109.848 -179.749 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 83.7 p -123.8 156.42 36.15 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.083 -1.011 . . . . 0.0 109.802 -179.692 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.477 ' HB ' ' HD2' ' A' ' 64' ' ' PRO . 5.8 p -118.18 161.51 34.52 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.374 -0.829 . . . . 0.0 109.192 179.824 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.477 ' HD2' ' HB ' ' A' ' 63' ' ' THR . 50.4 Cg_endo -70.62 -17.62 33.52 Favored 'Trans proline' 0 C--O 1.214 -0.697 0 C-N-CA 122.626 2.217 . . . . 0.0 111.838 -179.897 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -172.69 173.41 45.46 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.96 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 40.6 m -114.92 138.59 50.64 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.294 -1.121 . . . . 0.0 109.534 -180.0 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 17.0 p -120.95 159.36 25.74 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.293 -0.879 . . . . 0.0 109.459 179.872 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.9 -30.48 69.05 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.277 -0.889 . . . . 0.0 109.591 -179.889 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.7 -37.26 85.81 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.277 -0.889 . . . . 0.0 109.509 -179.97 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 43.4 m -56.47 -33.01 65.52 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.203 -0.935 . . . . 0.0 109.609 -179.944 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.92 151.71 76.55 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.243 -0.911 . . . . 0.0 109.479 -179.997 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -70.16 146.8 58.78 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 122.691 2.261 . . . . 0.0 111.889 179.999 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -70.1 163.56 38.1 Favored 'Trans proline' 0 C--O 1.215 -0.632 0 C-N-CA 122.641 2.227 . . . . 0.0 111.753 179.987 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 19.5 m -86.47 -7.87 58.06 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.26 -0.9 . . . . 0.0 109.679 -179.895 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.481 ' O ' ' CG ' ' A' ' 76' ' ' GLU . 85.1 m-20 -83.13 -25.12 32.23 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.214 -0.929 . . . . 0.0 109.537 -179.896 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.481 ' CG ' ' O ' ' A' ' 75' ' ' ASP . 90.7 mt-10 . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.501 179.988 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.7 m -55.54 -30.22 60.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.302 -0.874 . . . . 0.0 109.424 -179.978 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.456 ' HA ' ' HG3' ' A' ' 6' ' ' LYS . 5.6 mt-10 -57.82 -22.51 47.99 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.327 -0.858 . . . . 0.0 109.309 179.906 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 62.1 mmm -77.51 -26.58 51.3 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.313 -0.867 . . . . 0.0 109.141 179.755 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.544 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 3.3 m -82.32 -14.92 54.57 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.313 -0.867 . . . . 0.0 109.143 179.862 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.456 ' HG3' ' HA ' ' A' ' 3' ' ' GLU . 85.0 mttt -56.2 -25.09 45.81 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.205 -0.934 . . . . 0.0 109.585 -179.994 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -154.27 63.04 0.69 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.179 -0.951 . . . . 0.0 109.841 -179.833 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.544 ' CD1' ' HA ' ' A' ' 5' ' ' CYS . 7.9 p90 -119.84 174.15 6.61 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.172 -0.955 . . . . 0.0 109.308 179.591 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 66.9 mtt-85 -145.26 137.34 25.69 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.19 -0.944 . . . . 0.0 109.514 -179.969 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.86 HG11 ' CD2' ' A' ' 44' ' ' LEU . 98.7 t -134.21 139.82 47.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.243 -0.911 . . . . 0.0 109.48 -179.981 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.548 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.2 OUTLIER -131.28 175.57 3.58 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.345 -0.847 . . . . 0.0 109.389 -179.924 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.548 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 46.0 Cg_endo -67.76 -24.95 40.18 Favored 'Trans proline' 0 C--O 1.214 -0.69 0 C-N-CA 122.673 2.249 . . . . 0.0 111.729 179.884 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.48 ' HG2' ' O ' ' A' ' 13' ' ' ARG . 54.6 ttt180 -110.97 -20.54 12.39 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.328 -0.857 . . . . 0.0 109.204 179.778 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 80.6 mt -90.98 -38.53 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.344 -0.848 . . . . 0.0 109.406 179.978 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.843 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 67.97 -142.22 39.38 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.948 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.54 ' CE2' ' CE2' ' A' ' 8' ' ' TYR . 2.9 t80 -108.23 153.97 22.44 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.172 -1.193 . . . . 0.0 109.57 -179.898 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 29.4 tp -112.33 119.46 38.36 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.398 -0.814 . . . . 0.0 109.581 179.911 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.459 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 58.5 m -131.55 155.92 80.81 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.279 -0.888 . . . . 0.0 109.269 179.903 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -71.11 166.4 29.31 Favored 'Trans proline' 0 C--O 1.216 -0.62 0 C-N-CA 122.523 2.149 . . . . 0.0 111.661 -179.994 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -88.42 -7.13 57.12 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.274 -0.891 . . . . 0.0 109.541 -179.934 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -74.39 128.42 35.49 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.231 -0.918 . . . . 0.0 109.4 179.846 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.731 ' C ' HD13 ' A' ' 22' ' ' LEU . 3.2 tm? -85.5 113.81 22.05 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.212 -0.93 . . . . 0.0 109.666 -179.831 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.519 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 5.5 mmtt -132.75 102.84 13.46 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.271 -0.893 . . . . 0.0 108.818 179.606 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.529 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 41.4 Cg_endo -63.43 124.18 13.35 Favored 'Trans proline' 0 C--O 1.213 -0.734 0 C-N-CA 122.963 2.442 . . . . 0.0 112.417 -179.067 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.46 ' HB ' HG23 ' A' ' 52' ' ' ILE . 35.0 m -123.06 154.08 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.47 -0.769 . . . . 0.0 109.921 -179.93 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.457 ' SG ' ' HB3' ' A' ' 53' ' ' ARG . 43.8 t -100.67 136.47 40.49 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.611 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -93.8 139.07 14.38 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 110.109 -1.196 . . . . 0.0 110.109 -179.099 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.504 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 48.9 p30 -64.14 -13.33 47.34 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.327 -1.102 . . . . 0.0 109.348 179.67 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.441 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 31.6 m-20 -85.61 11.31 11.03 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.236 -0.915 . . . . 0.0 109.237 179.844 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.5 20.32 66.71 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.886 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.523 ' O ' ' N ' ' A' ' 27' ' ' GLY . 83.0 mt-30 -121.98 145.93 47.65 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.304 -1.115 . . . . 0.0 109.503 -179.955 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.512 ' CG2' ' HA ' ' A' ' 57' ' ' LYS . 85.5 m -111.43 153.25 26.38 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.245 -0.909 . . . . 0.0 109.494 179.975 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.53 ' OH ' ' CG ' ' A' ' 42' ' ' GLU . 62.9 m-85 -135.69 145.67 46.96 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.246 -0.909 . . . . 0.0 109.196 179.648 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.514 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 0.1 OUTLIER -63.92 -72.44 0.14 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.144 -0.972 . . . . 0.0 108.574 179.9 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.544 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 9.3 t-20 -83.09 146.9 52.66 Favored Pre-proline 0 C--N 1.299 -1.63 0 O-C-N 121.446 -0.784 . . . . 0.0 109.461 179.709 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.519 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 41.7 Cg_endo -64.15 -51.75 1.98 Allowed 'Trans proline' 0 C--O 1.215 -0.629 0 C-N-CA 122.512 2.141 . . . . 0.0 111.414 179.678 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.544 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 6.6 t -59.34 -25.85 64.54 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 178.8 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.489 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 10.2 mmm -65.6 -19.21 65.82 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.232 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 1.077 HD13 ' CD1' ' A' ' 52' ' ' ILE . 5.7 tt -73.97 -52.19 13.6 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.126 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.576 ' N ' HD23 ' A' ' 39' ' ' LEU . 7.3 t -47.92 -33.36 7.52 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 178.685 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 58.1 t60 -49.95 -56.0 12.32 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 178.934 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.53 ' CG ' ' OH ' ' A' ' 33' ' ' TYR . 16.8 tt0 -50.67 -23.13 2.42 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.072 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.511 ' HB2' ' O ' ' A' ' 40' ' ' CYS . 5.4 m-80 -80.92 -29.67 35.48 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 119.545 -0.862 . . . . 0.0 109.095 179.828 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.86 ' CD2' HG11 ' A' ' 10' ' ' VAL . 27.7 tp -77.39 -35.87 53.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.293 -0.879 . . . . 0.0 109.369 179.942 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 8.0 mm -77.25 -52.77 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.174 -0.954 . . . . 0.0 109.296 179.816 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.416 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 17.5 mtt-85 -79.84 -15.31 57.65 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.311 -0.868 . . . . 0.0 109.49 179.86 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.454 ' HA ' ' O ' ' A' ' 43' ' ' ASN . 92.8 mt-30 60.9 33.4 19.9 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.242 -0.911 . . . . 0.0 109.542 -179.978 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 18.4 p -108.96 176.28 5.16 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.318 -0.864 . . . . 0.0 109.451 179.978 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.488 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 88.8 m-20 -102.91 54.03 0.77 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.285 -0.884 . . . . 0.0 109.423 179.95 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.497 ' N ' ' OD1' ' A' ' 43' ' ' ASN . 60.7 m -73.53 124.24 25.49 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.282 -0.886 . . . . 0.0 109.467 -179.971 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.488 ' CE1' ' O ' ' A' ' 49' ' ' ASN . 11.9 m-70 -111.89 -171.19 1.8 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.201 -0.937 . . . . 0.0 109.379 179.908 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 1.077 ' CD1' HD13 ' A' ' 39' ' ' LEU . 21.4 mm -86.45 125.05 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.276 -0.89 . . . . 0.0 109.702 -179.992 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.504 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 59.8 ttt180 -80.73 -42.82 21.24 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.415 -0.803 . . . . 0.0 109.38 179.6 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.403 ' H ' ' HB3' ' A' ' 26' ' ' CYS . 7.6 p -160.87 131.67 5.37 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.6 -0.687 . . . . 0.0 109.305 -179.188 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.425 ' H ' HG23 ' A' ' 55' ' ' THR . 8.0 p -49.13 147.38 2.98 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.214 -0.929 . . . . 0.0 109.089 179.803 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.529 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 85.46 172.45 48.98 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.239 -1.544 . . . . 0.0 109.239 -179.713 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.512 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 55.9 mttm -66.27 149.4 50.41 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.279 -1.13 . . . . 0.0 109.676 -179.77 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.408 ' SG ' ' OG1' ' A' ' 32' ' ' THR . 93.4 m -51.5 -31.18 22.85 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.297 -0.877 . . . . 0.0 109.23 179.878 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 69.6 tt0 -82.87 -25.95 32.05 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.26 -0.9 . . . . 0.0 109.355 -179.967 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.5 tp10 -92.66 116.13 28.73 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.167 -0.958 . . . . 0.0 109.361 179.923 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 9.9 p -127.54 149.95 49.91 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.29 -0.881 . . . . 0.0 109.33 179.96 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 22.8 t -114.24 156.12 24.89 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.278 -0.889 . . . . 0.0 109.537 179.973 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 72.1 p -71.06 156.9 91.37 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.217 -0.927 . . . . 0.0 109.412 179.967 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -70.03 142.64 47.26 Favored 'Trans proline' 0 C--O 1.214 -0.686 0 C-N-CA 122.691 2.261 . . . . 0.0 111.77 179.998 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -81.07 -174.66 49.15 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.998 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 49.2 p -66.3 -26.08 67.15 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.305 -1.115 . . . . 0.0 109.464 -179.998 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.444 ' OG1' ' O ' ' A' ' 69' ' ' ALA . 22.7 p -120.53 164.07 17.01 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.309 -0.87 . . . . 0.0 109.458 179.944 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.69 -35.04 79.63 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.187 -0.945 . . . . 0.0 109.483 179.944 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.734 ' HB1' ' SD ' ' A' ' 71' ' ' MET . . . -104.31 138.06 41.3 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.2 -0.937 . . . . 0.0 109.427 -179.962 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 87.3 p -63.0 -27.38 69.38 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.187 -0.946 . . . . 0.0 109.475 179.935 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.734 ' SD ' ' HB1' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -60.61 149.79 77.38 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.3 -0.875 . . . . 0.0 109.478 -179.977 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -70.71 149.41 60.81 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 122.717 2.278 . . . . 0.0 111.84 179.98 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -70.61 -2.99 11.67 Favored 'Trans proline' 0 C--O 1.215 -0.632 0 C-N-CA 122.733 2.289 . . . . 0.0 111.927 -179.945 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 82.9 p -85.83 -10.66 55.06 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.128 -0.983 . . . . 0.0 109.43 -179.883 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 31.9 p-10 -72.42 -26.43 61.85 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.202 -0.936 . . . . 0.0 109.511 -179.973 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 117.97 -1.014 . . . . 0.0 109.501 179.997 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.525 ' HB2' ' CE1' ' A' ' 51' ' ' HIS . 13.0 m -58.09 -36.81 73.4 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.278 -0.889 . . . . 0.0 109.264 179.814 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -54.29 -26.12 27.52 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.376 -0.827 . . . . 0.0 108.941 179.766 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 72.8 mmm -74.91 -25.35 58.86 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.522 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.601 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 44.5 m -80.26 -19.26 47.19 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.48 -0.762 . . . . 0.0 109.392 179.936 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 20.8 mttt -80.08 4.82 15.98 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.24 -0.913 . . . . 0.0 109.652 -179.911 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -128.84 4.75 5.43 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.03 -1.044 . . . . 0.0 110.415 -179.409 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.689 ' CE2' ' CZ ' ' A' ' 16' ' ' TYR . 0.9 OUTLIER -120.43 150.21 41.14 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.912 -1.117 . . . . 0.0 109.554 179.78 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 81.2 mtt180 -131.87 130.69 41.98 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.26 -0.9 . . . . 0.0 109.167 179.76 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.777 HG13 ' O ' ' A' ' 15' ' ' GLY . 58.5 t -118.1 149.3 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.303 -0.873 . . . . 0.0 110.099 -179.484 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.551 ' HB2' HD12 ' A' ' 14' ' ' ILE . 0.7 OUTLIER -127.55 175.42 3.4 Favored Pre-proline 0 N--CA 1.488 1.459 0 O-C-N 121.375 -0.828 . . . . 0.0 108.905 179.484 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.55 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 43.6 Cg_endo -67.22 -22.37 46.78 Favored 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 122.465 2.11 . . . . 0.0 111.746 179.908 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 15.5 mtt-85 -102.04 -28.99 12.03 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.214 -0.929 . . . . 0.0 109.635 -179.999 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.551 HD12 ' HB2' ' A' ' 11' ' ' LEU . 84.9 mt -79.54 -48.7 20.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.229 -0.919 . . . . 0.0 109.582 -179.685 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.777 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 81.9 -167.97 48.59 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 -179.93 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.689 ' CZ ' ' CE2' ' A' ' 8' ' ' TYR . 1.0 OUTLIER -97.69 146.87 24.91 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.131 -1.217 . . . . 0.0 109.618 179.985 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 24.9 tp -118.24 120.63 38.26 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.355 -0.841 . . . . 0.0 109.527 179.969 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.435 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 80.1 m -129.22 156.15 78.78 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.325 -0.859 . . . . 0.0 109.128 179.67 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.525 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 46.2 Cg_endo -69.72 163.95 36.33 Favored 'Trans proline' 0 C--O 1.216 -0.613 0 C-N-CA 122.655 2.236 . . . . 0.0 111.729 -179.987 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -89.78 -7.83 53.52 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.278 -0.889 . . . . 0.0 109.412 -179.987 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 -73.62 120.82 19.74 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.297 -0.877 . . . . 0.0 109.375 179.903 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.921 HD21 ' OD1' ' A' ' 34' ' ' ASN . 3.1 tm? -81.41 124.0 29.05 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.283 -0.886 . . . . 0.0 109.417 -179.923 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.723 ' N ' HD13 ' A' ' 22' ' ' LEU . 11.9 mttt -146.31 104.74 4.06 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.308 -0.87 . . . . 0.0 109.371 179.769 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.549 ' HA ' ' O ' ' A' ' 34' ' ' ASN . 42.6 Cg_endo -65.23 123.61 11.77 Favored 'Trans proline' 0 C--O 1.213 -0.752 0 C-N-CA 122.954 2.436 . . . . 0.0 111.95 -179.92 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.529 ' O ' HG23 ' A' ' 32' ' ' THR . 27.2 m -118.69 154.51 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.191 -0.943 . . . . 0.0 109.637 179.978 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.445 ' SG ' ' HB3' ' A' ' 53' ' ' ARG . 41.5 t -96.59 138.4 34.22 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.273 -0.892 . . . . 0.0 108.83 179.327 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -91.99 139.46 14.71 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 179.995 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.51 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 55.5 t0 -71.03 -7.17 44.51 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.265 -1.138 . . . . 0.0 109.511 -179.925 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.415 ' OD1' ' C ' ' A' ' 29' ' ' ASP . 59.1 p30 -89.6 3.62 52.0 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.187 -0.946 . . . . 0.0 109.462 179.732 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.21 13.39 52.41 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 -179.891 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.451 ' O ' ' N ' ' A' ' 27' ' ' GLY . 76.9 mt-30 -118.72 174.04 6.51 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.256 -1.144 . . . . 0.0 109.402 -179.964 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.612 HG21 ' HG3' ' A' ' 57' ' ' LYS . 23.2 m -135.93 137.23 41.14 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.308 -0.87 . . . . 0.0 109.341 179.839 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.788 ' CD1' HD13 ' A' ' 39' ' ' LEU . 29.3 m-85 -114.2 129.12 56.63 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.299 -0.876 . . . . 0.0 109.348 -179.915 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.921 ' OD1' HD21 ' A' ' 22' ' ' LEU . 63.6 t-20 -52.55 -79.78 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.297 -0.877 . . . . 0.0 109.742 -179.583 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.537 ' HB3' ' CG ' ' A' ' 38' ' ' MET . 2.0 t-20 -81.17 149.66 66.53 Favored Pre-proline 0 C--N 1.3 -1.57 0 O-C-N 120.927 -1.108 . . . . 0.0 109.567 -179.813 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.508 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 39.9 Cg_endo -63.07 -54.53 1.08 Allowed 'Trans proline' 0 C--O 1.214 -0.68 0 C-N-CA 122.729 2.286 . . . . 0.0 111.925 -179.765 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.532 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 9.1 t -61.15 -29.15 69.61 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.997 -1.064 . . . . 0.0 108.224 179.116 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.537 ' CG ' ' HB3' ' A' ' 35' ' ' ASN . 69.6 mmm -62.56 -16.42 56.05 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 179.321 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.788 HD13 ' CD1' ' A' ' 33' ' ' TYR . 24.5 tp -69.08 -58.14 4.48 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.382 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.481 ' HB3' ' OH ' ' A' ' 16' ' ' TYR . 8.8 t -56.95 -29.82 63.49 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 178.685 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 54.9 t60 -64.1 -60.45 3.21 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.189 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.567 ' OE1' ' CE2' ' A' ' 33' ' ' TYR . 83.9 tt0 -57.79 -22.33 46.62 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.328 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.505 ' O ' ' N ' ' A' ' 47' ' ' GLN . 97.3 m-20 -76.4 -31.97 58.27 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.41 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 15.9 tp -66.49 -31.82 72.8 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.267 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 5.4 mt -75.81 -44.7 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 179.41 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.461 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 73.4 mtt-85 -80.61 -20.48 43.14 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.493 -0.754 . . . . 0.0 109.378 179.786 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.505 ' N ' ' O ' ' A' ' 43' ' ' ASN . 89.2 mt-30 63.3 43.49 6.15 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.313 -0.867 . . . . 0.0 109.43 -179.927 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.3 p -123.75 161.82 24.41 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.343 -0.848 . . . . 0.0 109.298 179.868 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.425 ' O ' ' CG ' ' A' ' 49' ' ' ASN . 44.8 p-10 -96.51 59.71 1.83 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.185 -0.947 . . . . 0.0 109.448 179.957 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 34.7 m -72.81 140.45 47.66 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.199 -0.938 . . . . 0.0 109.82 -179.872 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.525 ' CE1' ' HB2' ' A' ' 2' ' ' SER . 49.3 m-70 -118.49 172.03 7.75 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.39 -0.819 . . . . 0.0 108.918 179.578 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.478 HG23 ' HB ' ' A' ' 25' ' ' VAL . 35.9 mt -81.54 126.28 39.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.141 -0.974 . . . . 0.0 109.291 179.772 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.51 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 39.8 ttt180 -79.73 -44.17 21.25 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.458 -0.776 . . . . 0.0 109.202 179.978 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.3 t -160.0 157.99 29.79 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.909 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 29.9 p -72.38 144.95 48.03 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.159 -0.963 . . . . 0.0 109.444 -179.907 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.546 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 84.83 165.92 40.71 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.865 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.612 ' HG3' HG21 ' A' ' 32' ' ' THR . 41.5 tttt -53.1 150.23 6.01 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.43 -1.041 . . . . 0.0 109.438 -179.98 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 98.8 m -52.95 -25.97 13.64 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.248 -0.907 . . . . 0.0 109.317 179.887 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 78.1 tt0 -82.31 -20.52 37.24 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.346 -0.846 . . . . 0.0 109.339 179.935 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -89.61 123.16 33.43 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.252 -0.905 . . . . 0.0 109.365 179.914 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 41.6 p -135.75 155.18 50.77 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.202 -0.936 . . . . 0.0 109.536 179.966 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 95.5 p -117.74 157.23 26.9 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.277 -0.89 . . . . 0.0 109.543 -179.987 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -125.84 85.05 59.85 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.301 -0.874 . . . . 0.0 109.356 179.902 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -68.25 -22.11 40.75 Favored 'Trans proline' 0 C--O 1.214 -0.715 0 C-N-CA 122.757 2.305 . . . . 0.0 111.94 -179.948 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.86 12.39 68.75 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.837 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.821 HG22 ' H ' ' A' ' 68' ' ' ALA . 48.2 m -121.47 136.67 54.93 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.216 -1.167 . . . . 0.0 109.511 179.965 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 51.5 p -74.06 -13.51 60.85 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.282 -0.886 . . . . 0.0 109.445 -179.97 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.821 ' H ' HG22 ' A' ' 66' ' ' THR . . . -60.62 -32.36 71.51 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.244 -0.91 . . . . 0.0 109.489 -179.946 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.4 ' C ' ' HD2' ' A' ' 72' ' ' PRO . . . -57.5 147.22 27.27 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.159 -0.963 . . . . 0.0 109.487 179.971 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 85.3 p -67.81 -28.37 67.52 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.261 -0.9 . . . . 0.0 109.548 -179.983 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.486 ' N ' ' HD2' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -51.07 -60.15 6.19 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.278 -0.889 . . . . 0.0 109.439 -179.912 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.486 ' HD2' ' N ' ' A' ' 71' ' ' MET . 49.0 Cg_endo -70.16 151.97 67.04 Favored 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 122.651 2.234 . . . . 0.0 111.757 -179.973 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -68.78 149.3 72.82 Favored 'Trans proline' 0 C--O 1.216 -0.623 0 C-N-CA 122.683 2.255 . . . . 0.0 111.819 179.966 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 25.2 t -122.49 141.03 52.08 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.187 -0.946 . . . . 0.0 109.522 -179.918 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -68.34 142.03 55.61 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.254 -0.904 . . . . 0.0 109.475 179.883 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.435 -179.985 . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.562 ' HB2' ' CE1' ' A' ' 51' ' ' HIS . 5.1 m -56.4 -26.7 54.11 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.342 -0.849 . . . . 0.0 109.454 -179.997 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -52.33 -25.42 9.61 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.182 -0.949 . . . . 0.0 108.736 179.8 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 74.6 mtm -72.45 -26.73 61.94 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.171 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.582 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 24.5 m -80.48 -14.27 58.41 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.506 -0.746 . . . . 0.0 109.21 179.659 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.459 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 46.0 mttm -80.94 6.89 11.98 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.27 -0.894 . . . . 0.0 109.649 -179.954 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.459 ' OD1' ' O ' ' A' ' 6' ' ' LYS . 99.3 m-20 -139.12 14.94 2.63 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.108 -0.995 . . . . 0.0 110.309 -179.415 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.844 ' OH ' HD11 ' A' ' 44' ' ' LEU . 0.7 OUTLIER -123.93 152.38 42.51 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.889 -1.132 . . . . 0.0 109.561 179.876 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 16.8 mtm-85 -130.29 132.81 46.07 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.327 -0.858 . . . . 0.0 109.3 179.859 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.844 HG13 ' O ' ' A' ' 15' ' ' GLY . 53.2 t -123.85 145.98 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.144 -0.972 . . . . 0.0 109.462 -179.93 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.567 ' CG ' ' HD2' ' A' ' 12' ' ' PRO . 0.2 OUTLIER -125.12 175.92 2.74 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.241 -0.912 . . . . 0.0 109.339 -179.791 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.567 ' HD2' ' CG ' ' A' ' 11' ' ' LEU . 46.4 Cg_endo -67.65 -22.81 43.4 Favored 'Trans proline' 0 C--O 1.214 -0.681 0 C-N-CA 122.6 2.2 . . . . 0.0 111.664 179.971 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 62.6 ttt-85 -103.27 -22.87 13.65 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.323 -0.86 . . . . 0.0 109.493 179.927 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 36.3 mm -86.1 -51.33 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.223 -0.923 . . . . 0.0 109.425 -179.963 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.844 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 81.42 -163.23 44.47 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -179.917 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.629 ' CE2' ' CE2' ' A' ' 8' ' ' TYR . 1.4 t80 -99.29 150.48 22.06 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.172 -1.193 . . . . 0.0 109.514 179.957 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 18.1 tp -117.85 108.02 14.83 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.22 -0.925 . . . . 0.0 109.693 -179.841 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.442 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 61.3 m -118.13 155.74 51.14 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.258 -0.901 . . . . 0.0 109.269 179.792 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -72.3 167.28 27.34 Favored 'Trans proline' 0 C--O 1.216 -0.624 0 C-N-CA 122.671 2.248 . . . . 0.0 111.675 -179.929 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 61.3 tttm -83.08 -31.01 27.54 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.24 -0.913 . . . . 0.0 109.373 -179.932 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -57.73 126.97 29.73 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.257 -0.902 . . . . 0.0 109.541 179.941 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.575 HD11 ' HB3' ' A' ' 34' ' ' ASN . 66.3 tp -87.93 117.86 27.08 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.315 -0.866 . . . . 0.0 109.393 179.829 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.535 ' CB ' ' HD3' ' A' ' 36' ' ' PRO . 2.8 mttm -125.57 101.8 30.11 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.229 -0.919 . . . . 0.0 109.466 -179.795 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.546 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 42.5 Cg_endo -64.83 118.96 5.89 Favored 'Trans proline' 0 C--O 1.212 -0.809 0 C-N-CA 122.96 2.44 . . . . 0.0 112.28 -179.599 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.485 ' HB ' HG23 ' A' ' 52' ' ' ILE . 15.8 m -119.41 154.59 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.221 -0.925 . . . . 0.0 109.589 179.709 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.47 ' SG ' ' HB3' ' A' ' 53' ' ' ARG . 31.7 t -95.63 141.02 29.63 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.213 -0.93 . . . . 0.0 108.797 178.995 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -95.61 137.35 13.36 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 179.997 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.5 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 54.3 t0 -69.69 -5.41 24.8 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.236 -1.156 . . . . 0.0 109.579 -179.936 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -89.96 1.24 56.5 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.221 -0.924 . . . . 0.0 109.483 179.646 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.47 27.21 12.04 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.861 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.536 ' O ' ' N ' ' A' ' 27' ' ' GLY . 79.2 mt-30 -136.68 153.7 50.82 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.235 -1.156 . . . . 0.0 109.51 -179.968 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.818 HG21 ' HG3' ' A' ' 57' ' ' LYS . 3.5 m -114.96 139.59 49.7 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.294 -0.879 . . . . 0.0 109.31 179.854 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.83 ' CD1' HD13 ' A' ' 39' ' ' LEU . 86.0 m-85 -116.54 132.21 56.74 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.291 -0.881 . . . . 0.0 109.381 -179.904 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.575 ' HB3' HD11 ' A' ' 22' ' ' LEU . 9.8 m-20 -54.8 -78.93 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.352 -0.842 . . . . 0.0 109.728 -179.546 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.494 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 14.3 t-20 -82.35 146.5 54.38 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 120.999 -1.063 . . . . 0.0 109.664 -179.976 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.535 ' HD3' ' CB ' ' A' ' 23' ' ' LYS . 41.3 Cg_endo -63.81 -50.86 2.75 Favored 'Trans proline' 0 C--O 1.214 -0.715 0 C-N-CA 122.63 2.22 . . . . 0.0 111.282 179.367 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.528 ' SG ' ' CE1' ' A' ' 16' ' ' TYR . 7.8 t -60.9 -29.68 69.73 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 178.767 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.47 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 37.8 mmm -64.36 -15.88 61.23 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.103 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.83 HD13 ' CD1' ' A' ' 33' ' ' TYR . 54.5 tp -71.49 -58.84 3.14 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.346 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.447 ' HB3' ' OH ' ' A' ' 16' ' ' TYR . 13.6 t -53.51 -25.8 18.14 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 178.832 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 48.5 t60 -70.94 -63.32 1.12 Allowed 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.353 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.404 ' HA ' ' OE1' ' A' ' 42' ' ' GLU . 74.2 mm-40 -52.72 -21.73 4.4 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 179.237 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.474 ' OD1' ' HB ' ' A' ' 50' ' ' THR . 98.3 m-20 -75.21 -34.56 61.51 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.506 -0.746 . . . . 0.0 109.21 179.652 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.844 HD11 ' OH ' ' A' ' 8' ' ' TYR . 17.6 mt -64.16 -29.34 70.46 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.183 -0.948 . . . . 0.0 109.047 179.58 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.4 mt -80.42 -44.22 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.385 -0.822 . . . . 0.0 109.433 179.69 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.445 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 93.1 mtt-85 -79.97 -34.64 38.5 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.29 -0.881 . . . . 0.0 109.572 179.938 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.446 ' N ' ' O ' ' A' ' 43' ' ' ASN . 92.1 mt-30 63.01 43.74 6.4 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.334 -0.854 . . . . 0.0 109.561 179.979 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 68.4 p -117.31 16.56 14.8 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.329 -0.857 . . . . 0.0 109.295 179.77 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 47.9 t30 43.8 60.91 2.49 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.288 -0.882 . . . . 0.0 109.568 -179.902 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.474 ' HB ' ' OD1' ' A' ' 43' ' ' ASN . 25.7 m -77.96 147.34 34.98 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.26 -0.9 . . . . 0.0 109.626 179.869 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.562 ' CE1' ' HB2' ' A' ' 2' ' ' SER . 56.8 m-70 -121.63 168.16 12.09 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.362 -0.836 . . . . 0.0 108.788 179.481 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.485 HG23 ' HB ' ' A' ' 25' ' ' VAL . 26.2 mt -79.79 123.71 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.076 -1.015 . . . . 0.0 109.279 179.977 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.5 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 75.2 ttt-85 -80.21 -42.83 22.56 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.474 -0.766 . . . . 0.0 109.363 -179.94 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -158.45 147.3 18.93 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.444 -0.785 . . . . 0.0 109.279 179.998 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.9 p -66.51 149.74 49.99 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.207 -0.933 . . . . 0.0 109.42 -179.86 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.546 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 73.44 162.3 7.39 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 108.961 -1.656 . . . . 0.0 108.961 -179.594 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.818 ' HG3' HG21 ' A' ' 32' ' ' THR . 22.4 tttp -51.57 146.25 7.81 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.314 -1.109 . . . . 0.0 108.755 179.883 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.438 ' O ' ' O ' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -59.75 -155.34 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.171 -0.956 . . . . 0.0 109.543 -179.612 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.475 ' HG2' ' O ' ' A' ' 59' ' ' GLU . 86.4 tt0 -79.39 1.52 25.01 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.18 -0.95 . . . . 0.0 109.742 -179.552 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.434 ' HB2' ' HE3' ' A' ' 57' ' ' LYS . 6.0 mt-10 -59.99 -43.79 94.94 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.108 -0.995 . . . . 0.0 109.281 179.766 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.452 ' HB3' ' HD3' ' A' ' 57' ' ' LYS . 21.7 p -58.23 -21.92 49.99 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.276 -0.89 . . . . 0.0 109.482 -179.984 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 25.6 m -64.95 151.27 46.23 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.267 -0.896 . . . . 0.0 109.512 -179.94 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.21 156.63 48.93 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.308 -0.87 . . . . 0.0 109.495 -179.989 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -70.42 138.65 36.18 Favored 'Trans proline' 0 C--O 1.216 -0.614 0 C-N-CA 122.674 2.25 . . . . 0.0 111.775 -179.929 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -83.42 178.99 52.65 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.968 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 17.6 p -122.72 164.79 17.64 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.232 -1.158 . . . . 0.0 109.488 -179.917 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 16.0 p -123.03 159.3 28.7 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.269 -0.894 . . . . 0.0 109.473 179.983 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -60.03 -30.9 69.48 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.23 -0.918 . . . . 0.0 109.577 -179.973 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.404 ' O ' ' HD3' ' A' ' 72' ' ' PRO . . . -62.48 -35.14 78.39 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.192 -0.943 . . . . 0.0 109.458 -179.95 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.3 m -55.43 -30.24 60.11 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.291 -0.881 . . . . 0.0 109.542 -179.984 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.22 81.0 71.36 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.331 -0.855 . . . . 0.0 109.515 179.921 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.404 ' HD3' ' O ' ' A' ' 69' ' ' ALA . 49.7 Cg_endo -70.5 156.74 60.78 Favored 'Trans proline' 0 C--O 1.214 -0.701 0 C-N-CA 122.688 2.259 . . . . 0.0 111.806 -179.838 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -70.57 163.91 37.22 Favored 'Trans proline' 0 C--O 1.214 -0.69 0 C-N-CA 122.69 2.26 . . . . 0.0 111.764 179.991 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 89.6 p -82.4 -7.68 59.63 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.265 -0.897 . . . . 0.0 109.636 -179.957 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -66.44 -30.26 70.57 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.178 -0.951 . . . . 0.0 109.574 -179.978 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 117.931 -1.033 . . . . 0.0 109.569 179.939 . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 . . . . . 0 N--CA 1.491 1.621 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.3 m -52.36 -22.35 4.51 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.258 -0.901 . . . . 0.0 109.315 179.97 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.454 ' HA ' ' HG3' ' A' ' 6' ' ' LYS . 1.4 tt0 -50.94 -23.26 2.74 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.222 -0.924 . . . . 0.0 108.865 179.77 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 56.4 mtt -77.79 -28.78 50.53 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 179.598 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.437 ' O ' ' N ' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -89.8 -13.43 36.63 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.338 -0.851 . . . . 0.0 108.743 179.663 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.454 ' HG3' ' HA ' ' A' ' 3' ' ' GLU . 34.5 mttm -46.58 -27.46 1.14 Allowed 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 179.327 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.4 ' N ' ' C ' ' A' ' 5' ' ' CYS . 45.4 p-10 -119.15 39.26 3.6 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 178.752 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.573 ' CE2' ' OH ' ' A' ' 16' ' ' TYR . 1.6 t80 -79.48 157.43 27.48 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.62 -0.675 . . . . 0.0 109.839 -179.258 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 15.1 mtt180 -150.17 115.25 5.37 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.398 -0.814 . . . . 0.0 109.055 179.542 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.581 HG13 ' C ' ' A' ' 15' ' ' GLY . 54.4 t -123.22 146.88 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.342 -0.848 . . . . 0.0 109.521 -179.625 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.534 ' HB2' HD12 ' A' ' 14' ' ' ILE . 0.2 OUTLIER -121.2 172.91 4.35 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.384 -0.823 . . . . 0.0 109.347 -179.881 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.518 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 44.2 Cg_endo -66.29 -22.81 52.66 Favored 'Trans proline' 0 C--O 1.216 -0.592 0 C-N-CA 122.669 2.246 . . . . 0.0 111.594 179.802 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 86.6 mtt-85 -101.51 -25.86 13.76 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.365 -0.835 . . . . 0.0 109.328 179.824 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.534 HD12 ' HB2' ' A' ' 11' ' ' LEU . 85.7 mt -87.52 -47.41 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.281 -0.887 . . . . 0.0 109.415 179.966 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.581 ' C ' HG13 ' A' ' 10' ' ' VAL . . . 69.46 -172.35 38.79 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.894 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.573 ' OH ' ' CE2' ' A' ' 8' ' ' TYR . 1.5 t80 -95.0 150.86 19.7 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.203 -1.175 . . . . 0.0 109.494 179.927 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 21.8 tp -113.38 106.04 14.11 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.255 -0.903 . . . . 0.0 109.633 -179.83 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.418 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 56.0 m -124.54 154.89 69.8 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.304 -0.873 . . . . 0.0 109.389 179.774 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -72.5 170.77 18.55 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 C-N-CA 122.639 2.226 . . . . 0.0 111.491 179.823 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 41.3 tttp -86.77 -33.9 19.77 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.301 -0.875 . . . . 0.0 109.51 -179.926 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -54.14 133.16 44.12 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.318 -0.864 . . . . 0.0 109.383 179.97 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.628 HD11 ' HB3' ' A' ' 34' ' ' ASN . 54.7 tp -92.4 113.14 25.33 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.164 -0.96 . . . . 0.0 109.417 -179.974 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.545 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 5.3 mmtt -118.94 101.68 49.93 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.301 -0.874 . . . . 0.0 109.172 179.981 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.548 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 43.0 Cg_endo -65.35 118.15 5.2 Favored 'Trans proline' 0 C--O 1.213 -0.76 0 C-N-CA 122.848 2.365 . . . . 0.0 112.034 -179.491 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.636 ' O ' HG23 ' A' ' 32' ' ' THR . 11.1 m -114.26 155.99 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.224 -0.923 . . . . 0.0 109.583 179.842 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 46.1 t -96.32 133.77 40.29 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.124 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -91.12 137.01 13.64 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.555 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.48 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 49.9 p30 -66.19 -9.12 28.82 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.341 -1.094 . . . . 0.0 109.502 179.855 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 56.0 p30 -86.09 8.81 19.32 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.18 -0.95 . . . . 0.0 109.397 179.894 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.23 18.78 58.53 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 -179.921 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.405 ' O ' ' SG ' ' A' ' 58' ' ' CYS . 64.4 mt-30 -125.97 176.09 7.24 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.205 -1.174 . . . . 0.0 109.39 -179.942 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.662 HG21 ' HA ' ' A' ' 57' ' ' LYS . 25.1 m -135.44 139.3 44.01 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.258 -0.901 . . . . 0.0 109.442 -179.981 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.971 ' CD1' HD13 ' A' ' 39' ' ' LEU . 58.1 m-85 -113.38 130.57 56.26 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.36 -0.838 . . . . 0.0 109.293 179.855 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.628 ' HB3' HD11 ' A' ' 22' ' ' LEU . 13.9 m-20 -51.83 -80.47 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.317 -0.864 . . . . 0.0 109.693 -179.542 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.509 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 12.0 t-20 -82.39 146.04 53.16 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.005 -1.059 . . . . 0.0 109.482 179.945 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.545 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.9 Cg_endo -63.68 -50.86 2.84 Favored 'Trans proline' 0 C--O 1.216 -0.612 0 C-N-CA 122.653 2.235 . . . . 0.0 111.563 179.723 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.556 ' SG ' ' CE1' ' A' ' 16' ' ' TYR . 11.0 t -61.99 -28.21 69.41 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 178.931 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.461 ' HB2' ' HB3' ' A' ' 35' ' ' ASN . 43.0 mmm -68.92 -7.81 38.43 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 179.24 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.971 HD13 ' CD1' ' A' ' 33' ' ' TYR . 25.5 tp -73.72 -60.09 2.41 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.29 -0.881 . . . . 0.0 108.902 179.802 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.462 ' SG ' ' OH ' ' A' ' 16' ' ' TYR . 12.0 t -52.91 -24.84 10.08 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.382 -0.969 . . . . 0.0 108.382 179.273 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 33.8 t60 -65.09 -60.7 2.74 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.193 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 66.0 mt-10 -60.22 -21.57 61.95 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 179.063 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.501 ' ND2' ' HG ' ' A' ' 39' ' ' LEU . 97.2 m-20 -78.22 -27.01 47.64 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.512 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.97 HD13 ' O ' ' A' ' 44' ' ' LEU . 1.4 tm? -68.54 -36.34 78.68 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.269 -0.894 . . . . 0.0 108.732 179.422 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -77.24 -41.66 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.46 -0.775 . . . . 0.0 109.165 179.719 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.506 ' HB3' HG23 ' A' ' 48' ' ' THR . 93.2 mtt-85 -80.11 -36.23 35.67 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.329 -0.857 . . . . 0.0 109.307 179.898 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.445 ' N ' ' O ' ' A' ' 43' ' ' ASN . 53.1 mt-30 60.05 35.4 21.38 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.368 -0.832 . . . . 0.0 109.678 179.834 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.506 HG23 ' HB3' ' A' ' 46' ' ' ARG . 34.6 p -103.13 11.21 37.35 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.171 -0.956 . . . . 0.0 109.413 179.785 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 65.1 m-20 52.51 54.4 10.7 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.232 -0.918 . . . . 0.0 109.478 179.976 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.477 ' HB ' ' OD1' ' A' ' 43' ' ' ASN . 42.9 m -79.77 137.24 36.95 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.198 -0.938 . . . . 0.0 109.527 179.984 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 41.1 m80 -115.53 170.53 8.35 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.363 -0.836 . . . . 0.0 108.947 179.505 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.573 HG23 ' HB ' ' A' ' 25' ' ' VAL . 29.3 mt -79.62 125.79 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.183 -0.948 . . . . 0.0 109.312 179.884 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.48 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 47.8 ttt180 -81.74 -40.86 22.06 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.501 -0.75 . . . . 0.0 109.496 -179.887 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -158.91 150.59 20.77 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.398 -0.814 . . . . 0.0 109.237 -179.999 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 31.0 p -69.81 139.11 53.14 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.234 -0.917 . . . . 0.0 109.516 -179.873 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.548 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 92.44 162.92 37.44 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.85 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.662 ' HA ' HG21 ' A' ' 32' ' ' THR . 39.5 tttp -50.62 148.55 3.82 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.434 -1.039 . . . . 0.0 109.272 179.887 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.405 ' SG ' ' O ' ' A' ' 31' ' ' GLN . 57.8 m -52.07 -26.75 11.76 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.191 -0.943 . . . . 0.0 109.501 -179.975 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.438 ' O ' ' HG2' ' A' ' 59' ' ' GLU . 54.7 tt0 -87.48 -22.17 25.07 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.26 -0.9 . . . . 0.0 109.229 179.864 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 60.4 tt0 -68.45 -33.24 73.84 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.397 -0.814 . . . . 0.0 109.304 179.869 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 16.2 m -61.49 -32.75 72.78 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.213 -0.929 . . . . 0.0 109.438 179.97 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 23.0 t -106.4 153.77 21.77 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.316 -0.865 . . . . 0.0 109.48 179.992 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.49 82.85 66.64 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.228 -0.92 . . . . 0.0 109.437 -179.924 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -71.49 -14.82 30.88 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 122.741 2.294 . . . . 0.0 111.777 -179.967 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 83.04 -162.9 41.1 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.979 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.558 HG22 ' H ' ' A' ' 68' ' ' ALA . 38.0 m -119.62 142.24 48.59 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.232 -1.157 . . . . 0.0 109.498 -179.981 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 40.2 m -56.02 -31.96 63.58 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.293 -0.879 . . . . 0.0 109.527 -179.999 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.558 ' H ' HG22 ' A' ' 66' ' ' THR . . . -67.78 -30.56 70.04 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.313 -0.867 . . . . 0.0 109.369 -179.965 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.445 ' O ' ' HD3' ' A' ' 72' ' ' PRO . . . -62.85 -31.98 73.11 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.204 -0.935 . . . . 0.0 109.412 179.999 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 86.3 p -58.55 -28.28 65.36 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.193 -0.942 . . . . 0.0 109.47 -179.988 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 65.5 mtp -123.78 76.92 56.98 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.315 -0.866 . . . . 0.0 109.436 179.947 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.445 ' HD3' ' O ' ' A' ' 69' ' ' ALA . 50.4 Cg_endo -70.4 145.56 53.78 Favored 'Trans proline' 0 C--O 1.214 -0.7 0 C-N-CA 122.747 2.298 . . . . 0.0 111.832 179.992 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -71.21 144.0 45.39 Favored 'Trans proline' 0 C--O 1.215 -0.629 0 C-N-CA 122.641 2.227 . . . . 0.0 111.748 179.942 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 29.9 t -128.92 141.11 51.38 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.22 -0.925 . . . . 0.0 109.53 179.987 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -58.59 -36.0 73.31 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.215 -0.928 . . . . 0.0 109.426 -179.963 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 117.946 -1.026 . . . . 0.0 109.43 179.973 . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.1 m -52.79 -24.39 8.79 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.247 -0.908 . . . . 0.0 109.326 179.905 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.446 ' HA ' ' HG3' ' A' ' 6' ' ' LYS . 3.9 mt-10 -54.92 -21.73 12.57 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.326 -0.859 . . . . 0.0 109.133 179.933 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 76.8 mtm -76.11 -29.46 57.89 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.261 -0.9 . . . . 0.0 108.957 179.525 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.507 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 12.9 m -79.81 -14.0 59.01 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.289 -0.882 . . . . 0.0 109.0 179.696 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.446 ' HG3' ' HA ' ' A' ' 3' ' ' GLU . 47.2 mttm -56.6 -28.2 59.83 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.336 -0.853 . . . . 0.0 109.724 -179.792 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -149.21 61.89 1.04 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.196 -0.94 . . . . 0.0 110.044 -179.779 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.664 ' OH ' HD13 ' A' ' 44' ' ' LEU . 4.7 p90 -121.91 168.2 12.16 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.093 -1.005 . . . . 0.0 109.348 179.534 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 34.2 ttt85 -147.99 149.02 31.39 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.148 -0.97 . . . . 0.0 109.605 179.922 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.757 HG13 ' C ' ' A' ' 15' ' ' GLY . 87.2 t -140.94 134.96 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.302 -0.874 . . . . 0.0 109.369 179.888 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.551 HD23 ' HD2' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -120.59 173.71 3.55 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.15 -0.969 . . . . 0.0 109.391 179.961 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.551 ' HD2' HD23 ' A' ' 11' ' ' LEU . 47.3 Cg_endo -67.9 -23.94 40.51 Favored 'Trans proline' 0 C--O 1.215 -0.644 0 C-N-CA 122.604 2.203 . . . . 0.0 111.737 179.944 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -104.62 -26.87 12.16 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.283 -0.886 . . . . 0.0 109.453 179.992 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.437 HD12 ' HB2' ' A' ' 11' ' ' LEU . 95.2 mt -86.2 -44.43 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.241 -0.912 . . . . 0.0 109.512 -179.94 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.757 ' C ' HG13 ' A' ' 10' ' ' VAL . . . 73.92 -158.73 52.38 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -179.957 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.525 ' CD2' HG21 ' A' ' 10' ' ' VAL . 1.9 t80 -99.64 155.29 17.68 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.285 -1.126 . . . . 0.0 109.345 179.803 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.442 ' O ' ' SG ' ' A' ' 37' ' ' CYS . 30.5 tp -114.16 120.1 39.36 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.229 -0.919 . . . . 0.0 109.883 -179.63 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.401 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 69.4 m -138.65 156.22 73.15 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.279 -0.888 . . . . 0.0 109.366 179.894 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.489 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 52.0 Cg_endo -71.65 168.76 22.78 Favored 'Trans proline' 0 C--O 1.215 -0.635 0 C-N-CA 122.681 2.254 . . . . 0.0 111.638 -179.989 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 29.0 mttt -89.9 -12.72 38.09 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.156 -0.965 . . . . 0.0 109.366 179.961 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -72.2 132.06 43.59 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.285 -0.885 . . . . 0.0 109.202 179.698 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.425 HD11 ' HB3' ' A' ' 34' ' ' ASN . 28.7 tp -91.85 114.19 26.66 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.216 -0.927 . . . . 0.0 109.807 -179.679 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.554 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -126.96 106.78 22.21 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.344 -0.848 . . . . 0.0 108.897 179.604 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.546 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 44.0 Cg_endo -65.88 119.93 7.02 Favored 'Trans proline' 0 C--O 1.214 -0.722 0 C-N-CA 122.825 2.35 . . . . 0.0 112.144 -179.315 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.472 ' O ' HG23 ' A' ' 32' ' ' THR . 21.4 m -116.96 153.22 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.232 -0.917 . . . . 0.0 109.518 179.75 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.454 ' SG ' ' HB3' ' A' ' 53' ' ' ARG . 48.6 t -97.04 142.28 29.17 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 178.989 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -93.88 140.52 15.09 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 -178.999 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.473 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 52.4 p30 -67.41 -10.51 51.94 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.31 -1.112 . . . . 0.0 109.264 179.627 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.426 ' OD1' ' HB2' ' A' ' 31' ' ' GLN . 57.0 p30 -90.07 5.91 44.68 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.226 -0.922 . . . . 0.0 109.474 179.891 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.32 15.36 57.37 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 -179.925 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.458 ' O ' ' SG ' ' A' ' 58' ' ' CYS . 84.3 mt-30 -114.87 178.88 4.12 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.374 -1.074 . . . . 0.0 109.387 179.981 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.519 ' CG2' ' HA ' ' A' ' 57' ' ' LYS . 30.7 m -141.21 144.82 34.97 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.193 -0.942 . . . . 0.0 109.335 179.866 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.813 ' CD1' HD13 ' A' ' 39' ' ' LEU . 23.9 m-85 -124.59 126.7 46.22 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.269 -0.895 . . . . 0.0 109.278 -179.965 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.527 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 9.8 m-20 -48.38 -78.57 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.301 -0.874 . . . . 0.0 109.736 -179.467 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.542 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 4.5 t-20 -81.49 147.67 60.4 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 120.941 -1.1 . . . . 0.0 109.393 179.983 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.554 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 41.0 Cg_endo -63.66 -53.77 1.22 Allowed 'Trans proline' 0 C--O 1.215 -0.644 0 C-N-CA 122.872 2.381 . . . . 0.0 111.926 -179.963 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.542 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 11.3 t -62.98 -25.68 68.48 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 120.942 -1.099 . . . . 0.0 108.141 179.051 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.435 ' CG ' ' HB3' ' A' ' 35' ' ' ASN . 42.1 mmm -67.35 -13.08 61.67 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.21 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.813 HD13 ' CD1' ' A' ' 33' ' ' TYR . 19.1 tp -70.3 -57.55 4.74 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.427 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.473 ' HB3' ' OH ' ' A' ' 16' ' ' TYR . 3.3 t -56.05 -26.77 50.6 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.026 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.499 ' CE1' ' HB2' ' A' ' 16' ' ' TYR . 31.2 t60 -62.43 -59.55 4.82 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.963 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -58.33 -22.89 54.94 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 178.915 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.503 ' O ' ' N ' ' A' ' 47' ' ' GLN . 91.3 m-20 -79.19 -27.75 42.6 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.584 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.664 HD13 ' OH ' ' A' ' 8' ' ' TYR . 32.6 tp -70.22 -30.86 68.05 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.498 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 6.5 mm -80.31 -46.29 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.475 -0.766 . . . . 0.0 109.113 179.467 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.461 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 85.3 mtt180 -79.88 -36.56 36.42 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.309 -0.87 . . . . 0.0 109.394 179.712 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.503 ' N ' ' O ' ' A' ' 43' ' ' ASN . 92.4 mt-30 63.75 42.34 6.29 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.497 -0.752 . . . . 0.0 109.616 -179.862 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.404 HG23 ' HB3' ' A' ' 46' ' ' ARG . 49.4 p -106.8 10.16 30.82 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.195 -0.94 . . . . 0.0 109.417 179.737 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 51.51 54.68 10.62 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.273 -0.892 . . . . 0.0 109.71 179.874 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.46 ' HB ' ' OD1' ' A' ' 43' ' ' ASN . 51.5 m -79.88 139.93 36.94 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.215 -0.928 . . . . 0.0 109.528 179.985 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.449 ' CD2' ' OD2' ' A' ' 28' ' ' ASP . 8.4 m-70 -112.47 -173.42 2.24 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.239 -0.913 . . . . 0.0 109.397 179.722 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 39.8 mt -93.87 126.46 46.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.378 -0.826 . . . . 0.0 109.594 -179.933 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.473 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 68.1 ttt-85 -80.02 -45.77 17.78 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.43 -0.794 . . . . 0.0 109.3 179.787 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.41 ' H ' ' HB3' ' A' ' 26' ' ' CYS . 49.4 p -160.88 147.59 15.17 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 -179.445 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.3 p -61.23 144.14 54.32 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.137 -0.977 . . . . 0.0 109.411 179.929 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.546 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 87.51 164.01 39.66 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 -179.775 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.519 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 53.1 mttt -60.44 148.81 36.17 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.414 -1.051 . . . . 0.0 109.293 179.913 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.458 ' SG ' ' O ' ' A' ' 31' ' ' GLN . 61.8 m -54.7 -19.33 5.98 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.189 -0.944 . . . . 0.0 108.999 179.532 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -79.69 -13.12 59.7 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.448 -0.783 . . . . 0.0 109.236 179.873 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.434 ' HG2' ' HB2' ' A' ' 57' ' ' LYS . 13.8 mm-40 -87.37 -24.54 24.21 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 179.263 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 84.0 p -62.95 -13.39 34.15 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.39 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 9.0 t -127.92 155.0 44.89 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.42 -0.8 . . . . 0.0 109.326 179.996 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.99 83.03 64.87 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.14 -0.975 . . . . 0.0 109.737 -179.783 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -72.19 141.68 36.41 Favored 'Trans proline' 0 C--O 1.217 -0.567 0 C-N-CA 122.545 2.163 . . . . 0.0 111.682 179.815 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 89.85 14.93 58.74 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.802 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 58.3 m -112.61 139.4 48.24 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.195 -1.18 . . . . 0.0 109.486 179.877 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.626 HG22 ' H ' ' A' ' 69' ' ' ALA . 34.1 m -122.19 143.67 49.42 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.288 -0.883 . . . . 0.0 109.438 -179.985 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.0 -29.42 70.81 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.261 -0.9 . . . . 0.0 109.403 179.988 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.626 ' H ' HG22 ' A' ' 67' ' ' THR . . . -101.61 142.58 32.76 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.208 -0.933 . . . . 0.0 109.414 179.995 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 17.0 m -57.99 -28.77 64.71 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.237 -0.914 . . . . 0.0 109.414 -179.947 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.47 ' HB2' ' HD2' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -130.72 159.64 70.15 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.279 -0.888 . . . . 0.0 109.583 179.964 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.47 ' HD2' ' HB2' ' A' ' 71' ' ' MET . 49.4 Cg_endo -69.75 158.78 55.8 Favored 'Trans proline' 0 C--O 1.214 -0.69 0 C-N-CA 122.757 2.304 . . . . 0.0 111.747 -179.964 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -70.42 157.77 58.11 Favored 'Trans proline' 0 C--O 1.216 -0.62 0 C-N-CA 122.729 2.286 . . . . 0.0 111.811 -179.969 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 92.6 p -132.67 154.11 50.44 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.206 -0.934 . . . . 0.0 109.384 -179.983 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -70.07 139.04 52.53 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.218 -0.926 . . . . 0.0 109.471 179.997 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 . . . . . 0 N--CA 1.488 1.461 0 CA-C-O 117.945 -1.026 . . . . 0.0 109.532 179.998 . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.579 ' HB2' ' CE1' ' A' ' 51' ' ' HIS . 4.3 m -55.55 -34.48 64.78 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.295 -0.878 . . . . 0.0 109.345 179.952 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -53.75 -26.01 21.49 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.33 -0.856 . . . . 0.0 109.138 179.908 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 64.1 mmm -73.56 -24.73 60.14 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.297 -0.877 . . . . 0.0 108.821 179.434 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.576 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 29.3 m -81.82 -15.34 54.44 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.483 -0.761 . . . . 0.0 109.112 179.709 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.452 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 45.4 mttm -80.72 5.56 15.4 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.195 -0.94 . . . . 0.0 109.789 -179.954 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.452 ' OD1' ' O ' ' A' ' 6' ' ' LYS . 95.4 m-20 -135.97 12.05 3.36 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.025 -1.047 . . . . 0.0 110.333 -179.367 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.772 ' OH ' HD11 ' A' ' 44' ' ' LEU . 0.6 OUTLIER -123.11 155.94 35.98 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.866 -1.146 . . . . 0.0 109.576 179.822 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 47.0 mtt85 -134.19 132.81 40.21 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.372 -0.83 . . . . 0.0 109.149 179.804 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.902 HG13 ' O ' ' A' ' 15' ' ' GLY . 55.6 t -125.45 147.56 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.195 -0.941 . . . . 0.0 109.872 -179.535 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.541 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 1.3 mp -123.28 174.96 3.04 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.288 -0.883 . . . . 0.0 109.202 179.797 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.541 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 44.8 Cg_endo -67.2 -21.72 47.88 Favored 'Trans proline' 0 C--O 1.215 -0.647 0 C-N-CA 122.561 2.174 . . . . 0.0 111.732 179.923 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 95.0 mtt-85 -104.61 -25.73 12.62 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.369 -0.832 . . . . 0.0 109.684 -179.953 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 24.4 mm -80.95 -47.23 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.232 -0.917 . . . . 0.0 109.532 -179.703 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.902 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 82.38 -163.17 42.58 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.935 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.635 ' CE2' ' CE2' ' A' ' 8' ' ' TYR . 1.6 t80 -102.51 148.9 24.96 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.205 -1.174 . . . . 0.0 109.466 179.925 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 27.1 tp -115.63 111.86 21.26 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.31 -0.869 . . . . 0.0 109.532 179.885 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.431 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 80.7 m -120.23 157.54 53.07 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.197 -0.939 . . . . 0.0 109.353 -179.977 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.52 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 50.6 Cg_endo -71.57 166.48 29.26 Favored 'Trans proline' 0 C--O 1.215 -0.642 0 C-N-CA 122.713 2.275 . . . . 0.0 111.884 -179.774 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -87.3 -9.74 54.15 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.307 -0.87 . . . . 0.0 109.449 179.902 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -76.31 110.94 11.24 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.183 -0.948 . . . . 0.0 109.106 179.736 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 42.7 tp -79.66 123.62 27.81 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.216 -0.927 . . . . 0.0 109.708 -179.76 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.481 ' HD3' ' HG3' ' A' ' 36' ' ' PRO . 5.2 mtpt -139.66 107.98 7.12 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.308 -0.87 . . . . 0.0 109.052 179.661 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.556 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 41.5 Cg_endo -64.28 120.23 7.49 Favored 'Trans proline' 0 C--O 1.212 -0.779 0 C-N-CA 122.937 2.424 . . . . 0.0 112.082 -179.558 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.525 ' HB ' HG23 ' A' ' 52' ' ' ILE . 16.6 m -115.71 154.63 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.282 -0.886 . . . . 0.0 109.835 -179.937 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 43.9 t -97.21 126.28 42.29 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.456 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -78.57 137.66 19.9 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 -179.994 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.495 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 52.9 t0 -70.82 -10.33 59.32 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.174 -1.192 . . . . 0.0 109.566 -179.944 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.416 ' OD1' ' HB2' ' A' ' 31' ' ' GLN . 56.5 p30 -87.96 10.38 19.09 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.257 -0.902 . . . . 0.0 109.24 179.586 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.45 21.39 48.4 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.08 -1.608 . . . . 0.0 109.08 -179.722 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.456 ' O ' ' SG ' ' A' ' 58' ' ' CYS . 87.5 mt-30 -121.0 177.21 5.2 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.277 -1.131 . . . . 0.0 109.542 179.98 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 32' ' ' THR . . . . . 1.001 HG21 ' HG3' ' A' ' 57' ' ' LYS . 56.7 m -140.37 134.75 31.33 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.314 -0.866 . . . . 0.0 109.304 179.96 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.835 ' CD1' HD13 ' A' ' 39' ' ' LEU . 39.0 m-85 -117.36 130.09 56.28 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.309 -0.869 . . . . 0.0 109.295 179.994 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.53 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 7.1 m-20 -54.54 -77.83 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.221 -0.924 . . . . 0.0 109.73 -179.628 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.527 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 5.1 t-20 -81.68 148.69 62.43 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.094 -1.004 . . . . 0.0 109.641 -179.906 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.481 ' HG3' ' HD3' ' A' ' 23' ' ' LYS . 40.6 Cg_endo -63.1 -52.62 1.99 Allowed 'Trans proline' 0 C--O 1.215 -0.631 0 C-N-CA 122.568 2.179 . . . . 0.0 111.807 179.829 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.527 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 5.4 t -61.98 -28.18 69.38 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 178.982 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.494 ' CG ' ' HB3' ' A' ' 35' ' ' ASN . 52.6 mmm -63.32 -16.57 60.76 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.444 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.835 HD13 ' CD1' ' A' ' 33' ' ' TYR . 39.0 tp -68.71 -56.87 6.7 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 179.327 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.471 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 10.9 t -55.78 -23.14 28.13 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 178.864 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 47.1 t60 -71.69 -63.46 1.12 Allowed 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 179.393 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.439 ' HB2' ' CE2' ' A' ' 33' ' ' TYR . 62.2 mt-10 -54.35 -21.77 10.38 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.342 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.495 ' O ' ' N ' ' A' ' 47' ' ' GLN . 99.4 m-20 -73.29 -37.22 66.3 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.424 -0.797 . . . . 0.0 109.116 179.686 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.772 HD11 ' OH ' ' A' ' 8' ' ' TYR . 24.0 mt -61.41 -32.59 72.53 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.139 -0.975 . . . . 0.0 108.912 179.627 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.8 mt -74.4 -42.58 49.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.377 -0.827 . . . . 0.0 108.832 179.296 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.448 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 69.1 mtt-85 -79.85 -22.57 42.78 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.428 -0.795 . . . . 0.0 109.391 179.744 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.495 ' N ' ' O ' ' A' ' 43' ' ' ASN . 89.5 mt-30 63.21 41.69 7.73 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.395 -0.816 . . . . 0.0 109.427 -179.838 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 16.0 p -128.35 163.5 24.7 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.344 -0.847 . . . . 0.0 109.371 179.87 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 50.9 p-10 -94.3 61.48 2.83 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.175 -0.953 . . . . 0.0 109.428 -179.958 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 31.7 m -69.75 139.0 53.26 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.402 -0.811 . . . . 0.0 109.742 -179.937 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.579 ' CE1' ' HB2' ' A' ' 2' ' ' SER . 62.1 m-70 -119.8 169.36 10.2 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.307 -0.871 . . . . 0.0 109.032 179.538 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.525 HG23 ' HB ' ' A' ' 25' ' ' VAL . 41.1 mt -79.43 126.42 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.182 -0.949 . . . . 0.0 109.387 179.983 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.495 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 68.8 ttt180 -79.92 -47.98 14.17 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-O 121.638 0.732 . . . . 0.0 109.449 179.988 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 65.2 p -159.71 135.55 8.6 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -179.483 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.441 ' H ' HG23 ' A' ' 55' ' ' THR . 11.5 p -50.88 147.97 4.54 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.245 -0.91 . . . . 0.0 109.525 -179.834 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.556 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 85.94 164.22 38.97 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.326 -1.509 . . . . 0.0 109.326 -179.764 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 1.001 ' HG3' HG21 ' A' ' 32' ' ' THR . 26.0 tttt -59.32 153.72 18.2 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.374 -1.074 . . . . 0.0 109.387 -179.924 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.528 ' N ' ' HG2' ' A' ' 57' ' ' LYS . 98.2 m -55.96 -28.21 55.99 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.267 -0.896 . . . . 0.0 109.704 -179.772 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.482 ' HB3' ' HD3' ' A' ' 57' ' ' LYS . 78.6 tt0 -82.91 -22.57 33.87 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.241 -0.912 . . . . 0.0 109.552 -179.831 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 62.1 tt0 -68.82 -29.63 68.01 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.286 -0.884 . . . . 0.0 109.344 179.96 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 82.6 p -72.67 -19.9 61.34 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.334 -0.853 . . . . 0.0 109.64 -179.87 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 87.6 p -109.09 152.75 24.64 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.169 -0.957 . . . . 0.0 109.597 -179.856 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 11.3 p -126.72 85.6 60.32 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.34 -0.85 . . . . 0.0 109.326 179.888 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -69.62 -18.11 37.86 Favored 'Trans proline' 0 C--O 1.214 -0.684 0 C-N-CA 122.778 2.319 . . . . 0.0 111.886 -179.943 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.27 17.14 65.26 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 179.905 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 14.1 t -131.28 158.27 41.08 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.207 -1.172 . . . . 0.0 109.518 179.939 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 14.8 p -122.77 160.51 25.82 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.31 -0.869 . . . . 0.0 109.377 179.93 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.03 -30.91 66.51 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.219 -0.926 . . . . 0.0 109.52 -179.952 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.31 -34.26 76.26 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.309 -0.869 . . . . 0.0 109.486 -179.893 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 33.9 m -54.5 -33.34 59.66 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.23 -0.919 . . . . 0.0 109.563 179.987 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 7.9 mtp -72.76 151.83 91.19 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.36 -0.838 . . . . 0.0 109.47 -179.973 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -69.92 146.58 59.63 Favored 'Trans proline' 0 C--O 1.215 -0.646 0 C-N-CA 122.742 2.295 . . . . 0.0 111.839 179.997 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -69.79 157.98 58.48 Favored 'Trans proline' 0 C--O 1.215 -0.638 0 C-N-CA 122.765 2.31 . . . . 0.0 111.876 179.983 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 83.8 p -79.73 -10.07 59.74 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.208 -0.933 . . . . 0.0 109.572 -179.984 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.404 ' O ' ' HB2' ' A' ' 76' ' ' GLU . 87.3 m-20 -67.97 -34.61 76.89 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.189 -0.944 . . . . 0.0 109.435 -179.968 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.404 ' HB2' ' O ' ' A' ' 75' ' ' ASP . 75.0 mm-40 . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.498 179.993 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.453 ' OD1' HG13 ' A' ' 52' ' ' ILE . 92.0 m-20 . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 121.288 0.566 . . . . 0.0 109.486 . . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.411 ' HB2' ' CE1' ' A' ' 51' ' ' HIS . 0.5 OUTLIER -56.06 -34.83 66.3 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.303 -0.873 . . . . 0.0 109.367 179.888 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -56.56 -24.93 50.41 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.36 -0.837 . . . . 0.0 109.146 179.947 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.442 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 57.2 mmm -74.3 -23.11 59.03 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.316 -0.865 . . . . 0.0 108.722 179.401 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.411 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 17.2 m -81.97 -18.21 44.24 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.483 -0.761 . . . . 0.0 109.155 179.586 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 49.6 mttt -80.2 -3.78 50.41 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.32 -0.862 . . . . 0.0 109.745 -179.886 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' A' ' 4' ' ' MET . 19.3 p30 -118.56 -0.82 11.29 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.08 -1.013 . . . . 0.0 109.714 -179.835 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.484 ' OH ' ' CE2' ' A' ' 16' ' ' TYR . 0.1 OUTLIER -118.51 168.9 10.24 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.053 -1.029 . . . . 0.0 109.284 179.979 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 41.9 mtm-85 -149.63 128.14 12.29 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.243 -0.911 . . . . 0.0 109.254 179.817 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.542 HG21 ' C ' ' A' ' 15' ' ' GLY . 6.4 p -124.99 145.48 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.218 -0.926 . . . . 0.0 109.847 -179.77 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.66 HD23 ' HD2' ' A' ' 12' ' ' PRO . 0.2 OUTLIER -108.37 170.37 5.57 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.359 -0.838 . . . . 0.0 109.229 179.921 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.66 ' HD2' HD23 ' A' ' 11' ' ' LEU . 45.7 Cg_endo -67.54 -23.86 42.79 Favored 'Trans proline' 0 C--O 1.215 -0.659 0 C-N-CA 122.622 2.215 . . . . 0.0 111.787 179.951 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 73.2 mtt85 -87.7 -26.28 23.05 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.289 -0.882 . . . . 0.0 109.131 179.734 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 97.7 mt -90.26 -44.49 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.277 -0.889 . . . . 0.0 109.327 179.883 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.542 ' C ' HG21 ' A' ' 10' ' ' VAL . . . 72.97 148.9 1.0 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.991 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.542 ' N ' HG21 ' A' ' 10' ' ' VAL . 0.9 OUTLIER -47.48 148.91 1.24 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.327 -1.102 . . . . 0.0 109.788 -179.874 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 25.9 tp -115.82 110.29 18.84 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.373 -0.829 . . . . 0.0 109.521 -179.992 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 56.1 m -120.74 154.96 57.54 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.272 -0.892 . . . . 0.0 109.445 179.966 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -72.47 169.7 21.12 Favored 'Trans proline' 0 C--O 1.215 -0.669 0 C-N-CA 122.591 2.194 . . . . 0.0 111.475 179.978 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 47.6 mttm -88.7 -17.89 29.02 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.185 -0.947 . . . . 0.0 109.471 -179.911 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -66.94 130.34 42.83 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.262 -0.899 . . . . 0.0 109.296 179.721 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.498 HD11 ' HB3' ' A' ' 34' ' ' ASN . 43.3 tp -87.46 121.88 30.47 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.177 -0.952 . . . . 0.0 109.558 -179.894 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.541 ' CB ' ' HD3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -132.77 99.72 15.18 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.234 -0.916 . . . . 0.0 109.044 179.768 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.544 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 41.9 Cg_endo -63.88 119.77 6.93 Favored 'Trans proline' 0 C--O 1.214 -0.702 0 C-N-CA 122.899 2.399 . . . . 0.0 112.492 -179.248 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 32.9 m -115.71 154.37 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.345 -0.847 . . . . 0.0 109.473 179.689 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.404 ' O ' ' N ' ' A' ' 53' ' ' ARG . 41.6 t -100.65 121.32 41.43 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.323 -0.86 . . . . 0.0 108.819 179.372 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -74.83 141.62 28.6 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.804 -1.319 . . . . 0.0 109.804 -179.701 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.508 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 55.1 t0 -71.28 -9.69 58.53 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.156 -1.202 . . . . 0.0 109.598 179.969 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -86.81 6.62 30.74 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.234 -0.916 . . . . 0.0 109.198 179.64 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.79 16.6 54.36 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 -179.836 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.454 ' O ' ' SG ' ' A' ' 58' ' ' CYS . 87.5 mt-30 -118.19 169.58 9.58 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.194 -1.18 . . . . 0.0 109.532 179.992 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.481 HG23 ' HA ' ' A' ' 57' ' ' LYS . 27.8 m -132.39 134.47 45.19 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.224 -0.922 . . . . 0.0 109.367 179.874 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.812 ' CD1' HD13 ' A' ' 39' ' ' LEU . 47.6 m-85 -114.43 130.28 56.7 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.185 -0.947 . . . . 0.0 109.195 179.835 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.526 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 5.1 m-20 -52.49 -77.88 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.19 -0.944 . . . . 0.0 109.73 -179.516 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.517 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 13.7 t-20 -81.91 146.5 55.94 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 120.975 -1.078 . . . . 0.0 109.646 -179.895 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.541 ' HD3' ' CB ' ' A' ' 23' ' ' LYS . 40.1 Cg_endo -63.43 -51.29 2.69 Favored 'Trans proline' 0 C--O 1.214 -0.709 0 C-N-CA 122.592 2.195 . . . . 0.0 111.304 179.474 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.517 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 8.8 t -60.62 -28.79 68.8 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 178.835 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.45 ' HB2' ' HB3' ' A' ' 35' ' ' ASN . 12.3 mtt -65.25 -12.7 54.18 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.202 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.812 HD13 ' CD1' ' A' ' 33' ' ' TYR . 51.0 tp -71.47 -58.07 3.85 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.294 -0.879 . . . . 0.0 108.726 179.569 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.465 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 36.0 t -54.61 -24.75 22.67 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 179.048 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 35.1 t60 -68.52 -61.38 1.85 Allowed 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.293 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.438 ' HB2' ' CE2' ' A' ' 33' ' ' TYR . 72.3 mm-40 -56.08 -20.0 15.37 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.259 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.523 ' O ' ' N ' ' A' ' 47' ' ' GLN . 98.0 m-20 -78.61 -29.72 46.17 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.718 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.473 HD23 ' HA ' ' A' ' 44' ' ' LEU . 16.8 mt -68.95 -30.44 68.89 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.25 -0.906 . . . . 0.0 108.795 179.401 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -80.43 -47.33 21.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.346 -0.846 . . . . 0.0 109.355 179.715 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.445 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 94.9 mtt-85 -79.73 -34.47 39.97 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.285 -0.885 . . . . 0.0 109.321 179.875 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.523 ' N ' ' O ' ' A' ' 43' ' ' ASN . 92.1 mt-30 62.15 39.65 12.63 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.362 -0.836 . . . . 0.0 109.518 -179.939 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.408 ' O ' ' C ' ' A' ' 49' ' ' ASN . 68.1 p -107.63 17.08 23.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.302 -0.874 . . . . 0.0 109.468 179.986 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.408 ' C ' ' O ' ' A' ' 48' ' ' THR . 57.4 m-20 44.15 60.0 2.96 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.174 -0.954 . . . . 0.0 109.285 -179.936 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.48 ' HB ' ' OD1' ' A' ' 43' ' ' ASN . 22.1 m -77.12 145.77 37.59 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.213 -0.929 . . . . 0.0 109.669 -179.742 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.411 ' CE1' ' HB2' ' A' ' 2' ' ' SER . 28.6 m-70 -118.49 173.8 6.62 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.281 -0.887 . . . . 0.0 109.137 179.565 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.453 HG13 ' OD1' ' A' ' 1' ' ' ASP . 9.4 mt -86.32 124.66 40.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.224 -0.922 . . . . 0.0 109.713 -179.966 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.508 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 21.0 ttt180 -79.51 -51.82 8.82 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-O 121.631 0.729 . . . . 0.0 109.389 179.959 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 57.8 m -159.76 140.15 11.97 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.507 -0.746 . . . . 0.0 109.122 -179.738 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.408 ' H ' HG23 ' A' ' 55' ' ' THR . 21.8 p -52.85 148.06 8.13 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.151 -0.968 . . . . 0.0 109.518 -179.861 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.544 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 88.64 164.95 40.8 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 -179.883 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.527 ' HG3' ' HB2' ' A' ' 24' ' ' PRO . 24.3 mttt -64.32 150.73 45.56 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.493 -1.004 . . . . 0.0 109.224 179.871 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.454 ' SG ' ' O ' ' A' ' 31' ' ' GLN . 86.5 m -55.98 -22.02 24.31 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.23 -0.919 . . . . 0.0 109.429 179.964 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.458 ' HG2' ' O ' ' A' ' 59' ' ' GLU . 48.2 tt0 -80.19 -14.68 58.26 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.267 -0.896 . . . . 0.0 109.617 -179.871 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.509 ' HG3' ' N ' ' A' ' 57' ' ' LYS . 3.5 mt-10 -87.12 -27.88 22.83 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.117 -0.989 . . . . 0.0 109.355 -179.982 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.3 m -64.65 -10.45 26.86 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.249 -0.907 . . . . 0.0 109.544 -179.87 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 24.7 m -133.79 131.56 39.45 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.269 -0.894 . . . . 0.0 109.405 179.952 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.433 ' OG1' ' HD2' ' A' ' 64' ' ' PRO . 1.1 t -54.98 151.33 16.37 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.192 -0.942 . . . . 0.0 109.511 179.969 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.433 ' HD2' ' OG1' ' A' ' 63' ' ' THR . 51.0 Cg_endo -71.07 143.53 44.8 Favored 'Trans proline' 0 C--O 1.215 -0.636 0 C-N-CA 122.735 2.29 . . . . 0.0 111.799 -179.983 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 88.04 -154.53 25.59 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.867 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 19.4 p -127.43 153.8 45.83 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.348 -1.09 . . . . 0.0 109.417 179.994 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 65.6 p -60.98 -26.28 67.45 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.296 -0.878 . . . . 0.0 109.574 -179.983 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.72 -32.09 68.88 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.27 -0.894 . . . . 0.0 109.465 179.936 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -61.85 -37.63 85.24 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.279 -0.888 . . . . 0.0 109.487 179.973 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 21.3 m -53.24 -35.42 59.95 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.221 -0.924 . . . . 0.0 109.519 179.998 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.521 ' CG ' ' HD2' ' A' ' 72' ' ' PRO . 4.8 ttt -65.14 141.3 98.23 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.295 -0.878 . . . . 0.0 109.461 179.893 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.521 ' HD2' ' CG ' ' A' ' 71' ' ' MET . 47.7 Cg_endo -68.75 139.99 45.42 Favored 'Trans proline' 0 C--O 1.215 -0.658 0 C-N-CA 122.641 2.228 . . . . 0.0 111.908 -179.95 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -70.37 172.82 12.5 Favored 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 122.767 2.312 . . . . 0.0 111.784 -179.876 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 23.5 m -89.29 -5.94 57.15 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.311 -0.868 . . . . 0.0 109.633 -179.921 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.436 ' O ' ' HB2' ' A' ' 76' ' ' GLU . 84.0 m-20 -82.18 -23.07 35.7 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.198 -0.939 . . . . 0.0 109.411 179.96 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.445 ' OXT' ' HG2' ' A' ' 76' ' ' GLU . 87.5 tt0 . . . . . 0 N--CA 1.489 1.492 0 CA-C-O 117.949 -1.024 . . . . 0.0 109.437 -179.982 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.429 ' OD1' ' HG2' ' A' ' 4' ' ' MET . 51.1 p30 . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 121.264 0.554 . . . . 0.0 109.595 . . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.572 ' HB2' ' CD2' ' A' ' 51' ' ' HIS . 1.2 m -52.71 -35.56 55.89 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.272 -0.893 . . . . 0.0 109.088 179.68 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -55.72 -26.76 46.95 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.485 -0.759 . . . . 0.0 109.177 179.871 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.429 ' HG2' ' OD1' ' A' ' 1' ' ' ASP . 66.4 mmm -70.75 -27.16 63.74 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.32 -0.863 . . . . 0.0 108.917 179.545 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.584 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 39.1 m -80.71 -16.12 54.74 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.539 -0.726 . . . . 0.0 109.367 179.744 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.429 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 60.5 mttt -80.8 9.14 6.73 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.262 -0.899 . . . . 0.0 109.861 179.95 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.429 ' OD1' ' O ' ' A' ' 6' ' ' LYS . 90.6 m-20 -135.35 3.99 3.13 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.874 -1.141 . . . . 0.0 110.551 -179.526 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.664 ' CE2' ' CE2' ' A' ' 16' ' ' TYR . 1.5 p90 -114.76 156.87 24.06 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.805 -1.184 . . . . 0.0 109.803 -179.996 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 62.7 mtm180 -137.15 133.01 34.78 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.331 -0.855 . . . . 0.0 109.462 179.82 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.78 HG13 ' O ' ' A' ' 15' ' ' GLY . 79.3 t -121.55 143.29 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.351 -0.843 . . . . 0.0 109.687 -179.78 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.558 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 1.8 mp -123.99 176.09 2.47 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.329 -0.857 . . . . 0.0 109.103 179.877 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.558 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 44.3 Cg_endo -67.19 -22.68 46.46 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 122.561 2.174 . . . . 0.0 111.759 179.873 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 71.5 mtt85 -102.94 -28.45 12.02 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.277 -0.889 . . . . 0.0 109.506 179.907 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.508 HD12 ' HB2' ' A' ' 11' ' ' LEU . 94.8 mt -82.79 -46.43 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.358 -0.839 . . . . 0.0 109.766 -179.731 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.78 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 75.81 -169.99 54.7 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.391 -1.483 . . . . 0.0 109.391 -179.87 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.664 ' CE2' ' CE2' ' A' ' 8' ' ' TYR . 1.5 t80 -90.81 151.02 21.34 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.163 -1.198 . . . . 0.0 109.436 179.914 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.463 HD23 ' HA ' ' A' ' 17' ' ' LEU . 43.1 mt -120.26 126.16 49.91 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.269 -0.894 . . . . 0.0 109.721 -179.839 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.402 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 63.3 m -138.16 155.42 74.29 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.319 -0.863 . . . . 0.0 109.057 179.818 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.408 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 47.3 Cg_endo -70.02 165.06 32.54 Favored 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 122.583 2.189 . . . . 0.0 111.659 179.951 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 77.8 mttt -83.7 -21.71 32.27 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.338 -0.851 . . . . 0.0 109.433 -179.801 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -65.7 122.9 18.34 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.263 -0.898 . . . . 0.0 109.202 179.751 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.686 ' C ' HD13 ' A' ' 22' ' ' LEU . 3.5 tm? -89.68 108.33 19.61 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.18 -0.95 . . . . 0.0 109.338 -179.771 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.509 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 4.2 mtpm? -117.42 104.68 49.59 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.389 -0.819 . . . . 0.0 109.132 179.933 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.547 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 42.3 Cg_endo -63.95 119.93 7.14 Favored 'Trans proline' 0 C--O 1.213 -0.739 0 C-N-CA 123.067 2.511 . . . . 0.0 112.502 -179.353 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.442 ' O ' HG23 ' A' ' 32' ' ' THR . 30.1 m -117.35 154.32 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.342 -0.849 . . . . 0.0 109.424 179.703 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 26' ' ' CYS . . . . . 0.425 ' O ' ' N ' ' A' ' 53' ' ' ARG . 43.3 t -98.82 118.21 35.05 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.328 -0.857 . . . . 0.0 109.077 179.622 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -72.57 141.6 31.1 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 110.179 -1.169 . . . . 0.0 110.179 -179.405 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.522 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 54.5 p30 -69.98 -11.26 60.75 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.324 -1.103 . . . . 0.0 109.434 179.748 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.428 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 91.5 m-20 -83.52 9.24 11.79 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.21 -0.931 . . . . 0.0 109.291 179.778 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.52 13.71 67.2 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 -179.908 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.493 ' O ' ' N ' ' A' ' 27' ' ' GLY . 91.8 mt-30 -118.35 170.78 8.62 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.302 -1.116 . . . . 0.0 109.481 179.98 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.553 HG23 ' HA ' ' A' ' 57' ' ' LYS . 56.7 m -129.4 138.94 51.77 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.353 -0.842 . . . . 0.0 109.333 -179.95 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.627 ' CD1' ' CD1' ' A' ' 39' ' ' LEU . 23.2 m-85 -118.38 121.88 41.45 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.304 -0.872 . . . . 0.0 108.93 179.643 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.545 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 1.6 m-20 -47.8 -78.47 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.355 -0.841 . . . . 0.0 109.557 -179.361 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.531 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 9.6 t-20 -82.36 146.32 53.9 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.019 -1.05 . . . . 0.0 109.788 -179.706 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.509 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.9 Cg_endo -63.67 -51.63 2.33 Favored 'Trans proline' 0 C--O 1.215 -0.667 0 C-N-CA 122.706 2.271 . . . . 0.0 111.627 179.789 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.531 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 9.2 t -62.51 -26.09 68.37 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 178.842 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 38' ' ' MET . . . . . 0.46 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 41.6 mmm -67.37 -17.37 64.71 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.31 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.627 ' CD1' ' CD1' ' A' ' 33' ' ' TYR . 10.6 tp -70.18 -59.95 2.58 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.305 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.471 ' HB3' ' OH ' ' A' ' 16' ' ' TYR . 16.6 t -54.02 -25.62 22.15 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 178.803 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 72.9 t60 -65.19 -62.12 1.73 Allowed 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.096 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.405 ' OE1' ' CE2' ' A' ' 33' ' ' TYR . 82.3 mt-10 -57.46 -19.34 23.53 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 179.002 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.523 ' O ' ' N ' ' A' ' 47' ' ' GLN . 98.9 m-20 -79.72 -26.55 40.8 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.395 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 40.4 tp -72.98 -31.8 64.77 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.412 -0.805 . . . . 0.0 108.912 179.577 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 8.7 mm -80.04 -49.57 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.347 -0.846 . . . . 0.0 109.097 179.629 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.564 ' HB3' HG23 ' A' ' 48' ' ' THR . 53.3 mtt-85 -80.9 -34.27 33.62 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.294 -0.879 . . . . 0.0 109.246 179.832 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.523 ' N ' ' O ' ' A' ' 43' ' ' ASN . 92.9 mt-30 63.12 39.95 9.46 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.529 -0.732 . . . . 0.0 109.489 -179.887 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.564 HG23 ' HB3' ' A' ' 46' ' ' ARG . 41.7 p -97.26 2.15 50.49 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.243 -0.91 . . . . 0.0 109.534 179.826 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.456 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 70.4 m-20 55.5 56.23 6.49 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.175 -0.953 . . . . 0.0 109.623 179.989 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 55.7 m -79.72 143.06 34.89 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.174 -0.954 . . . . 0.0 109.674 -179.929 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 51' ' ' HIS . . . . . 0.572 ' CD2' ' HB2' ' A' ' 2' ' ' SER . 26.2 m80 -114.25 172.53 6.95 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.269 -0.894 . . . . 0.0 109.054 179.668 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 19.6 mt -85.74 124.38 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.131 -0.981 . . . . 0.0 109.706 -179.919 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.522 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 31.5 ttt-85 -79.77 -56.68 4.1 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.546 -0.721 . . . . 0.0 109.272 179.81 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -152.34 148.8 27.93 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.545 -0.722 . . . . 0.0 109.162 179.91 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 33.6 p -59.02 151.88 21.13 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.164 -0.96 . . . . 0.0 109.302 -179.963 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.547 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 85.5 166.51 42.06 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 108.955 -1.658 . . . . 0.0 108.955 -179.577 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.553 ' HA ' HG23 ' A' ' 32' ' ' THR . 88.6 mttt -66.35 166.67 11.81 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.296 -1.12 . . . . 0.0 109.443 -179.98 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.454 ' SG ' ' O ' ' A' ' 31' ' ' GLN . 85.9 m -72.92 -17.58 61.49 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.294 -0.879 . . . . 0.0 108.955 179.789 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.433 ' HG2' ' O ' ' A' ' 59' ' ' GLU . 56.3 tt0 -79.83 -18.31 51.15 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.482 -0.761 . . . . 0.0 109.43 -179.826 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.473 ' HG3' ' O ' ' A' ' 57' ' ' LYS . 6.7 mt-10 -70.34 -36.61 74.34 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.27 -0.894 . . . . 0.0 109.002 179.731 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 96.8 p -62.64 -15.2 50.83 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.388 -0.82 . . . . 0.0 109.289 179.778 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 23.1 t -121.53 156.31 33.11 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.263 -0.898 . . . . 0.0 109.434 -179.916 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.548 HG23 ' O ' ' A' ' 63' ' ' THR . 2.7 t -132.78 84.74 49.03 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.225 -0.922 . . . . 0.0 109.468 -179.977 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.528 ' HB2' ' HB3' ' A' ' 68' ' ' ALA . 50.3 Cg_endo -71.17 145.48 49.21 Favored 'Trans proline' 0 C--O 1.215 -0.635 0 C-N-CA 122.671 2.247 . . . . 0.0 111.727 179.877 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.77 -179.67 51.71 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.9 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 70.9 m -64.39 -29.47 70.53 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.241 -1.152 . . . . 0.0 109.55 -179.972 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 72.9 p -67.48 -27.81 67.33 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.197 -0.94 . . . . 0.0 109.392 179.941 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.528 ' HB3' ' HB2' ' A' ' 64' ' ' PRO . . . -62.38 -31.5 72.18 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.201 -0.937 . . . . 0.0 109.454 179.95 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.34 -32.21 73.0 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.176 -0.952 . . . . 0.0 109.475 179.923 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 25.3 m -54.41 -30.62 52.86 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.316 -0.865 . . . . 0.0 109.42 -179.931 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.44 ' HB3' ' HD2' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -116.28 166.66 12.01 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.335 -0.853 . . . . 0.0 109.443 179.947 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.44 ' HD2' ' HB3' ' A' ' 71' ' ' MET . 48.8 Cg_endo -70.2 150.7 65.95 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 122.687 2.258 . . . . 0.0 111.733 -179.965 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -70.2 158.51 56.16 Favored 'Trans proline' 0 C--O 1.215 -0.651 0 C-N-CA 122.661 2.24 . . . . 0.0 111.695 179.954 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 29.6 m -134.92 143.8 47.13 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.213 -0.929 . . . . 0.0 109.474 -179.983 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -57.51 -32.89 67.47 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.314 -0.866 . . . . 0.0 109.494 179.974 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.47 179.968 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 63.4 mmm . . . . . 0 N--CA 1.489 1.48 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 5.6 m -81.61 -13.92 57.38 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.328 -0.858 . . . . 0.0 109.251 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 40.5 mttm -54.78 -30.37 56.68 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.294 -0.879 . . . . 0.0 109.84 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -150.56 63.69 0.94 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.169 -0.957 . . . . 0.0 109.839 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.786 ' HE2' HD21 ' A' ' 44' ' ' LEU . 9.0 p90 -116.04 175.47 5.53 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.158 -0.963 . . . . 0.0 109.332 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 70.9 mtt180 -148.68 140.07 23.37 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.214 -0.929 . . . . 0.0 109.53 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.85 HG13 ' O ' ' A' ' 15' ' ' GLY . 92.3 t -133.01 139.8 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.365 -0.834 . . . . 0.0 109.349 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.575 HD13 HD12 ' A' ' 14' ' ' ILE . 0.4 OUTLIER -128.13 172.0 7.59 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.26 -0.9 . . . . 0.0 109.262 179.991 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.478 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 45.1 Cg_endo -67.32 -24.78 43.07 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 122.549 2.166 . . . . 0.0 111.439 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 55.6 mtt180 -106.89 -27.69 10.55 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.359 -0.838 . . . . 0.0 109.123 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.575 HD12 HD13 ' A' ' 11' ' ' LEU . 98.1 mt -85.66 -41.92 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.357 -0.839 . . . . 0.0 109.349 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.85 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 71.49 -140.35 30.5 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.464 ' CD2' HG21 ' A' ' 10' ' ' VAL . 3.1 t80 -110.52 151.34 27.69 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.125 -1.221 . . . . 0.0 109.486 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.458 ' HA ' HD23 ' A' ' 17' ' ' LEU . 52.2 mt -111.21 131.24 55.27 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.291 -0.881 . . . . 0.0 109.349 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.46 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 84.6 m -139.64 156.95 70.97 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.207 -0.933 . . . . 0.0 109.596 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.515 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 47.9 Cg_endo -69.81 166.38 27.86 Favored 'Trans proline' 0 C--O 1.215 -0.634 0 C-N-CA 122.666 2.244 . . . . 0.0 111.661 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 52.7 tttp -87.17 -17.62 32.27 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.307 -0.87 . . . . 0.0 109.359 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -66.98 121.73 16.18 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.254 -0.904 . . . . 0.0 109.379 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.755 HD21 ' OD1' ' A' ' 34' ' ' ASN . 3.5 tm? -85.66 125.29 33.05 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.266 -0.896 . . . . 0.0 109.465 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.672 ' N ' HD13 ' A' ' 22' ' ' LEU . 8.8 mtpt -147.49 113.03 4.04 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.254 -0.904 . . . . 0.0 109.739 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.542 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 43.5 Cg_endo -66.14 123.5 11.32 Favored 'Trans proline' 0 C--O 1.214 -0.711 0 C-N-CA 122.973 2.448 . . . . 0.0 111.74 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.49 ' O ' HG23 ' A' ' 32' ' ' THR . 29.8 m -118.54 154.13 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.246 -0.909 . . . . 0.0 109.86 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.408 ' O ' ' N ' ' A' ' 53' ' ' ARG . 45.5 t -97.09 142.16 29.36 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 178.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -99.5 139.28 14.35 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 -179.287 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.496 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 54.9 p30 -64.58 -10.85 29.1 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.357 -1.084 . . . . 0.0 109.52 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.457 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 70.5 m-20 -91.09 12.65 19.23 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.272 -0.893 . . . . 0.0 109.501 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 81.59 15.4 76.0 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.526 ' O ' ' N ' ' A' ' 27' ' ' GLY . 55.6 mt-30 -117.75 155.51 29.87 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.207 -1.173 . . . . 0.0 109.4 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.636 HG21 ' HG3' ' A' ' 57' ' ' LYS . 23.6 m -118.0 146.74 43.81 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.148 -0.97 . . . . 0.0 109.427 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.892 ' CD2' HD12 ' A' ' 39' ' ' LEU . 78.5 m-85 -124.01 128.01 48.74 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.253 -0.904 . . . . 0.0 109.478 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.755 ' OD1' HD21 ' A' ' 22' ' ' LEU . 56.7 t-20 -47.84 -79.95 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.277 -0.89 . . . . 0.0 109.604 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.517 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 3.9 t-20 -81.09 148.63 64.5 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 120.977 -1.077 . . . . 0.0 109.104 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.48 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 39.3 Cg_endo -62.09 -52.66 2.58 Favored 'Trans proline' 0 C--O 1.215 -0.644 0 C-N-CA 122.62 2.213 . . . . 0.0 111.958 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.517 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 4.8 t -60.34 -30.48 69.56 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 120.977 -1.077 . . . . 0.0 108.256 179.005 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.472 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 24.1 mtp -61.64 -18.29 58.86 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.492 -0.755 . . . . 0.0 109.175 179.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.892 HD12 ' CD2' ' A' ' 33' ' ' TYR . 6.7 tt -69.21 -52.74 24.75 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.245 -0.909 . . . . 0.0 108.919 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.499 ' O ' ' HB2' ' A' ' 43' ' ' ASN . 4.9 t -49.48 -32.78 12.79 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 179.053 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.476 ' O ' HG12 ' A' ' 45' ' ' ILE . 27.6 t60 -53.96 -48.08 70.66 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 179.122 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.587 ' HB2' ' CE1' ' A' ' 33' ' ' TYR . 24.5 tp10 -61.28 -16.84 49.76 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.519 ' OD1' ' N ' ' A' ' 50' ' ' THR . 2.8 m-80 -80.33 -32.8 37.84 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.379 -0.825 . . . . 0.0 109.271 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.786 HD21 ' HE2' ' A' ' 8' ' ' TYR . 7.9 mp -75.69 -31.68 59.81 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.33 -0.856 . . . . 0.0 109.596 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.476 HG12 ' O ' ' A' ' 41' ' ' HIS . 8.9 mm -78.77 -51.32 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.229 -0.919 . . . . 0.0 109.531 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.459 ' NH1' ' HG2' ' A' ' 46' ' ' ARG . 15.2 mtt-85 -81.77 -30.78 32.19 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.301 -0.874 . . . . 0.0 109.729 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.443 ' HA ' ' O ' ' A' ' 43' ' ' ASN . 14.6 mt-30 61.62 34.67 17.56 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.265 -0.897 . . . . 0.0 109.474 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.45 ' O ' ' HB2' ' A' ' 49' ' ' ASN . 52.7 p -106.03 2.86 27.65 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.207 -0.933 . . . . 0.0 109.667 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.45 ' HB2' ' O ' ' A' ' 48' ' ' THR . 22.3 m120 64.88 49.82 2.08 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.196 -0.94 . . . . 0.0 109.572 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.519 ' N ' ' OD1' ' A' ' 43' ' ' ASN . 88.4 m -77.77 128.77 34.55 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.264 -0.897 . . . . 0.0 109.465 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 7.3 m-70 -110.72 -173.35 2.22 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.28 -0.888 . . . . 0.0 109.257 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.768 HG12 HD13 ' A' ' 39' ' ' LEU . 22.1 mt -88.31 126.53 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.296 -0.877 . . . . 0.0 109.446 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.496 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 31.6 ttt180 -80.42 -40.93 25.45 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.363 -0.836 . . . . 0.0 109.274 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -160.53 151.71 19.12 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.497 -0.752 . . . . 0.0 109.09 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.2 p -67.46 148.42 51.57 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.121 -0.987 . . . . 0.0 109.422 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.542 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 84.6 165.7 40.06 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.636 ' HG3' HG21 ' A' ' 32' ' ' THR . 23.2 tttp -57.03 151.54 14.84 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.333 -1.098 . . . . 0.0 109.253 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.469 ' N ' ' HG2' ' A' ' 57' ' ' LYS . 96.6 m . . . . . 0 N--CA 1.489 1.52 0 O-C-N 121.202 -0.936 . . . . 0.0 109.33 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 74.8 mtm . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.588 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 3.9 m -92.91 -8.27 43.75 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.237 -0.914 . . . . 0.0 109.629 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.4 mttt -60.64 -24.65 65.7 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.281 -0.887 . . . . 0.0 109.745 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 59.5 t0 -153.56 63.06 0.74 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.135 -0.978 . . . . 0.0 109.912 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.588 ' CD1' ' HA ' ' A' ' 5' ' ' CYS . 9.2 p90 -122.0 178.59 4.83 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.082 -1.011 . . . . 0.0 109.501 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 37.5 mtm180 -150.1 144.42 25.72 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.276 -0.89 . . . . 0.0 109.295 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.944 HG13 ' O ' ' A' ' 15' ' ' GLY . 84.1 t -138.94 132.02 38.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.144 -0.972 . . . . 0.0 109.765 -179.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.553 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 2.3 mp -123.39 176.35 2.23 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.402 -0.811 . . . . 0.0 109.11 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.553 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 43.4 Cg_endo -65.57 -24.44 55.94 Favored 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 122.533 2.155 . . . . 0.0 111.733 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 10.5 mtm180 -108.26 -35.3 6.58 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.258 -0.901 . . . . 0.0 109.032 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 86.8 mt -76.55 -35.56 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.372 -0.83 . . . . 0.0 109.194 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.944 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 61.38 -134.56 48.05 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.154 -1.578 . . . . 0.0 109.154 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.528 ' CD2' HG21 ' A' ' 10' ' ' VAL . 3.4 t80 -113.65 155.6 25.21 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.149 -1.207 . . . . 0.0 109.547 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.445 ' HA ' HD12 ' A' ' 17' ' ' LEU . 18.3 tp -112.95 123.29 49.98 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.345 -0.847 . . . . 0.0 109.726 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.447 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 67.0 m -138.33 156.64 73.48 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.354 -0.842 . . . . 0.0 109.011 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.449 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 48.7 Cg_endo -70.89 165.95 30.59 Favored 'Trans proline' 0 C--O 1.214 -0.687 0 C-N-CA 122.491 2.127 . . . . 0.0 111.573 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 40.1 mttp -85.51 -17.83 35.26 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.232 -0.918 . . . . 0.0 109.41 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 -71.2 130.86 42.53 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.33 -0.856 . . . . 0.0 109.23 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.719 ' C ' HD13 ' A' ' 22' ' ' LEU . 3.4 tm? -95.05 112.65 24.33 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.147 -0.97 . . . . 0.0 109.588 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.505 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 0.2 OUTLIER -121.72 104.92 38.81 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.322 -0.861 . . . . 0.0 109.202 179.75 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.534 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 41.1 Cg_endo -63.43 117.74 4.68 Favored 'Trans proline' 0 C--O 1.213 -0.752 0 C-N-CA 123.039 2.493 . . . . 0.0 112.03 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.527 ' O ' HG23 ' A' ' 32' ' ' THR . 17.8 m -118.44 156.28 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.4 -0.813 . . . . 0.0 109.805 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.421 ' O ' ' N ' ' A' ' 53' ' ' ARG . 27.4 t -99.06 111.99 24.24 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.307 -0.87 . . . . 0.0 109.299 179.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.497 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -66.21 138.62 36.86 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.521 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 50.8 p30 -69.83 -10.03 56.92 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.303 -1.116 . . . . 0.0 109.539 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.413 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 91.0 m-20 -83.56 5.25 24.83 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.243 -0.911 . . . . 0.0 109.336 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.43 13.12 58.9 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.497 ' O ' ' N ' ' A' ' 27' ' ' GLY . 85.5 mt-30 -122.76 147.79 46.1 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.446 -1.032 . . . . 0.0 109.464 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.527 HG23 ' O ' ' A' ' 25' ' ' VAL . 28.9 m -108.82 141.89 40.2 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.211 -0.93 . . . . 0.0 109.357 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.693 ' CG ' HD12 ' A' ' 39' ' ' LEU . 10.8 m-85 -121.21 131.11 54.04 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.368 -0.833 . . . . 0.0 109.172 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.522 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 1.6 m-20 -53.95 -76.73 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.187 -0.946 . . . . 0.0 109.365 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.538 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 8.0 t-20 -82.17 146.74 55.57 Favored Pre-proline 0 C--N 1.3 -1.572 0 O-C-N 121.06 -1.025 . . . . 0.0 109.554 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.505 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 41.3 Cg_endo -63.46 -52.14 2.13 Favored 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 122.695 2.263 . . . . 0.0 111.858 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.538 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 11.4 t -64.27 -27.46 69.06 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.964 -1.085 . . . . 0.0 108.319 179.104 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.515 ' CG ' ' HB3' ' A' ' 35' ' ' ASN . 31.5 mmm -60.05 -20.66 59.14 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.578 -0.701 . . . . 0.0 109.165 179.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.693 HD12 ' CG ' ' A' ' 33' ' ' TYR . 6.3 tp -67.05 -51.81 50.05 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.307 -0.871 . . . . 0.0 108.883 179.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.486 ' HA ' ' HB2' ' A' ' 43' ' ' ASN . 2.0 t -54.59 -23.05 15.21 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.174 -0.954 . . . . 0.0 108.534 179.194 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 27.5 t60 -60.05 -59.3 5.64 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.473 ' OE1' ' CE2' ' A' ' 33' ' ' TYR . 53.2 tt0 -65.12 -21.31 66.78 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.519 ' O ' ' N ' ' A' ' 47' ' ' GLN . 87.7 m-20 -77.41 -26.8 52.03 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 28.6 tp -69.83 -33.98 73.03 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.373 -0.829 . . . . 0.0 109.219 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 10.7 mm -80.12 -51.41 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.31 -0.869 . . . . 0.0 109.536 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.543 ' HB3' HG23 ' A' ' 48' ' ' THR . 94.3 mtt-85 -80.18 -33.55 38.23 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.288 -0.882 . . . . 0.0 109.729 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.519 ' N ' ' O ' ' A' ' 43' ' ' ASN . 89.8 mt-30 63.96 39.89 7.7 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.308 -0.87 . . . . 0.0 109.434 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.543 HG23 ' HB3' ' A' ' 46' ' ' ARG . 44.2 p -94.52 -6.75 43.04 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.239 -0.913 . . . . 0.0 109.456 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.46 ' HB2' ' O ' ' A' ' 48' ' ' THR . 74.6 m-20 63.03 55.31 1.98 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.289 -0.882 . . . . 0.0 109.476 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 53.7 m -72.11 138.27 47.62 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.186 -0.946 . . . . 0.0 109.51 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 25.4 m-70 -109.62 177.59 4.69 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.325 -0.86 . . . . 0.0 109.204 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.431 HG23 ' HB ' ' A' ' 25' ' ' VAL . 17.7 mt -89.67 124.65 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.224 -0.923 . . . . 0.0 109.777 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.521 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 41.9 ttt180 -80.54 -56.34 4.24 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 121.722 0.772 . . . . 0.0 109.334 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 60.4 p -149.43 147.49 28.32 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 16.0 p -64.27 148.43 50.21 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.221 -0.925 . . . . 0.0 109.381 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.534 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 82.12 163.55 32.6 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.525 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 34.9 mttt -70.47 129.53 39.48 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.439 -1.036 . . . . 0.0 109.457 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 O-C-N 121.174 -0.954 . . . . 0.0 109.281 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 55.0 mmm . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.574 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 4.3 m -83.24 -0.92 51.68 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.464 -0.772 . . . . 0.0 109.4 179.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.9 mttm -68.53 -21.24 64.58 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.24 -0.913 . . . . 0.0 109.605 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -150.42 59.63 0.95 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.327 -0.858 . . . . 0.0 109.681 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.703 ' OH ' HD21 ' A' ' 44' ' ' LEU . 6.4 p90 -124.78 173.29 8.68 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.166 -0.959 . . . . 0.0 109.324 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 20.9 ptt-85 -156.0 143.77 19.58 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.259 -0.901 . . . . 0.0 109.383 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.882 HG13 ' O ' ' A' ' 15' ' ' GLY . 58.7 t -130.28 137.76 55.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.327 -0.858 . . . . 0.0 109.38 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.538 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 1.4 mp -119.26 174.4 2.81 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.22 -0.925 . . . . 0.0 109.514 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.538 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 46.3 Cg_endo -68.38 -25.02 36.33 Favored 'Trans proline' 0 C--O 1.215 -0.641 0 C-N-CA 122.602 2.201 . . . . 0.0 111.723 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 52.6 mtt180 -108.37 -25.29 11.07 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.332 -0.855 . . . . 0.0 109.318 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 29.3 mm -85.59 -44.5 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.238 -0.914 . . . . 0.0 109.503 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.882 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 69.33 -144.95 41.77 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.516 ' CE2' HD11 ' A' ' 44' ' ' LEU . 1.2 t80 -104.4 155.96 18.33 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.172 -1.193 . . . . 0.0 109.427 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.651 ' C ' HD13 ' A' ' 17' ' ' LEU . 1.8 tm? -119.12 113.01 20.26 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.262 -0.899 . . . . 0.0 109.622 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.568 ' N ' HD13 ' A' ' 17' ' ' LEU . 61.3 m -127.03 155.84 75.24 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.347 -0.846 . . . . 0.0 109.305 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -70.53 167.67 24.77 Favored 'Trans proline' 0 C--O 1.214 -0.683 0 C-N-CA 122.654 2.236 . . . . 0.0 111.787 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -87.7 -14.56 39.52 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.352 -0.843 . . . . 0.0 109.45 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -72.68 112.88 9.13 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.121 -0.987 . . . . 0.0 109.414 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.417 HD11 ' HB3' ' A' ' 34' ' ' ASN . 56.6 tp -74.53 121.49 21.62 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.11 -0.994 . . . . 0.0 109.449 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.529 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -132.17 100.64 15.42 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.217 -0.927 . . . . 0.0 109.185 179.88 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.532 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 42.6 Cg_endo -64.8 118.74 5.69 Favored 'Trans proline' 0 C--O 1.213 -0.758 0 C-N-CA 122.962 2.441 . . . . 0.0 112.27 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 5.4 m -117.91 156.39 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.284 -0.885 . . . . 0.0 109.784 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.453 ' O ' ' N ' ' A' ' 53' ' ' ARG . 33.8 t -100.41 108.19 20.13 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.33 -0.856 . . . . 0.0 109.287 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -61.77 139.91 46.89 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 -179.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.499 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 54.9 p30 -70.04 -9.01 53.91 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.347 -1.09 . . . . 0.0 109.613 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.423 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 55.0 p30 -83.2 1.54 40.15 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.24 -0.913 . . . . 0.0 109.463 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.33 18.34 36.51 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.131 -1.588 . . . . 0.0 109.131 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.472 ' O ' ' N ' ' A' ' 27' ' ' GLY . 91.1 mt-30 -124.72 165.53 17.79 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.29 -1.124 . . . . 0.0 109.37 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 93.7 m -120.88 133.84 55.3 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.3 -0.875 . . . . 0.0 109.277 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.642 ' CD2' HD12 ' A' ' 39' ' ' LEU . 7.8 m-85 -115.02 118.29 33.01 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.243 -0.911 . . . . 0.0 109.162 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.529 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 5.4 m-20 -43.88 -80.84 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.287 -0.883 . . . . 0.0 109.746 -179.35 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.487 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 13.6 t-20 -81.72 145.61 54.63 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 120.957 -1.089 . . . . 0.0 109.621 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.529 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.3 Cg_endo -63.27 -50.44 3.61 Favored 'Trans proline' 0 C--O 1.215 -0.667 0 C-N-CA 122.66 2.24 . . . . 0.0 111.351 179.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.487 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 5.3 t -61.62 -27.61 68.78 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 178.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.48 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 17.7 mtp -66.12 -18.68 65.5 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.642 HD12 ' CD2' ' A' ' 33' ' ' TYR . 30.0 tp -63.86 -52.82 58.28 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.492 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 4.3 t -59.27 -29.51 67.63 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.454 ' CE1' ' HB2' ' A' ' 16' ' ' TYR . 23.2 t60 -64.49 -59.23 4.57 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.565 ' OE1' ' CE2' ' A' ' 33' ' ' TYR . 79.6 mt-10 -58.34 -22.77 54.59 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 179.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.492 ' O ' ' N ' ' A' ' 47' ' ' GLN . 94.7 m-20 -73.31 -32.03 64.37 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.703 HD21 ' OH ' ' A' ' 8' ' ' TYR . 55.3 mt -61.38 -31.34 71.24 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 179.197 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.3 mt -80.37 -39.91 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.441 -0.787 . . . . 0.0 109.043 179.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.45 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 62.1 mtt85 -79.51 -24.04 42.53 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.36 -0.837 . . . . 0.0 109.112 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.492 ' N ' ' O ' ' A' ' 43' ' ' ASN . 90.3 mt-30 62.59 42.22 8.73 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.362 -0.836 . . . . 0.0 109.484 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 13.6 t -132.83 164.42 26.89 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.243 -0.911 . . . . 0.0 109.335 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.567 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 84.0 m-20 -94.86 61.21 2.53 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.247 -0.908 . . . . 0.0 109.435 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 86.4 m -66.23 135.63 54.74 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.229 -0.919 . . . . 0.0 109.542 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . 0.567 ' CE1' ' O ' ' A' ' 49' ' ' ASN . 57.5 m80 -110.82 -178.84 3.58 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.286 -0.884 . . . . 0.0 109.249 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 12.7 mt -89.6 127.13 42.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.1 -1.0 . . . . 0.0 109.742 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.499 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 20.2 ttt180 -80.1 -57.04 3.82 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.439 -0.788 . . . . 0.0 109.258 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 30.9 m -152.4 142.92 22.71 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.407 ' H ' HG23 ' A' ' 55' ' ' THR . 26.0 p -59.62 146.6 40.39 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.123 -0.986 . . . . 0.0 109.689 -179.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.532 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 86.15 162.21 36.42 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.518 ' HG3' ' HB2' ' A' ' 24' ' ' PRO . 67.6 mttt -71.07 124.77 25.16 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.483 -1.01 . . . . 0.0 109.401 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.526 0 O-C-N 121.227 -0.92 . . . . 0.0 109.626 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 73.8 mtp . . . . . 0 N--CA 1.489 1.493 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.587 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 3.7 m -87.43 -8.39 56.56 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.37 -0.831 . . . . 0.0 109.417 179.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 40.9 mttt -63.47 -20.09 65.29 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.167 -0.958 . . . . 0.0 109.592 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 -149.73 60.65 1.0 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.26 -0.9 . . . . 0.0 109.673 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.806 ' OH ' HD23 ' A' ' 44' ' ' LEU . 1.7 p90 -133.07 163.29 29.57 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.201 -0.937 . . . . 0.0 109.48 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 92.3 mtt180 -136.18 144.6 45.06 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.223 -0.923 . . . . 0.0 109.508 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.573 HG13 ' O ' ' A' ' 15' ' ' GLY . 53.4 t -141.13 136.24 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.244 -0.91 . . . . 0.0 109.473 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.559 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.2 OUTLIER -125.94 175.32 3.25 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.309 -0.869 . . . . 0.0 109.478 -179.936 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.559 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 45.1 Cg_endo -67.29 -25.9 42.17 Favored 'Trans proline' 0 C--O 1.214 -0.714 0 C-N-CA 122.655 2.237 . . . . 0.0 111.913 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 84.3 mtt-85 -104.86 -26.76 12.09 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.339 -0.85 . . . . 0.0 109.279 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 25.5 mm -82.37 -44.69 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.276 -0.89 . . . . 0.0 109.536 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.573 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 75.17 -156.43 48.82 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.618 ' CE2' ' CE2' ' A' ' 8' ' ' TYR . 2.8 t80 -101.92 154.62 18.78 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.238 -1.154 . . . . 0.0 109.429 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.412 ' HA ' HD12 ' A' ' 17' ' ' LEU . 20.7 tp -107.43 104.82 14.48 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.238 -0.914 . . . . 0.0 109.847 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.43 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 58.9 m -125.39 154.88 72.33 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.275 -0.891 . . . . 0.0 109.159 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -71.21 166.96 27.58 Favored 'Trans proline' 0 C--O 1.216 -0.611 0 C-N-CA 122.7 2.266 . . . . 0.0 111.759 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -82.79 -31.87 28.02 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.317 -0.864 . . . . 0.0 109.416 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -56.88 127.29 31.04 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.214 -0.929 . . . . 0.0 109.47 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.531 HD11 ' HB3' ' A' ' 34' ' ' ASN . 60.6 tp -87.74 117.65 26.72 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.217 -0.927 . . . . 0.0 109.281 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.531 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 19.2 mttt -123.78 99.99 37.96 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.26 -0.9 . . . . 0.0 109.463 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.533 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 42.9 Cg_endo -65.17 116.75 4.03 Favored 'Trans proline' 0 C--O 1.214 -0.712 0 C-N-CA 122.933 2.422 . . . . 0.0 111.901 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.508 ' O ' HG23 ' A' ' 32' ' ' THR . 11.4 m -119.84 156.35 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.254 -0.903 . . . . 0.0 109.976 -179.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.45 ' O ' ' N ' ' A' ' 53' ' ' ARG . 14.2 t -99.94 110.75 23.08 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.341 -0.849 . . . . 0.0 109.203 179.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -65.27 139.26 39.7 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.517 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 51.1 p30 -69.01 -10.61 58.42 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.294 -1.121 . . . . 0.0 109.638 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.441 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 89.6 m-20 -81.28 3.75 22.91 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.19 -0.944 . . . . 0.0 109.3 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.65 16.15 52.92 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.201 -1.56 . . . . 0.0 109.201 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.508 ' O ' ' N ' ' A' ' 27' ' ' GLY . 84.8 mt-30 -125.86 153.45 44.13 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.392 -1.064 . . . . 0.0 109.425 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.516 ' CG2' ' HA ' ' A' ' 57' ' ' LYS . 56.6 m -110.06 142.43 41.52 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.29 -0.881 . . . . 0.0 109.32 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.663 ' CG ' HD12 ' A' ' 39' ' ' LEU . 28.9 m-85 -121.24 119.23 31.67 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.364 -0.835 . . . . 0.0 109.212 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.531 ' HB3' HD11 ' A' ' 22' ' ' LEU . 8.7 m-20 -43.5 -78.82 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.268 -0.895 . . . . 0.0 109.255 -179.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.486 ' O ' ' HB2' ' A' ' 38' ' ' MET . 15.3 t-20 -82.63 145.88 51.9 Favored Pre-proline 0 C--N 1.301 -1.53 0 O-C-N 120.988 -1.07 . . . . 0.0 109.231 179.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.531 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 41.2 Cg_endo -63.66 -49.39 4.32 Favored 'Trans proline' 0 C--O 1.215 -0.67 0 C-N-CA 122.425 2.083 . . . . 0.0 111.493 179.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.484 ' SG ' ' CE1' ' A' ' 16' ' ' TYR . 7.6 t -63.02 -27.64 69.55 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.486 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 29.1 mmm -63.56 -14.66 53.54 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.478 -0.764 . . . . 0.0 109.123 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.663 HD12 ' CG ' ' A' ' 33' ' ' TYR . 9.3 tp -69.43 -53.32 19.87 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.242 -0.911 . . . . 0.0 108.881 179.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.499 ' HB3' ' CZ ' ' A' ' 16' ' ' TYR . 8.3 t -52.26 -22.18 4.19 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.187 -0.946 . . . . 0.0 108.451 179.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 53.0 t60 -59.44 -61.41 2.64 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.576 -0.702 . . . . 0.0 109.258 179.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -67.37 -15.43 63.68 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.19 -0.944 . . . . 0.0 108.895 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.522 ' O ' ' N ' ' A' ' 47' ' ' GLN . 98.1 m-20 -78.27 -24.03 47.0 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.379 -0.826 . . . . 0.0 109.012 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.96 HD13 ' O ' ' A' ' 44' ' ' LEU . 3.1 tm? -72.27 -34.67 68.39 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.249 -0.907 . . . . 0.0 108.825 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 8.4 mm -77.57 -49.86 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.372 -0.83 . . . . 0.0 109.132 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.554 ' HB3' HG23 ' A' ' 48' ' ' THR . 53.0 mtt-85 -80.0 -37.26 34.59 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.34 -0.85 . . . . 0.0 109.3 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.522 ' N ' ' O ' ' A' ' 43' ' ' ASN . 92.8 mt-30 63.21 37.01 11.53 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.381 -0.824 . . . . 0.0 109.65 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.554 HG23 ' HB3' ' A' ' 46' ' ' ARG . 43.5 p -100.34 8.85 43.41 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.31 -0.869 . . . . 0.0 109.428 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 66.5 m-20 52.77 56.96 6.88 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.26 -0.9 . . . . 0.0 109.52 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 36.7 m -68.02 135.9 53.01 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.254 -0.904 . . . . 0.0 109.39 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 80.2 m-70 -108.77 178.59 4.43 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.325 -0.859 . . . . 0.0 109.354 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 21.0 mt -88.78 125.75 41.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.134 -0.979 . . . . 0.0 109.655 179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.517 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 74.4 ttt-85 -81.69 -57.11 3.59 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.433 -0.792 . . . . 0.0 109.576 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 95.8 p -150.18 139.36 21.21 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -179.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.4 p -55.72 148.88 15.41 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.178 -0.951 . . . . 0.0 109.425 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.533 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 83.61 165.85 39.1 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.516 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 66.2 mttt -74.63 130.97 40.51 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.438 -1.036 . . . . 0.0 109.362 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.514 0 O-C-N 121.088 -1.007 . . . . 0.0 109.361 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 84.5 mtp . . . . . 0 N--CA 1.489 1.491 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.471 ' O ' ' HB2' ' A' ' 8' ' ' TYR . 57.8 m -80.05 -14.09 58.8 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.476 -0.765 . . . . 0.0 109.053 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.9 mttm -45.8 -28.2 1.01 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.288 -0.882 . . . . 0.0 109.307 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -109.98 29.87 7.23 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.316 -0.865 . . . . 0.0 108.947 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.675 ' CZ ' ' CE1' ' A' ' 16' ' ' TYR . 2.2 t80 -79.97 159.13 26.39 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.557 -0.714 . . . . 0.0 109.93 -179.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.3 mtt-85 -149.77 113.82 5.13 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.418 -0.801 . . . . 0.0 108.994 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.939 HG21 ' CD2' ' A' ' 16' ' ' TYR . 77.9 t -118.6 151.93 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.281 -0.887 . . . . 0.0 109.619 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.832 HD23 ' HD2' ' A' ' 12' ' ' PRO . 0.2 OUTLIER -130.03 171.87 8.19 Favored Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 121.303 -0.873 . . . . 0.0 108.991 179.842 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.832 ' HD2' HD23 ' A' ' 11' ' ' LEU . 43.5 Cg_endo -66.25 -22.63 53.18 Favored 'Trans proline' 0 C--O 1.214 -0.692 0 C-N-CA 122.541 2.161 . . . . 0.0 111.729 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -108.55 -26.37 10.45 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.248 -0.908 . . . . 0.0 109.58 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 24.0 mm -80.33 -51.49 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.193 -0.942 . . . . 0.0 109.655 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.89 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 84.12 -166.7 42.74 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.939 ' CD2' HG21 ' A' ' 10' ' ' VAL . 1.8 t80 -99.48 148.68 24.0 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.217 -1.166 . . . . 0.0 109.432 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.746 HD13 ' N ' ' A' ' 18' ' ' CYS . 2.0 tm? -111.94 120.83 43.25 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.258 -0.902 . . . . 0.0 109.564 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.746 ' N ' HD13 ' A' ' 17' ' ' LEU . 82.1 m -134.21 156.72 78.8 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.347 -0.846 . . . . 0.0 109.365 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.535 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 49.5 Cg_endo -70.19 167.07 26.05 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 122.726 2.284 . . . . 0.0 111.738 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 64.3 mttm -92.84 -5.77 50.26 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.252 -0.905 . . . . 0.0 109.482 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -75.98 110.34 10.36 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.145 -0.972 . . . . 0.0 109.324 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.823 HD21 ' OD1' ' A' ' 34' ' ' ASN . 3.5 tm? -74.21 121.37 21.13 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.348 -0.845 . . . . 0.0 109.466 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.609 ' N ' HD13 ' A' ' 22' ' ' LEU . 1.7 mtpm? -145.88 111.49 4.48 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.248 -0.908 . . . . 0.0 109.528 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.545 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 44.3 Cg_endo -65.71 124.48 12.83 Favored 'Trans proline' 0 C--O 1.213 -0.756 0 C-N-CA 123.049 2.499 . . . . 0.0 112.295 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.5 ' O ' HG23 ' A' ' 32' ' ' THR . 31.7 m -116.44 153.62 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.249 -0.907 . . . . 0.0 109.489 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.411 ' O ' ' N ' ' A' ' 53' ' ' ARG . 45.2 t -99.59 119.49 38.15 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.307 -0.87 . . . . 0.0 109.068 179.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -76.68 139.87 24.31 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.503 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 51.0 p30 -69.8 -11.61 60.99 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.32 -1.106 . . . . 0.0 109.409 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.467 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 70.5 m-20 -82.38 7.83 13.04 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.376 -0.828 . . . . 0.0 109.467 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 88.37 12.62 64.84 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 -118.22 170.54 8.79 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.337 -1.096 . . . . 0.0 109.533 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.5 HG23 ' O ' ' A' ' 25' ' ' VAL . 95.1 m -130.22 134.68 47.44 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.337 -0.852 . . . . 0.0 109.258 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.83 ' CD1' HD13 ' A' ' 39' ' ' LEU . 48.3 m-85 -112.68 126.79 55.77 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.168 -0.958 . . . . 0.0 109.346 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.823 ' OD1' HD21 ' A' ' 22' ' ' LEU . 60.1 t-20 -48.76 -80.23 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.356 -0.84 . . . . 0.0 110.023 -179.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.523 ' HB3' ' CG ' ' A' ' 38' ' ' MET . 2.0 t-20 -80.71 149.59 67.97 Favored Pre-proline 0 C--N 1.301 -1.518 0 O-C-N 120.864 -1.148 . . . . 0.0 109.357 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.456 ' HD2' ' CG ' ' A' ' 35' ' ' ASN . 40.1 Cg_endo -62.86 -54.42 1.19 Allowed 'Trans proline' 0 C--O 1.216 -0.614 0 C-N-CA 122.723 2.282 . . . . 0.0 111.876 -179.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.535 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 8.1 t -62.9 -28.52 70.11 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.062 -1.024 . . . . 0.0 108.475 179.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.523 ' CG ' ' HB3' ' A' ' 35' ' ' ASN . 59.2 mmm -62.31 -14.29 37.65 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.83 HD13 ' CD1' ' A' ' 33' ' ' TYR . 25.6 tp -68.49 -51.69 40.51 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.421 -0.799 . . . . 0.0 109.468 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.487 ' HB2' ' OH ' ' A' ' 16' ' ' TYR . 3.1 m -67.97 -17.86 64.56 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 179.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.52 ' CE1' ' HB2' ' A' ' 16' ' ' TYR . 46.7 t60 -73.28 -55.74 6.01 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.1 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.559 ' OE1' ' CE2' ' A' ' 33' ' ' TYR . 87.1 tt0 -63.75 -18.89 64.51 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.247 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.495 ' O ' ' N ' ' A' ' 47' ' ' GLN . 93.4 m-20 -74.77 -36.12 62.56 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.643 HD11 ' HE2' ' A' ' 16' ' ' TYR . 19.3 mt -61.25 -32.44 72.25 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.372 -0.83 . . . . 0.0 108.821 179.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.521 ' N ' HD13 ' A' ' 45' ' ' ILE . 3.6 mm -75.58 -42.75 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.41 -0.806 . . . . 0.0 108.913 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.464 ' NH1' ' HG2' ' A' ' 46' ' ' ARG . 29.0 mtp85 -80.05 -17.67 52.12 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.379 -0.826 . . . . 0.0 109.038 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.495 ' N ' ' O ' ' A' ' 43' ' ' ASN . 87.8 mt-30 62.21 42.92 9.0 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.278 -0.889 . . . . 0.0 109.409 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 15.4 p -127.66 164.96 20.91 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.292 -0.88 . . . . 0.0 109.353 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -102.3 63.6 0.89 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.181 -0.949 . . . . 0.0 109.433 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 49.8 m -75.03 141.83 43.85 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.302 -0.874 . . . . 0.0 109.567 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 -117.87 170.0 9.17 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.311 -0.868 . . . . 0.0 109.049 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.455 HG12 HD22 ' A' ' 39' ' ' LEU . 21.1 mt -79.95 123.37 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.198 -0.939 . . . . 0.0 109.222 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.503 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 49.7 tpt85 -79.62 -49.03 12.76 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.356 -0.84 . . . . 0.0 109.327 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.3 t -156.03 151.73 27.22 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.466 -0.771 . . . . 0.0 109.21 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 38.8 p -65.24 147.7 52.98 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.172 -0.955 . . . . 0.0 109.218 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.545 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 88.82 165.93 41.73 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 108.986 -1.646 . . . . 0.0 108.986 -179.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.525 ' CG ' ' HB2' ' A' ' 24' ' ' PRO . 89.7 mttt -64.28 161.26 17.01 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.43 -1.041 . . . . 0.0 109.579 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 86.5 m . . . . . 0 N--CA 1.491 1.624 0 O-C-N 121.229 -0.92 . . . . 0.0 109.366 179.922 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 90.4 mtp . . . . . 0 N--CA 1.489 1.498 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.465 ' O ' ' HB2' ' A' ' 8' ' ' TYR . 4.2 m -79.93 -23.46 41.73 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.357 -0.84 . . . . 0.0 109.136 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 73.0 mttt -48.45 -24.69 1.35 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.251 -0.906 . . . . 0.0 108.873 179.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -110.14 29.76 7.36 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.465 ' HB2' ' O ' ' A' ' 5' ' ' CYS . 1.6 t80 -85.94 153.79 21.94 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.55 -0.719 . . . . 0.0 109.932 -179.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 8.9 mtm180 -147.02 113.82 6.08 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.424 -0.797 . . . . 0.0 109.293 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.606 HG21 ' N ' ' A' ' 16' ' ' TYR . 4.6 p -130.64 152.26 37.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.328 -0.857 . . . . 0.0 109.12 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.548 ' CG ' ' HD2' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -109.32 171.64 4.28 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.152 -0.968 . . . . 0.0 109.711 -179.676 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.548 ' HD2' ' CG ' ' A' ' 11' ' ' LEU . 47.7 Cg_endo -69.51 -23.32 32.06 Favored 'Trans proline' 0 C--O 1.214 -0.687 0 C-N-CA 122.699 2.266 . . . . 0.0 111.497 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.472 ' HG2' ' O ' ' A' ' 13' ' ' ARG . 23.1 ttt180 -91.82 -16.23 27.08 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.351 -0.843 . . . . 0.0 109.147 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.422 HD13 ' HA ' ' A' ' 14' ' ' ILE . 26.3 mm -99.8 -41.86 9.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.237 -0.915 . . . . 0.0 109.391 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.564 ' C ' HG21 ' A' ' 10' ' ' VAL . . . 69.22 139.69 0.1 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.606 ' N ' HG21 ' A' ' 10' ' ' VAL . 0.9 OUTLIER -44.88 154.8 0.12 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.261 -1.141 . . . . 0.0 109.401 179.984 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.803 ' N ' HD12 ' A' ' 17' ' ' LEU . 0.3 OUTLIER -118.62 128.07 54.19 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.196 -0.94 . . . . 0.0 109.5 179.957 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.419 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 62.8 m -140.02 156.61 70.33 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.374 -0.828 . . . . 0.0 109.065 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -71.38 167.18 27.02 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.548 2.165 . . . . 0.0 111.492 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 33.3 mttp -86.9 -23.5 25.18 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.182 -0.949 . . . . 0.0 109.586 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -62.14 128.63 37.05 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.119 -0.988 . . . . 0.0 109.257 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.437 HD11 ' HB3' ' A' ' 34' ' ' ASN . 27.8 tp -87.49 117.52 26.34 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.158 -0.963 . . . . 0.0 109.619 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.55 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 0.2 OUTLIER -126.94 100.85 26.95 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.383 -0.823 . . . . 0.0 109.063 179.87 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.529 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 43.4 Cg_endo -65.46 117.93 5.02 Favored 'Trans proline' 0 C--O 1.214 -0.714 0 C-N-CA 123.102 2.535 . . . . 0.0 112.246 -179.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.67 ' O ' HG23 ' A' ' 32' ' ' THR . 15.5 m -116.31 154.75 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.359 -0.838 . . . . 0.0 109.568 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 40.3 t -95.97 131.83 41.93 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.368 -0.832 . . . . 0.0 108.803 179.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -90.49 134.63 12.44 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -179.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.506 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 1.5 m-20 -66.1 -9.02 27.23 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.3 -1.118 . . . . 0.0 109.606 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 50.1 p-10 -85.2 13.85 5.87 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.167 -0.958 . . . . 0.0 109.507 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 81.35 22.65 60.16 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.436 ' O ' ' N ' ' A' ' 27' ' ' GLY . 66.7 mt-30 -131.86 174.1 10.5 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.292 -1.122 . . . . 0.0 109.524 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.67 HG23 ' O ' ' A' ' 25' ' ' VAL . 49.5 m -134.52 137.92 44.25 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.348 -0.845 . . . . 0.0 109.192 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.923 ' CD1' HD13 ' A' ' 39' ' ' LEU . 55.1 m-85 -112.08 122.5 47.92 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.237 -0.914 . . . . 0.0 109.452 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.522 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 7.0 m-20 -46.32 -79.55 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.345 -0.847 . . . . 0.0 109.616 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.539 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 7.6 t-20 -81.94 146.73 56.34 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.034 -1.041 . . . . 0.0 109.358 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.55 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.1 Cg_endo -63.03 -52.96 1.78 Allowed 'Trans proline' 0 C--O 1.216 -0.623 0 C-N-CA 122.824 2.349 . . . . 0.0 111.793 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.539 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 7.8 t -60.67 -26.48 67.12 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 178.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.45 ' HB2' ' HB3' ' A' ' 35' ' ' ASN . 33.6 mmm -70.72 -8.37 51.64 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.175 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.923 HD13 ' CD1' ' A' ' 33' ' ' TYR . 21.8 tp -72.89 -56.02 5.78 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.332 -0.855 . . . . 0.0 109.233 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 3.6 m -63.15 -23.25 67.35 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 119.204 -0.998 . . . . 0.0 108.339 179.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.477 ' CE1' ' HB2' ' A' ' 16' ' ' TYR . 49.6 t60 -65.11 -54.66 26.53 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 178.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.438 ' HB2' ' CE2' ' A' ' 33' ' ' TYR . 75.6 mt-10 -66.73 -16.75 64.46 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.111 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.45 ' OD1' ' HB ' ' A' ' 50' ' ' THR . 94.3 m-20 -79.16 -26.53 42.73 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.407 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.974 HD13 ' O ' ' A' ' 44' ' ' LEU . 2.5 tm? -69.72 -35.07 74.72 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.8 mt -76.18 -43.48 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.471 -0.768 . . . . 0.0 109.071 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.443 ' HB3' HG23 ' A' ' 48' ' ' THR . 68.5 mtt85 -79.8 -36.1 37.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.343 -0.848 . . . . 0.0 109.385 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.429 ' N ' ' O ' ' A' ' 43' ' ' ASN . 91.0 mt-30 62.07 40.2 12.28 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.386 -0.821 . . . . 0.0 109.451 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.443 HG23 ' HB3' ' A' ' 46' ' ' ARG . 37.4 p -111.17 15.16 21.68 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.34 -0.85 . . . . 0.0 109.241 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.419 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 70.0 m-20 45.31 58.22 4.3 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.305 -0.872 . . . . 0.0 109.329 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.45 ' HB ' ' OD1' ' A' ' 43' ' ' ASN . 69.9 m -78.15 147.74 34.43 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.269 -0.894 . . . . 0.0 109.557 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . 0.419 ' CE1' ' O ' ' A' ' 49' ' ' ASN . 62.2 m80 -124.63 169.91 11.47 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.258 -0.901 . . . . 0.0 109.209 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.421 HG12 HD22 ' A' ' 39' ' ' LEU . 18.9 mt -79.45 122.31 34.41 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 121.099 -1.001 . . . . 0.0 109.307 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.506 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 59.7 ttt-85 -83.11 -38.62 22.19 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.351 -0.843 . . . . 0.0 109.463 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.4 t -158.37 155.08 28.05 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.373 -0.83 . . . . 0.0 109.2 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.2 p -75.33 132.74 41.18 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.187 -0.945 . . . . 0.0 109.49 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.529 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 98.4 165.15 30.86 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.658 ' HA ' HG21 ' A' ' 32' ' ' THR . 13.2 tttp -50.16 150.39 2.44 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.352 -1.087 . . . . 0.0 109.327 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.433 ' SG ' ' O ' ' A' ' 31' ' ' GLN . 43.2 m . . . . . 0 N--CA 1.49 1.542 0 O-C-N 121.279 -0.888 . . . . 0.0 109.396 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . 0.443 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 74.5 mtp . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.49 ' O ' ' HB2' ' A' ' 8' ' ' TYR . 11.5 m -85.65 -17.85 34.92 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.288 -0.883 . . . . 0.0 109.278 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 27.2 mttt -50.47 -24.34 3.06 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.218 -0.926 . . . . 0.0 108.941 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.443 ' OD1' ' O ' ' A' ' 4' ' ' MET . 55.9 p30 -112.97 32.65 5.55 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 179.227 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.49 ' HB2' ' O ' ' A' ' 5' ' ' CYS . 5.4 t80 -80.13 162.14 24.91 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 121.535 0.683 . . . . 0.0 110.225 -179.228 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 10.9 mtm180 -144.16 116.5 8.52 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.941 HG13 ' C ' ' A' ' 15' ' ' GLY . 53.3 t -112.17 139.11 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.143 -0.973 . . . . 0.0 109.684 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.691 HD23 ' HD2' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -119.92 172.7 4.27 Favored Pre-proline 0 N--CA 1.488 1.466 0 O-C-N 121.481 -0.762 . . . . 0.0 109.091 179.866 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.691 ' HD2' HD23 ' A' ' 11' ' ' LEU . 44.3 Cg_endo -66.85 -23.05 48.24 Favored 'Trans proline' 0 C--O 1.214 -0.678 0 C-N-CA 122.579 2.186 . . . . 0.0 111.729 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.425 ' HG2' ' O ' ' A' ' 13' ' ' ARG . 61.1 ttt-85 -110.5 -22.98 11.39 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.309 -0.869 . . . . 0.0 109.292 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.553 HD12 HD13 ' A' ' 11' ' ' LEU . 82.9 mt -89.43 -41.67 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.381 -0.825 . . . . 0.0 109.474 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.941 ' C ' HG13 ' A' ' 10' ' ' VAL . . . 62.04 -146.67 49.1 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.521 ' HD1' HG21 ' A' ' 10' ' ' VAL . 1.4 t80 -100.6 148.46 24.81 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.316 -1.108 . . . . 0.0 109.566 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.477 HD23 ' HA ' ' A' ' 17' ' ' LEU . 53.8 mt -118.43 128.88 55.03 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.376 -0.827 . . . . 0.0 109.557 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.45 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 79.1 m -139.0 157.2 71.87 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.312 -0.868 . . . . 0.0 109.254 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.486 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 47.4 Cg_endo -69.49 166.69 26.41 Favored 'Trans proline' 0 C--O 1.214 -0.695 0 C-N-CA 122.592 2.195 . . . . 0.0 111.455 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -87.76 -16.02 35.35 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.207 -0.933 . . . . 0.0 109.502 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -69.91 118.01 12.21 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.199 -0.938 . . . . 0.0 109.074 179.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 60.3 tp -84.51 122.39 28.94 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.174 -0.954 . . . . 0.0 109.82 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.49 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 0.3 OUTLIER -139.91 110.81 7.29 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.276 -0.89 . . . . 0.0 109.039 179.649 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.535 ' HA ' ' O ' ' A' ' 34' ' ' ASN . 42.2 Cg_endo -64.82 122.98 10.98 Favored 'Trans proline' 0 C--O 1.213 -0.747 0 C-N-CA 122.996 2.464 . . . . 0.0 112.496 -179.23 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.512 ' O ' HG23 ' A' ' 32' ' ' THR . 32.9 m -118.56 155.16 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.45 -0.781 . . . . 0.0 109.681 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.416 ' O ' ' N ' ' A' ' 53' ' ' ARG . 42.5 t -100.54 117.7 35.21 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.327 -0.858 . . . . 0.0 108.991 179.219 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -73.63 138.28 24.71 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 -179.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.497 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 53.1 p30 -67.74 -11.1 57.67 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.249 -1.148 . . . . 0.0 109.473 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.461 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 58.5 p30 -82.94 8.68 11.93 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.292 -0.88 . . . . 0.0 109.402 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.09 13.94 65.34 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.473 ' O ' ' N ' ' A' ' 27' ' ' GLY . 92.1 mt-30 -119.56 167.04 12.38 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.27 -1.135 . . . . 0.0 109.461 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.533 ' CG2' ' HA ' ' A' ' 57' ' ' LYS . 90.6 m -126.11 140.47 52.55 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.272 -0.893 . . . . 0.0 109.265 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.845 ' HD2' HD12 ' A' ' 39' ' ' LEU . 59.5 m-85 -118.85 126.24 51.36 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.228 -0.92 . . . . 0.0 109.327 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.535 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 5.9 m-20 -49.77 -75.94 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.21 -0.931 . . . . 0.0 109.397 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.531 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 4.6 t-20 -82.04 148.57 60.75 Favored Pre-proline 0 C--N 1.299 -1.6 0 O-C-N 121.105 -0.997 . . . . 0.0 109.527 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.49 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.0 Cg_endo -62.99 -53.35 1.62 Allowed 'Trans proline' 0 C--O 1.216 -0.619 0 C-N-CA 122.603 2.202 . . . . 0.0 111.728 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.531 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 4.5 t -60.64 -27.63 67.94 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 120.961 -1.087 . . . . 0.0 108.156 179.025 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.475 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 52.6 mmm -65.28 -20.08 66.25 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.845 HD12 ' HD2' ' A' ' 33' ' ' TYR . 6.6 tt -68.42 -51.84 39.44 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.287 -0.883 . . . . 0.0 108.788 179.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.51 ' HA ' ' ND2' ' A' ' 43' ' ' ASN . 64.0 m -51.22 -27.99 10.35 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.142 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.419 ' O ' HG13 ' A' ' 45' ' ' ILE . 28.2 t60 -58.63 -47.5 84.18 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.6 ' HB2' ' CE1' ' A' ' 33' ' ' TYR . 26.9 tp10 -60.36 -17.17 41.56 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 179.116 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.527 ' OD1' ' N ' ' A' ' 50' ' ' THR . 3.5 m-80 -80.07 -34.91 37.75 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.405 -0.81 . . . . 0.0 108.927 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.966 HD13 ' O ' ' A' ' 44' ' ' LEU . 2.6 tm? -70.27 -35.79 74.0 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.349 -0.844 . . . . 0.0 109.34 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.419 HG13 ' O ' ' A' ' 41' ' ' HIS . 2.8 mt -76.11 -53.22 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.302 -0.874 . . . . 0.0 109.678 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.449 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 49.8 mtp180 -80.37 -34.51 36.41 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.224 -0.923 . . . . 0.0 109.89 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.498 ' N ' ' O ' ' A' ' 43' ' ' ASN . 90.4 mt-30 62.32 35.17 15.31 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.215 -0.928 . . . . 0.0 109.547 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.427 ' O ' ' HB2' ' A' ' 49' ' ' ASN . 72.3 p -105.64 7.78 32.84 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.195 -0.941 . . . . 0.0 109.623 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.427 ' HB2' ' O ' ' A' ' 48' ' ' THR . 20.5 m120 64.23 49.82 2.52 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.254 -0.904 . . . . 0.0 109.391 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.527 ' N ' ' OD1' ' A' ' 43' ' ' ASN . 63.6 m -76.76 132.53 39.32 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.251 -0.906 . . . . 0.0 109.378 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 15.2 m-70 -115.21 -174.83 2.57 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.282 -0.886 . . . . 0.0 109.521 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.693 HG12 HD13 ' A' ' 39' ' ' LEU . 16.4 mt -86.68 124.77 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.324 -0.86 . . . . 0.0 109.678 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.497 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 75.8 ttt-85 -80.08 -54.73 5.5 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.525 -0.735 . . . . 0.0 109.503 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 77.7 p -151.87 138.95 19.15 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.716 -0.615 . . . . 0.0 109.357 -179.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 8.0 p -54.35 148.93 10.82 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.189 -0.944 . . . . 0.0 109.412 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.528 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 88.51 166.66 42.5 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.274 -1.53 . . . . 0.0 109.274 -179.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.533 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 27.1 mttt -66.32 143.37 57.22 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.376 -1.073 . . . . 0.0 109.562 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.413 ' C ' ' O ' ' A' ' 57' ' ' LYS . 66.9 m . . . . . 0 N--CA 1.491 1.595 0 O-C-N 121.278 -0.889 . . . . 0.0 109.47 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 56.5 mmm . . . . . 0 N--CA 1.488 1.449 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.598 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 59.2 m -80.12 -21.3 43.36 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.422 -0.799 . . . . 0.0 109.284 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 42.1 mttp -80.69 11.74 3.62 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.331 -0.856 . . . . 0.0 109.786 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -132.75 -1.82 3.37 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.023 -1.048 . . . . 0.0 110.181 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.598 ' CD1' ' HA ' ' A' ' 5' ' ' CYS . 1.6 p90 -114.24 156.56 24.09 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.868 -1.145 . . . . 0.0 109.98 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 31.8 mtm105 -137.16 133.86 35.71 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.351 -0.843 . . . . 0.0 109.202 179.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.848 HG13 ' O ' ' A' ' 15' ' ' GLY . 75.7 t -117.65 142.61 31.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.189 -0.944 . . . . 0.0 109.8 -179.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.596 ' HB2' HD12 ' A' ' 14' ' ' ILE . 0.4 OUTLIER -126.02 175.45 3.17 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.366 -0.834 . . . . 0.0 109.159 179.946 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.558 ' HD2' ' CG ' ' A' ' 11' ' ' LEU . 43.9 Cg_endo -67.22 -22.24 46.96 Favored 'Trans proline' 0 C--O 1.214 -0.679 0 C-N-CA 122.557 2.171 . . . . 0.0 111.672 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 89.7 mtt180 -103.69 -29.28 11.17 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.298 -0.876 . . . . 0.0 109.56 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.596 HD12 ' HB2' ' A' ' 11' ' ' LEU . 89.2 mt -80.04 -49.64 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.244 -0.91 . . . . 0.0 109.497 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.848 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 82.15 -163.63 43.45 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.558 ' CD1' HG21 ' A' ' 10' ' ' VAL . 0.9 OUTLIER -92.86 151.84 19.75 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.285 -1.126 . . . . 0.0 109.444 -179.973 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 26.0 tp -127.67 116.08 19.73 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.198 -0.939 . . . . 0.0 109.816 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.444 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 77.4 m -129.86 157.36 77.03 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.281 -0.887 . . . . 0.0 109.035 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.537 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 49.4 Cg_endo -70.94 167.96 24.47 Favored 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 122.558 2.172 . . . . 0.0 111.44 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 24.5 mttp -94.8 -6.13 43.62 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.191 -0.943 . . . . 0.0 109.585 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.46 ' OD2' ' HE2' ' A' ' 23' ' ' LYS . 58.6 t0 -76.09 117.4 17.76 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.198 -0.939 . . . . 0.0 109.253 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.754 HD21 ' OD1' ' A' ' 34' ' ' ASN . 3.2 tm? -78.4 122.5 25.88 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.234 -0.916 . . . . 0.0 109.706 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.686 ' N ' HD13 ' A' ' 22' ' ' LEU . 5.2 mttt -142.2 104.01 5.61 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.404 -0.81 . . . . 0.0 109.22 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.542 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 42.6 Cg_endo -65.09 120.86 8.17 Favored 'Trans proline' 0 C--O 1.213 -0.756 0 C-N-CA 123.056 2.504 . . . . 0.0 112.036 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 24.5 m -116.65 155.0 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.321 -0.862 . . . . 0.0 110.005 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.461 ' O ' ' N ' ' A' ' 53' ' ' ARG . 28.0 t -99.67 108.64 21.05 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.475 -0.766 . . . . 0.0 109.319 179.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -62.61 138.79 44.99 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.51 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 57.1 p30 -68.86 -10.31 56.25 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.258 -1.143 . . . . 0.0 109.482 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.452 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 90.0 m-20 -84.0 4.93 27.67 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.18 -0.95 . . . . 0.0 109.409 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.51 13.45 58.35 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.223 -1.551 . . . . 0.0 109.223 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.508 ' O ' ' N ' ' A' ' 27' ' ' GLY . 93.5 mt-30 -117.95 160.53 21.29 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.321 -1.106 . . . . 0.0 109.497 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 57.4 m -116.99 130.23 56.55 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.244 -0.91 . . . . 0.0 109.24 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.701 ' CD1' HD13 ' A' ' 39' ' ' LEU . 65.8 m-85 -111.25 119.36 38.65 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.273 -0.892 . . . . 0.0 109.157 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.754 ' OD1' HD21 ' A' ' 22' ' ' LEU . 51.2 t-20 -46.31 -80.44 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.399 -0.813 . . . . 0.0 110.092 -179.363 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.528 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 1.9 t-20 -81.03 150.0 67.72 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.003 -1.061 . . . . 0.0 109.722 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.506 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.9 Cg_endo -63.97 -55.23 0.68 Allowed 'Trans proline' 0 C--O 1.216 -0.612 0 C-N-CA 122.756 2.304 . . . . 0.0 111.818 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.537 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 10.8 t -60.92 -30.45 70.21 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 120.91 -1.119 . . . . 0.0 108.17 178.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.487 ' CG ' ' HB3' ' A' ' 35' ' ' ASN . 52.5 mmm -60.11 -17.73 42.19 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.701 HD13 ' CD1' ' A' ' 33' ' ' TYR . 33.5 tp -68.5 -58.27 4.57 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 179.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.456 ' SG ' ' OH ' ' A' ' 16' ' ' TYR . 8.1 t -56.38 -24.08 42.1 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 178.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 30.0 t60 -70.63 -62.81 1.25 Allowed 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 179.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.482 ' OE1' ' CE2' ' A' ' 33' ' ' TYR . 78.6 mt-10 -55.47 -21.87 18.25 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.176 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.511 ' O ' ' N ' ' A' ' 47' ' ' GLN . 98.7 m-20 -73.65 -35.88 65.32 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 179.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.931 HD13 ' O ' ' A' ' 44' ' ' LEU . 2.0 tm? -62.61 -37.33 85.86 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.399 -0.813 . . . . 0.0 109.005 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.9 mt -71.82 -42.13 69.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.386 -0.821 . . . . 0.0 109.113 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.451 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 12.8 mtt-85 -79.84 -22.3 43.14 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.36 -0.838 . . . . 0.0 109.174 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.511 ' N ' ' O ' ' A' ' 43' ' ' ASN . 92.5 mt-30 63.3 44.68 5.41 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.316 -0.865 . . . . 0.0 109.475 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 21.9 p -128.02 169.88 13.53 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.373 -0.83 . . . . 0.0 109.413 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.571 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 43.9 t30 -102.7 64.84 0.89 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.233 -0.917 . . . . 0.0 109.304 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 33.9 m -74.83 147.32 41.26 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.338 -0.851 . . . . 0.0 109.613 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . 0.571 ' CE1' ' O ' ' A' ' 49' ' ' ASN . 51.4 m80 -122.77 -173.65 2.75 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.383 -0.823 . . . . 0.0 109.263 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 11.3 mt -95.82 124.07 48.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.137 -0.977 . . . . 0.0 109.531 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.51 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 72.3 ttt-85 -80.04 -56.0 4.55 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 121.622 0.725 . . . . 0.0 109.558 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 88.7 p -153.95 139.22 17.53 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.45 ' H ' HG23 ' A' ' 55' ' ' THR . 6.5 p -56.56 148.49 19.51 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.116 -0.99 . . . . 0.0 109.349 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.542 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 82.66 161.39 29.93 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.526 ' HG3' ' HB2' ' A' ' 24' ' ' PRO . 26.1 mttp -68.36 131.75 45.86 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.558 -0.966 . . . . 0.0 109.535 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.504 0 O-C-N 121.198 -0.939 . . . . 0.0 109.475 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 75.6 mtp . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.584 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 3.4 m -91.95 -12.45 33.37 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.364 -0.835 . . . . 0.0 109.632 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.4 mttm -57.37 -25.07 58.9 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.276 -0.89 . . . . 0.0 109.721 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 61.5 t0 -152.69 64.45 0.8 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.108 -0.995 . . . . 0.0 109.776 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.997 ' OH ' HD23 ' A' ' 44' ' ' LEU . 4.5 p90 -126.42 169.01 13.42 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.169 -0.957 . . . . 0.0 109.324 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 79.9 mtt180 -142.56 145.98 34.16 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.202 -0.936 . . . . 0.0 109.496 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.732 HG13 ' C ' ' A' ' 15' ' ' GLY . 90.8 t -140.32 134.53 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.266 -0.896 . . . . 0.0 109.471 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.551 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 1.1 mp -123.34 176.08 2.38 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.289 -0.882 . . . . 0.0 109.251 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.551 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 45.4 Cg_endo -67.51 -27.24 39.59 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 122.547 2.165 . . . . 0.0 111.514 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 71.3 mtt-85 -104.06 -29.77 10.68 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.292 -0.88 . . . . 0.0 109.005 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.43 ' HA ' HD13 ' A' ' 14' ' ' ILE . 26.7 mm -81.79 -41.26 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.429 -0.794 . . . . 0.0 109.519 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.732 ' C ' HG13 ' A' ' 10' ' ' VAL . . . 64.78 -147.06 50.82 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.474 ' CE2' ' CE2' ' A' ' 8' ' ' TYR . 1.5 t80 -104.98 151.75 23.55 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.244 -1.151 . . . . 0.0 109.538 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.425 ' HA ' HD12 ' A' ' 17' ' ' LEU . 24.3 tp -104.9 109.41 21.37 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.245 -0.909 . . . . 0.0 109.476 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 63.6 m -129.24 156.43 78.36 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.325 -0.859 . . . . 0.0 109.371 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -72.04 172.6 14.37 Favored 'Trans proline' 0 C--O 1.215 -0.673 0 C-N-CA 122.663 2.242 . . . . 0.0 111.567 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 20.4 tttm -89.51 -15.58 32.67 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.18 -0.95 . . . . 0.0 109.393 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -73.4 108.9 6.53 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.305 -0.872 . . . . 0.0 109.496 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.674 ' C ' HD13 ' A' ' 22' ' ' LEU . 3.5 tm? -77.79 109.72 12.04 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.221 -0.924 . . . . 0.0 109.258 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.502 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 7.1 mtmt -120.49 106.84 39.58 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.313 -0.867 . . . . 0.0 109.308 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.547 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 41.4 Cg_endo -63.44 120.54 8.0 Favored 'Trans proline' 0 C--O 1.213 -0.743 0 C-N-CA 123.151 2.567 . . . . 0.0 112.376 -179.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.615 ' O ' HG23 ' A' ' 32' ' ' THR . 18.3 m -115.58 155.52 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.228 -0.92 . . . . 0.0 109.744 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 39.9 t -98.04 115.54 28.43 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.335 -0.853 . . . . 0.0 109.319 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -70.83 138.84 29.0 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.52 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 53.2 t0 -70.92 -9.44 57.8 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.281 -1.129 . . . . 0.0 109.654 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 58.5 p30 -85.72 8.58 19.24 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.11 -0.994 . . . . 0.0 109.253 179.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.31 9.63 66.9 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.511 ' O ' ' N ' ' A' ' 27' ' ' GLY . 69.6 mt-30 -118.14 156.64 28.35 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.329 -1.101 . . . . 0.0 109.317 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.623 HG21 ' HA ' ' A' ' 57' ' ' LYS . 33.5 m -116.9 151.88 35.68 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.212 -0.93 . . . . 0.0 109.293 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.841 ' CD1' HD13 ' A' ' 39' ' ' LEU . 73.7 m-85 -129.77 131.06 46.12 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.197 -0.939 . . . . 0.0 109.239 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.539 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 2.7 m-20 -53.21 -79.38 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.288 -0.882 . . . . 0.0 109.636 -179.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.521 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 13.2 t-20 -82.64 145.69 51.45 Favored Pre-proline 0 C--N 1.3 -1.555 0 O-C-N 120.893 -1.13 . . . . 0.0 109.826 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.502 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.3 Cg_endo -63.63 -51.13 2.66 Favored 'Trans proline' 0 C--O 1.214 -0.689 0 C-N-CA 122.67 2.247 . . . . 0.0 111.278 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.521 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 5.6 t -60.44 -29.78 69.23 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 178.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.447 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 35.9 mmm -66.29 -10.87 46.77 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 179.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.841 HD13 ' CD1' ' A' ' 33' ' ' TYR . 52.0 tp -69.24 -55.28 11.03 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.286 -0.884 . . . . 0.0 108.822 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.442 ' HA ' ' HB2' ' A' ' 43' ' ' ASN . 11.5 t -54.85 -29.6 55.58 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 179.085 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 32.5 t60 -60.15 -60.92 3.05 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.452 ' HA ' ' OE1' ' A' ' 42' ' ' GLU . 68.8 mm-40 -58.86 -22.61 59.49 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 179.057 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.508 ' O ' ' N ' ' A' ' 47' ' ' GLN . 98.5 m-20 -75.97 -23.2 55.32 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.997 HD23 ' OH ' ' A' ' 8' ' ' TYR . 2.0 tm? -72.4 -36.63 68.69 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.32 -0.862 . . . . 0.0 108.797 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.528 ' N ' HD13 ' A' ' 45' ' ' ILE . 3.8 mm -76.31 -41.96 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.428 -0.795 . . . . 0.0 109.154 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.462 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 21.1 mtt-85 -83.07 -40.2 20.18 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.41 -0.807 . . . . 0.0 109.482 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.508 ' N ' ' O ' ' A' ' 43' ' ' ASN . 89.8 mt-30 63.54 43.44 5.85 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.48 -0.763 . . . . 0.0 109.482 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 72.2 p -113.01 18.75 17.83 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.248 -0.908 . . . . 0.0 109.334 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 54.7 m-20 44.76 58.71 3.77 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.274 -0.891 . . . . 0.0 109.465 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.475 ' HB ' ' OD1' ' A' ' 43' ' ' ASN . 21.1 m -75.22 145.28 42.13 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.15 -0.969 . . . . 0.0 109.744 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 29.4 m-70 -118.69 171.77 7.97 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.302 -0.874 . . . . 0.0 108.981 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.481 HG23 ' HB ' ' A' ' 25' ' ' VAL . 20.2 mt -84.15 124.49 39.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.105 -0.997 . . . . 0.0 109.574 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.52 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 37.1 ttt180 -79.85 -52.41 7.93 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-O 121.701 0.762 . . . . 0.0 109.245 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 24.7 p -151.78 153.91 35.22 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 20.9 p -71.8 136.6 47.13 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.185 -0.947 . . . . 0.0 109.438 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.547 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 95.87 163.32 33.75 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.623 ' HA ' HG21 ' A' ' 32' ' ' THR . 73.6 tttt -49.64 152.62 1.38 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.46 -1.023 . . . . 0.0 109.373 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.42 ' N ' ' HG2' ' A' ' 57' ' ' LYS . 24.5 m . . . . . 0 N--CA 1.49 1.55 0 O-C-N 121.174 -0.954 . . . . 0.0 109.491 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 79.4 mmm . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.598 ' HB3' ' CE1' ' A' ' 8' ' ' TYR . 2.7 m -85.06 5.48 29.36 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.461 -0.775 . . . . 0.0 109.039 179.386 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.446 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 11.5 mttm -66.23 -28.35 68.67 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.18 -0.95 . . . . 0.0 109.554 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.446 ' OD1' ' O ' ' A' ' 6' ' ' LYS . 80.3 m-20 -146.2 65.76 1.2 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.269 -0.894 . . . . 0.0 110.153 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.718 ' CZ ' HD21 ' A' ' 44' ' ' LEU . 12.6 p90 -125.8 -177.7 4.02 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.146 -0.971 . . . . 0.0 109.234 179.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 66.4 mtm180 -150.39 143.48 24.85 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.171 -0.955 . . . . 0.0 109.634 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.797 HG13 ' O ' ' A' ' 15' ' ' GLY . 69.1 t -128.4 130.97 69.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.241 -0.912 . . . . 0.0 109.442 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.545 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.2 OUTLIER -111.41 175.0 2.05 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.291 -0.881 . . . . 0.0 109.415 -179.867 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.545 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 46.1 Cg_endo -67.6 -24.17 42.05 Favored 'Trans proline' 0 C--O 1.216 -0.611 0 C-N-CA 122.665 2.243 . . . . 0.0 111.565 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 82.3 mtp180 -94.36 -31.7 13.91 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.342 -0.849 . . . . 0.0 109.104 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 80.5 mt -85.38 -46.99 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.415 -0.803 . . . . 0.0 109.357 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.797 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 70.59 -165.06 52.56 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.527 ' OH ' ' CB ' ' A' ' 40' ' ' CYS . 0.8 OUTLIER -104.41 146.62 28.59 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.235 -1.156 . . . . 0.0 109.377 179.928 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.829 ' N ' HD12 ' A' ' 17' ' ' LEU . 0.6 OUTLIER -112.59 124.87 53.51 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.248 -0.907 . . . . 0.0 109.452 179.86 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.434 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 59.6 m -142.16 155.84 64.9 Favored Pre-proline 0 C--N 1.3 -1.585 0 O-C-N 121.373 -0.829 . . . . 0.0 108.81 179.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -70.88 164.45 35.61 Favored 'Trans proline' 0 C--O 1.214 -0.695 0 C-N-CA 122.236 1.957 . . . . 0.0 111.344 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.2 mtpm? -82.54 -26.43 32.46 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.311 -0.868 . . . . 0.0 109.415 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -63.29 124.83 22.23 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.311 -0.868 . . . . 0.0 109.446 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.753 ' C ' HD13 ' A' ' 22' ' ' LEU . 3.4 tm? -86.53 106.96 17.89 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.137 -0.977 . . . . 0.0 109.305 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.516 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 9.5 mttt -115.22 106.79 50.62 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.222 -0.924 . . . . 0.0 109.47 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.537 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 41.7 Cg_endo -63.21 116.94 3.91 Favored 'Trans proline' 0 C--O 1.214 -0.698 0 C-N-CA 123.032 2.488 . . . . 0.0 112.176 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.564 ' HB ' HG23 ' A' ' 52' ' ' ILE . 16.4 m -115.09 154.86 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.285 -0.885 . . . . 0.0 109.266 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.431 ' O ' ' N ' ' A' ' 53' ' ' ARG . 45.1 t -95.08 143.81 26.23 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 178.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -97.06 141.49 15.65 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 -178.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.489 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 54.6 p30 -67.42 -8.63 34.63 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.313 -1.11 . . . . 0.0 109.431 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -95.88 10.84 35.84 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.317 -0.864 . . . . 0.0 109.49 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.45 12.31 73.08 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.534 ' O ' ' N ' ' A' ' 27' ' ' GLY . 53.4 mt-30 -115.84 148.26 40.13 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.298 -1.119 . . . . 0.0 109.504 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.641 HG21 ' HA ' ' A' ' 57' ' ' LYS . 8.4 m -112.32 152.23 28.79 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.146 -0.971 . . . . 0.0 109.731 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.852 ' CD2' HD12 ' A' ' 39' ' ' LEU . 94.6 m-85 -129.34 133.4 47.4 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.303 -0.873 . . . . 0.0 109.187 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.693 ' CB ' HD21 ' A' ' 22' ' ' LEU . 1.5 m-20 -53.57 -75.37 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.111 -0.993 . . . . 0.0 109.194 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.526 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 8.4 t-20 -82.38 146.56 54.39 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.155 -0.966 . . . . 0.0 109.188 179.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.516 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 42.0 Cg_endo -64.69 -51.38 1.84 Allowed 'Trans proline' 0 C--O 1.216 -0.608 0 C-N-CA 122.649 2.233 . . . . 0.0 111.486 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.526 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 9.5 t -62.38 -27.24 68.94 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 178.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.499 ' CG ' ' HB3' ' A' ' 35' ' ' ASN . 44.9 mmm -66.44 -21.83 66.21 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.686 -0.634 . . . . 0.0 109.29 179.308 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.852 HD12 ' CD2' ' A' ' 33' ' ' TYR . 6.4 tt -64.83 -51.48 61.86 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.247 -0.908 . . . . 0.0 108.841 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.527 ' CB ' ' OH ' ' A' ' 16' ' ' TYR . 33.8 m -51.41 -33.64 31.26 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.06 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 19.1 t60 -53.3 -46.31 69.33 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.237 -0.915 . . . . 0.0 108.552 179.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.581 ' HB2' ' CE1' ' A' ' 33' ' ' TYR . 21.4 tp10 -62.03 -17.46 57.38 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.52 ' HB2' ' O ' ' A' ' 40' ' ' CYS . 2.7 m-80 -79.13 -33.93 43.77 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 119.492 -0.883 . . . . 0.0 109.247 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.718 HD21 ' CZ ' ' A' ' 8' ' ' TYR . 46.6 mt -70.5 -32.93 70.62 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.256 -0.903 . . . . 0.0 109.8 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.7 mm -79.39 -51.6 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.255 -0.903 . . . . 0.0 109.654 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.538 ' HB3' HG23 ' A' ' 48' ' ' THR . 18.5 mtt-85 -82.51 -33.98 28.1 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.21 -0.931 . . . . 0.0 109.833 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.486 ' N ' ' O ' ' A' ' 43' ' ' ASN . 89.6 mt-30 62.52 36.7 13.79 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.247 -0.908 . . . . 0.0 109.422 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.538 HG23 ' HB3' ' A' ' 46' ' ' ARG . 39.0 p -102.87 3.28 36.41 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.226 -0.921 . . . . 0.0 109.631 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.445 ' HB2' ' O ' ' A' ' 48' ' ' THR . 18.6 m120 65.07 48.31 2.29 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.317 -0.864 . . . . 0.0 109.512 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.518 ' N ' ' OD1' ' A' ' 43' ' ' ASN . 48.4 m -80.19 131.39 35.7 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.206 -0.933 . . . . 0.0 109.607 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 11.1 m-70 -114.25 -171.45 1.92 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.272 -0.893 . . . . 0.0 109.38 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.564 HG23 ' HB ' ' A' ' 25' ' ' VAL . 42.9 mt -89.03 127.05 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.311 -0.868 . . . . 0.0 109.574 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.489 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 39.3 ttt85 -81.37 -43.44 19.02 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.424 -0.798 . . . . 0.0 109.255 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.6 m -160.44 146.4 15.18 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.569 -0.707 . . . . 0.0 109.319 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.7 p -61.68 143.5 56.04 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.2 -0.937 . . . . 0.0 109.488 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.537 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 87.58 162.04 37.4 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.641 ' HA ' HG21 ' A' ' 32' ' ' THR . 62.0 tttt -52.91 152.46 3.94 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.667 -0.902 . . . . 0.0 109.603 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 85.3 m . . . . . 0 N--CA 1.492 1.63 0 O-C-N 121.302 -0.874 . . . . 0.0 109.552 179.963 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 92.2 mtp . . . . . 0 N--CA 1.488 1.469 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.6 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 26.2 m -81.42 -14.42 57.14 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.458 -0.776 . . . . 0.0 109.39 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.462 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 22.6 mttm -80.59 5.23 16.04 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.201 -0.937 . . . . 0.0 109.509 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.462 ' OD1' ' O ' ' A' ' 6' ' ' LYS . 93.2 m-20 -135.76 12.82 3.42 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.061 -1.024 . . . . 0.0 110.405 -179.405 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.613 ' CE2' ' CE2' ' A' ' 16' ' ' TYR . 0.6 OUTLIER -123.54 150.72 43.66 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.873 -1.142 . . . . 0.0 109.682 179.815 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 46.1 mtt85 -130.5 132.73 45.78 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.246 -0.908 . . . . 0.0 109.393 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.761 HG13 ' O ' ' A' ' 15' ' ' GLY . 54.2 t -123.39 147.08 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.187 -0.945 . . . . 0.0 109.716 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.709 HD23 ' HD2' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -128.97 176.26 2.93 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.423 -0.798 . . . . 0.0 109.17 -179.999 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.709 ' HD2' HD23 ' A' ' 11' ' ' LEU . 44.0 Cg_endo -66.64 -22.1 51.15 Favored 'Trans proline' 0 C--O 1.214 -0.681 0 C-N-CA 122.477 2.118 . . . . 0.0 111.782 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 60.5 mtt180 -101.55 -30.02 11.63 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.24 -0.913 . . . . 0.0 109.498 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.44 HD12 ' HB2' ' A' ' 11' ' ' LEU . 95.4 mt -81.47 -47.66 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.279 -0.888 . . . . 0.0 109.739 -179.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.761 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 77.14 -167.78 54.41 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.613 ' CE2' ' CE2' ' A' ' 8' ' ' TYR . 1.5 t80 -95.75 150.77 20.03 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.177 -1.19 . . . . 0.0 109.662 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 25.7 tp -117.51 105.81 12.49 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.322 -0.861 . . . . 0.0 109.465 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.402 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 76.2 m -117.77 157.3 48.43 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.239 -0.913 . . . . 0.0 109.183 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.485 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 49.5 Cg_endo -72.17 166.01 30.94 Favored 'Trans proline' 0 C--O 1.216 -0.622 0 C-N-CA 122.63 2.22 . . . . 0.0 111.545 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 60.1 mttt -89.38 -13.2 38.31 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.184 -0.948 . . . . 0.0 109.475 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -73.53 113.72 10.96 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.231 -0.918 . . . . 0.0 109.248 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.491 HD11 ' HB3' ' A' ' 34' ' ' ASN . 49.4 tp -76.54 112.54 13.18 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.174 -0.954 . . . . 0.0 109.628 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.489 ' O ' ' O ' ' A' ' 34' ' ' ASN . 14.2 mttt -126.22 110.14 24.0 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.295 -0.878 . . . . 0.0 108.941 179.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.542 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 43.5 Cg_endo -64.93 123.98 12.42 Favored 'Trans proline' 0 C--O 1.213 -0.744 0 C-N-CA 123.025 2.483 . . . . 0.0 112.487 -179.187 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.445 ' HB ' HG23 ' A' ' 52' ' ' ILE . 27.2 m -118.77 153.38 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.434 -0.791 . . . . 0.0 109.452 179.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 41.9 t -99.45 139.65 34.8 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 178.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -93.91 144.44 17.11 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 -178.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.497 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 49.3 p30 -68.87 -15.0 63.38 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.365 -1.079 . . . . 0.0 109.432 179.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.457 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 88.1 m-20 -84.46 5.73 26.26 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.232 -0.917 . . . . 0.0 109.542 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.04 17.17 56.65 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.444 ' O ' ' SG ' ' A' ' 58' ' ' CYS . 90.8 mt-30 -115.82 171.13 7.96 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.307 -1.113 . . . . 0.0 109.485 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.554 HG23 ' HA ' ' A' ' 57' ' ' LYS . 64.0 m -133.03 136.0 45.73 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.232 -0.918 . . . . 0.0 109.522 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.927 ' CD1' HD13 ' A' ' 39' ' ' LEU . 44.4 m-85 -116.14 133.17 56.32 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.292 -0.88 . . . . 0.0 109.247 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.54 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 7.7 m-20 -55.3 -77.57 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.262 -0.899 . . . . 0.0 110.031 -179.423 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.524 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 5.4 t-20 -81.63 147.66 59.84 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 120.91 -1.119 . . . . 0.0 109.728 -179.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.479 ' HD3' ' O ' ' A' ' 23' ' ' LYS . 41.3 Cg_endo -64.18 -53.09 1.27 Allowed 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 122.771 2.314 . . . . 0.0 111.552 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.524 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 10.1 t -62.34 -29.0 70.14 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 178.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.515 ' CG ' ' HB3' ' A' ' 35' ' ' ASN . 44.6 mmm -62.76 -14.09 40.63 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.241 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.927 HD13 ' CD1' ' A' ' 33' ' ' TYR . 39.8 tp -73.23 -60.17 2.37 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.407 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.455 ' HB3' ' OH ' ' A' ' 16' ' ' TYR . 17.8 t -54.54 -23.56 17.11 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 54.3 t60 -69.46 -62.25 1.46 Allowed 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 -58.09 -19.1 29.5 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.494 ' O ' ' N ' ' A' ' 47' ' ' GLN . 99.6 m-20 -76.36 -29.66 57.28 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.482 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.937 HD13 ' O ' ' A' ' 44' ' ' LEU . 1.8 tm? -69.81 -38.79 76.73 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.416 -0.803 . . . . 0.0 109.014 179.543 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.555 ' N ' HD13 ' A' ' 45' ' ' ILE . 3.7 mm -71.54 -46.42 63.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.301 -0.875 . . . . 0.0 109.385 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.447 ' HB3' HG23 ' A' ' 48' ' ' THR . 13.4 mtt-85 -79.59 -33.23 41.82 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.286 -0.884 . . . . 0.0 109.354 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.494 ' N ' ' O ' ' A' ' 43' ' ' ASN . 92.3 mt-30 61.24 39.43 15.7 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.368 -0.832 . . . . 0.0 109.52 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.447 HG23 ' HB3' ' A' ' 46' ' ' ARG . 52.2 p -104.28 8.21 35.99 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.261 -0.9 . . . . 0.0 109.481 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.58 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 35.5 t-20 50.78 57.69 6.36 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.296 -0.878 . . . . 0.0 109.505 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.457 ' HB ' ' OD1' ' A' ' 43' ' ' ASN . 26.6 m -80.32 148.54 30.64 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.182 -0.949 . . . . 0.0 109.785 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . 0.58 ' CE1' ' O ' ' A' ' 49' ' ' ASN . 13.7 m80 -122.0 171.34 9.02 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.396 -0.815 . . . . 0.0 108.851 179.472 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.453 HG12 HD22 ' A' ' 39' ' ' LEU . 11.7 mt -83.29 126.48 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.156 -0.965 . . . . 0.0 109.701 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.497 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 55.8 ttt180 -80.04 -46.45 16.55 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.452 -0.78 . . . . 0.0 109.409 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -160.54 142.92 12.89 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.418 ' H ' HG23 ' A' ' 55' ' ' THR . 25.8 p -54.71 148.4 12.84 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.192 -0.942 . . . . 0.0 109.112 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.542 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 84.42 168.2 43.83 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.068 -1.613 . . . . 0.0 109.068 -179.513 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.554 ' HA ' HG23 ' A' ' 32' ' ' THR . 81.7 mttt -63.93 167.14 6.52 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.257 -1.143 . . . . 0.0 109.238 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.444 ' SG ' ' O ' ' A' ' 31' ' ' GLN . 84.0 m . . . . . 0 N--CA 1.488 1.453 0 O-C-N 121.219 -0.926 . . . . 0.0 109.098 179.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 84.5 mmm . . . . . 0 N--CA 1.489 1.477 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 16.8 p -79.76 -7.76 58.84 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.14 -0.975 . . . . 0.0 109.286 179.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 24.7 mttm -49.05 -24.92 1.75 Allowed 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.079 -1.013 . . . . 0.0 108.391 179.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.401 ' OD1' ' C ' ' A' ' 7' ' ' ASP . 58.8 p30 -112.98 25.57 11.28 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.319 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.577 ' CZ ' ' CE1' ' A' ' 16' ' ' TYR . 3.7 t80 -79.19 162.82 25.49 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.544 -0.723 . . . . 0.0 109.99 -179.394 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 12.7 mtm180 -148.92 115.36 5.87 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.368 -0.832 . . . . 0.0 108.977 179.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.95 HG13 ' C ' ' A' ' 15' ' ' GLY . 99.8 t -111.32 148.99 14.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.229 -0.919 . . . . 0.0 109.468 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.562 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.5 OUTLIER -129.58 175.82 3.3 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.251 -0.905 . . . . 0.0 109.453 -179.674 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.562 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 43.7 Cg_endo -66.77 -22.26 49.93 Favored 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 122.644 2.229 . . . . 0.0 111.584 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.44 ' HB3' ' NH1' ' A' ' 13' ' ' ARG . 19.5 mtp-105 -114.29 -29.49 6.91 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.375 -0.828 . . . . 0.0 109.215 179.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.487 HD12 ' HB2' ' A' ' 11' ' ' LEU . 97.1 mt -78.92 -42.02 24.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.338 -0.851 . . . . 0.0 109.383 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.95 ' C ' HG13 ' A' ' 10' ' ' VAL . . . 64.12 -150.89 50.25 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.577 ' CE1' ' CZ ' ' A' ' 8' ' ' TYR . 1.0 OUTLIER -102.68 147.6 26.62 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.266 -1.138 . . . . 0.0 109.352 179.858 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.465 ' HB2' ' OH ' ' A' ' 8' ' ' TYR . 37.5 mt -113.86 124.14 51.49 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.118 -0.989 . . . . 0.0 109.919 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.413 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 61.4 m -138.97 156.32 72.57 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.433 -0.792 . . . . 0.0 109.026 179.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -70.74 167.05 26.84 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.573 2.182 . . . . 0.0 111.671 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -88.2 -13.7 40.44 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.208 -0.933 . . . . 0.0 109.698 -179.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -74.19 123.48 24.57 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.133 -0.98 . . . . 0.0 109.391 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.542 HD11 ' HB3' ' A' ' 34' ' ' ASN . 39.7 tp -80.61 118.55 22.29 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.275 -0.89 . . . . 0.0 109.515 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.532 ' CB ' ' HD3' ' A' ' 36' ' ' PRO . 10.8 mttp -127.65 100.09 25.69 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.347 -0.846 . . . . 0.0 109.17 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.541 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 42.2 Cg_endo -64.41 118.22 5.2 Favored 'Trans proline' 0 C--O 1.214 -0.713 0 C-N-CA 122.874 2.383 . . . . 0.0 112.133 -179.449 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.526 ' HB ' HG23 ' A' ' 52' ' ' ILE . 12.2 m -114.65 155.74 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.309 -0.87 . . . . 0.0 109.557 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.417 ' SG ' ' NE ' ' A' ' 53' ' ' ARG . 42.4 t -95.62 138.96 32.55 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.237 -0.914 . . . . 0.0 108.661 179.051 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -92.11 136.16 13.1 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.487 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 53.8 t0 -68.96 -7.15 32.51 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.196 -1.179 . . . . 0.0 109.426 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.413 ' OD1' ' C ' ' A' ' 29' ' ' ASP . 59.2 p30 -89.72 2.95 54.19 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.265 -0.897 . . . . 0.0 109.413 179.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.64 16.57 39.02 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.463 ' O ' ' SG ' ' A' ' 58' ' ' CYS . 66.2 mt-30 -121.78 -178.37 3.81 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.301 -1.117 . . . . 0.0 109.592 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.615 HG21 ' HA ' ' A' ' 57' ' ' LYS . 11.1 m -143.3 138.85 29.83 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.287 -0.883 . . . . 0.0 109.319 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.871 ' CD1' HD13 ' A' ' 39' ' ' LEU . 40.2 m-85 -116.13 134.09 55.31 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.217 -0.927 . . . . 0.0 109.366 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.542 ' HB3' HD11 ' A' ' 22' ' ' LEU . 13.1 m-20 -55.07 -78.94 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.255 -0.903 . . . . 0.0 109.666 -179.611 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.51 ' HB3' ' CG ' ' A' ' 38' ' ' MET . 10.9 t-20 -82.33 146.14 53.61 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.08 -1.013 . . . . 0.0 109.525 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.532 ' HD3' ' CB ' ' A' ' 23' ' ' LYS . 41.4 Cg_endo -63.94 -51.64 2.16 Favored 'Trans proline' 0 C--O 1.215 -0.651 0 C-N-CA 122.753 2.302 . . . . 0.0 111.621 179.438 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.505 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 8.0 t -62.06 -25.62 67.79 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 178.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.51 ' CG ' ' HB3' ' A' ' 35' ' ' ASN . 65.2 mmm -72.35 -3.02 21.47 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 179.191 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.871 HD13 ' CD1' ' A' ' 33' ' ' TYR . 21.2 tp -74.37 -60.03 2.46 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.287 -0.883 . . . . 0.0 109.175 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.488 ' HB3' ' OH ' ' A' ' 16' ' ' TYR . 2.2 t -56.44 -25.73 51.43 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.122 -0.986 . . . . 0.0 108.468 179.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 27.4 t60 -61.9 -56.91 14.42 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.468 ' OE1' ' CD2' ' A' ' 33' ' ' TYR . 65.1 tt0 -64.2 -20.57 66.11 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.145 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.501 ' O ' ' N ' ' A' ' 47' ' ' GLN . 88.6 m-20 -79.19 -29.88 43.12 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.61 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.977 HD13 ' O ' ' A' ' 44' ' ' LEU . 1.7 tm? -65.41 -36.9 85.35 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.284 -0.885 . . . . 0.0 109.165 179.629 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.2 mt -79.4 -38.88 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.372 -0.83 . . . . 0.0 109.317 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.456 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 17.0 mtt-85 -80.11 -32.79 39.08 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.174 -0.954 . . . . 0.0 109.417 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.501 ' N ' ' O ' ' A' ' 43' ' ' ASN . 73.8 mm-40 61.84 40.93 12.2 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.254 -0.904 . . . . 0.0 109.578 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 25.4 p -113.73 9.84 17.79 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.187 -0.946 . . . . 0.0 109.625 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 49.6 m-20 45.35 58.81 3.91 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.201 -0.937 . . . . 0.0 109.529 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.432 ' HB ' ' OD1' ' A' ' 43' ' ' ASN . 66.0 m -80.33 137.55 36.59 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.158 -0.964 . . . . 0.0 109.779 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 72.2 m80 -110.77 172.02 7.12 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.255 -0.903 . . . . 0.0 108.967 179.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.526 HG23 ' HB ' ' A' ' 25' ' ' VAL . 34.7 mt -82.12 126.03 39.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.131 -0.981 . . . . 0.0 109.435 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.487 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 46.6 ttp180 -79.99 -44.56 19.99 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 121.642 0.734 . . . . 0.0 109.309 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 17.1 p -158.49 156.1 29.67 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -179.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 36.5 p -71.68 140.32 49.58 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.119 -0.988 . . . . 0.0 109.407 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.541 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 89.5 162.25 38.24 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.551 -1.419 . . . . 0.0 109.551 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.615 ' HA ' HG21 ' A' ' 32' ' ' THR . 46.2 tttp -50.63 148.54 3.83 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.537 -0.978 . . . . 0.0 109.49 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.463 ' SG ' ' O ' ' A' ' 31' ' ' GLN . 92.5 m . . . . . 0 N--CA 1.489 1.523 0 O-C-N 121.318 -0.864 . . . . 0.0 109.331 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 77.4 mtm . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.592 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 48.7 m -80.09 -19.13 48.16 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.396 -0.815 . . . . 0.0 109.351 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.442 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 25.3 mttt -81.04 11.65 3.93 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.362 -0.836 . . . . 0.0 109.985 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' A' ' 6' ' ' LYS . 94.4 m-20 -136.23 4.05 2.91 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.026 -1.046 . . . . 0.0 109.972 -179.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.592 ' CD1' ' HA ' ' A' ' 5' ' ' CYS . 0.7 OUTLIER -121.12 147.98 44.81 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.946 -1.096 . . . . 0.0 109.675 -179.951 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 29.2 mtt180 -132.44 124.64 29.01 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.333 -0.854 . . . . 0.0 108.957 179.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.74 HG13 ' O ' ' A' ' 15' ' ' GLY . 75.8 t -108.95 141.44 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.333 -0.854 . . . . 0.0 110.183 -179.229 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.687 HD12 ' O ' ' A' ' 10' ' ' VAL . 2.0 mp -130.71 176.18 3.08 Favored Pre-proline 0 N--CA 1.489 1.503 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.546 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 44.2 Cg_endo -66.55 -23.05 50.39 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 122.593 2.196 . . . . 0.0 111.801 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 31.6 ttp180 -97.78 -35.06 10.65 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.332 -0.855 . . . . 0.0 109.404 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 87.3 mt -80.34 -50.75 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.324 -0.86 . . . . 0.0 109.398 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.74 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 82.51 -171.67 51.6 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.536 ' CD1' HG21 ' A' ' 10' ' ' VAL . 0.9 OUTLIER -86.73 152.92 22.12 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.235 -1.156 . . . . 0.0 109.548 179.984 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 19.1 tp -129.45 117.1 19.98 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.235 -0.915 . . . . 0.0 109.915 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.444 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 75.8 m -133.82 156.72 79.12 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.401 -0.812 . . . . 0.0 108.928 179.515 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.549 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 49.6 Cg_endo -70.62 167.37 25.75 Favored 'Trans proline' 0 C--O 1.216 -0.623 0 C-N-CA 122.689 2.259 . . . . 0.0 111.679 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -93.91 -6.77 44.84 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.302 -0.873 . . . . 0.0 109.573 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.541 ' CB ' ' HE2' ' A' ' 23' ' ' LYS . 77.5 m-20 -74.46 137.01 42.29 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.228 -0.92 . . . . 0.0 109.115 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.839 HD21 ' OD1' ' A' ' 34' ' ' ASN . 3.3 tm? -92.66 119.6 32.23 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.201 -0.937 . . . . 0.0 109.599 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.609 ' N ' HD13 ' A' ' 22' ' ' LEU . 11.5 mttt -139.22 104.26 7.24 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.176 -0.952 . . . . 0.0 109.403 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.543 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 44.2 Cg_endo -67.25 118.47 5.6 Favored 'Trans proline' 0 C--O 1.214 -0.691 0 C-N-CA 122.921 2.414 . . . . 0.0 111.857 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 23.2 m -112.89 155.57 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.247 -0.908 . . . . 0.0 109.927 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.461 ' O ' ' N ' ' A' ' 53' ' ' ARG . 39.3 t -101.49 109.57 21.41 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.315 -0.866 . . . . 0.0 109.338 179.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.485 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -62.5 142.17 47.64 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 -179.56 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.51 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 58.4 p30 -70.62 -10.37 59.18 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.326 -1.102 . . . . 0.0 109.378 179.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.438 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 55.1 p30 -85.33 6.58 25.74 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.224 -0.923 . . . . 0.0 109.312 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.65 9.47 64.45 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.191 -1.564 . . . . 0.0 109.191 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.485 ' O ' ' N ' ' A' ' 27' ' ' GLY . 88.0 mt-30 -111.18 168.28 9.63 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.381 -1.07 . . . . 0.0 109.517 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.566 HG23 ' HA ' ' A' ' 57' ' ' LYS . 30.3 m -127.68 130.79 49.5 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.243 -0.91 . . . . 0.0 109.402 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.805 ' CD1' HD13 ' A' ' 39' ' ' LEU . 47.1 m-85 -109.44 123.73 49.85 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.208 -0.932 . . . . 0.0 109.188 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.839 ' OD1' HD21 ' A' ' 22' ' ' LEU . 52.5 t-20 -48.3 -78.86 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.252 -0.905 . . . . 0.0 110.057 -179.387 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.535 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 1.4 t-20 -81.2 150.36 67.85 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.002 -1.061 . . . . 0.0 109.617 -179.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.469 ' HD2' ' CG ' ' A' ' 35' ' ' ASN . 40.7 Cg_endo -63.52 -55.5 0.7 Allowed 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 122.874 2.383 . . . . 0.0 112.037 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.549 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 13.6 t -63.31 -28.65 70.16 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.995 -1.066 . . . . 0.0 108.539 179.23 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.475 ' CG ' ' HB3' ' A' ' 35' ' ' ASN . 51.5 mmm -61.16 -17.66 54.06 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.345 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.805 HD13 ' CD1' ' A' ' 33' ' ' TYR . 30.7 tp -67.11 -59.0 3.83 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.269 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.458 ' HB3' ' OH ' ' A' ' 16' ' ' TYR . 8.2 t -55.8 -27.47 51.3 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.734 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.407 ' HB3' ' O ' ' A' ' 38' ' ' MET . 49.1 t60 -63.5 -61.09 2.56 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 63.1 mt-10 -57.47 -20.88 33.7 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 178.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.5 ' O ' ' N ' ' A' ' 47' ' ' GLN . 95.9 m-20 -80.27 -26.68 38.83 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.564 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 35.8 tp -71.3 -32.26 68.42 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.275 -0.891 . . . . 0.0 108.722 179.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 6.6 mm -80.57 -46.5 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.415 -0.803 . . . . 0.0 109.181 179.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.521 ' HB3' HG23 ' A' ' 48' ' ' THR . 58.0 mtt-85 -80.12 -36.69 34.96 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.253 -0.905 . . . . 0.0 109.285 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.5 ' N ' ' O ' ' A' ' 43' ' ' ASN . 91.7 mt-30 63.89 39.8 7.92 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.535 -0.728 . . . . 0.0 109.518 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.521 HG23 ' HB3' ' A' ' 46' ' ' ARG . 39.6 p -101.77 6.02 41.51 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.293 -0.879 . . . . 0.0 109.415 179.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.462 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 49.6 t30 52.78 57.24 6.58 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.301 -0.874 . . . . 0.0 109.687 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 58.4 m -80.12 141.34 35.85 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.185 -0.947 . . . . 0.0 109.633 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . 0.462 ' CE1' ' O ' ' A' ' 49' ' ' ASN . 13.9 m80 -111.13 178.83 4.22 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.331 -0.855 . . . . 0.0 109.192 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.9 mt -90.25 127.22 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.123 -0.985 . . . . 0.0 109.799 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.51 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 28.4 ttt180 -80.18 -59.83 2.56 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.494 -0.754 . . . . 0.0 109.287 179.694 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 21.1 m -154.04 142.25 20.45 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.3 p -53.3 143.41 18.71 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.157 -0.965 . . . . 0.0 109.542 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.543 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 95.26 162.95 34.46 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.566 ' HA ' HG23 ' A' ' 32' ' ' THR . 18.0 mttp -64.26 149.68 47.53 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.465 -1.02 . . . . 0.0 109.341 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.457 ' SG ' ' O ' ' A' ' 31' ' ' GLN . 70.2 m . . . . . 0 N--CA 1.489 1.524 0 O-C-N 121.223 -0.923 . . . . 0.0 109.41 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . 0.452 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 86.4 mtp . . . . . 0 N--CA 1.488 1.466 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.581 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 27.1 m -87.15 -16.64 34.83 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.479 -0.763 . . . . 0.0 109.123 179.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.7 mttp -81.15 14.25 2.43 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.303 -0.873 . . . . 0.0 109.943 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.452 ' OD1' ' O ' ' A' ' 4' ' ' MET . 51.7 p30 -145.79 10.5 1.21 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.918 -1.114 . . . . 0.0 110.098 -179.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.645 ' CE2' ' CE2' ' A' ' 16' ' ' TYR . 1.1 p90 -119.0 150.48 39.88 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.933 -1.104 . . . . 0.0 109.546 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 57.8 mtm180 -130.01 133.82 47.0 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.237 -0.914 . . . . 0.0 109.289 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.929 HG13 ' O ' ' A' ' 15' ' ' GLY . 54.1 t -122.92 149.98 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.202 -0.936 . . . . 0.0 109.711 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.553 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.2 OUTLIER -131.39 175.91 3.31 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.322 -0.861 . . . . 0.0 109.261 -179.971 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.553 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 43.7 Cg_endo -66.07 -22.97 54.04 Favored 'Trans proline' 0 C--O 1.214 -0.684 0 C-N-CA 122.65 2.233 . . . . 0.0 111.929 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 3.5 mtm180 -106.29 -31.77 8.47 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.301 -0.874 . . . . 0.0 109.357 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.488 HD12 ' HB2' ' A' ' 11' ' ' LEU . 92.9 mt -77.17 -39.33 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.374 -0.829 . . . . 0.0 109.347 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.929 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 70.73 -162.81 53.71 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.645 ' CE2' ' CE2' ' A' ' 8' ' ' TYR . 2.0 t80 -95.01 150.55 20.04 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.211 -1.17 . . . . 0.0 109.632 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 23.0 tp -113.13 111.33 21.92 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.412 -0.805 . . . . 0.0 109.593 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.452 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 84.6 m -128.68 156.63 77.17 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.147 -0.971 . . . . 0.0 109.317 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.525 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 48.9 Cg_endo -70.82 167.53 25.57 Favored 'Trans proline' 0 C--O 1.216 -0.611 0 C-N-CA 122.717 2.278 . . . . 0.0 111.577 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 62.6 mttm -94.94 -4.56 46.54 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.255 -0.903 . . . . 0.0 109.631 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -76.69 123.98 26.97 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.206 -0.934 . . . . 0.0 109.348 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.751 HD21 ' OD1' ' A' ' 34' ' ' ASN . 3.3 tm? -82.73 119.02 23.8 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.208 -0.933 . . . . 0.0 109.498 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.595 ' N ' HD13 ' A' ' 22' ' ' LEU . 15.5 mttp -141.88 107.51 5.87 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.302 -0.874 . . . . 0.0 109.476 179.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.546 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 43.3 Cg_endo -65.9 123.66 11.61 Favored 'Trans proline' 0 C--O 1.213 -0.728 0 C-N-CA 123.017 2.478 . . . . 0.0 112.14 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.663 ' O ' HG23 ' A' ' 32' ' ' THR . 29.7 m -116.32 155.02 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.265 -0.897 . . . . 0.0 109.71 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.455 ' O ' ' N ' ' A' ' 53' ' ' ARG . 43.5 t -99.27 122.94 43.12 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.428 -0.795 . . . . 0.0 108.914 179.418 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -81.45 137.99 18.36 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.514 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 47.0 p30 -68.54 -8.33 40.46 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.248 -1.148 . . . . 0.0 109.575 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -84.14 10.04 11.19 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.194 -0.941 . . . . 0.0 109.189 179.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.32 15.66 66.1 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.167 -1.573 . . . . 0.0 109.167 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.446 ' O ' ' N ' ' A' ' 27' ' ' GLY . 86.6 mt-30 -124.27 167.85 13.76 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.344 -1.092 . . . . 0.0 109.535 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.663 HG23 ' O ' ' A' ' 25' ' ' VAL . 42.1 m -127.96 137.91 52.43 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.251 -0.906 . . . . 0.0 109.526 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.879 ' CD1' HD13 ' A' ' 39' ' ' LEU . 71.4 m-85 -113.79 129.26 56.6 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.288 -0.882 . . . . 0.0 109.28 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.751 ' OD1' HD21 ' A' ' 22' ' ' LEU . 45.4 t-20 -51.09 -78.95 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.363 -0.836 . . . . 0.0 110.255 -179.197 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.53 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 1.7 t-20 -81.6 149.91 65.46 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 120.964 -1.085 . . . . 0.0 109.762 -179.492 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.469 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.9 Cg_endo -63.88 -55.53 0.64 Allowed 'Trans proline' 0 C--O 1.215 -0.674 0 C-N-CA 122.765 2.31 . . . . 0.0 111.864 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.53 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 12.9 t -61.41 -30.58 70.65 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.022 -1.049 . . . . 0.0 108.175 179.097 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.521 ' CG ' ' HB3' ' A' ' 35' ' ' ASN . 65.0 mmm -61.41 -15.15 34.05 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.016 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.879 HD13 ' CD1' ' A' ' 33' ' ' TYR . 37.8 tp -68.94 -58.55 3.97 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.434 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.453 ' HB3' ' OH ' ' A' ' 16' ' ' TYR . 19.5 t -53.28 -29.34 32.72 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 179.001 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 48.1 t60 -64.19 -61.57 2.17 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.444 ' HA ' ' OE1' ' A' ' 42' ' ' GLU . 71.2 mm-40 -56.06 -20.3 16.44 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.412 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.479 ' O ' ' N ' ' A' ' 47' ' ' GLN . 97.3 m-20 -79.44 -24.75 42.23 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.752 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.96 HD13 ' O ' ' A' ' 44' ' ' LEU . 1.7 tm? -71.86 -37.34 70.25 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.333 -0.855 . . . . 0.0 108.766 179.35 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.542 ' N ' HD13 ' A' ' 45' ' ' ILE . 3.8 mm -75.92 -44.68 38.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.404 -0.81 . . . . 0.0 109.232 179.609 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.447 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 14.7 mtt-85 -79.61 -37.72 35.53 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.359 -0.838 . . . . 0.0 109.19 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.479 ' N ' ' O ' ' A' ' 43' ' ' ASN . 91.6 mt-30 62.06 40.46 12.05 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.334 -0.854 . . . . 0.0 109.469 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.42 HG23 ' HB3' ' A' ' 46' ' ' ARG . 62.4 p -107.53 17.22 22.96 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.239 -0.913 . . . . 0.0 109.45 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.567 ' OD1' ' CE1' ' A' ' 51' ' ' HIS . 13.4 t-20 44.82 58.61 3.86 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.294 -0.879 . . . . 0.0 109.511 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.461 ' HB ' ' OD1' ' A' ' 43' ' ' ASN . 50.1 m -80.32 147.28 31.19 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.212 -0.93 . . . . 0.0 109.715 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . 0.567 ' CE1' ' OD1' ' A' ' 49' ' ' ASN . 30.6 m-70 -122.16 169.78 10.53 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.345 -0.847 . . . . 0.0 108.988 179.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.454 HG12 HD22 ' A' ' 39' ' ' LEU . 10.7 mt -81.2 122.29 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.15 -0.969 . . . . 0.0 109.611 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.514 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 56.5 ttt180 -79.9 -44.84 19.68 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.436 -0.79 . . . . 0.0 109.301 179.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.4 t -157.95 154.4 27.73 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.43 -0.794 . . . . 0.0 109.195 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.6 p -73.31 132.46 43.12 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.22 -0.925 . . . . 0.0 109.568 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.546 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 100.16 164.2 28.7 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.654 ' HA ' HG21 ' A' ' 32' ' ' THR . 39.7 tttt -50.2 150.31 2.51 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.443 -1.033 . . . . 0.0 109.263 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 36.2 m . . . . . 0 N--CA 1.49 1.541 0 O-C-N 121.179 -0.951 . . . . 0.0 109.42 -179.875 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . 0.428 ' O ' ' CG ' ' A' ' 7' ' ' ASP . 67.8 mmm . . . . . 0 N--CA 1.489 1.482 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 35.1 m -80.91 -17.17 51.47 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.376 -0.827 . . . . 0.0 109.198 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 34.3 mttp -80.28 8.18 7.97 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.313 -0.867 . . . . 0.0 109.665 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.428 ' CG ' ' O ' ' A' ' 4' ' ' MET . 17.4 p30 -117.45 -10.93 10.59 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.182 -0.948 . . . . 0.0 109.638 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.58 ' OH ' ' CZ ' ' A' ' 16' ' ' TYR . 1.5 p90 -104.3 171.28 7.42 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.159 -0.963 . . . . 0.0 109.546 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 85.9 mtt180 -131.42 157.06 44.46 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.294 -0.879 . . . . 0.0 109.215 179.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.849 HG21 ' C ' ' A' ' 15' ' ' GLY . 14.5 p -136.97 158.35 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.166 -0.959 . . . . 0.0 109.816 -179.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.543 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 1.6 mp -108.2 175.36 2.02 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.265 -0.897 . . . . 0.0 109.354 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.543 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 45.7 Cg_endo -67.56 -27.71 38.81 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 122.589 2.193 . . . . 0.0 111.682 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 37.6 mtm180 -84.15 -38.75 20.28 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.381 -0.824 . . . . 0.0 109.055 179.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.488 ' CG2' ' HG ' ' A' ' 17' ' ' LEU . 98.7 mt -77.12 -34.79 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.381 -0.824 . . . . 0.0 109.024 179.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.849 ' C ' HG21 ' A' ' 10' ' ' VAL . . . 68.2 -65.45 0.37 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 179.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.58 ' CZ ' ' OH ' ' A' ' 8' ' ' TYR . 1.2 t80 -160.59 150.82 18.0 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.31 -1.112 . . . . 0.0 109.328 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.827 ' N ' HD12 ' A' ' 17' ' ' LEU . 0.4 OUTLIER -123.07 141.61 51.78 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.25 -0.906 . . . . 0.0 109.472 179.976 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.451 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 75.0 m -146.26 158.01 48.39 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.308 -0.87 . . . . 0.0 109.15 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.538 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 46.6 Cg_endo -69.93 165.3 31.63 Favored 'Trans proline' 0 C--O 1.214 -0.695 0 C-N-CA 122.494 2.129 . . . . 0.0 111.308 179.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -91.81 -8.52 46.42 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.204 -0.935 . . . . 0.0 109.508 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 -74.54 129.48 37.82 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.274 -0.891 . . . . 0.0 109.218 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.809 HD21 ' OD1' ' A' ' 34' ' ' ASN . 3.4 tm? -87.92 121.24 30.09 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.207 -0.933 . . . . 0.0 109.37 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.615 ' N ' HD13 ' A' ' 22' ' ' LEU . 14.0 mttt -144.3 109.39 4.95 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.091 -1.006 . . . . 0.0 109.717 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.536 ' HA ' ' O ' ' A' ' 34' ' ' ASN . 44.1 Cg_endo -66.58 122.84 10.33 Favored 'Trans proline' 0 C--O 1.214 -0.706 0 C-N-CA 122.947 2.431 . . . . 0.0 111.899 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.507 ' HB ' HG23 ' A' ' 52' ' ' ILE . 8.7 m -117.46 156.9 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.22 -0.925 . . . . 0.0 109.858 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 45.5 t -97.54 136.62 37.69 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 178.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -94.04 135.19 12.4 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 -179.482 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.489 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 49.0 p30 -64.26 -11.31 30.27 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.303 -1.116 . . . . 0.0 109.349 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.458 ' OD1' ' HB2' ' A' ' 31' ' ' GLN . 58.0 p30 -84.24 9.49 12.79 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.323 -0.861 . . . . 0.0 109.488 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 83.87 23.51 52.43 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.458 ' HB2' ' OD1' ' A' ' 29' ' ' ASP . 67.8 mt-30 -129.17 171.71 12.16 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.312 -1.11 . . . . 0.0 109.409 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.576 HG21 ' HG3' ' A' ' 57' ' ' LYS . 24.0 m -131.12 139.42 49.82 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.284 -0.885 . . . . 0.0 109.26 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.821 ' CD1' HD13 ' A' ' 39' ' ' LEU . 70.9 m-85 -118.68 131.62 56.16 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.277 -0.889 . . . . 0.0 109.416 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.809 ' OD1' HD21 ' A' ' 22' ' ' LEU . 53.5 t-20 -51.65 -79.09 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.374 -0.829 . . . . 0.0 110.174 -179.381 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.527 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 1.9 t-20 -81.39 149.41 65.21 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 120.932 -1.105 . . . . 0.0 109.597 -179.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.486 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.4 Cg_endo -63.28 -55.1 0.81 Allowed 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 122.685 2.257 . . . . 0.0 111.884 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.538 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 10.6 t -60.06 -33.22 71.76 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 120.996 -1.065 . . . . 0.0 108.128 178.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.473 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 39.7 mmm -55.63 -20.21 13.08 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.086 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.821 HD13 ' CD1' ' A' ' 33' ' ' TYR . 51.5 tp -68.48 -46.59 69.28 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.563 -0.711 . . . . 0.0 109.098 179.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.484 ' HB2' ' OH ' ' A' ' 16' ' ' TYR . 3.2 m -69.04 -21.25 64.12 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 179.15 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 41.0 t60 -67.21 -54.83 17.46 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 178.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.436 ' HA ' ' OE1' ' A' ' 42' ' ' GLU . 68.6 mm-40 -62.51 -19.99 64.16 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 178.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.527 ' O ' ' N ' ' A' ' 47' ' ' GLN . 83.1 m-20 -80.27 -24.27 40.2 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 23.3 tp -73.24 -31.82 64.35 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.1 mm -80.11 -48.2 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.381 -0.824 . . . . 0.0 108.937 179.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.456 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 63.7 mtt-85 -80.66 -33.79 35.31 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.267 -0.896 . . . . 0.0 109.353 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.527 ' N ' ' O ' ' A' ' 43' ' ' ASN . 91.7 mt-30 63.31 38.54 10.2 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.386 -0.822 . . . . 0.0 109.659 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.435 HG23 ' HB3' ' A' ' 46' ' ' ARG . 55.1 p -101.68 3.84 40.13 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.21 -0.931 . . . . 0.0 109.452 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 63.9 m-20 54.64 58.08 5.18 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.227 -0.921 . . . . 0.0 109.427 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 31.6 m -78.46 139.22 38.72 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.239 -0.913 . . . . 0.0 109.589 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 49.3 m-70 -113.63 167.38 10.66 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.303 -0.873 . . . . 0.0 108.893 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.507 HG23 ' HB ' ' A' ' 25' ' ' VAL . 36.9 mt -79.63 125.59 38.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.169 -0.957 . . . . 0.0 109.256 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.489 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 69.9 ttt-85 -81.3 -38.61 26.5 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.415 -0.803 . . . . 0.0 109.346 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -160.45 151.16 18.59 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.47 -0.769 . . . . 0.0 109.084 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.3 p -70.46 143.59 51.71 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.168 -0.958 . . . . 0.0 109.467 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.533 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 88.87 164.37 40.28 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.576 ' HG3' HG21 ' A' ' 32' ' ' THR . 33.8 ttpt -54.53 151.08 8.31 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.474 -1.016 . . . . 0.0 109.442 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 88.8 m . . . . . 0 N--CA 1.489 1.481 0 O-C-N 121.247 -0.908 . . . . 0.0 109.446 179.948 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 84.3 mtp . . . . . 0 N--CA 1.489 1.497 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.571 ' SG ' ' CE1' ' A' ' 8' ' ' TYR . 10.6 t -84.19 -8.23 59.12 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.464 -0.772 . . . . 0.0 109.069 179.518 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.7 pttp -57.46 -15.7 7.6 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.32 -0.863 . . . . 0.0 109.733 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 51.0 p-10 -159.03 32.66 0.21 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.043 -1.035 . . . . 0.0 109.811 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.571 ' CE1' ' SG ' ' A' ' 5' ' ' CYS . 5.1 p90 -79.71 175.61 10.47 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.119 -0.988 . . . . 0.0 109.194 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 53.7 mtm180 -143.98 136.43 26.85 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.145 -0.972 . . . . 0.0 109.911 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.58 HG13 ' O ' ' A' ' 15' ' ' GLY . 23.4 t -137.41 135.61 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.371 -0.83 . . . . 0.0 109.097 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.662 ' HB2' HD12 ' A' ' 14' ' ' ILE . 1.6 mp -102.83 172.4 4.33 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.231 -0.918 . . . . 0.0 109.701 -179.532 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.487 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 45.7 Cg_endo -67.68 -22.78 43.31 Favored 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 122.637 2.225 . . . . 0.0 111.563 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 82.1 mtt180 -99.8 -24.96 14.53 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.341 -0.849 . . . . 0.0 109.16 179.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.662 HD12 ' HB2' ' A' ' 11' ' ' LEU . 79.2 mt -85.34 -47.3 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.312 -0.867 . . . . 0.0 109.428 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.58 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 71.58 -169.54 49.91 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.581 ' CB ' ' NE2' ' A' ' 41' ' ' HIS . 0.8 OUTLIER -92.36 150.2 20.97 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.259 -1.142 . . . . 0.0 109.591 -179.94 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.698 ' C ' HD13 ' A' ' 17' ' ' LEU . 2.3 tm? -119.66 105.35 11.1 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.254 -0.904 . . . . 0.0 109.309 179.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.445 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 58.5 m -118.75 155.64 52.39 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.305 -0.872 . . . . 0.0 109.305 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -72.42 171.73 16.43 Favored 'Trans proline' 0 C--O 1.215 -0.667 0 C-N-CA 122.618 2.212 . . . . 0.0 111.324 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 45.0 mttp -91.45 -23.32 20.04 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.213 -0.93 . . . . 0.0 109.355 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -62.34 130.49 45.52 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.339 -0.85 . . . . 0.0 109.179 179.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 24.0 tp -90.72 111.83 23.35 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.211 -0.931 . . . . 0.0 109.805 -179.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.479 ' O ' ' O ' ' A' ' 34' ' ' ASN . 0.0 OUTLIER -123.28 108.64 31.71 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.324 -0.86 . . . . 0.0 108.87 179.637 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.526 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 43.6 Cg_endo -66.16 119.58 6.62 Favored 'Trans proline' 0 C--O 1.214 -0.713 0 C-N-CA 122.865 2.377 . . . . 0.0 112.052 -179.417 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.591 ' O ' HG23 ' A' ' 32' ' ' THR . 11.2 m -112.57 155.31 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.418 -0.801 . . . . 0.0 109.512 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.411 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 43.4 t -97.07 141.4 30.27 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -98.47 133.85 11.48 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 -179.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.65 ' OD1' HG23 ' A' ' 50' ' ' THR . 37.5 p30 -61.83 -12.49 17.67 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.315 -1.109 . . . . 0.0 109.586 179.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -87.01 15.46 5.98 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.21 -0.931 . . . . 0.0 109.414 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 79.37 19.41 71.72 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.471 ' O ' ' SG ' ' A' ' 58' ' ' CYS . 44.5 mt-30 -120.95 179.33 4.4 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.152 -1.205 . . . . 0.0 109.496 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.605 HG21 ' HG3' ' A' ' 57' ' ' LYS . 14.5 m -143.36 137.2 28.57 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.264 -0.897 . . . . 0.0 109.557 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.572 ' CD1' ' HG ' ' A' ' 39' ' ' LEU . 41.2 m-85 -113.03 134.8 54.35 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.364 -0.835 . . . . 0.0 109.46 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.518 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 9.9 m-20 -54.16 -78.06 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.322 -0.861 . . . . 0.0 109.785 -179.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.53 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 4.1 t-20 -81.88 147.72 59.1 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.018 -1.051 . . . . 0.0 109.022 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.469 ' HD3' ' O ' ' A' ' 23' ' ' LYS . 41.7 Cg_endo -63.97 -52.55 1.63 Allowed 'Trans proline' 0 C--O 1.215 -0.629 0 C-N-CA 122.522 2.148 . . . . 0.0 111.758 -179.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.53 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 11.3 t -62.09 -29.03 70.03 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.078 -1.014 . . . . 0.0 108.324 179.021 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.473 ' HB2' ' HB3' ' A' ' 35' ' ' ASN . 35.3 mmm -69.04 -12.82 62.03 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.566 -0.709 . . . . 0.0 109.278 179.52 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.777 HD13 HG12 ' A' ' 52' ' ' ILE . 9.6 tt -67.97 -52.55 34.62 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.189 -0.945 . . . . 0.0 108.955 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.483 ' SG ' ' CE1' ' A' ' 8' ' ' TYR . 9.3 t -61.46 -34.17 74.99 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 179.19 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.581 ' NE2' ' CB ' ' A' ' 16' ' ' TYR . 0.2 OUTLIER -50.94 -46.69 61.03 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 178.51 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -66.11 -32.08 73.32 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.08 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.52 ' ND2' ' O ' ' A' ' 50' ' ' THR . 34.0 m-20 -68.74 -23.47 64.34 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.51 -0.744 . . . . 0.0 109.396 179.683 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.954 HD13 ' O ' ' A' ' 44' ' ' LEU . 2.4 tm? -72.2 -36.4 69.19 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.285 -0.884 . . . . 0.0 109.66 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.411 ' N ' HD13 ' A' ' 45' ' ' ILE . 4.8 mm -78.04 -46.04 26.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.242 -0.911 . . . . 0.0 109.381 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.491 ' HB3' HG23 ' A' ' 48' ' ' THR . 14.4 mtt-85 -81.73 -33.19 31.19 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.289 -0.882 . . . . 0.0 109.611 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.474 ' N ' ' O ' ' A' ' 43' ' ' ASN . 92.0 mt-30 62.49 33.76 15.83 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.272 -0.892 . . . . 0.0 109.63 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.491 HG23 ' HB3' ' A' ' 46' ' ' ARG . 58.9 p -95.65 7.43 46.31 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.224 -0.922 . . . . 0.0 109.415 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.577 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 57.8 t30 52.63 49.0 21.32 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.276 -0.89 . . . . 0.0 109.649 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.65 HG23 ' OD1' ' A' ' 28' ' ' ASP . 39.4 m -80.78 149.05 29.78 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.37 -0.831 . . . . 0.0 109.359 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . 0.577 ' CE1' ' O ' ' A' ' 49' ' ' ASN . 13.6 m80 -127.21 -176.76 3.82 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.189 -0.945 . . . . 0.0 109.348 179.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.777 HG12 HD13 ' A' ' 39' ' ' LEU . 29.4 mt -84.89 128.13 39.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 O-C-N 121.39 -0.819 . . . . 0.0 109.46 179.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.505 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 42.3 ttt85 -83.83 -38.55 21.08 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.321 -0.862 . . . . 0.0 109.059 179.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -160.75 148.83 16.08 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 27.0 p -67.17 135.97 54.33 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.123 -0.986 . . . . 0.0 109.462 -179.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.526 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 95.2 161.87 34.16 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.605 ' HG3' HG21 ' A' ' 32' ' ' THR . 47.5 tttp -50.03 148.23 3.46 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.402 -1.058 . . . . 0.0 109.287 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.471 ' SG ' ' O ' ' A' ' 31' ' ' GLN . 95.6 m . . . . . 0 N--CA 1.491 1.575 0 O-C-N 121.309 -0.869 . . . . 0.0 109.568 -179.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 82.8 mtp . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.539 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 70.2 m -79.92 -20.77 44.93 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.324 -0.86 . . . . 0.0 109.217 179.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 33.4 mttt -80.63 7.46 10.06 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.194 -0.941 . . . . 0.0 109.391 179.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -123.18 -3.63 8.49 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.199 -0.938 . . . . 0.0 110.217 -179.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.687 ' CE2' ' CZ ' ' A' ' 16' ' ' TYR . 2.1 p90 -114.57 173.0 6.68 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.959 -1.088 . . . . 0.0 109.848 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 39.5 ptt180 -157.34 134.47 10.3 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.8 HG13 ' O ' ' A' ' 15' ' ' GLY . 79.9 t -116.79 145.41 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.226 -0.921 . . . . 0.0 110.215 -179.071 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.756 ' HB2' HD12 ' A' ' 14' ' ' ILE . 2.1 mp -117.67 175.81 1.87 Allowed Pre-proline 0 N--CA 1.49 1.527 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.549 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 44.7 Cg_endo -67.56 -22.52 44.39 Favored 'Trans proline' 0 C--O 1.216 -0.621 0 C-N-CA 122.451 2.101 . . . . 0.0 111.81 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 63.1 mtt180 -113.63 -22.44 10.27 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.294 -0.879 . . . . 0.0 109.64 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.756 HD12 ' HB2' ' A' ' 11' ' ' LEU . 92.4 mt -78.23 -44.35 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.216 -0.927 . . . . 0.0 109.504 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.8 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 74.94 -165.33 54.74 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.687 ' CZ ' ' CE2' ' A' ' 8' ' ' TYR . 0.9 OUTLIER -93.76 149.55 21.14 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.16 -1.2 . . . . 0.0 109.557 179.999 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 16.8 tp -119.61 115.54 24.18 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.288 -0.883 . . . . 0.0 109.688 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 75.6 m -126.07 156.8 71.38 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.292 -0.88 . . . . 0.0 109.177 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.48 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 50.5 Cg_endo -71.35 167.33 26.6 Favored 'Trans proline' 0 C--O 1.216 -0.59 0 C-N-CA 122.64 2.227 . . . . 0.0 111.685 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.4 mttt -86.59 -23.43 25.77 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.271 -0.893 . . . . 0.0 109.328 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -63.21 130.48 44.74 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.29 -0.881 . . . . 0.0 109.241 179.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 48.7 tp -93.83 117.47 30.14 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.184 -0.947 . . . . 0.0 109.541 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.487 ' O ' ' O ' ' A' ' 34' ' ' ASN . 0.1 OUTLIER -129.1 106.52 17.93 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.324 -0.86 . . . . 0.0 108.941 179.719 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.538 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 43.2 Cg_endo -65.1 119.91 7.04 Favored 'Trans proline' 0 C--O 1.213 -0.765 0 C-N-CA 122.93 2.42 . . . . 0.0 112.086 -179.564 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.609 ' O ' HG23 ' A' ' 32' ' ' THR . 35.6 m -116.5 153.74 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.336 -0.852 . . . . 0.0 109.688 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 43.0 t -96.05 135.52 37.72 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.354 -0.841 . . . . 0.0 108.787 179.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -92.44 139.12 14.51 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -179.585 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.504 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 50.9 p30 -68.5 -7.86 36.01 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.366 -1.079 . . . . 0.0 109.579 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.427 ' OD1' ' HB2' ' A' ' 31' ' ' GLN . 56.6 p30 -88.52 9.21 24.62 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.163 -0.961 . . . . 0.0 109.35 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.23 13.99 64.97 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.464 ' O ' ' N ' ' A' ' 27' ' ' GLY . 83.2 mt-30 -120.26 171.97 8.12 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.278 -1.131 . . . . 0.0 109.447 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.661 HG21 ' HA ' ' A' ' 57' ' ' LYS . 25.9 m -133.95 138.31 45.39 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.248 -0.908 . . . . 0.0 109.353 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.811 ' CD1' HD13 ' A' ' 39' ' ' LEU . 28.7 m-85 -113.0 128.5 56.52 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.28 -0.888 . . . . 0.0 109.205 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.519 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 13.1 m-20 -51.66 -78.17 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.239 -0.913 . . . . 0.0 109.692 -179.543 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.533 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 5.1 t-20 -81.85 147.9 59.69 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.171 -0.956 . . . . 0.0 109.688 -179.692 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.469 ' HD2' ' CG ' ' A' ' 35' ' ' ASN . 40.5 Cg_endo -63.22 -52.98 1.7 Allowed 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.766 2.311 . . . . 0.0 111.909 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.533 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 9.2 t -62.54 -28.36 69.8 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 120.97 -1.081 . . . . 0.0 108.11 178.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.465 ' CG ' ' HB3' ' A' ' 35' ' ' ASN . 49.7 mmm -64.75 -14.2 57.92 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.377 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.811 HD13 ' CD1' ' A' ' 33' ' ' TYR . 23.7 tp -71.68 -65.33 0.77 Allowed 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 179.284 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.452 ' HB3' ' OH ' ' A' ' 16' ' ' TYR . 8.5 t -49.25 -28.33 4.56 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 66.5 t60 -63.02 -62.54 1.64 Allowed 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 77.2 tt0 -59.13 -19.08 41.58 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.471 ' O ' ' N ' ' A' ' 47' ' ' GLN . 98.1 m-20 -78.16 -29.65 48.74 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.391 -0.818 . . . . 0.0 108.815 179.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 17.6 tp -72.37 -27.75 62.58 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.313 -0.867 . . . . 0.0 108.847 179.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.3 mt -79.87 -49.64 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.321 -0.862 . . . . 0.0 108.9 179.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.549 ' HB3' HG23 ' A' ' 48' ' ' THR . 52.8 mtt180 -80.73 -32.82 35.58 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.338 -0.851 . . . . 0.0 109.307 179.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.471 ' N ' ' O ' ' A' ' 43' ' ' ASN . 92.1 mt-30 62.62 36.68 13.49 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.373 -0.829 . . . . 0.0 109.627 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.549 HG23 ' HB3' ' A' ' 46' ' ' ARG . 59.5 p -96.21 2.45 53.02 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.217 -0.927 . . . . 0.0 109.585 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.4 m120 58.0 54.76 5.75 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.251 -0.905 . . . . 0.0 109.449 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.404 ' HB ' ' OD1' ' A' ' 43' ' ' ASN . 43.3 m -79.94 144.06 33.66 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.292 -0.88 . . . . 0.0 109.68 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 30.5 m-70 -118.62 173.5 6.81 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.329 -0.857 . . . . 0.0 109.023 179.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.462 HG12 HD22 ' A' ' 39' ' ' LEU . 12.0 mt -84.38 123.99 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.16 -0.962 . . . . 0.0 109.472 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.504 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 45.2 ttt85 -79.75 -43.0 23.39 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.297 -0.877 . . . . 0.0 109.248 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.8 t -160.02 155.09 24.77 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.9 p -72.56 132.83 44.31 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.198 -0.939 . . . . 0.0 109.483 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.538 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 99.07 164.49 29.93 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -179.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.661 ' HA ' HG21 ' A' ' 32' ' ' THR . 71.1 tttt -53.13 148.4 8.27 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.429 -1.042 . . . . 0.0 109.397 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 91.2 m . . . . . 0 N--CA 1.491 1.61 0 O-C-N 121.263 -0.898 . . . . 0.0 109.376 179.963 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 44.4 ttm . . . . . 0 N--CA 1.488 1.465 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.593 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 15.6 m -79.56 -12.7 59.84 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.498 -0.751 . . . . 0.0 108.974 179.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.1 mtmp? -56.58 -24.54 48.1 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.255 -0.903 . . . . 0.0 109.714 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 64.8 m-20 -149.71 64.49 0.99 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.136 -0.978 . . . . 0.0 110.334 -179.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.983 ' OH ' HD21 ' A' ' 44' ' ' LEU . 5.0 p90 -131.44 170.25 14.94 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.045 -1.034 . . . . 0.0 109.359 179.259 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 12.5 tpt180 -145.32 150.13 36.06 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.21 -0.932 . . . . 0.0 109.593 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.554 HG13 ' C ' ' A' ' 15' ' ' GLY . 71.0 t -141.63 130.98 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.239 -0.913 . . . . 0.0 109.315 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.66 ' HB2' HD12 ' A' ' 14' ' ' ILE . 2.5 mp -118.56 172.86 3.8 Favored Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 121.321 -0.862 . . . . 0.0 109.317 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.491 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 46.5 Cg_endo -68.38 -24.96 36.34 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 122.575 2.184 . . . . 0.0 111.614 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 54.5 mtt180 -104.68 -26.04 12.46 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.262 -0.899 . . . . 0.0 109.254 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.66 HD12 ' HB2' ' A' ' 11' ' ' LEU . 87.9 mt -84.54 -46.88 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.267 -0.896 . . . . 0.0 109.41 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.554 ' C ' HG13 ' A' ' 10' ' ' VAL . . . 77.73 -155.51 43.14 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.597 ' CE2' ' CE2' ' A' ' 8' ' ' TYR . 2.5 t80 -105.4 152.56 22.82 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.307 -1.114 . . . . 0.0 109.503 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 34.6 tp -113.74 119.21 36.6 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.231 -0.918 . . . . 0.0 109.725 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 75.9 m -130.15 157.22 77.76 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.316 -0.865 . . . . 0.0 109.603 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.519 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 52.5 Cg_endo -72.55 168.93 23.06 Favored 'Trans proline' 0 C--O 1.215 -0.629 0 C-N-CA 122.762 2.308 . . . . 0.0 111.591 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 41.3 mmtt -89.61 -13.09 37.9 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.203 -0.936 . . . . 0.0 109.334 179.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -67.98 131.8 46.14 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.296 -0.878 . . . . 0.0 109.38 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.745 ' C ' HD13 ' A' ' 22' ' ' LEU . 3.3 tm? -90.63 123.65 34.42 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.263 -0.898 . . . . 0.0 109.332 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.691 ' N ' HD13 ' A' ' 22' ' ' LEU . 15.4 mttp -145.6 105.8 4.31 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.156 -0.965 . . . . 0.0 109.657 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.539 ' HA ' ' O ' ' A' ' 34' ' ' ASN . 44.1 Cg_endo -65.85 120.84 8.08 Favored 'Trans proline' 0 C--O 1.214 -0.705 0 C-N-CA 123.116 2.544 . . . . 0.0 112.324 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.463 ' O ' HG23 ' A' ' 32' ' ' THR . 19.7 m -116.18 154.57 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.382 -0.824 . . . . 0.0 109.35 179.562 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.418 ' O ' ' N ' ' A' ' 53' ' ' ARG . 41.6 t -96.07 138.26 33.95 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 178.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -95.6 139.21 14.37 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.726 -1.349 . . . . 0.0 109.726 -179.285 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.483 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 48.5 p30 -65.38 -11.15 39.52 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.38 -1.07 . . . . 0.0 109.454 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.447 ' OD1' ' HB2' ' A' ' 31' ' ' GLN . 59.0 p30 -83.09 7.33 16.19 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.226 -0.921 . . . . 0.0 109.398 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.22 22.59 51.41 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.456 ' O ' ' SG ' ' A' ' 58' ' ' CYS . 75.5 mt-30 -129.3 175.37 8.79 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.291 -1.123 . . . . 0.0 109.375 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.647 HG21 ' HA ' ' A' ' 57' ' ' LYS . 13.0 m -131.83 140.21 49.07 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.258 -0.901 . . . . 0.0 109.816 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.869 ' CD2' HD12 ' A' ' 39' ' ' LEU . 44.7 m-85 -115.86 127.15 54.81 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.431 -0.793 . . . . 0.0 109.139 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.745 ' OD1' HD21 ' A' ' 22' ' ' LEU . 41.1 t-20 -49.01 -78.98 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.299 -0.876 . . . . 0.0 110.032 -179.425 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.542 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 4.6 t-20 -81.14 147.28 60.62 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 120.863 -1.148 . . . . 0.0 109.263 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.514 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.8 Cg_endo -63.44 -52.89 1.66 Allowed 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 122.701 2.267 . . . . 0.0 111.849 -179.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.542 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 5.8 t -61.78 -28.23 69.31 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 178.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.429 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 35.7 mmm -65.51 -12.45 52.88 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.292 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.869 HD12 ' CD2' ' A' ' 33' ' ' TYR . 8.4 tt -72.99 -57.63 3.9 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.284 -0.885 . . . . 0.0 108.849 179.602 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.519 ' O ' ' HB2' ' A' ' 43' ' ' ASN . 2.2 t -46.59 -45.18 18.74 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 179.064 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.491 ' ND1' ' HB2' ' A' ' 16' ' ' TYR . 13.9 t60 -48.46 -50.37 31.66 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.062 -1.024 . . . . 0.0 108.309 178.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.578 ' HG3' ' CE1' ' A' ' 33' ' ' TYR . 34.2 mm-40 -56.41 -19.21 13.87 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.567 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.519 ' HB2' ' O ' ' A' ' 40' ' ' CYS . 2.3 m-80 -78.59 -35.33 45.9 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 119.471 -0.892 . . . . 0.0 108.617 179.209 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.983 HD21 ' OH ' ' A' ' 8' ' ' TYR . 40.3 mt -72.07 -30.79 65.48 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.332 -0.855 . . . . 0.0 109.302 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.485 HG13 ' O ' ' A' ' 41' ' ' HIS . 2.5 mt -79.74 -51.12 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.279 -0.888 . . . . 0.0 109.378 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.447 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 93.3 mtt-85 -80.3 -32.92 38.0 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.337 -0.852 . . . . 0.0 109.267 179.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.49 ' N ' ' O ' ' A' ' 43' ' ' ASN . 91.9 mt-30 62.19 40.22 11.91 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.403 -0.811 . . . . 0.0 109.537 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 35.6 p -113.63 5.62 16.59 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.32 -0.863 . . . . 0.0 109.541 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.566 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 11.8 t-20 62.39 50.91 3.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.236 -0.915 . . . . 0.0 109.45 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.789 HG21 ' OH ' ' A' ' 33' ' ' TYR . 99.6 m -78.87 134.7 36.91 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.298 -0.876 . . . . 0.0 109.729 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . 0.566 ' CE1' ' O ' ' A' ' 49' ' ' ASN . 8.0 m80 -115.98 -170.13 1.73 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.218 -0.926 . . . . 0.0 109.167 179.558 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.749 HG12 HD13 ' A' ' 39' ' ' LEU . 20.4 mt -92.91 122.97 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.306 -0.872 . . . . 0.0 109.445 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.483 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 46.9 ttt-85 -81.1 -41.62 22.23 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.304 -0.872 . . . . 0.0 109.542 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.0 p -160.45 145.01 14.33 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.543 -0.723 . . . . 0.0 109.505 -179.434 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 20.2 p -63.62 139.51 58.78 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.244 -0.91 . . . . 0.0 109.401 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.537 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 90.76 163.13 38.74 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.647 ' HA ' HG21 ' A' ' 32' ' ' THR . 48.1 tttp -49.46 148.65 2.64 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.498 -1.001 . . . . 0.0 109.48 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.456 ' SG ' ' O ' ' A' ' 31' ' ' GLN . 57.8 m . . . . . 0 N--CA 1.491 1.588 0 O-C-N 121.257 -0.902 . . . . 0.0 109.426 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 92.8 mmm . . . . . 0 N--CA 1.488 1.438 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 3.8 m -80.03 4.58 16.61 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.457 -0.777 . . . . 0.0 109.109 179.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.2 mttm -57.65 -30.13 65.15 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.082 -1.011 . . . . 0.0 109.514 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -143.29 69.94 1.31 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.281 -0.887 . . . . 0.0 109.938 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.552 ' CD1' ' N ' ' A' ' 9' ' ' ARG . 18.4 p90 -115.04 -172.88 2.21 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.125 -0.985 . . . . 0.0 109.311 179.605 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.552 ' N ' ' CD1' ' A' ' 8' ' ' TYR . 86.0 mtt180 -149.64 145.57 26.82 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.189 -0.944 . . . . 0.0 109.466 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.581 HG13 ' O ' ' A' ' 15' ' ' GLY . 34.0 t -148.11 142.66 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.284 -0.885 . . . . 0.0 109.17 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.472 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 1.4 mp -116.13 171.93 4.24 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.204 -0.935 . . . . 0.0 109.844 -179.536 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.472 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 48.2 Cg_endo -68.45 -23.77 37.27 Favored 'Trans proline' 0 C--O 1.215 -0.659 0 C-N-CA 122.628 2.219 . . . . 0.0 111.73 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 53.0 mtt180 -100.27 -23.86 14.69 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.288 -0.882 . . . . 0.0 109.17 179.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.426 HD12 ' HB2' ' A' ' 11' ' ' LEU . 97.6 mt -88.84 -40.91 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.306 -0.871 . . . . 0.0 109.774 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.581 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 70.53 -174.92 37.95 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.512 ' HB2' ' CE1' ' A' ' 41' ' ' HIS . 1.3 t80 -81.61 154.78 25.98 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.17 -1.194 . . . . 0.0 109.417 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 34.0 tp -112.65 117.92 33.62 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.215 -0.928 . . . . 0.0 109.749 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.419 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 76.9 m -134.86 156.54 78.42 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.267 -0.896 . . . . 0.0 109.423 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.497 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 51.5 Cg_endo -71.4 168.79 22.5 Favored 'Trans proline' 0 C--O 1.215 -0.674 0 C-N-CA 122.692 2.261 . . . . 0.0 111.83 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -93.11 -3.89 53.29 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.263 -0.898 . . . . 0.0 109.52 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -79.08 130.16 35.22 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.212 -0.93 . . . . 0.0 109.307 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.739 ' C ' HD13 ' A' ' 22' ' ' LEU . 3.1 tm? -85.77 124.12 31.91 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.246 -0.909 . . . . 0.0 109.447 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.733 ' N ' HD13 ' A' ' 22' ' ' LEU . 29.4 mttp -144.05 103.1 4.8 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.194 -0.941 . . . . 0.0 109.468 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.537 ' HA ' ' O ' ' A' ' 34' ' ' ASN . 44.0 Cg_endo -65.35 121.92 9.48 Favored 'Trans proline' 0 C--O 1.214 -0.719 0 C-N-CA 123.133 2.555 . . . . 0.0 112.064 -179.689 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.476 ' HB ' HG23 ' A' ' 52' ' ' ILE . 13.9 m -120.26 154.86 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.272 -0.892 . . . . 0.0 110.05 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.423 ' O ' ' N ' ' A' ' 53' ' ' ARG . 13.3 t -99.95 131.52 45.87 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.034 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -89.23 138.83 14.9 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 -179.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.494 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 38.1 p30 -65.86 -10.05 34.63 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.357 -1.084 . . . . 0.0 109.66 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 -85.64 10.55 13.02 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.241 -0.912 . . . . 0.0 109.44 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 81.9 27.65 45.06 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -131.04 161.31 32.29 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.289 -1.124 . . . . 0.0 109.384 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.451 HG21 ' CB ' ' A' ' 57' ' ' LYS . 98.8 m -122.35 135.04 54.64 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.134 -0.979 . . . . 0.0 109.36 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.65 ' CD1' HD13 ' A' ' 39' ' ' LEU . 47.8 m-85 -116.45 125.2 51.65 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.312 -0.867 . . . . 0.0 109.293 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.739 ' CG ' HD21 ' A' ' 22' ' ' LEU . 40.2 t-20 -48.56 -79.76 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.393 -0.817 . . . . 0.0 109.97 -179.386 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.533 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 5.4 t-20 -80.9 146.96 60.7 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 120.851 -1.156 . . . . 0.0 109.415 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.539 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.1 Cg_endo -62.7 -53.13 1.87 Allowed 'Trans proline' 0 C--O 1.216 -0.594 0 C-N-CA 122.902 2.401 . . . . 0.0 111.875 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.533 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 8.9 t -62.75 -27.9 69.6 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.005 -1.059 . . . . 0.0 108.212 178.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.451 ' HB2' ' HB3' ' A' ' 35' ' ' ASN . 28.1 mmm -64.54 -11.86 38.7 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.124 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.65 HD13 ' CD1' ' A' ' 33' ' ' TYR . 20.4 tp -69.88 -54.07 15.15 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.324 -0.86 . . . . 0.0 109.079 179.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.46 ' HB2' ' OH ' ' A' ' 16' ' ' TYR . 3.5 m -63.28 -14.26 47.53 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 119.021 -1.072 . . . . 0.0 108.253 179.087 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.512 ' CE1' ' HB2' ' A' ' 16' ' ' TYR . 19.5 t60 -67.26 -55.15 15.16 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 178.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 49.8 tt0 -67.19 -20.37 65.7 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.017 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.477 ' O ' ' N ' ' A' ' 47' ' ' GLN . 91.7 m-20 -76.26 -31.5 58.33 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.524 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.55 HD13 ' OH ' ' A' ' 8' ' ' TYR . 22.3 tp -67.48 -30.56 70.29 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.287 -0.883 . . . . 0.0 108.653 179.363 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -77.73 -44.74 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.451 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.452 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 60.0 mtt-85 -80.21 -19.33 47.26 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.393 -0.817 . . . . 0.0 109.175 179.669 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.477 ' N ' ' O ' ' A' ' 43' ' ' ASN . 91.1 mt-30 63.51 37.9 10.18 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.466 -0.771 . . . . 0.0 109.653 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 13.0 p -116.07 173.05 6.78 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.268 -0.895 . . . . 0.0 109.322 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -107.99 60.89 0.61 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.211 -0.931 . . . . 0.0 109.475 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.421 HG23 ' OD1' ' A' ' 28' ' ' ASP . 44.9 m -74.81 136.12 41.63 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.269 -0.895 . . . . 0.0 109.546 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 61.3 m-70 -115.01 173.27 6.57 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.247 -0.908 . . . . 0.0 109.229 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.476 HG23 ' HB ' ' A' ' 25' ' ' VAL . 20.0 mt -79.63 124.24 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.211 -0.93 . . . . 0.0 109.28 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.494 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 44.1 ttt180 -80.52 -47.48 14.19 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.352 -0.842 . . . . 0.0 109.367 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -154.07 149.22 26.92 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.488 -0.757 . . . . 0.0 109.115 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 27.5 p -66.45 143.48 57.08 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.209 -0.932 . . . . 0.0 109.567 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.536 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 90.44 167.35 41.76 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -179.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.496 ' HG3' ' HB2' ' A' ' 24' ' ' PRO . 43.4 mttt -76.19 120.98 22.21 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.303 -1.116 . . . . 0.0 109.477 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.408 ' C ' ' O ' ' A' ' 57' ' ' LYS . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.522 0 O-C-N 121.266 -0.896 . . . . 0.0 109.621 179.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 82.6 mmm . . . . . 0 N--CA 1.489 1.484 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.498 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 3.9 m -79.88 -7.97 59.03 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.38 -0.825 . . . . 0.0 109.321 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 26.3 mttm -58.79 -23.21 59.91 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.213 -0.929 . . . . 0.0 110.039 -179.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 61.9 t0 -150.1 64.46 0.97 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.079 -1.013 . . . . 0.0 110.37 -179.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.638 ' OH ' HD23 ' A' ' 44' ' ' LEU . 4.7 p90 -131.65 168.07 18.36 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.11 -0.994 . . . . 0.0 109.123 179.11 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 48.2 mtt180 -144.8 140.87 28.74 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.182 -0.949 . . . . 0.0 109.719 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.712 HG21 ' CD2' ' A' ' 16' ' ' TYR . 55.0 t -135.31 127.9 47.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.264 -0.898 . . . . 0.0 109.471 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.478 ' HB3' ' HD2' ' A' ' 12' ' ' PRO . 7.2 mp -114.81 168.17 8.53 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.275 -0.89 . . . . 0.0 109.312 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.478 ' HD2' ' HB3' ' A' ' 11' ' ' LEU . 43.0 Cg_endo -66.43 -24.63 49.36 Favored 'Trans proline' 0 C--O 1.216 -0.609 0 C-N-CA 122.479 2.119 . . . . 0.0 111.409 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 79.2 mtt-85 -98.71 -27.55 13.92 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.344 -0.848 . . . . 0.0 108.857 179.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 25.4 mm -87.67 -44.68 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.416 -0.803 . . . . 0.0 109.337 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.572 ' C ' HG13 ' A' ' 10' ' ' VAL . . . 73.0 -165.43 54.82 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.712 ' CD2' HG21 ' A' ' 10' ' ' VAL . 1.9 t80 -100.03 149.76 23.15 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.238 -1.154 . . . . 0.0 109.44 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.612 ' N ' HD22 ' A' ' 17' ' ' LEU . 3.0 mm? -111.01 135.51 51.4 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.288 -0.883 . . . . 0.0 109.453 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.437 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 85.6 m -147.12 157.71 45.72 Favored Pre-proline 0 N--CA 1.492 1.662 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.444 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 47.4 Cg_endo -70.82 165.59 31.69 Favored 'Trans proline' 0 C--O 1.215 -0.653 0 C-N-CA 122.448 2.099 . . . . 0.0 111.596 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.3 tptp -84.58 -29.45 25.81 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.3 -0.875 . . . . 0.0 109.539 -179.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -58.49 126.11 26.18 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.28 -0.888 . . . . 0.0 109.381 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 60.4 tp -90.0 116.99 28.46 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.2 -0.937 . . . . 0.0 109.494 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.529 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 3.5 mttp -128.36 106.45 19.4 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.153 -0.967 . . . . 0.0 109.203 179.754 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.544 ' HA ' ' O ' ' A' ' 34' ' ' ASN . 42.6 Cg_endo -64.79 122.62 10.51 Favored 'Trans proline' 0 C--O 1.214 -0.692 0 C-N-CA 123.036 2.49 . . . . 0.0 112.166 -179.404 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.53 ' HB ' HG23 ' A' ' 52' ' ' ILE . 17.3 m -118.19 154.26 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.318 -0.864 . . . . 0.0 109.934 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.442 ' SG ' ' HB3' ' A' ' 53' ' ' ARG . 41.4 t -97.78 138.06 35.71 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -92.35 140.37 15.1 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.911 -1.276 . . . . 0.0 109.911 -179.28 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.503 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 53.6 p30 -69.48 -11.37 60.77 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.305 -1.114 . . . . 0.0 109.436 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.451 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 57.0 p30 -89.57 10.43 23.01 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.303 -0.873 . . . . 0.0 109.593 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.59 18.95 57.7 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.47 ' O ' ' N ' ' A' ' 27' ' ' GLY . 90.0 mt-30 -119.32 170.17 9.34 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.329 -1.1 . . . . 0.0 109.385 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.581 HG23 ' HA ' ' A' ' 57' ' ' LYS . 54.7 m -134.04 134.25 42.16 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.199 -0.938 . . . . 0.0 109.3 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.898 ' CD1' HD13 ' A' ' 39' ' ' LEU . 38.4 m-85 -114.57 131.04 56.81 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.262 -0.899 . . . . 0.0 109.221 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.544 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 10.1 m-20 -55.7 -78.4 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.287 -0.883 . . . . 0.0 109.676 -179.661 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.519 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 7.1 t-20 -81.96 147.1 57.18 Favored Pre-proline 0 C--N 1.301 -1.527 0 O-C-N 120.927 -1.108 . . . . 0.0 109.645 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.529 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.2 Cg_endo -62.7 -52.07 2.64 Favored 'Trans proline' 0 C--O 1.216 -0.617 0 C-N-CA 122.753 2.302 . . . . 0.0 111.811 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.519 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 8.6 t -61.38 -29.99 70.26 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 120.882 -1.136 . . . . 0.0 108.046 178.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.402 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 13.0 mtt -63.87 -12.91 40.61 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.312 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.898 HD13 ' CD1' ' A' ' 33' ' ' TYR . 29.3 tp -68.04 -54.33 19.11 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 10.9 t -62.12 -22.43 65.81 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.437 ' CE1' ' HB2' ' A' ' 16' ' ' TYR . 37.4 t60 -69.7 -57.33 5.27 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.315 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.46 ' OE1' ' CD2' ' A' ' 33' ' ' TYR . 82.1 tt0 -63.61 -20.27 65.53 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 179.267 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.507 ' O ' ' N ' ' A' ' 47' ' ' GLN . 96.5 m-20 -75.42 -32.21 60.63 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.514 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.924 HD13 ' O ' ' A' ' 44' ' ' LEU . 2.8 tm? -65.82 -38.16 88.17 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.32 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.511 ' N ' HD13 ' A' ' 45' ' ' ILE . 4.6 mm -69.76 -43.16 80.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.392 -0.818 . . . . 0.0 108.953 179.481 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.453 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 73.2 mtt-85 -79.73 -23.37 42.36 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.415 -0.803 . . . . 0.0 109.098 179.692 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.507 ' N ' ' O ' ' A' ' 43' ' ' ASN . 92.6 mt-30 63.0 45.33 5.37 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.374 -0.829 . . . . 0.0 109.353 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.1 p -128.53 159.17 36.31 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.302 -0.874 . . . . 0.0 109.374 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.418 ' O ' ' CG ' ' A' ' 49' ' ' ASN . 47.6 p-10 -91.49 59.49 3.84 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.169 -0.957 . . . . 0.0 109.301 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 81.6 m -72.36 141.95 48.77 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.352 -0.843 . . . . 0.0 109.843 -179.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 62.6 m-70 -122.44 171.62 8.95 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.53 HG23 ' HB ' ' A' ' 25' ' ' VAL . 29.2 mt -79.72 126.85 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.075 -1.016 . . . . 0.0 109.581 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.503 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 67.2 ttt-85 -80.07 -44.63 19.72 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.447 -0.783 . . . . 0.0 109.035 179.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.4 t -160.23 155.59 25.14 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.706 -0.849 . . . . 0.0 108.706 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 26.1 p -67.5 140.22 57.03 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.091 -1.005 . . . . 0.0 109.314 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.532 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 94.89 169.04 36.59 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.167 -1.573 . . . . 0.0 109.167 -179.748 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.581 ' HA ' HG23 ' A' ' 32' ' ' THR . 44.8 mttp -68.1 144.62 54.97 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.304 -1.116 . . . . 0.0 109.446 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.461 ' SG ' ' O ' ' A' ' 31' ' ' GLN . 73.9 m . . . . . 0 N--CA 1.491 1.595 0 O-C-N 121.254 -0.904 . . . . 0.0 109.289 179.911 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 66.0 mtt . . . . . 0 N--CA 1.488 1.447 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.44 ' HB3' ' HB3' ' A' ' 40' ' ' CYS . 3.7 m -83.19 1.63 39.69 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.341 -0.849 . . . . 0.0 109.114 179.388 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.2 mttm -61.89 -31.74 72.05 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.138 -0.976 . . . . 0.0 109.416 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -145.21 68.54 1.23 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.212 -0.93 . . . . 0.0 109.952 -179.893 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.463 ' CE2' ' CE2' ' A' ' 16' ' ' TYR . 13.9 p90 -119.03 -171.23 2.06 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.175 -0.953 . . . . 0.0 109.19 179.524 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 21.4 ttt180 -150.83 152.32 33.58 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.232 -0.918 . . . . 0.0 109.747 -179.999 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.557 HG13 ' O ' ' A' ' 15' ' ' GLY . 45.4 t -148.63 131.46 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.293 -0.88 . . . . 0.0 109.46 179.839 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.682 HD23 ' HD2' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -104.26 174.86 2.47 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.253 -0.905 . . . . 0.0 109.249 179.81 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.682 ' HD2' HD23 ' A' ' 11' ' ' LEU . 45.8 Cg_endo -67.48 -24.62 42.26 Favored 'Trans proline' 0 C--O 1.215 -0.667 0 C-N-CA 122.706 2.271 . . . . 0.0 112.056 -179.995 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -96.62 -28.23 14.44 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.29 -0.881 . . . . 0.0 109.41 179.966 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.444 HD12 ' HB2' ' A' ' 11' ' ' LEU . 89.9 mt -83.05 -45.77 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.302 -0.874 . . . . 0.0 109.598 -179.916 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.557 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 68.66 -168.74 42.74 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 179.997 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.463 ' CE2' ' CE2' ' A' ' 8' ' ' TYR . 1.4 t80 -95.33 149.25 21.56 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.212 -1.169 . . . . 0.0 109.645 -179.907 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.687 ' C ' HD13 ' A' ' 17' ' ' LEU . 2.3 tm? -111.24 112.21 23.82 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.287 -0.883 . . . . 0.0 109.163 179.873 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.578 ' N ' HD13 ' A' ' 17' ' ' LEU . 62.0 m -128.63 155.77 78.47 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.26 -0.9 . . . . 0.0 109.608 -179.896 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.406 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 49.6 Cg_endo -71.28 168.52 23.17 Favored 'Trans proline' 0 C--O 1.215 -0.675 0 C-N-CA 122.694 2.263 . . . . 0.0 111.526 179.781 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 25.4 mttm -91.09 -14.92 30.34 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.219 -0.926 . . . . 0.0 109.639 -179.828 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 51.3 t0 -72.3 119.48 16.56 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.246 -0.908 . . . . 0.0 109.349 179.866 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.557 HD11 ' HB3' ' A' ' 34' ' ' ASN . 52.4 tp -79.59 113.64 17.9 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.199 -0.938 . . . . 0.0 109.646 -179.944 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.492 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -127.5 110.12 20.96 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.211 -0.931 . . . . 0.0 109.079 179.738 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.553 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 42.6 Cg_endo -64.66 122.48 10.36 Favored 'Trans proline' 0 C--O 1.213 -0.774 0 C-N-CA 122.943 2.428 . . . . 0.0 112.203 -179.715 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.487 ' HB ' HG23 ' A' ' 52' ' ' ILE . 18.8 m -119.31 154.71 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.283 -0.886 . . . . 0.0 109.4 179.785 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.456 ' SG ' ' HB3' ' A' ' 53' ' ' ARG . 39.7 t -96.56 142.71 28.3 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 178.598 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.481 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -95.69 139.43 14.49 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 -179.859 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.466 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 55.0 t0 -69.29 -6.18 27.84 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.234 -1.157 . . . . 0.0 109.592 -179.781 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.434 ' OD2' ' OG1' ' A' ' 50' ' ' THR . 41.7 m-20 -90.87 0.87 57.37 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.149 -0.969 . . . . 0.0 109.548 179.913 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.43 24.61 15.74 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.634 -1.387 . . . . 0.0 109.634 179.935 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.481 ' O ' ' N ' ' A' ' 27' ' ' GLY . 81.5 mt-30 -131.84 164.17 26.65 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.292 -1.122 . . . . 0.0 109.279 -179.982 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.978 HG21 ' HG3' ' A' ' 57' ' ' LYS . 12.0 m -121.03 150.32 41.34 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.123 -0.985 . . . . 0.0 109.384 179.797 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.844 ' CD2' HD12 ' A' ' 39' ' ' LEU . 36.7 m-85 -128.74 131.75 47.89 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.341 -0.849 . . . . 0.0 109.253 -179.909 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.557 ' HB3' HD11 ' A' ' 22' ' ' LEU . 11.8 m-20 -51.75 -78.77 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.358 -0.839 . . . . 0.0 109.889 -179.429 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.534 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 5.8 t-20 -82.01 147.7 58.55 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.104 -0.997 . . . . 0.0 109.827 -179.789 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.492 ' HD3' ' O ' ' A' ' 23' ' ' LYS . 41.7 Cg_endo -64.04 -52.76 1.49 Allowed 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 122.777 2.318 . . . . 0.0 111.606 179.826 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.534 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 11.6 t -62.2 -30.01 70.78 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.969 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.494 ' CG ' ' HB3' ' A' ' 35' ' ' ASN . 29.3 mtt -65.3 -16.12 63.24 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.435 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.844 HD12 ' CD2' ' A' ' 33' ' ' TYR . 8.0 tt -69.07 -52.87 24.02 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.34 -0.85 . . . . 0.0 108.899 179.71 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.513 ' O ' ' HB2' ' A' ' 43' ' ' ASN . 14.4 m -51.0 -39.66 56.3 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.424 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 13.3 t60 -49.2 -45.12 43.82 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.851 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.595 ' HG3' ' CE1' ' A' ' 33' ' ' TYR . 45.4 mm-40 -61.73 -20.99 64.12 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.263 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.524 ' O ' ' N ' ' A' ' 47' ' ' GLN . 2.5 m-80 -76.69 -31.33 57.17 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 119.694 -0.803 . . . . 0.0 109.034 179.508 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.975 HD13 ' O ' ' A' ' 44' ' ' LEU . 1.7 tm? -70.22 -36.46 74.55 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.265 -0.897 . . . . 0.0 109.396 179.932 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 6.4 mt -74.87 -51.46 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.258 -0.901 . . . . 0.0 109.554 -179.896 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.488 ' NH2' ' OE1' ' A' ' 42' ' ' GLU . 40.8 mtt85 -81.12 -36.74 29.92 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.299 -0.875 . . . . 0.0 109.842 -179.653 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.524 ' N ' ' O ' ' A' ' 43' ' ' ASN . 92.6 mt-30 63.07 34.05 14.13 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.309 -0.869 . . . . 0.0 109.554 -179.809 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.466 HG23 ' HB3' ' A' ' 46' ' ' ARG . 38.9 p -103.74 7.51 37.24 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.276 -0.89 . . . . 0.0 109.486 179.956 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.536 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 65.6 m-20 63.59 47.98 3.56 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.192 -0.942 . . . . 0.0 109.469 -179.895 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.524 ' N ' ' OD1' ' A' ' 43' ' ' ASN . 71.1 m -80.3 125.75 30.28 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.395 -0.815 . . . . 0.0 109.366 179.752 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . 0.536 ' CE1' ' O ' ' A' ' 49' ' ' ASN . 7.2 m80 -109.71 -171.09 1.77 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.124 -0.985 . . . . 0.0 109.459 179.822 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.822 HG12 HD13 ' A' ' 39' ' ' LEU . 43.6 mt -87.04 126.56 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.408 -0.808 . . . . 0.0 109.557 179.934 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.466 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 21.7 ttt85 -79.63 -46.4 17.27 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.446 -0.784 . . . . 0.0 109.275 179.841 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 95.3 p -158.31 138.84 12.71 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -179.72 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 20.8 p -56.02 151.33 12.13 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.134 -0.979 . . . . 0.0 109.49 -179.839 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.553 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 74.73 161.91 8.87 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 -179.595 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.978 ' HG3' HG21 ' A' ' 32' ' ' THR . 25.8 tttp -59.6 145.02 46.0 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.424 -1.045 . . . . 0.0 109.144 179.96 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.6 0 O-C-N 121.257 -0.902 . . . . 0.0 109.526 -179.846 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 90.7 mtp . . . . . 0 N--CA 1.488 1.429 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.605 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 19.9 m -80.32 -12.64 59.58 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.477 -0.765 . . . . 0.0 109.251 179.892 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.459 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 26.3 mttt -80.96 6.41 13.45 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.148 -0.97 . . . . 0.0 109.816 179.831 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.459 ' OD1' ' O ' ' A' ' 6' ' ' LYS . 96.3 m-20 -139.13 15.22 2.63 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.005 -1.06 . . . . 0.0 110.416 -179.387 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.686 ' CE2' ' CE2' ' A' ' 16' ' ' TYR . 1.0 OUTLIER -122.69 151.38 41.59 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.913 -1.117 . . . . 0.0 109.533 179.846 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 91.3 mtt180 -129.06 136.05 49.73 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.402 -0.811 . . . . 0.0 109.119 179.693 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.873 HG13 ' O ' ' A' ' 15' ' ' GLY . 49.7 t -127.16 148.43 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.246 -0.909 . . . . 0.0 109.499 -179.628 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.548 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.2 OUTLIER -123.65 175.12 2.99 Favored Pre-proline 0 N--CA 1.488 1.458 0 O-C-N 121.233 -0.917 . . . . 0.0 109.621 -179.689 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.548 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 45.1 Cg_endo -67.76 -22.27 43.55 Favored 'Trans proline' 0 C--O 1.215 -0.675 0 C-N-CA 122.691 2.261 . . . . 0.0 111.713 -179.987 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 69.9 mtt85 -105.7 -24.31 12.55 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.341 -0.85 . . . . 0.0 109.526 179.948 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 24.4 mm -81.9 -48.17 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.246 -0.909 . . . . 0.0 109.54 -179.893 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.873 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 82.17 -163.83 43.57 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.344 -1.503 . . . . 0.0 109.344 -179.923 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.686 ' CE2' ' CE2' ' A' ' 8' ' ' TYR . 2.1 t80 -97.57 150.6 20.94 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.125 -1.221 . . . . 0.0 109.621 179.983 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.696 ' C ' HD13 ' A' ' 17' ' ' LEU . 2.2 tm? -111.86 109.65 19.57 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.333 -0.854 . . . . 0.0 109.749 -179.779 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.519 ' N ' HD13 ' A' ' 17' ' ' LEU . 63.6 m -125.86 156.12 71.87 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.284 -0.885 . . . . 0.0 108.985 179.649 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -71.02 165.48 32.24 Favored 'Trans proline' 0 C--O 1.214 -0.686 0 C-N-CA 122.453 2.102 . . . . 0.0 111.701 -179.98 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 24.3 mttt -83.76 -22.93 31.75 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.261 -0.9 . . . . 0.0 109.521 -179.805 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 -63.62 125.41 24.19 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.226 -0.921 . . . . 0.0 109.401 179.781 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 41.2 tp -85.69 122.92 30.47 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.211 -0.931 . . . . 0.0 109.507 179.94 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.555 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 1.3 mmmt -135.21 103.28 10.59 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.305 -0.872 . . . . 0.0 109.284 179.987 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.536 ' HA ' ' O ' ' A' ' 34' ' ' ASN . 43.3 Cg_endo -65.02 120.02 7.16 Favored 'Trans proline' 0 C--O 1.213 -0.744 0 C-N-CA 123.18 2.587 . . . . 0.0 112.529 -179.125 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.475 ' O ' HG23 ' A' ' 32' ' ' THR . 7.8 m -116.98 155.94 18.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.399 -0.813 . . . . 0.0 109.754 179.683 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.428 ' O ' ' N ' ' A' ' 53' ' ' ARG . 14.8 t -102.67 109.9 21.66 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.389 -0.82 . . . . 0.0 108.97 179.369 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -66.03 137.7 36.3 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 -179.652 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.521 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 55.1 p30 -68.65 -10.14 54.31 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.316 -1.108 . . . . 0.0 109.57 179.858 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.443 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 38.9 m-20 -82.62 4.47 24.63 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.246 -0.909 . . . . 0.0 109.378 179.757 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.73 14.68 56.33 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.137 -1.585 . . . . 0.0 109.137 -179.809 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.501 ' O ' ' N ' ' A' ' 27' ' ' GLY . 88.9 mt-30 -121.36 157.54 30.22 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.382 -1.07 . . . . 0.0 109.373 -179.969 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.517 ' CG2' ' HA ' ' A' ' 57' ' ' LYS . 25.6 m -119.19 134.97 54.91 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.257 -0.902 . . . . 0.0 109.356 179.916 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.632 ' HD2' HD12 ' A' ' 39' ' ' LEU . 54.2 m-85 -113.13 129.67 56.43 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.289 -0.882 . . . . 0.0 109.288 179.986 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.536 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 6.6 m-20 -52.47 -76.29 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.216 -0.928 . . . . 0.0 109.441 -179.812 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.514 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 10.2 t-20 -81.99 147.35 57.72 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.039 -1.038 . . . . 0.0 109.495 179.797 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.555 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 39.9 Cg_endo -63.12 -51.68 2.63 Favored 'Trans proline' 0 C--O 1.214 -0.693 0 C-N-CA 122.673 2.248 . . . . 0.0 111.451 179.555 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.514 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 5.7 t -60.25 -28.36 67.98 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 178.81 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.482 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 34.7 mmm -66.02 -18.94 65.67 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.384 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.632 HD12 ' HD2' ' A' ' 33' ' ' TYR . 8.1 tt -66.84 -52.74 40.09 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.179 -0.951 . . . . 0.0 108.577 179.382 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.483 ' O ' ' HB2' ' A' ' 43' ' ' ASN . 38.0 t -50.81 -25.97 5.12 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 178.983 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.456 ' O ' HG12 ' A' ' 45' ' ' ILE . 28.1 t60 -60.09 -50.05 75.25 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.162 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.602 ' HB2' ' CE1' ' A' ' 33' ' ' TYR . 23.9 tp10 -58.66 -19.42 39.2 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.201 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.518 ' O ' ' N ' ' A' ' 47' ' ' GLN . 4.0 m-80 -78.26 -35.81 47.64 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.29 -0.881 . . . . 0.0 108.913 179.589 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 1.005 HD13 ' O ' ' A' ' 44' ' ' LEU . 2.1 tm? -69.34 -34.3 74.41 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.286 -0.884 . . . . 0.0 109.327 179.717 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.456 HG12 ' O ' ' A' ' 41' ' ' HIS . 6.1 mm -74.67 -53.84 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.382 -0.824 . . . . 0.0 110.118 -179.633 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.564 ' HB3' HG23 ' A' ' 48' ' ' THR . 10.5 mtt-85 -88.38 -30.3 19.62 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.145 -0.972 . . . . 0.0 110.36 -179.159 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.518 ' N ' ' O ' ' A' ' 43' ' ' ASN . 87.2 mt-30 62.33 37.07 14.13 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.128 -0.983 . . . . 0.0 109.277 -179.706 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.564 HG23 ' HB3' ' A' ' 46' ' ' ARG . 72.7 p -101.25 6.68 43.02 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.295 -0.878 . . . . 0.0 109.715 -179.84 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.452 ' HB2' ' O ' ' A' ' 48' ' ' THR . 73.0 m-20 61.65 51.77 3.85 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.165 -0.959 . . . . 0.0 109.556 179.894 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.506 ' N ' ' OD1' ' A' ' 43' ' ' ASN . 47.9 m -76.53 140.63 41.22 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.24 -0.913 . . . . 0.0 109.262 179.755 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 12.0 m-70 -119.53 -176.47 3.16 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.219 -0.926 . . . . 0.0 109.63 -179.879 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.595 HG12 HD13 ' A' ' 39' ' ' LEU . 15.9 mt -87.47 124.07 40.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 O-C-N 121.383 -0.823 . . . . 0.0 109.575 179.883 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.521 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 16.7 tpt180 -81.07 -56.38 4.14 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.476 -0.765 . . . . 0.0 109.477 179.904 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 72.8 m -148.9 141.17 24.07 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -179.832 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.428 ' H ' HG23 ' A' ' 55' ' ' THR . 12.2 p -58.34 144.51 41.25 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.197 -0.939 . . . . 0.0 109.522 -179.67 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.526 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 86.32 162.61 37.13 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.79 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.517 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 21.7 mttp -70.65 133.09 46.36 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.559 -0.965 . . . . 0.0 109.386 179.895 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.495 0 O-C-N 121.219 -0.926 . . . . 0.0 109.406 -179.995 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 70.7 mtm . . . . . 0 N--CA 1.487 1.415 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 3.4 m -82.93 7.56 15.09 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 179.41 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.6 mttm -61.11 -35.69 77.69 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.997 -1.064 . . . . 0.0 109.305 179.724 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -140.65 70.8 1.36 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.321 -0.862 . . . . 0.0 109.915 -179.793 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.457 ' CE2' HG23 ' A' ' 10' ' ' VAL . 26.9 p90 -115.07 -169.75 1.62 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.208 -0.933 . . . . 0.0 109.3 179.633 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.437 ' N ' ' CD2' ' A' ' 8' ' ' TYR . 71.9 mtt-85 -152.41 142.37 22.15 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.256 -0.903 . . . . 0.0 109.569 179.905 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.559 HG13 ' C ' ' A' ' 15' ' ' GLY . 39.9 t -143.06 138.7 27.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.264 -0.897 . . . . 0.0 109.2 179.98 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.549 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.7 OUTLIER -119.55 174.72 2.62 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.221 -0.924 . . . . 0.0 109.449 -179.788 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.549 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 46.6 Cg_endo -68.36 -24.31 37.24 Favored 'Trans proline' 0 C--O 1.214 -0.678 0 C-N-CA 122.748 2.299 . . . . 0.0 111.881 179.965 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.486 ' HG2' ' O ' ' A' ' 13' ' ' ARG . 23.4 ttm180 -101.18 -16.69 16.93 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.322 -0.861 . . . . 0.0 109.282 179.897 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 85.2 mt -96.99 -42.19 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.244 -0.91 . . . . 0.0 109.654 -179.754 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.559 ' C ' HG13 ' A' ' 10' ' ' VAL . . . 71.55 179.38 31.3 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 -179.812 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.487 ' OH ' ' HB2' ' A' ' 40' ' ' CYS . 1.8 t80 -77.61 153.92 32.76 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.153 -1.204 . . . . 0.0 109.546 -179.989 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.462 HD23 ' HA ' ' A' ' 17' ' ' LEU . 48.1 mt -110.42 123.58 50.15 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.216 -0.927 . . . . 0.0 109.594 179.999 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.466 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 82.4 m -146.98 156.72 47.27 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.453 -0.779 . . . . 0.0 109.032 179.895 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.518 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 48.9 Cg_endo -70.86 168.29 23.42 Favored 'Trans proline' 0 C--O 1.216 -0.608 0 C-N-CA 122.583 2.188 . . . . 0.0 111.515 179.889 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -94.26 -8.73 38.27 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.124 -0.985 . . . . 0.0 109.628 -179.796 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -76.62 118.53 19.36 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.169 -0.957 . . . . 0.0 109.414 179.957 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.501 HD11 ' HB3' ' A' ' 34' ' ' ASN . 44.3 tp -76.09 116.92 17.26 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.201 -0.937 . . . . 0.0 109.739 -179.973 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.539 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 2.2 mtpt -132.1 106.76 13.66 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.306 -0.871 . . . . 0.0 108.996 179.767 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.527 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 43.2 Cg_endo -64.58 120.24 7.48 Favored 'Trans proline' 0 C--O 1.214 -0.711 0 C-N-CA 122.912 2.408 . . . . 0.0 112.1 -179.448 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.492 ' HB ' HG23 ' A' ' 52' ' ' ILE . 11.4 m -120.26 155.2 23.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.445 -0.784 . . . . 0.0 110.047 -179.768 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.429 ' SG ' ' HB3' ' A' ' 53' ' ' ARG . 41.4 t -96.88 148.18 23.2 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 178.713 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -100.04 139.66 14.54 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.545 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.477 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 53.4 t0 -64.82 -10.7 30.08 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.279 -1.13 . . . . 0.0 109.409 179.834 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 59.9 p30 -90.39 1.6 56.43 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.24 -0.913 . . . . 0.0 109.667 -179.932 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.64 19.45 34.75 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.994 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.473 ' O ' ' N ' ' A' ' 27' ' ' GLY . 87.0 mt-30 -119.23 167.88 11.43 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.209 -1.171 . . . . 0.0 109.429 -179.946 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.549 HG23 ' HA ' ' A' ' 57' ' ' LYS . 94.3 m -127.73 146.91 50.42 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.118 -0.989 . . . . 0.0 109.445 179.792 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.62 ' CD1' ' N ' ' A' ' 33' ' ' TYR . 5.0 m-85 -128.8 128.64 44.34 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.23 -0.918 . . . . 0.0 109.463 -179.835 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.501 ' HB3' HD11 ' A' ' 22' ' ' LEU . 7.5 m-20 -49.79 -77.22 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.282 -0.886 . . . . 0.0 109.663 -179.551 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.543 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 2.0 t-20 -81.91 149.23 62.85 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.161 -0.962 . . . . 0.0 109.443 179.995 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.539 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 41.2 Cg_endo -64.62 -54.71 0.68 Allowed 'Trans proline' 0 C--O 1.216 -0.622 0 C-N-CA 122.842 2.361 . . . . 0.0 111.955 179.873 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.543 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 15.7 t -62.09 -28.6 69.73 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 120.974 -1.079 . . . . 0.0 108.417 179.049 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.444 ' CG ' ' HB3' ' A' ' 35' ' ' ASN . 37.0 mmm -61.45 -15.56 38.47 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 179.363 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.609 HD13 ' CD1' ' A' ' 33' ' ' TYR . 50.8 tp -63.47 -46.01 88.15 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.346 -0.846 . . . . 0.0 108.982 179.61 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.487 ' HB2' ' OH ' ' A' ' 16' ' ' TYR . 2.8 m -71.8 -19.98 61.92 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 178.764 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 28.4 t60 -66.89 -52.76 39.48 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.017 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.474 ' OE1' ' CE2' ' A' ' 33' ' ' TYR . 85.5 tt0 -66.91 -19.86 65.8 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 178.983 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.502 ' O ' ' N ' ' A' ' 47' ' ' GLN . 87.9 m-20 -77.46 -32.75 54.65 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.327 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.409 HD12 ' HA ' ' A' ' 44' ' ' LEU . 23.9 tp -64.28 -31.36 72.54 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.259 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.3 mm -77.63 -44.7 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.442 -0.787 . . . . 0.0 108.972 179.376 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.453 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 63.2 mtt-85 -79.89 -15.36 57.49 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.353 -0.842 . . . . 0.0 109.123 179.629 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.502 ' N ' ' O ' ' A' ' 43' ' ' ASN . 89.0 mt-30 63.09 44.32 5.91 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.421 -0.799 . . . . 0.0 109.486 179.995 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.408 ' O ' ' HB3' ' A' ' 43' ' ' ASN . 7.3 p -128.54 164.52 22.64 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.211 -0.93 . . . . 0.0 109.294 179.829 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 47.5 p-10 -104.58 58.62 0.7 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.123 -0.986 . . . . 0.0 109.573 -179.935 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 86.5 m -71.91 137.77 47.65 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.255 -0.903 . . . . 0.0 109.541 179.9 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 71.4 m80 -112.55 176.54 4.98 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.229 -0.92 . . . . 0.0 109.091 179.723 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.492 HG23 ' HB ' ' A' ' 25' ' ' VAL . 39.2 mt -80.28 126.66 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.231 -0.918 . . . . 0.0 109.509 179.999 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.477 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 67.6 ttt180 -79.88 -46.39 16.91 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.443 -0.786 . . . . 0.0 109.448 -179.922 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.405 ' H ' ' HB3' ' A' ' 26' ' ' CYS . 54.4 p -160.44 138.88 10.14 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -179.331 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.446 ' H ' HG23 ' A' ' 55' ' ' THR . 10.6 p -51.29 147.4 5.75 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.163 -0.961 . . . . 0.0 109.485 179.978 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.527 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 85.14 165.95 41.03 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.484 -1.447 . . . . 0.0 109.484 179.923 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.549 ' HA ' HG23 ' A' ' 32' ' ' THR . 33.7 mttm -65.33 146.24 55.16 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.49 -1.006 . . . . 0.0 109.406 179.981 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.45 ' SG ' ' O ' ' A' ' 31' ' ' GLN . 79.2 m . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.279 -0.888 . . . . 0.0 109.48 179.945 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 62.1 mmm . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.141 -0.689 . . . . 0.0 109.141 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.544 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 3.3 m -82.32 -14.92 54.57 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.313 -0.867 . . . . 0.0 109.143 179.862 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -56.2 -25.09 45.81 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.205 -0.934 . . . . 0.0 109.585 -179.994 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -154.27 63.04 0.69 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.179 -0.951 . . . . 0.0 109.841 -179.833 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.544 ' CD1' ' HA ' ' A' ' 5' ' ' CYS . 7.9 p90 -119.84 174.15 6.61 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.172 -0.955 . . . . 0.0 109.308 179.591 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 66.9 mtt-85 -145.26 137.34 25.69 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.19 -0.944 . . . . 0.0 109.514 -179.969 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.86 HG11 ' CD2' ' A' ' 44' ' ' LEU . 98.7 t -134.21 139.82 47.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.243 -0.911 . . . . 0.0 109.48 -179.981 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.548 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.2 OUTLIER -131.28 175.57 3.58 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.345 -0.847 . . . . 0.0 109.389 -179.924 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.548 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 46.0 Cg_endo -67.76 -24.95 40.18 Favored 'Trans proline' 0 C--O 1.214 -0.69 0 C-N-CA 122.673 2.249 . . . . 0.0 111.729 179.884 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.48 ' HG2' ' O ' ' A' ' 13' ' ' ARG . 54.6 ttt180 -110.97 -20.54 12.39 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.328 -0.857 . . . . 0.0 109.204 179.778 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 80.6 mt -90.98 -38.53 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.344 -0.848 . . . . 0.0 109.406 179.978 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.843 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 67.97 -142.22 39.38 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.948 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.54 ' CE2' ' CE2' ' A' ' 8' ' ' TYR . 2.9 t80 -108.23 153.97 22.44 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.172 -1.193 . . . . 0.0 109.57 -179.898 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 29.4 tp -112.33 119.46 38.36 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.398 -0.814 . . . . 0.0 109.581 179.911 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.459 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 58.5 m -131.55 155.92 80.81 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.279 -0.888 . . . . 0.0 109.269 179.903 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -71.11 166.4 29.31 Favored 'Trans proline' 0 C--O 1.216 -0.62 0 C-N-CA 122.523 2.149 . . . . 0.0 111.661 -179.994 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -88.42 -7.13 57.12 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.274 -0.891 . . . . 0.0 109.541 -179.934 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -74.39 128.42 35.49 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.231 -0.918 . . . . 0.0 109.4 179.846 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.731 ' C ' HD13 ' A' ' 22' ' ' LEU . 3.2 tm? -85.5 113.81 22.05 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.212 -0.93 . . . . 0.0 109.666 -179.831 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.519 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 5.5 mmtt -132.75 102.84 13.46 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.271 -0.893 . . . . 0.0 108.818 179.606 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.529 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 41.4 Cg_endo -63.43 124.18 13.35 Favored 'Trans proline' 0 C--O 1.213 -0.734 0 C-N-CA 122.963 2.442 . . . . 0.0 112.417 -179.067 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.46 ' HB ' HG23 ' A' ' 52' ' ' ILE . 35.0 m -123.06 154.08 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.47 -0.769 . . . . 0.0 109.921 -179.93 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.457 ' SG ' ' HB3' ' A' ' 53' ' ' ARG . 43.8 t -100.67 136.47 40.49 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.611 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -93.8 139.07 14.38 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 110.109 -1.196 . . . . 0.0 110.109 -179.099 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.504 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 48.9 p30 -64.14 -13.33 47.34 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.327 -1.102 . . . . 0.0 109.348 179.67 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.441 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 31.6 m-20 -85.61 11.31 11.03 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.236 -0.915 . . . . 0.0 109.237 179.844 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.5 20.32 66.71 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.886 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.523 ' O ' ' N ' ' A' ' 27' ' ' GLY . 83.0 mt-30 -121.98 145.93 47.65 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.304 -1.115 . . . . 0.0 109.503 -179.955 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.512 ' CG2' ' HA ' ' A' ' 57' ' ' LYS . 85.5 m -111.43 153.25 26.38 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.245 -0.909 . . . . 0.0 109.494 179.975 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.53 ' OH ' ' CG ' ' A' ' 42' ' ' GLU . 62.9 m-85 -135.69 145.67 46.96 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.246 -0.909 . . . . 0.0 109.196 179.648 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.528 ' ND2' ' N ' ' A' ' 34' ' ' ASN . 0.2 OUTLIER -63.92 -72.44 0.14 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.144 -0.972 . . . . 0.0 108.574 179.9 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.544 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 9.3 t-20 -83.09 146.9 52.66 Favored Pre-proline 0 C--N 1.299 -1.63 0 O-C-N 121.446 -0.784 . . . . 0.0 109.461 179.709 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.519 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 41.7 Cg_endo -64.15 -51.75 1.98 Allowed 'Trans proline' 0 C--O 1.215 -0.629 0 C-N-CA 122.512 2.141 . . . . 0.0 111.414 179.678 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.544 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 6.6 t -59.34 -25.85 64.54 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 178.8 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.489 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 10.2 mmm -65.6 -19.21 65.82 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.232 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 1.077 HD13 ' CD1' ' A' ' 52' ' ' ILE . 5.7 tt -73.97 -52.19 13.6 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.126 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.576 ' N ' HD23 ' A' ' 39' ' ' LEU . 7.3 t -47.92 -33.36 7.52 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 178.685 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 58.1 t60 -49.95 -56.0 12.32 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 178.934 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.53 ' CG ' ' OH ' ' A' ' 33' ' ' TYR . 16.8 tt0 -50.67 -23.13 2.42 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.072 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.511 ' HB2' ' O ' ' A' ' 40' ' ' CYS . 5.4 m-80 -80.92 -29.67 35.48 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 119.545 -0.862 . . . . 0.0 109.095 179.828 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.86 ' CD2' HG11 ' A' ' 10' ' ' VAL . 27.7 tp -77.39 -35.87 53.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.293 -0.879 . . . . 0.0 109.369 179.942 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 8.0 mm -77.25 -52.77 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.174 -0.954 . . . . 0.0 109.296 179.816 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.416 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 17.5 mtt-85 -79.84 -15.31 57.65 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.311 -0.868 . . . . 0.0 109.49 179.86 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.454 ' HA ' ' O ' ' A' ' 43' ' ' ASN . 92.8 mt-30 60.9 33.4 19.9 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.242 -0.911 . . . . 0.0 109.542 -179.978 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 18.4 p -108.96 176.28 5.16 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.318 -0.864 . . . . 0.0 109.451 179.978 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.488 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 88.8 m-20 -102.91 54.03 0.77 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.285 -0.884 . . . . 0.0 109.423 179.95 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.497 ' N ' ' OD1' ' A' ' 43' ' ' ASN . 60.7 m -73.53 124.24 25.49 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.282 -0.886 . . . . 0.0 109.467 -179.971 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . 0.488 ' CE1' ' O ' ' A' ' 49' ' ' ASN . 11.9 m-70 -111.89 -171.19 1.8 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.201 -0.937 . . . . 0.0 109.379 179.908 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 1.077 ' CD1' HD13 ' A' ' 39' ' ' LEU . 21.4 mm -86.45 125.05 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.276 -0.89 . . . . 0.0 109.702 -179.992 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.504 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 59.8 ttt180 -80.73 -42.82 21.24 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.415 -0.803 . . . . 0.0 109.38 179.6 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.403 ' H ' ' HB3' ' A' ' 26' ' ' CYS . 7.6 p -160.87 131.67 5.37 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.6 -0.687 . . . . 0.0 109.305 -179.188 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.425 ' H ' HG23 ' A' ' 55' ' ' THR . 8.0 p -49.13 147.38 2.98 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.214 -0.929 . . . . 0.0 109.089 179.803 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.529 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 85.46 172.45 48.98 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.239 -1.544 . . . . 0.0 109.239 -179.713 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.512 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 55.9 mttm -66.27 149.4 50.41 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.279 -1.13 . . . . 0.0 109.676 -179.77 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.408 ' SG ' ' OG1' ' A' ' 32' ' ' THR . 93.4 m . . . . . 0 N--CA 1.489 1.513 0 O-C-N 121.297 -0.877 . . . . 0.0 109.23 179.878 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 72.8 mmm . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.601 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 44.5 m -80.26 -19.26 47.19 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.48 -0.762 . . . . 0.0 109.392 179.936 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 20.8 mttt -80.08 4.82 15.98 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.24 -0.913 . . . . 0.0 109.652 -179.911 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -128.84 4.75 5.43 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.03 -1.044 . . . . 0.0 110.415 -179.409 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.689 ' CE2' ' CZ ' ' A' ' 16' ' ' TYR . 0.9 OUTLIER -120.43 150.21 41.14 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.912 -1.117 . . . . 0.0 109.554 179.78 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 81.2 mtt180 -131.87 130.69 41.98 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.26 -0.9 . . . . 0.0 109.167 179.76 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.777 HG13 ' O ' ' A' ' 15' ' ' GLY . 58.5 t -118.1 149.3 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.303 -0.873 . . . . 0.0 110.099 -179.484 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.551 ' HB2' HD12 ' A' ' 14' ' ' ILE . 0.7 OUTLIER -127.55 175.42 3.4 Favored Pre-proline 0 N--CA 1.488 1.459 0 O-C-N 121.375 -0.828 . . . . 0.0 108.905 179.484 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.55 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 43.6 Cg_endo -67.22 -22.37 46.78 Favored 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 122.465 2.11 . . . . 0.0 111.746 179.908 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 15.5 mtt-85 -102.04 -28.99 12.03 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.214 -0.929 . . . . 0.0 109.635 -179.999 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.551 HD12 ' HB2' ' A' ' 11' ' ' LEU . 84.9 mt -79.54 -48.7 20.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.229 -0.919 . . . . 0.0 109.582 -179.685 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.777 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 81.9 -167.97 48.59 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 -179.93 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.689 ' CZ ' ' CE2' ' A' ' 8' ' ' TYR . 1.0 OUTLIER -97.69 146.87 24.91 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.131 -1.217 . . . . 0.0 109.618 179.985 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 24.9 tp -118.24 120.63 38.26 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.355 -0.841 . . . . 0.0 109.527 179.969 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.435 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 80.1 m -129.22 156.15 78.78 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.325 -0.859 . . . . 0.0 109.128 179.67 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.525 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 46.2 Cg_endo -69.72 163.95 36.33 Favored 'Trans proline' 0 C--O 1.216 -0.613 0 C-N-CA 122.655 2.236 . . . . 0.0 111.729 -179.987 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -89.78 -7.83 53.52 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.278 -0.889 . . . . 0.0 109.412 -179.987 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 -73.62 120.82 19.74 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.297 -0.877 . . . . 0.0 109.375 179.903 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.921 HD21 ' OD1' ' A' ' 34' ' ' ASN . 3.1 tm? -81.41 124.0 29.05 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.283 -0.886 . . . . 0.0 109.417 -179.923 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.723 ' N ' HD13 ' A' ' 22' ' ' LEU . 11.9 mttt -146.31 104.74 4.06 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.308 -0.87 . . . . 0.0 109.371 179.769 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.549 ' HA ' ' O ' ' A' ' 34' ' ' ASN . 42.6 Cg_endo -65.23 123.61 11.77 Favored 'Trans proline' 0 C--O 1.213 -0.752 0 C-N-CA 122.954 2.436 . . . . 0.0 111.95 -179.92 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.529 ' O ' HG23 ' A' ' 32' ' ' THR . 27.2 m -118.69 154.51 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.191 -0.943 . . . . 0.0 109.637 179.978 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.445 ' SG ' ' HB3' ' A' ' 53' ' ' ARG . 41.5 t -96.59 138.4 34.22 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.273 -0.892 . . . . 0.0 108.83 179.327 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -91.99 139.46 14.71 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 179.995 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.51 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 55.5 t0 -71.03 -7.17 44.51 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.265 -1.138 . . . . 0.0 109.511 -179.925 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.415 ' OD1' ' C ' ' A' ' 29' ' ' ASP . 59.1 p30 -89.6 3.62 52.0 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.187 -0.946 . . . . 0.0 109.462 179.732 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.21 13.39 52.41 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 -179.891 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.451 ' O ' ' N ' ' A' ' 27' ' ' GLY . 76.9 mt-30 -118.72 174.04 6.51 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.256 -1.144 . . . . 0.0 109.402 -179.964 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.612 HG21 ' HG3' ' A' ' 57' ' ' LYS . 23.2 m -135.93 137.23 41.14 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.308 -0.87 . . . . 0.0 109.341 179.839 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.788 ' CD1' HD13 ' A' ' 39' ' ' LEU . 29.3 m-85 -114.2 129.12 56.63 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.299 -0.876 . . . . 0.0 109.348 -179.915 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.921 ' OD1' HD21 ' A' ' 22' ' ' LEU . 63.6 t-20 -52.55 -79.78 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.297 -0.877 . . . . 0.0 109.742 -179.583 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.537 ' HB3' ' CG ' ' A' ' 38' ' ' MET . 2.0 t-20 -81.17 149.66 66.53 Favored Pre-proline 0 C--N 1.3 -1.57 0 O-C-N 120.927 -1.108 . . . . 0.0 109.567 -179.813 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.508 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 39.9 Cg_endo -63.07 -54.53 1.08 Allowed 'Trans proline' 0 C--O 1.214 -0.68 0 C-N-CA 122.729 2.286 . . . . 0.0 111.925 -179.765 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.532 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 9.1 t -61.15 -29.15 69.61 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.997 -1.064 . . . . 0.0 108.224 179.116 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.537 ' CG ' ' HB3' ' A' ' 35' ' ' ASN . 69.6 mmm -62.56 -16.42 56.05 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 179.321 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.788 HD13 ' CD1' ' A' ' 33' ' ' TYR . 24.5 tp -69.08 -58.14 4.48 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.382 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.481 ' HB3' ' OH ' ' A' ' 16' ' ' TYR . 8.8 t -56.95 -29.82 63.49 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 178.685 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 54.9 t60 -64.1 -60.45 3.21 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.189 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.567 ' OE1' ' CE2' ' A' ' 33' ' ' TYR . 83.9 tt0 -57.79 -22.33 46.62 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.328 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.505 ' O ' ' N ' ' A' ' 47' ' ' GLN . 97.3 m-20 -76.4 -31.97 58.27 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.41 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 15.9 tp -66.49 -31.82 72.8 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.267 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 5.4 mt -75.81 -44.7 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 179.41 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.461 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 73.4 mtt-85 -80.61 -20.48 43.14 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.493 -0.754 . . . . 0.0 109.378 179.786 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.505 ' N ' ' O ' ' A' ' 43' ' ' ASN . 89.2 mt-30 63.3 43.49 6.15 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.313 -0.867 . . . . 0.0 109.43 -179.927 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.3 p -123.75 161.82 24.41 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.343 -0.848 . . . . 0.0 109.298 179.868 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.425 ' O ' ' CG ' ' A' ' 49' ' ' ASN . 44.8 p-10 -96.51 59.71 1.83 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.185 -0.947 . . . . 0.0 109.448 179.957 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 34.7 m -72.81 140.45 47.66 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.199 -0.938 . . . . 0.0 109.82 -179.872 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 49.3 m-70 -118.49 172.03 7.75 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.39 -0.819 . . . . 0.0 108.918 179.578 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.478 HG23 ' HB ' ' A' ' 25' ' ' VAL . 35.9 mt -81.54 126.28 39.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.141 -0.974 . . . . 0.0 109.291 179.772 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.51 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 39.8 ttt180 -79.73 -44.17 21.25 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.458 -0.776 . . . . 0.0 109.202 179.978 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.3 t -160.0 157.99 29.79 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.909 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 29.9 p -72.38 144.95 48.03 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.159 -0.963 . . . . 0.0 109.444 -179.907 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.546 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 84.83 165.92 40.71 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.865 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.612 ' HG3' HG21 ' A' ' 32' ' ' THR . 41.5 tttt -53.1 150.23 6.01 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.43 -1.041 . . . . 0.0 109.438 -179.98 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 98.8 m . . . . . 0 N--CA 1.49 1.551 0 O-C-N 121.248 -0.907 . . . . 0.0 109.317 179.887 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 74.6 mtm . . . . . 0 N--CA 1.488 1.453 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.582 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 24.5 m -80.48 -14.27 58.41 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.506 -0.746 . . . . 0.0 109.21 179.659 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.459 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 46.0 mttm -80.94 6.89 11.98 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.27 -0.894 . . . . 0.0 109.649 -179.954 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.459 ' OD1' ' O ' ' A' ' 6' ' ' LYS . 99.3 m-20 -139.12 14.94 2.63 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.108 -0.995 . . . . 0.0 110.309 -179.415 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.844 ' OH ' HD11 ' A' ' 44' ' ' LEU . 0.7 OUTLIER -123.93 152.38 42.51 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.889 -1.132 . . . . 0.0 109.561 179.876 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 16.8 mtm-85 -130.29 132.81 46.07 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.327 -0.858 . . . . 0.0 109.3 179.859 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.844 HG13 ' O ' ' A' ' 15' ' ' GLY . 53.2 t -123.85 145.98 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.144 -0.972 . . . . 0.0 109.462 -179.93 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.567 ' CG ' ' HD2' ' A' ' 12' ' ' PRO . 0.2 OUTLIER -125.12 175.92 2.74 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.241 -0.912 . . . . 0.0 109.339 -179.791 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.567 ' HD2' ' CG ' ' A' ' 11' ' ' LEU . 46.4 Cg_endo -67.65 -22.81 43.4 Favored 'Trans proline' 0 C--O 1.214 -0.681 0 C-N-CA 122.6 2.2 . . . . 0.0 111.664 179.971 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 62.6 ttt-85 -103.27 -22.87 13.65 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.323 -0.86 . . . . 0.0 109.493 179.927 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 36.3 mm -86.1 -51.33 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.223 -0.923 . . . . 0.0 109.425 -179.963 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.844 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 81.42 -163.23 44.47 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -179.917 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.629 ' CE2' ' CE2' ' A' ' 8' ' ' TYR . 1.4 t80 -99.29 150.48 22.06 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.172 -1.193 . . . . 0.0 109.514 179.957 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 18.1 tp -117.85 108.02 14.83 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.22 -0.925 . . . . 0.0 109.693 -179.841 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.442 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 61.3 m -118.13 155.74 51.14 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.258 -0.901 . . . . 0.0 109.269 179.792 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -72.3 167.28 27.34 Favored 'Trans proline' 0 C--O 1.216 -0.624 0 C-N-CA 122.671 2.248 . . . . 0.0 111.675 -179.929 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 61.3 tttm -83.08 -31.01 27.54 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.24 -0.913 . . . . 0.0 109.373 -179.932 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -57.73 126.97 29.73 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.257 -0.902 . . . . 0.0 109.541 179.941 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.575 HD11 ' HB3' ' A' ' 34' ' ' ASN . 66.3 tp -87.93 117.86 27.08 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.315 -0.866 . . . . 0.0 109.393 179.829 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.535 ' CB ' ' HD3' ' A' ' 36' ' ' PRO . 2.8 mttm -125.57 101.8 30.11 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.229 -0.919 . . . . 0.0 109.466 -179.795 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.546 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 42.5 Cg_endo -64.83 118.96 5.89 Favored 'Trans proline' 0 C--O 1.212 -0.809 0 C-N-CA 122.96 2.44 . . . . 0.0 112.28 -179.599 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.485 ' HB ' HG23 ' A' ' 52' ' ' ILE . 15.8 m -119.41 154.59 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.221 -0.925 . . . . 0.0 109.589 179.709 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.47 ' SG ' ' HB3' ' A' ' 53' ' ' ARG . 31.7 t -95.63 141.02 29.63 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.213 -0.93 . . . . 0.0 108.797 178.995 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -95.61 137.35 13.36 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 179.997 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.5 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 54.3 t0 -69.69 -5.41 24.8 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.236 -1.156 . . . . 0.0 109.579 -179.936 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -89.96 1.24 56.5 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.221 -0.924 . . . . 0.0 109.483 179.646 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.47 27.21 12.04 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.861 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.536 ' O ' ' N ' ' A' ' 27' ' ' GLY . 79.2 mt-30 -136.68 153.7 50.82 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.235 -1.156 . . . . 0.0 109.51 -179.968 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.818 HG21 ' HG3' ' A' ' 57' ' ' LYS . 3.5 m -114.96 139.59 49.7 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.294 -0.879 . . . . 0.0 109.31 179.854 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.83 ' CD1' HD13 ' A' ' 39' ' ' LEU . 86.0 m-85 -116.54 132.21 56.74 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.291 -0.881 . . . . 0.0 109.381 -179.904 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.575 ' HB3' HD11 ' A' ' 22' ' ' LEU . 9.8 m-20 -54.8 -78.93 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.352 -0.842 . . . . 0.0 109.728 -179.546 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.494 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 14.3 t-20 -82.35 146.5 54.38 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 120.999 -1.063 . . . . 0.0 109.664 -179.976 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.535 ' HD3' ' CB ' ' A' ' 23' ' ' LYS . 41.3 Cg_endo -63.81 -50.86 2.75 Favored 'Trans proline' 0 C--O 1.214 -0.715 0 C-N-CA 122.63 2.22 . . . . 0.0 111.282 179.367 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.528 ' SG ' ' CE1' ' A' ' 16' ' ' TYR . 7.8 t -60.9 -29.68 69.73 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 178.767 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.47 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 37.8 mmm -64.36 -15.88 61.23 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.103 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.83 HD13 ' CD1' ' A' ' 33' ' ' TYR . 54.5 tp -71.49 -58.84 3.14 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.346 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.447 ' HB3' ' OH ' ' A' ' 16' ' ' TYR . 13.6 t -53.51 -25.8 18.14 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 178.832 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 48.5 t60 -70.94 -63.32 1.12 Allowed 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.353 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.404 ' HA ' ' OE1' ' A' ' 42' ' ' GLU . 74.2 mm-40 -52.72 -21.73 4.4 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 179.237 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.474 ' OD1' ' HB ' ' A' ' 50' ' ' THR . 98.3 m-20 -75.21 -34.56 61.51 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.506 -0.746 . . . . 0.0 109.21 179.652 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.844 HD11 ' OH ' ' A' ' 8' ' ' TYR . 17.6 mt -64.16 -29.34 70.46 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.183 -0.948 . . . . 0.0 109.047 179.58 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.4 mt -80.42 -44.22 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.385 -0.822 . . . . 0.0 109.433 179.69 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.445 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 93.1 mtt-85 -79.97 -34.64 38.5 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.29 -0.881 . . . . 0.0 109.572 179.938 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.446 ' N ' ' O ' ' A' ' 43' ' ' ASN . 92.1 mt-30 63.01 43.74 6.4 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.334 -0.854 . . . . 0.0 109.561 179.979 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 68.4 p -117.31 16.56 14.8 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.329 -0.857 . . . . 0.0 109.295 179.77 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 47.9 t30 43.8 60.91 2.49 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.288 -0.882 . . . . 0.0 109.568 -179.902 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.474 ' HB ' ' OD1' ' A' ' 43' ' ' ASN . 25.7 m -77.96 147.34 34.98 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.26 -0.9 . . . . 0.0 109.626 179.869 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 56.8 m-70 -121.63 168.16 12.09 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.362 -0.836 . . . . 0.0 108.788 179.481 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.485 HG23 ' HB ' ' A' ' 25' ' ' VAL . 26.2 mt -79.79 123.71 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.076 -1.015 . . . . 0.0 109.279 179.977 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.5 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 75.2 ttt-85 -80.21 -42.83 22.56 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.474 -0.766 . . . . 0.0 109.363 -179.94 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -158.45 147.3 18.93 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.444 -0.785 . . . . 0.0 109.279 179.998 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.9 p -66.51 149.74 49.99 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.207 -0.933 . . . . 0.0 109.42 -179.86 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.546 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 73.44 162.3 7.39 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 108.961 -1.656 . . . . 0.0 108.961 -179.594 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.818 ' HG3' HG21 ' A' ' 32' ' ' THR . 22.4 tttp -51.57 146.25 7.81 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.314 -1.109 . . . . 0.0 108.755 179.883 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.438 ' O ' ' O ' ' A' ' 57' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.519 0 O-C-N 121.171 -0.956 . . . . 0.0 109.543 -179.612 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 56.4 mtt . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.437 ' O ' ' N ' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -89.8 -13.43 36.63 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.338 -0.851 . . . . 0.0 108.743 179.663 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.423 ' C ' ' O ' ' A' ' 5' ' ' CYS . 34.5 mttm -46.58 -27.46 1.14 Allowed 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 179.327 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.4 ' N ' ' C ' ' A' ' 5' ' ' CYS . 45.4 p-10 -119.15 39.26 3.6 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 178.752 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.573 ' CE2' ' OH ' ' A' ' 16' ' ' TYR . 1.6 t80 -79.48 157.43 27.48 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.62 -0.675 . . . . 0.0 109.839 -179.258 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 15.1 mtt180 -150.17 115.25 5.37 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.398 -0.814 . . . . 0.0 109.055 179.542 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.581 HG13 ' C ' ' A' ' 15' ' ' GLY . 54.4 t -123.22 146.88 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.342 -0.848 . . . . 0.0 109.521 -179.625 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.534 ' HB2' HD12 ' A' ' 14' ' ' ILE . 0.2 OUTLIER -121.2 172.91 4.35 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.384 -0.823 . . . . 0.0 109.347 -179.881 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.518 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 44.2 Cg_endo -66.29 -22.81 52.66 Favored 'Trans proline' 0 C--O 1.216 -0.592 0 C-N-CA 122.669 2.246 . . . . 0.0 111.594 179.802 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 86.6 mtt-85 -101.51 -25.86 13.76 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.365 -0.835 . . . . 0.0 109.328 179.824 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.534 HD12 ' HB2' ' A' ' 11' ' ' LEU . 85.7 mt -87.52 -47.41 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.281 -0.887 . . . . 0.0 109.415 179.966 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.581 ' C ' HG13 ' A' ' 10' ' ' VAL . . . 69.46 -172.35 38.79 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.894 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.573 ' OH ' ' CE2' ' A' ' 8' ' ' TYR . 1.5 t80 -95.0 150.86 19.7 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.203 -1.175 . . . . 0.0 109.494 179.927 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 21.8 tp -113.38 106.04 14.11 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.255 -0.903 . . . . 0.0 109.633 -179.83 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.418 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 56.0 m -124.54 154.89 69.8 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.304 -0.873 . . . . 0.0 109.389 179.774 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -72.5 170.77 18.55 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 C-N-CA 122.639 2.226 . . . . 0.0 111.491 179.823 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 41.3 tttp -86.77 -33.9 19.77 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.301 -0.875 . . . . 0.0 109.51 -179.926 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -54.14 133.16 44.12 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.318 -0.864 . . . . 0.0 109.383 179.97 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.628 HD11 ' HB3' ' A' ' 34' ' ' ASN . 54.7 tp -92.4 113.14 25.33 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.164 -0.96 . . . . 0.0 109.417 -179.974 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.545 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 5.3 mmtt -118.94 101.68 49.93 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.301 -0.874 . . . . 0.0 109.172 179.981 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.548 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 43.0 Cg_endo -65.35 118.15 5.2 Favored 'Trans proline' 0 C--O 1.213 -0.76 0 C-N-CA 122.848 2.365 . . . . 0.0 112.034 -179.491 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.636 ' O ' HG23 ' A' ' 32' ' ' THR . 11.1 m -114.26 155.99 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.224 -0.923 . . . . 0.0 109.583 179.842 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 46.1 t -96.32 133.77 40.29 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.124 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -91.12 137.01 13.64 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.555 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.48 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 49.9 p30 -66.19 -9.12 28.82 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.341 -1.094 . . . . 0.0 109.502 179.855 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 56.0 p30 -86.09 8.81 19.32 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.18 -0.95 . . . . 0.0 109.397 179.894 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.23 18.78 58.53 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 -179.921 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.405 ' O ' ' SG ' ' A' ' 58' ' ' CYS . 64.4 mt-30 -125.97 176.09 7.24 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.205 -1.174 . . . . 0.0 109.39 -179.942 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.662 HG21 ' HA ' ' A' ' 57' ' ' LYS . 25.1 m -135.44 139.3 44.01 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.258 -0.901 . . . . 0.0 109.442 -179.981 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.971 ' CD1' HD13 ' A' ' 39' ' ' LEU . 58.1 m-85 -113.38 130.57 56.26 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.36 -0.838 . . . . 0.0 109.293 179.855 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.628 ' HB3' HD11 ' A' ' 22' ' ' LEU . 13.9 m-20 -51.83 -80.47 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.317 -0.864 . . . . 0.0 109.693 -179.542 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.509 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 12.0 t-20 -82.39 146.04 53.16 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.005 -1.059 . . . . 0.0 109.482 179.945 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.545 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.9 Cg_endo -63.68 -50.86 2.84 Favored 'Trans proline' 0 C--O 1.216 -0.612 0 C-N-CA 122.653 2.235 . . . . 0.0 111.563 179.723 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.556 ' SG ' ' CE1' ' A' ' 16' ' ' TYR . 11.0 t -61.99 -28.21 69.41 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 178.931 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.461 ' HB2' ' HB3' ' A' ' 35' ' ' ASN . 43.0 mmm -68.92 -7.81 38.43 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 179.24 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.971 HD13 ' CD1' ' A' ' 33' ' ' TYR . 25.5 tp -73.72 -60.09 2.41 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.29 -0.881 . . . . 0.0 108.902 179.802 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.462 ' SG ' ' OH ' ' A' ' 16' ' ' TYR . 12.0 t -52.91 -24.84 10.08 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.382 -0.969 . . . . 0.0 108.382 179.273 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 33.8 t60 -65.09 -60.7 2.74 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.193 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 66.0 mt-10 -60.22 -21.57 61.95 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 179.063 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.501 ' ND2' ' HG ' ' A' ' 39' ' ' LEU . 97.2 m-20 -78.22 -27.01 47.64 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.512 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.97 HD13 ' O ' ' A' ' 44' ' ' LEU . 1.4 tm? -68.54 -36.34 78.68 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.269 -0.894 . . . . 0.0 108.732 179.422 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -77.24 -41.66 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.46 -0.775 . . . . 0.0 109.165 179.719 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.506 ' HB3' HG23 ' A' ' 48' ' ' THR . 93.2 mtt-85 -80.11 -36.23 35.67 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.329 -0.857 . . . . 0.0 109.307 179.898 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.445 ' N ' ' O ' ' A' ' 43' ' ' ASN . 53.1 mt-30 60.05 35.4 21.38 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.368 -0.832 . . . . 0.0 109.678 179.834 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.506 HG23 ' HB3' ' A' ' 46' ' ' ARG . 34.6 p -103.13 11.21 37.35 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.171 -0.956 . . . . 0.0 109.413 179.785 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 65.1 m-20 52.51 54.4 10.7 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.232 -0.918 . . . . 0.0 109.478 179.976 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.477 ' HB ' ' OD1' ' A' ' 43' ' ' ASN . 42.9 m -79.77 137.24 36.95 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.198 -0.938 . . . . 0.0 109.527 179.984 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 41.1 m80 -115.53 170.53 8.35 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.363 -0.836 . . . . 0.0 108.947 179.505 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.573 HG23 ' HB ' ' A' ' 25' ' ' VAL . 29.3 mt -79.62 125.79 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.183 -0.948 . . . . 0.0 109.312 179.884 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.48 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 47.8 ttt180 -81.74 -40.86 22.06 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.501 -0.75 . . . . 0.0 109.496 -179.887 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -158.91 150.59 20.77 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.398 -0.814 . . . . 0.0 109.237 -179.999 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 31.0 p -69.81 139.11 53.14 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.234 -0.917 . . . . 0.0 109.516 -179.873 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.548 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 92.44 162.92 37.44 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.85 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.662 ' HA ' HG21 ' A' ' 32' ' ' THR . 39.5 tttp -50.62 148.55 3.82 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.434 -1.039 . . . . 0.0 109.272 179.887 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.405 ' SG ' ' O ' ' A' ' 31' ' ' GLN . 57.8 m . . . . . 0 N--CA 1.49 1.539 0 O-C-N 121.191 -0.943 . . . . 0.0 109.501 -179.975 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 76.8 mtm . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.507 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 12.9 m -79.81 -14.0 59.01 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.289 -0.882 . . . . 0.0 109.0 179.696 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 47.2 mttm -56.6 -28.2 59.83 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.336 -0.853 . . . . 0.0 109.724 -179.792 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -149.21 61.89 1.04 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.196 -0.94 . . . . 0.0 110.044 -179.779 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.664 ' OH ' HD13 ' A' ' 44' ' ' LEU . 4.7 p90 -121.91 168.2 12.16 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.093 -1.005 . . . . 0.0 109.348 179.534 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 34.2 ttt85 -147.99 149.02 31.39 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.148 -0.97 . . . . 0.0 109.605 179.922 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.757 HG13 ' C ' ' A' ' 15' ' ' GLY . 87.2 t -140.94 134.96 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.302 -0.874 . . . . 0.0 109.369 179.888 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.551 HD23 ' HD2' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -120.59 173.71 3.55 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.15 -0.969 . . . . 0.0 109.391 179.961 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.551 ' HD2' HD23 ' A' ' 11' ' ' LEU . 47.3 Cg_endo -67.9 -23.94 40.51 Favored 'Trans proline' 0 C--O 1.215 -0.644 0 C-N-CA 122.604 2.203 . . . . 0.0 111.737 179.944 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -104.62 -26.87 12.16 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.283 -0.886 . . . . 0.0 109.453 179.992 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.437 HD12 ' HB2' ' A' ' 11' ' ' LEU . 95.2 mt -86.2 -44.43 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.241 -0.912 . . . . 0.0 109.512 -179.94 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.757 ' C ' HG13 ' A' ' 10' ' ' VAL . . . 73.92 -158.73 52.38 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -179.957 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.525 ' CD2' HG21 ' A' ' 10' ' ' VAL . 1.9 t80 -99.64 155.29 17.68 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.285 -1.126 . . . . 0.0 109.345 179.803 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.442 ' O ' ' SG ' ' A' ' 37' ' ' CYS . 30.5 tp -114.16 120.1 39.36 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.229 -0.919 . . . . 0.0 109.883 -179.63 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.401 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 69.4 m -138.65 156.22 73.15 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.279 -0.888 . . . . 0.0 109.366 179.894 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.489 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 52.0 Cg_endo -71.65 168.76 22.78 Favored 'Trans proline' 0 C--O 1.215 -0.635 0 C-N-CA 122.681 2.254 . . . . 0.0 111.638 -179.989 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 29.0 mttt -89.9 -12.72 38.09 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.156 -0.965 . . . . 0.0 109.366 179.961 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -72.2 132.06 43.59 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.285 -0.885 . . . . 0.0 109.202 179.698 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.425 HD11 ' HB3' ' A' ' 34' ' ' ASN . 28.7 tp -91.85 114.19 26.66 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.216 -0.927 . . . . 0.0 109.807 -179.679 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.554 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -126.96 106.78 22.21 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.344 -0.848 . . . . 0.0 108.897 179.604 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.546 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 44.0 Cg_endo -65.88 119.93 7.02 Favored 'Trans proline' 0 C--O 1.214 -0.722 0 C-N-CA 122.825 2.35 . . . . 0.0 112.144 -179.315 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.472 ' O ' HG23 ' A' ' 32' ' ' THR . 21.4 m -116.96 153.22 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.232 -0.917 . . . . 0.0 109.518 179.75 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.454 ' SG ' ' HB3' ' A' ' 53' ' ' ARG . 48.6 t -97.04 142.28 29.17 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 178.989 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -93.88 140.52 15.09 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 -178.999 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.473 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 52.4 p30 -67.41 -10.51 51.94 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.31 -1.112 . . . . 0.0 109.264 179.627 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.426 ' OD1' ' HB2' ' A' ' 31' ' ' GLN . 57.0 p30 -90.07 5.91 44.68 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.226 -0.922 . . . . 0.0 109.474 179.891 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.32 15.36 57.37 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 -179.925 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.458 ' O ' ' SG ' ' A' ' 58' ' ' CYS . 84.3 mt-30 -114.87 178.88 4.12 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.374 -1.074 . . . . 0.0 109.387 179.981 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.519 ' CG2' ' HA ' ' A' ' 57' ' ' LYS . 30.7 m -141.21 144.82 34.97 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.193 -0.942 . . . . 0.0 109.335 179.866 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.813 ' CD1' HD13 ' A' ' 39' ' ' LEU . 23.9 m-85 -124.59 126.7 46.22 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.269 -0.895 . . . . 0.0 109.278 -179.965 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.527 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 9.8 m-20 -48.38 -78.57 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.301 -0.874 . . . . 0.0 109.736 -179.467 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.542 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 4.5 t-20 -81.49 147.67 60.4 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 120.941 -1.1 . . . . 0.0 109.393 179.983 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.554 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 41.0 Cg_endo -63.66 -53.77 1.22 Allowed 'Trans proline' 0 C--O 1.215 -0.644 0 C-N-CA 122.872 2.381 . . . . 0.0 111.926 -179.963 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.542 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 11.3 t -62.98 -25.68 68.48 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 120.942 -1.099 . . . . 0.0 108.141 179.051 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.435 ' CG ' ' HB3' ' A' ' 35' ' ' ASN . 42.1 mmm -67.35 -13.08 61.67 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.21 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.813 HD13 ' CD1' ' A' ' 33' ' ' TYR . 19.1 tp -70.3 -57.55 4.74 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.427 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.473 ' HB3' ' OH ' ' A' ' 16' ' ' TYR . 3.3 t -56.05 -26.77 50.6 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.026 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.499 ' CE1' ' HB2' ' A' ' 16' ' ' TYR . 31.2 t60 -62.43 -59.55 4.82 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.963 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -58.33 -22.89 54.94 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 178.915 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.503 ' O ' ' N ' ' A' ' 47' ' ' GLN . 91.3 m-20 -79.19 -27.75 42.6 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.584 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.664 HD13 ' OH ' ' A' ' 8' ' ' TYR . 32.6 tp -70.22 -30.86 68.05 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.498 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 6.5 mm -80.31 -46.29 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.475 -0.766 . . . . 0.0 109.113 179.467 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.461 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 85.3 mtt180 -79.88 -36.56 36.42 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.309 -0.87 . . . . 0.0 109.394 179.712 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.503 ' N ' ' O ' ' A' ' 43' ' ' ASN . 92.4 mt-30 63.75 42.34 6.29 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.497 -0.752 . . . . 0.0 109.616 -179.862 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.404 HG23 ' HB3' ' A' ' 46' ' ' ARG . 49.4 p -106.8 10.16 30.82 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.195 -0.94 . . . . 0.0 109.417 179.737 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 51.51 54.68 10.62 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.273 -0.892 . . . . 0.0 109.71 179.874 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.46 ' HB ' ' OD1' ' A' ' 43' ' ' ASN . 51.5 m -79.88 139.93 36.94 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.215 -0.928 . . . . 0.0 109.528 179.985 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . 0.449 ' CD2' ' OD2' ' A' ' 28' ' ' ASP . 8.4 m-70 -112.47 -173.42 2.24 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.239 -0.913 . . . . 0.0 109.397 179.722 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 39.8 mt -93.87 126.46 46.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.378 -0.826 . . . . 0.0 109.594 -179.933 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.473 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 68.1 ttt-85 -80.02 -45.77 17.78 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.43 -0.794 . . . . 0.0 109.3 179.787 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.41 ' H ' ' HB3' ' A' ' 26' ' ' CYS . 49.4 p -160.88 147.59 15.17 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 -179.445 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.3 p -61.23 144.14 54.32 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.137 -0.977 . . . . 0.0 109.411 179.929 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.546 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 87.51 164.01 39.66 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 -179.775 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.519 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 53.1 mttt -60.44 148.81 36.17 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.414 -1.051 . . . . 0.0 109.293 179.913 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.458 ' SG ' ' O ' ' A' ' 31' ' ' GLN . 61.8 m . . . . . 0 N--CA 1.489 1.484 0 O-C-N 121.189 -0.944 . . . . 0.0 108.999 179.532 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 64.1 mmm . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.576 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 29.3 m -81.82 -15.34 54.44 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.483 -0.761 . . . . 0.0 109.112 179.709 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.452 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 45.4 mttm -80.72 5.56 15.4 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.195 -0.94 . . . . 0.0 109.789 -179.954 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.452 ' OD1' ' O ' ' A' ' 6' ' ' LYS . 95.4 m-20 -135.97 12.05 3.36 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.025 -1.047 . . . . 0.0 110.333 -179.367 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.772 ' OH ' HD11 ' A' ' 44' ' ' LEU . 0.6 OUTLIER -123.11 155.94 35.98 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.866 -1.146 . . . . 0.0 109.576 179.822 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 47.0 mtt85 -134.19 132.81 40.21 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.372 -0.83 . . . . 0.0 109.149 179.804 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.902 HG13 ' O ' ' A' ' 15' ' ' GLY . 55.6 t -125.45 147.56 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.195 -0.941 . . . . 0.0 109.872 -179.535 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.541 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 1.3 mp -123.28 174.96 3.04 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.288 -0.883 . . . . 0.0 109.202 179.797 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.541 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 44.8 Cg_endo -67.2 -21.72 47.88 Favored 'Trans proline' 0 C--O 1.215 -0.647 0 C-N-CA 122.561 2.174 . . . . 0.0 111.732 179.923 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 95.0 mtt-85 -104.61 -25.73 12.62 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.369 -0.832 . . . . 0.0 109.684 -179.953 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 24.4 mm -80.95 -47.23 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.232 -0.917 . . . . 0.0 109.532 -179.703 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.902 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 82.38 -163.17 42.58 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.935 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.635 ' CE2' ' CE2' ' A' ' 8' ' ' TYR . 1.6 t80 -102.51 148.9 24.96 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.205 -1.174 . . . . 0.0 109.466 179.925 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 27.1 tp -115.63 111.86 21.26 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.31 -0.869 . . . . 0.0 109.532 179.885 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.431 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 80.7 m -120.23 157.54 53.07 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.197 -0.939 . . . . 0.0 109.353 -179.977 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.52 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 50.6 Cg_endo -71.57 166.48 29.26 Favored 'Trans proline' 0 C--O 1.215 -0.642 0 C-N-CA 122.713 2.275 . . . . 0.0 111.884 -179.774 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -87.3 -9.74 54.15 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.307 -0.87 . . . . 0.0 109.449 179.902 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -76.31 110.94 11.24 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.183 -0.948 . . . . 0.0 109.106 179.736 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 42.7 tp -79.66 123.62 27.81 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.216 -0.927 . . . . 0.0 109.708 -179.76 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.481 ' HD3' ' HG3' ' A' ' 36' ' ' PRO . 5.2 mtpt -139.66 107.98 7.12 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.308 -0.87 . . . . 0.0 109.052 179.661 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.556 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 41.5 Cg_endo -64.28 120.23 7.49 Favored 'Trans proline' 0 C--O 1.212 -0.779 0 C-N-CA 122.937 2.424 . . . . 0.0 112.082 -179.558 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.525 ' HB ' HG23 ' A' ' 52' ' ' ILE . 16.6 m -115.71 154.63 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.282 -0.886 . . . . 0.0 109.835 -179.937 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 43.9 t -97.21 126.28 42.29 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.456 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -78.57 137.66 19.9 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 -179.994 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.495 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 52.9 t0 -70.82 -10.33 59.32 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.174 -1.192 . . . . 0.0 109.566 -179.944 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.416 ' OD1' ' HB2' ' A' ' 31' ' ' GLN . 56.5 p30 -87.96 10.38 19.09 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.257 -0.902 . . . . 0.0 109.24 179.586 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.45 21.39 48.4 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.08 -1.608 . . . . 0.0 109.08 -179.722 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.456 ' O ' ' SG ' ' A' ' 58' ' ' CYS . 87.5 mt-30 -121.0 177.21 5.2 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.277 -1.131 . . . . 0.0 109.542 179.98 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 1.001 HG21 ' HG3' ' A' ' 57' ' ' LYS . 56.7 m -140.37 134.75 31.33 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.314 -0.866 . . . . 0.0 109.304 179.96 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.835 ' CD1' HD13 ' A' ' 39' ' ' LEU . 39.0 m-85 -117.36 130.09 56.28 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.309 -0.869 . . . . 0.0 109.295 179.994 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.53 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 7.1 m-20 -54.54 -77.83 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.221 -0.924 . . . . 0.0 109.73 -179.628 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.527 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 5.1 t-20 -81.68 148.69 62.43 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.094 -1.004 . . . . 0.0 109.641 -179.906 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.481 ' HG3' ' HD3' ' A' ' 23' ' ' LYS . 40.6 Cg_endo -63.1 -52.62 1.99 Allowed 'Trans proline' 0 C--O 1.215 -0.631 0 C-N-CA 122.568 2.179 . . . . 0.0 111.807 179.829 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.527 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 5.4 t -61.98 -28.18 69.38 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 178.982 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.494 ' CG ' ' HB3' ' A' ' 35' ' ' ASN . 52.6 mmm -63.32 -16.57 60.76 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.444 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.835 HD13 ' CD1' ' A' ' 33' ' ' TYR . 39.0 tp -68.71 -56.87 6.7 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 179.327 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.471 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 10.9 t -55.78 -23.14 28.13 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 178.864 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 47.1 t60 -71.69 -63.46 1.12 Allowed 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 179.393 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.439 ' HB2' ' CE2' ' A' ' 33' ' ' TYR . 62.2 mt-10 -54.35 -21.77 10.38 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.342 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.495 ' O ' ' N ' ' A' ' 47' ' ' GLN . 99.4 m-20 -73.29 -37.22 66.3 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.424 -0.797 . . . . 0.0 109.116 179.686 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.772 HD11 ' OH ' ' A' ' 8' ' ' TYR . 24.0 mt -61.41 -32.59 72.53 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.139 -0.975 . . . . 0.0 108.912 179.627 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.8 mt -74.4 -42.58 49.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.377 -0.827 . . . . 0.0 108.832 179.296 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.448 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 69.1 mtt-85 -79.85 -22.57 42.78 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.428 -0.795 . . . . 0.0 109.391 179.744 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.495 ' N ' ' O ' ' A' ' 43' ' ' ASN . 89.5 mt-30 63.21 41.69 7.73 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.395 -0.816 . . . . 0.0 109.427 -179.838 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 16.0 p -128.35 163.5 24.7 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.344 -0.847 . . . . 0.0 109.371 179.87 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 50.9 p-10 -94.3 61.48 2.83 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.175 -0.953 . . . . 0.0 109.428 -179.958 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 31.7 m -69.75 139.0 53.26 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.402 -0.811 . . . . 0.0 109.742 -179.937 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 62.1 m-70 -119.8 169.36 10.2 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.307 -0.871 . . . . 0.0 109.032 179.538 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.525 HG23 ' HB ' ' A' ' 25' ' ' VAL . 41.1 mt -79.43 126.42 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.182 -0.949 . . . . 0.0 109.387 179.983 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.495 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 68.8 ttt180 -79.92 -47.98 14.17 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-O 121.638 0.732 . . . . 0.0 109.449 179.988 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 65.2 p -159.71 135.55 8.6 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -179.483 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.441 ' H ' HG23 ' A' ' 55' ' ' THR . 11.5 p -50.88 147.97 4.54 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.245 -0.91 . . . . 0.0 109.525 -179.834 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.556 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 85.94 164.22 38.97 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.326 -1.509 . . . . 0.0 109.326 -179.764 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 1.001 ' HG3' HG21 ' A' ' 32' ' ' THR . 26.0 tttt -59.32 153.72 18.2 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.374 -1.074 . . . . 0.0 109.387 -179.924 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.528 ' N ' ' HG2' ' A' ' 57' ' ' LYS . 98.2 m . . . . . 0 N--CA 1.492 1.633 0 O-C-N 121.267 -0.896 . . . . 0.0 109.704 -179.772 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . 0.442 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 57.2 mmm . . . . . 0 N--CA 1.488 1.444 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.411 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 17.2 m -81.97 -18.21 44.24 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.483 -0.761 . . . . 0.0 109.155 179.586 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 49.6 mttt -80.2 -3.78 50.41 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.32 -0.862 . . . . 0.0 109.745 -179.886 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' A' ' 4' ' ' MET . 19.3 p30 -118.56 -0.82 11.29 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.08 -1.013 . . . . 0.0 109.714 -179.835 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.484 ' OH ' ' CE2' ' A' ' 16' ' ' TYR . 0.1 OUTLIER -118.51 168.9 10.24 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.053 -1.029 . . . . 0.0 109.284 179.979 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 41.9 mtm-85 -149.63 128.14 12.29 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.243 -0.911 . . . . 0.0 109.254 179.817 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.542 HG21 ' C ' ' A' ' 15' ' ' GLY . 6.4 p -124.99 145.48 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.218 -0.926 . . . . 0.0 109.847 -179.77 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.66 HD23 ' HD2' ' A' ' 12' ' ' PRO . 0.2 OUTLIER -108.37 170.37 5.57 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.359 -0.838 . . . . 0.0 109.229 179.921 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.66 ' HD2' HD23 ' A' ' 11' ' ' LEU . 45.7 Cg_endo -67.54 -23.86 42.79 Favored 'Trans proline' 0 C--O 1.215 -0.659 0 C-N-CA 122.622 2.215 . . . . 0.0 111.787 179.951 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 73.2 mtt85 -87.7 -26.28 23.05 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.289 -0.882 . . . . 0.0 109.131 179.734 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 97.7 mt -90.26 -44.49 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.277 -0.889 . . . . 0.0 109.327 179.883 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.542 ' C ' HG21 ' A' ' 10' ' ' VAL . . . 72.97 148.9 1.0 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.991 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.542 ' N ' HG21 ' A' ' 10' ' ' VAL . 0.9 OUTLIER -47.48 148.91 1.24 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.327 -1.102 . . . . 0.0 109.788 -179.874 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 25.9 tp -115.82 110.29 18.84 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.373 -0.829 . . . . 0.0 109.521 -179.992 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 56.1 m -120.74 154.96 57.54 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.272 -0.892 . . . . 0.0 109.445 179.966 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -72.47 169.7 21.12 Favored 'Trans proline' 0 C--O 1.215 -0.669 0 C-N-CA 122.591 2.194 . . . . 0.0 111.475 179.978 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 47.6 mttm -88.7 -17.89 29.02 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.185 -0.947 . . . . 0.0 109.471 -179.911 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -66.94 130.34 42.83 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.262 -0.899 . . . . 0.0 109.296 179.721 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.498 HD11 ' HB3' ' A' ' 34' ' ' ASN . 43.3 tp -87.46 121.88 30.47 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.177 -0.952 . . . . 0.0 109.558 -179.894 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.541 ' CB ' ' HD3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -132.77 99.72 15.18 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.234 -0.916 . . . . 0.0 109.044 179.768 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.544 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 41.9 Cg_endo -63.88 119.77 6.93 Favored 'Trans proline' 0 C--O 1.214 -0.702 0 C-N-CA 122.899 2.399 . . . . 0.0 112.492 -179.248 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 32.9 m -115.71 154.37 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.345 -0.847 . . . . 0.0 109.473 179.689 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.404 ' O ' ' N ' ' A' ' 53' ' ' ARG . 41.6 t -100.65 121.32 41.43 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.323 -0.86 . . . . 0.0 108.819 179.372 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -74.83 141.62 28.6 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.804 -1.319 . . . . 0.0 109.804 -179.701 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.508 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 55.1 t0 -71.28 -9.69 58.53 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.156 -1.202 . . . . 0.0 109.598 179.969 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -86.81 6.62 30.74 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.234 -0.916 . . . . 0.0 109.198 179.64 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.79 16.6 54.36 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 -179.836 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.454 ' O ' ' SG ' ' A' ' 58' ' ' CYS . 87.5 mt-30 -118.19 169.58 9.58 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.194 -1.18 . . . . 0.0 109.532 179.992 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.481 HG23 ' HA ' ' A' ' 57' ' ' LYS . 27.8 m -132.39 134.47 45.19 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.224 -0.922 . . . . 0.0 109.367 179.874 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.812 ' CD1' HD13 ' A' ' 39' ' ' LEU . 47.6 m-85 -114.43 130.28 56.7 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.185 -0.947 . . . . 0.0 109.195 179.835 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.526 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 5.1 m-20 -52.49 -77.88 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.19 -0.944 . . . . 0.0 109.73 -179.516 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.517 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 13.7 t-20 -81.91 146.5 55.94 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 120.975 -1.078 . . . . 0.0 109.646 -179.895 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.541 ' HD3' ' CB ' ' A' ' 23' ' ' LYS . 40.1 Cg_endo -63.43 -51.29 2.69 Favored 'Trans proline' 0 C--O 1.214 -0.709 0 C-N-CA 122.592 2.195 . . . . 0.0 111.304 179.474 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.517 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 8.8 t -60.62 -28.79 68.8 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 178.835 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.45 ' HB2' ' HB3' ' A' ' 35' ' ' ASN . 12.3 mtt -65.25 -12.7 54.18 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.202 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.812 HD13 ' CD1' ' A' ' 33' ' ' TYR . 51.0 tp -71.47 -58.07 3.85 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.294 -0.879 . . . . 0.0 108.726 179.569 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.465 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 36.0 t -54.61 -24.75 22.67 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 179.048 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 35.1 t60 -68.52 -61.38 1.85 Allowed 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.293 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.438 ' HB2' ' CE2' ' A' ' 33' ' ' TYR . 72.3 mm-40 -56.08 -20.0 15.37 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.259 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.523 ' O ' ' N ' ' A' ' 47' ' ' GLN . 98.0 m-20 -78.61 -29.72 46.17 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.718 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.473 HD23 ' HA ' ' A' ' 44' ' ' LEU . 16.8 mt -68.95 -30.44 68.89 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.25 -0.906 . . . . 0.0 108.795 179.401 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -80.43 -47.33 21.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.346 -0.846 . . . . 0.0 109.355 179.715 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.445 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 94.9 mtt-85 -79.73 -34.47 39.97 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.285 -0.885 . . . . 0.0 109.321 179.875 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.523 ' N ' ' O ' ' A' ' 43' ' ' ASN . 92.1 mt-30 62.15 39.65 12.63 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.362 -0.836 . . . . 0.0 109.518 -179.939 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.408 ' O ' ' C ' ' A' ' 49' ' ' ASN . 68.1 p -107.63 17.08 23.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.302 -0.874 . . . . 0.0 109.468 179.986 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.408 ' C ' ' O ' ' A' ' 48' ' ' THR . 57.4 m-20 44.15 60.0 2.96 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.174 -0.954 . . . . 0.0 109.285 -179.936 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.48 ' HB ' ' OD1' ' A' ' 43' ' ' ASN . 22.1 m -77.12 145.77 37.59 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.213 -0.929 . . . . 0.0 109.669 -179.742 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 28.6 m-70 -118.49 173.8 6.62 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.281 -0.887 . . . . 0.0 109.137 179.565 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 9.4 mt -86.32 124.66 40.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.224 -0.922 . . . . 0.0 109.713 -179.966 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.508 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 21.0 ttt180 -79.51 -51.82 8.82 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-O 121.631 0.729 . . . . 0.0 109.389 179.959 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 57.8 m -159.76 140.15 11.97 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.507 -0.746 . . . . 0.0 109.122 -179.738 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.408 ' H ' HG23 ' A' ' 55' ' ' THR . 21.8 p -52.85 148.06 8.13 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.151 -0.968 . . . . 0.0 109.518 -179.861 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.544 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 88.64 164.95 40.8 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 -179.883 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.527 ' HG3' ' HB2' ' A' ' 24' ' ' PRO . 24.3 mttt -64.32 150.73 45.56 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.493 -1.004 . . . . 0.0 109.224 179.871 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.454 ' SG ' ' O ' ' A' ' 31' ' ' GLN . 86.5 m . . . . . 0 N--CA 1.492 1.639 0 O-C-N 121.23 -0.919 . . . . 0.0 109.429 179.964 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 66.4 mmm . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.584 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 39.1 m -80.71 -16.12 54.74 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.539 -0.726 . . . . 0.0 109.367 179.744 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.429 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 60.5 mttt -80.8 9.14 6.73 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.262 -0.899 . . . . 0.0 109.861 179.95 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.429 ' OD1' ' O ' ' A' ' 6' ' ' LYS . 90.6 m-20 -135.35 3.99 3.13 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.874 -1.141 . . . . 0.0 110.551 -179.526 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.664 ' CE2' ' CE2' ' A' ' 16' ' ' TYR . 1.5 p90 -114.76 156.87 24.06 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.805 -1.184 . . . . 0.0 109.803 -179.996 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 62.7 mtm180 -137.15 133.01 34.78 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.331 -0.855 . . . . 0.0 109.462 179.82 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.78 HG13 ' O ' ' A' ' 15' ' ' GLY . 79.3 t -121.55 143.29 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.351 -0.843 . . . . 0.0 109.687 -179.78 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.558 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 1.8 mp -123.99 176.09 2.47 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.329 -0.857 . . . . 0.0 109.103 179.877 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.558 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 44.3 Cg_endo -67.19 -22.68 46.46 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 122.561 2.174 . . . . 0.0 111.759 179.873 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 71.5 mtt85 -102.94 -28.45 12.02 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.277 -0.889 . . . . 0.0 109.506 179.907 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 14' ' ' ILE . . . . . 0.508 HD12 ' HB2' ' A' ' 11' ' ' LEU . 94.8 mt -82.79 -46.43 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.358 -0.839 . . . . 0.0 109.766 -179.731 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.78 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 75.81 -169.99 54.7 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.391 -1.483 . . . . 0.0 109.391 -179.87 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.664 ' CE2' ' CE2' ' A' ' 8' ' ' TYR . 1.5 t80 -90.81 151.02 21.34 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.163 -1.198 . . . . 0.0 109.436 179.914 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.463 HD23 ' HA ' ' A' ' 17' ' ' LEU . 43.1 mt -120.26 126.16 49.91 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.269 -0.894 . . . . 0.0 109.721 -179.839 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.402 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 63.3 m -138.16 155.42 74.29 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.319 -0.863 . . . . 0.0 109.057 179.818 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.408 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 47.3 Cg_endo -70.02 165.06 32.54 Favored 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 122.583 2.189 . . . . 0.0 111.659 179.951 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 77.8 mttt -83.7 -21.71 32.27 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.338 -0.851 . . . . 0.0 109.433 -179.801 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -65.7 122.9 18.34 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.263 -0.898 . . . . 0.0 109.202 179.751 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.686 ' C ' HD13 ' A' ' 22' ' ' LEU . 3.5 tm? -89.68 108.33 19.61 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.18 -0.95 . . . . 0.0 109.338 -179.771 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.509 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 4.2 mtpm? -117.42 104.68 49.59 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.389 -0.819 . . . . 0.0 109.132 179.933 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.547 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 42.3 Cg_endo -63.95 119.93 7.14 Favored 'Trans proline' 0 C--O 1.213 -0.739 0 C-N-CA 123.067 2.511 . . . . 0.0 112.502 -179.353 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.442 ' O ' HG23 ' A' ' 32' ' ' THR . 30.1 m -117.35 154.32 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.342 -0.849 . . . . 0.0 109.424 179.703 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 26' ' ' CYS . . . . . 0.425 ' O ' ' N ' ' A' ' 53' ' ' ARG . 43.3 t -98.82 118.21 35.05 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.328 -0.857 . . . . 0.0 109.077 179.622 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -72.57 141.6 31.1 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 110.179 -1.169 . . . . 0.0 110.179 -179.405 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.522 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 54.5 p30 -69.98 -11.26 60.75 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.324 -1.103 . . . . 0.0 109.434 179.748 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.428 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 91.5 m-20 -83.52 9.24 11.79 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.21 -0.931 . . . . 0.0 109.291 179.778 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.52 13.71 67.2 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 -179.908 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.493 ' O ' ' N ' ' A' ' 27' ' ' GLY . 91.8 mt-30 -118.35 170.78 8.62 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.302 -1.116 . . . . 0.0 109.481 179.98 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.553 HG23 ' HA ' ' A' ' 57' ' ' LYS . 56.7 m -129.4 138.94 51.77 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.353 -0.842 . . . . 0.0 109.333 -179.95 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.627 ' CD1' ' CD1' ' A' ' 39' ' ' LEU . 23.2 m-85 -118.38 121.88 41.45 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.304 -0.872 . . . . 0.0 108.93 179.643 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.545 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 1.6 m-20 -47.8 -78.47 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.355 -0.841 . . . . 0.0 109.557 -179.361 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . 0.531 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 9.6 t-20 -82.36 146.32 53.9 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.019 -1.05 . . . . 0.0 109.788 -179.706 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.509 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.9 Cg_endo -63.67 -51.63 2.33 Favored 'Trans proline' 0 C--O 1.215 -0.667 0 C-N-CA 122.706 2.271 . . . . 0.0 111.627 179.789 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.531 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 9.2 t -62.51 -26.09 68.37 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 178.842 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . 0.46 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 41.6 mmm -67.37 -17.37 64.71 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.31 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.627 ' CD1' ' CD1' ' A' ' 33' ' ' TYR . 10.6 tp -70.18 -59.95 2.58 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.305 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.471 ' HB3' ' OH ' ' A' ' 16' ' ' TYR . 16.6 t -54.02 -25.62 22.15 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 178.803 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 72.9 t60 -65.19 -62.12 1.73 Allowed 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.096 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.405 ' OE1' ' CE2' ' A' ' 33' ' ' TYR . 82.3 mt-10 -57.46 -19.34 23.53 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 179.002 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.523 ' O ' ' N ' ' A' ' 47' ' ' GLN . 98.9 m-20 -79.72 -26.55 40.8 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.395 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 40.4 tp -72.98 -31.8 64.77 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.412 -0.805 . . . . 0.0 108.912 179.577 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 8.7 mm -80.04 -49.57 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.347 -0.846 . . . . 0.0 109.097 179.629 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.564 ' HB3' HG23 ' A' ' 48' ' ' THR . 53.3 mtt-85 -80.9 -34.27 33.62 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.294 -0.879 . . . . 0.0 109.246 179.832 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.523 ' N ' ' O ' ' A' ' 43' ' ' ASN . 92.9 mt-30 63.12 39.95 9.46 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.529 -0.732 . . . . 0.0 109.489 -179.887 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.564 HG23 ' HB3' ' A' ' 46' ' ' ARG . 41.7 p -97.26 2.15 50.49 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.243 -0.91 . . . . 0.0 109.534 179.826 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.456 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 70.4 m-20 55.5 56.23 6.49 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.175 -0.953 . . . . 0.0 109.623 179.989 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 55.7 m -79.72 143.06 34.89 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.174 -0.954 . . . . 0.0 109.674 -179.929 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 51' ' ' HIS . . . . . 0.456 ' CE1' ' O ' ' A' ' 49' ' ' ASN . 26.2 m80 -114.25 172.53 6.95 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.269 -0.894 . . . . 0.0 109.054 179.668 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 19.6 mt -85.74 124.38 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.131 -0.981 . . . . 0.0 109.706 -179.919 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.522 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 31.5 ttt-85 -79.77 -56.68 4.1 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.546 -0.721 . . . . 0.0 109.272 179.81 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -152.34 148.8 27.93 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.545 -0.722 . . . . 0.0 109.162 179.91 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 33.6 p -59.02 151.88 21.13 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.164 -0.96 . . . . 0.0 109.302 -179.963 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.547 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 85.5 166.51 42.06 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 108.955 -1.658 . . . . 0.0 108.955 -179.577 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.553 ' HA ' HG23 ' A' ' 32' ' ' THR . 88.6 mttt -66.35 166.67 11.81 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.296 -1.12 . . . . 0.0 109.443 -179.98 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.454 ' SG ' ' O ' ' A' ' 31' ' ' GLN . 85.9 m . . . . . 0 N--CA 1.49 1.549 0 O-C-N 121.294 -0.879 . . . . 0.0 108.955 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.485 ' OD1' HD12 ' A' ' 52' ' ' ILE . 70.3 m-20 . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.5 m -51.27 -30.79 18.97 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.257 -0.902 . . . . 0.0 109.595 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.447 ' HA ' ' HG3' ' A' ' 6' ' ' LYS . 8.3 mt-10 -53.49 -25.55 17.0 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.278 -0.889 . . . . 0.0 109.011 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 63.4 mmm -74.79 -26.38 59.7 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.462 -0.774 . . . . 0.0 109.022 179.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 5.6 m -81.61 -13.92 57.38 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.328 -0.858 . . . . 0.0 109.251 179.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.447 ' HG3' ' HA ' ' A' ' 3' ' ' GLU . 40.5 mttm -54.78 -30.37 56.68 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.294 -0.879 . . . . 0.0 109.84 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 59.2 t0 -150.56 63.69 0.94 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.169 -0.957 . . . . 0.0 109.839 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.786 ' HE2' HD21 ' A' ' 44' ' ' LEU . 9.0 p90 -116.04 175.47 5.53 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.158 -0.963 . . . . 0.0 109.332 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 70.9 mtt180 -148.68 140.07 23.37 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.214 -0.929 . . . . 0.0 109.53 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.85 HG13 ' O ' ' A' ' 15' ' ' GLY . 92.3 t -133.01 139.8 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.365 -0.834 . . . . 0.0 109.349 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.575 HD13 HD12 ' A' ' 14' ' ' ILE . 0.4 OUTLIER -128.13 172.0 7.59 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.26 -0.9 . . . . 0.0 109.262 179.991 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.478 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 45.1 Cg_endo -67.32 -24.78 43.07 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 122.549 2.166 . . . . 0.0 111.439 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 55.6 mtt180 -106.89 -27.69 10.55 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.359 -0.838 . . . . 0.0 109.123 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.575 HD12 HD13 ' A' ' 11' ' ' LEU . 98.1 mt -85.66 -41.92 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.357 -0.839 . . . . 0.0 109.349 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.85 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 71.49 -140.35 30.5 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.464 ' CD2' HG21 ' A' ' 10' ' ' VAL . 3.1 t80 -110.52 151.34 27.69 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.125 -1.221 . . . . 0.0 109.486 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.458 ' HA ' HD23 ' A' ' 17' ' ' LEU . 52.2 mt -111.21 131.24 55.27 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.291 -0.881 . . . . 0.0 109.349 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.46 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 84.6 m -139.64 156.95 70.97 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.207 -0.933 . . . . 0.0 109.596 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.515 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 47.9 Cg_endo -69.81 166.38 27.86 Favored 'Trans proline' 0 C--O 1.215 -0.634 0 C-N-CA 122.666 2.244 . . . . 0.0 111.661 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 52.7 tttp -87.17 -17.62 32.27 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.307 -0.87 . . . . 0.0 109.359 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -66.98 121.73 16.18 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.254 -0.904 . . . . 0.0 109.379 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.755 HD21 ' OD1' ' A' ' 34' ' ' ASN . 3.5 tm? -85.66 125.29 33.05 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.266 -0.896 . . . . 0.0 109.465 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.672 ' N ' HD13 ' A' ' 22' ' ' LEU . 8.8 mtpt -147.49 113.03 4.04 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.254 -0.904 . . . . 0.0 109.739 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.542 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 43.5 Cg_endo -66.14 123.5 11.32 Favored 'Trans proline' 0 C--O 1.214 -0.711 0 C-N-CA 122.973 2.448 . . . . 0.0 111.74 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.49 ' O ' HG23 ' A' ' 32' ' ' THR . 29.8 m -118.54 154.13 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.246 -0.909 . . . . 0.0 109.86 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.408 ' O ' ' N ' ' A' ' 53' ' ' ARG . 45.5 t -97.09 142.16 29.36 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 178.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -99.5 139.28 14.35 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 -179.287 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.496 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 54.9 p30 -64.58 -10.85 29.1 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.357 -1.084 . . . . 0.0 109.52 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.457 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 70.5 m-20 -91.09 12.65 19.23 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.272 -0.893 . . . . 0.0 109.501 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 81.59 15.4 76.0 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.526 ' O ' ' N ' ' A' ' 27' ' ' GLY . 55.6 mt-30 -117.75 155.51 29.87 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.207 -1.173 . . . . 0.0 109.4 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.636 HG21 ' HG3' ' A' ' 57' ' ' LYS . 23.6 m -118.0 146.74 43.81 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.148 -0.97 . . . . 0.0 109.427 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.892 ' CD2' HD12 ' A' ' 39' ' ' LEU . 78.5 m-85 -124.01 128.01 48.74 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.253 -0.904 . . . . 0.0 109.478 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.755 ' OD1' HD21 ' A' ' 22' ' ' LEU . 56.7 t-20 -47.84 -79.95 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.277 -0.89 . . . . 0.0 109.604 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.517 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 3.9 t-20 -81.09 148.63 64.5 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 120.977 -1.077 . . . . 0.0 109.104 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.48 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 39.3 Cg_endo -62.09 -52.66 2.58 Favored 'Trans proline' 0 C--O 1.215 -0.644 0 C-N-CA 122.62 2.213 . . . . 0.0 111.958 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.517 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 4.8 t -60.34 -30.48 69.56 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 120.977 -1.077 . . . . 0.0 108.256 179.005 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.472 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 24.1 mtp -61.64 -18.29 58.86 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.492 -0.755 . . . . 0.0 109.175 179.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.892 HD12 ' CD2' ' A' ' 33' ' ' TYR . 6.7 tt -69.21 -52.74 24.75 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.245 -0.909 . . . . 0.0 108.919 179.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.499 ' O ' ' HB2' ' A' ' 43' ' ' ASN . 4.9 t -49.48 -32.78 12.79 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 179.053 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.476 ' O ' HG12 ' A' ' 45' ' ' ILE . 27.6 t60 -53.96 -48.08 70.66 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.509 -0.922 . . . . 0.0 108.509 179.122 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.587 ' HB2' ' CE1' ' A' ' 33' ' ' TYR . 24.5 tp10 -61.28 -16.84 49.76 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.519 ' OD1' ' N ' ' A' ' 50' ' ' THR . 2.8 m-80 -80.33 -32.8 37.84 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.379 -0.825 . . . . 0.0 109.271 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.786 HD21 ' HE2' ' A' ' 8' ' ' TYR . 7.9 mp -75.69 -31.68 59.81 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.33 -0.856 . . . . 0.0 109.596 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.476 HG12 ' O ' ' A' ' 41' ' ' HIS . 8.9 mm -78.77 -51.32 17.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.229 -0.919 . . . . 0.0 109.531 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.459 ' NH1' ' HG2' ' A' ' 46' ' ' ARG . 15.2 mtt-85 -81.77 -30.78 32.19 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.301 -0.874 . . . . 0.0 109.729 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.443 ' HA ' ' O ' ' A' ' 43' ' ' ASN . 14.6 mt-30 61.62 34.67 17.56 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.265 -0.897 . . . . 0.0 109.474 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.45 ' O ' ' HB2' ' A' ' 49' ' ' ASN . 52.7 p -106.03 2.86 27.65 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.207 -0.933 . . . . 0.0 109.667 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.45 ' HB2' ' O ' ' A' ' 48' ' ' THR . 22.3 m120 64.88 49.82 2.08 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.196 -0.94 . . . . 0.0 109.572 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.519 ' N ' ' OD1' ' A' ' 43' ' ' ASN . 88.4 m -77.77 128.77 34.55 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.264 -0.897 . . . . 0.0 109.465 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 7.3 m-70 -110.72 -173.35 2.22 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.28 -0.888 . . . . 0.0 109.257 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.768 HG12 HD13 ' A' ' 39' ' ' LEU . 22.1 mt -88.31 126.53 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 O-C-N 121.296 -0.877 . . . . 0.0 109.446 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.496 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 31.6 ttt180 -80.42 -40.93 25.45 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.363 -0.836 . . . . 0.0 109.274 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -160.53 151.71 19.12 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.497 -0.752 . . . . 0.0 109.09 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.2 p -67.46 148.42 51.57 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.121 -0.987 . . . . 0.0 109.422 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.542 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 84.6 165.7 40.06 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 -179.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.636 ' HG3' HG21 ' A' ' 32' ' ' THR . 23.2 tttp -57.03 151.54 14.84 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.333 -1.098 . . . . 0.0 109.253 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.469 ' N ' ' HG2' ' A' ' 57' ' ' LYS . 96.6 m -53.51 172.62 0.06 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.202 -0.936 . . . . 0.0 109.33 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.412 ' HG2' ' OG ' ' A' ' 62' ' ' SER . 59.4 tt0 -82.56 9.29 9.66 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.225 -0.922 . . . . 0.0 109.679 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -58.73 -39.54 81.18 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.207 -0.933 . . . . 0.0 109.39 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 82.5 p -55.05 -33.38 62.64 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.279 -0.888 . . . . 0.0 109.505 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.412 ' OG ' ' HG2' ' A' ' 59' ' ' GLU . 22.5 p -62.31 159.36 15.3 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.209 -0.932 . . . . 0.0 109.469 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -61.47 148.19 86.53 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.207 -0.933 . . . . 0.0 109.506 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -70.42 -17.22 34.72 Favored 'Trans proline' 0 C--O 1.216 -0.621 0 C-N-CA 122.693 2.262 . . . . 0.0 111.82 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -85.95 -173.28 49.3 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.712 HG22 ' H ' ' A' ' 68' ' ' ALA . 41.3 m -117.21 140.57 49.37 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.27 -1.135 . . . . 0.0 109.478 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 57.6 p -66.02 -23.8 66.63 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.296 -0.877 . . . . 0.0 109.497 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.712 ' H ' HG22 ' A' ' 66' ' ' THR . . . -61.68 -33.02 73.26 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.226 -0.921 . . . . 0.0 109.51 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.413 ' C ' ' HD2' ' A' ' 72' ' ' PRO . . . -64.6 -26.92 68.61 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.222 -0.924 . . . . 0.0 109.426 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 86.2 p -69.69 -28.46 65.86 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.189 -0.945 . . . . 0.0 109.46 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.497 ' N ' ' HD2' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -49.2 -59.3 6.72 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.228 -0.92 . . . . 0.0 109.495 -179.968 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.497 ' HD2' ' N ' ' A' ' 71' ' ' MET . 50.2 Cg_endo -70.38 146.64 56.94 Favored 'Trans proline' 0 C--O 1.215 -0.653 0 C-N-CA 122.684 2.256 . . . . 0.0 111.827 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -70.4 164.65 34.43 Favored 'Trans proline' 0 C--O 1.215 -0.642 0 C-N-CA 122.637 2.224 . . . . 0.0 111.721 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 50.9 m -136.6 141.9 43.29 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.244 -0.91 . . . . 0.0 109.484 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 49.7 t0 -55.51 -34.11 64.35 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.223 -0.923 . . . . 0.0 109.509 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 118.037 -0.983 . . . . 0.0 109.465 179.966 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.459 ' OD1' ' N ' ' A' ' 1' ' ' ASP . 14.5 p30 . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 121.274 0.559 . . . . 0.0 109.607 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.405 ' O ' ' N ' ' A' ' 5' ' ' CYS . 3.6 m -45.39 -26.86 0.6 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.36 -0.837 . . . . 0.0 109.562 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.452 ' HA ' ' HG3' ' A' ' 6' ' ' LYS . 2.9 tt0 -50.62 -25.14 3.85 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.158 -0.964 . . . . 0.0 108.924 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.726 ' HE3' ' HA ' ' A' ' 37' ' ' CYS . 74.8 mtm -80.45 -22.91 40.64 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.447 -0.783 . . . . 0.0 109.382 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.588 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 3.9 m -92.91 -8.27 43.75 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.237 -0.914 . . . . 0.0 109.629 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.452 ' HG3' ' HA ' ' A' ' 3' ' ' GLU . 56.4 mttt -60.64 -24.65 65.7 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.281 -0.887 . . . . 0.0 109.745 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 59.5 t0 -153.56 63.06 0.74 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.135 -0.978 . . . . 0.0 109.912 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.588 ' CD1' ' HA ' ' A' ' 5' ' ' CYS . 9.2 p90 -122.0 178.59 4.83 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.082 -1.011 . . . . 0.0 109.501 179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 37.5 mtm180 -150.1 144.42 25.72 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.276 -0.89 . . . . 0.0 109.295 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.944 HG13 ' O ' ' A' ' 15' ' ' GLY . 84.1 t -138.94 132.02 38.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.144 -0.972 . . . . 0.0 109.765 -179.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.553 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 2.3 mp -123.39 176.35 2.23 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.402 -0.811 . . . . 0.0 109.11 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.553 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 43.4 Cg_endo -65.57 -24.44 55.94 Favored 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 122.533 2.155 . . . . 0.0 111.733 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 10.5 mtm180 -108.26 -35.3 6.58 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.258 -0.901 . . . . 0.0 109.032 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 86.8 mt -76.55 -35.56 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.372 -0.83 . . . . 0.0 109.194 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.944 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 61.38 -134.56 48.05 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.154 -1.578 . . . . 0.0 109.154 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.528 ' CD2' HG21 ' A' ' 10' ' ' VAL . 3.4 t80 -113.65 155.6 25.21 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.149 -1.207 . . . . 0.0 109.547 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.445 ' HA ' HD12 ' A' ' 17' ' ' LEU . 18.3 tp -112.95 123.29 49.98 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.345 -0.847 . . . . 0.0 109.726 -179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.447 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 67.0 m -138.33 156.64 73.48 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.354 -0.842 . . . . 0.0 109.011 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.449 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 48.7 Cg_endo -70.89 165.95 30.59 Favored 'Trans proline' 0 C--O 1.214 -0.687 0 C-N-CA 122.491 2.127 . . . . 0.0 111.573 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 40.1 mttp -85.51 -17.83 35.26 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.232 -0.918 . . . . 0.0 109.41 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 -71.2 130.86 42.53 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.33 -0.856 . . . . 0.0 109.23 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.719 ' C ' HD13 ' A' ' 22' ' ' LEU . 3.4 tm? -95.05 112.65 24.33 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.147 -0.97 . . . . 0.0 109.588 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.505 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 0.2 OUTLIER -121.72 104.92 38.81 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.322 -0.861 . . . . 0.0 109.202 179.75 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.534 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 41.1 Cg_endo -63.43 117.74 4.68 Favored 'Trans proline' 0 C--O 1.213 -0.752 0 C-N-CA 123.039 2.493 . . . . 0.0 112.03 -179.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.527 ' O ' HG23 ' A' ' 32' ' ' THR . 17.8 m -118.44 156.28 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.4 -0.813 . . . . 0.0 109.805 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.421 ' O ' ' N ' ' A' ' 53' ' ' ARG . 27.4 t -99.06 111.99 24.24 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.307 -0.87 . . . . 0.0 109.299 179.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.497 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -66.21 138.62 36.86 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.521 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 50.8 p30 -69.83 -10.03 56.92 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.303 -1.116 . . . . 0.0 109.539 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.413 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 91.0 m-20 -83.56 5.25 24.83 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.243 -0.911 . . . . 0.0 109.336 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.43 13.12 58.9 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.497 ' O ' ' N ' ' A' ' 27' ' ' GLY . 85.5 mt-30 -122.76 147.79 46.1 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.446 -1.032 . . . . 0.0 109.464 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.527 HG23 ' O ' ' A' ' 25' ' ' VAL . 28.9 m -108.82 141.89 40.2 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.211 -0.93 . . . . 0.0 109.357 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.693 ' CG ' HD12 ' A' ' 39' ' ' LEU . 10.8 m-85 -121.21 131.11 54.04 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.368 -0.833 . . . . 0.0 109.172 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.522 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 1.6 m-20 -53.95 -76.73 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.187 -0.946 . . . . 0.0 109.365 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.538 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 8.0 t-20 -82.17 146.74 55.57 Favored Pre-proline 0 C--N 1.3 -1.572 0 O-C-N 121.06 -1.025 . . . . 0.0 109.554 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.505 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 41.3 Cg_endo -63.46 -52.14 2.13 Favored 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 122.695 2.263 . . . . 0.0 111.858 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.726 ' HA ' ' HE3' ' A' ' 4' ' ' MET . 11.4 t -64.27 -27.46 69.06 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.964 -1.085 . . . . 0.0 108.319 179.104 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.515 ' CG ' ' HB3' ' A' ' 35' ' ' ASN . 31.5 mmm -60.05 -20.66 59.14 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.578 -0.701 . . . . 0.0 109.165 179.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.693 HD12 ' CG ' ' A' ' 33' ' ' TYR . 6.3 tp -67.05 -51.81 50.05 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.307 -0.871 . . . . 0.0 108.883 179.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.486 ' HA ' ' HB2' ' A' ' 43' ' ' ASN . 2.0 t -54.59 -23.05 15.21 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.174 -0.954 . . . . 0.0 108.534 179.194 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 27.5 t60 -60.05 -59.3 5.64 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 179.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.473 ' OE1' ' CE2' ' A' ' 33' ' ' TYR . 53.2 tt0 -65.12 -21.31 66.78 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.519 ' O ' ' N ' ' A' ' 47' ' ' GLN . 87.7 m-20 -77.41 -26.8 52.03 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 28.6 tp -69.83 -33.98 73.03 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.373 -0.829 . . . . 0.0 109.219 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 10.7 mm -80.12 -51.41 16.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.31 -0.869 . . . . 0.0 109.536 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.543 ' HB3' HG23 ' A' ' 48' ' ' THR . 94.3 mtt-85 -80.18 -33.55 38.23 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.288 -0.882 . . . . 0.0 109.729 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.519 ' N ' ' O ' ' A' ' 43' ' ' ASN . 89.8 mt-30 63.96 39.89 7.7 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.308 -0.87 . . . . 0.0 109.434 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.543 HG23 ' HB3' ' A' ' 46' ' ' ARG . 44.2 p -94.52 -6.75 43.04 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.239 -0.913 . . . . 0.0 109.456 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.46 ' HB2' ' O ' ' A' ' 48' ' ' THR . 74.6 m-20 63.03 55.31 1.98 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.289 -0.882 . . . . 0.0 109.476 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 53.7 m -72.11 138.27 47.62 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.186 -0.946 . . . . 0.0 109.51 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 25.4 m-70 -109.62 177.59 4.69 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.325 -0.86 . . . . 0.0 109.204 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.431 HG23 ' HB ' ' A' ' 25' ' ' VAL . 17.7 mt -89.67 124.65 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.224 -0.923 . . . . 0.0 109.777 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.521 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 41.9 ttt180 -80.54 -56.34 4.24 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 121.722 0.772 . . . . 0.0 109.334 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 60.4 p -149.43 147.49 28.32 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 16.0 p -64.27 148.43 50.21 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.221 -0.925 . . . . 0.0 109.381 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.534 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 82.12 163.55 32.6 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.525 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 34.9 mttt -70.47 129.53 39.48 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.439 -1.036 . . . . 0.0 109.457 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -52.15 -32.35 35.42 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.174 -0.954 . . . . 0.0 109.281 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.456 ' HG2' ' O ' ' A' ' 59' ' ' GLU . 83.1 tt0 -81.04 -12.68 59.29 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.366 -0.834 . . . . 0.0 109.36 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.438 ' HB3' ' O ' ' A' ' 57' ' ' LYS . 61.2 tt0 -70.02 -31.49 69.17 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.271 -0.893 . . . . 0.0 109.39 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 32.7 t -83.08 127.82 33.93 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.27 -0.894 . . . . 0.0 109.593 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 98.5 p -111.64 152.63 27.44 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.245 -0.909 . . . . 0.0 109.395 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 45.9 p -65.62 152.27 93.0 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.199 -0.938 . . . . 0.0 109.439 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -69.6 -18.37 37.8 Favored 'Trans proline' 0 C--O 1.215 -0.642 0 C-N-CA 122.716 2.277 . . . . 0.0 111.82 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 91.35 5.79 66.98 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 19.2 p -125.43 161.95 25.93 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.15 -1.206 . . . . 0.0 109.422 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 17.8 p -121.33 163.06 19.23 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.237 -0.914 . . . . 0.0 109.452 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -60.92 -34.36 74.57 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.336 -0.853 . . . . 0.0 109.379 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.1 139.45 56.19 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.298 -0.876 . . . . 0.0 109.376 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 83.8 p -62.1 -27.53 68.99 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.256 -0.902 . . . . 0.0 109.516 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.47 137.82 94.78 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.258 -0.901 . . . . 0.0 109.46 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -70.52 161.16 47.02 Favored 'Trans proline' 0 C--O 1.214 -0.688 0 C-N-CA 122.701 2.267 . . . . 0.0 111.764 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -69.85 158.45 56.81 Favored 'Trans proline' 0 C--O 1.215 -0.642 0 C-N-CA 122.648 2.232 . . . . 0.0 111.748 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 48.9 m -135.94 146.06 46.89 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.223 -0.923 . . . . 0.0 109.459 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 77.6 m-20 -58.31 -33.97 70.06 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.218 -0.926 . . . . 0.0 109.485 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 118.053 -0.975 . . . . 0.0 109.422 179.923 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.403 ' OD1' HG13 ' A' ' 52' ' ' ILE . 37.0 m-20 . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.1 m -61.32 -24.31 66.34 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.245 -0.909 . . . . 0.0 109.641 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.443 ' HA ' ' HG3' ' A' ' 6' ' ' LYS . 1.5 mt-10 -52.99 -22.89 6.24 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.208 -0.932 . . . . 0.0 108.865 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 55.0 mmm -80.29 -34.65 36.73 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.387 -0.82 . . . . 0.0 108.84 179.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.574 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 4.3 m -83.24 -0.92 51.68 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.464 -0.772 . . . . 0.0 109.4 179.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.443 ' HG3' ' HA ' ' A' ' 3' ' ' GLU . 19.9 mttm -68.53 -21.24 64.58 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.24 -0.913 . . . . 0.0 109.605 -179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 52.0 m-20 -150.42 59.63 0.95 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.327 -0.858 . . . . 0.0 109.681 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.703 ' OH ' HD21 ' A' ' 44' ' ' LEU . 6.4 p90 -124.78 173.29 8.68 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.166 -0.959 . . . . 0.0 109.324 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 20.9 ptt-85 -156.0 143.77 19.58 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.259 -0.901 . . . . 0.0 109.383 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.882 HG13 ' O ' ' A' ' 15' ' ' GLY . 58.7 t -130.28 137.76 55.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.327 -0.858 . . . . 0.0 109.38 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.538 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 1.4 mp -119.26 174.4 2.81 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.22 -0.925 . . . . 0.0 109.514 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.538 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 46.3 Cg_endo -68.38 -25.02 36.33 Favored 'Trans proline' 0 C--O 1.215 -0.641 0 C-N-CA 122.602 2.201 . . . . 0.0 111.723 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 52.6 mtt180 -108.37 -25.29 11.07 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.332 -0.855 . . . . 0.0 109.318 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 29.3 mm -85.59 -44.5 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.238 -0.914 . . . . 0.0 109.503 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.882 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 69.33 -144.95 41.77 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.516 ' CE2' HD11 ' A' ' 44' ' ' LEU . 1.2 t80 -104.4 155.96 18.33 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.172 -1.193 . . . . 0.0 109.427 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.651 ' C ' HD13 ' A' ' 17' ' ' LEU . 1.8 tm? -119.12 113.01 20.26 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.262 -0.899 . . . . 0.0 109.622 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.568 ' N ' HD13 ' A' ' 17' ' ' LEU . 61.3 m -127.03 155.84 75.24 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.347 -0.846 . . . . 0.0 109.305 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -70.53 167.67 24.77 Favored 'Trans proline' 0 C--O 1.214 -0.683 0 C-N-CA 122.654 2.236 . . . . 0.0 111.787 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -87.7 -14.56 39.52 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.352 -0.843 . . . . 0.0 109.45 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -72.68 112.88 9.13 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.121 -0.987 . . . . 0.0 109.414 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.417 HD11 ' HB3' ' A' ' 34' ' ' ASN . 56.6 tp -74.53 121.49 21.62 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.11 -0.994 . . . . 0.0 109.449 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.529 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -132.17 100.64 15.42 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.217 -0.927 . . . . 0.0 109.185 179.88 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.532 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 42.6 Cg_endo -64.8 118.74 5.69 Favored 'Trans proline' 0 C--O 1.213 -0.758 0 C-N-CA 122.962 2.441 . . . . 0.0 112.27 -179.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 5.4 m -117.91 156.39 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.284 -0.885 . . . . 0.0 109.784 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.453 ' O ' ' N ' ' A' ' 53' ' ' ARG . 33.8 t -100.41 108.19 20.13 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.33 -0.856 . . . . 0.0 109.287 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -61.77 139.91 46.89 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 -179.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.499 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 54.9 p30 -70.04 -9.01 53.91 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.347 -1.09 . . . . 0.0 109.613 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.423 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 55.0 p30 -83.2 1.54 40.15 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.24 -0.913 . . . . 0.0 109.463 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.33 18.34 36.51 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.131 -1.588 . . . . 0.0 109.131 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.472 ' O ' ' N ' ' A' ' 27' ' ' GLY . 91.1 mt-30 -124.72 165.53 17.79 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.29 -1.124 . . . . 0.0 109.37 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 93.7 m -120.88 133.84 55.3 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.3 -0.875 . . . . 0.0 109.277 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.642 ' CD2' HD12 ' A' ' 39' ' ' LEU . 7.8 m-85 -115.02 118.29 33.01 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.243 -0.911 . . . . 0.0 109.162 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.529 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 5.4 m-20 -43.88 -80.84 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.287 -0.883 . . . . 0.0 109.746 -179.35 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.487 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 13.6 t-20 -81.72 145.61 54.63 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 120.957 -1.089 . . . . 0.0 109.621 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.529 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.3 Cg_endo -63.27 -50.44 3.61 Favored 'Trans proline' 0 C--O 1.215 -0.667 0 C-N-CA 122.66 2.24 . . . . 0.0 111.351 179.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.487 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 5.3 t -61.62 -27.61 68.78 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 178.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.48 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 17.7 mtp -66.12 -18.68 65.5 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.642 HD12 ' CD2' ' A' ' 33' ' ' TYR . 30.0 tp -63.86 -52.82 58.28 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.492 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 4.3 t -59.27 -29.51 67.63 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.454 ' CE1' ' HB2' ' A' ' 16' ' ' TYR . 23.2 t60 -64.49 -59.23 4.57 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 178.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.565 ' OE1' ' CE2' ' A' ' 33' ' ' TYR . 79.6 mt-10 -58.34 -22.77 54.59 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 179.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.492 ' O ' ' N ' ' A' ' 47' ' ' GLN . 94.7 m-20 -73.31 -32.03 64.37 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.703 HD21 ' OH ' ' A' ' 8' ' ' TYR . 55.3 mt -61.38 -31.34 71.24 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 179.197 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.3 mt -80.37 -39.91 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.441 -0.787 . . . . 0.0 109.043 179.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.45 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 62.1 mtt85 -79.51 -24.04 42.53 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.36 -0.837 . . . . 0.0 109.112 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.492 ' N ' ' O ' ' A' ' 43' ' ' ASN . 90.3 mt-30 62.59 42.22 8.73 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.362 -0.836 . . . . 0.0 109.484 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 13.6 t -132.83 164.42 26.89 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.243 -0.911 . . . . 0.0 109.335 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.567 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 84.0 m-20 -94.86 61.21 2.53 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.247 -0.908 . . . . 0.0 109.435 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 86.4 m -66.23 135.63 54.74 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.229 -0.919 . . . . 0.0 109.542 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.567 ' CE1' ' O ' ' A' ' 49' ' ' ASN . 57.5 m80 -110.82 -178.84 3.58 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.286 -0.884 . . . . 0.0 109.249 179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.403 HG13 ' OD1' ' A' ' 1' ' ' ASP . 12.7 mt -89.6 127.13 42.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.1 -1.0 . . . . 0.0 109.742 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.499 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 20.2 ttt180 -80.1 -57.04 3.82 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.439 -0.788 . . . . 0.0 109.258 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 30.9 m -152.4 142.92 22.71 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.407 ' H ' HG23 ' A' ' 55' ' ' THR . 26.0 p -59.62 146.6 40.39 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.123 -0.986 . . . . 0.0 109.689 -179.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.532 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 86.15 162.21 36.42 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.542 ' HB2' ' CB ' ' A' ' 60' ' ' GLU . 67.6 mttt -71.07 124.77 25.16 Favored 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.483 -1.01 . . . . 0.0 109.401 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -47.02 -35.81 7.16 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.227 -0.92 . . . . 0.0 109.626 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.478 ' HG2' ' O ' ' A' ' 59' ' ' GLU . 74.4 tt0 -81.18 -15.78 54.76 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.342 -0.849 . . . . 0.0 109.412 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.542 ' CB ' ' HB2' ' A' ' 57' ' ' LYS . 86.2 tt0 -95.74 120.6 36.29 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.305 -0.872 . . . . 0.0 109.571 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 71.4 p -140.28 150.84 44.55 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.316 -0.865 . . . . 0.0 109.313 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 49.1 m -111.87 146.49 37.63 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.222 -0.924 . . . . 0.0 109.518 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.498 ' O ' ' CB ' ' A' ' 69' ' ' ALA . 5.1 p -135.01 162.82 55.42 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.322 -0.861 . . . . 0.0 109.434 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.456 ' HD2' ' HB ' ' A' ' 63' ' ' THR . 50.7 Cg_endo -70.68 -17.69 33.24 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 122.717 2.278 . . . . 0.0 111.864 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -59.26 -31.49 69.72 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.652 HG22 ' H ' ' A' ' 68' ' ' ALA . 50.5 m -78.91 136.39 37.26 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.232 -1.158 . . . . 0.0 109.521 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 54.4 m -62.87 -28.85 70.31 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.246 -0.909 . . . . 0.0 109.528 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.652 ' H ' HG22 ' A' ' 66' ' ' THR . . . -69.45 -30.77 68.75 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.304 -0.872 . . . . 0.0 109.478 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.498 ' CB ' ' O ' ' A' ' 63' ' ' THR . . . -62.83 -34.54 77.53 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.341 -0.849 . . . . 0.0 109.43 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 85.4 p -60.46 -27.9 67.9 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.216 -0.927 . . . . 0.0 109.469 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 3.2 mtt -124.33 83.67 56.85 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.259 -0.9 . . . . 0.0 109.456 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -70.81 146.75 54.52 Favored 'Trans proline' 0 C--O 1.216 -0.621 0 C-N-CA 122.654 2.236 . . . . 0.0 111.856 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -71.09 145.14 48.79 Favored 'Trans proline' 0 C--O 1.215 -0.634 0 C-N-CA 122.688 2.259 . . . . 0.0 111.729 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 99.2 p -120.49 154.84 34.71 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.162 -0.961 . . . . 0.0 109.576 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 60.6 t0 -85.66 118.81 25.39 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.221 -0.925 . . . . 0.0 109.448 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 117.984 -1.008 . . . . 0.0 109.492 -179.998 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.441 ' OD1' HG13 ' A' ' 52' ' ' ILE . 83.5 m-20 . . . . . 0 N--CA 1.492 1.64 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.429 ' HB2' ' CE1' ' A' ' 51' ' ' HIS . 2.8 m -59.69 -26.44 65.59 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.295 -0.878 . . . . 0.0 109.426 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.455 ' HA ' ' HG3' ' A' ' 6' ' ' LYS . 1.2 mt-10 -54.35 -21.47 9.58 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.182 -0.948 . . . . 0.0 108.986 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 73.8 mtp -77.9 -28.27 49.76 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.363 -0.836 . . . . 0.0 108.964 179.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.587 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 3.7 m -87.43 -8.39 56.56 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.37 -0.831 . . . . 0.0 109.417 179.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.455 ' HG3' ' HA ' ' A' ' 3' ' ' GLU . 40.9 mttt -63.47 -20.09 65.29 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.167 -0.958 . . . . 0.0 109.592 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 -149.73 60.65 1.0 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.26 -0.9 . . . . 0.0 109.673 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.806 ' OH ' HD23 ' A' ' 44' ' ' LEU . 1.7 p90 -133.07 163.29 29.57 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.201 -0.937 . . . . 0.0 109.48 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 92.3 mtt180 -136.18 144.6 45.06 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.223 -0.923 . . . . 0.0 109.508 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.573 HG13 ' O ' ' A' ' 15' ' ' GLY . 53.4 t -141.13 136.24 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.244 -0.91 . . . . 0.0 109.473 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.559 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.2 OUTLIER -125.94 175.32 3.25 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.309 -0.869 . . . . 0.0 109.478 -179.936 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.559 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 45.1 Cg_endo -67.29 -25.9 42.17 Favored 'Trans proline' 0 C--O 1.214 -0.714 0 C-N-CA 122.655 2.237 . . . . 0.0 111.913 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 84.3 mtt-85 -104.86 -26.76 12.09 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.339 -0.85 . . . . 0.0 109.279 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 25.5 mm -82.37 -44.69 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.276 -0.89 . . . . 0.0 109.536 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.573 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 75.17 -156.43 48.82 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.618 ' CE2' ' CE2' ' A' ' 8' ' ' TYR . 2.8 t80 -101.92 154.62 18.78 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.238 -1.154 . . . . 0.0 109.429 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.412 ' HA ' HD12 ' A' ' 17' ' ' LEU . 20.7 tp -107.43 104.82 14.48 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.238 -0.914 . . . . 0.0 109.847 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.43 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 58.9 m -125.39 154.88 72.33 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.275 -0.891 . . . . 0.0 109.159 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -71.21 166.96 27.58 Favored 'Trans proline' 0 C--O 1.216 -0.611 0 C-N-CA 122.7 2.266 . . . . 0.0 111.759 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -82.79 -31.87 28.02 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.317 -0.864 . . . . 0.0 109.416 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -56.88 127.29 31.04 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.214 -0.929 . . . . 0.0 109.47 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.531 HD11 ' HB3' ' A' ' 34' ' ' ASN . 60.6 tp -87.74 117.65 26.72 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.217 -0.927 . . . . 0.0 109.281 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.531 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 19.2 mttt -123.78 99.99 37.96 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.26 -0.9 . . . . 0.0 109.463 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.533 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 42.9 Cg_endo -65.17 116.75 4.03 Favored 'Trans proline' 0 C--O 1.214 -0.712 0 C-N-CA 122.933 2.422 . . . . 0.0 111.901 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.508 ' O ' HG23 ' A' ' 32' ' ' THR . 11.4 m -119.84 156.35 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.254 -0.903 . . . . 0.0 109.976 -179.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.45 ' O ' ' N ' ' A' ' 53' ' ' ARG . 14.2 t -99.94 110.75 23.08 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.341 -0.849 . . . . 0.0 109.203 179.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -65.27 139.26 39.7 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.517 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 51.1 p30 -69.01 -10.61 58.42 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.294 -1.121 . . . . 0.0 109.638 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.441 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 89.6 m-20 -81.28 3.75 22.91 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.19 -0.944 . . . . 0.0 109.3 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.65 16.15 52.92 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.201 -1.56 . . . . 0.0 109.201 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.508 ' O ' ' N ' ' A' ' 27' ' ' GLY . 84.8 mt-30 -125.86 153.45 44.13 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.392 -1.064 . . . . 0.0 109.425 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.516 ' CG2' ' HA ' ' A' ' 57' ' ' LYS . 56.6 m -110.06 142.43 41.52 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.29 -0.881 . . . . 0.0 109.32 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.663 ' CG ' HD12 ' A' ' 39' ' ' LEU . 28.9 m-85 -121.24 119.23 31.67 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.364 -0.835 . . . . 0.0 109.212 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.531 ' HB3' HD11 ' A' ' 22' ' ' LEU . 8.7 m-20 -43.5 -78.82 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.268 -0.895 . . . . 0.0 109.255 -179.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.486 ' O ' ' HB2' ' A' ' 38' ' ' MET . 15.3 t-20 -82.63 145.88 51.9 Favored Pre-proline 0 C--N 1.301 -1.53 0 O-C-N 120.988 -1.07 . . . . 0.0 109.231 179.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.531 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 41.2 Cg_endo -63.66 -49.39 4.32 Favored 'Trans proline' 0 C--O 1.215 -0.67 0 C-N-CA 122.425 2.083 . . . . 0.0 111.493 179.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.484 ' SG ' ' CE1' ' A' ' 16' ' ' TYR . 7.6 t -63.02 -27.64 69.55 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.486 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 29.1 mmm -63.56 -14.66 53.54 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.478 -0.764 . . . . 0.0 109.123 179.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.663 HD12 ' CG ' ' A' ' 33' ' ' TYR . 9.3 tp -69.43 -53.32 19.87 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.242 -0.911 . . . . 0.0 108.881 179.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.499 ' HB3' ' CZ ' ' A' ' 16' ' ' TYR . 8.3 t -52.26 -22.18 4.19 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.187 -0.946 . . . . 0.0 108.451 179.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 53.0 t60 -59.44 -61.41 2.64 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.576 -0.702 . . . . 0.0 109.258 179.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -67.37 -15.43 63.68 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.19 -0.944 . . . . 0.0 108.895 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.522 ' O ' ' N ' ' A' ' 47' ' ' GLN . 98.1 m-20 -78.27 -24.03 47.0 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.379 -0.826 . . . . 0.0 109.012 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.96 HD13 ' O ' ' A' ' 44' ' ' LEU . 3.1 tm? -72.27 -34.67 68.39 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.249 -0.907 . . . . 0.0 108.825 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 8.4 mm -77.57 -49.86 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.372 -0.83 . . . . 0.0 109.132 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.554 ' HB3' HG23 ' A' ' 48' ' ' THR . 53.0 mtt-85 -80.0 -37.26 34.59 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.34 -0.85 . . . . 0.0 109.3 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.522 ' N ' ' O ' ' A' ' 43' ' ' ASN . 92.8 mt-30 63.21 37.01 11.53 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.381 -0.824 . . . . 0.0 109.65 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.554 HG23 ' HB3' ' A' ' 46' ' ' ARG . 43.5 p -100.34 8.85 43.41 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.31 -0.869 . . . . 0.0 109.428 179.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 66.5 m-20 52.77 56.96 6.88 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.26 -0.9 . . . . 0.0 109.52 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 36.7 m -68.02 135.9 53.01 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.254 -0.904 . . . . 0.0 109.39 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.429 ' CE1' ' HB2' ' A' ' 2' ' ' SER . 80.2 m-70 -108.77 178.59 4.43 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.325 -0.859 . . . . 0.0 109.354 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.441 HG13 ' OD1' ' A' ' 1' ' ' ASP . 21.0 mt -88.78 125.75 41.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.134 -0.979 . . . . 0.0 109.655 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.517 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 74.4 ttt-85 -81.69 -57.11 3.59 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.433 -0.792 . . . . 0.0 109.576 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 95.8 p -150.18 139.36 21.21 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -179.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.4 p -55.72 148.88 15.41 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.178 -0.951 . . . . 0.0 109.425 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.533 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 83.61 165.85 39.1 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.516 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 66.2 mttt -74.63 130.97 40.51 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.438 -1.036 . . . . 0.0 109.362 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -55.68 -31.92 62.82 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.088 -1.007 . . . . 0.0 109.361 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 21.3 mt-10 -82.41 -19.9 38.14 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.359 -0.838 . . . . 0.0 108.775 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.482 ' HB3' ' O ' ' A' ' 57' ' ' LYS . 24.3 tt0 -63.79 -16.25 60.74 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 19.1 m -78.32 -31.53 48.83 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.41 -0.806 . . . . 0.0 109.528 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 87.6 p -114.31 149.23 36.32 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.277 -0.889 . . . . 0.0 109.414 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 3.9 p -115.11 80.69 7.25 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.175 -0.953 . . . . 0.0 109.66 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -71.18 141.93 40.65 Favored 'Trans proline' 0 C--O 1.216 -0.601 0 C-N-CA 122.631 2.221 . . . . 0.0 111.679 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -166.5 -170.94 32.04 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 17.9 p -123.44 163.6 20.54 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.301 -1.117 . . . . 0.0 109.43 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.533 HG22 ' H ' ' A' ' 69' ' ' ALA . 37.1 m -115.34 140.64 48.94 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.241 -0.912 . . . . 0.0 109.524 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.56 -34.11 72.28 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.246 -0.909 . . . . 0.0 109.444 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.533 ' H ' HG22 ' A' ' 67' ' ' THR . . . -63.34 136.6 57.76 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.261 -0.9 . . . . 0.0 109.518 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 87.4 p -64.52 -27.67 69.12 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.301 -0.874 . . . . 0.0 109.501 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 3.2 mtt -129.04 82.64 68.23 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.198 -0.939 . . . . 0.0 109.395 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.407 ' HB3' ' HB ' ' A' ' 67' ' ' THR . 51.6 Cg_endo -70.81 154.4 63.6 Favored 'Trans proline' 0 C--O 1.214 -0.687 0 C-N-CA 122.75 2.3 . . . . 0.0 111.902 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -71.36 151.75 60.2 Favored 'Trans proline' 0 C--O 1.214 -0.713 0 C-N-CA 122.712 2.275 . . . . 0.0 111.675 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 31.6 t -136.27 141.74 43.9 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.245 -0.91 . . . . 0.0 109.494 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 50.2 t0 -54.85 -34.76 63.27 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.243 -0.911 . . . . 0.0 109.438 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 118.035 -0.983 . . . . 0.0 109.5 179.97 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 121.273 0.558 . . . . 0.0 109.499 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.482 ' HB2' ' HA ' ' A' ' 51' ' ' HIS . 3.1 m -45.95 -30.81 1.91 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.238 -0.914 . . . . 0.0 109.431 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.452 ' HA ' ' HG3' ' A' ' 6' ' ' LYS . 11.1 mt-10 -51.74 -27.87 13.37 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 84.5 mtp -76.83 -24.72 52.73 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 179.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.471 ' O ' ' HB2' ' A' ' 8' ' ' TYR . 57.8 m -80.05 -14.09 58.8 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.476 -0.765 . . . . 0.0 109.053 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.452 ' HG3' ' HA ' ' A' ' 3' ' ' GLU . 16.9 mttm -45.8 -28.2 1.01 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.288 -0.882 . . . . 0.0 109.307 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -109.98 29.87 7.23 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.316 -0.865 . . . . 0.0 108.947 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.675 ' CZ ' ' CE1' ' A' ' 16' ' ' TYR . 2.2 t80 -79.97 159.13 26.39 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.557 -0.714 . . . . 0.0 109.93 -179.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.3 mtt-85 -149.77 113.82 5.13 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.418 -0.801 . . . . 0.0 108.994 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.939 HG21 ' CD2' ' A' ' 16' ' ' TYR . 77.9 t -118.6 151.93 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.281 -0.887 . . . . 0.0 109.619 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.832 HD23 ' HD2' ' A' ' 12' ' ' PRO . 0.2 OUTLIER -130.03 171.87 8.19 Favored Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 121.303 -0.873 . . . . 0.0 108.991 179.842 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.832 ' HD2' HD23 ' A' ' 11' ' ' LEU . 43.5 Cg_endo -66.25 -22.63 53.18 Favored 'Trans proline' 0 C--O 1.214 -0.692 0 C-N-CA 122.541 2.161 . . . . 0.0 111.729 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -108.55 -26.37 10.45 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.248 -0.908 . . . . 0.0 109.58 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 24.0 mm -80.33 -51.49 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.193 -0.942 . . . . 0.0 109.655 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.89 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 84.12 -166.7 42.74 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.939 ' CD2' HG21 ' A' ' 10' ' ' VAL . 1.8 t80 -99.48 148.68 24.0 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.217 -1.166 . . . . 0.0 109.432 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.746 HD13 ' N ' ' A' ' 18' ' ' CYS . 2.0 tm? -111.94 120.83 43.25 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.258 -0.902 . . . . 0.0 109.564 -179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.746 ' N ' HD13 ' A' ' 17' ' ' LEU . 82.1 m -134.21 156.72 78.8 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.347 -0.846 . . . . 0.0 109.365 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.535 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 49.5 Cg_endo -70.19 167.07 26.05 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 122.726 2.284 . . . . 0.0 111.738 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 64.3 mttm -92.84 -5.77 50.26 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.252 -0.905 . . . . 0.0 109.482 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 57.4 t0 -75.98 110.34 10.36 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.145 -0.972 . . . . 0.0 109.324 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.823 HD21 ' OD1' ' A' ' 34' ' ' ASN . 3.5 tm? -74.21 121.37 21.13 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.348 -0.845 . . . . 0.0 109.466 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.609 ' N ' HD13 ' A' ' 22' ' ' LEU . 1.7 mtpm? -145.88 111.49 4.48 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.248 -0.908 . . . . 0.0 109.528 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.545 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 44.3 Cg_endo -65.71 124.48 12.83 Favored 'Trans proline' 0 C--O 1.213 -0.756 0 C-N-CA 123.049 2.499 . . . . 0.0 112.295 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.5 ' O ' HG23 ' A' ' 32' ' ' THR . 31.7 m -116.44 153.62 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.249 -0.907 . . . . 0.0 109.489 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.411 ' O ' ' N ' ' A' ' 53' ' ' ARG . 45.2 t -99.59 119.49 38.15 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.307 -0.87 . . . . 0.0 109.068 179.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -76.68 139.87 24.31 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.503 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 51.0 p30 -69.8 -11.61 60.99 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.32 -1.106 . . . . 0.0 109.409 179.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.467 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 70.5 m-20 -82.38 7.83 13.04 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.376 -0.828 . . . . 0.0 109.467 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 88.37 12.62 64.84 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 -118.22 170.54 8.79 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.337 -1.096 . . . . 0.0 109.533 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.5 HG23 ' O ' ' A' ' 25' ' ' VAL . 95.1 m -130.22 134.68 47.44 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.337 -0.852 . . . . 0.0 109.258 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.83 ' CD1' HD13 ' A' ' 39' ' ' LEU . 48.3 m-85 -112.68 126.79 55.77 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.168 -0.958 . . . . 0.0 109.346 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.823 ' OD1' HD21 ' A' ' 22' ' ' LEU . 60.1 t-20 -48.76 -80.23 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.356 -0.84 . . . . 0.0 110.023 -179.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.523 ' HB3' ' CG ' ' A' ' 38' ' ' MET . 2.0 t-20 -80.71 149.59 67.97 Favored Pre-proline 0 C--N 1.301 -1.518 0 O-C-N 120.864 -1.148 . . . . 0.0 109.357 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.456 ' HD2' ' CG ' ' A' ' 35' ' ' ASN . 40.1 Cg_endo -62.86 -54.42 1.19 Allowed 'Trans proline' 0 C--O 1.216 -0.614 0 C-N-CA 122.723 2.282 . . . . 0.0 111.876 -179.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.535 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 8.1 t -62.9 -28.52 70.11 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.062 -1.024 . . . . 0.0 108.475 179.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.523 ' CG ' ' HB3' ' A' ' 35' ' ' ASN . 59.2 mmm -62.31 -14.29 37.65 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.83 HD13 ' CD1' ' A' ' 33' ' ' TYR . 25.6 tp -68.49 -51.69 40.51 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.421 -0.799 . . . . 0.0 109.468 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.487 ' HB2' ' OH ' ' A' ' 16' ' ' TYR . 3.1 m -67.97 -17.86 64.56 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 179.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.52 ' CE1' ' HB2' ' A' ' 16' ' ' TYR . 46.7 t60 -73.28 -55.74 6.01 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.1 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.559 ' OE1' ' CE2' ' A' ' 33' ' ' TYR . 87.1 tt0 -63.75 -18.89 64.51 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.247 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.495 ' O ' ' N ' ' A' ' 47' ' ' GLN . 93.4 m-20 -74.77 -36.12 62.56 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.643 HD11 ' HE2' ' A' ' 16' ' ' TYR . 19.3 mt -61.25 -32.44 72.25 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.372 -0.83 . . . . 0.0 108.821 179.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.521 ' N ' HD13 ' A' ' 45' ' ' ILE . 3.6 mm -75.58 -42.75 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.41 -0.806 . . . . 0.0 108.913 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.464 ' NH1' ' HG2' ' A' ' 46' ' ' ARG . 29.0 mtp85 -80.05 -17.67 52.12 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.379 -0.826 . . . . 0.0 109.038 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.495 ' N ' ' O ' ' A' ' 43' ' ' ASN . 87.8 mt-30 62.21 42.92 9.0 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.278 -0.889 . . . . 0.0 109.409 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 15.4 p -127.66 164.96 20.91 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.292 -0.88 . . . . 0.0 109.353 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -102.3 63.6 0.89 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.181 -0.949 . . . . 0.0 109.433 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 49.8 m -75.03 141.83 43.85 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.302 -0.874 . . . . 0.0 109.567 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.482 ' HA ' ' HB2' ' A' ' 2' ' ' SER . 96.5 m-70 -117.87 170.0 9.17 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.311 -0.868 . . . . 0.0 109.049 179.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.455 HG12 HD22 ' A' ' 39' ' ' LEU . 21.1 mt -79.95 123.37 36.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.198 -0.939 . . . . 0.0 109.222 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.503 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 49.7 tpt85 -79.62 -49.03 12.76 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.356 -0.84 . . . . 0.0 109.327 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.3 t -156.03 151.73 27.22 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.466 -0.771 . . . . 0.0 109.21 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 38.8 p -65.24 147.7 52.98 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.172 -0.955 . . . . 0.0 109.218 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.545 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 88.82 165.93 41.73 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 108.986 -1.646 . . . . 0.0 108.986 -179.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.525 ' CG ' ' HB2' ' A' ' 24' ' ' PRO . 89.7 mttt -64.28 161.26 17.01 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.43 -1.041 . . . . 0.0 109.579 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 86.5 m -67.98 -18.99 64.89 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.229 -0.92 . . . . 0.0 109.366 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -80.76 -21.52 40.98 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.389 -0.819 . . . . 0.0 109.211 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.513 ' HG3' ' N ' ' A' ' 57' ' ' LYS . 2.1 mt-10 -74.2 -21.05 59.98 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 93.4 p -76.72 -11.55 59.86 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.591 -0.693 . . . . 0.0 109.36 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 16.6 m -72.5 162.78 29.02 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.338 -0.851 . . . . 0.0 109.503 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 24.1 p -133.16 90.6 30.26 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.225 -0.922 . . . . 0.0 109.421 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -70.63 141.75 42.45 Favored 'Trans proline' 0 C--O 1.215 -0.647 0 C-N-CA 122.772 2.314 . . . . 0.0 111.732 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.86 -173.26 43.14 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 61.6 m -63.05 -27.42 69.39 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.31 -1.112 . . . . 0.0 109.444 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 13.2 t -141.94 158.95 43.17 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.256 -0.902 . . . . 0.0 109.449 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.76 -33.3 75.54 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.195 -0.94 . . . . 0.0 109.508 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.62 139.27 58.63 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.297 -0.877 . . . . 0.0 109.527 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 83.1 p -60.87 -31.68 71.14 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.202 -0.936 . . . . 0.0 109.464 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 18.8 mmt -66.86 148.61 98.78 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.249 -0.907 . . . . 0.0 109.448 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -70.37 159.77 51.81 Favored 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 122.706 2.271 . . . . 0.0 111.8 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -70.39 169.34 19.95 Favored 'Trans proline' 0 C--O 1.215 -0.636 0 C-N-CA 122.735 2.29 . . . . 0.0 111.697 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 20.1 m -89.46 -6.96 56.03 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.225 -0.922 . . . . 0.0 109.587 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -81.04 -21.97 39.69 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.146 -0.971 . . . . 0.0 109.393 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.451 ' OXT' ' HG2' ' A' ' 76' ' ' GLU . 85.2 tt0 . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 118.018 -0.991 . . . . 0.0 109.491 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.457 ' OD1' ' N ' ' A' ' 1' ' ' ASP . 21.8 p-10 . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.307 0.575 . . . . 0.0 109.716 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.484 ' HB2' ' HA ' ' A' ' 51' ' ' HIS . 1.5 m -52.02 -35.39 46.71 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.289 -0.882 . . . . 0.0 109.46 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.422 ' HA ' ' HG3' ' A' ' 6' ' ' LYS . 6.1 mt-10 -49.71 -23.76 1.94 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.281 -0.887 . . . . 0.0 108.779 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 90.4 mtp -75.41 -29.86 59.89 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.492 -0.755 . . . . 0.0 109.015 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.465 ' O ' ' HB2' ' A' ' 8' ' ' TYR . 4.2 m -79.93 -23.46 41.73 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.357 -0.84 . . . . 0.0 109.136 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.422 ' HG3' ' HA ' ' A' ' 3' ' ' GLU . 73.0 mttt -48.45 -24.69 1.35 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.251 -0.906 . . . . 0.0 108.873 179.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -110.14 29.76 7.36 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.465 ' HB2' ' O ' ' A' ' 5' ' ' CYS . 1.6 t80 -85.94 153.79 21.94 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.55 -0.719 . . . . 0.0 109.932 -179.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 8.9 mtm180 -147.02 113.82 6.08 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.424 -0.797 . . . . 0.0 109.293 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.606 HG21 ' N ' ' A' ' 16' ' ' TYR . 4.6 p -130.64 152.26 37.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.328 -0.857 . . . . 0.0 109.12 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.548 ' CG ' ' HD2' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -109.32 171.64 4.28 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.152 -0.968 . . . . 0.0 109.711 -179.676 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.548 ' HD2' ' CG ' ' A' ' 11' ' ' LEU . 47.7 Cg_endo -69.51 -23.32 32.06 Favored 'Trans proline' 0 C--O 1.214 -0.687 0 C-N-CA 122.699 2.266 . . . . 0.0 111.497 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.472 ' HG2' ' O ' ' A' ' 13' ' ' ARG . 23.1 ttt180 -91.82 -16.23 27.08 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.351 -0.843 . . . . 0.0 109.147 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.422 HD13 ' HA ' ' A' ' 14' ' ' ILE . 26.3 mm -99.8 -41.86 9.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.237 -0.915 . . . . 0.0 109.391 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.564 ' C ' HG21 ' A' ' 10' ' ' VAL . . . 69.22 139.69 0.1 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.606 ' N ' HG21 ' A' ' 10' ' ' VAL . 0.9 OUTLIER -44.88 154.8 0.12 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.261 -1.141 . . . . 0.0 109.401 179.984 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.803 ' N ' HD12 ' A' ' 17' ' ' LEU . 0.3 OUTLIER -118.62 128.07 54.19 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.196 -0.94 . . . . 0.0 109.5 179.957 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.419 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 62.8 m -140.02 156.61 70.33 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.374 -0.828 . . . . 0.0 109.065 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -71.38 167.18 27.02 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.548 2.165 . . . . 0.0 111.492 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 33.3 mttp -86.9 -23.5 25.18 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.182 -0.949 . . . . 0.0 109.586 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -62.14 128.63 37.05 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.119 -0.988 . . . . 0.0 109.257 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.437 HD11 ' HB3' ' A' ' 34' ' ' ASN . 27.8 tp -87.49 117.52 26.34 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.158 -0.963 . . . . 0.0 109.619 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.55 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 0.2 OUTLIER -126.94 100.85 26.95 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.383 -0.823 . . . . 0.0 109.063 179.87 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.529 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 43.4 Cg_endo -65.46 117.93 5.02 Favored 'Trans proline' 0 C--O 1.214 -0.714 0 C-N-CA 123.102 2.535 . . . . 0.0 112.246 -179.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.67 ' O ' HG23 ' A' ' 32' ' ' THR . 15.5 m -116.31 154.75 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.359 -0.838 . . . . 0.0 109.568 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 40.3 t -95.97 131.83 41.93 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.368 -0.832 . . . . 0.0 108.803 179.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -90.49 134.63 12.44 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -179.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.506 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 1.5 m-20 -66.1 -9.02 27.23 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.3 -1.118 . . . . 0.0 109.606 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 50.1 p-10 -85.2 13.85 5.87 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.167 -0.958 . . . . 0.0 109.507 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 81.35 22.65 60.16 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.436 ' O ' ' N ' ' A' ' 27' ' ' GLY . 66.7 mt-30 -131.86 174.1 10.5 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.292 -1.122 . . . . 0.0 109.524 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.67 HG23 ' O ' ' A' ' 25' ' ' VAL . 49.5 m -134.52 137.92 44.25 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.348 -0.845 . . . . 0.0 109.192 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.923 ' CD1' HD13 ' A' ' 39' ' ' LEU . 55.1 m-85 -112.08 122.5 47.92 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.237 -0.914 . . . . 0.0 109.452 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.522 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 7.0 m-20 -46.32 -79.55 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.345 -0.847 . . . . 0.0 109.616 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.539 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 7.6 t-20 -81.94 146.73 56.34 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.034 -1.041 . . . . 0.0 109.358 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.55 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.1 Cg_endo -63.03 -52.96 1.78 Allowed 'Trans proline' 0 C--O 1.216 -0.623 0 C-N-CA 122.824 2.349 . . . . 0.0 111.793 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.539 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 7.8 t -60.67 -26.48 67.12 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 178.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.45 ' HB2' ' HB3' ' A' ' 35' ' ' ASN . 33.6 mmm -70.72 -8.37 51.64 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.175 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.923 HD13 ' CD1' ' A' ' 33' ' ' TYR . 21.8 tp -72.89 -56.02 5.78 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.332 -0.855 . . . . 0.0 109.233 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 3.6 m -63.15 -23.25 67.35 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 119.204 -0.998 . . . . 0.0 108.339 179.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.477 ' CE1' ' HB2' ' A' ' 16' ' ' TYR . 49.6 t60 -65.11 -54.66 26.53 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 178.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.438 ' HB2' ' CE2' ' A' ' 33' ' ' TYR . 75.6 mt-10 -66.73 -16.75 64.46 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.111 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.45 ' OD1' ' HB ' ' A' ' 50' ' ' THR . 94.3 m-20 -79.16 -26.53 42.73 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.407 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.974 HD13 ' O ' ' A' ' 44' ' ' LEU . 2.5 tm? -69.72 -35.07 74.72 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.8 mt -76.18 -43.48 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.471 -0.768 . . . . 0.0 109.071 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.443 ' HB3' HG23 ' A' ' 48' ' ' THR . 68.5 mtt85 -79.8 -36.1 37.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.343 -0.848 . . . . 0.0 109.385 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.429 ' N ' ' O ' ' A' ' 43' ' ' ASN . 91.0 mt-30 62.07 40.2 12.28 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.386 -0.821 . . . . 0.0 109.451 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.443 HG23 ' HB3' ' A' ' 46' ' ' ARG . 37.4 p -111.17 15.16 21.68 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.34 -0.85 . . . . 0.0 109.241 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.419 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 70.0 m-20 45.31 58.22 4.3 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.305 -0.872 . . . . 0.0 109.329 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.45 ' HB ' ' OD1' ' A' ' 43' ' ' ASN . 69.9 m -78.15 147.74 34.43 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.269 -0.894 . . . . 0.0 109.557 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.484 ' HA ' ' HB2' ' A' ' 2' ' ' SER . 62.2 m80 -124.63 169.91 11.47 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.258 -0.901 . . . . 0.0 109.209 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.421 HG12 HD22 ' A' ' 39' ' ' LEU . 18.9 mt -79.45 122.31 34.41 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 O-C-N 121.099 -1.001 . . . . 0.0 109.307 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.506 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 59.7 ttt-85 -83.11 -38.62 22.19 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.351 -0.843 . . . . 0.0 109.463 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.4 t -158.37 155.08 28.05 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.373 -0.83 . . . . 0.0 109.2 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.2 p -75.33 132.74 41.18 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.187 -0.945 . . . . 0.0 109.49 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.529 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 98.4 165.15 30.86 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.658 ' HA ' HG21 ' A' ' 32' ' ' THR . 13.2 tttp -50.16 150.39 2.44 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.352 -1.087 . . . . 0.0 109.327 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.433 ' SG ' ' O ' ' A' ' 31' ' ' GLN . 43.2 m -55.91 -27.26 51.33 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.279 -0.888 . . . . 0.0 109.396 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.421 ' O ' ' HG2' ' A' ' 59' ' ' GLU . 54.4 tt0 -88.35 -22.78 23.64 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.346 -0.846 . . . . 0.0 109.243 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 54.2 tt0 -62.76 -35.94 81.43 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.353 -0.842 . . . . 0.0 109.31 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 15.6 m -65.92 -33.36 75.65 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.272 -0.892 . . . . 0.0 109.509 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 50.3 m -62.53 153.01 33.13 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.264 -0.897 . . . . 0.0 109.467 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.628 HG23 ' O ' ' A' ' 63' ' ' THR . 4.6 t -121.5 84.24 41.88 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.273 -0.892 . . . . 0.0 109.465 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -72.09 137.72 29.52 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 122.647 2.231 . . . . 0.0 111.793 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 88.75 -164.47 32.82 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.499 -1.441 . . . . 0.0 109.499 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 18.1 p -128.6 156.83 42.75 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.257 -1.143 . . . . 0.0 109.431 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 51.8 p -62.26 -14.57 40.01 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.254 -0.904 . . . . 0.0 109.517 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -61.43 -27.62 68.68 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.223 -0.923 . . . . 0.0 109.389 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -52.16 145.61 10.33 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.294 -0.879 . . . . 0.0 109.563 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 34.8 m -67.77 -26.24 66.01 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.236 -0.915 . . . . 0.0 109.353 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.42 81.3 49.4 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.288 -0.883 . . . . 0.0 109.32 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -70.04 149.65 65.42 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 122.73 2.287 . . . . 0.0 111.919 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -71.47 -19.44 28.55 Favored 'Trans proline' 0 C--O 1.215 -0.669 0 C-N-CA 122.699 2.266 . . . . 0.0 111.684 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 25.9 t -132.12 137.33 47.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.279 -0.888 . . . . 0.0 109.485 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -55.31 -36.7 66.48 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.149 -0.97 . . . . 0.0 109.447 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 118.029 -0.986 . . . . 0.0 109.48 -179.899 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.454 ' OG ' ' HA ' ' A' ' 51' ' ' HIS . 4.6 m -52.08 -25.56 8.98 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.237 -0.915 . . . . 0.0 109.456 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.446 ' HA ' ' HG3' ' A' ' 6' ' ' LYS . 2.4 tt0 -52.35 -24.72 8.1 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.263 -0.898 . . . . 0.0 109.158 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.443 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 74.5 mtp -72.2 -29.25 63.8 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.436 -0.79 . . . . 0.0 109.391 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.49 ' O ' ' HB2' ' A' ' 8' ' ' TYR . 11.5 m -85.65 -17.85 34.92 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.288 -0.883 . . . . 0.0 109.278 179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.446 ' HG3' ' HA ' ' A' ' 3' ' ' GLU . 27.2 mttt -50.47 -24.34 3.06 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.218 -0.926 . . . . 0.0 108.941 179.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.443 ' OD1' ' O ' ' A' ' 4' ' ' MET . 55.9 p30 -112.97 32.65 5.55 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 179.227 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.49 ' HB2' ' O ' ' A' ' 5' ' ' CYS . 5.4 t80 -80.13 162.14 24.91 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 121.535 0.683 . . . . 0.0 110.225 -179.228 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 10.9 mtm180 -144.16 116.5 8.52 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.941 HG13 ' C ' ' A' ' 15' ' ' GLY . 53.3 t -112.17 139.11 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.143 -0.973 . . . . 0.0 109.684 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.691 HD23 ' HD2' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -119.92 172.7 4.27 Favored Pre-proline 0 N--CA 1.488 1.466 0 O-C-N 121.481 -0.762 . . . . 0.0 109.091 179.866 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.691 ' HD2' HD23 ' A' ' 11' ' ' LEU . 44.3 Cg_endo -66.85 -23.05 48.24 Favored 'Trans proline' 0 C--O 1.214 -0.678 0 C-N-CA 122.579 2.186 . . . . 0.0 111.729 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.425 ' HG2' ' O ' ' A' ' 13' ' ' ARG . 61.1 ttt-85 -110.5 -22.98 11.39 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.309 -0.869 . . . . 0.0 109.292 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.553 HD12 HD13 ' A' ' 11' ' ' LEU . 82.9 mt -89.43 -41.67 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.381 -0.825 . . . . 0.0 109.474 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.941 ' C ' HG13 ' A' ' 10' ' ' VAL . . . 62.04 -146.67 49.1 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.521 ' HD1' HG21 ' A' ' 10' ' ' VAL . 1.4 t80 -100.6 148.46 24.81 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.316 -1.108 . . . . 0.0 109.566 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.477 HD23 ' HA ' ' A' ' 17' ' ' LEU . 53.8 mt -118.43 128.88 55.03 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.376 -0.827 . . . . 0.0 109.557 179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.45 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 79.1 m -139.0 157.2 71.87 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.312 -0.868 . . . . 0.0 109.254 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.486 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 47.4 Cg_endo -69.49 166.69 26.41 Favored 'Trans proline' 0 C--O 1.214 -0.695 0 C-N-CA 122.592 2.195 . . . . 0.0 111.455 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -87.76 -16.02 35.35 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.207 -0.933 . . . . 0.0 109.502 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -69.91 118.01 12.21 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.199 -0.938 . . . . 0.0 109.074 179.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 60.3 tp -84.51 122.39 28.94 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.174 -0.954 . . . . 0.0 109.82 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.49 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 0.3 OUTLIER -139.91 110.81 7.29 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.276 -0.89 . . . . 0.0 109.039 179.649 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.535 ' HA ' ' O ' ' A' ' 34' ' ' ASN . 42.2 Cg_endo -64.82 122.98 10.98 Favored 'Trans proline' 0 C--O 1.213 -0.747 0 C-N-CA 122.996 2.464 . . . . 0.0 112.496 -179.23 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.512 ' O ' HG23 ' A' ' 32' ' ' THR . 32.9 m -118.56 155.16 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.45 -0.781 . . . . 0.0 109.681 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.416 ' O ' ' N ' ' A' ' 53' ' ' ARG . 42.5 t -100.54 117.7 35.21 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.327 -0.858 . . . . 0.0 108.991 179.219 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -73.63 138.28 24.71 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 -179.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.497 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 53.1 p30 -67.74 -11.1 57.67 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.249 -1.148 . . . . 0.0 109.473 179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.461 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 58.5 p30 -82.94 8.68 11.93 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.292 -0.88 . . . . 0.0 109.402 179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.09 13.94 65.34 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.473 ' O ' ' N ' ' A' ' 27' ' ' GLY . 92.1 mt-30 -119.56 167.04 12.38 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.27 -1.135 . . . . 0.0 109.461 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.533 ' CG2' ' HA ' ' A' ' 57' ' ' LYS . 90.6 m -126.11 140.47 52.55 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.272 -0.893 . . . . 0.0 109.265 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.845 ' HD2' HD12 ' A' ' 39' ' ' LEU . 59.5 m-85 -118.85 126.24 51.36 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.228 -0.92 . . . . 0.0 109.327 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.535 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 5.9 m-20 -49.77 -75.94 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.21 -0.931 . . . . 0.0 109.397 -179.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.531 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 4.6 t-20 -82.04 148.57 60.75 Favored Pre-proline 0 C--N 1.299 -1.6 0 O-C-N 121.105 -0.997 . . . . 0.0 109.527 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.49 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.0 Cg_endo -62.99 -53.35 1.62 Allowed 'Trans proline' 0 C--O 1.216 -0.619 0 C-N-CA 122.603 2.202 . . . . 0.0 111.728 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.531 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 4.5 t -60.64 -27.63 67.94 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 120.961 -1.087 . . . . 0.0 108.156 179.025 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.475 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 52.6 mmm -65.28 -20.08 66.25 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.845 HD12 ' HD2' ' A' ' 33' ' ' TYR . 6.6 tt -68.42 -51.84 39.44 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.287 -0.883 . . . . 0.0 108.788 179.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.51 ' HA ' ' ND2' ' A' ' 43' ' ' ASN . 64.0 m -51.22 -27.99 10.35 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.142 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.419 ' O ' HG13 ' A' ' 45' ' ' ILE . 28.2 t60 -58.63 -47.5 84.18 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.6 ' HB2' ' CE1' ' A' ' 33' ' ' TYR . 26.9 tp10 -60.36 -17.17 41.56 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 179.116 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.527 ' OD1' ' N ' ' A' ' 50' ' ' THR . 3.5 m-80 -80.07 -34.91 37.75 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.405 -0.81 . . . . 0.0 108.927 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.966 HD13 ' O ' ' A' ' 44' ' ' LEU . 2.6 tm? -70.27 -35.79 74.0 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.349 -0.844 . . . . 0.0 109.34 179.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.419 HG13 ' O ' ' A' ' 41' ' ' HIS . 2.8 mt -76.11 -53.22 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.302 -0.874 . . . . 0.0 109.678 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.449 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 49.8 mtp180 -80.37 -34.51 36.41 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.224 -0.923 . . . . 0.0 109.89 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.498 ' N ' ' O ' ' A' ' 43' ' ' ASN . 90.4 mt-30 62.32 35.17 15.31 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.215 -0.928 . . . . 0.0 109.547 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.427 ' O ' ' HB2' ' A' ' 49' ' ' ASN . 72.3 p -105.64 7.78 32.84 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.195 -0.941 . . . . 0.0 109.623 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.427 ' HB2' ' O ' ' A' ' 48' ' ' THR . 20.5 m120 64.23 49.82 2.52 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.254 -0.904 . . . . 0.0 109.391 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.527 ' N ' ' OD1' ' A' ' 43' ' ' ASN . 63.6 m -76.76 132.53 39.32 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.251 -0.906 . . . . 0.0 109.378 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.454 ' HA ' ' OG ' ' A' ' 2' ' ' SER . 15.2 m-70 -115.21 -174.83 2.57 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.282 -0.886 . . . . 0.0 109.521 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.693 HG12 HD13 ' A' ' 39' ' ' LEU . 16.4 mt -86.68 124.77 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.324 -0.86 . . . . 0.0 109.678 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.497 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 75.8 ttt-85 -80.08 -54.73 5.5 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.525 -0.735 . . . . 0.0 109.503 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 77.7 p -151.87 138.95 19.15 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.716 -0.615 . . . . 0.0 109.357 -179.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 8.0 p -54.35 148.93 10.82 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.189 -0.944 . . . . 0.0 109.412 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.528 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 88.51 166.66 42.5 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.274 -1.53 . . . . 0.0 109.274 -179.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.533 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 27.1 mttt -66.32 143.37 57.22 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.376 -1.073 . . . . 0.0 109.562 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.413 ' C ' ' O ' ' A' ' 57' ' ' LYS . 66.9 m -44.61 -34.47 2.18 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.278 -0.889 . . . . 0.0 109.47 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -81.2 -36.11 30.5 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.334 -0.854 . . . . 0.0 109.208 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.454 ' OE1' ' CA ' ' A' ' 56' ' ' GLY . 35.6 tt0 -56.84 -21.98 33.27 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.325 -0.859 . . . . 0.0 108.87 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 16.5 m -65.58 -34.31 77.94 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.434 -0.791 . . . . 0.0 109.539 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 91.0 p -119.34 155.95 30.95 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.12 -0.987 . . . . 0.0 109.501 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.1 m 62.16 70.65 0.8 Allowed Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.27 -0.894 . . . . 0.0 109.644 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -70.38 145.77 54.49 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 122.648 2.232 . . . . 0.0 111.767 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -82.48 179.32 53.17 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.79 HG22 ' H ' ' A' ' 68' ' ' ALA . 50.0 m -122.43 142.48 50.5 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.245 -1.15 . . . . 0.0 109.465 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 60.4 p -70.08 -20.31 63.22 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.253 -0.905 . . . . 0.0 109.345 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.79 ' H ' HG22 ' A' ' 66' ' ' THR . . . -63.8 -32.03 73.4 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.261 -0.899 . . . . 0.0 109.379 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.22 144.78 55.07 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.235 -0.916 . . . . 0.0 109.437 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.2 t -51.96 -29.38 20.21 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.18 -0.95 . . . . 0.0 109.475 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 2.6 ttp 47.56 70.7 1.92 Allowed Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.208 -0.932 . . . . 0.0 109.498 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -70.21 153.01 67.24 Favored 'Trans proline' 0 C--O 1.215 -0.674 0 C-N-CA 122.76 2.306 . . . . 0.0 111.82 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -70.14 155.34 64.92 Favored 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 122.564 2.176 . . . . 0.0 111.666 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 83.1 p -81.23 -10.31 59.63 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.288 -0.883 . . . . 0.0 109.528 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.436 ' O ' ' O ' ' A' ' 76' ' ' GLU . 88.1 m-20 -68.13 -31.48 71.1 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.244 -0.91 . . . . 0.0 109.377 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.436 ' O ' ' O ' ' A' ' 75' ' ' ASP . 81.8 tt0 . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 118.054 -0.974 . . . . 0.0 109.41 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 . . . . . 0 N--CA 1.489 1.492 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.537 ' HB2' ' CD2' ' A' ' 51' ' ' HIS . 5.0 m -56.19 -34.35 66.16 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.304 -0.873 . . . . 0.0 109.537 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -54.75 -24.63 23.24 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.33 -0.856 . . . . 0.0 109.101 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 56.5 mmm -73.06 -24.33 60.67 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.343 -0.848 . . . . 0.0 108.909 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.598 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 59.2 m -80.12 -21.3 43.36 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.422 -0.799 . . . . 0.0 109.284 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 42.1 mttp -80.69 11.74 3.62 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.331 -0.856 . . . . 0.0 109.786 -179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -132.75 -1.82 3.37 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.023 -1.048 . . . . 0.0 110.181 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.598 ' CD1' ' HA ' ' A' ' 5' ' ' CYS . 1.6 p90 -114.24 156.56 24.09 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.868 -1.145 . . . . 0.0 109.98 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 31.8 mtm105 -137.16 133.86 35.71 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.351 -0.843 . . . . 0.0 109.202 179.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.848 HG13 ' O ' ' A' ' 15' ' ' GLY . 75.7 t -117.65 142.61 31.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.189 -0.944 . . . . 0.0 109.8 -179.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.596 ' HB2' HD12 ' A' ' 14' ' ' ILE . 0.4 OUTLIER -126.02 175.45 3.17 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.366 -0.834 . . . . 0.0 109.159 179.946 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.558 ' HD2' ' CG ' ' A' ' 11' ' ' LEU . 43.9 Cg_endo -67.22 -22.24 46.96 Favored 'Trans proline' 0 C--O 1.214 -0.679 0 C-N-CA 122.557 2.171 . . . . 0.0 111.672 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 89.7 mtt180 -103.69 -29.28 11.17 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.298 -0.876 . . . . 0.0 109.56 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.596 HD12 ' HB2' ' A' ' 11' ' ' LEU . 89.2 mt -80.04 -49.64 18.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.244 -0.91 . . . . 0.0 109.497 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.848 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 82.15 -163.63 43.45 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.558 ' CD1' HG21 ' A' ' 10' ' ' VAL . 0.9 OUTLIER -92.86 151.84 19.75 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.285 -1.126 . . . . 0.0 109.444 -179.973 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 26.0 tp -127.67 116.08 19.73 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.198 -0.939 . . . . 0.0 109.816 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.444 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 77.4 m -129.86 157.36 77.03 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.281 -0.887 . . . . 0.0 109.035 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.537 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 49.4 Cg_endo -70.94 167.96 24.47 Favored 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 122.558 2.172 . . . . 0.0 111.44 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 24.5 mttp -94.8 -6.13 43.62 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.191 -0.943 . . . . 0.0 109.585 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.46 ' OD2' ' HE2' ' A' ' 23' ' ' LYS . 58.6 t0 -76.09 117.4 17.76 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.198 -0.939 . . . . 0.0 109.253 179.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.754 HD21 ' OD1' ' A' ' 34' ' ' ASN . 3.2 tm? -78.4 122.5 25.88 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.234 -0.916 . . . . 0.0 109.706 -179.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.686 ' N ' HD13 ' A' ' 22' ' ' LEU . 5.2 mttt -142.2 104.01 5.61 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.404 -0.81 . . . . 0.0 109.22 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.542 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 42.6 Cg_endo -65.09 120.86 8.17 Favored 'Trans proline' 0 C--O 1.213 -0.756 0 C-N-CA 123.056 2.504 . . . . 0.0 112.036 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 24.5 m -116.65 155.0 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.321 -0.862 . . . . 0.0 110.005 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.461 ' O ' ' N ' ' A' ' 53' ' ' ARG . 28.0 t -99.67 108.64 21.05 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.475 -0.766 . . . . 0.0 109.319 179.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -62.61 138.79 44.99 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.51 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 57.1 p30 -68.86 -10.31 56.25 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.258 -1.143 . . . . 0.0 109.482 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.452 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 90.0 m-20 -84.0 4.93 27.67 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.18 -0.95 . . . . 0.0 109.409 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.51 13.45 58.35 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.223 -1.551 . . . . 0.0 109.223 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.508 ' O ' ' N ' ' A' ' 27' ' ' GLY . 93.5 mt-30 -117.95 160.53 21.29 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.321 -1.106 . . . . 0.0 109.497 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 57.4 m -116.99 130.23 56.55 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.244 -0.91 . . . . 0.0 109.24 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.701 ' CD1' HD13 ' A' ' 39' ' ' LEU . 65.8 m-85 -111.25 119.36 38.65 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.273 -0.892 . . . . 0.0 109.157 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.754 ' OD1' HD21 ' A' ' 22' ' ' LEU . 51.2 t-20 -46.31 -80.44 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.399 -0.813 . . . . 0.0 110.092 -179.363 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.528 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 1.9 t-20 -81.03 150.0 67.72 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.003 -1.061 . . . . 0.0 109.722 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.506 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.9 Cg_endo -63.97 -55.23 0.68 Allowed 'Trans proline' 0 C--O 1.216 -0.612 0 C-N-CA 122.756 2.304 . . . . 0.0 111.818 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.537 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 10.8 t -60.92 -30.45 70.21 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 120.91 -1.119 . . . . 0.0 108.17 178.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.487 ' CG ' ' HB3' ' A' ' 35' ' ' ASN . 52.5 mmm -60.11 -17.73 42.19 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.701 HD13 ' CD1' ' A' ' 33' ' ' TYR . 33.5 tp -68.5 -58.27 4.57 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 179.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.456 ' SG ' ' OH ' ' A' ' 16' ' ' TYR . 8.1 t -56.38 -24.08 42.1 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 178.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 30.0 t60 -70.63 -62.81 1.25 Allowed 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 179.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.482 ' OE1' ' CE2' ' A' ' 33' ' ' TYR . 78.6 mt-10 -55.47 -21.87 18.25 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.176 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.511 ' O ' ' N ' ' A' ' 47' ' ' GLN . 98.7 m-20 -73.65 -35.88 65.32 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 179.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.931 HD13 ' O ' ' A' ' 44' ' ' LEU . 2.0 tm? -62.61 -37.33 85.86 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.399 -0.813 . . . . 0.0 109.005 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.9 mt -71.82 -42.13 69.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.386 -0.821 . . . . 0.0 109.113 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.451 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 12.8 mtt-85 -79.84 -22.3 43.14 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.36 -0.838 . . . . 0.0 109.174 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.511 ' N ' ' O ' ' A' ' 43' ' ' ASN . 92.5 mt-30 63.3 44.68 5.41 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.316 -0.865 . . . . 0.0 109.475 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 21.9 p -128.02 169.88 13.53 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.373 -0.83 . . . . 0.0 109.413 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.571 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 43.9 t30 -102.7 64.84 0.89 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.233 -0.917 . . . . 0.0 109.304 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 33.9 m -74.83 147.32 41.26 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.338 -0.851 . . . . 0.0 109.613 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.571 ' CE1' ' O ' ' A' ' 49' ' ' ASN . 51.4 m80 -122.77 -173.65 2.75 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.383 -0.823 . . . . 0.0 109.263 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 11.3 mt -95.82 124.07 48.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.137 -0.977 . . . . 0.0 109.531 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.51 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 72.3 ttt-85 -80.04 -56.0 4.55 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 121.622 0.725 . . . . 0.0 109.558 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 88.7 p -153.95 139.22 17.53 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.45 ' H ' HG23 ' A' ' 55' ' ' THR . 6.5 p -56.56 148.49 19.51 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.116 -0.99 . . . . 0.0 109.349 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.542 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 82.66 161.39 29.93 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.382 -1.487 . . . . 0.0 109.382 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.526 ' HG3' ' HB2' ' A' ' 24' ' ' PRO . 26.1 mttp -68.36 131.75 45.86 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.558 -0.966 . . . . 0.0 109.535 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -55.01 -34.32 63.37 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.198 -0.939 . . . . 0.0 109.475 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.472 ' HG2' ' O ' ' A' ' 59' ' ' GLU . 78.9 tt0 -81.67 -15.74 53.57 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.312 -0.868 . . . . 0.0 109.462 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.486 ' HB2' ' HB2' ' A' ' 57' ' ' LYS . 51.9 tt0 -73.43 -30.16 63.04 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.219 -0.925 . . . . 0.0 109.29 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.9 m -63.11 -31.15 72.23 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.317 -0.864 . . . . 0.0 109.434 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 49.9 m -115.28 146.72 41.22 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.271 -0.893 . . . . 0.0 109.577 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.402 ' HB ' ' HD2' ' A' ' 64' ' ' PRO . 20.3 p -70.05 159.68 83.41 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.311 -0.868 . . . . 0.0 109.287 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.402 ' HD2' ' HB ' ' A' ' 63' ' ' THR . 48.8 Cg_endo -69.92 -17.38 36.88 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 122.704 2.269 . . . . 0.0 111.721 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -147.34 171.69 27.92 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.409 -1.476 . . . . 0.0 109.409 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 19.2 p -121.82 157.45 31.06 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.251 -1.146 . . . . 0.0 109.388 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 59.9 m -65.7 -28.26 68.94 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.293 -0.879 . . . . 0.0 109.536 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.454 ' O ' ' HB3' ' A' ' 71' ' ' MET . . . -65.31 -36.97 85.7 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.228 -0.92 . . . . 0.0 109.463 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.409 ' C ' ' O ' ' A' ' 68' ' ' ALA . . . 44.17 -151.37 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.267 -0.896 . . . . 0.0 109.475 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 83.8 p -54.88 -31.31 59.72 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.209 -0.932 . . . . 0.0 109.557 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.517 ' CG ' ' HD2' ' A' ' 72' ' ' PRO . 6.3 ttm -57.68 143.12 76.67 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.302 -0.874 . . . . 0.0 109.457 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.517 ' HD2' ' CG ' ' A' ' 71' ' ' MET . 49.3 Cg_endo -69.75 153.48 68.94 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 122.691 2.261 . . . . 0.0 111.806 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -70.65 158.01 57.02 Favored 'Trans proline' 0 C--O 1.214 -0.691 0 C-N-CA 122.63 2.22 . . . . 0.0 111.754 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 86.2 p -82.72 -9.18 59.47 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.3 -0.875 . . . . 0.0 109.593 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.484 ' OD1' ' N ' ' A' ' 76' ' ' GLU . 39.7 p30 -73.6 -15.75 61.26 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.178 -0.951 . . . . 0.0 109.416 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.484 ' N ' ' OD1' ' A' ' 75' ' ' ASP . 83.3 tt0 . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 118.048 -0.977 . . . . 0.0 109.414 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.445 ' OD1' ' HB2' ' A' ' 3' ' ' GLU . 7.0 p30 . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.311 0.577 . . . . 0.0 109.496 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.6 m -46.48 -28.71 1.47 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.273 -0.892 . . . . 0.0 109.479 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.445 ' HB2' ' OD1' ' A' ' 1' ' ' ASP . 1.5 tt0 -51.87 -25.86 8.84 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.198 -0.939 . . . . 0.0 108.946 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 75.6 mtp -80.04 -21.06 43.92 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.486 -0.759 . . . . 0.0 109.115 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.584 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 3.4 m -91.95 -12.45 33.37 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.364 -0.835 . . . . 0.0 109.632 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.441 ' HG3' ' HA ' ' A' ' 3' ' ' GLU . 23.4 mttm -57.37 -25.07 58.9 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.276 -0.89 . . . . 0.0 109.721 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 61.5 t0 -152.69 64.45 0.8 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.108 -0.995 . . . . 0.0 109.776 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.997 ' OH ' HD23 ' A' ' 44' ' ' LEU . 4.5 p90 -126.42 169.01 13.42 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.169 -0.957 . . . . 0.0 109.324 179.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 79.9 mtt180 -142.56 145.98 34.16 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.202 -0.936 . . . . 0.0 109.496 -179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.732 HG13 ' C ' ' A' ' 15' ' ' GLY . 90.8 t -140.32 134.53 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.266 -0.896 . . . . 0.0 109.471 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.551 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 1.1 mp -123.34 176.08 2.38 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.289 -0.882 . . . . 0.0 109.251 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.551 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 45.4 Cg_endo -67.51 -27.24 39.59 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 122.547 2.165 . . . . 0.0 111.514 179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 71.3 mtt-85 -104.06 -29.77 10.68 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.292 -0.88 . . . . 0.0 109.005 179.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.43 ' HA ' HD13 ' A' ' 14' ' ' ILE . 26.7 mm -81.79 -41.26 18.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.429 -0.794 . . . . 0.0 109.519 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.732 ' C ' HG13 ' A' ' 10' ' ' VAL . . . 64.78 -147.06 50.82 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.474 ' CE2' ' CE2' ' A' ' 8' ' ' TYR . 1.5 t80 -104.98 151.75 23.55 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.244 -1.151 . . . . 0.0 109.538 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.425 ' HA ' HD12 ' A' ' 17' ' ' LEU . 24.3 tp -104.9 109.41 21.37 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.245 -0.909 . . . . 0.0 109.476 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 63.6 m -129.24 156.43 78.36 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.325 -0.859 . . . . 0.0 109.371 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -72.04 172.6 14.37 Favored 'Trans proline' 0 C--O 1.215 -0.673 0 C-N-CA 122.663 2.242 . . . . 0.0 111.567 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 20.4 tttm -89.51 -15.58 32.67 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.18 -0.95 . . . . 0.0 109.393 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 36.9 t0 -73.4 108.9 6.53 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.305 -0.872 . . . . 0.0 109.496 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.674 ' C ' HD13 ' A' ' 22' ' ' LEU . 3.5 tm? -77.79 109.72 12.04 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.221 -0.924 . . . . 0.0 109.258 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.502 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 7.1 mtmt -120.49 106.84 39.58 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.313 -0.867 . . . . 0.0 109.308 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.547 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 41.4 Cg_endo -63.44 120.54 8.0 Favored 'Trans proline' 0 C--O 1.213 -0.743 0 C-N-CA 123.151 2.567 . . . . 0.0 112.376 -179.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.615 ' O ' HG23 ' A' ' 32' ' ' THR . 18.3 m -115.58 155.52 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.228 -0.92 . . . . 0.0 109.744 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 39.9 t -98.04 115.54 28.43 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.335 -0.853 . . . . 0.0 109.319 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -70.83 138.84 29.0 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.52 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 53.2 t0 -70.92 -9.44 57.8 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.281 -1.129 . . . . 0.0 109.654 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 58.5 p30 -85.72 8.58 19.24 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.11 -0.994 . . . . 0.0 109.253 179.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.31 9.63 66.9 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.511 ' O ' ' N ' ' A' ' 27' ' ' GLY . 69.6 mt-30 -118.14 156.64 28.35 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.329 -1.101 . . . . 0.0 109.317 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.623 HG21 ' HA ' ' A' ' 57' ' ' LYS . 33.5 m -116.9 151.88 35.68 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.212 -0.93 . . . . 0.0 109.293 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.841 ' CD1' HD13 ' A' ' 39' ' ' LEU . 73.7 m-85 -129.77 131.06 46.12 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.197 -0.939 . . . . 0.0 109.239 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.539 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 2.7 m-20 -53.21 -79.38 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.288 -0.882 . . . . 0.0 109.636 -179.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.521 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 13.2 t-20 -82.64 145.69 51.45 Favored Pre-proline 0 C--N 1.3 -1.555 0 O-C-N 120.893 -1.13 . . . . 0.0 109.826 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.502 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.3 Cg_endo -63.63 -51.13 2.66 Favored 'Trans proline' 0 C--O 1.214 -0.689 0 C-N-CA 122.67 2.247 . . . . 0.0 111.278 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.521 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 5.6 t -60.44 -29.78 69.23 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 178.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.447 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 35.9 mmm -66.29 -10.87 46.77 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 179.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.841 HD13 ' CD1' ' A' ' 33' ' ' TYR . 52.0 tp -69.24 -55.28 11.03 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.286 -0.884 . . . . 0.0 108.822 179.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.442 ' HA ' ' HB2' ' A' ' 43' ' ' ASN . 11.5 t -54.85 -29.6 55.58 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 179.085 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 32.5 t60 -60.15 -60.92 3.05 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.452 ' HA ' ' OE1' ' A' ' 42' ' ' GLU . 68.8 mm-40 -58.86 -22.61 59.49 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 179.057 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.508 ' O ' ' N ' ' A' ' 47' ' ' GLN . 98.5 m-20 -75.97 -23.2 55.32 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.997 HD23 ' OH ' ' A' ' 8' ' ' TYR . 2.0 tm? -72.4 -36.63 68.69 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.32 -0.862 . . . . 0.0 108.797 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.528 ' N ' HD13 ' A' ' 45' ' ' ILE . 3.8 mm -76.31 -41.96 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.428 -0.795 . . . . 0.0 109.154 179.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.462 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 21.1 mtt-85 -83.07 -40.2 20.18 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.41 -0.807 . . . . 0.0 109.482 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.508 ' N ' ' O ' ' A' ' 43' ' ' ASN . 89.8 mt-30 63.54 43.44 5.85 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.48 -0.763 . . . . 0.0 109.482 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 72.2 p -113.01 18.75 17.83 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.248 -0.908 . . . . 0.0 109.334 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 54.7 m-20 44.76 58.71 3.77 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.274 -0.891 . . . . 0.0 109.465 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.475 ' HB ' ' OD1' ' A' ' 43' ' ' ASN . 21.1 m -75.22 145.28 42.13 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.15 -0.969 . . . . 0.0 109.744 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 29.4 m-70 -118.69 171.77 7.97 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.302 -0.874 . . . . 0.0 108.981 179.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.481 HG23 ' HB ' ' A' ' 25' ' ' VAL . 20.2 mt -84.15 124.49 39.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.105 -0.997 . . . . 0.0 109.574 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.52 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 37.1 ttt180 -79.85 -52.41 7.93 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-O 121.701 0.762 . . . . 0.0 109.245 179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 24.7 p -151.78 153.91 35.22 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 20.9 p -71.8 136.6 47.13 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.185 -0.947 . . . . 0.0 109.438 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.547 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 95.87 163.32 33.75 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.623 ' HA ' HG21 ' A' ' 32' ' ' THR . 73.6 tttt -49.64 152.62 1.38 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.46 -1.023 . . . . 0.0 109.373 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.42 ' N ' ' HG2' ' A' ' 57' ' ' LYS . 24.5 m -57.87 -28.75 64.45 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.174 -0.954 . . . . 0.0 109.491 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.448 ' O ' ' O ' ' A' ' 62' ' ' SER . 61.7 tt0 -89.3 -25.02 21.88 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.224 -0.922 . . . . 0.0 109.178 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 64.1 tt0 -61.35 -29.62 70.01 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.325 -0.86 . . . . 0.0 109.407 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 86.6 p -67.2 -22.81 65.7 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.36 -0.838 . . . . 0.0 109.56 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.448 ' O ' ' O ' ' A' ' 59' ' ' GLU . 60.7 m -125.57 139.6 53.45 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.246 -0.908 . . . . 0.0 109.443 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.533 ' OG1' ' HB2' ' A' ' 69' ' ' ALA . 20.0 p -117.18 93.02 41.4 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.331 -0.855 . . . . 0.0 109.575 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -70.91 -18.19 31.79 Favored 'Trans proline' 0 C--O 1.214 -0.691 0 C-N-CA 122.738 2.292 . . . . 0.0 111.783 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -53.32 -28.47 35.32 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.739 HG22 ' H ' ' A' ' 68' ' ' ALA . 45.3 m -126.92 138.09 53.24 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.12 -1.224 . . . . 0.0 109.549 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 61.3 p -70.88 -22.17 62.32 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.267 -0.896 . . . . 0.0 109.421 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.739 ' H ' HG22 ' A' ' 66' ' ' THR . . . -62.19 -28.63 69.81 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.22 -0.925 . . . . 0.0 109.49 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.533 ' HB2' ' OG1' ' A' ' 63' ' ' THR . . . -67.96 -26.79 66.11 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.201 -0.937 . . . . 0.0 109.395 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 30.6 m -59.58 -28.73 67.41 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.305 -0.872 . . . . 0.0 109.45 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 4.9 tpt -130.55 78.57 73.82 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.301 -0.874 . . . . 0.0 109.39 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.442 ' HD3' ' O ' ' A' ' 69' ' ' ALA . 50.2 Cg_endo -70.28 163.43 38.71 Favored 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 122.754 2.303 . . . . 0.0 111.838 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -70.88 164.48 35.49 Favored 'Trans proline' 0 C--O 1.215 -0.658 0 C-N-CA 122.706 2.27 . . . . 0.0 111.669 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 87.0 p -86.18 -5.56 59.17 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.265 -0.897 . . . . 0.0 109.562 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.483 ' O ' ' CG ' ' A' ' 76' ' ' GLU . 85.4 m-20 -74.31 -27.12 60.56 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.24 -0.912 . . . . 0.0 109.526 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.483 ' CG ' ' O ' ' A' ' 75' ' ' ASP . 93.7 mt-10 . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 118.051 -0.976 . . . . 0.0 109.477 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.415 ' O ' ' C ' ' A' ' 2' ' ' SER . 79.5 m-20 . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.415 ' C ' ' O ' ' A' ' 1' ' ' ASP . 4.0 m -43.93 -29.43 0.57 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.335 -0.853 . . . . 0.0 109.409 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.421 ' HA ' ' HG3' ' A' ' 6' ' ' LYS . 15.3 mt-10 -50.15 -28.27 7.12 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 79.4 mmm -77.4 -33.2 55.11 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.598 ' HB3' ' CE1' ' A' ' 8' ' ' TYR . 2.7 m -85.06 5.48 29.36 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.461 -0.775 . . . . 0.0 109.039 179.386 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.446 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 11.5 mttm -66.23 -28.35 68.67 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.18 -0.95 . . . . 0.0 109.554 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.446 ' OD1' ' O ' ' A' ' 6' ' ' LYS . 80.3 m-20 -146.2 65.76 1.2 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.269 -0.894 . . . . 0.0 110.153 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.718 ' CZ ' HD21 ' A' ' 44' ' ' LEU . 12.6 p90 -125.8 -177.7 4.02 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.146 -0.971 . . . . 0.0 109.234 179.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 66.4 mtm180 -150.39 143.48 24.85 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.171 -0.955 . . . . 0.0 109.634 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.797 HG13 ' O ' ' A' ' 15' ' ' GLY . 69.1 t -128.4 130.97 69.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.241 -0.912 . . . . 0.0 109.442 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.545 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.2 OUTLIER -111.41 175.0 2.05 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.291 -0.881 . . . . 0.0 109.415 -179.867 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.545 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 46.1 Cg_endo -67.6 -24.17 42.05 Favored 'Trans proline' 0 C--O 1.216 -0.611 0 C-N-CA 122.665 2.243 . . . . 0.0 111.565 179.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 82.3 mtp180 -94.36 -31.7 13.91 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.342 -0.849 . . . . 0.0 109.104 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 80.5 mt -85.38 -46.99 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.415 -0.803 . . . . 0.0 109.357 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.797 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 70.59 -165.06 52.56 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.527 ' OH ' ' CB ' ' A' ' 40' ' ' CYS . 0.8 OUTLIER -104.41 146.62 28.59 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.235 -1.156 . . . . 0.0 109.377 179.928 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.829 ' N ' HD12 ' A' ' 17' ' ' LEU . 0.6 OUTLIER -112.59 124.87 53.51 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.248 -0.907 . . . . 0.0 109.452 179.86 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.434 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 59.6 m -142.16 155.84 64.9 Favored Pre-proline 0 C--N 1.3 -1.585 0 O-C-N 121.373 -0.829 . . . . 0.0 108.81 179.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -70.88 164.45 35.61 Favored 'Trans proline' 0 C--O 1.214 -0.695 0 C-N-CA 122.236 1.957 . . . . 0.0 111.344 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.2 mtpm? -82.54 -26.43 32.46 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.311 -0.868 . . . . 0.0 109.415 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -63.29 124.83 22.23 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.311 -0.868 . . . . 0.0 109.446 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.753 ' C ' HD13 ' A' ' 22' ' ' LEU . 3.4 tm? -86.53 106.96 17.89 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.137 -0.977 . . . . 0.0 109.305 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.516 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 9.5 mttt -115.22 106.79 50.62 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.222 -0.924 . . . . 0.0 109.47 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.537 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 41.7 Cg_endo -63.21 116.94 3.91 Favored 'Trans proline' 0 C--O 1.214 -0.698 0 C-N-CA 123.032 2.488 . . . . 0.0 112.176 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.564 ' HB ' HG23 ' A' ' 52' ' ' ILE . 16.4 m -115.09 154.86 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.285 -0.885 . . . . 0.0 109.266 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.431 ' O ' ' N ' ' A' ' 53' ' ' ARG . 45.1 t -95.08 143.81 26.23 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 178.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -97.06 141.49 15.65 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 -178.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.489 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 54.6 p30 -67.42 -8.63 34.63 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.313 -1.11 . . . . 0.0 109.431 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -95.88 10.84 35.84 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.317 -0.864 . . . . 0.0 109.49 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.45 12.31 73.08 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.534 ' O ' ' N ' ' A' ' 27' ' ' GLY . 53.4 mt-30 -115.84 148.26 40.13 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.298 -1.119 . . . . 0.0 109.504 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.641 HG21 ' HA ' ' A' ' 57' ' ' LYS . 8.4 m -112.32 152.23 28.79 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.146 -0.971 . . . . 0.0 109.731 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.852 ' CD2' HD12 ' A' ' 39' ' ' LEU . 94.6 m-85 -129.34 133.4 47.4 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.303 -0.873 . . . . 0.0 109.187 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.693 ' CB ' HD21 ' A' ' 22' ' ' LEU . 1.5 m-20 -53.57 -75.37 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.111 -0.993 . . . . 0.0 109.194 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.526 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 8.4 t-20 -82.38 146.56 54.39 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.155 -0.966 . . . . 0.0 109.188 179.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.516 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 42.0 Cg_endo -64.69 -51.38 1.84 Allowed 'Trans proline' 0 C--O 1.216 -0.608 0 C-N-CA 122.649 2.233 . . . . 0.0 111.486 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.526 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 9.5 t -62.38 -27.24 68.94 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 178.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.499 ' CG ' ' HB3' ' A' ' 35' ' ' ASN . 44.9 mmm -66.44 -21.83 66.21 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.686 -0.634 . . . . 0.0 109.29 179.308 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.852 HD12 ' CD2' ' A' ' 33' ' ' TYR . 6.4 tt -64.83 -51.48 61.86 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.247 -0.908 . . . . 0.0 108.841 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.527 ' CB ' ' OH ' ' A' ' 16' ' ' TYR . 33.8 m -51.41 -33.64 31.26 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.06 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 19.1 t60 -53.3 -46.31 69.33 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.237 -0.915 . . . . 0.0 108.552 179.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.581 ' HB2' ' CE1' ' A' ' 33' ' ' TYR . 21.4 tp10 -62.03 -17.46 57.38 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.52 ' HB2' ' O ' ' A' ' 40' ' ' CYS . 2.7 m-80 -79.13 -33.93 43.77 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 119.492 -0.883 . . . . 0.0 109.247 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.718 HD21 ' CZ ' ' A' ' 8' ' ' TYR . 46.6 mt -70.5 -32.93 70.62 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.256 -0.903 . . . . 0.0 109.8 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.7 mm -79.39 -51.6 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.255 -0.903 . . . . 0.0 109.654 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.538 ' HB3' HG23 ' A' ' 48' ' ' THR . 18.5 mtt-85 -82.51 -33.98 28.1 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.21 -0.931 . . . . 0.0 109.833 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.486 ' N ' ' O ' ' A' ' 43' ' ' ASN . 89.6 mt-30 62.52 36.7 13.79 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.247 -0.908 . . . . 0.0 109.422 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.538 HG23 ' HB3' ' A' ' 46' ' ' ARG . 39.0 p -102.87 3.28 36.41 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.226 -0.921 . . . . 0.0 109.631 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.445 ' HB2' ' O ' ' A' ' 48' ' ' THR . 18.6 m120 65.07 48.31 2.29 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.317 -0.864 . . . . 0.0 109.512 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.518 ' N ' ' OD1' ' A' ' 43' ' ' ASN . 48.4 m -80.19 131.39 35.7 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.206 -0.933 . . . . 0.0 109.607 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 11.1 m-70 -114.25 -171.45 1.92 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.272 -0.893 . . . . 0.0 109.38 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.564 HG23 ' HB ' ' A' ' 25' ' ' VAL . 42.9 mt -89.03 127.05 42.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.311 -0.868 . . . . 0.0 109.574 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.489 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 39.3 ttt85 -81.37 -43.44 19.02 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.424 -0.798 . . . . 0.0 109.255 179.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.6 m -160.44 146.4 15.18 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.569 -0.707 . . . . 0.0 109.319 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.7 p -61.68 143.5 56.04 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.2 -0.937 . . . . 0.0 109.488 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.537 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 87.58 162.04 37.4 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.691 -1.364 . . . . 0.0 109.691 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.641 ' HA ' HG21 ' A' ' 32' ' ' THR . 62.0 tttt -52.91 152.46 3.94 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.667 -0.902 . . . . 0.0 109.603 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 85.3 m -58.74 -23.46 59.88 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.302 -0.874 . . . . 0.0 109.552 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.485 ' HB3' ' HD3' ' A' ' 57' ' ' LYS . 62.0 tt0 -79.66 -21.13 45.16 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.378 -0.827 . . . . 0.0 109.543 -179.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.491 ' HG3' ' HB3' ' A' ' 57' ' ' LYS . 5.4 mt-10 -74.2 -33.28 63.36 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.306 -0.871 . . . . 0.0 109.254 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 95.1 p -70.91 -7.58 46.78 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.402 -0.811 . . . . 0.0 109.573 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 42.0 p -84.3 173.81 10.66 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.147 -0.971 . . . . 0.0 109.563 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.47 ' HB ' ' HD2' ' A' ' 64' ' ' PRO . 43.0 p -123.09 160.34 50.16 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.318 -0.863 . . . . 0.0 109.333 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.524 ' HB2' ' HB3' ' A' ' 68' ' ' ALA . 48.0 Cg_endo -69.16 130.34 19.9 Favored 'Trans proline' 0 C--O 1.214 -0.721 0 C-N-CA 122.589 2.193 . . . . 0.0 111.765 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -74.79 -166.54 17.02 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 50.3 m -70.31 -31.51 68.86 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.29 -1.123 . . . . 0.0 109.349 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 64.3 m -65.09 -30.27 71.2 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.287 -0.883 . . . . 0.0 109.381 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.524 ' HB3' ' HB2' ' A' ' 64' ' ' PRO . . . -76.71 -29.36 56.21 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.24 -0.913 . . . . 0.0 109.336 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.62 143.42 54.83 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.265 -0.897 . . . . 0.0 109.317 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 83.7 p -57.29 -28.61 63.17 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.151 -0.968 . . . . 0.0 109.549 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 9.6 mtt -60.59 147.74 82.86 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.287 -0.883 . . . . 0.0 109.52 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -70.3 166.79 27.12 Favored 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 122.684 2.256 . . . . 0.0 111.846 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -69.9 158.49 56.61 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 122.668 2.245 . . . . 0.0 111.778 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 46.8 m -135.3 144.85 46.99 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.277 -0.89 . . . . 0.0 109.521 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.434 ' O ' ' HB2' ' A' ' 76' ' ' GLU . 76.1 m-20 -57.89 -35.44 71.02 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.174 -0.953 . . . . 0.0 109.436 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.434 ' HB2' ' O ' ' A' ' 75' ' ' ASP . 83.4 tt0 . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.453 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.556 ' HB2' ' CD2' ' A' ' 51' ' ' HIS . 3.8 m -61.78 -31.35 71.55 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.215 -0.928 . . . . 0.0 109.322 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -53.51 -26.52 21.15 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.286 -0.883 . . . . 0.0 108.905 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 92.2 mtp -75.51 -26.08 57.8 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.353 -0.842 . . . . 0.0 108.833 179.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.6 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 26.2 m -81.42 -14.42 57.14 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.458 -0.776 . . . . 0.0 109.39 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.462 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 22.6 mttm -80.59 5.23 16.04 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.201 -0.937 . . . . 0.0 109.509 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.462 ' OD1' ' O ' ' A' ' 6' ' ' LYS . 93.2 m-20 -135.76 12.82 3.42 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.061 -1.024 . . . . 0.0 110.405 -179.405 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.613 ' CE2' ' CE2' ' A' ' 16' ' ' TYR . 0.6 OUTLIER -123.54 150.72 43.66 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.873 -1.142 . . . . 0.0 109.682 179.815 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 46.1 mtt85 -130.5 132.73 45.78 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.246 -0.908 . . . . 0.0 109.393 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.761 HG13 ' O ' ' A' ' 15' ' ' GLY . 54.2 t -123.39 147.08 27.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.187 -0.945 . . . . 0.0 109.716 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.709 HD23 ' HD2' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -128.97 176.26 2.93 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.423 -0.798 . . . . 0.0 109.17 -179.999 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.709 ' HD2' HD23 ' A' ' 11' ' ' LEU . 44.0 Cg_endo -66.64 -22.1 51.15 Favored 'Trans proline' 0 C--O 1.214 -0.681 0 C-N-CA 122.477 2.118 . . . . 0.0 111.782 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 60.5 mtt180 -101.55 -30.02 11.63 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.24 -0.913 . . . . 0.0 109.498 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.44 HD12 ' HB2' ' A' ' 11' ' ' LEU . 95.4 mt -81.47 -47.66 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.279 -0.888 . . . . 0.0 109.739 -179.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.761 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 77.14 -167.78 54.41 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.613 ' CE2' ' CE2' ' A' ' 8' ' ' TYR . 1.5 t80 -95.75 150.77 20.03 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.177 -1.19 . . . . 0.0 109.662 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 25.7 tp -117.51 105.81 12.49 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.322 -0.861 . . . . 0.0 109.465 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.402 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 76.2 m -117.77 157.3 48.43 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.239 -0.913 . . . . 0.0 109.183 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.485 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 49.5 Cg_endo -72.17 166.01 30.94 Favored 'Trans proline' 0 C--O 1.216 -0.622 0 C-N-CA 122.63 2.22 . . . . 0.0 111.545 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 60.1 mttt -89.38 -13.2 38.31 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.184 -0.948 . . . . 0.0 109.475 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -73.53 113.72 10.96 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.231 -0.918 . . . . 0.0 109.248 179.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.491 HD11 ' HB3' ' A' ' 34' ' ' ASN . 49.4 tp -76.54 112.54 13.18 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.174 -0.954 . . . . 0.0 109.628 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.489 ' O ' ' O ' ' A' ' 34' ' ' ASN . 14.2 mttt -126.22 110.14 24.0 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.295 -0.878 . . . . 0.0 108.941 179.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.542 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 43.5 Cg_endo -64.93 123.98 12.42 Favored 'Trans proline' 0 C--O 1.213 -0.744 0 C-N-CA 123.025 2.483 . . . . 0.0 112.487 -179.187 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.445 ' HB ' HG23 ' A' ' 52' ' ' ILE . 27.2 m -118.77 153.38 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.434 -0.791 . . . . 0.0 109.452 179.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 41.9 t -99.45 139.65 34.8 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 178.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -93.91 144.44 17.11 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 -178.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.497 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 49.3 p30 -68.87 -15.0 63.38 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.365 -1.079 . . . . 0.0 109.432 179.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.457 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 88.1 m-20 -84.46 5.73 26.26 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.232 -0.917 . . . . 0.0 109.542 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 89.04 17.17 56.65 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.321 -1.512 . . . . 0.0 109.321 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.444 ' O ' ' SG ' ' A' ' 58' ' ' CYS . 90.8 mt-30 -115.82 171.13 7.96 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.307 -1.113 . . . . 0.0 109.485 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.554 HG23 ' HA ' ' A' ' 57' ' ' LYS . 64.0 m -133.03 136.0 45.73 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.232 -0.918 . . . . 0.0 109.522 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.927 ' CD1' HD13 ' A' ' 39' ' ' LEU . 44.4 m-85 -116.14 133.17 56.32 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.292 -0.88 . . . . 0.0 109.247 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.54 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 7.7 m-20 -55.3 -77.57 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.262 -0.899 . . . . 0.0 110.031 -179.423 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.524 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 5.4 t-20 -81.63 147.66 59.84 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 120.91 -1.119 . . . . 0.0 109.728 -179.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.479 ' HD3' ' O ' ' A' ' 23' ' ' LYS . 41.3 Cg_endo -64.18 -53.09 1.27 Allowed 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 122.771 2.314 . . . . 0.0 111.552 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.524 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 10.1 t -62.34 -29.0 70.14 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 178.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.515 ' CG ' ' HB3' ' A' ' 35' ' ' ASN . 44.6 mmm -62.76 -14.09 40.63 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.241 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.927 HD13 ' CD1' ' A' ' 33' ' ' TYR . 39.8 tp -73.23 -60.17 2.37 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.407 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.455 ' HB3' ' OH ' ' A' ' 16' ' ' TYR . 17.8 t -54.54 -23.56 17.11 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 54.3 t60 -69.46 -62.25 1.46 Allowed 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 80.1 mt-10 -58.09 -19.1 29.5 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.494 ' O ' ' N ' ' A' ' 47' ' ' GLN . 99.6 m-20 -76.36 -29.66 57.28 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.482 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.937 HD13 ' O ' ' A' ' 44' ' ' LEU . 1.8 tm? -69.81 -38.79 76.73 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.416 -0.803 . . . . 0.0 109.014 179.543 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.555 ' N ' HD13 ' A' ' 45' ' ' ILE . 3.7 mm -71.54 -46.42 63.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.301 -0.875 . . . . 0.0 109.385 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.447 ' HB3' HG23 ' A' ' 48' ' ' THR . 13.4 mtt-85 -79.59 -33.23 41.82 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.286 -0.884 . . . . 0.0 109.354 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.494 ' N ' ' O ' ' A' ' 43' ' ' ASN . 92.3 mt-30 61.24 39.43 15.7 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.368 -0.832 . . . . 0.0 109.52 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.447 HG23 ' HB3' ' A' ' 46' ' ' ARG . 52.2 p -104.28 8.21 35.99 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.261 -0.9 . . . . 0.0 109.481 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.58 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 35.5 t-20 50.78 57.69 6.36 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.296 -0.878 . . . . 0.0 109.505 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.457 ' HB ' ' OD1' ' A' ' 43' ' ' ASN . 26.6 m -80.32 148.54 30.64 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.182 -0.949 . . . . 0.0 109.785 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.58 ' CE1' ' O ' ' A' ' 49' ' ' ASN . 13.7 m80 -122.0 171.34 9.02 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.396 -0.815 . . . . 0.0 108.851 179.472 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.453 HG12 HD22 ' A' ' 39' ' ' LEU . 11.7 mt -83.29 126.48 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.156 -0.965 . . . . 0.0 109.701 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.497 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 55.8 ttt180 -80.04 -46.45 16.55 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.452 -0.78 . . . . 0.0 109.409 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -160.54 142.92 12.89 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.418 ' H ' HG23 ' A' ' 55' ' ' THR . 25.8 p -54.71 148.4 12.84 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.192 -0.942 . . . . 0.0 109.112 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.542 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 84.42 168.2 43.83 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.068 -1.613 . . . . 0.0 109.068 -179.513 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.554 ' HA ' HG23 ' A' ' 32' ' ' THR . 81.7 mttt -63.93 167.14 6.52 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.257 -1.143 . . . . 0.0 109.238 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.444 ' SG ' ' O ' ' A' ' 31' ' ' GLN . 84.0 m -74.38 -15.52 60.93 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.219 -0.926 . . . . 0.0 109.098 179.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.459 ' HG2' ' O ' ' A' ' 59' ' ' GLU . 65.3 tt0 -79.71 -16.56 55.45 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.48 -0.763 . . . . 0.0 109.368 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.457 ' HG3' ' O ' ' A' ' 57' ' ' LYS . 9.1 mt-10 -73.7 -33.8 64.56 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.278 -0.889 . . . . 0.0 108.96 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 93.1 p -60.11 -18.22 45.7 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.433 -0.792 . . . . 0.0 109.108 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 42.5 m -119.4 152.29 37.07 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.29 -0.881 . . . . 0.0 109.412 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 17.1 m -123.47 79.52 54.3 Favored Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.215 -0.928 . . . . 0.0 109.502 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -70.38 147.07 58.08 Favored 'Trans proline' 0 C--O 1.216 -0.61 0 C-N-CA 122.709 2.273 . . . . 0.0 111.771 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.24 172.9 55.25 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.559 -1.417 . . . . 0.0 109.559 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 16.9 p -123.74 163.53 20.96 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.287 -1.125 . . . . 0.0 109.437 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 17.4 p -123.32 160.82 25.9 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.255 -0.903 . . . . 0.0 109.503 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.417 ' O ' ' O ' ' A' ' 71' ' ' MET . . . -60.67 -33.6 73.08 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.205 -0.934 . . . . 0.0 109.46 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -68.04 -25.7 65.5 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.316 -0.865 . . . . 0.0 109.547 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 27.8 m -61.65 -27.77 68.91 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.185 -0.947 . . . . 0.0 109.51 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.417 ' O ' ' O ' ' A' ' 68' ' ' ALA . 22.5 mtt -133.03 158.64 75.31 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.252 -0.905 . . . . 0.0 109.579 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -70.48 148.95 61.51 Favored 'Trans proline' 0 C--O 1.214 -0.695 0 C-N-CA 122.708 2.272 . . . . 0.0 111.723 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -69.8 -5.46 16.29 Favored 'Trans proline' 0 C--O 1.214 -0.712 0 C-N-CA 122.668 2.245 . . . . 0.0 111.833 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 83.7 p -84.62 -11.45 55.95 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.173 -0.954 . . . . 0.0 109.37 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -67.1 -29.65 69.46 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.229 -0.919 . . . . 0.0 109.399 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 . . . . . 0 N--CA 1.489 1.506 0 CA-C-O 118.024 -0.989 . . . . 0.0 109.504 179.931 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.624 ' OD1' HD12 ' A' ' 52' ' ' ILE . 58.9 m-20 . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.453 ' O ' ' SG ' ' A' ' 5' ' ' CYS . 1.3 m -47.13 -34.95 6.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.179 -0.95 . . . . 0.0 109.231 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.476 ' HA ' ' HG3' ' A' ' 6' ' ' LYS . 9.2 mt-10 -50.72 -25.53 4.46 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.261 -0.9 . . . . 0.0 108.758 179.591 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 84.5 mmm -75.63 -32.5 60.27 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.46 -0.775 . . . . 0.0 109.389 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.453 ' SG ' ' O ' ' A' ' 2' ' ' SER . 16.8 p -79.76 -7.76 58.84 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.14 -0.975 . . . . 0.0 109.286 179.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.476 ' HG3' ' HA ' ' A' ' 3' ' ' GLU . 24.7 mttm -49.05 -24.92 1.75 Allowed 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.079 -1.013 . . . . 0.0 108.391 179.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.401 ' OD1' ' C ' ' A' ' 7' ' ' ASP . 58.8 p30 -112.98 25.57 11.28 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.319 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.577 ' CZ ' ' CE1' ' A' ' 16' ' ' TYR . 3.7 t80 -79.19 162.82 25.49 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.544 -0.723 . . . . 0.0 109.99 -179.394 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 12.7 mtm180 -148.92 115.36 5.87 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.368 -0.832 . . . . 0.0 108.977 179.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.95 HG13 ' C ' ' A' ' 15' ' ' GLY . 99.8 t -111.32 148.99 14.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.229 -0.919 . . . . 0.0 109.468 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.562 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.5 OUTLIER -129.58 175.82 3.3 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.251 -0.905 . . . . 0.0 109.453 -179.674 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.562 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 43.7 Cg_endo -66.77 -22.26 49.93 Favored 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 122.644 2.229 . . . . 0.0 111.584 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.44 ' HB3' ' NH1' ' A' ' 13' ' ' ARG . 19.5 mtp-105 -114.29 -29.49 6.91 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.375 -0.828 . . . . 0.0 109.215 179.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.487 HD12 ' HB2' ' A' ' 11' ' ' LEU . 97.1 mt -78.92 -42.02 24.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.338 -0.851 . . . . 0.0 109.383 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.95 ' C ' HG13 ' A' ' 10' ' ' VAL . . . 64.12 -150.89 50.25 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.577 ' CE1' ' CZ ' ' A' ' 8' ' ' TYR . 1.0 OUTLIER -102.68 147.6 26.62 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.266 -1.138 . . . . 0.0 109.352 179.858 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.465 ' HB2' ' OH ' ' A' ' 8' ' ' TYR . 37.5 mt -113.86 124.14 51.49 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.118 -0.989 . . . . 0.0 109.919 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.413 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 61.4 m -138.97 156.32 72.57 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.433 -0.792 . . . . 0.0 109.026 179.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -70.74 167.05 26.84 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.573 2.182 . . . . 0.0 111.671 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -88.2 -13.7 40.44 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.208 -0.933 . . . . 0.0 109.698 -179.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 33.3 m-20 -74.19 123.48 24.57 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.133 -0.98 . . . . 0.0 109.391 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.542 HD11 ' HB3' ' A' ' 34' ' ' ASN . 39.7 tp -80.61 118.55 22.29 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.275 -0.89 . . . . 0.0 109.515 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.532 ' CB ' ' HD3' ' A' ' 36' ' ' PRO . 10.8 mttp -127.65 100.09 25.69 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.347 -0.846 . . . . 0.0 109.17 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.541 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 42.2 Cg_endo -64.41 118.22 5.2 Favored 'Trans proline' 0 C--O 1.214 -0.713 0 C-N-CA 122.874 2.383 . . . . 0.0 112.133 -179.449 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.526 ' HB ' HG23 ' A' ' 52' ' ' ILE . 12.2 m -114.65 155.74 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.309 -0.87 . . . . 0.0 109.557 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.417 ' SG ' ' NE ' ' A' ' 53' ' ' ARG . 42.4 t -95.62 138.96 32.55 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.237 -0.914 . . . . 0.0 108.661 179.051 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -92.11 136.16 13.1 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -179.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.487 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 53.8 t0 -68.96 -7.15 32.51 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.196 -1.179 . . . . 0.0 109.426 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.413 ' OD1' ' C ' ' A' ' 29' ' ' ASP . 59.2 p30 -89.72 2.95 54.19 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.265 -0.897 . . . . 0.0 109.413 179.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.64 16.57 39.02 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.282 -1.527 . . . . 0.0 109.282 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.463 ' O ' ' SG ' ' A' ' 58' ' ' CYS . 66.2 mt-30 -121.78 -178.37 3.81 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.301 -1.117 . . . . 0.0 109.592 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.615 HG21 ' HA ' ' A' ' 57' ' ' LYS . 11.1 m -143.3 138.85 29.83 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.287 -0.883 . . . . 0.0 109.319 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.871 ' CD1' HD13 ' A' ' 39' ' ' LEU . 40.2 m-85 -116.13 134.09 55.31 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.217 -0.927 . . . . 0.0 109.366 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.542 ' HB3' HD11 ' A' ' 22' ' ' LEU . 13.1 m-20 -55.07 -78.94 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.255 -0.903 . . . . 0.0 109.666 -179.611 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.51 ' HB3' ' CG ' ' A' ' 38' ' ' MET . 10.9 t-20 -82.33 146.14 53.61 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.08 -1.013 . . . . 0.0 109.525 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.532 ' HD3' ' CB ' ' A' ' 23' ' ' LYS . 41.4 Cg_endo -63.94 -51.64 2.16 Favored 'Trans proline' 0 C--O 1.215 -0.651 0 C-N-CA 122.753 2.302 . . . . 0.0 111.621 179.438 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.505 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 8.0 t -62.06 -25.62 67.79 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 178.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.51 ' CG ' ' HB3' ' A' ' 35' ' ' ASN . 65.2 mmm -72.35 -3.02 21.47 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 179.191 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.871 HD13 ' CD1' ' A' ' 33' ' ' TYR . 21.2 tp -74.37 -60.03 2.46 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.287 -0.883 . . . . 0.0 109.175 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.488 ' HB3' ' OH ' ' A' ' 16' ' ' TYR . 2.2 t -56.44 -25.73 51.43 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.122 -0.986 . . . . 0.0 108.468 179.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 27.4 t60 -61.9 -56.91 14.42 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.468 ' OE1' ' CD2' ' A' ' 33' ' ' TYR . 65.1 tt0 -64.2 -20.57 66.11 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.145 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.501 ' O ' ' N ' ' A' ' 47' ' ' GLN . 88.6 m-20 -79.19 -29.88 43.12 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.61 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.977 HD13 ' O ' ' A' ' 44' ' ' LEU . 1.7 tm? -65.41 -36.9 85.35 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.284 -0.885 . . . . 0.0 109.165 179.629 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.2 mt -79.4 -38.88 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.372 -0.83 . . . . 0.0 109.317 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.456 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 17.0 mtt-85 -80.11 -32.79 39.08 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.174 -0.954 . . . . 0.0 109.417 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.501 ' N ' ' O ' ' A' ' 43' ' ' ASN . 73.8 mm-40 61.84 40.93 12.2 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.254 -0.904 . . . . 0.0 109.578 -179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 25.4 p -113.73 9.84 17.79 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.187 -0.946 . . . . 0.0 109.625 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 49.6 m-20 45.35 58.81 3.91 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.201 -0.937 . . . . 0.0 109.529 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.432 ' HB ' ' OD1' ' A' ' 43' ' ' ASN . 66.0 m -80.33 137.55 36.59 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.158 -0.964 . . . . 0.0 109.779 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 72.2 m80 -110.77 172.02 7.12 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.255 -0.903 . . . . 0.0 108.967 179.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.624 HD12 ' OD1' ' A' ' 1' ' ' ASP . 34.7 mt -82.12 126.03 39.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.131 -0.981 . . . . 0.0 109.435 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.487 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 46.6 ttp180 -79.99 -44.56 19.99 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 121.642 0.734 . . . . 0.0 109.309 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 17.1 p -158.49 156.1 29.67 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 -179.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 36.5 p -71.68 140.32 49.58 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.119 -0.988 . . . . 0.0 109.407 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.541 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 89.5 162.25 38.24 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.551 -1.419 . . . . 0.0 109.551 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.615 ' HA ' HG21 ' A' ' 32' ' ' THR . 46.2 tttp -50.63 148.54 3.83 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.537 -0.978 . . . . 0.0 109.49 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.463 ' SG ' ' O ' ' A' ' 31' ' ' GLN . 92.5 m -52.53 -25.48 10.5 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.318 -0.864 . . . . 0.0 109.331 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 80.4 tt0 -85.3 -20.87 29.35 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.367 -0.833 . . . . 0.0 109.29 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -91.68 116.57 28.99 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.317 -0.865 . . . . 0.0 109.328 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 25.3 t -129.21 140.64 51.41 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.199 -0.938 . . . . 0.0 109.579 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 97.3 p -120.08 155.28 33.3 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.2 -0.938 . . . . 0.0 109.415 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.31 77.42 61.29 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.249 -0.907 . . . . 0.0 109.482 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -69.95 149.16 65.28 Favored 'Trans proline' 0 C--O 1.214 -0.682 0 C-N-CA 122.723 2.282 . . . . 0.0 111.814 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.426 ' HA3' ' CB ' ' A' ' 70' ' ' SER . . . -78.87 -176.73 48.49 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 63.7 m -64.29 -29.27 70.36 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.278 -1.13 . . . . 0.0 109.428 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 17.7 p -133.28 158.76 42.11 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.366 -0.834 . . . . 0.0 109.465 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -57.86 -30.31 65.71 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.228 -0.92 . . . . 0.0 109.461 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.72 -35.28 79.23 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.287 -0.883 . . . . 0.0 109.53 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.426 ' CB ' ' HA3' ' A' ' 65' ' ' GLY . 32.0 m -53.46 -34.35 57.59 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.238 -0.914 . . . . 0.0 109.513 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -63.43 154.56 78.63 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.266 -0.896 . . . . 0.0 109.473 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -69.96 142.46 47.1 Favored 'Trans proline' 0 C--O 1.214 -0.692 0 C-N-CA 122.736 2.291 . . . . 0.0 111.844 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -70.26 166.82 26.95 Favored 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 122.727 2.285 . . . . 0.0 111.815 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 20.2 m -90.74 -8.03 50.89 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.263 -0.898 . . . . 0.0 109.626 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 54.7 t0 -104.48 109.71 21.69 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.14 -0.975 . . . . 0.0 109.498 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 91.2 mt-10 . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 118.027 -0.987 . . . . 0.0 109.451 179.957 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.344 0.593 . . . . 0.0 109.556 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.504 ' HB2' ' CD2' ' A' ' 51' ' ' HIS . 4.6 m -61.75 -24.91 67.12 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.266 -0.896 . . . . 0.0 109.571 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -54.95 -22.03 13.71 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.167 -0.958 . . . . 0.0 109.041 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 77.4 mtm -73.8 -30.02 62.49 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.239 -0.913 . . . . 0.0 109.061 179.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.592 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 48.7 m -80.09 -19.13 48.16 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.396 -0.815 . . . . 0.0 109.351 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.442 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 25.3 mttt -81.04 11.65 3.93 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.362 -0.836 . . . . 0.0 109.985 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' A' ' 6' ' ' LYS . 94.4 m-20 -136.23 4.05 2.91 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.026 -1.046 . . . . 0.0 109.972 -179.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.592 ' CD1' ' HA ' ' A' ' 5' ' ' CYS . 0.7 OUTLIER -121.12 147.98 44.81 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.946 -1.096 . . . . 0.0 109.675 -179.951 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 29.2 mtt180 -132.44 124.64 29.01 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.333 -0.854 . . . . 0.0 108.957 179.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.74 HG13 ' O ' ' A' ' 15' ' ' GLY . 75.8 t -108.95 141.44 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.333 -0.854 . . . . 0.0 110.183 -179.229 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.687 HD12 ' O ' ' A' ' 10' ' ' VAL . 2.0 mp -130.71 176.18 3.08 Favored Pre-proline 0 N--CA 1.489 1.503 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.546 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 44.2 Cg_endo -66.55 -23.05 50.39 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 122.593 2.196 . . . . 0.0 111.801 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 31.6 ttp180 -97.78 -35.06 10.65 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.332 -0.855 . . . . 0.0 109.404 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 87.3 mt -80.34 -50.75 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.324 -0.86 . . . . 0.0 109.398 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.74 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 82.51 -171.67 51.6 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.536 ' CD1' HG21 ' A' ' 10' ' ' VAL . 0.9 OUTLIER -86.73 152.92 22.12 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.235 -1.156 . . . . 0.0 109.548 179.984 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 19.1 tp -129.45 117.1 19.98 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.235 -0.915 . . . . 0.0 109.915 -179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.444 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 75.8 m -133.82 156.72 79.12 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.401 -0.812 . . . . 0.0 108.928 179.515 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.549 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 49.6 Cg_endo -70.62 167.37 25.75 Favored 'Trans proline' 0 C--O 1.216 -0.623 0 C-N-CA 122.689 2.259 . . . . 0.0 111.679 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -93.91 -6.77 44.84 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.302 -0.873 . . . . 0.0 109.573 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.541 ' CB ' ' HE2' ' A' ' 23' ' ' LYS . 77.5 m-20 -74.46 137.01 42.29 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.228 -0.92 . . . . 0.0 109.115 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.839 HD21 ' OD1' ' A' ' 34' ' ' ASN . 3.3 tm? -92.66 119.6 32.23 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.201 -0.937 . . . . 0.0 109.599 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.609 ' N ' HD13 ' A' ' 22' ' ' LEU . 11.5 mttt -139.22 104.26 7.24 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.176 -0.952 . . . . 0.0 109.403 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.543 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 44.2 Cg_endo -67.25 118.47 5.6 Favored 'Trans proline' 0 C--O 1.214 -0.691 0 C-N-CA 122.921 2.414 . . . . 0.0 111.857 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 23.2 m -112.89 155.57 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.247 -0.908 . . . . 0.0 109.927 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.461 ' O ' ' N ' ' A' ' 53' ' ' ARG . 39.3 t -101.49 109.57 21.41 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.315 -0.866 . . . . 0.0 109.338 179.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.485 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -62.5 142.17 47.64 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 -179.56 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.51 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 58.4 p30 -70.62 -10.37 59.18 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.326 -1.102 . . . . 0.0 109.378 179.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.438 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 55.1 p30 -85.33 6.58 25.74 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.224 -0.923 . . . . 0.0 109.312 179.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.65 9.47 64.45 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.191 -1.564 . . . . 0.0 109.191 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.485 ' O ' ' N ' ' A' ' 27' ' ' GLY . 88.0 mt-30 -111.18 168.28 9.63 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.381 -1.07 . . . . 0.0 109.517 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.566 HG23 ' HA ' ' A' ' 57' ' ' LYS . 30.3 m -127.68 130.79 49.5 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.243 -0.91 . . . . 0.0 109.402 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.805 ' CD1' HD13 ' A' ' 39' ' ' LEU . 47.1 m-85 -109.44 123.73 49.85 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.208 -0.932 . . . . 0.0 109.188 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.839 ' OD1' HD21 ' A' ' 22' ' ' LEU . 52.5 t-20 -48.3 -78.86 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.252 -0.905 . . . . 0.0 110.057 -179.387 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.535 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 1.4 t-20 -81.2 150.36 67.85 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.002 -1.061 . . . . 0.0 109.617 -179.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.469 ' HD2' ' CG ' ' A' ' 35' ' ' ASN . 40.7 Cg_endo -63.52 -55.5 0.7 Allowed 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 122.874 2.383 . . . . 0.0 112.037 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.549 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 13.6 t -63.31 -28.65 70.16 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.995 -1.066 . . . . 0.0 108.539 179.23 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.475 ' CG ' ' HB3' ' A' ' 35' ' ' ASN . 51.5 mmm -61.16 -17.66 54.06 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.345 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.805 HD13 ' CD1' ' A' ' 33' ' ' TYR . 30.7 tp -67.11 -59.0 3.83 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.269 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.458 ' HB3' ' OH ' ' A' ' 16' ' ' TYR . 8.2 t -55.8 -27.47 51.3 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.734 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.407 ' HB3' ' O ' ' A' ' 38' ' ' MET . 49.1 t60 -63.5 -61.09 2.56 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 63.1 mt-10 -57.47 -20.88 33.7 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 178.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.5 ' O ' ' N ' ' A' ' 47' ' ' GLN . 95.9 m-20 -80.27 -26.68 38.83 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.564 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 35.8 tp -71.3 -32.26 68.42 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.275 -0.891 . . . . 0.0 108.722 179.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 6.6 mm -80.57 -46.5 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.415 -0.803 . . . . 0.0 109.181 179.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.521 ' HB3' HG23 ' A' ' 48' ' ' THR . 58.0 mtt-85 -80.12 -36.69 34.96 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.253 -0.905 . . . . 0.0 109.285 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.5 ' N ' ' O ' ' A' ' 43' ' ' ASN . 91.7 mt-30 63.89 39.8 7.92 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.535 -0.728 . . . . 0.0 109.518 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.521 HG23 ' HB3' ' A' ' 46' ' ' ARG . 39.6 p -101.77 6.02 41.51 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.293 -0.879 . . . . 0.0 109.415 179.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.462 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 49.6 t30 52.78 57.24 6.58 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.301 -0.874 . . . . 0.0 109.687 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 58.4 m -80.12 141.34 35.85 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.185 -0.947 . . . . 0.0 109.633 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.504 ' CD2' ' HB2' ' A' ' 2' ' ' SER . 13.9 m80 -111.13 178.83 4.22 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.331 -0.855 . . . . 0.0 109.192 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.9 mt -90.25 127.22 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.123 -0.985 . . . . 0.0 109.799 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.51 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 28.4 ttt180 -80.18 -59.83 2.56 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.494 -0.754 . . . . 0.0 109.287 179.694 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 21.1 m -154.04 142.25 20.45 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.3 p -53.3 143.41 18.71 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.157 -0.965 . . . . 0.0 109.542 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.543 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 95.26 162.95 34.46 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.566 ' HA ' HG23 ' A' ' 32' ' ' THR . 18.0 mttp -64.26 149.68 47.53 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.465 -1.02 . . . . 0.0 109.341 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.457 ' SG ' ' O ' ' A' ' 31' ' ' GLN . 70.2 m -56.16 -25.76 47.8 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.223 -0.923 . . . . 0.0 109.41 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.466 ' O ' ' HG2' ' A' ' 59' ' ' GLU . 66.0 tt0 -86.08 -19.06 30.8 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.323 -0.86 . . . . 0.0 109.375 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 53.9 tt0 -76.87 -27.84 55.18 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.296 -0.877 . . . . 0.0 109.478 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 17.3 m -71.73 -26.71 62.59 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.279 -0.888 . . . . 0.0 109.683 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 97.3 p -120.34 152.82 37.32 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.173 -0.954 . . . . 0.0 109.663 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.465 ' OG1' ' HD2' ' A' ' 64' ' ' PRO . 0.1 OUTLIER -68.57 153.8 95.31 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.323 -0.861 . . . . 0.0 109.504 179.976 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.726 ' HB2' ' HB3' ' A' ' 68' ' ' ALA . 49.2 Cg_endo -69.26 141.25 46.73 Favored 'Trans proline' 0 C--O 1.215 -0.647 0 C-N-CA 122.71 2.273 . . . . 0.0 111.752 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -76.54 -171.53 33.54 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 56.1 m -68.12 -29.96 68.99 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.27 -1.135 . . . . 0.0 109.355 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 57.9 m -65.66 -29.11 69.63 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.291 -0.881 . . . . 0.0 109.406 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.726 ' HB3' ' HB2' ' A' ' 64' ' ' PRO . . . -72.78 -29.4 63.27 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.212 -0.93 . . . . 0.0 109.374 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.465 ' O ' ' HD3' ' A' ' 72' ' ' PRO . . . -70.57 -19.78 62.84 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.242 -0.911 . . . . 0.0 109.27 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 19.7 m -69.44 -27.0 64.87 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.271 -0.893 . . . . 0.0 109.199 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 6.8 mtp -128.63 71.41 80.76 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.33 -0.857 . . . . 0.0 109.276 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.465 ' HD3' ' O ' ' A' ' 69' ' ' ALA . 48.4 Cg_endo -69.54 169.41 18.69 Favored 'Trans proline' 0 C--O 1.215 -0.631 0 C-N-CA 122.739 2.293 . . . . 0.0 111.938 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -70.39 -14.69 34.34 Favored 'Trans proline' 0 C--O 1.216 -0.61 0 C-N-CA 122.833 2.355 . . . . 0.0 111.96 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 97.0 p -142.25 152.7 43.3 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.147 -0.97 . . . . 0.0 109.62 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -60.04 134.99 57.57 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.24 -0.912 . . . . 0.0 109.451 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 118.022 -0.989 . . . . 0.0 109.442 -179.939 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.458 ' HB2' ' CE1' ' A' ' 51' ' ' HIS . 2.1 m -57.52 -34.85 69.54 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.234 -0.916 . . . . 0.0 109.408 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -55.12 -27.03 42.22 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.331 -0.855 . . . . 0.0 109.054 179.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.452 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 86.4 mtp -72.3 -21.56 61.32 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.576 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.581 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 27.1 m -87.15 -16.64 34.83 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.479 -0.763 . . . . 0.0 109.123 179.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.7 mttp -81.15 14.25 2.43 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.303 -0.873 . . . . 0.0 109.943 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.452 ' OD1' ' O ' ' A' ' 4' ' ' MET . 51.7 p30 -145.79 10.5 1.21 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.918 -1.114 . . . . 0.0 110.098 -179.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.645 ' CE2' ' CE2' ' A' ' 16' ' ' TYR . 1.1 p90 -119.0 150.48 39.88 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.933 -1.104 . . . . 0.0 109.546 179.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 57.8 mtm180 -130.01 133.82 47.0 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.237 -0.914 . . . . 0.0 109.289 179.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.929 HG13 ' O ' ' A' ' 15' ' ' GLY . 54.1 t -122.92 149.98 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.202 -0.936 . . . . 0.0 109.711 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.553 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.2 OUTLIER -131.39 175.91 3.31 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.322 -0.861 . . . . 0.0 109.261 -179.971 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.553 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 43.7 Cg_endo -66.07 -22.97 54.04 Favored 'Trans proline' 0 C--O 1.214 -0.684 0 C-N-CA 122.65 2.233 . . . . 0.0 111.929 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 3.5 mtm180 -106.29 -31.77 8.47 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.301 -0.874 . . . . 0.0 109.357 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.488 HD12 ' HB2' ' A' ' 11' ' ' LEU . 92.9 mt -77.17 -39.33 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.374 -0.829 . . . . 0.0 109.347 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.929 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 70.73 -162.81 53.71 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.645 ' CE2' ' CE2' ' A' ' 8' ' ' TYR . 2.0 t80 -95.01 150.55 20.04 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.211 -1.17 . . . . 0.0 109.632 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 23.0 tp -113.13 111.33 21.92 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.412 -0.805 . . . . 0.0 109.593 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.452 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 84.6 m -128.68 156.63 77.17 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.147 -0.971 . . . . 0.0 109.317 179.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.525 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 48.9 Cg_endo -70.82 167.53 25.57 Favored 'Trans proline' 0 C--O 1.216 -0.611 0 C-N-CA 122.717 2.278 . . . . 0.0 111.577 179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 62.6 mttm -94.94 -4.56 46.54 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.255 -0.903 . . . . 0.0 109.631 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -76.69 123.98 26.97 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.206 -0.934 . . . . 0.0 109.348 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.751 HD21 ' OD1' ' A' ' 34' ' ' ASN . 3.3 tm? -82.73 119.02 23.8 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.208 -0.933 . . . . 0.0 109.498 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.595 ' N ' HD13 ' A' ' 22' ' ' LEU . 15.5 mttp -141.88 107.51 5.87 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.302 -0.874 . . . . 0.0 109.476 179.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.546 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 43.3 Cg_endo -65.9 123.66 11.61 Favored 'Trans proline' 0 C--O 1.213 -0.728 0 C-N-CA 123.017 2.478 . . . . 0.0 112.14 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.663 ' O ' HG23 ' A' ' 32' ' ' THR . 29.7 m -116.32 155.02 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.265 -0.897 . . . . 0.0 109.71 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.455 ' O ' ' N ' ' A' ' 53' ' ' ARG . 43.5 t -99.27 122.94 43.12 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.428 -0.795 . . . . 0.0 108.914 179.418 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -81.45 137.99 18.36 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.514 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 47.0 p30 -68.54 -8.33 40.46 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.248 -1.148 . . . . 0.0 109.575 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -84.14 10.04 11.19 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.194 -0.941 . . . . 0.0 109.189 179.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.32 15.66 66.1 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.167 -1.573 . . . . 0.0 109.167 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.446 ' O ' ' N ' ' A' ' 27' ' ' GLY . 86.6 mt-30 -124.27 167.85 13.76 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.344 -1.092 . . . . 0.0 109.535 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.663 HG23 ' O ' ' A' ' 25' ' ' VAL . 42.1 m -127.96 137.91 52.43 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.251 -0.906 . . . . 0.0 109.526 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.879 ' CD1' HD13 ' A' ' 39' ' ' LEU . 71.4 m-85 -113.79 129.26 56.6 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.288 -0.882 . . . . 0.0 109.28 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.751 ' OD1' HD21 ' A' ' 22' ' ' LEU . 45.4 t-20 -51.09 -78.95 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.363 -0.836 . . . . 0.0 110.255 -179.197 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.53 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 1.7 t-20 -81.6 149.91 65.46 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 120.964 -1.085 . . . . 0.0 109.762 -179.492 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.469 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.9 Cg_endo -63.88 -55.53 0.64 Allowed 'Trans proline' 0 C--O 1.215 -0.674 0 C-N-CA 122.765 2.31 . . . . 0.0 111.864 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.53 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 12.9 t -61.41 -30.58 70.65 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.022 -1.049 . . . . 0.0 108.175 179.097 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.521 ' CG ' ' HB3' ' A' ' 35' ' ' ASN . 65.0 mmm -61.41 -15.15 34.05 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 179.016 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.879 HD13 ' CD1' ' A' ' 33' ' ' TYR . 37.8 tp -68.94 -58.55 3.97 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.434 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.453 ' HB3' ' OH ' ' A' ' 16' ' ' TYR . 19.5 t -53.28 -29.34 32.72 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 179.001 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 48.1 t60 -64.19 -61.57 2.17 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.444 ' HA ' ' OE1' ' A' ' 42' ' ' GLU . 71.2 mm-40 -56.06 -20.3 16.44 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.412 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.479 ' O ' ' N ' ' A' ' 47' ' ' GLN . 97.3 m-20 -79.44 -24.75 42.23 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.752 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.96 HD13 ' O ' ' A' ' 44' ' ' LEU . 1.7 tm? -71.86 -37.34 70.25 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.333 -0.855 . . . . 0.0 108.766 179.35 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.542 ' N ' HD13 ' A' ' 45' ' ' ILE . 3.8 mm -75.92 -44.68 38.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.404 -0.81 . . . . 0.0 109.232 179.609 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.447 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 14.7 mtt-85 -79.61 -37.72 35.53 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.359 -0.838 . . . . 0.0 109.19 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.479 ' N ' ' O ' ' A' ' 43' ' ' ASN . 91.6 mt-30 62.06 40.46 12.05 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.334 -0.854 . . . . 0.0 109.469 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.42 HG23 ' HB3' ' A' ' 46' ' ' ARG . 62.4 p -107.53 17.22 22.96 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.239 -0.913 . . . . 0.0 109.45 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.567 ' OD1' ' CE1' ' A' ' 51' ' ' HIS . 13.4 t-20 44.82 58.61 3.86 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.294 -0.879 . . . . 0.0 109.511 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.461 ' HB ' ' OD1' ' A' ' 43' ' ' ASN . 50.1 m -80.32 147.28 31.19 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.212 -0.93 . . . . 0.0 109.715 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.567 ' CE1' ' OD1' ' A' ' 49' ' ' ASN . 30.6 m-70 -122.16 169.78 10.53 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.345 -0.847 . . . . 0.0 108.988 179.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.454 HG12 HD22 ' A' ' 39' ' ' LEU . 10.7 mt -81.2 122.29 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.15 -0.969 . . . . 0.0 109.611 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.514 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 56.5 ttt180 -79.9 -44.84 19.68 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.436 -0.79 . . . . 0.0 109.301 179.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.4 t -157.95 154.4 27.73 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.43 -0.794 . . . . 0.0 109.195 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.6 p -73.31 132.46 43.12 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.22 -0.925 . . . . 0.0 109.568 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.546 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 100.16 164.2 28.7 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.654 ' HA ' HG21 ' A' ' 32' ' ' THR . 39.7 tttt -50.2 150.31 2.51 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.443 -1.033 . . . . 0.0 109.263 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 36.2 m -56.25 -31.7 63.82 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.179 -0.951 . . . . 0.0 109.42 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.42 ' CD ' ' HE2' ' A' ' 57' ' ' LYS . 19.0 mt-10 -82.12 -31.34 30.69 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.308 -0.87 . . . . 0.0 108.892 179.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.467 ' OE1' ' HA3' ' A' ' 56' ' ' GLY . 37.9 tt0 -53.52 -21.98 7.37 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.466 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 13.5 m -68.76 -35.94 77.71 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.433 -0.792 . . . . 0.0 109.547 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 43.7 m -113.04 143.17 44.78 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.256 -0.902 . . . . 0.0 109.558 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -122.05 77.32 41.43 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.322 -0.861 . . . . 0.0 109.278 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -69.39 -20.12 36.99 Favored 'Trans proline' 0 C--O 1.215 -0.664 0 C-N-CA 122.735 2.29 . . . . 0.0 111.762 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 171.05 -179.03 43.15 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 21.0 p -122.12 159.94 26.12 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.201 -1.176 . . . . 0.0 109.487 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 63.2 p -68.07 -26.93 66.09 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.231 -0.918 . . . . 0.0 109.42 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -62.72 -33.31 74.84 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.274 -0.891 . . . . 0.0 109.506 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.427 ' O ' ' HD3' ' A' ' 72' ' ' PRO . . . -66.49 -31.69 72.57 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.221 -0.924 . . . . 0.0 109.409 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 32.9 t -60.92 -28.53 69.0 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.218 -0.926 . . . . 0.0 109.495 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.87 77.72 76.28 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.278 -0.889 . . . . 0.0 109.404 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.427 ' HD3' ' O ' ' A' ' 69' ' ' ALA . 49.9 Cg_endo -70.07 151.03 67.11 Favored 'Trans proline' 0 C--O 1.215 -0.635 0 C-N-CA 122.69 2.26 . . . . 0.0 111.894 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -70.45 156.72 60.93 Favored 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 122.689 2.259 . . . . 0.0 111.788 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 81.4 p -82.71 -8.21 59.6 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.275 -0.891 . . . . 0.0 109.61 -179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 -69.69 -28.86 66.2 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.189 -0.945 . . . . 0.0 109.472 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 118.038 -0.982 . . . . 0.0 109.438 -179.999 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.408 ' HA ' ' SG ' ' A' ' 40' ' ' CYS . 0.9 OUTLIER -54.12 -32.28 54.65 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.214 -0.929 . . . . 0.0 109.346 179.887 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.447 ' HA ' ' HG3' ' A' ' 6' ' ' LYS . 5.0 mt-10 -53.93 -23.13 11.84 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.2 -0.937 . . . . 0.0 108.92 179.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.428 ' O ' ' CG ' ' A' ' 7' ' ' ASP . 67.8 mmm -71.15 -27.98 63.94 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.277 -0.889 . . . . 0.0 108.98 179.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 35.1 m -80.91 -17.17 51.47 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.376 -0.827 . . . . 0.0 109.198 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.447 ' HG3' ' HA ' ' A' ' 3' ' ' GLU . 34.3 mttp -80.28 8.18 7.97 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.313 -0.867 . . . . 0.0 109.665 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.428 ' CG ' ' O ' ' A' ' 4' ' ' MET . 17.4 p30 -117.45 -10.93 10.59 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.182 -0.948 . . . . 0.0 109.638 -179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.58 ' OH ' ' CZ ' ' A' ' 16' ' ' TYR . 1.5 p90 -104.3 171.28 7.42 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.159 -0.963 . . . . 0.0 109.546 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 85.9 mtt180 -131.42 157.06 44.46 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.294 -0.879 . . . . 0.0 109.215 179.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.849 HG21 ' C ' ' A' ' 15' ' ' GLY . 14.5 p -136.97 158.35 36.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.166 -0.959 . . . . 0.0 109.816 -179.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.543 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 1.6 mp -108.2 175.36 2.02 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.265 -0.897 . . . . 0.0 109.354 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.543 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 45.7 Cg_endo -67.56 -27.71 38.81 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 122.589 2.193 . . . . 0.0 111.682 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 37.6 mtm180 -84.15 -38.75 20.28 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.381 -0.824 . . . . 0.0 109.055 179.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.488 ' CG2' ' HG ' ' A' ' 17' ' ' LEU . 98.7 mt -77.12 -34.79 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.381 -0.824 . . . . 0.0 109.024 179.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.849 ' C ' HG21 ' A' ' 10' ' ' VAL . . . 68.2 -65.45 0.37 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 179.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.58 ' CZ ' ' OH ' ' A' ' 8' ' ' TYR . 1.2 t80 -160.59 150.82 18.0 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.31 -1.112 . . . . 0.0 109.328 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.827 ' N ' HD12 ' A' ' 17' ' ' LEU . 0.4 OUTLIER -123.07 141.61 51.78 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.25 -0.906 . . . . 0.0 109.472 179.976 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.451 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 75.0 m -146.26 158.01 48.39 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.308 -0.87 . . . . 0.0 109.15 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.538 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 46.6 Cg_endo -69.93 165.3 31.63 Favored 'Trans proline' 0 C--O 1.214 -0.695 0 C-N-CA 122.494 2.129 . . . . 0.0 111.308 179.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -91.81 -8.52 46.42 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.204 -0.935 . . . . 0.0 109.508 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 -74.54 129.48 37.82 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.274 -0.891 . . . . 0.0 109.218 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.809 HD21 ' OD1' ' A' ' 34' ' ' ASN . 3.4 tm? -87.92 121.24 30.09 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.207 -0.933 . . . . 0.0 109.37 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.615 ' N ' HD13 ' A' ' 22' ' ' LEU . 14.0 mttt -144.3 109.39 4.95 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.091 -1.006 . . . . 0.0 109.717 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.536 ' HA ' ' O ' ' A' ' 34' ' ' ASN . 44.1 Cg_endo -66.58 122.84 10.33 Favored 'Trans proline' 0 C--O 1.214 -0.706 0 C-N-CA 122.947 2.431 . . . . 0.0 111.899 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.507 ' HB ' HG23 ' A' ' 52' ' ' ILE . 8.7 m -117.46 156.9 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.22 -0.925 . . . . 0.0 109.858 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 45.5 t -97.54 136.62 37.69 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 178.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.403 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -94.04 135.19 12.4 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 -179.482 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.489 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 49.0 p30 -64.26 -11.31 30.27 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.303 -1.116 . . . . 0.0 109.349 179.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.458 ' OD1' ' HB2' ' A' ' 31' ' ' GLN . 58.0 p30 -84.24 9.49 12.79 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.323 -0.861 . . . . 0.0 109.488 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 83.87 23.51 52.43 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.458 ' HB2' ' OD1' ' A' ' 29' ' ' ASP . 67.8 mt-30 -129.17 171.71 12.16 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.312 -1.11 . . . . 0.0 109.409 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.576 HG21 ' HG3' ' A' ' 57' ' ' LYS . 24.0 m -131.12 139.42 49.82 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.284 -0.885 . . . . 0.0 109.26 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.821 ' CD1' HD13 ' A' ' 39' ' ' LEU . 70.9 m-85 -118.68 131.62 56.16 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.277 -0.889 . . . . 0.0 109.416 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.809 ' OD1' HD21 ' A' ' 22' ' ' LEU . 53.5 t-20 -51.65 -79.09 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.374 -0.829 . . . . 0.0 110.174 -179.381 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.527 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 1.9 t-20 -81.39 149.41 65.21 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 120.932 -1.105 . . . . 0.0 109.597 -179.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.486 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.4 Cg_endo -63.28 -55.1 0.81 Allowed 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 122.685 2.257 . . . . 0.0 111.884 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.538 ' HB3' ' HD2' ' A' ' 19' ' ' PRO . 10.6 t -60.06 -33.22 71.76 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 120.996 -1.065 . . . . 0.0 108.128 178.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.473 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 39.7 mmm -55.63 -20.21 13.08 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.086 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.821 HD13 ' CD1' ' A' ' 33' ' ' TYR . 51.5 tp -68.48 -46.59 69.28 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.563 -0.711 . . . . 0.0 109.098 179.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.484 ' HB2' ' OH ' ' A' ' 16' ' ' TYR . 3.2 m -69.04 -21.25 64.12 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 179.15 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 41.0 t60 -67.21 -54.83 17.46 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 178.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.436 ' HA ' ' OE1' ' A' ' 42' ' ' GLU . 68.6 mm-40 -62.51 -19.99 64.16 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 178.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.527 ' O ' ' N ' ' A' ' 47' ' ' GLN . 83.1 m-20 -80.27 -24.27 40.2 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 23.3 tp -73.24 -31.82 64.35 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.1 mm -80.11 -48.2 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.381 -0.824 . . . . 0.0 108.937 179.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.456 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 63.7 mtt-85 -80.66 -33.79 35.31 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.267 -0.896 . . . . 0.0 109.353 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.527 ' N ' ' O ' ' A' ' 43' ' ' ASN . 91.7 mt-30 63.31 38.54 10.2 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.386 -0.822 . . . . 0.0 109.659 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.435 HG23 ' HB3' ' A' ' 46' ' ' ARG . 55.1 p -101.68 3.84 40.13 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.21 -0.931 . . . . 0.0 109.452 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 63.9 m-20 54.64 58.08 5.18 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.227 -0.921 . . . . 0.0 109.427 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 31.6 m -78.46 139.22 38.72 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.239 -0.913 . . . . 0.0 109.589 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 49.3 m-70 -113.63 167.38 10.66 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.303 -0.873 . . . . 0.0 108.893 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.507 HG23 ' HB ' ' A' ' 25' ' ' VAL . 36.9 mt -79.63 125.59 38.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.169 -0.957 . . . . 0.0 109.256 179.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.489 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 69.9 ttt-85 -81.3 -38.61 26.5 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.415 -0.803 . . . . 0.0 109.346 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -160.45 151.16 18.59 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.47 -0.769 . . . . 0.0 109.084 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.3 p -70.46 143.59 51.71 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.168 -0.958 . . . . 0.0 109.467 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.533 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 88.87 164.37 40.28 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.576 ' HG3' HG21 ' A' ' 32' ' ' THR . 33.8 ttpt -54.53 151.08 8.31 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.474 -1.016 . . . . 0.0 109.442 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 88.8 m -57.07 -179.71 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.247 -0.908 . . . . 0.0 109.446 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -93.73 19.84 8.27 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.179 -0.951 . . . . 0.0 109.711 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 66.9 tt0 -60.86 -35.85 77.64 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.253 -0.904 . . . . 0.0 109.356 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 24.7 p -58.96 144.99 43.24 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.346 -0.846 . . . . 0.0 109.502 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 40.8 m -115.81 153.45 31.44 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.252 -0.905 . . . . 0.0 109.447 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 62.6 p -86.66 130.73 47.85 Favored Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.298 -0.877 . . . . 0.0 109.514 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -70.69 -17.01 33.65 Favored 'Trans proline' 0 C--O 1.214 -0.679 0 C-N-CA 122.755 2.303 . . . . 0.0 111.83 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -55.07 -30.57 54.69 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 24.0 p -120.13 163.65 17.39 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.259 -1.142 . . . . 0.0 109.486 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.654 HG22 ' H ' ' A' ' 69' ' ' ALA . 39.1 m -116.87 139.08 51.04 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.139 -0.976 . . . . 0.0 109.465 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.45 ' O ' ' HB2' ' A' ' 71' ' ' MET . . . -65.0 -28.13 69.3 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.248 -0.907 . . . . 0.0 109.473 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.654 ' H ' HG22 ' A' ' 67' ' ' THR . . . -65.63 -31.84 73.09 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.228 -0.92 . . . . 0.0 109.459 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 87.2 p -65.56 -27.4 68.41 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.311 -0.868 . . . . 0.0 109.452 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.502 ' CB ' ' CD ' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -53.79 -61.41 5.26 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.314 -0.866 . . . . 0.0 109.495 -179.981 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.502 ' CD ' ' CB ' ' A' ' 71' ' ' MET . 50.1 Cg_endo -70.62 151.28 64.08 Favored 'Trans proline' 0 C--O 1.214 -0.71 0 C-N-CA 122.599 2.199 . . . . 0.0 111.75 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -70.74 143.73 46.93 Favored 'Trans proline' 0 C--O 1.215 -0.626 0 C-N-CA 122.668 2.245 . . . . 0.0 111.815 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 32.1 t -115.52 142.33 46.86 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.282 -0.886 . . . . 0.0 109.456 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 54.8 p30 -91.71 10.04 29.99 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.233 -0.917 . . . . 0.0 109.478 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.474 -179.971 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.395 0.617 . . . . 0.0 109.532 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.517 ' OG ' HD22 ' A' ' 39' ' ' LEU . 37.5 m -74.31 -0.67 17.81 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.47 -0.769 . . . . 0.0 109.632 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.44 ' O ' ' HG2' ' A' ' 6' ' ' LYS . 3.4 mt-10 -48.27 -23.81 1.0 Allowed 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.122 -0.987 . . . . 0.0 108.741 179.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 84.3 mtp -66.95 -29.14 68.91 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.377 -0.827 . . . . 0.0 108.797 179.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.571 ' SG ' ' CE1' ' A' ' 8' ' ' TYR . 10.6 t -84.19 -8.23 59.12 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.464 -0.772 . . . . 0.0 109.069 179.518 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.44 ' HG2' ' O ' ' A' ' 3' ' ' GLU . 3.7 pttp -57.46 -15.7 7.6 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.32 -0.863 . . . . 0.0 109.733 -179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 51.0 p-10 -159.03 32.66 0.21 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.043 -1.035 . . . . 0.0 109.811 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.571 ' CE1' ' SG ' ' A' ' 5' ' ' CYS . 5.1 p90 -79.71 175.61 10.47 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.119 -0.988 . . . . 0.0 109.194 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 53.7 mtm180 -143.98 136.43 26.85 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.145 -0.972 . . . . 0.0 109.911 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.58 HG13 ' O ' ' A' ' 15' ' ' GLY . 23.4 t -137.41 135.61 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.371 -0.83 . . . . 0.0 109.097 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.662 ' HB2' HD12 ' A' ' 14' ' ' ILE . 1.6 mp -102.83 172.4 4.33 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.231 -0.918 . . . . 0.0 109.701 -179.532 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.487 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 45.7 Cg_endo -67.68 -22.78 43.31 Favored 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 122.637 2.225 . . . . 0.0 111.563 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 82.1 mtt180 -99.8 -24.96 14.53 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.341 -0.849 . . . . 0.0 109.16 179.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.662 HD12 ' HB2' ' A' ' 11' ' ' LEU . 79.2 mt -85.34 -47.3 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.312 -0.867 . . . . 0.0 109.428 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.58 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 71.58 -169.54 49.91 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.581 ' CB ' ' NE2' ' A' ' 41' ' ' HIS . 0.8 OUTLIER -92.36 150.2 20.97 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.259 -1.142 . . . . 0.0 109.591 -179.94 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.698 ' C ' HD13 ' A' ' 17' ' ' LEU . 2.3 tm? -119.66 105.35 11.1 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.254 -0.904 . . . . 0.0 109.309 179.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.445 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 58.5 m -118.75 155.64 52.39 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.305 -0.872 . . . . 0.0 109.305 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -72.42 171.73 16.43 Favored 'Trans proline' 0 C--O 1.215 -0.667 0 C-N-CA 122.618 2.212 . . . . 0.0 111.324 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 45.0 mttp -91.45 -23.32 20.04 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.213 -0.93 . . . . 0.0 109.355 179.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -62.34 130.49 45.52 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.339 -0.85 . . . . 0.0 109.179 179.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 24.0 tp -90.72 111.83 23.35 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.211 -0.931 . . . . 0.0 109.805 -179.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.479 ' O ' ' O ' ' A' ' 34' ' ' ASN . 0.0 OUTLIER -123.28 108.64 31.71 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.324 -0.86 . . . . 0.0 108.87 179.637 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.526 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 43.6 Cg_endo -66.16 119.58 6.62 Favored 'Trans proline' 0 C--O 1.214 -0.713 0 C-N-CA 122.865 2.377 . . . . 0.0 112.052 -179.417 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.591 ' O ' HG23 ' A' ' 32' ' ' THR . 11.2 m -112.57 155.31 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.418 -0.801 . . . . 0.0 109.512 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.411 ' O ' ' HA ' ' A' ' 52' ' ' ILE . 43.4 t -97.07 141.4 30.27 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -98.47 133.85 11.48 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 -179.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.65 ' OD1' HG23 ' A' ' 50' ' ' THR . 37.5 p30 -61.83 -12.49 17.67 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.315 -1.109 . . . . 0.0 109.586 179.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -87.01 15.46 5.98 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.21 -0.931 . . . . 0.0 109.414 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 79.37 19.41 71.72 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.471 ' O ' ' SG ' ' A' ' 58' ' ' CYS . 44.5 mt-30 -120.95 179.33 4.4 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.152 -1.205 . . . . 0.0 109.496 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.605 HG21 ' HG3' ' A' ' 57' ' ' LYS . 14.5 m -143.36 137.2 28.57 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.264 -0.897 . . . . 0.0 109.557 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.572 ' CD1' ' HG ' ' A' ' 39' ' ' LEU . 41.2 m-85 -113.03 134.8 54.35 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.364 -0.835 . . . . 0.0 109.46 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.518 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 9.9 m-20 -54.16 -78.06 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.322 -0.861 . . . . 0.0 109.785 -179.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.53 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 4.1 t-20 -81.88 147.72 59.1 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.018 -1.051 . . . . 0.0 109.022 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.469 ' HD3' ' O ' ' A' ' 23' ' ' LYS . 41.7 Cg_endo -63.97 -52.55 1.63 Allowed 'Trans proline' 0 C--O 1.215 -0.629 0 C-N-CA 122.522 2.148 . . . . 0.0 111.758 -179.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.53 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 11.3 t -62.09 -29.03 70.03 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.078 -1.014 . . . . 0.0 108.324 179.021 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.473 ' HB2' ' HB3' ' A' ' 35' ' ' ASN . 35.3 mmm -69.04 -12.82 62.03 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.566 -0.709 . . . . 0.0 109.278 179.52 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.777 HD13 HG12 ' A' ' 52' ' ' ILE . 9.6 tt -67.97 -52.55 34.62 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.189 -0.945 . . . . 0.0 108.955 179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.483 ' SG ' ' CE1' ' A' ' 8' ' ' TYR . 9.3 t -61.46 -34.17 74.99 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 179.19 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.581 ' NE2' ' CB ' ' A' ' 16' ' ' TYR . 0.2 OUTLIER -50.94 -46.69 61.03 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 178.51 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -66.11 -32.08 73.32 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 179.08 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.52 ' ND2' ' O ' ' A' ' 50' ' ' THR . 34.0 m-20 -68.74 -23.47 64.34 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.51 -0.744 . . . . 0.0 109.396 179.683 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.954 HD13 ' O ' ' A' ' 44' ' ' LEU . 2.4 tm? -72.2 -36.4 69.19 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.285 -0.884 . . . . 0.0 109.66 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.411 ' N ' HD13 ' A' ' 45' ' ' ILE . 4.8 mm -78.04 -46.04 26.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.242 -0.911 . . . . 0.0 109.381 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.491 ' HB3' HG23 ' A' ' 48' ' ' THR . 14.4 mtt-85 -81.73 -33.19 31.19 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.289 -0.882 . . . . 0.0 109.611 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.474 ' N ' ' O ' ' A' ' 43' ' ' ASN . 92.0 mt-30 62.49 33.76 15.83 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.272 -0.892 . . . . 0.0 109.63 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.491 HG23 ' HB3' ' A' ' 46' ' ' ARG . 58.9 p -95.65 7.43 46.31 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.224 -0.922 . . . . 0.0 109.415 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.577 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 57.8 t30 52.63 49.0 21.32 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.276 -0.89 . . . . 0.0 109.649 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.65 HG23 ' OD1' ' A' ' 28' ' ' ASP . 39.4 m -80.78 149.05 29.78 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.37 -0.831 . . . . 0.0 109.359 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.577 ' CE1' ' O ' ' A' ' 49' ' ' ASN . 13.6 m80 -127.21 -176.76 3.82 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.189 -0.945 . . . . 0.0 109.348 179.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.777 HG12 HD13 ' A' ' 39' ' ' LEU . 29.4 mt -84.89 128.13 39.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 O-C-N 121.39 -0.819 . . . . 0.0 109.46 179.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.505 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 42.3 ttt85 -83.83 -38.55 21.08 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.321 -0.862 . . . . 0.0 109.059 179.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -160.75 148.83 16.08 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 27.0 p -67.17 135.97 54.33 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.123 -0.986 . . . . 0.0 109.462 -179.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.526 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 95.2 161.87 34.16 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.302 -1.519 . . . . 0.0 109.302 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.605 ' HG3' HG21 ' A' ' 32' ' ' THR . 47.5 tttp -50.03 148.23 3.46 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.402 -1.058 . . . . 0.0 109.287 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.471 ' SG ' ' O ' ' A' ' 31' ' ' GLN . 95.6 m -51.43 -30.19 18.54 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.309 -0.869 . . . . 0.0 109.568 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -84.6 -30.4 25.02 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.304 -0.873 . . . . 0.0 109.13 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 17.3 tt0 -60.39 -16.9 39.96 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.286 -0.884 . . . . 0.0 108.801 179.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 30.1 m -71.34 142.82 50.4 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.386 -0.822 . . . . 0.0 109.515 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 87.7 p -115.71 153.13 31.92 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.181 -0.949 . . . . 0.0 109.433 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.432 ' HB ' ' HD2' ' A' ' 64' ' ' PRO . 1.6 p -62.16 163.68 13.12 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.246 -0.908 . . . . 0.0 109.458 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.432 ' HD2' ' HB ' ' A' ' 63' ' ' THR . 52.5 Cg_endo -72.28 -20.81 24.05 Favored 'Trans proline' 0 C--O 1.215 -0.664 0 C-N-CA 122.598 2.198 . . . . 0.0 111.659 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.72 19.76 62.96 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 41.6 m -121.25 136.11 55.02 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.339 -1.095 . . . . 0.0 109.416 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 18.9 p -123.17 164.94 17.73 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.312 -0.867 . . . . 0.0 109.559 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -62.96 -33.53 75.57 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.327 -0.858 . . . . 0.0 109.522 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -144.48 155.11 43.56 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.339 -0.85 . . . . 0.0 109.44 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 25.1 m -60.08 -29.56 68.66 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.225 -0.922 . . . . 0.0 109.387 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 23.4 mtt -74.86 145.4 81.32 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.276 -0.89 . . . . 0.0 109.46 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -70.46 148.06 59.74 Favored 'Trans proline' 0 C--O 1.215 -0.644 0 C-N-CA 122.664 2.243 . . . . 0.0 111.834 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -71.94 -15.96 29.31 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 122.677 2.251 . . . . 0.0 111.742 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.447 ' O ' ' HG3' ' A' ' 76' ' ' GLU . 86.1 p -145.83 154.16 41.69 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.221 -0.924 . . . . 0.0 109.551 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -55.23 -36.29 65.86 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.215 -0.928 . . . . 0.0 109.471 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.447 ' HG3' ' O ' ' A' ' 74' ' ' SER . 96.7 mt-10 . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.509 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.568 ' OG ' ' CE1' ' A' ' 51' ' ' HIS . 2.1 m -55.46 -31.68 62.15 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.306 -0.871 . . . . 0.0 109.515 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -53.29 -25.61 15.38 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.327 -0.858 . . . . 0.0 109.023 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 82.8 mtp -73.84 -26.78 60.76 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.385 -0.822 . . . . 0.0 109.245 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.539 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 70.2 m -79.92 -20.77 44.93 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.324 -0.86 . . . . 0.0 109.217 179.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 33.4 mttt -80.63 7.46 10.06 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.194 -0.941 . . . . 0.0 109.391 179.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -123.18 -3.63 8.49 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.199 -0.938 . . . . 0.0 110.217 -179.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.687 ' CE2' ' CZ ' ' A' ' 16' ' ' TYR . 2.1 p90 -114.57 173.0 6.68 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.959 -1.088 . . . . 0.0 109.848 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 39.5 ptt180 -157.34 134.47 10.3 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.8 HG13 ' O ' ' A' ' 15' ' ' GLY . 79.9 t -116.79 145.41 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.226 -0.921 . . . . 0.0 110.215 -179.071 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.756 ' HB2' HD12 ' A' ' 14' ' ' ILE . 2.1 mp -117.67 175.81 1.87 Allowed Pre-proline 0 N--CA 1.49 1.527 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.549 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 44.7 Cg_endo -67.56 -22.52 44.39 Favored 'Trans proline' 0 C--O 1.216 -0.621 0 C-N-CA 122.451 2.101 . . . . 0.0 111.81 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 63.1 mtt180 -113.63 -22.44 10.27 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.294 -0.879 . . . . 0.0 109.64 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.756 HD12 ' HB2' ' A' ' 11' ' ' LEU . 92.4 mt -78.23 -44.35 27.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.216 -0.927 . . . . 0.0 109.504 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.8 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 74.94 -165.33 54.74 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.687 ' CZ ' ' CE2' ' A' ' 8' ' ' TYR . 0.9 OUTLIER -93.76 149.55 21.14 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.16 -1.2 . . . . 0.0 109.557 179.999 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 16.8 tp -119.61 115.54 24.18 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.288 -0.883 . . . . 0.0 109.688 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 75.6 m -126.07 156.8 71.38 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.292 -0.88 . . . . 0.0 109.177 179.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.48 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 50.5 Cg_endo -71.35 167.33 26.6 Favored 'Trans proline' 0 C--O 1.216 -0.59 0 C-N-CA 122.64 2.227 . . . . 0.0 111.685 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.4 mttt -86.59 -23.43 25.77 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.271 -0.893 . . . . 0.0 109.328 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 49.2 m-20 -63.21 130.48 44.74 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.29 -0.881 . . . . 0.0 109.241 179.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 48.7 tp -93.83 117.47 30.14 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.184 -0.947 . . . . 0.0 109.541 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.487 ' O ' ' O ' ' A' ' 34' ' ' ASN . 0.1 OUTLIER -129.1 106.52 17.93 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.324 -0.86 . . . . 0.0 108.941 179.719 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.538 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 43.2 Cg_endo -65.1 119.91 7.04 Favored 'Trans proline' 0 C--O 1.213 -0.765 0 C-N-CA 122.93 2.42 . . . . 0.0 112.086 -179.564 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.609 ' O ' HG23 ' A' ' 32' ' ' THR . 35.6 m -116.5 153.74 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.336 -0.852 . . . . 0.0 109.688 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 43.0 t -96.05 135.52 37.72 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.354 -0.841 . . . . 0.0 108.787 179.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -92.44 139.12 14.51 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -179.585 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.504 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 50.9 p30 -68.5 -7.86 36.01 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.366 -1.079 . . . . 0.0 109.579 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.427 ' OD1' ' HB2' ' A' ' 31' ' ' GLN . 56.6 p30 -88.52 9.21 24.62 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.163 -0.961 . . . . 0.0 109.35 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.23 13.99 64.97 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.464 ' O ' ' N ' ' A' ' 27' ' ' GLY . 83.2 mt-30 -120.26 171.97 8.12 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.278 -1.131 . . . . 0.0 109.447 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.661 HG21 ' HA ' ' A' ' 57' ' ' LYS . 25.9 m -133.95 138.31 45.39 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.248 -0.908 . . . . 0.0 109.353 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.811 ' CD1' HD13 ' A' ' 39' ' ' LEU . 28.7 m-85 -113.0 128.5 56.52 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.28 -0.888 . . . . 0.0 109.205 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.519 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 13.1 m-20 -51.66 -78.17 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.239 -0.913 . . . . 0.0 109.692 -179.543 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.533 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 5.1 t-20 -81.85 147.9 59.69 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.171 -0.956 . . . . 0.0 109.688 -179.692 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.469 ' HD2' ' CG ' ' A' ' 35' ' ' ASN . 40.5 Cg_endo -63.22 -52.98 1.7 Allowed 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.766 2.311 . . . . 0.0 111.909 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.533 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 9.2 t -62.54 -28.36 69.8 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 120.97 -1.081 . . . . 0.0 108.11 178.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.465 ' CG ' ' HB3' ' A' ' 35' ' ' ASN . 49.7 mmm -64.75 -14.2 57.92 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.377 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.811 HD13 ' CD1' ' A' ' 33' ' ' TYR . 23.7 tp -71.68 -65.33 0.77 Allowed 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 179.284 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.452 ' HB3' ' OH ' ' A' ' 16' ' ' TYR . 8.5 t -49.25 -28.33 4.56 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 66.5 t60 -63.02 -62.54 1.64 Allowed 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 179.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 77.2 tt0 -59.13 -19.08 41.58 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.471 ' O ' ' N ' ' A' ' 47' ' ' GLN . 98.1 m-20 -78.16 -29.65 48.74 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.391 -0.818 . . . . 0.0 108.815 179.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 17.6 tp -72.37 -27.75 62.58 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.313 -0.867 . . . . 0.0 108.847 179.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.3 mt -79.87 -49.64 18.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.321 -0.862 . . . . 0.0 108.9 179.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.549 ' HB3' HG23 ' A' ' 48' ' ' THR . 52.8 mtt180 -80.73 -32.82 35.58 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.338 -0.851 . . . . 0.0 109.307 179.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.471 ' N ' ' O ' ' A' ' 43' ' ' ASN . 92.1 mt-30 62.62 36.68 13.49 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.373 -0.829 . . . . 0.0 109.627 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.549 HG23 ' HB3' ' A' ' 46' ' ' ARG . 59.5 p -96.21 2.45 53.02 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.217 -0.927 . . . . 0.0 109.585 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.4 m120 58.0 54.76 5.75 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.251 -0.905 . . . . 0.0 109.449 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.404 ' HB ' ' OD1' ' A' ' 43' ' ' ASN . 43.3 m -79.94 144.06 33.66 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.292 -0.88 . . . . 0.0 109.68 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.568 ' CE1' ' OG ' ' A' ' 2' ' ' SER . 30.5 m-70 -118.62 173.5 6.81 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.329 -0.857 . . . . 0.0 109.023 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.462 HG12 HD22 ' A' ' 39' ' ' LEU . 12.0 mt -84.38 123.99 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.16 -0.962 . . . . 0.0 109.472 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.504 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 45.2 ttt85 -79.75 -43.0 23.39 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.297 -0.877 . . . . 0.0 109.248 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.8 t -160.02 155.09 24.77 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.9 p -72.56 132.83 44.31 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.198 -0.939 . . . . 0.0 109.483 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.538 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 99.07 164.49 29.93 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -179.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.661 ' HA ' HG21 ' A' ' 32' ' ' THR . 71.1 tttt -53.13 148.4 8.27 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.429 -1.042 . . . . 0.0 109.397 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 91.2 m -54.81 -25.93 31.6 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.263 -0.898 . . . . 0.0 109.376 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.403 ' HB3' ' HD3' ' A' ' 57' ' ' LYS . 76.6 tt0 -86.06 -21.55 27.65 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.36 -0.838 . . . . 0.0 109.346 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.443 ' OE1' ' HA3' ' A' ' 56' ' ' GLY . 71.7 tt0 -63.53 -34.35 77.59 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.299 -0.876 . . . . 0.0 109.372 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 32.6 t -71.34 135.96 47.59 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.382 -0.823 . . . . 0.0 109.449 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 23.3 t -117.67 153.18 33.76 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.194 -0.942 . . . . 0.0 109.559 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 37.4 m -134.55 78.71 55.71 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.322 -0.861 . . . . 0.0 109.457 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -69.59 -23.01 32.04 Favored 'Trans proline' 0 C--O 1.216 -0.617 0 C-N-CA 122.74 2.293 . . . . 0.0 111.714 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 59.31 -131.28 51.43 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 12.3 t -136.32 161.4 35.89 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.224 -1.162 . . . . 0.0 109.482 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.711 ' O ' ' HB2' ' A' ' 68' ' ' ALA . 53.0 m -59.45 -40.38 86.66 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.27 -0.894 . . . . 0.0 109.46 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.711 ' HB2' ' O ' ' A' ' 67' ' ' THR . . . 163.3 53.88 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.389 -0.819 . . . . 0.0 109.478 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.406 ' O ' ' HD3' ' A' ' 72' ' ' PRO . . . -62.54 -35.59 79.94 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.268 -0.895 . . . . 0.0 109.525 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.8 m -60.31 -31.07 69.92 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.182 -0.949 . . . . 0.0 109.475 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -128.3 78.9 74.93 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.281 -0.887 . . . . 0.0 109.43 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.406 ' HD3' ' O ' ' A' ' 69' ' ' ALA . 50.6 Cg_endo -70.32 152.96 66.72 Favored 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 122.697 2.264 . . . . 0.0 111.765 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -69.93 157.42 60.13 Favored 'Trans proline' 0 C--O 1.214 -0.69 0 C-N-CA 122.71 2.273 . . . . 0.0 111.66 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 87.5 p -82.83 -9.64 59.23 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.303 -0.873 . . . . 0.0 109.55 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 84.4 m-20 -73.3 -26.93 61.27 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.191 -0.943 . . . . 0.0 109.536 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 118.002 -0.999 . . . . 0.0 109.437 -179.997 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.2 m -46.47 -32.36 3.27 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.332 -0.855 . . . . 0.0 109.333 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.455 ' HA ' ' HG3' ' A' ' 6' ' ' LYS . 18.6 mt-10 -52.45 -28.59 20.72 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.742 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 44.4 ttm -71.74 -26.21 62.37 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.441 -0.787 . . . . 0.0 108.951 179.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.593 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 15.6 m -79.56 -12.7 59.84 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.498 -0.751 . . . . 0.0 108.974 179.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.455 ' HG3' ' HA ' ' A' ' 3' ' ' GLU . 4.1 mtmp? -56.58 -24.54 48.1 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.255 -0.903 . . . . 0.0 109.714 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 64.8 m-20 -149.71 64.49 0.99 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.136 -0.978 . . . . 0.0 110.334 -179.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.983 ' OH ' HD21 ' A' ' 44' ' ' LEU . 5.0 p90 -131.44 170.25 14.94 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.045 -1.034 . . . . 0.0 109.359 179.259 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 12.5 tpt180 -145.32 150.13 36.06 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.21 -0.932 . . . . 0.0 109.593 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.554 HG13 ' C ' ' A' ' 15' ' ' GLY . 71.0 t -141.63 130.98 24.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.239 -0.913 . . . . 0.0 109.315 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.66 ' HB2' HD12 ' A' ' 14' ' ' ILE . 2.5 mp -118.56 172.86 3.8 Favored Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 121.321 -0.862 . . . . 0.0 109.317 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.491 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 46.5 Cg_endo -68.38 -24.96 36.34 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 122.575 2.184 . . . . 0.0 111.614 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 54.5 mtt180 -104.68 -26.04 12.46 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.262 -0.899 . . . . 0.0 109.254 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.66 HD12 ' HB2' ' A' ' 11' ' ' LEU . 87.9 mt -84.54 -46.88 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.267 -0.896 . . . . 0.0 109.41 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.554 ' C ' HG13 ' A' ' 10' ' ' VAL . . . 77.73 -155.51 43.14 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.597 ' CE2' ' CE2' ' A' ' 8' ' ' TYR . 2.5 t80 -105.4 152.56 22.82 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.307 -1.114 . . . . 0.0 109.503 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 34.6 tp -113.74 119.21 36.6 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.231 -0.918 . . . . 0.0 109.725 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 75.9 m -130.15 157.22 77.76 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.316 -0.865 . . . . 0.0 109.603 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.519 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 52.5 Cg_endo -72.55 168.93 23.06 Favored 'Trans proline' 0 C--O 1.215 -0.629 0 C-N-CA 122.762 2.308 . . . . 0.0 111.591 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 41.3 mmtt -89.61 -13.09 37.9 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.203 -0.936 . . . . 0.0 109.334 179.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -67.98 131.8 46.14 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.296 -0.878 . . . . 0.0 109.38 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.745 ' C ' HD13 ' A' ' 22' ' ' LEU . 3.3 tm? -90.63 123.65 34.42 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.263 -0.898 . . . . 0.0 109.332 179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.691 ' N ' HD13 ' A' ' 22' ' ' LEU . 15.4 mttp -145.6 105.8 4.31 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.156 -0.965 . . . . 0.0 109.657 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.539 ' HA ' ' O ' ' A' ' 34' ' ' ASN . 44.1 Cg_endo -65.85 120.84 8.08 Favored 'Trans proline' 0 C--O 1.214 -0.705 0 C-N-CA 123.116 2.544 . . . . 0.0 112.324 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.463 ' O ' HG23 ' A' ' 32' ' ' THR . 19.7 m -116.18 154.57 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.382 -0.824 . . . . 0.0 109.35 179.562 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.418 ' O ' ' N ' ' A' ' 53' ' ' ARG . 41.6 t -96.07 138.26 33.95 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 178.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -95.6 139.21 14.37 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.726 -1.349 . . . . 0.0 109.726 -179.285 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.483 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 48.5 p30 -65.38 -11.15 39.52 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.38 -1.07 . . . . 0.0 109.454 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.447 ' OD1' ' HB2' ' A' ' 31' ' ' GLN . 59.0 p30 -83.09 7.33 16.19 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.226 -0.921 . . . . 0.0 109.398 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.22 22.59 51.41 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.456 ' O ' ' SG ' ' A' ' 58' ' ' CYS . 75.5 mt-30 -129.3 175.37 8.79 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.291 -1.123 . . . . 0.0 109.375 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.647 HG21 ' HA ' ' A' ' 57' ' ' LYS . 13.0 m -131.83 140.21 49.07 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.258 -0.901 . . . . 0.0 109.816 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.869 ' CD2' HD12 ' A' ' 39' ' ' LEU . 44.7 m-85 -115.86 127.15 54.81 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.431 -0.793 . . . . 0.0 109.139 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.745 ' OD1' HD21 ' A' ' 22' ' ' LEU . 41.1 t-20 -49.01 -78.98 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.299 -0.876 . . . . 0.0 110.032 -179.425 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.542 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 4.6 t-20 -81.14 147.28 60.62 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 120.863 -1.148 . . . . 0.0 109.263 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.514 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.8 Cg_endo -63.44 -52.89 1.66 Allowed 'Trans proline' 0 C--O 1.215 -0.643 0 C-N-CA 122.701 2.267 . . . . 0.0 111.849 -179.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.542 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 5.8 t -61.78 -28.23 69.31 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 178.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.429 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 35.7 mmm -65.51 -12.45 52.88 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.292 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.869 HD12 ' CD2' ' A' ' 33' ' ' TYR . 8.4 tt -72.99 -57.63 3.9 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.284 -0.885 . . . . 0.0 108.849 179.602 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.519 ' O ' ' HB2' ' A' ' 43' ' ' ASN . 2.2 t -46.59 -45.18 18.74 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 179.064 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.491 ' ND1' ' HB2' ' A' ' 16' ' ' TYR . 13.9 t60 -48.46 -50.37 31.66 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.062 -1.024 . . . . 0.0 108.309 178.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.578 ' HG3' ' CE1' ' A' ' 33' ' ' TYR . 34.2 mm-40 -56.41 -19.21 13.87 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.567 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.519 ' HB2' ' O ' ' A' ' 40' ' ' CYS . 2.3 m-80 -78.59 -35.33 45.9 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 119.471 -0.892 . . . . 0.0 108.617 179.209 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.983 HD21 ' OH ' ' A' ' 8' ' ' TYR . 40.3 mt -72.07 -30.79 65.48 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.332 -0.855 . . . . 0.0 109.302 179.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.485 HG13 ' O ' ' A' ' 41' ' ' HIS . 2.5 mt -79.74 -51.12 16.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.279 -0.888 . . . . 0.0 109.378 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.447 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 93.3 mtt-85 -80.3 -32.92 38.0 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.337 -0.852 . . . . 0.0 109.267 179.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.49 ' N ' ' O ' ' A' ' 43' ' ' ASN . 91.9 mt-30 62.19 40.22 11.91 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.403 -0.811 . . . . 0.0 109.537 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 35.6 p -113.63 5.62 16.59 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.32 -0.863 . . . . 0.0 109.541 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.566 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 11.8 t-20 62.39 50.91 3.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.236 -0.915 . . . . 0.0 109.45 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.789 HG21 ' OH ' ' A' ' 33' ' ' TYR . 99.6 m -78.87 134.7 36.91 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.298 -0.876 . . . . 0.0 109.729 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.566 ' CE1' ' O ' ' A' ' 49' ' ' ASN . 8.0 m80 -115.98 -170.13 1.73 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.218 -0.926 . . . . 0.0 109.167 179.558 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.749 HG12 HD13 ' A' ' 39' ' ' LEU . 20.4 mt -92.91 122.97 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.306 -0.872 . . . . 0.0 109.445 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.483 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 46.9 ttt-85 -81.1 -41.62 22.23 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.304 -0.872 . . . . 0.0 109.542 -179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.424 ' OG ' ' HB3' ' A' ' 61' ' ' SER . 2.0 p -160.45 145.01 14.33 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.543 -0.723 . . . . 0.0 109.505 -179.434 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 20.2 p -63.62 139.51 58.78 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.244 -0.91 . . . . 0.0 109.401 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.537 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 90.76 163.13 38.74 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.647 ' HA ' HG21 ' A' ' 32' ' ' THR . 48.1 tttp -49.46 148.65 2.64 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.498 -1.001 . . . . 0.0 109.48 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.456 ' SG ' ' O ' ' A' ' 31' ' ' GLN . 57.8 m -51.51 -32.68 28.54 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.257 -0.902 . . . . 0.0 109.426 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -83.09 -34.37 26.17 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.348 -0.845 . . . . 0.0 108.782 179.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -58.72 -23.69 60.16 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.424 ' HB3' ' OG ' ' A' ' 54' ' ' SER . 60.0 p -72.08 142.54 49.21 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.304 -0.872 . . . . 0.0 109.567 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 43.8 m -112.95 144.14 43.04 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.258 -0.901 . . . . 0.0 109.38 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -120.26 74.2 21.69 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.218 -0.926 . . . . 0.0 109.573 -179.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.403 ' HA ' ' HG3' ' A' ' 71' ' ' MET . 50.6 Cg_endo -70.98 -20.02 29.58 Favored 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 122.665 2.243 . . . . 0.0 111.74 179.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.14 -166.96 41.05 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 58.9 p -73.13 -27.3 61.6 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.14 -1.212 . . . . 0.0 109.437 179.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.63 HG22 ' H ' ' A' ' 69' ' ' ALA . 55.0 m -126.71 137.64 53.28 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.263 -0.898 . . . . 0.0 109.481 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -62.48 -30.81 71.53 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.323 -0.861 . . . . 0.0 109.532 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.63 ' H ' HG22 ' A' ' 67' ' ' THR . . . -64.1 -28.67 69.93 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.226 -0.921 . . . . 0.0 109.454 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 28.9 m -57.73 -27.85 63.35 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.261 -0.899 . . . . 0.0 109.407 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.403 ' HG3' ' HA ' ' A' ' 64' ' ' PRO . 0.0 OUTLIER -74.54 134.4 76.15 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.239 -0.913 . . . . 0.0 109.524 -179.947 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -70.31 143.4 48.08 Favored 'Trans proline' 0 C--O 1.216 -0.602 0 C-N-CA 122.707 2.271 . . . . 0.0 111.822 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -70.27 143.11 47.41 Favored 'Trans proline' 0 C--O 1.215 -0.629 0 C-N-CA 122.768 2.312 . . . . 0.0 111.838 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 24.0 t -114.51 142.33 46.54 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.331 -0.855 . . . . 0.0 109.397 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 53.2 p30 -90.38 11.0 22.84 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.237 -0.914 . . . . 0.0 109.518 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.428 ' OXT' ' HG2' ' A' ' 76' ' ' GLU . 84.5 tt0 . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 118.065 -0.969 . . . . 0.0 109.449 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.43 ' O ' ' C ' ' A' ' 2' ' ' SER . 14.2 p-10 . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.489 ' O ' ' N ' ' A' ' 5' ' ' CYS . 1.7 m -43.18 -29.22 0.36 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.373 -0.829 . . . . 0.0 109.283 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.46 ' HA ' ' HG3' ' A' ' 6' ' ' LYS . 19.4 mt-10 -46.96 -29.85 2.26 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.434 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 92.8 mmm -80.47 -34.47 35.88 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.101 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.489 ' N ' ' O ' ' A' ' 2' ' ' SER . 3.8 m -80.03 4.58 16.61 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.457 -0.777 . . . . 0.0 109.109 179.258 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.46 ' HG3' ' HA ' ' A' ' 3' ' ' GLU . 14.2 mttm -57.65 -30.13 65.15 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.082 -1.011 . . . . 0.0 109.514 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -143.29 69.94 1.31 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.281 -0.887 . . . . 0.0 109.938 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.552 ' CD1' ' N ' ' A' ' 9' ' ' ARG . 18.4 p90 -115.04 -172.88 2.21 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.125 -0.985 . . . . 0.0 109.311 179.605 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.552 ' N ' ' CD1' ' A' ' 8' ' ' TYR . 86.0 mtt180 -149.64 145.57 26.82 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.189 -0.944 . . . . 0.0 109.466 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.581 HG13 ' O ' ' A' ' 15' ' ' GLY . 34.0 t -148.11 142.66 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.284 -0.885 . . . . 0.0 109.17 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.472 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 1.4 mp -116.13 171.93 4.24 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.204 -0.935 . . . . 0.0 109.844 -179.536 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.472 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 48.2 Cg_endo -68.45 -23.77 37.27 Favored 'Trans proline' 0 C--O 1.215 -0.659 0 C-N-CA 122.628 2.219 . . . . 0.0 111.73 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 53.0 mtt180 -100.27 -23.86 14.69 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.288 -0.882 . . . . 0.0 109.17 179.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.426 HD12 ' HB2' ' A' ' 11' ' ' LEU . 97.6 mt -88.84 -40.91 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.306 -0.871 . . . . 0.0 109.774 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.581 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 70.53 -174.92 37.95 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.512 ' HB2' ' CE1' ' A' ' 41' ' ' HIS . 1.3 t80 -81.61 154.78 25.98 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.17 -1.194 . . . . 0.0 109.417 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 34.0 tp -112.65 117.92 33.62 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.215 -0.928 . . . . 0.0 109.749 -179.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.419 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 76.9 m -134.86 156.54 78.42 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.267 -0.896 . . . . 0.0 109.423 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.497 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 51.5 Cg_endo -71.4 168.79 22.5 Favored 'Trans proline' 0 C--O 1.215 -0.674 0 C-N-CA 122.692 2.261 . . . . 0.0 111.83 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -93.11 -3.89 53.29 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.263 -0.898 . . . . 0.0 109.52 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -79.08 130.16 35.22 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.212 -0.93 . . . . 0.0 109.307 179.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.739 ' C ' HD13 ' A' ' 22' ' ' LEU . 3.1 tm? -85.77 124.12 31.91 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.246 -0.909 . . . . 0.0 109.447 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.733 ' N ' HD13 ' A' ' 22' ' ' LEU . 29.4 mttp -144.05 103.1 4.8 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.194 -0.941 . . . . 0.0 109.468 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.537 ' HA ' ' O ' ' A' ' 34' ' ' ASN . 44.0 Cg_endo -65.35 121.92 9.48 Favored 'Trans proline' 0 C--O 1.214 -0.719 0 C-N-CA 123.133 2.555 . . . . 0.0 112.064 -179.689 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.476 ' HB ' HG23 ' A' ' 52' ' ' ILE . 13.9 m -120.26 154.86 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.272 -0.892 . . . . 0.0 110.05 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.423 ' O ' ' N ' ' A' ' 53' ' ' ARG . 13.3 t -99.95 131.52 45.87 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.034 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -89.23 138.83 14.9 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 -179.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.494 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 38.1 p30 -65.86 -10.05 34.63 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.357 -1.084 . . . . 0.0 109.66 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 59.1 m-20 -85.64 10.55 13.02 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.241 -0.912 . . . . 0.0 109.44 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 81.9 27.65 45.06 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -131.04 161.31 32.29 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.289 -1.124 . . . . 0.0 109.384 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.451 HG21 ' CB ' ' A' ' 57' ' ' LYS . 98.8 m -122.35 135.04 54.64 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.134 -0.979 . . . . 0.0 109.36 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.65 ' CD1' HD13 ' A' ' 39' ' ' LEU . 47.8 m-85 -116.45 125.2 51.65 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.312 -0.867 . . . . 0.0 109.293 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.739 ' CG ' HD21 ' A' ' 22' ' ' LEU . 40.2 t-20 -48.56 -79.76 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.393 -0.817 . . . . 0.0 109.97 -179.386 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.533 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 5.4 t-20 -80.9 146.96 60.7 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 120.851 -1.156 . . . . 0.0 109.415 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.539 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.1 Cg_endo -62.7 -53.13 1.87 Allowed 'Trans proline' 0 C--O 1.216 -0.594 0 C-N-CA 122.902 2.401 . . . . 0.0 111.875 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.533 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 8.9 t -62.75 -27.9 69.6 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.005 -1.059 . . . . 0.0 108.212 178.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.451 ' HB2' ' HB3' ' A' ' 35' ' ' ASN . 28.1 mmm -64.54 -11.86 38.7 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 179.124 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.65 HD13 ' CD1' ' A' ' 33' ' ' TYR . 20.4 tp -69.88 -54.07 15.15 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.324 -0.86 . . . . 0.0 109.079 179.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.46 ' HB2' ' OH ' ' A' ' 16' ' ' TYR . 3.5 m -63.28 -14.26 47.53 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 119.021 -1.072 . . . . 0.0 108.253 179.087 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.512 ' CE1' ' HB2' ' A' ' 16' ' ' TYR . 19.5 t60 -67.26 -55.15 15.16 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 178.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 49.8 tt0 -67.19 -20.37 65.7 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.017 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.477 ' O ' ' N ' ' A' ' 47' ' ' GLN . 91.7 m-20 -76.26 -31.5 58.33 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.524 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.55 HD13 ' OH ' ' A' ' 8' ' ' TYR . 22.3 tp -67.48 -30.56 70.29 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.287 -0.883 . . . . 0.0 108.653 179.363 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -77.73 -44.74 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 179.451 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.452 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 60.0 mtt-85 -80.21 -19.33 47.26 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.393 -0.817 . . . . 0.0 109.175 179.669 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.477 ' N ' ' O ' ' A' ' 43' ' ' ASN . 91.1 mt-30 63.51 37.9 10.18 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.466 -0.771 . . . . 0.0 109.653 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 13.0 p -116.07 173.05 6.78 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.268 -0.895 . . . . 0.0 109.322 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -107.99 60.89 0.61 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.211 -0.931 . . . . 0.0 109.475 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.421 HG23 ' OD1' ' A' ' 28' ' ' ASP . 44.9 m -74.81 136.12 41.63 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.269 -0.895 . . . . 0.0 109.546 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 61.3 m-70 -115.01 173.27 6.57 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.247 -0.908 . . . . 0.0 109.229 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.476 HG23 ' HB ' ' A' ' 25' ' ' VAL . 20.0 mt -79.63 124.24 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.211 -0.93 . . . . 0.0 109.28 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.494 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 44.1 ttt180 -80.52 -47.48 14.19 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.352 -0.842 . . . . 0.0 109.367 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -154.07 149.22 26.92 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.488 -0.757 . . . . 0.0 109.115 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 27.5 p -66.45 143.48 57.08 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.209 -0.932 . . . . 0.0 109.567 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.536 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 90.44 167.35 41.76 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -179.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.501 ' HB2' ' HB2' ' A' ' 60' ' ' GLU . 43.4 mttt -76.19 120.98 22.21 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.303 -1.116 . . . . 0.0 109.477 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.408 ' C ' ' O ' ' A' ' 57' ' ' LYS . 0.5 OUTLIER -45.02 -35.26 2.85 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.266 -0.896 . . . . 0.0 109.621 179.736 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -82.23 -21.36 36.39 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.331 -0.856 . . . . 0.0 109.465 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.501 ' HB2' ' HB2' ' A' ' 57' ' ' LYS . 28.6 tt0 -55.54 -19.37 9.72 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.509 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 93.9 p -68.61 -33.22 73.67 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.286 -0.884 . . . . 0.0 109.735 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 7.5 t -108.49 149.41 28.85 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.281 -0.887 . . . . 0.0 109.627 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.738 HG21 ' HA ' ' A' ' 68' ' ' ALA . 69.4 p -65.85 147.6 98.68 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.213 -0.929 . . . . 0.0 109.404 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -71.16 -14.85 31.92 Favored 'Trans proline' 0 C--O 1.215 -0.636 0 C-N-CA 122.702 2.268 . . . . 0.0 111.827 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.494 ' HA3' ' CB ' ' A' ' 70' ' ' SER . . . -88.5 -176.6 47.16 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 69.1 p -74.6 -25.13 59.05 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.245 -1.15 . . . . 0.0 109.425 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 13.6 p -128.17 164.93 21.44 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.222 -0.924 . . . . 0.0 109.425 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.738 ' HA ' HG21 ' A' ' 63' ' ' THR . . . -67.56 -26.97 66.56 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.188 -0.945 . . . . 0.0 109.499 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -64.25 -24.18 67.57 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.201 -0.937 . . . . 0.0 109.479 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.494 ' CB ' ' HA3' ' A' ' 65' ' ' GLY . 36.7 m -58.0 -28.39 64.37 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.223 -0.923 . . . . 0.0 109.525 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.22 146.48 96.85 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.326 -0.859 . . . . 0.0 109.55 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -70.47 144.55 50.55 Favored 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 122.66 2.24 . . . . 0.0 111.724 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -70.62 0.32 6.47 Favored 'Trans proline' 0 C--O 1.214 -0.68 0 C-N-CA 122.748 2.299 . . . . 0.0 111.866 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 41.8 m -140.54 138.7 34.72 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.219 -0.926 . . . . 0.0 109.558 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -51.72 -35.43 43.06 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.326 -0.859 . . . . 0.0 109.52 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 117.972 -1.013 . . . . 0.0 109.568 -179.991 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.591 ' HB2' ' CE1' ' A' ' 51' ' ' HIS . 3.6 m -48.36 -28.8 3.41 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.174 -0.953 . . . . 0.0 109.48 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.472 ' HA ' ' HG3' ' A' ' 6' ' ' LYS . 16.5 mt-10 -48.97 -27.41 3.13 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 179.714 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 82.6 mmm -76.48 -29.96 57.07 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 179.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.498 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 3.9 m -79.88 -7.97 59.03 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.38 -0.825 . . . . 0.0 109.321 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.472 ' HG3' ' HA ' ' A' ' 3' ' ' GLU . 26.3 mttm -58.79 -23.21 59.91 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.213 -0.929 . . . . 0.0 110.039 -179.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 61.9 t0 -150.1 64.46 0.97 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.079 -1.013 . . . . 0.0 110.37 -179.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.638 ' OH ' HD23 ' A' ' 44' ' ' LEU . 4.7 p90 -131.65 168.07 18.36 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.11 -0.994 . . . . 0.0 109.123 179.11 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 48.2 mtt180 -144.8 140.87 28.74 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.182 -0.949 . . . . 0.0 109.719 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.712 HG21 ' CD2' ' A' ' 16' ' ' TYR . 55.0 t -135.31 127.9 47.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.264 -0.898 . . . . 0.0 109.471 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.478 ' HB3' ' HD2' ' A' ' 12' ' ' PRO . 7.2 mp -114.81 168.17 8.53 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.275 -0.89 . . . . 0.0 109.312 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.478 ' HD2' ' HB3' ' A' ' 11' ' ' LEU . 43.0 Cg_endo -66.43 -24.63 49.36 Favored 'Trans proline' 0 C--O 1.216 -0.609 0 C-N-CA 122.479 2.119 . . . . 0.0 111.409 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 79.2 mtt-85 -98.71 -27.55 13.92 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.344 -0.848 . . . . 0.0 108.857 179.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 25.4 mm -87.67 -44.68 16.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.416 -0.803 . . . . 0.0 109.337 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.572 ' C ' HG13 ' A' ' 10' ' ' VAL . . . 73.0 -165.43 54.82 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -179.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.712 ' CD2' HG21 ' A' ' 10' ' ' VAL . 1.9 t80 -100.03 149.76 23.15 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.238 -1.154 . . . . 0.0 109.44 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.612 ' N ' HD22 ' A' ' 17' ' ' LEU . 3.0 mm? -111.01 135.51 51.4 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.288 -0.883 . . . . 0.0 109.453 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.437 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 85.6 m -147.12 157.71 45.72 Favored Pre-proline 0 N--CA 1.492 1.662 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.444 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 47.4 Cg_endo -70.82 165.59 31.69 Favored 'Trans proline' 0 C--O 1.215 -0.653 0 C-N-CA 122.448 2.099 . . . . 0.0 111.596 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.3 tptp -84.58 -29.45 25.81 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.3 -0.875 . . . . 0.0 109.539 -179.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -58.49 126.11 26.18 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.28 -0.888 . . . . 0.0 109.381 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 60.4 tp -90.0 116.99 28.46 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.2 -0.937 . . . . 0.0 109.494 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.529 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 3.5 mttp -128.36 106.45 19.4 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.153 -0.967 . . . . 0.0 109.203 179.754 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.544 ' HA ' ' O ' ' A' ' 34' ' ' ASN . 42.6 Cg_endo -64.79 122.62 10.51 Favored 'Trans proline' 0 C--O 1.214 -0.692 0 C-N-CA 123.036 2.49 . . . . 0.0 112.166 -179.404 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.53 ' HB ' HG23 ' A' ' 52' ' ' ILE . 17.3 m -118.19 154.26 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.318 -0.864 . . . . 0.0 109.934 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.442 ' SG ' ' HB3' ' A' ' 53' ' ' ARG . 41.4 t -97.78 138.06 35.71 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -92.35 140.37 15.1 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.911 -1.276 . . . . 0.0 109.911 -179.28 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.503 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 53.6 p30 -69.48 -11.37 60.77 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.305 -1.114 . . . . 0.0 109.436 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.451 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 57.0 p30 -89.57 10.43 23.01 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.303 -0.873 . . . . 0.0 109.593 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.59 18.95 57.7 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.47 ' O ' ' N ' ' A' ' 27' ' ' GLY . 90.0 mt-30 -119.32 170.17 9.34 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.329 -1.1 . . . . 0.0 109.385 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.581 HG23 ' HA ' ' A' ' 57' ' ' LYS . 54.7 m -134.04 134.25 42.16 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.199 -0.938 . . . . 0.0 109.3 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.898 ' CD1' HD13 ' A' ' 39' ' ' LEU . 38.4 m-85 -114.57 131.04 56.81 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.262 -0.899 . . . . 0.0 109.221 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.544 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 10.1 m-20 -55.7 -78.4 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.287 -0.883 . . . . 0.0 109.676 -179.661 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.519 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 7.1 t-20 -81.96 147.1 57.18 Favored Pre-proline 0 C--N 1.301 -1.527 0 O-C-N 120.927 -1.108 . . . . 0.0 109.645 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.529 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.2 Cg_endo -62.7 -52.07 2.64 Favored 'Trans proline' 0 C--O 1.216 -0.617 0 C-N-CA 122.753 2.302 . . . . 0.0 111.811 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.519 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 8.6 t -61.38 -29.99 70.26 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 120.882 -1.136 . . . . 0.0 108.046 178.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.402 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 13.0 mtt -63.87 -12.91 40.61 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.312 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.898 HD13 ' CD1' ' A' ' 33' ' ' TYR . 29.3 tp -68.04 -54.33 19.11 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 179.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 10.9 t -62.12 -22.43 65.81 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.437 ' CE1' ' HB2' ' A' ' 16' ' ' TYR . 37.4 t60 -69.7 -57.33 5.27 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.315 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.46 ' OE1' ' CD2' ' A' ' 33' ' ' TYR . 82.1 tt0 -63.61 -20.27 65.53 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 179.267 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.507 ' O ' ' N ' ' A' ' 47' ' ' GLN . 96.5 m-20 -75.42 -32.21 60.63 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.514 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.924 HD13 ' O ' ' A' ' 44' ' ' LEU . 2.8 tm? -65.82 -38.16 88.17 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.32 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.511 ' N ' HD13 ' A' ' 45' ' ' ILE . 4.6 mm -69.76 -43.16 80.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.392 -0.818 . . . . 0.0 108.953 179.481 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.453 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 73.2 mtt-85 -79.73 -23.37 42.36 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.415 -0.803 . . . . 0.0 109.098 179.692 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.507 ' N ' ' O ' ' A' ' 43' ' ' ASN . 92.6 mt-30 63.0 45.33 5.37 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.374 -0.829 . . . . 0.0 109.353 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.1 p -128.53 159.17 36.31 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.302 -0.874 . . . . 0.0 109.374 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.418 ' O ' ' CG ' ' A' ' 49' ' ' ASN . 47.6 p-10 -91.49 59.49 3.84 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.169 -0.957 . . . . 0.0 109.301 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 81.6 m -72.36 141.95 48.77 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.352 -0.843 . . . . 0.0 109.843 -179.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.591 ' CE1' ' HB2' ' A' ' 2' ' ' SER . 62.6 m-70 -122.44 171.62 8.95 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.275 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.53 HG23 ' HB ' ' A' ' 25' ' ' VAL . 29.2 mt -79.72 126.85 39.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.075 -1.016 . . . . 0.0 109.581 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.503 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 67.2 ttt-85 -80.07 -44.63 19.72 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.447 -0.783 . . . . 0.0 109.035 179.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.4 t -160.23 155.59 25.14 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.706 -0.849 . . . . 0.0 108.706 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 26.1 p -67.5 140.22 57.03 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.091 -1.005 . . . . 0.0 109.314 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.532 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 94.89 169.04 36.59 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.167 -1.573 . . . . 0.0 109.167 -179.748 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.581 ' HA ' HG23 ' A' ' 32' ' ' THR . 44.8 mttp -68.1 144.62 54.97 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.304 -1.116 . . . . 0.0 109.446 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.461 ' SG ' ' O ' ' A' ' 31' ' ' GLN . 73.9 m -49.54 -27.46 4.43 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.254 -0.904 . . . . 0.0 109.289 179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.46 ' O ' ' O ' ' A' ' 62' ' ' SER . 82.5 tt0 -84.21 -25.42 29.51 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.301 -0.874 . . . . 0.0 109.485 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.425 ' OE1' ' HA3' ' A' ' 56' ' ' GLY . 63.2 tt0 -66.37 -30.37 70.74 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.226 -0.921 . . . . 0.0 109.429 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 21.1 m -63.43 -37.75 88.51 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.247 -0.908 . . . . 0.0 109.754 -179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.46 ' O ' ' O ' ' A' ' 59' ' ' GLU . 46.4 m -115.88 148.07 40.39 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.168 -0.958 . . . . 0.0 109.688 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -65.26 158.52 71.9 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.214 -0.929 . . . . 0.0 109.394 179.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.445 ' HB2' HG23 ' A' ' 66' ' ' THR . 48.6 Cg_endo -69.63 -20.61 35.21 Favored 'Trans proline' 0 C--O 1.215 -0.673 0 C-N-CA 122.618 2.212 . . . . 0.0 111.77 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 91.01 7.75 65.59 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.445 HG23 ' HB2' ' A' ' 64' ' ' PRO . 71.9 p -68.5 -22.69 64.53 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.291 -1.123 . . . . 0.0 109.509 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.423 ' O ' ' OG ' ' A' ' 70' ' ' SER . 59.6 p -69.71 -22.89 63.36 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.198 -0.939 . . . . 0.0 109.533 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -62.11 -32.77 73.38 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.257 -0.902 . . . . 0.0 109.466 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.405 ' C ' ' HD2' ' A' ' 72' ' ' PRO . . . -65.85 -27.04 67.94 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.26 -0.9 . . . . 0.0 109.463 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.423 ' OG ' ' O ' ' A' ' 67' ' ' THR . 85.3 p -68.41 -27.64 66.38 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.331 -0.856 . . . . 0.0 109.542 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.498 ' N ' ' HD2' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -53.61 -59.52 9.33 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.244 -0.91 . . . . 0.0 109.491 179.995 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.498 ' HD2' ' N ' ' A' ' 71' ' ' MET . 49.9 Cg_endo -70.1 150.84 66.73 Favored 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 122.651 2.234 . . . . 0.0 111.8 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -69.36 -23.16 32.92 Favored 'Trans proline' 0 C--O 1.215 -0.625 0 C-N-CA 122.706 2.271 . . . . 0.0 111.78 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 49.1 m -129.01 142.33 50.95 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.264 -0.897 . . . . 0.0 109.447 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -58.62 -36.59 74.3 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.306 -0.871 . . . . 0.0 109.538 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 118.004 -0.998 . . . . 0.0 109.519 179.998 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.41 ' O ' ' C ' ' A' ' 2' ' ' SER . 72.5 m-20 . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.556 ' OG ' HD22 ' A' ' 39' ' ' LEU . 3.5 m -44.71 -33.42 1.85 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.291 -0.881 . . . . 0.0 109.475 179.932 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.429 ' HA ' ' HG3' ' A' ' 6' ' ' LYS . 21.1 mt-10 -51.31 -28.98 13.55 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.311 -0.868 . . . . 0.0 108.711 179.728 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 66.0 mtt -78.33 -32.13 49.03 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 179.389 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.44 ' HB3' ' HB3' ' A' ' 40' ' ' CYS . 3.7 m -83.19 1.63 39.69 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.341 -0.849 . . . . 0.0 109.114 179.388 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.429 ' HG3' ' HA ' ' A' ' 3' ' ' GLU . 14.2 mttm -61.89 -31.74 72.05 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.138 -0.976 . . . . 0.0 109.416 179.994 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -145.21 68.54 1.23 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.212 -0.93 . . . . 0.0 109.952 -179.893 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.463 ' CE2' ' CE2' ' A' ' 16' ' ' TYR . 13.9 p90 -119.03 -171.23 2.06 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.175 -0.953 . . . . 0.0 109.19 179.524 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 21.4 ttt180 -150.83 152.32 33.58 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.232 -0.918 . . . . 0.0 109.747 -179.999 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.557 HG13 ' O ' ' A' ' 15' ' ' GLY . 45.4 t -148.63 131.46 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.293 -0.88 . . . . 0.0 109.46 179.839 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.682 HD23 ' HD2' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -104.26 174.86 2.47 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.253 -0.905 . . . . 0.0 109.249 179.81 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.682 ' HD2' HD23 ' A' ' 11' ' ' LEU . 45.8 Cg_endo -67.48 -24.62 42.26 Favored 'Trans proline' 0 C--O 1.215 -0.667 0 C-N-CA 122.706 2.271 . . . . 0.0 112.056 -179.995 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -96.62 -28.23 14.44 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.29 -0.881 . . . . 0.0 109.41 179.966 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.444 HD12 ' HB2' ' A' ' 11' ' ' LEU . 89.9 mt -83.05 -45.77 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.302 -0.874 . . . . 0.0 109.598 -179.916 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.557 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 68.66 -168.74 42.74 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 179.997 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.463 ' CE2' ' CE2' ' A' ' 8' ' ' TYR . 1.4 t80 -95.33 149.25 21.56 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.212 -1.169 . . . . 0.0 109.645 -179.907 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.687 ' C ' HD13 ' A' ' 17' ' ' LEU . 2.3 tm? -111.24 112.21 23.82 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.287 -0.883 . . . . 0.0 109.163 179.873 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.578 ' N ' HD13 ' A' ' 17' ' ' LEU . 62.0 m -128.63 155.77 78.47 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.26 -0.9 . . . . 0.0 109.608 -179.896 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.406 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 49.6 Cg_endo -71.28 168.52 23.17 Favored 'Trans proline' 0 C--O 1.215 -0.675 0 C-N-CA 122.694 2.263 . . . . 0.0 111.526 179.781 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 25.4 mttm -91.09 -14.92 30.34 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.219 -0.926 . . . . 0.0 109.639 -179.828 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 51.3 t0 -72.3 119.48 16.56 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.246 -0.908 . . . . 0.0 109.349 179.866 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.557 HD11 ' HB3' ' A' ' 34' ' ' ASN . 52.4 tp -79.59 113.64 17.9 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.199 -0.938 . . . . 0.0 109.646 -179.944 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.492 ' O ' ' HD3' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -127.5 110.12 20.96 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.211 -0.931 . . . . 0.0 109.079 179.738 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.553 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 42.6 Cg_endo -64.66 122.48 10.36 Favored 'Trans proline' 0 C--O 1.213 -0.774 0 C-N-CA 122.943 2.428 . . . . 0.0 112.203 -179.715 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.487 ' HB ' HG23 ' A' ' 52' ' ' ILE . 18.8 m -119.31 154.71 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.283 -0.886 . . . . 0.0 109.4 179.785 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.456 ' SG ' ' HB3' ' A' ' 53' ' ' ARG . 39.7 t -96.56 142.71 28.3 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 178.598 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.481 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -95.69 139.43 14.49 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 -179.859 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.466 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 55.0 t0 -69.29 -6.18 27.84 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.234 -1.157 . . . . 0.0 109.592 -179.781 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.434 ' OD2' ' OG1' ' A' ' 50' ' ' THR . 41.7 m-20 -90.87 0.87 57.37 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.149 -0.969 . . . . 0.0 109.548 179.913 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.43 24.61 15.74 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.634 -1.387 . . . . 0.0 109.634 179.935 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.481 ' O ' ' N ' ' A' ' 27' ' ' GLY . 81.5 mt-30 -131.84 164.17 26.65 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.292 -1.122 . . . . 0.0 109.279 -179.982 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.978 HG21 ' HG3' ' A' ' 57' ' ' LYS . 12.0 m -121.03 150.32 41.34 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.123 -0.985 . . . . 0.0 109.384 179.797 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.844 ' CD2' HD12 ' A' ' 39' ' ' LEU . 36.7 m-85 -128.74 131.75 47.89 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.341 -0.849 . . . . 0.0 109.253 -179.909 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.557 ' HB3' HD11 ' A' ' 22' ' ' LEU . 11.8 m-20 -51.75 -78.77 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.358 -0.839 . . . . 0.0 109.889 -179.429 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.534 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 5.8 t-20 -82.01 147.7 58.55 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.104 -0.997 . . . . 0.0 109.827 -179.789 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.492 ' HD3' ' O ' ' A' ' 23' ' ' LYS . 41.7 Cg_endo -64.04 -52.76 1.49 Allowed 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 122.777 2.318 . . . . 0.0 111.606 179.826 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.534 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 11.6 t -62.2 -30.01 70.78 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.969 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.494 ' CG ' ' HB3' ' A' ' 35' ' ' ASN . 29.3 mtt -65.3 -16.12 63.24 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.435 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.844 HD12 ' CD2' ' A' ' 33' ' ' TYR . 8.0 tt -69.07 -52.87 24.02 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.34 -0.85 . . . . 0.0 108.899 179.71 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.513 ' O ' ' HB2' ' A' ' 43' ' ' ASN . 14.4 m -51.0 -39.66 56.3 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 179.424 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 13.3 t60 -49.2 -45.12 43.82 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.851 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.595 ' HG3' ' CE1' ' A' ' 33' ' ' TYR . 45.4 mm-40 -61.73 -20.99 64.12 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.263 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.524 ' O ' ' N ' ' A' ' 47' ' ' GLN . 2.5 m-80 -76.69 -31.33 57.17 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 119.694 -0.803 . . . . 0.0 109.034 179.508 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.975 HD13 ' O ' ' A' ' 44' ' ' LEU . 1.7 tm? -70.22 -36.46 74.55 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.265 -0.897 . . . . 0.0 109.396 179.932 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 6.4 mt -74.87 -51.46 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.258 -0.901 . . . . 0.0 109.554 -179.896 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.488 ' NH2' ' OE1' ' A' ' 42' ' ' GLU . 40.8 mtt85 -81.12 -36.74 29.92 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.299 -0.875 . . . . 0.0 109.842 -179.653 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.524 ' N ' ' O ' ' A' ' 43' ' ' ASN . 92.6 mt-30 63.07 34.05 14.13 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.309 -0.869 . . . . 0.0 109.554 -179.809 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.466 HG23 ' HB3' ' A' ' 46' ' ' ARG . 38.9 p -103.74 7.51 37.24 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.276 -0.89 . . . . 0.0 109.486 179.956 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.536 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 65.6 m-20 63.59 47.98 3.56 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.192 -0.942 . . . . 0.0 109.469 -179.895 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.524 ' N ' ' OD1' ' A' ' 43' ' ' ASN . 71.1 m -80.3 125.75 30.28 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.395 -0.815 . . . . 0.0 109.366 179.752 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.536 ' CE1' ' O ' ' A' ' 49' ' ' ASN . 7.2 m80 -109.71 -171.09 1.77 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.124 -0.985 . . . . 0.0 109.459 179.822 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.822 HG12 HD13 ' A' ' 39' ' ' LEU . 43.6 mt -87.04 126.56 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.408 -0.808 . . . . 0.0 109.557 179.934 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.466 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 21.7 ttt85 -79.63 -46.4 17.27 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.446 -0.784 . . . . 0.0 109.275 179.841 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 95.3 p -158.31 138.84 12.71 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -179.72 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 20.8 p -56.02 151.33 12.13 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.134 -0.979 . . . . 0.0 109.49 -179.839 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.553 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 74.73 161.91 8.87 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 -179.595 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.978 ' HG3' HG21 ' A' ' 32' ' ' THR . 25.8 tttp -59.6 145.02 46.0 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.424 -1.045 . . . . 0.0 109.144 179.96 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -61.72 -35.37 77.88 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.257 -0.902 . . . . 0.0 109.526 -179.846 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -81.27 -22.79 38.41 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.503 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.475 ' CB ' ' HB3' ' A' ' 57' ' ' LYS . 32.7 tt0 -66.9 -19.05 65.66 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 179.838 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 94.6 p -79.03 -25.51 43.23 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.409 -0.807 . . . . 0.0 109.728 -179.846 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 60.0 p -69.36 158.65 34.67 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.197 -0.94 . . . . 0.0 109.57 -179.85 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.43 HG23 ' H ' ' A' ' 63' ' ' THR . 15.9 p -57.81 154.55 26.61 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.239 -0.913 . . . . 0.0 109.532 179.99 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.927 ' CG ' ' HB2' ' A' ' 69' ' ' ALA . 49.3 Cg_endo -69.6 -14.14 36.13 Favored 'Trans proline' 0 C--O 1.215 -0.666 0 C-N-CA 122.721 2.28 . . . . 0.0 111.768 179.957 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 91.43 10.05 62.48 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.947 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 18.8 p -122.38 159.51 27.35 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.266 -1.138 . . . . 0.0 109.449 179.966 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 41.8 p -73.44 -15.04 61.35 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.299 -0.875 . . . . 0.0 109.416 -179.966 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -66.2 -29.99 70.37 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.319 -0.863 . . . . 0.0 109.41 -179.984 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.927 ' HB2' ' CG ' ' A' ' 64' ' ' PRO . . . -60.66 142.99 55.07 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.221 -0.925 . . . . 0.0 109.498 179.959 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 33.0 t -59.48 -33.23 71.06 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.359 -0.838 . . . . 0.0 109.508 -179.928 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.27 153.0 87.16 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.262 -0.899 . . . . 0.0 109.531 -179.945 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -69.99 149.63 65.68 Favored 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 122.824 2.349 . . . . 0.0 111.873 -179.923 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -69.75 165.56 30.53 Favored 'Trans proline' 0 C--O 1.214 -0.681 0 C-N-CA 122.706 2.271 . . . . 0.0 111.797 179.928 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 91.2 p -86.56 -11.67 50.9 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.25 -0.907 . . . . 0.0 109.497 -179.907 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.448 ' O ' ' HB2' ' A' ' 76' ' ' GLU . 22.6 t70 -89.73 117.98 28.99 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.201 -0.937 . . . . 0.0 109.497 179.987 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.448 ' HB2' ' O ' ' A' ' 75' ' ' ASP . 73.3 mm-40 . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 118.021 -0.99 . . . . 0.0 109.481 179.967 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 . . . . . 0 N--CA 1.489 1.507 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.7 m -56.85 -34.95 68.31 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.256 -0.902 . . . . 0.0 109.514 179.931 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -52.28 -26.61 12.4 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.265 -0.897 . . . . 0.0 108.779 179.819 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 90.7 mtp -75.1 -27.42 59.86 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.325 -0.86 . . . . 0.0 108.856 179.316 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.605 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 19.9 m -80.32 -12.64 59.58 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.477 -0.765 . . . . 0.0 109.251 179.892 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.459 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 26.3 mttt -80.96 6.41 13.45 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.148 -0.97 . . . . 0.0 109.816 179.831 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.459 ' OD1' ' O ' ' A' ' 6' ' ' LYS . 96.3 m-20 -139.13 15.22 2.63 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.005 -1.06 . . . . 0.0 110.416 -179.387 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.686 ' CE2' ' CE2' ' A' ' 16' ' ' TYR . 1.0 OUTLIER -122.69 151.38 41.59 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.913 -1.117 . . . . 0.0 109.533 179.846 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 91.3 mtt180 -129.06 136.05 49.73 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.402 -0.811 . . . . 0.0 109.119 179.693 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.873 HG13 ' O ' ' A' ' 15' ' ' GLY . 49.7 t -127.16 148.43 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.246 -0.909 . . . . 0.0 109.499 -179.628 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.548 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.2 OUTLIER -123.65 175.12 2.99 Favored Pre-proline 0 N--CA 1.488 1.458 0 O-C-N 121.233 -0.917 . . . . 0.0 109.621 -179.689 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.548 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 45.1 Cg_endo -67.76 -22.27 43.55 Favored 'Trans proline' 0 C--O 1.215 -0.675 0 C-N-CA 122.691 2.261 . . . . 0.0 111.713 -179.987 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 69.9 mtt85 -105.7 -24.31 12.55 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.341 -0.85 . . . . 0.0 109.526 179.948 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 24.4 mm -81.9 -48.17 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.246 -0.909 . . . . 0.0 109.54 -179.893 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.873 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 82.17 -163.83 43.57 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.344 -1.503 . . . . 0.0 109.344 -179.923 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.686 ' CE2' ' CE2' ' A' ' 8' ' ' TYR . 2.1 t80 -97.57 150.6 20.94 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.125 -1.221 . . . . 0.0 109.621 179.983 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.696 ' C ' HD13 ' A' ' 17' ' ' LEU . 2.2 tm? -111.86 109.65 19.57 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.333 -0.854 . . . . 0.0 109.749 -179.779 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.519 ' N ' HD13 ' A' ' 17' ' ' LEU . 63.6 m -125.86 156.12 71.87 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.284 -0.885 . . . . 0.0 108.985 179.649 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -71.02 165.48 32.24 Favored 'Trans proline' 0 C--O 1.214 -0.686 0 C-N-CA 122.453 2.102 . . . . 0.0 111.701 -179.98 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 24.3 mttt -83.76 -22.93 31.75 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.261 -0.9 . . . . 0.0 109.521 -179.805 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 -63.62 125.41 24.19 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.226 -0.921 . . . . 0.0 109.401 179.781 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 41.2 tp -85.69 122.92 30.47 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.211 -0.931 . . . . 0.0 109.507 179.94 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.555 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 1.3 mmmt -135.21 103.28 10.59 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.305 -0.872 . . . . 0.0 109.284 179.987 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.536 ' HA ' ' O ' ' A' ' 34' ' ' ASN . 43.3 Cg_endo -65.02 120.02 7.16 Favored 'Trans proline' 0 C--O 1.213 -0.744 0 C-N-CA 123.18 2.587 . . . . 0.0 112.529 -179.125 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.475 ' O ' HG23 ' A' ' 32' ' ' THR . 7.8 m -116.98 155.94 18.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.399 -0.813 . . . . 0.0 109.754 179.683 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.428 ' O ' ' N ' ' A' ' 53' ' ' ARG . 14.8 t -102.67 109.9 21.66 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.389 -0.82 . . . . 0.0 108.97 179.369 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -66.03 137.7 36.3 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.773 -1.331 . . . . 0.0 109.773 -179.652 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.521 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 55.1 p30 -68.65 -10.14 54.31 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.316 -1.108 . . . . 0.0 109.57 179.858 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.443 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 38.9 m-20 -82.62 4.47 24.63 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.246 -0.909 . . . . 0.0 109.378 179.757 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.73 14.68 56.33 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.137 -1.585 . . . . 0.0 109.137 -179.809 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.501 ' O ' ' N ' ' A' ' 27' ' ' GLY . 88.9 mt-30 -121.36 157.54 30.22 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.382 -1.07 . . . . 0.0 109.373 -179.969 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.517 ' CG2' ' HA ' ' A' ' 57' ' ' LYS . 25.6 m -119.19 134.97 54.91 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.257 -0.902 . . . . 0.0 109.356 179.916 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.632 ' HD2' HD12 ' A' ' 39' ' ' LEU . 54.2 m-85 -113.13 129.67 56.43 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.289 -0.882 . . . . 0.0 109.288 179.986 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.536 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 6.6 m-20 -52.47 -76.29 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.216 -0.928 . . . . 0.0 109.441 -179.812 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.514 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 10.2 t-20 -81.99 147.35 57.72 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.039 -1.038 . . . . 0.0 109.495 179.797 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.555 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 39.9 Cg_endo -63.12 -51.68 2.63 Favored 'Trans proline' 0 C--O 1.214 -0.693 0 C-N-CA 122.673 2.248 . . . . 0.0 111.451 179.555 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.514 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 5.7 t -60.25 -28.36 67.98 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 178.81 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.482 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 34.7 mmm -66.02 -18.94 65.67 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.384 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.632 HD12 ' HD2' ' A' ' 33' ' ' TYR . 8.1 tt -66.84 -52.74 40.09 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.179 -0.951 . . . . 0.0 108.577 179.382 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.483 ' O ' ' HB2' ' A' ' 43' ' ' ASN . 38.0 t -50.81 -25.97 5.12 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.288 -1.005 . . . . 0.0 108.288 178.983 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.456 ' O ' HG12 ' A' ' 45' ' ' ILE . 28.1 t60 -60.09 -50.05 75.25 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.162 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.602 ' HB2' ' CE1' ' A' ' 33' ' ' TYR . 23.9 tp10 -58.66 -19.42 39.2 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.201 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.518 ' O ' ' N ' ' A' ' 47' ' ' GLN . 4.0 m-80 -78.26 -35.81 47.64 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.29 -0.881 . . . . 0.0 108.913 179.589 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 1.005 HD13 ' O ' ' A' ' 44' ' ' LEU . 2.1 tm? -69.34 -34.3 74.41 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.286 -0.884 . . . . 0.0 109.327 179.717 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.456 HG12 ' O ' ' A' ' 41' ' ' HIS . 6.1 mm -74.67 -53.84 15.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.382 -0.824 . . . . 0.0 110.118 -179.633 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.564 ' HB3' HG23 ' A' ' 48' ' ' THR . 10.5 mtt-85 -88.38 -30.3 19.62 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.145 -0.972 . . . . 0.0 110.36 -179.159 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.518 ' N ' ' O ' ' A' ' 43' ' ' ASN . 87.2 mt-30 62.33 37.07 14.13 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.128 -0.983 . . . . 0.0 109.277 -179.706 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.564 HG23 ' HB3' ' A' ' 46' ' ' ARG . 72.7 p -101.25 6.68 43.02 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.295 -0.878 . . . . 0.0 109.715 -179.84 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.452 ' HB2' ' O ' ' A' ' 48' ' ' THR . 73.0 m-20 61.65 51.77 3.85 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.165 -0.959 . . . . 0.0 109.556 179.894 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.506 ' N ' ' OD1' ' A' ' 43' ' ' ASN . 47.9 m -76.53 140.63 41.22 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.24 -0.913 . . . . 0.0 109.262 179.755 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 12.0 m-70 -119.53 -176.47 3.16 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.219 -0.926 . . . . 0.0 109.63 -179.879 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.595 HG12 HD13 ' A' ' 39' ' ' LEU . 15.9 mt -87.47 124.07 40.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 O-C-N 121.383 -0.823 . . . . 0.0 109.575 179.883 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.521 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 16.7 tpt180 -81.07 -56.38 4.14 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.476 -0.765 . . . . 0.0 109.477 179.904 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 72.8 m -148.9 141.17 24.07 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -179.832 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.428 ' H ' HG23 ' A' ' 55' ' ' THR . 12.2 p -58.34 144.51 41.25 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.197 -0.939 . . . . 0.0 109.522 -179.67 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.526 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 86.32 162.61 37.13 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.79 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.517 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 21.7 mttp -70.65 133.09 46.36 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.559 -0.965 . . . . 0.0 109.386 179.895 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -60.21 -30.95 69.71 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.219 -0.926 . . . . 0.0 109.406 -179.995 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.468 ' HG2' ' O ' ' A' ' 59' ' ' GLU . 83.2 tt0 -83.78 -13.18 54.49 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.265 -0.897 . . . . 0.0 109.412 179.838 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.496 ' HB2' ' HB2' ' A' ' 57' ' ' LYS . 51.6 tt0 -71.8 -29.46 64.48 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.324 -0.86 . . . . 0.0 109.16 179.904 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 34.6 m -63.26 -35.28 79.83 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.307 -0.871 . . . . 0.0 109.415 179.866 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.452 ' O ' ' O ' ' A' ' 59' ' ' GLU . 43.2 m -118.48 149.16 41.75 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.223 -0.923 . . . . 0.0 109.644 -179.946 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.405 ' HB ' ' HD2' ' A' ' 64' ' ' PRO . 0.8 OUTLIER -117.85 164.88 17.77 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.282 -0.886 . . . . 0.0 109.335 179.905 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.405 ' HD2' ' HB ' ' A' ' 63' ' ' THR . 50.1 Cg_endo -70.47 -20.72 31.12 Favored 'Trans proline' 0 C--O 1.215 -0.641 0 C-N-CA 122.649 2.232 . . . . 0.0 111.831 -179.842 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -87.05 -175.47 49.15 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.943 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 17.3 p -123.99 161.8 24.72 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.307 -1.114 . . . . 0.0 109.435 179.972 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.452 HG21 ' HG3' ' A' ' 72' ' ' PRO . 25.3 p -116.25 165.32 13.31 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.218 -0.926 . . . . 0.0 109.535 -179.953 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.76 -29.66 70.2 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.215 -0.928 . . . . 0.0 109.446 -179.958 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.429 ' O ' ' OG1' ' A' ' 67' ' ' THR . . . -106.25 137.81 43.54 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.209 -0.932 . . . . 0.0 109.495 179.948 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 18.5 m -55.74 -33.09 63.96 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.196 -0.94 . . . . 0.0 109.479 179.99 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 9.6 mmt -124.37 88.12 53.38 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.362 -0.836 . . . . 0.0 109.456 179.933 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.452 ' HG3' HG21 ' A' ' 67' ' ' THR . 50.0 Cg_endo -70.07 154.54 66.4 Favored 'Trans proline' 0 C--O 1.216 -0.624 0 C-N-CA 122.674 2.249 . . . . 0.0 111.773 179.947 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -70.59 0.35 6.39 Favored 'Trans proline' 0 C--O 1.216 -0.612 0 C-N-CA 122.682 2.255 . . . . 0.0 111.933 -179.875 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 85.7 p -92.33 -13.31 30.43 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.163 -0.961 . . . . 0.0 109.451 -179.968 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -94.97 106.13 18.09 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.305 -0.872 . . . . 0.0 109.274 179.947 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 118.001 -1.0 . . . . 0.0 109.531 -179.829 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.601 ' OD1' HD12 ' A' ' 52' ' ' ILE . 51.5 m-20 . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.518 ' O ' ' N ' ' A' ' 5' ' ' CYS . 5.8 m -43.76 -26.8 0.27 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.268 -0.895 . . . . 0.0 109.484 179.945 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.478 ' HG2' ' HE3' ' A' ' 6' ' ' LYS . 39.6 mt-10 -47.04 -31.58 3.4 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 179.704 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 70.7 mtm -77.18 -33.6 56.42 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.056 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.518 ' N ' ' O ' ' A' ' 2' ' ' SER . 3.4 m -82.93 7.56 15.09 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 179.41 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.478 ' HE3' ' HG2' ' A' ' 3' ' ' GLU . 12.6 mttm -61.11 -35.69 77.69 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.997 -1.064 . . . . 0.0 109.305 179.724 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -140.65 70.8 1.36 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.321 -0.862 . . . . 0.0 109.915 -179.793 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.457 ' CE2' HG23 ' A' ' 10' ' ' VAL . 26.9 p90 -115.07 -169.75 1.62 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.208 -0.933 . . . . 0.0 109.3 179.633 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.437 ' N ' ' CD2' ' A' ' 8' ' ' TYR . 71.9 mtt-85 -152.41 142.37 22.15 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.256 -0.903 . . . . 0.0 109.569 179.905 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.559 HG13 ' C ' ' A' ' 15' ' ' GLY . 39.9 t -143.06 138.7 27.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.264 -0.897 . . . . 0.0 109.2 179.98 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.549 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.7 OUTLIER -119.55 174.72 2.62 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.221 -0.924 . . . . 0.0 109.449 -179.788 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.549 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 46.6 Cg_endo -68.36 -24.31 37.24 Favored 'Trans proline' 0 C--O 1.214 -0.678 0 C-N-CA 122.748 2.299 . . . . 0.0 111.881 179.965 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.486 ' HG2' ' O ' ' A' ' 13' ' ' ARG . 23.4 ttm180 -101.18 -16.69 16.93 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.322 -0.861 . . . . 0.0 109.282 179.897 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 85.2 mt -96.99 -42.19 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.244 -0.91 . . . . 0.0 109.654 -179.754 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.559 ' C ' HG13 ' A' ' 10' ' ' VAL . . . 71.55 179.38 31.3 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 -179.812 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.487 ' OH ' ' HB2' ' A' ' 40' ' ' CYS . 1.8 t80 -77.61 153.92 32.76 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.153 -1.204 . . . . 0.0 109.546 -179.989 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.462 HD23 ' HA ' ' A' ' 17' ' ' LEU . 48.1 mt -110.42 123.58 50.15 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.216 -0.927 . . . . 0.0 109.594 179.999 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.466 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 82.4 m -146.98 156.72 47.27 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.453 -0.779 . . . . 0.0 109.032 179.895 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.518 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 48.9 Cg_endo -70.86 168.29 23.42 Favored 'Trans proline' 0 C--O 1.216 -0.608 0 C-N-CA 122.583 2.188 . . . . 0.0 111.515 179.889 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -94.26 -8.73 38.27 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.124 -0.985 . . . . 0.0 109.628 -179.796 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -76.62 118.53 19.36 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.169 -0.957 . . . . 0.0 109.414 179.957 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.501 HD11 ' HB3' ' A' ' 34' ' ' ASN . 44.3 tp -76.09 116.92 17.26 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.201 -0.937 . . . . 0.0 109.739 -179.973 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.539 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 2.2 mtpt -132.1 106.76 13.66 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.306 -0.871 . . . . 0.0 108.996 179.767 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.527 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 43.2 Cg_endo -64.58 120.24 7.48 Favored 'Trans proline' 0 C--O 1.214 -0.711 0 C-N-CA 122.912 2.408 . . . . 0.0 112.1 -179.448 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.492 ' HB ' HG23 ' A' ' 52' ' ' ILE . 11.4 m -120.26 155.2 23.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.445 -0.784 . . . . 0.0 110.047 -179.768 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.429 ' SG ' ' HB3' ' A' ' 53' ' ' ARG . 41.4 t -96.88 148.18 23.2 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 178.713 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -100.04 139.66 14.54 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.545 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.477 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 53.4 t0 -64.82 -10.7 30.08 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.279 -1.13 . . . . 0.0 109.409 179.834 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 59.9 p30 -90.39 1.6 56.43 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.24 -0.913 . . . . 0.0 109.667 -179.932 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.64 19.45 34.75 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.994 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.473 ' O ' ' N ' ' A' ' 27' ' ' GLY . 87.0 mt-30 -119.23 167.88 11.43 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.209 -1.171 . . . . 0.0 109.429 -179.946 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.549 HG23 ' HA ' ' A' ' 57' ' ' LYS . 94.3 m -127.73 146.91 50.42 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.118 -0.989 . . . . 0.0 109.445 179.792 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.62 ' CD1' ' N ' ' A' ' 33' ' ' TYR . 5.0 m-85 -128.8 128.64 44.34 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.23 -0.918 . . . . 0.0 109.463 -179.835 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.501 ' HB3' HD11 ' A' ' 22' ' ' LEU . 7.5 m-20 -49.79 -77.22 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.282 -0.886 . . . . 0.0 109.663 -179.551 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.543 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 2.0 t-20 -81.91 149.23 62.85 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.161 -0.962 . . . . 0.0 109.443 179.995 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.539 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 41.2 Cg_endo -64.62 -54.71 0.68 Allowed 'Trans proline' 0 C--O 1.216 -0.622 0 C-N-CA 122.842 2.361 . . . . 0.0 111.955 179.873 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.543 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 15.7 t -62.09 -28.6 69.73 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 120.974 -1.079 . . . . 0.0 108.417 179.049 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.444 ' CG ' ' HB3' ' A' ' 35' ' ' ASN . 37.0 mmm -61.45 -15.56 38.47 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 179.363 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.609 HD13 ' CD1' ' A' ' 33' ' ' TYR . 50.8 tp -63.47 -46.01 88.15 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.346 -0.846 . . . . 0.0 108.982 179.61 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.487 ' HB2' ' OH ' ' A' ' 16' ' ' TYR . 2.8 m -71.8 -19.98 61.92 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 178.764 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 28.4 t60 -66.89 -52.76 39.48 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.017 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.474 ' OE1' ' CE2' ' A' ' 33' ' ' TYR . 85.5 tt0 -66.91 -19.86 65.8 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 178.983 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.502 ' O ' ' N ' ' A' ' 47' ' ' GLN . 87.9 m-20 -77.46 -32.75 54.65 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.327 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.409 HD12 ' HA ' ' A' ' 44' ' ' LEU . 23.9 tp -64.28 -31.36 72.54 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.259 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.3 mm -77.63 -44.7 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.442 -0.787 . . . . 0.0 108.972 179.376 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.453 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 63.2 mtt-85 -79.89 -15.36 57.49 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.353 -0.842 . . . . 0.0 109.123 179.629 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.502 ' N ' ' O ' ' A' ' 43' ' ' ASN . 89.0 mt-30 63.09 44.32 5.91 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.421 -0.799 . . . . 0.0 109.486 179.995 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.408 ' O ' ' HB3' ' A' ' 43' ' ' ASN . 7.3 p -128.54 164.52 22.64 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.211 -0.93 . . . . 0.0 109.294 179.829 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 47.5 p-10 -104.58 58.62 0.7 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.123 -0.986 . . . . 0.0 109.573 -179.935 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 86.5 m -71.91 137.77 47.65 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.255 -0.903 . . . . 0.0 109.541 179.9 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.458 ' CD2' ' HB2' ' A' ' 2' ' ' SER . 71.4 m80 -112.55 176.54 4.98 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.229 -0.92 . . . . 0.0 109.091 179.723 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.601 HD12 ' OD1' ' A' ' 1' ' ' ASP . 39.2 mt -80.28 126.66 39.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.231 -0.918 . . . . 0.0 109.509 179.999 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.477 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 67.6 ttt180 -79.88 -46.39 16.91 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.443 -0.786 . . . . 0.0 109.448 -179.922 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.405 ' H ' ' HB3' ' A' ' 26' ' ' CYS . 54.4 p -160.44 138.88 10.14 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -179.331 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.446 ' H ' HG23 ' A' ' 55' ' ' THR . 10.6 p -51.29 147.4 5.75 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.163 -0.961 . . . . 0.0 109.485 179.978 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.527 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 85.14 165.95 41.03 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.484 -1.447 . . . . 0.0 109.484 179.923 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.549 ' HA ' HG23 ' A' ' 32' ' ' THR . 33.7 mttm -65.33 146.24 55.16 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.49 -1.006 . . . . 0.0 109.406 179.981 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.45 ' SG ' ' O ' ' A' ' 31' ' ' GLN . 79.2 m -49.37 -30.21 7.4 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.279 -0.888 . . . . 0.0 109.48 179.945 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -80.22 -32.31 38.5 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.335 -0.853 . . . . 0.0 109.314 -179.83 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -58.01 -20.3 37.63 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.287 -0.883 . . . . 0.0 108.948 179.718 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 20.4 m -72.93 -32.42 65.27 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.376 -0.827 . . . . 0.0 109.848 -179.749 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 83.7 p -123.8 156.42 36.15 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.083 -1.011 . . . . 0.0 109.802 -179.692 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.477 ' HB ' ' HD2' ' A' ' 64' ' ' PRO . 5.8 p -118.18 161.51 34.52 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.374 -0.829 . . . . 0.0 109.192 179.824 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.477 ' HD2' ' HB ' ' A' ' 63' ' ' THR . 50.4 Cg_endo -70.62 -17.62 33.52 Favored 'Trans proline' 0 C--O 1.214 -0.697 0 C-N-CA 122.626 2.217 . . . . 0.0 111.838 -179.897 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -172.69 173.41 45.46 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.96 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 40.6 m -114.92 138.59 50.64 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.294 -1.121 . . . . 0.0 109.534 -180.0 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 17.0 p -120.95 159.36 25.74 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.293 -0.879 . . . . 0.0 109.459 179.872 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -59.9 -30.48 69.05 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.277 -0.889 . . . . 0.0 109.591 -179.889 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.7 -37.26 85.81 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.277 -0.889 . . . . 0.0 109.509 -179.97 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 43.4 m -56.47 -33.01 65.52 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.203 -0.935 . . . . 0.0 109.609 -179.944 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.92 151.71 76.55 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.243 -0.911 . . . . 0.0 109.479 -179.997 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -70.16 146.8 58.78 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 122.691 2.261 . . . . 0.0 111.889 179.999 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -70.1 163.56 38.1 Favored 'Trans proline' 0 C--O 1.215 -0.632 0 C-N-CA 122.641 2.227 . . . . 0.0 111.753 179.987 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 19.5 m -86.47 -7.87 58.06 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.26 -0.9 . . . . 0.0 109.679 -179.895 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.481 ' O ' ' CG ' ' A' ' 76' ' ' GLU . 85.1 m-20 -83.13 -25.12 32.23 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.214 -0.929 . . . . 0.0 109.537 -179.896 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.481 ' CG ' ' O ' ' A' ' 75' ' ' ASP . 90.7 mt-10 . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.501 179.988 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.7 m -55.54 -30.22 60.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.302 -0.874 . . . . 0.0 109.424 -179.978 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.456 ' HA ' ' HG3' ' A' ' 6' ' ' LYS . 5.6 mt-10 -57.82 -22.51 47.99 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.327 -0.858 . . . . 0.0 109.309 179.906 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 62.1 mmm -77.51 -26.58 51.3 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.313 -0.867 . . . . 0.0 109.141 179.755 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.544 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 3.3 m -82.32 -14.92 54.57 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.313 -0.867 . . . . 0.0 109.143 179.862 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.456 ' HG3' ' HA ' ' A' ' 3' ' ' GLU . 85.0 mttt -56.2 -25.09 45.81 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.205 -0.934 . . . . 0.0 109.585 -179.994 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -154.27 63.04 0.69 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.179 -0.951 . . . . 0.0 109.841 -179.833 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.544 ' CD1' ' HA ' ' A' ' 5' ' ' CYS . 7.9 p90 -119.84 174.15 6.61 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.172 -0.955 . . . . 0.0 109.308 179.591 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 66.9 mtt-85 -145.26 137.34 25.69 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.19 -0.944 . . . . 0.0 109.514 -179.969 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.86 HG11 ' CD2' ' A' ' 44' ' ' LEU . 98.7 t -134.21 139.82 47.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.243 -0.911 . . . . 0.0 109.48 -179.981 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.548 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 0.2 OUTLIER -131.28 175.57 3.58 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.345 -0.847 . . . . 0.0 109.389 -179.924 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.548 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 46.0 Cg_endo -67.76 -24.95 40.18 Favored 'Trans proline' 0 C--O 1.214 -0.69 0 C-N-CA 122.673 2.249 . . . . 0.0 111.729 179.884 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.48 ' HG2' ' O ' ' A' ' 13' ' ' ARG . 54.6 ttt180 -110.97 -20.54 12.39 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.328 -0.857 . . . . 0.0 109.204 179.778 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 80.6 mt -90.98 -38.53 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.344 -0.848 . . . . 0.0 109.406 179.978 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.843 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 67.97 -142.22 39.38 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.948 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.54 ' CE2' ' CE2' ' A' ' 8' ' ' TYR . 2.9 t80 -108.23 153.97 22.44 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.172 -1.193 . . . . 0.0 109.57 -179.898 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 29.4 tp -112.33 119.46 38.36 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.398 -0.814 . . . . 0.0 109.581 179.911 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.459 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 58.5 m -131.55 155.92 80.81 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.279 -0.888 . . . . 0.0 109.269 179.903 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -71.11 166.4 29.31 Favored 'Trans proline' 0 C--O 1.216 -0.62 0 C-N-CA 122.523 2.149 . . . . 0.0 111.661 -179.994 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 90.1 mttt -88.42 -7.13 57.12 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.274 -0.891 . . . . 0.0 109.541 -179.934 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -74.39 128.42 35.49 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.231 -0.918 . . . . 0.0 109.4 179.846 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.731 ' C ' HD13 ' A' ' 22' ' ' LEU . 3.2 tm? -85.5 113.81 22.05 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.212 -0.93 . . . . 0.0 109.666 -179.831 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.519 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 5.5 mmtt -132.75 102.84 13.46 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.271 -0.893 . . . . 0.0 108.818 179.606 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.529 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 41.4 Cg_endo -63.43 124.18 13.35 Favored 'Trans proline' 0 C--O 1.213 -0.734 0 C-N-CA 122.963 2.442 . . . . 0.0 112.417 -179.067 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.46 ' HB ' HG23 ' A' ' 52' ' ' ILE . 35.0 m -123.06 154.08 28.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.47 -0.769 . . . . 0.0 109.921 -179.93 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.457 ' SG ' ' HB3' ' A' ' 53' ' ' ARG . 43.8 t -100.67 136.47 40.49 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 178.611 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -93.8 139.07 14.38 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 110.109 -1.196 . . . . 0.0 110.109 -179.099 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.504 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 48.9 p30 -64.14 -13.33 47.34 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.327 -1.102 . . . . 0.0 109.348 179.67 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.441 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 31.6 m-20 -85.61 11.31 11.03 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.236 -0.915 . . . . 0.0 109.237 179.844 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.5 20.32 66.71 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.886 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.523 ' O ' ' N ' ' A' ' 27' ' ' GLY . 83.0 mt-30 -121.98 145.93 47.65 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.304 -1.115 . . . . 0.0 109.503 -179.955 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.512 ' CG2' ' HA ' ' A' ' 57' ' ' LYS . 85.5 m -111.43 153.25 26.38 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.245 -0.909 . . . . 0.0 109.494 179.975 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.53 ' OH ' ' CG ' ' A' ' 42' ' ' GLU . 62.9 m-85 -135.69 145.67 46.96 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.246 -0.909 . . . . 0.0 109.196 179.648 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.528 ' ND2' ' N ' ' A' ' 34' ' ' ASN . 0.2 OUTLIER -63.92 -72.44 0.14 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.144 -0.972 . . . . 0.0 108.574 179.9 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.544 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 9.3 t-20 -83.09 146.9 52.66 Favored Pre-proline 0 C--N 1.299 -1.63 0 O-C-N 121.446 -0.784 . . . . 0.0 109.461 179.709 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.519 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 41.7 Cg_endo -64.15 -51.75 1.98 Allowed 'Trans proline' 0 C--O 1.215 -0.629 0 C-N-CA 122.512 2.141 . . . . 0.0 111.414 179.678 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.544 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 6.6 t -59.34 -25.85 64.54 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 178.8 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.489 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 10.2 mmm -65.6 -19.21 65.82 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.232 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 1.077 HD13 ' CD1' ' A' ' 52' ' ' ILE . 5.7 tt -73.97 -52.19 13.6 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.126 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.576 ' N ' HD23 ' A' ' 39' ' ' LEU . 7.3 t -47.92 -33.36 7.52 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 178.685 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 58.1 t60 -49.95 -56.0 12.32 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 178.934 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.53 ' CG ' ' OH ' ' A' ' 33' ' ' TYR . 16.8 tt0 -50.67 -23.13 2.42 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.072 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.511 ' HB2' ' O ' ' A' ' 40' ' ' CYS . 5.4 m-80 -80.92 -29.67 35.48 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 119.545 -0.862 . . . . 0.0 109.095 179.828 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.86 ' CD2' HG11 ' A' ' 10' ' ' VAL . 27.7 tp -77.39 -35.87 53.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.293 -0.879 . . . . 0.0 109.369 179.942 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 8.0 mm -77.25 -52.77 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.174 -0.954 . . . . 0.0 109.296 179.816 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.416 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 17.5 mtt-85 -79.84 -15.31 57.65 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.311 -0.868 . . . . 0.0 109.49 179.86 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.454 ' HA ' ' O ' ' A' ' 43' ' ' ASN . 92.8 mt-30 60.9 33.4 19.9 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.242 -0.911 . . . . 0.0 109.542 -179.978 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 18.4 p -108.96 176.28 5.16 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.318 -0.864 . . . . 0.0 109.451 179.978 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.488 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 88.8 m-20 -102.91 54.03 0.77 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.285 -0.884 . . . . 0.0 109.423 179.95 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.497 ' N ' ' OD1' ' A' ' 43' ' ' ASN . 60.7 m -73.53 124.24 25.49 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.282 -0.886 . . . . 0.0 109.467 -179.971 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.488 ' CE1' ' O ' ' A' ' 49' ' ' ASN . 11.9 m-70 -111.89 -171.19 1.8 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.201 -0.937 . . . . 0.0 109.379 179.908 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 1.077 ' CD1' HD13 ' A' ' 39' ' ' LEU . 21.4 mm -86.45 125.05 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.276 -0.89 . . . . 0.0 109.702 -179.992 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.504 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 59.8 ttt180 -80.73 -42.82 21.24 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.415 -0.803 . . . . 0.0 109.38 179.6 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.403 ' H ' ' HB3' ' A' ' 26' ' ' CYS . 7.6 p -160.87 131.67 5.37 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.6 -0.687 . . . . 0.0 109.305 -179.188 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.425 ' H ' HG23 ' A' ' 55' ' ' THR . 8.0 p -49.13 147.38 2.98 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.214 -0.929 . . . . 0.0 109.089 179.803 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.529 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 85.46 172.45 48.98 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.239 -1.544 . . . . 0.0 109.239 -179.713 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.512 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 55.9 mttm -66.27 149.4 50.41 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.279 -1.13 . . . . 0.0 109.676 -179.77 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.408 ' SG ' ' OG1' ' A' ' 32' ' ' THR . 93.4 m -51.5 -31.18 22.85 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.297 -0.877 . . . . 0.0 109.23 179.878 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 69.6 tt0 -82.87 -25.95 32.05 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.26 -0.9 . . . . 0.0 109.355 -179.967 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.5 tp10 -92.66 116.13 28.73 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.167 -0.958 . . . . 0.0 109.361 179.923 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 9.9 p -127.54 149.95 49.91 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.29 -0.881 . . . . 0.0 109.33 179.96 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 22.8 t -114.24 156.12 24.89 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.278 -0.889 . . . . 0.0 109.537 179.973 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 72.1 p -71.06 156.9 91.37 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.217 -0.927 . . . . 0.0 109.412 179.967 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -70.03 142.64 47.26 Favored 'Trans proline' 0 C--O 1.214 -0.686 0 C-N-CA 122.691 2.261 . . . . 0.0 111.77 179.998 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -81.07 -174.66 49.15 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.998 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 49.2 p -66.3 -26.08 67.15 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.305 -1.115 . . . . 0.0 109.464 -179.998 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.444 ' OG1' ' O ' ' A' ' 69' ' ' ALA . 22.7 p -120.53 164.07 17.01 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.309 -0.87 . . . . 0.0 109.458 179.944 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.69 -35.04 79.63 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.187 -0.945 . . . . 0.0 109.483 179.944 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.734 ' HB1' ' SD ' ' A' ' 71' ' ' MET . . . -104.31 138.06 41.3 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.2 -0.937 . . . . 0.0 109.427 -179.962 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 87.3 p -63.0 -27.38 69.38 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.187 -0.946 . . . . 0.0 109.475 179.935 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.734 ' SD ' ' HB1' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -60.61 149.79 77.38 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.3 -0.875 . . . . 0.0 109.478 -179.977 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -70.71 149.41 60.81 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 122.717 2.278 . . . . 0.0 111.84 179.98 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -70.61 -2.99 11.67 Favored 'Trans proline' 0 C--O 1.215 -0.632 0 C-N-CA 122.733 2.289 . . . . 0.0 111.927 -179.945 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 82.9 p -85.83 -10.66 55.06 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.128 -0.983 . . . . 0.0 109.43 -179.883 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 31.9 p-10 -72.42 -26.43 61.85 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.202 -0.936 . . . . 0.0 109.511 -179.973 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 117.97 -1.014 . . . . 0.0 109.501 179.997 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.525 ' HB2' ' CE1' ' A' ' 51' ' ' HIS . 13.0 m -58.09 -36.81 73.4 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.278 -0.889 . . . . 0.0 109.264 179.814 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -54.29 -26.12 27.52 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.376 -0.827 . . . . 0.0 108.941 179.766 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 72.8 mmm -74.91 -25.35 58.86 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.522 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.601 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 44.5 m -80.26 -19.26 47.19 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.48 -0.762 . . . . 0.0 109.392 179.936 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 20.8 mttt -80.08 4.82 15.98 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.24 -0.913 . . . . 0.0 109.652 -179.911 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -128.84 4.75 5.43 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.03 -1.044 . . . . 0.0 110.415 -179.409 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.689 ' CE2' ' CZ ' ' A' ' 16' ' ' TYR . 0.9 OUTLIER -120.43 150.21 41.14 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.912 -1.117 . . . . 0.0 109.554 179.78 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 81.2 mtt180 -131.87 130.69 41.98 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.26 -0.9 . . . . 0.0 109.167 179.76 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.777 HG13 ' O ' ' A' ' 15' ' ' GLY . 58.5 t -118.1 149.3 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.303 -0.873 . . . . 0.0 110.099 -179.484 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.551 ' HB2' HD12 ' A' ' 14' ' ' ILE . 0.7 OUTLIER -127.55 175.42 3.4 Favored Pre-proline 0 N--CA 1.488 1.459 0 O-C-N 121.375 -0.828 . . . . 0.0 108.905 179.484 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.55 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 43.6 Cg_endo -67.22 -22.37 46.78 Favored 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 122.465 2.11 . . . . 0.0 111.746 179.908 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 15.5 mtt-85 -102.04 -28.99 12.03 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.214 -0.929 . . . . 0.0 109.635 -179.999 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.551 HD12 ' HB2' ' A' ' 11' ' ' LEU . 84.9 mt -79.54 -48.7 20.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.229 -0.919 . . . . 0.0 109.582 -179.685 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.777 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 81.9 -167.97 48.59 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 -179.93 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.689 ' CZ ' ' CE2' ' A' ' 8' ' ' TYR . 1.0 OUTLIER -97.69 146.87 24.91 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.131 -1.217 . . . . 0.0 109.618 179.985 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 24.9 tp -118.24 120.63 38.26 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.355 -0.841 . . . . 0.0 109.527 179.969 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.435 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 80.1 m -129.22 156.15 78.78 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.325 -0.859 . . . . 0.0 109.128 179.67 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.525 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 46.2 Cg_endo -69.72 163.95 36.33 Favored 'Trans proline' 0 C--O 1.216 -0.613 0 C-N-CA 122.655 2.236 . . . . 0.0 111.729 -179.987 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -89.78 -7.83 53.52 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.278 -0.889 . . . . 0.0 109.412 -179.987 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 -73.62 120.82 19.74 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.297 -0.877 . . . . 0.0 109.375 179.903 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.921 HD21 ' OD1' ' A' ' 34' ' ' ASN . 3.1 tm? -81.41 124.0 29.05 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.283 -0.886 . . . . 0.0 109.417 -179.923 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.723 ' N ' HD13 ' A' ' 22' ' ' LEU . 11.9 mttt -146.31 104.74 4.06 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.308 -0.87 . . . . 0.0 109.371 179.769 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.549 ' HA ' ' O ' ' A' ' 34' ' ' ASN . 42.6 Cg_endo -65.23 123.61 11.77 Favored 'Trans proline' 0 C--O 1.213 -0.752 0 C-N-CA 122.954 2.436 . . . . 0.0 111.95 -179.92 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.529 ' O ' HG23 ' A' ' 32' ' ' THR . 27.2 m -118.69 154.51 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.191 -0.943 . . . . 0.0 109.637 179.978 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.445 ' SG ' ' HB3' ' A' ' 53' ' ' ARG . 41.5 t -96.59 138.4 34.22 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.273 -0.892 . . . . 0.0 108.83 179.327 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -91.99 139.46 14.71 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.306 -1.518 . . . . 0.0 109.306 179.995 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.51 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 55.5 t0 -71.03 -7.17 44.51 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.265 -1.138 . . . . 0.0 109.511 -179.925 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.415 ' OD1' ' C ' ' A' ' 29' ' ' ASP . 59.1 p30 -89.6 3.62 52.0 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.187 -0.946 . . . . 0.0 109.462 179.732 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.21 13.39 52.41 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 -179.891 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.451 ' O ' ' N ' ' A' ' 27' ' ' GLY . 76.9 mt-30 -118.72 174.04 6.51 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.256 -1.144 . . . . 0.0 109.402 -179.964 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.612 HG21 ' HG3' ' A' ' 57' ' ' LYS . 23.2 m -135.93 137.23 41.14 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.308 -0.87 . . . . 0.0 109.341 179.839 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.788 ' CD1' HD13 ' A' ' 39' ' ' LEU . 29.3 m-85 -114.2 129.12 56.63 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.299 -0.876 . . . . 0.0 109.348 -179.915 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.921 ' OD1' HD21 ' A' ' 22' ' ' LEU . 63.6 t-20 -52.55 -79.78 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.297 -0.877 . . . . 0.0 109.742 -179.583 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.537 ' HB3' ' CG ' ' A' ' 38' ' ' MET . 2.0 t-20 -81.17 149.66 66.53 Favored Pre-proline 0 C--N 1.3 -1.57 0 O-C-N 120.927 -1.108 . . . . 0.0 109.567 -179.813 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.508 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 39.9 Cg_endo -63.07 -54.53 1.08 Allowed 'Trans proline' 0 C--O 1.214 -0.68 0 C-N-CA 122.729 2.286 . . . . 0.0 111.925 -179.765 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.532 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 9.1 t -61.15 -29.15 69.61 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 120.997 -1.064 . . . . 0.0 108.224 179.116 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.537 ' CG ' ' HB3' ' A' ' 35' ' ' ASN . 69.6 mmm -62.56 -16.42 56.05 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 179.321 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.788 HD13 ' CD1' ' A' ' 33' ' ' TYR . 24.5 tp -69.08 -58.14 4.48 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.382 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.481 ' HB3' ' OH ' ' A' ' 16' ' ' TYR . 8.8 t -56.95 -29.82 63.49 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 178.685 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 54.9 t60 -64.1 -60.45 3.21 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.189 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.567 ' OE1' ' CE2' ' A' ' 33' ' ' TYR . 83.9 tt0 -57.79 -22.33 46.62 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.328 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.505 ' O ' ' N ' ' A' ' 47' ' ' GLN . 97.3 m-20 -76.4 -31.97 58.27 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.41 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 15.9 tp -66.49 -31.82 72.8 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.267 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 5.4 mt -75.81 -44.7 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 179.41 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.461 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 73.4 mtt-85 -80.61 -20.48 43.14 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.493 -0.754 . . . . 0.0 109.378 179.786 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.505 ' N ' ' O ' ' A' ' 43' ' ' ASN . 89.2 mt-30 63.3 43.49 6.15 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.313 -0.867 . . . . 0.0 109.43 -179.927 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.3 p -123.75 161.82 24.41 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.343 -0.848 . . . . 0.0 109.298 179.868 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.425 ' O ' ' CG ' ' A' ' 49' ' ' ASN . 44.8 p-10 -96.51 59.71 1.83 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.185 -0.947 . . . . 0.0 109.448 179.957 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 34.7 m -72.81 140.45 47.66 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.199 -0.938 . . . . 0.0 109.82 -179.872 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.525 ' CE1' ' HB2' ' A' ' 2' ' ' SER . 49.3 m-70 -118.49 172.03 7.75 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.39 -0.819 . . . . 0.0 108.918 179.578 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.478 HG23 ' HB ' ' A' ' 25' ' ' VAL . 35.9 mt -81.54 126.28 39.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.141 -0.974 . . . . 0.0 109.291 179.772 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.51 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 39.8 ttt180 -79.73 -44.17 21.25 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.458 -0.776 . . . . 0.0 109.202 179.978 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.3 t -160.0 157.99 29.79 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.909 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 29.9 p -72.38 144.95 48.03 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.159 -0.963 . . . . 0.0 109.444 -179.907 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.546 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 84.83 165.92 40.71 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.865 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.612 ' HG3' HG21 ' A' ' 32' ' ' THR . 41.5 tttt -53.1 150.23 6.01 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.43 -1.041 . . . . 0.0 109.438 -179.98 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . . . . . . . . . 98.8 m -52.95 -25.97 13.64 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.248 -0.907 . . . . 0.0 109.317 179.887 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 78.1 tt0 -82.31 -20.52 37.24 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.346 -0.846 . . . . 0.0 109.339 179.935 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -89.61 123.16 33.43 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.252 -0.905 . . . . 0.0 109.365 179.914 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 41.6 p -135.75 155.18 50.77 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.202 -0.936 . . . . 0.0 109.536 179.966 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 95.5 p -117.74 157.23 26.9 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.277 -0.89 . . . . 0.0 109.543 -179.987 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -125.84 85.05 59.85 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.301 -0.874 . . . . 0.0 109.356 179.902 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -68.25 -22.11 40.75 Favored 'Trans proline' 0 C--O 1.214 -0.715 0 C-N-CA 122.757 2.305 . . . . 0.0 111.94 -179.948 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 86.86 12.39 68.75 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.837 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.821 HG22 ' H ' ' A' ' 68' ' ' ALA . 48.2 m -121.47 136.67 54.93 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.216 -1.167 . . . . 0.0 109.511 179.965 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 51.5 p -74.06 -13.51 60.85 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.282 -0.886 . . . . 0.0 109.445 -179.97 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.821 ' H ' HG22 ' A' ' 66' ' ' THR . . . -60.62 -32.36 71.51 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.244 -0.91 . . . . 0.0 109.489 -179.946 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.4 ' C ' ' HD2' ' A' ' 72' ' ' PRO . . . -57.5 147.22 27.27 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.159 -0.963 . . . . 0.0 109.487 179.971 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 85.3 p -67.81 -28.37 67.52 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.261 -0.9 . . . . 0.0 109.548 -179.983 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.486 ' N ' ' HD2' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -51.07 -60.15 6.19 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.278 -0.889 . . . . 0.0 109.439 -179.912 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.486 ' HD2' ' N ' ' A' ' 71' ' ' MET . 49.0 Cg_endo -70.16 151.97 67.04 Favored 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 122.651 2.234 . . . . 0.0 111.757 -179.973 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -68.78 149.3 72.82 Favored 'Trans proline' 0 C--O 1.216 -0.623 0 C-N-CA 122.683 2.255 . . . . 0.0 111.819 179.966 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 25.2 t -122.49 141.03 52.08 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.187 -0.946 . . . . 0.0 109.522 -179.918 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 -68.34 142.03 55.61 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.254 -0.904 . . . . 0.0 109.475 179.883 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.435 -179.985 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.562 ' HB2' ' CE1' ' A' ' 51' ' ' HIS . 5.1 m -56.4 -26.7 54.11 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.342 -0.849 . . . . 0.0 109.454 -179.997 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -52.33 -25.42 9.61 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.182 -0.949 . . . . 0.0 108.736 179.8 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 74.6 mtm -72.45 -26.73 61.94 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.171 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.582 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 24.5 m -80.48 -14.27 58.41 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.506 -0.746 . . . . 0.0 109.21 179.659 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.459 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 46.0 mttm -80.94 6.89 11.98 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.27 -0.894 . . . . 0.0 109.649 -179.954 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.459 ' OD1' ' O ' ' A' ' 6' ' ' LYS . 99.3 m-20 -139.12 14.94 2.63 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.108 -0.995 . . . . 0.0 110.309 -179.415 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.844 ' OH ' HD11 ' A' ' 44' ' ' LEU . 0.7 OUTLIER -123.93 152.38 42.51 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.889 -1.132 . . . . 0.0 109.561 179.876 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 16.8 mtm-85 -130.29 132.81 46.07 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.327 -0.858 . . . . 0.0 109.3 179.859 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.844 HG13 ' O ' ' A' ' 15' ' ' GLY . 53.2 t -123.85 145.98 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.144 -0.972 . . . . 0.0 109.462 -179.93 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.567 ' CG ' ' HD2' ' A' ' 12' ' ' PRO . 0.2 OUTLIER -125.12 175.92 2.74 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.241 -0.912 . . . . 0.0 109.339 -179.791 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.567 ' HD2' ' CG ' ' A' ' 11' ' ' LEU . 46.4 Cg_endo -67.65 -22.81 43.4 Favored 'Trans proline' 0 C--O 1.214 -0.681 0 C-N-CA 122.6 2.2 . . . . 0.0 111.664 179.971 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 62.6 ttt-85 -103.27 -22.87 13.65 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.323 -0.86 . . . . 0.0 109.493 179.927 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 36.3 mm -86.1 -51.33 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.223 -0.923 . . . . 0.0 109.425 -179.963 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.844 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 81.42 -163.23 44.47 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -179.917 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.629 ' CE2' ' CE2' ' A' ' 8' ' ' TYR . 1.4 t80 -99.29 150.48 22.06 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.172 -1.193 . . . . 0.0 109.514 179.957 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 18.1 tp -117.85 108.02 14.83 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.22 -0.925 . . . . 0.0 109.693 -179.841 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.442 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 61.3 m -118.13 155.74 51.14 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.258 -0.901 . . . . 0.0 109.269 179.792 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -72.3 167.28 27.34 Favored 'Trans proline' 0 C--O 1.216 -0.624 0 C-N-CA 122.671 2.248 . . . . 0.0 111.675 -179.929 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 61.3 tttm -83.08 -31.01 27.54 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.24 -0.913 . . . . 0.0 109.373 -179.932 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -57.73 126.97 29.73 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.257 -0.902 . . . . 0.0 109.541 179.941 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.575 HD11 ' HB3' ' A' ' 34' ' ' ASN . 66.3 tp -87.93 117.86 27.08 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.315 -0.866 . . . . 0.0 109.393 179.829 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.535 ' CB ' ' HD3' ' A' ' 36' ' ' PRO . 2.8 mttm -125.57 101.8 30.11 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.229 -0.919 . . . . 0.0 109.466 -179.795 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.546 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 42.5 Cg_endo -64.83 118.96 5.89 Favored 'Trans proline' 0 C--O 1.212 -0.809 0 C-N-CA 122.96 2.44 . . . . 0.0 112.28 -179.599 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.485 ' HB ' HG23 ' A' ' 52' ' ' ILE . 15.8 m -119.41 154.59 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.221 -0.925 . . . . 0.0 109.589 179.709 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.47 ' SG ' ' HB3' ' A' ' 53' ' ' ARG . 31.7 t -95.63 141.02 29.63 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.213 -0.93 . . . . 0.0 108.797 178.995 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.536 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -95.61 137.35 13.36 Favored Glycine 0 N--CA 1.488 2.121 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 179.997 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.5 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 54.3 t0 -69.69 -5.41 24.8 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.236 -1.156 . . . . 0.0 109.579 -179.936 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -89.96 1.24 56.5 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.221 -0.924 . . . . 0.0 109.483 179.646 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.47 27.21 12.04 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.861 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.536 ' O ' ' N ' ' A' ' 27' ' ' GLY . 79.2 mt-30 -136.68 153.7 50.82 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.235 -1.156 . . . . 0.0 109.51 -179.968 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.818 HG21 ' HG3' ' A' ' 57' ' ' LYS . 3.5 m -114.96 139.59 49.7 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.294 -0.879 . . . . 0.0 109.31 179.854 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.83 ' CD1' HD13 ' A' ' 39' ' ' LEU . 86.0 m-85 -116.54 132.21 56.74 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.291 -0.881 . . . . 0.0 109.381 -179.904 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.575 ' HB3' HD11 ' A' ' 22' ' ' LEU . 9.8 m-20 -54.8 -78.93 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.352 -0.842 . . . . 0.0 109.728 -179.546 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.494 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 14.3 t-20 -82.35 146.5 54.38 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 120.999 -1.063 . . . . 0.0 109.664 -179.976 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.535 ' HD3' ' CB ' ' A' ' 23' ' ' LYS . 41.3 Cg_endo -63.81 -50.86 2.75 Favored 'Trans proline' 0 C--O 1.214 -0.715 0 C-N-CA 122.63 2.22 . . . . 0.0 111.282 179.367 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.528 ' SG ' ' CE1' ' A' ' 16' ' ' TYR . 7.8 t -60.9 -29.68 69.73 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 178.767 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.47 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 37.8 mmm -64.36 -15.88 61.23 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.103 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.83 HD13 ' CD1' ' A' ' 33' ' ' TYR . 54.5 tp -71.49 -58.84 3.14 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.346 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.447 ' HB3' ' OH ' ' A' ' 16' ' ' TYR . 13.6 t -53.51 -25.8 18.14 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 178.832 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 48.5 t60 -70.94 -63.32 1.12 Allowed 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.353 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.404 ' HA ' ' OE1' ' A' ' 42' ' ' GLU . 74.2 mm-40 -52.72 -21.73 4.4 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.504 -0.925 . . . . 0.0 108.504 179.237 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.474 ' OD1' ' HB ' ' A' ' 50' ' ' THR . 98.3 m-20 -75.21 -34.56 61.51 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.506 -0.746 . . . . 0.0 109.21 179.652 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.844 HD11 ' OH ' ' A' ' 8' ' ' TYR . 17.6 mt -64.16 -29.34 70.46 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.183 -0.948 . . . . 0.0 109.047 179.58 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.4 mt -80.42 -44.22 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.385 -0.822 . . . . 0.0 109.433 179.69 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.445 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 93.1 mtt-85 -79.97 -34.64 38.5 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.29 -0.881 . . . . 0.0 109.572 179.938 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.446 ' N ' ' O ' ' A' ' 43' ' ' ASN . 92.1 mt-30 63.01 43.74 6.4 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.334 -0.854 . . . . 0.0 109.561 179.979 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 68.4 p -117.31 16.56 14.8 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.329 -0.857 . . . . 0.0 109.295 179.77 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 47.9 t30 43.8 60.91 2.49 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.288 -0.882 . . . . 0.0 109.568 -179.902 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.474 ' HB ' ' OD1' ' A' ' 43' ' ' ASN . 25.7 m -77.96 147.34 34.98 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.26 -0.9 . . . . 0.0 109.626 179.869 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.562 ' CE1' ' HB2' ' A' ' 2' ' ' SER . 56.8 m-70 -121.63 168.16 12.09 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.362 -0.836 . . . . 0.0 108.788 179.481 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.485 HG23 ' HB ' ' A' ' 25' ' ' VAL . 26.2 mt -79.79 123.71 36.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.076 -1.015 . . . . 0.0 109.279 179.977 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.5 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 75.2 ttt-85 -80.21 -42.83 22.56 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.474 -0.766 . . . . 0.0 109.363 -179.94 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -158.45 147.3 18.93 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.444 -0.785 . . . . 0.0 109.279 179.998 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.9 p -66.51 149.74 49.99 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.207 -0.933 . . . . 0.0 109.42 -179.86 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.546 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 73.44 162.3 7.39 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 108.961 -1.656 . . . . 0.0 108.961 -179.594 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.818 ' HG3' HG21 ' A' ' 32' ' ' THR . 22.4 tttp -51.57 146.25 7.81 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.314 -1.109 . . . . 0.0 108.755 179.883 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.438 ' O ' ' O ' ' A' ' 57' ' ' LYS . 0.0 OUTLIER -59.75 -155.34 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.171 -0.956 . . . . 0.0 109.543 -179.612 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.475 ' HG2' ' O ' ' A' ' 59' ' ' GLU . 86.4 tt0 -79.39 1.52 25.01 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.18 -0.95 . . . . 0.0 109.742 -179.552 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.434 ' HB2' ' HE3' ' A' ' 57' ' ' LYS . 6.0 mt-10 -59.99 -43.79 94.94 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.108 -0.995 . . . . 0.0 109.281 179.766 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.452 ' HB3' ' HD3' ' A' ' 57' ' ' LYS . 21.7 p -58.23 -21.92 49.99 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.276 -0.89 . . . . 0.0 109.482 -179.984 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 25.6 m -64.95 151.27 46.23 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.267 -0.896 . . . . 0.0 109.512 -179.94 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.21 156.63 48.93 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.308 -0.87 . . . . 0.0 109.495 -179.989 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -70.42 138.65 36.18 Favored 'Trans proline' 0 C--O 1.216 -0.614 0 C-N-CA 122.674 2.25 . . . . 0.0 111.775 -179.929 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -83.42 178.99 52.65 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.443 -1.463 . . . . 0.0 109.443 179.968 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 17.6 p -122.72 164.79 17.64 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.232 -1.158 . . . . 0.0 109.488 -179.917 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 16.0 p -123.03 159.3 28.7 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.269 -0.894 . . . . 0.0 109.473 179.983 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -60.03 -30.9 69.48 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.23 -0.918 . . . . 0.0 109.577 -179.973 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.404 ' O ' ' HD3' ' A' ' 72' ' ' PRO . . . -62.48 -35.14 78.39 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.192 -0.943 . . . . 0.0 109.458 -179.95 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.3 m -55.43 -30.24 60.11 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.291 -0.881 . . . . 0.0 109.542 -179.984 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.22 81.0 71.36 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.331 -0.855 . . . . 0.0 109.515 179.921 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.404 ' HD3' ' O ' ' A' ' 69' ' ' ALA . 49.7 Cg_endo -70.5 156.74 60.78 Favored 'Trans proline' 0 C--O 1.214 -0.701 0 C-N-CA 122.688 2.259 . . . . 0.0 111.806 -179.838 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -70.57 163.91 37.22 Favored 'Trans proline' 0 C--O 1.214 -0.69 0 C-N-CA 122.69 2.26 . . . . 0.0 111.764 179.991 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 89.6 p -82.4 -7.68 59.63 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.265 -0.897 . . . . 0.0 109.636 -179.957 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 82.8 m-20 -66.44 -30.26 70.57 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.178 -0.951 . . . . 0.0 109.574 -179.978 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 117.931 -1.033 . . . . 0.0 109.569 179.939 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 . . . . . 0 N--CA 1.491 1.621 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.3 m -52.36 -22.35 4.51 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.258 -0.901 . . . . 0.0 109.315 179.97 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.454 ' HA ' ' HG3' ' A' ' 6' ' ' LYS . 1.4 tt0 -50.94 -23.26 2.74 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.222 -0.924 . . . . 0.0 108.865 179.77 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 56.4 mtt -77.79 -28.78 50.53 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 179.598 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.437 ' O ' ' N ' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -89.8 -13.43 36.63 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.338 -0.851 . . . . 0.0 108.743 179.663 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.454 ' HG3' ' HA ' ' A' ' 3' ' ' GLU . 34.5 mttm -46.58 -27.46 1.14 Allowed 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 179.327 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.4 ' N ' ' C ' ' A' ' 5' ' ' CYS . 45.4 p-10 -119.15 39.26 3.6 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 178.752 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.573 ' CE2' ' OH ' ' A' ' 16' ' ' TYR . 1.6 t80 -79.48 157.43 27.48 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.62 -0.675 . . . . 0.0 109.839 -179.258 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 15.1 mtt180 -150.17 115.25 5.37 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.398 -0.814 . . . . 0.0 109.055 179.542 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.581 HG13 ' C ' ' A' ' 15' ' ' GLY . 54.4 t -123.22 146.88 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.342 -0.848 . . . . 0.0 109.521 -179.625 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.534 ' HB2' HD12 ' A' ' 14' ' ' ILE . 0.2 OUTLIER -121.2 172.91 4.35 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.384 -0.823 . . . . 0.0 109.347 -179.881 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.518 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 44.2 Cg_endo -66.29 -22.81 52.66 Favored 'Trans proline' 0 C--O 1.216 -0.592 0 C-N-CA 122.669 2.246 . . . . 0.0 111.594 179.802 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 86.6 mtt-85 -101.51 -25.86 13.76 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.365 -0.835 . . . . 0.0 109.328 179.824 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.534 HD12 ' HB2' ' A' ' 11' ' ' LEU . 85.7 mt -87.52 -47.41 15.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.281 -0.887 . . . . 0.0 109.415 179.966 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.581 ' C ' HG13 ' A' ' 10' ' ' VAL . . . 69.46 -172.35 38.79 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.894 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.573 ' OH ' ' CE2' ' A' ' 8' ' ' TYR . 1.5 t80 -95.0 150.86 19.7 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.203 -1.175 . . . . 0.0 109.494 179.927 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 21.8 tp -113.38 106.04 14.11 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.255 -0.903 . . . . 0.0 109.633 -179.83 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.418 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 56.0 m -124.54 154.89 69.8 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.304 -0.873 . . . . 0.0 109.389 179.774 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -72.5 170.77 18.55 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 C-N-CA 122.639 2.226 . . . . 0.0 111.491 179.823 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 41.3 tttp -86.77 -33.9 19.77 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.301 -0.875 . . . . 0.0 109.51 -179.926 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -54.14 133.16 44.12 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.318 -0.864 . . . . 0.0 109.383 179.97 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.628 HD11 ' HB3' ' A' ' 34' ' ' ASN . 54.7 tp -92.4 113.14 25.33 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.164 -0.96 . . . . 0.0 109.417 -179.974 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.545 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 5.3 mmtt -118.94 101.68 49.93 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.301 -0.874 . . . . 0.0 109.172 179.981 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.548 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 43.0 Cg_endo -65.35 118.15 5.2 Favored 'Trans proline' 0 C--O 1.213 -0.76 0 C-N-CA 122.848 2.365 . . . . 0.0 112.034 -179.491 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.636 ' O ' HG23 ' A' ' 32' ' ' THR . 11.1 m -114.26 155.99 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.224 -0.923 . . . . 0.0 109.583 179.842 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 46.1 t -96.32 133.77 40.29 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.124 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -91.12 137.01 13.64 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.555 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.48 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 49.9 p30 -66.19 -9.12 28.82 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.341 -1.094 . . . . 0.0 109.502 179.855 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 56.0 p30 -86.09 8.81 19.32 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.18 -0.95 . . . . 0.0 109.397 179.894 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.23 18.78 58.53 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 -179.921 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.405 ' O ' ' SG ' ' A' ' 58' ' ' CYS . 64.4 mt-30 -125.97 176.09 7.24 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.205 -1.174 . . . . 0.0 109.39 -179.942 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.662 HG21 ' HA ' ' A' ' 57' ' ' LYS . 25.1 m -135.44 139.3 44.01 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.258 -0.901 . . . . 0.0 109.442 -179.981 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.971 ' CD1' HD13 ' A' ' 39' ' ' LEU . 58.1 m-85 -113.38 130.57 56.26 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.36 -0.838 . . . . 0.0 109.293 179.855 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.628 ' HB3' HD11 ' A' ' 22' ' ' LEU . 13.9 m-20 -51.83 -80.47 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.317 -0.864 . . . . 0.0 109.693 -179.542 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.509 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 12.0 t-20 -82.39 146.04 53.16 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.005 -1.059 . . . . 0.0 109.482 179.945 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.545 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.9 Cg_endo -63.68 -50.86 2.84 Favored 'Trans proline' 0 C--O 1.216 -0.612 0 C-N-CA 122.653 2.235 . . . . 0.0 111.563 179.723 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.556 ' SG ' ' CE1' ' A' ' 16' ' ' TYR . 11.0 t -61.99 -28.21 69.41 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 178.931 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.461 ' HB2' ' HB3' ' A' ' 35' ' ' ASN . 43.0 mmm -68.92 -7.81 38.43 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 179.24 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.971 HD13 ' CD1' ' A' ' 33' ' ' TYR . 25.5 tp -73.72 -60.09 2.41 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.29 -0.881 . . . . 0.0 108.902 179.802 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.462 ' SG ' ' OH ' ' A' ' 16' ' ' TYR . 12.0 t -52.91 -24.84 10.08 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.382 -0.969 . . . . 0.0 108.382 179.273 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 33.8 t60 -65.09 -60.7 2.74 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.193 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 66.0 mt-10 -60.22 -21.57 61.95 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 179.063 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.501 ' ND2' ' HG ' ' A' ' 39' ' ' LEU . 97.2 m-20 -78.22 -27.01 47.64 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.512 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.97 HD13 ' O ' ' A' ' 44' ' ' LEU . 1.4 tm? -68.54 -36.34 78.68 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.269 -0.894 . . . . 0.0 108.732 179.422 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -77.24 -41.66 30.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.46 -0.775 . . . . 0.0 109.165 179.719 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.506 ' HB3' HG23 ' A' ' 48' ' ' THR . 93.2 mtt-85 -80.11 -36.23 35.67 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.329 -0.857 . . . . 0.0 109.307 179.898 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.445 ' N ' ' O ' ' A' ' 43' ' ' ASN . 53.1 mt-30 60.05 35.4 21.38 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.368 -0.832 . . . . 0.0 109.678 179.834 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.506 HG23 ' HB3' ' A' ' 46' ' ' ARG . 34.6 p -103.13 11.21 37.35 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.171 -0.956 . . . . 0.0 109.413 179.785 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 65.1 m-20 52.51 54.4 10.7 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.232 -0.918 . . . . 0.0 109.478 179.976 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.477 ' HB ' ' OD1' ' A' ' 43' ' ' ASN . 42.9 m -79.77 137.24 36.95 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.198 -0.938 . . . . 0.0 109.527 179.984 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . . . . . . . . . 41.1 m80 -115.53 170.53 8.35 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.363 -0.836 . . . . 0.0 108.947 179.505 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.573 HG23 ' HB ' ' A' ' 25' ' ' VAL . 29.3 mt -79.62 125.79 38.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.183 -0.948 . . . . 0.0 109.312 179.884 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.48 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 47.8 ttt180 -81.74 -40.86 22.06 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.501 -0.75 . . . . 0.0 109.496 -179.887 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -158.91 150.59 20.77 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.398 -0.814 . . . . 0.0 109.237 -179.999 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 31.0 p -69.81 139.11 53.14 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.234 -0.917 . . . . 0.0 109.516 -179.873 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.548 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 92.44 162.92 37.44 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.85 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.662 ' HA ' HG21 ' A' ' 32' ' ' THR . 39.5 tttp -50.62 148.55 3.82 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.434 -1.039 . . . . 0.0 109.272 179.887 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.405 ' SG ' ' O ' ' A' ' 31' ' ' GLN . 57.8 m -52.07 -26.75 11.76 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.191 -0.943 . . . . 0.0 109.501 -179.975 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.438 ' O ' ' HG2' ' A' ' 59' ' ' GLU . 54.7 tt0 -87.48 -22.17 25.07 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.26 -0.9 . . . . 0.0 109.229 179.864 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 60.4 tt0 -68.45 -33.24 73.84 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.397 -0.814 . . . . 0.0 109.304 179.869 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 16.2 m -61.49 -32.75 72.78 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.213 -0.929 . . . . 0.0 109.438 179.97 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 23.0 t -106.4 153.77 21.77 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.316 -0.865 . . . . 0.0 109.48 179.992 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.49 82.85 66.64 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.228 -0.92 . . . . 0.0 109.437 -179.924 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -71.49 -14.82 30.88 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 122.741 2.294 . . . . 0.0 111.777 -179.967 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 83.04 -162.9 41.1 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.979 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.558 HG22 ' H ' ' A' ' 68' ' ' ALA . 38.0 m -119.62 142.24 48.59 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.232 -1.157 . . . . 0.0 109.498 -179.981 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 40.2 m -56.02 -31.96 63.58 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.293 -0.879 . . . . 0.0 109.527 -179.999 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.558 ' H ' HG22 ' A' ' 66' ' ' THR . . . -67.78 -30.56 70.04 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.313 -0.867 . . . . 0.0 109.369 -179.965 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.445 ' O ' ' HD3' ' A' ' 72' ' ' PRO . . . -62.85 -31.98 73.11 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.204 -0.935 . . . . 0.0 109.412 179.999 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 86.3 p -58.55 -28.28 65.36 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.193 -0.942 . . . . 0.0 109.47 -179.988 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 65.5 mtp -123.78 76.92 56.98 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.315 -0.866 . . . . 0.0 109.436 179.947 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.445 ' HD3' ' O ' ' A' ' 69' ' ' ALA . 50.4 Cg_endo -70.4 145.56 53.78 Favored 'Trans proline' 0 C--O 1.214 -0.7 0 C-N-CA 122.747 2.298 . . . . 0.0 111.832 179.992 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -71.21 144.0 45.39 Favored 'Trans proline' 0 C--O 1.215 -0.629 0 C-N-CA 122.641 2.227 . . . . 0.0 111.748 179.942 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 29.9 t -128.92 141.11 51.38 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.22 -0.925 . . . . 0.0 109.53 179.987 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -58.59 -36.0 73.31 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.215 -0.928 . . . . 0.0 109.426 -179.963 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 117.946 -1.026 . . . . 0.0 109.43 179.973 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.1 m -52.79 -24.39 8.79 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.247 -0.908 . . . . 0.0 109.326 179.905 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.446 ' HA ' ' HG3' ' A' ' 6' ' ' LYS . 3.9 mt-10 -54.92 -21.73 12.57 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.326 -0.859 . . . . 0.0 109.133 179.933 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 76.8 mtm -76.11 -29.46 57.89 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.261 -0.9 . . . . 0.0 108.957 179.525 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.507 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 12.9 m -79.81 -14.0 59.01 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.289 -0.882 . . . . 0.0 109.0 179.696 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.446 ' HG3' ' HA ' ' A' ' 3' ' ' GLU . 47.2 mttm -56.6 -28.2 59.83 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.336 -0.853 . . . . 0.0 109.724 -179.792 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 64.5 m-20 -149.21 61.89 1.04 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.196 -0.94 . . . . 0.0 110.044 -179.779 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.664 ' OH ' HD13 ' A' ' 44' ' ' LEU . 4.7 p90 -121.91 168.2 12.16 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.093 -1.005 . . . . 0.0 109.348 179.534 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 34.2 ttt85 -147.99 149.02 31.39 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.148 -0.97 . . . . 0.0 109.605 179.922 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.757 HG13 ' C ' ' A' ' 15' ' ' GLY . 87.2 t -140.94 134.96 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.302 -0.874 . . . . 0.0 109.369 179.888 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.551 HD23 ' HD2' ' A' ' 12' ' ' PRO . 0.1 OUTLIER -120.59 173.71 3.55 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.15 -0.969 . . . . 0.0 109.391 179.961 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.551 ' HD2' HD23 ' A' ' 11' ' ' LEU . 47.3 Cg_endo -67.9 -23.94 40.51 Favored 'Trans proline' 0 C--O 1.215 -0.644 0 C-N-CA 122.604 2.203 . . . . 0.0 111.737 179.944 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -104.62 -26.87 12.16 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.283 -0.886 . . . . 0.0 109.453 179.992 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.437 HD12 ' HB2' ' A' ' 11' ' ' LEU . 95.2 mt -86.2 -44.43 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.241 -0.912 . . . . 0.0 109.512 -179.94 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.757 ' C ' HG13 ' A' ' 10' ' ' VAL . . . 73.92 -158.73 52.38 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 -179.957 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.525 ' CD2' HG21 ' A' ' 10' ' ' VAL . 1.9 t80 -99.64 155.29 17.68 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.285 -1.126 . . . . 0.0 109.345 179.803 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.442 ' O ' ' SG ' ' A' ' 37' ' ' CYS . 30.5 tp -114.16 120.1 39.36 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.229 -0.919 . . . . 0.0 109.883 -179.63 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.401 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 69.4 m -138.65 156.22 73.15 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.279 -0.888 . . . . 0.0 109.366 179.894 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.489 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 52.0 Cg_endo -71.65 168.76 22.78 Favored 'Trans proline' 0 C--O 1.215 -0.635 0 C-N-CA 122.681 2.254 . . . . 0.0 111.638 -179.989 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 29.0 mttt -89.9 -12.72 38.09 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.156 -0.965 . . . . 0.0 109.366 179.961 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -72.2 132.06 43.59 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.285 -0.885 . . . . 0.0 109.202 179.698 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.425 HD11 ' HB3' ' A' ' 34' ' ' ASN . 28.7 tp -91.85 114.19 26.66 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.216 -0.927 . . . . 0.0 109.807 -179.679 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.554 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 0.1 OUTLIER -126.96 106.78 22.21 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.344 -0.848 . . . . 0.0 108.897 179.604 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.546 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 44.0 Cg_endo -65.88 119.93 7.02 Favored 'Trans proline' 0 C--O 1.214 -0.722 0 C-N-CA 122.825 2.35 . . . . 0.0 112.144 -179.315 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.472 ' O ' HG23 ' A' ' 32' ' ' THR . 21.4 m -116.96 153.22 18.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.232 -0.917 . . . . 0.0 109.518 179.75 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.454 ' SG ' ' HB3' ' A' ' 53' ' ' ARG . 48.6 t -97.04 142.28 29.17 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 178.989 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -93.88 140.52 15.09 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 110.084 -1.206 . . . . 0.0 110.084 -178.999 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.473 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 52.4 p30 -67.41 -10.51 51.94 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.31 -1.112 . . . . 0.0 109.264 179.627 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.426 ' OD1' ' HB2' ' A' ' 31' ' ' GLN . 57.0 p30 -90.07 5.91 44.68 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.226 -0.922 . . . . 0.0 109.474 179.891 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.32 15.36 57.37 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 -179.925 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.458 ' O ' ' SG ' ' A' ' 58' ' ' CYS . 84.3 mt-30 -114.87 178.88 4.12 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.374 -1.074 . . . . 0.0 109.387 179.981 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.519 ' CG2' ' HA ' ' A' ' 57' ' ' LYS . 30.7 m -141.21 144.82 34.97 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.193 -0.942 . . . . 0.0 109.335 179.866 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.813 ' CD1' HD13 ' A' ' 39' ' ' LEU . 23.9 m-85 -124.59 126.7 46.22 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.269 -0.895 . . . . 0.0 109.278 -179.965 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.527 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 9.8 m-20 -48.38 -78.57 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.301 -0.874 . . . . 0.0 109.736 -179.467 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.542 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 4.5 t-20 -81.49 147.67 60.4 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 120.941 -1.1 . . . . 0.0 109.393 179.983 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.554 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 41.0 Cg_endo -63.66 -53.77 1.22 Allowed 'Trans proline' 0 C--O 1.215 -0.644 0 C-N-CA 122.872 2.381 . . . . 0.0 111.926 -179.963 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.542 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 11.3 t -62.98 -25.68 68.48 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 120.942 -1.099 . . . . 0.0 108.141 179.051 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.435 ' CG ' ' HB3' ' A' ' 35' ' ' ASN . 42.1 mmm -67.35 -13.08 61.67 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.21 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.813 HD13 ' CD1' ' A' ' 33' ' ' TYR . 19.1 tp -70.3 -57.55 4.74 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.427 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.473 ' HB3' ' OH ' ' A' ' 16' ' ' TYR . 3.3 t -56.05 -26.77 50.6 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.026 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.499 ' CE1' ' HB2' ' A' ' 16' ' ' TYR . 31.2 t60 -62.43 -59.55 4.82 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.963 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -58.33 -22.89 54.94 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 178.915 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.503 ' O ' ' N ' ' A' ' 47' ' ' GLN . 91.3 m-20 -79.19 -27.75 42.6 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.584 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.664 HD13 ' OH ' ' A' ' 8' ' ' TYR . 32.6 tp -70.22 -30.86 68.05 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.498 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 6.5 mm -80.31 -46.29 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 121.475 -0.766 . . . . 0.0 109.113 179.467 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.461 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 85.3 mtt180 -79.88 -36.56 36.42 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.309 -0.87 . . . . 0.0 109.394 179.712 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.503 ' N ' ' O ' ' A' ' 43' ' ' ASN . 92.4 mt-30 63.75 42.34 6.29 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.497 -0.752 . . . . 0.0 109.616 -179.862 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.404 HG23 ' HB3' ' A' ' 46' ' ' ARG . 49.4 p -106.8 10.16 30.82 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.195 -0.94 . . . . 0.0 109.417 179.737 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 51.51 54.68 10.62 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.273 -0.892 . . . . 0.0 109.71 179.874 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.46 ' HB ' ' OD1' ' A' ' 43' ' ' ASN . 51.5 m -79.88 139.93 36.94 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.215 -0.928 . . . . 0.0 109.528 179.985 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.449 ' CD2' ' OD2' ' A' ' 28' ' ' ASP . 8.4 m-70 -112.47 -173.42 2.24 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.239 -0.913 . . . . 0.0 109.397 179.722 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 39.8 mt -93.87 126.46 46.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.378 -0.826 . . . . 0.0 109.594 -179.933 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.473 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 68.1 ttt-85 -80.02 -45.77 17.78 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.43 -0.794 . . . . 0.0 109.3 179.787 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.41 ' H ' ' HB3' ' A' ' 26' ' ' CYS . 49.4 p -160.88 147.59 15.17 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 -179.445 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.3 p -61.23 144.14 54.32 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.137 -0.977 . . . . 0.0 109.411 179.929 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.546 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 87.51 164.01 39.66 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 -179.775 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.519 ' HA ' ' CG2' ' A' ' 32' ' ' THR . 53.1 mttt -60.44 148.81 36.17 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.414 -1.051 . . . . 0.0 109.293 179.913 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.458 ' SG ' ' O ' ' A' ' 31' ' ' GLN . 61.8 m -54.7 -19.33 5.98 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.189 -0.944 . . . . 0.0 108.999 179.532 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -79.69 -13.12 59.7 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.448 -0.783 . . . . 0.0 109.236 179.873 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.434 ' HG2' ' HB2' ' A' ' 57' ' ' LYS . 13.8 mm-40 -87.37 -24.54 24.21 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.934 -1.135 . . . . 0.0 107.934 179.263 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 84.0 p -62.95 -13.39 34.15 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.39 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 9.0 t -127.92 155.0 44.89 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.42 -0.8 . . . . 0.0 109.326 179.996 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -129.99 83.03 64.87 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.14 -0.975 . . . . 0.0 109.737 -179.783 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -72.19 141.68 36.41 Favored 'Trans proline' 0 C--O 1.217 -0.567 0 C-N-CA 122.545 2.163 . . . . 0.0 111.682 179.815 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 89.85 14.93 58.74 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.802 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 58.3 m -112.61 139.4 48.24 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.195 -1.18 . . . . 0.0 109.486 179.877 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.626 HG22 ' H ' ' A' ' 69' ' ' ALA . 34.1 m -122.19 143.67 49.42 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.288 -0.883 . . . . 0.0 109.438 -179.985 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.0 -29.42 70.81 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.261 -0.9 . . . . 0.0 109.403 179.988 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.626 ' H ' HG22 ' A' ' 67' ' ' THR . . . -101.61 142.58 32.76 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.208 -0.933 . . . . 0.0 109.414 179.995 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 17.0 m -57.99 -28.77 64.71 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.237 -0.914 . . . . 0.0 109.414 -179.947 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.47 ' HB2' ' HD2' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -130.72 159.64 70.15 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.279 -0.888 . . . . 0.0 109.583 179.964 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.47 ' HD2' ' HB2' ' A' ' 71' ' ' MET . 49.4 Cg_endo -69.75 158.78 55.8 Favored 'Trans proline' 0 C--O 1.214 -0.69 0 C-N-CA 122.757 2.304 . . . . 0.0 111.747 -179.964 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -70.42 157.77 58.11 Favored 'Trans proline' 0 C--O 1.216 -0.62 0 C-N-CA 122.729 2.286 . . . . 0.0 111.811 -179.969 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 92.6 p -132.67 154.11 50.44 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.206 -0.934 . . . . 0.0 109.384 -179.983 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -70.07 139.04 52.53 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.218 -0.926 . . . . 0.0 109.471 179.997 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 . . . . . 0 N--CA 1.488 1.461 0 CA-C-O 117.945 -1.026 . . . . 0.0 109.532 179.998 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.579 ' HB2' ' CE1' ' A' ' 51' ' ' HIS . 4.3 m -55.55 -34.48 64.78 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.295 -0.878 . . . . 0.0 109.345 179.952 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -53.75 -26.01 21.49 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.33 -0.856 . . . . 0.0 109.138 179.908 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 64.1 mmm -73.56 -24.73 60.14 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.297 -0.877 . . . . 0.0 108.821 179.434 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.576 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 29.3 m -81.82 -15.34 54.44 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.483 -0.761 . . . . 0.0 109.112 179.709 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.452 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 45.4 mttm -80.72 5.56 15.4 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.195 -0.94 . . . . 0.0 109.789 -179.954 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.452 ' OD1' ' O ' ' A' ' 6' ' ' LYS . 95.4 m-20 -135.97 12.05 3.36 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.025 -1.047 . . . . 0.0 110.333 -179.367 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.772 ' OH ' HD11 ' A' ' 44' ' ' LEU . 0.6 OUTLIER -123.11 155.94 35.98 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.866 -1.146 . . . . 0.0 109.576 179.822 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 47.0 mtt85 -134.19 132.81 40.21 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.372 -0.83 . . . . 0.0 109.149 179.804 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.902 HG13 ' O ' ' A' ' 15' ' ' GLY . 55.6 t -125.45 147.56 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.195 -0.941 . . . . 0.0 109.872 -179.535 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.541 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 1.3 mp -123.28 174.96 3.04 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.288 -0.883 . . . . 0.0 109.202 179.797 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.541 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 44.8 Cg_endo -67.2 -21.72 47.88 Favored 'Trans proline' 0 C--O 1.215 -0.647 0 C-N-CA 122.561 2.174 . . . . 0.0 111.732 179.923 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 95.0 mtt-85 -104.61 -25.73 12.62 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.369 -0.832 . . . . 0.0 109.684 -179.953 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 24.4 mm -80.95 -47.23 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.232 -0.917 . . . . 0.0 109.532 -179.703 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.902 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 82.38 -163.17 42.58 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.935 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.635 ' CE2' ' CE2' ' A' ' 8' ' ' TYR . 1.6 t80 -102.51 148.9 24.96 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.205 -1.174 . . . . 0.0 109.466 179.925 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 27.1 tp -115.63 111.86 21.26 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.31 -0.869 . . . . 0.0 109.532 179.885 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.431 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 80.7 m -120.23 157.54 53.07 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.197 -0.939 . . . . 0.0 109.353 -179.977 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.52 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 50.6 Cg_endo -71.57 166.48 29.26 Favored 'Trans proline' 0 C--O 1.215 -0.642 0 C-N-CA 122.713 2.275 . . . . 0.0 111.884 -179.774 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -87.3 -9.74 54.15 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.307 -0.87 . . . . 0.0 109.449 179.902 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 54.5 t0 -76.31 110.94 11.24 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.183 -0.948 . . . . 0.0 109.106 179.736 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 42.7 tp -79.66 123.62 27.81 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.216 -0.927 . . . . 0.0 109.708 -179.76 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.481 ' HD3' ' HG3' ' A' ' 36' ' ' PRO . 5.2 mtpt -139.66 107.98 7.12 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.308 -0.87 . . . . 0.0 109.052 179.661 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.556 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 41.5 Cg_endo -64.28 120.23 7.49 Favored 'Trans proline' 0 C--O 1.212 -0.779 0 C-N-CA 122.937 2.424 . . . . 0.0 112.082 -179.558 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.525 ' HB ' HG23 ' A' ' 52' ' ' ILE . 16.6 m -115.71 154.63 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.282 -0.886 . . . . 0.0 109.835 -179.937 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . . . . . . . . . 43.9 t -97.21 126.28 42.29 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.456 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -78.57 137.66 19.9 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 -179.994 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.495 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 52.9 t0 -70.82 -10.33 59.32 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.174 -1.192 . . . . 0.0 109.566 -179.944 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.416 ' OD1' ' HB2' ' A' ' 31' ' ' GLN . 56.5 p30 -87.96 10.38 19.09 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.257 -0.902 . . . . 0.0 109.24 179.586 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.45 21.39 48.4 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.08 -1.608 . . . . 0.0 109.08 -179.722 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.456 ' O ' ' SG ' ' A' ' 58' ' ' CYS . 87.5 mt-30 -121.0 177.21 5.2 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.277 -1.131 . . . . 0.0 109.542 179.98 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 1.001 HG21 ' HG3' ' A' ' 57' ' ' LYS . 56.7 m -140.37 134.75 31.33 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.314 -0.866 . . . . 0.0 109.304 179.96 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.835 ' CD1' HD13 ' A' ' 39' ' ' LEU . 39.0 m-85 -117.36 130.09 56.28 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.309 -0.869 . . . . 0.0 109.295 179.994 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.53 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 7.1 m-20 -54.54 -77.83 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.221 -0.924 . . . . 0.0 109.73 -179.628 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.527 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 5.1 t-20 -81.68 148.69 62.43 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.094 -1.004 . . . . 0.0 109.641 -179.906 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.481 ' HG3' ' HD3' ' A' ' 23' ' ' LYS . 40.6 Cg_endo -63.1 -52.62 1.99 Allowed 'Trans proline' 0 C--O 1.215 -0.631 0 C-N-CA 122.568 2.179 . . . . 0.0 111.807 179.829 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.527 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 5.4 t -61.98 -28.18 69.38 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 178.982 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.494 ' CG ' ' HB3' ' A' ' 35' ' ' ASN . 52.6 mmm -63.32 -16.57 60.76 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.444 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.835 HD13 ' CD1' ' A' ' 33' ' ' TYR . 39.0 tp -68.71 -56.87 6.7 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 179.327 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.471 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 10.9 t -55.78 -23.14 28.13 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 178.864 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 47.1 t60 -71.69 -63.46 1.12 Allowed 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 179.393 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.439 ' HB2' ' CE2' ' A' ' 33' ' ' TYR . 62.2 mt-10 -54.35 -21.77 10.38 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.342 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.495 ' O ' ' N ' ' A' ' 47' ' ' GLN . 99.4 m-20 -73.29 -37.22 66.3 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.424 -0.797 . . . . 0.0 109.116 179.686 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.772 HD11 ' OH ' ' A' ' 8' ' ' TYR . 24.0 mt -61.41 -32.59 72.53 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.139 -0.975 . . . . 0.0 108.912 179.627 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.8 mt -74.4 -42.58 49.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.377 -0.827 . . . . 0.0 108.832 179.296 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.448 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 69.1 mtt-85 -79.85 -22.57 42.78 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.428 -0.795 . . . . 0.0 109.391 179.744 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.495 ' N ' ' O ' ' A' ' 43' ' ' ASN . 89.5 mt-30 63.21 41.69 7.73 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.395 -0.816 . . . . 0.0 109.427 -179.838 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 16.0 p -128.35 163.5 24.7 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.344 -0.847 . . . . 0.0 109.371 179.87 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 50.9 p-10 -94.3 61.48 2.83 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.175 -0.953 . . . . 0.0 109.428 -179.958 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 31.7 m -69.75 139.0 53.26 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.402 -0.811 . . . . 0.0 109.742 -179.937 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.579 ' CE1' ' HB2' ' A' ' 2' ' ' SER . 62.1 m-70 -119.8 169.36 10.2 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.307 -0.871 . . . . 0.0 109.032 179.538 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.525 HG23 ' HB ' ' A' ' 25' ' ' VAL . 41.1 mt -79.43 126.42 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.182 -0.949 . . . . 0.0 109.387 179.983 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.495 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 68.8 ttt180 -79.92 -47.98 14.17 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-O 121.638 0.732 . . . . 0.0 109.449 179.988 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 65.2 p -159.71 135.55 8.6 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -179.483 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.441 ' H ' HG23 ' A' ' 55' ' ' THR . 11.5 p -50.88 147.97 4.54 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.245 -0.91 . . . . 0.0 109.525 -179.834 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.556 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 85.94 164.22 38.97 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.326 -1.509 . . . . 0.0 109.326 -179.764 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 1.001 ' HG3' HG21 ' A' ' 32' ' ' THR . 26.0 tttt -59.32 153.72 18.2 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.374 -1.074 . . . . 0.0 109.387 -179.924 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.528 ' N ' ' HG2' ' A' ' 57' ' ' LYS . 98.2 m -55.96 -28.21 55.99 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.267 -0.896 . . . . 0.0 109.704 -179.772 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.482 ' HB3' ' HD3' ' A' ' 57' ' ' LYS . 78.6 tt0 -82.91 -22.57 33.87 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.241 -0.912 . . . . 0.0 109.552 -179.831 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 62.1 tt0 -68.82 -29.63 68.01 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.286 -0.884 . . . . 0.0 109.344 179.96 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 82.6 p -72.67 -19.9 61.34 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.334 -0.853 . . . . 0.0 109.64 -179.87 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 87.6 p -109.09 152.75 24.64 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.169 -0.957 . . . . 0.0 109.597 -179.856 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 11.3 p -126.72 85.6 60.32 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.34 -0.85 . . . . 0.0 109.326 179.888 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -69.62 -18.11 37.86 Favored 'Trans proline' 0 C--O 1.214 -0.684 0 C-N-CA 122.778 2.319 . . . . 0.0 111.886 -179.943 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.27 17.14 65.26 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 179.905 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 14.1 t -131.28 158.27 41.08 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.207 -1.172 . . . . 0.0 109.518 179.939 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 14.8 p -122.77 160.51 25.82 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.31 -0.869 . . . . 0.0 109.377 179.93 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.03 -30.91 66.51 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.219 -0.926 . . . . 0.0 109.52 -179.952 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.31 -34.26 76.26 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.309 -0.869 . . . . 0.0 109.486 -179.893 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 33.9 m -54.5 -33.34 59.66 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.23 -0.919 . . . . 0.0 109.563 179.987 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . . . . . . . . . 7.9 mtp -72.76 151.83 91.19 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.36 -0.838 . . . . 0.0 109.47 -179.973 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -69.92 146.58 59.63 Favored 'Trans proline' 0 C--O 1.215 -0.646 0 C-N-CA 122.742 2.295 . . . . 0.0 111.839 179.997 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -69.79 157.98 58.48 Favored 'Trans proline' 0 C--O 1.215 -0.638 0 C-N-CA 122.765 2.31 . . . . 0.0 111.876 179.983 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 83.8 p -79.73 -10.07 59.74 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.208 -0.933 . . . . 0.0 109.572 -179.984 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.404 ' O ' ' HB2' ' A' ' 76' ' ' GLU . 87.3 m-20 -67.97 -34.61 76.89 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.189 -0.944 . . . . 0.0 109.435 -179.968 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.404 ' HB2' ' O ' ' A' ' 75' ' ' ASP . 75.0 mm-40 . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.498 179.993 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.453 ' OD1' HG13 ' A' ' 52' ' ' ILE . 92.0 m-20 . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 121.288 0.566 . . . . 0.0 109.486 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.411 ' HB2' ' CE1' ' A' ' 51' ' ' HIS . 0.5 OUTLIER -56.06 -34.83 66.3 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.303 -0.873 . . . . 0.0 109.367 179.888 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -56.56 -24.93 50.41 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.36 -0.837 . . . . 0.0 109.146 179.947 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.442 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 57.2 mmm -74.3 -23.11 59.03 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.316 -0.865 . . . . 0.0 108.722 179.401 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.411 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 17.2 m -81.97 -18.21 44.24 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.483 -0.761 . . . . 0.0 109.155 179.586 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 49.6 mttt -80.2 -3.78 50.41 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.32 -0.862 . . . . 0.0 109.745 -179.886 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.442 ' OD1' ' O ' ' A' ' 4' ' ' MET . 19.3 p30 -118.56 -0.82 11.29 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.08 -1.013 . . . . 0.0 109.714 -179.835 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.484 ' OH ' ' CE2' ' A' ' 16' ' ' TYR . 0.1 OUTLIER -118.51 168.9 10.24 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.053 -1.029 . . . . 0.0 109.284 179.979 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 41.9 mtm-85 -149.63 128.14 12.29 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.243 -0.911 . . . . 0.0 109.254 179.817 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.542 HG21 ' C ' ' A' ' 15' ' ' GLY . 6.4 p -124.99 145.48 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.218 -0.926 . . . . 0.0 109.847 -179.77 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.66 HD23 ' HD2' ' A' ' 12' ' ' PRO . 0.2 OUTLIER -108.37 170.37 5.57 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.359 -0.838 . . . . 0.0 109.229 179.921 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.66 ' HD2' HD23 ' A' ' 11' ' ' LEU . 45.7 Cg_endo -67.54 -23.86 42.79 Favored 'Trans proline' 0 C--O 1.215 -0.659 0 C-N-CA 122.622 2.215 . . . . 0.0 111.787 179.951 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 73.2 mtt85 -87.7 -26.28 23.05 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.289 -0.882 . . . . 0.0 109.131 179.734 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 97.7 mt -90.26 -44.49 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.277 -0.889 . . . . 0.0 109.327 179.883 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.542 ' C ' HG21 ' A' ' 10' ' ' VAL . . . 72.97 148.9 1.0 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.991 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.542 ' N ' HG21 ' A' ' 10' ' ' VAL . 0.9 OUTLIER -47.48 148.91 1.24 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.327 -1.102 . . . . 0.0 109.788 -179.874 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 25.9 tp -115.82 110.29 18.84 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.373 -0.829 . . . . 0.0 109.521 -179.992 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 56.1 m -120.74 154.96 57.54 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.272 -0.892 . . . . 0.0 109.445 179.966 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -72.47 169.7 21.12 Favored 'Trans proline' 0 C--O 1.215 -0.669 0 C-N-CA 122.591 2.194 . . . . 0.0 111.475 179.978 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 47.6 mttm -88.7 -17.89 29.02 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.185 -0.947 . . . . 0.0 109.471 -179.911 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -66.94 130.34 42.83 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.262 -0.899 . . . . 0.0 109.296 179.721 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.498 HD11 ' HB3' ' A' ' 34' ' ' ASN . 43.3 tp -87.46 121.88 30.47 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.177 -0.952 . . . . 0.0 109.558 -179.894 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.541 ' CB ' ' HD3' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -132.77 99.72 15.18 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.234 -0.916 . . . . 0.0 109.044 179.768 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.544 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 41.9 Cg_endo -63.88 119.77 6.93 Favored 'Trans proline' 0 C--O 1.214 -0.702 0 C-N-CA 122.899 2.399 . . . . 0.0 112.492 -179.248 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 32.9 m -115.71 154.37 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.345 -0.847 . . . . 0.0 109.473 179.689 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.404 ' O ' ' N ' ' A' ' 53' ' ' ARG . 41.6 t -100.65 121.32 41.43 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.323 -0.86 . . . . 0.0 108.819 179.372 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -74.83 141.62 28.6 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.804 -1.319 . . . . 0.0 109.804 -179.701 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.508 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 55.1 t0 -71.28 -9.69 58.53 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.156 -1.202 . . . . 0.0 109.598 179.969 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -86.81 6.62 30.74 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.234 -0.916 . . . . 0.0 109.198 179.64 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.79 16.6 54.36 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 -179.836 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.454 ' O ' ' SG ' ' A' ' 58' ' ' CYS . 87.5 mt-30 -118.19 169.58 9.58 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.194 -1.18 . . . . 0.0 109.532 179.992 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.481 HG23 ' HA ' ' A' ' 57' ' ' LYS . 27.8 m -132.39 134.47 45.19 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.224 -0.922 . . . . 0.0 109.367 179.874 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.812 ' CD1' HD13 ' A' ' 39' ' ' LEU . 47.6 m-85 -114.43 130.28 56.7 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.185 -0.947 . . . . 0.0 109.195 179.835 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.526 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 5.1 m-20 -52.49 -77.88 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.19 -0.944 . . . . 0.0 109.73 -179.516 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.517 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 13.7 t-20 -81.91 146.5 55.94 Favored Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 120.975 -1.078 . . . . 0.0 109.646 -179.895 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.541 ' HD3' ' CB ' ' A' ' 23' ' ' LYS . 40.1 Cg_endo -63.43 -51.29 2.69 Favored 'Trans proline' 0 C--O 1.214 -0.709 0 C-N-CA 122.592 2.195 . . . . 0.0 111.304 179.474 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.517 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 8.8 t -60.62 -28.79 68.8 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 178.835 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.45 ' HB2' ' HB3' ' A' ' 35' ' ' ASN . 12.3 mtt -65.25 -12.7 54.18 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.202 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.812 HD13 ' CD1' ' A' ' 33' ' ' TYR . 51.0 tp -71.47 -58.07 3.85 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.294 -0.879 . . . . 0.0 108.726 179.569 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.465 ' O ' ' HG ' ' A' ' 44' ' ' LEU . 36.0 t -54.61 -24.75 22.67 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 179.048 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 35.1 t60 -68.52 -61.38 1.85 Allowed 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.293 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.438 ' HB2' ' CE2' ' A' ' 33' ' ' TYR . 72.3 mm-40 -56.08 -20.0 15.37 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.259 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.523 ' O ' ' N ' ' A' ' 47' ' ' GLN . 98.0 m-20 -78.61 -29.72 46.17 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.718 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.473 HD23 ' HA ' ' A' ' 44' ' ' LEU . 16.8 mt -68.95 -30.44 68.89 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.25 -0.906 . . . . 0.0 108.795 179.401 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -80.43 -47.33 21.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.346 -0.846 . . . . 0.0 109.355 179.715 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.445 ' O ' ' HB2' ' A' ' 47' ' ' GLN . 94.9 mtt-85 -79.73 -34.47 39.97 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.285 -0.885 . . . . 0.0 109.321 179.875 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.523 ' N ' ' O ' ' A' ' 43' ' ' ASN . 92.1 mt-30 62.15 39.65 12.63 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.362 -0.836 . . . . 0.0 109.518 -179.939 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.408 ' O ' ' C ' ' A' ' 49' ' ' ASN . 68.1 p -107.63 17.08 23.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.302 -0.874 . . . . 0.0 109.468 179.986 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.408 ' C ' ' O ' ' A' ' 48' ' ' THR . 57.4 m-20 44.15 60.0 2.96 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.174 -0.954 . . . . 0.0 109.285 -179.936 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.48 ' HB ' ' OD1' ' A' ' 43' ' ' ASN . 22.1 m -77.12 145.77 37.59 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.213 -0.929 . . . . 0.0 109.669 -179.742 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.411 ' CE1' ' HB2' ' A' ' 2' ' ' SER . 28.6 m-70 -118.49 173.8 6.62 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.281 -0.887 . . . . 0.0 109.137 179.565 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.453 HG13 ' OD1' ' A' ' 1' ' ' ASP . 9.4 mt -86.32 124.66 40.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.224 -0.922 . . . . 0.0 109.713 -179.966 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.508 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 21.0 ttt180 -79.51 -51.82 8.82 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-O 121.631 0.729 . . . . 0.0 109.389 179.959 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 57.8 m -159.76 140.15 11.97 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.507 -0.746 . . . . 0.0 109.122 -179.738 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.408 ' H ' HG23 ' A' ' 55' ' ' THR . 21.8 p -52.85 148.06 8.13 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.151 -0.968 . . . . 0.0 109.518 -179.861 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.544 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 88.64 164.95 40.8 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 -179.883 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.527 ' HG3' ' HB2' ' A' ' 24' ' ' PRO . 24.3 mttt -64.32 150.73 45.56 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.493 -1.004 . . . . 0.0 109.224 179.871 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.454 ' SG ' ' O ' ' A' ' 31' ' ' GLN . 86.5 m -55.98 -22.02 24.31 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.23 -0.919 . . . . 0.0 109.429 179.964 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.458 ' HG2' ' O ' ' A' ' 59' ' ' GLU . 48.2 tt0 -80.19 -14.68 58.26 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.267 -0.896 . . . . 0.0 109.617 -179.871 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.509 ' HG3' ' N ' ' A' ' 57' ' ' LYS . 3.5 mt-10 -87.12 -27.88 22.83 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.117 -0.989 . . . . 0.0 109.355 -179.982 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 6.3 m -64.65 -10.45 26.86 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.249 -0.907 . . . . 0.0 109.544 -179.87 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 24.7 m -133.79 131.56 39.45 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.269 -0.894 . . . . 0.0 109.405 179.952 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.433 ' OG1' ' HD2' ' A' ' 64' ' ' PRO . 1.1 t -54.98 151.33 16.37 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.192 -0.942 . . . . 0.0 109.511 179.969 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.433 ' HD2' ' OG1' ' A' ' 63' ' ' THR . 51.0 Cg_endo -71.07 143.53 44.8 Favored 'Trans proline' 0 C--O 1.215 -0.636 0 C-N-CA 122.735 2.29 . . . . 0.0 111.799 -179.983 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 88.04 -154.53 25.59 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.867 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 19.4 p -127.43 153.8 45.83 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.348 -1.09 . . . . 0.0 109.417 179.994 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 65.6 p -60.98 -26.28 67.45 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.296 -0.878 . . . . 0.0 109.574 -179.983 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.72 -32.09 68.88 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.27 -0.894 . . . . 0.0 109.465 179.936 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -61.85 -37.63 85.24 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.279 -0.888 . . . . 0.0 109.487 179.973 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 21.3 m -53.24 -35.42 59.95 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.221 -0.924 . . . . 0.0 109.519 179.998 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.521 ' CG ' ' HD2' ' A' ' 72' ' ' PRO . 4.8 ttt -65.14 141.3 98.23 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.295 -0.878 . . . . 0.0 109.461 179.893 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.521 ' HD2' ' CG ' ' A' ' 71' ' ' MET . 47.7 Cg_endo -68.75 139.99 45.42 Favored 'Trans proline' 0 C--O 1.215 -0.658 0 C-N-CA 122.641 2.228 . . . . 0.0 111.908 -179.95 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -70.37 172.82 12.5 Favored 'Trans proline' 0 C--O 1.215 -0.66 0 C-N-CA 122.767 2.312 . . . . 0.0 111.784 -179.876 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 23.5 m -89.29 -5.94 57.15 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.311 -0.868 . . . . 0.0 109.633 -179.921 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.436 ' O ' ' HB2' ' A' ' 76' ' ' GLU . 84.0 m-20 -82.18 -23.07 35.7 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.198 -0.939 . . . . 0.0 109.411 179.96 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.445 ' OXT' ' HG2' ' A' ' 76' ' ' GLU . 87.5 tt0 . . . . . 0 N--CA 1.489 1.492 0 CA-C-O 117.949 -1.024 . . . . 0.0 109.437 -179.982 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.429 ' OD1' ' HG2' ' A' ' 4' ' ' MET . 51.1 p30 . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 121.264 0.554 . . . . 0.0 109.595 . . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.572 ' HB2' ' CD2' ' A' ' 51' ' ' HIS . 1.2 m -52.71 -35.56 55.89 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.272 -0.893 . . . . 0.0 109.088 179.68 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -55.72 -26.76 46.95 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.485 -0.759 . . . . 0.0 109.177 179.871 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.429 ' HG2' ' OD1' ' A' ' 1' ' ' ASP . 66.4 mmm -70.75 -27.16 63.74 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.32 -0.863 . . . . 0.0 108.917 179.545 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.584 ' HA ' ' CD1' ' A' ' 8' ' ' TYR . 39.1 m -80.71 -16.12 54.74 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.539 -0.726 . . . . 0.0 109.367 179.744 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.429 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 60.5 mttt -80.8 9.14 6.73 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.262 -0.899 . . . . 0.0 109.861 179.95 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.429 ' OD1' ' O ' ' A' ' 6' ' ' LYS . 90.6 m-20 -135.35 3.99 3.13 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.874 -1.141 . . . . 0.0 110.551 -179.526 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.664 ' CE2' ' CE2' ' A' ' 16' ' ' TYR . 1.5 p90 -114.76 156.87 24.06 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.805 -1.184 . . . . 0.0 109.803 -179.996 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 62.7 mtm180 -137.15 133.01 34.78 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.331 -0.855 . . . . 0.0 109.462 179.82 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.78 HG13 ' O ' ' A' ' 15' ' ' GLY . 79.3 t -121.55 143.29 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.351 -0.843 . . . . 0.0 109.687 -179.78 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.558 ' CB ' ' HD2' ' A' ' 12' ' ' PRO . 1.8 mp -123.99 176.09 2.47 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.329 -0.857 . . . . 0.0 109.103 179.877 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.558 ' HD2' ' CB ' ' A' ' 11' ' ' LEU . 44.3 Cg_endo -67.19 -22.68 46.46 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 122.561 2.174 . . . . 0.0 111.759 179.873 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 71.5 mtt85 -102.94 -28.45 12.02 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.277 -0.889 . . . . 0.0 109.506 179.907 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.508 HD12 ' HB2' ' A' ' 11' ' ' LEU . 94.8 mt -82.79 -46.43 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.358 -0.839 . . . . 0.0 109.766 -179.731 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.78 ' O ' HG13 ' A' ' 10' ' ' VAL . . . 75.81 -169.99 54.7 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.391 -1.483 . . . . 0.0 109.391 -179.87 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.664 ' CE2' ' CE2' ' A' ' 8' ' ' TYR . 1.5 t80 -90.81 151.02 21.34 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.163 -1.198 . . . . 0.0 109.436 179.914 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.463 HD23 ' HA ' ' A' ' 17' ' ' LEU . 43.1 mt -120.26 126.16 49.91 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.269 -0.894 . . . . 0.0 109.721 -179.839 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.402 ' HB3' ' HB3' ' A' ' 37' ' ' CYS . 63.3 m -138.16 155.42 74.29 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.319 -0.863 . . . . 0.0 109.057 179.818 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.408 ' HD2' ' HB3' ' A' ' 37' ' ' CYS . 47.3 Cg_endo -70.02 165.06 32.54 Favored 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 122.583 2.189 . . . . 0.0 111.659 179.951 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 77.8 mttt -83.7 -21.71 32.27 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.338 -0.851 . . . . 0.0 109.433 -179.801 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -65.7 122.9 18.34 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.263 -0.898 . . . . 0.0 109.202 179.751 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.686 ' C ' HD13 ' A' ' 22' ' ' LEU . 3.5 tm? -89.68 108.33 19.61 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.18 -0.95 . . . . 0.0 109.338 -179.771 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.509 ' HB2' ' HD3' ' A' ' 36' ' ' PRO . 4.2 mtpm? -117.42 104.68 49.59 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.389 -0.819 . . . . 0.0 109.132 179.933 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.547 ' O ' ' CA ' ' A' ' 56' ' ' GLY . 42.3 Cg_endo -63.95 119.93 7.14 Favored 'Trans proline' 0 C--O 1.213 -0.739 0 C-N-CA 123.067 2.511 . . . . 0.0 112.502 -179.353 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.442 ' O ' HG23 ' A' ' 32' ' ' THR . 30.1 m -117.35 154.32 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.342 -0.849 . . . . 0.0 109.424 179.703 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 26' ' ' CYS . . . . . 0.425 ' O ' ' N ' ' A' ' 53' ' ' ARG . 43.3 t -98.82 118.21 35.05 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.328 -0.857 . . . . 0.0 109.077 179.622 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 31' ' ' GLN . . . -72.57 141.6 31.1 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 110.179 -1.169 . . . . 0.0 110.179 -179.405 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.522 ' HA ' ' HB2' ' A' ' 53' ' ' ARG . 54.5 p30 -69.98 -11.26 60.75 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.324 -1.103 . . . . 0.0 109.434 179.748 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.428 ' N ' ' OD1' ' A' ' 28' ' ' ASP . 91.5 m-20 -83.52 9.24 11.79 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.21 -0.931 . . . . 0.0 109.291 179.778 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.52 13.71 67.2 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 109.245 -1.542 . . . . 0.0 109.245 -179.908 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.493 ' O ' ' N ' ' A' ' 27' ' ' GLY . 91.8 mt-30 -118.35 170.78 8.62 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.302 -1.116 . . . . 0.0 109.481 179.98 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.553 HG23 ' HA ' ' A' ' 57' ' ' LYS . 56.7 m -129.4 138.94 51.77 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.353 -0.842 . . . . 0.0 109.333 -179.95 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.627 ' CD1' ' CD1' ' A' ' 39' ' ' LEU . 23.2 m-85 -118.38 121.88 41.45 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.304 -0.872 . . . . 0.0 108.93 179.643 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.545 ' O ' ' HA ' ' A' ' 24' ' ' PRO . 1.6 m-20 -47.8 -78.47 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.355 -0.841 . . . . 0.0 109.557 -179.361 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.531 ' OD1' ' N ' ' A' ' 37' ' ' CYS . 9.6 t-20 -82.36 146.32 53.9 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.019 -1.05 . . . . 0.0 109.788 -179.706 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.509 ' HD3' ' HB2' ' A' ' 23' ' ' LYS . 40.9 Cg_endo -63.67 -51.63 2.33 Favored 'Trans proline' 0 C--O 1.215 -0.667 0 C-N-CA 122.706 2.271 . . . . 0.0 111.627 179.789 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.531 ' N ' ' OD1' ' A' ' 35' ' ' ASN . 9.2 t -62.51 -26.09 68.37 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 178.842 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . 0.46 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 41.6 mmm -67.37 -17.37 64.71 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.31 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.627 ' CD1' ' CD1' ' A' ' 33' ' ' TYR . 10.6 tp -70.18 -59.95 2.58 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.305 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.471 ' HB3' ' OH ' ' A' ' 16' ' ' TYR . 16.6 t -54.02 -25.62 22.15 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 178.803 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 72.9 t60 -65.19 -62.12 1.73 Allowed 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 179.096 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.405 ' OE1' ' CE2' ' A' ' 33' ' ' TYR . 82.3 mt-10 -57.46 -19.34 23.53 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 179.002 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.523 ' O ' ' N ' ' A' ' 47' ' ' GLN . 98.9 m-20 -79.72 -26.55 40.8 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.395 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 40.4 tp -72.98 -31.8 64.77 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.412 -0.805 . . . . 0.0 108.912 179.577 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 8.7 mm -80.04 -49.57 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.347 -0.846 . . . . 0.0 109.097 179.629 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.564 ' HB3' HG23 ' A' ' 48' ' ' THR . 53.3 mtt-85 -80.9 -34.27 33.62 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.294 -0.879 . . . . 0.0 109.246 179.832 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.523 ' N ' ' O ' ' A' ' 43' ' ' ASN . 92.9 mt-30 63.12 39.95 9.46 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.529 -0.732 . . . . 0.0 109.489 -179.887 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.564 HG23 ' HB3' ' A' ' 46' ' ' ARG . 41.7 p -97.26 2.15 50.49 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.243 -0.91 . . . . 0.0 109.534 179.826 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.456 ' O ' ' CE1' ' A' ' 51' ' ' HIS . 70.4 m-20 55.5 56.23 6.49 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.175 -0.953 . . . . 0.0 109.623 179.989 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 55.7 m -79.72 143.06 34.89 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.174 -0.954 . . . . 0.0 109.674 -179.929 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 51' ' ' HIS . . . . . 0.572 ' CD2' ' HB2' ' A' ' 2' ' ' SER . 26.2 m80 -114.25 172.53 6.95 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.269 -0.894 . . . . 0.0 109.054 179.668 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 19.6 mt -85.74 124.38 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.131 -0.981 . . . . 0.0 109.706 -179.919 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.522 ' HB2' ' HA ' ' A' ' 28' ' ' ASP . 31.5 ttt-85 -79.77 -56.68 4.1 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.546 -0.721 . . . . 0.0 109.272 179.81 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -152.34 148.8 27.93 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.545 -0.722 . . . . 0.0 109.162 179.91 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 33.6 p -59.02 151.88 21.13 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.164 -0.96 . . . . 0.0 109.302 -179.963 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.547 ' CA ' ' O ' ' A' ' 24' ' ' PRO . . . 85.5 166.51 42.06 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 108.955 -1.658 . . . . 0.0 108.955 -179.577 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.553 ' HA ' HG23 ' A' ' 32' ' ' THR . 88.6 mttt -66.35 166.67 11.81 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.296 -1.12 . . . . 0.0 109.443 -179.98 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.454 ' SG ' ' O ' ' A' ' 31' ' ' GLN . 85.9 m -72.92 -17.58 61.49 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.294 -0.879 . . . . 0.0 108.955 179.789 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.433 ' HG2' ' O ' ' A' ' 59' ' ' GLU . 56.3 tt0 -79.83 -18.31 51.15 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.482 -0.761 . . . . 0.0 109.43 -179.826 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.473 ' HG3' ' O ' ' A' ' 57' ' ' LYS . 6.7 mt-10 -70.34 -36.61 74.34 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.27 -0.894 . . . . 0.0 109.002 179.731 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 96.8 p -62.64 -15.2 50.83 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.388 -0.82 . . . . 0.0 109.289 179.778 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 23.1 t -121.53 156.31 33.11 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.263 -0.898 . . . . 0.0 109.434 -179.916 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.548 HG23 ' O ' ' A' ' 63' ' ' THR . 2.7 t -132.78 84.74 49.03 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.225 -0.922 . . . . 0.0 109.468 -179.977 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.528 ' HB2' ' HB3' ' A' ' 68' ' ' ALA . 50.3 Cg_endo -71.17 145.48 49.21 Favored 'Trans proline' 0 C--O 1.215 -0.635 0 C-N-CA 122.671 2.247 . . . . 0.0 111.727 179.877 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -78.77 -179.67 51.71 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -179.9 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 70.9 m -64.39 -29.47 70.53 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.241 -1.152 . . . . 0.0 109.55 -179.972 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 72.9 p -67.48 -27.81 67.33 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.197 -0.94 . . . . 0.0 109.392 179.941 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.528 ' HB3' ' HB2' ' A' ' 64' ' ' PRO . . . -62.38 -31.5 72.18 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.201 -0.937 . . . . 0.0 109.454 179.95 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -67.34 -32.21 73.0 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.176 -0.952 . . . . 0.0 109.475 179.923 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 25.3 m -54.41 -30.62 52.86 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.316 -0.865 . . . . 0.0 109.42 -179.931 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.44 ' HB3' ' HD2' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -116.28 166.66 12.01 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.335 -0.853 . . . . 0.0 109.443 179.947 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.44 ' HD2' ' HB3' ' A' ' 71' ' ' MET . 48.8 Cg_endo -70.2 150.7 65.95 Favored 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 122.687 2.258 . . . . 0.0 111.733 -179.965 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -70.2 158.51 56.16 Favored 'Trans proline' 0 C--O 1.215 -0.651 0 C-N-CA 122.661 2.24 . . . . 0.0 111.695 179.954 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 29.6 m -134.92 143.8 47.13 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.213 -0.929 . . . . 0.0 109.474 -179.983 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -57.51 -32.89 67.47 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.314 -0.866 . . . . 0.0 109.494 179.974 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.47 179.968 . . . . . . . . 0 0 . 1 stop_ save_